The search: NTP in the database(s) CHRIS 2000, ERG2000, HSDB (through 2003/06), IRIS (through 2003/06), NIOSH Pocket Guide (NPG) (2003), OHMTADS (Final version), RTECS (through 2003/06), TSCA (through 2003/02), SERFILE 2003 returned 1119 records Record 601 of 1119 in RTECS (through 2003/06) AN: DS2200000 PN: Beryllium-aluminum-alloy- SY: Aluminium-alloy,-Al,Be-; Aluminum-alloy,-Al,Be- (9CI); Aluminum-beryllium-alloy-; Beryllium-aluminium-alloy- RN: Current: 12770-50-2 UD: 200012 CC: Tumorigen (C) TE: V03-J60-P62 itr-rat TDLo: 13 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 21, p. 63, 1980 (ENVRAL) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.002 mg(Be)/m3, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.003 mg(Be)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWEDEN: NGV 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 602 of 1119 in RTECS (through 2003/06) AN: DS2625000 PN: Beryllium-chloride- SY: Beryllium-dichloride- RN: Current: 7787-47-5 UD: 200302 MF: Be-Cl2 MW: 79.91 WL: BE G2 CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-hmn 0.25%/12H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 97, 1988 (VCVN1*) ME: mmo-esc 10 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 126, p. 9, 1984 (MUREAV); dnr-bcs 750 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 264, p. 163, 1991 (MUREAV); sce-ham-lng 31 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 264, p. 163, 1991 (MUREAV); msc-ham-lng 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 259, 1979 (MUREAV) RE: T34-T59 itr-rat TDLo: 1685 ug/kg (3D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(8), p. 44, 1986 (GISAAA); T24-T59 itr-rat TDLo: 1685 ug/kg (5D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(8), p. 44, 1986 (GISAAA) TE: V03-J60 ihl-rat TCLo: 20 ug/m3/1H/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(7), p. 34, 1975 (GTPZAB) ORNG: 86000000 ng/kg. [86.000000 mg/kg] T/E unlistd AT: T/E unlistd ipr-rat LD50: 5320 ug/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 9, p. 264, 1950 (FEPRA7); T/E unlistd ipr-mus LD50: 11987 ug/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 256, p. 1043, 1963 (COREAF); T/E unlistd ipr-gpg LD50: 50 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd orl-mus LD50: 92 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 93, 1988 (VCVN1*); T/E unlistd orl-rat LD50: 86 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 93, 1988 (VCVN1*); D25-J30-U25 ihl-hmn TCLo: 1 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*) MD: J13-J30-Z01 ihl-rat TCLo: 0.02 mg(Be)/m3/1H/16W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); J61-Z01 ihl-rat TCLo: 0.02 mg(Be)/m3/1H/78W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 6, p. 497, 1973 (CTOXAO) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-INDIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.002 mg(Be)/m3, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.003 mg(Be)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWEDEN: NGV 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA GENETOX PROGRAM 1988, Negative: B subtilis rec assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 603 of 1119 in RTECS (through 2003/06) AN: DS2800000 PN: Beryllium-fluoride- SY: Beryllium-difluoride- RN: Current: 7787-49-7 Previous: 12323-05-6 UD: 200302 MF: Be-F2 MW: 47.01 WL: BE F2 CC: Tumorigen (C) TE: V03-J60 ihl-rat TCLo: 20 ug/m3/1H/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(7), p. 34, 1975 (GTPZAB); V03-J60 ihl-rat TC :49 ug/m3/26W Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 2, p. 203, 1961 (PEXTAR) ORNG: 98000000 ng/kg. [98.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 98 mg/kg U.S. Atomic Energy Commission, University of Rochester, Research and Development Reports. (Rochester, NY) UR-154, 1951 (XEURAQ); T/E unlistd orl-mus LD50: 100 mg/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd scu-mus LD50: 20 mg/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd ivn-mus LD50: 1800 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd ipr-ham LD50: 21 mg/kg U.S. Atomic Energy Commission, University of Rochester, Research and Development Reports. (Rochester, NY) UR-154, 1951 (XEURAQ) MD: Z01 ihl-rat TCLo: 1 mg/m3/6H/30W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 493, 1953 (AMIHBC); U01-Z01 ihl-mus TCLo: 10 mg/m3/6H/15D-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 493, 1953 (AMIHBC); J30-P30-Z01 ihl-dog TCLo: 1 mg/m3/6H/30W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 493, 1953 (AMIHBC); U01 ihl-cat TCLo: 10 mg/m3/6H/30W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 493, 1953 (AMIHBC); M16-P30 ihl-rbt TCLo: 1 mg/m3/6H/30W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 493, 1953 (AMIHBC); U01-Z01 ihl-gpg TCLo: 10 mg/m3/6H/30W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 493, 1953 (AMIHBC); Z01 ihl-mam TCLo: 1.1 mg/m3/6H/8D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P05-Z01 ihl-rbt TCLo: 2.2 mg/m3/23W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); J13-J30-Z01 ihl-rat TCLo: 0.4 mg(Be)/m3/1H/16W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); J61-Z01 ihl-rat TCLo: 0.4 mg(Be)/m3/1H/78W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-TWA 2.5 mg(F)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 6, p. 497, 1973 (CTOXAO); TOXICOLOGY REVIEW AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 1, 1953 (AMIHBC) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Gen Indu): 8H TWA 2.5 mg(F)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 2.5 mg(F)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 2.5 mg(F)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 2.5 mg(F)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRALIA: TWA 2.5 mg(F)/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-AUSTRIA: MAK 2.5 mg(F)/m3, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-BELGIUM: TWA 2.5 mg(F)/m3, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-DENMARK: TWA 2.5 mg(F)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FINLAND: TWA 2.5 mg(F)/m3, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen, JAN 1999; OEL-FRANCE: VME 2.5 mg(F)/m3, JAN 1999; OEL-GERMANY: MAK 2.5 mg(F)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-HUNGARY: TWA 1 mg(F)/m3, STEL 2 mg(F)/m3, JAN 1993; OEL-INDIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.002 mg(Be)/m3, 2A Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-K 3.5 mg(F)/m3, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-NORWAY: TWA 0.6 mg(F)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-THE PHILIPPINES: TWA 2.5 mg(F)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.002 mg(Be)/m3, JAN 1999; OEL-POLAND: MAC(TWA) 1 mg(HF)/m3, MAC(STEL) 3 mg(HF)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWEDEN: NGV 2 mg(F)/m3, JAN 1999; OEL-SWEDEN: NGV 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 1.8 ppm (1.5 mg(F)/m3), KZG-W 1.8 ppm (3.0 mg(F)/m3), JAN 1999; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-THAILAND: TWA 2.5 mg(F)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 2.5 mg(F)/m3, JAN 1993; OEL-UNITED KINGDOM: LTEL 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: LTEL 2.5 mg(F)/m3, JAN 1993; OEL-UNITED KINGDOM: LTEL 2.5 mg(F)/m3, JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, Carcinogen, SEP 2000; OEL-UNITED KINGDOM: TWA 2.5 mg(F)/m3, SEP 2000 ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 604 of 1119 in RTECS (through 2003/06) AN: DS2975000 PN: Beryllium-hydrogen-phosphate- (1:1) SY: Beryllium-phosphate- (BeHPO4); Phosphoric-acid,-beryllium-salt- (1:1); Phosphorous-acid,-beryllium-salt- RN: Current: 13598-15-7 UD: 200012 MF: Be-H-O4-P MW: 104.99 WL: BE3 P-O4*2 CC: Tumorigen (C) TE: V03-J60 ihl-rat TCLo: 3571 ug/m3/17W Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 2, p. 203, 1961 (PEXTAR); V03-J60 ihl-mky TDLo: 900 ug/kg/17W Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 2, p. 203, 1961 (PEXTAR); V03-J60 ihl-mky TC :97 mg/m3/8D-I Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 33, p. 1, 1964 (IMSUAI) AT: T/E unlistd ivn-mus LD50: 16 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 24, p. 497, 1973 (TXAPA9) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 1, p. 17, 1972 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-INDIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.002 mg(Be)/m3, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.003 mg(Be)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWEDEN: NGV 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 605 of 1119 in RTECS (through 2003/06) AN: DS3150000 PN: Beryllium-hydroxide- SY: Beryllium-dihydroxide-; Beryllium-hydrate- RN: Current: 13327-32-7 Previous: 1304-49-0 UD: 200012 MF: H2-O2.Be MW: 43.03 WL: BE Q2 CC: Tumorigen (C) TE: V03-J60 itr-rat TDLo: 1125 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 17, p. 299, 1970 (TXAPA9); V03-J60-J61 itr-rat TD :1785 ug/kg/43W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 21, p. 63, 1980 (ENVRAL) AT: T/E unlistd ivn-rat LDLo: 3821 ug/kg U.S. Atomic Energy Commission, University of Rochester, Research and Development Reports. (Rochester, NY) UR-70, 1949 (XEURAQ) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-INDIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.002 mg(Be)/m3, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.003 mg(Be)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, Carcinogen, SEP 2000; OEL-UNITED KINGDOM: TWA 5 mg(Mn)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 606 of 1119 in RTECS (through 2003/06) AN: DS4025000 PN: Beryllium-oxide- SY: Beryllia-; Beryllium-monoxide-; Thermalox- RN: Current: 1304-56-9 UD: 200302 MF: Be-O MW: 25.01 WL: BE O CC: Tumorigen (C); Mutagen (M); Human-Data (P); Reproductive-Effector (T) RE: T24-T34-T59 itr-rat TDLo: 139 mg/kg (3D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(8), p. 44, 1986 (GISAAA) TE: V03-J60 ihl-rat TCLo: 28 mg/m3/17W-C Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 40, p. 23, 1971 (IMSUAI); V03-J60 itr-rat TDLo: 75 mg/kg/15W-I Fukuoka Igaku Zasshi. (c/o Kyushu Daigaku Igakubu, Tatekasu, Fukuoka-shi, Fukuoka, Japan) V.33- 1940- v. 71, p. 19, 1980 (FKIZA4); V03-J60-Q60 ihl-rbt TCLo: 17 mg/m3/5H/48W-I AMA Archives of Pathology. (Chicago, IL) V.50(4)-69, 1950-60. For publisher information, see APLMAS. v. 51, p. 473, 1951 (AMPLAO); V03-Q60 ivn-rbt TDLo: 500 mg/kg/6W-I Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 5, p. 221, 1946 (FEPRA7); V03-J60-Q60 imp-rbt TDLo: 10 mg/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 88, p. 89, 1969 (ARPAAQ); V03-J60-Q60 ivn-rbt TD :500 mg/kg/48W-I Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 2, p. 203, 1961 (PEXTAR); V03-J16-Y20 itr-rat TD :169 mg/kg/2W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 19, p. 190, 1959 (AMIHAB); V03-Q60 ivn-rbt TD :625 mg/kg/25W-I Acta Morphologica Academiae Scientiarum Hungaricae. (Budapest, Hungary) V.1-30, 1951-82. v. 25, p. 99, 1977 (AMSHAR); V03-J60 itr-rat TD :79 mg/kg/15W-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 20, p. 230, 1978 (SAIGBL) AT: T/E unlistd orl-mus LD50: 2062 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 93, 1988 (VCVN1*); J30-J61-U01 itr-rat TDLo: 5 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 94, 1988 (VCVN1*); J30-S20 ihl-mam TCLo: 0.2 mg/m3/1H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 94, 1988 (VCVN1*); D25-J30-U25 ihl-hmn TCLo: 0.67 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*) MD: J13-L02-Z01 ihl-rat TCLo: 2 mg/m3/110D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 1, p. 17, 1972 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 6, p. 497, 1973 (CTOXAO); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-INDIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.002 mg(Be)/m3, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.003 mg(Be)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWEDEN: NGV 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X3577; NIS 6; TNF 66; NOS 9; TNE 4305; TFE 849 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 607 of 1119 in RTECS (through 2003/06) AN: DS4800000 PN: Beryllium-sulfate- (1:1) SY: Beryllium-sulfate- (6CI,7CI); Beryllium-sulphate-; Sulfuric-acid,-beryllium-salt- (1:1) RN: Current: 13510-49-1 UD: 200302 MF: O4-S.Be MW: 105.07 WL: BE S-O4 CC: Tumorigen (C); Mutagen (M); Human-Data (P) ME: dnr-bcs 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 109, 1980 (MUREAV); mtr-rat-emb 60 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); cyt-rat-orl 910 ug/kg/26W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 54(8), p. 73, 1989 (GISAAA); mtr-mus-fbr 200 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dns-mus-lym 5 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 30, p. 89, 1986 (TOLED5); dns-mus-oth 3 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 56, p. 207, 1985 (ARTODN); mtr-ham-emb 560 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 193, 1979 (CNREA8) TE: V03-J60 ihl-rat TCLo: 432 ug/m3/26W Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 2, p. 203, 1961 (PEXTAR); V03-J60 itr-rat TDLo: 17 mg/kg/2W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 19, p. 190, 1959 (AMIHAB); V01-J60 ipr-mus TDLo: 48 mg/kg/8W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 217, 1990 (MUREAV); V03-J60 ihl-rat TC :643 ug/m3/39W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 19, p. 190, 1959 (AMIHAB) ORNG: 82000000 ng/kg. [82.000000 mg/kg] T/E unlistd AT: T/E unlistd ihl-rat LCLo: 10 mg/m3 Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd ipr-rat LDLo: 18 mg/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd scu-rat LD50: 1500 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd ivn-rat LD50: 7200 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd itr-rat LDLo: 10 mg/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd ihl-mus LCLo: 47 mg/m3 Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd ipr-mus LD50: 1200 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); T/E unlistd scu-mus LD50: 1500 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd ivn-dog LDLo: 600 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd itr-dog LDLo: 1000 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd ivn-mky LDLo: 600 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd itr-mky LDLo: 1000 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd ihl-cat LCLo: 10 mg/m3 Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd ihl-rbt LCLo: 10 mg/m3 Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd scu-rbt LD50: 1500 ug/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 2173, p. 23, 1972 (XPHPAW); T/E unlistd ihl-gpg LC50: 47 mg/m3 Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd ipr-gpg LDLo: 100 mg/kg National Institutes of Health, Bulletin. (Bethesda, MD) v. 181, p. 1, 1943 (NIHBAZ); T/E unlistd orl-mus LD50: 80 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 93, 1988 (VCVN1*); T/E unlistd orl-rat LD50: 82 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 93, 1988 (VCVN1*); T/E unlistd ivn-mus LD50: 0.265 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 93, 1988 (VCVN1*); H30-L30-M30 ims-rat TDLo: 4.5 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 93, 1988 (VCVN1*); D25-J30-U25 ihl-hmn TCLo: 0.67 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*) MD: P30-Y03 orl-rat TDLo: 2682 mg/kg/52W-C Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 22, p. 335, 1988 (CHYCDW); Z01 ihl-mam TCLo: 1.1 mg/m3/6H/8D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P26-P71-Z01 ihl-rat TCLo: 10 mg/m3/6H/95D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P26-P71-Z01 ihl-mus TCLo: 50 mg(Be)/m3/6H/95D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P26-P71-Z01 ihl-dog TCLo: 50 mg(Be)/m3/6H/95D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P26-P71-Z01 ihl-cat TCLo: 50 mg(Be)/m3/6H/95D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P26-P71-Z01 ihl-gpg TCLo: 50 mg(Be)/m3/6H/95D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P26-P71-Z01 ihl-mky TCLo: 50 mg(Be)/m3/6H/95D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P26-P71-Z01 ihl-dom TCLo: 50 mg(Be)/m3/6H/95D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*); P26-P71-Z01 ihl-pig TCLo: 50 mg(Be)/m3/6H/95D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 95, 1988 (VCVN1*) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 6, p. 497, 1973 (CTOXAO); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-INDIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.002 mg(Be)/m3, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.003 mg(Be)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWEDEN: NGV 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X9972; NIS 3; TNF 30; NOS 4; TNE 120 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, B subtilis rec assay; EPA GENETOX PROGRAM 1988, Positive/dose response: Cell transform.-BALB/c-3T3; EPA GENETOX PROGRAM 1988, Negative: Host-mediated assay, In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 608 of 1119 in RTECS (through 2003/06) AN: DS5000000 PN: Beryllium-sulfate,-tetrahydrate- (1:1:4) SY: Beryllium-sulphate-tetrahydrate-; Sulfuric acid, beryllium salt (1:1), tetrahydrate RN: Current: 7787-56-6 UD: 200012 MF: O4-S.Be.4 H2-O MW: 177.15 WL: BE S-O4 &QH 4 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 3300 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); cyt-hmn-lym 5 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 597, 1981 (ENMUDM); sce-hmn-lym 1 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 597, 1981 (ENMUDM); oms-rat-par 30 umol/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 26, p. 48, 1973 (AEHLAU); mtr-ham-emb 312 ug/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); cyt-ham-emb 5 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 597, 1981 (ENMUDM); sce-ham-emb 1 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 597, 1981 (ENMUDM) TE: V01-J60 ihl-rat TCLo: 668 ug/m3/40W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 27, p. 439, 1967 (CNREA8) AT: T/E unlistd ivn-rat LD50: 3850 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 344, 1986 (TXAPA9); T/E unlistd ipr-mus LD50: 41 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 63, p. 461, 1982 (TXAPA9); T/E unlistd ivn-mus LD50: 4971 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 24, p. 497, 1973 (TXAPA9); F16-R21 scu-ckn LD50: 2500 ug/kg Archiv fuer Gefluegelkunde. (Verlag Eugen Ulmer, Postfach 700561, D-7000 Stuttgart 70, Fed. Rep. Ger.) V.1- 1927- v. 42, p. 225, 1978 (AGEFAB); F16-R21 ivn-ckn LD50: 470 ug/kg Archiv fuer Gefluegelkunde. (Verlag Eugen Ulmer, Postfach 700561, D-7000 Stuttgart 70, Fed. Rep. Ger.) V.1- 1927- v. 42, p. 225, 1978 (AGEFAB) MD: J16-M03-Z01 ihl-rat TCLo: 90 mg/m3/6H/2W-I U.S. Atomic Energy Commission, AECD Reports. (U.S. Atomic Energy Commission, Technical Information Division, AEC, Oak Ridge, Tenn.) AECD-2102, 1948 (XETIAS); F33-L30-Z01 ihl-mus TCLo: 90 mg/m3/6H/2W-I U.S. Atomic Energy Commission, AECD Reports. (U.S. Atomic Energy Commission, Technical Information Division, AEC, Oak Ridge, Tenn.) AECD-2102, 1948 (XETIAS); D26-P72-R02 ihl-dog TCLo: 90 mg/m3/6H/2W-I U.S. Atomic Energy Commission, AECD Reports. (U.S. Atomic Energy Commission, Technical Information Division, AEC, Oak Ridge, Tenn.) AECD-2102, 1948 (XETIAS); J16-M03-P72 ihl-rbt TCLo: 90 mg/m3/6H/2W-I U.S. Atomic Energy Commission, AECD Reports. (U.S. Atomic Energy Commission, Technical Information Division, AEC, Oak Ridge, Tenn.) AECD-2102, 1948 (XETIAS); D25 ihl-gpg TCLo: 90 mg/m3/6H/2W-I U.S. Atomic Energy Commission, AECD Reports. (U.S. Atomic Energy Commission, Technical Information Division, AEC, Oak Ridge, Tenn.) AECD-2102, 1948 (XETIAS); J16-P01-Z01 ihl-ham TCLo: 90 mg/m3/6H/2W-I U.S. Atomic Energy Commission, AECD Reports. (U.S. Atomic Energy Commission, Technical Information Division, AEC, Oak Ridge, Tenn.) AECD-2102, 1948 (XETIAS) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 1, p. 17, 1972 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-INDIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.002 mg(Be)/m3, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.003 mg(Be)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWEDEN: NGV 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X6326; NIS 1; TNF 7; NOS 2; TNE 1822; TFE 230 SL: EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 609 of 1119 in RTECS (through 2003/06) AN: DU8850000 PN: 2-Biphenylamine- SY: 2-Aminobifenyl- (Czech); o-Aminobiphenyl-; 2-Aminobiphenyl-; o-Aminodiphenyl-; 2-Aminodiphenyl-; o-Biphenylamine-; (1,1'-Biphenyl)-2-amine (9CI); o-Phenylaniline-; 2-Phenylaniline- RN: Current: 90-41-5 BRN: 471874 BHR: 4-12-00-03223 UD: 200006 MF: C12-H11-N MW: 169.24 WL: ZR BR CC: Mutagen (M) ME: mmo-sat 33 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-sat 4 ug/plate (-S9) British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); pic-esc 250 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 532, 1981 (CNREA8); dnd-rat-lvr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 69, 1987 (MUREAV); mtr-mus-emb 10 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 52, p. 1167, 1974 (JNCIAM); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); oms-ham-ovr 800 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 45, 1992 (MUREAV); cyt-ham-ovr 1100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 45, 1992 (MUREAV) ORNG: 2340000000 ng/kg. [2340.000000 mg/kg] F24-J22-U01 AT: F24-J22-U01 orl-rat LD50: 2340 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 29, p. 1, 1947 (JIHTAB); F07-F17-J25 orl-mus LDLo: 10 gm/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-233, 1982 (NTPTR*); F24-J22-U01 orl-rbt LD50: 1020 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 29, p. 1, 1947 (JIHTAB) MD: M03-P27-P72 orl-rat TDLo: 137 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-233, 1982 (NTPTR*); P27 orl-rat TDLo: 7 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-233, 1982 (NTPTR*); L30-P26-P27 orl-mus TDLo: 10920 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-233, 1982 (NTPTR*); P01-P27-U01 orl-mus TDLo: 50400 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-233, 1982 (NTPTR*) ND: NOHS 1974: HZD 82091; NIS 1; TNF 28; NOS 2; TNE 700 SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-mouse embryo; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Body fluid assay, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-RLV F344 rat embryo, Host-mediated assay; EPA GENETOX PROGRAM 1988, Negative: E coli polA with S9, In vitro UDS in rat liver; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat, E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 Record 610 of 1119 in RTECS (through 2003/06) AN: DU8925000 PN: 4-Biphenylamine- SY: (1,1'-Biphenyl)-4-amine; 4-Aminobifenyl- (Czech); 4-Aminobiphenyl-; 4-Aminodifenil- (Spanish); 4-Aminodiphenyl-; 4-Aminodiphenyl- (ACGIH:OSHA); 4-Bifenylamin- (Czech); Biphenylamine-; Paraaminodiphenyl-; Xenylamin- (Czech); Xenylamine-; p-Aminobiphenyl-; p-Aminodiphenyl-; p-Biphenylamine-; p-Phenylaniline- RN: Current: 92-67-1 BRN: 386533 BHR: 4-12-00-03241 UD: 200305 MF: C12-H11-N MW: 169.24 WL: ZR DR CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 2 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-esc 900 ug/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 682, 1979 (CNREA8); dnr-esc 250 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); dna-esc 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 25 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 532, 1981 (CNREA8); dnr-bcs 200 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); slt-dmg-orl 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 169, 1990 (MUREAV); mrc-smc 2 pph JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 901, 1979 (JJIND8); dns-hmn-lvr 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 91, 1988 (MUREAV); dns-hmn-fbr 800 ug/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 21, p. 151, 1981 (TXCYAC); msc-hmn-fbr 60 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 121, p. 71, 1983 (MUREAV); mtr-rat-orl 100 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 1157, 1980 (CNREA8); mtr-rat-emb 10 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 799, 1973 (JNCIAM); dnd-rat-lvr 30 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); dns-rat-orl 200 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 474, 1984 (ENMUDM); dns-rat-lvr 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 216, p. 101, 1989 (MUREAV); bfa-rat-sat 250 umol/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 16, p. 113, 1980 (TXCYAC); cyt-rat-ipr 10 mg/kg/72H Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 23, p. 36, 1980 (NULSAK); hma-rat-sat 1 mmol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 317, 1982 (MUREAV); mnt-mus-ipr 28 mg/kg/24H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 216, p. 321, 1989 (MUREAV); mnt-mus-orl 50 mg/kg/48H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); mtr-mus-emb 10 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 52, p. 1167, 1974 (JNCIAM); dns-mus-orl 200 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 474, 1984 (ENMUDM); oms-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 268, p. 255, 1992 (MUREAV); oms-mus-lym 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 69, 1994 (MUREAV); cyt-mus-ipr 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 268, p. 255, 1992 (MUREAV); cyt-mus-lym 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 69, 1994 (MUREAV); msc-mus-lym 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 291, 1984 (MUREAV); msc-mus-orl 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 400, p. 245, 1998 (MUREAV); hma-mus-esc 67 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 161, 1992 (MUREAV); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-ham-emb 5 mg/L National Cancer Institute, Monograph. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1959- v. 58, p. 243, 1981 (NCIMAV); dnd-ham-lng 300 umol/L/2H Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 732, 1976 (BBRCA9); sce-ham-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); sce-ham-orl 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); msc-ham-lng 5 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5194, 1983 (CNREA8); dna-dog-orl 5 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 6336, 1988 (CNREA8); bfa-dog-sat 10 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 1757, 1977 (CNREA8); dns-rbt-lvr 500 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 3120, 1983 (CNREA8); mmo-sat 3 ug/plate (+S9) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 56, p. 351, 2000 (TOSCF2); mmo-sat 10 ug/plate/20M (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 515, p. 15, 2002 (MUREAV); mmo-sat 1 nmol/plate/20M Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 38, p. 268, 2001 (EMMUEG); dnd-hmn-oth 60 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 38, p. 1, 2001 (EMMUEG); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG); slt-ham-ovr 5 mg/L/9D Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 16, p. 260, 1990 (EMMUEG) TE: V03-R60 orl-rat TDLo: 5 gm/kg/52W-C Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 12, p. 270, 1962 (ARZNAD); V03-L60-M61 scu-rat TDLo: 4560 mg/kg/44W-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 175, p. 1131, 1955 (NATUAS); V03-L60-M60 orl-mus TDLo: 1520 mg/kg/39W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 19, p. 297, 1965 (BJCAAI); V01-L60 scu-mus TDLo: 216 mg/kg/3D-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 41, p. 403, 1968 (JNCIAM); V03-K60-L60 scu-rat TD :5000 mg/kg/1W-I British Medical Bulletin. (Longman Group UK Ltd., Longman House, Burnt Mill, Harlow, Essex CM20 2JE, UK) V.1- 1943- v. 14, p. 141, 1958 (BMBUAQ); V03-J60-M60 orl-dog TD :5580 mg/kg/4Y-I Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 15, p. 3, 1968 (NEOLA4); V03-M60 orl-dog TD :8200 mg/kg/90W-I JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 172, p. 1611, 1960 (JAMAAP); V03-M60 orl-dog TD :8200 mg/kg/2Y-I Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 27, p. 25, 1958 (IMSUAI); V03-M60 orl-dog TD :9600 mg/kg/3Y-I Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 27, p. 25, 1958 (IMSUAI); V03-M60 orl-dog TD :8400 mg/kg/2Y-I Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 27, p. 25, 1958 (IMSUAI); V03-M60 orl-dog TD :14 gm/kg/3Y-I Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 27, p. 25, 1958 (IMSUAI); V01-M60-P60 orl-mus TD :5460 ug/kg European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 21, p. 865, 1985 (EJCODS); V01-L60 ipr-mus TDLo: 85 ug/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 185, p. 13, 2002 (CALEDQ) ORNG: 500000000 ng/kg. [500.000000 mg/kg] F24-J22-U01 AT: F24-J22-U01 orl-rat LD50: 500 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 29, p. 1, 1947 (JIHTAB); T/E unlistd orl-mus LD50: 205 mg/kg European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 21, p. 865, 1985 (EJCODS); F12-F19-J22 ipr-mus LDLo: 250 mg/kg "Summary Tables of Biological Tests," National Research Council Chemical-Biological Coordination Center. (National Academy of Science Library, 2101 Constitution Ave., NW, Washington, DC 20418) v. 6, p. 54, 1954 (CBCCT*); P24 orl-dog LDLo: 25 mg/kg Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 167, p. 992, 1970 (SCIEAS); F24-J22-U01 orl-rbt LD50: 690 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 29, p. 1, 1947 (JIHTAB) TR: ACGIH TLV-Confirmed Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 1, p. 74, 1972 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 1, p. 74, 1972 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 28, p. 151, 1982 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 91, 1987 (IMSUDL); TOXICOLOGY REVIEW Khimiya i Zhizn. Chemistry and Life. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1965- v. 12(2), p. 85, 1976 (KHZHAZ); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 13, p. 271, 1970 (ADCSAJ); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 253, 1983 (BLFSBY) SR: MSHA STANDARD: skin-HUMAN CARCINOGEN, NO ASSIGNED TWA The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 10, 1971 (DTLVS*); OSHA PEL (Gen Indu): see CFR 29,1910.1011 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): see CFR 29,1926.1111 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): see CFR 29,1915.1011 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA-cancer suspect agent Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1011, 1987 (CFRGBR); OEL-AUSTRALIA: Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FINLAND: TWA 10 mg/m3, STEL 20 mg/m3, Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.001 ppm (0.007 mg/m3), C1 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.1 mg/m3, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: Skin, Carcinogen, JAN 1999; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 4-AMINODIPHENYL-air: CA use 29 CFR 1910.1011 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA GENETOX PROGRAM 1988, Positive: Body fluid assay, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay, Cell transform.-mouse embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: E coli polA with S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS in rat liver, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #93 Record 611 of 1119 in RTECS (through 2003/06) AN: DU9649000 PN: 2-Biphenylamine,-hydrochloride- SY: 2-Biphenylamine-hydrochloride-; NCI-C50282- RN: Current: 2185-92-4 UD: 200302 MF: C12-H11-N.Cl-H MW: 205.70 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 10 ug/plate (-S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); mmo-mus-lym 110 mg/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); cyt-ham-ovr 200 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V01-H60 orl-mus TDLo: 260 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-233, 1982 (NTPTR*); V01-H60 orl-mus TD :262 gm/kg/2Y-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 2, p. 201, 1982 (FAATDF); V03-P60 orl-mus TDLo: 259560 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-138842 (NTIS**); V01-P60 orl-mus TDLo: 259560 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-138842 (NTIS**) MD: P27-U01 orl-rat TDLo: 25400 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-233, 1982 (NTPTR*); P27-U01 orl-mus TDLo: 60984 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-233, 1982 (NTPTR*); P27-P72 orl-rat TDLo: 13650 mg/kg/13W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-138842 (NTIS**); P05-P20-P27 orl-mus TDLo: 10920 mg/kg/13W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-138842 (NTIS**); P61-V30 orl-rat TDLo: 43260 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-138842 (NTIS**); R60-V30 orl-rat TDLo: 36050 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-138842 (NTIS**) SL: NCI Carcinogenesis Studies (feed), clear evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat Record 612 of 1119 in RTECS (through 2003/06) AN: DV2094500 PN: 1,1'-Biphenyl,-2,2',3,3',4,4',5,5',6,6'-decabromo- SY: Adine-0102-; Biphenyl,-decabromo-; Berkflam-B-10-; Decabromobiphenyl-; 2,2',3,3',4,4',5,5',6,6'-Decabromobiphenyl-; Decabromodiphenyl-; Flammex-B-10-; Perbromobiphenyl- RN: Current: 13654-09-6 Previous: 39282-95-6 UD: 200006 MF: C12-Br10 MW: 943.22 CC: Tumorigen (C) SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 613 of 1119 in RTECS (through 2003/06) AN: DV5350000 PN: 1,1'-Biphenyl,-2,2',4,4',5,5'-hexachloro- SY: 2,2',4,4',5,5'-Hexachloro-1,1'-biphenyl- (9CI); 2,2',4,4',5,5'-Hexachlorobiphenyl-; 2,2',4,4'5,5'-Hexachlorobiphenyl-; 2,4,5,2',4',5'-Hexachlorobiphenyl-; CB-153-; K-153-; PCB-153- RN: Current: 35065-27-1 UD: 200302 MF: C12-H4-Cl6 MW: 360.86 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: dna-mus-orl 36400 ug/kg/5D Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 27, p. 99, 1979 (CBINA8); oms-mus-orl 36400 ug/kg/5D Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 27, p. 99, 1979 (CBINA8); dna-ctl-oth 1 mmol/L/1H Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 79, 2000 (EMMUEG) RE: T83 orl-rat TDLo: 50 mg/kg (8-18D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 51, p. 233, 1979 (TXAPA9); T81 orl-rat TDLo: 448 mg/kg (10-16D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 68, p. 311, 1993 (TOLED5); T83 orl-rat TDLo: 112 mg/kg (10-16D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 68, p. 311, 1993 (TOLED5); T81-T85-T86 orl-rat TDLo: 448 mg/kg (10-16D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 26, p. 117, 1995 (FAATDF); T24 orl-mus TDLo: 120 mg/kg (1-6D preg) Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 42, p. 323, 1978 (APTOA6); T81 orl-mus TDLo: 78 mg/kg (5-21D preg/22D post) Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 42, p. 275, 1978 (APTOA6); T53 orl-mus TDLo: 200 mg/kg (13-21D preg/24D post) Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 61, p. 220, 1987 (PHTOEH); T19 orl-mus TDLo: 271 mg/kg (10D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 34, p. 1605, 1997 (CMSHAF); T19 orl-gpg TDLo: 1080 mg/kg (45-62D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 38, p. 293, 1985 (ENVRAL); T55-T72 orl-rat TDLo: 50 mg/kg (8-18D preg) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 28, p. 2511, 1979 (BCPCA6); T52 orl-rat TDLo: 96 mg/kg (10-16D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 68, p. 311, 1993 (TOLED5); T25-T34-T46 ipr-mam TDLo: 20 mg/kg (1D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 127, p. 9, 1994 (TXAPA9); T12 orl-mus TDLo: 150 mg/kg (105D pre) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 750, 1997 (EVHPAZ) TE: V03-L60 orl-rat TDLo: 3650 mg/kg/104W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A181, 1979 (TXAPA9) AT: Y07 ipr-mus TDLo: 10 mg/kg Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 13, p. 924, 1977 (MOPMA3); N17-T13-Y07 ipr-mam TDLo: 20 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 127, p. 9, 1994 (TXAPA9); N17-T13 ipr-mam TDLo: 20 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 127, p. 9, 1994 (TXAPA9) MD: L70-N74-P28 orl-rat TDLo: 370 mg/kg/30D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 57, p. 99, 1981 (TXAPA9); K30-L70-Y07 orl-rat TDLo: 322 mg/kg/13W-C JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 16, p. 121, 1996 (JJATDK); L70-Y02-Y21 ipr-rat TDLo: 150 mg/kg/3D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 33, p. 94, 1975 (TXAPA9); L70-Y15-Y36 skn-rbt TDLo: 960 mg/kg/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 563, 1972 (TXAPA9); L70-Y09-Y15 orl-ckn TDLo: 1470 mg/kg/21D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 36, p. 81, 1976 (TXAPA9); Z74-Y07 ipr-rat TDLo: 60 mg/kg/2D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102, p. 568, 1994 (EVHPAZ); L30-Y20 ipr-rat TDLo: 144.4 mg/kg/2W-I Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 62, p. 273, 2001 (BCPCA6); L30-Y20 ipr-rat TDLo: 216.6 mg/kg/3W-I Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 62, p. 273, 2001 (BCPCA6); Y07-L30-L70 ipr-rat TDLo: 72.2 mg/kg/1W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 171, p. 85, 2001 (TXAPA9); L30-Y07 ipr-rat TDLo: 72.2 mg/kg/1W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 171, p. 85, 2001 (TXAPA9); L30-Y07 ipr-rat TDLo: 60 mg/kg/2D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102, p. 568, 1994 (EVHPAZ); Z74 ipr-rat TDLo: 50 mg/kg/2D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 53, p. 583, 1994 (BECTA6); Y07 ipr-rat TDLo: 16 mg/kg/2D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 53, p. 583, 1994 (BECTA6); Y07 orl-rat TDLo: 136.5 mg/kg/91D-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 2023, 1992 (CMSHAF); L70 orl-rat TDLo: 455 mg/kg/91D-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 2023, 1992 (CMSHAF); Y07 ipr-rat TDLo: 150 mg/kg/5D-I Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 13, p. 924, 1977 (MOPMA3); N08 orl-rat TDLo: 14 mg/kg/4W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 1239, 1992 (CMSHAF); Y53 orl-rat TDLo: 42 mg/kg/4W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 1239, 1992 (CMSHAF); L30-U02 orl-rat TDLo: 45.5 mg/kg/13W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 1239, 1992 (CMSHAF); N74-Z71 orl-mus TDLo: 150 mg/kg/15W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 750, 1997 (EVHPAZ) SR: OEL-AUSTRIA: MAK 0.1 ppm (1 mg/m3), Skin, Suspected Carcinogen, JAN 1999; OEL-DENMARK: TWA 0.01 mg/m3, Skin, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, STEL 1.5 mg/m3, JAN 1999; OEL-JAPAN: OEL 0.1 mg/m3, Skin, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.01 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 0.1 mg/m3, Skin, SEP 2000 SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 614 of 1119 in RTECS (through 2003/06) AN: DV5775000 PN: 2-Biphenylol- SY: o-Biphenylol-; Invalon-OP-; NCI-C50351-; Nectryl-; o-Phenylphenol-; 2-Phenylphenol-; Torsite-; (1,1'-Biphenyl)-2-ol; Biphenyl,-2-hydroxy-; o-Diphenylol-; Dowicide-1-; Dowicide-1-antimicrobial-; 2-Fenylfenol- (Czech); 2-Hydroxybifenyl- (Czech); o-Hydroxybiphenyl-; 2-Hydroxybiphenyl-; o-Hydroxydiphenyl-; 2-Hydroxydiphenyl-; Orthohydroxydiphenyl-; Orthophenylphenol-; Orthoxenol-; Phenol,-o-phenyl-; Preventol-O-Extra-; Remol-TRF-; Tetrosin-OE-; Tumescal-OPE-; USAF-EK-2219-; o-Xenol- RN: Current: 90-43-7 BRN: 606907 BHR: 4-06-00-04579 UD: 200302 MF: C12-H10-O MW: 170.22 WL: QR BR CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 250 mg Personal Communication from S.B. McCollister, Dow Chemical USA, Midland, MI 48640, June 15, 1984 15 JUN 1984 (MccSB#); skn-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,228,1986 (85JCAE); eye-rbt 50 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,228,1986 (85JCAE) ME: mmo-sat 60 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); dnr-esc 1 mg/disc Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 10, p. 223, 1981 (CMSHAF); sln-asn 52 umol/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 31, p. 81, 1979 (EVHPAZ); cyt-hmn-fbr 200 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 255, 1978 (MUREAV); msc-hmn-emb 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 123, 1985 (MUREAV); msc-hmn-oth 15 mg/L Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 35, p. 399, 1984 (TRENAF); dns-rat-orl 336 gm/kg/4W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 48, p. 19, 1989 (CALEDQ); mmo-mus-lym 5 mg/L (+S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-301, 1986 (NTPTR*); dnd-mus-orl 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 395, p. 189, 1997 (MUREAV); msc-mus-lym 50 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-301, 1986 (NTPTR*); cyt-ham-ovr 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 141, p. 95, 1984 (MUREAV); sce-ham-ovr 29900 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-301, 1986 (NTPTR*); mnt-rat-orl 2 pph/14D Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 89, 2002 (MUTAEX) RE: T34-T35 orl-rat TDLo: 6 gm/kg (6-15D preg) Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 3, p. 365, 1978 (NNGADV); T02-T03 orl-rat TDLo: 52168 mg/kg (13W male) Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 32-2, p. 33, 1981 (TRENAF); T41-T42-T46 orl-mus TDLo: 13050 mg/kg (7-15D preg) Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 29, p. 89, 1978 (TRENAF); T34 orl-mus TDLo: 13050 mg/kg (7-15D preg) Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 29, p. 89, 1978 (TRENAF); T19 orl-rbt TDLo: 6500 mg/kg (7-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0544434 (NTIS**) TE: V01-L60 orl-rat TDLo: 478 gm/kg/91W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 865, 1984 (FCTOD7); V01-M60 orl-rat TD :478 gm/kg/91W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 865, 1984 (FCTOD7); V02-M60 orl-rat TD :135 gm/kg/26W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 359, 1987 (FCTOD7) ORNG: 2000000000 ng/kg. [2000.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2 gm/kg Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 3, p. 365, 1978 (NNGADV); T/E unlistd unr-rat LD50: 2700 mg/kg Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 29, p. 89, 1978 (TRENAF); F19-G30-J25 orl-mus LD50: 1050 mg/kg Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken, Japan) V.1- 1950- v. 32, p. 425, 1981 (NAIZAM); T/E unlistd ipr-mus LD50: 50 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); F07-J22-P01 orl-cat LD50: 500 mg/kg Analyst (London). (Royal Soc. of Chemistry, Distribution Centre, Blackhorse Rd., Letchworth Herts SG6 1HN, UK) V.1- 1877- v. 70, p. 334, 1945 (ANALAO) MD: M30-U01 orl-rat TDLo: 876 gm/kg/2Y-C Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 35, p. 779, 1984 (YKYUA6); M03-U01-Z73 orl-rat TDLo: 728 gm/kg/2Y-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 104, p. 202, 1952 (JPETAB); U01-Z01 orl-rat TDLo: 46500 mg/kg/31D-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 104, p. 202, 1952 (JPETAB); S04-S05 orl-mus TDLo: 61250 ug/kg/7W-C Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 2, p. 167, 1979 (DCTODJ); N73-N74-P71 orl-mus TDLo: 2 gm/kg/2W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 58, p. 252, 1981 (TXAPA9); R03 skn-mus TDLo: 26640 mg/kg/4W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-301, 1986 (NTPTR*); Z01 orl-dog TDLo: 31 gm/kg/31D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 104, p. 202, 1952 (JPETAB) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 451, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 30, p. 329, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 30, p. 329, 1983 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 451, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 451, 1999 (IMEMDT); TOXICOLOGY REVIEW Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 61, 2000 (ARTODN) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 81040; NIS 67; TNF 7224; NOS 58; TNE 221003; NOES 1983: HZD 81040; NIS 135; TNF 15646; NOS 114; TNE 617394; TFE 379044 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (derm), no evidence: rat Record 615 of 1119 in RTECS (through 2003/06) AN: DV8100000 PN: Biphenyl,-pentachloro- SY: Apirolio-1476-C-; 1,1'-Biphenyl,-pentachloro- (9CI); Kanekrol-500-; Pyralene-1476-; Diphenyl-pentachloride-; Pentachlorobiphenyl-; Pentachloro-1,1'-biphenyl-; Pentachlorodiphenyl-; Pyroclor-5- RN: Current: 25429-29-2 UD: 200012 MF: C12-H5-Cl5 MW: 326.42 CC: Tumorigen (C) AT: T/E unlistd unr-rat LD50: 3580 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 53(5), p. 6, 1988 (GISAAA) MD: L30-L70-Y21 ipr-rat TDLo: 600 mg/kg/3D-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 6, p. 29, 1992 (WDZAEK) SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 616 of 1119 in RTECS (through 2003/06) AN: DV8203000 PN: 1,1'-Biphenyl,-2,3',4,4',5-pentachloro- SY: Biphenyl,-2,3',4,4',5-pentachloro-; PCB-118-; 2,3',4,4',5-Pentachlorobiphenyl-; 3,4,2',4',5'-Pentachlorobiphenyl- RN: Current: 31508-00-6 BRN: 2379471 UD: 200204 MF: C12-H5-Cl5 MW: 326.42 CC: Tumorigen (C); Reproductive-Effector (T) RE: T81-T83 orl-rat TDLo: 28 mg/kg (10-16D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 68, p. 311, 1993 (TOLED5); T81-T85-T86 orl-rat TDLo: 112 mg/kg (10-16D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 26, p. 117, 1995 (FAATDF); T41-T52-T81 orl-rat TDLo: 24 mg/kg (10-16D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 68, p. 311, 1993 (TOLED5) MD: A30-L30-Y65 orl-rat TDLo: 15470 ug/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 26, p. 282, 1995 (FAATDF) SR: OEL-AUSTRIA: MAK 0.1 ppm (1 mg/m3), Skin, Suspected Carcinogen, JAN 1999; OEL-DENMARK: TWA 0.1 mg/m3, Skin, JAN 1999; OEL-JAPAN: OEL 0.1 mg/m3, Skin, 2a Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.01 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 0.1 mg/m3, Skin, SEP 2000 SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 617 of 1119 in RTECS (through 2003/06) AN: DV8205000 PN: 1,1'-Biphenyl,-3,3',4,4',5-pentachloro- SY: 3,3',4,4',5-Pentachloro-1,1'-biphenyl-; 3,3',4,4',5-Pentachlorobiphenyl-; 3,4,3',4',5'-Pentachlorobiphenyl-; PCB-126-; PCB126- RN: Current: 57465-28-8 BRN: 4190261 UD: 200305 MF: C12-H5-Cl5 MW: 326.42 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: dna-ctl-oth 1 mmol/L/1H Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 79, 2000 (EMMUEG) RE: T81-T85-T86 orl-rat TDLo: 10 ug/kg (15D preg) Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 17, p. 365, 1998 (HETOEA); T43-T53 orl-mus TDLo: 522 ug/kg (10D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 104, 1992 (TOXID9); T53 orl-mus TDLo: 131 ug/kg (10D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 77, p. 123, 1993 (TXCYAC); T19-T43 orl-mus TDLo: 783 ug/kg (10D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 34, p. 1605, 1997 (CMSHAF); T51 orl-rat TDLo: 1.75 ug/kg (10-16D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 78, p. 253, 1995 (TOLED5); T91-T81 orl-rat TDLo: 52.5 ug/kg (13-17D preg) Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 14, p. 213, 2001 (TOPADD); T13-T12-T69 orl-mus TDLo: 5000 ug/kg (105D pre) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 750, 1997 (EVHPAZ) AT: S04 ipr-mus TDLo: 0.12 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 92, p. 155, 1994 (TXCYAC); L30-Y04-Y07 ipr-mus TDLo: 0.01 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 51, p. 131, 1997 (JTEHD6); Y07 ipr-mus TDLo: 0.01 mg/kg Japanese Journal of Toxicology and Environmental Health. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.38- 1992- v. 51, p. 131, 1997 (JJTHEC); S04-S05 ipr-mus TDLo: 6.9 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 199, 1995 (TXCYAC); L70-U01-Y37 ipr-rat TDLo: 25 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 91, p. 99, 1997 (TOLED5); P27-S02-S05 ipr-mus TDLo: 14 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 80, p. 217, 1993 (TXCYAC); L30-Y04 ipr-mus TDLo: 12 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 80, p. 217, 1993 (TXCYAC) MD: L30 orl-rat TDLo: 455 ng/kg/13W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 136, p. 107, 1999 (TXCYAC); L70-Q30 ipr-rat TDLo: 384 ug/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 154, p. 236, 1999 (TXAPA9); N74-Y07 orl-rat TDLo: 42.77 ug/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 127, p. 209, 1994 (TXAPA9); L70-N08-U01 orl-rat TDLo: 289.38 ug/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 127, p. 209, 1994 (TXAPA9); N74 ipr-mus TDLo: 0.07 mg/kg/7D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 51, p. 131, 1997 (JTEHD6); L70 ipr-mus TDLo: 7 mg/kg/7D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 51, p. 131, 1997 (JTEHD6); L30-Y04-Y07 ipr-mus TDLo: 0.7 mg/kg/7D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 51, p. 131, 1997 (JTEHD6); V08-Y07-Z71 orl-mus TDLo: 5000 ug/kg/15W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 750, 1997 (EVHPAZ); U01 orl-mam TDLo: 16.8 ug/kg/14D-C Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 43, p. 22, 2001 (VHTODE); Q01-U01-Z01 orl-mam TDLo: 33.6 ug/kg/28D-C Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 43, p. 22, 2001 (VHTODE); Q01-Z01 orl-mam TDLo: 33.6 ug/kg/28D-C Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 43, p. 22, 2001 (VHTODE) SR: OEL-AUSTRIA: MAK 0.1 ppm (1 mg/m3), Skin, Suspected Carcinogen, JAN 1999; OEL-DENMARK: TWA 0.1 mg/m3, Skin, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, STEL 1.5 mg/m3, Skin, JAN 1999; OEL-JAPAN: OEL 0.1 mg/m3, Skin, 2A Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.01 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 0.1 mg/m3, Skin, SEP 2000 SL: NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 618 of 1119 in RTECS (through 2003/06) AN: ED4550000 PN: Boric-acid- SY: Basilit-B-; Boracic-acid-; Boron-trihydroxide-; Borsaure- (German); Borofax-; Dr.'s 1 Flea Terminator DF; Dr.'s 1 Flea Terminator DFPBO; Dr.'s 1 Flea Terminator DT; Dr.'s 1 Flea Terminator DTPBO; Flea-Prufe-; NCI-C56417-; Orthoboric-acid-; Super-Flea-Eliminator-; Three-elephant-; Trihydroxyborone- RN: Current: 10043-35-3 Previous: 12795-04-9 UD: 200305 MF: B-H3-O3 MW: 61.84 WL: QBQQ CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-hmn 15 mg/3D-I MLD "Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar, eds., New York, Academic Press, Inc. 1977 -,127,1977 (85DKA8) ME: mmo-esc 17000 ppm/24H (-S9) American Naturalist. (Univ. of Chicago Press, Journals Div., POB 37005, Chicago, IL 60637) V.1- 1867- v. 85, p. 119, 1951 (AMNTA4) RE: T46 orl-rat TDLo: 1600 mg/kg (6-9D preg) Biological Trace Element Research. (Humana Press Inc., POB 2148, Clifton, NJ 07015) V.1- 1979- v. 66, p. 373, 1998 (BTERDG); T34-T46-T59 orl-rat TDLo: 6600 mg/kg (1-21D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 266, 1992 (FAATDF); T02 orl-rat TDLo: 45 gm/kg (90D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 351, 1972 (TXAPA9); T25-T35-T46 orl-rat TDLo: 5390 mg/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 266, 1992 (FAATDF); T34-T46 orl-rat TDLo: 1596 mg/kg (0-20D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 179, 1996 (FAATDF); T01 orl-rat TDLo: 52 mg/kg (26W male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 13, p. 69, 1976 (EVHPAZ); T01-T02 ihl-rat TCLo: 9600 ug/m3/4H (16W male) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 16(11), p. 13, 1972 (GTPZAB); T34 orl-mus TDLo: 7684 mg/kg (1-17D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 266, 1992 (FAATDF); T25 orl-mus TDLo: 17051 mg/kg (1-17D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 266, 1992 (FAATDF); T13-T25 orl-mus TDLo: 18054 mg/kg (1-18D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102(Suppl 7), p. 107, 1994 (EVHPAZ); T19-T34 orl-mus TDLo: 8136 mg/kg (1-18D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102(Suppl 7), p. 107, 1994 (EVHPAZ); T46 orl-mus TDLo: 800 mg/kg (7D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 51, p. 181, 1995 (TJADAB); T35-T47 orl-rbt TDLo: 3500 mg/kg (6-19D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 103, 1992 (TOXID9); T25-T26-T47 orl-rbt TDLo: 3500 mg/kg (6-19D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 34, p. 176, 1996 (FAATDF); T25-T34-T46 orl-rbt TDLo: 3500 mg/kg (7-20D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102(Suppl 7), p. 107, 1994 (EVHPAZ); T43-T59 orl-rbt TDLo: 3500 mg/kg (6-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-129550 (NTIS**); T13-T19 orl-rbt TDLo: 1750 mg/kg (7-20D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102(Suppl 7), p. 107, 1994 (EVHPAZ); T01-T02-T26 orl-mus TDLo: 136080 mg/kg (multigeneration) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 9, p. 226, 1989 (TOXID9); T34 orl-mus TDLo: 9492 mg/kg (0-21D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T25-T34 orl-mus TDLo: 21.063 gm/kg (0-21D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T34 orl-rat TDLo: 1716 mg/kg (0-22D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T35 orl-rat TDLo: 5390 mg/kg (6-15D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T34 orl-rat TDLo: 2000 mg/kg (6-15D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T34-T35 orl-rbt TDLo: 3500 mg/kg (6-19D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T34 orl-rat TDLo: 5000 mg/kg (5-9D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T34 orl-rat TDLo: 5000 mg/kg (6-10D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T34 orl-rat TDLo: 1000 mg/kg (9D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T34 orl-rat TDLo: 1000 mg/kg (10D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T34 orl-rat TDLo: 76 mg/kg (20D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1432, 2001 (HBPTO*); T72-T81 orl-mus TDLo: 22.26 gm/kg (7D male/7D pre/21D preg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**); T21-T23 orl-mus TDLo: 93.5 gm/kg (21W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**); T22-T81 orl-mus TDLo: 93.5 gm/kg (15W pre-3W post) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**); T81 orl-mus TDLo: 152 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**); T53 orl-mus TDLo: 152 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**); T51-T52-T53 orl-mus TDLo: 152 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**) ORNG: 2660000000 ng/kg. [2660.000000 mg/kg] T/E unlistd AT: K13-K30-R03 orl-wmn TDLo: 400 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 32, p. 804, 1990 (YAKUD5); G30-M03 orl-man LDLo: 429 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 31, p. 345, 1993 (JTCTDW); K13 orl-chd TDLo: 500 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 24, p. 269, 1986 (JTCTDW); F16-K12-K13 orl-wmn LDLo: 200 mg/kg Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 162, 1917 (LANCAO); F12-K12-K13 orl-inf TDLo: 800 mg/kg/4W-I Archives of Disease in Childhood. (British Medical Journal, POB 560B, Kennebunkport, ME 04046) V.1- 1926- v. 58, p. 737, 1983 (ADCHAK); F12-R03-U25 skn-inf LDLo: 1200 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 129, p. 332, 1945 (JAMAAP); T/E unlistd skn-chd LDLo: 4 gm/kg/4D Muenchener Medicinische Wochenschrift. (Munich, Fed. Rep. Ger.) V.33-115, 1886-1973. v. 52, p. 763, 1905 (MMWOAU); K12-R10-U25 skn-man LDLo: 2430 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 128, p. 266, 1945 (JAMAAP); D25-J25-K12 skn-chd LDLo: 1500 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 6, p. 714, 1933 (QJPPAL); F11-K12-K13 scu-inf LDLo: 1100 mg/kg U.S. Army, Chemical Corps Medical Division Special Report. (Army Chemical Center, MD) #2, 1950 (MDSR**); F03-F14-K13 unr-man TDLo: 170 mg/kg Rassegna di Terapia e Patologia Clinica. (Rome, Italy) V.1-8, 1929-36. For publisher information, see RFCTAJ. v. 1, p. 472, 1929 (RTPCAT); T/E unlistd unr-man LDLo: 147 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); F07-F19-U28 scu-rat LD50: 1400 mg/kg "Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley and Sons, Inc., 1964 -,693,1964 (14KTAK); F11-K12-K13 ivn-rat LD50: 1330 mg/kg U.S. Army, Chemical Corps Medical Division Special Report. (Army Chemical Center, MD) #2, 1950 (MDSR**); F07-F19-U28 ipr-mus LDLo: 800 mg/kg "Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley and Sons, Inc., 1964 -,693,1964 (14KTAK); T/E unlistd scu-mus LD50: 1740 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 128, p. 266, 1945 (JAMAAP); F12-J25-K12 ivn-mus LD50: 1240 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 134, p. 117, 1961 (JPETAB); A01-J24-K13 orl-dog LDLo: 1780 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 128, p. 266, 1945 (JAMAAP); A01-J24-K13 scu-dog LDLo: 1 gm/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 128, p. 266, 1945 (JAMAAP); C08 par-dog LDLo: 1 gm/kg Rassegna di Terapia e Patologia Clinica. (Rome, Italy) V.1-8, 1929-36. For publisher information, see RFCTAJ. v. 1, p. 472, 1929 (RTPCAT); F11-K12-K13 orl-rbt LDLo: 4 gm/kg U.S. Army, Chemical Corps Medical Division Special Report. (Army Chemical Center, MD) #2, 1950 (MDSR**); T/E unlistd scu-rbt LDLo: 150 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); F07-F19-U28 ivn-rbt LDLo: 800 mg/kg "Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley and Sons, Inc., 1964 -,693,1964 (14KTAK); U28 par-rbt LDLo: 670 mg/kg Rassegna di Terapia e Patologia Clinica. (Rome, Italy) V.1-8, 1929-36. For publisher information, see RFCTAJ. v. 1, p. 472, 1929 (RTPCAT); K13-K30 orl-gpg LDLo: 1 gm/kg Revista de la Asociacion Medica Argentina. (Buenos Aires, Argentina) V.1-89, 1915-76. Discontinued. v. 46, p. 1493, 1932 (RAMAAB); F11-K12-K13 scu-gpg LD50: 1200 mg/kg U.S. Army, Chemical Corps Medical Division Special Report. (Army Chemical Center, MD) #2, 1950 (MDSR**); T01-T02 orl-rat TDLo: 2000 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 491, 1992 (REPTED); T/E unlistd orl-rat LD50: 2660 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1413, 2001 (HBPTO*); T/E unlistd orl-mus LD50: 3450 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1413, 2001 (HBPTO*); T/E unlistd ivn-rat LD50: 1330 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1413, 2001 (HBPTO*); T/E unlistd ivn-mus LD50: 1780 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1413, 2001 (HBPTO*); T/E unlistd orl-inf LDLo: 400 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1414, 2001 (HBPTO*); T/E unlistd orl-chd LDLo: 250 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1414, 2001 (HBPTO*); T/E unlistd orl-hmn LDLo: 214.28 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1414, 2001 (HBPTO*); F12-F19 orl-rat LD50: 2500 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1430, 2001 (HBPTO*); T/E unlistd ihl-rat LCLo: 28 mg/m3/4H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 193, 1988 (VCVN1*); T02 orl-rat LDLo: 3000 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 195, 1988 (VCVN1*) MD: A70-U01-Z73 orl-rat TDLo: 45 gm/kg/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 351, 1972 (TXAPA9); U01-U07-U08 orl-rat TDLo: 68 mg/kg/9W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 35, p. 205, 1997 (FAATDF); Z01 orl-mus TDLo: 42 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-324, 1987 (NTPTR*); K30-P27-Z01 orl-mus TDLo: 156 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-324, 1987 (NTPTR*); L70-N75-Z73 orl-dog TDLo: 23 gm/kg/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 351, 1972 (TXAPA9); N16-P30 orl-rat TDLo: 2160 mg/kg/4D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 107, p. 325, 1991 (TXAPA9); T01 orl-rat TDLo: 3780 mg/kg/7D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 107, p. 325, 1991 (TXAPA9); U01 orl-rat TDLo: 15120 mg/kg/28D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 107, p. 325, 1991 (TXAPA9); T02 orl-rat TDLo: 15.12 gm/kg/4W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); T02 orl-rat TDLo: 11.34 gm/kg/9W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); M30 orl-mus TDLo: 5208 mg/kg/21D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1431, 2001 (HBPTO*); F12-K12-K13 orl-inf TDLo: 2744 mg/kg/4W-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1433, 2001 (HBPTO*); Z01 orl-rbt TDLo: 6000 mg/kg/3D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 194, 1988 (VCVN1*); Z01 orl-rbt TDLo: 15000 mg/kg/15D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 194, 1988 (VCVN1*); Z01 orl-rbt TDLo: 15000 mg/kg/30D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 194, 1988 (VCVN1*); P14-P28-P71 orl-rbt TDLo: 14700 mg/kg/12W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 195, 1988 (VCVN1*); T02-Z01 orl-rat TDLo: 24000 mg/kg/30D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 195, 1988 (VCVN1*); U01 orl-mus TDLo: 238518 mg/kg/27W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**); L70-M71-N72 orl-mus TDLo: 120204 mg/kg/27W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**); T01-T02-T03 orl-mus TDLo: 120204 mg/kg/27W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**); T01 orl-mus TDLo: 28728 mg/kg/27W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90253808 (NTIS**) TR: TOXICOLOGY REVIEW Clinical Chemistry (Winston-Salem, NC). (American Assoc. for Clinical Chemistry, 1725 K St., NW, Washington, DC 20006) V.1- 1955- v. 19, p. 361, 1973 (CLCHAU); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6); TOXICOLOGY REVIEW Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 61, p. 531, 1962 (JOPDAB) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-RUSSIA: STEL 10 mg/m3, JAN 1993 ND: NOES 1983: HZD X7080; NIS 187; TNF 27071; NOS 128; TNE 489668; TFE 211838; NOES 1983: HZD X8324; NIS 3; TNF 84; NOS 4; TNE 2919; TFE 1712 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 619 of 1119 in RTECS (through 2003/06) AN: EF8750000 PN: Bromic-acid,-sodium-salt- SY: Bromate-de-sodium- (French); Neutralizer-K-126-; Neutralizer-K-140-; Neutralizer-K-938-; Sodium-bromate- (NaBrO3); Dyetone- RN: Current: 7789-38-0 UD: 200302 MF: Br-O3.Na MW: 150.90 WL: NA E-O3 CC: Tumorigen (C); Human-Data (P) AT: D40-F07-M11 orl-wmn TDLo: 150 mg/kg Journal of the Formosan Medical Association. (Excerpta Medica Asia Ltd., 3/F, 13 Duddell St. Central, Hong Kong, Hong Kong) V. 90- 1991- v. 92(Suppl 4), p. S262, 1993 (JFASEO); T/E unlistd ipr-mus LD50: 140 mg/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 257, p. 791, 1963 (COREAF); F18-J25-P30 scu-dog LDLo: 120 mg/kg Skandinavisches Archiv fuer Physiologie. (Stockholm, Sweden) V.1-83, 1899-1940. For publisher information, see APSCAX. v. 30, p. 337, 1913 (SAPHAO); F07-K12-P30 orl-rbt LDLo: 250 mg/kg Skandinavisches Archiv fuer Physiologie. (Stockholm, Sweden) V.1-83, 1899-1940. For publisher information, see APSCAX. v. 30, p. 337, 1913 (SAPHAO); J22-K12-P30 ivn-rbt LDLo: 360 mg/kg Skandinavisches Archiv fuer Physiologie. (Stockholm, Sweden) V.1-83, 1899-1940. For publisher information, see APSCAX. v. 30, p. 337, 1913 (SAPHAO); J25-M14-P30 scu-gpg LDLo: 100 mg/kg Skandinavisches Archiv fuer Physiologie. (Stockholm, Sweden) V.1-83, 1899-1940. For publisher information, see APSCAX. v. 30, p. 337, 1913 (SAPHAO) MD: N73-P70 orl-mus TDLo: 4480 mg/kg/28D-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 156, 2000 (TOXID9); T01 orl-rat TDLo: 896 mg/kg/35D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-190640 (NTIS**) ND: NOES 1983: HZD X4132; NIS 5; TNF 2680; NOS 9; TNE 27921; TFE 18633 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 620 of 1119 in RTECS (through 2003/06) AN: EG3500000 PN: Bromkal-80- RN: Current: 61288-13-9 UD: 200006 CC: Tumorigen (C) SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 621 of 1119 in RTECS (through 2003/06) AN: EI9275000 PN: 1,3-Butadiene- SY: 1,3-Butadiene- (ACGIH:OSHA); Biethylene-; Bivinyl-; Buta-1,3-dieen- (Dutch); Buta-1,3-dien- (German); Buta-1,3-diene-; Butadieen- (Dutch); Butadien- (Polish); Butadiene-; Butadiene- (OSHA); Butadiene-1,3-; Divinyl-; Erythrene-; NCI-C50602-; Pyrrolylene-; Vinylethylene-; alpha,gamma-Butadiene- RN: Current: 106-99-0 Previous: 130983-70-9 UD: 200302 MF: C4-H6 MW: 54.10 WL: 1U2U1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 20 pph/20H-C (+S9) Toxicological European Research. (S.P.E., 10, Ave. de Messine, 75008 Paris, France) V.1- 1978- v. 3, p. 131, 1981 (TOERD9); mmo-sat 2 pph (-S9) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 6, p. 125, 1980 (TOLED5); sce-hmn-lym 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 117, 1991 (MUREAV); mnt-mus-ihl 6250 ppb/6H/13W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 209, p. 171, 1988 (MUREAV); slt-mus-ihl 500 ppm/6H/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 309, p. 307, 1994 (MUREAV); dnd-mus-ihl 125 ppm/6H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 397, p. 67, 1998 (MUREAV); dna-mus-ihl 200 ppm/5D/6H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 397, p. 3, 1998 (MUREAV); cyt-mus-ihl 625 ppm/6H/10D-I Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 235, 1987 (ENMUDM); sce-mus-ihl 6250 ppb/6H/10D-I Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 235, 1987 (ENMUDM); dlt-mus-ihl 1250 ppm/6H/10W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 309, p. 295, 1994 (MUREAV); msc-mus-lym 20 pph Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 75, 1986 (ENMUDM); msc-mus-ihl 625 ppm/6H/2W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 719, 1994 (CRNGDP); spm-mus-ihl 130 ppm/5D/6H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 397, p. 55, 1998 (MUREAV); trn-mus-ihl 500 ppm/6H/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 397, p. 85, 1998 (MUREAV); sce-ham-ovr 25 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 263, p. 47, 1991 (MUREAV); slt-mus-ihl 3 ppm/14D-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 343, 2001 (CBINA8); dnd-mus-ihl 20 ppm/1Y-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 373, 2001 (CBINA8); mnt-mus-ihl 500 ppm/5D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 491, p. 81, 2001 (MUREAV) RE: T46 ihl-rat TCLo: 8000 ppm/6H (6-15D preg) United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0382-0441 (EPASR*); T02-T33 ihl-mus TCLo: 500 ppm/6H (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 397, p. 55, 1998 (MUREAV); T25-T31-T34 ihl-mus TCLo: 1000 ppm/6H (6-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 86, p. 79, 1990 (EVHPAZ); T13 ihl-mus TCLo: 1000 ppm/6H (6-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 86, p. 79, 1990 (EVHPAZ) TE: V01-G60-J60 ihl-rat TCLo: 625 ppm/6H/61W National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-288, 1984 (NTPTR*); V01-D09-G60 ihl-mus TCLo: 625 ppm/6H/13W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 50, p. 6592, 1990 (CNREA8); V01-R60 ihl-rat TC :1000 ppm/6H/2Y-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 48, p. 407, 1987 (AIHAAP); V02-K60-N62 ihl-rat TC :8000 ppm/6H/2Y-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 48, p. 407, 1987 (AIHAAP); V01-N60 ihl-rat TC :8000 ppm/6H/15W-I United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0482-0370 (EPASR*); V03-K60 ihl-mus TC :200 ppm/40W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 86, p. 37, 1990 (EVHPAZ); V01-N62-R60 ihl-rat TC :8000 ppm/6H/2Y-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 86, p. 19, 1990 (EVHPAZ); V03-D29-G60 ihl-mus TC :625 ppm/6H/65W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 86, p. 27, 1990 (EVHPAZ); V01-H60-L60 ihl-mus TC :63 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-434, 1993 (NTPTR*); V02-K60-V08 ihl-mus TC :200 ppm/6H/1Y-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 373, 2001 (CBINA8); V02-K60-V08 ihl-mus TCLo: 20 ppm/6H/1Y-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 373, 2001 (CBINA8); V01-J30 ihl-mus TC :216 mg/kg/8W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 152, p. 129, 2000 (CALEDQ); V01-G60-J60 ihl-mus TCLo: 22500 mg/kg/60W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-179646/AS (NTIS**); V01-G60-J60 ihl-mus TCLo: 22875 mg/kg/61W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-179646/AS (NTIS**); V01-L60-R60 ihl-mus TCLo: 45750 mg/kg/61W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-179646/AS (NTIS**); V01-L60-P62 ihl-mus TCLo: 1730.4 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-101631 (NTIS**); V01-L60-P62 ihl-mus TCLo: 540.75 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-101631 (NTIS**) ORNG: 5480000000 ng/kg. [5480.000000 mg/kg] T/E unlistd IHNG: 285000000000 ng/m3/4H. [285000.000000 mg/m3/4H] F01-J25 AT: D35-F08 ihl-hmn TCLo: 2000 ppm/7H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 26, p. 69, 1944 (JIHTAB); D14-D25-J21 ihl-hmn TCLo: 8000 ppm Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 17, p. 199, 1948 (INMEAF); T/E unlistd orl-rat LD50: 5480 mg/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,14,1986 (85JCAE); F01-J25 ihl-rat LC50: 285 gm/m3/4H Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 31, p. 162, 1968 (RPTOAN); T/E unlistd orl-mus LD50: 3210 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-288, 1984 (NTPTR*); T/E unlistd ihl-mus LC50: 270 gm/m3/2H Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 18, p. 878, 1969 (AEHLAU); D16-F11-F18 ihl-rbt LCLo: 25 pph/23M Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 26, p. 69, 1944 (JIHTAB) MD: L70-M70 ihl-rat TCLo: 1000 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 1, 1996 (FAATDF); L70-Z01 ihl-rat TCLo: 1000 ppm/6H/1Y-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 48, p. 407, 1987 (AIHAAP); P14-Y37-Y40 ihl-rat TCLo: 2200 mg/m3/4H/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(12), p. 18, 1966 (GISAAA); F19-M70-Z01 ihl-rat TCLo: 8000 ppm/6H/2Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0538010 (NTIS**); Z01 ihl-mus TCLo: 1250 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-288, 1984 (NTPTR*); P05-P26-P71 ihl-mus TCLo: 1250 ppm/6H/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 85, p. 450, 1986 (TXAPA9); P08-P71-P72 ihl-mus TCLo: 1250 ppm/6H/24W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 83, p. 95, 1986 (TXAPA9); U01 ihl-mus TCLo: 8000 ppm/6H/15D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-288, 1984 (NTPTR*); S02-Y01 ihl-rbt TCLo: 100 mg/m3/4H/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(12), p. 18, 1966 (GISAAA); M30 ihl-gpg TCLo: 14800 mg/m3/7H/32W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 61, 1990 (VCVGH*) TR: ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 155, 1986 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 109, 1999 (IMEMDT); IARC Cancer Review: Animal SUFFICENT EVIDENCE IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 54, p. 237, 1992 (IMEMDT); IARC Cancer Review: Human LIMITED EVIDENC IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 54, p. 237, 1992 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 109, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 155, 1986 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 109, 1999 (IMEMDT); TOXICOLOGY REVIEW Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 27, 2001 (CBINA8); TOXICOLOGY REVIEW Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 65, 2001 (CBINA8) SR: MSHA STANDARD-air: TWA 1000 ppm (2200 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 28, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1000 ppm (2200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1000 ppm (2200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1000 ppm (2200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1000 ppm (2200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 ppm (22 mg/m3), Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 10 ppm (22 mg/m3), Carcinogen, JAN 1993; OEL-DENMARK: TWA 10 ppm (22 mg/m3), JAN 1999; OEL-FINLAND: TWA 50 ppm (73 mg/m3), Carcinogen, JAN 1999; OEL-FRANCE: VME 10 ppm (36 mg/m3), JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 10 mg/m3, Carcinogen, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 50 ppm (110 mg/m3), JAN 1999; OEL-NORWAY: TWA 1 ppm (2.2 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1000 ppm (2200 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 10 mg/m3, STEL 40 mg/m3, JAN 1999; OEL-RUSSIA: STEL 100 mg/m3, JAN 1993; OEL-SWEDEN: NGV 10 ppm (20 mg/m3), KTV 20 ppm (40 mg/m3), Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (11 mg/m3), Carcinogen, JAN 1999; OEL-TURKEY: TWA 1000 ppm (2200 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 10 ppm (22 mg/m3), Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 1,3-BUTADIENE-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 13410; NIS 26; TNF 3086; NOS 71; TNE 66326; NOES 1983: HZD 13410; NIS 20; TNF 2201; NOS 34; TNE 51971; TFE 1410 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 41, 1984; NIOSH Analytical Method, 1994: 1, 3-Butadiene, 1024; NCI Carcinogenesis Studies (inhal), clear evidence: mouse; NTP Carcinogenesis studies (inhalation), clear evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-434, 1993 (NTPTR*); NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID-56 Record 622 of 1119 in RTECS (through 2003/06) AN: EI9625000 PN: 1,3-Butadiene,-2-chloro- SY: 2-Chloor-1,3-butadieen- (Dutch); 2-Chlor-1,3-butadien- (German); 2-Chloro-1,3-butadiene-; 2-Chloro-1,3-butadiene- (OSHA); 2-Chlorobuta-1,3-diene-; 2-Cloro-1,3-butadiene- (Italian); Chlorobutadiene-; Chloropreen- (Dutch); Chloropren- (German, Polish); Chloroprene-; Cloroprene- (Italian); beta-Chloroprene-; beta-Chloroprene- (ACGIH:OSHA) RN: Current: 126-99-8 UD: 200305 MF: C4-H5-Cl MW: 88.54 WL: 1UYG1U1 CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 500 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535986 (NTIS**) ME: mmo-sat 70 umol/L (+S9) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 255, p. 641, 1975 (NATUAS); mmo-sat 2 pph/4H (-S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 41, p. 249, 1979 (ARTODN); sln-dmg-orl 5700 umol/L/3D-I "In Vitro Metabolic Activation in Mutagenic Testing, Proceedings of the Symposium, Research Triangle Park, NC, 1976," De Serres, F.J., et al., eds., New York, Elsevier Science Pub. Co., Inc., 1976 -,63,1976 (35WYAM); cyt-hmn-unr 1 mg/m3 Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 301, 1985 (MUREAV); cyt-rat-ihl 1960 ug/m3/16W Biologicheskii Zhurnal Armenii. Biological Journal of Armenia. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.19- 1966- v. 27(6), p. 102, 1974 (BZARAZ); dlt-rat-ihl 4 ug/L/48D-I Toxicology of New Industrial Chemical Substances. English translation of TPKVAL. (USSR Academy of Medical Sciences, Meditsina, Moscow, USSR) v. 13, p. 56, 1973 (TNICS*); mnt-mus-ihl 1480 ug/m3/2H/2D-C Huaxi Yike Daxue Xuebao. Journal of West China University of Medical Sciences. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.17- 1986- v. 17, p. 209, 1986 (HYDXET); cyt-mus-ihl 320 ug/m3/4W-C Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 20(3), p. 31, 1976 (GTPZAB); mtr-ham-emb 125 mg/L Advances in Modern Environmental Toxicology. (Senate Press, Inc., P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980- v. 1, p. 241, 1980 (AETODY); dnd-mus-ihl 32 ppm/104W-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 373, 2001 (CBINA8); hma-mus-sat 375 mg/kg/4H Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny. Journal of Experimental and Clinical Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1962- v. 16, p. 41, 1976 (ZKMAAX) RE: T01 orl-rat TDLo: 9100 ug/kg (26W male) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(2), p. 17, 1980 (GISAAA); T41 orl-rat TDLo: 1 mg/kg (11-12D preg) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(3), p. 30, 1975 (GTPZAB); T34 orl-rat TDLo: 1 mg/kg (11-12D preg) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(7), p. 30, 1975 (GTPZAB); T59 orl-rat TDLo: 1 mg/kg (9-10D preg) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(7), p. 30, 1975 (GTPZAB); T35 ihl-rat TCLo: 4 mg/m3/24H (3-4D preg) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(3), p. 30, 1975 (GTPZAB); T41 ihl-rat TCLo: 4 mg/m3/24H (11-12D preg) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(3), p. 30, 1975 (GTPZAB); T25 ihl-rat TCLo: 10 ppm/4H (3-20D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 44, p. 81, 1978 (TXAPA9); T01 ihl-rat TCLo: 150 ug/m3/24H (19W male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 17, p. 85, 1976 (EVHPAZ); T14 ihl-rat TCLo: 500 mg/m3/5H (17W pre) Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 60(7), p. 107, 1965 (BEBMAE); T12 ihl-rat TCLo: 500 mg/m3/5H (30W pre) Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 60(7), p. 107, 1965 (BEBMAE); T35 ihl-rat TCLo: 0.15 mg/m3 (multigenerations) "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 505, 1990 (VCVGH*) TE: V01-D09 ihl-rat TCLo: 80 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-467, 1998 (NTPTR*); V01-L60-J60 ihl-mus TCLo: 32 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-467, 1998 (NTPTR*); V02-K60-V08 ihl-mus TCLo: 32 ppm/6H/104W -I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 373, 2001 (CBINA8); V02-K60-V08 ihl-mus TCLo: 80 ppm/5H/104W -I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 373, 2001 (CBINA8); V03-K60-M60 ihl-rat TCLo: 988.9 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-123671 (NTIS**); V03-K60-N62 ihl-rat TCLo: 2060 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-123671 (NTIS**); V01-J60 ihl-mus TCLo: 791.04 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-123671 (NTIS**); V01-R60-L60 ihl-mus TCLo: 1977.6 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-123671 (NTIS**) ORNG: 450000000 ng/kg. [450.000000 mg/kg] T/E unlistd IHNG: 11800000000 ng/m3/4H. [11800.000000 mg/m3/4H] T/E unlistd AT: T/E unlistd orl-rat LD50: 450 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,38,1982 (85GMAT); T/E unlistd ihl-rat LC50: 11800 mg/m3/4H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,38,1982 (85GMAT); F12-J22-J24 scu-rat LDLo: 500 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 240, 1936 (JIHTAB); T/E unlistd orl-mus LD50: 146 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,38,1982 (85GMAT); T/E unlistd ihl-mus LC50: 2300 mg/m3 Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny. Journal of Experimental and Clinical Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1962- v. (6), p. 66, 1969 (ZKMAAX); F12-J22-J24 scu-mus LDLo: 1 gm/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 240, 1936 (JIHTAB); T/E unlistd ihl-cat LCLo: 1290 mg/m3/8H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 240, 1936 (JIHTAB); T/E unlistd scu-cat LDLo: 100 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 240, 1936 (JIHTAB); T/E unlistd ihl-rbt LCLo: 3870 mg/m3/8H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 240, 1936 (JIHTAB); P30-R03 ivn-rbt LDLo: 96 mg/kg Sbornik Lekarsky. Collection of Medical Works. (PNS-Ustredni Expedice a Dovoz Tisku, Kafkova 19, 160 00 Prague 6, Czechoslovakia) V.1- 1887- v. 44, p. 63, 1942 (SBLEA2); T/E unlistd scu-pgn LDLo: 13 gm/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 240, 1936 (JIHTAB) MD: L70-N73-Y10 orl-rat TDLo: 9100 ug/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(2), p. 17, 1980 (GISAAA); L01-L30-Y07 orl-rat TDLo: 1680 mg/kg/3W-I Zhongguo Yaolixue Yu Dulixue Zazhi. (Chinese Pharmacological Society, 27 Tai-Ping Road, Beijing 100850, China) V.1- 1986- v. 9, p. 283, 1995 (ZYYZEW); L70-M70-U01 ihl-rat TCLo: 161 ppm/6H/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 46, p. 375, 1978 (TXAPA9); A30-L30-Y03 ihl-rat TCLo: 220 ug/m3/24H/60D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 29(9), p. 13, 1964 (GISAAA); A30-K09-P27 ihl-rat TCLo: 200 mg/m3/24H/91D-C Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 240, 1936 (JIHTAB); J70-R21-U01 ihl-rat TCLo: 50 ppm/6H/2Y-I Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 10, p. 443, 1998 (INHTE5); D07 ihl-rat TCLo: 32 ppm/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-467, 1998 (NTPTR*); P28-L30-P30 ipr-rat TDLo: 168 mg/kg/21D-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 6, p. 126, 1992 (WDZAEK); S05 orl-mus TDLo: 63 mg/m3/21D-I Zhongguo Yaolixue Yu Dulixue Zazhi. (Chinese Pharmacological Society, 27 Tai-Ping Road, Beijing 100850, China) V.1- 1986- v. 2, p. 57, 1988 (ZYYZEW); N74-S02-S04 ihl-mus TDLo: 1260 mg/m3/14D-I Zhongguo Yaolixue Yu Dulixue Zazhi. (Chinese Pharmacological Society, 27 Tai-Ping Road, Beijing 100850, China) V.1- 1986- v. 3, p. 125, 1989 (ZYYZEW); K09-P27-Z01 ihl-mus TCLo: 200 mg/m3/24H/91D-C Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 240, 1936 (JIHTAB); S05-Y40 scu-mus TDLo: 42 mg/kg/21D-I Zhongguo Yaolixue Yu Dulixue Zazhi. (Chinese Pharmacological Society, 27 Tai-Ping Road, Beijing 100850, China) V.1- 1986- v. 2, p. 57, 1988 (ZYYZEW); L02-U01-Z01 ihl-ham TCLo: 162 ppm/6H/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 46, p. 375, 1978 (TXAPA9); U01 ihl-ham TCLo: 50 ppm/6H/78W-I Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 10, p. 443, 1998 (INHTE5) TR: ACGIH TLV-TWA 10 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 227, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 131, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 131, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 227, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 227, 1999 (IMEMDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 13, p. 153, 1978 (CTOXAO); TOXICOLOGY REVIEW Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 27, 2001 (CBINA8); TOXICOLOGY REVIEW Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 81, 2001 (CBINA8) SR: MSHA STANDARD-air: TWA 25 ppm (90 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 54, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 25 ppm (90 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 25 ppm (90 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 25 ppm (90 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 25 ppm (90 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 ppm (35 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 10 ppm (36 mg/m3), JAN 1999; OEL-BELGIUM: TWA 10 ppm (36 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 1 ppm (3.6 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 10 ppm (36 mg/m3), STEL 20 ppm (72 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 10 ppm (36 mg/m3), JAN 1999; OEL-GERMANY: MAK 5 ppm (18 mg/m3), Skin, JAN 1999; OEL-HUNGARY: TWA 10 mg/m3, STEL 30 mg/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 10 ppm (36 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 1 ppm (3.6 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 2 mg/m3, STEL, 16 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.05 mg/m3, JAN 1993; OEL-SWEDEN: NGV 10 ppm (35 mg/m3), KTV 15 ppm (60 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 10 ppm (36 mg/m3), KZG-W 20 ppm (72 mg/m3), Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 10 ppm (37 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO beta-CHLOROPRENE-air: CA CL 1 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #95-121, 1995 (NIOSH*); NOHS 1974: HZD 18260; NIS 39; TNF 3538; NOS 26; TNE 43712; NOES 1983: HZD 18260; NIS 17; TNF 1864; NOS 21; TNE 17750; TFE 654 SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, Sperm morphology-rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 1, 1975; NIOSH Analytical Method, 1994: beta-Chloroprene, 1002; NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #112 Record 623 of 1119 in RTECS (through 2003/06) AN: EJ0700000 PN: 1,3-Butadiene,-hexachloro- SY: 1,1,2,3,4,4-Hexachloro-1,3-butadiene-; 1,3-Hexachlorobutadiene-; Dolen-pur-; GP-40-66:120; HCBD-; Hexachlor-1,3-butadien- (Czech); Hexachlorbutadiene-; Hexachloro-1,3-butadiene-; Hexachlorobutadiene-; Hexachlorobutadiene- (ACGIH); Perchlorobutadiene-; RCRA-waste-number-U128- RN: Current: 87-68-3 BRN: 1766570 BHR: 4-01-00-00988 UD: 200305 MF: C4-Cl6 MW: 260.74 WL: GYGUYGYGUYGG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 810 mg/24H MOD European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 171, 1976 (EJTXAZ); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,116,1986 (85JCAE); eye-rbt 162 mg MLD European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 171, 1976 (EJTXAZ); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,116,1986 (85JCAE) ME: mmo-sat 1 mg/plate (+S9) HEW Publication (FDA. United States). (Washington, DC) ?-1979(?). For publisher information, see HPFSDS. FDA-78-1046, 1978 (DHEFDK); mmo-sat 320 ug/plate (-S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 431, 1986 (CRNGDP); cyt-hmn-lym 1 mg/L Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 22(4), p. 46, 1988 (CYGEDX); dns-rat-orl 77 gm/kg/11W Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 287, 1981 (TXAPA9); cyt-mus-orl 2 mg/kg Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 22(4), p. 46, 1988 (CYGEDX); cyt-mus-ihl 10 mg/m3 Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 22(4), p. 46, 1988 (CYGEDX); dns-ham-emb 2 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 23, p. 297, 1984 (CALEDQ); sce-ham-ovr 1400 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); mtr-ham-emb 10 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 23, p. 297, 1984 (CALEDQ) RE: T83 orl-rat TDLo: 45 mg/kg (13W male/13W pre-3W post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 42, p. 387, 1977 (TXAPA9); T81 orl-rat TDLo: 4 gm/kg (13W male/13W pre-3W post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 42, p. 387, 1977 (TXAPA9); T41-T81 orl-rat TDLo: 178 mg/kg (1-22D preg) Arkhiv Anatomii, Gistologii i Embriologii. Archives of Anatomy, Histology and Embryology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-101, 1916-91. Discontinued v. 89(8), p. 44, 1985 (AAGEAA); T34 ihl-rat TCLo: 15 ppm/6H (6-20D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 47, p. 235, 1989 (TOLED5); T25-T34 ipr-rat TDLo: 150 mg/kg (1-15D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO); T76 scu-rat TDLo: 20 mg/kg (1D pre) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31, p. 33, 1966 (GISAAA); T01 orl-mus TDLo: 10920 ug/kg (13W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-185884 (NTIS**); T34 orl-rat TDLo: 20 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); T53-T83 orl-rat TDLo: 75 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); T72 orl-rat TDLo: 225 mg/kg (17-22D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); T75-T83 orl-rat TDLo: 37.5 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); T81 orl-rat TDLo: 5 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**) TE: V01-M61 orl-rat TDLo: 15 gm/kg/2Y-C American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 38, p. 589, 1977 (AIHAAP) ORNG: 82000000 ng/kg. [82.000000 mg/kg] T/E unlistd SRNG: 100000000 ng/kg. [100.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 82 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(2), p. 32, 1972 (GISAAA); F07-F33 ipr-rat LD50: 175 mg/kg European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 8, p. 180, 1975 (EJTXAZ); T/E unlistd orl-mus LD50: 87 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 28(2), p. 9, 1963 (GISAAA); T/E unlistd ihl-mus LC50: 370 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(2), p. 32, 1972 (GISAAA); T/E unlistd skn-mus LD50: 150 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(2), p. 32, 1972 (GISAAA); T/E unlistd ipr-mus LD50: 76 mg/kg European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 7, p. 247, 1974 (EJTXAZ); T/E unlistd orl-cat LD50: 187 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(2), p. 32, 1972 (GISAAA); T/E unlistd skn-rbt LD50: 100 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(2), p. 32, 1972 (GISAAA); T/E unlistd orl-gpg LD50: 90 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 28(2), p. 9, 1963 (GISAAA); T/E unlistd orl-ham LD50: 960 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A192, 1979 (TXAPA9); T/E unlistd ihl-mam LC50: 370 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(5), p. 72, 1990 (GISAAA); T/E unlistd unr-mam LD50: 200 mg/kg "Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971 -,40,1971 (30ZDA9) MD: A30-F41-P28 orl-rat TDLo: 1274 mg/kg/26W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 11(3), p. 23, 1967 (GTPZAB); M16-M30-U01 orl-rat TDLo: 14600 mg/kg/2Y-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 21, p. 49, 1977 (EVHPAZ); M70-U01 orl-rat TDLo: 105 mg/kg/14D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 47, p. 1, 1979 (TXAPA9); M03-M70-L70 orl-rat TDLo: 794 mg/kg/18W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 47, p. 1, 1979 (TXAPA9); M03-U01-Z01 ihl-rat TCLo: 100 ppm/6H/2W-I British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 27, p. 1, 1970 (BJIMAG); M16-N72-Y15 orl-rat TDLo: 560 mg/kg/4W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 125, 1993 (FCTOD7); P30-P72-U01 ihl-rat TCLo: 26 mg/m3/2H/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(2), p. 32, 1972 (GISAAA); L30-P28-Y03 ipr-rat TDLo: 313 mg/kg/3D-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 8, p. 191, 1992 (TIHEEC); G70-N73-U01 orl-mus TDLo: 540 mg/kg/15D-C Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 9, p. 323, 1989 (JEPOEC); G70-M70-U01 orl-mus TDLo: 1092 mg/kg/13W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-185884 (NTIS**); L30-P28-S01 orl-gpg TDLo: 420 mg/kg/30W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 9(11), p. 50, 1965 (GTPZAB); L15-P28 ihl-man TCLo: 0.02 ppm/9Y-I British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 49, p. 700, 1992 (BJIMAG); F15-M30-U01 orl-rat TDLo: 80 mg/kg/16D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); F11-F18 orl-rat TDLo: 160 mg/kg/16D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); F04 orl-rat TDLo: 160 mg/kg/16D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); M03-M71 orl-rat TDLo: 160 mg/kg/16D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); M16 orl-rat TDLo: 1040 mg/kg/16D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); F16 orl-rat TDLo: 320 mg/kg/16D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); M10 orl-rat TDLo: 600 mg/kg/16D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**); Z01 orl-rat TDLo: 385 mg/kg/7D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-123867 (NTIS**) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.02 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 179, 1979 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 277, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 179, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 277, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 277, 1999 (IMEMDT) SR: OEL-AUSTRALIA: TWA 0.02 ppm (0.24 mg/m3), Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Skin, Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.02 ppm (0.21 mg/m3), Skin, Carcinogen, JAN 1993; OEL-FINLAND: Carcinogen, JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.02 ppm (0.24 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.02 ppm (0.24 mg/m3), JAN 1999; OEL-RUSSIA: STEL 0.005 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: MAK-W 0.02 ppm (0.24 mg/m3), Skin, JAN 1999; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO HEXACHLOROBUTADIENE-air: 10H CA TWA 0.02 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X6278; NIS 1; TNF 3; NOS 11; TNE 1010; TFE 26 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/100160/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hexachlorobutadiene, 2543; NTP Toxicity studies, RPT# TOX-01, October 2000 Record 624 of 1119 in RTECS (through 2003/06) AN: EJ4025000 PN: 1-Butanamine,-N-butyl-N-nitroso- SY: Butylamine,-N-nitrosodi-; DBA-; DBN-; DBNA-; Di-n-butylnitrosamin- (German); Di-n-butylnitrosamine-; Dibutylamine,-N-nitroso- (6CI); Dibutylnitrosamine-; N,N-Di-n-butylnitrosamine-; N,N-Dibutylnitrosoamine-; N-Butyl-N-nitroso-1-butamine-; N-Di-N-butylnitrosamine-; N-Nitroso-di-n-butylamine-; N-Nitrosodibutylamine-; NDBA-; Nitrosodibutylamine-; RCRA-waste-number-U172- RN: Current: 924-16-3 BRN: 1760378 BHR: 4-04-00-03389 UD: 200204 MF: C8-H18-N2-O MW: 158.28 WL: ONN4&4 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 20 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 1, 1979 (MUREAV); oms-esc 125 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); mmo-esc 1 umol/plate (+S9) Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 75, p. 8, 1984 (GANNA2); dnd-esc 100 nmol/tube Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 781, 1982 (CRNGDP); mmo-bcs 5 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 19, 1977 (MUREAV); dnr-bcs 5 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 19, 1977 (MUREAV); slt-dmg-orl 10 umol/vial Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 252, p. 119, 1991 (MUREAV); dns-hmn-lvr 180 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dns-hmn-hla 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dnd-rat-orl 83 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-lvr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2592, 1982 (CNREA8); dns-rat-lvr 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); bfa-rat-sat 158 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 967, 1985 (CRNGDP); hma-rat-smc 2912 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 3, p. 41, 1983 (TCMUD8); dnd-mus-ipr 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dns-mus-scu 960 mg/kg Acta Pathologica et Microbiologica Scandinavica, Section A, Supplement. (Copenhagen, Denmark) No.210-274, 1970-81. For publisher information, see ACPADQ. v. 274, p. 304, 1981 (APMSBI); dni-mus-scu 9600 mg/kg Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1968- v. 27, p. 119, 1978 (VAAZA2); dni-mus-ipr 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 37, p. 67, 1976 (MUREAV); cyt-mus-scu 960 mg/kg/24W Acta Pathologica et Microbiologica Scandinavica, Section A, Supplement. (Copenhagen, Denmark) No.210-274, 1970-81. For publisher information, see ACPADQ. v. 274, p. 304, 1981 (APMSBI); mmo-ham-lng 500 umol/L (+S9) IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 27, p. 179, 1980 (IAPUDO); cyt-ham-lng 150 mg/L/27H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 277, 1979 (MUREAV); msc-ham-ovr 100 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 539, 1984 (ENMUDM); dnd-gpg-lvr 3130 nmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 15, p. 24, 1990 (EMMUEG) RE: T34 orl-rat TDLo: 1200 mg/kg (12D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1308, 1974 (BEXBAN); T35 orl-rat TDLo: 1200 mg/kg (10D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 112, 1973 (IARCCD); T35 ipr-rat TDLo: 1 gm/kg (10D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 112, 1973 (IARCCD); T76 scu-ham TDLo: 30 mg/kg (15D preg) Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 86, p. 69, 1976 (ZKKOBW) TE: V01-K60 orl-rat TDLo: 140 mg/kg/4W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 6160, 1986 (CNREA8); V03-M60 scu-rat TDLo: 8 gm/kg/20W-I Xenobiotica. (Taylor and Francis Ltd., 4 John St., London WC1N 2ET, UK) V.1- 1971- v. 3, p. 271, 1973 (XENOBH); V02-J60 orl-mus TDLo: 1200 mg/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 19, 1986 (TXAPA9); V02-J60 ipr-mus TDLo: 240 mg/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 19, 1986 (TXAPA9); V01-L60-M60 scu-mus TDLo: 800 mg/kg/40W-I European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 6, p. 433, 1970 (EJCAAH); V01-P61-R60 ivn-mus TDLo: 12 mg/kg/25W-I Japanese Journal of Genetics. Idengaku Zasshi. (Genetics Soc. of Japan, 111 Tanida, Mishima, Shizuoka-ken, Japan) V.1- 1921- v. 45, p. 71, 1970 (IDZAAW); V02-J60-M60 scu-rbt TDLo: 34 gm/kg/78W-I Investigative Urology. (Baltimore, MD) V.1-19, 1963-81. For publisher information, see JOURAA. v. 12, p. 262, 1975 (INURAQ); V03-L60-M60 orl-gpg TDLo: 24 gm/kg/2Y-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 71, p. 183, 1968 (ZEKBAI); V03-T65-J60 orl-ham TDLo: 9 gm/kg (30D post) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 136, p. 1007, 1971 (PSEBAA); V03-K60 orl-ham TDLo: 3900 mg/kg/13W-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 136, p. 168, 1971 (PSEBAA); V03-J60-K60 ipr-ham TDLo: 200 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 79, p. 85, 1973 (ZKKOBW); V01-T65-J61 scu-ham TDLo: 240 mg/kg (8-15D preg) Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 86, p. 69, 1976 (ZKKOBW); V01-J61 scu-ham TDLo: 240 mg/kg/8D-I Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 86, p. 69, 1976 (ZKKOBW); V03-K60 scu-rat TD :7400 mg/kg/37W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 1077, 1969 (ARZNAD); V03-D09-M60 scu-ham TD :2162 mg/kg/46W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 57, p. 401, 1976 (JNCIAM); V03-L60 orl-rat TD :64 gm/kg/20W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 67, p. 825, 1976 (GANNA2); V03-M14-M60 scu-mus TD :3200 mg/kg/30W-I Annual Report--Cancer Research Campaign. (Cancer Research Campaign, 2 Carlton House Terrace, London SW1Y 5AR, UK) V.1- 1924- v. 46, p. 271, 1968 (BECCAN); V03-K60 orl-rat TD :3900 mg/kg/56W-C Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 1077, 1969 (ARZNAD); V03-K60-M60 orl-rat TD :12600 mg/kg/30W-C IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 649, 1982 (IAPUDO); V03-L60 orl-rat TD :3640 mg/kg/26W-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 50, p. 169, 1983 (EVHPAZ); V02-K60-L60 orl-mus TD :2190 mg/kg/1Y-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 60, p. 353, 1969 (GANNA2); V01-K60-L60 orl-rat TD :648 mg/kg/2Y-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 19, p. 207, 1983 (CALEDQ); V03-M60 orl-rat TD :882 mg/kg/2W-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 78, p. 227, 1987 (JJCREP); V01-T64 iut-mus TDLo: 14 gm/kg/20W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 165, p. 123, 2001 (CALEDQ) ORNG: 1200000000 ng/kg. [1200.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1200 mg/kg Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 50, p. 735, 1963 (NATWAY); T/E unlistd scu-rat LD50: 1200 mg/kg Xenobiotica. (Taylor and Francis Ltd., 4 John St., London WC1N 2ET, UK) V.1- 1971- v. 3, p. 271, 1973 (XENOBH); L30-M03-N30 orl-ham LD50: 2150 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 79, p. 85, 1973 (ZKKOBW); L30-M03-N30 ipr-ham LD50: 1200 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 79, p. 85, 1973 (ZKKOBW); G01-M02-N30 scu-ham LD50: 561 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 136, p. 168, 1971 (PSEBAA) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 51, 1978 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 28, p. 151, 1982 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 51, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 64, p. 77, 1976 (RREVAH); TOXICOLOGY REVIEW Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 17, p. 161, 1975 (GMCRDC); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 13, p. 271, 1970 (ADCSAJ) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.001 mg/m3, Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-nonhuman, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Nitrosamines, 2522; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #27 Record 625 of 1119 in RTECS (through 2003/06) AN: EJ6300000 PN: Butane,-1-chloro- SY: Butyl-chloride-; n-Butyl-chloride-; 1-Chlorobutane-; Chlorure-de-butyle- (French); NCI-C06155-; n-Propylcarbinyl-chloride- RN: Current: 109-69-3 BRN: 1730909 BHR: 4-01-00-00246 UD: 200210 MF: C4-H9-Cl MW: 92.58 WL: G4 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: msc-mus-lym 500 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-312, 1986 (NTPTR*) RE: T35 orl-rat TDLo: 13927 mg/kg (1-19D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(3), p. 11, 1979 (GISAAA) TE: V03-L60 orl-mus TDLo: 257500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-218526/AS (NTIS**) ORNG: 2670000000 ng/kg. [2670.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2670 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 61, 1954 (AMIHBC); T/E unlistd ihl-rat LCLo: 8000 ppm/4H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 61, 1954 (AMIHBC); T/E unlistd unr-rat LD50: 2200 mg/kg Vrachebnoe Delo. Medical Practice. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1918- v. (7), p. 105, 1979 (VRDEA5); T/E unlistd unr-mus LD50: 5600 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(3), p. 11, 1979 (GISAAA); T/E unlistd skn-rbt LDLo: 20 gm/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,745,1969 (34ZIAG); T/E unlistd unr-gpg LD50: 8 gm/kg Vrachebnoe Delo. Medical Practice. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1918- v. (7), p. 105, 1979 (VRDEA5) MD: Y01-Y03-Y10 orl-rat TDLo: 364 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(3), p. 11, 1979 (GISAAA); F11-F12-Z01 orl-rat TDLo: 10500 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-312, 1986 (NTPTR*); Z01 orl-rat TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-312, 1986 (NTPTR*); Z01 orl-mus TDLo: 21 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-312, 1986 (NTPTR*); Z01 orl-mus TDLo: 65 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-312, 1986 (NTPTR*) SR: OEL-NORWAY: TWA 0.5 ppm (1.5 mg/m3), JAN 1999; OEL-RUSSIA: STEL 0.5 mg/m3, Skin, JAN 1993 ND: NOES 1983: HZD X3168; NIS 2; TNF 33; NOS 4; TNE 3202; TFE 880 SL: EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat Record 626 of 1119 in RTECS (through 2003/06) AN: EJ8225000 PN: Butane, 1,2:3,4-diepoxy- SY: 1,1'-Bi(ethylene oxide); 1,2:3,4-Diepoxybutane; 1,3-Butadiene-diepoxide-; 2,4-Diepoxybutane-; Bioxiran-; Bioxirane-; Butadiendioxyd- (German); Butadiene-diepoxide-; Butadiene-dioxide-; Butane-diepoxide-; DEB-; Diepoxybutane-; Dioxybutadiene-; ENT-26592-; RCRA-waste-number-U085- RN: Current: 1464-53-5 BRN: 79833 BHR: 5-19-01-00185 UD: 200305 MF: C4-H6-O2 MW: 86.10 WL: T3OTJ B- BT3OTJ CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 5 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,771,1986 (85JCAE); eye-rbt 3 ppm/3D Journal of the Air Pollution Control Association. (Air Pollution Control Assoc., POB 2861, Pittsburgh, PA 15230) V.5- 1955- v. 10, p. 17, 1960 (JPCAAC) ME: mmo-sat 20 ug/plate (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 367, 1979 (MUREAV); mmo-esc 10 mmol/L (-S9) Toxicological European Research. (S.P.E., 10, Ave. de Messine, 75008 Paris, France) V.1- 1978- v. 3, p. 131, 1981 (TOERD9); dnr-esc 50 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 53, 1977 (MUREAV); dns-esc 80 mmol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 92, p. 157, 1978 (ZKKOBW); pic-esc 7500 ug/L Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. v. 12, p. 234, 1964 (APMBAY); dnr-bcs 200 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); mmo-klp 50 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 269, 1981 (MUREAV); mmo-omi 1000 ppm/30M-C (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 16, p. 197, 1971 (FOMIAZ); dnd-omi 2 mmol/L/2H-C Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 174, p. 674, 1969 (BBACAQ); dnd-omi 13 mmol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 73, p. 2629, 1976 (PNASA6); dnd-omi 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); slt-dmg-orl 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 107, 1982 (MUREAV); slt-dmg-par 11600 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 195, 1970 (CNREA8); dnd-dmg-orl 5 mmol/L/24H-C Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 115, p. 323, 1987 (GENTAE); cyt-dmg-par 5 mmol/L Zeitschrift fuer Vererbungslehre. (Berlin, Fed. Rep. Ger.) V.89-98, 1958-66. For publisher information, see MGGEAE. v. 92, p. 457, 1961 (ZEVBA5); sln-dmg-par 1000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 49, p. 219, 1978 (MUREAV); sln-dmg-orl 100 ppm Journal of Genetics. (Belghoria, India) V.1-63, 1910-77. Discontinued. v. 50, p. 480, 1952 (JOGNAU); trn-dmg-unr 1000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 3, p. 455, 1966 (MUREAV); mmo-nsc 3 mmol/L (-S9) Japanese Journal of Genetics. Idengaku Zasshi. (Genetics Soc. of Japan, 111 Tanida, Mishima, Shizuoka-ken, Japan) V.1- 1921- v. 43, p. 1, 1968 (IDZAAW); mmo-smc 48 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 61, p. 207, 1979 (MUREAV); mmo-smc 400 ppm (+S9) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB80-133226 (NTIS**); mrc-smc 400 ppm JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 901, 1979 (JJIND8); dni-smc 5000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 132, p. 161, 1984 (MUREAV); mmo-asn 20 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 3, p. 145, 1966 (MUREAV); dlt-oin-par 3 ug Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 63, 1969 (MUREAV); mnt-hmn-lym 500 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 1687, 1997 (CRNGDP); dnd-hmn-leu 6500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 93, 2000 (MUREAV); cyt-hmn-lym 100 ug/L Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 34, p. 230, 1982 (CGCGBR); cyt-hmn-bmr 100 ug/L Cancer Genetics and Cytogenetics. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1979- v. 9, p. 51, 1983 (CGCYDF); sce-hmn-lym 5 mg/L Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 101, p. 97, 1982 (BIZNAT); sln-hmn-lym 1 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 1687, 1997 (CRNGDP); msc-hmn-lym 3500 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 713, 1994 (CRNGDP); mtr-rat-emb 170 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); cyt-rat-scu 1 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 653, 1969 (TXAPA9); cyt-rat-lvr 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 64, p. 329, 1979 (MUREAV); sce-rat-lvr 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 439, p. 13, 1999 (MUREAV); spm-mus-ipr 16 mg/kg Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 46, p. 291, 1961 (GENTAE); mnt-mus-orl 36 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); mnt-mus-ipr 30 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 354, p. 49, 1996 (MUREAV); mtr-mus-fbr 8 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dnd-mus-ipr 60 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); cyt-mus-lym 10 ug/L Human Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.31- 1976- v. 73, p. 86, 1986 (HUGEDQ); sce-mus-lvr 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 439, p. 13, 1999 (MUREAV); sce-mus-ipr 10 umol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 108, p. 251, 1983 (MUREAV); sce-mus-ivn 193 umol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 108, p. 251, 1983 (MUREAV); msc-mus-ipr 21 mg/kg/6D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 719, 1994 (CRNGDP); hma-mus-sat 444 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); mtr-ham-emb 50 ug/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); cyt-ham-ovr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 212, p. 103, 1989 (MUREAV); sce-ham-lng 1 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3270, 1984 (CNREA8); sce-ham-ovr 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 263, p. 47, 1991 (MUREAV); dnd-mam-lym 10 mmol/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 138, p. 611, 1967 (BBACAQ); dna-hmn-fbr 10 mmol/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 484, p. 3, 2001 (MUREAV); mnt-mus-fbr 2.5 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 472, p. 105, 2000 (MUREAV); slt-mus-fbr 2.5 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 472, p. 105, 2000 (MUREAV); dnd-oin-orl 0.5 mmol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 476, p. 149, 2001 (MUREAV) RE: T31-T34-T35 ipr-rat TDLo: 86.1 mg/kg (5-8D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S164, 2002 (TOLED5) TE: V02-D29 ihl-rat TCLo: 5 ppm/6H/6W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 341, 1999 (TOXID9); V03-Q60-V10 ipr-rat TDLo: 380 mg/kg/13W-I British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 6, p. 235, 1951 (BJPCAL); V03-R60-V10 skn-mus TDLo: 95 gm/kg/78W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 305, 1963 (AIHAAP); V03-P62-R60 unr-mus TDLo: 3400 mg/kg Radiation Research, Supplement. (New York, NY) No.1-7, 1959-67. Discontinued. v. 3, p. 193, 1963 (RARSAM) ORNG: 78000000 ng/kg. [78.000000 mg/kg] T/E unlistd SRNL: 89000 nL/kg. [0.089000 mL/kg] T/E unlistd IHPB: 90000 ppb/4H. [90.000000 ppm/4H] T/E unlistd AT: T/E unlistd orl-rat LD50: 78 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 61, 1954 (AMIHBC); T/E unlistd ihl-rat LC50: 90 ppm/4H Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 2, 1961 (SCCUR*); T/E unlistd orl-mus LD50: 72 mg/kg Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 2, 1961 (SCCUR*); T/E unlistd ipr-mus LD50: 31 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 230, p. 559, 1957 (AEPPAE); T/E unlistd skn-rbt LD50: 89 uL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 61, 1954 (AMIHBC) MD: T22-U01-Z01 ihl-rat TCLo: 5 ppm/6H/6W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 36(1, p. pt2), 177,1997 (TOXID9); U01-Z01 ims-rat TDLo: 25 mg/kg/10D-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 2, p. 50, 1961 (AEHLAU); D02-J22-P70 ihl-mus TCLo: 5 ppm/6H/6W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 36(1, p. pt2), 177,1997 (TOXID9); T11 ipr-mus TDLo: 361.2 mg/kg/30D-I Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 8, p. 963, 1995 (CRTOEC) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 109, 1999 (IMEMDT) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000 SL: EPA GENETOX PROGRAM 1988, Positive: Aspergillus-forward mutation, Aspergillus-recombination; EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: N crassa-reversion, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion, S pombe-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: Cell transform.-BALB/c-3T3, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 627 of 1119 in RTECS (through 2003/06) AN: EK0525000 PN: 1,4-Butanediol- SY: Agrisynth-B1D-; Butanediol-; Butane-1,4-diol-; 1,4-Butylene-glycol-; 1,4-Dihydroxybutane-; DIOL-14B-; Sucol-B-; Tetramethylene-1,4-diol-; 1,4-Tetramethylene-glycol- RN: Current: 110-63-4 BRN: 1633445 BHR: 4-01-00-02515 UD: 200302 MF: C4-H10-O2 MW: 90.14 WL: Q4Q CC: Tumorigen (C); Mutagen (M); Human-Data (P) ORNG: 1525000000 ng/kg. [1525.000000 mg/kg] F05-F07-P30 AT: F05 unr-wmn LDLo: 300 mg/kg Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 3, p. 110, 1948 (PHARAT); T/E unlistd rec-man LDLo: 429 mg/kg Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 3, p. 110, 1948 (PHARAT); F05-F07-P30 orl-rat LD50: 1525 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 41, 1968 (HYSAAV); D07-J30-U01 ihl-rat LCLo: 15 gm/m3/4H Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 3, p. 379, 1991 (INHTE5); T/E unlistd ipr-rat LD50: 1070 mg/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 26, p. 597, 1974 (JPPMAB); F05-F07-P30 orl-mus LD50: 2062 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 41, 1968 (HYSAAV); T/E unlistd ipr-mus LD50: 1650 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 385, 1979 (TXAPA9); F05-F07-P30 orl-rbt LD50: 2531 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 41, 1968 (HYSAAV); F05-F07-P30 orl-gpg LD50: 1200 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 41, 1968 (HYSAAV); T/E unlistd orl-mus LD50: 2062 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 152, 1984 (VCVGK*); T/E unlistd ipr-mus LDLo: 500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 152, 1984 (VCVGK*); T/E unlistd orl-rat LD50: 1525 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 152, 1984 (VCVGK*); F19 ipr-rat TDLo: 250 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 152, 1984 (VCVGK*); T/E unlistd orl-gpg LD50: 1200 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 152, 1984 (VCVGK*); T/E unlistd orl-rbt LD50: 2531 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 152, 1984 (VCVGK*) MD: P28-Y01-Y44 orl-rat TDLo: 5460 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 37, 1968 (GISAAA); P30-Y10-Y16 orl-rat TDLo: 14 gm/kg/28D-I Polish Journal of Occupational Medicine. (Polish Journal of Occupational Medicine, P.O. Box 199, 90-950 Lodz, Poland) V.1-3: 1988-90. Discontinued. v. 3, p. 421, 1990 (PJOMEY); P28-P71-U01 ihl-rat TCLo: 5200 mg/m3/6H/2W-I Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 3, p. 379, 1991 (INHTE5); J13 ihl-mam TCLo: 1500 mg/m3/4H/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 152, 1994 (VCVGK*) ND: NOHS 1974: HZD M0752; NIS 7; TNF 226; NOS 22; TNE 16785; NOES 1983: HZD M0752; NIS 21; TNF 759; NOS 25; TNE 16811; TFE 3870 SL: EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-54, October 2000 Record 628 of 1119 in RTECS (through 2003/06) AN: EK1750000 PN: 1,4-Butanediol,-dimethanesulfonate- SY: AN-33501-; Busulphane-; 1,4-Bis(methanesulfonoxy)butane; (1,4-Bis(methanesulfonyloxy)butane); Busulfan-; Busulphan-; 1,4-Butanediol-dimethanesulfonate-; 1,4-Butanediol-dimethanesulphonate-; C.B. 2041; 2041 C.B.; Citosulfan-; 1,4-Dimesyloxybutane-; 1,4-Dimethanesulfonoxybutane-; 1,4-Dimethanesulfonoxylbutane-; 1,4-Dimethanesulfonyloxybutane-; 1,4-Dimethanesulphonyloxybutane-; 1,4-Dimethylsulfonoxybutane-; 1,4-Dimethylsulfonyloxybutane-; GT-41-; Leucosulfan-; Mablin-; Methanesulfonic-acid,-tetramethylene-ester-; Mielevcin-; Mielosan-; Mielucin-; Milecitan-; Mileran-; Misulban-; Mitostan-; Myeleukon-; Myeloleukon-; Myelosan-; Mylecytan-; Myleran-; NCI-C01592-; NSC-750-; NSC-750-sulphabutin-; Sulfabutin-; Sulphabutin-; Tetramethylene bis(methanesulfonate); Tetramethylene-dimethane-sulfonate-; Tetramethylenester-kyseliny-methansulfonove- (Czech); X-149- RN: Current: 55-98-1 BRN: 1791786 BHR: 4-04-00-00019 UD: 200305 MF: C6-H14-O6-S2 MW: 246.32 WL: WS1&O4OSW1 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 333 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); mmo-esc 10 mg/disc (-S9) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 76, p. 475, 1958 (ANYAA9); mmo-esc 25 ug/plate (+S9) Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- v. 44, p. 96, 1985 (TAKHAA); dnd-omi 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); slt-dmg-orl 6 mmol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 359, 1989 (MUREAV); sln-dmg-par 10 mmol/L Journal of Genetics. (Belghoria, India) V.1-63, 1910-77. Discontinued. v. 54, p. 146, 1956 (JOGNAU); sln-dmg-unr 10 mmol/L Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 160, p. 228, 1969 (ANYAA9); sln-dmg-orl 90 umol/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 175, 1981 (EVSRBT); trn-dmg-orl 1 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); oms-oin-imp 600 mg/kg Annales de Biologie Animale, Biochimie, Biophysique. (Versailles, France) V.1-19, 1961-79. v. 17, p. 661, 1977 (ABABAC); cyt-oin-par 30 ug Annales de Biologie Animale, Biochimie, Biophysique. (Versailles, France) V.1-19, 1961-79. v. 17, p. 661, 1977 (ABABAC); spm-oin-imp 600 mg/kg Annales de Biologie Animale, Biochimie, Biophysique. (Versailles, France) V.1-19, 1961-79. v. 17, p. 661, 1977 (ABABAC); spm-oin-par 30 ug Annales de Biologie Animale, Biochimie, Biophysique. (Versailles, France) V.1-19, 1961-79. v. 17, p. 661, 1977 (ABABAC); dni-hmn-hla 10 mol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 113, 1978 (MUREAV); oms-hmn-leu 10 mg/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 54, p. 377, 1969 (ECREAL); oms-hmn-lym 80 umol/L Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. v. 7, p. 126, 1969 (HUMAA7); cyt-wmn-unr 138 mg/kg German Medical Monthly. English Translation. Translation of DMWOAX. (Stuttgart, Fed. Rep. Ger.) 1956-70. For publisher information, see GRMDAI. v. 14, p. 383, 1969 (GRMMAB); cyt-hmn-leu 10 mg/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 54, p. 377, 1969 (ECREAL); cyt-hmn-lym 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 35, 1978 (MUREAV); cyt-hmn-bmr 1 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3435, 1988 (CNREA8); sce-hmn-orl 2 mg/kg/5W Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 289, 1979 (MUREAV); sce-hmn-lym 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 35, 1978 (MUREAV); sce-hmn-bmr 1 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3435, 1988 (CNREA8); dnd-rat-ipr 43500 ug/kg Experimental Cell Biology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.44- 1976- v. 47, p. 92, 1979 (ECEBDI); dnd-rat-unr 4 mg/kg Pure and Applied Chemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1960- v. 42, p. 209, 1975 (PACHAS); dni-rat-ipr 4400 ug/kg European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 13, p. 215, 1977 (EJCAAH); dni-rat-orl 30 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 275, 1979 (MUREAV); dlt-rat-ipr 4 mg/kg Genetical Research. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1960- v. 4, p. 333, 1963 (GENRA8); mnt-mus-ipr 50 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 619, 1977 (JTEHD6); mmo-mus-lym 3 mg/L/4H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); slt-mus-ipr 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 249, p. 285, 1991 (MUREAV); dna-mus-leu 40 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 80, p. 496, 1961 (BIJOAK); dna-mus-ast 20 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 80, p. 496, 1961 (BIJOAK); dnd-mus-ipr 40 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dnd-mus-unr 10 mg/kg Pure and Applied Chemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1960- v. 42, p. 209, 1975 (PACHAS); dns-mus-ipr 30 mg/kg Japanese Journal of Genetics. Idengaku Zasshi. (Genetics Soc. of Japan, 111 Tanida, Mishima, Shizuoka-ken, Japan) V.1- 1921- v. 54, p. 405, 1979 (IDZAAW); dni-mus-leu 10 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 18, p. 1229, 1969 (BCPCA6); oms-mus-leu 10 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 18, p. 1229, 1969 (BCPCA6); cyt-mus-ipr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 329, 1978 (MUREAV); cyt-mus-unr 5 mg/kg Genetika (Zemun, Yugoslavia). (Unija Bioloskih Naucnih Drustava Jugoslavije, Postanski fah 12 7, Zemun, Yugoslavia) V.1- 1969- v. 11, p. 203, 1979 (GNTKDF); dlt-mus-ipr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 249, p. 285, 1991 (MUREAV); msc-mus-lym 6 mg/L/4H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); spm-mus-ipr 30 mg/kg/5D Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 4425, 1975 (PNASA6); mnt-ham-ovr 2 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 263, p. 237, 1991 (MUREAV); mtr-ham-kdy 20 mg/L Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 84, 1980 (ATSUDG); dnd-ham-lng 1 gm/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 1163, 1986 (BCPCA6); cyt-ham-orl 50 mg/kg Nutrition Research. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1981- v. 8, p. 635, 1986 (NTRSDC); cyt-ham-lng 1570 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); cyt-ham-ovr 4 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 263, p. 237, 1991 (MUREAV); sce-ham-ipr 25 mg/kg Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 29B, p. 613, 1984 (BLFSBY); sce-ham-ovr 20 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 577, 1983 (CNREA8); msc-ham-ovr 40 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 577, 1983 (CNREA8); dnd-oin-par 2.5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 476, p. 149, 2001 (MUREAV); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T42-T43-T52 orl-wmn TDLo: 17 mg/kg (4-36W preg) Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 25, p. 85, 1960 (PEDIAU); T53-T59-T81 orl-wmn TDLo: 17 mg/kg (4-36W preg) Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 25, p. 85, 1960 (PEDIAU); T05 orl-man TDLo: 5400 ug/kg (90D male) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 68, p. 967, 1958 (ANYAA9); T13 orl-wmn TDLo: 8460 ug/kg (22W pre) Obstetrics and Gynecology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1953- v. 21, p. 466, 1963 (OBGNAS); T50 unr-wmn TDLo: 5280 ug/kg (14-26W preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 92, p. 580, 1965 (AJOGAH); T14 unr-wmn TDLo: 4400 ug/kg (4W pre) Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 7, p. 397, 1960 (NEOLA4); T91 orl-rat TDLo: 10 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30(1), p. 14A, 1984 (TJADAB); T35 orl-rat TDLo: 48 mg/kg (7-14D preg) Proceedings of the European Society for the Study of Drug Toxicity. (Princeton, NJ 08540) V.1-15, 1963-74. For publisher information, see PESTD5. v. 11, p. 151, 1970 (PSDTAP); T34-T46 orl-rat TDLo: 5600 ug/kg (7-14D preg) Proceedings of the European Society for the Study of Drug Toxicity. (Princeton, NJ 08540) V.1-15, 1963-74. For publisher information, see PESTD5. v. 11, p. 151, 1970 (PSDTAP); T53 orl-rat TDLo: 5 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30(1), p. 14A, 1984 (TJADAB); T34-T43 orl-rat TDLo: 8 mg/kg (11-14D preg) Bulletin of Tokyo Dental College. (Tokyo Dental College, 1-2-2 Masago, Chiba, 260, Japan) V.1- 1960- v. 13, p. 103, 1972 (BTDCAV); T01-T02 orl-rat TDLo: 10 mg/kg (1D male) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 7, p. 147, 1984 (ATSUDG); T23 orl-rat TDLo: 49 mg/kg (49D male) "Antifertility Compounds in the Male and Female," Jackson, H., Springfield, IL, Charles C. Thomas, 1966 -,55,1966 (85GUAJ); T23 ipr-rat TDLo: 6 mg/kg (1D male) "Antifertility Compounds in the Male and Female," Jackson, H., Springfield, IL, Charles C. Thomas, 1966 -,55,1966 (85GUAJ); T85 ipr-rat TDLo: 1 mg/kg (9D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 68, p. 1230, 1969 (BEXBAN); T25-T29-T31 ipr-rat TDLo: 10 mg/kg (2D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 61, p. 423, 1966 (BEXBAN); T53-T91 ipr-rat TDLo: 10 mg/kg (15D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 17, p. 325, 1968 (JRPFA4); T24 ipr-rat TDLo: 6 mg/kg (1D male) Genetical Research. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1960- v. 4, p. 333, 1963 (GENRA8); T35 ipr-rat TDLo: 10 mg/kg (8D preg) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 209, p. 1215, 1966 (NATUAS); T01-T02 ipr-rat TDLo: 10 mg/kg (1D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 26, p. 247, 1971 (JRPFA4); T53 scu-rat TDLo: 20 mg/kg (20D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 70, p. 67, 1984 (JRPFA4); T25 ivn-rat TDLo: 10 mg/kg (8D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 100, 1973 (IARCCD); T53 unr-rat TDLo: 10 mg/kg (14D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 27, p. 401, 1977 (ARZNAD); T46 orl-mus TDLo: 100 mg/kg (7D preg) Annual Report of the Research Institute of Environmental Medicine, Nagoya University. (Nagoya, Japan) V.1-25, 1951-80. v. 14, p. 61, 1966 (ARINAU); T34 orl-mus TDLo: 40 mg/kg (6-9D preg) Bulletin of Tokyo Dental College. (Tokyo Dental College, 1-2-2 Masago, Chiba, 260, Japan) V.1- 1960- v. 13, p. 103, 1972 (BTDCAV); T25 orl-mus TDLo: 240 mg/kg (6-9D preg) Bulletin of Tokyo Dental College. (Tokyo Dental College, 1-2-2 Masago, Chiba, 260, Japan) V.1- 1960- v. 13, p. 103, 1972 (BTDCAV); T43 orl-mus TDLo: 160 mg/kg (10-12D preg) Bulletin of Tokyo Dental College. (Tokyo Dental College, 1-2-2 Masago, Chiba, 260, Japan) V.1- 1960- v. 13, p. 103, 1972 (BTDCAV); T81 orl-mus TDLo: 200 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 361, 1986 (TCMUD8); T01 ipr-mus TDLo: 20 mg/kg (1D male) Zeitschrift fuer Zellforschung und Mikroskopische Anatomie. (Berlin, Fed. Rep. Ger.) V.1-147, 1924-73. For publisher information, see CTSRCS. v. 92, p. 400, 1968 (ZZACAG); T26-T29 ipr-mus TDLo: 10 mg/kg (1D pre) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 171, 1971 (MUREAV); T34-T35 ipr-mus TDLo: 30 mg/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 3, p. 363, 1970 (TJADAB); T48 ipr-mus TDLo: 30 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 3, p. 363, 1970 (TJADAB); T25 ipr-mus TDLo: 25 mg/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 288, 1972 (TXAPA9); T91 ipr-mus TDLo: 10 mg/kg (18D preg) "Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks In New Drugs, Proceedings of the Symposium on Toxicological Testing for Safety of New Drugs, 3rd, Prague, 1976," Benesova, O., et al., eds., Prague, Czechoslovakia, Univerzita Karlova, 1979 -,141,1979 (40YJAX); T02-T03 ipr-mky TDLo: 10 mg/kg (1D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 16, p. 165, 1968 (JRPFA4); T34-T51-T53 orl-rbt TDLo: 32 mg/kg (7-14D preg) Proceedings of the European Society for the Study of Drug Toxicity. (Princeton, NJ 08540) V.1-15, 1963-74. For publisher information, see PESTD5. v. 10, p. 227, 1969 (PSDTAP); T01 ipr-ham TDLo: 40 mg/kg (1D male) Zeitschrift fuer Zellforschung und Mikroskopische Anatomie. (Berlin, Fed. Rep. Ger.) V.1-147, 1924-73. For publisher information, see CTSRCS. v. 92, p. 400, 1968 (ZZACAG); T24 orl-mam TDLo: 8 mg/kg (1D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 33, p. 1237, 1985 (BIREBV); T24 orl-mam TDLo: 4 mg/kg (1D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 33, p. 1237, 1985 (BIREBV); T23 ipr-mus TDLo: 13 mg/kg (1D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 176, p. 259, 1987 (MUREAV); T24 ipr-mus TDLo: 20 mg/kg (1D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 176, p. 259, 1987 (MUREAV) TE: V01-P61 orl-man TDLo: 5684 ug/kg/21W-C British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 1513, 1977 (BMJOAE); V02-P61-P62 ivn-mus TDLo: 48 mg/kg/42D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 25, p. 20, 1965 (CNREA8); V03-J60 ipr-mus TD :1200 mg/kg/8W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 3069, 1973 (CNREA8); V03-P25-P61 ipr-mus TD :70 mg/kg/6W-I Blood. (Grune and Stratton, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1946- v. 44, p. 49, 1974 (BLOOAW); V01-M61-T69 orl-wmn TD :1140 mg/kg/9Y-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 124, p. 66, 1969 (AIMDAP); V01-T64 orl-wmn TD :16720 ug/kg/2Y-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 108, p. 362, 1984 (JCROD7) AT: D35-H05-K01 orl-wmn TDLo: 80 mg/kg/8Y JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 238, p. 1951, 1977 (JAMAAP); F12 orl-man TDLo: 8 mg/kg/2D-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 1463, 1984 (LANCAO); U01 orl-rat LDLo: 15 mg/kg Khimiya i Meditsina. (Moscow, USSR) No.1-16, 1954-61. v. 13, p. 34, 1960 (KMFOAP); K30-P26-U01 ipr-rat LD50: 18 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 1, p. 39, 1958 (BCPCA6); F07-K12 scu-rat LD50: 22 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 5, p. 1894, 1971 (KSRNAM); T/E unlistd ivn-rat LD50: 1800 ug/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 20, p. 1467, 1970 (ARZNAD); T/E unlistd unr-rat LD50: 10 mg/kg Chemical Abstracts. (Chemical Abstracts Service, Box 3012, Columbus, OH 43210) V.1- 1907- v. 55, p. 10679a, 1961 (CHABA8); K12-R21 orl-mus LD50: 110 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 5, p. 1894, 1971 (KSRNAM); D07-F07-K12 ipr-mus LD50: 86 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 5, p. 1894, 1971 (KSRNAM); F07-K12 scu-mus LD50: 63 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 5, p. 1894, 1971 (KSRNAM); T/E unlistd unr-mus LD50: 46 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 6, p. 160, 1952 (BJCAAI); P14-P15-P30 ivn-dog LDLo: 8 mg/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 203, 1965 (CCSUBJ); P14-P15-P30 ivn-mky LDLo: 8 mg/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 203, 1965 (CCSUBJ); T/E unlistd orl-bwd LD50: 56200 ug/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV); T02 ipr-rat TDLo: 10 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 491, 1992 (REPTED); T01 ipr-mus TDLo: 13 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 176, p. 259, 1987 (MUREAV); P05-P14 ipr-mus LDLo: 40 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 176, p. 259, 1987 (MUREAV); T/E unlistd ipr-mus LD50: 44.9 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 176, p. 259, 1987 (MUREAV) MD: N74-P05-Z73 orl-rat TDLo: 45 mg/kg/30D-I Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 5, p. 2070, 1971 (KSRNAM); P26-P71-P72 ipr-mus TDLo: 84 mg/kg/23D-I Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 51(Suppl), p. 136, 1999 (JPPMAB); P25-U01-Z01 ipr-mus TDLo: 90 mg/kg/8W-I Blood. (Grune and Stratton, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1946- v. 44, p. 49, 1974 (BLOOAW); P14-K07-Z01 orl-rbt TDLo: 100 mg/kg/5D-I Khimiya i Meditsina. (Moscow, USSR) No.1-16, 1954-61. v. 13, p. 34, 1960 (KMFOAP); P26-P30-P72 orl-dom TDLo: 33 mg/kg/3D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 298, p. 820, 2001 (JPETAB) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 247, 1974 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 137, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 247, 1974 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 137, 1987 (IMSUDL); TOXICOLOGY REVIEW Experimental Hematology (New York). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1973- v. 2, p. 101, 1974 (EXHMA6); TOXICOLOGY REVIEW JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 172, p. 1765, 1960 (JAMAAP); TOXICOLOGY REVIEW Minnesota Medicine. (Minnesota Medical Assoc., 2221 University Ave., SE, Suite 400, Minneapolis, MN 55414) V.1- 1918- v. 57, p. 19, 1974 (MIMDAL); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 1(1), p. 93, 1971 (CRTXB2); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 5, p. 447, 1965 (ARVPAX); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3); TOXICOLOGY REVIEW Klinische Monatsblaetter fuer Augenheilkunde. (Ferdinand Enke Verlag, POB 1304, D-7000 Stuttgart 1, Fed. Rep. Ger.) V.1- 1863- v. 170, p. 818, 1977 (KMAUAI) ND: NOES 1983: HZD X4342; NIS 1; TNF 74; NOS 3; TNE 1764; TFE 892 SL: EPA GENETOX PROGRAM 1988, Positive: Rodent dominant lethal, L5178Y cells in vitro-TK test; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse, Sperm morphology-rabbit; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive/dose response: In vivo cytogenetics-nonhuman bone marrow; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human lymphocytes; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human; EPA GENETOX PROGRAM 1988, Negative: Mouse specific locus; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat, Cytogenetics-male germ cell; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 629 of 1119 in RTECS (through 2003/06) AN: EK2625000 PN: 2,3-Butanedione- SY: Biacetyl-; 2,3-Butadione-; Diacetyl-; 2,3-Diketobutane-; Dimethyl-diketone-; Dimethylglyoxal-; Glyoxal,-dimethyl- RN: Current: 431-03-8 BRN: 605398 BHR: 4-01-00-03644 UD: 200210 MF: C4-H6-O2 MW: 86.10 WL: 1VV1 CC: Tumorigen (C); Drug (D); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MOD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 765, 1979 (FCTXAV) ME: mmo-sat 1 mg/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 367, 1979 (MUREAV); dns-rat-orl 1500 mg/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 76, p. 809, 1985 (JJCREP) ORNG: 1580000000 ng/kg. [1580.000000 mg/kg] F07-F12 AT: F07-F12 orl-rat LD50: 1580 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV); F12-F17-H05 ipr-rat LD50: 400 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 7, p. 571, 1969 (FCTXAV); T/E unlistd skn-rbt LD50: >5 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 765, 1979 (FCTXAV); F19-F24-J22 orl-gpg LD50: 990 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV); T/E unlistd orl-rat LD50: 3000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 448, 1994 (VCVGK*) MD: L70-N72-P08 orl-rat TDLo: 48600 mg/kg/90D-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 7, p. 571, 1969 (FCTXAV) ND: NOHS 1974: HZD 84595; NIS 3; TNF 126; NOS 6; TNE 1503; NOES 1983: HZD 84595; NIS 3; TNF 185; NOS 13; TNE 3438; TFE 1628 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, selected, October 2000 Record 630 of 1119 in RTECS (through 2003/06) AN: EK3675000 PN: Butane,-1,2-epoxy- SY: 1,2-Butene-oxide-; 1,2-Butylene-oxide-; 1,2-Epoxybutane-; 1-Butene-oxide-; Butylene-oxide-; Ethyl-ethylene-oxide-; Ethyl-oxirane-; Ethylene-oxide,-ethyl-; Ethyloxirane-; NCI-C55527- RN: Current: 106-88-7 BRN: 102411 BHR: 5-17-01-00056 UD: 200210 MF: C4-H8-O MW: 72.12 WL: T3OTJ B2 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,770,1986 (85JCAE); eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,770,1986 (85JCAE) ME: mmo-sat 3333 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 105, 1986 (MUREAV); oms-sat 780 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 20 umol/L (-S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); dnr-esc 50 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); dnd-esc 1 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); mmo-klp 1 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 269, 1981 (MUREAV); slt-dmg-orl 5 pph/72H National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-329, 1988 (NTPTR*); slt-dmg-ihl 3800 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 405, p. 259, 1998 (MUREAV); sln-dmg-orl 5 pph Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); trn-dmg-orl 5 pph Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); mrc-smc 6000 ppm JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 901, 1979 (JJIND8); mmo-ssp 1600 umol/L (+S9) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 3, p. 75, 1983 (TCMUD8); mtr-rat-emb 700 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); mmo-mus-lym 400 mg/L (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 143, 1987 (ENMUDM); msc-mus-lym 400 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 143, 1987 (ENMUDM); mtr-ham-emb 50 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); sce-ham-lng 2500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 249, p. 55, 1991 (MUREAV); dnd-mam-lym 100 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 9, p. 97, 1974 (CBINA8) RE: T25 ihl-rbt TCLo: 1000 ppm/7H (1-24D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB81-168510 (NTIS**) TE: V01-D09-J60 ihl-rat TCLo: 400 ppm/6H/5D/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-329, 1988 (NTPTR*); V01-J60 ihl-rat TCLo: 12360 mg/kg/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-216262/AS (NTIS**); V02-D09 ihl-rat TCLo: 10300 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-216262/AS (NTIS**); V02-D09 ihl-mus TCLo: 3090 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-216262/AS (NTIS**) ORNG: 500000000 ng/kg. [500.000000 mg/kg] T/E unlistd SRNL: 2100000 nL/kg. [2.100000 mL/kg] T/E unlistd IHNG: 6300000000 ng/m3/4H. [6300.000000 mg/m3/4H] T/E unlistd AT: T/E unlistd orl-rat LD50: 500 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB81-168510 (NTIS**); T/E unlistd ihl-rat LC50: 6300 mg/m3/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528421 (NTIS**); T/E unlistd ihl-mus LCLo: 398 ppm/4H National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-329, 1988 (NTPTR*); T/E unlistd skn-rbt LD50: 2100 uL/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 95, 1962 (AIHAAP) MD: L70 ihl-rat TCLo: 800 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-329, 1988 (NTPTR*); Z01 ihl-rat TCLo: 1600 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-329, 1988 (NTPTR*); D07-M16-U01 ihl-rat TCLo: 600 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 1, p. 319, 1981 (FAATDF); Z01 ihl-mus TCLo: 800 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-329, 1988 (NTPTR*); L70 ihl-mus TCLo: 400 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-329, 1988 (NTPTR*); D07-Z01 ihl-mus TCLo: 1600 ppm/6H/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 1, p. 319, 1981 (FAATDF); D07-U01 ihl-mus TCLo: 600 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 1, p. 319, 1981 (FAATDF) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 47, p. 217, 1989 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 629, 1999 (IMEMDT); IARC Cancer Review: Human No Adquate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 629, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 629, 1999 (IMEMDT) SR: OEL-AUSTRIA: Skin, Carcinogen, JAN 1999 ND: NOES 1983: HZD X9126; NIS 166; TNF 14049; NOS 104; TNE 261650; TFE 42961 SL: EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay, Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: N crassa-reversion, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: E coli polA with S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-BALB/c-3T3; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (inhal), clear evidence: rat; NCI Carcinogenesis Studies (inhal), no evidence: mouse Record 631 of 1119 in RTECS (through 2003/06) AN: EL1225000 PN: 1-Butanol, 4-(butylnitrosoamino)- SY: BBN-; Butanol (4)-butyl-nitrosamine; 4-(Butylnitrosamino)-1-butanol; Butyl-butanol(4)-nitrosamin (German); Butyl-butanol-nitrosamine-; N-Butyl-N-(4-hydroxybutyl)nitrosamine; n-Butyl-(4-hydroxybutyl)nitrosamine; 4-(n-Butylnitrosamino)-1-butanol; Dibutylamine,-4-hydroxy-N-nitroso-; 4-Hydroxybutylbutylnitrosamine-; N-Nitrosobutylbutanolamine-; N-Nitroso-n-butyl-(4-hydroxybutyl)amine RN: Current: 3817-11-6 BRN: 2080574 UD: 200302 MF: C8-H18-N2-O2 MW: 174.28 WL: Q4N4&NO CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 250 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 219, 1978 (MUREAV); mmo-sat 10 umol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 140, p. 147, 1984 (MUREAV); mtr-rat-orl 700 mg/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 78, p. 473, 1987 (JJCREP); dnd-rat-kdy 12500 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2435, 1992 (CRNGDP); dns-rat-orl 840 mg/kg/4W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 99, p. 37, 1989 (TXAPA9); sce-rat-lvr 1500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); sce-rat-oth 1500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); cyt-ham-fbr 1200 mg/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); cyt-ham-lng 900 mg/L/27H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 277, 1979 (MUREAV) TE: V01-M61-V08 orl-rat TDLo: 560 mg/kg/8W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 71, p. 138, 1980 (GANNA2); V01-M60 orl-mus TDLo: 800 mg/kg/10W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 251, 1981 (CRNGDP); V01-M60-P05 orl-dog TDLo: 10 gm/kg/2Y-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1958, 1981 (CNREA8); V02-T65-N60 scu-ham TDLo: 100 mg/kg (14D preg) Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 119, 1977 (ZKKOBW); V01-K61-M60 scu-ham TDLo: 22500 mg/kg/75W-I Cancer Detection and Prevention. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1976- v. 4, p. 79, 1981 (CDPRD4); V01-M60 orl-mus TD :2400 mg/kg/8W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1473, 1982 (CRNGDP); V01-M60 orl-rat TD :1348 mg/kg/8W-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 45, p. 474, 1982 (BJCAAI); V01-M60 orl-rat TD :280 mg/kg/4W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 895, 1983 (CRNGDP); V01-M60 orl-rat TD :1400 mg/kg/8W-C Nagoya Shiritsu Daigaku Igakkai Zasshi. Journal of the Nagoya City University Medical Association. (Nagoya-shiritsu Daigaku Igakkai, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan) V.1- 1950- v. 33, p. 1, 1982 (NASDA6); V01-M60 orl-rat TD :2800 mg/kg/8W-C Gan to Kagaku Ryoho. Cancer and Chemotherapy. (1-8-9 Yaesu, Chuo-ku, Tokyo 103, Japan) V.1- 1974- v. 9, p. 836, 1982 (GTKRDX); V01-M60 orl-mus TD :1820 mg/kg/26W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 2001, 1986 (CNREA8); V01-M60 orl-rat TD :12 gm/kg/43W-C Arkhiv Patologii. Archives of Pathology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.8- 1946- v. 41(12), p. 23, 1979 (ARPTAF); V01-M60 orl-mus TD :1200 mg/kg/10W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 251, 1981 (CRNGDP); V01-M60 orl-rat TD :1638 mg/kg/20W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 79, p. 263, 1987 (JJIND8); V01-M60 orl-rat TD :2100 mg/kg/6W-C Urological Research. (Springer Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1973- v. 3, p. 73, 1975 (URLRA5); V03-M60-V08 orl-mus TDLo: 1120 mg/kg/20W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 477, p. 125, 2001 (MUREAV); V03-M60-V08 orl-mus TD :2800 mg/kg/20W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 477, p. 125, 2001 (MUREAV); V03-M61 orl-rat TD :2100 mg/kg/20W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 170, p. 125, 2001 (CALEDQ); V02-P60 orl-rat TDLo: 0.7 mg/kg/2W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 154, p. 121, 2000 (CALEDQ); V01-M60 orl-rat TDLo: 1400 mg/kg/4W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 195, 2000 (CRNGDP); V01-M60 orl-rat TDLo: 1400 mg/kg/4W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 146, p. 67, 1999 (CALEDQ); V02-M60 orl-mus TDLo: 1200 mg/kg/60D-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 135, p. 137, 1999 (CALEDQ); V02-M60 orl-mus TDLo: 600 mg/kg/30D-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 135, p. 137, 1999 (CALEDQ); V01-M60 orl-rat TDLo: 3500 mg/kg/10W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 140, p. 129, 1999 (CALEDQ); V01-M60 orl-rat TDLo: 3360 mg/kg/12W-C Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 47, p. 601, 2001 (VOONC*); V01-M60 orl-rat TDLo: 1500 mg/kg/30D-C Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 37, p. 203, 1991 (VOONC*); V01-M60 orl-rat TDLo: 1400 mg/kg/4W-C Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. -, p. 1309, 1992 (VOONC*) ORNG: 1800000000 ng/kg. [1800.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1800 mg/kg Xenobiotica. (Taylor and Francis Ltd., 4 John St., London WC1N 2ET, UK) V.1- 1971- v. 3, p. 271, 1973 (XENOBH); H30-P01 scu-ham LD50: 3 gm/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 1, p. 15, 1975 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 51, 1978 (IMEMDT); TOXICOLOGY REVIEW Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 17, p. 161, 1975 (GMCRDC); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 13, p. 271, 1970 (ADCSAJ); TOXICOLOGY REVIEW Nutrition and Cancer. (Franklin Institute Press, POB 2266, Phildelphia, PA 19103) V.1- 1978- v. 3, p. 109, 1981 (NUCADQ); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 253, 1983 (BLFSBY) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-nonhuman; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9, In vitro SCE-nonhuman; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 632 of 1119 in RTECS (through 2003/06) AN: EL9275000 PN: 2-Butanone,-oxime- SY: Ethyl-methyl-ketone-oxime-; Ethyl-methylketonoxim- (Czech); Ethyl-methyl-ketoxime-; MEK-oxime-; Methyl-ethyl-ketoxime-; Skino #2; Troykyd-anti-skin-B-; USAF-AM-3-; USAF-EK-906- RN: Current: 96-29-7 BRN: 1698241 BHR: 4-01-00-03250 UD: 200012 MF: C4-H9-N-O MW: 87.14 WL: QNUY2&1 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: eye-rbt 100 uL SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0524693 (NTIS**) ME: msc-mus-lym 4600 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 149, 1988 (MUREAV) TE: V03-L60 ihl-rat TCLo: 75 ppm/6H/26W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0573008 (NTIS**); V01-L60 ihl-rat TC :75 ppm/6H/26W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 183, 1995 (TOXID9) ORNG: 930000000 ng/kg. [930.000000 mg/kg] T/E unlistd SRNL: 200000 nL/kg. [0.200000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 930 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 513319 (TSCAT*); F07 ihl-rat LC :>50 gm/m3/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0524693 (NTIS**); T/E unlistd skn-rat LD :>2 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530016 (NTIS**); T/E unlistd scu-rat LD50: 2702 mg/kg Nagoya Journal of Medical Science. (Nagoya Univ. School of Medicine, 65 Tsuruma-cho, Showa- ku, Nagoya 466, Japan) V.2- 1927- v. 29, p. 393, 1967 (NJMSAG); T/E unlistd orl-mus LD50: 1 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0524679 (NTIS**); T/E unlistd ipr-mus LD50: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd skn-rbt LD50: 200 uL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0529835 (NTIS**) MD: N73-P08-P71 orl-rat TDLo: 6825 mg/kg/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0524679 (NTIS**); L70-N73-P24 ihl-rat TCLo: 400 ppm/6H/4W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0529838 (NTIS**); F07-N73-P24 ihl-rat TCLo: 1000 ppm/6H/8W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0529842 (NTIS**); J30-N73-P27 scu-rat TDLo: 14 mL/kg/4W-I Nagoya Journal of Medical Science. (Nagoya Univ. School of Medicine, 65 Tsuruma-cho, Showa- ku, Nagoya 466, Japan) V.2- 1927- v. 29, p. 393, 1967 (NJMSAG); N72-N73-P24 ihl-mus TCLo: 400 ppm/6H/4W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0529838 (NTIS**); F07-N73-P24 ihl-mus TCLo: 1000 ppm/6H/8W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0529842 (NTIS**) ND: NOHS 1974: HZD T1326; NIS 1; TNF 60; NOS 3; TNE 180; NOHS 1974: HZD 82905; NIS 15; TNF 1540; NOS 36; TNE 12114; NOES 1983: HZD 82905; NIS 192; TNF 26030; NOS 112; TNE 313185; TFE 25609 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0293-8713; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-59, October 2000 Record 633 of 1119 in RTECS (through 2003/06) AN: EL9450000 PN: 2-Butanone,-peroxide- SY: Butanox-LPT-; Butanox-M-105-; Butanox-M-50-; Chaloxyd-MEKP-HA-1-; Chaloxyd-MEKP-LA-1-; Esperfoam-FR-; Ethyl-methyl-ketone-peroxide-; FR-222-; HI-Point-180-; HI-Point-90-; HI-Point-PD-1-; Kayamek-A-; Kayamek-M-; Ketonox-; Lucidol-DDM-9-; Lucidol-Delta-X-; Lupersol-DDA-30-; Lupersol-DDM-; Lupersol-DNF-; Lupersol-DSW-; Lupersol-Delta-X-; MEK-peroxide-; MEKPO-; Mepox-; Methyl-ethyl-ketone-hydroperoxide-; Methyl-ethyl-ketone-peroxide-; Methyl-ethyl-ketone-peroxide- (ACGIH); Methylethylketonhydroperoxide-; NCI-C55447-; Permek-G-; Permek-N-; Quickset-Extra-; Quickset-super-; RCRA-waste-number-U160-; Sprayset-MEKP-; Superox-46-710-; Thermacure- RN: Current: 1338-23-4 UD: 200210 MF: C8-H16-O4 MW: 176.24 WL: 1V2OO2V1 CC: Tumorigen (C); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); eye-rbt 3 mg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); eye-rbt 40% "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 529, 1994 (VCVGK*) TE: V03-J60-P62 unr-mus TDLo: 282 mg/kg Radiation Research, Supplement. (New York, NY) No.1-7, 1959-67. Discontinued. v. 3, p. 193, 1963 (RARSAM) ORNG: 484000000 ng/kg. [484.000000 mg/kg] T/E unlistd IHPB: 200000 ppb/4H. [200.000000 ppm/4H] J22 AT: K03-K13-K30 orl-hmn TDLo: 480 mg/kg National Clearinghouse for Poison Control Centers, Bulletin. (U.S. Department of Health, Education, and Welfare, Washington, DC) Jan/Feb, 1969 (NCPBBY); T/E unlistd orl-rat LD50: 484 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); J22 ihl-rat LC50: 200 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); F18-F19 ipr-rat LD50: 65 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); T/E unlistd orl-mus LD50: 470 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 165, p. 201, 1957 (JAMAAP); J22 ihl-mus LC50: 170 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP) MD: U01-Z01 orl-rat TDLo: 2033 mg/kg/7W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); Z01 ipr-rat TDLo: 273 mg/kg/7W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP) TR: ACGIH TLV-CL 0.2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: OEL-AUSTRALIA: TWA 0.2 ppm (1.5 mg/m3), JAN 1993; OEL-BELGIUM: STEL 0.2 ppm (1.5 mg/m3), JAN 1993; OEL-DENMARK: TWA 1 mg/m3, JAN 1999; OEL-FINLAND: STEL 0.2 ppm (1.5 mg/m3), Skin, JAN 1999; OEL-FRANCE: VLE 0.2 ppm (1.5 mg/m3), JAN 1999; OEL-GERMANY: Produces severe skin effects, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.2 ppm (1.5 mg/m3), JAN 1999; OEL-NORWAY: TWA 1 mg/m3, JAN 1999; OEL-SWEDEN: TGV 0.2 ppm (1.5 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 0.2 ppm (1.5 mg/m3), JAN 1999; OEL-UNITED KINGDOM: STEL 0.2 ppm (1.5 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO METHYL ETHYL KETONE PEROXIDE-air: CL 0.2 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 80105; NIS 29; TNF 2226; NOS 31; TNE 20053; NOES 1983: HZD 80105; NIS 23; TNF 1879; NOS 31; TNE 25827; TFE 6514 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Methyl ethyl ketone peroxide, 3508; NTP Toxicity studies, RPT# TOX-18, October 2000; OSHA ANALYTICAL METHOD #77 Record 634 of 1119 in RTECS (through 2003/06) AN: EM4760000 PN: 2-Butene,-1,3-dichloro- SY: 1,3-Dichloro-2-butene- RN: Current: 926-57-8 BRN: 906754 UD: 200012 MF: C4-H6-Cl2 MW: 125.00 CC: Tumorigen (C) IHNG: 3930000000 ng/m3/4H. [3930.000000 mg/m3/4H] T/E unlistd AT: T/E unlistd ihl-rat LC50: 3930 mg/m3/4H Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny. Journal of Experimental and Clinical Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1962- v. 9(6), p. 66, 1969 (ZKMAAX); T/E unlistd ihl-mus LC50: 4400 mg/m3/2H Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny. Journal of Experimental and Clinical Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1962- v. 9(6), p. 66, 1969 (ZKMAAX) MD: M16-P08-U01 ihl-rat TCLo: 850 mg/m3/4H/5W-I Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny. Journal of Experimental and Clinical Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1962- v. 9(6), p. 66, 1969 (ZKMAAX); A11-P28-Y01 ihl-rat TCLo: 100 mg/m3/6H/24W-I Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny. Journal of Experimental and Clinical Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1962- v. 9(6), p. 66, 1969 (ZKMAAX); L30-P30-Y01 ihl-rbt TCLo: 100 mg/m3/6H/24W-I Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny. Journal of Experimental and Clinical Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1962- v. 9(6), p. 66, 1969 (ZKMAAX) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 635 of 1119 in RTECS (through 2003/06) AN: EN0330050 PN: 3-Buten-2-one, 4-phenyl-, (E)- SY: trans-Benzalacetone-; trans-Benzylidenacetone-; trans-Benzylideneacetone-; Methyl-trans-styryl-ketone-; trans-4-Phenyl-3-butene-2-one-; TPBO- RN: Current: 1896-62-4 BRN: 742047 BHR: 4-07-00-01003 UD: 200012 MF: C10-H10-O MW: 146.20 WL: 1V1U1R CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 300 ug/plate (-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 427, 1982 (FCTOD7) SL: NTP Carcinogenesis studies, selected, October 2000 Record 636 of 1119 in RTECS (through 2003/06) AN: EO1925000 PN: tert-Butyl-alcohol- SY: 1,1-Dimethylethanol-; 2-Methyl-2-propanol-; 2-Methylpropan-2-ol-; 2-Propanol,-2-methyl-; Alcool-butylique-tertiaire- (French); Arconol-; Butanol-tertiaire- (French); Methanol,-trimethyl-; NCI-C55367-; Tertiary-Butyl-alcohol-; Trimethyl-methanol-; Trimethylcarbinol-; t-Butanol-; t-Butyl-alcohol-; t-Butyl-hydroxide-; tert-Butanol-; tert-Butyl-alcohol- (OSHA) RN: Current: 75-65-0 BRN: 906698 BHR: 4-01-00-01609 UD: 200302 MF: C4-H10-O MW: 74.14 WL: QX1&1&1 CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 500 uL/24H MLD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572351 (NTIS**); eye-rbt 100 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572351 (NTIS**) ME: mmo-sat 2 mg/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 446, p. 15, 1999 (MUREAV); cyt-oin-par 12500 mg/kg Environment and Ecology. (Environment and Ecology, C/o Dr. S.K. Konar, Dept. of Zoology, Kalyani University, Kalyani 741253, West Bengal, India) V.1- 1983- v. 5, p. 321, 1989 (ENECEV) RE: T34 ihl-rat TCLo: 2000 ppm/7H (1-19D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 469, 1989 (FAATDF); T46 ihl-rat TCLo: 3500 ppm/7H (1-19D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 469, 1989 (FAATDF); T71-T81 orl-mus TDLo: 103 gm/kg (6-20D preg) Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 222, p. 294, 1982 (JPETAB); T72 orl-mus TDLo: 135 gm/kg (6-20D preg) Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 222, p. 294, 1982 (JPETAB); T25 orl-mus TDLo: 20240 mg/kg (6-18D preg) Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 45, p. 1989, 1989 (LIFSAK); T35-T81-T87 orl-mus TDLo: 15000 mg/kg (6-20D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 103, 1994 (VCVGK*) TE: V02-M61 orl-rat TDLo: 146 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-436, 1995 (NTPTR*); V02-N62 orl-mus TDLo: 1540 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-436, 1995 (NTPTR*); V02-M61 orl-rat TDLo: 144200 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-162748 (NTIS**); V02-M61 orl-rat TDLo: 468650 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-162748 (NTIS**); V03-N62 orl-mus TDLo: 749840 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-162748 (NTIS**); V02-N62 orl-mus TDLo: 1521310 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-162748 (NTIS**) ORNG: 2743000000 ng/kg. [2743.000000 mg/kg] D17-J25-K30 AT: D17-J25-K30 orl-rat LD50: 2743 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572351 (NTIS**); F19-J22-J27 ihl-rat LC50: >10000 ppm/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572351 (NTIS**); L30 ipr-mus LD50: 399 mg/kg Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 26, p. 75, 1979 (RCOCB8); D26-G08-J22 orl-rbt LD50: 3559 mg/kg Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 41, p. 31, 1972 (IMSUAI); R03 skn-rbt LD50: >2 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572351 (NTIS**); R03-R21 skn-gpg LD50: >10 mL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0556680 (NTIS**); C06-F07 par-frg LDLo: 12 gm/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 50, p. 296, 1935 (AIPTAK); T/E unlistd ivn-mus LD50: 1500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 102, 1984 (VCVGK*); T/E unlistd ipr-mus LD50: 900 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 102, 1984 (VCVGK*); T/E unlistd orl-rat LD50: 3500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 102, 1984 (VCVGK*); T/E unlistd orl-rbt LD50: 3600 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 102, 1984 (VCVGK*); T/E unlistd orl-rbt LDLo: 3500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 102, 1984 (VCVGK*); D25 eye-hmn TDLo: 72.5 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 103, 1984 (VCVGK*) MD: F12-F31-Z01 orl-rat TDLo: 73176 mg/kg/21D-C Proceedings of the University of Otago Medical School. (Otago Medical School Research Soc., Box 913, Dunedin, New Zealand) V.1- 1922- v. 54, p. 86, 1976 (PUOMA5); F16-M11-U01 orl-rat TDLo: 150 gm/kg/94D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 19, p. 91, 1992 (FAATDF); L30-U01 orl-rat TDLo: 9545 uL/kg/10W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 80, p. 97, 1995 (TOLED5); M30-Y21 ihl-rat TCLo: 500 ppm/6H/5D-I Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 418, 1985 (ATSUDG); F16-M20-U01 orl-mus TDLo: 703 gm/kg/94D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 19, p. 91, 1992 (FAATDF); Z73 orl-mus TDLo: 6 gm/kg/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0559651 (NTIS**) TR: ACGIH TLV-TWA 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 8, p. 627, 1989 (JACTDZ); TOXICOLOGY REVIEWS Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 61, p. 1, 2001 (TOSCF2) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 100 ppm (300 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 32, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm (300 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (300 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (300 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (300 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 100 ppm (300 mg/m3), STEL 150 ppm, JAN 1993; OEL-AUSTRIA: MAK 50 ppm (150 mg/m3), JAN 1999; OEL-BELGIUM: TWA 100 ppm (303 mg/m3), STEL 150 ppm (455 mg/m3), JAN 1993; OEL-FRANCE: VME 100 ppm (300 mg/m3), JAN 1999; OEL-GERMANY: MAK 100 ppm (300 mg/m3), JAN 1999; OEL-JAPAN: OEL 50 ppm (150 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 100 ppm (300 mg/m3), JAN 1999; OEL-NORWAY: TWA 25 ppm (75 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (300 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 300 mg/m3, MAC(STEL) 450 mg/m3, JAN 1999; OEL-SWEDEN: NGV 50 ppm (150 mg/m3), KTV 75 ppm (250 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 100 ppm (300 mg/m3), KZG-W 200 ppm (600 mg/m3), JAN 1999; OEL-TURKEY: TWA 100 ppm (300 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 100 ppm (308 mg/m3), STEL 150 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO t-BUTYL ALCOHOL-air: 10H TWA 100 ppm, STEL 150 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 14400; NIS 11; TNF 820; NOS 25; TNE 3121; NOES 1983: HZD 14400; NIS 128; TNF 10682; NOS 84; TNE 171420; TFE 26045 SL: EPA GENETOX PROGRAM 1988, Negative: N crassa-reversion; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Alcohols I, 1400; NTP Carcinogenesis Studies (drinking water), some evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-436, 1995 (NTPTR*); NCI Carcinogenesis Studies (water), equivocal evidence: mouse, rat; NTP Toxicity studies, RPT# TOX-53, October 2000 Record 637 of 1119 in RTECS (through 2003/06) AN: ES0525000 PN: 2-Butyne-1,4-diol- SY: Agrisynth-B3D-; 2-Butin-1,4-diol- (Czech); Bis(hydroxymethyl)acetylene; Butynediol- RN: Current: 110-65-6 BRN: 1071237 BHR: 4-01-00-02687 UD: 200302 MF: C4-H6-O2 MW: 86.10 WL: Q2UU2Q CC: Tumorigen (C); Reproductive-Effector (T) RE: T19 orl-rat TDLo: 880 mg/kg (5-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0557862 (NTIS**); T19-T34-T46 orl-rat TDLo: 800 mg/kg (6-15D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 92, p. 221, 1997 (TOLED5) ORNG: 105000000 ng/kg. [105.000000 mg/kg] F07-J26-P30 AT: F07-J26-P30 orl-rat LD50: 105 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 41, 1968 (HYSAAV); F07-J02-P01 ihl-rat LCLo: 150 mg/m3/2H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 7, p. 13, 1965 (TPKVAL); T/E unlistd ipr-rat LD50: 52435 ug/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 26, p. 597, 1974 (JPPMAB); F07-J26-P30 orl-mus LD50: 105 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 41, 1968 (HYSAAV); F07-J02-P01 ihl-mus LCLo: 150 mg/m3/2H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 7, p. 13, 1965 (TPKVAL); F07-J26-P30 orl-rbt LD50: 150 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 41, 1968 (HYSAAV); F07-J26-P30 orl-gpg LD50: 130 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 41, 1968 (HYSAAV); T/E unlistd orl-bwd LD50: 75 mg/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV); T/E unlistd orl-mus LD50: 100 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 153, 1984 (VCVGK*); T/E unlistd orl-rat LD50: 100 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 153, 1984 (VCVGK*); T/E unlistd orl-gpg LD50: 130 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 153, 1984 (VCVGK*); T/E unlistd orl-rbt LD50: 150 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 153, 1984 (VCVGK*); R10-Y55 skn-rbt TDLo: 100 pph "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 153, 1984 (VCVGK*); D25 eye-rbt TDLo: 100 pph "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 153, 1984 (VCVGK*) MD: L70-P72-Y10 orl-rat TDLo: 1400 mg/kg/28D-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 12, p. 117, 1992 (JJATDK); P28-Y01-Y44 orl-rat TDLo: 364 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 37, 1968 (GISAAA); L70-U01 orl-rat TDLo: 1400 mg/kg/14D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 43, p. 87, 1989 (BECTA6); A11-H02-L14 ihl-rat TCLo: 8 mg/m3/4H/26W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 7, p. 13, 1965 (TPKVAL); A30-P01-Z01 ihl-mus TCLo: 90 mg/m3/2H/30D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 7, p. 13, 1965 (TPKVAL); L14-M30-U01 ihl-rat TCLo: 80 mg/m3/4H/60D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 153, 1994 (VCVGK*); L14-M30-U01 ihl-rat TCLo: 8 mg/m3/4H/28W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 153, 1994 (VCVGK*) SR: OEL-RUSSIA: STEL 1 mg/m3, JAN 1993 ND: NOHS 1974: HZD M2524; NIS 7; TNF 307; NOS 11; TNE 2173; NOES 1983: HZD M2524; NIS 21; TNF 1139; NOS 20; TNE 16527; TFE 4755 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 638 of 1119 in RTECS (through 2003/06) AN: ES3500000 PN: Butyraldehyde,-oxime- SY: Butanal-oxime-; n-Butyraldoxime-; m-Butyraldehyde-oxime-; Exkin-1-; Exkin No. 1 anti-skinning agent; Skino #1; Troykyd-Anti-skin-BTO-; USAF-AM-6- RN: Current: 110-69-0 BRN: 1698799 BHR: 4-01-00-03234 UD: 200012 MF: C4-H9-N-O MW: 87.14 WL: QNU4 CC: Tumorigen (C); Mutagen (M) ME: msc-mus-lym 1700 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 149, 1988 (MUREAV) AT: T/E unlistd ipr-mus LD50: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd orl-rbt LDLo: 100 mg/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-1185-0573 (EPASR*) ND: NOHS 1974: HZD M4058; NIS 10; TNF 535; NOS 27; TNE 12650; NOES 1983: HZD M4058; NIS 33; TNF 2983; NOS 33; TNE 40183; TFE 6225 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 639 of 1119 in RTECS (through 2003/06) AN: ES7525000 PN: Butyric acid, 4-(p-bis(2-chloroethyl)aminophenyl)- SY: 4(p-Bis(beta-chloroethyl)aminophenyl)butyric acid; 4-(Bis(2-chloroethyl)amino)benzenebutanoic acid; 4-(p-(Bis(2-chloroethyl)amino)phenyl)butyric acid; Ambochlorin-; Amboclorin-; Benzenebutanoic acid, 4-(bis(2-chloroethyl)amino)-; Butanoic acid, 4-(bis(2-chloroethyl)amino)benzene-; CAB-; CB-1348-; Chlorambucil-; Chloraminophen-; Chloraminophene-; Chlorobutin-; Chlorobutine-; Ecloril-; Kyselina 4-(N,N-bis-(2-chlorethyl)-p-aminofenyl)maselna (Czech); Leukeran-; Linfolizin-; Linfolysin-; Lympholysin-; N,N-Di-2-chloroethyl-gamma-p-aminophenylbutyric-acid-; NCI-C03485-; NSC-3088-; Phenylbuttersaeure-lost- (German); Phenylbutyric-acid-nitrogen-mustard-; RCRA-waste-number-U035-; gamma-(p-Bis(2-chloroethyl)aminophenyl)butyric acid; gamma-(p-Di(2-chloroethyl)aminophenyl)butyric acid; p-(N,N-Di-2-chloroethyl)aminophenyl butyric acid; p-N,N-Di-(beta-chloroethyl)aminophenyl butyric acid RN: Current: 305-03-3 BRN: 999011 BHR: 4-14-00-01715 UD: 200305 MF: C14-H19-Cl2-N-O2 MW: 304.24 WL: QV3R DN2G2G CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 1 mg/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 29, 1992 (MUREAV); mmo-sat 100 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); dna-esc 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 200 mg/L Archiv fuer Mikrobiologie. (Berlin, Fed. Rep. Ger.) V.1-94, 1930-73. For publisher information, see AMICCW. v. 51, p. 9, 1965 (ARMKA7); dnd-omi 500 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 7031, 1989 (CNREA8); pic-omi 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 1, p. 355, 1964 (MUREAV); slt-dmg-orl 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 169, 1990 (MUREAV); sln-dmg-unr 10 mmol/L Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 160, p. 228, 1969 (ANYAA9); sln-dmg-orl 2000 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 677, 1985 (ENMUDM); trn-dmg-orl 3000 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 677, 1985 (ENMUDM); mmo-smc 2 mmol/L (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 92, p. 83, 1979 (GENTAE); mrc-smc 1000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 11, p. 327, 1971 (MUREAV); dnd-smc 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 241, 1978 (MUREAV); dnd-hmn-lym 40 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 7031, 1989 (CNREA8); dns-hmn-lym 1 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 1059, 1980 (JTEHD6); oms-hmn-hla 5 mg/L Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 20, p. 1974, 1986 (KSRNAM); dni-hmn-hla 15 umol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 16, p. 91, 1975 (IJCNAW); cyt-hmn-unr 3 mg/kg/8W-I Human Heredity. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.19- 1969- v. 29, p. 100, 1979 (HUHEAS); cyt-hmn-lym 250 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 205, 1974 (MUREAV); sce-hmn-unr 8800 ug/kg/44D European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 18, p. 979, 1982 (EJCODS); sce-hmn-lym 200 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 205, 1987 (MUREAV); sce-hmn-lym 225 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 6, 1989 (EMMUEG); dna-rat-ipr 12 mg/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 34, p. 1215, 1978 (EXPEAM); oms-rat-ipr 12 mg/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 34, p. 1215, 1978 (EXPEAM); dni-rat-orl 19 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 275, 1979 (MUREAV); dns-rat-oth 3300 nmol/L European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 11, p. 9, 1975 (EJCAAH); oms-rat-ipr 10 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 665, 1984 (FCTOD7); oms-rat-orl 55 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 665, 1984 (FCTOD7); cyt-rat-ipr 10 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 665, 1984 (FCTOD7); cyt-rat-orl 55 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 665, 1984 (FCTOD7); mnt-mus-ipr 4 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); slt-mus-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 358, p. 25, 1996 (MUREAV); dnd-mus-ipr 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dna-mus-ast 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dni-mus-skn 1 pph British Journal of Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.63- 1951- v. 94, p. 1, 1976 (BJDEAZ); dni-mus-ivg 5000 ppm Journal of Investigative Dermatology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1938- v. 62, p. 378, 1974 (JIDEAE); dni-mus-emb 15 mg/L Journal of Embryology and Experimental Morphology. (Essex, UK) V.1-98, 1953-86. For Publisher information, see DEVPED v. 36, p. 273, 1976 (JEEMAF); dlt-mus-ipr 6 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 345, p. 167, 1995 (MUREAV); hma-mus-ast 365 ug/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 321, 1990 (TCMUD8); trn-mus-ipr 6 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 345, p. 167, 1995 (MUREAV); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); cyt-ham-lng 2 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 75, 1992 (MUREAV); sce-ham-lng 200 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 75, 1992 (MUREAV); sce-ham-ovr 75 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 175, p. 165, 1986 (MUREAV); msc-ham-lng 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 75, 1992 (MUREAV); msc-ham-ovr 20 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 577, 1983 (CNREA8); dnd-mam-lym 2500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); slt-oin-orl 5 mmol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 478, p. 107, 2001 (MUREAV); slt-hmn-orl 3.65 mg/kg/16W Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 197, 2001 (MUTAEX); slt-hmn-lym 0.5 umol/L/1H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 197, 2001 (MUTAEX); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T14 orl-wmn TDLo: 13 mg/kg (56D pre) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 191, p. 444, 1965 (JAMAAP); T53 orl-wmn TDLo: 5160 ug/kg (33-75D preg) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 186, p. 74, 1963 (JAMAAP); T01 unr-man TDLo: 143 ug/kg (6D male) Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 25, p. 1026, 1970 (CANCAR); T01 unr-man TDLo: 1 mg/kg (55W male) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 217, p. 1662, 1971 (JAMAAP); T01 unr-man TDLo: 5857 ug/kg (30W male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 33, p. 155, 1973 (JRPFA4); T41-T42 orl-rat TDLo: 8 mg/kg (15D preg) "Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks In New Drugs, Proceedings of the Symposium on Toxicological Testing for Safety of New Drugs, 3rd, Prague, 1976," Benesova, O., et al., eds., Prague, Czechoslovakia, Univerzita Karlova, 1979 -,107,1979 (40YJAX); T46 orl-rat TDLo: 6 mg/kg (11D preg) "Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks In New Drugs, Proceedings of the Symposium on Toxicological Testing for Safety of New Drugs, 3rd, Prague, 1976," Benesova, O., et al., eds., Prague, Czechoslovakia, Univerzita Karlova, 1979 -,107,1979 (40YJAX); T25 orl-rat TDLo: 8 mg/kg (11D preg) "Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks In New Drugs, Proceedings of the Symposium on Toxicological Testing for Safety of New Drugs, 3rd, Prague, 1976," Benesova, O., et al., eds., Prague, Czechoslovakia, Univerzita Karlova, 1979 -,107,1979 (40YJAX); T35 orl-rat TDLo: 10 mg/kg (15D preg) "Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks In New Drugs, Proceedings of the Symposium on Toxicological Testing for Safety of New Drugs, 3rd, Prague, 1976," Benesova, O., et al., eds., Prague, Czechoslovakia, Univerzita Karlova, 1979 -,107,1979 (40YJAX); T35 ipr-rat TDLo: 12 mg/kg (13D preg) Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 477, 1976 (CTRRDO); T41-T43 ipr-rat TDLo: 6 mg/kg (13D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 139, p. 62, 1972 (PSEBAA); T43-T46 ipr-rat TDLo: 4 mg/kg (13D preg) Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 477, 1976 (CTRRDO); T53 ipr-rat TDLo: 6 mg/kg (10D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 139, p. 145, 1961 (ANREAK); T31-T34 ipr-rat TDLo: 6 mg/kg (12D preg) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 27, p. 1329, 1971 (EXPEAM); T25-T33 ipr-rat TDLo: 3 mg/kg (3D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 4, p. 341, 1984 (TCMUD8); T33 par-rat TDLo: 8 mg/kg (13D preg) Journal of Embryology and Experimental Morphology. (Essex, UK) V.1-98, 1953-86. For Publisher information, see DEVPED v. 18, p. 215, 1967 (JEEMAF); T25-T41-T46 orl-mus TDLo: 14200 ug/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 12, p. 71, 1975 (TJADAB); T33-T41 orl-mus TDLo: 3 mg/kg (7D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30(1), p. 8A, 1984 (TJADAB); T72 orl-mus TDLo: 80 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 361, 1986 (TCMUD8); T34-T41-T46 orl-mus TDLo: 4 mg/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 449, 1986 (TJADAB); T01 ipr-mus TDLo: 4 mg/kg (1D male) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); T43-T46 ipr-mus TDLo: 7 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 28, p. 29, 1983 (TJADAB); T34-T47-T53 scu-mus TDLo: 5 mg/kg (10D preg) Revue Francaise de Gynecologie et d'Obstetrique. (Masson Pub. USA, Inc., Year Book Medical Pub., 35 E. Wacker Dr., Chicago, IL 60601) V.20- 1920- v. 70, p. 419, 1975 (RFGOAO); T59 ipr-ham TDLo: 13500 ug/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 30A, 1984 (TJADAB) TE: V01-P61 orl-man TDLo: 84 mg/kg/2.5Y-C Acta Medica Scandinavica. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.52-224, 1919-88. v. 199, p. 373, 1976 (AMSVAZ); V01-P61 orl-wmn TDLo: 101 mg/kg/82W-C Gynecologic Oncology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1972- v. 6, p. 115, 1978 (GYNOA3); V01-P61 unr-wmn TDLo: 161 mg/kg/3Y-I Scandinavian Journal of Haematology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.1- 1964- v. 13, p. 179, 1974 (SJHAAQ); V01-P61-P62 ipr-rat TDLo: 120 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V02-J60-R60 skn-mus TDLo: 108 mg/kg/9W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 10, p. 363, 1956 (BJCAAI); V01-J60 ipr-mus TDLo: 18 mg/kg/4W Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 36, p. 915, 1966 (JNCIAM); V01-P61-P62 ipr-rat TD :170 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V01-P61 orl-man TD :59 mg/kg/96W-C Nouvelle Presse Medicale. (Paris, France) V.1-11, 1972-82. v. 10, p. 1717, 1981 (NPMDAD); V01-P61 orl-wmn TD :200 mg/kg/6Y-C Acta Haematologica. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.1- 1948- v. 63, p. 283, 1980 (ACHAAH); V01-P61 orl-wmn TD :307 mg/kg/7Y-C Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 134, p. 728, 1974 (AIMDAP); V01-P61 orl-hmn TD :141 mg/kg/5Y-I New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 304, p. 441, 1981 (NEJMAG); V01-P61 orl-wmn TD :180 mg/kg/3Y-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 137, p. 355, 1977 (AIMDAP); V01-P61 orl-wmn TD :135 mg/kg/4Y-C Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 137, p. 355, 1977 (AIMDAP); V01-P61 orl-hmn TD :84 mg/kg/3Y-C Acta Clinica Belgica. (Ave. E. Mounier, 52 1200 Brussels, Belgium) V.1- 1946- v. 38, p. 228, 1983 (ACCBAT); V01-P61 orl-wmn TD :70 mg/kg/94W-C Acta Clinica Belgica. (Ave. E. Mounier, 52 1200 Brussels, Belgium) V.1- 1946- v. 38, p. 228, 1983 (ACCBAT); V01-P61 orl-chd TD :108 mg/kg/77W-C Archives Francaises de Pediatrie. (Doin Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1942- v. 36, p. 592, 1979 (AFPEAM) ORNG: 76000000 ng/kg. [76.000000 mg/kg] T/E unlistd AT: J13-J21-J22 orl-wmn TDLo: 82600 ug/kg Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 41, p. 455, 1978 (CANCAR); F12 orl-man TDLo: 3571 ug/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 20, p. 361, 1983 (JTCTDW); T/E unlistd orl-rat LD50: 76 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 665, 1984 (FCTOD7); T/E unlistd ipr-rat LD50: 14 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 13, p. 969, 1964 (BCPCA6); V30 scu-rat LDLo: 32 mg/kg European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 13, p. 873, 1977 (EJCAAH); T/E unlistd ice-rat LD50: >400 ug/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 18, p. 760, 1966 (JPPMAB); T/E unlistd orl-mus LD50: 80 mg/kg British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) #2028335 (BAXXDU); T/E unlistd ipr-mus LD50: 20 mg/kg British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) #2028335 (BAXXDU); T/E unlistd scu-mus LD50: 26 mg/kg British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) #2028335 (BAXXDU); K30-P30 ivn-dog LDLo: 3 mg/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 201, 1965 (CCSUBJ); K30-P30 ivn-mky LDLo: 3 mg/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 201, 1965 (CCSUBJ) MD: N73-S04-U01 orl-rat TDLo: 21 mg/kg/7D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 107, p. 47, 1996 (TXCYAC); N74-Z73 orl-rat TDLo: 140 mg/kg/28D-I Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 504, 1985 (ATSUDG); P14-T01 orl-hmn TDLo: 16.6 mg/kg/12W-I Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 97, p. 653, 1980 (JOPDAB) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 125, 1975 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 144, 1987 (IMSUDL); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 115, 1981 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 125, 1975 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 144, 1987 (IMSUDL); TOXICOLOGY REVIEW JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 172, p. 1765, 1960 (JAMAAP); TOXICOLOGY REVIEW Minnesota Medicine. (Minnesota Medical Assoc., 2221 University Ave., SE, Suite 400, Minneapolis, MN 55414) V.1- 1918- v. 57, p. 19, 1974 (MIMDAL); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Arquivos de Neuro-Psiquiatria. (Caixa Postal 30.657, 01051 Sao Paulo, Brazil) V.1- 1943- v. 5, p. 447, 1965 (ANPIAM); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3) ND: NOES 1983: HZD X3995; NIS 1; TNF 105; NOS 4; TNE 3719; TFE 2018 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Sperm morphology-human; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human lymphocytes; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (ipr), clear evidence: mouse, rat Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 640 of 1119 in RTECS (through 2003/06) AN: ES8125000 PN: Butyric acid, 4-(N-butyl-N-nitrosamino)- SY: BCPN-; Butanoic acid, 4-(butylnitrosoamino)-; N-Butyl-(3-carboxypropyl)nitrosamine; 4-(Butylnitrosoamino)butanoic acid; N-Nitrosobutylcarboxypropylamine-; N-Nitroso-N-butyl-N-(3-carboxypropyl)amine RN: Current: 38252-74-3 BRN: 2257968 UD: 200006 MF: C8-H16-N2-O3 MW: 188.26 WL: QV3N4&NO CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 10 umol/plate (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 399, 1977 (CNREA8); dnd-rat-par 50 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 29, p. 291, 1980 (CBINA8); dnd-rat-kdy 50 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2435, 1992 (CRNGDP) TE: V01-M60 orl-rat TDLo: 3760 mg/kg/12W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 617, 1983 (CRNGDP); V03-M60 orl-mus TDLo: 7 gm/kg/20W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 67, p. 175, 1976 (GANNA2); V03-M60 orl-rat TD :4700 mg/kg/14W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 63, p. 637, 1972 (GANNA2); V03-M60 orl-rat TD :4375 mg/kg/20W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 67, p. 175, 1976 (GANNA2) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 51, 1978 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Weakly Positive: Histidine reversion-Ames test; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 641 of 1119 in RTECS (through 2003/06) AN: EU9800000 PN: Cadmium- SY: C.I. 77180; Cadmium- (ACGIH:OSHA); Cadmium-dust-fume- (OSHA); Cadmium-powder-; Cadmium,-elemental-; Colloidal-cadmium-; Kadmium- (German) RN: Current: 7440-43-9 UD: 200302 MF: Cd MW: 112.40 WL: .CD CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mnt-mus-emb 6 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 57, 1990 (TIVIEQ); cyt-ham-ovr 1 umol/L Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 26, p. 251, 1980 (CGCGBR) RE: T81-T85 orl-rat TDLo: 155 mg/kg (13W male/13W pre-3W preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 20, p. 96, 1978 (BECTA6); T39 orl-rat TDLo: 220 mg/kg (1-22D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 11, p. 233, 1982 (TOLED5); T24-T82 orl-rat TDLo: 21500 ug/kg (multigenerations) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 22, p. 466, 1980 (ENVRAL); T48 orl-rat TDLo: 23 mg/kg (1-22D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 158, p. 614, 1978 (PSEBAA); T01 ipr-rat TDLo: 1124 ug/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 194, 1977 (TXAPA9); T83 scu-rat TDLo: 250 ug/kg (19D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A122, 1980 (APTOD9); T45-T53 ivn-rat TDLo: 1250 ug/kg (14D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 264, 1981 (JJATDK); T41-T42 ivn-rat TDLo: 1250 ug/kg (9D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 264, 1981 (JJATDK); T34 ivn-rat TDLo: 8 mg/kg (8-15D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 264, 1981 (JJATDK); T34-T35 orl-mus TDLo: 448 mg/kg (multigenerations) Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 23, p. 102, 1971 (AEHLAU); T75-T81 orl-mus TDLo: 1700 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 361, 1986 (TCMUD8); T41 ipr-mus TDLo: 1686 ug/kg (7D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 28, p. 39A, 1983 (TJADAB); T43 par-ham TDLo: 2 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 31, p. 52A, 1985 (TJADAB) TE: V01-J60 ihl-wmn TCLo: 129 ug/m3/20Y-C American Journal of Industrial Medicine. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 153, 1986 (AJIMD8); V01-V10 scu-rat TDLo: 3372 ug/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 55, p. 40, 1991 (ENVRAL); V01-Q60-V10 ims-rat TDLo: 40 mg/kg/4W-I Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(1), p. 51, 1977 (JEPTDQ); V03-T61-V10 unr-rat TDLo: 1200 mg/kg Zeitschrift fuer die Gesamte Hygiene und Ihre Grenzgebiete. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1955- v. 31, p. 224, 1985 (ZHYGAM); V03-P62-V10 ims-rat TD :70 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 18, p. 124, 1964 (BJCAAI); V03-P62-V10 ims-rat TD :63 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 193, p. 592, 1962 (NATUAS); V02-Q60-V10 ims-rat TD :45 mg/kg/4W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*) ORNG: 2330000000 ng/kg. [2330.000000 mg/kg] T/E unlistd AT: M13 ihl-man TCLo: 88 ug/m3/8.6Y Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 28, p. 147, 1974 (AEHLAU); G30-H17-J25 ihl-hmn LCLo: 39 mg/m3/20M American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 31, p. 180, 1970 (AIHAAP); T/E unlistd unr-man LDLo: 15 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 2330 mg/kg "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); J22 ihl-rat LC50: 25 mg/m3/30M Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 16, p. 212, 1974 (SAIGBL); T/E unlistd unr-rat LD50: 1140 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(5), p. 6, 1978 (GTPZAB); T/E unlistd ipr-mus LD50: 5700 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 37, p. 403, 1976 (TXAPA9); T/E unlistd unr-mus LD50: 890 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(5), p. 6, 1978 (GTPZAB); T/E unlistd orl-rbt LDLo: 70 mg/kg Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 34, p. 127, 1973 (AMPMAR); T/E unlistd scu-rbt LDLo: 6 mg/kg "Problemes de Toxicologie Alimentaire," Truhaut, R., Paris, France, L'evolution Pharmaceutique, 1955(?) v. -, p. -, 1955 (PROTA*); T/E unlistd ivn-rbt LDLo: 5 mg/kg Journal of Obstetrics and Gynaecology of the British Empire. (London, UK) V.1-27, 1902-15: V.28-67, 1921-60. For publisher information, see BJOGAS. v. 35, p. 693, 1928 (JOBSAK); L02-M02-P13 ivn-rbt LD :2.5 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 174, p. 225, 2001 (TXAPA9); L50-M02-P13 ivn-rbt LD :3.5 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 174, p. 225, 2001 (TXAPA9); T/E unlistd skn-mus LDLo: 77.5 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 176, p. 24, 2001 (TXAPA9); T/E unlistd orl-mus LD50: 890 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 164, 1988 (VCVN1*) MD: P28-U01-Y15 orl-rat TDLo: 546 mg/kg/26W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 2, p. 52, 1982 (TOXID9); L30-M30-U11 orl-rat TDLo: 1512 mg/kg/48W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 5, p. 105, 1980 (TOLED5); H01 orl-pig TDLo: 21880 mg/kg/78W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 13, p. 162, 1993 (TOXID9) TR: ACGIH TLV-TWA 0.01 mg(Cd)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.01 mg(Cd)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 2, p. 74, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 39, 1976 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 139, 1987 (IMSUDL); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); TOXICOLOGY REVIEW Texas Reports on Biology and Medicine. (Galveston, TX) V.1-41(2), 1943-81/82. Discontinued. v. 33, p. 85, 1975 (TRBMAV); TOXICOLOGY REVIEW Journal of Dairy Science. (American Dairy Science Assoc., 309 W. Clark St., Champaign, IL 61820) V.1- 1917- v. 58, p. 1767, 1975 (JDSCAE); TOXICOLOGY REVIEW Journal of Food Science. (Institute of Food Technologists, Suite 2120, 221 N. La Salle St., Chicago, IL 60601) V.26- 1961- v. 39, p. 321, 1974 (JFDSAZ); TOXICOLOGY REVIEW Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 3, p. 55, 1974 (AMBOCX); TOXICOLOGY REVIEW Quarterly Reviews of Biophysics. (Cambridge Univ. Press, The Edinburgh Bldg., Shaftesbury Rd., Cambridge CB2 2RU, UK) V.1- 1968- v. 7, p. 75, 1974 (QURBAW); TOXICOLOGY REVIEW Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 40, p. 239, 1973 (AEMBAP); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB221-198 (NTIS**); TOXICOLOGY REVIEW Kogai to Taisaku. Journal of Environmental Pollution Control. (Kogai Taisaku Gijutsu Dokokai, Shuwa-Akasaka Bldg., 9-1-244, Akasaka, Minato-ku, Tokyo 107, Japan) V.1- 1965- v. 11, p. 1300, 1975 (KOTTAM); TOXICOLOGY REVIEW Food Research. (Champaign, IL) V.1-25, 1936-60. For publisher information, see JFDSAZ. v. 7, p. 313, 1942 (FOREAE); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 2, p. 341, 1974 (STEVA8); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ); TOXICOLOGY REVIEW Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 4, p. 71, 1971 (ENVRAL); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,63,1970 (85CVA2); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR); TOXICOLOGY REVIEW Paediatrician. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1972- v. 6, p. 204, 1977 (PDTNBH); TOXICOLOGY REVIEW Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- v. 54, p. 413, 1978 (BNYMAM); TOXICOLOGY REVIEW Advances in Modern Toxicology. (John Wiley and Sons, Inc., 605 Third Ave., New York, NY 10016) V.1, 1976-79. Discontinued. v. 3, p. 209, 1977 (AMTODM); TOXICOLOGY REVIEW Memoir--Geological Society of America. (POB 9140, Boulder, CO 80302) No.1- 1934- v. 123, p. 109, 1971 (GSAMAQ); TOXICOLOGY REVIEW "Health Evaluation of Heavy Metals in Infant Formula and Junior Food, Proceedings of the Symposium, 1981," Schmidt, E.H.F., and A.G. Hildebrandt, eds., Berlin, Springer-Verlag, 1983 -,57,1983 (49DXAV); TOXICOLOGY REVIEW "Cadmium in the Environment," Nriagu, J.O., ed., 2 vols., New York, John Wiley and Sons, Inc., 1980-81 2,743,1981 (43QNAO); TOXICOLOGY REVIEW Critical Reviews in Oncology/Hematology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1983- v. 42, p. 93, 2002 (CREOH*) SR: MSHA STANDARD-air: TWA 0.2 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 35, 1971 (DTLVS*); OSHA PEL (Gen Indu): see CFR 29,1910.1027 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): see CFR 29,1926.1127 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): see CFR 29,1915.1027 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.2 mg(Cd)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.05 mg/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.05 mg/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.05 mg/m3, JAN 1993; OEL-DENMARK: TWA 0.01 mg/m3, JAN 1999; OEL-FINLAND: TWA 0.02 mg/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.05 mg/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-INDIA: TWA 0.05 mg/m3, JAN 1993; OEL-JAPAN: OEL 0.05 mg/m3, Group 1 Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.02 mg/m3, MAC-K 0.1 mg/m3, JAN 1999; OEL-NORWAY: TWA 0.05 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.2 mg/m3, JAN 1993; OEL-POLAND: MAC(TWA) fume 0.02 mg/m3, MAC(STEL) fume 0.05 mg/m3, JAN 1999; OEL-POLAND: MAC(TWA) dust 0.04 mg/m3, MAC(STEL) dust 0.2 mg/m3, JAN 1999; OEL-RUSSIA: TWA 0.01 mg/m3, STEL 0.05 mg/m3, JAN 1993; OEL-SWEDEN: NGV 0.05 mg/m3 (total dust), JAN 1999; OEL-SWEDEN: TWA 0.01 mg/m3 (resp. dust), JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 mg/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.2 mg/m3, STEL 0.5 mg/m3, JAN 1993; OEL-TURKEY: TWA 0.2 mg/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.025 mg(Cd)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CADMIUM, dust and fume-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD T0608; NIS 1; TNF 48; NOS 1; TNE 96; NOHS 1974: HZD 15570; NIS 41; TNF 1256; NOS 50; TNE 14717; NOES 1983: HZD T0608; NIS 2; TNF 25; NOS 3; TNE 335; TFE 22; NOES 1983: HZD X2776; NIS 5; TNF 248; NOS 6; TNE 3893; TFE 1887; NOES 1983: HZD X5979; NIS 2; TNF 95; NOS 2; TNE 486; NOES 1983: HZD 15570; NIS 77; TNF 4811; NOS 64; TNE 88968; TFE 14541 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/166621); EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: In vivo cytogenetics-human lymphocyte; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 42, 1984; NIOSH Analytical Method, 1994: Cadmium and compounds, as Cd, 7048; NIOSH Analytical Method, 1994: Elements by ICP, 7300; NIOSH Analytical Method, 1994: Elements in blood or tissue, 8005; NIOSH Analytical Method, 1994: Metals in urine, 8310; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID189; OSHA ANALYTICAL METHOD #ID206 Record 642 of 1119 in RTECS (through 2003/06) AN: EV0175000 PN: Cadmium-chloride- SY: Anhydrous-cadmium-chloride-; Caddy-; Cadmium-dichloride-; Dichlorocadmium-; Kadmiumchlorid- (German); VI-Cad- RN: Current: 10108-64-2 UD: 200305 MF: Cd-Cl2 MW: 183.30 WL: CD G2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 500 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 138, p. 9, 1984 (MUREAV); mmo-sat 500 mg/L (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 13, p. 737, 1977 (SOGEBZ); dnr-esc 40 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); dnr-bcs 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 109, 1980 (MUREAV); dnd-omi 350 umol/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 198, p. 513, 1977 (SCIEAS); sln-dmg-orl 20 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 259, p. 147, 1991 (MUREAV); mmo-smc 1 umol/L (-S9) Chemical and Pharmaceutical Bulletin. (Japan Pub. Trading Co., USA, 1255 Howard St., San Francisco, CA 94103) V.6- 1958- v. 33, p. 1571, 1985 (CPBTAL); sln-smc 4 umol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 21, 1986 (MUTAEX); cyt-ofs-mul 630 ug/L/4W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 36, p. 199, 1986 (BECTA6); dnd-hmn-fbr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 193, p. 237, 1988 (MUREAV); dni-hmn-hla 15 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); cyt-hmn-lym 50 umol/L/24H Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 10, p. 67, 1978 (TXCYAC); cyt-hmn-leu 1 umol/L Tokyo Igaku Zasshi. Tokyo Journal of Medical Sciences. (Tokyo, Japan) V.59-76, 1951-68. v. 82, p. 232, 1974 (TKIZAM); sce-hmn-lym 5 umol/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 30, p. 521, 1992 (FCTOD7); sln-hmn-lym 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 57, 1993 (MUREAV); sln-hmn-lng 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 469, p. 35, 2000 (MUREAV); mtr-rat-oth 300 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 198, p. 115, 1988 (MUREAV); dns-rat-ipr 10 mg/kg/5D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 38, p. 145, 1976 (TXAPA9); dns-rat-scu 12 mg/kg/3D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 74, p. 337, 1984 (TXAPA9); oms-rat-scu 12 mg/kg/3D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 74, p. 337, 1984 (TXAPA9); dni-rat-ipr 6 mg/kg/3D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 38, p. 145, 1976 (TXAPA9); dni-rat-oth 10 nmol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 74, p. 337, 1984 (TXAPA9); cyt-rat-emb 3500 nmol/L Doklady Akademii Nauk SSSR. Proceedings of the Academy of Sciences of the USSR. For English translation, see DBIOAM and DKBSAS. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1933- v. 224, p. 1189, 1975 (DANKAS); spm-rat-scu 1824 ug/kg Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 24, p. 453, 1962 (JOENAK); mnt-mus-ipr 50 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 306, p. 85, 1994 (MUREAV); mtr-mus-fbr 9 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 448, p. 23, 2000 (MUREAV); dns-mus-ihl 4900 ug/m3/1H-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 80, p. 215, 1985 (TXAPA9); dni-mus-ipr 4 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 40, p. 13, 1986 (TXCYAC); dni-mus-oth 10 umol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 84, p. 379, 1986 (TXAPA9); oms-mus-scu 3 mg/kg Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 32, p. 472, 1977 (NEZAAQ); cyt-mus-scu 3 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 563, 1982 (ENMUDM); cyt-mus-ipr 420 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 285, 1988 (MUREAV); sce-mus-ipr 840 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 285, 1988 (MUREAV); sln-mus-ipr 10 umol/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 29, p. 412, 1982 (BECTA6); dlt-mus-ipr 2 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 30, p. 365, 1975 (MUREAV); dlt-mus-orl 15 mg/kg Archiv fuer Experimentelle Veterinaermedizin. (S. Hirzel Verlag, Postfach 506, Leipzig DDR-7010, Ger. Dem. Rep.) V.6- 1952- v. 34, p. 399, 1980 (AXVMAW); msc-mus-lym 140 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); hma-mus-sat 6 mg/kg Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 13, p. 737, 1977 (SOGEBZ); spm-mus-ipr 1 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 187, p. 641, 1973 (JPETAB); spm-mus-scu 20250 ug/kg British Journal of Experimental Pathology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1920- v. 40, p. 503, 1959 (BJEPA5); spm-mus-unr 1 mg/kg Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 16, p. 1397, 1980 (GNKAA5); mnt-ham-ovr 500 ug/L Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 36, p. 342, 1986 (BECTA6); mnt-ham-lng 625 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 71, 1993 (MUREAV); mtr-ham-emb 2 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 193, 1979 (CNREA8); dnd-ham-ovr 2 umol/L Biophysical Journal. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1960- v. 25, p. 229a, 1979 (BIOJAU); dnd-ham-lng 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 111, p. 69, 1983 (MUREAV); dns-ham-emb 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 131, p. 173, 1984 (MUREAV); dni-ham-lng 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 137, p. 103, 1984 (MUREAV); oms-ham-ovr 500 ug/L Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 36, p. 342, 1986 (BECTA6); oms-ham-emb 1100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 47, 1993 (MUREAV); cyt-ham-ovr 250 ug/L Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 36, p. 342, 1986 (BECTA6); cyt-ham-lng 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 85, p. 288, 1981 (MUREAV); sln-ham-emb 600 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 47, 1993 (MUREAV); msc-ham-lng 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 111, p. 69, 1983 (MUREAV); spm-ham-scu 40 umol/kg Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 1, p. 294, 1960 (JRPFA4); spm-gpg-scu 40 umol/kg Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 1, p. 294, 1960 (JRPFA4); dnd-ckn-oth 100 umol/L Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 12, p. 173, 1986 (TECSDY); dnd-mam-lym 350 umol/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 198, p. 513, 1977 (SCIEAS); dni-mam-kdy 2 umol/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 34, p. 189, 1985 (TXCYAC); spm-rbt-scu 40 umol/kg Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 1, p. 294, 1960 (JRPFA4); mnt-ofs-ipr 1000 ppm Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 28, p. 176, 1985 (NULSAK); sce-mus-oth 10 mg/L/24H JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 20, p. 231, 2000 (JJATDK); cyt-mus-oth 15 mg/L/24H JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 20, p. 231, 2000 (JJATDK); dnd-hmn-fbr 4 umol/l/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 47, 2001 (MUREAV); mnt-hmn-fbr 2 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 490, p. 99, 2001 (MUREAV); dnd-mus-lvr 0.01 umol/L/10M Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 265, 2001 (MUTAEX); dnd-mus-kdy 0.01 umol/L/10M Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 265, 2001 (MUTAEX); dnd-mus-ihl 4.8 mg/L/60M Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 265, 2001 (MUTAEX); mtr-mus-fbr 0.1 umol/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG); cyt-ham-scu 2 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 349, 1979 (MUREAV) RE: T12-T25-T26 orl-rat TDLo: 652 mg/kg (7-16D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 2, p. 255, 1982 (JJATDK); T24-T34-T35 orl-rat TDLo: 326 mg/kg (1-20D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 54(4), p. 86, 1989 (GISAAA); T87 orl-rat TDLo: 48 mg/kg (90D pre/1-22D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. CONF-771017 (NTIS**); T35-T53 orl-rat TDLo: 14677 ug/kg (6-14D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 222, 1972 (TXAPA9); T46 orl-rat TDLo: 17 mg/kg (6W male/6W pre-20D preg) Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 4, p. 51, 1980 (EESADV); T81-T87 orl-rat TDLo: 210 mg/kg (1-21D preg/21D post) Arhiv za Higijenu Rada i Toksikologiju. Archives of Industrial Hygiene and Toxicology. (Jugoslovenska Knjiga, POB 36, YU-11001 Belgrade, Yugoslavia) V.7- 1956- v. 47, p. 245, 1996 (AHRTAN); T47 orl-rat TDLo: 280 mg/kg (6-19D preg) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 239, p. 231, 1972 (NATUAS); T39-T19-U01 ihl-rat TCLo: 200 ug/m3/24H (1-21D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 10, p. 297, 1978 (TXCYAC); T34 ihl-rat TCLo: 600 ug/m3/24H (1-21D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 10, p. 297, 1978 (TXCYAC); T34-T35 ihl-rat TCLo: 130 ug/m3 (1-19D preg) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 31(8), p. 25, 1987 (GTPZAB); T72-T83 orl-rat TDLo: 55 mg/kg (1-22D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 19, p. 213, 1997 (NETEEC); T02 ipr-rat TDLo: 2 mg/kg (1D male) Shengzhi Yu Biyun. Reproduction and Contraception. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) 1980- v. 19, p. 290, 1999 (SCYYDZ); T45-T46-T50 ipr-rat TDLo: 2933 ug/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 7, p. 237, 1973 (TJADAB); T53-T31 ipr-rat TDLo: 2933 ug/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 7, p. 237, 1973 (TJADAB); T25-T34 ipr-rat TDLo: 2 mg/kg (10D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 59, p. 443, 1987 (ARTODN); T41-T46-T53 ipr-rat TDLo: 2 mg/kg (10D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 59, p. 443, 1987 (ARTODN); T32 scu-rat TDLo: 7 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 74A, 1987 (TJADAB); T31-T34-T35 scu-rat TDLo: 4892 ug/kg (19D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 18, p. 103, 1980 (TXCYAC); T49 scu-rat TDLo: 32 mg/kg (12-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 23, p. 75, 1981 (TJADAB); T01-T02-T03 scu-rat TDLo: 1250 ug/kg (1D male) Acta Biologica et Medica Germanica. (Berlin, Ger. Dem. Rep.) V.1-41, 1958-82. For publisher information, see BBIADT. v. 5, p. 153, 1960 (ABMGAJ); T25-T26-T46 ivn-rat TDLo: 2 mg/kg (8D preg) Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 70, p. 84P, 1974 (NYKZAU); T34-T41-T42 ivn-rat TDLo: 4500 ug/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 44, p. 259, 1991 (TJADAB); T41-T46-T53 ivn-rat TDLo: 2 mg/kg (12D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 59, p. 443, 1987 (ARTODN); T25-T35 ivn-rat TDLo: 2 mg/kg (14D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 59, p. 443, 1987 (ARTODN); T03 ims-rat TDLo: 4 mg/kg (1D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 15, p. 594, 1977 (IJEBA6); T34-T87 orl-mus TDLo: 6197 ug/kg (1-19D preg) Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 33, p. 36, 1978 (AEHLAU); T34-T48 orl-mus TDLo: 248 gm/kg (1-19D preg) Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 109, p. 1640, 1979 (JONUAI); T52-T81-T91 orl-mus TDLo: 6 mg/kg (15-19D preg) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(3), p. 187, 1978 (JEPTDQ); T34-T35 orl-mus TDLo: 33 mg/kg (7-9D preg) Chiba Igaku Zasshi. Chiba Medical Journal. (Chiba Daigaku Igakkai, 1-8-1 Inohana, Chiba 280, Japan) V.50- 1974- v. 61, p. 335, 1985 (CIZAAZ); T25-T34-T35 ipr-mus TDLo: 2 mg/kg (7D preg) Chemical and Pharmaceutical Bulletin. (Japan Pub. Trading Co., USA, 1255 Howard St., San Francisco, CA 94103) V.6- 1958- v. 30, p. 2141, 1982 (CPBTAL); T25-T26-T46 ipr-mus TDLo: 4 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 79, 1980 (TJADAB); T41-T42-T43 ipr-mus TDLo: 1833 ug/kg (7D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. CONF-771017 (NTIS**); T23 ipr-mus TDLo: 1 mg/kg (1D male) Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 187, p. 641, 1973 (JPETAB); T25-T31-T34 scu-mus TDLo: 4 mg/kg (7D preg) Zeitschrift fuer Mikroskopisch-Anatomische Forschung. (Buchexport, Postfach 160, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1924- v. 100, p. 419, 1986 (ZMAFA2); T11 scu-mus TDLo: 3 mg/kg (1D pre) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 16, p. 127, 1977 (TJADAB); T25-T31 scu-mus TDLo: 5700 ug/kg (8-10D preg) Experimental Pathology (1981). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.19- 1981- v. 36, p. 75, 1989 (EXPADD); T35 scu-mus TDLo: 3666 ug/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 10, p. 243, 1974 (TJADAB); T41-T42-T46 scu-mus TDLo: 2500 ug/kg (7D preg) Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 11, p. 127, 1973 (INHEAO); T02 ivn-mus TDLo: 73 mg/kg (1D male) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 164, 1984 (TOXID9); T46-T59 imp-mus TDLo: 20530 ug/kg (5-18D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 76, p. 195, 1995 (TOLED5); T02 itt-dog TDLo: 7330 ug/kg (1D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 14, p. 613, 1976 (IJEBA6); T02-T03 scu-mky TDLo: 12 mg/kg (1D male) Acta Europaea Fertilitatis. (COFESE Eds., Piazzale Ungheria 73, 90141 Palermo, Italy) V.1- 1969- v. 7, p. 339, 1976 (AEFTAA); T29 orl-rbt TDLo: 990 mg/kg (1-6D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 70, p. 323, 1984 (JRPFA4); T34-T51-T53 scu-rbt TDLo: 815 ug/kg (29D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 211, 1982 (TXAPA9); T35 scu-rbt TDLo: 1 mg/kg (20D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 1, p. 16, 1981 (TOXID9); T01-T02 scu-rbt TDLo: 4583 ng/kg (1D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 14, p. 348, 1967 (JRPFA4); T29 scu-rbt TDLo: 2500 ug/kg (1D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 26, p. 181, 1982 (CCPTAY); T24 scu-rbt TDLo: 5 mg/kg (1D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 26, p. 181, 1982 (CCPTAY); T39 scu-rbt TDLo: 204 ug/kg (29D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 211, 1982 (TXAPA9); T02-T03-T23 itt-rbt TDLo: 1520 ug/kg (1D male) Journal of Anatomy. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.51- 1916- v. 99, p. 907, 1965 (JOANAY); T12 par-gpg TDLo: 2500 ug/kg (1D pre) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 3, p. 50, 1965 (IJEBA6); T02 ipr-ham TDLo: 3666 ug/kg (1D male) Archives of Andrology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 15, p. 91, 1985 (ARANDR); T22-T29 scu-ham TDLo: 5 mg/kg (1D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 29, p. 249, 1983 (BIREBV); T02 scu-ham TDLo: 8 mg/kg (1D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 886, 1978 (BIREBV); T43 ivn-ham TDLo: 2 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 50A, 1979 (TJADAB); T39-T41-T42 ivn-ham TDLo: 2 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25, p. 101, 1982 (TJADAB); T25-T34-T43 ivn-rbt TDLo: 2 mg/kg (8D preg) Biochemical Medicine and Metabolic Biology. (Academic Press, Inc., Journal Customer Service, POB 6250, Duluth, MN 55802-0250) V.35- 1986- v. 48, p. 159, 1992 (BMMBES); T02-T03 scu-grb TDLo: 5600 ug/kg (1D male) Journal of the Royal Microscopical Society. (London, UK) V.47-88, 1927-68. For publisher information, see JMICAR. v. 85, p. 297, 1965 (JRMSAS); T02-T03 scu-sql TDLo: 7332 mg/kg (1D male) Acta Europaea Fertilitatis. (COFESE Eds., Piazzale Ungheria 73, 90141 Palermo, Italy) V.1- 1969- v. 7, p. 257, 1976 (AEFTAA); T02 scu-mam TDLo: 7332 ug/kg (1D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 12, p. 200, 1974 (IJEBA6); T02 unr-mam TDLo: 2400 ug/kg (1D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 18, p. 1398, 1980 (IJEBA6); T02-T03 itt-mam TDLo: 500 ug/kg (1D male) Acta Europaea Fertilitatis. (COFESE Eds., Piazzale Ungheria 73, 90141 Palermo, Italy) V.1- 1969- v. 7, p. 75, 1976 (AEFTAA); T23 scu-rat TDLo: 2.5 mg/kg (1D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 16, p. 609, 1977 (BIREBV); T21 scu-rat TDLo: 12.5 mg/kg (1D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 16, p. 609, 1977 (BIREBV); T24 scu-rat TDLo: 10 mg/kg (1D pre) The Indian journal of veterinary science and animal husbandry. (New Delhi, Indian Council of Agricultural Research) V1-38- 1931-1968 v. 32, p. 210, 1962 (IJVSA*); T24-T81 scu-rat TDLo: 10 mg/kg (1D pre) The Indian journal of veterinary science and animal husbandry. (New Delhi, Indian Council of Agricultural Research) V1-38- 1931-1968 v. 32, p. 210, 1962 (IJVSA*); T24-T81 scu-rat TDLo: 10 mg/kg (1D preg) The Indian journal of veterinary science and animal husbandry. (New Delhi, Indian Council of Agricultural Research) V1-38- 1931-1968 v. 32, p. 210, 1962 (IJVSA*); T85 orl-dog TDLo: 52.5 mg/kg (21D post) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S52, 2002 (TOLED5) TE: V01-J60 ihl-rat TCLo: 20 ug/m3/23H/78W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 70, p. 367, 1983 (JJIND8); V01-T61-V10 scu-rat TDLo: 3666 ug/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 84, 1983 (PAACA3); V03-V16 ims-rat TDLo: 4500 ug/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 83, p. 493, 1967 (ARPAAQ); V03-V16 par-rat TDLo: 1700 ug/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 83, p. 493, 1967 (ARPAAQ); V03-N60 par-rat TDLo: 6163 ug/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 114, p. 273, 1988 (JCROD7); V03-T61 scu-mus TDLo: 5499 ug/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 31, p. 745, 1963 (JNCIAM); V03-V10 scu-rat TD :4500 ug/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 83, p. 493, 1967 (ARPAAQ); V01-J60 ihl-rat TC :41 ug/m3/23H/78W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 70, p. 367, 1983 (JJIND8); V01-J60 ihl-rat TC :82 ug/m3/23H/78W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 70, p. 367, 1983 (JJIND8); V01-T61-V10 scu-rat TD :7332 ug/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 84, 1983 (PAACA3); V02-T61-V10 scu-rat TD :5499 ug/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 115, p. 653, 1964 (PSEBAA); V01-K60-T61 scu-rat TD :3666 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4575, 1983 (CNREA8); V01-K60-T61 scu-rat TD :7332 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4575, 1983 (CNREA8); V01-V10 scu-rat TD :40770 ng/kg/2D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4656, 1988 (CNREA8); V01-T61-V10 scu-rat TD :9 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 4282, 1989 (CNREA8); V01-J60-Q60 scu-rat TDLo: 32.99 mg/kg/18W-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 110, 2000 (TOSCF2); V01-J60-Q60 scu-rat TDLo: 66 mg/kg/18W-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 110, 2000 (TOSCF2); V01-T61 scu-rat TDLo: 32.99 mg/kg/18W-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 110, 2000 (TOSCF2); V01-T61 scu-rat TDLo: 66 mg/kg/18W-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 110, 2000 (TOSCF2) ORNG: 88000000 ng/kg. [88.000000 mg/kg] K01-K12-K13 AT: H02-J15-K12 orl-wmn LDLo: 3 gm/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 292, p. 1559, 1986 (BMJOAE); K01-K12-K13 orl-rat LD50: 88 mg/kg Quarterly Bulletin--Association of Food and Drug Officials of the United States. (Denver, CO) V.3-38, 1939-74. v. 15, p. 122, 1951 (AFDOAQ); T/E unlistd ipr-rat LD50: 1800 ug/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 28, p. 89, 1979 (EVHPAZ); T/E unlistd scu-rat LD50: 15166 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 667, 1977 (TXAPA9); T/E unlistd ivn-rat LD50: 5463 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 667, 1977 (TXAPA9); T/E unlistd ims-rat LD50: 25 mg/kg "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); J15-J70-U01 itr-rat LDLo: 241 ug/kg Eisei Kagaku. Hygienic Chemistry. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1953- v. 33, p. 360, 1987 (ESKGA2); U01 orl-mus LD50: 60 mg/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 48, p. 108, 1981 (APTOA6); P01 ipr-mus LD50: 9300 ug/kg Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 32, p. 472, 1977 (NEZAAQ); U01 scu-mus LD50: 3200 ug/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 48, p. 108, 1981 (APTOA6); T/E unlistd ivn-mus LD50: 3500 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 510, 1980 (TXAPA9); G08-J15-K13 ihl-dog LC90: 420 mg/m3/30M Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 29, p. 302, 1947 (JIHTAB); T/E unlistd ivn-dog LDLo: 5 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd scu-cat LDLo: 25 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd ivn-cat LDLo: 5 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-rbt LDLo: 70 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd scu-rbt LDLo: 18 mg/kg Journal of Anatomy. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.51- 1916- v. 97, p. 269, 1963 (JOANAY); T/E unlistd ivn-rbt LD50: 2500 ug/kg "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); T/E unlistd orl-gpg LD50: 63 mg/kg Food Research. (Champaign, IL) V.1-25, 1936-60. For publisher information, see JFDSAZ. v. 7, p. 313, 1942 (FOREAE); T/E unlistd skn-gpg LDLo: 233 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 11, p. 201, 1965 (AEHLAU); T/E unlistd ipr-gpg LDLo: 233 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 11, p. 201, 1965 (AEHLAU); T/E unlistd scu-pgn LDLo: 30 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-ckn LD50: 165 mg/kg "Kadmium-Symposium, Jena, Ger. Dem. Rep., 1977," Bolck F., ed., Jena, Ger. Dem. Rep., Abteilung Wissenschaftliche Pub., 1979 -,160,1979 (41PDA9); T/E unlistd scu-grb LDLo: 7500 ug/kg Journal of the Royal Microscopical Society. (London, UK) V.47-88, 1927-68. For publisher information, see JMICAR. v. 85, p. 297, 1965 (JRMSAS); T/E unlistd scu-frg LDLo: 30 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); Y03-Y10-Y16 ims-frg LD50: 10 mg/kg Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- v. 85, p. 249, 1986 (CBPCEE); U11 orl-mus TDLo: 2.8 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 571, 2001 (FCTOD7); T/E unlistd orl-mus LD50: 3.3 mg/kg Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 5, p. 43, 1998 (ETOPFR); N16-N72-Z73 scu-rat TDLo: 0.45 mg/kg mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 15, p. 699, 2001 (REPTED); T/E unlistd scu-mus TDLo: 1 mg/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 474, 2000 (TOSCF2); L30-M30-Y40 scu-rat LD50: 5490 ug/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 110, 2000 (TOSCF2); F42 ivn-rat TDLo: 3 mg/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 65, p. 151, 2002 (TOSCF2); H06-T02 scu-rat TDLo: 5.5 mg/kg Comparative Biochemistry and Physiology, A: Comparative Physiology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.30- 1971- v. 41A, p. 451, 1972 (CBPAB5); N19 scu-rat TDLo: 5 mg/kg Acta Physiologica Hungarica. (Kultura, POB 149, H-1389 Budapest, Hungary) V.61- 1983- v. 76, p. 245, 1990 (APHHDU); T02-T03 scu-rat TDLo: 5.5 mg/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 71, p. 52, 1961 (ARPAAQ); T02 scu-rat TDLo: 18.3 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 177, p. 1036, 1956 (NATUAS); T11-T12 scu-ham TDLo: 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 349, 1979 (MUREAV); T02 scu-grb TDLo: 7.5 mg/kg Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 13, p. 240, 1975 (BIREBV); Z73 scu-rat TDLo: 20 mg/kg Endokrinologie. (Leipzig, Ger. Dem. Rep.) V.1-80, 1928-82. For publisher information, see EXCEDS. v. 74, p. 6, 1979 (ENDKAC); T03-T23-Z72 scu-rat TDLo: 4 mg/kg Endokrinologie. (Leipzig, Ger. Dem. Rep.) V.1-80, 1928-82. For publisher information, see EXCEDS. v. 74, p. 6, 1979 (ENDKAC); T02 scu-mus TDLo: 2.2 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 122, p. 1036, 1966 (PSEBAA); T/E unlistd ipr-rat LD :8.3 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 73, p. 250, 1984 (TXAPA9); U01 ipr-rat TDLo: 3.66 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 73, p. 250, 1984 (TXAPA9); T03-Z73 ipr-rat TDLo: 1.8 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 73, p. 250, 1984 (TXAPA9); T01 ipr-rat TDLo: 0.83 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 73, p. 250, 1984 (TXAPA9); N16-P28 ipr-rat TDLo: 0.18 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 73, p. 250, 1984 (TXAPA9); L30-U11-Y37 scu-rat TDLo: 5.5 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 50, p. 203, 1990 (TOLED5) MD: M02-M16-M30 ipr-rat TDLo: 49 mg/kg/15D-I Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 32, p. 318, 1998 (CHYCDW); U01-Z73 orl-rat TDLo: 40040 mg/kg/65W-C Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 14, p. 205, 1981 (BCTKAG); M16-P28-Y40 orl-rat TDLo: 42770 ug/kg/6W-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 40, p. 273, 1988 (BECTA6); L30-Q30-U11 orl-rat TDLo: 7162 mg/kg/47W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 15, p. 95, 1983 (TOLED5); U05-U07-U11 orl-rat TDLo: 2808 mg/kg/83W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 54, p. 223, 1980 (TXAPA9); L70-P08-U01 orl-rat TDLo: 412 mg/kg/4W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 28, p. 435, 1990 (FCTOD7); M13-M16-M70 orl-rat TDLo: 1505 mg/kg/43W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 116, p. 155, 1992 (TXAPA9); M13-Q02-U07 ihl-rat TCLo: 33 ug/m3/24H/20W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 52(5), p. 85, 1987 (GISAAA); P28-P30-U09 orl-rat TDLo: 216 mg/kg/14W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 929, 1977 (JTEHD6); P28-Y15-Y03 orl-rat TDLo: 270 mg/kg/26W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 15, p. 521, 1985 (JTEHD6); M03-Y50 orl-rat TDLo: 27397 ug/kg/40W-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 24, p. 215, 1972 (AEHLAU); M30-Y03-Y15 ipr-rat TDLo: 7 mg/kg/4W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 12, p. 27, 1982 (TOLED5); L30-M16-N30 ipr-rat TDLo: 49 mg/kg/7W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 12, p. 131, 1982 (TOLED5); M10-M16-Y03 scu-rat TDLo: 52 mg/kg/16D-I Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 63, p. 342, 1988 (PHTOEH); M03-M16-Y15 scu-rat TDLo: 63700 ug/kg/26D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 98, p. 39, 1969 (TXAPA9); M16 scu-rat TDLo: 50 mg/kg/10W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 22, p. 255, 1987 (JTEHD6); K30-Y03-Y10 orl-rat TDLo: 293 mg/kg/30D-C Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 6, p. 121, 1977 (AECTCV); L30-L70-P30 scu-rat TDLo: 7338 ug/kg/9W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 8, p. 323, 1981 (TOLED5); L01-M13-Y15 scu-rat TDLo: 127 mg/kg/28W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 77, p. 414, 1985 (TXAPA9); L30-M16-U11 scu-rat TDLo: 9780 ug/kg/8W-I Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 18, p. 268, 1989 (EESADV); A30-E01-F43 scu-rat TDLo: 73385 ug/kg/15W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 457, 1981 (TOLED5); U01 ihl-rat TCLo: 327 ug/m3/24H/66D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 17, p. 585, 1977 (BECTA6); J30-M30-Y37 ihl-rat TCLo: 81 mg/m3/4H/15D-I Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 3, p. 419, 1991 (INHTE5); Q01-U09 ivn-rat TDLo: 65 mg/kg/13W-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 24, p. 451, 1996 (TOPADD); L30-M30-Y21 ipr-rat TDLo: 74 mg/kg/13W-I Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 41, p. 65, 1999 (VHTODE); L30-P28 orl-mus TDLo: 2235 ug/kg/85D-C Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 9, p. 29, 1984 (JTSCDR); A30-F16-U01 orl-mus TDLo: 185 mg/kg/22W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 55, p. 193, 1989 (TXCYAC); S04 orl-mus TDLo: 275 mg/kg/10W-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 598, 1975 (AEHLAU); N73-P05-U01 orl-mus TDLo: 6825 mg/kg/65W-C Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 70, p. 85P, 1974 (NYKZAU); P27-S02 orl-mus TDLo: 566 mg/kg/14D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 86, p. 39, 1996 (TOLED5); N73-P27-S01 ipr-mus TDLo: 14 mg/kg/14D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 86, p. 39, 1996 (TOLED5); N73-P70-P71 scu-mus TDLo: 35 mg/kg/7W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 24, p. 192, 1981 (ENVRAL); P27-P70-S04 scu-mus TDLo: 8154 ug/kg/5D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 19, p. 29, 1983 (TOLED5); N08-P28 orl-mky TDLo: 1369 mg/kg/24W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 34, p. 85, 1986 (TOLED5); P26-Q10 ivn-mky TDLo: 195 mg/kg/65W-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 24, p. 344, 1999 (JTSCDR); M16-U01-Y03 orl-rbt TDLo: 5547 mg/kg/54W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 31, p. 4, 1975 (TXAPA9); G12-G30-U11 orl-rbt TDLo: 1522 mg/kg/43W-C Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 322, 1985 (ATSUDG); P08-P28-P73 orl-rbt TDLo: 686 mg/kg/40W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 34, p. 611, 1996 (FCTOD7); M03-M16-Y03 scu-rbt TDLo: 28750 ug/kg/23W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 12, p. 360, 1966 (AEHLAU); M13-M70-N73 scu-rbt TDLo: 156 mg/kg/32W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 6, p. 225, 1980 (TOLED5); M16-M30-Y21 scu-rbt TDLo: 63600 ug/kg/13W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 61, p. 105, 1987 (ARTODN); D35-Y15 ivn-rbt TDLo: 2250 ug/kg/3W-I Klinika Oczna. Eye Clinic. (Ars Polona, POB 100, 100-068 Warsaw, Poland) V.1- 1923- v. 93, p. 1, 1991 (KOAOAE); F15-U01-Z01 orl-ckn TDLo: 1375 mg/kg/3W-C "Kadmium-Symposium, Jena, Ger. Dem. Rep., 1977," Bolck F., ed., Jena, Ger. Dem. Rep., Abteilung Wissenschaftliche Pub., 1979 -,160,1979 (41PDA9); F15-U01-Y40 orl-ckn TDLo: 3179 mg/kg/26W-C "Kadmium-Symposium, Jena, Ger. Dem. Rep., 1977," Bolck F., ed., Jena, Ger. Dem. Rep., Abteilung Wissenschaftliche Pub., 1979 -,160,1979 (41PDA9); M05-M70-Z73 orl-dck TDLo: 1803 mg/kg/90D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 551, 1978 (JTEHD6); M70-N72 orl-dck TDLo: 630 mg/kg/42D-C Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 13, p. 765, 1984 (AECTCV); L30-U01-Y15 scu-brd TDLo: 53 mg/kg/26W-I Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 48, p. 130, 1993 (NEZAAQ); F16-Q10 orl-rat TDLo: 512.4 mg/kg/12W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 729, 2001 (FCTOD7); K17-L02-Z01 scu-mus TDLo: 157 mg/kg/10W-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 223, 2000 (TOSCF2); P23 orl-rat TDLo: 42 mg/kg/182D-C Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 8, p. 79, 2000 (ETOPFR); F16 orl-rat TDLo: 54 mg/kg/8D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 66, p. 125, 2001 (BECTA6); U01-N30 scu-rat TDLo: 50 mg/kg/10W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 42, p. 400, 1987 (ENVRAL); T02-T23 scu-mus TDLo: 4.4 mg/kg/2D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 9, p. 53, 1989 (JEPOEC); U01-Z72-Z73 scu-rat TDLo: 77 mg/kg/14D-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 18, p. 111, 1993 (JTSCDR); Z01 ihl-mus TCLo: 0.1 mg/m3/2W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1367, 2001 (HBPTO*); Z01 ihl-rat TCLo: 0.1 mg/m3/2W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1367, 2001 (HBPTO*); Z01 orl-rat TDLo: 14 mg/kg/2W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1367, 2001 (HBPTO*); M71-U01 orl-mus TDLo: 13.6 mg/kg/5W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 630, 2001 (JTPAE7); L70-M71-U01 orl-mus TDLo: 27.2 mg/kg/10W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 630, 2001 (JTPAE7); Z73 scu-mus TDLo: 5 mg/kg/5D-I Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 29, p. 174, 1995 (AECTCV); Y03 scu-mus TDLo: 4 mg/kg/2D-I Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 29, p. 174, 1995 (AECTCV); T02 scu-mus TDLo: 3 mg/kg/3D-I Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 29, p. 174, 1995 (AECTCV); N15-U01 ipr-rat TDLo: 14 mg/kg/7D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 70, p. 185, 1991 (TXCYAC); N30 ipr-rat TDLo: 1.4 mg/kg/7D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 70, p. 185, 1991 (TXCYAC); M11 ipr-rat TDLo: 0.14 mg/kg/7D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 70, p. 185, 1991 (TXCYAC); N15-P30-Y21 scu-rat TDLo: 18 mg/kg/24W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 55, p. 117, 1989 (TXCYAC); M13-M16 scu-rat TDLo: 72 mg/kg/24W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 55, p. 117, 1989 (TXCYAC); N72 ipr-rat TDLo: 18 mg/kg/18W-I Acta Physiologica Hungarica. (Kultura, POB 149, H-1389 Budapest, Hungary) V.61- 1983- v. 78, p. 221, 1991 (APHHDU); F40-C16-F17 ims-rat TDLo: 14 mg/kg/70D-I Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 14, p. 689, 1976 (RCOCB8); U01 ims-rat TDLo: 15 mg/kg/15D-I Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 14, p. 689, 1976 (RCOCB8); L70-M71-N72 ims-rat TDLo: 70 mg/kg/70D-I Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 14, p. 689, 1976 (RCOCB8); F07-R21-Y07 ims-rat TDLo: 11.67 mg/kg/70D-I Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 14, p. 689, 1976 (RCOCB8); L70-M71-U01 ims-rat TDLo: 58.33 mg/kg/70D-I Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 14, p. 689, 1976 (RCOCB8); A01-P71 orl-rat TDLo: 360.08 mg/kg/8W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 178, p. 161, 2002 (TXCYAC); M16-M30-Y37 orl-rat TDLo: 152 mg/kg/19D-C Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 1428, 2001 (CRTOEC) TR: ACGIH TLV-TWA 0.01 mg(Cd)/m3, inhalable dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-TWA 0.002 mg(Cd)/m3, respirable dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 2, p. 74, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 39, 1976 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); TOXICOLOGY REVIEW Food Research. (Champaign, IL) V.1-25, 1936-60. For publisher information, see JFDSAZ. v. 7, p. 313, 1942 (FOREAE); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW "Cadmium in the Environment," Nriagu, J.O., ed., 2 vols., New York, John Wiley and Sons, Inc., 1980-81 2,743,1981 (43QNAO) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 0.2 mg(Cd)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 34, 1971 (DTLVS*); OEL-ARAB Republic of Egypt: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-DENMARK: TWA 0.01 mg(Cd)/m3, JAN 1999; OEL-FINLAND: TWA 0.02 mg(Cd)/m3, Carcinogen, Jan 1999; OEL-FRANCE: VME 0.05 mg(Cd)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-INDIA: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-JAPAN: OEL 0.05 mg(Cd)/m3, Group 1 Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.02 mg(Cd)/m3, MAC-K 0.1 mg(Cd)/m3, JAN 1999; OEL-NORWAY: TWA 0.05 mg(Cd)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.2 mg(Cd)/m3, JAN 1993; OEL-POLAND: MAC(TWA) fume 0.02 mg(Cd)/m3, MAC(STEL) fume 0.05 mg(Cd)/m3, JAN 1999; OEL-POLAND: MAC(TWA) dust 0.04 mg(Cd)/m3, MAC(STEL) dust 0.2 mg(Cd)/m3, JAN 1999; OEL-RUSSIA: TWA 0.01 mg(Cd)/m3, STEL 0.05 mg(Cd)/m3, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 mg(Cd)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1993; OEL-THAILAND: TWA 0.2 mg(Cd)/m3, STEL 0.5 mg(Cd)/m3, JAN 1993; OEL-TURKEY: TWA 0.2 mg(Cd)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.025 mg(Cd)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CADMIUM, dust and fume-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84478; NIS 5; TNF 68; NOS 5; TNE 447; NOES 1983: HZD 84478; NIS 12; TNF 753; NOS 13; TNE 4750; TFE 397 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss, B subtilis rec assay; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-rat, Sperm morphology-rabbit; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal, Host-mediated assay; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-mouse; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 643 of 1119 in RTECS (through 2003/06) AN: EV1925000 PN: Cadmium-oxide- SY: Cadmium-monoxide-; Cadmium-oxide- (ACGIH); Cadmium-oxide-fume-; Kadmu-tlenek- (Polish); NCI-C02551- RN: Current: 1306-19-0 UD: 200305 MF: Cd-O MW: 128.40 WL: CD O CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) RE: T32-T34-T35 orl-rat TDLo: 21640 ug/kg (1-19D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(8), p. 11, 1985 (GISAAA); T47-T76-T81 orl-rat TDLo: 21640 ug/kg (1-19D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(8), p. 11, 1985 (GISAAA); T75-T81 ihl-rat TCLo: 183 ug/m3/5H (21W pre/1-20D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 22, p. 53, 1984 (TOLED5); T85 ihl-rat TCLo: 23 ug/m3/5H (21W pre/1-20D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 22, p. 53, 1984 (TOLED5); T34 ihl-rat TCLo: 91 ug/m3 (1-19D preg) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 31(8), p. 25, 1987 (GTPZAB); T34-T46 ihl-rat TCLo: 2 mg/m3/6H (4-19D preg) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3388 (NTPTR*); T01 ihl-rat TCLo: 16 ug/m3/24H (1-21D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 46(10), p. 13, 1981 (GISAAA); T25-T34-T46 ihl-mus TCLo: 2 mg/m3/6H (4-17D preg) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3388 (NTPTR*); T21-T34 ihl-mus TCLo: 500 ug/m3/6H (4-17D preg) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3388 (NTPTR*) TE: V02-V10 scu-rat TDLo: 90 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 20, p. 190, 1966 (BJCAAI) ORNG: 72000000 ng/kg. [72.000000 mg/kg] T/E unlistd AT: T/E unlistd ihl-hmn TCLo: 8630 ug/m3/5H Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 455, 1980 (YAKUD5); D04-M13 ihl-man TCLo: 500 ug/m3/5Y-I Quarterly Journal of Medicine. (Oxford Univ. Press, Walton St., Oxford OX2 6DP, UK) V.1- 1932- v. 38, p. 425, 1969 (QJMEA7); G10-H01-M30 ihl-man TCLo: 40 ug/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 22, 1980 (GISAAA); T/E unlistd orl-rat LD50: 72 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 455, 1980 (YAKUD5); T/E unlistd ipr-rat LD50: 12 mg/kg Zdravookhranenie Kazakhstana. Public Health of Kazakhstan. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1941- v. 38(9), p. 18, 1978 (ZDKAA8); T/E unlistd ivn-rat LD50: 25 mg/kg "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); T/E unlistd ihl-mus LC50: 250 mg/m3/2H "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); T/E unlistd scu-mus LD50: 94 mg/kg "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); T/E unlistd ihl-dog LC50: 4 gm/m3/10M "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); T/E unlistd ihl-mky LC50: 1500 mg/m3/10M "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); T/E unlistd ihl-rbt LC50: 2500 mg/m3/10M "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); T/E unlistd ihl-gpg LC50: 3500 mg/m3/10M "Evaluation of the Impact of Cadmium on the Health of Man", Oxford, UK. Pergamon Press Ltd., 1978 -,67,1978 (85PDAD); T/E unlistd orl-mam LD50: 72 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(7-9), p. 187, 1968 (HYSAAV); T/E unlistd orl-mus LD50: 67 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 164, 1988 (VCVN1*); T/E unlistd ihl-rat LC50: 45 mg/m3/1H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 164, 1988 (VCVN1*) MD: M13-P30-Q30 orl-rat TDLo: 156 ug/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 52(6), p. 70, 1987 (GISAAA); M13-Q02-U07 ihl-rat TCLo: 23 ug/m3/24H/20W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 52(5), p. 85, 1987 (GISAAA); J70-P08-Y03 ihl-rat TCLo: 57 ug/m3/90D-C Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 231, 1978 (ARTODN); G70-J30-M70 ihl-rat TCLo: 300 ug/m3/6H/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3388 (NTPTR*); J12-J70 ihl-mus TCLo: 300 ug/m3/6H/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3388 (NTPTR*); J30-N73-N74 ihl-mus TCLo: 50 ug/m3/6H/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3388 (NTPTR*); F14-K13 orl-dog TDLo: 0.5 mg/kg/2D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S124, 2002 (TOLED5); M04-P71-U01 orl-dog TDLo: 7 mg/kg/28D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S124, 2002 (TOLED5); F14-K13-P71 orl-dog TDLo: 0.75 mg/kg/3D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S124, 2002 (TOLED5); F14-K13-U03 orl-dog TDLo: 1.75 mg/kg/7D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S124, 2002 (TOLED5) TR: ACGIH TLV-TWA 0.01 mg(Cd)/m3, inhalable dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-TWA 0.002 mg(Cd)/m3, respirable dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 2, p. 74, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 39, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 39, 1976 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR); TOXICOLOGY REVIEW Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 34, p. 127, 1973 (AMPMAR) SR: OEL-AUSTRALIA: TWA 0.05 mg/m3, Carcinogen (fume), JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: STEL 0.05 mg/m3, Carcinogen (fume), JAN 1993; OEL-BELGIUM: TWA 0.05 mg/m3, JAN 1993; OEL-DENMARK: TWA 0.01 mg(Cd)/m3, JAN 1999; OEL-FINLAND: TWA 0.01 mg/m3, Carcinogen (fume), JAN 1999; OEL-FINLAND: Carcinogen, JAN 1993; OEL-FRANCE: VLE 0.05 mg/m3 (fume), Carcinogen, JAN 1999; OEL-FRANCE: VME 0.05 mg/m3, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.05 mg/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.05 mg(Cd)/m3, Group 1 Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.05 mg/m3, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.05 mg(Cd)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.1 mg/m3 (fume), JAN 1993; OEL-POLAND: MAC(TWA) fume 0.02 mg(Cd)/m3, MAC(STEL) fume 0.05 mg(Cd)/m3, JAN 1999; OEL-POLAND: MAC(TWA) dust 0.04 mg(Cd)/m3, MAC(STEL) dust 0.2 mg(Cd)/m3, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 mg/m3 (fume), Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.1 mg/m3, STEL 0.3 mg/m3 (fume), JAN 1993; OEL-TURKEY: TWA 0.1 mg/m3 (fume), JAN 1993; OEL-UNITED KINGDOM: TWA 0.025 mg(Cd)/m3, STEL 0.05 mg(Cd)/m3, SEP 2000; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CADMIUM, dust and fume-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M1554; NIS 37; TNF 1127; NOS 28; TNE 10110; NOES 1983: HZD M1554; NIS 27; TNF 556; NOS 31; TNE 15727; TFE 4850 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Cadmium and compounds, as Cd, 7048; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; NTP Toxicity studies, RPT# TOX-39, October 2000 Record 644 of 1119 in RTECS (through 2003/06) AN: EV2700000 PN: Cadmium-sulfate- (1:1) SY: Cadmium-sulfate-; Cadmium-sulphate-; Sulphuric-acid,-cadmium-salt- (1:1) RN: Current: 10124-36-4 Previous: 31119-53-6; 62642-07-3 UD: 200302 MF: O4-S.Cd MW: 208.46 WL: CD S-O4 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: dnr-esc 50 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); dnr-bcs 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 109, 1980 (MUREAV); dnd-nsc 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 405, p. 29, 1998 (MUREAV); dnd-hmn-lym 500 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 299, 1994 (EMMUEG); sln-hmn-lng 67 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 469, p. 35, 2000 (MUREAV); dnd-rat-lvr 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 357, 1983 (MUREAV); mnt-mus-ipr 4300 ug/kg Gongye Weisheng Yu Zhiyebing. Industrial Health and Occupational Diseases. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1973- v. 12, p. 77, 1986 (GWZHEW); msc-mus-lym 150 ug/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 367, 1982 (JTEHD6); oms-ham-ovr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 45, 1992 (MUREAV); cyt-ham-ovr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 45, 1992 (MUREAV); dnd-hmn-fbr 0.033 umol/l/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 47, 2001 (MUREAV); mnt-hmn-fbr 0.033 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 490, p. 99, 2001 (MUREAV) RE: T24-T25-T32 orl-rat TDLo: 35230 mg/kg (1-19D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(8), p. 11, 1985 (GISAAA); T47-T76-T81 orl-rat TDLo: 35230 mg/kg (1-19D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(8), p. 11, 1985 (GISAAA); T39 ipr-mus TDLo: 5150 ug/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 32, p. 407, 1985 (TJADAB); T25 ipr-mus TDLo: 5150 ug/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29, p. 427, 1984 (TJADAB); T41 ipr-mus TDLo: 3 mg/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 54A, 1983 (TJADAB); T34 ipr-mus TDLo: 1030 ug/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29, p. 427, 1984 (TJADAB); T46 ipr-mus TDLo: 2570 ug/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29, p. 427, 1984 (TJADAB); T35-T43-T46 par-mus TDLo: 28 ug/kg (12D preg) Igaku to Seibutsugaku. Medicine and Biology. (c/o Ogato Igaku Kagaku Kenkyusho, 2-3-5 Bakuro-cho, Nihonbashi, Chuo-ku, Tokyo 103, Japan) V.1- 1942- v. 92, p. 65, 1976 (IGSBAL); T59 ipr-ham TDLo: 2800 ug/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 30A, 1984 (TJADAB); T25-T42-T41 ivn-ham TDLo: 2 mg/kg (8D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 22, p. 175, 1979 (BECTA6); T46-T55-T43 ivn-ham TDLo: 2 mg/kg (8D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 22, p. 175, 1979 (BECTA6); T41-T43-T42 ivn-ham TDLo: 2 mg/kg (8D preg) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 25, p. 56, 1969 (EXPEAM); T34-T55 ivn-ham TDLo: 2 mg/kg (8D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 6, p. 95, 1973 (ENVRAL) ORNG: 280000000 ng/kg. [280.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 280 mg/kg "Aktual'nye Problemy Gigieny Truda. Current Problems of Labor Hygiene," Tarasenko, N.Y., ed., Moscow, Pervyi Moskovskii Meditsinskii Inst., 1978 -,14,1978 (41HTAH); T/E unlistd ipr-mus LD50: 6879 ug/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 256, p. 1043, 1963 (COREAF); T/E unlistd orl-dog LDLo: 105 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd scu-dog LDLo: 27 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd scu-frg LDLo: 105 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1317, 1935 (HBAMAK); T/E unlistd orl-mus LD50: 47 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 164, 1988 (VCVN1*) TR: ACGIH TLV-TWA 0.01 mg(Cd)/m3, inhalable dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-TWA 0.002 mg(Cd)/m3, respirable dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 2, p. 74, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 39, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); TOXICOLOGY REVIEW Advances in Teratology. (New York, NY) V.1-5, 1966-72. Discontinued. v. 5, p. 51, 1972 (ADTEAS); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR); TOXICOLOGY REVIEW "Cadmium in the Environment," Nriagu, J.O., ed., 2 vols., New York, John Wiley and Sons, Inc., 1980-81 2,743,1981 (43QNAO) SR: MSHA STANDARD-air: TWA 0.2 mg(Cd)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 34, 1971 (DTLVS*); OEL-ARAB Republic of Egypt: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-DENMARK: TWA 0.01 mg(Cd)/m3, JAN 1999; OEL-FINLAND: TWA 0.02 mg(Cd)/m3, Carcinogen, Jan 1999; OEL-FRANCE: VME 0.05 mg(Cd)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-INDIA: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-JAPAN: OEL 0.05 mg(Cd)/m3, Group 1 Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.02 mg(Cd)/m3, MAC-K 0.1 mg(Cd)/m3, JAN 1999; OEL-NORWAY: TWA 0.05 mg(Cd)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.2 mg(Cd)/m3, JAN 1993; OEL-POLAND: MAC(TWA) fume 0.02 mg(Cd)/m3, MAC(STEL) fume 0.05 mg(Cd)/m3, JAN 1999; OEL-POLAND: MAC(TWA) dust 0.04 mg(Cd)/m3, MAC(STEL) dust 0.2 mg(Cd)/m3, JAN 1999; OEL-RUSSIA: TWA 0.01 mg(Cd)/m3, STEL 0.05 mg(Cd)/m3, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 mg(Cd)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.2 mg(Cd)/m3, STEL 0.5 mg(Cd)/m3, JAN 1993; OEL-TURKEY: TWA 0.2 mg(Cd)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.025 mg(Cd)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CADMIUM, dust and fume-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 80247; NIS 5; TNF 1041; NOS 5; TNE 15328; NOES 1983: HZD 80247; NIS 5; TNF 79; NOS 4; TNE 1313; TFE 172 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, B subtilis rec assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 645 of 1119 in RTECS (through 2003/06) AN: EV3150000 PN: Cadmium-sulfide- SY: Cadmium-monosulfide-; Cadmium-golden-366-; Cadmium-lemon-Yellow-527-; Cadmium-Orange-; Cadmium-primrose-819-; Cadmium-sulphide-; Cadmium-Yellow-; Cadmium-Yellow-000-; Cadmium-Yellow-892-; Cadmium Yellow Conc. Deep; Cadmium Yellow Conc. Golden; Cadmium Yellow Conc. Lemon; Cadmium Yellow Conc. Primrose; Cadmium-Yellow-10G-Conc-; Cadmium-Yellow-OZ-Dark-; Cadmium-Yellow-Primrose-47-4100-; Cadmopur-Golden-Yellow-N-; Cadmopur-Yellow-; Capsebon-; C.P. Golden Yellow 55; Ferro-Lemon-Yellow-; Ferro-Orange-Yellow-; Ferro-Yellow-; Greenockite-; GSK-; NCI-C02711-; PC-108-; Primrose-1466- RN: Current: 1306-23-6 Previous: 106496-20-2 UD: 200012 MF: Cd-S MW: 144.46 WL: CD S CC: Tumorigen (C); Mutagen (M) ME: cyt-hmn-leu 62 ug/L Proceedings of the Japan Academy. (Tokyo, Japan) V.21-53, 1945-77. For publisher information, see PJABDW. v. 48, p. 133, 1972 (PJACAW); mtr-ham-emb 1 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2757, 1982 (CNREA8); dnd-ham-ovr 10 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 657, 1982 (CRNGDP) TE: V01-V10 scu-rat TDLo: 90 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 20, p. 190, 1966 (BJCAAI); V03-V10 ims-rat TDLo: 120 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 20, p. 190, 1966 (BJCAAI); V03-V10 scu-rat TD :135 mg/kg Progress in Biochemical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1965- v. 14, p. 47, 1978 (PBPHAW); V03-P62-V10 scu-rat TD :250 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 198, p. 1213, 1963 (NATUAS) ORNG: 7080000000 ng/kg. [7080.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 7080 mg/kg "Aktual'nye Problemy Gigieny Truda. Current Problems of Labor Hygiene," Tarasenko, N.Y., ed., Moscow, Pervyi Moskovskii Meditsinskii Inst., 1978 -,14,1978 (41HTAH); T/E unlistd ihl-rat LC :>140 mg/m3/2H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0539392 (NTIS**); T/E unlistd orl-mus LD50: 1166 mg/kg "Aktual'nye Problemy Gigieny Truda. Current Problems of Labor Hygiene," Tarasenko, N.Y., ed., Moscow, Pervyi Moskovskii Meditsinskii Inst., 1978 -,14,1978 (41HTAH) TR: ACGIH TLV-TWA 0.01 mg(Cd)/m3, inhalable dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-TWA 0.002 mg(Cd)/m3, respirable dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 2, p. 74, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 39, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 119, 1993 (IMEMDT); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV) SR: MSHA STANDARD-air: TWA 0.2 mg(Cd)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 34, 1971 (DTLVS*); OEL-ARAB Republic of Egypt: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-DENMARK: TWA 0.01 mg(Cd)/m3, JAN 1999; OEL-FINLAND: TWA 0.02 mg(Cd)/m3, Carcinogen, Jan 1999; OEL-FRANCE: VME 0.05 mg(Cd)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-INDIA: TWA 0.05 mg(Cd)/m3, JAN 1993; OEL-JAPAN: OEL 0.05 mg(Cd)/m3, Group 1 Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.02 mg(Cd)/m3, MAC-K 0.1 mg(Cd)/m3, JAN 1999; OEL-NORWAY: TWA 0.05 mg(Cd)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.2 mg(Cd)/m3, JAN 1993; OEL-POLAND: MAC(TWA) fume 0.02 mg(Cd)/m3, MAC(STEL) fume 0.05 mg(Cd)/m3, JAN 1999; OEL-POLAND: MAC(TWA) dust 0.04 mg(Cd)/m3, MAC(STEL) dust 0.2 mg(Cd)/m3, JAN 1999; OEL-RUSSIA: TWA 0.01 mg(Cd)/m3, STEL 0.05 mg(Cd)/m3, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 mg(Cd)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.2 mg(Cd)/m3, STEL 0.5 mg(Cd)/m3, JAN 1993; OEL-TURKEY: TWA 0.2 mg(Cd)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.03 mg(Cd)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CADMIUM, dust and fume-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 83628; NIS 29; TNF 1041; NOS 41; TNE 19293; NOES 1983: HZD 83628; NIS 32; TNF 1625; NOS 38; TNE 42562; TFE 16685 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-human lymphocyte; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 646 of 1119 in RTECS (through 2003/06) AN: EX1225000 PN: Camphor- SY: 1,7,7-Trimethylbicyclo(2.2.1)-2-heptanone; 2-Bornanone-; 2-Camphanone-; 2-Kamfanon- (Czech); 2-Keto-1,7,7-trimethylnorcamphane-; Bicyclo(2.2.1)heptan-2-one, 1,7,7-trimethyl-; Bornane,-2-oxo-; Camphor,-natural-; Camphor,-synthetic-; Camphor,-synthetic- (ACGIH:OSHA); Formosa-camphor-; Gum-camphor-; Huile-de-camphre- (French); Japan-camphor-; Kampfer- (German); Laurel-camphor-; Matricaria-camphor-; Norcamphor,-1,7,7-trimethyl- RN: Current: 76-22-2 BRN: 3196099 BHR: 4-07-00-00213 UD: 200302 MF: C10-H16-O MW: 152.26 WL: L55 A CVTJ A1 A1 B1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P); Natural-Product (N) ME: sce-mus-ipr 80 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 157, 1989 (MUREAV) AT: D16-F12-K01 orl-inf LDLo: 70 mg/kg American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 30, p. 857, 1954 (AJPAA4); F07-F12 orl-chd TDLo: 51 mg/kg American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- v. 7, p. 41, 1989 (AJEMEN); T/E unlistd unr-chd LDLo: 100 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 31, p. 1499, 1980 (YKYUA6); T/E unlistd unr-man LDLo: 29 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); F12 ipr-rat LDLo: 900 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 65, p. 275, 1939 (JPETAB); T/E unlistd scu-rat LD50: 70 mg/kg "Ueber die Pharmakologische Wirkung eines dem Pentamethylentetrazol (Cardiazol) nahestehenden stickstoffhaltigen Kampherab-Kommlings, Dissertation," Czygan, H.H., Hessischen Ludwigs- Universitat zu Giessen, Fed. Rep. Ger., 1934 v. -, p. -, 1934 (CDGU**); T/E unlistd orl-mus LD50: 1310 mg/kg Shika Gakuho. Journal of Dentistry. (Tokyo Shika Daigaku Gakkai, 1-2-2 Masago, Chiba 260, Japan) V.1- 1895- v. 75, p. 934, 1975 (SHGKA3); F23 ihl-mus LCLo: 400 mg/m3/3H Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 22(11), p. 83, 1957 (GISAAA); F12-F17-F21 ipr-mus LD50: 3 gm/kg American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 30, p. 857, 1954 (AJPAA4); F13 scu-mus LDLo: 200 mg/kg "Pharmakologische Prufung von Analgetika, Dissertation," Herrlen, G., Pharmakologischen Institut der Universitat Tubingen, Fed. Rep. Ger., 1933 v. -, p. -, 1933 (HDTU**); T/E unlistd orl-dog LDLo: 800 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd ipr-cat LDLo: 400 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); F12-F17-F21 orl-rbt LDLo: 2 gm/kg American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 30, p. 857, 1954 (AJPAA4); C06 scu-frg LDLo: 240 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 50, p. 199, 1903 (AEXPBL); T/E unlistd ihl-rat LC50: 500 mg/m3 "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 296, 1998 (VCVPS*); F13-F23-K13 ihl-mus LC50: 450 mg/m3 "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 296, 1998 (VCVPS*); F07-F22-J25 unr-hmn TDLo: 0.01 gm/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 296, 1998 (VCVPS*) MD: J06 ihl-mus TCLo: 210 mg/m3/3H/7W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 22(11), p. 83, 1957 (GISAAA); A30-G30-J06 ihl-rbt TCLo: 33 mg/m3/3H/7W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 22(11), p. 83, 1957 (GISAAA) TR: ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 3 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- v. 12, p. 27, 1974 (JRPMAP); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB293-503 (NTIS**) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 2 ppm (12 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 37, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 2 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 2 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 2 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 2 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2 ppm (12 mg/m3), STEL 3 ppm (18 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 2 ppm (13 mg/m3), JAN 1999; OEL-BELGIUM: TWA 2 ppm (12 mg/m3), STEL 3 ppm (19 mg/m3), JAN 1993; OEL-DENMARK: TWA 2 ppm (12 mg/m3), JAN 1999; OEL-FINLAND: TWA 0.3 ppm (2 mg/m3), STEL 0.9 ppm (6 mg/m3), JAN 1993; OEL-FRANCE: VME 2 ppm (12 mg/m3), JAN 1999; OEL-GERMANY: MAK 2 ppm (13 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 2 ppm (12 mg/m3), JAN 1999; OEL-NORWAY: TWA 2 ppm (12 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 12 mg/m3, MAC(STEL) 18 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 2 ppm, JAN 1999; OEL-RUSSIA: STEL 3 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 2 ppm (13 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 2 ppm (13 mg/m3), STEL 3 ppm (19 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CAMPHOR, synthetic-air: 10H TWA 2 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #95-121, 1995 (NIOSH*); NOHS 1974: HZD 15800; NIS 68; TNF 8356; NOS 63; TNE 95578; NOES 1983: HZD X1190; NIS 1; TNF 25; NOS 1; TNE 427; TFE 176; NOES 1983: HZD 15800; NIS 101; TNF 9166; NOS 87; TNE 153554; TFE 53187 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Ketones II, 1301; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 647 of 1119 in RTECS (through 2003/06) AN: EZ5075000 PN: Carbamic-acid,-diethyldithio-,-2-chloroallyl-ester- SY: Carbamodithioic-acid,-diethyl-,-2-chloro-2-propenyl-ester- (9CI); CDEC-; Chlorallyl-diethyldithiocarbamate-; 2-Chloroallyl-diethyldithiocarbamate-; 2-Chloroallyl-N,N-diethyldithiocarbamate-; 2-Chloro-2-propene-1-thiol-diethyldithiocarbamate-; 2-Chloro-2-propenyl-diethylcarbamodithioate-; CP-4572-; CP-4,742-; Diethylcarbamodithioic-acid-2-chloro-2-propenyl-ester-; Diethyldithiocarbamic-acid-2-chloroallyl-ester-; NCI-C00453-; 2-Propene-1-thiol,-2-chloro-,-diethyldithiocarbamate-; Sulfallate-; Thioallate-; Vegadex-; Vegadex-super-; Vegedex- RN: Current: 95-06-7 BRN: 1772271 BHR: 4-04-00-00395 UD: 200007 MF: C8-H14-Cl-N-S2 MW: 223.80 WL: 2N2&YUS&S1YGU1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 10 uL/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 2, p. 87, 1981 (PMRSDJ); mmo-sat 10 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-omi 1100 ug/plate (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 297, 1978 (CBINA8); mmo-asn 20 uL/plate (-S9) Journal of the Science of Food and Agriculture. (Blackwell Scientific Pub. Inc., 52 Beacon St., Boston, MA 02108) V.1- 1950- v. 32, p. 826, 1981 (JSFAAE); dni-hmn-lym 500 mg/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 101, 1980 (ARTODN); dni-rat-oth 1 gm/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 101, 1980 (ARTODN) TE: V01-K60-R60 orl-rat TDLo: 6825 mg/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-115, 1978 (NCITR*); V01-J60-R60 orl-mus TDLo: 59 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-115, 1978 (NCITR*); V01-K60-R60 orl-rat TD :11 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-115, 1978 (NCITR*); V01-J60-R60 orl-mus TD :120 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-115, 1978 (NCITR*) ORNG: 850000000 ng/kg. [850.000000 mg/kg] T/E unlistd SRNG: 2200000000 ng/kg. [2200.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 850 mg/kg Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 10, p. 97, 1965 (RREVAH); T/E unlistd skn-rbt LD50: 2200 mg/kg "Wirksubstanzen der Pflanzenschutz und Schadlingsbekampfungsmittel," Perkow, W., Berlin, Verlag Paul Parey, 1971-1976 -,-,1971/1976 (85DPAN) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 30, p. 283, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 30, p. 283, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-AUSTRIA: Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Histidine reversion-Ames test; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9130; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-115, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 648 of 1119 in RTECS (through 2003/06) AN: FA8400000 PN: Carbamic-acid,-ethyl-ester- SY: A-11032-; Aethylcarbamat- (German); Aethylurethan- (German); Carbamidsaeure-aethylester- (German); Ethyl-carbamate-; Ethylester-kyseliny-karbaminove- (Czech); Ethylurethan-; Ethyl-urethane-; O-Ethylurethane-; Leucethane-; Leucothane-; NSC-746-; Pracarbamin-; Pracarbamine-; RCRA-waste-number-U238-; U-Compound-; Uretan-; Uretan-etylowy- (Polish); Urethan-; Urethane-; X-41- RN: Current: 51-79-6 UD: 200305 MF: C3-H7-N-O2 MW: 89.11 WL: ZVO2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 50 ug/plate (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 351, 1981 (PMRSDJ); mmo-esc 50 gm/L/1H (-S9) Cancer Research Supplement. (Baltimore, MD) No.1-4, 1953-56. v. 3, p. 69, 1955 (CRSUBM); mmo-esc 50 ug/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 351, 1981 (PMRSDJ); pic-esc 100 mmol/L Medycyna Doswiadczalna i Mikrobiologia. For English translation, see EXMMAV. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1949- v. 31, p. 11, 1979 (MDMIAZ); dnd-bcs 2 mg/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); mmo-omi 1000 ppm (-S9) Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. v. 6, p. 45, 1958 (APMBAY); slt-dmg-orl 500 umol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 17, p. 55, 1975 (CNJGA8); slt-dmg-mul 10 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1083, 1996 (CRNGDP); sln-dmg-mul 40 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1083, 1996 (CRNGDP); sln-dmg-ihl 55000 ppm/6H Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 4224, 1979 (CNREA8); sln-dmg-orl 100 mmol/L/3D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 571, 1984 (CRNGDP); sln-dmg-par 56200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 195, 1970 (CNREA8); spm-dmg-ihl 55000 ppm/6H Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 4224, 1979 (CNREA8); trn-dmg-orl 11 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 51, 1994 (EMMUEG); mmo-smc 71200 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 309, 1977 (MUREAV); mrc-smc 150 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 491, 1981 (PMRSDJ); sln-smc 150 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); sln-asn 169 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 139, 1986 (MUREAV); dnd-hmn-fbr 3 mmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 267, 1985 (ENMUDM); dns-hmn-hla 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-fbr 20 mg/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 21, p. 151, 1981 (TXCYAC); dni-hmn-fbr 200 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 183, p. 89, 1987 (MUREAV); sce-hmn-lym 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 75, 1981 (MUREAV); mnt-rat-ipr 15 gm/kg/10W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 127, p. 169, 1984 (MUREAV); mnt-rat-orl 600 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 262, p. 247, 1991 (MUREAV); mtr-rat-ipr 800 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 1157, 1980 (CNREA8); mtr-rat-orl 5040 mg/kg/6W Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 387, 1988 (CRNGDP); dnd-rat-lvr 100 mmol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); dns-rat-lvr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3010, 1982 (CNREA8); dns-rat-oth 1 mol/L Shika Kiso Igakkai Zasshi. Journal of the Japanese Association for Basic Dentistry. (Shika Kiso Igakkai, Hanayama Bldg., 1-44-2 Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1959- v. 22, p. 300, 1980 (SHKKAN); dni-rat-ipr 1 gm/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 2149, 1973 (CNREA8); oms-rat-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 371, p. 259, 1996 (MUREAV); sce-rat-ipr 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 126, p. 159, 1984 (MUREAV); cyt-rat-ivn 800 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 831, 1981 (JJIND8); cyt-rat-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 371, p. 259, 1996 (MUREAV); sce-rat-unr 400 mg/kg Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 13, p. 293, 1982 (BANRDU); sce-rat-lvr 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); mnt-mus-ipr 30 mg/kg/2D-I Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 705, 1981 (PMRSDJ); mnt-mus-par 40 mg/kg Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 69, p. 387, 1983 (TUMOAB); mnt-mus-orl 900 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 245, p. 227, 1990 (MUREAV); mnt-mus-skn 2 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17, p. 163, 1991 (EMMUEG); slt-mus-scu 1 gm/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 1342, 1983 (CNREA8); mtr-mus-emb 1100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 152, p. 113, 1985 (MUREAV); mtr-mus-fbr 500 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1235, 1982 (CRNGDP); dnd-mus-par 1 gm/kg Indian Journal of Cancer. (Indian Cancer Soc., Parel, Bombay, 400 012, India) V.1- 1963- v. 10, p. 403, 1973 (IJCAAR); dna-mus-ipr 400 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 6, p. 99, 1973 (CBINA8); oms-mus-par 750 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 76, p. 69, 1971 (ZKKOBW); dns-mus-ipr 750 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 68, 1994 (EMMUEG); dni-mus-ipr 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); dni-mus-skn 13600 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 769, 1973 (CNREA8); dni-mus-scu 1200 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 19, p. 327, 1977 (CBINA8); oms-mus-ipr 741 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 4, p. 329, 1971/1972 (CBINA8); cyt-mus-scu 20 mg/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 76, p. 1141, 1985 (JJCREP); cyt-mus-ipr 5 gm/kg/10D-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 4, p. 327, 1969 (IJCNAW); cyt-mus-skn 8 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 271, p. 223, 1992 (MUREAV); cyt-mus-ihl 1280 ug/L/48H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 369, p. 59, 1996 (MUREAV); sce-mus-ipr 3300 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 399, 1984 (CRNGDP); sce-mus-ihl 220 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 88, p. 223, 1981 (MUREAV); sce-mus-ivn 1100 umol/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 1, 1990 (TCMUD8); sce-mus-unr 400 mg/kg Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 13, p. 293, 1982 (BANRDU); hma-mus-esc 670 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 161, 1992 (MUREAV); spm-mus-ipr 25 gm/kg/5D-I Chemical Mutagens. Principles and Methods for Their Detection. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1971- v. 5, p. 257, 1978 (CMMUAO); mtr-ham-ipr 1 gm/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 95, p. 380, 1973 (ARPAAQ); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); cyt-ham-lng 10 gm/L Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 41, 1980 (ATSUDG); cyt-ham-fbr 8 gm/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); sce-ham-unr 400 mg/kg Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 13, p. 293, 1982 (BANRDU); sce-ham-fbr 10 mmol/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 58, p. 1635, 1977 (JNCIAM); sce-ham-ipr 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 126, p. 159, 1984 (MUREAV); msc-mus-ipr 3000 gm/L/1W Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 153, p. 199, 2000 (CALEDQ); mtr-mus-fbr 0.5 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG); slt-dmg 5 mmol/L/7D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 513, p. 61, 2002 (MUREAV) RE: T34 orl-rat TDLo: 7 gm/kg (6-12D preg) Japanese Journal of Pharmacology. (Japanese Pharmacological Soc., c/o Dept. of Pharmacology, Faculty of Medicine, Kyoto Univ., Sakyo-ku, Kyoto 606, Japan) V.1- 1951- v. 16, p. 63, 1966 (JJPAAZ); T46 orl-rat TDLo: 2 gm/kg (8-9D preg) Japanese Journal of Pharmacology. (Japanese Pharmacological Soc., c/o Dept. of Pharmacology, Faculty of Medicine, Kyoto Univ., Sakyo-ku, Kyoto 606, Japan) V.1- 1951- v. 16, p. 63, 1966 (JJPAAZ); T25 orl-rat TDLo: 2 gm/kg (6-7D preg) Japanese Journal of Pharmacology. (Japanese Pharmacological Soc., c/o Dept. of Pharmacology, Faculty of Medicine, Kyoto Univ., Sakyo-ku, Kyoto 606, Japan) V.1- 1951- v. 16, p. 63, 1966 (JJPAAZ); T29 ipr-rat TDLo: 1200 mg/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 90, p. 1594, 1972 (ENDOAO); T01 ipr-rat TDLo: 10 gm/kg (20D male) Hinyokika Kiyo. Journal of Urology. (Kyoto Daigaku Igakubu, Hinyokikagaku Kyoshitsu, 54 Kawara-machi, Shogain, Sakyo-ku, Kyoto 606, Japan) V.1- 1955- v. 12, p. 1339, 1966 (HIKYAJ); T29 scu-rat TDLo: 1200 mg/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 90, p. 1594, 1972 (ENDOAO); T29 ivn-rat TDLo: 1300 mg/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 91, p. 87, 1972 (ENDOAO); T26 orl-mus TDLo: 1600 mg/kg (4-7D preg) Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 8, p. 82, 1952 (APTOA6); T72-T75-T81 orl-mus TDLo: 4 gm/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 361, 1986 (TCMUD8); T69 ipr-mus TDLo: 1500 mg/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 158, p. 161, 1999 (TXAPA9); T14 ipr-mus TDLo: 3750 mg/kg (5D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 51, p. 159, 1977 (JRPFA4); T12-T29 ipr-mus TDLo: 3 gm/kg (6D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 51, p. 159, 1977 (JRPFA4); T25-T35 ipr-mus TDLo: 1200 mg/kg (7-9D preg) Proceedings of the Oklahoma Academy of Science. (Oklahoma Academy of Science, c/o Executive Secretary-Treasurer, Southwestern Oklahoma State Univ., Weatherford, OK 73096) V.1- 1910/1920- v. 56, p. 10, 1976 (POASAD); T83 ipr-mus TDLo: 1 gm/kg (18D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 24, p. 251, 1982 (TXCYAC); T34-T43-T46 ipr-mus TDLo: 1200 mg/kg (9D preg) Kaibogaku Zasshi. Journal of Anatomy. (Nippon Kaibo Gakkai, c/o Tokyo Daigaku Igakubu, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan) V.1- 1928- v. 43, p. 378, 1968 (KAIZAN); T35-T51 ipr-mus TDLo: 1250 mg/kg (9D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 8, p. 167, 1970 (IJEBA6); T49 ipr-mus TDLo: 1250 mg/kg (11D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 8, p. 167, 1970 (IJEBA6); T71 scu-mus TDLo: 1 gm/kg (15D preg) Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 63, p. 731, 1972 (GANNA2); T42 scu-mus TDLo: 45 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**); T48-T54 scu-mus TDLo: 550 mg/kg (7-17D preg) Journal of Immunopharmacology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1978/79- v. 8, p. 243, 1986 (JOIMD6); T26-T35 scu-mus TDLo: 418 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**); T41-T49-T53 scu-mus TDLo: 30 mg/kg (1-18D preg) Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 15, p. 36, 1979 (TPKVAL); T33 ivn-mus TDLo: 490 mg/kg (13-17D preg) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 90, 1989 (EMMUEG); T35 ivn-dog TDLo: 1 gm/kg (20D preg) Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- v. 6, p. 37, 1980 (JZKEDZ); T41-T42-T44 ipr-ham TDLo: 499 mg/kg (8D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 27, p. 1696, 1967 (CNREA8); T34 ipr-ham TDLo: 499 mg/kg (8D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 27, p. 1696, 1967 (CNREA8); T35-T41-T47 ipr-ham TDLo: 400 mg/kg (8D preg) Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 81, p. 174, 1966 (ARPAAQ); T35 ivn-ham TDLo: 400 mg/kg (8D preg) Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 81, p. 174, 1966 (ARPAAQ); T41-T47 ivn-ham TDLo: 200 mg/kg (8D preg) Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 81, p. 174, 1966 (ARPAAQ); T54 iut-mus TDLo: 10000 mg/kg (7-16D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 776, 2001 (HBPTO*) TE: V03-J60-L60 orl-rat TDLo: 30 gm/kg/52W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 7, p. 107, 1947 (CNREA8); V03-T65-L60 ipr-rat TDLo: 500 mg/kg (19D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 2552, 1970 (CNREA8); V02-J60 ipr-rat TDLo: 500 mg/kg Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 29, 1975 (RRCRBU); V03-D29 scu-rat TDLo: 8 gm/kg/8W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 43, p. 749, 1969 (JNCIAM); V01-R60 orl-mus TDLo: 12 gm/kg/15D-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 53, p. 81, 1967 (TUMOAB); V01-J60 ihl-mus TCLo: 2500 mg/m3/10D-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 81, p. 742, 1990 (JJCREP); V02-J60 ihl-mus TCLo: 138 ppm/130D-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 22, p. 663, 1971 (AEHLAU); V01-J60-R60 skn-mus TDLo: 90 gm/kg/56W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 911, 1984 (CRNGDP); V02-T65-T63 ipr-mus TDLo: 2500 mg/kg (7-11D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 14, 1973 (IARCCD); V02-T65-J60 ipr-mus TDLo: 500 mg/kg (19D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 137, 1978 (CNREA8); V01-J60 ipr-mus TDLo: 7 mg/kg/39W-I Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 147, p. 1443, 1965 (SCIEAS); V01-T65-J60 scu-mus TDLo: 1 gm/kg (11D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 18, p. 131, 1983 (CALEDQ); V01-T65-J60 scu-mus TDLo: 1000 mg/kg (15D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 2552, 1970 (CNREA8); V02-J60-T63 scu-mus TDLo: 200 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 2217, 1974 (CNREA8); V02-T65-J60 ivn-mus TDLo: 1000 mg/kg (18D preg) Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 8, p. 63, 1947 (JNCIAM); V02-J60-R60 ivn-mus TDLo: 1 gm/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 22, p. 299, 1962 (CNREA8); V03-T65-J60 unr-mus TDLo: 1 gm/kg (17D preg) Biochemical Society Transactions. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1973- v. 2, p. 710, 1974 (BCSTB5); V03-T65-L60 unr-mus TDLo: 1000 mg/kg (17D preg) Biochemical Society Transactions. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1973- v. 2, p. 710, 1974 (BCSTB5); V03-J60-L60 orl-mky TDLo: 325 gm/kg/5Y-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 78, 1980 (PAACA3); V02-K60-R60 orl-ham TDLo: 55 gm/kg/64W-C European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 5, p. 165, 1969 (EJCAAH); V01-R60 skn-ham TDLo: 1000 mg/kg/1W-I Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 158, p. 440, 1964 (CRSBAW); V03-K60-R60 scu-ham TDLo: 1 gm/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 6, p. 63, 1970 (IJCNAW); V01-J60-P62 orl-mus TD :1200 mg/kg/4W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 15, p. 322, 1961 (BJCAAI); V01-D45-L60 ipr-mus TD :880 mg/kg/7W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 1194, 1980 (CNREA8); V02-J60 ipr-mus TD :4990 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 1124, 1983 (CNREA8); V02-J60 ipr-mus TD :800 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 1744, 1976 (CNREA8); V02-J60 ipr-mus TD :10 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 3069, 1973 (CNREA8); V02-J60 ipr-mus TD :400 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 1411, 1975 (CNREA8); V02-J61-V15 scu-mus TD :500 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 1677, 1973 (CNREA8); V02-J60 ipr-mus TD :500 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 107, 1984 (CNREA8); V02-T65-J60 ipr-mus TD :1000 mg/kg (18D preg) Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 8, p. 63, 1947 (JNCIAM); V01-J60-P62 orl-mus TD :1280 mg/kg/4W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 15, p. 322, 1961 (BJCAAI); V02-J60 ipr-mus TDLo: 250 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 145, p. 101, 1999 (CALEDQ); V02-J60 ipr-mus TDLo: 125 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 145, p. 101, 1999 (CALEDQ); V01-V02-H60 orl-mus TDLo: 18 gm/kg/103W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 108, p. 61, 2000 (EVHPAZ); V03-J60 ipr-mus TDLo: 1500 mg/kg Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 42, p. 129, 2000 (VHTODE); V01-V16-J60 ipr-mus TDLo: 1000 mg/kg/15D-I Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. -, p. 704, 1992 (VOONC*) ORNG: 1809000000 ng/kg. [1809.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1809 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 57, p. 37, 1991 (CALEDQ); T/E unlistd ipr-rat LD50: 1500 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 26, p. 1448, 1966 (CNREA8); T/E unlistd scu-rat LDLo: 1800 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 182, p. 348, 1936 (AEPPAE); T/E unlistd ims-rat LD50: 1400 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 84, p. 227, 1975 (ZKKOBW); T/E unlistd orl-mus LD50: 2500 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 9, p. 595, 1959 (ARZNAD); T/E unlistd ipr-mus LD50: 1539 mg/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 682, 1981 (PMRSDJ); T/E unlistd scu-mus LD50: 1750 mg/kg Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 63, p. 731, 1972 (GANNA2); T/E unlistd ivn-mus LD50: 500 mg/kg Acta Pharmaceutica Jugoslavica. (FDH, Masarykova 2, 41000 Zagreb, Yugoslavia) V.1-41, 1951-91. For publisher information, see ACPHEE v. 5, p. 43, 1955 (APJUA8); K17 par-mus LDLo: 1 gm/kg Progress Report for Contract No. PH-43-63-1132, Submitted to the National Cancer Institute by Scientific Associates, Inc. (6200 S. Lindberg Blvd., St. Louis, MO 63123) PH-43-62-483 (NCISA*); T/E unlistd unr-mus LD50: 2 gm/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 6, p. 160, 1952 (BJCAAI); T/E unlistd ivn-rbt LDLo: 2 gm/kg "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973 -,272,1973 (27ZIAQ); T/E unlistd ivn-gpg LDLo: 800 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 131, p. 171, 1928 (AEPPAE); T/E unlistd iat-gpg LDLo: 800 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 131, p. 171, 1928 (AEPPAE); T/E unlistd orl-pgn LDLo: 800 mg/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931 v. -, p. -, 1931 (FDWU**); T/E unlistd orl-ckn LDLo: 2188 mg/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931 v. -, p. -, 1931 (FDWU**); A30-N24-N30 ipr-rat TDLo: 1300 mg/kg Australian Journal of Biological Sciences. (Commonwealth Scientific and Industrial Research Organization, 314 Albert St., E. Melbourne, Vic. 3002, Australia) V.6- 1953- v. 40, p. 91, 1987 (AJBSAM); F04 ipr-rat TDLo: 150 mg/kg Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 106, p. 343, 1980 (ENDOAO); F01 unr-rat TDLo: 800 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 107, 1986 (FATOAO) MD: L70-M70-P72 orl-rat TDLo: 7098 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3937 (NTPTR*); J30-M30-J70 orl-mus TDLo: 20 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3937 (NTPTR*); N73-N74-S05 ipr-mus TDLo: 700 mg/kg/7D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 161, 2000 (TOXID9) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 111, 1974 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 111, 1974 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 35, p. 89, 1976 (FEPRA7); TOXICOLOGY REVIEW JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 172, p. 1765, 1960 (JAMAAP); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 5, p. 480, 1964 (CLPTAT); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3); TOXICOLOGY REVIEW Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2895, 1975 (CNREA8); TOXICOLOGY REVIEW Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 33, p. 66, 1976 (ONCOBS); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY); TOXICOLOGY REVIEW Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 5, p. 1045, 1989 (TIHEEC) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999 ND: NOES 1983: HZD X3213; NIS 8; TNF 1299; NOS 8; TNE 9459; TFE 5050 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-mouse embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-nondisjunction, Host-mediated assay; EPA GENETOX PROGRAM 1988, Negative: E coli polA with S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, TRP reversion; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9, In vitro UDS-human fibroblast; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Toxicity studies, RPT# TOX-52, October 2000; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 649 of 1119 in RTECS (through 2003/06) AN: FB3325000 PN: Carbamic acid, isopropyl-, 2-(hydroxymethyl)-2-methylpentyl ester carbamate (ester) SY: Apesan-; Arusal-; Atonalyt-; Brianil-; Calenfa-; Caprodat-; Carbamic acid, ester with 2-(hydroxymethyl)-2-methylpentyl isopropylcarbamate; Carbamic-acid,-ester-with-2-methyl-2-propyl-1,3-propanediol-isopropylcarbamate-; Carisol-; Carisoma-; Carisoprodate-; Carisoprodatum-; Carisoprodol-; Carlsoma-; Carlsoprol-; Carsodal-; Carsodol-; CB-8019-; Isobamate-; Isomeprobamate-; Isopropylcarbamic acid, ester with 2-(hydroxymethyl)-2-methylpentyl carbamate; Isopropyl-meprobamate-; N-Isopropyl-2-methyl-2-propyl-1,3-propanediol-dicarbamate-; Isoprotan-; Isoprotane-; Soma-; Diolene-; Domarax-; Flexal-; Flexartal-; Izoprotan-; Mediquil-; (1-Methylethyl)carbamic acid 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester; 2-Methyl-2-propyl-1,3-propanediol-carbamate-isopropylcarbamate-; Mioartrina-; Miolisodal-; Mioril-; Mioriodol-; NCI-C56235-; Nospasm-; 1,3-Propanediol,-2-methyl-2-propyl-,-carbamate-isopropylcarbamate- (ester); Rela-; Relasom-; Sch-7307-; Sanoma-; Skutamil-; Somadril-; Somalgit-; Somanil-; Stialgin-; Tonolyt-isopropyl-meprobamate- RN: Current: 78-44-4 BRN: 1791537 BHR: 4-04-00-00520 UD: 200305 MF: C12-H24-N2-O4 MW: 260.38 WL: ZVO1X3&1&1OVMY1&1 CC: Tumorigen (C); Drug (D); Reproductive-Effector (T) RE: T14-T81 orl-mus TDLo: 277 gm/kg (15W male-21D post) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 24, p. 132, 1995 (FAATDF); T51-T72-T81 orl-mus TDLo: 157500 mg/kg (multigeneration) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 197, 1992 (TOXID9); T72 orl-mus TDLo: 42 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); T53 orl-mus TDLo: 300 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); T51-T81 orl-mus TDLo: 300 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); T75 orl-mus TDLo: 750 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); T73 orl-mus TDLo: 1200 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); T81 orl-mus TDLo: 750 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**) ORNG: 1320000000 ng/kg. [1320.000000 mg/kg] C06-F05-J30 AT: C06-F05-J30 orl-rat LD50: 1320 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 127, p. 66, 1959 (JPETAB); C06-F05-J30 ipr-rat LD50: 450 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 127, p. 66, 1959 (JPETAB); T/E unlistd ivn-rat LD50: 450 mg/kg Psychopharmacology Service Center, Bulletin. (Bethesda, MD) V.1-3, 1961-65. For publisher information, see PSYBB9. v. 2, p. 17, 1963 (PSCBAY); F05-F12 orl-mus LD50: 1800 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 12, p. 340, 1962 (ARZNAD); T/E unlistd ipr-mus LD50: 800 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 238, p. 92, 1960 (AEPPAE); C06-F05-J30 ivn-mus LD50: 165 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 127, p. 66, 1959 (JPETAB); D35-F05-F21 ivn-rbt LD50: 124 mg/kg International Journal of Neuropharmacology. (New York, NY) V.1-8, 1962-69. For publisher information, see NEPHBW. v. 5, p. 305, 1966 (IJNEAQ) MD: L70 orl-rat TDLo: 126 gm/kg/15W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 197, 1992 (TOXID9); L70-M03-M71 orl-rat TDLo: 18200 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-00-4404 (NTPTR*); L70-Z73 orl-mus TDLo: 13650 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-00-4404 (NTPTR*); Z01 ims-mus TDLo: 10500 mg/kg/1W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); Z01 ims-mus TDLo: 33600 mg/kg/28D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); L70-T02 ims-mus TDLo: 42000 mg/kg/21W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); M71-T72 ims-mus TDLo: 42000 mg/kg/21W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); F26 ims-mus TDLo: 8400 mg/kg/1W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**); U01 ims-mus TDLo: 8400 mg/kg/28D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92128404 (NTIS**) ND: NOES 1983: HZD X4826; NIS 2; TNF 62; NOS 7; TNE 2431; TFE 1194 SL: EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, test completed (post peer review), October 2000 Record 650 of 1119 in RTECS (through 2003/06) AN: FC2450000 PN: Carbamic-acid,-methyl-ester- SY: Methyl-carbamate-; Methylester-kyseliny-karbaminove- (Czech); Methylkarbamat- (Czech); Methylurethan-; Methylurethane-; NCI-C55594-; Urethylane- RN: Current: 598-55-0 BRN: 635779 BHR: 4-03-00-00037 UD: 200210 MF: C2-H5-N-O2 MW: 75.08 WL: ZVO1 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: eye-rbt 100 mg MOD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535979 (NTIS**) ME: mmo-esc 50 gm/L/3H (-S9) Cancer Research Supplement. (Baltimore, MD) No.1-4, 1953-56. v. 3, p. 69, 1955 (CRSUBM); mtr-rat-emb 120 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dns-rat-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 189, 1994 (MUREAV); oms-mus-par 375 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 76, p. 69, 1971 (ZKKOBW) TE: V01-L60 orl-rat TDLo: 102 gm/kg/2Y National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-328, 1987 (NTPTR*); V03-R60 skn-mus TDLo: 45 mg/kg/14W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 9, p. 177, 1955 (BJCAAI); V01-L60 orl-rat TD :104 gm/kg/1Y-I Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 83, p. 258, 1992 (JJCREP); V01-L60 orl-rat TDLo: 104000 mg/kg/1Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-168570/AS (NTIS**); V01-L60 orl-rat TDLo: 103000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-168570/AS (NTIS**); V02-J60 orl-mus TDLo: 515000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-168570/AS (NTIS**) ORNG: 2500000000 ng/kg. [2500.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2500 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-328, 1987 (NTPTR*); T/E unlistd orl-mus LD50: 6200 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-328, 1987 (NTPTR*); T/E unlistd ipr-mus LDLo: 200 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 288, 1972 (TXAPA9); F07 scu-mus LD50: 4450 mg/kg Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. v. 45, p. 507, 1967 (AJEBAK); D28-F05-J22 skn-rbt LD50: >2 gm/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 161, 1992 (ATDAEI); F12-F19-J22 orl-qal LD50: 21 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 8, p. 551, 1984 (EESADV) MD: Z01 orl-rat TDLo: 16 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-328, 1987 (NTPTR*); L70-N30-P26 orl-rat TDLo: 26 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-328, 1987 (NTPTR*); L70 orl-rat TDLo: 3500 mg/kg/7D-I Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 13, p. 319, 1989 (ATSUDG); L70 orl-mus TDLo: 130 gm/kg/26W-I Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 83, p. 258, 1992 (JJCREP); L70-Z01 orl-mus TDLo: 130 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-328, 1987 (NTPTR*); Z01 orl-mus TDLo: 24 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-328, 1987 (NTPTR*); P61-V30 orl-rat TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-168570/AS (NTIS**) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 151, 1976 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 151, 1976 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Negative: Aspergillus-aneuploidy, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Negative: E coli polA with S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat, E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 651 of 1119 in RTECS (through 2003/06) AN: FD4200000 PN: Carbamoyl-chloride,-dimethyl- SY: (Dimethylamino)carbonyl chloride; Carbamic-acid,-dimethyl- (9CI); Carbamyl-chloride,-N,N-dimethyl-; Chlorid-kyseliny-dimethylkarbaminove- (Czech); Chloroformic-acid-dimethylamide-; Dimethyl-carbamoyl-chloride-; Dimethyl-carbamoyl-chloride- (ACGIH); Dimethylamid-kyseliny-chlormravenci- (Czech); Dimethylcarbamic-acid-chloride-; Dimethylcarbamic-chloride-; Dimethylcarbamidoyl-chloride-; Dimethylcarbamoyl-chloride-; Dimethylcarbamyl-chloride-; Dimethylchloroformamide-; Dimethylkarbamoylchlorid- (Czech); N,N-Dimethylaminocarbonyl-chloride-; N,N-Dimethylcarbamic-acid-chloride-; N,N-Dimethylcarbamidoyl-chloride-; N,N-Dimethylcarbamoyl-chloride-; N,N-Dimethylcarbamyl-chloride-; RCRA-waste-number-U097-; TL-389- RN: Current: 79-44-7 BRN: 878197 BHR: 4-04-00-00224 UD: 200210 MF: C3-H6-Cl-N-O MW: 107.55 WL: GVN1&1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 33 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-sat 300 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); mmo-esc 100 ug/plate (+/-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); oms-esc 540 pmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); dnr-esc 10 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); pic-esc 500 uL/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 224, 1981 (PMRSDJ); sln-dmg-par 10 pph Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); mmo-smc 89 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 414, 1981 (PMRSDJ); dnr-smc 136 umol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 24, p. 771, 1982 (CNJGA8); mrc-smc 2 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 481, 1981 (PMRSDJ); sln-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mmo-ssp 2 mg/L (+/-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 424, 1981 (PMRSDJ); dnr-ssp 136 umol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 24, p. 771, 1982 (CNJGA8); dns-hmn-fbr 32 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 528, 1981 (PMRSDJ); mnt-mus-ipr 1400 ug/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 698, 1981 (PMRSDJ); mmo-mus-lym 187 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 49, 1982 (MUREAV); msc-mus-lym 1200 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 580, 1981 (PMRSDJ); hma-mus-sat 1 gm/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-ham-emb 100 ug/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); cyt-ham-ovr 33 uL/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 551, 1981 (PMRSDJ); sce-ham-ovr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 103, 1983 (MUREAV); sce-ham-lng 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 103, 1983 (MUREAV) TE: V01-D09 ihl-rat TCLo: 1 ppm/6H/6W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 33, p. 175, 1986 (CALEDQ); V01-R60-V10 skn-mus TDLo: 17280 mg/kg/72W-I Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 6(4), p. 479, 1987 (JACTDZ); V02-J60-V10 ipr-mus TDLo: 2560 mg/kg/64W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 53, p. 695, 1974 (JNCIAM); V01-R60-V10 scu-mus TDLo: 894 mg/kg/52W-I Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 6(4), p. 479, 1987 (JACTDZ); V01-D09-U01 ihl-ham TCLo: 1 ppm/6H/89W-I Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(1), p. 107, 1980 (JEPTDQ); V02-J60-R60 skn-mus TD :13 gm/kg/55W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 48, p. 1539, 1972 (JNCIAM); V02-V10 scu-mus TD :8 gm/kg/40W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 53, p. 695, 1974 (JNCIAM); V03-J60 ihl-rat TC :1 ppm/6H/6W-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 106, 1980 (PAACA3); V03-D09 ihl-rat TC :1 ppm Occupational Health and Safety Letter. (Environews, Inc., 1097 National Press Bldg., Washington, DC 20045) V.1- 1970- v. 6, p. 5, 1976 (OHSLAM); V02-J60-V10 scu-mus TD :5200 mg/kg/26W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 48, p. 1539, 1972 (JNCIAM); V02-R60-V10 skn-mus TD :13 gm/kg/55W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 53, p. 695, 1974 (JNCIAM); V03-D09 ihl-ham TC :1 ppm/6H/2Y-I Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(1), p. 107, 1980 (JEPTDQ) ORNG: 1000000000 ng/kg. [1000.000000 mg/kg] F07 AT: F07 orl-rat LD50: 1 gm/kg Zentralblatt fuer Arbeitsmedizin und Arbeitsschutz. (Darmstadt, Fed. Rep. Ger.) V.1-25, 1951-75. v. 24, p. 71, 1974 (ZAARAM); T/E unlistd ihl-rat LC50: 180 ppm/6H Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(1), p. 107, 1980 (JEPTDQ); T/E unlistd ihl-mus LCLo: 1000 mg/m3/10M National Defense Research Committee, Office of Scientific Research and Development, Progress Report. NDCrc-132, OCT1942 (NDRC**); F07 ipr-mus LD50: 300 mg/kg Zentralblatt fuer Arbeitsmedizin und Arbeitsschutz. (Darmstadt, Fed. Rep. Ger.) V.1-25, 1951-75. v. 24, p. 71, 1974 (ZAARAM) TR: ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 77, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 531, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 77, 1976 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 531, 1999 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 531, 1999 (IMEMDT) SR: OEL-AUSTRALIA: Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: Carcinogen, JAN 1993; OEL-FINLAND: Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DIMETHYLCARBAMOYLCHLORIDE-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 11, 1976; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 652 of 1119 in RTECS (through 2003/06) AN: FF2160000 PN: Carbodiimide,-dicyclohexyl- SY: Bis(cyclohexyl)carbodiimide; N,N'-Methanetetrayl-biscyclohexanamine-; Cyclohexaamine,-N,N'-methanetetraylbis- (9CI); DCC-; DCCD-; DCCI-; Dicyclohexylcarbodiimide-; N,N'-Dicyclohexylcarbodiimide-; 1,3-Dicyclohexylcarbodiimide- RN: Current: 538-75-0 BRN: 610662 BHR: 4-12-00-00072 UD: 200012 MF: C13-H22-N2 MW: 206.37 CC: Tumorigen (C) ORNG: 400000000 ng/kg. [400.000000 mg/kg] F18-K12-R21 AT: F18-K12-R21 orl-rat LD50: 400 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555962 (NTIS**); D17-H05-R21 ihl-rat LC50: 159 mg/m3/6H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555962 (NTIS**); F12-J22-J24 ipr-rat LD50: 10 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555962 (NTIS**); F18-R21 orl-mus LD50: >800 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555962 (NTIS**); F18-R21 ipr-mus LD50: >800 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555962 (NTIS**); T/E unlistd skn-gpg LD50: 10 mL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555962 (NTIS**) ND: NOES 1983: HZD X4836; NIS 1; TNF 7; NOS 1; TNE 28 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 653 of 1119 in RTECS (through 2003/06) AN: FF2175000 PN: Carbodiimide,-diisopropyl- SY: Diisopropylcarbodiimide-; N,N'-Methanetetraylbis-2-propanamine-; 2-Propanamine,-N,N'-methanetetraylbis- (9CI) RN: Current: 693-13-0 BRN: 878281 BHR: 4-04-00-00531 UD: 200012 MF: C7-H14-N2 MW: 126.23 CC: Tumorigen (C) AT: T/E unlistd ivn-mus LD50: 36 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#05886 (CSLNX*) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 654 of 1119 in RTECS (through 2003/06) AN: FF9410000 PN: Carbonic-acid,-chromium-salt- SY: Basic-chromium-carbonate-; Chromium-carbonate- (6CI) RN: Current: 29689-14-3 Previous: 51142-19-9 UD: 200007 MF: C-H2-O3.x Cr MW: 426.03 CC: Tumorigen (C) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: known to be human carcinogen Record 655 of 1119 in RTECS (through 2003/06) AN: FG4900000 PN: Carbon-tetrachloride- SY: Benzinoform-; Carbona-; Carbon-chloride- (CCl4); Carbon-TET-; Carbon-tetrachloride- (ACGIH:OSHA); Chlorid-uhlicity- (Czech); Czterochlorek-wegla- (Polish); ENT-4,705-; ENT-27164-; Flukoids-; Halon-1040-; Methane-tetrachloride-; Methane,-tetrachloro-; Necatorina-; Perchloromethane-; R-10-; RCRA-waste-number-U211-; R-10- (Refrigerant); Tetrafinol-; Tetrachloorkoolstof- (Dutch); Tetrachloormetaan-; Tetrachlorkohlenstoff,-tetra- (German); Tetrachlormethan- (German); Tetrachlorocarbon-; Tetrachloromethane- (OSHA); Tetrachlorure-de-carbone- (French); Tetraclorometano- (Italian); Tetracloruro-di-carbonio- (Italian); Tetraform-; Tetrasol-; Univerm-; Vermoestricid- RN: Current: 56-23-5 UD: 200305 MF: C-Cl4 MW: 153.81 WL: GXGGG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 4 mg MLD U.S. Atomic Energy Commission, University of Rochester, Research and Development Reports. (Rochester, NY) MDDC-1715 (XEURAQ); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,91,1986 (85JCAE); eye-rbt 2200 ug/30S MLD U.S. Atomic Energy Commission, University of Rochester, Research and Development Reports. (Rochester, NY) MDDC-1715 (XEURAQ); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,91,1986 (85JCAE) ME: mmo-sat 20 uL/L (+S9) Egyptian Journal of Microbiology. (National Information and Documentation Centre, A1-Tahrir St., Awqaf P.O. Dokki, Cairo, Egypt) V.7- 1972- v. 18, p. 213, 1983 (EJMBA2); dnr-esc 12500 ng/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); dna-esc 300 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 200 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); mrc-smc 2 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 397, p. 271, 1998 (MUREAV); mmo-asn 5000 ppm (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 288, 1985 (MUREAV); mrc-asn 5000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 288, 1985 (MUREAV); sln-asn 5000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 288, 1985 (MUREAV); dna-rat-ipr 367 umol/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 11, p. 419, 1973 (IJCNAW); dnd-rat-scu 31 gm/kg/12W-I Folia Histochemica et Cytochemica. (Cracow, Poland) V.1-21, 1963-83. v. 13, p. 207, 1975 (FHCYAI); dnd-rat-lvr 3 mmol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); oms-rat-ipr 100 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 35, p. 191, 1987 (TOLED5); dns-rat-ipr 100 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 35, p. 191, 1987 (TOLED5); dns-rat-orl 1400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 189, 1994 (MUREAV); oms-rat-orl 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 344, p. 109, 1995 (MUREAV); cyt-rat-scu 31 gm/kg/12W-I Folia Histochemica et Cytochemica. (Cracow, Poland) V.1-21, 1963-83. v. 13, p. 207, 1975 (FHCYAI); dna-mus-ipr 367 umol/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 11, p. 419, 1973 (IJCNAW); dna-mus-lvr 10 umol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 81, 1983 (PAACA3); dnd-mus-orl 335 umol/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 175, p. 237, 1984 (PSEBAA); dnd-mus-lym 6550 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 155, 1988 (MUREAV); dns-mus-orl 100 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 474, 1984 (ENMUDM); dni-mus-orl 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); mtr-ham-emb 500 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 291, 1983 (CRNGDP); sln-ham-lng 1600 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 135, 1987 (MUREAV); dna-mam-lym 1 mmol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 11, p. 243, 1982 (TOLED5); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T25 orl-rat TDLo: 2 gm/kg (7-8D preg) "Malformations Congenitales des Mammiferes," Tuchmann-Duplessis, H., Paris, Masson et Cie, 1971 -,95,1971 (85DJA5); T31 orl-rat TDLo: 3 gm/kg (14D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 82, p. 1262, 1976 (BEXBAN); T19-T25 orl-rat TDLo: 150 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 56, p. 252, 1997 (TJADAB); T25 orl-rat TDLo: 750 mg/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 40, p. 30, 1997 (FAATDF); T34-T46-T55 ihl-rat TCLo: 300 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 452, 1974 (TXAPA9); T75-T76 ihl-rat TCLo: 250 ppm/8H (10-15D preg) Dissertation Abstracts International, B: The Sciences and Engineering. (University Microfilms International, 300 N. Zeeb Rd., Ann Arbor, MI 48106) V.30- 1969- v. 32, p. 2021, 1971 (DABBBA); T02-T03 ipr-rat TDLo: 71500 mg/kg (15D male) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 22, p. 395, 1966 (EXPEAM); T09 ipr-rat TDLo: 5 gm/kg (1D male) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 10, p. 39, 1978 (TXCYAC); T34-T51 par-rat TDLo: 2384 mg/kg (18D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 76, p. 1467, 1973 (BEXBAN) TE: V03-L60 scu-rat TDLo: 15600 mg/kg/12W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 38, p. 891, 1967 (JNCIAM); V02-L60-R60 orl-mus TDLo: 4400 mg/kg/19W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 20, p. 431, 1958 (JNCIAM); V03-L60 par-mus TDLo: 305 gm/kg/30W-I Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 89, p. 845, 1980 (BEXBAN); V03-L04-L60 orl-ham TDLo: 9250 mg/kg/30W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 26, p. 855, 1961 (JNCIAM); V02-L60 orl-mus TD :12 gm/kg/88D-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 4, p. 385, 1944 (JNCIAM); V03-L60 scu-rat TD :100 gm/kg/25W-I Kurume Medical Journal. (Kurume Univ. School of Medicine, Dept. of Physiology, 67, Asahi- machi, Kurume 830, Japan) V.1- 1954- v. 12, p. 37, 1965 (KRMJAC); V03-L60 scu-rat TD :31 gm/kg/12W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 45, p. 1237, 1970 (JNCIAM); V01-L60-N62 scu-rat TD :182 gm/kg/70W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 44, p. 419, 1970 (JNCIAM); V02-L60 orl-mus TD :8580 mg/kg/9W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 4, p. 385, 1944 (JNCIAM); V02-L60 orl-mus TD :57600 mg/kg/12W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 2, p. 197, 1941 (JNCIAM) ORNG: 2350000000 ng/kg. [2350.000000 mg/kg] T/E unlistd SKNG: 5070000000 ng/kg. [5070.000000 mg/kg] T/E unlistd IHPB: 8000000 ppb/4H. [8000.000000 ppm/4H] T/E unlistd AT: K13 ihl-hmn TCLo: 20 ppm "Chemistry of Industrial Toxicology," 2nd ed., Elkins, H.B., New York, John Wiley and Sons, Inc., 1959 2,136,1959 (85CYAB); D15-F24-F25 orl-wmn TDLo: 1800 mg/kg Texas Medicine. (Texas Medical Assoc., 1801 N. Lamar Blvd., Austin, TX 78701) V.60- 1964- v. 69, p. 86, 1973 (TXMDAX); F11-J30-K30 orl-man TDLo: 1700 mg/kg South African Medical Journal. (Medical Assoc. of South Africa, Secy., P.O. Box 643, Cape Town, S. Africa) V.6- 1932- v. 49, p. 635, 1975 (SAMJAF); G10-J24-M05 orl-man LDLo: 429 mg/kg Zeitschrift fuer die Gesamte Hygiene und Ihre Grenzgebiete. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1955- v. 19, p. 781, 1973 (ZHYGAM); T/E unlistd ihl-hmn LCLo: 1000 ppm Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 198, 1966 (PCOC**); F07-F14-K13 ihl-hmn TCLo: 45 ppm/3D Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 360, 1960 (LANCAO); K13 ihl-hmn TCLo: 317 ppm/30M JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 103, p. 962, 1934 (JAMAAP); T/E unlistd ihl-hmn LCLo: 5 pph/5M Tabulae Biologicae. (The Hague, Netherlands) V.1-22, 1925-63. Discontinued. v. 3, p. 231, 1933 (TABIA2); T/E unlistd unr-man LDLo: 93 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 2350 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 54, p. 275, 1983 (ARTODN); T/E unlistd ihl-rat LC50: 8000 ppm/4H Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 16, 1974 (NPIRI*); T/E unlistd skn-rat LD50: 5070 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 16, 1978 (SPEADM); T/E unlistd ipr-rat LD50: 1500 uL/kg U.S. Atomic Energy Commission, University of Rochester, Research and Development Reports. (Rochester, NY) MDDC-1715 (XEURAQ); T/E unlistd itr-rat LDLo: 90 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520615 (NTIS**); T/E unlistd orl-mus LD50: 8263 mg/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 3, p. 169, 1951 (JPPMAB); T/E unlistd ihl-mus LC50: 9526 ppm/8H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 29, p. 382, 1947 (JIHTAB); T/E unlistd ipr-mus LD50: 572 mg/kg Pharmacologist. (American Soc. for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1959- v. 10, p. 172, 1968 (PHMCAA); F04-F19 scu-mus LD50: 31 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 123, p. 224, 1958 (JPETAB); T/E unlistd orl-dog LDLo: 1 gm/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); F01-H02-U28 ihl-dog LCLo: 14620 ppm/8H National Institutes of Health, Bulletin. (Bethesda, MD) v. 191, p. 1, 1949 (NIHBAZ); L14 ipr-dog LD50: 1500 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 119, 1967 (TXAPA9); T/E unlistd ivn-dog LDLo: 125 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd ihl-cat LCLo: 38110 ppm/2H "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1405, 1935 (HBAMAK); J30-L03-P01 scu-cat LDLo: 300 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 63, p. 153, 1938 (JPETAB); T/E unlistd orl-rbt LD50: 5760 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 32, 1968 (GISAAA); T/E unlistd skn-rbt LD50: >20 gm/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 712, 1992 (ATDAEI); T/E unlistd ipr-rbt LDLo: 477 mg/kg Gastroenterology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1943- v. 71, p. 118, 1976 (GASTAB); T/E unlistd scu-rbt LDLo: 3 gm/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); F13-F24-J22 ivn-rbt LD50: 5840 mg/kg Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie. (VEB Gustav Fischer Verlag, Postfach 176, Jena DDR-6900, Ger. Dem. Rep.) V.1- 1890- v. 118, p. 305, 1974 (ZAPPAN); T/E unlistd orl-gpg LD50: 5760 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 32, 1968 (GISAAA); T/E unlistd ihl-gpg LCLo: 20000 ppm/2H Fluorine Chemistry Reviews. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1967- v. 1, p. 197, 1967 (FLCRAP); T/E unlistd skn-gpg LD50: >9400 uL/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 7, p. 559, 1965 (TXAPA9); K08-K30 ipr-ckn LD50: 4497 mg/kg British Veterinary Journal. (Bailliere Tindall, 33 The Avenue, Eastbourne BN21 3UN, UK) V.105- 1949- v. 127, p. 304, 1971 (BVJOA9); T/E unlistd ihl-frg LCLo: 58 gm/m3 Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 97, p. 86, 1923 (AEXPBL); T/E unlistd orl-mam LD50: 6 gm/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); T/E unlistd ihl-mam LC50: 34500 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 17, 1980 (GTPZAB); L02-Y10-Y15 orl-rbt TDLo: 0.25 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 87, 1984 (FATOAO); L14-Y10-Y15 orl-rbt LD :250 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 191, 1981 (FATOAO) MD: F15-L04-M03 orl-rat TDLo: 4800 uL/kg/8W-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 25, p. 33, 2000 (JTSCDR); L70-Y07-Y15 orl-rat TDLo: 1200 mg/kg/12W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 15, p. 558, 1990 (FAATDF); L30 orl-rat TDLo: 4197 ug/kg/28D-I Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 3, p. 169, 1951 (JPPMAB); L70-U01-Y15 orl-rat TDLo: 400 mg/kg/10D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 17, p. 186, 1991 (FAATDF); N08 ihl-rat TCLo: 41 mg/m3/4H/8D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 12, p. 5, 1971 (TPKVAL); L03-L30 ihl-rat TCLo: 61 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); L70 ihl-rat TCLo: 400 ppm/1H/46D-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 50, 1952 (AMIHBC); L02-L03-Z01 ihl-rat TCLo: 200 ppm/7H/27W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 50, 1952 (AMIHBC); L03 ihl-rat TCLo: 50 ppm/3H/8W-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 11, p. 48, 1973 (INHEAO); C18-Z01 ihl-rat TCLo: 400 ppm/8H/46W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 277, 1936 (JIHTAB); L04 scu-rat TDLo: 31200 uL/kg/12W-I Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 85, p. 275, 1968 (ARPAAQ); L30-P28-Y03 ipr-rat TDLo: 4200 uL/kg/2W-I Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 37, p. 1025, 1999 (IJEBA6); L70-N73-Z01 orl-mus TDLo: 8750 mg/kg/14D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 454, 1986 (FAATDF); L70-N73-Y03 orl-mus TDLo: 1080 mg/kg/90D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 454, 1986 (FAATDF); L01-P28-Y16 ihl-mus TCLo: 20 ppm/12W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 408, 1999 (TOXID9); F18-P02-Z01 orl-dog TDLo: 636 gm/kg/16D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 22, p. 215, 1923 (JPETAB); L03 ihl-dog TCLo: 515 mg/m3/8H/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); J13-U01-Z01 ihl-mky TCLo: 515 mg/m3/8H/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); L30-R21 ihl-mky TCLo: 61 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); C18 ihl-mky TCLo: 200 ppm/8H/46W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 277, 1936 (JIHTAB); L03 ihl-rbt TCLo: 515 mg/m3/8H/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); L30 ihl-rbt TCLo: 61 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); U01 ihl-rbt TCLo: 100 ppm/7H/30W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 50, 1952 (AMIHBC); L14-M16-S05 ihl-rbt TCLo: 100 mg/m3/3H/35W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(5), p. 47, 1981 (GTPZAB); L03-U01-Z01 ihl-gpg TCLo: 515 mg/m3/8H/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); L03-U01-Z01 ihl-gpg TCLo: 61 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); L01-Z01 ihl-gpg TCLo: 100 ppm/7H/33W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 50, 1952 (AMIHBC); L03-M30-N30 ihl-gpg TCLo: 25 ppm/8H/46W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 18, p. 277, 1936 (JIHTAB); L01-P28-Y16 ihl-ham TCLo: 100 ppm/12W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 408, 1999 (TOXID9); L01-U01-Y20 orl-rbt TDLo: 117.2 mg/kg/16W-I Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 987, 2000 (CEXPB9); L30-Y16 ipr-rat TDLo: 2 mL/kg/1W-I Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 694, 2000 (CEXPB9); L04-Y16 ipr-rat TDLo: 4 mL/kg/2W-I Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 694, 2000 (CEXPB9); L04-Y16-Y40 ipr-rat TDLo: 10 mL/kg/5W-I Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 694, 2000 (CEXPB9); L04-Y20-Y40 ipr-rat TDLo: 14 mL/kg/7W-I Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 694, 2000 (CEXPB9); L50 scu-rat TDLo: 8000 mg/kg/4D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 66, 1987 (FATOAO); L02-U01-Z01 ipr-rat TDLo: 20 mL/kg/10W-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 67, 1984 (FATOAO); Y15-L30-L03 ims-mus TDLo: 32 mg/kg/30D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 46, p. 103, 1983 (FATOAO); L01-L50-Y20 ims-rat TDLo: 5 mg/kg/4D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 67, 1987 (FATOAO); L01-L03-L19 orl-rat TDLo: 8000 mg/kg/4D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 66, 1987 (FATOAO) TR: ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 10 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 371, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 401, 1999 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 1, p. 53, 1972 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 1, p. 53, 1972 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 371, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 401, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 401, 1999 (IMEMDT); TOXICOLOGY REVIEW Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 24, p. 173, 1974 (ARZNAD); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Pharmacological Reviews. (Williams and Wilkins, 428 E. Preston St., Baltimore, MD 21202) V.1- 1949- v. 4, p. 1, 1952 (PAREAQ); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ); TOXICOLOGY REVIEW Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- v. 54, p. 413, 1978 (BNYMAM); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 13, p. 231, 1978 (CTOXAO); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,250,1970 (85CVA2); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 7, p. 177, 1980 (CRTXB2); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 1133, 1980 (JTEHD6); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB256-732 (NTIS**) SR: MSHA STANDARD-air: TWA 10 ppm (65 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 43, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 10 ppm;CL 25 ppm;Pk 200 ppm/5M/4H Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 10 ppm (65 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 10 ppm (65 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 10 ppm (65 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 5 ppm (30 mg/m3), Skin, JAN 1993; OEL-AUSTRALIA: TWA 5 ppm (30 mg/m3), Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: MAK 10 ppm (65 mg/m3), Skin, Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 5 ppm (31 mg/m3), Skin, Carcinogen, JAN 1993; OEL-DENMARK: TWA 2 ppm (13 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 5 ppm (31 mg/m3), STEL 10 ppm (63 mg/m3), Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 2 ppm (12 mg/m3), VLE 10 ppm (60 mg/m3), C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 10 ppm (65 mg/m3), Skin, Carcinogen, JAN 1999; OEL-HUNGARY: STEL 10 mg/m3, Skin, Carcinogen, JAN 1993; OEL-INDIA: TWA 5 ppm (30 mg/m3), Skin, Carcinogen, JAN 1993; OEL-JAPAN: OEL 5 ppm (31 mg/m3), Skin, 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 2 ppm (12.6 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 2 ppm (13 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 10 ppm (65 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 20 mg/m3, MAC(STEL) 100 mg/m3, JAN 1999; OEL-RUSSIA: TWA 10 ppm, STEL 20 mg/m3, JAN 1993; OEL-SWEDEN: NGV 2 ppm (13 mg/m3), KTV 3 ppm (19 mg/m3), Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (30 mg/m3), STEL 10 ppm (60 mg/m3), Skin, JAN 1999; OEL-THAILAND: TWA 10 ppm, STEL 25 ppm, JAN 1993; OEL-UNITED KINGDOM: TWA 2 ppm (13 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CARBON TETRACHLORIDE-air: CA STEL 2 ppm/60M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #95-121, 1995 (NIOSH*); NOHS 1974: HZD 17490; NIS 73; TNF 5152; NOS 56; TNE 64009; NOES 1983: HZD 17490; NIS 77; TNF 6629; NOS 72; TNE 104174; TFE 20699 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/100103/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test, Sperm morphology-mouse; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 656 of 1119 in RTECS (through 2003/06) AN: FG6400000 PN: Carbonyl-sulfide- SY: Carbon-oxide-sulfide- (9CI); Carbon-oxysulfide-; Carbon-monoxide-monosulfide-; Oxycarbon-sulfide- RN: Current: 463-58-1 BRN: 1697284 BHR: 4-03-00-00271 UD: 200302 MF: C-O-S MW: 60.07 WL: SCO CC: Tumorigen (C) IHPB: 1070000 ppb/4H. [1070.000000 ppm/4H] F12-J22-U01 AT: F12-J22-U01 ihl-rat LC50: 1070 ppm/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534820 (NTIS**); F19-J22-J24 ipr-rat LD50: 23 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 55, p. 198, 1980 (TXAPA9); F01-F12-F19 ihl-mus LC50: 2770 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(7), p. 52, 1979 (GTPZAB); F01-F12-F19 ihl-rbt LC50: 2550 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(7), p. 52, 1979 (GTPZAB); F01-F19-F22 ihl-mus LC50: 2770 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 204, 1993 (VCVN5*); F01-F19-F22 ihl-rat LC50: 2270 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 204, 1993 (VCVN5*); F01-F19-F22 ihl-rbt LC50: 2550 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 204, 1993 (VCVN5*); J22 ihl-cat TCLo: 2100 mg/m3/15M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 207, 1993 (VCVN5*) MD: A30-P24-U01 ihl-rat TCLo: 453 ppm/6H/2W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555041 (NTIS**); D07-P30-U01 ihl-rat TCLo: 162 ppm/6H/14W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555041 (NTIS**); P20-P24-U01 ihl-rat TCLo: 100 mg/m3/4H/17W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 204, 1989 (VCVN5*) SR: OEL-HUNGARY: TWA 10 mg/m3, STEL 20 mg/m3, JAN 1993; OEL-NORWAY: TWA 10 mg/m3, JAN 1999; OEL-RUSSIA: STEL 10 mg/m3, JAN 1993 ND: NOHS 1974: HZD 84320; NIS 1; TNF 11; NOS 3; TNE 357 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 657 of 1119 in RTECS (through 2003/06) AN: FI4100000 PN: Castor-oil- SY: Aromatic-castor-oil-; Castor-oil-aromatic-; Cosmetol-; Crystal-O-; Gold-bond-; NCI-C55163-; Neoloid-; Oil-of-Palma-christi-; Phorbyol-; Ricinus-oil-; Ricirus-oil-; Tangantangan-oil- RN: Current: 8001-79-4 Previous: 8021-37-2 UD: 200305 CC: Tumorigen (C); Primary-Irritant (S) ID: skn-man 50 mg/48H MLD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-rat 100 mg/24H MLD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-rbt 100 mg/24H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); eye-rbt 500 mg MLD American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); skn-gpg 100 mg/24H MLD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG) AT: K12 orl-rat TDLo: 10 mL/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 299, p. 247, 2001 (JPETAB) ND: NOHS 1974: HZD M1030; NIS 259; TNF 34810; NOS 134; TNE 487959; NOES 1983: HZD M1030; NIS 195; TNF 32342; NOS 136; TNE 444011; TFE 172359 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-12, October 2000 Record 658 of 1119 in RTECS (through 2003/06) AN: FK0735000 PN: Ceramic-fibres- SY: Fybex-; Nextel-; Saffil-; Fiberfrax-; Fibermax-; Fireline-Ceramic- CD: Comprise a wide range of amorphous or crystalline, synthetic mineral fibres characterized by their refractory properties (IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 43, p. 39, 1988 - IMEMDT) UD: 200006 CC: Tumorigen (C) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 43, p. 39, 1988 (IMEMDT); IARC Cancer Review: Human No Availabe Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 43, p. 39, 1988 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 43, p. 39, 1988 (IMEMDT) SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 659 of 1119 in RTECS (through 2003/06) AN: FM8750000 PN: Chloral-hydrate- SY: Aquachloral-; Bi-3411-; Chloraldurat-; Dormal-; 1,1-Ethanediol,-2,2,2-trichloro- (9CI); Hydral-; Hydrate-de-chloral-; Kessodrate-; Lorinal-; Phaldrone-; Rectules-; SK-Chloral-hydrate-; Somni-SED-; Somnos-; Sontec-; Tosyl-; Trawotox-; Trichloracetaldehyd-hydrat- (German); Trichloroacetaldehyde-hydrate-; Trichloroacetaldehyde-monohydrate-; 1,1,1-Trichloro-2,2-dihydroxyethane-; 1,1,1-Trichloro-2,2-ethanediol-; 2,2,2-Trichloro-1,1-ethanediol-; Felsules-; Noctec-; Nycoton-; Nycton- RN: Current: 302-17-0 BRN: 1698497 BHR: 4-01-00-03143 UD: 200305 MF: C2-H3-Cl3-O2 MW: 165.40 WL: QYQXGGG CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 1 mg/plate (+/-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-omi 2 mg/plate (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 30, p. 9, 1980 (CBINA8); slt-dmg-orl 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 111, 1994 (MUREAV); mrc-smc 15 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 141, p. 19, 1984 (MUREAV); mmo-asn 5 mg/plate (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 30, p. 9, 1980 (CBINA8); sln-asn 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 155, p. 105, 1985 (MUREAV); mnt-nml-mul 200 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 83, 1993 (MUREAV); oms-nml-oth 100 mmol/L Chromosoma. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1939- v. 45, p. 215, 1974 (CHROAU); cyt-nml-oth 100 mmol/L Chromosoma. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1939- v. 45, p. 215, 1974 (CHROAU); mnt-hmn-lym 500 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 1687, 1997 (CRNGDP); oms-hmn-lym 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 334, p. 1, 1995 (MUREAV); sce-hmn-lym 54 mg/L Annales de Genetique. (Expansion Scientifique Francaise, 15 rue Saint-Benoit, F-75278, Paris Cedex 06, France) V.1- 1958- v. 24, p. 105, 1981 (AGTQAH); sln-hmn-lym 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 57, 1993 (MUREAV); mnt-mus-ipr 41 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 323, p. 81, 1994 (MUREAV); cyt-mus-lym 1250 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 413, p. 265, 1998 (MUREAV); sln-mus-ipr 82700 ug/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 695, 1984 (ENMUDM); msc-mus-lym 1 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 413, p. 265, 1998 (MUREAV); hma-mus-smc 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 141, p. 19, 1984 (MUREAV); mnt-ham-lng 80 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 71, 1993 (MUREAV); mtr-ham-emb 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 7, 1995 (MUREAV); oms-ham-emb 165 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 47, 1993 (MUREAV); sln-ham-emb 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 47, 1993 (MUREAV); sln-ham-lng 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 29, 1993 (MUREAV); dna-mus-ipr 2000 nmol/L/1W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 185, p. 13, 2002 (CALEDQ) RE: T85 orl-mus TDLo: 13 gm/kg (3W pre-3W post) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 6, p. 137, 1984 (NTOTDY) TE: V01-L60 orl-mus TDLo: 10 mg/kg Cancer Detection and Prevention. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1976- v. 9, p. 279, 1986 (CDPRD4); V03-R60 skn-mus TDLo: 960 mg/kg/1W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 9, p. 177, 1955 (BJCAAI) ORNG: 479000000 ng/kg. [479.000000 mg/kg] T/E unlistd SKNG: 3030000000 ng/kg. [3030.000000 mg/kg] T/E unlistd AT: D15-F12-G07 orl-chd TDLo: 70 mg/kg Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 131, p. 787, 1997 (JOPDAB); F24-G07-J24 orl-man TDLo: 1 gm/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 34, p. 97, 1996 (JTCTDW); G04 orl-chd TDLo: 219 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 34, p. 101, 1996 (JTCTDW); F07-F08-G07 orl-wmn TDLo: 960 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 34, p. 101, 1996 (JTCTDW); D35-F24-H02 orl-wmn TDLo: 465 mg/kg Acta Medica Scandinavica. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.52-224, 1919-88. v. 223, p. 269, 1988 (AMSVAZ); D15-K13 orl-hmn LDLo: 4 mg/kg "Pharmacology: Basis of Therapy," 3rd ed., Goodman, L.S., ed., New York, Macmillan Pub. Co., 1967 v. 3, p. 132, 1967 (PHBTH*); F01-G04-H02 orl-hmn TDLo: 300 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 994, 1977 (BMJOAE); F07-R03 ivn-chd TDLo: 39 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 34, p. 101, 1996 (JTCTDW); F07-J24-J25 ivn-chd TDLo: 88 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 34, p. 101, 1996 (JTCTDW); G07 unr-chd TDLo: 48 mg/kg/6H-I Anesthesia and Analgesia (New York). (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.36- 1957- v. 65, p. 691, 1986 (AACRAT); T/E unlistd unr-man LDLo: 103 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); G04 unr-inf TDLo: 160 mg/kg/3D-I Anesthesia and Analgesia (New York). (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.36- 1957- v. 65, p. 691, 1986 (AACRAT); G07 rec-chd TDLo: 97 mg/kg Anesthesia and Analgesia (New York). (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.36- 1957- v. 65, p. 691, 1986 (AACRAT); T/E unlistd orl-rat LD50: 479 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 185, 1971 (TXAPA9); T/E unlistd skn-rat LD50: 3030 mg/kg "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A065,1984 (85JFAN); F07-J30 ipr-rat LD50: 472 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 41, p. 100, 1952 (JAPMA8); T/E unlistd par-rat LD50: 710 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 784, 1982 (NIIRDN); F07-F13-F19 unr-rat LD50: 725 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(3), p. 14, 1970 (GISAAA); T/E unlistd rec-rat LD50: 710 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 1114, 1990 (NIIRDN); T/E unlistd orl-mus LD50: 1100 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 106, p. 444, 1952 (JPETAB); F07 ipr-mus LD50: 580 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 10, p. 665, 1960 (ARZNAD); F01-F13-J30 scu-mus LDLo: 800 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 166, p. 437, 1932 (AEPPAE); T/E unlistd ivn-mus LD50: 530 mg/kg Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- v. 38, p. 65, 1980 (APFRAD); F07-F13-F19 unr-mus LD50: 850 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(3), p. 14, 1970 (GISAAA); F04 orl-dog LDLo: 1 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 78, p. 340, 1943 (JPETAB); F01 ivn-dog LDLo: 180 mg/kg "Nachprufung der Toxicitat von Novocain und Tutocain bei Chloralisierten Tieren, Dissertation," Barke, A., Pharmakologischen Institut der Tierarztlichen Hochschule zu Hannover, Fed. Rep. Ger., 1936 v. -, p. -, 1936 (BDHU**); F04 orl-cat LDLo: 400 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 78, p. 340, 1943 (JPETAB); F01 orl-rbt LDLo: 1200 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 132, p. 214, 1928 (AEPPAE); F01-J30 scu-rbt LDLo: 1 gm/kg Zeitschrift fuer Experimentelle Pathologie und Therapie. (Berlin, Ger.) V.1-22, 1905-21. For publisher information, see REXMAS. v. 18, p. 61, 1916 (ZEPTAT); T/E unlistd ivn-rbt LDLo: 400 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 63, p. 453, 1938 (JPETAB); F07-F13-F19 unr-rbt LD50: 1400 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(3), p. 14, 1970 (GISAAA); F01-J30 rec-rbt LDLo: 1 gm/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 132, p. 214, 1928 (AEPPAE); T/E unlistd ivn-gpg LDLo: 400 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 131, p. 171, 1928 (AEPPAE); F07-F13-F19 unr-gpg LD50: 940 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(3), p. 14, 1970 (GISAAA); T/E unlistd iat-gpg LDLo: 400 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 131, p. 171, 1928 (AEPPAE); T/E unlistd orl-pgn LDLo: 300 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-frg LDLo: 938 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 8, p. 77, 1901 (AIPTAK); T/E unlistd par-frg LDLo: 900 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 166, p. 437, 1932 (AEPPAE); T/E unlistd orl-ctl LDLo: 30 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd ivn-ctl LDLo: 10 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd rec-ctl LDLo: 30 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); U28 ipr-rat TDLo: 400 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 21, 1984 (FATOAO) MD: L02-P28-Y15 orl-rat TDLo: 15120 mg/kg/90D-C Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 15, p. 217, 1992 (DCTODJ); P30-Y01 orl-rat TDLo: 210 mg/kg/30W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(3), p. 14, 1970 (GISAAA); U28 orl-rat TDLo: 1413 mg/kg/90D-C Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 6, p. 137, 1984 (NTOTDY); F07-U01 orl-rat TDLo: 4800 mg/kg/17D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-99-3944 (NTPTR*); L70-N73-P28 orl-mus TDLo: 2016 mg/kg/14D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 44, p. 137, 1982 (EVHPAZ); L70-U30-Y07 orl-mus TDLo: 1440 mg/kg/90D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 44, p. 137, 1982 (EVHPAZ); L70 orl-mus TDLo: 4800 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-99-3944 (NTPTR*); L30-Y10 orl-rat TDLo: 17.5 mg/kg/7D-C JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 20, p. 455, 2000 (JJATDK); L30-Y16 orl-rat TDLo: 1750 mg/kg/7D-C JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 20, p. 455, 2000 (JJATDK) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 245, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 245, 1995 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 245, 1995 (IMEMDT) ND: NOHS 1974: HZD 84490; NIS 3; TNF 1191; NOS 10; TNE 10916; NOES 1983: HZD 84490; NIS 4; TNF 264; NOS 11; TNE 11278; TFE 8131 SL: EPA GENETOX PROGRAM 1988, Positive: Aspergillus-aneuploidy, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Aspergillus-recombination, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat, Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat; NTP Toxicity studies, RPT# TOX-59, October 2000; NTP Carcinogenesis studies, test completed (post peer review), October 2000 Record 660 of 1119 in RTECS (through 2003/06) AN: FN0275000 PN: Chloramide- SY: Chloraminated-water-; Chloramine-; Chloramine- (inorganic compound); Chloroamine-; Monochloramide-; Monochloramine-; Monochloroamine-; Monochloroammonia- RN: Current: 10599-90-3 UD: 200302 MF: Cl-H2-N MW: 51.48 WL: ZG CC: Tumorigen (C); Mutagen (M) ME: mmo-bcs 18 umol/L (-S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 192, p. 1141, 1976 (SCIEAS); dnr-bcs 18 umol/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 192, p. 1141, 1976 (SCIEAS); mnt-nml-mul 150 ppb Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 170, 1989 (MUTAEX) TE: V03-P61 orl-rat TDLo: 7280 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-392, 1992 (NTPTR*); V03-P61 orl-rat TDLo: 3605 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191659 (NTIS**) MD: P30-U01 orl-rat TDLo: 2028 mg/kg/1Y-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 13, p. 825, 1984 (JTEHD6); K30-N73-Y37 orl-rat TDLo: 170 mg/kg/9W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 44, p. 257, 1987 (TXCYAC) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; NCI Carcinogenesis Studies (water), equivocal evidence: rat; NCI Carcinogenesis Studies (water), no evidence: mouse Record 661 of 1119 in RTECS (through 2003/06) AN: FO0525000 PN: Chloric-acid,-sodium-salt- SY: Agrosan-; Asex-; Atlacide-; Atratol-; B-Herbatox-; Chlorate-de-sodium-; Chlorate-salt-of-sodium-; Desolet-; Drexel-defol-; Grain-sorghum-harvest-aid-; Granex-O-; Harvest-aid-; Hibar-C-; Kusa-tohru-; Kusatol-; Leafex-2-; Natriumchloraat- (Dutch); Natriumchlorat- (German); Rasikal-; Shed-A-leaf-; Soda-chlorate-; Sodakem-; Sodio (clorato di) (Italian); Sodium-chlorate-; Sodium(chlorate de) (French); Travex-; Evau-super-; Ortho C-1 defoliant & weed killer; Oxycil-; Tumbleaf-; United Chemical Defoliant No. 1; VAL-DROP- RN: Current: 7775-09-9 Previous: 11096-45-0 UD: 200302 MF: Cl-O3.Na MW: 106.44 WL: NA G-O3 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 24-3/1971 (BIOFX*); eye-rbt 10 mg MLD BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 24-3/1971 (BIOFX*) ME: mmo-sat 40 umol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 91, 1981 (MUREAV); sln-dmg-orl 250 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 91, 1981 (MUREAV); dni-rat-orl 84 mg/kg/12W-C Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 6(1), p. 105, 1985 (JEPOEC) ORNG: 1200000000 ng/kg. [1200.000000 mg/kg] T/E unlistd AT: J30-P23-P24 orl-wmn TDLo: 800 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,539,1969 (34ZIAG); J24-P20-P24 orl-man TDLo: 286 mg/kg Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 15, p. 185, 1979 (CTOXAO); T/E unlistd unr-hmn LDLo: 214 mg/kg Guide to the Chemicals Used in Crop Protection. (Information Canada, 171 Slater St., Ottawa, Ont., Canada) v. 6, p. 461, 1973 (GUCHAZ); T/E unlistd unr-chd LD50: 185 mg/kg Guide to the Chemicals Used in Crop Protection. (Information Canada, 171 Slater St., Ottawa, Ont., Canada) v. 6, p. 461, 1973 (GUCHAZ); T/E unlistd ihl-rat LC50: >28 gm/m3/1H BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 24-3/1971 (BIOFX*); T/E unlistd orl-dog LDLo: 700 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-cat LDLo: 1350 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 1013, 1966 (PCOC**); T/E unlistd orl-rbt LD50: 7200 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 31(1), p. 49, 1987 (GTPZAB); T/E unlistd skn-rbt LD50: >10 gm/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 24-3/1971 (BIOFX*); T/E unlistd orl-mus LD50: 3600 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 36, 1998 (VCVN1*); T/E unlistd orl-gpg LD50: 6100 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 36, 1998 (VCVN1*); T/E unlistd orl-rat LD50: 1200 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1412, 2001 (HBPTO*); T/E unlistd ipr-mus LD50: 596 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1412, 2001 (HBPTO*); T/E unlistd orl-hmn LDLo: 107.14 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1412, 2001 (HBPTO*) MD: P08-P71-U01 orl-rat TDLo: 495 mg/kg/1Y-C Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 6(1), p. 105, 1985 (JEPOEC); A70-N30-P71 orl-rat TDLo: 58819 mg/kg/13W-C Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 18, p. 185, 1995 (DCTODJ); F15-P72-U01 orl-dog TDLo: 1630 mg/kg/5D-I Veterinary Record. (7 Mansfield St., London W1M 0AT, UK) V.1- 1888- v. 90, p. 416, 1972 (VETRAX); N08 orl-rat TDLo: 400 mg/kg/4D-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 250, 2001 (JTPAE7) TR: TOXICOLOGY REVIEW Journal of the American Veterinary Medical Association. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.48- 1915- v. 164, p. 277, 1974 (JAVMA4) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 68870; NIS 15; TNF 334; NOS 14; TNE 3058; NOES 1983: HZD 68870; NIS 35; TNF 1023; NOS 34; TNE 28583; TFE 5207 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 662 of 1119 in RTECS (through 2003/06) AN: FO2000000 PN: Chlorinated-trisodium-phosphate- SY: NCI-C55754-; Sodium hypochlorite phosphate (Na13(ClO)(PO4)4) (9CI); Sodium-phosphate-hypochlorite- RN: Current: 11084-85-8 Previous: 56802-99-4 UD: 200207 MF: Cl-Na13-O17-P4 MW: 730.20 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 3333 ug/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11(Suppl 12), p. 1, 1988 (EMMUEG); cyt-ham-ovr 2 gm/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 60, 1989 (EMMUEG); sce-ham-ovr 600 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 60, 1989 (EMMUEG) MD: U01-Z01 orl-rat TDLo: 14 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-294, 1986 (NTPTR*); A70-M70-Z73 orl-rat TDLo: 91 gm/kg/13W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 3, p. 125, 1983 (TOXID9); Z01 orl-mus TDLo: 28 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-294, 1986 (NTPTR*) SL: NCI Carcinogenesis Studies (gavage), no evidence: mouse; NCI Carcinogenesis Studies (gavage), inadequate study: rat Record 663 of 1119 in RTECS (through 2003/06) AN: FO2100000 PN: Chlorine- SY: Bertholite-; Chloor- (Dutch); Chlor- (German); Chlore- (French); Chlorinated-water-; Chlorine- (ACGIH:OSHA); Chlorine mol.; Cloro- (Italian); Molecular-chlorine- RN: Current: 7782-50-5 UD: 200302 MF: Cl2 MW: 70.90 WL: G2 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 1800 ug/L (-S9) Ozone: Science and Engineering. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1979- v. 8, p. 217, 1986 (OZSEDS); cyt-hmn-lym 20 ppm Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 6, p. 375, 1973 (CBINA8); spm-mus-orl 20 mg/kg/5D-C Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 201, 1985 (ENMUDM) RE: T83 orl-rat TDLo: 565 mg/kg (8W male/2W pre-3W post) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 43A, 1987 (TJADAB) TE: V03-P61 orl-rat TDLo: 5096 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-392, 1992 (NTPTR*); V02-J60 ihl-mky TCLo: 2300 ppb/6H/1Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571476 (NTIS**); V03-P61 orl-rat TDLo: 5047 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191659 (NTIS**) AT: F30 ihl-hmn TCLo: 500 ppb/2D-I Journal of Applied Physiology. (Bethesda, MD) V.1-41, 1948-76. v. 54, p. 1120, 1983 (JAPYAA); J02-J06-J16 ihl-hmn LCLo: 2530 mg/m3/30M "Chemicals in War," Prentiss, A.M., New York, McGraw Hill Book Co., 1937 -,150,1937 (28ZOAH); T/E unlistd ihl-hmn LCLo: 500 ppm/5M Tabulae Biologicae. (The Hague, Netherlands) V.1-22, 1925-63. Discontinued. v. 3, p. 231, 1933 (TABIA2); F27-J21-J22 ihl-hmn TCLo: 66 ppm/1H Diagnostic Cytopathology. (Wiley-Liss, 605 Third Ave., New York, NY 10158) V.1- 1985- v. 4, p. 28, 1988 (DICYE7); T/E unlistd ihl-rat LC50: 293 ppm/1H Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) TR-72-62, 1972 (AMRL**); T/E unlistd ihl-mus LC50: 137 ppm/1H Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) TR-72-62, 1972 (AMRL**); F18-K13-J22 ihl-dog LCLo: 800 ppm/30M Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 14, p. 65, 1919 (JPETAB); T/E unlistd ihl-gpg LCLo: 3200 ppm/3H Archiv fuer Hygiene. (Munich, Fed. Rep. Ger.) V.1-100, 1883-1928. For publisher information, see ZHPMAT. v. 7, p. 231, 1887 (AHYGAJ); T/E unlistd ihl-mam LCLo: 500 ppm/5M Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 138, p. 65, 1928 (AEPPAE) MD: P02 orl-rat TDLo: 3312 mg/kg/92D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 20, p. 401, 1987 (JTEHD6); N73-P70-Y39 orl-rat TDLo: 109 gm/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 427, 1983 (FCTOD7); M30-P72-Y03 ihl-rat TCLo: 9 ppm/6H/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 77, 1979 (TXAPA9); F15-L70-M70 orl-rat TDLo: 7568 mg/kg/28D-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 423, 1983 (FCTOD7); A70-L70-M70 orl-rat TDLo: 42 gm/kg/2W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 1161, 1977 (JTEHD6); D07-J02-U01 ihl-rat TCLo: 9100 ppb/6H/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 71, p. 225, 1983 (TXAPA9); D07 ihl-rat TCLo: 400 ppb/6H/2Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0538318 (NTIS**); G70-M70-Z71 orl-mus TDLo: 153 gm/kg/73W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 435, 1983 (FCTOD7); D07-J02-U01 ihl-mus TCLo: 9100 ppb/6H/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 71, p. 225, 1983 (TXAPA9); D07 ihl-mus TCLo: 400 ppb/6H/2Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0538318 (NTIS**); D07-D25-J30 ihl-mky TCLo: 2300 ppb/6H/1Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 557, 1987 (FAATDF) TR: ACGIH TLV-TWA 0.5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 1 ppm (3 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 46, 1971 (DTLVS*); OSHA PEL (Gen Indu): CL 1 ppm (3 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 1 ppm (3 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 1 ppm (3 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 1 ppm (3 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 1 ppm (3 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 1 ppm (3 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 0.5 ppm (1.5 mg/m3), JAN 1999; OEL-BELGIUM: TWA 0.5 ppm (1.5 mg/m3), STEL 1 ppm, JAN 1993; OEL-DENMARK: TWA 0.5 ppm (1.5 mg/m3), JAN 1999; OEL-FINLAND: TWA 0.5 ppm (1.5 mg/m3), STEL 1 ppm (3 mg/m3), JAN 1999; OEL-FRANCE: VLE 1 ppm (3 mg/m3), JAN 1999; OEL-GERMANY: MAK 0.5 ppm (1.5 mg/m3), JAN 1999; OEL-HUNGARY: STEL 1 mg/m3, JAN 1993; OEL-INDIA: TWA 1 ppm (3 mg/m3), STEL 3 ppm (9 mg/m3), JAN 1993; OEL-JAPAN: OEL 1 ppm (2.9 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (3 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.5 ppm (1.5 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1 ppm (3 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 1.5 mg/m3, STEL 9 mg/m3, JAN 1999; OEL-RUSSIA: TWA 1 ppm, STEL 1 mg/m3, JAN 1993; OEL-SWEDEN: NGV 0.5 ppm (1.5 mg/m3), TGV(C) 1 ppm (3 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 ppm (1.5 mg/m3), KZG-W 1 ppm (3 mg/m3), JAN 1999; OEL-THAILAND: TWA 1 ppm (3 mg/m3), JAN 1993; OEL-TURKEY: TWA 1 ppm (3 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 0.5 ppm (1.5 mg/m3), STEL 1 ppm (2.9 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHLORINE-air: 10H TWA 0.5 ppm, STEL 1 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 18040; NIS 169; TNF 21429; NOS 86; TNE 220544; NOES 1983: HZD X9656; NIS 3; TNF 338; NOS 6; TNE 4768; TFE 1862; NOES 1983: HZD 18040; NIS 70; TNF 5343; NOS 75; TNE 178105; TFE 20221 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Bromine and chlorine, 6011; NCI Carcinogenesis Studies (water), equivocal evidence: rat; NCI Carcinogenesis Studies (water), no evidence: mouse; OSHA ANALYTICAL METHOD #ID-101 Record 664 of 1119 in RTECS (through 2003/06) AN: FS9100000 PN: Chloroform- SY: Chloroforme- (French); Formyl-trichloride-; Methane-trichloride-; Methane,-trichloro-; Methenyl-trichloride-; Methyl-trichloride-; NCI-C02686-; R-20- (Refrigerant); RCRA-waste-number-U044-; Trichloormethaan- (Dutch); Trichlormethan- (Czech); Trichloroform-; Trichloromethane- (OSHA); Chloroform- (ACGIH:OSHA); Cloroformio- (Italian); R-20-; Triclorometano- (Italian) RN: Current: 67-66-3 Previous: 8013-54-5 BRN: 1731042 BHR: 4-01-00-00042 UD: 200305 MF: C-H-Cl3 MW: 119.37 WL: GYGG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 10 mg/24H open MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 95, 1962 (AIHAAP); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,89,1986 (85JCAE); eye-rbt 148 mg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 697, 1976 (AIHAAP); eye-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,89,1986 (85JCAE) ME: mmo-sat 20 ug/plate (+/-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 280, 1981 (PMRSDJ); dnr-esc 500 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 195, 1981 (PMRSDJ); dnr-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 2980 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 397, p. 271, 1998 (MUREAV); mmo-ssp 5 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 424, 1981 (PMRSDJ); oms-grh-ihl 15 pph/16H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 467, 1983 (MUREAV); dni-hmn-hla 19 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); sce-hmn-lym 10 mmol/L Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 72, 1983 (ENVRAL); mnt-rat-orl 4 mmol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 413, p. 1, 1998 (MUREAV); dns-rat-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 189, 1994 (MUREAV); cyt-rat-ipr 1200 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 111, 1990 (MUREAV); cyt-rat-orl 597 mg/kg/5D-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 111, 1990 (MUREAV); sce-rat-leu 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 241, 1993 (MUREAV); mmo-mus-lym 12 mg/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 103, 1988 (EMMUEG); dns-mus-ipr 50 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 21, p. 357, 1984 (TOLED5); sce-mus-ihl 300 ppm/6H Igaku No Ayumi. Progress in Medicine. (Ishiyaku Shuppan K.K., 1-7-10, Honkomagom, Bunkyo-ku, Tokyo, Japan) V.1- 1946- v. 122, p. 978, 1982 (IGAYAY); sce-mus-orl 200 mg/kg/4D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 72, 1983 (ENVRAL); spm-mus-ihl 400 ppm/4H/5D-I Anesthesiology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1940- v. 54, p. 53, 1981 (ANESAV); mtr-ham-kdy 4430 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 626, 1981 (PMRSDJ); oms-ham-fbr 1 pph Anesthesiology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1940- v. 43, p. 21, 1975 (ANESAV); sce-ham-emb 100 umol/L Shigaku. Ondotology. (Nippon Shika Daigaku Shigakkai, 1-9-20 Fujimi, Chiyodaku, Tokyo 102, Japan) V.38- 1949- v. 74, p. 1385, 1987 (SHIGAZ); sln-ham-lng 60 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 135, 1987 (MUREAV); msc-ham-lng 1 mg/L Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 39, p. 359, 1986 (BLFSBY); dna-mam-lym 1 mmol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 11, p. 243, 1982 (TOLED5); mtr-mus-fbr 0.1 pph/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T34-T46 orl-rat TDLo: 1260 mg/kg (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 29, p. 348, 1974 (TXAPA9); T34 orl-rat TDLo: 4 gm/kg (6-15D preg) Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 18, p. 333, 1983 (JPFCD2); T29-T34-T46 ihl-rat TCLo: 30 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 442, 1974 (TXAPA9); T50-T55 ihl-rat TCLo: 100 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 442, 1974 (TXAPA9); T22-T25 ihl-rat TCLo: 300 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 442, 1974 (TXAPA9); T34-T35 ihl-rat TCLo: 20100 ug/m3/1H (7-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB277-077 (NTIS**); T81-T83 orl-mus TDLo: 2177 mg/kg (3W male/3W pre-7D post) Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information, see NTOTDY. v. 1, p. 199, 1979 (NETOD7); T87 orl-mus TDLo: 2115 mg/kg (3W male/3W pre-5D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 46, p. 127, 1982 (EVHPAZ); T22-T25-T34 ihl-mus TCLo: 100 ppm/7H (1-7D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 50, p. 515, 1979 (TXAPA9); T43 ihl-mus TCLo: 100 ppm/7H (8-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 50, p. 515, 1979 (TXAPA9); T34-T46 orl-rbt TDLo: 260 mg/kg (6-18D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 29, p. 348, 1974 (TXAPA9); T53 orl-rat TDLo: 41 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89148639 (NTIS**) TE: V01-P61 orl-rat TDLo: 13832 mg/kg/2Y-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 760, 1985 (FAATDF); V01-L60 orl-mus TDLo: 127 gm/kg/92W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-0, 1976 (NCITR*); V02-M61-N62 orl-rat TD :98 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-0, 1976 (NCITR*); V02-L60 orl-mus TD :18 gm/kg/17W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 5, p. 251, 1945 (JNCIAM); V01-L60-M61 orl-rat TD :7020 mg/kg/78W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 31, p. 171, 1979 (EVHPAZ); V02-M61-N62 orl-rat TD :70 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-0, 1976 (NCITR*); V03-L60 orl-mus TD :24752 mg/kg/2Y-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 760, 1985 (FAATDF); V02-N62-P60 orl-rat TD :58968 mg/kg/2Y-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 760, 1985 (FAATDF); V02-L60-M60 orl-mus TD :130 gm/kg/2Y-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 33(8), p. 81, 1987 (VOONAW) ORNG: 695000000 ng/kg. [695.000000 mg/kg] F17-F19-J26 IHNG: 47702000000 ng/m3/4H. [47702.000000 mg/m3/4H] T/E unlistd AT: F23-G30-M03 orl-man LDLo: 2514 mg/kg American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- v. 6, p. 507, 1988 (AJEMEN); F14-K13-K30 ihl-hmn TCLo: 10 mg/m3/1Y Internationales Archiv fuer Gewerbepathologie und Gewerbehygiene. (Heidelberg, Fed. Rep. Ger.) V.19-25, 1962-69. For publisher information, see IAEHDW. v. 24, p. 127, 1967 (IRGGAJ); T/E unlistd ihl-hmn LCLo: 25000 ppm/5M Tabulae Biologicae. (The Hague, Netherlands) V.1-22, 1925-63. Discontinued. v. 3, p. 231, 1933 (TABIA2); F08 ihl-hmn TCLo: 5000 mg/m3/7M Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); T/E unlistd unr-man LDLo: 546 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); F17-F19-J26 orl-rat LD50: 695 mg/kg Khigiena i Zdraveopazvane. Hygiene and Sanitation. (Hemus, Blvd. Russki 6, Sofia, Bulgaria) V.9- 1966- v. 29(5), p. 39, 1986 (KHZDAN); T/E unlistd ihl-rat LC50: 47702 mg/m3/4H Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); T/E unlistd ipr-rat LD50: 894 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); T/E unlistd orl-mus LD50: 36 mg/kg Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 2, p. 371, 1979 (ATSUDG); C06-F01-F17 ihl-mus LCLo: 23 gm/m3/56M Biochemische Zeitschrift. (Berlin, Ger.) V.1-346, 1906-67. For publisher information, see EJBCAI. v. 115, p. 235, 1921 (BIZEA2); T/E unlistd ipr-mus LD50: 623 mg/kg Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 18, p. 109, 1960 (AGGHAR); T/E unlistd scu-mus LD50: 704 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 123, p. 224, 1958 (JPETAB); T/E unlistd orl-dog LDLo: 1 gm/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd ihl-dog LCLo: 100 gm/m3 Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 230, 1966 (PCOC**); L14 ipr-dog LD50: 1 gm/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 119, 1967 (TXAPA9); T/E unlistd ivn-dog LDLo: 75 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); F01-K01-K13 ihl-cat LCLo: 35 gm/m3/4H Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); T/E unlistd orl-rbt LDLo: 500 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 97, p. 86, 1923 (AEXPBL); T/E unlistd ihl-rbt LCLo: 59 gm/m3 Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 230, 1966 (PCOC**); T/E unlistd skn-rbt LD50: >20 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A062-138 (NTIS**); T/E unlistd scu-rbt LDLo: 800 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd orl-gpg LD50: 820 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 48(3), p. 10, 1983 (GISAAA); T/E unlistd ihl-gpg LCLo: 20000 ppm/2H Fluorine Chemistry Reviews. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1967- v. 1, p. 197, 1967 (FLCRAP); T/E unlistd ihl-frg LCLo: 6 gm/m3 Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 97, p. 86, 1923 (AEXPBL); T/E unlistd ihl-mam LCLo: 25000 ppm/5M Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 138, p. 65, 1928 (AEPPAE) MD: P70 orl-rat TDLo: 840 mg/kg/28D-C Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 17, p. 205, 1982 (JPFCD2); L70-U01-Y15 orl-rat TDLo: 7560 mg/kg/21D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 48(3), p. 10, 1983 (GISAAA); L30-Y10-Y16 orl-rat TDLo: 5 mg/kg/10D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 14, p. 23, 1979 (TXCYAC); J12-L30-M70 ihl-rat TCLo: 50 ppm/7H/26W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 697, 1976 (AIHAAP); L01-M03-U01 ihl-rat TCLo: 90 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 109, 1996 (FAATDF); D07-Q30 ihl-rat TCLo: 300 ppm/6H/7D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 125, p. 214, 1994 (TXAPA9); F15-L30-M30 ihl-rat TCLo: 592 mg/m3/2.5H/2W-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 6, p. 243, 1992 (WDZAEK); L70-N73-U01 orl-mus TDLo: 1750 mg/kg/14D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 46, p. 117, 1982 (EVHPAZ); L01-M03-M30 orl-mus TDLo: 560 mg/kg/4D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 50, p. 90, 1999 (TOSCF2); Z01 ihl-mus TCLo: 12 ppm/6H/13W-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 18, p. 423, 1993 (JTSCDR); L30-L70-U01 ihl-mus TCLo: 100 ppm/6H/7D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 22, p. 431, 1994 (FAATDF); L70-M30-M71 orl-mus TDLo: 9100 mg/kg/13W-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 50, p. 90, 1999 (TOSCF2); M03 ihl-dog TCLo: 25 ppm/7H/26W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 697, 1976 (AIHAAP); J12 ihl-rbt TCLo: 85 ppm/7H/26W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 697, 1976 (AIHAAP); J12 ihl-gpg TCLo: 85 ppm/7H/26W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 697, 1976 (AIHAAP) TR: ACGIH TLV-TWA 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 401, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 131, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 401, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 131, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 131, 1999 (IMEMDT); TOXICOLOGY REVIEW Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 24, p. 173, 1974 (ARZNAD); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6); TOXICOLOGY REVIEW Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 1, p. 259, 1978 (DCTODJ); TOXICOLOGY REVIEW Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- v. 54, p. 413, 1978 (BNYMAM); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 13, p. 231, 1978 (CTOXAO) SR: MSHA STANDARD: air-CL 50 ppm (240 mg/m3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 14, 1973 (DTLWS*); OSHA PEL (Gen Indu): CL 50 ppm (240 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 50 ppm (240 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 50 ppm (240 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 50 ppm (240 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 10 ppm (50 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 10 ppm (50 mg/m3), Carcinogen, JAN 1993; OEL-AUSTRIA: MAK 10 ppm (50 mg/m3), Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 10 ppm (49 mg/m3), Carcinogen JAN 1993; OEL-DENMARK: TWA 2 ppm (10 mg/m3), JAN 1999; OEL-FINLAND: TWA 10 ppm (50 mg/m3), STEL 20 ppm, Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 5 ppm (25 mg/m3), VLE 50 ppm (250 mg/m3), C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 10 ppm (50 mg/m3), Carcinogen, JAN 1999; OEL-HUNGARY: STEL 10 mg/m3, JAN 1993; OEL-INDIA: TWA 10 ppm (50 mg/m3), Carcinogen, JAN 1993; OEL-JAPAN: OEL 10 ppm (49 mg/m3), 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (5 mg/m3), MAC-K 5 ppm (25 mg/m3), JAN 1999; OEL-NORWAY: TWA 2 ppm (10 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 50 ppm (240 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 50 mg/m3, MAC(STEL) 225 mg/m3, JAN 1999; OEL-RUSSIA: TWA 50 ppm, JAN 1993; OEL-SWEDEN: NGV 2 ppm (10 mg/m3), KTV 5 ppm (25 mg/m3), Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 10 ppm (50 mg/m3), KZG-W 20 ppm (100 mg/m3), JAN 1999; OEL-THAILAND: TWA 50 ppm (240 mg/m3), JAN 1993; OEL-TURKEY: TWA 50 ppm (240 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 2 ppm (9.9 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHLOROFORM-air: CA STEL 2 ppm/60M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NIOSH REL TO WASTE ANESTHETIC GASES AND VAPORS-air: CL 2 ppm/1H MMWR. Morbidity and Mortality Weekly Report. (Centers for Disease Control, Atlanta, GA 30333) V.25(10)- 1976- for RTECS citation, only V.34(Suppl 1S), 1985 is used. v. 37(S-7), p. 28, 1988 (MMWR**); NOHS 1974: HZD 18500; NIS 78; TNF 5120; NOS 66; TNE 96747; NOES 1983: HZD 18500; NIS 65; TNF 4890; NOS 55; TNE 95773; TFE 41397 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101140/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE, V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, Sperm morphology-mouse; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 9, 1976; NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003; NCI Carcinogenesis Bioassay (gavage), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR, 1976 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #05 Record 665 of 1119 in RTECS (through 2003/06) AN: GB2750000 PN: Chromic-acid,-calcium-salt- (1:1) SY: Calcium-Chrome-Yellow-; Calcium-chromate-; Calcium-chromate- (ACGIH); Calcium chromate(VI); Calcium-chromium-oxide- (CaCrO4); Calcium-monochromate-; Gelbin-; RCRA-waste-number-U032-; Yellow-ultramarine- RN: Current: 13765-19-0 UD: 200210 MF: Cr-O4.Ca MW: 156.08 WL: CA CR-O4 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 50 nmol/plate (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 283, 1981 (CRNGDP); mmo-sat 10 ug/plate (-S9) Applied and Environmental Microbiology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.31- 1976- v. 33, p. 805, 1977 (AEMIDF); mmo-esc 50 nmol/plate (-S9) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 250, p. 493, 1974 (NATUAS); mmo-esc 100 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); dnr-esc 50 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); sln-dmg-orl 500 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 87, 1985 (ENMUDM); mmo-smc 961 umol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 174, p. 39, 1979 (MGGEAE); sce-hmn-lym 650 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 359, p. 7, 1996 (MUREAV); mtr-rat-emb 58 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); mmo-mus-lym 2500 ug/L (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 143, 1987 (ENMUDM); mtr-mus-fbr 500 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); cyt-mus-fbr 5 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 2142, 1987 (CNREA8); dlt-mus-unr 40 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 180, 1982 (MUREAV); msc-mus-lym 160 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 37, 1988 (EMMUEG); mtr-ham-emb 6 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 193, 1979 (CNREA8); mtr-ham-kdy 250 ug/L Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 4, p. 185, 1981 (DCTODJ); dnd-ham-ovr 25 umol/L/1H-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 74, 1983 (PAACA3); cyt-ham-ovr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 2142, 1987 (CNREA8); sce-ham-ovr 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 219, 1985 (MUREAV); sce-ham-ipr 10 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE83-770037 (NTIS**); msc-ham-ovr 30 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 5280, 1988 (CNREA8) RE: T29 unr-mus TDLo: 1400 mg/kg (35W male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 180, 1982 (MUREAV) TE: V02-V10 ims-rat TDLo: 76 mg/kg/19W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 23, p. 172, 1969 (BJCAAI); V01-J60 itr-rat TDLo: 163 mg/kg/130W-I Experimental Pathology (1981). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.19- 1981- v. 30, p. 129, 1986 (EXPADD); V01-J60 imp-rat TDLo: 8 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 831, 1986 (CRNGDP); V03-V10 scu-mus TDLo: 400 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 21, p. 530, 1960 (AMIHAB); V01-V10 imp-mus TDLo: 400 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 21, p. 530, 1960 (AMIHAB); V03-J60 imp-rat TD :50 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 5, p. 445, 1962 (AEHLAU); V02-M61-V10 ims-rat TD :216 mg/kg/1Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 1779, 1976 (CNREA8); V01-V10 imp-rat TD :125 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 20, p. 274, 1959 (AIHAAP); V01-J60 imp-rat TD :10866 ug/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 43, p. 243, 1986 (BJIMAG) ORNG: 327000000 ng/kg. [327.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 327 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 42, p. 417, 1977 (TXAPA9); V10 imp-rat LDLo: 112 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 21, p. 530, 1960 (AMIHAB) TR: ACGIH TLV-TWA 0.001 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.001 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV) SR: MSHA STANDARD-air: TWA 0.5 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 35, 1971 (DTLVS*); OSHA PEL (Gen Indu): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.5 mg/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.5 mg/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.5 mg/m3, JAN 1993; OEL-DENMARK: TWA 0.5 mg(Cr)/m3, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1993; OEL-FRANCE: VME 0.05 mg(Cr)/m3, JAN 1999; OEL-FRANCE: Skin, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-INDIA: TWA 0.5 mg/m3, JAN 1993; OEL-JAPAN: OEL 0.05 mg(Cr)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-K 0.01 MG(Cr)/m3, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.02 mg(CrO3)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.5 mg/m3, JAN 1993; OEL-POLAND: TWA 0.1 mg/m3, STEL 0.3 mg/m3, JAN 1999; OEL-SWEDEN: NGV 0.5 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 mg(Cr)/m3, JAN 1999; OEL-THAILAND: TWA 1 mg/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.05 mg(Cr)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHROMIUM(VI)-air: 10H CA TWA 0.001 mg(Cr)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 83496; NIS 13; TNF 355; NOS 17; TNE 3519; NOES 1983: HZD 83496; NIS 10; TNF 347; NOS 11; TNE 32129; TFE 5565 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: TRP reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: Cell transform.-BALB/c-3T3; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 4, 1975/1976; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 666 of 1119 in RTECS (through 2003/06) AN: GB2975000 PN: Chromic acid, lead(2+) salt (1:1) SY: Chromate-de-plomb- (French); Lead-chromate-; Lead chromate(VI); Lead-chromate- (ACGIH); Lead-chromium-oxide-; Plumbous-chromate- RN: Current: 7758-97-6 Previous: 8049-64-7 UD: 200305 MF: Cr-O4.Pb MW: 323.19 WL: PB CR-O4 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 200 ug/plate (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 357, 1979 (MUREAV); mmo-esc 2 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 33, 1981 (MUREAV); mrc-smc 62500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 357, 1979 (MUREAV); mtr-hmn-fbr 500 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3815, 1987 (CNREA8); oms-hmn-oth 500 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); cyt-hmn-lym 13 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 157, 1980 (MUREAV); cyt-hmn-oth 500 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); sce-hmn-lym 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 157, 1980 (MUREAV); mnt-mus-ipr 500 mg/kg Tohoku Journal of Experimental Medicine. (Maruzen Co. Ltd., Export Dept., P.O. Box 5050, Tokyo Int., 100-31 Tokyo, Japan) V.1- 1920- v. 146, p. 373, 1985 (TJEMAO); mtr-mus-fbr 25 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 5280, 1988 (CNREA8); mtr-ham-kdy 156 mg/L Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 12, p. 185, 1986 (TECSDY); mtr-ham-emb 40 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 193, 1979 (CNREA8); dnd-ham-ovr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 129, 1992 (MUREAV); dni-ham-kdy 150 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); oms-ham-kdy 150 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); cyt-ham-ovr 5 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); sce-ham-ovr 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 219, 1985 (MUREAV); msc-ham-ovr 8 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2053, 1992 (CRNGDP); dnd-ham-ovr 350 umol/L/24H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 146, p. 270, 1997 (TXAPA9) TE: V02-V10 scu-rat TDLo: 135 mg/kg Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 57, p. 213, 1971 (TUMOAB); V02-M61-V10 ims-rat TDLo: 324 mg/kg/39W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 1779, 1976 (CNREA8); V03-V10 scu-rat TD :135 mg/kg Progress in Biochemical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1965- v. 14, p. 47, 1978 (PBPHAW) AT: T/E unlistd orl-mus LD50: >12 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 2, p. 76, 1968 (OYYAA2); T/E unlistd ipr-gpg LD75: 156 mg/kg "Merck Index: an Encyclopedia of Chemicals, Drugs, and Biologicals", 11th ed., Rahway, NJ 07065, Merck and Co., Inc. 1989 11,852,1989 (85KYAH) MD: M30-P30-P72 orl-rat TDLo: 108 gm/kg/90D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571260 (NTIS**); F19-M03-Z01 orl-dog TDLo: 11250 mg/kg/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 37, p. 160, 1976 (TXAPA9) TR: ACGIH TLV-TWA 0.012 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.05 mg(Pb)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.05 mg/m3, as Pb The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-TWA 0.012 mg/m3, as Cr The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT) SR: OSHA PEL (Gen Indu): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.05 mg/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.05 mg/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.02 mg(Cr)/m3, JAN 1999; OEL-DENMARK: TWA 0.1 mg(Pb)/m3, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: VME 0.05 mg(Cr)/m3, JAN 1999; OEL-FRANCE: VME 0.15 mg(Pb)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-JAPAN: OEL 0.01 mg(Cr)/m3, JAN 1999; OEL-JAPAN: OEL 0.1 mg(Pb)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.01 mg(Cr)/m3, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.1 mg(CrO3)/m3, JAN 1999; OEL-NORWAY: TWA 0.05 mg(Pb)/m3, JAN 1999; OEL-POLAND: TWA 0.1 mg/m3, STEL 0.3 mg/m3, JAN 1999; OEL-POLAND: MAC(TWA) 0.05 mg(Pb)/m3, JAN 1999; OEL-SWEDEN: TWA 0.02 mg(Cr)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 mg(Cr)/m3, Carcinogen, JAN 1999; OEL-UNITED KINGDOM: TWA 0.05 mg(Cr)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHROMIUM(VI)-air: 10H CA TWA 0.001 mg(Cr)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NIOSH REL TO LEAD, INORGANIC-air: 10H TWA <0.1 mg(Pb)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 81876; NIS 173; TNF 12060; NOS 87; TNE 131959; NOES 1983: HZD 81876; NIS 33; TNF 1628; NOS 28; TNE 31932; TFE 8639 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 4, 1975/1976; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 667 of 1119 in RTECS (through 2003/06) AN: GB3240000 PN: Chromic-acid,-strontium-salt- (1:1) SY: C.I. 77839; C.I. Pigment Yellow 32; Deep-Lemon-Yellow-; Pigment-Yellow-32-; Strontium-chromate-; Strontium-chromate- (1:1); Strontium-chromate-12170-; Strontium-chromate-A-; Strontium-chromate- (ACGIH); Strontium-chromate- (VI); Strontium-chromate-X-2396-; Strontium-Yellow-; Sutokuro-T-; X-2396- RN: Current: 7789-06-2 Previous: 54322-60-0 UD: 200302 MF: Cr-O4.Sr MW: 203.62 WL: SR CR-O2-Q2 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 800 ng/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 219, 1985 (MUREAV); mtr-ham-emb 100 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1811, 1991 (CRNGDP); sce-ham-ovr 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 219, 1985 (MUREAV) TE: V03-J60-V10 itr-rat TDLo: 40 mg/kg/34W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 5, p. 445, 1962 (AEHLAU); V03-V10 imp-rat TDLo: 125 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 20, p. 274, 1959 (AIHAAP) ORNG: 3118000000 ng/kg. [3118.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-mam LD50: >1500 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(8), p. 43, 1975 (GTPZAB); F40 ihl-rat TCLo: 40 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 128, 1988 (VCVN1*); U30 ihl-rat TCLo: 20 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 128, 1988 (VCVN1*); T/E unlistd orl-rat LD50: 3118 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 128, 1988 (VCVN1*); T/E unlistd itr-rat LD50: 16.6 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 128, 1988 (VCVN1*) TR: ACGIH TLV-TWA 0.0005 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.0005 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-STEL 0.0005 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT) SR: MSHA STANDARD-air: TWA 0.5 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 35, 1971 (DTLVS*); OSHA PEL (Gen Indu): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.5 mg/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.5 mg/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.5 mg/m3, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Cr)/m3, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, JAN 1993; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: VME 0.05 mg(Cr)/m3, JAN 1999; OEL-FRANCE: Skin, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-INDIA: TWA 0.5 mg/m3, JAN 1993; OEL-JAPAN: OEL 0.01 mg(Cr)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-K 0.025 mg(Cr)/m3, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.02 mg(CrO3)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.5 mg/m3, JAN 1993; OEL-POLAND: TWA 0.5 mg/m3, JAN 1999; OEL-SWEDEN: NGV 0.02 mg/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 mg(Cr)/m3, JAN 1999; OEL-THAILAND: TWA 1 mg/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.05 mg(Cr)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHROMIUM(VI)-air: 10H CA TWA 0.001 mg(Cr)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M2287; NIS 19; TNF 627; NOS 28; TNE 10145; NOES 1983: HZD M2287; NIS 28; TNF 1164; NOS 36; TNE 38744; TFE 2855 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 4, 1975/1976; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 668 of 1119 in RTECS (through 2003/06) AN: GB3290000 PN: Chromic-acid,-zinc-salt- SY: Buttercup-Yellow-; C.I. 77955; Chromium-zinc-oxide- (ZrCrO4); ZTO-; Zinc-Chrome-Yellow-; Zinc-chromate- (ACGIH:OSHA); Zinc-chromate-AM-; Zinc-chromate-C-; Zinc-chromate-O-; Zinc-chromate-T-; Zinc-chromate-Z-; Zinc chromate(VI) hydroxide; Zinc-chromates-; Zinc-chromates- (ACGIH); Zinc-chrome-; Zinc-chrome- (anti-corrosion); Zinc-chromium-oxide- (ZrCrO4); Zinc-hydroxychromate-; Zinc-tetraoxychromate-; Zinc-tetraoxychromate-76A-; Zinc-tetraoxychromate-780B-; Zincro-ZTO- RN: Current: 13530-65-9 Previous: 1308-13-0; 1328-67-2; 14675-41-3 UD: 200210 MF: Cr-O4.Zn MW: 181.37 WL: .ZN2.CR-O4-Q2 CC: Tumorigen (C); Mutagen (M); Human-Data (P) ME: mmo-sat 800 ng/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 219, 1985 (MUREAV); oms-hmn-oth 500 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); cyt-hmn-oth 500 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); mtr-ham-kdy 14 mg/L Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 12, p. 185, 1986 (TECSDY); mtr-ham-emb 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 193, 1979 (CNREA8); dni-ham-kdy 50 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); oms-ham-kdy 50 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); cyt-ham-ovr 5 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 219, 1981 (BJCAAI); sce-ham-ovr 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 219, 1985 (MUREAV); msc-ham-lng 4 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 55, 1979 (MUREAV) TE: V01-J61 ihl-man TCLo: 5 mg/m3/8H/7Y-I British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 32, p. 62, 1975 (BJIMAG); V03-V10 scu-rat TDLo: 135 mg/kg Progress in Biochemical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1965- v. 14, p. 47, 1978 (PBPHAW); V01-J61 imp-rat TDLo: 12928 ug/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 43, p. 243, 1986 (BJIMAG) AT: T/E unlistd ivn-mus LDLo: 30 mg/kg Air Quality Monographs. (Washington, DC) No.69-1 - No.75-25, 1969-75(?). Discontinued. #70-15, 1970 (AQMOAC) TR: ACGIH TLV-TWA 0.01 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.01 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Cr,22,1974 (85DHAX) SR: OSHA PEL (Gen Indu): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.01 mg/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.01 mg/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.02 mg(Cr)/m3, JAN 1999; OEL-FRANCE: VME 0.05 mg(Cr)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-JAPAN: OEL 0.05 mg(Cr)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.01 mg(Cr)/m3, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.02 mg(CrO3)/m3, JAN 1999; OEL-POLAND: TWA 0.1 mg/m3, STEL 0.3 mg/m3, JAN 1999; OEL-SWEDEN: TWA 0.02 mg(Cr)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.01 mg(Cr)/m3, Carcinogen, JAN 1999; OEL-UNITED KINGDOM: TWA 0.5 mg(Cr)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ZINC CHROMATE-air: 10H CA TWA 0.001 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M0900; NIS 108; TNF 9236; NOS 57; TNE 79219; NOES 1983: HZD M0900; NIS 71; TNF 5081; NOS 57; TNE 58924; TFE 4190 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/SHE; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 4, 1975/1976; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 669 of 1119 in RTECS (through 2003/06) AN: GB6262000 PN: Chromium,-ion- (Cr 6+) SY: Chromium- (Cr +6); Chromium- (cr(sup 6+)); Chromium-hexavalent-ion-; Chromium(6+); Chromium(6+) ion; Chromium(VI); Chromium,-hexavalent-; Chromium, ion (Cr(sup 6+)) (8CI,9CI); Hexavalent-chromium-; NCI-C04273- RN: Current: 18540-29-9 UD: 200302 MF: Cr MW: 52.00 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 100 nmol/plate (+/-S9) Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 65, p. 207, 1978 (NATWAY); dna-esc 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dna-hmn-hla 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dnd-hmn-leu 50 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 46, p. 189, 1983 (CBINA8); cyt-hmn-fbr 25 umol/L NATO ASI Series, Series G: Ecological Sciences. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1983- v. 3, p. 237, 1985 (NASGEJ) AT: N30 orl-rat TDLo: 0.8 gm/kg Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 11, p. 299, 1992 (JEPOEC) TR: ACGIH TLV-TWA 0.05 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Confirmed human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: MSHA STANDARD-air: TWA 0.5 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 35, 1971 (DTLVS*); OSHA PEL (Gen Indu): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR) ND: NIOSH REL TO CHROMIUM, hexavalent-air: 10H CA TWA 0.001 mg/m3/10H National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X4822; NIS 4; TNF 29; NOS 5; TNE 744; TFE 39 SL: EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Chromium hexavalent, 7600 and 7604; NIOSH Analytical Method, 1994: Elements by ICP, 7300; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID103; OSHA ANALYTICAL METHOD #ID215 Record 670 of 1119 in RTECS (through 2003/06) AN: GB6650000 PN: Chromium(VI) oxide (1:3) SY: Anhydride-chromique- (French); Anidride-cromica- (Italian); Chromium-oxide- (Cr4O12); Chrome (trioxyde de) (French); Chromia- (CrO3); Chromic-anhydride-; Chromium(VI) oxide; Chromsaeureanhydrid- (German); Chromtrioxid- (German); Chroomtrioxyde- (Dutch); Chroomzuuranhydride- (Dutch); Cromo(triossido di) (Italian); Monochromium-trioxide-; Puratronic-chromium-trioxide-; Chromium-trioxide-; Chromium(6+) trioxide RN: Current: 1333-82-0 Previous: 12324-05-9; 12324-08-2 UD: 200302 MF: Cr-O3 MW: 100.00 WL: CR2 O3 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 1 mmol/L (+S9) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 8, p. 195, 1981 (TOLED5); mmo-sat 10 ug/plate (-S9) Applied and Environmental Microbiology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.31- 1976- v. 33, p. 805, 1977 (AEMIDF); dnr-sat 50 mmol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 439, 1981 (TOLED5); mmo-esc 8 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 357, 1979 (MUREAV); oms-esc 1500 nmol/tube Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 571, 1986 (ENMUDM); dnr-esc 18700 ng/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); dnr-bcs 50 mmol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 439, 1981 (TOLED5); slt-dmg-ipr 300 ppm Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 51, p. 421, 1986 (CYTOAN); slt-dmg-orl 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 266, p. 197, 1992 (MUREAV); mtr-hmn-fbr 100 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3815, 1987 (CNREA8); cyt-hmn-leu 2 mg/L Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 18, p. 136, 1976 (SAIGBL); cyt-mus-orl 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 33, 1993 (MUREAV); cyt-mus-mmr 1 umol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 221, 1979 (MUREAV); mnt-ham-ovr 1 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17(Suppl 19), p. 32, 1991 (EMMUEG); cyt-ham-emb 68 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 87, 1977 (MUREAV); cyt-ham-ovr 250 ug/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 17, p. 219, 1980 (TXCYAC); sce-ham-ovr 250 ug/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 17, p. 219, 1980 (TXCYAC); sce-ham-fbr 320 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 104, p. 141, 1982 (MUREAV); msc-ham-ovr 6 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2053, 1992 (CRNGDP) RE: T31-T34 scu-mus TDLo: 20 mg/kg (8D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 19, p. 171, 1979 (SEIJBO); T55-T43-T41 ivn-ham TDLo: 5 mg/kg (8D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 16, p. 101, 1978 (ENVRAL); T25-T34-T46 ivn-ham TDLo: 7500 ug/kg (8D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 16, p. 101, 1978 (ENVRAL); T25-T55 ivn-ham TDLo: 7500 ug/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 9, p. A17, 1974 (TJADAB); T45 ivn-ham TDLo: 8 mg/kg (8D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 199, p. 89A, 1981 (ANREAK); T59 ivn-ham TDLo: 8 mg/kg (8D preg) "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 301, 1989 (VCVN5*) TE: V01-D09-J60 ihl-hmn TCLo: 110 ug/m3/3Y-C Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 13, p. 528, 1955 (AGGHAR); V01-V10 imp-rat TDLo: 125 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 20, p. 274, 1959 (AIHAAP); V03-D09 ihl-mus TCLo: 3480 ug/m3/2H/1Y-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 29, p. 17, 1987 (SAIGBL) ORNG: 80000000 ng/kg. [80.000000 mg/kg] J24-K12-R21 AT: T/E unlistd ihl-hmn TCLo: 110 ug/m3 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 291, 1980 (YAKUD5); J24-K12-R21 orl-rat LD50: 80 mg/kg Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 27, p. 119, 1976 (TRENAF); F07-F15-R03 skn-rat LDLo: 55 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0537097 (NTIS**); T/E unlistd ipr-rat LD50: 58400 ug/kg Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221 005, India) V.1- 1968(?)- v. 23, p. 153, 1991 (INJPD2); T/E unlistd ivn-rat LD50: 9260 ug/kg Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221 005, India) V.1- 1968(?)- v. 23, p. 153, 1991 (INJPD2); T/E unlistd orl-mus LD50: 127 mg/kg Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 14, p. 86, 1980 (CHYCDW); T/E unlistd ipr-mus LD50: 14 mg/kg Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 34, p. 193, 1979 (NEZAAQ); T/E unlistd scu-mus LDLo: 20 mg/kg Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 19, p. 171, 1979 (SEIJBO); T/E unlistd ivn-mus LD50: 17100 ug/kg Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221 005, India) V.1- 1968(?)- v. 23, p. 153, 1991 (INJPD2) MD: F23-J30-Y05 ihl-rat TCLo: 29 ug/m3/20H/90D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 28(11), p. 9, 1963 (GISAAA); C16-P20-Y21 ihl-rat TCLo: 0.03 mg/m3/24H/90D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 302, 1989 (VCVN5*); J13-J15 ihl-rat TCLo: 1 mg/m3/4H/28W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 302, 1989 (VCVN5*) TR: ACGIH TLV-TWA 0.05 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Confirmed human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 205, 1980 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 49, 1990 (IMEMDT); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Cr,22,1974 (85DHAX) SR: MSHA STANDARD-air: TWA 0.5 mg(Cr)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 35, 1971 (DTLVS*); OSHA PEL (Gen Indu): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 0.1 mg(CrO3)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-DENMARK: TWA 0.02 mg(Cr)/m3, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1993; OEL-FRANCE: VME 0.05 mg/m3, VLE 0.1 mg/m3, C1 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-JAPAN: EOL 0.05 mg(Cr)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.025 mg(Cr)/m3, MAC-K 0.05 mg(Cr)/m3, JAN 1999; OEL-NORWAY: TWA 0.02 mg/m3, JAN 1999; OEL-POLAND: TWA 0.1 mg(Cr)/m3, STEL 0.3 mg(Cr)/m3, JAN 1999; OEL-RUSSIA: STEL 0.01 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: TWA 0.02 mg/m3, Carcinogen, JAN 1999; OEL-UNITED KINGDOM: TWA 0.05 mg(Cr)/m3, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHROMIUM(VI)-air: 10H CA TWA 0.001 mg(Cr)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 19430; NIS 28; TNF 1253; NOS 44; TNE 20618; NOES 1983: HZD 19430; NIS 55; TNF 2873; NOS 65; TNE 68271; TFE 11533 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, In vitro cytogenetics-nonhuman; EPA GENETOX PROGRAM 1988, Positive: B subtilis rec assay, Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 671 of 1119 in RTECS (through 2003/06) AN: GC1575000 PN: Chrysene,-5-methyl- SY: 5-Methylchrysene- RN: Current: 3697-24-3 BRN: 2048519 BHR: 4-05-00-02573 UD: 200006 MF: C19-H14 MW: 242.33 WL: L E6 B666J C1 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 3 ug/plate (-S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 673, 1986 (CRNGDP); msc-hmn-lym 21 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 371, p. 123, 1996 (MUREAV); dna-mus-skn 467 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 843, 1983 (CRNGDP); dna-mus-ipr 50 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 2613, 1994 (CRNGDP) TE: V01-R60 skn-mus TDLo: 32 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 6406, 1985 (CNREA8); V01-V10 scu-mus TDLo: 20 mg/kg/20W-I Carcinogenesis--A Comprehensive Survey. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1976- v. 1, p. 325, 1976 (CCSUDL); V02-R60 skn-mus TD :40 mg/kg/30W-I Carcinogenesis--A Comprehensive Survey. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1976- v. 1, p. 325, 1976 (CCSUDL); V03-J60-V10 scu-mus TD :80 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 3, p. 606, 1943 (CNREA8); V02-R60 skn-mus TD :40 mg/kg/30W-I Carcinogenesis--A Comprehensive Survey. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1976- v. 1, p. 325, 1976 (CCSUDL); V03-R60-V10 skn-mus TD :132 mg/kg/11W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 53, p. 1121, 1974 (JNCIAM) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 379, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 379, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Histidine reversion-Ames test; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 672 of 1119 in RTECS (through 2003/06) AN: GC1930000 PN: Chrysene,-6-nitro- SY: 6-Nitrochrysene- RN: Current: 7496-02-8 BRN: 2134652 BHR: 3-05-00-02383 UD: 200302 MF: C18-H11-N-O2 MW: 273.30 WL: L E6 B666J DNW CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 5 ug/plate (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3408, 1984 (CNREA8); dna-hmn-lym 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 310, p. 45, 1994 (MUREAV); dna-hmn-lng 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); mtr-rat-oth 50 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 11, p. 155, 1990 (CRNGDP); dna-rat-lvr 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); mnt-mus-ipr 500 mg/kg Tokyo Jikeikai Ika Daigaku Zasshi. Tokyo Jikeikai Medical Journal. (3-25-8, Nishi Shinbashi, Minato-ku, Tokyo 105, Japan) V.66- 1951- v. 101, p. 259, 1986 (TJIDAH); mtr-ham-emb 3700 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 357, 1983 (CRNGDP); dna-ham-ovr 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 279, p. 153, 1992 (MUREAV); dna-ham-lng 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); msc-ham-ovr 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 279, p. 153, 1992 (MUREAV); msc-mus-ipr 8.7 mg/kg/8D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 137, p. 137, 1999 (CALEDQ); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) TE: V01-J60 ipr-mus TDLo: 9163 ug/kg/2W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 801, 1985 (CRNGDP); V01-J60-L60 ipr-mus TDLo: 25.8 mg/kg/15D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 146, p. 1, 1999 (CALEDQ); V01-L60 ipr-mus TDLo: 8.7 mg/kg/8D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 137, p. 137, 1999 (CALEDQ); V01-L60 ipr-mus TDLo: 7.900 mg/kg/7D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 143, p. 81, 1999 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 267, 1989 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 267, 1989 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 267, 1989 (IMEMDT) SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 673 of 1119 in RTECS (through 2003/06) AN: GD6476000 PN: Cinnamaldehyde, (E)- SY: (E)-2-Cinnamic aldehyde; (E)-3-Phenyl-2-propenal; (E)-3-Phenylpropenal; (E)-Cinnamaldehyde; 2-Propenal, 3-phenyl-, (E)- (9CI); CA-; trans-Cinnamaldehyde-; trans-Cinnamic-aldehyde-; trans-Cinnamylaldehyde- RN: Current: 14371-10-9 BRN: 1071571 BHR: 4-07-00-00984 UD: 200302 MF: C9-H8-O MW: 132.17 CC: Tumorigen (C); Mutagen (M) ME: mnt-rat-orl 1100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 1, 1994 (MUREAV); mnt-mus-orl 850 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 1, 1994 (MUREAV); mtr-ham-fbr 10 nmol/L Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 10, p. 177, 1985 (JTSCDR); cyt-ham-fbr 2 nmol/L Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 10, p. 177, 1985 (JTSCDR); sce-ham-ovr 340 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); dnd-ham-fbr 500 umol/l/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 185, 2001 (MUREAV); dnd-hmn-oth 600 umol/l/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 185, 2001 (MUREAV) ORNG: 3350000000 ng/kg. [3350.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 3350 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 401, 1984 (VCVGK*) MD: F15-K06-U01 orl-rat TDLo: 1092 gm/kg/13W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 42, p. 56, 1998 (TOXID9); F15-K30-U01 orl-mus TDLo: 227 gm/kg/13W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 42, p. 56, 1998 (TOXID9); L30 orl-rat TDLo: 1115 mg/kg/223D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 401, 1994 (VCVGK*) SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 674 of 1119 in RTECS (through 2003/06) AN: GE5925000 PN: C.I. Solvent Yellow 33 SY: 2-(2-Quinolinyl)-1H-indene-1,3(2H)-dione; 2-(2-Quinolyl)-1,3-indandione; Arlosol-Yellow-S-; CI-47000-; Chinoline Yellow D sol. in spirits; Chinoline-Yellow-ZSS-; D and C Yellow No. 11; D&C Yellow No. 11; Nitro-Fast-Yellow-SL-; Oil-Yellow-SIS-; Petrol-Yellow-C-; Quinoline-Yellow-A-Spirit-Soluble-; Quinoline-Yellow-Base-; Quinoline-Yellow-SS-; Quinoline-Yellow-Spirit-Soluble-; Solvant-Yellow-33-; Waxoline-Yellow-T-; Yellow-204- RN: Current: 8003-22-3 UD: 200302 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 333 ug/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11(Suppl 12), p. 1, 1988 (EMMUEG); mmo-mus-lym 5 mg/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 219, 1988 (EMMUEG); cyt-mus-lym 1 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 24, 1986 (ENMUDM); sce-mus-lym 20 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 219, 1988 (EMMUEG); msc-mus-lym 15 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 219, 1988 (EMMUEG) RE: T81 orl-rat TDLo: 67 gm/kg (4W pre/1-21D preg/4W post) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3127 (NTPTR*); V02-T65 orl-rat TDLo: 73570 mg/kg (multigeneration) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-463, 1997 (NTPTR*); T01 orl-mus TDLo: 5384 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3127 (NTPTR*) TE: V02-L60-M03 orl-rat TDLo: 183750 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-107154 (NTIS**); V03-L60-M03 orl-rat TDLo: 207760 mg/kg/106W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-107154 (NTIS**) AT: K30 orl-rat LDLo: 5 gm/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 15(Suppl 1), p. S19, 1996 (ATDAEI); K12-L30-M30 skn-rbt LD50: >2 gm/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 15(Suppl 1), p. S19, 1996 (ATDAEI) MD: L70 orl-rat TDLo: 345 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3127 (NTPTR*); L70 orl-rat TDLo: 2243 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3127 (NTPTR*); J02-U01 ihl-rat TCLo: 230 mg/m3/6H/4W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 358, 1987 (FAATDF); U01 ihl-rat TCLo: 100 mg/m3/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 358, 1987 (FAATDF); L70 orl-mus TDLo: 828 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3127 (NTPTR*); L70-M70-Y16 orl-mus TDLo: 5384 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3127 (NTPTR*) ND: NOHS 1974: HZD M3135; NIS 3; TNF 149; NOS 12; TNE 2406; NOES 1983: HZD M3135; NIS 7; TNF 1501; NOS 12; TNE 14314; TFE 4310 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies (feed), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-463, 1997 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NTP Toxicity studies, RPT# TOX-08, October 2000 Record 675 of 1119 in RTECS (through 2003/06) AN: GF8600000 PN: Coal-tar- SY: Carbo-cort-; Coal-tar,-aerosol-; Estar- (skin treatment); KC-261-; Lavatar-; Picis-carbonis-; Pixalbol-; Polytar-bath-; Supertah-; Syntar-; Tar,-coal-; Coal-tar-solution-USP-; Crude-coal-tar-; Impervotar-; Zetar- RN: Current: 8007-45-2 Previous: 8050-41-7; 8055-92-3 UD: 200210 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-hmn 15 ug/3D-I MLD "Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar, eds., New York, Academic Press, Inc. 1977 -,127,1977 (85DKA8); skn-rbt 5%/3H MLD Scientia Pharmaceutica. (Oesterreichische Apotheker-Verlagsgesellschaft MBH, Spitalgasse 31, 1094 Vienna 9, Austria) V.1- 1930- v. 43, p. 11, 1975 (SCPHA4) ME: mmo-sat 5 ug/plate (+S9) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-138973 (NTIS**); mmo-esc 50 ug/plate (+S9) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-138973 (NTIS**); mrc-smc 100 ppm National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-138973 (NTIS**); oms-hmn-skn 5000 ppm "Psoriasis, Proceedings of the International Symposium, Stanford, CA, 1971," Farber, E.M., and A.J. Cox, eds., Stanford, CA, Stanford Univ. Press, 1971 -,335,1971 (26UYA8); bfa-rat-sat 63 mg/kg Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 12, p. 137, 1986 (SWEHDO); dna-mus-skn 240 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1253, 1988 (CRNGDP); dnd-mus-skn 25 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 117, 2000 (MUREAV); msc-mus-skn 100 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 117, 2000 (MUREAV) TE: V01-J60 ihl-rat TCLo: 10 mg/m3/90D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A041-973 (NTIS**); V03-R60 orl-mus TDLo: 12 gm/kg/30W-C American Journal of Cancer. (New York, NY) V.15-40, 1931-40. For publisher information, see CNREA8. v. 26, p. 552, 1936 (AJCAA7); V01-J60 ihl-mus TCLo: 22 gm/m3/55W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 39, p. 175, 1967 (JNCIAM); V01-R60-V10 skn-mus TDLo: 64 gm/kg/36W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 299, 1951 (AMIHBC); V03-R60-V10 skn-mus TD :8400 mg/kg/64W-I Archiv fuer Dermatologische Forschung. (Berlin, Ger.) V.240-252, 1971-75. For publisher information, see ADREDL. v. 242, p. 176, 1972 (ADMFAU) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 35, p. 83, 1985 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 35, p. 83, 1985 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 34, p. 65, 1984 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 34, p. 65, 1984 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 22, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 22, 1973 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 175, 1987 (IMSUDL); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,63,1970 (85CVA2); TOXICOLOGY REVIEW Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 166, p. 113, 1978 (ZHPMAT); TOXICOLOGY REVIEW Publication of the American Association for the Advancement of Science. (Washington, DC) No.1-94, 1934-73. Discontinued. v. 54, p. 171, 1959 (PAASAH) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-AUSTRALIA: TWA 0.2 mg/m3, Carcinogen, JAN 1993; OEL-FRANCE: VME 0.2 mg/m3, Skin, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.2 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.2 mg/m3, JAN 1993; OEL-RUSSIA: STEL 5 mg/m3, Carcinogen, JAN 1993; OEL-SWITZERLAND: MAK-W 0.2 mg/m3, Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000 ND: NIOSH REL TO COAL TAR-air: 10H CA TWA 0.1 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X3773; NIS 2; TNF 117; NOS 3; TNE 852; TFE 739 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/97/121024/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 676 of 1119 in RTECS (through 2003/06) AN: GF8615000 PN: Coal-tar-creosote- SY: AWPA #1; Brick-oil-; Creosotum-; Heavy-oil-; Liquid-pitch-oil-; Naphthalene-oil-; RCRA-waste-number-U051-; Preserv-O-sote-; Tar-oil-; Coal-tar-oil-; Creosote-; Creosote,-from-coal-tar-; Creosote-oil-; Creosote-P1-; Cresylic-creosote-; Wash-oil- RN: Current: 8001-58-9 UD: 200210 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 20 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 119, p. 21, 1983 (MUREAV); oms-esc 1 ug/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 223, 1992 (MUREAV); bfa-rat-sat 250 mg/kg IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 59, p. 279, 1984 (IAPUDO); mnt-mus-ipr 185 mg/kg/48H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); sce-ham-ovr 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 223, 1992 (MUREAV) RE: T19-T34 orl-mus TDLo: 2 gm/kg (5-9D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 82, p. 371, 1993 (RCOCB8) TE: V01-R60 skn-mus TDLo: 99 gm/kg/33W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 228, 1986 (FAATDF) ORNG: 725000000 ng/kg. [725.000000 mg/kg] F07 AT: F07 orl-rat LD50: 725 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 6, p. 378, 1964 (TXAPA9); F12-F24-J25 orl-mus LD50: 433 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 21, p. 899, 1981 (OYYAA2) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 35, p. 83, 1985 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 35, p. 83, 1985 (IMEMDT); IARC Cancer Review: Animal SUFFICIENT EVICENCE IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 22, 1973 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 177, 1987 (IMSUDL) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NIOSH REL TO CREOSOTE-air: 10H CA TWA 0.1 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X2258; NIS 1; TNF 3; NOS 1; TNE 241; TFE 17 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/97/121024/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 677 of 1119 in RTECS (through 2003/06) AN: GF8620000 PN: Coal-tar-dye- UD: 200007 CC: Tumorigen (C) SL: NTP 9th Report on Carcinogens, 2000: known to be human carcinogen Record 678 of 1119 in RTECS (through 2003/06) AN: GG3200000 PN: Cobalt(II) sulfate (1:1), heptahydrate SY: Cobalt-monosulfate-heptahydrate-; Cobalt-sulfate-heptahydrate-; Cobalt(II) sulphate heptahydrate; Cobaltous-sulfate-heptahydrate-; Sulfuric acid, cobalt(2+) salt (1:1), heptahydrate (8CI,9CI) RN: Current: 10026-24-1 UD: 200207 MF: Co-O4-S.7 H2-O MW: 281.13 WL: .CO..S-O4 &QH 7 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mnt-ham-emb 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 392, p. 61, 1997 (MUREAV) RE: T01-T02 ihl-mus TCLo: 30 mg/m3/6H (13W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 15, p. 357, 1990 (FAATDF) ORNG: 582000000 ng/kg. [582.000000 mg/kg] F07-F19-K12 AT: F07-F19-K12 orl-rat LD50: 582 mg/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 688, 1992 (ATDAEI); T/E unlistd ims-rat LD50: 320 mg/kg Farmakologiya i Toksikologiya (Kiev). Pharmacology and Toxicology. (Kievskii Nauchno- Issledovatel'skii Institut Farmakologii i Toksikologii, Kiev, USSR) No.1- 1964- v. 13, p. 94, 1978 (FATOBP); T/E unlistd ivn-dog LDLo: 16200 ug/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX) MD: D18-J02-N74 ihl-rat TCLo: 91 mg/m3/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3124 (NTPTR*); J70-M70-P08 ihl-rat TCLo: 18 mg/m3/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3124 (NTPTR*); J70-N19-Z73 ihl-mus TCLo: 30 mg/m3/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 15, p. 357, 1990 (FAATDF) ND: NOES 1983: HZD X2377; NIS 5; TNF 126; NOS 5; TNE 3264; TFE 1853 SL: NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP Toxicity studies, RPT# TOX-05, October 2000 Record 679 of 1119 in RTECS (through 2003/06) AN: GG6200000 PN: Coconut-oil-acid-diethanolamine- SY: Amides, coco, N,N-bis(hydroxyethyl); Clindrol-200CGN-; Clindrol-202CGN-; Clindrol-superamide-100CG-; Cocamide-DEA-; Coconut-diethanolamide-; Coconut-diethanolamine-; Coconut-oil-acid-diethanolamine-; Coconut-oil-acid-diethanolamine-condensate-; Ethylan-LD-; N,N-Bis(2-hydroxyethyl)cocoamide; N,N-Bis(2-hydroxyethyl)coconut fatty acid amide; N,N-Bis(2-hydroxyethyl)coconut oil amide; NCI-C55312-; Ninol-2012E- RN: Current: 68603-42-9 Previous: 8036-48-4 UD: 200302 CC: Tumorigen (C); Primary-Irritant (S) ID: skn-rbt 300 uL MOD Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(5), p. 415, 1986 (JACTDZ); eye-rbt 100 uL SEV Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15(6), p. 527, 1996 (JACTDZ) TE: V03-M61 skn-rat TDLo: 26000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2001-103205 (NTIS**); V01-L60 skn-mus TDLo: 52000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2001-103205 (NTIS**) ORNL: 12400000 nL/kg. [12.400000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 12400 uL/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(5), p. 415, 1986 (JACTDZ) MD: M03-R03 skn-rat TDLo: 2275 mg/kg/13W-I Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15(6), p. 527, 1996 (JACTDZ); J70-L70-M70 skn-mus TDLo: 4550 mg/kg/13W-I Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15(6), p. 527, 1996 (JACTDZ) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOES 1983: HZD X9024; NIS 164; TNF 22119; NOS 153; TNE 588915; TFE 256658 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (derm), clear evidence: mouse; NCI Carcinogenesis Studies (derm), equivocal evidence: rat; NTP Carcinogenesis studies, test completed (post peer review), October 2000 Record 680 of 1119 in RTECS (through 2003/06) AN: GH0346000 PN: Coke-oven-emissions- SY: Coke-oven-emissions- (OSHA) UD: 200006 CC: Tumorigen (C); Mutagen (M) ME: dna-hmn-lng 25 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); dna-rat-lvr 25 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); mmo-ham-ovr 10 mg/L (+S9) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. LMF-102 (NTIS**); dna-ham-lng 25 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); sce-ham-lng 5 mg/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. LMF-102 (NTIS**) SR: OSHA PEL (Construc): see CFR 29,1926.1129 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA-cancer hazard Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1029, 1987 (CFRGBR) ND: NIOSH REL TO THE CHEMICAL-air: CA 0.5-0.7 mg/m3 (total particulates) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID-58 Record 681 of 1119 in RTECS (through 2003/06) AN: GL7375000 PN: Copper, (5-((4'-((2,5-dihydroxy-4-((2-hydroxy-5-sulfophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4- yl)azo)-2-hydroxybenzoato(2-))-, disodium salt SY: Aizen-Primula-Brown-BRLH-; Aizen-Primula-Brown-PLH-; Amanil-Fast-Brown-BRL-; Amanil-Supra-Brown-LBL-; Atlantic-Fast-Brown-BRL-; Atlantic-Resin-Fast-Brown-BRL-; Belamine-Fast-Brown-BRLL-; Chrome-Leather-Brown-BRLL-; Chrome-Leather-Brown-BRSL-; C.I. 30145; C.I. Direct Brown; Benzamil-Supra-Brown-BRLL-; Benzanil-Supra-Brown-BRLN-; Brown-4EMBL-; Calcodur-Brown-BRL-; Chloramine-Fast-Brown-BRL-; Chloramine-Fast-Brown-BRLL-; Chloramine-Fast-Cutch-Brown-PL-; Derma-Fast-Brown-W-GL-; Dermafix-Brown-PL-; Dialuminous-Brown-BRS-; Diaphtamine-Light-Brown-BRLL-; Diazine-Fast-Brown-RSL-; Diazol-Light-Brown-BRN-; Dicorel-Brown-LMR-; Direct-Brown-95-; Direct-Brown-BRL-; Direct-Fast-Brown-BRL-; Direct-Fast-Brown-LMR-; Direct-Light-Brown-BRS-; Direct-Supra-Light-Brown-ML-; Durazol-Brown-BR-; DuroFast-Brown-BRL-; Eliamina-Light-Brown-BRL-; Enianil-Light-Brown-BRL-; Fastolite-Brown-BRL-; Fastusol-Brown-LBRSA-; Fastusol-Brown-LBRSN-; Fenaluz-Brown-BRL-; Helion-Brown-BRSL-; Hispaluz-Brown-BRL-; Hned-prima-95- (Czech); Kayarus-Supra-Brown-BRS-; Kca-Light-Fast-Brown-BR-; NCI-C54568-; Paranol-Fast-Brown-BRL-; Peeramine-Fast-Brown-BRL-; Pontamine-Fast-Brown-BRL-; Pontamine-Fast-Brown-NP-; Pyrazol-Fast-Brown-BRL-; Pyrazoline-Brown-BRL-; Saturn-Brown-LBR-; Sirius-Supra-Brown-BRL-; Sirius-Supra-Brown-BRS-; Solantine-Brown-BRL-; Solar-Brown-PL-; Solex-Brown-R-; Solius-Light-Brown-BRLL-; Solius-Light-Brown-BRS-; Sumilight-Supra-Brown-BRS-; Suprazo-Brown-BRL-; Suprexcel-Brown-BRL-; Triantine-Brown-BRS-; Triantine-Fast-Brown-OG-; Triantine-Fast-Brown-OR-; Triantine-Light-Brown-BRS-; Triantine-Light-Brown-OG-; Cuprofix-Brown-GL-; Diphenyl-Fast-Brown-BRL-; Tertrodirect-Fast-Brown-BR-; Tetramine-Fast-Brown-BRDN-Extra-; Tetramine-Fast-Brown-BRP-; Tetramine-Fast-Brown-BRS- RN: Current: 16071-86-6 UD: 200012 MF: C31-H18-Cu-N6-O9-S.2 Na MW: 760.13 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 100 nmol (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 33, 1984 (MUREAV); dns-rat-orl 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 147, 1984 (MUREAV); bfa-rat-sat 250 umol/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 31, p. 271, 1984 (TXCYAC) TE: V02-L60 orl-rat TDLo: 2625 mg/kg/5W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); V03-L60 orl-rat TD :6825 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 54, p. 431, 1980 (TXAPA9) ORNG: 12060000000 ng/kg. [12060.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 12060 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*); T/E unlistd orl-rbt LDLo: 2 gm/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 321, 1982 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 125, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 321, 1982 (IMEMDT) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993 ND: NOHS 1974: HZD M1412; NIS 3; TNF 37; NOS 11; TNE 1112; NOES 1983: HZD M1412; NIS 1; TNF 119; NOS 1; TNE 830 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 24, 1978; NIOSH Analytical Method, 1994: Dyes, 5013; NCI Carcinogenesis Bioassay (feed), clear evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); NCI Carcinogenesis Bioassay (feed), no evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); NTP Toxicity studies, RPT# TR-108, October 2000 Record 682 of 1119 in RTECS (through 2003/06) AN: GL8900000 PN: Copper(II) sulfate, pentahydrate (1:1:5) SY: Blue-copper-AS-; Copper-sulphate-pentahydrate-; Copper(2+) sulfate pentahydrate; Copper(II) sulfate pentahydrate; Cupric-sulfate-pentahydrate-; Kupfersulfat-pentahydrat- (German); Kupfervitriol- (German); Salzburg-vitriol-; Sulfuric acid copper(2+) salt (1:1), pentahydrate (8CI,9CI); Sulfuric acid, copper(2+) salt, pentahydrate; Vencedor- RN: Current: 7758-99-8 UD: 200305 MF: O4-S.Cu.5 H2-O MW: 249.70 WL: CU S-O4 &QH 5 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P) ME: dni-hmn-lym 76 umol/L International Archives of Allergy and Applied Immunology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.1- 1950- v. 79, p. 83, 1986 (IAAAAM); dns-rat-lvr 31 umol/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 5, p. 15, 1989 (CBTOE2); cyt-rat-ast 300 mg/kg Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 54, p. 155, 1963 (GANNA2); mnt-mus-ipr 5 mg/kg Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 52, p. 801, 1987 (CYTOAN); cyt-mus-ipr 1100 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 243, p. 1, 1990 (MUREAV); spm-mus-ipr 5 mg/kg/5D-I Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 52, p. 801, 1987 (CYTOAN); mnt-ckn-ipr 7500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 57, 1996 (MUREAV); mnt-ckn-orl 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 57, 1996 (MUREAV); cyt-ckn-orl 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 57, 1996 (MUREAV); cyt-ckn-ipr 7500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 57, 1996 (MUREAV) ORNG: 300000000 ng/kg. [300.000000 mg/kg] T/E unlistd AT: L30-M30-P23 orl-hmn TDLo: 272 mg/kg Indian Practitioner. (Sassoon Bldg., III Floor, 143 M. G. Rd., Bombay 400 023, India) V.1- 1947/48- v. 18, p. 807, 1965 (IPRAA8); F24-L30-P23 orl-hmn LDLo: 1088 mg/kg Indian Practitioner. (Sassoon Bldg., III Floor, 143 M. G. Rd., Bombay 400 023, India) V.1- 1947/48- v. 18, p. 807, 1965 (IPRAA8); F04-H02-U28 orl-man TDLo: 429 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 41, p. 193, 1999 (YAKUD5); T/E unlistd unr-man LDLo: 221 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd skn-rat LD50: >2 gm/kg Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 18, p. S161, 1993 (NNGADV); T/E unlistd ipr-rat LD50: 18700 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 53(4), p. 78, 1988 (GISAAA); T/E unlistd ipr-mus LD50: 33 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 14, p. 289, 1965 (BCPCA6); T/E unlistd orl-dog LDLo: 60 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); E08-F24-K12 scu-gpg LDLo: 62 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 217, 1913 (BMJOAE); F07-F24-U01 orl-pgn LDLo: 1 gm/kg Australian Veterinary Journal. (Australian Veterinary Assoc., Executive Director, 134-136 Hampden Road, Artarmon, N.S.W., Australia) V.2- 1927- v. 16, p. 147, 1940 (AUVJA2); F07-F24-U01 orl-dck LDLo: 600 mg/kg Australian Veterinary Journal. (Australian Veterinary Assoc., Executive Director, 134-136 Hampden Road, Artarmon, N.S.W., Australia) V.2- 1927- v. 16, p. 147, 1940 (AUVJA2); F07-K12-P01 orl-dom LDLo: 5 mg/kg Journal of Comparative Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.75- 1965- v. 82, p. 47, 1972 (JCVPAR); F07-K01-K13 ipr-mam LD50: 7500 ug/kg Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 55, p. 337, 1982 (JANSAG); F07-F24-U01 orl-bwd LDLo: 300 mg/kg Australian Veterinary Journal. (Australian Veterinary Assoc., Executive Director, 134-136 Hampden Road, Artarmon, N.S.W., Australia) V.2- 1927- v. 16, p. 147, 1940 (AUVJA2); T/E unlistd orl-rat LD50: 300 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 67, 1998 (VCVN1*); T/E unlistd orl-mus LD50: 43 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 67, 1998 (VCVN1*); T/E unlistd orl-ckn LD50: 693 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 67, 1998 (VCVN1*); K13 orl-mam TDLo: 100 mg/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 453, p. 299, 2002 (EJPHAZ) MD: L30-P30-U09 orl-rat TDLo: 1427 mg/kg/1Y-I Khigiena i Zdraveopazvane. Hygiene and Sanitation. (Hemus, Blvd. Russki 6, Sofia, Bulgaria) V.9- 1966- v. 30(3), p. 34, 1987 (KHZDAN); F16-U01 orl-rat TDLo: 2625 mg/kg/2W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3352 (NTPTR*); K30-P08-Y15 orl-rat TDLo: 24 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3352 (NTPTR*); U01-Z01 orl-mus TDLo: 3390 mg/kg/2W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3352 (NTPTR*); L70 orl-mus TDLo: 67 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3352 (NTPTR*); K12-L30-P30 scu-trk TDLo: 100 mg/kg/14W-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 128, p. 627, 1968 (PSEBAA); F15-K12-Z01 orl-mam TDLo: 1 gm/kg/5D-I Journal of Comparative Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.75- 1965- v. 108, p. 191, 1993 (JCVPAR); F15-F18-Z01 ivn-mam TDLo: 190 mg/kg/95D-I Journal of Comparative Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.75- 1965- v. 108, p. 191, 1993 (JCVPAR); L14 orl-rat TDLo: 10 gm/kg/5D/4W-I Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 42, p. 261, 2000 (VHTODE); L30-P30 orl-rat TDLo: 5 gm/kg/5D/2W-I Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 42, p. 261, 2000 (VHTODE) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-ARAB Republic of Egypt: TWA 0.1 mg(Cu)/m3 (fume), JAN 1993; OEL-AUSTRALIA: TWA 0.2 mg(Cu)/m3 (fume), JAN 1993; OEL-AUSTRALIA: TWA 1 mg(Cu)/m3 (dust), JAN 1993; OEL-BELGIUM: TWA 0.2 mg(Cu)/m3 (fume), JAN 1993; OEL-BELGIUM: TWA 1 mg(Cu)/m3 (dust), JAN 1993; OEL-FINLAND: TWA 0.2 mg(Cu)/m3 (fume), JAN 1999; OEL-FINLAND: TWA 1 mg(Cu)/m3 (dust), JAN 1999; OEL-FRANCE: VME 0.2 mg(Cu)/m3 (fume), JAN 1993; OEL-FRANCE: VME 1 mg(Cu)/m3, STEL 2 mg(Cu)/m3 (dust), JAN 1993; OEL-GERMANY: MAK 0.1 mg(Cu)/m3 (fume), JAN 1999; OEL-GERMANY: MAK 1 mg(Cu)/m3 (dust), JAN 1999; OEL-HUNGARY: TWA 0.2 mg(Cu)/m3, STEL 0.4 mg(Cu)/m3 (dust), JAN 1993; OEL-INDIA: TWA 0.2 mg(Cu)/m3 (fume), JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 02 mg(Cu)/m3 (fume), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 mg(Cu)/m3 (dust), JAN 1999; OEL-THE PHILIPPINES: TWA 1.0 mg(Cu)/m3 (fume), JAN 1993; OEL-POLAND: MAC(TWA) 0.1 mg(Cu)/m3 (fume), JAN 1993; OEL-RUSSIA: STEL 0.5 ppm (1 mg(Cu)/m3) (dust), JAN 1993; OEL-SWEDEN: NGV 0.2 mg(Cu)/m3 (resp. dust), JAN 1999; OEL-SWEDEN: NGV 1 mg(Cu)/m3 (total dust), JAN 1999; OEL-SWITZERLAND: TWA 0.1 mg(Cu)/m3, STEL 0.2 mg(Cu)/m3 (fume), JAN 1999; OEL-SWITZERLAND: TWA 1 mg(Cu)/m3, STEL 1 mg(Cu)/m3, JAN 1999; OEL-THAILAND: TWA 0.1 mg(Cu)/m3 (fume), JAN 1993; OEL-THAILAND: TWA 1 mg(Cu)/m3, JAN 1993; OEL-UNITED KINGDOM: LTEL 0.2 mg(Cu)/m3 (fume), JAN 1993; OEL-UNITED KINGDOM: LTEL 1 mg(Cu)/m3, JAN 1993 ND: NOES 1983: HZD X5421; NIS 13; TNF 979; NOS 21; TNE 10821; TFE 3606 SL: NTP Toxicity studies, RPT# TOX-29, October 2000 Record 683 of 1119 in RTECS (through 2003/06) AN: GM4800000 PN: Corn-oil- SY: Maise-oil-; Maydol-; Mazola-oil- RN: Current: 8001-30-7 UD: 200305 CC: Tumorigen (C); Reproductive-Effector (T); Natural-Product (N); Primary-Irritant (S) ID: skn-hmn 300 mg/3D-I MLD "Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar, eds., New York, Academic Press, Inc. 1977 -,127,1977 (85DKA8) RE: T48-T54 orl-rat TDLo: 12500 mg/kg (15-19D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 75A, 1983 (TJADAB); T83 orl-rat TDLo: 360 gm/kg (10-22D preg/23D post) Developmental Pharmacology and Therapeutics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.1- 1980- v. 14, p. 135, 1989 (DPTHDL); T34-T39 orl-rat TDLo: 50 mL/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-122246 (NTIS**); T19-T75 orl-rat TDLo: 390 mL/kg (2W pre-3D post) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 56, p. 156, 2000 (TOSCF2); T54 orl-mus TDLo: 30 gm/kg (15-17D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 57A, 1984 (TJADAB); T34-T39 orl-mus TDLo: 100 mL/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-122246 (NTIS**) TE: V02-K60 orl-rat TDLo: 2600 mL/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-426, 1994 (NTPTR*); V02-K60 orl-rat TDLo: 1287500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-103958 (NTIS**) AT: T/E unlistd orl-rat LD50: >100 mL/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3); T/E unlistd ipr-mus LD50: >50 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD691-490 (NTIS**) MD: P61-N61-V30 orl-rat TDLo: 2575000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-103958 (NTIS**); P30-Y01 orl-rat TDLo: 315 gm/kg/15W-C Pesticide Biochemistry and Physiology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1971- v. 14, p. 1, 1980 (PCBPBS); R25-V16 orl-rat TDLo: 240 gm/kg/60D-C Kansai Ika Daigaku Zasshi. Journal of the Kansai Medical University. (Kansai Ika Daigaku Igakkai, 1, Fumizono-cho, Moriguchi, Osaka, Japan) V.8- 1956- v. 33, p. 360, 1981 (KIDZAK); R25-V16-Y37 orl-rat TDLo: 1200 gm/kg/60D-C Kansai Ika Daigaku Zasshi. Journal of the Kansai Medical University. (Kansai Ika Daigaku Igakkai, 1, Fumizono-cho, Moriguchi, Osaka, Japan) V.8- 1956- v. 33, p. 360, 1981 (KIDZAK) ND: NOHS 1974: HZD M0850; NIS 21; TNF 769; NOS 32; TNE 19075; NOES 1983: HZD M0850; NIS 34; TNF 4529; NOS 63; TNE 154495; TFE 101949 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies (gavage) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-426, 1994 (NTPTR*) Record 684 of 1119 in RTECS (through 2003/06) AN: GN4200000 PN: Coumarin- SY: Cinnamic-acid,-o-hydroxy-,-delta-lactone-; 2H-1-Benzopyran-2-one-; 2H-1-Benzopyran,-2-oxo-; Benzo-alpha-pyrone-; 1,2-Benzopyrone-; Cumarin-; o-Hydroxycinnamic-acid-lactone-; o-Hydroxycinnamic-lactone-; o-Hydroxyzimtsaure-lacton- (German); Kumarin- (Czech); NCI-C07103-; Rattex-; Tonka-bean-camphor-; cis-o-Coumarinic-acid-lactone-; Coumarinic-anhydride-; 2-Oxo-1,2-benzopyran-; 2-Propenoic acid, 3-(2-hydroxyphenyl)-delta-lactone RN: Current: 91-64-5 BRN: 383644 BHR: 5-17-10-00143 UD: 200302 MF: C9-H6-O2 MW: 146.15 WL: T66 BOVJ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Natural-Product (N) ME: mmo-sat 1 mg/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); oms-esc 62500 ng/tube (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 445, p. 81, 1999 (MUREAV); cyt-ham-ovr 1600 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 100 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); dnd-mam-lym 20 mmol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 48, p. 686, 1962 (PNASA6); mtr-mus-fbr 1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T34 orl-mus TDLo: 3600 mg/kg (6-17D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 17, p. 97, 1967 (ARZNAD) TE: V02-M61 orl-rat TDLo: 18025 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-422, 1993 (NTPTR*); V01-J61 orl-mus TDLo: 144 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-422, 1993 (NTPTR*); V03-L60 orl-rat TD :200 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 1, p. 93, 1973 (TXCYAC); V02-L01-M61 orl-rat TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-215761 (NTIS**); V02-J60-K60 orl-mus TDLo: 25750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-215761 (NTIS**); V01-J60 orl-mus TDLo: 103000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-215761 (NTIS**) ORNG: 293000000 ng/kg. [293.000000 mg/kg] T/E unlistd AT: L14 orl-man TDLo: 87 mg/kg/17W-I Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- v. 8, p. 501, 1989 (HUTODJ); L14 orl-wmn TDLo: 30 mg/kg/30D-I Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- v. 8, p. 501, 1989 (HUTODJ); T/E unlistd orl-rat LD50: 293 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 12, p. 385, 1974 (FCTXAV); T/E unlistd orl-mus LD50: 196 mg/kg Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- v. 83, p. 1124, 1963 (YKKZAJ); F29-Y01 ipr-mus LD50: 220 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 15, p. 897, 1965 (ARZNAD); T/E unlistd scu-mus LD50: 242 mg/kg Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- v. 83, p. 1124, 1963 (YKKZAJ); F07-L30 orl-gpg LD50: 202 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV); F07 orl-mus TDLo: 100 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 837, p. 39, 2001 (FCTOD7); F07 orl-mus LD :200 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 837, 2001 (FCTOD7) MD: L70-Y03-Y10 orl-rat TDLo: 1400 mg/kg/7D-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 3, p. 457, 1965 (FCTXAV); Z01 orl-rat TDLo: 4800 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-422, 1993 (NTPTR*); L02-P71-Y15 orl-rat TDLo: 9750 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-422, 1993 (NTPTR*); L30-U01-Y16 orl-rat TDLo: 88 gm/kg/42W-C Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 9, p. 323, 1990 (HETOEA); L01-L14-P73 orl-rat TDLo: 27300 mg/kg/39W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555582 (NTIS**); Z01 orl-mus TDLo: 3600 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-422, 1993 (NTPTR*); L70-P05 orl-mus TDLo: 9750 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-422, 1993 (NTPTR*); L12-P01-Z01 orl-dog TDLo: 1900 mg/kg/19D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 118, p. 348, 1956 (JPETAB); L70-U01 orl-ham TDLo: 109 gm/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 34, p. 105, 1996 (FAATDF) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); TOXICOLOGY REVIEW Progress in Medical Chemistry. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1961- v. 10, p. 85, 1974 (PMDCAY); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 161, 1978 (MUREAV); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 277, 1979 (FCTXAV) ND: NOHS 1974: HZD 20340; NIS 14; TNF 379; NOS 39; TNE 31272; NOES 1983: HZD 20340; NIS 113; TNF 16304; NOS 99; TNE 239705; TFE 110313 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NTP Carcinogenesis studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-422, 1993 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: rat Record 685 of 1119 in RTECS (through 2003/06) AN: GO5870000 PN: Creosote,-wood- SY: Beechwood-creosote-; RCRA-waste-number-U051-; Wood-creosote- RN: Current: 8021-39-4 UD: 200210 CC: Tumorigen (C) MD: L70-U01-Z71 orl-rat TDLo: 52416 mg/kg/91D-C Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 21, p. 899, 1981 (OYYAA2); M03-M70-U01 orl-rat TDLo: 210 gm/kg/96W-C Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 28, p. 925, 1984 (OYYAA2); A70-M70-U01 orl-mus TDLo: 197 gm/kg/91D-C Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 21, p. 899, 1981 (OYYAA2) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/97/121024/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 686 of 1119 in RTECS (through 2003/06) AN: GO5950000 PN: Cresol- SY: Acede-cresylique- (French); Bacillol-; Cresol- (ACGIH:OSHA); Cresol,-mixed-isomers-; Cresoli- (Italian); Cresols-; Hydroxytoluole- (German); Kresole- (German); Kresolen- (Dutch); Krezol- (Polish); Methylphenol-; Phenol,-methyl- (9CI); RCRA-waste-number-U052-; Tekresol-; Tricresol-; Tricresol,-mixture-of-isomers-; ar-Toluenol- RN: Current: 1319-77-3 Previous: 8026-94-6 BRN: 506719 BHR: 4-06-00-02035 UD: 200210 MF: C7-H8-O MW: 108.15 WL: QR X1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Human-Data (P) ORNG: 1454000000 ng/kg. [1454.000000 mg/kg] T/E unlistd SRNG: 2000000000 ng/kg. [2000.000000 mg/kg] T/E unlistd AT: P28-P30-Y15 orl-wmn TDLo: 700 uL/kg American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- v. 16, p. 667, 1998 (AJEMEN); P23-P30 orl-man TDLo: 177 mg/kg Canadian Medical Association Journal. (Canadian Medical Assoc., POB 8650, Ottawa, ON K1G 0G8, Canada) V.1- 1911- v. 130, p. 1319, 1984 (CMAJAX); H30 orl-hmn LDLo: 114 mg/kg "Merck Index: an Encyclopedia of Chemicals, Drugs, and Biologicals", 11th ed., Rahway, NJ 07065, Merck and Co., Inc. 1989 11,404,1989 (85KYAH); T/E unlistd orl-rat LD50: 1454 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-270 (NTIS**); T/E unlistd orl-mus LD50: 760 mg/kg Kyushu Shika Gakkai Zasshi. Journal of the Kyushu Dental Society. (c/o Kyushu Shika Daigaku, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, Japan) V.1- 1933- Suspended 1941-50. v. 36, p. 932, 1982 (KSGZA3); T/E unlistd skn-rbt LD50: 2 gm/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 42, p. 417, 1977 (TXAPA9) MD: N30 ihl-rat TCLo: 4 mg/m3/4H/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 208, 1994 (VCVGK*) TR: ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD: skin 5 ppm (22 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 61, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 5 ppm (23 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 5 ppm (22 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 5 ppm (22 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 5 ppm (22 mg/m3), STEL 10 ppm (44 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (22 mg/m3), JAN 1999; OEL-JAPAN: OEL 5 ppm (22 mg/m3), JAN 1999; OEL-HUNGARY: TWA 5 mg/m3, STEL 10 mg/m3, JAN 1993; OEL-INDIA: TWA 5 ppm (22 mg/m3), Skin, JAN 1993; OEL-JAPAN: OEL 5 ppm (22 mg/m3), Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (22 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (22 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 15 mg/m3, JAN 1999; OEL-RUSSIA: TWA 5 ppm, STEL 0.5 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: MAK-W 5 ppm (22 mg/m3), KZG-W 10 ppm (44 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 5 ppm (22 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (22 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CRESOL, all isomers-air: 10H TWA 2.3 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 20380; NIS 86; TNF 8215; NOS 78; TNE 71952; NOES 1983: HZD 20380; NIS 84; TNF 7461; NOS 65; TNE 132742; TFE 28184 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110732/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Cresol (all isomers) and phenol, 2546; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NTP Toxicity studies, RPT# TOX-09, October 2000; OSHA ANALYTICAL METHOD #32 Record 687 of 1119 in RTECS (through 2003/06) AN: GO6125000 PN: m-Cresol- SY: 1-Hydroxy-3-methylbenzene-; 3-Cresol-; 3-Hydroxytoluene-; 3-Methylphenol-; MPCRE); Mixture of meta and para-cresol (59%:41%; Phenol,-3-methyl- (9CI); RCRA-waste-number-U052-; m-Cresol- (ACGIH:OSHA); m-Cresole-; m-Cresylic-acid-; m-Hydroxytoluene-; m-Kresol-; m-Methylphenol-; m-Oxytoluene-; m-Toluol-; o-Cresol- RN: Current: 108-39-4 UD: 200210 MF: C7-H8-O MW: 108.15 WL: QR C1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 517 mg/24H SEV BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 3-5/1969 (BIOFX*); eye-rbt 103 mg SEV BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 3-5/1969 (BIOFX*) ME: dni-hmn-hla 10 umol/L/4H Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 32, p. 220, 1984 (BECTA6) RE: T34 scu-rbt TDLo: 134 gm/kg (6-18D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 16, p. 1191, 1978 (OYYAA2); T26 orl-rat TDLo: 2100 mg/kg (multigeneration) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 198, 1992 (TOXID9); T81 orl-rat TDLo: 1400 mg/kg (multigeneration) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 198, 1992 (TOXID9) TE: V02-R60 skn-mus TDLo: 2280 mg/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 19, p. 413, 1959 (CNREA8) ORNG: 242000000 ng/kg. [242.000000 mg/kg] F07-F12-K17 SRNG: 2050000000 ng/kg. [2050.000000 mg/kg] D17-F12-K01 SKNG: 1100000000 ng/kg. [1100.000000 mg/kg] T/E unlistd AT: F07-F12-K17 orl-rat LD50: 242 mg/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 3-5/1969 (BIOFX*); T/E unlistd ihl-rat LC50: >710 mg/m3/1H BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 3-5/1969 (BIOFX*); T/E unlistd skn-rat LD50: 1100 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(2), p. 58, 1974 (GTPZAB); T/E unlistd scu-rat LDLo: 900 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 56, 1959 (HBTXAC); T/E unlistd orl-mus LD50: 828 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(2), p. 58, 1974 (GTPZAB); T/E unlistd ipr-mus LD50: 168 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 56, 1959 (HBTXAC); T/E unlistd scu-mus LDLo: 450 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK); T/E unlistd unr-mus LD50: 600 mg/kg Gigiena Truda i Professional'naya Patologiya v Estonskoi SSR. Labor Hygiene and Occupational Pathology in the Estonian SSR. (Institut Eksperimental'noi i Klinicheskoi Meditsiny Ministerstva Zdravookhraneniya Estonskoi SSR, Tallinn, USSR) V.8- 1972- v. 8, p. 145, 1972 (GTPPAF); T/E unlistd ivn-dog LDLo: 150 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 56, 1959 (HBTXAC); T/E unlistd scu-cat LDLo: 180 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); T/E unlistd orl-rbt LDLo: 1400 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); D17-F12-K01 skn-rbt LD50: 2050 mg/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 3-5/1969 (BIOFX*); T/E unlistd scu-rbt LDLo: 500 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK); T/E unlistd ivn-rbt LDLo: 280 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); T/E unlistd ipr-gpg LDLo: 100 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK); T/E unlistd scu-gpg LDLo: 300 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 56, 1959 (HBTXAC); T/E unlistd scu-frg LDLo: 250 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK); M14-R03 orl-rat LD50: 825 mg/kg Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 9, p. 108, 1995 (WDZAEK) MD: A70-L70-M70 orl-rat TDLo: 42 gm/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-174242 (NTIS**); A70-M70-U01 orl-mus TDLo: 101 gm/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-174242 (NTIS**); M30-Y04-Y21 ihl-rbt TCLo: 2 mg/m3/24H/6W-I Voprosy Meditsinskoi Khimii. Problems of Medical Chemistry. (V/O Me zhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1955- v. 24, p. 151, 1978 (VMDKAM) TR: ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 75, 1978 (MUREAV) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 5 ppm (22 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 61, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-DENMARK: TWA 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (22 mg/m3), JAN 1999; OEL-JAPAN: OEL 5 ppm (22 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (22 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 5 ppm (22 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO m-CRESOL-air: 10H TWA 2.3 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84497; NIS 16; TNF 1317; NOS 20; TNE 11161; NOES 1983: HZD 84497; NIS 5; TNF 144; NOS 11; TNE 5615; TFE 1174 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Cresol (all isomers) and phenol, 2546; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NTP Toxicity studies, RPT# TOX-09, October 2000 Record 688 of 1119 in RTECS (through 2003/06) AN: GO6300000 PN: o-Cresol- SY: 1-Hydroxy-2-methylbenzene-; 2-Cresol-; 2-Hydroxytoluene-; 2-Methylphenol-; Orthocresol-; Phenol,-2-methyl- (9CI); RCRA-waste-number-U052-; m-Cresol-; o-Cresol- (ACGIH:OSHA); o-Cresylic-acid-; o-Hydroxytoluene-; o-Kresol- (German); o-Methylphenol-; o-Methylphenylol-; o-Oxytoluene-; o-Toluol- RN: Current: 95-48-7 UD: 200305 MF: C7-H8-O MW: 108.15 WL: QR B1 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 524 mg/24H SEV BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 4-5/1969 (BIOFX*); eye-rbt 105 mg SEV BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 4-5/1969 (BIOFX*) ME: sce-hmn-fbr 8 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 137, p. 51, 1984 (MUREAV) RE: T16 orl-mus TDLo: 2.31 gm/kg (7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-176890 (NTIS**); T81 orl-mus TDLo: 660 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-176890 (NTIS**) TE: V02-R60 skn-mus TDLo: 4800 mg/kg/12W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 19, p. 413, 1959 (CNREA8) ORNG: 121000000 ng/kg. [121.000000 mg/kg] F12-J22-K06 SRNG: 890000000 ng/kg. [890.000000 mg/kg] T/E unlistd SKNG: 620000000 ng/kg. [620.000000 mg/kg] T/E unlistd AT: F12-J22-K06 orl-rat LD50: 121 mg/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 4-5/1969 (BIOFX*); D17-F07 ihl-rat LC50: >1220 mg/m3/1H BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 4-5/1969 (BIOFX*); T/E unlistd skn-rat LD50: 620 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(2), p. 58, 1974 (GTPZAB); D15-F13-J15 scu-rat LDLo: 65 mg/kg Revue Medicale de la Suisse Romande. (Societe Medicale de La Suisse Romande, 2 rue Bellefontaine, 1003 Lausanne, Switzerland) V.1- 1881- v. 15, p. 561, 1895 (RMSRA6); T/E unlistd orl-mus LD50: 344 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(2), p. 58, 1974 (GTPZAB); T/E unlistd ihl-mus LC50: 179 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,40,1982 (85GMAT); T/E unlistd ipr-mus LDLo: 200 mg/kg Revue Belge de Pathologie et de Medecine Experimentale. (Brussels, Belgium) V.18-31, 1947-65. For publisher information, see PTEUA6. v. 22, p. 1, 1952 (RBPMAZ); T/E unlistd scu-mus LDLo: 410 mg/kg Zeitschrift fuer Hygiene und Infektionskrankheiten. (Berlin, Fed. Rep. Ger.) V.11-151, 1892-1965. For publisher information, see MMIYAO. v. 64, p. 113, 1909 (ZHINAV); T/E unlistd ivn-dog LDLo: 80 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 57, 1959 (HBTXAC); T/E unlistd scu-cat LDLo: 55 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); T/E unlistd orl-rbt LDLo: 940 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); T/E unlistd skn-rbt LD50: 890 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 42, p. 417, 1977 (TXAPA9); T/E unlistd scu-rbt LDLo: 450 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK); T/E unlistd ivn-rbt LDLo: 180 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); T/E unlistd ipr-gpg LDLo: 720 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK); D15-F13-J15 scu-gpg LDLo: 35 mg/kg Revue Medicale de la Suisse Romande. (Societe Medicale de La Suisse Romande, 2 rue Bellefontaine, 1003 Lausanne, Switzerland) V.1- 1881- v. 15, p. 561, 1895 (RMSRA6); T/E unlistd scu-frg LDLo: 200 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK) MD: L70-M70 orl-rat TDLo: 21 gm/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-174242 (NTIS**); L70-M70-N74 orl-rat TDLo: 82 gm/kg/13W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-174242 (NTIS**); A70-L70-U01 orl-mus TDLo: 101 gm/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-174242 (NTIS**); A70-N74-Z73 orl-mus TDLo: 218 gm/kg/13W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-174242 (NTIS**); L70 orl-mam TDLo: 1169 mg/kg/28D-C Environmental Toxicology and Chemistry. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1982- v. 5, p. 713, 1986 (ETOCDK); M71 orl-mus TDLo: 18480 mg/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-176890 (NTIS**) TR: ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 75, 1978 (MUREAV) SR: MSHA STANDARD-air: TWA 5 ppm (22 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 61, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-DENMARK: TWA 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (22 mg/m3), JAN 1999; OEL-JAPAN: OEL 5 ppm (22 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (22 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 5 ppm (22 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO o-CRESOL-air: 10H TWA 2.3 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84364; NIS 26; TNF 1724; NOS 28; TNE 14550; NOES 1983: HZD 84364; NIS 16; TNF 1707; NOS 24; TNE 10985; TFE 483 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Cresol (all isomers) and phenol, 2546; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NTP Toxicity studies, RPT# TOX-09, October 2000 Record 689 of 1119 in RTECS (through 2003/06) AN: GO6475000 PN: p-Cresol- SY: 4-Cresol-; p-Cresylic-acid-; 1-Hydroxy-4-methylbenzene-; p-Hydroxytoluene-; 4-Hydroxytoluene-; p-Kresol-; p-Methylhydroxybenzene-; 1-Methyl-4-hydroxybenzene-; p-Methylphenol-; 4-Methylphenol-; Paramethyl-phenol-; RCRA-waste-number-U052-; p-Toluol-; p-Tolyl-alcohol-; p-Cresol- (ACGIH:OSHA); p-Oxytoluene-; para-Cresol-; Phenol,-4-methyl- (9CI) RN: Current: 106-44-5 UD: 200210 MF: C7-H8-O MW: 108.15 WL: QR D1 CC: Tumorigen (C); Drug (D); Mutagen (M); Natural-Product (N); Primary-Irritant (S) ID: skn-rbt 517 mg/24H SEV BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 5-5/1969 (BIOFX*); eye-rbt 103 mg SEV BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 5-5/1969 (BIOFX*) ME: dni-hmn-lym 25 umol/L Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 54, p. 133, 1986 (RCOCB8); dni-ham-lng 150 umol/L Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 4, p. 151, 1991 (CRTOEC); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V02-R60 skn-mus TDLo: 2280 mg/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 19, p. 413, 1959 (CNREA8) ORNG: 207000000 ng/kg. [207.000000 mg/kg] D07-F12-K06 SRNG: 301000000 ng/kg. [301.000000 mg/kg] F11-K01-M30 SKNG: 750000000 ng/kg. [750.000000 mg/kg] T/E unlistd AT: D07-F12-K06 orl-rat LD50: 207 mg/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 5-5/1969 (BIOFX*); T/E unlistd ihl-rat LC50: >710 mg/m3/1H BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 5-5/1969 (BIOFX*); T/E unlistd skn-rat LD50: 750 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(2), p. 58, 1974 (GTPZAB); T/E unlistd scu-rat LDLo: 500 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 58, 1959 (HBTXAC); T/E unlistd unr-rat LD50: 1440 mg/kg Gigiena Truda i Professional'naya Patologiya v Estonskoi SSR. Labor Hygiene and Occupational Pathology in the Estonian SSR. (Institut Eksperimental'noi i Klinicheskoi Meditsiny Ministerstva Zdravookhraneniya Estonskoi SSR, Tallinn, USSR) V.8- 1972- v. 8, p. 145, 1972 (GTPPAF); T/E unlistd orl-mus LD50: 344 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(2), p. 58, 1974 (GTPZAB); T/E unlistd ipr-mus LD50: 25 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 58, 1959 (HBTXAC); T/E unlistd scu-mus LDLo: 150 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK); T/E unlistd unr-mus LD50: 160 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 6, p. 160, 1952 (BJCAAI); T/E unlistd scu-cat LDLo: 80 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); T/E unlistd orl-rbt LDLo: 620 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); F11-K01-M30 skn-rbt LD50: 301 mg/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 5-5/1969 (BIOFX*); T/E unlistd scu-rbt LDLo: 300 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK); T/E unlistd ivn-rbt LDLo: 180 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 233, 1944 (JPETAB); T/E unlistd scu-gpg LDLo: 200 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 58, 1959 (HBTXAC); T/E unlistd scu-frg LDLo: 150 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1361, 1935 (HBAMAK) MD: L70-M70 orl-rat TDLo: 21 gm/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-174242 (NTIS**); G70-L70-M70 orl-rat TDLo: 33600 mg/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-174242 (NTIS**) TR: ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 75, 1978 (MUREAV) SR: MSHA STANDARD-air: TWA 5 ppm (22 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 61, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-DENMARK: TEA 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (22 mg/m3), JAN 1999; OEL-JAPAN: OEL 5 ppm (22 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (22 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 5 ppm (22 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO p-CRESOL-air: 10H TWA 2.3 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84266; NIS 48; TNF 4394; NOS 34; TNE 33253; NOES 1983: HZD 84266; NIS 8; TNF 1057; NOS 14; TNE 21313; TFE 16798 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: p-Cresol in urine, 8305; NIOSH Analytical Method, 1994: Cresol (all isomers) and phenol, 2546; NTP Toxicity studies, RPT# TOX-09, October 2000 Record 690 of 1119 in RTECS (through 2003/06) AN: GO7175000 PN: o-Cresol,-4-chloro-alpha-phenyl- SY: 4-Chloro-alpha-phenyl-o-cresol-; 4-Chloro-2-(phenylmethyl)phenol; Clorofene-; Clorophene-; Benzylchlorophenol-; o-Benzyl-p-chlorophenol-; 2-Benzyl-4-chlorophenol-; Bio-Clave-; 5-Chloro-2-hydroxydiphenylmethane-; Chlorophene-; Ketolin-H-; NCI-C61201-; Neosabenyl-; Santophen-; Santophen-1-; Santophen-1-flake-; Santophen-1-solution-; Santophen-I-; Santophen-I-germicide-; Septiphene-; Orthobenzyl-p-chlorophenol-; Orthobenzylparachlorophenol-; Phenol, 4-chloro-2-(phenylmethyl)- (9CI) RN: Current: 120-32-1 BRN: 1959194 BHR: 4-06-00-04636 UD: 200302 MF: C13-H11-Cl-O MW: 218.69 WL: QR DG B1R CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ID: skn-hmn 1%/48H MLD Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975- v. 14, p. 247, 1986 (CODEDG) ME: msc-hmn-lym 40 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 196, p. 61, 1988 (MUREAV); msc-mus-lym 25 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 196, p. 61, 1988 (MUREAV) TE: V03-M61 orl-rat TDLo: 87600 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-424, 1994 (NTPTR*); V02-M61 orl-mus TDLo: 175 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-424, 1994 (NTPTR*); V03-R60 skn-mus TDLo: 14 gm/kg/34W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 19, p. 413, 1959 (CNREA8); V01-M61 orl-mus TDLo: 123600 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-214202 (NTIS**) ORNG: 1700000000 ng/kg. [1700.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1700 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 63, p. 1068, 1974 (JPMSAE); T/E unlistd ihl-rat LC :>13200 mg/m3/6H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520434 (NTIS**); F07-F12-J22 orl-mus LD50: 65 mg/kg Pharmacology and Toxicology. English translation of FATOAO. (New York, NY) V.20-22, 1957-59. Discontinued. v. 22, p. 270, 1959 (PHTXA6); F07-F12-J22 scu-mus LD50: 350 mg/kg Pharmacology and Toxicology. English translation of FATOAO. (New York, NY) V.20-22, 1957-59. Discontinued. v. 22, p. 270, 1959 (PHTXA6); T/E unlistd orl-rbt LDLo: 620 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0518161 (NTIS**); F18-L15-P27 skn-rbt LDLo: 5010 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520434 (NTIS**); T/E unlistd orl-gpg LDLo: 3 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520317 (NTIS**) MD: M03-M70 orl-rat TDLo: 43680 mg/kg/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 27, p. 252, 1995 (FAATDF); M04-U01 orl-rat TDLo: 12 gm/kg/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 615, 1986 (FAATDF); M70-N74-P28 orl-rat TDLo: 31200 mg/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 615, 1986 (FAATDF); M04 orl-mus TDLo: 12 gm/kg/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 615, 1986 (FAATDF); L70-M70 orl-mus TDLo: 42250 mg/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 615, 1986 (FAATDF); M03-M70-U01 orl-mus TDLo: 87360 mg/kg/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 27, p. 252, 1995 (FAATDF); R03-Z01 skn-rbt TDLo: 80 mL/kg/2W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0518161 (NTIS**) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 11610; NIS 98; TNF 11150; NOS 56; TNE 236872; NOES 1983: HZD 11610; NIS 59; TNF 8083; NOS 71; TNE 347634; TFE 244212 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9188, 8EHQ-0892-9200; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-8880, 8EHQ-0892-9226; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9239, 8EHQ-0892-9264; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies (gavage), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-424, 1994 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 691 of 1119 in RTECS (through 2003/06) AN: GP3150000 PN: m-Cresol, 4,4'-thiobis(6-tert-butyl- SY: 1,1'-Thiobis(2-methyl-4-hydroxy-5-tert-butylbenzene); 4,4'-Thiobis-; 4,4'-Thiobis(2-(1,1-dimethylethyl)-5-methylphenol); 4,4'-Thiobis(2-tert-butyl-5-methylphenol); 4,4'-Thiobis(3-methyl-6-tert-butylphenol); 4,4'-Thiobis(6-tert-butyl-3-methylphenol); 4,4'-Thiobis(6-tert-butyl-m-cresol); 4,4'-Thiobis(6-tert-butyl-m-cresol) (ACGIH,OSHA); AO-4-; Antage-Crystal-; Antioxidant-AO-; Antioxidant-TMB-6-; Bis(3-tert-butyl-4-hydroxy-6-methylphenyl) sulfide; Bis(4-hydroxy-5-tert-butyl-2-methylphenyl) sulfide; Disperse-MB-61-; Nocrac-300-; Nonflex-BPS-; Phenol, 4,4'-thiobis(2-(1,1-dimethylethyl)-5-methyl- (9CI); Santonox-; Santonox-BM-; Santonox-R-; Santowhite-crystals-; Santox-; Sumilizer-WX-; Sumilizer-WX-R-; Thioalkofen-BM-4-; Thioalkofen-BMCH-; Thioalkofen-MBCH-; Thioalkophene-BM-4-; USAF-B-15-; Yoshinox-S-; Yoshinox-SR- RN: Current: 96-69-5 BRN: 1147776 BHR: 4-06-00-06043 UD: 200210 MF: C22-H30-O2-S MW: 358.58 WL: 1X1&1&R BQ D1 ESR DQ B1 EX1&1&1 CC: Tumorigen (C) ORNG: 2345000000 ng/kg. [2345.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2345 mg/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3); T/E unlistd ipr-mus LD50: 50 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd orl-rbt LD50: 3200 mg/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3) MD: K06-M03-P72 orl-rat TDLo: 5475 mg/kg/15D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-435, 1994 (NTPTR*); L70-P05-Y03 orl-rat TDLo: 15015 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-435, 1994 (NTPTR*); L70-N73-Y07 orl-mus TDLo: 1400 mg/kg/14D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 10, p. 691, 1988 (FAATDF); L70-N73 orl-mus TDLo: 5915 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-435, 1994 (NTPTR*) TR: ACGIH TLV-TWA 10 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: OSHA PEL (Gen Indu): 8H TWA 15 mg/m3, total dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Gen Indu): 8H TWA 5 mg/m3, respirable fraction Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 15 mg/m3, total dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 mg/m3, respirable fraction Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 15 mg/m3, total dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 mg/m3, respirable fraction Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OEL-DENMARK: TWA 10 mg/m3, JAN 1999; OEL-FRANCE: VME 10 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 10 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 10 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 10 mg/m3, STEL 20 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 4,4'-THIOBIS(6-t-BUTYL-m-CRESOL), dust-air: TWA 10 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NIOSH REL TO 4,4'-THIOBIS(6-t-BUTYL-m-CRESOL)-air: 10H TWA 5 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84755; NIS 51; TNF 4402; NOS 47; TNE 36695; NOES 1983: HZD 84755; NIS 10; TNF 1286; NOS 11; TNE 12349; TFE 2177 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9277, 8EHQ-0892-9283; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 692 of 1119 in RTECS (through 2003/06) AN: GR8575000 PN: Cumene- SY: Cumeen- (Dutch); Benzene,-isopropyl-; Benzene, (1-methylethyl)- (9CI); 2-Fenilpropano- (Italian); 2-Fenyl-propaan- (Dutch); Isopropylbenzeen- (Dutch); Isopropilbenzene- (Italian); Isopropyl-benzene-; Isopropylbenzol-; Isopropyl-benzol- (German); (1-Methylethyl)benzene; 2-Phenylpropane-; RCRA-waste-number-U055-; Cumene- (ACGIH:OSHA); Cumol-; Propane,-2-phenyl- RN: Current: 98-82-8 UD: 200210 MF: C9-H12 MW: 120.21 WL: 1Y1&R CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 10 mg/24H open MLD AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); skn-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,33,1986 (85JCAE); eye-rbt 86 mg MLD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,33,1986 (85JCAE) ME: mmo-sat 100 ug/plate/3H (-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 1, 2002 (FCTOD7) ORNG: 1400000000 ng/kg. [1400.000000 mg/kg] K05 SRNL: 12300000 nL/kg. [12.300000 mL/kg] T/E unlistd AT: F07-F25-F33 ihl-hmn TCLo: 200 ppm "Handbook of Organic Industrial Solvents," 2nd ed., Chicago, National Assoc. of Mutual Casualty Companies, 1961 v. 2, p. 39, 1961 (TGNCDL); K05 orl-rat LD50: 1400 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); T/E unlistd ihl-rat LCLo: 8000 ppm/4H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); T/E unlistd orl-mus LD50: 12750 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 36(9), p. 18, 1971 (GISAAA); L50-M04-P27 ihl-mus LC50: 10 gm/m3/7H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 26, p. 264, 1944 (JIHTAB); T/E unlistd skn-rbt LD50: 12300 uL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC) MD: D35-F17-P08 ihl-rat TCLo: 1200 ppm/6H/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0522342 (NTIS**); M71 orl-rbt TDLo: 89628 mg/kg/194D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 169, 1990 (VCVGH*); J15-P01-P72 ihl-rbt TCLo: 10000 mg/m3/2H/24W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 170, 1990 (VCVGH*); F07 ihl-mus TCLo: 2000 mg/m3/14W-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 170, 1990 (VCVGH*) TR: ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: MSHA STANDARD-air: TWA 50 ppm (245 mg/m3) (skin) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 14, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 50 ppm (245 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 50 ppm (245 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 50 ppm (245 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 50 ppm (245 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 50 ppm (245 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 50 ppm (245 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 50 ppm (246 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 25 ppm (120 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 50 ppm (245 mg/m3), STEL 75 ppm (370 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 50 ppm (245 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 50 ppm (245 mg/m3), Skin, JAN 1999; OEL-HUNGARY: TWA 80 mg/m3, STEL 100 mg/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 25 ppm (120 mg/m3), MAC-K 70 ppm, Skin, JAN 1999; OEL-NORWAY: TWA 25 ppm (125 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 50 ppm (245 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 350 mg/m3, JAN 1999; OEL-RUSSIA: STEL 50 mg/m3, JAN 1993; OEL-SWEDEN: NGV 25 ppm (120 mg/m3), KTV 35 ppm (170 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (245 mg/m3), Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 25 ppm (125 mg/m3), STEL 75 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CUMENE-air: 10H TWA 50 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 20850; NIS 2; TNF 24; NOS 8; TNE 669; NOES 1983: HZD 20850; NIS 15; TNF 1199; NOS 24; TNE 14268; TFE 2760 SL: EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test, S cerevisiae-homozygosis; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrocarbons, aromatic, 1501; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 693 of 1119 in RTECS (through 2003/06) AN: GS2169000 PN: Cuprate(4-), (mu-((3,3'-((3,3'-dihydroxy(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis(5-amino-4- hydroxy-2,7-naphthalenedisulfonato))(8-)))di-, tetrasodium SY: Amanil-Supra-Blue-9GL-; C.I. 24401; C.I. Direct Blue 218; Fastusol-Blue-9GLP-; NCI-C60877-; Pontamine-Bond-Blue-B-; Pontamine-Fast-Blue-7GLN-; Solantine-Blue-10GL- RN: Current: 28407-37-6 Previous: 10401-50-0 UD: 200302 MF: C32-H16-Cu2-N6-O16-S4.4 Na MW: 1087.82 WL: L66J BQ DSWO HSWO CNUNR BQ DR CQ DNUN- CL66J DSWO HSWO &-NA- 4 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1 mg/plate (+S9) Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 22, p. 413, 1980 (VHTODE) TE: V02-J60 orl-rat TDLo: 438 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-430, 1994 (NTPTR*); V01-L60 orl-mus TDLo: 876 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-430, 1994 (NTPTR*); V03-K60 orl-rat TDLo: 86520 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-215993 (NTIS**); V01-L60 orl-mus TDLo: 1095920 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-215993 (NTIS**); V01-L60 orl-mus TDLo: 1478050 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-215993 (NTIS**) ORNG: 3290000000 ng/kg. [3290.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 3290 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*); T/E unlistd orl-rbt LDLo: 3920 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*); T/E unlistd skn-rbt LDLo: 8 gm/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*) MD: G70-N74-U01 orl-rat TDLo: 25200 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-430, 1994 (NTPTR*); L30-M70-P08 orl-rat TDLo: 45500 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-430, 1994 (NTPTR*); G70-L70-N74 orl-mus TDLo: 50 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-430, 1994 (NTPTR*); U01 orl-mus TDLo: 109 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-430, 1994 (NTPTR*) ND: NOHS 1974: HZD M2161; NIS 4; TNF 60; NOS 9; TNE 2461; NOES 1983: HZD M2161; NIS 10; TNF 530; NOS 13; TNE 12290; TFE 4390 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: mouse; NTP Carcinogenesis studies (feed), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-430, 1994 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: rat Record 694 of 1119 in RTECS (through 2003/06) AN: GS3774080 PN: Curcuma-oil- SY: Curcuma-longa-oils-; Oil-of-turmeric-; Oils,-curcuma-; Turmeric-oil-; Turmeric-oleoresin- RN: Current: 8024-37-1 UD: 200302 CC: Tumorigen (C); Mutagen (M); Natural-Product (N); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 839, 1983 (FCTOD7) ME: cyt-hmn-lym 6 mg/L Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 9, 1976 (FCTXAV); cyt-mus-oth 50 mg/L/4H-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 9, 1976 (FCTXAV); dni-ham-fbr 10 mg/L Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 9, 1976 (FCTXAV); cyt-ham-fbr 50 mg/L/4H-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 9, 1976 (FCTXAV); cyt-mam-oth 10 mg/L/4H Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 9, 1976 (FCTXAV) TE: V03-T69 orl-rat TDLo: 72800 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-427, 1993 (NTPTR*); V03-K60-L60 orl-mus TDLo: 437 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-427, 1993 (NTPTR*); V03-T69 orl-rat TDLo: 64890 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-184173 (NTIS**); V02-L60 orl-mus TDLo: 374920 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-184173 (NTIS**); V02-L60 orl-mus TDLo: 1168020 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-184173 (NTIS**) AT: T/E unlistd orl-rat LD50: >5 gm/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 839, 1983 (FCTOD7); T/E unlistd skn-rbt LD50: >5 gm/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 839, 1983 (FCTOD7) MD: L70-P30 orl-rat TDLo: 27300 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-427, 1993 (NTPTR*); L70 orl-mus TDLo: 13650 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-427, 1993 (NTPTR*); L70-N75 orl-pig TDLo: 6120 mg/kg/15W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 23, p. 967, 1985 (FCTOD7) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), equivocal evidence: mouse, rat; NTP Carcinogenesis studies (feed), equivocal evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-427, 1993 (NTPTR*) Record 695 of 1119 in RTECS (through 2003/06) AN: GT2275000 PN: Cyanogen-chloride- SY: Chlorcyan-; Chlorine-cyanide-; Chlorocyan-; Chlorocyanide-; Chlorocyanogen-; Chlorure-de-cyanogene- (French); Cyanogen-chloride- (ACGIH); RCRA-waste-number-P033- RN: Current: 506-77-4 BRN: 969190 BHR: 4-03-00-00090 UD: 200302 MF: C-Cl-N MW: 61.47 WL: G CN CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Human-Data (P) AT: D17-D25-J16 ihl-hmn TCLo: 10 mg/m3 World Health Organization, Technical Report Series. (WHO, 1211 Geneva, 27, Switzerland) No.1- 1950- v. -, p. 31, 1970 (WHOTAC); R10 ihl-man TCLo: 2 gm/m3 National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd scu-dog LDLo: 5 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1341, 1935 (HBAMAK); T/E unlistd unr-dog LD50: 3300 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd orl-cat LD50: 6 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd scu-rbt LDLo: 20 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1341, 1935 (HBAMAK); T/E unlistd unr-rbt LD50: 3150 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd scu-pgn LDLo: 8700 ug/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1341, 1935 (HBAMAK); T/E unlistd unr-dom LD50: 2970 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**) TR: ACGIH TLV-CL 0.3 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: OEL-AUSTRALIA: TWA 0.3 ppm (0.6 mg/m3), JAN 1993; OEL-BELGIUM: STEL 0.3 ppm (0.75 mg/m3), JAN 1993; OEL-DENMARK: TWA 0.1 ppm (0.3 mg/m3), JAN 1999; OEL-FINLAND: STEL 0.1 ppm (0.3 mg/m3), Skin, JAN 1999; OEL-FRANCE: VLE 0.3 ppm (0.6 mg/m3), JAN 1999; OEL-GERMANY: No MAK Established, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.3 ppm (0.6 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.25 ppm (0.6 mg/m3), JAN 1999; OEL-SWEDEN: NGV 0.1 ppm (0.3 mg/m3), KTV 0.3 ppm (0.8 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 0.3 ppm (0.8 mg/m3), JAN 1999; OEL-UNITED KINGDOM: STEL 0.3 ppm (0.77 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CYANOGEN CHLORIDE-air: CL 0.3 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #95-121, 1995 (NIOSH*); NOHS 1974: HZD 84337; NIS 1; TNF 34; NOS 1; TNE 134; NOES 1983: HZD 84337; NIS 1; TNF 4; NOS 16; TNE 1391 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101207/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9033; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 696 of 1119 in RTECS (through 2003/06) AN: GV3150000 PN: Cyclohexane,-1,2,3,4,5,6-hexachloro- SY: 1,2,3,4,5,6-Hexachlorocyclohexane-; BHC-; Benzene-hexachloride-; ENT-8,601-; HCH-; Hexachlorocyclohexane-; Hexachlorocyclohexane-technical-; Latka-666- (Czech) RN: Current: 608-73-1 BRN: 1907331 BHR: 2-05-00-00011 UD: 200302 MF: C6-H6-Cl6 MW: 290.82 WL: L6TJ AG BG CG DG EG FG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-omi 100 mg/L (-S9) Microbios Letters. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1976- v. 5, p. 103, 1977 (MILEDM); mmo-omi 100 mg/L (-S9) Microbios Letters. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1976- v. 5, p. 103, 1977 (MILEDM); mtr-rat-orl 875 mg/kg/7W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 479, 1984 (CRNGDP) RE: T02 orl-rat TDLo: 8100 mg/kg (90D male) Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 52, p. 12, 1983 (APTOA6); T01 orl-mus TDLo: 9120 mg/kg (22W male) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 26, p. 508, 1981 (BECTA6); T02 orl-mus TDLo: 5460 mg/kg (91D male) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 23, p. 431, 1979 (BECTA6) TE: V01-L60-P60 orl-mus TDLo: 6720 mg/kg/80W-C Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 14, p. 305, 1979 (JPFCD2); V03-L60-P60 skn-mus TDLo: 1600 mg/kg/80W-I Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 14, p. 305, 1979 (JPFCD2); V03-L60-P60 orl-mus TD :800 mg/kg/80W-I Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 14, p. 305, 1979 (JPFCD2); V01-L60 orl-mus TD :12600 mg/kg/30W-C Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 99, p. 143, 1981 (JCROD7); V01-L60 orl-mus TD :12960 mg/kg/26W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 279, 1972 (CMSHAF); V01-L60 orl-mus TD :21600 mg/kg/52W-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 69, p. 383, 1983 (TUMOAB); V02-L60 orl-mus TD :5400 mg/kg/13W-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 69, p. 383, 1983 (TUMOAB); V03-L60 orl-mus TD :7200 mg/kg/17W-C Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 19, p. 1159, 1981 (IJEBA6); V03-L60 orl-mus TD :9 gm/kg/21W-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 37, p. 156, 1982 (AEHLAU); V03-L60 orl-mus TD :10800 mg/kg/26W-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 37, p. 156, 1982 (AEHLAU); V03-L60 orl-mus TD :7200 mg/kg/17W-C Cellular and Molecular Biology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.22- 1977- v. 27, p. 231, 1981 (CMBID4); V03-L60 orl-mus TD :10800 mg/kg/26W-C Cellular and Molecular Biology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.22- 1977- v. 27, p. 231, 1981 (CMBID4) ORNG: 100000000 ng/kg. [100.000000 mg/kg] T/E unlistd SKNG: 900000000 ng/kg. [900.000000 mg/kg] T/E unlistd IHNG: 690000000 ng/m3/4H. [690.000000 mg/m3/4H] T/E unlistd AT: F27-K13-U25 ihl-man TCLo: 400 ug/kg/3D Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 49(10), p. 26, 1984 (GISAAA); T/E unlistd orl-rat LD50: 100 mg/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 22, p. 115, 1966 (ATXKA8); T/E unlistd ihl-rat LC50: 690 mg/m3/4H Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 56(2), p. 80, 1991 (GISAAA); T/E unlistd skn-rat LD50: 900 mg/kg "Wirksubstanzen der Pflanzenschutz und Schadlingsbekampfungsmittel," Perkow, W., Berlin, Verlag Paul Parey, 1971-1976 -,-,1971/1976 (85DPAN); T/E unlistd orl-mus LD50: 59 mg/kg Pesticide Manual. (The British Crop Protection Council, 20 Bridport Rd., Thornton Heath CR4 7QG, UK) V.1- 1968- v. 9, p. 452, 1991 (PEMNDP); T/E unlistd scu-rbt LD50: 75 mg/kg U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1950- v. 414, p. 273, 1955 (XPHPAW); T/E unlistd orl-gpg LDLo: 1400 mg/kg Medizinische Monatsschrift. (Stuttgart, Fed. Rep. Ger.) V.1-31, 1947-77. v. 4, p. 25, 1950 (MEMOAQ); C08-F12-F19 orl-ckn LD50: 597 mg/kg Poultry Science. (Poultry Science Assoc., Inc., 309 W. Clark St., Champaign, IL 61820) V.1- 1921- v. 60, p. 2599, 1981 (POSCAL); T/E unlistd orl-qal LD50: 120 mg/kg Pesticide Manual. (The British Crop Protection Council, 20 Bridport Rd., Thornton Heath CR4 7QG, UK) V.1- 1968- v. 9, p. 452, 1991 (PEMNDP); T/E unlistd orl-bwd LD50: 56 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 315, 1972 (TXAPA9) MD: L30-N30-Y15 orl-rat TDLo: 2500 mg/kg/90D-C Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 19, p. 1163, 1981 (IJEBA6); L30-M30-Y40 orl-mus TDLo: 750 mg/kg/15D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 41, p. 822, 1988 (BECTA6); D20-U01-U02 ipr-rbt TDLo: 650 mg/kg/65W-I Journal of Toxicology, Cutaneous and Ocular Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1982- v. 6, p. 161, 1987 (JTOTDO); L03-M30-Y20 skn-gpg TDLo: 3 gm/kg/30D-I Journal of Toxicology, Cutaneous and Ocular Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1982- v. 11, p. 3, 1992 (JTOTDO); N16-T01-Y20 skn-rat TDLo: 6000 mg/kg/120D-I Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 14, p. 484, 1995 (HETOEA); F11-L01-Z01 orl-rat TDLo: 2259 mg/kg/90D-C Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 75, 2001 (JAPTO*); L01-P20-Y20 orl-rat TDLo: 4500 mg/kg/90D-C Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 75, 2001 (JAPTO*); L30-L60-L70 orl-mus TDLo: 13104 mg/kg/26W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 279, 1972 (CMSHAF) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 5, p. 47, 1974 (IMEMDT); TOXICOLOGY REVIEW Annals of Applied Biology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1914- v. 35, p. 505, 1948 (AABIAV); TOXICOLOGY REVIEW Economie et Medecine Animales. (Paris, France) V.1-17, 1960-76. Discontinued. v. 14, p. 141, 1973 (ECMAAI) SR: OEL-AUSTRALIA: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-BELGIUM: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-DENMARK: TWA 0.5 mg/m3, Skin, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.5 mg/m3, Skin, JAN 1993; OEL-GERMANY: MAK 0.5 mg/m3, Skin, JAN 1999; OEL-HUNGARY: TWA 0.5 mg/m3, STEL 0.1 mg/m3, Skin, JAN 1993; OEL-POLAND: MAC(TWA) 0.05 mg/m3, MAC(STEL) 0.4 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.05 mg/m3, Skin, JAN 1993; OEL-RUSSIA: STEL 0.1 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: MAK-W 0.5 mg/m3, Skin, JAN 1999; OEL-UNITED KINGDOM: LTEL 0.5 mg/m3, STEL 1.5 mg/m3, Skin, JAN 1993 SL: EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 697 of 1119 in RTECS (through 2003/06) AN: GV3500000 PN: Cyclohexane,-1,2,3,4,5,6-hexachloro-,-alpha-isomer- SY: 1-alpha,2-alpha,3-beta,4-alpha,5-beta,6-beta-Hexachlorocyclohexane-; Benzene-hexachloride-alpha-isomer-; Cyclohexane,-1,2,3,4,5,6-hexachloro-,-alpha-; Cyclohexane,-alpha-1,2,3,4,5,6-hexachloro-; ENT-9,232-; Hexachlorcyclohexan- (German); alpha-1,2,3,4,5,6-Hexachlorocyclohexane-; alpha-BHC-; alpha-Benzenehexachloride-; alpha-HCH-; alpha-Hexachloran-; alpha-Hexachlorane-; alpha-Hexachlorcyclohexane-; alpha-Hexachlorocyclohexane-; alpha-Isomer-of-benzene-hexachloride-; alpha-Lindane- RN: Current: 319-84-6 BRN: 3195880 BHR: 4-05-00-00060 UD: 200302 MF: C6-H6-Cl6 MW: 290.82 WL: L6TJ AG BG CG DG EG FG ALPHA CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P) ME: mtr-rat-orl 2520 mg/kg/6W Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 387, 1988 (CRNGDP); dns-rat-orl 100 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1433, 1987 (CRNGDP); dns-rat-lvr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3010, 1982 (CNREA8); cyt-rat-orl 756 mg/kg/3W Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 1245, 1975 (JNCIAM) TE: V02-L60 orl-rat TDLo: 20 gm/kg/48W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 801, 1975 (JNCIAM); V01-L60 orl-mus TDLo: 5 gm/kg/24W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1637, 1973 (JNCIAM); V01-L60 orl-mus TD :10 gm/kg/24W-C Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken, Japan) V.1- 1950- v. 25, p. 635, 1974 (NAIZAM); V03-L60 orl-rat TD :11040 mg/kg/86W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4140, 1981 (CNREA8); V03-L60 orl-rat TD :13020 mg/kg/92W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4140, 1981 (CNREA8); V01-L60 orl-mus TD :12960 mg/kg/26W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 279, 1972 (CMSHAF); V03-L60 orl-mus TD :8820 mg/kg/21W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 71, p. 1307, 1983 (JJIND8); V03-L60 orl-mus TD :5040 mg/kg/24W-C Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 17, p. 54, 1975 (SAIGBL); V01-L60 orl-mus TD :10080 mg/kg/24W-C Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken, Japan) V.1- 1950- v. 24, p. 1, 1973 (NAIZAM); V02-L60-V16 orl-rat TDLo: 5.040 mg/kg/6W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 163, p. 179, 2001 (CALEDQ) ORNG: 177000000 ng/kg. [177.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-hmn LDLo: 14 gm/kg "Pflanzenschutz-und Schaedlingsbekaempfungsmittel: Abriss einer Toxikologie und Therapie von Vergiftungen," 2nd ed., Klimmer, O.R., Hattingen, Fed. Rep. Ger., Hundt-Verlag, 1971 -,54,1971 (85GYAV); T/E unlistd orl-rat LD50: 177 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 39, p. 455, 1976 (FATOAO); T/E unlistd orl-mus LD50: 78 mg/kg Osaka Shiritsu Daigaku Igaku Zasshi. Journal of the Osaka City Medical Center. (Osaka, Japan) V.4-23, 1955-74. For publisher information, see OIGZDE. v. 15, p. 553, 1966 (OSDIAF) MD: Y07-Y11-Y12 orl-rat TDLo: 18 mg/kg/15D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 56, p. 137, 1991 (TOLED5); Y07-Y11-Y12 orl-rat TDLo: 36 mg/kg/30D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 56, p. 137, 1991 (TOLED5); L70-U01-Z01 orl-rat TDLo: 8736 mg/kg/26W-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 100, p. 59, 1950 (JPETAB); L30-L60-L70 orl-mus TDLo: 13104 mg/kg/26W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 279, 1972 (CMSHAF); L30-L60-L70 orl-mus TDLo: 6048 mg/kg/12W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 153, 1972 (CMSHAF); L60 orl-rat TDLo: 30.2 gm/kg/72W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 195, 1979 (IMEMDT) SR: OEL-AUSTRALIA: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-BELGIUM: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-DENMARK: TWA 0.5 mg/m3, Skin, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.5 mg/m3, Skin, JAN 1993; OEL-GERMANY: MAK 0.5 mg/m3, Skin, JAN 1999; OEL-HUNGARY: TWA 0.5 mg/m3, STEL 0.1 mg/m3, Skin, JAN 1993; OEL-RUSSIA: STEL 0.05 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: MAK-W 0.5 mg/m3, Skin, JAN 1999; OEL-UNITED KINGDOM: LTEL 0.5 mg/m3, STEL 1.5 mg/m3, Skin, JAN 1993 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/90/171406/AS); EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-reversion; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 698 of 1119 in RTECS (through 2003/06) AN: GV4375000 PN: Cyclohexane,-1,2,3,4,5,6-hexachloro-,-beta-isomer- SY: trans-alpha-Benzenehexachloride-; beta-BHC-; Cyclohexane,-1,2,3,4,5,6-hexachloro-,-beta-; Cyclohexane,-beta-1,2,3,4,5,6-hexachloro-; Cyclohexane,-1,2,3,4,5,6-hexachloro-,-trans-; ENT-9,233-; beta-HCH-; beta-Hexachlorobenzene-; beta-Hexachlorocyclohexane-; 1-alpha,2-beta,3-alpha,4-beta,5-alpha,6-beta-Hexachlorocyclohexane-; beta-1,2,3,4,5,6-Hexachlorocyclohexane-; beta-Lindane- RN: Current: 319-85-7 BRN: 1907338 BHR: 4-05-00-00061 UD: 200302 MF: C6-H6-Cl6 MW: 290.82 WL: L6TJ AG BG CG DG EG FG BETA CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Reproductive-Effector (T) RE: T02 orl-rat TDLo: 672 mg/kg (2W male) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 41, p. 531, 1988 (BECTA6) TE: V02-J60-L60 orl-mus TDLo: 18 gm/kg/2Y-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 433, 1973 (FCTXAV) ORNG: 6000000000 ng/kg. [6000.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 6 gm/kg Alimentation et la Vie. (Societe Scientifique d'Hygiene Alimentaire, 16, rue de l'Estrapade, 75005 Paris, France) V.39- 1951- v. 43, p. -, 1955 (ALLVAR); F07-F19-J22 orl-mus LDLo: 1500 mg/kg Pharmacology and Toxicology. English translation of FATOAO. (New York, NY) V.20-22, 1957-59. Discontinued. v. 22, p. 273, 1959 (PHTXA6) MD: L30-L70-P28 orl-rat TDLo: 672 mg/kg/2W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 41, p. 531, 1988 (BECTA6); L70-P72-Y07 orl-rat TDLo: 22750 mg/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 697, 1986 (FAATDF); L30-L70-Z01 orl-rat TDLo: 8736 mg/kg/26W-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 100, p. 59, 1950 (JPETAB); C16 orl-rat TDLo: 1989 mg/kg/30D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 27, p. 704, 1981 (BECTA6); N73-P70-S02 orl-mus TDLo: 9 gm/kg/30D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 293, 1988 (FAATDF); L03-L70-Y15 orl-mky TDLo: 2250 mg/kg/90D-I Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 70, p. 85P, 1974 (NYKZAU); L30-L60-L70 orl-mus TDLo: 13104 mg/kg/26W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 279, 1972 (CMSHAF); L30-L70 orl-mus TDLo: 6048 mg/kg/12W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 153, 1972 (CMSHAF) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 195, 1979 (IMEMDT) SR: OEL-AUSTRIA: MAK 0.5 mg/m3, Skin, JAN 1999; OEL-DENMARK: TWA 0.5 mg/m3, Skin, JAN 1999; OEL-GERMANY: MAK 0.5 mg/m3, Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 mg/m3, Skin, JAN 1999 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/166662); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 699 of 1119 in RTECS (through 2003/06) AN: GV4900000 PN: Cyclohexane,-1,2,3,4,5,6-hexachloro-,-gamma-isomer- SY: Aalindan-; Aficide-; Agrocide-; Agrocide-2-; Agrocide-III-; Agrocide-7-; Agrocide-6G-; Agrocide-WP-; Agronexit-; Ameisenmittel-merck-; Ameisentod-; Aparasin-; Aphtiria-; Aplidal-; Arbitex-; BBH-; Ben-Hex-; Benhexol-; Bentox-10-; Benzene-hexachloride-; gamma-Benzene-hexachloride-; gamma-Benzohexachloride-; Bexol-; BHC-; gamma-BHC-; Chloresene-; Codechine-; Celanex-; Inexit-; Detmol-extrakt-; Detox-25-; Devoran-; Dol-Granule-; Drilltox-Spezial-Aglukon-; ENT-7,796-; Entomoxan-; Fenoform-forte-; Forst-Nexen-; Gallogama-; Gamacarbatox-; Gamacid-; Gamaphex-; Gamene-; Gamiso-; Gammalin-; Gammalin-20-; Gamma-mean-400-; Gammaterr-; Geobilan-; Geolin-G-3-; Gexane-; HCC-; HCCH-; HCH-; gamma-HCH-; Heclotox-; gamma-Hexachlorane-; gamma-Hexachlorobenzene-; HEXA-; Hexachloran-; gamma-Hexachloran-; Hexachlorane-; Hexachlorocyclohexane-; gamma-Hexachlorocyclohexane-; 1-alpha,2-alpha,3-beta,4-alpha,5-alpha,6-beta-Hexachlorocyclohexane-; gamma-1,2,3,4,5,6-Hexachlorocyclohexane-; 1,2,3,4,5,6-Hexachlorocyclohexane-; 1,2,3,4,5,6-Hexachlorocyclohexane,-alpha-isomer-; Hexachlorocyclohexane,-gamma-isomer-; 1,2,3,4,5,6-Hexachlorocyclohexane,-gamma-isomer-; Hexaverm-; Hexicide-; Hexyclan-; HGI-; Hilbeech-; Hortex-; Hungaria-L7-; Isotox-; Jacutin-; Kokotine-; Kwell-; Lacco-HI-lin-; Lasochron-; Lendine-; Lentox-; Lidenal-; Lorexane-; Lindafor-; Lindagam-; Lindagrain-; Lindagranox-; Lindane-; gamma-Lindane-; Lindane- (ACGIH:OSHA); Lindapoudre-; Lindatox-; Lindex-; Lindosep-; Lintox-; Linvur-; Mglawik-L-; Milbol-49-; Mszycol-; NCI-C00204-; Neo-Scabicidol-; Nexen-FB-; Nexit-; Nexit-stark-; Nexol-E-; Nicochloran-; Novigam-; Omnitox-; Ovadziak-; Owadziak-; Pedraczak-; Pflanzol-; PLK-; Quellada-; RCRA-waste-number-U129-; Sang-gamma-; Silvanol-; Spritzlindane-; Spritz-Rapidin-; Spruehpflanzol-; Streunex-; TAP-85-; Tri-6-; Verindal-Ultra-; Viton- RN: Current: 58-89-9 Previous: 8007-42-9; 55963-79-6 BRN: 1907337 BHR: 4-05-00-00058 UD: 200302 MF: C6-H6-Cl6 MW: 290.82 WL: L6TJ AG BG CG DG EG FG GAMMA CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: pic-esc 1070 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 193, 1987 (MUREAV); slt-dmg-orl 6 ug/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 33, p. 309, 1995 (FCTOD7); dlt-dmg-orl 22 ug/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 33, p. 309, 1995 (FCTOD7); dns-ofs-lvr 45 umol/L Huanjing Kexue Xuebao. Environmental Sciences Journal. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1981- v. 4, p. 368, 1984 (HKXUDL); dnd-hmn-oth 500 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 23, 1994 (EMMUEG); dni-hmn-lym 500 mg/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 101, 1980 (ARTODN); oms-hmn-fbr 100 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(3), p. 32, 1973 (GTPZAB); oms-hmn-lym 5 mg/L Bibliotheca Haematologica (Basel). (S. Karger AG, Postfach, CH-4009 Basel, Switzerland) No.1- 1955- v. 38(Pt 1), p. 344, 1971 (BIHAA2); cyt-hmn-lym 5 mg/L Bibliotheca Haematologica (Basel). (S. Karger AG, Postfach, CH-4009 Basel, Switzerland) No.1- 1955- v. 38(Pt 1), p. 344, 1971 (BIHAA2); dnd-rat-oth 500 nmol/tube Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 271, 1993 (FCTOD7); dnd-rat-lvr 30 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); dnd-rat-oth 500 nmol/tube Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 271, 1993 (FCTOD7); dnd-rat-orl 60 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 271, 1993 (FCTOD7); dns-rat-lvr 100 pmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1547, 1984 (CRNGDP); dni-rat-oth 1 gm/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 101, 1980 (ARTODN); spm-rat-par 10 mg/kg/10D-C Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 31, p. 1, 1972 (APTOA6); mnt-mus-ipr 100 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 49(5), p. 82, 1984 (GISAAA); cyt-mus-ipr 5 mg/kg Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 2, p. 80, 1966 (SOGEBZ); cyt-mus-orl 12600 ug/kg/7D-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 33, p. 309, 1995 (FCTOD7); dlt-mus-orl 6720 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 101, p. 315, 1982 (MUREAV); cyt-ham-fbr 63 mg/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); msc-ham-lng 200 mg/L Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 49(5), p. 82, 1984 (GISAAA); mnt-ckn-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 175, 1992 (MUREAV); mnt-ckn-orl 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 175, 1992 (MUREAV); cyt-ckn-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 175, 1992 (MUREAV); cyt-ckn-orl 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 175, 1992 (MUREAV) RE: T35 orl-wmn TDLo: 5 mL/kg (18W preg) Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- v. 37, p. 992, 1993 (JRPMAP); T91 orl-rat TDLo: 30 mg/kg (15D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 59, p. 360, 1997 (BECTA6); T46 orl-rat TDLo: 200 mg/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 9, p. 239, 1978 (TXCYAC); T34 orl-rat TDLo: 100 mg/kg (9D preg) Bulletin of the Veterinary Institute in Pulawy. (Instytut Weterynaryjny, Aleja Partyzantow 55, Pulawy, Poland) V.1- 1957- v. 21, p. 85, 1977 (BVIPA7); T14 orl-rat TDLo: 6100 ug/kg (18W pre) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 36(5), p. 19, 1971 (GISAAA); T32 orl-rat TDLo: 12500 ug/kg (16D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 47, p. 508, 1991 (BECTA6); T91 orl-rat TDLo: 6 mg/kg (9-14D post) Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 16, p. 146, 1997 (HETOEA); T14 unr-rat TDLo: 25 mg/kg (1D pre) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 48, p. 21, 1989 (TOLED5); T19 unr-rat TDLo: 33 mg/kg (1D pre) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 48, p. 21, 1989 (TOLED5); T02 itt-rat TDLo: 10 mg/kg (10D male) Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 31, p. 1, 1972 (APTOA6); T02 orl-mus TDLo: 2730 mg/kg (13W male) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 131, 1981 (FCTXAV); T24 orl-mus TDLo: 43300 ug/kg (1-4D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 59, p. 171, 1989 (TXCYAC); T25-T34 orl-mus TDLo: 44 mg/kg (6-12D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 59, p. 171, 1989 (TXCYAC); T34 orl-mus TDLo: 22500 ug/kg (14-19D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 59, p. 171, 1989 (TXCYAC); T71 orl-dog TDLo: 473 mg/kg (1-63D preg) "Pesticide and the Environment: a Continuing Controversy, Selected Papers Presented and Papers Reviewed at the 8th Inter-American Conference on Toxicology and Occupational Medicine, Miami, FL, 1973," Deichmann, W.B., ed., New York, Stratton Intercontinental Medical Book Corp., 1973 -,253,1973 (32OAAP); T24-T46 orl-rbt TDLo: 260 mg/kg (6-18D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 9, p. 239, 1978 (TXCYAC); T34 orl-rbt TDLo: 40 mg/kg (9D preg) Bulletin of the Veterinary Institute in Pulawy. (Instytut Weterynaryjny, Aleja Partyzantow 55, Pulawy, Poland) V.1- 1957- v. 21, p. 85, 1977 (BVIPA7); T86 orl-rbt TDLo: 60 mg/kg (9D preg) Bulletin of the Veterinary Institute in Pulawy. (Instytut Weterynaryjny, Aleja Partyzantow 55, Pulawy, Poland) V.1- 1957- v. 21, p. 85, 1977 (BVIPA7); T34 orl-ham TDLo: 20 mg/kg (8D preg) Bulletin of the Veterinary Institute in Pulawy. (Instytut Weterynaryjny, Aleja Partyzantow 55, Pulawy, Poland) V.1- 1957- v. 21, p. 85, 1977 (BVIPA7); T27-T72-T91 orl-man TDLo: 124 mg/kg (multigeneration) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 113, p. 95, 1998 (JRPFA4); T35 orl-rat TDLo: 5 mg/kg (1-10D preg) "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 541, 1990 (VCVGH*) TE: V01-L60 orl-mus TDLo: 14 gm/kg/2Y-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1889, 1987 (CRNGDP); V02-J60-L60 orl-mus TD :25 gm/kg/73W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 433, 1973 (FCTXAV); V01-V15 orl-rat TDLo: 3780 mg/kg/80W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); V01-L60 orl-mus TDLo: 36960 mg/kg/110W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); V01-L60 orl-mus TDLo: 36960 mg/kg/110W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); V01-L60 orl-mus TDLo: 5376 mg/kg/80W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); V01-P60 orl-mus TDLo: 10752 mg/kg/80W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); V02-L60 orl-mus TDLo: 13204 mg/kg/26W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL) ORNG: 76000000 ng/kg. [76.000000 mg/kg] T/E unlistd SRNG: 50000000 ng/kg. [50.000000 mg/kg] F13-F12 SKNG: 414000000 ng/kg. [414.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-hmn LDLo: 840 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 34, p. 1232, 1992 (YAKUD5); F12-J22-J24 orl-chd TDLo: 180 mg/kg "Clinical Memoranda on Economic Poisons," U.S. Dept. HEW, Public Health Service, Communicable Disease Center, Atlanta, GA, 1956 v. -, p. 1, 1956 (CMEP**); F12 orl-chd TDLo: 111 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 25, p. 374, 1972 (AEHLAU); F08-F13-R03 skn-wmn TDLo: 19 mg/kg/1H-I Annals of Emergency Medicine. (American College of Emergency Physicians, 1125 Executive Circle, Irving, TX 75038) v. 24, p. 972, 1994 (AEMED3); D14-G30 skn-man TDLo: 20 mg/kg/6W-I American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 141, p. 125, 1987 (AJDCAI); T/E unlistd orl-rat LD50: 76 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 11, 1978 (SPEADM); T/E unlistd skn-rat LD50: 414 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(7), p. 87, 1990 (GISAAA); T/E unlistd ipr-rat LD50: 35 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 212, p. 463, 1951 (AEPPAE); F12-K01-U01 unr-rat LD50: 125 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 28(8), p. 29, 1963 (GISAAA); T/E unlistd orl-mus LD50: 44 mg/kg Journal of Economic Entomology. (Entomological Soc. of America, 4603 Calvert Rd., College Park, MD 20740) V.1- 1908- v. 65, p. 632, 1972 (JEENAI); P70-P72 ihl-mus LCLo: 120 mg/m3/6H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 8(10), p. 55, 1964 (GTPZAB); T/E unlistd ipr-mus LD50: 125 mg/kg Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 2, p. 80, 1966 (SOGEBZ); F12 ice-mus LD50: 60 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 60, p. 289, 1992 (TOLED5); T/E unlistd orl-dog LD50: 40 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 11, 1978 (SPEADM); T/E unlistd ivn-dog LDLo: 7500 ug/kg Tieraerztliche Umschau. (Terra-Verlag, Heizmann, Postfach 1222, 7750 Konstanze, Fed. Rep. Ger.) V.1- 1946- v. 5, p. 61, 1950 (TIEUA7); T/E unlistd orl-cat LD50: 25 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,72,1982 (85GMAT); F11-J26-K01 unr-cat LDLo: 50 mg/kg Pharmacology and Toxicology. English translation of FATOAO. (New York, NY) V.20-22, 1957-59. Discontinued. v. 22, p. 273, 1959 (PHTXA6); T/E unlistd orl-rbt LD50: 60 mg/kg Journal of Hygiene, Epidemiology, Microbiology, and Immunology. (Avicenum, Malostranske namesti 28, 11802 Prague 1, Czechoslovakia) V.1- 1957- v. 22, p. 115, 1978 (JHEMA2); F13-F12 skn-rbt LD50: 50 mg/kg Quarterly Bulletin--Association of Food and Drug Officials of the United States. (Denver, CO) V.3-38, 1939-74. v. 16, p. 3, 1952 (AFDOAQ); F11-F12-J26 ivn-rbt LDLo: 4500 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 92, p. 140, 1948 (JPETAB); T/E unlistd orl-gpg LD50: 127 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 6, p. 386, 1947 (FEPRA7); T/E unlistd orl-ham LD50: 360 mg/kg European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 7, p. 159, 1974 (EJTXAZ); T/E unlistd ipr-ham LD50: 640 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 152, 1986 (ARTODN); T/E unlistd unr-mam LD50: 300 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(3), p. 32, 1973 (GTPZAB); T01 orl-rat TDLo: 30 mg/kg Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 51, p. 22A, 1995 (TJADAB); T/E unlistd orl-brd LDLo: 400 mg/kg Canadian Veterinary Journal. (339 Booth St., Ottawa, ON K1R 6J3, Canada) V.1- 1960- v. 23, p. 267, 1982 (CNVJA9); T/E unlistd orl-dck LDLo: 2 gm/kg Canadian Veterinary Journal. (339 Booth St., Ottawa, ON K1R 6J3, Canada) V.1- 1960- v. 23, p. 267, 1982 (CNVJA9) MD: S02-Y17 orl-rat TDLo: 101 mg/kg/8W-C Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 35, p. 1132, 1997 (IJEBA6); P28-Y03-Y10 ihl-rat TCLo: 1700 ug/m3/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(3), p. 41, 1978 (GISAAA); F15-U01 orl-rat TDLo: 70 mg/kg/7D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 49, p. 389, 1988 (TXCYAC); P05-P08-P70 orl-rat TDLo: 364 mg/kg/13W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(10), p. 14, 1976 (GISAAA); P28-S02-S04 orl-rat TDLo: 185 mg/kg/22W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 51, p. 795, 1993 (BECTA6); L30-L70-P28 orl-rat TDLo: 672 mg/kg/2W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 41, p. 531, 1988 (BECTA6); Y07-Y12 orl-rat TDLo: 36 mg/kg/30D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 56, p. 137, 1991 (TOLED5); G06-H01-Y03 orl-rat TDLo: 126 mg/kg/6W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 15, p. 245, 1995 (JJATDK); U01-Z73 ipr-rat TDLo: 40 mg/kg/10D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 38, p. 154, 1987 (BECTA6); N30-N72-Y53 orl-mus TDLo: 1954 mg/kg/2W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 66, p. 75, 1991 (TXCYAC); N30-N72-Y53 orl-mus TDLo: 1298 mg/kg/4W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 66, p. 75, 1991 (TXCYAC); L70-M16-M70 orl-mus TDLo: 10483 mg/kg/78W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 20, p. 411, 1987 (JTEHD6); N30-N72-Y53 orl-mus TDLo: 7280 mg/kg/8W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 66, p. 75, 1991 (TXCYAC); P26 ihl-mus TCLo: 1 mg/m3/80D-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 8(10), p. 55, 1964 (GTPZAB); L70-S04 orl-mus TDLo: 302 mg/kg/12W-C Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 34, p. 1109, 1996 (IJEBA6); S05-Z01 ihl-cat TCLo: 2 mg/m3/4H/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 28(8), p. 29, 1963 (GISAAA); P08-P71-S06 orl-rbt TDLo: 364 mg/kg/13W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(1), p. 72, 1980 (GISAAA); F15-U01-Y15 orl-rbt TDLo: 118 mg/kg/28D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 54, p. 258, 1995 (BECTA6); L70-P28-Z01 skn-pig TDLo: 7500 mg/kg/15D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 10, p. 55, 1978 (TXCYAC); A30-Y01 orl-gpg TDLo: 142 mg/kg/14D-I Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 7, p. 37, 1974 (BCTKAG); P28-U07-Y21 orl-dck TDLo: 480 mg/kg/8W-I Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 29, p. 94, 1991 (IJEBA6); T01 orl-rat TDLo: 30 mg/kg/5D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 51, p. 22A, 1995 (TJADAB); N19-Z74 unr-rat TDLo: 280 mg/kg/7D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 734, 2001 (HBPTO*); A30-F17-F40 unr-rat TDLo: 70 mg/kg/7D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 879, 2001 (HBPTO*); N30-N72-P28 orl-mus TDLo: 42.98 mg/kg/2W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 66, p. 75, 1991 (TXCYAC); N30-N72-P28 orl-mus TDLo: 28.56 mg/kg/4W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 66, p. 75, 1991 (TXCYAC); N30-N72-P28 orl-mus TDLo: 42.84 mg/kg/6W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 66, p. 75, 1991 (TXCYAC); N30-N72-P28 orl-mus TDLo: 160.16 mg/kg/8W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 66, p. 75, 1991 (TXCYAC); L30-L60-L70 orl-mus TDLo: 13104 mg/kg/26W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 279, 1972 (CMSHAF); L30-L70-U01 orl-mus TDLo: 6048 mg/kg/12W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 153, 1972 (CMSHAF); M30-R03-T02 orl-rat TDLo: 7929.6 mg/kg/80W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); M30-R03 orl-rat TDLo: 3780 mg/kg/80W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); Z01 orl-mus TDLo: 2856 mg/kg/17W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); F43-R21-T02 orl-mus TDLo: 5376 mg/kg/80W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); F13-R21 orl-mus TDLo: 5376 mg/kg/80W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); L70 orl-mus TDLo: 13104 mg/kg/26W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); P61 orl-mus TDLo: 840 mg/kg/80W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); L70 orl-rat TDLo: 10080 mg/kg/24W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); Z01 orl-rat TDLo: 11116 mg/kg/40W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); L70 orl-rat TDLo: 4494 mg/kg/107W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); F12-L70-Z01 orl-dog TDLo: 383.1 mg/kg/613D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); F12-Z01 orl-dog TDLo: 465 mg/kg/93D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); P30-Y03-L30 orl-dog TDLo: 875 mg/kg/50W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); G06-P30-Y03 orl-dog TDLo: 1120 mg/kg/32W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); Z01 orl-dog TDLo: 170 mg/kg/17D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL); F12-F11-L03 orl-dog TDLo: 480 mg/kg/48D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 460, 1979 (ENVRAL) TR: ACGIH TLV-TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 220, 1987 (IMSUDL); TOXICOLOGY REVIEW Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- v. 10(3), p. 43, 1975 (CNDQA8); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 56, p. 107, 1975 (RREVAH); TOXICOLOGY REVIEW Progress in Medical Chemistry. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1961- v. 10, p. 85, 1974 (PMDCAY); TOXICOLOGY REVIEW Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970. v. 80, p. 485, 1973 (DTTIAF); TOXICOLOGY REVIEW Archives of Dermatology. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.82- 1960- v. 113, p. 353, 1977 (ARDEAC); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 13, p. 231, 1978 (CTOXAO); TOXICOLOGY REVIEW Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 42(9), p. 66, 1977 (GISAAA); TOXICOLOGY REVIEW Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- v. 14, p. 49, 1979 (CNDQA8) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 146, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 0.5 mg/m3, Skin, JAN 1999; OEL-DENMARK: TWA 0.5 mg/m3, Skin, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 0.5 mg/m3, Skin, JAN 1999; OEL-GERMANY: MAK 0.5 mg/m3, Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.5 mg/m3, Skin, JAN 1999; OEL-NORWAY: TWA 0.5 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: MAK-W 0.5 mg/m3, Skin, JAN 1999; OEL-THAILAND: TWA 0.5 mg/m3, JAN 1993; OEL-TURKEY: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 0.1 mg/m3, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO LINDANE-air: 8H TWA 0.5 mg/m3 (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 09318; NIS 5; TNF 424; NOS 6; TNE 689; NOES 1983: HZD 09318; NIS 6; TNF 2617; NOS 11; TNE 15036; TFE 5153 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/166662); EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: Host-mediated assay, D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Lindane, 5502; NCI Carcinogenesis Bioassay (feed), no evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-14, 1977 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 700 of 1119 in RTECS (through 2003/06) AN: GW1925000 PN: Cyclohexanone,-oxime- SY: Antioxidant-D-; (Hydroxyimino)cyclohexane RN: Current: 100-64-1 BRN: 1616769 BHR: 4-07-00-00021 UD: 200012 MF: C6-H11-N-O MW: 113.18 WL: L6YTJ AUNQ CC: Tumorigen (C); Drug (D); Mutagen (M) ME: msc-mus-lym 1938 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 149, 1988 (MUREAV) AT: T/E unlistd orl-rat LD :>500 mg/kg National Academy of Sciences, National Research Council, Chemical-Biological Coordination Center, Review. (Washington, DC) v. 5, p. 26, 1953 (NCNSA6); T/E unlistd ipr-mus LD50: 250 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD691-490 (NTIS**); E15 unr-mus LD50: 710 mg/kg Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- v. 12, p. 227, 1978 (PCJOAU) MD: N73-P71-P72 orl-rat TDLo: 250 mg/kg/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 117, 1985 (FAATDF); N73-P71-P72 orl-rat TDLo: 1625 mg/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 117, 1985 (FAATDF); P24-P71-Y01 ihl-rat TCLo: 1 mg/m3/24H/90D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 40(2), p. 23, 1975 (GISAAA); P26 unr-rat TDLo: 3 gm/kg/10D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 202, 2000 (TOXID9); L70 orl-mus TDLo: 175 mg/kg/2W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3934 (NTPTR*); D01-L30-M70 orl-mus TDLo: 26117 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3934 (NTPTR*) SR: OEL-RUSSIA: STEL 10 mg/m3, JAN 1993 SL: EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-50, October 2000 Record 701 of 1119 in RTECS (through 2003/06) AN: GW6360000 PN: Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (R)- SY: (+)-4-Isopropenyl-1-methylcyclohexene; (+)-R-Limonene; (R)-1-Methyl-4-(1-methylethenyl)cyclohexene; 1-Methyl-4-(1-methylethenyl)cyclohexene; Cajeputene-; Carvene-; Cinene-; Cyclohexene,-4-isopropenyl-1-methyl-; D-(+)-Limonene; NCI-C55572-; Refchole-; d-Limonene-; d-Limoneno- (Spanish); d-p-Mentha-1,8-diene-; p-Mentha-1,8-diene-; p-Mentha-1,8-diene, (R)-(+)- RN: Current: 5989-27-5 Previous: 7705-13-7; 95327-98-3 UD: 200210 MF: C10-H16 MW: 136.26 WL: L6UTJ A1 DY1&U1 -R CC: Tumorigen (C); Drug (D); Mutagen (M); Natural-Product (N); Reproductive-Effector (T) ME: mtr-mus-fbr 0.005 pph/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T46-T81-T86 orl-rat TDLo: 20083 mg/kg (9-15D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 10, p. 179, 1975 (OYYAA2); T46-T86 orl-mus TDLo: 3546 mg/kg (7-12D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 13, p. 863, 1977 (OYYAA2); T81 orl-mus TDLo: 14178 mg/kg (7-12D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 13, p. 863, 1977 (OYYAA2); T86 orl-rbt TDLo: 3250 mg/kg (6-18D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 13, p. 885, 1977 (OYYAA2) TE: V01-M61-T61 orl-rat TDLo: 38625 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-347, 1990 (NTPTR*); V03-K60 orl-mus TDLo: 67 gm/kg/39W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 35, p. 771, 1965 (JNCIAM); V01-M61 orl-rat TDLo: 38625 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-231416/AS (NTIS**) ORNG: 4400000000 ng/kg. [4400.000000 mg/kg] F17-J25-R21 AT: F17-J25-R21 orl-rat LD50: 4400 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 9, p. 387, 1975 (OYYAA2); F17-J25-R21 ipr-rat LD50: 3600 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 9, p. 387, 1975 (OYYAA2); F13-J25-R21 scu-rat LDLo: 30200 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 9, p. 387, 1975 (OYYAA2); F12-J25-R21 ivn-rat LD50: 110 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 9, p. 387, 1975 (OYYAA2); F17-J25-R21 orl-mus LD50: 5600 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 9, p. 387, 1975 (OYYAA2); F05-F07-U28 ipr-mus LD50: 600 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 8, p. 1439, 1974 (OYYAA2); C06 scu-mus LD50: 3170 mg/kg Sapporo Igaku Zasshi. Sapporo Medical Journal. (Sapporo Igaku Daigaku, Nishi-17-chome, Minami-1-jo, Chuo-ku, Sapporo 060, Japan) V.3- 1952- v. 3, p. 73, 1952 (SIZSAR); F05-F07-U28 idu-mus LDLo: 1 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 8, p. 1439, 1974 (OYYAA2); T/E unlistd skn-rbt LD50: >5 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 825, 1975 (FCTXAV); T/E unlistd skn-mam LD50: >5 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 12, p. 703, 1974 (FCTXAV) MD: M03 orl-rat TDLo: 11550 mg/kg/7D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 104, p. 83, 1999 (TOLED5); Z01 orl-rat TDLo: 39600 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-347, 1990 (NTPTR*); M16-M30 orl-rat TDLo: 840 mg/kg/4W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 125, 1993 (FCTOD7); L70-M30-M70 orl-rat TDLo: 4875 mg/kg/91D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 27, p. 639, 1989 (FCTOD7); L70-M70 orl-rat TDLo: 1500 mg/kg/5D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 345, 1987 (FCTOD7); Z01 orl-mus TDLo: 39600 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-347, 1990 (NTPTR*); Z01 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-347, 1990 (NTPTR*); M70 orl-dog TDLo: 180 gm/kg/26W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 28, p. 669, 1990 (FCTOD7); K60-V25-V30 orl-rat TDLo: 21000 mg/kg/25W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 137, p. 131, 1999 (CALEDQ) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 56, p. 135, 1993 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 307, 1999 (IMEMDT); IARC Cancer Review: Human No Available Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 56, p. 135, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 307, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 307, 1999 (IMEMDT); TOXICOLOGY REVIEW Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 1171, 1976 (CTRRDO) ND: NOES 1983: HZD X9088; NIS 87; TNF 8310; NOS 65; TNE 138309; TFE 35634 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 702 of 1119 in RTECS (through 2003/06) AN: GW6650000 PN: 1-Cyclohexene,-4-vinyl- SY: 1,2,3,4-Tetrahydrostyrene-; 1-Vinylcyclohex-3-ene-; 1-Vinylcyclohexene-3-; 4-Ethenyl-1-cyclohexene-; 4-Ethenylcyclohexene-; 4-Vinyl-1-cyclohexene-; 4-Vinylcyclohexene-; 4-Vinylcyclohexene- (ACGIH); 4-Vinylcyclohexene-1-; Butadiene-dimer-; Cyclohexene,-4-ethenyl-; Cyclohexenylethylene-; NCI-C54999- RN: Current: 100-40-3 BRN: 1901553 BHR: 4-05-00-00406 UD: 200302 MF: C8-H12 MW: 108.20 WL: L6UTJ D1U1 CC: Tumorigen (C); Reproductive-Effector (T) RE: T12 ipr-mus TDLo: 24 gm/kg (30D pre) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 433, 1992 (TOXID9); T12 ipr-mus TDLo: 19500 mg/kg (30D pre) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 119, p. 302, 1993 (TXAPA9); T81 orl-mus TDLo: 500 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91211250 (NTIS**) TE: V01-T63 orl-mus TDLo: 103 gm/kg/2Y-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 21, p. 507, 1987 (JTEHD6); V03-R60-V10 skn-mus TDLo: 16 gm/kg/54W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 31, p. 41, 1963 (JNCIAM); V02-T63 orl-mus TD :103 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-303, 1986 (NTPTR*); V01-P62 orl-mus TD :206 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-303, 1986 (NTPTR*); V03-T69 orl-rat TDLo: 103000 mg/kg/102W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-116182 (NTIS**); V03-J60-P62 orl-mus TDLo: 206000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-116182 (NTIS**); V01-T63 orl-mus TDLo: 103000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-116182 (NTIS**) ORNL: 3080000 nL/kg. [3.080000 mL/kg] T/E unlistd SRNL: 20000000 nL/kg. [20.000000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 3080 uL/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); T/E unlistd ihl-rat LCLo: 8000 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); T/E unlistd ihl-mus LC50: 27 gm/m3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 279, 1976 (IMEMDT); T/E unlistd skn-rbt LD50: 20 mL/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP) MD: Z01 orl-rat TDLo: 17500 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-303, 1986 (NTPTR*); M03-Z01 orl-rat TDLo: 52 gm/kg/13W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 21, p. 493, 1987 (JTEHD6); L70-M70-U01 ihl-rat TCLo: 1500 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 1, 1996 (FAATDF); U01-Z01 ihl-rat TCLo: 1500 ppm/6H/2W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0556756 (NTIS**); Z01 orl-mus TDLo: 17500 mg/kg/14D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 21, p. 493, 1987 (JTEHD6); Z01 orl-mus TDLo: 78 gm/kg/13W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 21, p. 493, 1987 (JTEHD6); Z01 ihl-mus TCLo: 1000 ppm/6H/4W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 182, 1995 (TOXID9); P08-P71-Z01 ihl-mus TCLo: 1000 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 1, 1996 (FAATDF); F11-U01-Z01 ihl-mus TCLo: 1500 ppm/6H/2W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0556756 (NTIS**); T11 ipr-mus TDLo: 19500 mg/kg/30D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 119, p. 302, 1993 (TXAPA9); T11-T14 ipr-mus TDLo: 24000 mg/kg/30D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 42, p. 67, 1990 (BIREBV); T12 ipr-mus TDLo: 3000 mg/kg/30D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 379, 1991 (REPTED); U01 orl-mus TDLo: 63000 mg/kg/18W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91211250 (NTIS**) TR: ACGIH TLV-TWA 0.1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 181, 1986 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 347, 1994 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 181, 1986 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 347, 1994 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 347, 1994 (IMEMDT) SR: OEL-POLAND: MAC(TWA) 10 mg/m3, JAN 1999 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0293-8735; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NCI Carcinogenesis Studies (gavage), inadequate study: rat Record 703 of 1119 in RTECS (through 2003/06) AN: GW7700000 PN: 2-Cyclohexen-1-one,-3,5,5-trimethyl- SY: 1,1,3-Trimethyl-3-cyclohexene-5-one-; 3,3,5-Trimethyl-5-cyclohexen-1-one-; 3,5,5-Trimethyl-2-cyclohexen-1-on- (German, Dutch); 3,5,5-Trimethyl-2-cyclohexen-1-one-; 3,5,5-Trimethyl-2-cyclohexene-1-one-; 3,5,5-Trimethylcyclohex-2-ene-1-one-; 3,5,5-Trimetil-2-cicloesen-1-one- (Italian); Isoacetophorone-; Isoforon-; Isoforone- (Italian); Isophoron-; Isophorone-; Isophorone- (ACGIH:OSHA); Izoforon- (Polish); NCI-C55618- RN: Current: 78-59-1 BRN: 1280721 BHR: 4-07-00-00165 UD: 200210 MF: C9-H14-O MW: 138.23 WL: L6V BUTJ C1 D1 D1 CC: Tumorigen (C); Hormone (H); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: eye-hmn 25 ppm/15M Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28, p. 262, 1946 (JIHTAB); skn-rbt 100 mg/24H MLD Journal Europeen de Toxicologie. (Paris, France) V.1-6, 1968-72. For publisher information, see TOERD9. v. 5, p. 31, 1972 (JETOAS); eye-rbt 920 ug SEV Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 11/15/1971 (UCDS**); eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,290,1986 (85JCAE); eye-gpg 840 ppm/4H SEV Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 22, p. 477, 1940 (JIHTAB); skn-rbt 0.5 mL/24H MOD "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 460, 1994 (VCVGK*) ME: dns-rat-lvr 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 315, p. 147, 1994 (MUREAV); msc-mus-lym 400 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); cyt-ham-lng 1250 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 369, p. 243, 1996 (MUREAV); sce-ham-ovr 1 gm/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-291, 1986 (NTPTR*) RE: T19 ihl-rat TCLo: 115 ppm/6H (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0546532 (NTIS**); T19 ihl-mus TCLo: 115 ppm/6H (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0546532 (NTIS**) TE: V03-M60 orl-rat TDLo: 180 gm/kg/2Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571092 (NTIS**); V01-M61 orl-mus TDLo: 258 gm/kg/2Y-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 39, p. 207, 1986 (TXCYAC); V01-M61-T69 orl-rat TDLo: 128750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-181823/AS (NTIS**); V01-L60 orl-mus TDLo: 257500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-181823/AS (NTIS**); V01-P62 orl-mus TDLo: 128750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-181823/AS (NTIS**) ORNG: 1870000000 ng/kg. [1870.000000 mg/kg] T/E unlistd SRNL: 1500000 nL/kg. [1.500000 mL/kg] T/E unlistd SKNG: 1390000000 ng/kg. [1390.000000 mg/kg] T/E unlistd AT: D07-D25-J30 ihl-hmn TCLo: 25 ppm Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28, p. 262, 1946 (JIHTAB); T/E unlistd orl-rat LD50: 1870 mg/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 11/15/1971 (UCDS**); F07-J22-R21 ihl-rat LC50: 7 gm/m3 National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572861 (NTIS**); T/E unlistd skn-rat LD50: 1390 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0526403 (NTIS**); T/E unlistd orl-mus LD50: 2690 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 17, p. 498, 1970 (TXAPA9); J15 ihl-mus LC :>3500 mg/kg/6H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535380 (NTIS**); F12-G08-J26 ivn-dog LD :>10 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535380 (NTIS**); T/E unlistd orl-rbt LD50: 1420 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535380 (NTIS**); T/E unlistd skn-rbt LD50: 1500 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 11/15/1971 (UCDS**); T/E unlistd orl-gpg LD50: 700 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535380 (NTIS**); T/E unlistd ihl-gpg LC50: 4600 ppm/8H "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,290,1986 (85JCAE) MD: Z01 orl-rat TDLo: 24 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-291, 1986 (NTPTR*); Z01 orl-rat TDLo: 65 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-291, 1986 (NTPTR*); J30-M04-Z01 ihl-rat TCLo: 500 ppm/8H/6W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 24, p. 46, 1942 (JIHTAB); D35-L30-M16 ihl-rat TCLo: 500 ppm/8H/6W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535380 (NTIS**); L70-U01 ihl-rat TCLo: 208 mg/m3/6H/4W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535380 (NTIS**); Z01 orl-mus TDLo: 24 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-291, 1986 (NTPTR*); Z01 orl-mus TDLo: 65 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-291, 1986 (NTPTR*); J30-M04-Z01 ihl-gpg TCLo: 500 ppm/8H/6W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 24, p. 46, 1942 (JIHTAB); L30-M03-P70 ihl-gpg TCLo: 500 ppm/8H/6W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535380 (NTIS**); Z01 ihl-rat TCLo: 2800 mg/m3/8H/6W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 459, 1994 (VCVGK*); Z01 ihl-gpg TCLo: 2800 mg/m3/8H/6W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 459, 1994 (VCVGK*); M30 ihl-rat TCLo: 280 mg/m3/8H/6W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 459, 1994 (VCVGK*); M30 ihl-gpg TCLo: 280 mg/m3/8H/6W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 459, 1994 (VCVGK*); F07 ihl-hmn TCLo: 5 ppm/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 460, 1994 (VCVGK*) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-CL 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: MSHA STANDARD-air: TWA 25 ppm (140 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 140, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 25 ppm (140 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 25 ppm (140 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 25 ppm (140 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 25 ppm (140 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 ppm (25 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 5 ppm (28 mg/m3), JAN 1999; OEL-BELGIUM: STEL 5 ppm (28 mg/m3), JAN 1993; OEL-DENMARK: TWA 5 ppm (25 mg/m3), JAN 1999; OEL-FINLAND: TWA 5 ppm (28 mg/m3), STEL 10 ppm (56 mg/m3), JAN 1999; OEL-FRANCE: VLE 5 ppm (25 mg/m3), JAN 1999; OEL-GERMANY: MAK 5 ppm (28 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (25 mg/m3), JAN 1999; OEL-NORWAY: TWA 10 ppm (40 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 25 ppm (140 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(C) 25 mg/m3, JAN 1999; OEL-RUSSIA: STEL 1 mg/m3, JAN 1993; OEL-SWEDEN: KTV 5 ppm (30 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (28 mg/m3), JAN 1999; OEL-TURKEY: TWA 25 ppm (149 mg/m3), JAN 1993; OEL-UNITED KINGDOM: STEL 5 ppm (29 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ISOPHORONE-air: 10H TWA 4 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 40910; NIS 44; TNF 2934; NOS 40; TNE 26825; NOES 1983: HZD 40910; NIS 43; TNF 3593; NOS 47; TNE 47097; TFE 10353 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/90/180225/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Isophorone, 2508; NTP Carcinogenesis Studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-291, 1986 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 704 of 1119 in RTECS (through 2003/06) AN: GY1225000 PN: 1,3-Cyclopentadiene,-1,2,3,4,5,5-hexachloro- SY: C-56-; Graphlox-; Hexachlorcyklopentadien- (Czech); Hexachlorocyclopentadiene-; Hexachlorocyclopentadiene- (ACGIH); Hexachloro-1,3-cyclopentadiene-; 1,2,3,4,5,5-Hexachloro-1,3-cyclopentadiene-; HRS-1655-; NCI-C55607-; Perchlorocyclopentadiene-; RCRA-waste-number-U130- RN: Current: 77-47-4 BRN: 976722 BHR: 4-05-00-00381 UD: 200210 MF: C5-Cl6 MW: 272.75 WL: L5 AHJ AG AG BG CG DG EG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-mky 10 mg SEV AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 459, 1955 (AMIHAB); skn-rbt 500 mg/4H SEV Velsicol Chemical Corp., Product Bulletin. (341 E. Ohio St., Chicago, IL 60611) #50101-2, 1976 (VELPB*); skn-rbt 500 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0537036 (NTIS**); eye-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,149,1986 (85JCAE); eye-rbt 100 mg/5M SEV Velsicol Chemical Corp., Product Bulletin. (341 E. Ohio St., Chicago, IL 60611) #50101-2, 1976 (VELPB*); skn-gpg 20 mg MLD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 459, 1955 (AMIHAB) RE: T46 orl-rbt TDLo: 975 mg/kg (6-18D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 497, 1980 (TXAPA9) ORNG: 315000000 ng/kg. [315.000000 mg/kg] T/E unlistd SRNG: 430000000 ng/kg. [430.000000 mg/kg] T/E unlistd IHPB: 1600 ppb/4H. [1.600000 ppm/4H] F07-J30 AT: T/E unlistd orl-rat LD50: 315 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-437, 1994 (NTPTR*); F07-J30 ihl-rat LC50: 1600 ppb/4H Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 743, 1982 (JTEHD6); T/E unlistd orl-mus LD50: 505 mg/kg Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 23, p. 967, 1975 (JAFCAU); T/E unlistd ihl-mus LCLo: 1500 ppb/7H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 497, 1980 (TXAPA9); T/E unlistd orl-rbt LDLo: 420 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 586, 1966 (PCOC**); T/E unlistd ihl-rbt LCLo: 1500 ppb/7H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 497, 1980 (TXAPA9); T/E unlistd skn-rbt LD50: 430 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,308,1969 (34ZIAG); T/E unlistd ihl-gpg LCLo: 3200 ppb/7H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 459, 1955 (AMIHAB) MD: L70-M03-U01 orl-rat TDLo: 2470 mg/kg/13W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 4, p. 75, 1984 (JJATDK); N73-P08-P71 ihl-rat TCLo: 100 ppb/6H/30W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0539137 (NTIS**); J70-P08-U01 ihl-rat TCLo: 500 ppb/6H/2W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 743, 1982 (JTEHD6); D07-J02-J70 ihl-rat TCLo: 400 ppb/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-437, 1994 (NTPTR*); K30-M03-M70 orl-mus TDLo: 2470 mg/kg/13W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 4, p. 75, 1984 (JJATDK); J30-Z01 ihl-mus TCLo: 150 ppb/6H/13W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 6, p. 57, 1986 (TOXID9); J16-U01-Z01 ihl-mus TCLo: 340 ppb/7H/6W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 459, 1955 (AMIHAB); J16-U01-Z01 ihl-rbt TCLo: 340 ppb/7H/6W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 459, 1955 (AMIHAB); J02-J16-U01 ihl-gpg TCLo: 340 ppb/7H/6W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 459, 1955 (AMIHAB) TR: ACGIH TLV-TWA 0.01 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.01 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: OEL-AUSTRALIA: TWA 001 ppm (0.1 mg/m3), JAN 1993; OEL-BELGIUM: TWA 0.01 ppm (0.11 mg/m3), JAN 1993; OEL-DENMARK: TWA 0.01 ppm (0.1 mg/m3), JAN 1999; OEL-FINLAND: TWA 0.1 ppm (1 mg/m3), STEL 0.3 ppm (3 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 0.01 ppm (0.1 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.01 ppm (0.11 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.01 ppm (0.1 mg/m3), JAN 1999; OEL-RUSSIA: STEL 0.01 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: MAK-W 0.01 ppm (0.1 mg/m3), JAN 1999; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO HEXACHLOROCYCLOPENTADIENE-air: 10H TWA 0.01 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD T0175; NIS 2; TNF 61; NOS 14; TNE 1427 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/166670); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hexachloro-1, 3-cyclopentadiene, 2518; NCI Carcinogenesis Studies (inhal), no evidence: mouse, rat; NTP Carcinogenesis studies (inhalation), no evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-437, 1994 (NTPTR*) Record 705 of 1119 in RTECS (through 2003/06) AN: GZ4120000 PN: Cyclosporin-A- SY: Antibiotic-S-7481F1-; Cyclosporin-; Cyclosporine-; Cyclosporine-A-; Neoral-; OL-27-400-; Ramihyphin-A-; S-7481F1-; Sandimmun-; Sandimmune- RN: Current: 59865-13-3 Previous: 104250-72-8 UD: 200305 MF: C62-H111-N11-O12 MW: 1202.84 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: oms-hmn-lym 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 217, 1994 (MUREAV); sce-hmn-lym 1 mg/L Igaku No Ayumi. Progress in Medicine. (Ishiyaku Shuppan K.K., 1-7-10, Honkomagom, Bunkyo-ku, Tokyo, Japan) V.1- 1946- v. 134, p. 403, 1985 (IGAYAY) RE: T01-T09-T23 scu-rat TDLo: 166 mg/kg (45D male) Journal of Andrology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1980- v. 11, p. 17, 1990 (JOAND3); T01 scu-rat TDLo: 420 mg/kg (14D male) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 109, p. 75, 1996 (TXCYAC); T01-T02-T09 scu-rat TDLo: 560 mg/kg (14D male) Nippon Hinyokika Gakkai Zasshi. Japanese Journal of Urology. (Japanese Urological Association, c/o Dept. of Urology, Faculty of Medicine, University of Tokyo, 7-3-1 Bunkyo-ku, Tokyo 113 Japan) V.1- 1917- v. 82, p. 1059, 1991 (NGKZA6); T25-T35 ipr-mus TDLo: 90 mg/kg (6-8D preg) Biology of the Neonate. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.15- 1970- v. 56, p. 165, 1989 (BNEOBV); T25-T43 ipr-mus TDLo: 50 mg/kg (12D preg) Journal of Craniofacial Genetics and Developmental Biology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 12, p. 155, 1992 (JCGBDF); T12-T29 ims-rbt TDLo: 210 mg/kg (14D pre) International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS 66044) V.1- 1955- v. 29, p. 218, 1984 (INJFA3); T23 scu-rat TDLo: 280 mg/kg (14D male) Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 138, p. 991, 1987 (JOURAA) TE: V01-P62 orl-man TDLo: 259 mg/kg/2W-C Clinical and Experimental Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1976- v. 8, p. 159, 1983 (CEDEDE) ORNG: 1480000000 ng/kg. [1480.000000 mg/kg] F23-K12-R21 AT: F11-F13-G04 orl-man TDLo: 14286 ug/kg Annals of Pharmacotherpy. (Harvey Whitney Books Co., POB 42696, Cincinnati, OH 45242) V. 26- 1992- v. 34, p. 405, 2000 (APHRER); F12-F24-M03 orl-wmn TDLo: 1911 mg/kg/91W-I British Journal of Rheumatology. (Bailliere Tindall, 33 The Avenue, Eastborn BN21 3UN, UK) v. 33, p. 90, 1994 (BJRHDF); M30-U25 orl-wmn TDLo: 62500 ug/kg/5D-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 1221, 1986 (LANCAO); F27-H15-J24 orl-man TDLo: 20 mg/kg/2D-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 1092, 1986 (LANCAO); H01-N01 orl-hmn TDLo: 12 mg/kg Journal of Hypertension. (Current Science, 1201 Locust St., Philadelphia, PA 19107) V.1- 1983- v. 11, p. 1209, 1993 (JOHYD3); D14-D23-D35 par-man TDLo: 20 mg/kg/5D-I American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 126, p. 607, 1998 (AJOPAA); M03 unr-man TDLo: 30 mg/kg/4D-I Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 107, p. 786, 1987 (AIMEAS); F23-K12-R21 orl-rat LD50: 1480 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 107, 1983 (ARTODN); T/E unlistd ipr-rat LD50: 147 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 17, p. 365, 1986 (IYKEDH); T/E unlistd scu-rat LD50: 286 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 17, p. 365, 1986 (IYKEDH); T/E unlistd ivn-rat LD50: 24 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 17, p. 365, 1986 (IYKEDH); F23-K12-R21 orl-mus LD50: 2329 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 107, 1983 (ARTODN); T/E unlistd ivn-mus LD50: 96 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 17, p. 365, 1986 (IYKEDH); F23-K12-R21 orl-rbt LD50: >1 gm/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 107, 1983 (ARTODN); T/E unlistd ivn-rbt LD50: 10 mg/kg Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 14, p. 73, 1986 (TOPADD) MD: N73-P27 orl-rat TDLo: 140 mg/kg/14D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 39, p. 53, 1997 (FAATDF); M16-P28-Y20 orl-rat TDLo: 350 mg/kg/7D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 32, p. 163, 1986 (TOLED5); F15-U01-Z01 orl-rat TDLo: 800 mg/kg/10D-I Transplantation Proceedings. (Appleton and Lange, 25 Van Zant St., East Norwalk, CT 06855) V.1- 1969- v. 24(Suppl 2), p. 39, 1992 (TRPPA8); P28-Q30 orl-rat TDLo: 420 mg/kg/28D-I Transplantation. (Williams and Wilkins, Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1963- v. 57, p. 1231, 1994 (TRPLAU); Q01-U01 orl-rat TDLo: 1260 mg/kg/6W-I Journal of Periodontology. (American Academy of Periodontology, 211 E. Chicago Ave., Chicago, IL 60611) V.1- 1930- v. 68, p. 1231, 1997 (JOPRAJ); L30-Y06-Y15 orl-rat TDLo: 150 mg/kg/3D-I Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 50, p. 501, 1998 (JPPMAB); H01-H06-M71 orl-rat TDLo: 315 mg/kg/21D-I Nephrology. (Blackwell Science PTY. LTD., POB 378 54 University Street, Carlton, Victoria 3053, Australia) V.1- 1995- v. 4, p. 397, 1998 (NEPHF2); M03-M16 ipr-rat TDLo: 700 mg/kg/28D-I Kidney and Blood Pressure Research. (S. Karger Publishers, POB 529, Farmington, CT 06085) V.19- 1996- v. 20, p. 38, 1997 (KBPRFC); M12-M16-Y16 ipr-rat TDLo: 210 mg/kg/14D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 58, p. 169, 1991 (TOLED5); M16-Y38-Y39 ipr-rat TDLo: 1200 mg/kg/40D-I Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 55, p. 83, 1991 (EXMPA6); H01-H05 scu-rat TDLo: 140 mg/kg/7D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 259, p. 905, 1991 (JPETAB); G30-G70-U01 scu-rat TDLo: 315 mg/kg/3W-I American Journal of Physiology. (American Physiological Soc., 9650 Rockville Pike, Bethesda, MD 20814) V.1- 1898- v. 276, p. H865, 1999 (AJPHAP); H01-H16-P28 ivn-rat TDLo: 60 mg/kg/3D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 259, p. 905, 1991 (JPETAB); M03-M16-Y17 scu-rat TDLo: 420 mg/kg/28D-I Renal Failure. (Marcel Dekker Journals, POB 5005, Monticello, NY 12701) V.10- 1987- v. 16, p. 161, 1994 (REFAE8); M03-M30-P28 ims-rat TDLo: 420 mg/kg/14D-I Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 51, p. 941, 1999 (JPPMAB); M03-P28-U01 ipl-rat TDLo: 1400 mg/kg/8W-C American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 151, p. 1705, 1997 (AJPAA4); M03-M12-U01 ipr-mus TDLo: 400 mg/kg/4D-I Immunopharmacology and Immunotoxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.9- 1987- v. 15, p. 45, 1993 (IITOEF); L30-U01-Z01 orl-dog TDLo: 840 mg/kg/4W-I Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 38, p. 1890, 1996 (YAKUD5); F07-U01-Z01 orl-rbt TDLo: 9 gm/kg/60D-I Laboratory Animals. (Laboratory Animals Ltd., 1 Thrifts Mead, Theydon Bois, Essex CM16 7NF, UK) V.1- 1967- v. 20, p. 213, 1986 (LBANAX); H01-M71-U01 ipr-rbt TDLo: 560 mg/kg/8W-I Transplantation Proceedings. (Appleton and Lange, 25 Van Zant St., East Norwalk, CT 06855) V.1- 1969- v. 3(Suppl 3), p. 578, 1988 (TRPPA8); F07-F15-Z01 scu-rbt TDLo: 900 mg/kg/60D-I Laboratory Animals. (Laboratory Animals Ltd., 1 Thrifts Mead, Theydon Bois, Essex CM16 7NF, UK) V.1- 1967- v. 20, p. 213, 1986 (LBANAX); M30 ivn-rbt TDLo: 120 mg/kg/4D-I Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 17, p. 613, 1998 (HETOEA); F07-U01-Z01 ivn-rbt TDLo: 900 mg/kg/60D-I Laboratory Animals. (Laboratory Animals Ltd., 1 Thrifts Mead, Theydon Bois, Essex CM16 7NF, UK) V.1- 1967- v. 20, p. 213, 1986 (LBANAX); P72 orl-rat TDLo: 49 mg/kg/7D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 157, p. 207, 2001 (TXCYAC); M12-Y40 orl-rat TDLo: 56 mg/kg/28D-I European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 418, p. 127, 2001 (EJPHAZ); M10-M12-Y40 orl-rat TDLo: 280 mg/kg/28D-I European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 418, p. 127, 2001 (EJPHAZ); M10-M12-Y40 scu-rat TDLo: 420 mg/kg/28D-I European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 418, p. 127, 2001 (EJPHAZ); N16-T01-Z72 scu-rat TDLo: 140 mg/kg/14D-I Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 138, p. 991, 1987 (JOURAA); N04-U01-Z73 scu-rat TDLo: 280 mg/kg/14D-I Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 138, p. 991, 1987 (JOURAA); N02-N16-Y53 orl-rat TDLo: 420 mg/kg/28D-I Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 121, p. 586, 1987 (ENDOAO); N02-N16-Z72 orl-rat TDLo: 840 mg/kg/4W-I Transplantation. (Williams and Wilkins, Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1963- v. 45, p. 784, 1988 (TRPLAU); N02-N16 orl-rat TDLo: 840 mg/kg/4W-I Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 123, p. 1069, 1988 (ENDOAO); M71-U01-Z73 scu-rat TDLo: 560 mg/kg/14D-I Transplantation. (Williams and Wilkins, Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1963- v. 49, p. 17, 1990 (TRPLAU); Z01 ipr-rat TDLo: 90 mg/kg/10D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 3651, 1985 (CNREA8); N19-P26-T12 ipr-rat TDLo: 210 mg/kg/21D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 3651, 1985 (CNREA8); U01-Z71-Z74 ipr-rat TDLo: 250 mg/kg/21D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 3651, 1985 (CNREA8); S05-V15 scu-mus TDLo: 150 mg/kg/15D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 297, p. 1144, 2001 (JPETAB); N16 scu-rat TDLo: 150 mg/kg/6D-I Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 129, p. 2647, 1991 (ENDOAO); N04-T02-Y53 scu-rat TDLo: 240 mg/kg/6D-I Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 129, p. 2647, 1991 (ENDOAO); L30-Y40 ipr-rat TDLo: 70 mg/kg/1W-I Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 991, 2000 (CEXPB9); L30-M30-Y40 ipr-rat TDLo: 280 mg/kg/4W-I Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 991, 2000 (CEXPB9); L30-M30-Y20 ipr-rat TDLo: 560 mg/kg/4W-I Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 991, 2000 (CEXPB9); L30-U01-Y53 ims-rat TDLo: 700 mg/kg/4W-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 299, p. 858, 2001 (JPETAB) TR: IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 77, 1990 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 77, 1990 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 77, 1990 (IMEMDT) SL: NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 706 of 1119 in RTECS (through 2003/06) AN: HA3870000 PN: Cytidine,-2',3'-dideoxy- SY: D-2C-; ddC-; Hivid-; NSC-606170-; Ro 24-2027/000; Zalcitabine-; Dideoxycytidine-; 2',3'-Dideoxycytidine- RN: Current: 7481-89-2 Previous: 176485-55-5 BRN: 654956 BHR: 5-25-14-00313 UD: 200207 MF: C9-H13-N3-O3 MW: 211.25 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: dni-hmn-lym 200 nmol/L Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 39, p. 625, 1991 (MOPMA3); cyt-mus-orl 600 mg/kg/3D-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 168, 1991 (EMMUEG) RE: T34-T43-T46 orl-mus TDLo: 10 gm/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 42, p. 131, 1990 (TJADAB); T25-T35 orl-mus TDLo: 20 gm/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 42, p. 131, 1990 (TJADAB) TE: V02-N60 orl-mus TDLo: 91 mg/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 27, p. 263, 1995 (FAATDF); V01-P62 orl-mus TDLo: 90000 mg/kg/12W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 152, p. 129, 2000 (CALEDQ) AT: T/E unlistd orl-rat LD :>2 gm/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 38, p. 2615, 1996 (YAKUD5); T/E unlistd orl-mus LD :>4 gm/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 38, p. 2615, 1996 (YAKUD5); T/E unlistd ivn-mus LD :>500 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 38, p. 2615, 1996 (YAKUD5) MD: P26-P71-P72 orl-rat TDLo: 188 gm/kg/94D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 17, p. 159, 1991 (FAATDF); P30-P70-P71 orl-mus TDLo: 94 gm/kg/94D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 17, p. 159, 1991 (FAATDF); P30-P70-P71 orl-mus TDLo: 14500 mg/kg/29D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 17, p. 159, 1991 (FAATDF); Z01 unr-dog TDLo: 5600 mg/kg/4W-I Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 38, p. 2615, 1996 (YAKUD5); Z01 unr-mky TDLo: 1400 mg/kg/4W-I Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 38, p. 2615, 1996 (YAKUD5); C02-E08-P05 orl-rat TDLo: 5880 mg/kg/24W-I Laboratory Investigation. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1952- v. 70, p. 724, 1994 (LAINAW) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 129, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 129, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 129, 2000 (IMEMDT) SL: NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 707 of 1119 in RTECS (through 2003/06) AN: HD3000000 PN: 2,4-Decadienal, (E,E)- SY: (2E,4E)-Decadienal; trans,trans-2,4-Decadienal-; (E,E)-2,4-Decadienal; (2E,4E)-2,4-Decadienal RN: Current: 25152-84-5 BRN: 1704897 BHR: 4-01-00-03566 UD: 200012 MF: C10-H16-O MW: 152.26 CC: Tumorigen (C) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 708 of 1119 in RTECS (through 2003/06) AN: HN0875000 PN: Dibenz(a,h)acridine SY: 7-Azadibenz(a,h)anthracene; DB(a,h)AC; Dibenz(a,d)acridine; 1,2,5,6-Dibenzacridine-; 1,2,5,6-Dibenzoacridine-; 1,2,5,6-Dinaphthacridine- RN: Current: 226-36-8 BRN: 209261 BHR: 5-20-08-00657 UD: 200302 MF: C21-H13-N MW: 279.35 WL: T G6 D6 B666 CNJ CC: Tumorigen (C); Mutagen (M) ME: mnt-rat-itr 300 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 312, p. 165, 1994 (MUREAV); mtr-rat-emb 1 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 799, 1973 (JNCIAM); dna-rat-itr 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 312, p. 165, 1994 (MUREAV); sce-rat-itr 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 312, p. 165, 1994 (MUREAV); mtr-mus-fbr 0.001 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) TE: V01-J60-V10 imp-rat TDLo: 5 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 20, p. 97, 1983 (CALEDQ); V03-K60-R60 orl-mus TDLo: 13 gm/kg/63W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 129, p. 439, 1940 (PRLBA4); V03-R60-V10 skn-mus TDLo: 540 mg/kg/45W-I Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- v. 4, p. 315, 1956 (ACRSAJ); V03-V10 scu-mus TDLo: 430 mg/kg/24W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 123, p. 343, 1937 (PRLBA4); V03-J60 ivn-mus TDLo: 10 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 1, p. 225, 1940 (JNCIAM); V03-R60-V10 skn-mus TD :790 mg/kg/33W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 117, p. 318, 1935 (PRLBA4); V03-V10 scu-mus TD :1600 mg/kg/24W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 129, p. 439, 1940 (PRLBA4); V03-J60-V10 imp-rat TD :1500 ug/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 20, p. 97, 1983 (CALEDQ); V01-R60 skn-mus TDLo: 5.59 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 22, p. 951, 2001 (CRNGDP) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 247, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 277, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 277, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Pc,4,1972 (85DHAX) SR: OEL-FRANCE: Carcinogen, JAN 1993; OEL-NORWAY: TWA 0.04 mg/m3, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 709 of 1119 in RTECS (through 2003/06) AN: HN1050000 PN: Dibenz(a,j)acridine SY: 7-Azadibenz(a,j)anthracene; DB(a,j)AC; Dibenz(a,f)acridine; 1,2,7,8-Dibenzacridine-; 3,4,5,6-Dibenzacridine-; Dibenzo(a,j)acridine; 3,4,6,7-Dinaphthacridine- RN: Current: 224-42-0 BRN: 18508 BHR: 5-20-08-00656 UD: 200305 MF: C21-H13-N MW: 279.35 WL: T E6 D6 B666 NNJ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 4 ug/plate (-S9) British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); dna-esc 10 umol/L Proceedings, National Cancer Conference. (Philadelphia, PA) V.1-7, 1949-72. For publisher information, see CANCAR. v. 5, p. 39, 1965 (PNCCA2); pic-esc 50 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 532, 1981 (CNREA8); mnt-hmn-lym 5 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 109, 1995 (EMMUEG); mtr-rat-emb 5 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 799, 1973 (JNCIAM); mmo-ham-lng 20 umol/L (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1079, 1989 (CRNGDP) RE: T22 orl-mus TDLo: 2520 mg/kg (21D pre) Dissertation Abstracts B: The Sciences and Engineering. (Ann Arbor, MI) V.27-29, 1966-69. For publisher information, see DABBBA. v. 29, p. 4777, 1969 (DABSAQ) TE: V01-R60 skn-mus TDLo: 99 mg/kg/99W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 37, p. 337, 1987 (CALEDQ); V03-J60-V10 scu-mus TDLo: 40 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 1, p. 225, 1940 (JNCIAM); V03-R60-V10 skn-mus TD :700 mg/kg/29W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 117, p. 318, 1935 (PRLBA4); V03-R60-V10 skn-mus TD :590 mg/kg/25W-I Bulletin de l'Association Francaise pour l'Etude du Cancer. (Paris, France) V.1-52, 1908-65. For publisher information, see BUCABS. v. 42, p. 186, 1955 (BAFEAG); V01-R60 skn-mus TDLo: 641 mg/kg/82W-I Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 871, 2001 (CRTOEC) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 254, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 283, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 283, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Pc,4,1972 (85DHAX) SR: OEL-FRANCE: Carcinogen, JAN 1993; OEL-NORWAY: TWA 0.04 mg/m3, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 710 of 1119 in RTECS (through 2003/06) AN: HN2625000 PN: Dibenz(a,h)anthracene SY: 1,2:5,6-Benzanthracene; DB(a,h)A; 1,2,5,6-Dba-; 1,2,5,6-Dibenzanthraceen- (Dutch); Dibenzo(a,h)anthracene; 1,2:5,6-Dibenzoanthracene; RCRA-waste-number-U063-; 1,2:5,6-Dibenzanthracene; 1,2:5,6-Dibenz(a)anthracene RN: Current: 53-70-3 UD: 200305 MF: C22-H14 MW: 278.36 WL: L G6 D6 B666J CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 5 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 174, p. 247, 1986 (MUREAV); dnr-esc 25 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 53, 1977 (MUREAV); dna-esc 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 2 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); cyt-dmg-ihl 2700 mg/L Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 33, p. 337, 1948 (GENTAE); sln-dmg-par 5 mmol/L Egyptian Journal of Genetics and Cytology. (Egyptian Soc. of Genetics, c/o Alexandria Univ., Faculty of Agriculture, Dept. of Genetics, Alexandria, Egypt) V.1- 1972- v. 4, p. 400, 1975 (EJGCA9); sln-dmg-ihl 2700 mg/L Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 33, p. 337, 1948 (GENTAE); mmo-nsc 500 ppm (-S9) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 1072, 1958 (ANYAA9); dna-sal-tes 5 ug/1H-C Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 110, p. 159, 1968 (BIJOAK); dns-ofs-oth 100 umol/L Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- v. 86, p. 399, 1987 (CBPCEE); dna-hmn-emb 360 nmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 257, 1978 (CBINA8); dns-hmn-fbr 100 umol/L Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- v. 86, p. 399, 1987 (CBPCEE); dns-hmn-oth 10 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2091, 1978 (CNREA8); dns-hmn-hla 100 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); msc-hmn-lym 54 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 371, p. 123, 1996 (MUREAV); mnt-rat-itr 25500 ug/kg/16H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 326, p. 147, 1995 (MUREAV); mtr-rat-orl 200 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 1157, 1980 (CNREA8); mtr-rat-emb 100 ug/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 799, 1973 (JNCIAM); dna-rat-itr 25560 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 312, p. 165, 1994 (MUREAV); sce-rat-itr 51150 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 312, p. 165, 1994 (MUREAV); mnt-mus-ipr 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); mmo-mus-lym 4250 ug/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 106, p. 101, 1982 (MUREAV); mtr-mus-fbr 500 ug/L Advances in Modern Environmental Toxicology. (Senate Press, Inc., P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980- v. 1, p. 133, 1980 (AETODY); mtr-mus-emb 100 ug/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 52, p. 1167, 1974 (JNCIAM); dna-mus-lvr 6 umol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 947, 1979 (JJIND8); dna-mus-skn 40 umol/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 23, p. 201, 1979 (IJCNAW); dna-mus-oth 1 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 4, p. 389, 1971/1972 (CBINA8); oms-mus-oth 1 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 4, p. 389, 1971/1972 (CBINA8); dna-mus-emb 510 nmol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 9, p. 349, 1972 (IJCNAW); oms-mus-emb 510 nmol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 9, p. 349, 1972 (IJCNAW); mmo-ham-lng 56400 nmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 27, 1977 (MUREAV); mtr-ham-emb 2500 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 32, p. 1391, 1972 (CNREA8); mtr-ham-kdy 25 ug/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 143, 1980 (TOLED5); dnd-ham-fbr 5 mg/L/24H Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 20, p. 1297, 1971 (BCPCA6); dna-ham-emb 360 nmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 257, 1978 (CBINA8); dnd-ham-kdy 5 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 20, p. 1297, 1971 (BCPCA6); dna-ham-lng 1 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 4, p. 389, 1971/1972 (CBINA8); oms-ham-lng 1 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 4, p. 389, 1971/1972 (CBINA8); cyt-ham-fbr 1 mmol/L Proceedings of the Japan Academy. (Tokyo, Japan) V.21-53, 1945-77. For publisher information, see PJABDW. v. 53, p. 46, 1977 (PJACAW); sce-ham-ipr 900 mg/kg/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 65, 1979 (MUREAV); msc-ham-lng 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 65, 1984 (MUREAV); dnd-mam-lym 2 nmol/L Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 5, p. 521, 1962 (JMOBAK); dnd-esc 1207.1 ug/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 515, p. 85, 2002 (MUREAV); mrc-dmg 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 514, p. 193, 2002 (MUREAV); dna-mus-orl 6.3 mg/kg/9W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 15, p. 59, 1995 (JJATDK); mnt-mus-orl 6.3 mg/kg/9W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 15, p. 59, 1995 (JJATDK); dns-mus-orl 6.3 mg/kg/9W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 15, p. 59, 1995 (JJATDK) TE: V01-J60 itr-rat TDLo: 100 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(7), p. 12, 1966 (GISAAA); V01-J60 orl-mus TDLo: 4160 mg/kg/26W-I Journal of Pathology and Bacteriology. (London, UK) V.1-96, 1892-1968. For publisher information, see JPTLAS. v. 49, p. 21, 1939 (JPBAA7); V01-R60-V10 skn-mus TDLo: 1200 mg/kg/50W-I "Mycotoxins in Foodstuffs, Proceedings of the Symposium held at the Massachusetts Institute of Technology, 1964," Wogan, G.N., ed., Cambridge, MA, MIT Press, 1965 -,275,1965 (14JTAF); V01-R60-V10 scu-mus TDLo: 445 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 11, p. 1721, 1990 (CRNGDP); V02-J60-L60 ivn-mus TDLo: 40 mg/kg Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878- v. 54, p. 1158, 1939 (PHRPA6); V01-M60 imp-mus TDLo: 80 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 11, p. 212, 1957 (BJCAAI); V03-J60-V10 mul-mus TDLo: 40 mg/kg/12D-I Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878- v. 52, p. 637, 1937 (PHRPA6); V03-J60-V10 scu-gpg TDLo: 250 mg/kg/24D-I Arkhiv Biologicheskikh Nauk. Archives of Biological Sciences. For French translation, see ASBUAN. (Moscow, USSR) V.1-64, 1892-1941. Discontinued. v. 51, p. 112, 1938 (AKBNAE); V03-J60-V10 ivn-gpg TDLo: 30 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 13, p. 705, 1952 (JNCIAM); V01-L60-V10 ims-pgn TDLo: 6 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 32, p. 905, 1964 (JNCIAM); V02-J60-M61 irn-frg TDLo: 12 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 24, p. 1969, 1964 (CNREA8); V02-V10 imp-mus TD :14 mg/kg American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 16, p. 287, 1940 (AJPAA4); V02-V10 scu-mus TD :78 ug/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 3, p. 503, 1943 (JNCIAM); V01-J60-K60 orl-mus TD :4520 mg/kg/36W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 1, p. 17, 1940 (JNCIAM); V02-J61-V10 imp-mus TD :200 mg/kg American Journal of Cancer. (New York, NY) V.15-40, 1931-40. For publisher information, see CNREA8. v. 36, p. 201, 1939 (AJCAA7); V02-R60 skn-mus TD :6 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 20, p. 1179, 1960 (CNREA8); V03-V10 scu-mus TD :6 mg/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 32, p. 765, 1983 (IJCNAW); V02-R60 skn-mus TD :400 mg/kg/40W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 22, p. 78, 1962 (CNREA8); V01-M60-V10 imp-mus TD :100 mg/kg British Medical Bulletin. (Longman Group UK Ltd., Longman House, Burnt Mill, Harlow, Essex CM20 2JE, UK) V.1- 1943- v. 14, p. 147, 1958 (BMBUAQ); V02-J60-V10 scu-rat TD :135 mg/kg/9W-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 68, p. 330, 1948 (PSEBAA); V02-V10 scu-mus TD :400 mg/kg/10W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 2, p. 500, 1967 (IJCNAW) AT: T/E unlistd ivn-mus LDLo: 10 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 1, p. 225, 1940 (JNCIAM) MD: S25 unr-mus TDLo: 180 mg/kg/12D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 13, 1999 (TOXID9) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 178, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 299, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 299, 1983 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 23, p. 6, 1971 (AEHLAU); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 39, p. 257, 1977 (MUREAV); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY) SR: OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.04 mg/m3, JAN 1999; OEL-POLAND: TWA 0.004 mg/m3, JAN 1999 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264370); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/F344 rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-BALB/c-3T3, SHE-focus assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-C3H/10T1/2, Cell transform.-mouse embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive/dose response: SHE-clonal assay; EPA GENETOX PROGRAM 1988, Inconclusive: Cell transform.-mouse prostate, In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro UDS-human fibroblast; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Polynuclear aromatic hydrocarbons by HPLC, 5506, by GC, 5515; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 711 of 1119 in RTECS (through 2003/06) AN: HO5600000 PN: 7H-Dibenzo(c,g)carbazole SY: 3,4,5,6-Dibenzcarbazol-; 3,4,5,6-Dibenzcarbazole-; 3,4,5,6-Dibenzocarbazole-; 3,4,5,6-Dinaphthacarbazole-; 7-Aza-7H-dibenzo(c,g)fluorene; 7H-DB(c,g)C; 7H-dibenzo(c,g)carbazole RN: Current: 194-59-2 BRN: 213015 BHR: 5-20-08-00621 UD: 200210 MF: C20-H13-N MW: 267.34 WL: T D6 C6 B566 MMJ CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 20 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 198, p. 15, 1988 (MUREAV); dna-ofs-orl 125 umol/kg/5D-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 427, p. 135, 1999 (MUREAV); mnt-hmn-lym 50 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 109, 1995 (EMMUEG); dna-hmn-fbr 1400 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 4706, 1986 (CNREA8); dnd-hmn-oth 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 469, p. 259, 2000 (MUREAV); dni-hmn-oth 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 4706, 1986 (CNREA8); msc-hmn-fbr 500 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 4706, 1986 (CNREA8); dna-mus-orl 80 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 2633, 1989 (CNREA8); dna-mus-scu 44 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1271, 1985 (CRNGDP); dna-mus-ipr 37 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 591, 1987 (CRNGDP); dna-mus-ipr 5 umol/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 25, p. 202, 1995 (EMMUEG); mmo-ham-emb 400 nmol/L (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 419, 1989 (CRNGDP); mnt-ham-oth 0.5 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 491, p. 87, 2001 (MUREAV); slt-ham-oth 0.5 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 517, p. 135, 2002 (MUREAV) TE: V03-V10 scu-rat TDLo: 150 mg/kg/17W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 122, p. 429, 1937 (PRLBA4); V03-K60-L60 orl-mus TDLo: 280 mg/kg/32W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 4, p. 203, 1950 (BJCAAI); V01-R60 skn-mus TDLo: 99 mg/kg/99W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 37, p. 337, 1987 (CALEDQ); V03-V10 ipr-mus TDLo: 13 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 32, p. 1460, 1938 (BIJOAK); V03-K60-L60 orl-mus TDLo: 280 mg/kg/32W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 4, p. 203, 1950 (BJCAAI); V03-J60 ivn-mus TDLo: 10 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 1, p. 225, 1940 (JNCIAM); V03-V10 imp-mus TDLo: 40 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 6, p. 412, 1952 (BJCAAI); V03-M60 imp-dog TDLo: 65 mg/kg/52W-I Journal of Pathology and Bacteriology. (London, UK) V.1-96, 1892-1968. For publisher information, see JPTLAS. v. 68, p. 561, 1954 (JPBAA7); V02-J60-J61 itr-ham TDLo: 72 mg/kg/18W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 935, 1977 (JTEHD6); V03-L60-R60 skn-mus TD :90 mg/kg/23W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 122, p. 429, 1937 (PRLBA4) AT: L30 ipr-mus LDLo: 13 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 32, p. 1460, 1938 (BIJOAK) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 260, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 315, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 315, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Pc,4,1972 (85DHAX) SR: OEL-NORWAY: TWA 0.04 mg/m3, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 712 of 1119 in RTECS (through 2003/06) AN: HO5775000 PN: Dibenzo(b,def)chrysene SY: DB(a,h)P; Dibenzo(a,h)pyrene; 1,2,6,7-Dibenzopyrene-; 3,4,8,9-Dibenzopyrene-; 3,4,8,9-Dibenzpyrene- RN: Current: 189-64-0 BRN: 2054067 BHR: 4-05-00-02802 UD: 200007 MF: C24-H14 MW: 302.38 WL: L D6 B66 O666 2AB A&J CC: Tumorigen (C); Mutagen (M) ME: msc-hmn-lym 500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 342, p. 9, 1995 (MUREAV); mmo-ham-lng 30 ug/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 1646, 1982 (CNREA8) TE: V03-R60 par-rat TDLo: 96761 ug/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 115, p. 67, 1989 (JCROD7); V03-V10 imp-rat TDLo: 100 mg/kg Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 26, p. 23, 1979 (NEOLA4); V01-R60-V10 skn-mus TDLo: 287 mg/kg/30W-I Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 89, p. 113, 1977 (ZKKOBW); V03-J60-L60 scu-mus TDLo: 72 mg/kg/9W-I Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 246, p. 1477, 1958 (COREAF); V03-R60-V10 skn-mus TD :330 mg/kg/15W Arkhiv Biologicheskikh Nauk. Archives of Biological Sciences. For French translation, see ASBUAN. (Moscow, USSR) V.1-64, 1892-1941. Discontinued. v. 56(12), p. 39, 1939 (AKBNAE); V03-J60-R60 skn-mus TD :700 mg/kg/42W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 129, p. 439, 1940 (PRLBA4); V03-R60-V10 skn-mus TD :1060 mg/kg/44W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 123, p. 343, 1937 (PRLBA4) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 207, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 331, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 331, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Pc,4,1972 (85DHAX) SR: OEL-FRANCE: Carcinogen, JAN 1993; OEL-NORWAY: TWA 0.04 mg/m3, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 713 of 1119 in RTECS (through 2003/06) AN: HO6125000 PN: Dibenzo(def,p)chrysene SY: 1,2,3,4-Dibenzpyrene-; 1,2,9,10-Dibenzopyrene-; 1,2:3,4-Dibenzopyrene; 2,3:4,5-Dibenzopyrene; 4,5,6,7-Dibenzpyrene-; BA-51-090462-; DB(a,l)P; DBP-; Dibenzo(a,d)pyrene; Dibenzo(a,l)pyrene RN: Current: 191-30-0 BRN: 2054068 BHR: 4-05-00-02803 UD: 200207 MF: C24-H14 MW: 302.38 WL: L D66 K666 B6 2AB A&J CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 5 nmol/plate (-S9) Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 3, p. 580, 1990 (CRTOEC); dna-ofs-orl 200 ppm/2W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 19, p. 1323, 1998 (CRNGDP); dna-hmn-mmr 500 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1769, 1996 (CRNGDP); msc-hmn-lym 310 pmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 342, p. 9, 1995 (MUREAV); dna-rat-oth 5 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 20, p. 1147, 1999 (CRNGDP); dna-rat-orl 5 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 20, p. 1147, 1999 (CRNGDP); dna-rat-ipr 5 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 20, p. 1147, 1999 (CRNGDP); mtr-mus-emb 100 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 1973, 1997 (CRNGDP); dna-mus-emb 100 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 1973, 1997 (CRNGDP); dna-hmn-mmr 0.004 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 480-481, p. 97, 2001 (MUREAV); dna-hmn-mmr 0.01 umol/L/4H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 480-481, p. 97, 2001 (MUREAV); dna-hmn-mmr 0.01 umol/L/12H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 480-481, p. 97, 2001 (MUREAV); dna-hmn-mmr 0.01 umol/L/36H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 480-481, p. 97, 2001 (MUREAV); dna-hmn-mmr 0.01 umol/L/72H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 480-481, p. 97, 2001 (MUREAV); dna-hmn-fbr 0.01 mmol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 471, p. 57, 2000 (MUREAV); mtr-mus-emb 33 nmol/L/24H Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 1253, 2000 (CRNGDP); dna-mus-emb 33 nmol/L/24H Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 1253, 2000 (CRNGDP) TE: V01-R60 par-rat TDLo: 96761 ug/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 115, p. 67, 1989 (JCROD7); V03-R60-V10 skn-mus TDLo: 890 mg/kg/37W-I Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 123, p. 343, 1937 (PRLBA4); V03-V10 scu-mus TDLo: 48 mg/kg/4W-I Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 55, p. 43, 1968 (NATWAY); V03-V10 scu-mus TD :72 mg/kg/9W-I Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 258, p. 3387, 1964 (COREAF); V01-V16-R60 skn-mus TDLo: 483.8 ug/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 136, p. 119, 1999 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 343, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 343, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Pc,4,1972 (85DHAX) SR: OEL-FRANCE: Carcinogen, JAN 1993; OEL-NORWAY: TWA 0.04 mg/m3, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 714 of 1119 in RTECS (through 2003/06) AN: HP3500000 PN: Dibenzo-p-dioxin,-2,3,7,8-tetrachloro- SY: 2,3,7,8-Czterochlorodwubenzo-p-dwuoksyny- (Polish); 2,3,7,8-TCDD-; 2,3,7,8-Tetrachlorodibenzo(b,e)(1,4)dioxan; 2,3,7,8-Tetrachlorodibenzo-1,4-dioxin-; 2,3,7,8-Tetrachlorodibenzo-p-dioxin-; 2,3,7,8-Tetrachlorodibenzo-p-dioxin- (TCDD); Dibenzo(b,e)(1,4)dioxin, 2,3,7,8-tetrachloro-; Dioksyny- (Polish); Dioxin-; Dioxin- (herbicide contaminant); Dioxine-; NCI-C03714-; TCDBD-; TCDD-; Tetradioxin- RN: Current: 1746-01-6 Previous: 56795-67-6 BRN: 271116 BHR: 5-19-02-00041 UD: 200305 MF: C12-H4-Cl4-O2 MW: 321.96 WL: T C666 BO IOJ EG FG LG MG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: eye-rbt 2 mg MOD EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 87, 1973 (EVHPAZ) ME: mmo-sat 2 mg/L (+S9) Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 32, 1972 (AMBOCX); mmo-esc 2 mg/L (-S9) Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 1, 1972 (AMBOCX); pic-esc 500 ug/L Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 1, 1972 (AMBOCX); mmo-smc 10 mg/L (-S9) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 12, p. 549, 1983 (CMSHAF); mmo-smc 2 mg/L (+S9) Pergamon Series on Environmental Science. (Oxford, UK) V.1-7, 1978-82. Discontinued. v. 5, p. 429, 1982 (PSSID2); mrc-smc 10 mg/L Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 12, p. 549, 1983 (CMSHAF); dns-hmn-oth 100 pmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 11, p. 1335, 1990 (CRNGDP); dni-hmn-oth 10 nmol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 77, p. 434, 1985 (TXAPA9); dnd-rat-orl 100 ug/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 39, p. 281, 1988 (CALEDQ); dns-rat-ivn 4 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 31, p. 2459, 1982 (BCPCA6); dns-rat-orl 5 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 28, p. 133, 1983 (TXCYAC); dni-rat-ipr 10 ug/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 8, p. 31, 1974 (CBINA8); dni-rat-orl 200 ug/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 8, p. 31, 1974 (CBINA8); cyt-rat-orl 100 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 141, 1978 (MUREAV); cyt-rat-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 141, 1978 (MUREAV); mtr-mus-fbr 200 nmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 461, 1984 (ENMUDM); oms-mus-oth 1 nmol/L Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905- v. 259, p. 12357, 1984 (JBCHA3); dns-mus-orl 800 pmol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1433, 1987 (CRNGDP); dni-mus-ipr 400 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); oms-mus-orl 50 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 56, p. 239, 1989 (TXCYAC); cyt-mus-orl 100 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 29, p. 229, 1974 (TXAPA9); cyt-mus-ipr 10 ug/kg Pergamon Series on Environmental Science. (Oxford, UK) V.1-7, 1978-82. Discontinued. v. 5, p. 419, 1982 (PSSID2); msc-mus-lym 50 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 391, 1982 (ENMUDM); hma-mus-smc 25 ug/kg Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 12, p. 549, 1983 (CMSHAF); mtr-mus-fbr 10 nmol/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG); dnd-rat-unr 100 ug/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 29, p. 281, 1988 (CALEDQ); dna-rat-ipr 40 ug/kg/4W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 975, 1992 (CMSHAF) RE: T34-T53 orl-rat TDLo: 1500 ng/kg (1-3D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(1), p. 21A, 1982 (TJADAB); T35-T34-T59 orl-rat TDLo: 1250 ng/kg (6-15D preg) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 405, 1971 (FCTXAV); T35-T53-T77 orl-rat TDLo: 1 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 150, p. 254, 1998 (TXAPA9); T29-T48-T81 orl-rat TDLo: 1270 ng/kg (multigenerations) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 50, p. 241, 1979 (TXAPA9); T86 orl-rat TDLo: 1 ug/kg (15D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 140, p. 146, 1996 (TXAPA9); T13 orl-rat TDLo: 20 ug/kg (1D pre) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 21, p. 77, 1981 (TXCYAC); T52 orl-rat TDLo: 1 ug/kg (15D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 56, p. 1498, 1997 (BIREBV); T83 ipr-rat TDLo: 6 ug/kg (17D preg) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 26, p. 1383, 1977 (BCPCA6); T53 scu-rat TDLo: 5 mg/kg (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 20, p. 396, 1971 (TXAPA9); T81 scu-rat TDLo: 2200 ng/kg (19D preg/21D post) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 1227, 1992 (CMSHAF); T02-T03 unr-rat TDLo: 1500 mg/kg (1D male) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 11, p. 344, 1987 (ATSUDG); T53 orl-mus TDLo: 1 ug/kg (10D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 81, 1973 (EVHPAZ); T43 orl-mus TDLo: 9 ug/kg (12D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 98, p. 487, 1989 (TXAPA9); T52 orl-mus TDLo: 13500 mg/kg (6-14D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 44, p. 385, 1991 (TJADAB); T54 orl-mus TDLo: 235 ug/kg (28D pre-21D post) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 2, p. 77, 1979 (DCTODJ); T81-T87 orl-mus TDLo: 20 ug/kg (14D preg/3D post) International Journal of Immunopharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1979- v. 2, p. 301, 1980 (IJIMDS); T25-T35 orl-mus TDLo: 12 ug/kg (10-13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 33, p. 29, 1986 (TJADAB); T33-T53 orl-rat TDLo: 12 ug/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 55, p. 326, 1997 (TJADAB); T34-T43 ipr-mus TDLo: 25 ug/kg (7-11D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 20, p. 299, 1981 (TXCYAC); T43 ipr-mus TDLo: 20 ug/kg (11D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 43, 1985 (ATSUDG); T43-T46-T53 scu-mus TDLo: 250 ug/kg (7-16D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 16, p. 674, 1976 (BECTA6); T26-T35 scu-mus TDLo: 250 ug/kg (7-16D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 16, p. 674, 1976 (BECTA6); T25 scu-mus TDLo: 100 ug/kg (2D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 4, p. 427, 1984 (TCMUD8); T43 scu-mus TDLo: 30 ug/kg (10D preg) Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 17, p. 86, 1980 (MOPMA3); T43 scu-mus TDLo: 100 ug/kg (10D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 4, p. 427, 1984 (TCMUD8); T85-T91 orl-mky TDLo: 92 ng/kg (46W pre-17W post) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 11, p. 13, 1989 (NETEEC); T85 orl-mky TDLo: 107 mg/kg (4Y male) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 20, p. 1103, 1990 (CMSHAF); T85 orl-mky TDLo: 123 ng/kg (30W pre-17W post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 3, p. 68, 1983 (TOXID9); T85 orl-mky TDLo: 163 ng/kg (182W pre) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 14, p. 433, 1992 (NETEEC); T27 orl-mky TDLo: 2 ug/kg (12D preg) Biomedical and Environmental Sciences. (Academic Press, 525 B St., Suite 1900, San Diego, CA 92101) V.1- 1988- v. 13, p. 26, 2000 (BESCE5); T25-T53 orl-rbt TDLo: 2500 ng/kg (6-15D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 27, p. 74, 1982 (ENVRAL); T24-T27 orl-rbt TDLo: 10 ug/kg (6-15D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 27, p. 74, 1982 (ENVRAL); T46 orl-rbt TDLo: 1 ug/kg (6-15D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 27, p. 74, 1982 (ENVRAL); T35 orl-ham TDLo: 18 ug/kg (9D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 20, p. 1117, 1990 (CMSHAF); T81-T87 orl-ham TDLo: 2 ug/kg (11D preg) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 51, p. 259, 1999 (TOSCF2); T49-T83 scu-rat TDLo: 0.5 ug/kg (7-20D preg/9-16D post) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 62, p. 617, 2001 (BCPCA6); T53 orl-ham TDLo: 1 ug/kg (11D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 131, p. 108, 1995 (TXAPA9); T86 orl-ham TDLo: 2 ug/kg (11D preg) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 51, p. 259, 1999 (TOSCF2); T54 orl-mus TDLo: 10 ug/kg (14D preg) Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 35, p. 18, 1989 (MOPMA3); T33-T43 orl-mus TDLo: 12 ug/kg (10-13D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 13, p. 103, 1993 (TOXID9); T76 orl-mus TDLo: 240 ug/kg (1D post) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 69, p. 87, 1994 (ARTODN); T81 orl-mus TDLo: 320 ug/kg (1D post) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 69, p. 87, 1994 (ARTODN); T53 orl-mus TDLo: 480 ug/kg (1D post) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 69, p. 87, 1994 (ARTODN); T34 orl-rat TDLo: 1 ug/kg (15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 13, p. 104, 1993 (TOXID9); T29-T52-T53 orl-rat TDLo: 1 ug/kg (8D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 133, p. 285, 1995 (TXAPA9); T52-T53-T81 orl-rat TDLo: 1 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 133, p. 285, 1995 (TXAPA9); T53 orl-rat TDLo: 0.05 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 146, p. 11, 1997 (TXAPA9); T52-T54 orl-rat TDLo: 56 mg/kg (10-16D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 78, p. 253, 1995 (TOLED5); T41-T85 orl-rat TDLo: 0.7 ug/kg (15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 14, p. 197, 1994 (TOXID9); T01-T02-T53 orl-rat TDLo: 0.064 ug/kg (15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 10, p. 313, 1990 (TOXID9); T01-T53-T81 orl-rat TDLo: 1 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 127, p. 241, 1994 (TXAPA9); T34-T35-T53 orl-rat TDLo: 0.7 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 127, p. 250, 1994 (TXAPA9); T52-T53 orl-rat TDLo: 1 ug/kg (15D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 55, p. 62, 1996 (BIREBV); T25-T34-T53 orl-rat TDLo: 1 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 140, p. 146, 1996 (TXAPA9); T53 orl-rat TDLo: 1 ug/kg (11D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 292, 1995 (TOXID9); T53 orl-rat TDLo: 1 ug/kg (18D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 292, 1995 (TOXID9); T53 par-rat TDLo: 1 ug/kg (15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 14, p. 197, 1994 (TOXID9); T82 scu-rat TDLo: 185 ng/kg (2W pre-3W post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 150, p. 383, 1998 (TXAPA9); T52 scu-rat TDLo: 2700 ng/kg (2W pre-3W post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 150, p. 383, 1998 (TXAPA9); T83 scu-rat TDLo: 3 ug/kg (19D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 40, p. 292, 1989 (TJADAB); T53 unr-rat TDLo: 0.7 ug/kg (15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 14, p. 382, 1994 (TOXID9); T81-T86 orl-rat TDLo: 1 ug/kg (8D preg) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 52, p. 45, 1999 (TOSCF2); T81-T86 orl-mus TDLo: 3 ug/kg (8D preg) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 52, p. 45, 1999 (TOSCF2); T26-T39-T83 orl-rat TDLo: 800 ng/kg (15D preg) Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 11, p. 1, 2002 (ETOPFR); T87 ipr-rat TDLo: 50 ug/kg (1D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 173, p. 38, 2001 (TXAPA9); T43 orl-rat TDLo: 0.03 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 174, p. 216, 2001 (TXAPA9); T81-T87 orl-rat TDLo: 1.4 ug/kg (10-15D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 22, p. 511, 2001 (NETEEC); T54-T48 orl-mus TDLo: 15 ug/kg (14D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 103, 1992 (CMSHAF); T81 unr-rat TDLo: 0.8 ug/kg (15D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 741, 2001 (HBPTO*); T53 unr-rat TDLo: 0.2 ug/kg (15D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 741, 2001 (HBPTO*); T52-T86 unr-rat TDLo: 0.05 ug/kg (15D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 741, 2001 (HBPTO*); T52-T53-T75 orl-rat TDLo: 1 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 134, p. 241, 1995 (TXAPA9); T81-T91 orl-rat TDLo: 1 ug/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 134, p. 241, 1995 (TXAPA9); T52 orl-rat TDLo: 0.35 ug/kg (16D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 18, p. 955, 1989 (CMSHAF); T51 orl-rat TDLo: 0.125 ug/kg (16D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 18, p. 955, 1989 (CMSHAF); T50-T59 orl-rat TDLo: 13 ug/kg (7-19D preg) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 32, p. 991, 1983 (BCPCA6); T50 orl-rat TDLo: 12 ug/kg (4-15D preg) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 32, p. 991, 1983 (BCPCA6); T25-T27 orl-mky TDLo: 0.535 ug/kg (30W pre) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. -, p. 419, 1979 (ANYAA9); T13-T12-T69 orl-mus TDLo: 50 ug/kg (105D pre) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 750, 1997 (EVHPAZ); T54 unr-mus TDLo: 12 ug/kg (6-14D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 115, 1992 (CMSHAF); T52-T81-T86 orl-rat TDLo: 1 ug/kg (15D preg) Biology of Reproduction, Supplement. (Champaign, IL) No.1-4, 1969-71(?). Discontinued. For publisher information, see BIREBV. v. 62, p. 184, 2000 (BIRSB5); T39-T43 orl-mus TDLo: 5 ug/kg (9D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 67, p. 591, 1993 (ARTODN); T85-T91 orl-rat TDLo: 0.18 ug/kg (15D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 209, 2002 (NETEEC); T43 scu-mus TDLo: 90 ug/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 62A, 1980 (TJADAB); T43 scu-mus TDLo: 90 ug/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 62A, 1980 (TJADAB); T43 scu-mus TDLo: 90 ug/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 62A, 1980 (TJADAB) TE: V01-L60-N62 orl-rat TDLo: 52 ug/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-209, 1982 (NTPTR*); V01-L60-N62 orl-mus TDLo: 52 ug/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-209, 1982 (NTPTR*); V01-R60 skn-mus TDLo: 62 ug/kg/2Y-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-201, 1982 (NCITR*); V03-J60 orl-rat TD :328 ug/kg/78W-C Pesticide and Toxic Chemical News. (Food Chemical News, Inc., 400 Wyatt Bldg., 777 14th St., NW, Washington, DC 20005) V.1- 1972- v. 5, p. 12, 1977 (PESTC*); V03-L60-M61 orl-rat TD :137 ug/kg/65W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 36, p. 396, 1977 (FEPRA7); V01-L60 orl-rat TD :73 ug/kg/2Y-C Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 320, p. 397, 1979 (ANYAA9); V03-L60-N62 orl-rat TD :1 ug/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-209, 1982 (NTPTR*); V03-L60-N62 orl-mus TD :1 ug/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-209, 1982 (NTPTR*); V01-J60-L60 orl-rat TDLo: 164 ug/kg/78W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 6, p. 625, 1977 (CMSHAF); V03-J60-L60 orl-rat TD :190 ug/kg/95W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 6, p. 537, 1977 (CMSHAF); V03-L60-M61 orl-rat TD :27 ug/kg/65W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 36, p. 396, 1977 (FEPRA7); V02-J60-L60 orl-mus TD :36 ug/kg/52W-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 278, p. 548, 1979 (NATUAS); V03-R60-V10 skn-mus TD :80 ug/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 18, p. 552, 1977 (BECTA6); V01-R60 skn-mus TDLo: 0.0594 mg/kg/99W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-163684 (NTIS**); V03-R60 skn-mus TDLo: 0.01188 mg/kg/99W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-163684 (NTIS**); V02-N62 orl-rat TDLo: 0.052 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-163445 (NTIS**); V01-L60 orl-rat TDLo: 0.052 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-163445 (NTIS**); V01-L60 orl-mus TDLo: 0.052 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-163445 (NTIS**); V01-L60-N62 orl-mus TDLo: 0.208 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-163445 (NTIS**) ORNG: 20000 ng/kg. [0.020000 mg/kg] T/E unlistd SRNG: 275000 ng/kg. [0.275000 mg/kg] T/E unlistd AT: R12 skn-hmn TDLo: 107 ug/kg Scientific American. (Scientific American, Inc., 415 Madison Ave., New York, NY 10017) V.1- 1859- v. 254, p. 29, 1986 (SCAMAC); T/E unlistd orl-rat LD50: 20 ug/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 38, p. 879, 1982 (EXPEAM); T/E unlistd ipr-rat LD50: 24600 ng/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 513, 1978 (TXAPA9); D16-F12-G30 orl-mus LD50: 114 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 29, p. 229, 1974 (TXAPA9); K30 skn-mus LDLo: 80 ug/kg Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 20, p. 101, 1978 (RCOCB8); T/E unlistd ipr-mus LD50: 120 ug/kg Scientific American. (Scientific American, Inc., 415 Madison Ave., New York, NY 10017) V.1- 1859- v. 254, p. 29, 1986 (SCAMAC); L03-U01 unr-mus LDLo: 200 ug/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 320, p. 204, 1979 (ANYAA9); T/E unlistd orl-dog LD50: 1 ug/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 38, p. 879, 1982 (EXPEAM); T/E unlistd orl-mky LD50: 2 ug/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 38, p. 879, 1982 (EXPEAM); T/E unlistd orl-rbt LD50: 115 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 35, p. 553, 1976 (TXAPA9); T/E unlistd skn-rbt LD50: 275 ug/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 87, 1973 (EVHPAZ); T/E unlistd ipr-rbt LD50: 252 ug/kg Scientific American. (Scientific American, Inc., 415 Madison Ave., New York, NY 10017) V.1- 1859- v. 254, p. 29, 1986 (SCAMAC); T/E unlistd orl-gpg LD50: 500 ng/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 2, p. 708, 1973 (EVSRBT); K30-P28-U01 orl-ham LD50: 1157 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 55, p. 67, 1980 (TXAPA9); N74-P28-U01 ipr-ham LD50: >3 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 55, p. 67, 1980 (TXAPA9); J22-U01 orl-ckn LDLo: 25 ug/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 585, 1973 (FCTXAV); F15-U01-U30 ipr-ckn LDLo: 25 ug/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 35, p. 187, 1992 (JTEHD6); T/E unlistd orl-frg LD50: 1 mg/kg Scientific American. (Scientific American, Inc., 415 Madison Ave., New York, NY 10017) V.1- 1859- v. 254, p. 29, 1986 (SCAMAC); L30-M30-P27 orl-mam LD50: 4200 ng/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 17, p. 33, 1988 (AECTCV); N13-N30 orl-rat TDLo: 50 ug/kg Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 15, p. 365, 1993 (NETEEC); T01 ipr-rat TDLo: 1 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 150, p. 427, 1998 (TXAPA9); T02-Y20 ipr-rat TDLo: 10 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 150, p. 427, 1998 (TXAPA9); N73 orl-rat TDLo: 90 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 106, p. 221, 1996 (TXCYAC); S03-U01 orl-rat TDLo: 10 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 106, p. 221, 1996 (TXCYAC); N74-S05-U01 orl-rat TDLo: 1 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 106, p. 221, 1996 (TXCYAC); S04 ipr-mus TDLo: 0.6 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 92, p. 155, 1994 (TXCYAC); N74 orl-rat TDLo: 5 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 128, p. 97, 1994 (TXAPA9); T02-T03-U01 ipr-rat TDLo: 12.5 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 89, p. 49, 1994 (TXCYAC); N02-N04 orl-rat TDLo: 0.03 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 142, p. 264, 1997 (TXAPA9); L70 scu-rat TDLo: 20 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 133, p. 313, 1995 (TXAPA9); L70-U01 scu-rat TDLo: 40 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 133, p. 313, 1995 (TXAPA9); T12-T14 orl-mky TDLo: 0.004 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 15, p. 377, 2001 (REPTED); P14-P26 ipr-mus TDLo: 10 ug/kg Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 43, p. 819, 2001 (CMSHAF); L30-U11-Y40 orl-rat TDLo: 1 ug/kg Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 1291, 2001 (LIFSAK); U09 orl-rat TDLo: 2 ug/kg Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 1291, 2001 (LIFSAK); U11 orl-rat TDLo: 4 ug/kg Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 1291, 2001 (LIFSAK); F17 orl-mus TDLo: 10 ug/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 56, p. 114, 2000 (TOSCF2); H01-G08-U28 orl-rat TDLo: 1 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 145, p. 227, 2000 (TXCYAC); Y07 orl-rat TDLo: 0.2 ug/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 199, 1973 (EVHPAZ); Y09 orl-rat TDLo: 1 ug/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 199, 1973 (EVHPAZ); N17-N30 ipr-rat TDLo: 82.4 ug/kg Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 19, p. 785, 1989 (CMSHAF); N30-U01-Z01 ipr-rat TDLo: 100 ug/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 16, p. 481, 1985 (JTEHD6); N02-N16-T02 orl-rat TDLo: 50 ug/kg Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 45, p. 143, 1991 (BIREBV); N16 orl-rat TDLo: 100 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 105, p. 78, 1990 (TXAPA9); Y07 ipr-mus TDLo: 9.66 ug/kg Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 13, p. 924, 1977 (MOPMA3); Y07 ipr-rat TDLo: 9.66 ug/kg Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 13, p. 924, 1977 (MOPMA3); N08-U01 ipr-rat TDLo: 1 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 44, p. 297, 1987 (TXCYAC); N30 ipr-rat LDLo: 25 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 44, p. 297, 1987 (TXCYAC); F15-N22 ipr-rat TDLo: 125 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 44, p. 297, 1987 (TXCYAC); F15-J25-N30 orl-rat TDLo: 6.25 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 84, p. 45, 1986 (TXAPA9); U01 orl-rat TDLo: 12.5 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 84, p. 45, 1986 (TXAPA9); L30-N17 ipr-rat TDLo: 10.3 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 95, p. 435, 1988 (TXAPA9); Z74 ipr-rat TDLo: 82.4 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 95, p. 435, 1988 (TXAPA9); N74-P26 ipr-mus TDLo: 30 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 47, p. 2039, 1994 (BCPCA6); Y07 ipr-ham TDLo: 1 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 2737, 1986 (BCPCA6); L70-U01 ipr-ham TDLo: 10 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 2737, 1986 (BCPCA6); N74 ipr-ham TDLo: 100 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 2737, 1986 (BCPCA6); L30 ipr-ham TDLo: 500 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 2737, 1986 (BCPCA6); N30 orl-rat TDLo: 25 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 33, p. 2531, 1984 (BCPCA6); T03-Y09 orl-rat TDLo: 10 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 215, p. 601, 1980 (JPETAB); N17 ipr-rat TDLo: 20 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 92, p. 368, 1988 (TXAPA9); T03-Y07 ipr-rat TDLo: 10 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 29, p. 61, 1983 (TXCYAC); N73-L30-Y04 ipr-rat TDLo: 5 ug/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 53, p. 177, 1983 (ATXKA8); T/E unlistd orl-ham LD50: 5051 ug/kg Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health Organization) 1- 1976- v. VI:88 , p. 1, 1989 (TAEHC*); P30-P72 skn-mky TDLo: 10 ng/kg Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health Organization) 1- 1976- v. VI:205, p. 1, 1998 (TAEHC*); L30-P27-Y04 ipr-rat TDLo: 5 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 177, 1983 (ARTODN); S04-S05 ipr-mus TDLo: 782 ng/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 94, p. 141, 1988 (TXAPA9); L30-Y20 ipr-gpg TDLo: 29.9 ng/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 36, p. 1535, 1988 (BCPCA6); U01 ipr-gpg TDLo: 1.8 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 36, p. 1535, 1988 (BCPCA6); N30-Y40-Y53 orl-mus TDLo: 50 ug/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 23, p. 783, 2002 (NRTXDN); N30-P27-Y04 ipr-rat TDLo: 5 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 177, 1983 (ARTODN); F15-L30-Y37 ipr-rat TDLo: 125 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 62, p. 146, 1988 (ARTODN); U01-L30-Y37 ipr-rat TDLo: 10 ug/kg Lipids. (American Oil Chemists' Soc., POB 5037, Stn. A., Champaign, IL 61820) V.1- 1966- v. 23, p. 904, 1988 (LPDSAP); L70-L30-Y37 ipr-rat TDLo: 1 ug/kg Lipids. (American Oil Chemists' Soc., POB 5037, Stn. A., Champaign, IL 61820) V.1- 1966- v. 23, p. 904, 1988 (LPDSAP); L30-Y20-Y37 ipr-rat TDLo: 10 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 248, p. 62, 1989 (JPETAB); P27-S02-S05 ipr-mus TDLo: 1.5 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 80, p. 217, 1993 (TXCYAC); L30-Y04 ipr-mus TDLo: 0.29 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 80, p. 217, 1993 (TXCYAC) MD: P28-P73-Y20 orl-rat TDLo: 30 ug/kg/30D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 111, 1973 (EVHPAZ); L70-N74-P08 orl-rat TDLo: 6500 ng/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 35, p. 553, 1976 (TXAPA9); L02-L70-M16 orl-rat TDLo: 7300 mg/kg/2Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 46(2), p. 279, 1978 (TXAPA9); L30-M16-Y36 orl-rat TDLo: 16 ug/kg/16W-I Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 31, p. 1607, 1982 (BCPCA6); L30-U09-Y07 orl-rat TDLo: 120 ug/kg/3D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 45, p. 436, 1990 (BECTA6); M16 orl-rat TDLo: 450 ng/kg/45W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 57, p. 156, 1981 (TXAPA9); P02-P71-P73 orl-rat TDLo: 140 ug/kg/14D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 119, 1973 (EVHPAZ); L70-N73-N74 orl-mus TDLo: 588 ug/kg/14D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 112, p. 128, 1992 (TXAPA9); N30-N74-S02 orl-mus TDLo: 20 ug/kg/4W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 149, 1973 (EVHPAZ); L30-Z01 orl-mus TDLo: 520 ug/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-209, 1982 (NTPTR*); P30-P72-S04 orl-mus TDLo: 336 ug/kg/8W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(2-3), p. 401, 1980 (JEPTDQ); L01-P27-Z01 skn-mus TDLo: 97 ug/kg/13W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-201-82 (NCITR*); L03-N74-P28 orl-mus TDLo: 150 ug/kg/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 29, p. 229, 1974 (TXAPA9); L70-N74-P71 ipr-mus TDLo: 9260 ng/kg/4W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 60, p. 247, 1992 (TOLED5); L70-P28-Y15 ipr-mus TDLo: 180 ug/kg/6W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 14, p. 949, 1985 (CMSHAF); L70-N74-P70 ipr-mus TDLo: 120 ug/kg/12W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 19, p. 927, 1989 (CMSHAF); K06-U30-Z01 orl-mky TDLo: 10 ug/kg/12D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 18, p. 108, 1977 (BECTA6); S02-S04-Z01 orl-rbt TDLo: 80 ug/kg/8W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0544117 (NTIS**); L70-N74-U01 orl-gpg TDLo: 441 ng/kg/90D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 454, 1986 (FAATDF); N74-U01 orl-gpg TDLo: 1600 ng/kg/8W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 101, 1973 (EVHPAZ); N30-M30-Z01 orl-gpg TDLo: 5 ug/kg/5W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 125, 1973 (EVHPAZ); L30-Y12-Y16 orl-ham TDLo: 600 ug/kg/3D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 31, p. 649, 1983 (BECTA6); N74-S04 orl-rat TDLo: 3 ug/kg/80D-C European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 293, p. 429, 1995 (EJPHAZ); N74-S04 orl-rat TDLo: 2.9 ug/kg/30D-C European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 293, p. 429, 1995 (EJPHAZ); Y07-Y39 orl-mus TDLo: 97.5 ng/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 124, p. 82, 1994 (TXAPA9); N74-U01-Z01 orl-rat TDLo: 70 ug/kg/13W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 29, p. 2381, 1994 (CMSHAF); P73-Z01 orl-rat TDLo: 41.9 ug/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 146, p. 217, 1997 (TXAPA9); L70 orl-mus TDLo: 12 ug/kg/4D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 33, p. 29, 1986 (TJADAB); L30-Y20-Y37 orl-rat TDLo: 7000 ng/kg/28D-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 43, p. 807, 2001 (CMSHAF); U01-L70-P06 orl-rat TDLo: 28000 ng/kg/28D-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 43, p. 807, 2001 (CMSHAF); S05 orl-mky TDLo: 2.143 ug/kg/120D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 56, p. 374, 2000 (TOSCF2); T19 orl-mky TDLo: 170.4 ug/kg/240D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 56, p. 374, 2000 (TOSCF2); L70-N74-U01 orl-rat TDLo: 22.75 ug/kg/91D-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 2023, 1992 (CMSHAF); Y07 orl-rat TDLo: 2.275 ug/kg/91D-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 2023, 1992 (CMSHAF); R25-Z71-Z74 orl-rat TDLo: 10 ug/kg/7D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 708, 1995 (EVHPAZ); N74-S02 orl-rat TDLo: 2.9 ug/kg/30D-C European Journal of Pharmacology, Environmental Toxicology and Pharmacology Section. (Elsevier Science Publishers B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.228- 1992- v. 293, p. 429, 1995 (EPEPEG); S02 orl-rat TDLo: 3 ug/kg/180D-C European Journal of Pharmacology, Environmental Toxicology and Pharmacology Section. (Elsevier Science Publishers B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.228- 1992- v. 293, p. 429, 1995 (EPEPEG); L30-L70-V05 scu-rat TDLo: 3500 ng/kg/5W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 1143, 1994 (CRNGDP); Y03 scu-rat TDLo: 6300 ng/kg/9W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 1143, 1994 (CRNGDP); U01-Y07-Y53 orl-rat TDLo: 13 ug/kg/13D-I Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 32, p. 991, 1983 (BCPCA6); N08 orl-rat TDLo: 7 ug/kg/4W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 1239, 1992 (CMSHAF); Y53 orl-rat TDLo: 0.7 ug/kg/4W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 1239, 1992 (CMSHAF); L30-U02 orl-rat TDLo: 2.275 ug/kg/13W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 1239, 1992 (CMSHAF); N17-N30 orl-mky TDLo: 5.35 ug/kg/30W-C Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. -, p. 419, 1979 (ANYAA9); T22-T16 orl-mky TDLo: 0.535 ug/kg/30W-C Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. -, p. 419, 1979 (ANYAA9); L70-V08-Y07 orl-mus TDLo: 50 ug/kg/15W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 750, 1997 (EVHPAZ); L70-R03-V16 skn-mus TDLo: 8 mg/kg/20W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 102, p. 362, 1990 (TXAPA9); U01 orl-mam TDLo: 1.68 ug/kg/14D-C Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 43, p. 22, 2001 (VHTODE); Q01-Z01 orl-mam TDLo: 3.36 ug/kg/28D-C Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 43, p. 22, 2001 (VHTODE) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 69, p. 33, 1997 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 41, 1977 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 350, 1987 (IMSUDL); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 69, p. 33, 1997 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 69, p. 33, 1997 (IMEMDT); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 59, p. 1, 1975 (RREVAH); TOXICOLOGY REVIEW Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 94, p. 125, 1972 (ARPAAQ); TOXICOLOGY REVIEW Chemistry. (Washington, DC) V.18-52, 1944-79. v. 47(2), p. 15, 1974 (CHRYAQ); TOXICOLOGY REVIEW Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 3, p. 187, 1975 (TXCYAC); TOXICOLOGY REVIEW Roczniki Panstwowego Zakladu Higieny. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 26, p. 623, 1975 (RPZHAW); TOXICOLOGY REVIEW Biologico. (Instituto Biologica, Av. Cons. Rodriques Alves, 1252, CEP 04014, Sao Paulo, Brazil) V.1- 1935- v. 40(2), p. 44, 1974 (BIOGAL); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 2, p. 305, 1974 (STEVA8); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 15, p. 121, 1976 (EVHPAZ); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 95, 1979 (FCTXAV); TOXICOLOGY REVIEW Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.4- 1979- v. 7, p. 513, 1979 (PHTHDT); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 141, 1978 (MUREAV); TOXICOLOGY REVIEW Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 161, 1978 (ARTODN); TOXICOLOGY REVIEW Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 2, p. 708, 1973 (EVSRBT); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-922905 (NTIS**); TOXICOLOGY REVIEW Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 29, p. 59, 1978 (MEPAAX); TOXICOLOGY REVIEW Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 22, p. 31, 1980 (VHTODE); TOXICOLOGY REVIEW Monographs of the Giovanni Lorenzini Foundation. (New York, NY) V.1, 1978. Discontinued. v. -, p. 123, 1978 (MGLFDB); TOXICOLOGY REVIEW Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 257, 1987 (FCTOD7); TOXICOLOGY REVIEW Annual Review of Pharmacology and Toxicology. (Annual Reviews, Inc., POB 10139, Palo Alto, CA 94303) V.16- 1976- v. 22, p. 517, 1982 (ARPTDI); TOXICOLOGY REVIEW Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 44, p. 211, 1980 (ARTODN); TOXICOLOGY REVIEW Drug Metabolism Reviews. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1972- v. 13, p. 387, 1982 (DMTRAR) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999 ND: NIOSH REL TO TCDD-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X7301; NIS 1; TNF 3; NOS 1; TNE 14; TFE 5 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/89/214522/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 40, 1984; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NCI Carcinogenesis Bioassay (dermal), clear evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-201, 1982 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Carcinogenesis studies, on test (two year studies), October 2000; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 715 of 1119 in RTECS (through 2003/06) AN: HP5295150 PN: Dibenzofuran,-2,3,4,7,8-pentachloro- SY: 2,3,4,7,8-Pentachlorodibenzofuran- RN: Current: 57117-31-4 UD: 200305 MF: C12-H3-Cl5-O MW: 340.40 WL: T B656 HOJ DG EG FG KG LG CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: dna-rat-ipr 80 ug/kg/4W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 975, 1992 (CMSHAF) RE: T35 orl-rat TDLo: 100 ug/kg (8D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 358, 1989 (FAATDF); T34 orl-rat TDLo: 30 ug/kg (8D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 358, 1989 (FAATDF); T43-T49-T52 orl-rat TDLo: 300 ug/kg (8D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 358, 1989 (FAATDF); T34 orl-mus TDLo: 4 ug/kg (10-13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 90, p. 206, 1987 (TXAPA9); T19-N01-T31 orl-mus TDLo: 320 ug/kg (10-13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 45, p. 611, 1992 (TJADAB); T43 orl-mus TDLo: 120 ug/kg (10-13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 90, p. 206, 1987 (TXAPA9); T53 orl-mus TDLo: 20 ug/kg (10-13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 91, p. 246, 1987 (TXAPA9); T52 orl-rat TDLo: 10 ug/kg (16D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 18, p. 955, 1989 (CMSHAF); T51 orl-rat TDLo: 2 ug/kg (16D preg) Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 18, p. 955, 1989 (CMSHAF); T13-T12-T69 orl-mus TDLo: 500 ug/kg (105D pre) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 750, 1997 (EVHPAZ); T52-T81-T86 orl-rat TDLo: 1 ug/kg (15D preg) Biology of Reproduction, Supplement. (Champaign, IL) No.1-4, 1969-71(?). Discontinued. For publisher information, see BIREBV. v. 62, p. 184, 2000 (BIRSB5); T39-T43 orl-mus TDLo: 20 ug/kg (9D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 67, p. 591, 1993 (ARTODN) ORNG: 916000 ng/kg. [0.916000 mg/kg] F17-R21-U01 AT: F17-R21-U01 orl-rat LD50: 916 ug/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 236, 1988 (FAATDF); N30-R21-U01 ivn-mky LDLo: 34 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 93, p. 231, 1988 (TXAPA9); U28 orl-gpg LDLo: 10 ug/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 320, p. 151, 1979 (ANYAA9); L30-Y07-Y09 orl-mus TDLo: 408 ng/kg Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 25, p. 1851, 1992 (CMSHAF); L30-Y04 ipr-rat TDLo: 5 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 177, 1983 (ARTODN); L30-U01-Y20 ipr-rat TDLo: 500 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 32, p. 131, 1984 (TXCYAC); S04-S05 ipr-mus TDLo: 1021 ng/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 94, p. 141, 1988 (TXAPA9); L30-Y20 ipr-gpg TDLo: 242 ng/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 36, p. 1535, 1988 (BCPCA6); U01 ipr-gpg TDLo: 4085 ng/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 36, p. 1535, 1988 (BCPCA6); P27-S02-S05 ipr-mus TDLo: 2 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 80, p. 217, 1993 (TXCYAC); L30-Y04 ipr-mus TDLo: 0.56 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 80, p. 217, 1993 (TXCYAC) MD: L70-N74-U01 orl-rat TDLo: 91 ug/kg/13W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 18, p. 265, 1989 (CMSHAF); L70-N74-P72 orl-rat TDLo: 1820 ug/kg/13W-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 17, p. 1099, 1988 (CMSHAF); L70-M70-N74 ipr-mus TDLo: 360 ug/kg/10W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 20, p. 1165, 1990 (CMSHAF); P28-Y07-Y15 ipr-mus TDLo: 360 ug/kg/12W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 14, p. 953, 1985 (CMSHAF); L70 orl-mus TDLo: 40 ug/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 98, p. 454, 1989 (TXAPA9); L30-Y07 orl-mus TDLo: 20 ug/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 98, p. 454, 1989 (TXAPA9); V08-Y07-Z71 orl-mus TDLo: 500 ug/kg/15W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 750, 1997 (EVHPAZ); Y04-Y37 ipr-mus TDLo: 180 ug/kg/6W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 14, p. 953, 1985 (CMSHAF); L30-N74-Y20 ipr-mus TDLo: 180 ug/kg/6W-I Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 14, p. 953, 1985 (CMSHAF); R03-U01-V16 skn-mus TDLo: 40 ug/kg/20W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 102, p. 362, 1990 (TXAPA9) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 69, p. 345, 1997 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 69, p. 345, 1997 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 69, p. 345, 1997 (IMEMDT) SL: EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 716 of 1119 in RTECS (through 2003/06) AN: HP8225000 PN: 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-3-pentyl-6,6,9-trimethyl- (6ar-trans)- SY: (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol; (-)-delta(sup 9)-trans-Tetrahydrocannabinol; (l)-delta(sup 1)-Tetrahydrocannabinol; 1-trans-delta(sup 9)-Tetrahydrocannabinol; 1-trans-delta9-Tetrahydrocannabinol-; 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; Abbott-40566-; Cannabinol, 1-trans-delta(sup 9)-tetrahydro-; Dronabinol-; Marinol-; QCD-84924-; SP-104-; THC-; Tetrahydrocannabinol-; delta(sup 1)-Tetrahydrocannabinol; delta(sup 1)-Thc; delta(sup 9)-Tetrahydrocannabinol; delta(sup 9)-Thc; trans-delta(sup 9)-Tetrahydrocannabinol RN: Current: 1972-08-3 Previous: 14146-43-1 UD: 200302 MF: C21-H30-O2 MW: 314.51 WL: T B666 HO MU&TTJ CQ E5 I1 I1 M1 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Natural-Product (N) ME: dni-omi 400 mg/L Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 26, p. 75, 1979 (CYTBAI); dni-hmn-lym 100 umol/L Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 36, p. 1748, 1977 (FEPRA7); dni-hmn-fbr 10 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 35, p. 127, 1976 (ARTODN); dni-hmn-oth 10 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 35, p. 127, 1976 (ARTODN); dni-hmn-hla 40 umol/L Anticancer Research. (5 Argyropoulou St., Kato Patissia, Athens 907, Greece) V.1- 1981- v. 3, p. 211, 1983 (ANTRD4); oms-hmn-fbr 5 umol/L Anticancer Research. (5 Argyropoulou St., Kato Patissia, Athens 907, Greece) V.1- 1981- v. 3, p. 211, 1983 (ANTRD4); oms-hmn-hla 40 umol/L Anticancer Research. (5 Argyropoulou St., Kato Patissia, Athens 907, Greece) V.1- 1981- v. 3, p. 211, 1983 (ANTRD4); oms-hmn-oth 10 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 35, p. 127, 1976 (ARTODN); oms-hmn-lym 100 umol/L Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 36, p. 1748, 1977 (FEPRA7); cyt-hmn-lym 6400 nmol/L Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 36, p. 1748, 1977 (FEPRA7); mtr-rat-emb 10 ug/L Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 140, p. 454, 1972 (PSEBAA); mnt-mus-ipr 50 mg/kg/5D-I Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1968- v. 21, p. 277, 1980 (PHMGBN); dni-mus-ipr 200 mg/kg Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 17, p. 703, 1977 (RCOCB8); dni-mus-oth 10 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 35, p. 127, 1976 (ARTODN); oms-mus-oth 10 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 35, p. 127, 1976 (ARTODN); dni-mus-lng 4180 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 95, 1976 (CNREA8); dni-mus-leu 32600 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 95, 1976 (CNREA8); dni-mus-bmr 20600 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 95, 1976 (CNREA8); oms-mus-ipr 200 mg/kg Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 17, p. 703, 1977 (RCOCB8); cyt-mus-ipr 50 mg/kg/5D-I Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1968- v. 21, p. 277, 1980 (PHMGBN); spm-mus-ipr 25 mg/kg/5D-C Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1968- v. 18, p. 143, 1979 (PHMGBN); oms-ham-scu 1 gm/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 34, p. 1205, 1978 (EXPEAM) RE: T83 orl-rat TDLo: 110 mg/kg (1-22D preg) Advances in the Biosciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1967- v. 22/23, p. 531, 1979 (AVBIB9); T34 orl-rat TDLo: 125 mg/kg (6-15D preg) Advances in the Biosciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1967- v. 22/23, p. 479, 1979 (AVBIB9); T44 orl-rat TDLo: 70 mg/kg (9-22D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 42, p. 339, 1977 (TXAPA9); T25-T35 orl-rat TDLo: 62500 ug/kg (6-15D preg) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(1), p. 471, 1980 (JEPTDQ); T85 orl-rat TDLo: 40 mg/kg (3-22D preg) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 4, p. 249, 1976 (PBBHAU); T75-T76 orl-rat TDLo: 145 mg/kg (15-22D preg/21D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 38, p. 223, 1976 (TXAPA9); T27 orl-rat TDLo: 1100 mg/kg (1-22D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 3B, 1984 (TJADAB); T83 orl-rat TDLo: 195 mg/kg (5-22D preg/21D post) Brain Research Bulletin. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1976- v. 43, p. 173, 1997 (BRBUDU); T16-T19-T71 ipr-rat TDLo: 140 ug/kg (15-21D preg) Neuroendocrinology Letters. (Brain Research Promotion, D-7400, Tubingen, Germany) V.1- 1979- v. 17, p. 271, 1995 (NLETDU); T59 scu-rat TDLo: 90 mg/kg (10-12D preg) Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 16, p. 64, 1973 (PWPSA8); T16 scu-rat TDLo: 200 mg/kg (1-20D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 20, p. 480, 1971 (TXAPA9); T81-T85 scu-rat TDLo: 30 mg/kg (10-12D preg) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 1, p. 203, 1973 (PBBHAU); T76 scu-rat TDLo: 1 gm/kg (1-20D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 20, p. 480, 1971 (TXAPA9); T34 scu-rat TDLo: 500 mg/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 11, p. 99, 1975 (TJADAB); T03 scu-rat TDLo: 100 mg/kg (10D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 20, p. 1039, 1979 (BIREBV); T51-T87 orl-mus TDLo: 50 mg/kg (12D preg) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 8, p. 391, 1986 (NTOTDY); T23 orl-mus TDLo: 400 mg/kg (8D male) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 12, p. 143, 1980 (PBBHAU); T25-T35 orl-mus TDLo: 300 mg/kg (6-15D preg) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(1), p. 471, 1980 (JEPTDQ); T41 orl-mus TDLo: 400 mg/kg (11D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 181, p. 387, 1975 (ANREAK); T72-T75-T76 orl-mus TDLo: 350 mg/kg (20-21D preg/5D post) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 8, p. 141, 1981 (TOLED5); T91 orl-mus TDLo: 50 mg/kg (20D preg) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 205, p. 1420, 1979 (SCIEAS); T25 ihl-mus TDLo: 900 ug/kg/4M (6-15D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 37, p. 737, 1978 (FEPRA7); T25-T34 ipr-mus TDLo: 400 mg/kg (10-11D preg) Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 180, p. 446, 1972 (JPETAB); T25-T35 ipr-mus TDLo: 100 mg/kg (8-9D preg) Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 202, p. 455, 1977 (JPETAB); T34 ipr-mus TDLo: 100 mg/kg (10-11D preg) Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 202, p. 455, 1977 (JPETAB); T11 ipr-mus TDLo: 105 mg/kg (21D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 29, p. 663, 1983 (BIREBV); T34 scu-mus TDLo: 4500 ug/kg (8D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 36, p. 151, 1976 (TXAPA9); T26-T34 scu-mus TDLo: 400 mg/kg (6-21D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 36, p. 193, 1987 (TJADAB); T34 ivn-mus TDLo: 10 mg/kg (7D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 36, p. 151, 1976 (TXAPA9); T25 unr-mus TDLo: 150 mg/kg (8-10D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 32, p. 746, 1973 (FEPRA7); T34 unr-mus TDLo: 100 mg/kg (10-11D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 32, p. 746, 1973 (FEPRA7); T35-T76-T81 orl-mky TDLo: 396 mg/kg (1-23W preg) Advances in the Biosciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1967- v. 22/23, p. 501, 1979 (AVBIB9); T85 orl-mky TDLo: 648 mg/kg (1-23W preg/15W post) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 4, p. 469, 1982 (NTOTDY); T27 ims-mky TDLo: 388 mg/kg (1-22W preg) Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- v. 31, p. 1071, 1986 (JRPMAP); T31 orl-rbt TDLo: 19500 ug/kg (6-18D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 39, p. 849, 1980 (FEPRA7); T31 scu-rbt TDLo: 19500 ug/kg (6-18D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 39, p. 849, 1980 (FEPRA7); T29 ims-rbt TDLo: 1250 ug/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 31, p. 331, 1979 (FESTAS); T34 orl-ham TDLo: 100 mg/kg (7-10D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 1031, 1977 (JTEHD6); T46 orl-ham TDLo: 400 mg/kg (7-10D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 1031, 1977 (JTEHD6) TE: V03-N62 orl-mus TDLo: 91875 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-446, 1996 (NTPTR*); V03-R60-V10 scu-mus TDLo: 800 ug/kg/1W-I Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 38, p. 1450, 1979 (FEPRA7); V03-V10 scu-mus TD :800 ug/kg/1W-I Advances in the Biosciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1967- v. 22/23, p. 359, 1979 (AVBIB9); V02-N62 orl-mus TDLo: 65625 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-182208 (NTIS**) ORNG: 666000000 ng/kg. [666.000000 mg/kg] F11-F13-K12 AT: F11-F13-K12 orl-rat LD50: 666 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 136, p. 260, 1971 (PSEBAA); F11-F13-K12 ipr-rat LD50: 373 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 136, p. 260, 1971 (PSEBAA); F19-J25-F13 ivn-rat LD50: 29 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 191, p. 74, 1971 (ANYAA9); F11-F13-K12 orl-mus LD50: 482 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 136, p. 260, 1971 (PSEBAA); F07-F29 ipr-mus LD50: 168 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 196, p. 133, 1972 (AIPTAK); T/E unlistd scu-mus LD50: >11 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 88, p. 154, 1946 (JPETAB); F19-J25-F13 ivn-mus LD50: 42 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 191, p. 74, 1971 (ANYAA9); T/E unlistd ice-mus LD50: >12580 ug/kg Research Communiations in Alcohol and Substances of Abuse. (PJD Publicatios, POB 966, Westbury, NY 11590) V.15(3-4),- 1994- v. 17, p. 151, 1996 (RCAAE3); F07-F23-K13 orl-dog LDLo: 525 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 25, p. 363, 1973 (TXAPA9); T/E unlistd orl-mky LD :>3150 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 25, p. 363, 1973 (TXAPA9); T/E unlistd ivn-mky LD50: 125 mg/kg Medical Journal of Australia. (Australasian Medical Pub. Co. Ltd., 71-79 Arundel St., Glebe, N.S.W., Australia) V.1- 1914- v. 145, p. 82, 1986 (MJAUAJ); F19 ipr-mus TDLo: 100 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 297, p. 629, 2001 (JPETAB) MD: U01-Z74 orl-rat TDLo: 3250 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-446, 1996 (NTPTR*); M10-N72-Z72 orl-rat TDLo: 29750 mg/kg/17W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 25, p. 373, 1973 (TXAPA9); A30-Y01-Y08 orl-rat TDLo: 1400 mg/kg/28D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 27, p. 158, 1974 (TXAPA9); F12-Y01-Z01 orl-rat TDLo: 9 gm/kg/26W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 418, 1975 (TXAPA9); A30 ipr-rat TDLo: 150 mg/kg/5D-I Arhiv za Higijenu Rada i Toksikologiju. Archives of Industrial Hygiene and Toxicology. (Jugoslovenska Knjiga, POB 36, YU-11001 Belgrade, Yugoslavia) V.7- 1956- v. 31, p. 293, 1980 (AHRTAN); J70-L70-U01 ipr-rat TDLo: 900 mg/kg/30D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 414, 1971 (TXAPA9); L30-Y37 ipr-rat TDLo: 210 mg/kg/21D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 34, p. 525, 1975 (TXAPA9); F43 ipr-rat TDLo: 70 mg/kg/5W-I "Marihuana and Medicine, (Conference on Marihuana and Medicine), New York University, School of Medicine, New York, March 20-21, 1998," Nahas, Gabriel G., et al., Humana Press Inc. Totowa, NJ, 1999 -,233,1999 (67VJAJ); F07-F43-U01 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-446, 1996 (NTPTR*); K02-P28-Z01 orl-mky TDLo: 45 gm/kg/90D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 29, p. 77, 1974 (TXAPA9); K02-P28-Z01 orl-mky TDLo: 14 gm/kg/28D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 27, p. 648, 1974 (TXAPA9); J12-L70-N30 ivn-mky TDLo: 1260 mg/kg/28D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 27, p. 648, 1974 (TXAPA9); L70-P28-U01 scu-rbt TDLo: 1300 mg/kg/13D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 1, p. 769, 1976 (JTEHD6); N02-N17-N19 ims-mky TDLo: 45 mg/kg/18D-I Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 52, p. 50, 1981 (JCEMAZ) TR: TOXICOLOGY REVIEW Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 56, p. 134, 1975 (PEDIAU) ND: NOES 1983: HZD X5841; NIS 1; TNF 25; NOS 1; TNE 1358; TFE 956 SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: In vivo cytogenetics-human lymphocyte, In vitro SCE-human; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, Histidine reversion-Ames test; NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse; NCI Carcinogenesis Studies (gavage), no evidence: rat Record 717 of 1119 in RTECS (through 2003/06) AN: HZ1760000 PN: Diesel-exhaust-particles- CD: Particulate samples collected from the exhaust of a 1979 2.3 L diesel powered automobile running on no. 2 diesel fuel (Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 56, p. 110, 1980 - TXAPA9) UD: 200302 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 200 ug/plate (+/-S9) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 56, p. 110, 1980 (TXAPA9); mmo-esc 125 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 237, 1991 (MUREAV); oms-bcs 100 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 239, 1980 (ENMUDM); oms-bcs 60 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 253, 1981 (ENMUDM); msc-hmn-lym 100 mg/L Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 10, p. 277, 1982 (DTESD7); dna-rat-ihl 10 mg/m3 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 96, p. 336, 1988 (TXAPA9); mtr-mus-fbr 50 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 42, p. 61, 1988 (CALEDQ); sce-mus-unr 300 mg/kg Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 10, p. 265, 1982 (DTESD7); dns-ham-oth 1 mg/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 27, p. 277, 1983 (EVSRBT); cyt-ham-lng 250 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 42, p. 61, 1988 (CALEDQ); sce-ham-lng 150 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 42, p. 61, 1988 (CALEDQ); sce-ham-ihl 12 mg/m3/14W Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 10, p. 265, 1982 (DTESD7); sce-ham-itr 130 mg/kg Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 10, p. 265, 1982 (DTESD7); hma-ham-emb 320 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 215, 1982 (ENMUDM); dnd-hmn-lym 16 ug/L/48H Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 155, 2001 (EMMUEG) TE: V01-J60 ihl-rat TCLo: 4 mg/m3/16H/2.5Y-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 13, p. 329, 1986 (DTESD7); V03-J60-R60 ihl-rat TC :8300 ug/kg/6H/86W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 42, p. 382, 1981 (AIHAAP); V03-J60-R60 ihl-rat TC :8300 ug/m3/6H/86W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 42, p. 382, 1981 (AIHAAP); V03-L60 ihl-rat TC :7 mg/m3/7H/2Y-I Annals of the American Conference of Governmental Industrial Hygienists. (American Conference of Governmental Industrial Hygienists, 6500 Glenway Ave., Bldg. D-5, Cincinnati, OH 45211) V.1- 1981- v. 13, p. 3, 1985 (ACGHD2); V02-J60 ihl-rat TC :2200 ug/m3/16H/2Y-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 13, p. 471, 1986 (DTESD7) ND: NIOSH REL TO DIESEL EXHAUST-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: NIOSH CURRENT INTELLIGENCE BULLETIN #50; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 718 of 1119 in RTECS (through 2003/06) AN: HZ1780000 PN: Diesel-fuel-marine- SY: DFM-; Distillate fuel, marine, petroleum deriv.; Marine-diesel-fuel-; NCI-C54795-; Petroleum-derived-distillate-fuel,-marine-; Diesel fuel No. 4 UD: 200210 CC: Tumorigen (C); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 703, 1992 (ATDAEI) TE: V03-R60 skn-mus TDLo: 130000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-131678/AS (NTIS**) ORNG: 43000000000 ng/kg. [43000.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 43 gm/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 101, 1986 (FAATDF); T/E unlistd skn-mus LD :>40 gm/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-310, 1986 (NTPTR*) MD: Z01 skn-mus TDLo: 280 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-310, 1986 (NTPTR*); R03-U01-Z01 skn-mus TDLo: 260 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-310, 1986 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 45, p. 219, 1989 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 45, p. 219, 1989 (IMEMDT) SL: NCI Carcinogenesis Studies (derm), equivocal evidence: mouse Record 719 of 1119 in RTECS (through 2003/06) AN: HZ8750000 PN: Diethylamine- SY: DEN-; Diaethylamin- (German); Diethamine-; Dwuetyloamina- (Polish); Ethanamine,-N-ethyl-; Diethylamine- (ACGIH:OSHA); N,N-Diethylamine-; Dietilamina- (Italian) RN: Current: 109-89-7 UD: 200210 MF: C4-H11-N MW: 73.16 WL: 2M2 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 5/21/1971 (UCDS**) ME: mmo-omi 50 uL/plate (-S9) Egyptian Journal of Microbiology. (National Information and Documentation Centre, A1-Tahrir St., Awqaf P.O. Dokki, Cairo, Egypt) V.7- 1972- v. 16, p. 133, 1981 (EJMBA2); mmo-omi 400 uL/plate (-S9) Egyptian Journal of Microbiology. (National Information and Documentation Centre, A1-Tahrir St., Awqaf P.O. Dokki, Cairo, Egypt) V.7- 1972- v. 15, p. 113, 1980 (EJMBA2); mmo-omi 200 uL/plate (-S9) Egyptian Journal of Microbiology. (National Information and Documentation Centre, A1-Tahrir St., Awqaf P.O. Dokki, Cairo, Egypt) V.7- 1972- v. 15, p. 113, 1980 (EJMBA2) ORNG: 540000000 ng/kg. [540.000000 mg/kg] T/E unlistd SRNL: 820000 nL/kg. [0.820000 mL/kg] T/E unlistd IHPB: 4000000 ppb/4H. [4000.000000 ppm/4H] T/E unlistd AT: T/E unlistd orl-rat LD50: 540 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 1, p. 343, 1960 (AEHLAU); T/E unlistd ihl-rat LC50: 4000 ppm/4H Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 1, p. 343, 1960 (AEHLAU); T/E unlistd ipr-rat LDLo: 50 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 31, p. 238, 1968 (FATOAO); F04-F07 orl-mus LD50: 500 mg/kg Biomedica Biochimica Acta. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086, Ger. Dem. Rep.) V.42- 1983- v. 44, p. 795, 1985 (BBIADT); A11-J15-L03 ihl-mus LCLo: 3 gm/m3/2H Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 20(4), p. 28, 1955 (GISAAA); T/E unlistd ipr-mus LD50: 585 mg/kg Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- v. 97, p. 1117, 1977 (YKKZAJ); D07-J06-L03 ihl-rbt LCLo: 20 gm/m3 "Voprosy Promyshlennoi Toksikologii," Pravdin, N.S., ed., Akademiya Meditsinskikh Nauk-SSSR, Moscos, Russia, 1960 -,176,1960 (12OVAW); T/E unlistd skn-rbt LD50: 820 uL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); T/E unlistd ihl-mam LC50: 5000 mg/m3 Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 14, p. 80, 1975 (TPKVAL) MD: U01 orl-rat TDLo: 4994 mg/kg/11W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 30(9), p. 28, 1965 (GISAAA); J70-S16-U01 ihl-rat TCLo: 250 ppm/6H/24W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 559, 1986 (FAATDF); M16-P28-Y01 ihl-rat TCLo: 4 mg/m3/24H/93D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 28, 1968 (GISAAA) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 15 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Chemical Reviews. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1924- v. 9, p. 389, 1931 (CHREAY) SR: MSHA STANDARD-air: TWA 25 ppm (75 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 84, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 25 ppm (75 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 25 ppm (75 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 25 ppm (75 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 25 ppm (75 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 ppm (30 mg/m3), STEL 25 ppm, JAN 1993; OEL-AUSTRIA: MAK 10 ppm (30 mg/m3), JAN 1999; OEL-BELGIUM: TWA 10 ppm (30 mg/m3), STEL 25 ppm, JAN 1993; OEL-FINLAND: STEL 10 ppm (30 mg/m3), Skin, JAN 1999; OEL-FRANCE: VLE 10 ppm (30 mg/m3), JAN 1999; OEL-GERMANY: MAK 10 ppm (30 mg/m3), JAN 1999; OEL-HUNGARY: TWA 30 mg/m3, STEL 60 mg/m3, JAN 1993; OEL-JAPAN: OEL 10 ppm (30 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (15 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 10 ppm (30 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 25 ppm (75 mg/m3), JAN 1993; OEL-RUSSIA: TWA 10 ppm, STEL 30 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 10 ppm (30 mg/m3), KTV 15 ppm (45 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 10 ppm (30 mg/m3), KZG-W 20 ppm (60 mg/m3), JAN 1999; OEL-TURKEY: TWA 25 ppm (75 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 10 ppm (30 mg/m3), STEL 25 ppm (76 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DIETHYLAMINE-air: 10H TWA 10 ppm, STEL 25 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 24680; NIS 20; TNF 2138; NOS 28; TNE 34647; NOES 1983: HZD 24680; NIS 22; TNF 1387; NOS 24; TNE 28361; TFE 6878 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Amines, aliphatic, 2010; NTP Carcinogenesis studies, selected, October 2000; OSHA ANALYTICAL METHOD #41 Record 720 of 1119 in RTECS (through 2003/06) AN: IA2100000 PN: Diethylamine,-2,2'-dichloro-N-methyl,-hydrochloride- SY: Antimit-; Azotoyperite-; Dichloren-; beta,beta'-Dichlorodiethyl-N-methylamine-hydrochloride-; 1,5-Dichloro-3-methyl-3-azapentane-hydrochloride-; N,N-Bis(2-chloraethyl)methylamin-hydrochlorid (German); Bis(2-chloroethyl)methylamine hydrochloride; N,N-Bis(2-chloroethyl)methylamine hydrochloride; C-6866-; Caryolysine-; Chloramin-; Chlormethine-hydrochloride-; Chlormethinum-; 2-Chloro-N-(2-chloroethyl)-N-methylethanamine hydrochlroide; Di(2-chloroethyl)methylamine hydrochloride; 2,2'-Dichloro-N-methyldiethylamine-hydrochloride-; Embichin-; Erasol-; Ethanamine, 2-chloro-N-(2-chloroethyl)-N-methyl-, hydrochloride; HN2-hydrochloride-; N-Lost- (German); Kloramin-; MBA-hydrochloride-; Mechlorethamine-hydrochloride-; N-Methyl-bis-beta-chlorethylamine-hydrochloride-; N-Methylbis(2-chloroethyl)amine hydrochloride; N-Methyl-2,2'-dichlorodiethylamine-hydrochloride-; N-Methyl-di-2-chloroethylamine-hydrochloride-; Methyldi(beta-chloroethyl)amine hydrochloride; Methyldi(2-chloroethyl)amine hydrochloride; NCI-C56382-; Nitrogen-mustard-hydrochloride-; Nitrogranulogen-; Pliva-; Stickstofflost-; Dimitan-; N-Mustard- (German); Mustargen-hydrochloride-; Mustine-hydrochloride-; NSC-762-hydrochloride-; Zagreb- RN: Current: 55-86-7 UD: 200006 MF: C5-H11-Cl2-N.Cl-H MW: 192.53 WL: G2N1&2G &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 66 ug/plate (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19(Suppl 21), p. 2, 1992 (EMMUEG); mmo-sat 8 ug/plate (-S9) American Journal of Hospital Pharmacy. (American Soc. of Hospital Pharmacists, 4630 Montgomery Ave., Bethesda, MD 20814) V.15- 1958- v. 43, p. 344, 1986 (AJHPA9); mmo-esc 100 ug/disc (-S9) Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. v. 6, p. 23, 1958 (APMBAY); pic-esc 200 mg/L Archiv fuer Mikrobiologie. (Berlin, Fed. Rep. Ger.) V.1-94, 1930-73. For publisher information, see AMICCW. v. 51, p. 9, 1965 (ARMKA7); mmo-bcs 100 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 38, p. 271, 1976 (MUREAV); oms-bcs 10 umol/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 521, p. 484, 1978 (BBACAQ); dnd-bcs 10 umol/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 521, p. 484, 1978 (BBACAQ); mmo-omi 1 mmol/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 15, p. 275, 1970 (FOMIAZ); sln-dmg-orl 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 95, p. 237, 1982 (MUREAV); dlt-dmg-orl 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 95, p. 237, 1982 (MUREAV); dnd-smc 40 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 241, 1978 (MUREAV); mmo-asn 2500 umol/L (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 6, p. 220, 1970 (SOGEBZ); mmo-ssp 21 mmol/L (-S9) Abhandlungen der Deutschen Akademie der Wissenschaften zu Berlin, Klasse fuer Medizin. (Berlin, Ger. Dem. Rep.) 1950-68. Discontinued. v. -, p. 193, 1962 (ADWMAX); dnd-hmn-hla 8 mg/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 103, p. 175, 1976 (ECREAL); dni-hmn-lym 10 umol/L Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 4, p. 117, 1974 (AGACBH); dni-hmn-hla 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); cyt-hmn-leu 10 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 26, p. 2437, 1966 (CNREA8); cyt-hmn-lym 50 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1637, 1984 (CRNGDP); sce-hmn-lym 6250 ng/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1637, 1984 (CRNGDP); dnd-rat-mmr 1 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 1171, 1986 (BCPCA6); dnd-rat-lvr 30 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); dnd-rat-oth 500 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1697, 1987 (CRNGDP); sce-rat-mmr 250 nmol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 1171, 1986 (BCPCA6); sce-rat-oth 200 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1697, 1987 (CRNGDP); mnt-mus-ipr 98250 ng/kg Yaowu Fenxi Zazhi. Journal of Pharmaceutical Analysis. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1981- v. 11, p. 30, 1991 (YFZADL); mnt-mus-scu 1563 ug/kg Yaowu Fenxi Zazhi. Journal of Pharmaceutical Analysis. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1981- v. 11, p. 30, 1991 (YFZADL); dnd-mus-emb 25 umol/L Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 92, p. 1692, 1981 (BEXBAN); dni-mus-ipr 2 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 29, p. 994, 1969 (CNREA8); dlt-mus-ipr 2500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 43, p. 231, 1977 (MUREAV); msc-mus-lym 20 ug/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 23, p. 115, 1985 (FCTOD7); hma-mus-ast 3 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 8, p. 1, 1974 (CBINA8); trn-mus-ipr 2400 ug/kg Journal of Genetics. (Belghoria, India) V.1-63, 1910-77. Discontinued. v. 51, p. 81, 1952 (JOGNAU); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); dnd-ham-fbr 120 umol/L Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 92, p. 943, 1981 (BEXBAN) RE: T83 orl-rat TDLo: 1130 mg/kg (8W male/2W pre-3W post) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 43A, 1987 (TJADAB); T46-T34-T43 ipr-rat TDLo: 700 ug/kg (12D preg) Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 23, p. 231, 1959 (PEDIAU); T43-T41-T46 scu-rat TDLo: 1 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 151, 1976 (TJADAB); T25 scu-rat TDLo: 750 ug/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 151, 1976 (TJADAB); T42 scu-rat TDLo: 1 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 151, 1976 (TJADAB); T01 ivn-rat TDLo: 500 ug/kg (1D male) Zeitschrift fuer die Gesamte Experimentelle Medizin. (Berlin, Fed. Rep. Ger.) V.1-139, 1913-65. For publisher information, see REXMAS. v. 117, p. 467, 1951 (ZGEMAZ); T25-T34-T43 ipr-mus TDLo: 1600 ug/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 4, p. 141, 1971 (TJADAB); T46 ipr-mus TDLo: 1600 ug/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 4, p. 141, 1971 (TJADAB); T02 ipr-mus TDLo: 4 mg/kg (1D male) Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 2, p. 1075, 1949 (CANCAR); T35-T46 scu-mus TDLo: 2500 ug/kg (10D preg) Acta Medica University Kioto. (Kioto, Japan) v. 36, p. 20, 1959 (AMUK**); T34 scu-mus TDLo: 2500 ug/kg (10D preg) Acta Scholae Medicinalis Universitatis in Kioto. (Kyoto, Japan) V.27-40, 1947-70. Discontinued. v. 36, p. 20, 1959 (ASMUAA); T47-T48-T53 scu-mam TDLo: 1 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 151, 1976 (TJADAB); T42-T43-T41 scu-mam TDLo: 1 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 151, 1976 (TJADAB); T25 scu-mam TDLo: 500 ug/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 151, 1976 (TJADAB); T46 scu-mam TDLo: 2 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 151, 1976 (TJADAB) TE: V01-J60 ipr-mus TDLo: 6 mg/kg/4W Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 36, p. 915, 1966 (JNCIAM); V01-J60 scu-mus TDLo: 22 mg/kg/21W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 3, p. 118, 1949 (BJCAAI); V02-J60 ivn-mus TDLo: 4 mg/kg/6D-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 11, p. 415, 1950 (JNCIAM); V03-V10 scu-mus TD :6 mg/kg/6W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 14, p. 131, 1953 (JNCIAM) ORNG: 10000000 ng/kg. [10.000000 mg/kg] T/E unlistd AT: K13-P14-P17 ivn-hmn TDLo: 400 ug/kg Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 6, p. 50, 1965 (CLPTAT); T/E unlistd orl-rat LD50: 10 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 91, p. 224, 1947 (JPETAB); T/E unlistd ipr-rat LD50: 1500 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 5, p. 735, 1963 (TXAPA9); T/E unlistd scu-rat LD50: 1900 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 91, p. 224, 1947 (JPETAB); T/E unlistd ivn-rat LD50: 1100 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 91, p. 224, 1947 (JPETAB); T/E unlistd ims-rat LD50: 1100 ug/kg Archiv der Pharmazie (Weinheim, Germany) (VCH Pub., Inc., 303 NW 12th Ave., Deerfield Beach, FL 33441) V.51-261, 1835-1923: V.305- 1972- v. 306, p. 64, 1973 (ARPMAS); T/E unlistd par-rat LD50: 1700 ug/kg Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 76, 1975 (RRCRBU); T/E unlistd orl-mus LD50: 20 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 91, p. 224, 1947 (JPETAB); T/E unlistd ipr-mus LD50: 2900 ug/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 62, p. 96, 1966 (NYKZAU); T/E unlistd scu-mus LD50: 2600 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 91, p. 224, 1947 (JPETAB); T/E unlistd ivn-mus LD50: 2 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 91, p. 224, 1947 (JPETAB); T/E unlistd ims-mus LD50: 2750 ug/kg Archiv der Pharmazie (Weinheim, Germany) (VCH Pub., Inc., 303 NW 12th Ave., Deerfield Beach, FL 33441) V.51-261, 1835-1923: V.305- 1972- v. 306, p. 64, 1973 (ARPMAS); T/E unlistd ivn-dog LD50: 1 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 91, p. 224, 1947 (JPETAB); K30-P14-P30 ivn-mky LDLo: 340 ug/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 201, 1965 (CCSUBJ); C08-J30-K01 ivn-cat LDLo: 3850 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 95, p. 131, 1949 (JPETAB); T/E unlistd orl-rbt LD50: 12500 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); T/E unlistd ivn-rbt LD50: 1600 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 91, p. 224, 1947 (JPETAB) MD: P26 ims-rat TDLo: 500 mg/kg/10D-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 2, p. 50, 1961 (AEHLAU); K30-P26-Z01 ivn-mus TDLo: 6550 ug/kg/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB81-175440 (NTIS**) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 193, 1975 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 269, 1987 (IMSUDL); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 269, 1987 (IMSUDL) ND: NOES 1983: HZD X4355; NIS 1; TNF 162; NOS 4; TNE 4618; TFE 2398 SL: EPA GENETOX PROGRAM 1988, Positive: Aspergillus-reversion, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 721 of 1119 in RTECS (through 2003/06) AN: IA3500000 PN: Diethylamine,-N-nitroso- SY: DEN-; DEN- (mutagen); DENA-; Diaethylnitrosamin- (German); Diethyl-nitrosamine-; Diethylnitrosamide-; Diethylnitrosamine-; Diethylnitrosoamine-; Ethanamine,-N-ethyl-N-nitroso- (9CI); Ethylamine,-N-nitrosodi-; N,N-Diethylnitrosamine-; N-Diethylnitrosamine-; N-Ethyl-N-nitroso-ethanamine-; N-Nitroso-N,N-diethylamine-; N-Nitroso-diaethylamine- (German); N-Nitrosodiethylamine-; NDEA-; Nitrosodiethylamine-; RCRA-waste-number-U174- RN: Current: 55-18-5 BRN: 1744991 BHR: 4-04-00-03386 UD: 200305 MF: C4-H10-N2-O MW: 102.16 WL: ONN2&2 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 50 uL/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 101, 1978 (MUREAV); mmo-sat 50 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 111, p. 135, 1983 (MUREAV); oms-sat 5100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); pic-sat 100 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 121, 1979 (ENMUDM); oms-esc 30 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); mmo-esc 2 umol/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 87, 1984 (MUREAV); dnr-esc 50 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); pic-esc 3 gm/L Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 99, p. 257, 1979 (VIRLAX); dnr-bcs 50 gm/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 19, 1981 (EVSRBT); mmo-omi 2 mg/plate (+S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 297, 1978 (CBINA8); slt-dmg-par 5 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 4504, 1976 (CNREA8); slt-dmg-orl 20 mmol/L/6H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 120, p. 233, 1983 (MUREAV); sln-dmg-orl 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 29, p. 383, 1975 (MUREAV); sln-dmg-unr 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); sln-dmg-par 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 149, p. 193, 1985 (MUREAV); mmo-nsc 100 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 3, p. 537, 1966 (MUREAV); dnr-smc 115 umol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 24, p. 771, 1982 (CNJGA8); mrc-smc 3 pph JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 901, 1979 (JJIND8); mmo-asn 4711 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mrc-asn 18844 ug/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mmo-hmn-fbr 1 mmol/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1873, 1981 (CNREA8); mtr-hmn-fbr 10 ug/L Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 12, p. 3, 1982 (BANRDU); mtr-hmn-oth 1 gm/L/9W-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 135, 1984 (PAACA3); mtr-hmn-oth 900 mg/L Kexue Tongbao (Foreign Language Edition). Science Bulletin. (Scientific and Technical Book Service, Ltd., POB 197, London, WC2N 4DE, UK) V.17, 1966: V.25- 1980- Suspended 1966-79. v. 31, p. 72, 1986 (KHTPBU); mtr-hmn-lng 900 mg/L Scientia Sinica, Series B: Chemical, Biological, Agricultural, Medical, and Earth Sciences (English Edition). (Scientific and Technical Books Service Ltd., POB 197, London WC2N 4DE, UK) V.25- 1982- v. 29, p. 1192, 1986 (SSBSEF); dnd-hmn-kdy 32 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 41, 1996 (MUREAV); dnd-hmn-lng 100 umol/plate Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 59, p. 1401, 1977 (JNCIAM); dnd-hmn-lym 50 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 21, 2000 (MUREAV); dnd-hmn-oth 50 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 21, 2000 (MUREAV); dns-hmn-lym 10 mmol/L Biological Trace Element Research. (Humana Press Inc., POB 2148, Clifton, NJ 07015) V.1- 1979- v. 5, p. 331, 1983 (BTERDG); dns-hmn-hla 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-oth 100 umol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 69, p. 557, 1982 (JJIND8); dns-hmn-lvr 5 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 683, 1983 (CRNGDP); dns-hmn-oth 450 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1079, 1985 (CRNGDP); cyt-hmn-lym 1 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 412, p. 55, 1998 (MUREAV); cyt-hmn-hla 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 369, 1978 (MUREAV); msc-hmn-fbr 2 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 683, 1983 (CRNGDP); mnt-rat-ipr 230 umol/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 35, p. 313, 1987 (CALEDQ); mnt-rat-unr 40 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); dnr-rat-lvr 10 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 107, 1991 (EMMUEG); mtr-rat-orl 10 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 49, p. 93, 1972 (JNCIAM); mtr-rat-ipr 15 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 40, p. 274, 1979 (BJCAAI); mtr-rat-emb 10 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); mtr-rat-par 100 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 69, p. 1299, 1982 (JJIND8); dnd-rat-lvr 30 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2592, 1982 (CNREA8); dna-rat-ipr 2 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3806, 1984 (CNREA8); dnd-rat-orl 67 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-par 100 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 107, 1977 (ZKKOBW); dna-rat-oth 1500 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dns-rat-orl 100 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 57, p. 55, 1986 (CBINA8); dns-rat-lvr 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 144, p. 197, 1985 (MUREAV); dns-rat-oth 100 mmol/L Shika Kiso Igakkai Zasshi. Journal of the Japanese Association for Basic Dentistry. (Shika Kiso Igakkai, Hanayama Bldg., 1-44-2 Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1959- v. 22, p. 300, 1980 (SHKKAN); dna-rat-oth 15 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dni-rat-orl 210 mg/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 31, p. 87, 1975 (EXPEAM); dni-rat-lvr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 337, 1985 (CNREA8); dnd-rat-kdy 32 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 41, 1996 (MUREAV); oms-rat-orl 70 mg/kg/7D-C European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 13, p. 13, 1977 (EJCAAH); bfa-rat-ovr 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 263, 1985 (MUREAV); cyt-rat-ipr 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 140, p. 181, 1984 (MUREAV); cyt-rat-orl 126 mg/kg/3W Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 1245, 1975 (JNCIAM); cyt-rat-scu 10 mg/kg Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 44, p. 94, 1974 (RRCRBU); sce-rat-ipr 67 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); hma-rat-smc 2574 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 3, p. 41, 1983 (TCMUD8); mnt-mus-ipr 60 mg/kg/2D Yonsei Medical Journal. (Yonsei Univ. College of Medicine, P.O. Box 71, Seoul, S. Korea) V.1- 1960- v. 20, p. 105, 1979 (YOMJA9); mnt-mus-orl 1280 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 174, p. 141, 1986 (MUREAV); mmo-mus-lym 10 mg/L/4H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); slt-mus-par 30 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 38, p. 75, 1977 (ARTODN); mtr-mus-emb 200 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 324, p. 93, 1994 (MUREAV); mtr-mus-fbr 20 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); mtr-mus-mmr 10 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 801, 1982 (CRNGDP); dnd-mus-ipr 100 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 6, p. 221, 1979 (CALEDQ); dna-mus-oth 700 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dna-mus-oth 15 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dns-mus-lvr 10 umol/L Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 12, p. 119, 1984 (TOPADD); dni-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 37, p. 67, 1976 (MUREAV); sce-mus-ipr 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); sce-mus-lng 600 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 158, p. 269, 1978 (PSEBAA); sce-mus-mmr 14600 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 165, 1985 (MUREAV); hma-mus-sat 60 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 291, 1977 (MUREAV); hma-mus-lng 600 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 158, p. 269, 1978 (PSEBAA); hma-mus-esc 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); hma-mus-smc 1900 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 6, p. 83, 1973 (EVHPAZ); mmo-ham-lng 2500 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); mtr-ham-ipr 500 mg/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 95, p. 380, 1973 (ARPAAQ); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-ham-emb 2500 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 519, 1979 (JJIND8); dnd-ham-ipr 200 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 541, 1983 (CRNGDP); dnd-ham-lng 300 umol/L/2H Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 732, 1976 (BBRCA9); dns-ham-lvr 500 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 1, 1984 (ENMUDM); dns-ham-ipr 200 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 82, 1984 (PAACA3); cyt-ham-scu 50 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 1385, 1983 (CRNGDP); cyt-ham-lng 1 gm/L Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 41, 1980 (ATSUDG); cyt-ham-ovr 4 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 37, p. 83, 1976 (MUREAV); sce-ham-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); sce-ham-ovr 4 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 37, p. 83, 1976 (MUREAV); sce-ham-lng 2500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 188, p. 7, 1987 (MUREAV); msc-ham-lng 4500 umol/L/48H Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 75, p. 2864, 1978 (PNASA6); msc-ham-ipr 250 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 9, p. 185, 1980 (CALEDQ); msc-ham-ovr 100 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 539, 1984 (ENMUDM); mtr-gpg-ipr 20 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 1035, 1975 (CNREA8); dnd-trk-par 125 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 329, p. 113, 1995 (MUREAV); dna-ofs-mul 125 ppm Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 699, 1988 (FCTOD7); dna-hmn-fbr 1 mmol/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 484, p. 3, 2001 (MUREAV); mmo-sat 5 umol/plate/48H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 484, p. 61, 2001 (MUREAV); slt-oin-oth 5 mmol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 483, p. 95, 2001 (MUREAV); dnd-mus-orl 320 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); mmo-sat 1 mg/plate/48H (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 479, 2002 (MUTAEX); mtr-mus-fbr 0.05 gm/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG); msc-rat-orl 600 mg/kg/30D-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 147, p. 39, 1999 (CALEDQ); mmo-sat 25 ug/plate/30M (+S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 638, 2000 (ARTODN) RE: T34 orl-rat TDLo: 200 mg/kg (10D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1308, 1974 (BEXBAN); T35 orl-rat TDLo: 158 mg/kg (22D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD); T39 orl-rat TDLo: 51 mg/kg (18D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 157, 1989 (TCMUD8); T35 ipr-rat TDLo: 180 mg/kg (10D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 112, 1973 (IARCCD); T39 ipr-rat TDLo: 70 mg/kg (12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 12, p. 231, 1992 (TCMUD8); T35 ivn-rat TDLo: 140 mg/kg (10D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD); T35 ipc-rat TDLo: 500 ug/kg (13D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1308, 1974 (BEXBAN); T48 ipr-mus TDLo: 100 mg/kg (17D preg) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 104, p. 165, 1982 (MUREAV); T51-T53-T76 orl-ham TDLo: 150 mg/kg (30D post) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 136, p. 1007, 1971 (PSEBAA); T49 scu-ham TDLo: 53400 ug/kg (13-15D preg) American Review of Respiratory Disease. (American Lung Assoc., 1740 Broadway, New York, NY 10019) V.80- 1959- v. 126, p. 152, 1982 (ARDSBL) TE: V01-L60 orl-rat TDLo: 119 mg/kg/3.3Y-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1635, 1987 (CRNGDP); V01-T65-L60 orl-rat TDLo: 150 mg/kg (22D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 92, 1973 (IARCCD); V02-L60 ipr-rat TD :75 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 2492, 1988 (CNREA8); V03-M61 scu-rat TDLo: 480 mg/kg/12D-I Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 54, p. 47, 1967 (NATWAY); V03-T65-M61 scu-rat TDLo: 480 mg/kg (10-21D preg) Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 54, p. 47, 1967 (NATWAY); V01-M61 ivn-rat TDLo: 80 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 49, p. 1729, 1972 (JNCIAM); V01-T65-D09 ivn-rat TDLo: 150 mg/kg (22D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD); V03-L60 rec-rat TDLo: 633 mg/kg/28W-C Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 65, p. 529, 1963 (ZEKBAI); V01-J60-L60 orl-mus TDLo: 57 mg/kg/10D-C International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 5, p. 119, 1970 (IJCNAW); V02-J61-V08 skn-mus TDLo: 800 mg/kg/20W-I European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 16, p. 695, 1980 (EJCAAH); V02-T65-J60 ipr-mus TDLo: 120 mg/kg (21D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 17(1), p. 45, 1971 (VOONAW); V01-J60-P61 ipr-mus TDLo: 90 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 1, p. 249, 1976 (CALEDQ); V01-J60-L60 scu-mus TDLo: 104 mg/kg/52W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 31, p. 813, 1980 (IAPUDO); V02-T65-J60 scu-mus TDLo: 80 mg/kg (15-20D preg) Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 67, p. 152, 1965 (ZEKBAI); V03-P60 orl-dog TDLo: 210 mg/kg/5W-C Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 14, p. 73, 1964 (ARZNAD); V03-L60 mul-dog TDLo: 560 mg/kg/26W Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 23, p. 497, 1967 (EXPEAM); V03-L60 orl-mky TDLo: 5140 mg/kg/2Y-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 36, p. 323, 1966 (JNCIAM); V03-L60 ipr-mky TDLo: 280 mg/kg/60W-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 74, 1984 (PAACA3); V02-L60 orl-cat TDLo: 870 mg/kg/78W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 22, p. 552, 1978 (IJCNAW); V01-L60-P62 orl-rbt TDLo: 1250 mg/kg/52W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 34, p. 453, 1965 (JNCIAM); V03-L60-M61 orl-pig TDLo: 750 mg/kg/67W-C Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 72, p. 102, 1969 (ZEKBAI); V03-L60 orl-gpg TDLo: 172 mg/kg/12W-C Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 25, p. 296, 1969 (EXPEAM); V03-T65-J60 orl-ham TDLo: 150 mg/kg (30D post) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 136, p. 1007, 1971 (PSEBAA); V01-D09-J60 orl-ham TDLo: 480 mg/kg/20W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 30, p. 305, 1980 (IAPUDO); V03-J60 ihl-ham TDLo: 216 mg/kg/9W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 64, p. 499, 1962 (ZEKBAI); V03-D09 skn-ham TDLo: 5600 mg/kg/26W-I Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 78, p. 189, 1964 (ARPAAQ); V03-D09 ipr-ham TDLo: 272 mg/kg/17W-I Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 78, p. 189, 1964 (ARPAAQ); V03-J60-T65 ipr-ham TDLo: 30 mg/kg (15D preg) Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie. (VEB Gustav Fischer Verlag, Postfach 176, Jena DDR-6900, Ger. Dem. Rep.) V.1- 1890- v. 121, p. 82, 1977 (ZAPPAN); V01-D09-J60 scu-ham TDLo: 336 mg/kg/12W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 30, p. 305, 1980 (IAPUDO); V02-T65-J60 scu-ham TDLo: 1250 ug/kg (15D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 5112, 1987 (CNREA8); V03-D09 idr-ham TDLo: 588 mg/kg/21W-I Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 78, p. 189, 1964 (ARPAAQ); V02-J60 itr-ham TDLo: 12 mg/kg/15W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 847, 1988 (FCTOD7); V03-L60-M61 ims-ckn TDLo: 400 mg/kg/20W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 22, p. 552, 1978 (IJCNAW); V01-D09-L60 scu-grb TDLo: 198 mg/kg/33W-I Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 83, p. 233, 1975 (ZKKOBW); V01-D09-L60 ivn-grb TDLo: 50 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 83, p. 233, 1975 (ZKKOBW); V03-L60 ims-bwd TDLo: 540 mg/kg/27W-I Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 53, p. 437, 1966 (NATWAY); V02-J60 itr-ham TD :60 mg/kg/15W-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 24, p. 523, 1982 (SAIGBL); V02-D09-J60 scu-ham TD :60 mg/kg/11W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 28, p. 2197, 1968 (CNREA8); V02-J60 ipr-mus TD :40 mg/kg/24W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 313, 1984 (TXAPA9); V01-K60-L60 orl-mus TD :75 mg/kg/30W-C Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 11(6), p. 74, 1965 (VOONAW); V02-J60-L60 ipr-mus TD :50 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 79, 1984 (PAACA3); V01-D09 scu-ham TD :700 mg/kg/21W-I Beitraege zur Pathologie. (Stuttgart, Fed. Rep. Ger.) V.141-161, 1970-77. For publisher information, see PARPDS. v. 151, p. 134, 1974 (BTPGAZ); V02-K60-L60 orl-rat TD :55 mg/kg/2Y-I Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 29, 1980 (ATSUDG); V03-L60 orl-pig TD :1400 mg/kg/45W Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 23, p. 497, 1967 (EXPEAM); V02-J60 scu-ham TD :2500 ug/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 94, p. 1, 1979 (JCROD7); V01-J60-K60 orl-mus TD :330 mg/kg/7W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 12, p. 367, 1974 (FCTXAV); V03-L60 ipr-mus TDLo: 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 477, p. 41, 2001 (MUREAV); V01-J30 ipr-rat TDLo: 200 mg/kg/3W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 152, p. 37, 2000 (CALEDQ); V02-P60 ipr-rat TDLo: 100 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 154, p. 121, 2000 (CALEDQ); V03-L60 orl-rat TDLo: 175 mg/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 330, 2000 (TOSCF2); V02-P60 ipr-rat TDLo: 100 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 154, p. 121, 2000 (CALEDQ); V01-L60 ipr-mus TDLo: 0.02 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 331, 2000 (CRNGDP); V01-L60 orl-rat TDLo: 2800 mg/kg/20W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 136, p. 11, 1999 (CALEDQ); V02-L60 orl-rat TDLo: 168 mg/kg/10W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 138, p. 151, 1999 (CALEDQ); V01-L60 orl-rat TDLo: 504 mg/kg/30W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 138, p. 151, 1999 (CALEDQ); V02-L60 ipr-rat TDLo: 200 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 140, p. 59, 1999 (CALEDQ); V02-L60 ipr-rat TDLo: 200 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 141, p. 211, 1999 (CALEDQ); V01-L60 ipr-mus TDLo: 10 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 82, p. 467, 2000 (BJCAAI); V01-L60 ipr-rat TDLo: 300 mg/kg/3W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 183, p. 9, 2002 (CALEDQ); V01-J60 scu-ham TDLo: 200 mg/kg/1W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 147, p. 125, 1999 (CALEDQ) ORNG: 220000000 ng/kg. [220.000000 mg/kg] K12-L03-U01 AT: K12-L03-U01 orl-rat LD50: 220 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 14, p. 1167, 1964 (ARZNAD); T/E unlistd ipr-rat LD50: 216 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 85, p. 72, 1962 (BIJOAK); J30-K08-L30 scu-rat LD50: 195 mg/kg Experimental Pathology (1981). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.19- 1981- v. 27, p. 171, 1985 (EXPADD); T/E unlistd ivn-rat LD50: 280 mg/kg IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD); T/E unlistd unr-rat LD50: 245 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(8), p. 11, 1980 (GISAAA); F07 orl-mus LD50: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555387 (NTIS**); T/E unlistd ipr-mus LD50: 132 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); T/E unlistd ivn-mus LD50: 293 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(10), p. 51, 1973 (GTPZAB); T/E unlistd ims-mus LD50: 356 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(10), p. 51, 1973 (GTPZAB); T/E unlistd unr-mus LD50: 210 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(8), p. 11, 1980 (GISAAA); T/E unlistd orl-gpg LD50: 250 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); T/E unlistd ipr-gpg LD50: 175 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 533, 1984 (CRNGDP); J30-L30-P30 scu-ham LD50: 232 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 33, p. 411, 1976 (BJCAAI); J30-L30-M20 unr-ham LD50: 246 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 49, p. 595, 1972 (JNCIAM); J08-J25-K12 orl-rat TDLo: 175 mg/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 330, 2000 (TOSCF2); Y16 orl-rat LD50: 280 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 81, 1987 (FATOAO) MD: U01-M71 ipr-rat TDLo: 260 mg/kg/13D-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 73, p. 54, 2000 (ARTODN) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 83, 1978 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 28, p. 151, 1982 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 83, 1978 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 35, p. 89, 1976 (FEPRA7); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 64, p. 77, 1976 (RREVAH); TOXICOLOGY REVIEW Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 17, p. 107, 1975 (GMCRDC); TOXICOLOGY REVIEW Alimentation et la Vie. (Societe Scientifique d'Hygiene Alimentaire, 16, rue de l'Estrapade, 75005 Paris, France) V.39- 1951- v. 50, p. 77, 1962 (ALLVAR); TOXICOLOGY REVIEW Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 33, p. 66, 1976 (ONCOBS); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY); TOXICOLOGY REVIEW Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 37, p. 259, 1980 (ONCOBS) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: 0.001 mg/m3, Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-nonhuman, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: N crassa-reversion, E coli polA with S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS in rat liver, V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman, In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal, Mouse spot test; EPA GENETOX PROGRAM 1988, Negative: E coli polA without S9, In vitro SCE-human lymphocytes; EPA GENETOX PROGRAM 1988, Negative: In vitro SCE-human, Mouse specific locus; EPA GENETOX PROGRAM 1988, Negative: UDS in mouse germ cells; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Nitrosamines, 2522; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #27; OSHA ANALYTICAL METHOD #13, SUPERSEDED BY #27 Record 722 of 1119 in RTECS (through 2003/06) AN: IQ0525000 PN: Dimethylamine,-N-nitroso- SY: DMN-; DMNA-; Dimethylnitrosamin- (German); Dimethylnitrosamine-; Dimethylnitrosoamine-; Dimethylnitrosoamine- (OSHA); Methanamine,-N-methyl-N-nitroso- (9CI); N,N-Dimethylnitrosamine-; N-Methyl-N-nitrosomethanamine-; N-Nitroso-N,N-dimethylamine-; N-Nitrosodimethylamine-; N-Nitrosodimethylamine- (ACGIH:OSHA); NDMA-; Nitrosodimethylamine-; RCRA-waste-number-P082- RN: Current: 62-75-9 BRN: 1738979 BHR: 4-04-00-03384 UD: 200305 MF: C2-H6-N2-O MW: 74.10 WL: ONN1&1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 50 uL/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 101, 1978 (MUREAV); mmo-sat 10 mmol/L (-S9) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 47, p. 63, 1989 (CALEDQ); oms-sat 1500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); oms-esc 40 nmol/tube Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 5971, 1982 (PNASA6); mmo-esc 140 nmol/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 87, 1984 (MUREAV); dnr-esc 50 ng/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 53, 1977 (MUREAV); dnr-bcs 25 gm/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 19, 1981 (EVSRBT); mmo-omi 1 pph/72H-C (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 522, 1974 (SOGEBZ); slt-dmg-orl 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 455, 1983 (ENMUDM); slt-dmg-par 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 3780, 1975 (CNREA8); sln-dmg-par 2 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 14, p. 21, 1976 (CBINA8); sln-dmg-orl 2500 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 187, 1980 (ENMUDM); dlt-dmg-orl 10 mmol/L Roczniki Panstwowego Zakladu Higieny. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 33, p. 215, 1982 (RPZHAW); mmo-nsc 100 nmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 3, p. 537, 1966 (MUREAV); mmo-nsc 90 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 31, p. 195, 1975 (MUREAV); mmo-smc 450 mmol/L (-S9) Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 83, p. 14, 1978 (BBRCA9); mmo-smc 350 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 309, 1977 (MUREAV); mrc-smc 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 108, p. 161, 1983 (MUREAV); mmo-asn 20096 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mrc-asn 20096 ug/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mrc-clr 68 umol/L Current Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1979- v. 10, p. 393, 1986 (CUGED5); dns-ofs-lvr 100 umol/L National Cancer Institute, Monograph. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1959- v. 65, p. 163, 1984 (NCIMAV); mnt-hmn-lvr 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 414, p. 37, 1998 (MUREAV); mtr-hmn-oth 200 ug/L Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 47, p. 1543, 1981 (CANCAR); mtr-hmn-fbr 1 ug/L Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 12, p. 3, 1982 (BANRDU); dnd-hmn-kdy 32 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 41, 1996 (MUREAV); dna-hmn-lng 27600 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2309, 1977 (CNREA8); dna-hmn-oth 1300 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dna-hmn-oth 4100 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dns-hmn-oth 1300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 235, p. 81, 1990 (MUREAV); dns-hmn-fbr 1 mmol/L/1H International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 16, p. 284, 1975 (IJCNAW); dns-hmn-hla 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-oth 1 mmol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 69, p. 557, 1982 (JJIND8); dns-hmn-lvr 1 mmol/L Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 13, p. 101, 1982 (BANRDU); dni-hmn-hla 100 mmol/L/1H-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(1), p. 65, 1978 (JEPTDQ); dns-hmn-oth 30 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 271, p. 201, 1992 (MUREAV); dnd-hmn-oth 90 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 441, p. 215, 1999 (MUREAV); cyt-hmn-hla 10 umol/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 9, p. 21, 1978 (TXCYAC); cyt-hmn-lym 50 mmol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 39, p. 159, 1977 (ARTODN); sce-hmn-fbr 3 mmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 203, 1982 (ENMUDM); sce-hmn-lym 29 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 4775, 1980 (CNREA8); msc-hmn-lym 14 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 128, p. 221, 1984 (MUREAV); mnt-rat-par 30 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 84, p. 135, 1975 (ZKKOBW); mnt-rat-ipr 10 mg/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 4, p. 267, 1982 (PMRSDJ); mnt-rat-orl 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 225, p. 143, 1989 (MUREAV); mtr-rat-ipr 60 mg/kg Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 34, p. 16, 1977 (ONCOBS); mtr-rat-orl 100 umol/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 43, p. 313, 1983 (CBINA8); dna-rat-oth 175 umol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dna-rat-oth 6300 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); mtr-rat-lvr 100 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 28, p. 215, 1973 (BJCAAI); mtr-rat-emb 1300 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dnd-rat-unr 5 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 15, p. 101, 1976 (CBINA8); dnd-rat-ivn 1 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 3128, 1981 (CNREA8); dnd-rat-ipr 5 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 40, p. 203, 1988 (CALEDQ); dnd-rat-orl 22 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-par 2 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 248, p. 153, 1974 (NATUAS); dns-rat-scu 1560 ug/kg Biomedicine. (Paris, France) V.18-34, 1973-81. v. 20, p. 119, 1974 (BIMDB3); dns-rat-lvr 30 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 299, 1983 (MUREAV); dns-rat-orl 625 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 344, p. 109, 1995 (MUREAV); dns-rat-ipr 1 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1071, 1982 (CRNGDP); dni-rat-ipr 9 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 27, p. 81, 1979 (CBINA8); dni-rat-scu 12500 ug/kg Biomedicine. (Paris, France) V.18-34, 1973-81. v. 20, p. 119, 1974 (BIMDB3); oms-rat-ipr 30 mg/kg Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 654, p. 31, 1981 (BBACAQ); dns-rat-oth 1 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 773, 1984 (CRNGDP); dns-rat-oth 5 mmol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 106, 1984 (PAACA3); oms-rat-ipr 4 mg/kg Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 697, p. 336, 1982 (BBACAQ); dns-rat-ihl 500 ppm/4H Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 106, 1984 (PAACA3); dnd-rat-oth 1 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1453, 1984 (CRNGDP); dns-rat-oth 5 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1453, 1984 (CRNGDP); bfa-rat-ovr 320 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 263, 1985 (MUREAV); dnd-rat-kdy 32 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 41, 1996 (MUREAV); cyt-rat-scu 40 mg/kg Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 23, p. 121, 1980 (NULSAK); cyt-rat-lvr 45 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1077, 1987 (CRNGDP); cyt-rat-orl 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 251, p. 59, 1991 (MUREAV); sce-rat-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 107, p. 131, 1983 (MUREAV); sce-rat-lvr 100 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1077, 1987 (CRNGDP); sce-rat-orl 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 251, p. 59, 1991 (MUREAV); msc-rat-emb 100 ug/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 79, 1978 (JTEHD6); hma-rat-smc 3705 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 31, p. 381, 1975 (MUREAV); hma-rat-sat 600 ug/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 277, 1979 (ENMUDM); mnt-mus-ihl 1030 mg/m3 Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 40, p. 280, 1985 (NEZAAQ); mnt-mus-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 278, p. 103, 1992 (MUREAV); mnt-mus-orl 12500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 43, 1982 (MUREAV); mmo-mus-mmr 10 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 30, p. 249, 1975 (MUREAV); mmo-mus-lym 100 ug/L (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 331, 1987 (ENMUDM); slt-mus-ipr 7500 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 38, p. 87, 1977 (ARTODN); mtr-mus-fbr 500 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dnd-mus-oth 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 213, p. 185, 1989 (MUREAV); dnd-mus-mul 57400 ug/kg/6W-C Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 4, p. 321, 1971/1972 (CBINA8); dnd-mus-ipr 5700 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 39, 1978 (MUREAV); dnd-mus-orl 15 mg/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 17, p. 765, 1976 (IJCNAW); dna-mus-oth 5 umol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dna-mus-oth 72 umol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dns-mus-orl 1200 ug/kg Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 58, p. 242, 1974 (BBRCA9); dns-mus-lvr 10 umol/L Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 12, p. 119, 1984 (TOPADD); dns-mus-ipr 3 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 357, 1980 (TXAPA9); oms-mus-ivn 25 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 54, p. 215, 1983 (ARTODN); dni-mus-ipr 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); dnd-mus-ipr 5 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 19, p. 731, 1998 (CRNGDP); dni-mus-par 20 mg/kg Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 21, p. 281, 1978 (RCOCB8); oms-mus-orl 35 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 21, p. 45, 1978 (CBINA8); oms-mus-ipr 40 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 5110, 1984 (CNREA8); dns-mus-scu 150 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 145, p. 1339, 1974 (PSEBAA); sce-mus-ipr 120 umol/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 219, 1989 (TCMUD8); sce-mus-lng 15 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 158, p. 269, 1978 (PSEBAA); dlt-mus-ipr 4400 ug/kg Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 117, p. 197, 1972 (MGGEAE); dlt-mus-scu 45 mg/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 135, 1971 (ATXKA8); msc-mus-ipr 4 mg/kg/4D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 412, p. 161, 1998 (MUREAV); msc-mus-lym 3700 mg/L Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(2-3), p. 327, 1980 (JEPTDQ); hma-mus-leu 2500 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 3073, 1974 (CNREA8); hma-mus-ssp 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 85, p. 57, 1981 (MUREAV); hma-mus-sat 24200 ug/kg Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 117, p. 197, 1972 (MGGEAE); hma-mus-srm 12 mg/kg/2H Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 117, p. 197, 1972 (MGGEAE); hma-mus-smc 10 umol/kg Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 3, p. 99, 1973 (AGACBH); hma-mus-esc 15 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 25, p. 187, 1974 (MUREAV); spm-mus-ipr 2 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 12, p. 183, 1979 (TXCYAC); hma-mus-oth 2 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 207, p. 57, 1988 (MUREAV); mnt-ham-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 43, p. 255, 1977 (MUREAV); mmo-ham-lng 100 umol/L (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1403, 1985 (CRNGDP); mmo-ham-ovr 150 umol/L (+S9) Molecular Toxicology. (Taylor and Francis, Inc., 242 Cherry St., Philadelphia, PA USA 19106) V.1- 1987- v. 1, p. 217, 1987 (MOTOEX); slt-ham-ovr 700 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 594, 1981 (PMRSDJ); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-ham-emb 100 mg/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); mtr-ham-orl 200 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 45, p. 119, 1982 (EVHPAZ); dnd-ham-ipr 10 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 50, 1979 (CNREA8); dnd-ham-lng 3 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 181, 1987 (MUREAV); dnd-ham-ovr 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 259, 1980 (MUREAV); dnd-ham-lvr 50 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 15, p. 24, 1990 (EMMUEG); dns-ham-lvr 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 1, 1984 (ENMUDM); dns-ham-lng 10 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 454, 1984 (ENMUDM); cyt-ham-emb 100 mmol/L Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 56, p. 41, 1980 (PJABDW); cyt-ham-ipr 20 mg/kg Cancer Genetics and Cytogenetics. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1979- v. 10, p. 23, 1983 (CGCYDF); cyt-ham-lng 500 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); cyt-ham-fbr 40 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 51, p. 397, 1978 (MUREAV); cyt-ham-ovr 1110 umol/L Molecular Toxicology. (Taylor and Francis, Inc., 242 Cherry St., Philadelphia, PA USA 19106) V.1- 1987- v. 1, p. 217, 1987 (MOTOEX); sce-ham-ipr 15 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 158, p. 269, 1978 (PSEBAA); sce-ham-fbr 40 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 51, p. 397, 1978 (MUREAV); sce-ham-ovr 500 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 1, 1985 (ENMUDM); sce-ham-oth 40 mmol/L/30M Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 61, 1980 (ARTODN); sce-ham-lng 10 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 454, 1984 (ENMUDM); sce-ham-orl 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); msc-ham-ipr 200 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 2, p. 277, 1978 (TOLED5); msc-ham-lng 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 454, 1984 (ENMUDM); msc-ham-ovr 100 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 539, 1984 (ENMUDM); dnd-grb-ipr 100 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 1306, 1983 (CNREA8); dns-mky-lvr 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 91, 1988 (MUREAV); dnd-mam-kdy 1 mmol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); dnd-mam-lym 430 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 87, 1984 (MUREAV); cyt-ctl-lym 60 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 290, p. 311, 1993 (MUREAV); sce-ctl-lym 6 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 290, p. 311, 1993 (MUREAV); hma-mam-esc 100 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 24, p. 1422, 1974 (ARZNAD); mmo-sat 0.2 umol/plate/48H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 484, p. 61, 2001 (MUREAV); dnd-oin-orl 0.25 umol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 480-481, p. 139, 2001 (MUREAV); dnd-rat-lvr 5 mmol/L Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 71, 2000 (TOSCF2); dnd-hmn-lvr 5 mmol/L Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 71, 2000 (TOSCF2); mnt-rat-lvr 5 mmol/L Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 71, 2000 (TOSCF2); slt-ham-ovr 0.2 gm/L/24H (+S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 22, p. 45, 2001 (JAPTO*); sce-ham-ovr 0.2 gm/L/4H (+S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 22, p. 45, 2001 (JAPTO*); mmo-sat 20 ug/plate/48H (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 523, 2001 (MUTAEX); mrc-smc 200 mmol/L/3H (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 97, 2000 (EMMUEG); mrc-smc 200 mmol/L/3H (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 97, 2000 (EMMUEG); msc-ham-ovr 200 mg/L/5H (-S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 449, 2001 (JAPTO*); msc-ham-ovr 200 mg/L/5H (+S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 449, 2001 (JAPTO*); sce-ham-ovr 300 mg/L/2H (+S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 449, 2001 (JAPTO*); mrc-dmg 0.01 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 514, p. 193, 2002 (MUREAV) RE: T34 orl-rat TDLo: 20 mg/kg (20D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 453, 1983 (FCTOD7); T35 orl-rat TDLo: 30 mg/kg (10D preg) Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 71, p. 32, 1968 (ZEKBAI); T25-T35-T59 orl-rat TDLo: 35 mg/kg (8-14D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 13(5), p. 87, 1967 (VOONAW); T27 orl-rat TDLo: 30 mg/kg (10D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 13(5), p. 87, 1967 (VOONAW); T24 orl-rat TDLo: 35 mg/kg (1-7D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 13(5), p. 87, 1967 (VOONAW); T35 ipr-rat TDLo: 5 mg/kg (12D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 2231, 1973 (CNREA8); T35 ivn-rat TDLo: 20 mg/kg (10D preg) Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 71, p. 32, 1968 (ZEKBAI); T39 unr-rat TDLo: 7 mg/kg (1-7D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 1, 1973 (IARCCD); T35 ipc-rat TDLo: 500 ug/kg (13D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1308, 1974 (BEXBAN); T71-T75 orl-mus TDLo: 1940 ug/kg (75D pre/1-22D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 19, p. 311, 1978 (RCOCB8); T83 ipr-mus TDLo: 10 mg/kg (18D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 24, p. 251, 1982 (TXCYAC) TE: V03-T65-M61 orl-rat TDLo: 30 mg/kg (21D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1308, 1974 (BEXBAN); V01-K60-L60 orl-rat TDLo: 23 mg/kg/2Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4997, 1981 (CNREA8); V01-L60-M61 ihl-rat TCLo: 200 ug/m3/45W-C Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 21(6), p. 107, 1975 (VOONAW); V01-M61 ipr-rat TDLo: 30 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 2796, 1970 (CNREA8); V03-L60 scu-rat TDLo: 24466 ug/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 498, 1986 (CNREA8); V03-M61 ims-rat TDLo: 18 mg/kg Investigative Urology. (Baltimore, MD) V.1-19, 1963-81. For publisher information, see JOURAA. v. 4, p. 39, 1966 (INURAQ); V02-T65-M61 unr-rat TDLo: 7 mg/kg (15-21D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 1, 1973 (IARCCD); V03-M61 ivn-rat TDLo: 18 mg/kg Investigative Urology. (Baltimore, MD) V.1-19, 1963-81. For publisher information, see JOURAA. v. 4, p. 39, 1966 (INURAQ); V03-M61 mul-rat TDLo: 420 mg/kg/2W-C Acta Pathologica Japonica. (Japan Publications Trading Co., Ltd., POB 5030, Tokyo International, Tokyo 101-31, Japan) V.1- 1951- v. 23, p. 87, 1973 (APJAAG); V03-M61 irn-rat TDLo: 20 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 71, p. 787, 1983 (JJIND8); V02-T65-J60 orl-mus TDLo: 140 ug/kg (4W pre-3W post) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 1553, 1979 (JJIND8); V01-J60 orl-mus TDLo: 80 mg/kg/8W-C International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 28, p. 199, 1981 (IJCNAW); V02-J60-L60 ihl-mus TCLo: 200 ug/m3/45W-C Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 21(6), p. 107, 1975 (VOONAW); V02-J61-V08 skn-mus TDLo: 800 mg/kg/20W-I European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 16, p. 695, 1980 (EJCAAH); V01-J60 ipr-mus TDLo: 7 mg/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 28, p. 199, 1981 (IJCNAW); V01-T65-J60 scu-mus TDLo: 38 mg/kg (17-19D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 17(8), p. 75, 1971 (VOONAW); V02-J60-M61 scu-mus TDLo: 70 mg/kg/1W-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 20, p. 871, 1966 (BJCAAI); V03-J60-L60 orl-rbt TDLo: 325 mg/kg/37W-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 23, p. 125, 1969 (BJCAAI); V03-L60 orl-ham TDLo: 13 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 46, p. 985, 1982 (BJCAAI); V02-L60 ipr-ham TDLo: 20 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 91, 1980 (CRNGDP); V01-L60 scu-ham TDLo: 62 mg/kg/44W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1295, 1973 (JNCIAM); V02-T65-N60 scu-ham TDLo: 12 mg/kg (14D preg) Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 79, 1977 (ZKKOBW); V03-J60 itr-ham TDLo: 12 mg/kg/8W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 947, 1988 (CRNGDP); V02-J60 itr-ham TDLo: 12 mg/kg/15W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 847, 1988 (FCTOD7); V01-L60 orl-frg TDLo: 3076 mg/kg/29W-C Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 92, p. 1084, 1981 (BEXBAN); V03-L60 orl-mam TDLo: 49 mg/kg/71W-C IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 14, p. 443, 1976 (IARCCD); V02-J60-L60 ipr-mus TD :7 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 1, p. 395, 1969/1970 (CBINA8); V01-J60-L60 orl-mus TD :370 mg/kg/56W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 41, p. 1213, 1968 (JNCIAM); V01-K60-L60 orl-rat TD :42 mg/kg/30W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4997, 1981 (CNREA8); V02-J60 orl-mus TD :11 mg/kg/16W-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 98, 1984 (PAACA3); V01-J08-M61 ipr-rat TD :40 mg/kg British Journal of Experimental Pathology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1920- v. 51, p. 587, 1970 (BJEPA5); V02-L60 orl-rat TD :114 mg/kg/81W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 48(3), p. 19, 1983 (GISAAA); V01-J60-M60 ipr-rat TD :30 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1003, 1984 (CRNGDP); V01-L60-M61 ipr-rat TD :20 mg/kg Journal of Surgical Oncology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1969- v. 8, p. 539, 1976 (JSONAU); V02-M61 orl-rat TD :336 mg/kg/2W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 18(Suppl 1), p. 115, 1983 (TOLED5); V01-L60 scu-ham TD :74200 ug/kg/53W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 31, p. 181, 1986 (CALEDQ); V03-L60 ipr-mus TDLo: 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 477, p. 41, 2001 (MUREAV); V01-L60 ipr-mus TDLo: 2.400 mg/kg/7D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 143, p. 81, 1999 (CALEDQ) ORNG: 37000000 ng/kg. [37.000000 mg/kg] T/E unlistd IHPB: 78000 ppb/4H. [78.000000 ppm/4H] D35-F07-P01 AT: K08-K13-U25 orl-wmn LDLo: 20 mg/kg/2.5Y Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 37, p. 273, 1980 (ONCOBS); T/E unlistd orl-rat LD50: 37 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(8), p. 81, 1985 (GISAAA); D35-F07-P01 ihl-rat LC50: 78 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 12, p. 617, 1955 (AMIHAB); F07-K30-R21 ipr-rat LD50: 26500 ug/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 11, p. 167, 1954 (BJIMAG); L14-M02-P17 scu-rat LD50: 15 mg/kg "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 183, 1999 (STGNBT); F07-K30-R21 ivn-rat LDLo: 40 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 11, p. 167, 1954 (BJIMAG); T/E unlistd unr-rat LD50: 36 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(8), p. 11, 1980 (GISAAA); D35-F07-P01 ihl-mus LC50: 57 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 12, p. 617, 1955 (AMIHAB); T/E unlistd ipr-mus LD50: 19 mg/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 32, p. 495, 1976 (EXPEAM); L30 unr-mus LDLo: 20 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 11, p. 167, 1954 (BJIMAG); F18-K13-P01 orl-dog LDLo: 20 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 11, p. 167, 1954 (BJIMAG); F15-K13-U25 ihl-dog LCLo: 16 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 12, p. 617, 1955 (AMIHAB); L14-M02-P17 orl-rbt LDLo: 10 mg/kg "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 183, 1999 (STGNBT); L30 unr-rbt LDLo: 10 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 11, p. 167, 1954 (BJIMAG); L14-M02-P17 orl-gpg LDLo: 25 mg/kg "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 183, 1999 (STGNBT); T/E unlistd ipr-gpg LD50: 13700 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 533, 1984 (CRNGDP); P01 unr-gpg LDLo: 25 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 11, p. 167, 1954 (BJIMAG); K06-L01-L03 orl-ham LD50: 28 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 33, p. 341, 1964 (JNCIAM); T/E unlistd ipr-ham LDLo: 30 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 91, 1980 (CRNGDP); J30-L30-P30 scu-ham LD50: 17700 ug/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 33, p. 411, 1976 (BJCAAI); L30-L30-Y15 scu-mam LD50: 10 mg/kg Acta Veterinaria Scandinavica. (Danske Dyrlargeforening, Alhambravej 15, DK-1826 Copenhagen V, Denmark) V.1- 1959- v. 22, p. 501, 1981 (AVSCA7); L50 unr-rat TDLo: 30 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 103, 1985 (FATOAO); F07-F15-Y07 ipr-rat TDLo: 50 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 46, p. 111, 1983 (FATOAO) MD: Y03-Y04 orl-rat TDLo: 156 mg/kg/7D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 626, 1970 (TXAPA9); U01 orl-rat TDLo: 412 mg/kg/16W-C British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 11, p. 167, 1954 (BJIMAG); P28-Y37 scu-rat TDLo: 63 mg/kg/3W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(8), p. 81, 1985 (GISAAA); S02-S04-Z01 orl-mus TDLo: 23800 ug/kg/17W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 37, p. 351, 1992 (JTEHD6) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 125, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 125, 1978 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 64, p. 77, 1976 (RREVAH); TOXICOLOGY REVIEW Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 17, p. 107, 1975 (GMCRDC); TOXICOLOGY REVIEW Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 157, 1977 (TXAPA9); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,257,1970 (85CVA2); TOXICOLOGY REVIEW Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 135, 1971 (ATXKA8); TOXICOLOGY REVIEW Archives of Pathology and Laboratory Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-5(2), 1926-28: V.100- 1976- v. 107, p. 54, 1983 (APLMAS); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY); TOXICOLOGY REVIEW Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 37, p. 259, 1980 (ONCOBS) SR: MSHA STANDARD: skin-SUSPECTED CARCINOGEN "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 25, 1973 (DTLWS*); OSHA PEL (Gen Indu): see CFR 29,1910.1016 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): see CFR 29,1926.1116 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): see CFR 29,1915.1016 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): see Appendix A3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OSHA-cancer suspect agent Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1016, 1987 (CFRGBR); OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.001 mg/m3, Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO N-NITROSODIMETHYLAMINE-air: CA use 29 CFR 1910.1016 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD 51110; NIS 1; TNF 75; NOS 1; TNE 747; TFE 299 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/90/182130/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, L5178Y cells in vitro-TK test; EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: N crassa-reversion, E coli polA with S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS in rat liver, V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive: TRP reversion, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S pombe-forward mutation; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro cytogenetics-nonhuman; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman, In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Negative: Cytogenetics-male germ cell, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: UDS in mouse germ cells; EPA GENETOX PROGRAM 1988, Inconclusive: SHE-clonal assay, Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Inconclusive: Rodent dominant lethal, Mouse spot test; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Nitrosamines, 2522; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #6; OSHA ANALYTICAL METHOD #27 Record 723 of 1119 in RTECS (through 2003/06) AN: JG8225000 PN: p-Dioxane- SY: Dioxan-; Dioxan-1,4- (German); p-Dioxan- (Czech); Dioxane-; Dioxane-1,4-; Glycol-ethylene-ether-; NCI-C03689-; RCRA-waste-number-U108-; Tetrahydro-p-dioxin-; Tetrahydro-1,4-dioxin-; 1,4-Dioxane-; Dioxane- (ACGIH:OSHA); 1,4-Dioxacyclohexane-; Diethylene-dioxide-; 1,4-Diethylene-dioxide-; Diethylene-dioxide- (OSHA); Diethylene-ether-; Di(ethylene oxide); Diokan-; Dioksan- (Polish); Diossano-1,4- (Italian); Dioxaan-1,4- (Dutch); Dioxanne- (French); p-Dioxin,-tetrahydro-; Dioxyethylene-ether- RN: Current: 123-91-1 BRN: 102551 BHR: 5-19-01-00016 UD: 200210 MF: C4-H8-O2 MW: 88.12 WL: T6O DOTJ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-hmn 300 ppm/15M Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28, p. 262, 1946 (JIHTAB); skn-rbt 515 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 12/17/1971 (UCDS**); eye-rbt 100 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,810,1986 (85JCAE); eye-gpg 10 ug MOD Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 11, p. 150, 1959 (JPPMAB) ME: dni-hmn-hla 400 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); dnd-rat-orl 2550 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 53, p. 67, 1990 (CALEDQ); dnd-rat-lvr 300 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); oms-rat-ivn 50 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 49, p. 29, 1981 (ARTODN); dns-rat-orl 20 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 287, 1981 (TXAPA9); oms-rat-ivn 50 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 49, p. 29, 1981 (ARTODN); mnt-mus-orl 900 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 142, 1994 (MUREAV); mnt-mus-orl 3 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 145, 1994 (MUREAV); mtr-mus-fbr 1 gm/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 41, 1988 (EMMUEG); sce-ham-ovr 10500 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T34-T46 orl-rat TDLo: 10 gm/kg (6-15D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 26, p. 85, 1985 (TOLED5) TE: V01-D09-L60 orl-rat TDLo: 185 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-80, 1978 (NCITR*); V03-P60-P62 ihl-rat TCLo: 111 ppm/7H/2Y-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 30, p. 287, 1974 (TXAPA9); V01-L60 orl-mus TDLo: 239 gm/kg/90W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-80, 1978 (NCITR*); V03-R60 skn-mus TDLo: 14 gm/kg/60W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 5, p. 163, 1973 (EVHPAZ); V02-J60 ipr-mus TDLo: 12 gm/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 19, 1986 (TXAPA9); V03-D09-L60 orl-rat TD :416 gm/kg/57W-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 24, p. 164, 1970 (BJCAAI); V01-D09-L60 orl-rat TD :408 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-80, 1978 (NCITR*); V01-L60 orl-mus TD :523 gm/kg/90W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-80, 1978 (NCITR*); V01-D09-L60 orl-rat TD :416 gm/kg/57W-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 24, p. 164, 1970 (BJCAAI); V03-L60-M61 orl-rat TD :528 gm/kg/63W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 35, p. 949, 1965 (JNCIAM) ORNG: 4200000000 ng/kg. [4200.000000 mg/kg] T/E unlistd SRNL: 7600000 nL/kg. [7.600000 mL/kg] T/E unlistd AT: F12-H01-K30 ihl-hmn TCLo: 470 ppm AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 20, p. 445, 1959 (AMIHAB); D17-D25-J30 ihl-hmn TCLo: 5500 ppm/1M Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878- v. 45, p. 2023, 1930 (PHRPA6); A30-J30-L30 ihl-hmn LCLo: 470 ppm/3D Pollution Engineering. (P.O. Box 1151, Skokie, IL 60077) V.1- 1969- v. 7(9), p. 22, 1975 (PLENBW); T/E unlistd orl-rat LD50: 4200 mg/kg Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 32, p. 145, 1994 (INHEAO); D35 ihl-rat LC50: 46 gm/m3/2H Kosmicheskaya Biologiya I Aviakosmicheskaya Meditsina. Space Biology and Aerospace Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.8- 1974- v. 11(6), p. 53, 1977 (KBAMAJ); T/E unlistd ipr-rat LD50: 799 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); T/E unlistd orl-mus LD50: 5300 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 16, p. 54, 1978 (IJEBA6); T/E unlistd ihl-mus LC50: 37 gm/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,63,1982 (85GMAT); J30-M03 ipr-mus LD50: 790 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 6, p. 342, 1947 (FEPRA7); T/E unlistd orl-cat LD50: 2 gm/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 21, p. 173, 1939 (JIHTAB); F13-J22 ihl-cat LCLo: 44 gm/m3/7H "Beitrag zur Toxikologischen Wirkung Technischer Losungsmittel, Dissertation," Klimmer, O., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1937 v. -, p. -, 1937 (KDPU**); F05-F33 ivn-cat LDLo: 1500 mg/kg Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 35, p. 540, 1935 (JOHYAY); T/E unlistd orl-rbt LD50: 2 gm/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 21, p. 173, 1939 (JIHTAB); T/E unlistd skn-rbt LD50: 7600 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 12/17/1971 (UCDS**); M10-M11-U01 ivn-rbt LDLo: 1500 mg/kg Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 35, p. 540, 1935 (JOHYAY); F01-K30-M30 orl-gpg LD50: 3150 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); T/E unlistd ihl-mam LC50: 20500 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(5), p. 61, 1986 (GISAAA) MD: F42 ihl-rat TCLo: 6000 ppm/4H/2W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 25, p. 369, 1964 (AIHAAP); M13-U06-Y15 ihl-rat TCLo: 20500 ug/m3/13W-I Kosmicheskaya Biologiya I Aviakosmicheskaya Meditsina. Space Biology and Aerospace Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.8- 1974- v. 11(6), p. 53, 1977 (KBAMAJ) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 20 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 247, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 589, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 201, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 589, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 589, 1999 (IMEMDT); TOXICOLOGY REVIEW Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- v. 54, p. 413, 1978 (BNYMAM); TOXICOLOGY REVIEW European Chemical Industry Ecology and Toxicology Centre. Joint Assessment of Commodity Chemicals. (Avenue Louise 250, B-63, B-1050 Brussels, Belgium) v. (2), p. -, 1983 (ECIET*) SR: MSHA STANDARD-air: TWA 100 ppm (360 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 94, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm (360 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (360 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (360 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (360 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 25 ppm (90 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 50 ppm (180 mg/m3), Skin, Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 25 ppm (90 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 10 ppm (36 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 25 ppm (90 mg/m3), STEL 40 ppm (135 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 10 ppm (35 mg/m3), VLE 40 ppm, C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 50 ppm (180 mg/m3), Skin, Carcinogen, JAN 1999; OEL-HUNGARY: STEL 10 mg/m3, Skin, Carcinogen, JAN 1993; OEL-JAPAN: OEL 10 ppm (36 mg/m3), Skin, 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 11 ppm (40 mg/m3), MAC-K 22 ppm, Skin, JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (360 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 10 mg/m3, MAC(STEL) 80 mg/me, JAN 1999; OEL-RUSSIA: TWA 10 ppm, STEL 10 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 25 ppm (90 mg/m3), KTV 50 ppm, Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 25 ppm (90 mg/m3), STEL 50 ppm, Skin, JAN 1999; OEL-TURKEY: TWA 100 ppm (360 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 25 ppm (91 mg/m3), STEL 100 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DIOXANE-air: CA CL 1 ppm/30M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 25145; NIS 135; TNF 12911; NOS 101; TNE 147783; NOES 1983: HZD 25145; NIS 181; TNF 20994; NOS 137; TNE 429330; TFE 149697 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Dioxane, 1602; NCI Carcinogenesis Bioassay (oral), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-80, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 724 of 1119 in RTECS (through 2003/06) AN: JI1800000 PN: 1,3-Dioxolane-4-methanol, 2-(1-iodoethyl)- SY: Iodinated-glycerol-; 2-(1-Iodoethyl)-1,3-dioxolane-4-methanol; Iodopropylidene-glycerol-; NCI-C55469-; Organidin- RN: Current: 5634-39-9 UD: 200210 MF: C6-H11-I-O3 MW: 258.07 WL: T5O COTJ BYI1 D1Q &T5O COTJ B2I D1Q CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 333 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9(Suppl 9), p. 1, 1987 (ENMUDM); sce-mus-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 395, p. 29, 1997 (MUREAV); msc-mus-lym 250 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*); cyt-ham-ovr 2500 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*); sce-ham-ovr 167 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*) TE: V01-N62-P60 orl-rat TDLo: 64375 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*); V02-D09-N60 orl-mus TDLo: 64375 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*); V01-N62-P61 orl-rat TDLo: 64375 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-259102 (NTIS**); V02-K60 orl-mus TDLo: 64375 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-259102 (NTIS**) MD: Z01 orl-rat TDLo: 6 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*); M03-Z01 orl-rat TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*); M03-Z01 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*) ND: NOHS 1974: HZD 81848; NIS 2; TNF 864; NOS 2; TNE 1099; NOES 1983: HZD 81848; NIS 2; TNF 85; NOS 6; TNE 854; TFE 265 SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-340, 1990 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 725 of 1119 in RTECS (through 2003/06) AN: JL9700000 PN: Dipropylamine,-N-nitroso- SY: Di-n-propylnitrosamine-; Propylamine,-N-nitroso-N-di-; RCRA-waste-number-U111-; Dipropylnitrosamine-; N-Nitrosodipropylamine-; N-Nitrosodi-n-propylamine-; N-Nitroso-N-propyl-1-propanamine-; 1-Propanamine,-N-nitroso-N-propyl- (9CI) RN: Current: 621-64-7 BRN: 1752621 BHR: 4-04-00-03388 UD: 200302 MF: C6-H14-N2-O MW: 130.22 WL: ONN3&3 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 1 umol/plate (-S9) Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 75, p. 8, 1984 (GANNA2); oms-esc 380 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); mmo-esc 1 umol/plate (+S9) Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 75, p. 8, 1984 (GANNA2); pic-esc 100 mg/L Topics in Chemical Mutagenesis. (Plenum Pub. Corp., 233 Spring Street, New York, NY 10013) V.1- 1984- v. 1, p. 91, 1984 (TCMUE9); dnd-hmn-lvr 3200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dnd-hmn-kdy 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 41, 1996 (MUREAV); dns-hmn-lvr 1800 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dns-hmn-hla 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dnd-rat-orl 310 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-lvr 30 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2592, 1982 (CNREA8); dnd-rat-kdy 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 41, 1996 (MUREAV); dns-rat-lvr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 144, p. 197, 1985 (MUREAV); mmo-mus-lym 500 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 106, p. 305, 1982 (MUREAV); dnd-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dni-mus-ipr 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); msc-mus-ipr 250 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 444, p. 309, 1999 (MUREAV); mmo-ham-lng 1 umol/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 406, 1980 (CNREA8); cyt-ham-lng 200 mg/L/27H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 277, 1979 (MUREAV); mmo-sat 50 ug/plate/48H (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 523, 2001 (MUTAEX) TE: V01-D09-L60 orl-rat TDLo: 660 mg/kg/60W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 19, p. 207, 1983 (CALEDQ); V02-D09-K60 scu-rat TDLo: 926 mg/kg/38W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 937, 1975 (JNCIAM); V03-J60-K60 orl-mus TDLo: 120 mg/kg/50W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 643, 1982 (IAPUDO); V01-D09-K60 scu-mus TDLo: 1516 mg/kg/44W-I Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 253, 1977 (ZKKOBW); V01-J60-K60 scu-ham TDLo: 1760 mg/kg/27W-I Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 141, 1977 (ZKKOBW); V02-T65-K60 scu-ham TDLo: 100 mg/kg (14D preg) Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 79, 1977 (ZKKOBW); V02-J60 itr-ham TDLo: 12 mg/kg/8W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 947, 1988 (CRNGDP); V03-D09-J60 scu-ham TD :143 mg/kg/38W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1019, 1973 (JNCIAM); V03-K60-L60 orl-rat TD :1880 mg/kg/30W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 407, 1979 (JJIND8); V03-K60-L60 orl-rat TD :1350 mg/kg/30W-I Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 2, p. 421, 1978 (EESADV); V02-J60-M60 scu-ham TD :100 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 79, 1977 (ZKKOBW); V03-K60 orl-rat TD :1150 mg/kg/30W-C Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 1077, 1969 (ARZNAD); V01-D09-L60 orl-rat TD :1056 mg/kg/30W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 19, p. 207, 1983 (CALEDQ); V03-J60-K60 orl-rat TD :675 mg/kg/30W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 14, p. 297, 1981 (CALEDQ) ORNG: 480000000 ng/kg. [480.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 480 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); J30-K06 scu-rat LD50: 487 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 937, 1975 (JNCIAM); T/E unlistd scu-mus LD50: 689 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 253, 1977 (ZKKOBW); T/E unlistd orl-ham LD50: >400 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 31, p. 361, 1975 (TXAPA9); T/E unlistd scu-ham LD50: 600 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1019, 1973 (JNCIAM) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 177, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 177, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (300 mg/m3), STEL 100 ppm (600 mg/m3), JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/90/180258/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro UDS-human fibroblast; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Nitrosamines, 2522; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #27 Record 726 of 1119 in RTECS (through 2003/06) AN: JR1925000 PN: Dodecanamide, N,N-bis(2-hydroxyethyl)- SY: Clindrol-101CG-; Clindrol-203CG-; Clindrol-210CGN-; Clindrol-200L-; Clindrol-superamide-100L-; Coco-diethanolamide-; Coconut-oil-amide-of-diethanolamine-; Comperlan-LD-; Condensate-PL-; Crillon L.D.E.; Diethanollauramide-; N,N-Diethanollauramide-; N,N-Diethanollauric-acid-amide-; N,N-Bis(2-hydroxyethyl)dodecanamide; Bis(2-hydroxyethyl)lauramide; N,N-Bis(hydroxyethyl)lauramide; N,N-Bis(beta-hydroxyethyl)lauramide; N,N-Bis(2-hydroxyethyl)lauramide; Hetamide-ML-; Lauramide-dea-; Lauric-acid-diethanolamide-; Lauric-acid-diethanolamine-condensate-; Lauric-diethanolamide-; Lauroyl-diethanolamide-; Lauryl-diethanolamide-; LDA-; LDE-; Monamid-150-LW-; NCI-C55323-; Ninol-4821-; Ninol-AA62-; Ninol-AA-62-Extra-; Ninol-P-621-; Standamidd-LD-; Steinamid-DL-203-S-; EMID-6511-; EMID-6541-; Ethylan-MLD-; Onyxol-345-; Rewomid-DLMS-; Rewomid DL 203/S; Richamide-6310-; Rolamid-CD-; Super-amide-L-9A-; Super-amide-L-9C-; Synotol-L-60-; Unamide-J-56-; Varamid-ML-1- RN: Current: 120-40-1 BRN: 1791417 BHR: 4-04-00-01539 UD: 200302 MF: C16-H33-N-O3 MW: 287.50 WL: Q2N2QV11 CC: Tumorigen (C); Drug (D); Primary-Irritant (S) ID: skn-rbt 500 uL SEV Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(5), p. 415, 1986 (JACTDZ); eye-rbt 100 uL MOD Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(5), p. 415, 1986 (JACTDZ) TE: V01-L60 skn-mus TDLo: 52500 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-480, 1999 (NTPTR*); V03-L60 skn-mus TDLo: 73500 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-169989 (NTIS**) ORNG: 2700000000 ng/kg. [2700.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2700 mg/kg Journal of the Society of Cosmetic Chemists. (Soc. of Cosmetic Chemists, 1995 Broadway, Suite 1701, New York, NY 10023) V.1- 1947- v. 13, p. 469, 1962 (JSCCA5) MD: P28-Y15 orl-rat TDLo: 108 mg/kg/90D-C Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(5), p. 415, 1986 (JACTDZ); M71-R03 skn-rat TDLo: 7 gm/kg/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-480, 1999 (NTPTR*); M71 skn-mus TDLo: 3500 mg/kg/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-480, 1999 (NTPTR*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD M3417; NIS 54; TNF 15809; NOS 49; TNE 155446; NOES 1983: HZD M3417; NIS 73; TNF 14469; NOS 84; TNE 792326; TFE 638641 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP carcinogenesis studies (dermal), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-480, 1999 (NTPTR*); NCI Carcinogenesis Studies (derm), no evidence: mouse, rat Record 727 of 1119 in RTECS (through 2003/06) AN: JW5020000 PN: Echinacea purpurea, ext. RN: Current: 90028-20-9 UD: 200012 CC: Tumorigen (C) SL: NTP Carcinogenesis studies, selected, October 2000 Record 728 of 1119 in RTECS (through 2003/06) AN: KB2625000 PN: Ephedrine sulfate (2:1) (salt), (-)- SY: 1-Phenyl-2-methylamine-propanol-1-sulfate-; 1-alpha-(1-(Methylamino)ethyl)benzyl alcohol sulfate; Ephedrine-sulfate-; Isofedrol-; NCI-C55652-; l-Ephedrine-sulfate- RN: Current: 134-72-5 UD: 200207 MF: C20-H30-N2-O2.H2-O4-S MW: 428.60 WL: QYR&Y1&M1 2 WSQQ -L CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: dnd-rat-lvr 3 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV) ORNG: 404000000 ng/kg. [404.000000 mg/kg] C08-F12-J30 AT: G07-H01 ivn-hmn TDLo: 1 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 120, p. 189, 1927 (AEPPAE); C08-F12-J30 orl-rat LD50: 404 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 94, p. 150, 1948 (JPETAB); C08-F12-J30 scu-rat LD50: 318 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 94, p. 150, 1948 (JPETAB); C08-F12-J30 ivn-rat LD50: 102 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 94, p. 150, 1948 (JPETAB); D07-F07-F19 orl-mus LD50: 812 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-307, 1986 (NTPTR*); F34-K01-R21 ipr-mus LD50: 270 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 15, p. 304, 1969 (TXAPA9); D16-F18-J26 ivn-dog LDLo: 70 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 27, p. 61, 1926 (JPETAB); D16-J26-K13 ivn-cat LDLo: 75 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 27, p. 61, 1926 (JPETAB); C08-F12-J30 orl-rbt LD50: 825 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 94, p. 150, 1948 (JPETAB); D16-F11-F12 ipr-rbt LDLo: 310 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 27, p. 61, 1926 (JPETAB); C08-F12-J30 scu-rbt LD50: 383 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 94, p. 150, 1948 (JPETAB); C08-F12-J30 ivn-rbt LD50: 73 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 94, p. 150, 1948 (JPETAB); D16-F11-F12 ims-rbt LDLo: 340 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 27, p. 61, 1926 (JPETAB); D16-F12-F19 scu-gpg LDLo: 425 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 27, p. 61, 1926 (JPETAB); F18-F19 par-frg LDLo: 530 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 27, p. 61, 1926 (JPETAB) MD: G70-N72 orl-rat TDLo: 18200 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-307, 1986 (NTPTR*); F13-F15-R21 orl-rat TDLo: 1050 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-307, 1986 (NTPTR*); P30 orl-mus TDLo: 8120 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-307, 1986 (NTPTR*); P30 orl-mus TDLo: 91 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-307, 1986 (NTPTR*) ND: NOHS 1974: HZD 84417; NIS 4; TNF 2470; NOS 9; TNE 9457; NOES 1983: HZD 84417; NIS 1; TNF 233; NOS 5; TNE 5373; TFE 3199 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 729 of 1119 in RTECS (through 2003/06) AN: KF0115500 PN: Erionite (cakna (al2Si7O18)2.14H2O) RN: Current: 66733-21-9 UD: 200006 MF: Al2-O18-Si7.1/2 Ca.7 H2-O.1/2 Na MW: 715.68 CC: Tumorigen (C); Natural-Product (N) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 225, 1987 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 225, 1987 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 203, 1987 (IMSUDL) SL: EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 730 of 1119 in RTECS (through 2003/06) AN: KF5785000 PN: Erythromycin,-stearate- (salt) SY: Bristamycin-; Dowmycin-E-; Erypar-; Erythrocin-stearate-; Erythromycin-stearate-; Erythromycin-stearic-acid-salt-; Erythromycin,-octadecanoate- (salt); Ethril-; Gallimycin-; NCI-C55674-; Pfizer-E-; Qidmycin-; SK-Erythromycin- RN: Current: 643-22-1 UD: 200207 MF: C37-H67-N-O13.C18-H36-O2 MW: 1018.59 WL: T-14-VO GVTJ C2 DQ D EQ F H JQ J L N KO- BT6OTJ CQ DN1&1 F& MO- FT6OTJ B CQ DO1 D &622 CC: Tumorigen (C); Human-Data (P) AT: K02-K13-Y21 orl-wmn TDLo: 60 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 34, p. 93, 1996 (JTCTDW); T/E unlistd orl-mus LD50: 3112 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 211, 1990 (NIIRDN); T/E unlistd scu-mus LD50: >2500 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 211, 1990 (NIIRDN); T/E unlistd ipr-gpg LD50: 413 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 211, 1990 (NIIRDN) MD: F15-K30-U01 orl-rat TDLo: 13037 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-338, 1988 (NTPTR*); F15-K30-Z01 orl-mus TDLo: 71 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-338, 1988 (NTPTR*) ND: NOHS 1974: HZD M0726; NIS 2; TNF 592; NOS 2; TNE 1977; NOES 1983: HZD M0726; NIS 1; TNF 78; NOS 1; TNE 1108; TFE 615 SL: NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 731 of 1119 in RTECS (through 2003/06) AN: KG2975000 PN: Estradiol- SY: 1,3,5-Estratriene-3,17-beta-diol-; 17-beta-Estra-1,3,5(10)-triene-3,17-diol; 17-beta-Estradiol-; 17-beta-OH-estradiol-; 17-beta-OH-oestradiol-; 17-beta-Oestra-1,3,5(10)-triene-3,17-diol; 17-beta-Oestradiol-; 3,17-Epidihydroxyestratriene-; 3,17-beta-Dihydroxy-1,3,5(10)-estratriene; 3,17-beta-Dihydroxy-1,3,5(10)-oestratriene; 3,17-beta-Dihydroxyestra-1,3,5(10)-triene; 3,17-beta-Dihydroxyoestra-1,3,5-triene-; 3,17-beta-Estradiol-; 3,17-beta-Oestradiol-; Altrad-; Bardiol-; D-3,17-beta-Estradiol-; D-3,17-beta-Oestradiol-; Dihydrofollicular-hormone-; Dihydrofolliculin-; Dihydromenformon-; Dihydrotheelin-; Dihydroxyestrin-; Dihydroxyoestrin-; Dimenformon-; Dimenformon-prolongatum-; Diogyn-; Diogynets-; E(sub 2); Estra-1,3,5(10)-triene-3,17-beta-diol; Estradiol-17-beta-; Estraldine-; Estrovite-; Femestral-; Femogen-; Gynergon-; Gynestrel-; Gynoestryl-; Lamdiol-; Macrodiol-; Macrol-; Microdiol-; NSC-9895-; Nordicol-; Oestergon-; Oestra-1,3,5(10)-triene-3,17-beta-diol; Oestradiol-; Oestradiol-R-; Oestradiol-17-beta-; Oestroglandol-; Oestrogynal-; Ovahormon-; Ovasterol-; Ovastevol-; Ovociclina-; Ovocyclin-; Ovocycline-; Ovocylin-; Primofol-; Profoliol-; Progynon-; Progynon-DH-; Syndiol-; Theelin,-dihydro-; alpha-Estradiol-; alpha-Oestradiol-; beta-Estradiol-; beta-Oestradiol-; cis-Estradiol-; cis-Oestradiol-; d-Estradiol-; d-Oestradiol- RN: Current: 50-28-2 UD: 200305 MF: C18-H24-O2 MW: 272.42 WL: L E5 B666TTT&J E1 FQ OQ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Hormone (H) ME: dns-nml-lvr 1 umol/L In Vitro Cellular and Developmental Biology. (Tissue Culture Assoc., 19110 Montgomery Village Ave., Suite 300, Gaithersburg, MD 20879) V.21- 1985- v. 22, p. 457, 1986 (ICDBEO); mnt-hmn-lym 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 199, 1985 (MUREAV); dns-hmn-mmr 10 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 1644, 1985 (CNREA8); dni-hmn-lym 10 umol/L Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 146, p. 401, 1974 (PSEBAA); oms-hmn-fbr 20 mg/kg Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 75, 1990 (TIVIEQ); cyt-hmn-lym 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 345, p. 87, 1995 (MUREAV); sce-hmn-lym 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 345, p. 87, 1995 (MUREAV); sln-hmn-fbr 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 241, 1990 (MUREAV); mtr-rat-orl 21 mg/kg/6W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 195, 1989 (CALEDQ); dna-rat-oth 10 nmol/L Cell (Cambridge, Mass.). (MIT Press, 28 Carleton St., Cambridge, MA 02142) V.1- 1974- v. 14, p. 857, 1978 (CELLB5); oms-rat-scu 10500 ng/kg Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 656, p. 45, 1981 (BBACAQ); dns-rat-lvr 100 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3010, 1982 (CNREA8); dns-rat-scu 18500 ug/kg/5D-I Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 656, p. 45, 1981 (BBACAQ); dns-rat-par 10 ug/kg Acta Histochemica et Cytochemica. (Japan Soc. of Histochemistry and Cytochemistry, Dept. Anatomy, Faculty of Medicine, Kyoto Univ., Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1968- v. 18, p. 213, 1985 (ACHCBO); dns-rat-ipr 40 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 29, p. 1469, 1980 (BCPCA6); oms-rat-scu 800 ng/kg/4D Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 385, 1978 (BIREBV); cyt-rat-par 10 mg/kg Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 54, p. 98, 1967 (NATWAY); mnt-mus-oth 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 181, 1991 (MUREAV); mnt-mus-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 345, p. 87, 1995 (MUREAV); mtr-mus-fbr 20 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 2583, 1987 (CNREA8); dns-mus-scu 1190 ug/kg Cell and Tissue Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.148- 1974- v. 156, p. 551, 1975 (CTSRCS); dni-mus-orl 40 ug/kg Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 61, p. 117, 1974 (JOENAK); cyt-mus-emb 1 mg/L Doklady Akademii Nauk SSSR. Proceedings of the Academy of Sciences of the USSR. For English translation, see DBIOAM and DKBSAS. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1933- v. 282, p. 173, 1985 (DANKAS); sce-mus-oth 10 umol/L Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 97, 1989 (TCMUD8); sce-mus-scu 200 mg/L Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 11, p. 135, 1991 (TCMUD8); sce-mus-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 345, p. 87, 1995 (MUREAV); spm-mus-scu 250 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 181, 1991 (MUREAV); mnt-ham-emb 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 311, p. 85, 1994 (MUREAV); mtr-ham-emb 3 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1715, 1987 (CRNGDP); dnd-ham-scu 200 mg/kg/2W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 997, 1994 (CRNGDP); oms-ham-emb 6 mg/kg Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 75, 1990 (TIVIEQ); cyt-ham-ovr 50 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 29, p. 201, 1985 (TOLED5); cyt-ham-scu 160 mg/kg/20W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 311, p. 191, 1994 (MUREAV); sce-ham-ovr 10 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 44, p. 62, 1988 (EXPEAM); sln-ham-emb 10 mg/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 27, p. 39, 1986 (PAACA3); sln-ham-fbr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 171, p. 31, 1986 (MUREAV); sln-ham-lng 40 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 431, p. 105, 1999 (MUREAV); dna-gpg-kdy 52 nmol/L Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 338, 1978 (BIREBV); dna-gpg-lng 52 nmol/L Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 338, 1978 (BIREBV); mnt-dom-oth 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 311, p. 85, 1994 (MUREAV); dna-mam-lym 5 nmol/L FEBS Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1968- v. 61, p. 223, 1976 (FEBLAL); dns-rbt-oth 100 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 703, 1982 (CRNGDP); dns-frg-par 40 mg/kg Developmental Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 108, p. 332, 1985 (DEBIAO); oms-ckn-ims 25 mg/kg Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 112, p. 425, 1983 (BBRCA9); dnd-ham-ipr 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 474, p. 87, 2001 (MUREAV); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG); mnt-hmn-oth 8 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 504, p. 119, 2002 (MUREAV); cyt-hmn-oth 2 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 504, p. 119, 2002 (MUREAV) RE: T29 orl-wmn TDLo: 4400 ug/kg (31W pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 105, p. 7, 1966 (ACEDAB); T25-T27 orl-rat TDLo: 1 gm/kg (4-8D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 22, p. 735, 1971 (FESTAS); T13 orl-rat TDLo: 750 ug/kg (3D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 13, p. 101, 1967 (JRPFA4); T22 orl-rat TDLo: 875 ug/kg (7D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 10, p. 105, 1965 (JRPFA4); T13 orl-rat TDLo: 4195 ng/kg (1D pre) Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 23, p. 329, 1980 (JMCMAR); T09-N02 ipr-rat TDLo: 1280 ng/kg (8D male) Andrologia. (Grosse Verlag GmbH, Kurfuerstenstr. 112-113, D-1000 Berlin 30, Fed. Rep. Ger.) V.6- 1974- v. 23, p. 339, 1991 (ANDRDQ); T13 scu-rat TDLo: 2400 ng/kg (3D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 60, p. 519, 1957 (ENDOAO); T02 scu-rat TDLo: 205 ug/kg (5D male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 60, p. 519, 1957 (ENDOAO); T29 scu-rat TDLo: 20 ug/kg (4D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 105, p. 7, 1966 (ACEDAB); T34 scu-rat TDLo: 14400 ng/kg (5-16D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 7, p. 701, 1974 (RCOCB8); T22 scu-rat TDLo: 10500 ng/kg (7D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 10, p. 105, 1965 (JRPFA4); T53 scu-rat TDLo: 6250 ug/kg (16-20D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 59, p. 43, 1980 (JRPFA4); T24-T26 scu-rat TDLo: 15300 ng/kg (1-9D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T14 scu-rat TDLo: 500 ug/kg (1D pre) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 50, p. 279, 1982 (ARTODN); T13 ivn-rat TDLo: 10 ug/kg (1D pre) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 42, p. 165, 1986 (EXPEAM); T13 ims-rat TDLo: 2 ug/kg (4D pre) Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- v. 1, p. 215, 1977 (PBPSDY); T53 ims-rat TDLo: 60 mg/kg (15-16D preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 28, p. 231, 1968 (JCEMAZ); T52 ims-rat TDLo: 60 mg/kg (19-20D preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 28, p. 231, 1968 (JCEMAZ); T12 ims-rat TDLo: 1800 mg/kg (15-20D preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 29, p. 30, 1969 (JCEMAZ); T01-T02-T03 ims-rat TDLo: 6720 ng/kg (14D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 15, p. 16, 1977 (IJEBA6); T14-T19 ims-rat TDLo: 70 ug/kg (14D pre) Nippon Funin Gakkai Zasshi. Japanese Journal of Fertility and Sterility. (Nippon Funin Gakkai, 1-1 Sadohara-cho, Ichigaya, Shinjuku-ku, Toyko 162, Japan) V.1- 1956- v. 30, p. 1, 1985 (NFGZAD); T25 par-rat TDLo: 4 ug/kg (14-17D preg) Nagasaki Igakkai Zasshi. Journal of Nagasaki Medical Association. (Nagasaki Igakkai, c/o Nagasaki Daigaku Igakubu, 12-4 Sakamoto-machi, Nagasaki 852, Japan) V.1- 1923- v. 33, p. 1678, 1958 (NAGZAC); T01-T02 par-rat TDLo: 1600 ug/kg (3W male) "The Control of Fertility," Pincus, G., New York, Academic Press, 1965 -,29,1965 (85GRAA); T03 imp-rat TDLo: 3600 ng/kg (90D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 269, p. 409, 1977 (NATUAS); T01-T02 imp-rat TDLo: 437 ug/kg (91D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 21, p. 455, 1979 (BIREBV); T01-T03-T23 imp-rat TDLo: 262 ug/kg (91D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 37, p. 327, 1987 (BIREBV); T29 unr-rat TDLo: 5 ug/kg (1D pre) "Agents Affecting Fertility, a Symposium, 1964," Austin, C.R., and J.S. Perry, eds., Boston, Little, Brown and Co., 1965 -,195,1965 (15QWAW); T13 iut-rat TDLo: 25 ng/kg (1D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 31, p. 705, 1984 (BIREBV); T12-T13 orl-mus TDLo: 219 mg/kg (52W pre) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(1), p. 1, 1977 (JEPTDQ); T13 orl-mus TDLo: 667 ng/kg (3D pre) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 20, p. 37, 1987 (JTEHD6); T14 ipr-mus TDLo: 4 mg/kg (5D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 160, p. 94, 1979 (PSEBAA); T02-T03-T23 scu-mus TDLo: 10 mg/kg (5D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 20, p. 310, 1979 (BIREBV); T01 scu-mus TDLo: 1 mg/kg (5D male) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 165, p. 17, 1980 (PSEBAA); T91 scu-mus TDLo: 20 mg/kg (19D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 1099, 1977 (CNREA8); T29 scu-mus TDLo: 12 ug/kg (1-3D preg) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 42, p. 17, 1968 (JOENAK); T13-T24 scu-mus TDLo: 14400 ng/kg (4-6D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 5, p. 239, 1963 (JRPFA4); T13 scu-mus TDLo: 204 ng/kg (3D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T13 scu-mus TDLo: 2 ug/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 25, p. 636, 1974 (FESTAS); T26 par-mus TDLo: 9600 ug/kg (4-6D preg) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 20, p. 299, 1960 (JOENAK); T29 par-mus TDLo: 4800 ug/kg (4-6D preg) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 20, p. 299, 1960 (JOENAK); T13 par-mus TDLo: 4 ug/kg (1D pre) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 25, p. 252, 1966 (FEPRA7); T16-T26 imp-mus TDLo: 1720 ug/kg (16-21D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 22, p. 509, 1970 (JRPFA4); T22 orl-mky TDLo: 10 mg/kg (1-6D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 115, p. 101, 1973 (AJOGAH); T01-T02 ihl-mky TCLo: 30 ug/kg/30M (60D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 22, p. 935, 1980 (BIREBV); T02-T03 orl-rbt TDLo: 60 ug/kg (8D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 55, 1972 (TXAPA9); T29 orl-rbt TDLo: 50 ug/kg (1D pre) "Control of Ovulation, Proceedings of the Conference, Dedham, MA, 1960," Villee, C.A., ed., Oxford, UK, Pergamon Press Ltd., 1961 -,37,1961 (13OPAL); T26 scu-rbt TDLo: 90 ug/kg (6-11D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 77, p. 337, 1965 (ENDOAO); T24 scu-rbt TDLo: 45 mg/kg (1-3D preg) International Congress Series--Excerpta Medica. (Excerpta Medica, Inc., POB 3085, Princeton, NJ 08540) No.1- 1952- v. (133), p. 406, 1967 (EXMDA4); T24 scu-rbt TDLo: 45 ug/kg (5-7D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 3, p. 246, 1962 (JRPFA4); T26-T35 ims-rbt TDLo: 30 ug/kg (18-20D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 53, p. 237, 1978 (JRPFA4); T29 ims-rbt TDLo: 5 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 10, p. 155, 1959 (FESTAS); T24-T34 unr-rbt TDLo: 190 ug/kg (1-19D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 2, p. 85, 1970 (CCPTAY); T25 par-pig TDLo: 7692 ng/kg (9-10D preg) Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 63, p. 1208, 1986 (JANSAG); T25-T26 scu-ham TDLo: 90 ug/kg (1-9D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T25 scu-ham TDLo: 900 ug/kg (1-9D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T02 imp-ham TDLo: 160 mg/kg (50W male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 57, p. 255, 1955 (ENDOAO); T02-T03 scu-grb TDLo: 15 mg/kg (15D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 61, p. 217, 1981 (JRPFA4); T29 scu-dom TDLo: 14 ug/kg (1D pre) Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 42, p. 677, 1976 (JANSAG); T14-T22 scu-ctl TDLo: 126 ug/kg (48W pre/1-28D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 89, p. 527, 1990 (JRPFA4); T02 imp-ctl TDLo: 900 ug/kg (26W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 10, p. 73, 1988 (FAATDF); T14 imp-ctl TDLo: 1 mg/kg (26-47D post) Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 66, p. 1, 1988 (JANSAG); T02-T09 imp-ctl TDLo: 147 mg/kg (82D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 94, p. 57, 1992 (JRPFA4); T52-T53 orl-rat TDLo: 0.225 mg/kg (multigeneration) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 143, 1998 (TOSCF2); T02-T05-T15 orl-rat TDLo: 99 mg/kg (multigeneration) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 116, 1998 (TOSCF2); T12-T13-T22 orl-rat TDLo: 99 mg/kg (multigeneration) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 116, 1998 (TOSCF2); T01-T81 orl-rat TDLo: 99 mg/kg (multigeneration) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 155, 1998 (TOSCF2); T53 orl-rat TDLo: 24.75 mg/kg (multigeneration) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 155, 1998 (TOSCF2); T22-T29 scu-mus TDLo: 0.99 mg/kg (5-7D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 29, 2002 (NETEEC) TE: V03-N60 ipr-rat TDLo: 1400 mg/kg/13W-I Archiv fuer Japanische Chirurgie. (Nippon Geka Hokan Henshushitsu, c/o Kyoto Daigaku Igakubu Geka Seikei Geka Kyoshitsu, 54 Kawara- machi, Shogoin, Sakyo-ku, Kyoto 606, Japan) V.1- 1924- v. 52, p. 655, 1983 (NIGHAE); V01-R60 imp-rat TDLo: 100 mg/kg/52W-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 78, p. 134, 1987 (JJCREP); V01-T64 orl-mus TDLo: 84 mg/kg/20W-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 82, p. 1391, 1991 (JJCREP); V03-T64 scu-gpg TDLo: 7 mg/kg/12W-I Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 130, p. 9, 1939 (CRSBAW); V03-V10 imp-gpg TDLo: 1200 ug/kg Revue Canadienne de Biologie. (Montreal, Quebec, Canada) V.1-40, 1942-81. v. 3, p. 108, 1944 (RCBIAS); V01-M61 imp-ham TDLo: 200 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 64, p. 23, 1992 (CALEDQ); V01-M61 imp-ham TD :360 mg/kg/15W-I Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 23, p. 278, 1983 (MOPMA3); V03-T64 imp-gpg TD :2400 ug/kg Boletin de la Sociedad de Biologia de Santiago de Chile. (Santiago, Chile) V.1-12, 1943-55. Discontinued. v. 8, p. 142, 1951 (BSBSAS); V01-R60 orl-mus TD :58 mg/kg/82W-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 35, p. 322, 1977 (BJCAAI); V03-T64 imp-gpg TD :40 mg/kg Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 1313, 1939 (LANCAO); V03-T64 imp-gpg TD :100 mg/kg Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 1313, 1939 (LANCAO); V03-R60-V15 orl-mus TD :44 mg/kg/52W-I Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(1), p. 1, 1977 (JEPTDQ); V03-N60-R60 imp-rat TD :62500 ug/kg/36W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 73, p. 123, 1984 (JJIND8); V03-M60-J61 imp-ham TD :160 mg/kg Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 10, p. 757, 1957 (CANCAR); V03-R60 imp-mus TD :30 mg/kg Revue Europeenne d'Etudes Cliniques et Biologiques. European Journal of Clinical and Biological Research. (Paris, France) V.15-17, 1970-72. For publisher information, see BIMDB3. v. 16, p. 425, 1971 (REEBB3); V03-R60 imp-mus TD :34 mg/kg European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 11, p. 39, 1975 (EJCAAH) AT: T/E unlistd scu-rat LD :>300 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 26, p. 740, 1995 (IYKEDH); Z74 scu-rat TDLo: 10 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 133, p. 313, 1995 (TXAPA9); Z74 ipr-rat TDLo: 150 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 358, 1969 (TXAPA9) MD: N20-P05-U30 orl-rat TDLo: 45 mg/kg/90D-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 42, p. 99, 1998 (TOXID9); N02-U01-Z73 ipr-rat TDLo: 750 ug/kg/15D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 116, 1998 (TOSCF2); P71-U01-Z74 scu-rat TDLo: 4200 ug/kg/12W-I Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 20, p. 3899, 1992 (YACHDS); L70 orl-rat TDLo: 45 mg/kg/90D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 116, 1998 (TOSCF2); Y37 orl-rat TDLo: 225 mg/kg/90D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 116, 1998 (TOSCF2); N71-P05-P27 orl-rat TDLo: 45 mg/kg/90D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 116, 1998 (TOSCF2); U01 orl-rat TDLo: 11.25 mg/kg/90D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 116, 1998 (TOSCF2); U01-Z73 orl-rat TDLo: 54 mg/kg/90D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 44, p. 155, 1998 (TOSCF2); T13-Y20-Z74 ipr-mus TDLo: 30 ug/kg/3D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 122, p. 89, 2001 (TOLED5); N17-Z74 scu-mus TDLo: 0.99 ug/kg/3D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 1211, 2001 (FCTOD7); N74-N73 scu-mus TDLo: 14.5 mg/kg/5D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 60, p. 185, 2000 (JTEHD6); T13 scu-rat TDLo: 0.07 mg/kg/14D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); Z74 scu-rat TDLo: 0.015 mg/kg/3D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); T14 scu-rat TDLo: 0.125 mg/kg/25D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); L30-Z74 ipr-rat TDLo: 40 ug/kg/2D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102, p. 568, 1994 (EVHPAZ); Z74 ipr-rat TDLo: 60 ug/kg/5D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102, p. 568, 1994 (EVHPAZ); N04-N02 scu-rat TDLo: 833.2 ug/kg/2D-I Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 105, p. 211, 1985 (JOENAK); N02-N04-N16 scu-rat TDLo: 111.2 ug/kg/2D-I Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 105, p. 211, 1985 (JOENAK); T13-Z74 scu-mus TDLo: 30 ug/kg/3D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 75, p. 130, 1997 (ENVRAL); N17-T13-Z74 scu-rat TDLo: 6 ug/kg/3D-I Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 59, p. 443, 1994 (STEDAM); T11-T12 par-mus TDLo: 50000 ug/kg/5D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 29, 1986 (TJADAB); N04-N17 orl-wmn TDLo: 1.12 mg/kg/4W-I Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 54, p. 404, 1982 (JCEMAZ); T12 ipr-mus TDLo: 55.5 mg/kg/5D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 29, 1986 (TJADAB); N17-T13 scu-mus TDLo: 69444 mg/kg/5D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 577, 1997 (EVHPAZ); N17-T13 imp-mus TDLo: 252000 mg/kg/12W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 105, p. 577, 1997 (EVHPAZ); T13-Z74 orl-rat TDLo: 1.2 mg/kg/3D-I Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 149, 2001 (CRTOEC); T13-U01-Z74 scu-rat TDLo: 1.2 mg/kg/3D-I Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 149, 2001 (CRTOEC); T12-Y09 ims-rat TDLo: 1740 ug/kg/2D-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 63, p. 15, 1987 (CBINA8) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 21, p. 279, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 6, p. 99, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 72, p. 339, 1999 (IMEMDT); TOXICOLOGY REVIEW Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 5, p. 480, 1964 (CLPTAT); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3); TOXICOLOGY REVIEW Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1825, 1977 (CANCAR); TOXICOLOGY REVIEW Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- v. 1, p. 173, 1953 (ACRSAJ); TOXICOLOGY REVIEW Clinical Endocrinology (Oxford). (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1972- v. 4, p. 551, 1975 (CLECAP) ND: NOHS 1974: HZD 80407; NIS 1; TNF 68; NOS 6; TNE 2770; NOES 1983: HZD 80407; NIS 4; TNF 151; NOS 5; TNE 9083; TFE 8217 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Sperm morphology-rat; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 732 of 1119 in RTECS (through 2003/06) AN: KG6670000 PN: Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt SY: Equilin-sodium-sulfate-; Equilin,-sulfate,-sodium-salt- (6CI); Estra-1,3,5(10),7-tetraen-17-one, 3-hydroxy-, hydrogen sulfate sodium salt (8CI); Sodium-equilin-3-monosulfate-; Sodium-equilin-sulfate- RN: Current: 16680-47-0 UD: 200006 MF: C18-H20-O5-S.Na MW: 371.43 CC: Tumorigen (C) SL: NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 733 of 1119 in RTECS (through 2003/06) AN: KG7785000 PN: Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1) SY: Estropipate-; Harmogen-; Piperazine, compd. with 3-(sulfooxy)estra-1,3,5(10)-trien-17-one (1:1) (9CI); Estrone, hydrogen sulfate, compd. with piperazine (1:1) (8CI); OGEN-; Piperazine, compd. with estrone hydrogen sulfate (1:1) (8CI); Piperazine-estrone-sulfate-; Sulestrex- RN: Current: 7280-37-7 Previous: 29080-16-8 UD: 200006 MF: C18-H22-O5-S.C4-H10-N2 MW: 436.62 CC: Tumorigen (C) SL: NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 734 of 1119 in RTECS (through 2003/06) AN: KG8575000 PN: Estrone- SY: Aquacrine-; Crinovaryl-; Cristallovar-; Crystogen-; Disynformon-; E(sub 1); Endofolliculina-; Estrugenone-; Estrusol-; 1,3,5-Estratrien-3-ol-17-one-; Estron-; Delta-1,3,5-estratrien-3-beta-ol-17-one-; Delta-1,3,5-oestratrien-3-beta-ol-17-one-; Destrone-; 1,3,5(10)-Estratrien-3-ol-17-one; Estra-1,3,5(10)-trien-17-one, 3-hydroxy- (9CI); Estrona- (Spanish); Folikrin-; Folipex-; Folisan-; Follestrine-; Follicular-hormone-; Folliculin-; Folliculine-; Folliculine-benzoate-; Follicunodis-; Follidrin-; Glandubolin-; Hiestrone-; Hormofollin-; Hormovarine-; 3-Hydroxyestra-1,3,5(10)-trien-17-one; 3-Hydroxy-17-keto-estra-1,3,5-triene-; 3-Hydroxy-17-keto-oestra-1,3,5-triene-; 3-Hydroxy-oestra-1,3,5(10)-trien-17-one; 3-Hydroxy-1,3,5(10)-oestratrien-17-one; Kestrone-; Ketodestrin-; Ketohydroxy-estratriene-; Ketohydroxyestrin-; Ketohydroxyoestrin-; Kolpon-; Menagen-; Menformon-; Solliculin-; Estrone-A-; Femestrone-injection-; Femidyn-; 1,3,5-Oestratrien-3-ol-17-one-; 1,3,5(10)-Oestratrien-3-ol-17-one; Oestrin-; Oestroform-; Oestrone-; Oestroperos-; Ovifollin-; Perlatan-; Theelin-; Thelestrin-; Thelykinin-; Thynestron-; Tokokin-; Unden-; Wynestron- RN: Current: 53-16-7 Previous: 37242-41-4 BRN: 1915077 BHR: 3-08-00-01171 UD: 200305 MF: C18-H22-O2 MW: 270.40 WL: L E5 B666 FVTTT&J E1 OQ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Hormone (H); Natural-Product (N) ME: dna-rat-orl 870 nmol/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 23, p. 13, 1978 (CBINA8); cyt-rat-ipr 10 mg/kg Current Science. (Current Science Assoc., Sadashivanagar P.O., Bangalore 560 080, India) V.1- 1932- v. 50, p. 425, 1981 (CUSCAM); cyt-ham-ovr 50 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 29, p. 201, 1985 (TOLED5); sce-ham-ovr 10 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 44, p. 62, 1988 (EXPEAM) RE: T01-T04 imp-man TDLo: 1586 ug/kg (60D male) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 25, p. 591, 1982 (CCPTAY); T13 orl-rat TDLo: 100 ug/kg (1D pre) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 15, p. 1144, 1977 (IJEBA6); T03 orl-rat TDLo: 560 ug/kg (14D male) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 500, 1958 (ANYAA9); T02 orl-rat TDLo: 2240 ug/kg (14D male) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 500, 1958 (ANYAA9); T13 orl-rat TDLo: 4945 ng/kg (1D pre) Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 23, p. 329, 1980 (JMCMAR); T02-T03 skn-rat TDLo: 12 mg/kg (30D male) Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 10, p. 687, 1967 (STEDAM); T13 ipr-rat TDLo: 1250 ng/kg (1D pre) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 348, 1971 (TXAPA9); T13 scu-rat TDLo: 1500 ng/kg (3D pre) International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS 66044) V.1- 1955- v. 24, p. 188, 1979 (INJFA3); T02-T03 scu-rat TDLo: 500 ug/kg (60D male) Endokrinologie. (Leipzig, Ger. Dem. Rep.) V.1-80, 1928-82. For publisher information, see EXCEDS. v. 49, p. 55, 1965 (ENDKAC); T29 scu-rat TDLo: 10 ug/kg (3D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 77, p. 873, 1965 (ENDOAO); T85 scu-rat TDLo: 50 ug/kg (9D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 74, p. 1255, 1972 (BEXBAN); T35 scu-rat TDLo: 10 ug/kg (2D preg) International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS 66044) V.1- 1955- v. 14, p. 56, 1969 (INJFA3); T22 scu-rat TDLo: 25 ug/kg (2D preg) International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS 66044) V.1- 1955- v. 14, p. 56, 1969 (INJFA3); T24 scu-rat TDLo: 50 ug/kg (2D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 63, p. 566, 1958 (ENDOAO); T13 ivn-rat TDLo: 3 ug/kg (3D pre) Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- v. 5, p. 63, 1979 (JZKEDZ); T26-T29 par-rat TDLo: 25 ug/kg (2D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 12, p. 178, 1961 (FESTAS); T29 unr-rat TDLo: 500 ug/kg (1D pre) "Agents Affecting Fertility, a Symposium, 1964," Austin, C.R., and J.S. Perry, eds., Boston, Little, Brown and Co., 1965 -,195,1965 (15QWAW); T13 iut-rat TDLo: 120 ng/kg (1D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 31, p. 705, 1984 (BIREBV); T13 orl-mus TDLo: 40 ug/kg (3D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 5, p. 331, 1963 (JRPFA4); T43-T27 scu-mus TDLo: 28 mg/kg (12-16D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 97, p. 809, 1958 (PSEBAA); T13 scu-mus TDLo: 8 ug/kg (3D pre) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 36, p. 1069, 1986 (ARZNAD); T13 scu-mus TDLo: 2520 ng/kg (3D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T29 unr-mus TDLo: 40 mg/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 12, p. 346, 1961 (FESTAS); T13 ivg-mus TDLo: 48 ng/kg (1D pre) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 20, p. 198, 1960 (JOENAK); T13 orl-mky TDLo: 6250 ug/kg (5D pre) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 15, p. 1144, 1977 (IJEBA6); T29 orl-rbt TDLo: 300 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 16, p. 281, 1965 (FESTAS); T24-T31 orl-rbt TDLo: 630 ug/kg (6-8D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 16, p. 281, 1965 (FESTAS); T24 ipr-rbt TDLo: 225 ug/kg (3-4D preg) American Journal of Physiology. (American Physiological Soc., 9650 Rockville Pike, Bethesda, MD 20814) V.1- 1898- v. 115, p. 219, 1936 (AJPHAP); T29 scu-rbt TDLo: 200 ug/kg (1D pre) "Control of Ovulation, Proceedings of the Conference, Dedham, MA, 1960," Villee, C.A., ed., Oxford, UK, Pergamon Press Ltd., 1961 -,37,1961 (13OPAL); T25 scu-rbt TDLo: 5500 ug/kg (15-25D preg) Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 49, p. 146, 1933 (JPETAB); T24 scu-rbt TDLo: 6 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T29 ims-rbt TDLo: 5 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 10, p. 155, 1959 (FESTAS); T31-T39 ims-rbt TDLo: 13 iu/kg (9D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 111, p. 1083, 1971 (AJOGAH); T24 unr-rbt TDLo: 3 ug/kg (1-3D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 2, p. 85, 1970 (CCPTAY); T22 orl-ham TDLo: 24 mg/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 16, p. 281, 1965 (FESTAS); T29 par-ham TDLo: 2 mg/kg (1D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 35, p. 612, 1973 (JRPFA4); T02 imp-ham TDLo: 160 mg/kg (58W male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 57, p. 255, 1955 (ENDOAO); T13 ipr-mam TDLo: 12500 ng/kg (1D pre) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 348, 1971 (TXAPA9) TE: V03-R60 imp-rat TDLo: 16 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 13, p. 147, 1953 (CNREA8); V02-P62-R60 scu-mus TDLo: 108 mg/kg/90W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 56, p. 482, 1949 (ZEKBAI); V03-R60 par-mus TDLo: 1200 ug/kg/1W-I Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 195, p. 630, 1932 (COREAF); V03-P61-P62 imp-mus TDLo: 48 mg/kg Yale Journal of Biology and Medicine. (333 Cedar St., New Haven, CT 06510) V.1- 1928- v. 17, p. 75, 1944 (YJBMAU); V03-T64 scu-gpg TDLo: 40 mg/kg/18W-I Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 130, p. 9, 1939 (CRSBAW); V03-T64 imp-gpg TDLo: 640 ug/kg Boletin de la Sociedad de Biologia de Santiago de Chile. (Santiago, Chile) V.1-12, 1943-55. Discontinued. v. 8, p. 142, 1951 (BSBSAS); V03-M61 imp-ham TDLo: 320 mg/kg/59W-C National Cancer Institute, Monograph. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1959- v. 1, p. 1, 1959 (NCIMAV); V03-T64 imp-gpg TD :2 mg/kg Revista Brasileira de Biologia. Brazilian Review of Biology. (Academia Brasileira de Ciencias, Caixa Postal 229, ZC-00 Rio de Janeiro, Brazil) V.1- 1941- v. 5, p. 1, 1945 (RBBIAL); V03-V10 imp-gpg TD :1800 ug/kg Revue Canadienne de Biologie. (Montreal, Quebec, Canada) V.1-40, 1942-81. v. 3, p. 108, 1944 (RCBIAS); V03-R60 imp-rat TD :80 mg/kg Proceedings of the Canadian Cancer Research Conference. (Toronto, Ont., Canada) V.1-11, 1954-76. Discontinued. v. 6, p. 50, 1966 (PCCRA4); V03-M61 imp-ham TD :640 mg/kg/38W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5200, 1983 (CNREA8); V03-R60-V15 scu-mus TD :48 mg/kg/24W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 1, p. 119, 1940 (JNCIAM) MD: T13-T19 scu-rat TDLo: 6 mg/kg/3D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 170, p. 21, 2002 (TXCYAC); N17-Z74 orl-mus TDLo: 50 ug/kg/4D-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 10, p. 410, 1962 (JAFCAU); N17-T13-Z74 scu-mus TDLo: 2.5 ug/kg/3D-I Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 34, p. 215, 1966 (JOENAK); T13 scu-rat TDLo: 40 ug/kg/8D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 90, p. 330, 1987 (TXAPA9); L30-T13 ivg-rat TDLo: 784 ug/kg/8W-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 117, 1981 (FATOAO); T13 scu-rat TDLo: 784 ug/kg/8W-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 117, 1981 (FATOAO); L30-N72 scu-rat TDLo: 33.6 mg/kg/8W-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 117, 1981 (FATOAO) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 6, p. 123, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 21, p. 343, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 72, p. 339, 1999 (IMEMDT); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 243, 1977 (JTEHD6); TOXICOLOGY REVIEW Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1825, 1977 (CANCAR); TOXICOLOGY REVIEW Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- v. 1, p. 173, 1953 (ACRSAJ); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 5, p. 157, 1964 (PEXTAR) ND: NOHS 1974: HZD 80410; NIS 1; TNF 68; NOS 6; TNE 2770; NOES 1983: HZD 80410; NIS 2; TNF 70; NOS 4; TNE 4444; TFE 3848 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 735 of 1119 in RTECS (through 2003/06) AN: KG8775000 PN: Estrone,-hydrogen-sulfate,-sodium-salt- SY: Conestoral-; Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, sodium salt (9CI); Estrone-sodium-sulfate-; Estrone-sulfate-sodium-; Estrone-sulfate-sodium-salt-; Estrone-3-sulfate-sodium-salt-; Morestin-; Sodium-estrone-sulfate-; Sodium-estrone-3-sulfate-; Oestrone-3-sulphate-sodium-salt- RN: Current: 438-67-5 UD: 200006 MF: C18-H22-O5-S.Na MW: 373.45 CC: Tumorigen (C); Reproductive-Effector (T); Hormone (H) RE: T14 scu-ctl TDLo: 504 ug/kg (9D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 55, p. 191, 1979 (JRPFA4) SL: NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 736 of 1119 in RTECS (through 2003/06) AN: KH5790000 PN: Ethane, 2,2-bis(p-ethylphenyl)-1,1-dichloro- SY: a,a-Dichloro-2,2-bis(p-ethylphenyl)ethane; 1,1-Dichloro-2,2-bis(p-ethylphenyl)ethane; 1,1-Dichloro-2,2-bis(4-ethylphenyl)ethane; 2,2-Dichloro-1,1-bis(p-ethylphenyl)ethane; Diethyl-diphenyl-dichloroethane-; Di(p-ethylphenyl)dichloroethane; ENT-17,082-; 1,1-Bis(p-ethylphenyl)-2,2-dichloroethane; 2,2-Bis(p-ethylphenyl)-1,1-dichloroethane; NCI-C02868-; Q-137-; Ethane, 1,1-dichloro-2,2-bis(p-ethylphenyl)-; Ethylan-; p,p-Ethyl-DDD-; p,p'-Ethyl-ddd-; Perthane- RN: Current: 72-56-0 BRN: 2054366 BHR: 4-05-00-01985 UD: 200302 MF: C18-H20-Cl2 MW: 307.28 WL: GYGYR D2&R D2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 333 ug/plate (-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) APR1982 (NTPTB*) RE: T24-T31 scu-mus TDLo: 900 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**) TE: V01-L60 orl-mus TDLo: 210 gm/kg/2Y-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 66, p. 277, 1980 (TUMOAB); V03-L60 orl-mus TD :547 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-156, 1979 (NCITR*) ORNG: 6600000000 ng/kg. [6600.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 6600 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 16, 1978 (SPEADM); F11 ivn-rat LD50: 73 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 103, p. 404, 1955 (AIPTAK); T/E unlistd orl-mus LD50: 6600 mg/kg "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A317,1983 (85JFAN); F11 ivn-mus LD50: 173 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 103, p. 404, 1955 (AIPTAK); T/E unlistd orl-bwd LD50: 9 gm/kg Down to Earth. (Dow Chemical USA, Agricultural Products Dept., Midland, MI 48640) V.1- 1945- v. 35, p. 25, 1979 (DOEAAH); T/E unlistd ivn-rat LD50: 73 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1336, 2001 (HBPTO*); T/E unlistd ivn-mus LD50: 173 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1336, 2001 (HBPTO*); A30-L30-M04 unr-mam TDLo: 750 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 76, 1984 (VCVGK*) MD: Z01 orl-dog TDLo: 19.25 gm/kg/22W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1336, 2001 (HBPTO*); N72 orl-dog TDLo: 7665 mg/kg/1Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1336, 2001 (HBPTO*); Y12-N30 orl-dog TDLo: 500 mg/kg/10D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1336, 2001 (HBPTO*); N72 orl-dog TDLo: 4200 mg/kg/3W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1336, 2001 (HBPTO*); L30-M30-P27 unr-rat TDLo: 15000 mg/kg/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 76, 1994 (VCVGK*); L30-M30-P27 unr-rat TDLo: 61000 mg/kg/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 76, 1994 (VCVGK*); A30-M30-U01 unr-rat TDLo: 6720 mg/kg/48W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 76, 1994 (VCVGK*); A30-M30-U01 unr-cat TDLo: 3360 mg/kg/48W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 76, 1994 (VCVGK*); T02 unr-rat TDLo: 6720 mg/kg/48W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 76, 1994 (VCVGK*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 83493; NIS 2; TNF 1274; NOS 4; TNE 10159 SL: EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-156, 1979 (NCITR*); NCI Carcinogenesis Bioassay (feed), no evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-156, 1979 (NCITR*) Record 737 of 1119 in RTECS (through 2003/06) AN: KH6475000 PN: Ethane,-bromo- SY: Bromic-ether-; Bromoethane-; Bromure-d'ethyle-; Ethyl-bromide-; Ethyl-bromide- (ACGIH:OSHA); Etylu-bromek- (Polish); Halon-2001-; Hydrobromic-ether-; Monobromoethane-; NCI-C55481- RN: Current: 74-96-4 UD: 200210 MF: C2-H5-Br MW: 108.98 WL: E2 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 75 ng/plate (+S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-363, 1989 (NTPTR*); sce-ham-ovr 100 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 60, 1989 (EMMUEG) TE: V03-A60 ihl-rat TCLo: 100 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-363, 1989 (NTPTR*); V01-T64 ihl-mus TCLo: 200 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-363, 1989 (NTPTR*) ORNG: 1350000000 ng/kg. [1350.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1350 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,65,1982 (85GMAT); T/E unlistd ihl-rat LC50: 26980 ppm/1H Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) TR-72-62, 1972 (AMRL**); T/E unlistd ipr-rat LD50: 1750 mg/kg Journal fuer Praktische Chemie. (Johann Ambrosius Barth Verlag, Postfach 109, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1834- v. 320, p. 133, 1978 (JPCEAO); F07-K12 ihl-mus LC50: 16230 ppm/1H Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) TR-72-62, 1972 (AMRL**); T/E unlistd ipr-mus LD50: 2850 mg/kg Journal fuer Praktische Chemie. (Johann Ambrosius Barth Verlag, Postfach 109, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1834- v. 320, p. 133, 1978 (JPCEAO) MD: Z01 ihl-rat TCLo: 2 pph/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-363, 1989 (NTPTR*); P27-Z01 ihl-rat TCLo: 1600 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-363, 1989 (NTPTR*); Z01 ihl-mus TCLo: 1 pph/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-363, 1989 (NTPTR*); L30 ihl-rat TCLo: 47 mg/m3/4H/20W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 585, 1990 (VCVGH*); L30 ihl-rbt TCLo: 47 mg/m3/4H/20W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 585, 1990 (VCVGH*) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 299, 1991 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1305, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1305, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1305, 1999 (IMEMDT) SR: MSHA STANDARD-air: TWA 200 ppm (890 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 105, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 200 ppm (890 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 200 ppm (890 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 200 ppm (890 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 200 ppm (890 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 200 ppm (890 mg/m3), STEL 250 ppm, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 200 ppm (891 mg/m3), STEL 250 ppm (1100 mg/m3), JAN 1993; OEL-DENMARK: TWA 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 200 ppm (890 mg/m3), STEL 250 ppm (1115 mg/m3), JAN 1999; OEL-FRANCE: VME 288 ppm (890 mg/m3), JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: TWA 50 mg/m3, STEL 100 mg/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (22 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 300 ppm (890 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 50 mg/m3, MAC(STEL) 400 mg/m3, JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 5 ppm (22 mg/m3), Skin, Carcinogen, JAN 1999; OEL-TURKEY: TWA 200 ppm (890 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 200 ppm (906 mg/m3), STEL 250 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 31900; NIS 1; TNF 14; NOS 1; TNE 196; NOES 1983: HZD 31900; NIS 15; TNF 1452; NOS 13; TNE 12285; TFE 1535 SL: EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Ethyl bromide, 1011; NCI Carcinogenesis Studies (inhal), clear evidence: mouse; NTP Carcinogenesis Studies (inhalation), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-363, 1989 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: rat Record 738 of 1119 in RTECS (through 2003/06) AN: KH7525000 PN: Ethane,-chloro- SY: Aethylchlorid- (German); Aethylis-; Aethylis-chloridum-; Anodynon-; Chelen-; Chloorethaan- (Dutch); Chlorene-; Chlorethyl-; Chloroaethan- (German); Chloroethane-; Chloroethyl-; Chlorure-d'ethyle- (French); Chloryl-; Chloryl-anesthetic-; Cloretilo-; Cloroetano- (Italian); Cloruro-di-etile- (Italian); Dublofix-; Ether-chloratus-; Ether-chloridum-; Ether-hydrochloric-; Ether-muriatic-; Ethyl-chloride-; Ethyl-chloride- (ACGIH:OSHA); Etylu-chlorek- (Polish); Hydrochloric-ether-; Kelene-; Monochlorethane-; Monochloroethane-; Muriatic-ether-; NCI-C06224-; Narcotile- RN: Current: 75-00-3 UD: 200302 MF: C2-H5-Cl MW: 64.52 WL: G2 CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P); Reproductive-Effector (T) ME: mmo-sat 10 ug/plate (+/-S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-346, 1988 (NTPTR*); mmo-esc 1 pph (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 307, p. 335, 1994 (MUREAV); msc-ham-ovr 2340 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 33, 1994 (MUREAV) RE: T01 ihl-rat TCLo: 60 mg/m3/4H (26W male) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 10(2), p. 37, 1966 (GTPZAB) TE: V03-R60 ihl-rat TCLo: 15000 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-346, 1989 (NTPTR*); V01-L60-T64 ihl-mus TCLo: 15000 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-346, 1989 (NTPTR*); V03-R60 ihl-rat TCLo: 463500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-225053/AS (NTIS**); V03-A60 ihl-rat TCLo: 386250 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-225053/AS (NTIS**); V01-T64 ihl-mus TCLo: 927000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-225053/AS (NTIS**) AT: A30-F01-P01 ihl-rat LC50: 152 gm/m3/2H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 6, p. 45, 1964 (TPKVAL); T/E unlistd ihl-mus LC50: 146 gm/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,66,1982 (85GMAT); F07-F13-J15 ihl-gpg LCLo: 40000 ppm/45M U.S. Public Health Service, Public Health Bulletin. (Washington, DC) v. 185, p. 1, 1929 (XPHBAO) MD: L70 ihl-rat TCLo: 19000 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-346, 1989 (NTPTR*); A11-S02 ihl-rat TCLo: 14 gm/m3/2H/60D-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 10(2), p. 37, 1966 (GTPZAB); L14-S02-U01 ihl-rat TCLo: 570 mg/m3/4H/26W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 10(2), p. 37, 1966 (GTPZAB); L70 ihl-mus TCLo: 5000 ppm/23H/11D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 516, 1989 (FAATDF); L70 ihl-mus TCLo: 19000 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-346, 1989 (NTPTR*); N19 ihl-mus TCLo: 15000 ppm/21D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 130, p. 169, 1995 (TXAPA9) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 100 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 315, 1991 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1345, 1999 (IMEMDT); IARC Cancer Review: Human No Available Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 315, 1991 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1345, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1345, 1999 (IMEMDT); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40(3), p. A46, 1979 (AIHAAP) SR: MSHA STANDARD-air: TWA 1000 ppm (2600 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 106, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1000 ppm (2600 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1000 ppm (2600 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1000 ppm (2600 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1000 ppm (2600 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 1000 ppm (2600 mg/m3), JAN 1993; OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 1000 ppm (2640 mg/m3), JAN 1993; OEL-DENMARK: TWA 1000 ppm (2600 mg/m3), JAN 1999; OEL-FINLAND: TWA 500 ppm (1300 mg/m3), STEL 625 ppm (1625 mg/m3), JAN 1999; OEL-FRANCE: VME 1000 ppm (2600 mg/m3), JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: TWA 100 mg/m3, STEL 300 mg/m3, JAN 1993; OEL-JAPAN: OEL 100 ppm (260 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1000 ppm (2600 mg/m3), JAN 1999; OEL-NORWAY: TWA 500 ppm (1300 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1000 ppm (2600 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 200 mg/m3, MAC(STEL) 1600 mg/m3, JAN 1999; OEL-RUSSIA: TWA 1000 ppm, STEL 50 mg/m3, JAN 1993; OEL-SWEDEN: NGV 500 ppm (1300 mg/m3), KTV 700 ppm (1900 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 1000 ppm (2600 mg/m3), JAN 1999; OEL-TURKEY: TWA 1000 ppm (2600 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 1000 ppm (2700 mg/m3), STEL 1250 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO MONOCHLOROETHANE-air: Handle with caution National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 31970; NIS 80; TNF 6154; NOS 66; TNE 96531; NOES 1983: HZD 31970; NIS 12; TNF 766; NOS 47; TNE 49210; TFE 35368 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/121956); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 27, 1978; NIOSH Analytical Method, 1994: Ethyl chloride, 2519; NCI Carcinogenesis Studies (inhal), clear evidence: mouse; NCI Carcinogenesis Studies (inhal), equivocal evidence: rat Record 739 of 1119 in RTECS (through 2003/06) AN: KH9275000 PN: Ethane,-1,2-dibromo- SY: 1,2-Dibromaethan- (German); 1,2-Dibromoetano- (Italian); 1,2-Dibromoethane-; 1,2-Dibromoethane- (OSHA); 1,2-Dibroomethaan- (Dutch); 1,2-Ethylene-dibromide-; Aadibroom-; Aethylenbromid- (German); Bromofume-; Bromuro-di-etile- (Italian); Celmide-; Dibromure-d'ethylene- (French); Dowfume-40-; Dowfume-EDB-; Dowfume-W-100-; Dowfume-W-8-; Dowfume-W-85-; Dowfume-W-90-; Dwubromoetan- (Polish); EDB-; EDB-85-; ENT-15,349-; Ethylene-bromide-; Ethylene-dibromide-; Ethylene-dibromide- (ACGIH:OSHA); Fumo-gas-; Glycol-bromide-; Glycol-dibromide-; Iscobrome-D-; NCI-C00522-; Nefis-; Nephis-; Pestmaster-; Pestmaster-edb-85-; RCRA-waste-number-U067-; Soilbrom-; Soilbrom-100-; Soilbrom-40-; Soilbrom-85-; Soilbrom-90-; Soilbrom-90EC-; Soilbrome-85-; Soilfume-; Unifume-; alpha,beta-Dibromoethane-; sym-Dibromoethane- RN: Current: 106-93-4 BRN: 605266 BHR: 4-01-00-00158 UD: 200305 MF: C2-H4-Br2 MW: 187.88 WL: E2E CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-hmn 1538 mg/2H SEV Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 8, p. 591, 1938 (AGGHAR); skn-rbt 1%/14D SEV AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); eye-rbt 1% AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC) ME: mmo-sat 1 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); oms-sat 1600 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 171, 1987 (ENMUDM); mmo-esc 20 uL/disc (-S9) Biken Journal. (Research Institute for Microbial Diseases, Osaka Univ., 3-1 Yamadaoka, Suita, Osaka-fu, Japan) V.1- 1958- v. 23, p. 69, 1980 (BKNJA5); oms-esc 350 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); mmo-esc 333 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); dnr-esc 10 mg/plate Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 2576, 1974 (CNREA8); dnd-esc 1 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); dni-esc 23 mmol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 2345, 1974 (BCPCA6); oms-esc 23 mmol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 2345, 1974 (BCPCA6); mmo-omi 2 uL/plate (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 2, p. 87, 1981 (PMRSDJ); slt-dmg-ihl 14 ppm/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 243, 1987 (MUREAV); sln-dmg-orl 300 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 30, p. 621, 1974 (EXPEAM); sln-dmg-ihl 2 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 59, 1979 (MUREAV); trn-dmg-orl 25 ppm Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); mmo-nsc 36000 ppm (-S9) Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 11, p. 223, 1979 (STEVA8); mrc-smc 170 umol/L IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 10, p. 161, 1974 (IARCCD); mmo-asn 10 uL/plate (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 2, p. 87, 1981 (PMRSDJ); mnt-nml-mul 5300 nmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 17, 1989 (MUTAEX); cyt-ofs-lym 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 555, 1986 (ENMUDM); sce-ofs-lym 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 555, 1986 (ENMUDM); mnt-hmn-lym 1 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 20, p. 117, 1992 (EMMUEG); dni-hmn-lym 5 mL/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 13, p. 213, 1981 (CALEDQ); sce-hmn-fbr 2500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 291, 1997 (MUREAV); sce-hmn-lym 10 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 188, 1982 (MUREAV); msc-hmn-lym 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 142, p. 133, 1985 (MUREAV); mtr-rat-orl 75 mg/kg Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 12, p. 307, 1984 (TOPADD); mtr-rat-emb 12 ug/plate JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 190, 1981 (JJATDK); dna-rat-ipr 15 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 5843, 1989 (CNREA8); dna-rat-ipr 16800 nmol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2438, 1978 (CNREA8); dna-rat-lvr 80 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1129, 1982 (CRNGDP); oms-rat-lvr 80 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1129, 1982 (CRNGDP); dnd-rat-orl 20 umol/kg Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 141, p. 723, 1986 (BBRCA9); dns-rat-orl 75 gm/kg Laboratory Investigation. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1952- v. 38, p. 279, 1978 (LAINAW); dns-rat-lvr 50 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 359, 1982 (MUREAV); dns-rat-spr 1 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 489, 1983 (ENMUDM); dns-rat-ipr 100 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 467, 1986 (CRNGDP); msc-mus-ihl 30 ppm/10D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 405, p. 193, 1998 (MUREAV); spm-rat-ipr 50 mg/kg/5D Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 11, p. 223, 1979 (STEVA8); mmo-mus-lym 45 mg/L/4H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); mtr-mus-orl 75 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 118, 1985 (ARTODN); dnd-mus-ipr 50 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 839, 1981 (CRNGDP); dnd-mus-orl 150 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 39, p. 1022, 1980 (FEPRA7); dni-mus-ipr 55 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 163, p. 193, 1986 (MUREAV); msc-mus-lym 150 mg/L/4H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); hma-mus-sat 500 mg/kg Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 91, p. 311, 1972 (BIZNAT); mmo-ham-ovr 400 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 183, 1981 (MUREAV); mtr-ham-emb 500 mg/L Advances in Modern Environmental Toxicology. (Senate Press, Inc., P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980- v. 1, p. 241, 1980 (AETODY); cyt-ham-ovr 150 mg/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 432, 1989 (MUTAEX); cyt-ham-lng 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 78, p. 177, 1980 (MUREAV); sce-ham-ovr 5 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-lng 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 78, p. 177, 1980 (MUREAV); msc-ham-ovr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 183, 1981 (MUREAV); dna-mam-lym 1 mmol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 11, p. 243, 1982 (TOLED5); dns-mam-lym 10 mmol/L Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 11, p. 223, 1979 (STEVA8); spm-mam-scu 93600 ug/kg/12D-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 743, 1980 (FCTXAV) RE: T01 ihl-man TCLo: 88 ppb/8H (5Y male) British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 44, p. 317, 1987 (BJIMAG); T35 orl-rat TDLo: 50 mg/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 71, 1980 (MUREAV); T81 ihl-rat TCLo: 66670 ppb/4H (3-20D preg) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 5, p. 579, 1983 (NTOTDY); T35 ihl-rat TCLo: 80 ppm/23H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 347, 1978 (TXAPA9); T02-T03-T23 ihl-rat TCLo: 89 ppm/7H (10W male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 97, 1979 (TXAPA9); T21 ihl-rat TCLo: 39 ppm/7H (3W pre) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 97, 1979 (TXAPA9); T22 ihl-rat TCLo: 80 ppm/7H (3W pre) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 97, 1979 (TXAPA9); T85 unr-rat TDLo: 25 mg/kg (1D male) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 27A, 1983 (TJADAB); T35 ihl-mus TCLo: 38 ppm/23H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 347, 1978 (TXAPA9); T25-T34 ihl-mus TCLo: 20 ppm/23H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 46, p. 173, 1978 (TXAPA9); T26 ihl-mus TCLo: 38 ppm/23H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 46, p. 173, 1978 (TXAPA9); T34-T46 ihl-mus TCLo: 32 ppm/23H (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB256-659 (NTIS**); T01 scu-rbt TDLo: 225 mg/kg (5D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 16, p. 687, 1991 (FAATDF); T01 orl-ctl TDLo: 40 mg/kg (10D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 44, p. 561, 1975 (JRPFA4); T01 scu-ctl TDLo: 93600 ug/kg (12D male) Journal of Ultrastructure Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1975- v. 67, p. 124, 1979 (JULRA7) TE: V01-H60-P60 orl-rat TDLo: 540 mg/kg/78W-C Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 5, p. 279, 1980 (BANRDU); V01-D09-H60 ihl-rat TCLo: 10 ppm/6H/2Y-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-201, 1982 (NCITR*); V01-J60-K60 orl-mus TDLo: 16 gm/kg/53W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-86, 1978 (NCITR*); V03-D09 ihl-mus TCLo: 40 ppm/6H/90W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 12, p. 121, 1981 (CALEDQ); V02-J60-R60 skn-mus TDLo: 190 gm/kg/62W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 1433, 1979 (JJIND8); V02-J60 ipr-mus TDLo: 840 mg/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 19, 1986 (TXAPA9); V01-K60-L60 orl-rat TD :16 gm/kg/61W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-86, 1978 (NCITR*); V01-J60-K60 orl-mus TD :23 gm/kg/53W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-86, 1978 (NCITR*); V01-K60-L60 orl-rat TD :24 gm/kg/57W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-86, 1978 (NCITR*); V01-K60-L60 orl-rat TD :6630 mg/kg/34W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-86, 1978 (NCITR*); V01-J60-K60 orl-mus TD :28 gm/kg/53W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-86, 1978 (NCITR*); V01-N61-R60 ihl-rat TC :20 ppm/7H/78W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 63, p. 155, 1982 (TXAPA9); V01-K60-L60 orl-rat TD :7000 mg/kg/47W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-86, 1978 (NCITR*); V01-K60-L60 orl-rat TD :18 gm/kg/44W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-86, 1978 (NCITR*); V01-H60-J60 ihl-rat TC :10 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-210, 1982 (NTPTR*); V01-D09-H60 ihl-rat TC :40 ppm/6H/88W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-201, 1982 (NCITR*); V01-D09-N62 ihl-rat TCLo: 327.6 mg/kg/78W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-181710 (NTIS**); V01-N62-P60 ihl-rat TCLo: 1310.4 mg/kg/78W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-181710 (NTIS**); V01-N62-R60 ihl-rat TCLo: 273 mg/kg/78W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-181710 (NTIS**); V01-J61-R60 ihl-rat TCLo: 1092 mg/kg/78W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-181710 (NTIS**); V01-J61 ihl-mus TCLo: 2620.8 mg/kg/78W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-181710 (NTIS**); V01-P60-R60 ihl-mus TCLo: 655.2 mg/kg/78W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-181710 (NTIS**) ORNG: 108000000 ng/kg. [108.000000 mg/kg] T/E unlistd SRNG: 300000000 ng/kg. [300.000000 mg/kg] U28-R11 SKNG: 300000000 ng/kg. [300.000000 mg/kg] T/E unlistd AT: K12-K13-M11 orl-wmn LDLo: 90 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,257,1969 (34ZIAG); L12-M03-U20 orl-man TDLo: 43 uL/kg Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 19, p. 152, 2000 (HETOEA); T/E unlistd orl-rat LD50: 108 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 17, 1978 (SPEADM); C08-F07-J22 ihl-rat LC50: 14300 mg/m3/30M Farmakologiya i Toksikologiya (Kiev). Pharmacology and Toxicology. (Kievskii Nauchno- Issledovatel'skii Institut Farmakologii i Toksikologii, Kiev, USSR) No.1- 1964- v. 8, p. 140, 1973 (FATOBP); T/E unlistd skn-rat LD50: 300 mg/kg "Wirksubstanzen der Pflanzenschutz und Schadlingsbekampfungsmittel," Perkow, W., Berlin, Verlag Paul Parey, 1971-1976 -,-,1971/1976 (85DPAN); T/E unlistd orl-mus LDLo: 250 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 288, 1972 (TXAPA9); T/E unlistd ipr-mus LD50: 220 mg/kg Journal fuer Praktische Chemie. (Johann Ambrosius Barth Verlag, Postfach 109, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1834- v. 320, p. 133, 1978 (JPCEAO); T/E unlistd unr-mus LD50: 146 mg/kg "Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971 -,38,1971 (30ZDA9); T/E unlistd orl-rbt LD50: 55 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); U28-R11 skn-rbt LD50: 300 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); J30-L01 rec-rbt LDLo: 2500 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 34, p. 223, 1928 (JPETAB); T/E unlistd orl-gpg LD50: 110 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); U02-J16-L02 ihl-gpg LCLo: 400 ppm/3H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); T/E unlistd orl-ckn LD50: 79 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); F07-J22-K12 orl-qal LD50: 130 mg/kg British Poultry Science. (Longman Group UK Ltd., Longman House, Burnt Mill, Harlow, Essex CM20 2JE, UK) V.1- 1960- v. 22, p. 355, 1981 (BPOSA4); J25-M12-R20 orl-man TDLo: 42800 mL/kg Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 43, p. 91, 2001 (VHTODE); K12-K13 orl-man TDLo: 42800 mL/kg Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 43, p. 91, 2001 (VHTODE) MD: L70-P08-U01 ihl-rat TCLo: 40 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 1, p. 437, 1981 (FAATDF); L70-U01-Z01 ihl-rat TCLo: 100 ppm/7H/9D-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); M30 ipr-rat TDLo: 160 mg/kg/2D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 8, p. 317, 1981 (TOLED5); Z01 ihl-mus TCLo: 3 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-210, 1982 (NTPTR*); F13-U01 ihl-mky TCLo: 50 ppm/7H/70D-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); L02-L03-Z01 ihl-rbt TCLo: 100 ppm/7H/4D-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); J70-L70-U01 ihl-gpg TCLo: 50 ppm/7H/80D-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 6, p. 158, 1952 (AMIHBC); L70-P08-Y37 orl-qal TDLo: 162 mg/kg/7D-I British Poultry Science. (Longman Group UK Ltd., Longman House, Burnt Mill, Harlow, Essex CM20 2JE, UK) V.1- 1960- v. 22, p. 355, 1981 (BPOSA4); P28-Y01-Y16 orl-qal TDLo: 486 mg/kg/21D-I British Poultry Science. (Longman Group UK Ltd., Longman House, Burnt Mill, Harlow, Essex CM20 2JE, UK) V.1- 1960- v. 22, p. 355, 1981 (BPOSA4); T01-T02-Z73 orl-ctl TDLo: 1066 mg/kg/533D-I Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 18, p. 144, 1967 (FESTAS) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 195, 1977 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 641, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 204, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 641, 1999 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 641, 1999 (IMEMDT); TOXICOLOGY REVIEW Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- v. 54, p. 413, 1978 (BNYMAM); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-184325 (NTIS**) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 20 ppm (145 mg/m3) (skin) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 15, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 20 ppm;CL 30 ppm;Pk 50 ppm/5M/8H Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 25 ppm (190 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 25 ppm (190 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 25 ppm (190 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.13 ppm (1 mg/m3), JAN 1999; OEL-AUSTRALIA: Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-BELGIUM: Skin, Carcinogen, JAN 1993; OEL-FINLAND: TWA 20 ppm (145 mg/m3), STEL 30 ppm, Skin, Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-HUNGARY: STEL 0.8 mg/m3, Skin, Carcinogen, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 20 ppm (155 mg/m3), Skin, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.1 ppm (1 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 25 ppm (190 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 0.5 mg/m3, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.1 ppm (0.8 mg/m3), Skin, Carcinogen, JAN 1999; OEL-THAILAND: TWA 20 ppm, STEL 30 ppm, JAN 1993; OEL-TURKEY: TWA 25 ppm (190 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 0.5 ppm (3.9 mg/m3), Skin, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ETHYLENE DIBROMIDE-air: CA TWA 0.045 ppm, CL 0.13 ppm/15M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 23660; NIS 5; TNF 438; NOS 8; TNE 7921; NOES 1983: HZD 23660; NIS 7; TNF 496; NOS 13; TNE 8559; TFE 792 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110740/AS); EPA GENETOX PROGRAM 1988, Positive: Aspergillus-forward mutation, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Sperm morphology-human; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Negative: UDS in mouse germ cells; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 3, 1975, AND BULLETIN 37, 1981; NIOSH Analytical Method, 1994: Ethylene dibromide, 1008; NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP Carcinogenesis Bioassay (inhalation), clear evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-210, 1982 (NTPTR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #02 Record 740 of 1119 in RTECS (through 2003/06) AN: KI0525000 PN: Ethane,-1,2-dichloro- SY: 1,2-Bichloroethane-; 1,2-DCE-; 1,2-Dichloorethaan- (Dutch); 1,2-Dichlor-aethan- (German); 1,2-Dichlorethane-; 1,2-Dichloroethane-; 1,2-Dichloroethane- (OSHA); 1,2-Dicloroetano- (Italian); 1,2-Ethylene-dichloride-; Aethylenchlorid- (German); Bichlorure-d'ethylene- (French); Borer-sol-; Brocide-; Chlorure-d'ethylene- (French); Cloruro-di-ethene- (Italian); Destruxol-borer-sol-; Di-chlor-mulsion-; Dichloremulsion-; Dichloro-1,2-ethane- (French); Dutch-liquid-; Dutch-oil-; EDC-; ENT-1,656-; Ethane-dichloride-; Ethyleendichloride- (Dutch); Ethylene-chloride-; Ethylene-dichloride-; Ethylene-dichloride- (ACGIH:OSHA); Glycol-dichloride-; NCI-C00511-; RCRA-waste-number-U077-; alpha,beta-Dichloroethane-; sym-Dichloroethane- RN: Current: 107-06-2 UD: 200302 MF: C2-H4-Cl2 MW: 98.96 WL: G2G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 625 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 3/23/1970 (UCDS**); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,93,1986 (85JCAE); eye-rbt 63 mg SEV Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 3/23/1970 (UCDS**); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,93,1986 (85JCAE) ME: mmo-sat 10 umol/plate (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 2576, 1974 (CNREA8); mmo-sat 10 ug/plate (-S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 15, p. 101, 1987 (TECSDY); dnd-sat 7060 umol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 190, 1982 (TXAPA9); oms-esc 316 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19, p. 98, 1992 (EMMUEG); dnr-esc 10 mg/plate Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 2576, 1974 (CNREA8); slt-dmg-orl 1000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 163, 1978 (MUREAV); slt-dmg-ihl 250 mg/m3 Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 252, p. 17, 1991 (MUREAV); sln-dmg-orl 120 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 285, p. 209, 1993 (MUREAV); sln-dmg-ihl 2 ppm/96H-C Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 32, p. 65, 1985 (EVSRBT); sln-asn 2000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 201, p. 401, 1988 (MUREAV); dni-hmn-lym 5 mL/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 13, p. 213, 1981 (CALEDQ); msc-hmn-lym 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 142, p. 133, 1985 (MUREAV); dnd-rat-orl 150 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 190, 1982 (TXAPA9); dnd-rat-ihl 150 ppm/6H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 190, 1982 (TXAPA9); dns-rat-lvr 130 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 221, p. 263, 1989 (MUREAV); slt-mus-ipr 300 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 201, 1983 (MUREAV); dnd-mus-ipr 2 mmol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 1491, 1983 (CRNGDP); dnd-mus-orl 100 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 4267, 1984 (CNREA8); dni-mus-ipr 29 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 163, p. 193, 1986 (MUREAV); bfa-mus-sat 80 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 24, p. 265, 1979 (CBINA8); mmo-ham-ovr 2 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 183, 1981 (MUREAV); mtr-ham-emb 200 uL/plate Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 25, p. 75, 1982 (EVSRBT); cyt-ham-lng 1 gm/L Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (103), p. 64, 1985 (ESKHA5); msc-ham-ovr 40 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 183, 1981 (MUREAV); mtr-mus-fbr 0.01 pph/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T25 ihl-rat TCLo: 300 ppm/7H (6-15D preg) Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 5, p. 149, 1980 (BANRDU); T24 ihl-rat TCLo: 208 mg/m3/6H (2W pre/1-21D preg) Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 23, p. 199, 1989 (CHYCDW); T34-T35 ihl-rat TCLo: 57 mg/m3 (24W pre) "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 364, 1990 (VCVGH*) TE: V01-K60-R60 orl-rat TDLo: 5286 mg/kg/69W-I Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 5, p. 35, 1980 (BANRDU); V03-P61-R60 ihl-rat TCLo: 5 ppm/7H/78W-I Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 5, p. 3, 1980 (BANRDU); V01-J60-R60 orl-mus TDLo: 3536 mg/kg/78W-I Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 5, p. 35, 1980 (BANRDU); V03-J60-R60 ihl-mus TCLo: 5 ppm/7H/78W-I Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 5, p. 3, 1980 (BANRDU); V02-J60-R60 skn-mus TDLo: 1120 gm/kg/74W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 1433, 1979 (JJIND8); V01-H60-K60 orl-rat TD :38 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-55, 1978 (NCITR*); V01-R60-T64 orl-mus TD :76 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-55, 1978 (NCITR*); V01-H60-K60 orl-rat TD :18 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-55, 1978 (NCITR*); V01-R60-T64 orl-mus TD :38 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-55, 1978 (NCITR*) ORNG: 670000000 ng/kg. [670.000000 mg/kg] T/E unlistd SRNG: 2800000000 ng/kg. [2800.000000 mg/kg] D17-F01-F19 AT: C08-F24-K13 ihl-man TCLo: 4000 ppm/1H Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 500, 1966 (PCOC**); K06-K13-L03 orl-hmn LDLo: 286 mg/kg Casopis Lekaru Ceskych. Journal of Czech Physicians. (ARTIA, Ve Smeckach 30, 111 27 Prague 1, Czeckoslovakia) V.1- 1862- v. 86, p. 203, 1947 (CLCEAL); F07-J21-K13 orl-hmn TDLo: 428 mg/kg Sovetskaia Meditsina. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1937- v. 22(10), p. 132, 1958 (SOMEAU); K12-K13-L12 orl-man TDLo: 892 mg/kg Wiadomosci Lekarskie. Medical News. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1948- v. 28, p. 983, 1975 (WILEAR); F07-G10-J24 orl-man LDLo: 714 mg/kg Klinische Wochenscrift. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1922- v. 48, p. 822, 1970 (KLWOAZ); T/E unlistd orl-rat LD50: 670 mg/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C130, 1991 (FMCHA2); F24-J24-U28 ihl-rat LC50: 1000 ppm/7H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 482, 1951 (AMIHBC); T/E unlistd ipr-rat LD50: 807 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 26(4), p. 26, 1982 (GTPZAB); D17-F01-F19 scu-rat LD50: 1 gm/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 48A, p. 91, 1970 (FAONAU); T/E unlistd itr-rat LDLo: 120 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520615 (NTIS**); J30-L30 orl-mus LD50: 413 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 43, p. 41, 1982 (EVHPAZ); T/E unlistd ihl-mus LCLo: 5 gm/m3/2H Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 141, p. 19, 1929 (AEPPAE); T/E unlistd ipr-mus LD50: 470 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 11, p. 902, 1961 (ARZNAD); T/E unlistd scu-mus LDLo: 380 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 84, p. 53, 1945 (JPETAB); D17-F01-F19 orl-dog LD50: 5700 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 48A, p. 91, 1970 (FAONAU); T/E unlistd ivn-dog LDLo: 175 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd ihl-mky LC50: 3000 ppm/7H "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,93,1986 (85JCAE); T/E unlistd ihl-cat LC :>3000 ppm/7H Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 84, p. 53, 1945 (JPETAB); T/E unlistd orl-rbt LD50: 860 mg/kg Guide to the Chemicals Used in Crop Protection. (Information Canada, 171 Slater St., Ottawa, Ont., Canada) v. 6, p. 264, 1973 (GUCHAZ); F07-J22-J30 ihl-rbt LCLo: 3000 ppm/7H Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 84, p. 53, 1945 (JPETAB); D17-F01-F19 skn-rbt LD50: 2800 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 48A, p. 91, 1970 (FAONAU); T/E unlistd scu-rbt LDLo: 1200 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); D17-F07-J22 ihl-pig LCLo: 3000 ppm/7H Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 84, p. 53, 1945 (JPETAB); D17-F07-M03 ihl-gpg LCLo: 1500 ppm/7H Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 84, p. 53, 1945 (JPETAB); Y16 ipr-gpg LDLo: 600 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 35, p. 21, 1974 (AIHAAP); T/E unlistd ihl-mam LC :>3000 ppm/7H Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 84, p. 53, 1945 (JPETAB) MD: L70-M70 orl-rat TDLo: 21840 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3123 (NTPTR*); P28-L70-Z01 orl-rat TDLo: 1 gm/kg/10D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 17, p. 463, 1994 (DCTODJ); Z01 ihl-rat TCLo: 200 ppm/7H/6W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(4), p. 113, 1946 (JIHTAB); J25-M03-Z01 ihl-rat TCLo: 1500 ppm/7H/5D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 84, p. 53, 1945 (JPETAB); L70-M03-M70 orl-mus TDLo: 43680 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3123 (NTPTR*); Z01 ihl-mus TCLo: 200 ppm/7H/9D-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(4), p. 113, 1946 (JIHTAB); P72-S04 orl-mus TDLo: 685 mg/kg/14D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 43, p. 41, 1982 (EVHPAZ); D26-Z01 ihl-dog TCLo: 1500 ppm/7H/5D-I Archives of Ophthalmology (Chicago). (AMA, 535 N. Dearborn St., Chicago, IL 60610) New series: V.1-44(3), 1929-50: V.64- 1960- v. 32, p. 391, 1944 (AROPAW); F24-Z01 ihl-mky TCLo: 1000 ppm/7H/9W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(4), p. 113, 1946 (JIHTAB); Z01 ihl-cat TCLo: 1000 ppm/7H/11W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(4), p. 113, 1946 (JIHTAB); Z01 ihl-rbt TCLo: 400 ppm/7H/19W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(4), p. 113, 1946 (JIHTAB); Z01 ihl-gpg TCLo: 200 ppm/7H/25W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(4), p. 113, 1946 (JIHTAB); G30-M03-Z01 ihl-gpg TCLo: 1500 ppm/7H/5D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 84, p. 53, 1945 (JPETAB) TR: ACGIH TLV-TWA 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 429, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 501, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 429, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 501, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 501, 1999 (IMEMDT); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40(3), p. A46, 1979 (AIHAAP); TOXICOLOGY REVIEW Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 22, p. 31, 1980 (VHTODE); TOXICOLOGY REVIEW Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 5, p. 319, 1982 (DCTODJ); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-182825 (NTIS**) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 50 ppm (200 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 79, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 50 ppm;CL 100 ppm;Pk 200 ppm/5M/3H Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 50 ppm (200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 50 ppm (200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 50 ppm (200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 5 ppm (2 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 10 ppm (40 mg/m3), JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 10 ppm (40 mg/m3), JAN 1993; OEL-FINLAND: TWA 10 ppm (40 mg/m3), STEL 20 ppm (80 mg/m3), Carcinogen, JAN 1999; OEL-FRANCE: VME 10 ppm (40 mg/m3), C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 4 mg/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 10 ppm (40 mg/m3), 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 50 ppm (200 mg/m3), Carcinogen, JAN 1999; OEL-NORWAY: TWA 1 ppm (4 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 50 ppm (200 mg/m3), JAN 1993; OEL-POLAND: TWA 50 mg/m3, STEL 60 mg/m3, JAN 1999; OEL-RUSSIA: TWA 10 ppm, JAN 1993; OEL-SWEDEN: NGV 1 ppm (4 mg/m3), KTV 5 ppm (20 mg/m3), Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (20 mg/m3), Carcinogen, JAN 1999; OEL-TURKEY: TWA 50 ppm (200 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (21 mg/m3), Skin, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ETHYLENE DICHLORIDE-air: 10H CA TWA 1 ppm, STEL 2 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 24130; NIS 92; TNF 7148; NOS 60; TNE 77671; NOES 1983: HZD 24130; NIS 38; TNF 2226; NOS 61; TNE 83246; TFE 33361 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/2001/109103/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-nondisjunction, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 25, 1978, AND BULLETIN 27, 1978; NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003; NCI Carcinogenesis Bioassay (gavage), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-55, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Toxicity studies, RPT# TOX-04, October 2000; OSHA ANALYTICAL METHOD #03 Record 741 of 1119 in RTECS (through 2003/06) AN: KI0950000 PN: Ethane,-1,2-dichloro-1,1-difluoro- SY: 1,2-Dichloro-1,1-difluoroethane-; HCFC-132b- RN: Current: 1649-08-7 BRN: 1733206 BHR: 4-01-00-00135 UD: 200012 MF: C2-H2-Cl2-F2 MW: 134.94 WL: GXFF1G CC: Tumorigen (C); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 100 uL MOD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530580 (NTIS**) RE: T01 ihl-rat TCLo: 2000 ppm/6H (14W male) United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0587-0676 (EPASR*); T25-T26-T34 ihl-rat TCLo: 5000 ppm/6H (7-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530577 (NTIS**) AT: F07-F19-J25 orl-rat LDLo: 25 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530581 (NTIS**); F01-F07-L30 ihl-rat LCLo: 20000 ppm/4H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 1, 1971 (TXAPA9) MD: L30-U01-Y03 ihl-rat TCLo: 2000 ppm/6H/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530614 (NTIS**) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-45, October 2000 Record 742 of 1119 in RTECS (through 2003/06) AN: KI1420000 PN: Ethane,-1,2-difluoro-1,1,2,2-tetrachloro- SY: 1,1,2,2-Tetrachloro-1,2-difluoroethane-; 1,1,2,2-Tetrachloro-1,2-difluoroethane- (ACGIH:OSHA); 1,2-Difluoro-1,1,2,2-tetrachloroethane-; CFC-112-; Daiflon-112-; Daiflon-S2-; Ethane,-1,1,2,2-tetrachloro-1,2-difluoro-; F-112-; Freon-112-; Genetron-112-; Halocarbon-112-; R-112-; Refrigerant-112-; Ucon-112- RN: Current: 76-12-0 BRN: 1740336 BHR: 4-01-00-00146 UD: 200210 MF: C2-Cl4-F2 MW: 203.82 WL: GXGFXGGF CC: Tumorigen (C); Primary-Irritant (S) ID: skn-gpg 100%/24H open MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 27, p. 332, 1966 (AIHAAP); eye-gpg 100 mg/20S rinse MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 27, p. 332, 1966 (AIHAAP) AT: F11-F12-J25 ihl-rat LC50: 2 pph/15M Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- v. 1, p. 239, 1982 (HUTODJ); T/E unlistd orl-mus LD50: 800 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,54,1982 (85GMAT); F07-F19-J24 ihl-mus LC50: 50 gm/m3/2H Trudy Leningradskogo Sanitarno-Gigienicheskogo Meditsinskogo Instituta. (Leningrad, Russia) V.1-145, 1949-82. Discontinued. v. 75, p. 241, 1963 (TLSMA6); T/E unlistd orl-gpg LDLo: >10 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520705 (NTIS**) MD: L30-P14 ihl-rat TCLo: 1000 ppm/6H/31D-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 27, p. 332, 1966 (AIHAAP) TR: ACGIH TLV-TWA 500 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: MSHA STANDARD-air: TWA 500 ppm (4170 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 249, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 500 ppm (4170 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 500 ppm (4170 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 500 ppm (4170 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 500 ppm (4170 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 500 ppm (4170 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 200 ppm (1690 mg/m3), JAN 1999; OEL-BELGIUM: TWA 500 ppm (4170 mg/m3), JAN 1993; OEL-DENMARK: TWA 200 ppm (1665 mg/m3), JAN 1999; OEL-FINLAND: TWA 500 ppm (4170 mg/m3), STEL 625 ppm (5215 mg/m3), JAN 1999; OEL-FRANCE: VME 500 ppm (4170 mg/m3), JAN 1999; OEL-GERMANY: MAK 200 ppm (1690 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 100 ppm (850 mg/m3), JAN 1999; OEL-NORWAY: TWA 250 ppm (2085 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 500 ppm (4170 mg/m3), JAN 1993; OEL-SWITZERLAND: MAK-W 500 ppm (4200 mg/m3), STEL 1000 ppm, JAN 1999; OEL-UNITED KINGDOM: TWA 100 PPM (847 MG/M3), STEL 100 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 1,1,2,2-TETRACHLORO-1,2-DIFLUOROETHANE-air: TWA 500 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 71447; NIS 8; TNF 451; NOS 7; TNE 7803; NOES 1983: HZD 71447; NIS 5; TNF 95; NOS 5; TNE 1434; TFE 191 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: 1, 1, 2, 2-Tetrachloro-1, 2-difluoroethane, 1016; NTP Toxicity studies, RPT# TOX-45, October 2000 Record 743 of 1119 in RTECS (through 2003/06) AN: KI4025000 PN: Ethane,-hexachloro- SY: Avlothane-; Distokal-; Distopan-; Distopin-; Egitol-; Ethane-hexachloride-; Carbon-hexachloride-; Hexachlor-aethan- (German); Hexachlorethane-; Hexachloroethane-; 1,1,1,2,2,2-Hexachloroethane-; Hexachloroethane- (ACGIH:OSHA); Hexachloroethylene-; NCI-C04604-; RCRA-waste-number-U131-; Ethylene-hexachloride-; Falkitol-; Fasciolin-; Mottenhexe-; Perchloroethane-; Phenohep- RN: Current: 67-72-1 BRN: 1740341 BHR: 4-01-00-00148 UD: 200210 MF: C2-Cl6 MW: 236.72 WL: GXGGXGGG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: oms-mus-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); sce-ham-ovr 330 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T26-T29 orl-rat TDLo: 5500 mg/kg (6-16D preg) American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP) TE: V01-L60 orl-rat TDLo: 10300 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-361, 1989 (NTPTR*); V01-L60 orl-mus TDLo: 230 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-68, 1978 (NCITR*); V01-L60 orl-mus TD :460 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-68, 1978 (NCITR*); V01-M61 orl-rat TDLo: 10300 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-170895/AS (NTIS**); V02-N61 orl-rat TDLo: 5150 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-170895/AS (NTIS**) ORNG: 4460000000 ng/kg. [4460.000000 mg/kg] T/E unlistd SRNG: 32000000000 ng/kg. [32000.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 4460 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP); F18 ihl-rat LCLo: 5900 ppm/8H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP); T/E unlistd ipr-rat LDLo: 2900 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP); T/E unlistd ipr-mus LD50: 4500 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 11, p. 902, 1961 (ARZNAD); T/E unlistd ivn-dog LDLo: 325 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd orl-rbt LD :>1 gm/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP); T/E unlistd skn-rbt LD50: 32 gm/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP); T/E unlistd scu-rbt LDLo: 4 gm/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd orl-gpg LD50: 4970 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP) MD: L70-M03-M70 orl-rat TDLo: 6944 mg/kg/16W-C Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 8, p. 155, 1985 (DCTODJ); Z01 orl-rat TDLo: 9 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-361, 1989 (NTPTR*); A70-L70-M70 orl-rat TDLo: 48750 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-361, 1989 (NTPTR*); M70-N73-Z73 ihl-rat TCLo: 260 ppm/6H/6W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP); L30-M30-U01 orl-rbt TDLo: 12 gm/kg/12D-C American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP); L70-Z01 ihl-gpg TCLo: 260 ppm/6H/6W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 187, 1979 (AIHAAP) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 467, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 295, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 467, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 295, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 295, 1999 (IMEMDT); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40(3), p. A46, 1979 (AIHAAP) SR: MSHA STANDARD-air: TWA 1 ppm (10 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 124, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 ppm (10 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 ppm (10 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 ppm (10 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 ppm (10 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 ppm (100 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 1 ppm (10 mg/m3), JAN 1999; OEL-BELGIUM: TWA 1 ppm (9.7 mg/m3), JAN 1993; OEL-DENMARK: TWA 1 ppm (10 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 1 ppm (10 mg/m3), STEL 3 ppm (30 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 1 ppm, VLE 10 ppm, JAN 1999; OEL-GERMANY: MAK 1 ppm (10 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (10 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 1 ppm (10 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1 ppm (10 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 10 mg/m3, MAC(STEL) 30 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 1 ppm (10 mg/m3), Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 5 ppm (49 mg/m3), vapor, SEP 2000; OEL-UNITED KINGDOM: TWA 10 mg/m3, total inhalable dust, SEP 2000; OEL-UNITED KINGDOM: TWA 4 mg/m3, respirable dust, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO HEXACHLOROETHANE-air: 8H CA TWA 1 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 17385; NIS 5; TNF 219; NOS 9; TNE 1488; NOES 1983: HZD 17385; NIS 12; TNF 170; NOS 23; TNE 8516; TFE 576 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101041/AS); EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test, S cerevisiae-homozygosis; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, PROPOSED RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 27009, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 27, 1978; NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NTP Carcinogenesis Studies (gavage), clear evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-361, 1989 (NTPTR*); NCI Carcinogenesis Bioassay (gavage), no evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-68, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Toxicity studies, RPT# TOX-45, October 2000 Record 744 of 1119 in RTECS (through 2003/06) AN: KI6150000 PN: Ethane,-pentabromo- SY: Pentabromoethane-; 1,1,1,2,2-Pentabromoethane- RN: Current: 75-95-6 BRN: 1737429 BHR: 3-01-00-00193 UD: 200012 MF: C2-H-Br5 MW: 424.58 CC: Tumorigen (C) SL: NTP Toxicity studies, RPT# TOX-45, October 2000 Record 745 of 1119 in RTECS (through 2003/06) AN: KI6300000 PN: Ethane,-pentachloro- SY: Ethane-pentachloride-; NCI-C53894-; Pentachloorethaan- (Dutch); Pentachloraethan- (German); Pentachlorethane- (French); Pentachloroethane-; Pentacloroetano- (Italian); Pentalin-; RCRA-waste-number-U184- RN: Current: 76-01-7 BRN: 1736845 BHR: 4-01-00-00147 UD: 200302 MF: C2-H-Cl5 MW: 202.28 WL: GYGXGGG CC: Tumorigen (C); Drug (D); Mutagen (M) ME: oms-esc 25814 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19, p. 98, 1992 (EMMUEG); mmo-smc 2500 umol/L (+S9) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 349, 1989 (TCMUD8); oms-mus-orl 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); msc-mus-lym 70 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); cyt-ham-lng 80 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 369, p. 243, 1996 (MUREAV); sce-ham-ovr 100 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sln-hmn-lng 80 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 369, p. 243, 1996 (MUREAV) TE: V02-M61 orl-rat TDLo: 108150 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-206748 (NTIS**); V01-L60 orl-mus TDLo: 71750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-206748 (NTIS**) ORNG: 920000000 ng/kg. [920.000000 mg/kg] F05-F19-L30 AT: F05-F19-L30 orl-rat LD50: 920 mg/kg Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. (Tohoku University, Research Institute for Tuberculosis and Cancer, 4-1 Seiryo-machi, Sendai, Japan) V.1- 1949- v. 36(1-4), p. 10, 1989 (SRTCAC); T/E unlistd ihl-rat LC50: 4238 ppm/2H "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,97,1986 (85JCAE); T/E unlistd ihl-mus LCLo: 35 gm/m3/2H Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 141, p. 19, 1929 (AEPPAE); F04-L02-L03 orl-dog LDLo: 500 mg/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 16, p. 325, 1932 (AJHYA2); T/E unlistd ivn-dog LDLo: 100 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd scu-rbt LDLo: 700 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL) MD: Z01 orl-rat TDLo: 7 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-232, 1982 (NTPTR*); Z01 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-232, 1982 (NTPTR*); Z01 orl-mus TDLo: 14 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-232, 1982 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 99, 1986 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1519, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 99, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1519, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1519, 1999 (IMEMDT); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40(3), p. A46, 1979 (AIHAAP) SR: OEL-AUSTRIA: MAK 5 ppm (40 mg/m3), JAN 1999; OEL-FINLAND: TWA 5 ppm (40 mg/m3), STEL 10 ppm (80 mg/m3), JAN 1999; OEL-GERMANY: MAK 5 ppm (40 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (40 mg/m3), JAN 1999; OEL-NORWAY: TWA 5 ppm (40 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (40 mg/m3), KZG-W 10 ppm (80 mg/m3), JAN 1999; OEL-TURKEY: TWA 5 ppm (40 mg/m3), JAN 1993 ND: NIOSH REL TO PENTACHLOROETHANE-air: Handle with caution National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X6173; NIS 1; TNF 3; NOS 7; TNE 232; TFE 3 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 27, 1978; NIOSH Analytical Method, 1994: Pentachloroethane, 2517; NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; NTP Toxicity studies, RPT# TOX-45, October 2000 Record 746 of 1119 in RTECS (through 2003/06) AN: KI8224900 PN: Ethane,-1,1,1,2-tetrabromo- SY: 1,1,1,2-Tetrabromoethane- RN: Current: 630-16-0 BRN: 1733245 BHR: 4-01-00-00162 UD: 200012 MF: C2-H2-Br4 MW: 345.68 CC: Tumorigen (C) IHNG: 900000000000 ng/m3/4H. [900000.000000 mg/m3/4H] T/E unlistd AT: T/E unlistd ihl-rat LC50: 900 gm/m3/4H Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (3), p. 25, 1996 (TOVEFN) SL: NTP Toxicity studies, RPT# TOX-45, October 2000 Record 747 of 1119 in RTECS (through 2003/06) AN: KI8225000 PN: Ethane,-1,1,2,2-tetrabromo- SY: 1,1,2,2-Tetrabromaethan- (German); 1,1,2,2-Tetrabromoetano- (Italian); 1,1,2,2-Tetrabromoethane-; 1,1,2,2-Tetrabroomethaan- (Dutch); Acetylene-tetrabromide-; Acetylene-tetrabromide- (ACGIH:OSHA); Muthmann's-liquid-; TBE-; Tetrabromoacetylene-; s-Tetrabromoethane- RN: Current: 79-27-6 BRN: 1098321 BHR: 4-01-00-00162 UD: 200210 MF: C2-H2-Br4 MW: 345.68 WL: EYEYEE CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MOD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 28, 1963 (AIHAAP); eye-rbt 100 mg MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 28, 1963 (AIHAAP) ME: mmo-sat 10 ug/plate (+/-S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 15, p. 101, 1987 (TECSDY); dnr-esc 29640 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 61, 1976 (MUREAV); sce-ham-ovr 158 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V02-J60-R60 skn-mus TDLo: 130 gm/kg/74W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 1433, 1979 (JJIND8) ORNG: 1200000000 ng/kg. [1200.000000 mg/kg] T/E unlistd SKNG: 5250000000 ng/kg. [5250.000000 mg/kg] T/E unlistd IHNG: 549000000 ng/m3/4H. [549.000000 mg/m3/4H] T/E unlistd AT: T/E unlistd orl-rat LD50: 1200 mg/kg Vrachebnoe Delo. Medical Practice. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1918- v. (3), p. 80, 1967 (VRDEA5); T/E unlistd ihl-rat LC50: 549 mg/m3/4H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,107,1982 (85GMAT); T/E unlistd skn-rat LD50: 5250 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,107,1982 (85GMAT); T/E unlistd orl-mus LD50: 269 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,107,1982 (85GMAT); T/E unlistd ipr-mus LD50: 443 mg/kg Acta Biologica et Medica Germanica. (Berlin, Ger. Dem. Rep.) V.1-41, 1958-82. For publisher information, see BBIADT. v. 41, p. 945, 1982 (ABMGAJ); F01-L03-P01 orl-rbt LD50: 400 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 2, p. 407, 1950 (AMIHBC); T/E unlistd orl-gpg LD50: 400 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 251, 1969 (AIHAAP) MD: L14-L70-P30 orl-rat TDLo: 10920 mg/kg/13W-I Vrachebnoe Delo. Medical Practice. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1918- v. (3), p. 80, 1967 (VRDEA5); L14-L70-P01 ihl-rat TCLo: 100 mg/m3/4H/17W-I Vrachebnoe Delo. Medical Practice. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1918- v. (3), p. 80, 1967 (VRDEA5); L70 ihl-rat TCLo: 14 ppm/7H/14W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 28, 1963 (AIHAAP); L70 ihl-rat TCLo: 4 ppm/7H/26W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 28, 1963 (AIHAAP); L70 ihl-mus TCLo: 14 ppm/7H/15W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 28, 1963 (AIHAAP); L70 ihl-rbt TCLo: 14 ppm/7H/15W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 28, 1963 (AIHAAP); U01 ihl-gpg TCLo: 14 ppm/7H/14W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 28, 1963 (AIHAAP); U01 ihl-gpg TCLo: 4 ppm/7H/26W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 28, 1963 (AIHAAP) TR: ACGIH TLV-TWA 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: MSHA STANDARD-air: TWA 1 ppm (14 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 248, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 ppm (14 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 ppm (14 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 ppm (14 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 ppm (14 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 1 ppm (15 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 1 ppm (14 mg/m3), JAN 1999; OEL-BELGIUM: TWA 1 ppm (14 mg/m3), JAN 1993; OEL-DENMARK: TWA 1 ppm (14 mg/m3), JAN 1999; OEL-FINLAND: TWA 1 ppm (14 mg/m3), STEL 3 ppm (42 mg/m3), JAN 1999; OEL-FRANCE: VME 1 ppm (15 mg/m3), JAN 1999; OEL-GERMANY: MAK 1 ppm (14 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (14 mg/m3), JAN 1999; OEL-NORWAY: TWA 1 ppm (14 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1 ppm (14 mg/m3), JAN 1993; OEL-SWEDEN: TWA 1 ppm (14 mg/m3), STEL 2 ppm (30 mg/m3), JAN 1999; OEL-TURKEY: TWA 1 ppm (14 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 0.5 ppm (7.2 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 71401; NIS 2; TNF 39; NOS 3; TNE 440; NOES 1983: HZD 71401; NIS 5; TNF 172; NOS 5; TNE 2516 SL: EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: 1, 1, 2, 2-Tetrabromoethane, 2003; NTP Toxicity studies, RPT# TOX-45, October 2000 Record 748 of 1119 in RTECS (through 2003/06) AN: KI8450000 PN: Ethane,-1,1,1,2-tetrachloro- SY: NCI-C52459-; RCRA-waste-number-U208-; 1,1,1,2-Tetrachloroethane- RN: Current: 630-20-6 BRN: 1733216 BHR: 4-01-00-00143 UD: 200302 MF: C2-H2-Cl4 MW: 167.84 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 35, p. 593, 1974 (AMPMAR); eye-rbt 100 mg SEV Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 35, p. 593, 1974 (AMPMAR) ME: mmo-sat 10 ug/plate (+/-S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 15, p. 101, 1987 (TECSDY); mrc-asn 250 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 201, p. 401, 1988 (MUREAV); sln-asn 125 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 201, p. 401, 1988 (MUREAV); mmo-mus-lym 200 mg/L (+S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); oms-mus-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); msc-mus-lym 200 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); sce-ham-ovr 158 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sln-hmn-lng 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 369, p. 243, 1996 (MUREAV) TE: V03-L60 orl-rat TDLo: 128750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-218206 (NTIS**); V02-R60 orl-rat TDLo: 64375 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-218206 (NTIS**); V01-L60 orl-mus TDLo: 128750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-218206 (NTIS**) ORNG: 670000000 ng/kg. [670.000000 mg/kg] T/E unlistd SRNG: 20000000000 ng/kg. [20000.000000 mg/kg] T/E unlistd IHPB: 2100000 ppb/4H. [2100.000000 ppm/4H] K12 AT: T/E unlistd orl-rat LD50: 670 mg/kg Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 35, p. 593, 1974 (AMPMAR); K12 ihl-rat LC50: 2100 ppm/4H Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 35, p. 593, 1974 (AMPMAR); T/E unlistd orl-mus LD50: 1500 mg/kg Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 35, p. 593, 1974 (AMPMAR); T/E unlistd ipr-mus LD50: 1275 mg/kg Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 8, p. 371, 1966 (SAIGBL); K12 ihl-rbt LC50: 2800 ppm/4H Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 35, p. 593, 1974 (AMPMAR); T/E unlistd skn-rbt LD50: 20 gm/kg Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 35, p. 593, 1974 (AMPMAR) MD: Z01 orl-rat TDLo: 7 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-237, 1982 (NTPTR*); Z01 orl-mus TDLo: 14 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-237, 1982 (NTPTR*); Z01 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-237, 1982 (NTPTR*); F04 ipr-mus TDLo: 16 gm/kg/40D-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 8, p. 371, 1966 (SAIGBL); F04-Z01 ipr-mus TDLo: 2400 mg/kg/3D-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 8, p. 371, 1966 (SAIGBL); A60-V30 orl-rat TDLo: 128750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-218206 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 87, 1986 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1133, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 87, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1133, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1133, 1999 (IMEMDT); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40(3), p. A46, 1979 (AIHAAP) ND: NIOSH REL TO 1,1,1,2-TETRACHLOROETHANE-air: Handle with caution National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 27, 1978; NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; NTP Toxicity studies, RPT# TOX-45, October 2000 Record 749 of 1119 in RTECS (through 2003/06) AN: KI8575000 PN: Ethane,-1,1,2,2-tetrachloro- SY: Acetylene-tetrachloride-; 1,1-Dichloro-2,2-dichloroethane-; Bonoform-; Cellon-; 1,1,2,2-Czterochloroetan- (Polish); NCI-C03554-; RCRA-waste-number-U209-; TCE-; 1,1,2,2-Tetrachloorethaan- (Dutch); 1,1,2,2-Tetrachloraethan- (German); Tetrachlorethane-; 1,1,2,2-Tetrachlorethane- (French); Tetrachloroethane-; s-Tetrachloroethane-; 1,1,2,2-Tetrachloroethane-; 1,1,2,2-Tetrachloroethane- (ACGIH:OSHA); sym-Tetrachloroethane-; Tetrachlorure-d'acetylene- (French); 1,1,2,2-Tetracloroetano- (Italian); Westron- RN: Current: 79-34-5 BRN: 969206 BHR: 4-01-00-00144 UD: 200210 MF: C2-H2-Cl4 MW: 167.84 WL: GYGYGG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: mmo-sat 10 ug/plate (+/-S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 15, p. 101, 1987 (TECSDY); oms-esc 14768 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19, p. 98, 1992 (EMMUEG); dnr-esc 15866 ug/plate Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 2576, 1974 (CNREA8); sln-asn 200 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 201, p. 401, 1988 (MUREAV); dni-hmn-hla 6 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); oms-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); sce-ham-ovr 56 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V03-L60 orl-rat TDLo: 42 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-27, 1978 (NCITR*); V01-L60 orl-mus TDLo: 55 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-27, 1978 (NCITR*); V01-L60 orl-mus TD :110 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-27, 1978 (NCITR*) ORNG: 200000000 ng/kg. [200.000000 mg/kg] T/E unlistd AT: F01 orl-hmn TDLo: 30 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 1110, 1966 (PCOC**); F07-F08 ihl-hmn TCLo: 1000 mg/m3/30M Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); T/E unlistd orl-rat LD50: 200 mg/kg Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 32, p. 145, 1994 (INHEAO); T/E unlistd ihl-rat LCLo: 1000 ppm/4H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 31, p. 343, 1949 (JIHTAB); T/E unlistd ihl-mus LC50: 4500 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,107,1982 (85GMAT); T/E unlistd ipr-mus LD50: 821 mg/kg Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 8, p. 371, 1966 (SAIGBL); F04-F19 scu-mus LD50: 1108 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 123, p. 224, 1958 (JPETAB); L02-F04-L03 orl-dog LDLo: 300 mg/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 16, p. 325, 1932 (AJHYA2); T/E unlistd ivn-dog LDLo: 50 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); D17-F01-K01 ihl-cat LCLo: 19 gm/m3/45M Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); T/E unlistd scu-rbt LDLo: 500 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); L03 ipr-gpg LDLo: 500 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 35, p. 21, 1974 (AIHAAP) MD: Z01 orl-rat TDLo: 9480 mg/kg/6W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-27, 1978 (NCITR*); A11-L70-P28 ihl-rat TCLo: 50 mg/m3/4H/6W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 21(2), p. 30, 1977 (GTPZAB); F04-L03-Z01 ipr-mus TDLo: 16 gm/kg/40D-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 8, p. 371, 1966 (SAIGBL) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 477, 1979 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 817, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 354, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 817, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 817, 1999 (IMEMDT); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40(3), p. A46, 1979 (AIHAAP) SR: MSHA STANDARD-air: TWA 5 ppm (35 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 249, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (35 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (35 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (35 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (35 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 1 ppm (7 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 1 ppm (7 mg/m3), Skin, Suspected Carcinogen, JAN 1993; OEL-BELGIUM: TWA 1 ppm (6.9 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 1 ppm (7 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 1 ppm (7 mg/m3), STEL 3 ppm (21 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 1 ppm (7 mg/m3), VLE 5 ppm (35 mg/m3), JAN 1999; OEL-GERMANY: MAK 1 ppm (7 mg/m3), Skin, Carcinogen, JAN 1999; OEL-JAPAN: OEL 1 ppm (6.9 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (7 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 1 ppm (7 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (35 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 35 mg/m3, JAN 1999; OEL-RUSSIA: TWA 1 ppm, JAN 1993; OEL-SWITZERLAND: MAK-W 1 ppm (7 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 5 ppm (35 mg/m3), JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 1,1,2,2-TETRACHLOROETHANE-air: 10H CA TWA 1 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 71460; NIS 8; TNF 244; NOS 15; TNE 7044; NOES 1983: HZD 71460; NIS 2; TNF 501; NOS 10; TNE 4145; TFE 926 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/97/121099/AS); EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 27, 1978; NIOSH Analytical Method, 1994: 1, 1, 2, 2-Tetrachloroethane, 1019; NCI Carcinogenesis Bioassay (gavage), clear evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-27, 1978 (NCITR*); NCI Carcinogenesis Bioassay (gavage), equivocal evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-27, 1978 (NCITR*); NTP Toxicity studies, RPT# TOX-45, October 2000; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 750 of 1119 in RTECS (through 2003/06) AN: KJ2975000 PN: Ethane,-1,1,1-trichloro- SY: 1,1,1-TCE-; 1,1,1-Trichloorethaan- (Dutch); 1,1,1-Trichloraethan- (German); 1,1,1-Trichloroethane-; 1,1,1-Trichloroethane- (DOT:OSHA); 1,1,1-Tricloroetano- (Italian); Aerothene-TT-; Analytical-grade-1,1,1-trichloroethane-; CF-2-; Chloroethene- (inhibited); Chloroform,-methyl-; Chlorothene-; Chlorothene-NU-; Chlorothene-SM-; Chlorothene-VG-; Chlorten-; Ethana-NU-; F-140a-; HCC-140a-; ICI-CF-2-; Inhibisol-; Methyl-chloroform-; Methyl-chloroform- (ACGIH:OSHA); Methylchloroform-; Methyltrichloromethane-; NCI-C04626-; RCRA-waste-number-U226-; Solvent-111-; Tafclean-; Trichloro-1,1,1-ethane- (French); Trichloroethane-; Trichloromethylmethane-; alpha-T-; alpha-Trichloroethane- RN: Current: 71-55-6 Previous: 74552-83-3 BRN: 1731614 BHR: 4-01-00-00138 UD: 200305 MF: C2-H3-Cl3 MW: 133.40 WL: GXGG1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-man 450 ppm/8H British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 28, p. 286, 1971 (BJIMAG); skn-rbt 5 gm/12D-I MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 353, 1958 (AIHAAP); skn-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,94,1986 (85JCAE); eye-rbt 100 mg MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 353, 1958 (AIHAAP); eye-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,94,1986 (85JCAE) ME: mmo-sat 10 ug/plate (+/-S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 15, p. 101, 1987 (TECSDY); dnr-esc 500 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 195, 1981 (PMRSDJ); mrc-smc 5350 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 397, p. 271, 1998 (MUREAV); mtr-rat-emb 99 umol/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 14, p. 290, 1978 (ITCSAF); mmo-mus-lym 31300 ug/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 103, 1988 (EMMUEG); mtr-mus-emb 20 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 28, p. 85, 1985 (CALEDQ); mtr-ham-kdy 562 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 626, 1981 (PMRSDJ); mtr-ham-emb 100 uL/plate Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 25, p. 75, 1982 (EVSRBT); cyt-ham-ovr 160 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T47 orl-rat TDLo: 43 mg/kg (1-22D preg/21D post) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 25A, 1984 (TJADAB); T34 ihl-rat TCLo: 2100 ppm/6H (1-20D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 251, 1982 (JTEHD6); T19-T72-T85 ihl-rat TCLo: 7000 ppm/3H (13-19D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 21, p. 699, 1999 (NETEEC) ORNG: 9600000000 ng/kg. [9600.000000 mg/kg] G08-U01 IHPB: 18000000 ppb/4H. [18000.000000 ppm/4H] T/E unlistd AT: F08-F17-F42 ihl-man TCLo: 350 ppm Work, Environment, Health. (Helsinki, Finland) V.1-11, 1962-74. For publisher information, see SWEHDO. v. 10, p. 82, 1973 (WEHRBJ); K12-K13-K30 orl-hmn TDLo: 670 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB257-185 (NTIS**); F17-D25 ihl-hmn TCLo: 920 ppm/70M American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 353, 1958 (AIHAAP); F17-F33 ihl-man TCLo: 200 ppm/4H Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 5, p. 96, 1982 (ATSUDG); D07 ihl-man TCLo: 200 ppm/4H International Archives of Occupational and Environmental Health. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.35- 1975- v. 72, p. 485, 1999 (IAEHDW); G08-U01 orl-rat LD50: 9600 mg/kg Gigiena Naselennykh Mest. Hygiene in Populated Places. (Izdatel'stvo Zdorov'ya, Kiev, USSR) V.7- 1967- v. 29, p. 45, 1990 (GNAMAP); T/E unlistd ihl-rat LC50: 18000 ppm/4H "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,28,1972 (28ZPAK); T/E unlistd ipr-rat LD50: 3593 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); G08-U01 orl-mus LD50: 6 gm/kg Gigiena Naselennykh Mest. Hygiene in Populated Places. (Izdatel'stvo Zdorov'ya, Kiev, USSR) V.7- 1967- v. 29, p. 45, 1990 (GNAMAP); F13 ihl-mus LC50: 3911 ppm/2H Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 13, p. 226, 1971 (SAIGBL); T/E unlistd ipr-mus LD50: 2568 mg/kg Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 8, p. 371, 1966 (SAIGBL); F04-F19 scu-mus LD50: 16 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 123, p. 224, 1958 (JPETAB); T/E unlistd orl-dog LD50: 750 mg/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C310, 1991 (FMCHA2); L14 ipr-dog LD50: 3100 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 119, 1967 (TXAPA9); T/E unlistd ivn-dog LDLo: 95 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 72, 1959 (HBTXAC); F11-F19 ihl-mky LC :>5000 ppm/7H Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.1-2(3), 1950. For publisher information, see AEHLAU. v. 1, p. 225, 1950 (AIHOAX); T/E unlistd ihl-cat LC50: 24400 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(8), p. 127, 1970 (GISAAA); T/E unlistd orl-rbt LD50: 5660 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 353, 1958 (AIHAAP); T/E unlistd skn-rbt LDLo: 15800 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 353, 1958 (AIHAAP); T/E unlistd scu-rbt LDLo: 500 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 72, 1959 (HBTXAC); T/E unlistd orl-gpg LD50: 9470 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 353, 1958 (AIHAAP); A30-Y53 ihl-mus TCLo: 5000 ppm/40M Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 60, p. 331, 2000 (JTEHD6); J70-M71-U01 ihl-rat TCLo: 5000 ppm/40M Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 60, p. 331, 2000 (JTEHD6); F19 ihl-mus TCLo: 4000 ppm/30M Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 56, p. 365, 2000 (TOSCF2); A30 ihl-mus TCLo: 12000 ppm/30M Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 56, p. 365, 2000 (TOSCF2) MD: M03 orl-rat TDLo: 109 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-00-4402 (NTPTR*); L30 ihl-rat TCLo: 10000 ppm/1H/13W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 353, 1958 (AIHAAP); U01 orl-mus TDLo: 319 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-00-4402 (NTPTR*); F17-L30-P71 ihl-mus TCLo: 1000 ppm/2H/3W-I Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 18, p. 175, 1963 (NEZAAQ); N73-S20 ipr-mus TDLo: 8004 mg/kg/6D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0557868 (NTIS**); L30 ihl-gpg TCLo: 1000 ppm/1H/13W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 353, 1958 (AIHAAP); U01 ihl-gpg TCLo: 3000 ppm/7H/29D-I Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.1-2(3), 1950. For publisher information, see AEHLAU. v. 1, p. 225, 1950 (AIHOAX); U01 ihl-gpg TCLo: 650 ppm/7H/58D-I Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.1-2(3), 1950. For publisher information, see AEHLAU. v. 1, p. 225, 1950 (AIHOAX); L70-A30-Y37 ims-rat TDLo: 1200 ppm/30D-C Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 67, p. 384, 1990 (PHTOEH) TR: ACGIH TLV-TWA 350 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 450 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 350 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 515, 1979 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 881, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 515, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 881, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 881, 1999 (IMEMDT); TOXICOLOGY REVIEW Fortschritte der Arzneimittelforschung. Progress in Drug Research. (Birkhauser Boston, Inc., c/o Springer-Verlag New York, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1959- v. 18, p. 365, 1974 (FAZMAE); TOXICOLOGY REVIEW U.S. Army, Edgewood Arsenal Technical Report. (Aberdeen Proving Ground, MD 21010) EB-TR-75047 (EATR**); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40(3), p. A46, 1979 (AIHAAP) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 350 ppm (1900 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 161, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 350 ppm (1900 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 350 ppm (1900 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 350 ppm (1900 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 350 ppm (1900 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 125 ppm (680 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 200 ppm (1080 mg/m3), JAN 1999; OEL-BELGIUM: TWA 350 ppm (1910 mg/m3), STEL 450 ppm (2460 mg/m3), JAN 1993; OEL-DENMARK: TWA 50 ppm (275 mg/m3), JAN 1999; OEL-FINLAND: TWA 100 ppm (540 mg/m3), STEL 250 ppm (1400 mg/m3), JAN 1999; OEL-FRANCE: VME 300 ppm (1650 mg/m3), VLE 450 ppm (2500 mg/m3), JAN 1999; OEL-GERMANY: MAK 200 ppm (1080 mg/m3), JAN 1999; OEL-HUNGARY: TWA 100 mg/m3, STEL 300 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 200 ppm (1100 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 200 ppm (1080 mg/m3), MAC-K 500 ppm, JAN 1999; OEL-NORWAY: TWA 50 ppm (270 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 350 ppm (1900 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 300 mg/m3, MAC(STEL) 1400 mg/m3, JAN 1999; OEL-RUSSIA: TWA 200 ppm, STEL 20 mg/m3, JAN 1993; OEL-SWEDEN: NGV 50 ppm (300 mg/m3), KTV 90 ppm (500 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 200 ppm (1080 mg/m3), KZG-W 1000 ppm, JAN 1999; OEL-TURKEY: TWA 350 ppm (1900 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 200 ppm (1110 mg/m3), STEL 400 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 1,1,1-TRICHLOROETHANE-air: CL 350 ppm/15M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 46970; NIS 412; TNF 109850; NOS 205; TNE 1511801; NOES 1983: HZD 46970; NIS 417; TNF 120527; NOS 243; TNE 2528300; TFE 762399 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264396); EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat, Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 27, 1978; NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NCI Carcinogenesis Bioassay (gavage), inadequate studies: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-3, 1977 (NCITR*); NTP Toxicity studies, RPT# TOX-45, October 2000; NTP Carcinogenesis studies, test completed (post peer review), October 2000; OSHA ANALYTICAL METHOD #14 Record 751 of 1119 in RTECS (through 2003/06) AN: KJ3325000 PN: Ethane, 1,1,1-trichloro-2,2-bis(p-chlorophenyl)- SY: 1,1,1-Trichloor-2,2-bis(4-chloor fenyl)-ethaan (Dutch); 1,1,1-Trichlor-2,2-bis(4-chlor-phenyl)-aethan (German); 1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane; 1,1,1-Trichloro-2,2-di(4-chlorophenyl)-ethane; 1,1,1-Tricloro-2,2-bis(4-cloro-fenil)-etano (Italian); 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane; 1,1-Bis-(p-chlorophenyl)-2,2,2-trichloroethane; 2,2-Bis(p-chlorophenyl)-1,1,1-trichloroethane; 4,4'-DDT-; 4,4'-Dichlorodiphenyltrichloroethane-; Aavero-extra-; Agritan-; Arkotine-; Azotox-; Azotox-M-33-; Benzene, 1,1'-(2,2,2-trichloroethylidene)bis(4-chloro-; Benzochloryl-; Bosan-Supra-; Bovidermol-; Chlorophenothan-; Chlorophenothane-; Chlorophenotoxum-; Citox-; Clofenotane-; DDT-; DDT- (ACGIH:OSHA); DDT-technical-; Deoval-; Detox-; Detoxan-; Dibovin-; Dichlorodiphenyltrichloroethane-; Dichlorodiphenyltrichloroethane- (ACGIH:OSHA); Dicophane-; Dodat-; Dykol-; ENT-1,506-; Estonate-; Gesafid-; Gesarol-; Hildit-; Ivoran-; Mutoxan-; NCI-C00464-; Neocid-; Neocidol- (solid); OMS-16-; PEB1-; Parachlorocidum-; Pentachlorin-; RCRA-waste-number-U061-; Santobane-; Tafidex-; Trichlorobis(4-chlorophenyl)ethane; Zerdane-; alpha,alpha-Bis(p-chlorophenyl)-beta,beta,beta-trichlorethane; p,p'-DDT-; p,p'-Dichlorodiphenyltrichloroethane- RN: Current: 50-29-3 BRN: 1882657 BHR: 4-05-00-01885 UD: 200305 MF: C14-H9-Cl5 MW: 354.48 WL: GXGGYR DG&R DG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: dna-esc 15 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dni-omi 50 ppm/24H Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 19, p. 568, 1981 (IJEBA6); oms-omi 50 ppm/24H Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 19, p. 568, 1981 (IJEBA6); dni-dmg-oth 250 ppb Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 41, p. 745, 1985 (EXPEAM); cyt-dmg-orl 1 ug Australian Journal of Biological Sciences. (Commonwealth Scientific and Industrial Research Organization, 314 Albert St., E. Melbourne, Vic. 3002, Australia) V.6- 1953- v. 27, p. 427, 1974 (AJBSAM); sln-dmg-orl 1 ug Australian Journal of Biological Sciences. (Commonwealth Scientific and Industrial Research Organization, 314 Albert St., E. Melbourne, Vic. 3002, Australia) V.6- 1953- v. 27, p. 427, 1974 (AJBSAM); dlt-dmg-orl 1 ug Australian Journal of Biological Sciences. (Commonwealth Scientific and Industrial Research Organization, 314 Albert St., E. Melbourne, Vic. 3002, Australia) V.6- 1953- v. 27, p. 427, 1974 (AJBSAM); oms-qal-emb 5 gm/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 30, p. 920, 1974 (EXPEAM); oms-ckn-emb 5 gm/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 30, p. 920, 1974 (EXPEAM); cyt-qal-emb 5 gm/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 30, p. 920, 1974 (EXPEAM); cyt-ckn-emb 5 gm/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 30, p. 920, 1974 (EXPEAM); dlt-oin-orl 200 ppm Entomologia Experimentalis et Applicata. (Kluwer Academic Pub. Group, Distribution Centre, POB 322, 3300 AH Dordrecht, Netherlands) V.1- 1958- v. 12, p. 221, 1969 (ETEAAT); dni-hmn-lym 500 mg/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 101, 1980 (ARTODN); oms-hmn-fbr 100 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(3), p. 32, 1973 (GTPZAB); cyt-hmn-leu 40 mg/L Hokkaidoritsu Eisei Kenkyushoho. Report of the Hokkaido Institute of Public Health. (Nishi- 12-chome, Kita-19-jo, Kita-ku, Sapporo 060, Japan) No.1- 1951- v. 29, p. 33, 1979 (HOEKAN); cyt-hmn-lym 200 ug/L/72H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 131, 1976 (MUREAV); mtr-rat-orl 4620 mg/kg/77D-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 11, p. 1413, 1990 (CRNGDP); dns-rat-lvr 100 pmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1547, 1984 (CRNGDP); dns-rat-orl 50 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1433, 1987 (CRNGDP); dni-rat-oth 100 mg/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 101, 1980 (ARTODN); cyt-rat-ipr 100 mg/kg Journal of Cell Biology. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10003) V.12- 1962- v. 47, p. 78a, 1970 (JCLBA3); cyt-rat-oth 10 ug/L "Insecticide Biochemistry and Physiology," Wilkinson, C.F., ed., New York, Plenum Pub. Corp., 1976 -,555,1976 (34LXAP); dlt-rat-orl 100 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 53, 1973 (FCTXAV); spm-rat-orl 1 gm/kg/2D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 14, p. 171, 1975 (BECTA6); mtr-mus-emb 42600 nmol/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 981, 1975 (JNCIAM); dna-mus-ast 15 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); oms-mus-orl 18 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); dni-mus-ipr 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); cyt-mus-ipr 50 ppm Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 16, p. 491, 1974 (CNJGA8); cyt-mus-unr 50 mg/kg Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.4- 1979- v. 6, p. 147, 1979 (PHTHDT); cyt-mus-orl 300 mg/kg Australian Journal of Biological Sciences. (Commonwealth Scientific and Industrial Research Organization, 314 Albert St., E. Melbourne, Vic. 3002, Australia) V.6- 1953- v. 27, p. 427, 1974 (AJBSAM); dlt-mus-orl 100 mg/kg Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.4- 1979- v. 6, p. 147, 1979 (PHTHDT); dlt-mus-unr 200 mg/kg/10W-I Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.4- 1979- v. 6, p. 147, 1979 (PHTHDT); oms-mam-fbr 50 mg/L Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 15, p. 581, 1986 (AECTCV) RE: T01-T02 orl-rat TDLo: 112 mg/kg (56D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 16, p. 1002, 1978 (IJEBA6); T24 orl-rat TDLo: 100 mg/kg (1D male) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 53, 1973 (FCTXAV); T81 orl-rat TDLo: 430 mg/kg (1-22D preg/21D post) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 12, p. 373, 1974 (BECTA6); T22 orl-rat TDLo: 1890 mg/kg (36W pre) Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 3, p. 479, 1975/1976 (AECTCV); T53 orl-rat TDLo: 250 mg/kg (15-19D preg) Biology of the Neonate. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.15- 1970- v. 26, p. 283, 1975 (BNEOBV); T29 orl-rat TDLo: 50 mg/kg (1D male) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 53, 1973 (FCTXAV); T13 ipr-rat TDLo: 60 mg/kg (3D pre) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 348, 1971 (TXAPA9); T76-T81 ipr-rat TDLo: 21 mg/kg (21D post) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 228, p. 1222, 1970 (NATUAS); T85 orl-mus TDLo: 504 mg/kg (21D post) Environmental Physiology and Biochemistry. (Copenhagen, Denmark) V.2-5, 1972-75. Discontinued. v. 4, p. 189, 1974 (ENPBBC); T29 orl-mus TDLo: 81 mg/kg (4W male/4W pre-2W post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 54, 1967 (TXAPA9); T14 orl-mus TDLo: 124 mg/kg (62D pre) Environmental Physiology and Biochemistry. (Copenhagen, Denmark) V.2-5, 1972-75. Discontinued. v. 3, p. 127, 1973 (ENPBBC); T24 orl-mus TDLo: 148 mg/kg (66D pre/1-8D preg) Environmental Physiology and Biochemistry. (Copenhagen, Denmark) V.2-5, 1972-75. Discontinued. v. 3, p. 127, 1973 (ENPBBC); T24 ipr-mus TDLo: 40 mg/kg (1-3D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 9, p. 267, 1973 (BECTA6); T14 ipr-mus TDLo: 40 mg/kg (1D pre) Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 148, 1972 (AMBOCX); T31 scu-mus TDLo: 418 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**); T91 scu-mus TDLo: 143 mg/kg (21D post) Environmental Physiology and Biochemistry. (Copenhagen, Denmark) V.2-5, 1972-75. Discontinued. v. 5, p. 54, 1975 (ENPBBC); T12-T13-T14 scu-mus TDLo: 40 mg/kg (3D pre) Indian Journal of Medical Research. (Indian Council of Medical Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913- v. 65, p. 576, 1977 (IJMRAQ); T53-T91 unr-mus TDLo: 3 mg/kg (10-17D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 22, p. 327, 1972 (TXAPA9); T85 unr-mus TDLo: 17500 ug/kg (8-14D preg) Psychopharmacologia (Berlin). (Berlin, Ger.) V.1-46, 1959-76. For publisher information, see PSCHDL. v. 12, p. 424, 1968 (PSYPAG); T16-T91 orl-dog TDLo: 3540 mg/kg (multigenerations) Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 6, p. 83, 1977 (AECTCV); T16-T25-T34 orl-rbt TDLo: 150 mg/kg (7-9D preg) Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 192, p. 286, 1971 (AIPTAK); T12-T22 orl-rat TDLo: 420 mg/kg (34D pre/1-22D preg) Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 3, p. 479, 1976 (AECTCV) TE: V01-L60 orl-rat TDLo: 1225 mg/kg/7W-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 61, p. 113, 1975 (TUMOAB); V02-T65-L60 orl-mus TDLo: 24 mg/kg (multigenerations) Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 983, 1973 (JNCIAM); V01-J60-P62 orl-mus TDLo: 73 mg/kg/26W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 7, p. 215, 1969 (FCTXAV); V02-J60-P62 scu-mus TDLo: 370 mg/kg/80W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 725, 1977 (IJCNAW); V03-N62-T64 orl-ham TDLo: 21280 mg/kg/38W-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 134, p. 113, 1970 (PSEBAA); V02-L60 orl-rat TD :12096 mg/kg/3Y-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 68, p. 11, 1982 (TUMOAB); V02-J60-L60 orl-mus TD :7560 mg/kg/90W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 433, 1973 (FCTXAV); V02-J60-P62 orl-mus TD :5600 mg/kg/80W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 725, 1977 (IJCNAW); V03-L60-M03 orl-rat TD :8100 mg/kg/2Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 11, p. 88, 1967 (TXAPA9); V03-L60 orl-mus TD :3150 mg/kg/15W-C Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 82, p. 25, 1974 (ZKKOBW); V02-T65-J60 orl-mus TD :3408 mg/kg (multigenerations) International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 11, p. 688, 1973 (IJCNAW); V02-L60-P62 orl-rat TD :19 gm/kg/2Y-C International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 179, 1977 (IJCNAW); V02-L60-P62 orl-rat TD :438 mg/kg/2Y-C Revista Espanola de Oncologia. (Instituto Nacional de Oncologia, Ciudad Universitaria, Madrid 3, Spain) V.1- 1952- v. 26, p. 177, 1979 (REONBL); V02-L60 orl-rat TD :17976 mg/kg/2Y-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 68, p. 11, 1982 (TUMOAB); V02-L60 orl-rat TD :24192 mg/kg/3Y-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 68, p. 11, 1982 (TUMOAB); V01-L60 orl-rat TDLo: 29.2 gm/kg/2Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*); V01-L60 orl-rat TDLo: 31.76 gm/kg/4Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*); V01-L60 orl-rat TDLo: 26.5 gm/kg/151W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*); V01-L60 orl-rat TDLo: 20.99 gm/kg/120W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*); V01-L60 orl-mus TDLo: 8760 mg/kg/2Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*); V01-L60 orl-mus TDLo: 4380 mg/kg/2Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*) ORNG: 87000000 ng/kg. [87.000000 mg/kg] T/E unlistd SRNG: 300000000 ng/kg. [300.000000 mg/kg] F11-F18-F19 SKNG: 1931000000 ng/kg. [1931.000000 mg/kg] T/E unlistd AT: J15 orl-inf LDLo: 150 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 845, 1945 (BMJOAE); F27-K13-R20 orl-man TDLo: 6 mg/kg "Clinical Memoranda on Economic Poisons," U.S. Dept. HEW, Public Health Service, Communicable Disease Center, Atlanta, GA, 1956 v. -, p. 1, 1956 (CMEP**); F12-G04-J30 orl-hmn LDLo: 500 mg/kg "Merck Index: an Encyclopedia of Chemicals, Drugs, and Biologicals", 11th ed., Rahway, NJ 07065, Merck and Co., Inc. 1989 11,446,1989 (85KYAH); F01-F29 orl-hmn TDLo: 5 mg/kg Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 2, p. 268, 1947 (PHARAT); T/E unlistd unr-man LDLo: 221 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 87 mg/kg Down to Earth. (Dow Chemical USA, Agricultural Products Dept., Midland, MI 48640) V.1- 1945- v. 35, p. 25, 1979 (DOEAAH); T/E unlistd skn-rat LD50: 1931 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 14, 1978 (SPEADM); T/E unlistd ipr-rat LD50: 9100 ug/kg Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. v. 17, p. 351, 1976 (PESTD5); F11-F18-F19 scu-rat LD50: 1500 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 865, 1945 (BMJOAE); T/E unlistd unr-rat LD50: 300 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(10), p. 27, 1972 (GISAAA); T/E unlistd orl-mus LD50: 135 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 12, p. 368, 1953 (FEPRA7); T/E unlistd ipr-mus LD50: 32 mg/kg Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. v. 17, p. 351, 1976 (PESTD5); T/E unlistd orl-dog LD50: 150 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 32, p. 463, 1981 (YKYUA6); F07-F11-F12 ivn-dog LDLo: 75 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 86, p. 213, 1946 (JPETAB); T/E unlistd orl-mky LD50: 200 mg/kg Advances in Pharmacology and Chemotherapy. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.7-20, 1969-84. v. 12, p. 31, 1975 (AVPCAQ); F07-F11-F12 ivn-mky LDLo: 50 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 86, p. 213, 1946 (JPETAB); F11-F12-F13 orl-cat LDLo: 250 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 86, p. 213, 1946 (JPETAB); F11-F12-F13 ivn-cat LDLo: 40 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 86, p. 213, 1946 (JPETAB); T/E unlistd orl-rbt LD50: 250 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 347, 1966 (PCOC**); F11-F18-F19 skn-rbt LD50: 300 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 865, 1945 (BMJOAE); F11-F18-F19 scu-rbt LD50: 250 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 865, 1945 (BMJOAE); F11-F12-F13 ivn-rbt LDLo: 50 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 86, p. 213, 1946 (JPETAB); T/E unlistd orl-gpg LD50: 150 mg/kg European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 7, p. 159, 1974 (EJTXAZ); F11-F18-F19 skn-gpg LD50: 1 gm/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 865, 1945 (BMJOAE); F11-F18-F19 scu-gpg LD50: 900 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 865, 1945 (BMJOAE); T/E unlistd orl-ham LD50: >5 gm/kg Laboratory Animal Science. (American Assoc. for Laboratory Animal Science, 210 N. Hammes Ave., Suite 205, Joliet, IL 60435) V.21- 1971- v. 26, p. 274, 1976 (LBASAE); T/E unlistd orl-ckn LDLo: 300 mg/kg Medizinische Monatsschrift. (Stuttgart, Fed. Rep. Ger.) V.1-31, 1947-77. v. 4, p. 25, 1950 (MEMOAQ); T/E unlistd orl-frg LD50: 7600 ug/kg Environmental Pollution. (Barking, UK) V.1-20, 1970-79. v. 20, p. 45, 1979 (ENVPAF); T/E unlistd par-frg LD50: 24100 ug/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 74, p. 343, 1947 (AIPTAK); T/E unlistd orl-dom LDLo: 300 mg/kg Medizinische Monatsschrift. (Stuttgart, Fed. Rep. Ger.) V.1-31, 1947-77. v. 4, p. 25, 1950 (MEMOAQ); T/E unlistd unr-mam LD50: 200 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(3), p. 32, 1973 (GTPZAB); U01 orl-rat TDLo: 100 mg/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 81, 2000 (TOSCF2); Y07 orl-rat TDLo: 0.1 mg/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 81, 2000 (TOSCF2); T01 orl-rat TDLo: 100 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 491, 1992 (REPTED); L14 orl-mus TDLo: 0.5 mg/kg Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 2, p. 307, 1996 (ETOPFR); N17-Z74 ipr-rat TDLo: 5 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 358, 1969 (TXAPA9); N17-N70-Y44 scu-rat TDLo: 160 mg/kg/18H Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 18, p. 1108, 1970 (JAFCAU); F11-F12 orl-rat TDLo: 180 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1316, 2001 (HBPTO*); N24 orl-rat TDLo: 100 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1317, 2001 (HBPTO*); U25 orl-rat TDLo: 600 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1318, 2001 (HBPTO*); Z74 ipr-rat TDLo: 5 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1320, 2001 (HBPTO*); F42 orl-rat TDLo: 12.5 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1321, 2001 (HBPTO*); F12 orl-hmn TDLo: 16 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1322, 2001 (HBPTO*); D50 orl-hmn TDLo: 3.57 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1323, 2001 (HBPTO*); C04-F19 orl-hmn TDLo: 10.71 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1323, 2001 (HBPTO*); F11-F27-K13 orl-hmn TDLo: 21.43 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1323, 2001 (HBPTO*); F11-F19-L12 orl-man TDLo: 71.43 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1329, 2001 (HBPTO*); G09-F27-K13 orl-man TDLo: 4.29 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1329, 2001 (HBPTO*); N30-Y21 orl-rat TDLo: 60 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 8, p. 15, 1987 (NRTXDN); N17 scu-rat TDLo: 95 mg/kg Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 18, p. 1108, 1970 (JAFCAU); F22-J25-K13 orl-mus LD50: 200 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 67, 1984 (VCVGK*); F22-J25-K13 orl-rat LD50: 350 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 67, 1984 (VCVGK*); F22-J25-K13 orl-rbt LD50: 400 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 67, 1984 (VCVGK*); F22-J25-K13 orl-dog LD50: 1000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 67, 1984 (VCVGK*); F22-J25-K13 ihl-mam LCLo: 200 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 67, 1984 (VCVGK*); T/E unlistd unr-hmn LDLo: 70 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 68, 1984 (VCVGK*) MD: S02-Y17 orl-rat TDLo: 336 mg/kg/8W-C Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 35, p. 1132, 1997 (IJEBA6); L70 orl-rat TDLo: 91250 ug/kg/2Y-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 3, p. 402, 1955 (JAFCAU); L70-P28-Y15 orl-rat TDLo: 754 mg/kg/52D-I Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 10, p. 459, 1981 (AECTCV); M16-N30-N72 orl-rat TDLo: 91 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 42, 1968 (GISAAA); L70-N72-U01 orl-rat TDLo: 4300 mg/kg/14W-I Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 28, p. 149, 1970 (APTOA6); N73-P28-S02 orl-rat TDLo: 462 mg/kg/22W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 39, p. 827, 1987 (BECTA6); F11-Z01 orl-rat TDLo: 6510 mg/kg/14D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 171, 1970 (TXAPA9); J30-L30-L70 itr-rat TDLo: 150 mg/kg/3D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 34, p. 63, 1985 (BECTA6); L70-N73-S04 orl-mus TDLo: 504 mg/kg/12W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 37, p. 433, 1986 (BECTA6); S04 orl-mus TDLo: 53088 ug/kg/24W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 48, p. 535, 1992 (BECTA6); Y04-Y15-Z01 orl-mky TDLo: 11200 mg/kg/32W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 626, 1969 (TXAPA9); Y07 orl-mky TDLo: 91 mg/kg/26W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 98, 1972 (TXAPA9); F12-U30-Z01 orl-mky TDLo: 17500 mg/kg/10W-C Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 141, p. 111, 1963 (AIPTAK); A30-Y37 orl-mky TDLo: 1 gm/kg/14W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 34, p. 47, 1986 (TOLED5); F11-L02-Z01 orl-rbt TDLo: 1 gm/kg/20D-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 865, 1945 (BMJOAE); J70-L70-N73 scu-rbt TDLo: 20 mg/kg/20D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 9, p. 283, 1989 (JEPOEC); A30-Y01 orl-gpg TDLo: 1867 mg/kg/42D-I Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 7, p. 37, 1974 (BCTKAG); L70-N30-N75 orl-pgn TDLo: 1517 mg/kg/42D-I Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 166, p. 1278, 1969 (SCIEAS); L30-U02 orl-qal TDLo: 12200 mg/kg/61D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 9, p. 179, 1973 (BECTA6); L70-N05-N75 orl-qal TDLo: 60714 mg/kg/17W-C Poultry Science. (Poultry Science Assoc., Inc., 309 W. Clark St., Champaign, IL 61820) V.1- 1921- v. 53, p. 125, 1974 (POSCAL); L70-N30-N75 orl-qal TDLo: 12600 mg/kg/18W-C Poultry Science. (Poultry Science Assoc., Inc., 309 W. Clark St., Champaign, IL 61820) V.1- 1921- v. 53, p. 125, 1974 (POSCAL); L30-Y09 scu-mus TDLo: 300 mg/kg/3D-I Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 62, p. 161, 2001 (BCPCA6); L30 orl-rat TDLo: 38.64 mg/kg/161D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 59, 2001 (HBPTO*); Z74 ipr-rat TDLo: 150 mg/kg/3D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 358, 1969 (TXAPA9); S04 orl-ckn TDLo: 612.5 mg/kg/35D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 770, 2001 (HBPTO*); S02-S04 orl-rat TDLo: 420 mg/kg/35D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 770, 2001 (HBPTO*); L30 orl-mus TDLo: 25.19 gm/kg/78W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*); P30-Y01 orl-ham TDLo: 65.7 gm/kg/78W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*); N30-U01-Y16 ipr-rat TDLo: 600 mg/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 111, p. 99, 1991 (TXAPA9); P27-S04 orl-rbt TDLo: 10.5 mg/kg/57D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 587, 1975 (TXAPA9); N73 orl-rbt TDLo: 52.4 mg/kg/57D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 587, 1975 (TXAPA9); Z01-A30-L14 orl-rbt TDLo: 0.75 gm/kg/15D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 99, p. 140, 1950 (JPETAB); L30 orl-mus TDLo: 8760 mg/kg/2Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1310, 2001 (HBPTO*); L50 orl-rat TDLo: 547.5 mg/kg/2Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1311, 2001 (HBPTO*); N24 orl-rat TDLo: 225 mg/kg/45D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1317, 2001 (HBPTO*); F19 orl-rat TDLo: 105 mg/kg/21D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1321, 2001 (HBPTO*); T01 orl-brd TDLo: 630 gm/kg/12D-C The Auk. Bulletin of the Nuttall Ornithological Club. (Washington, D.C. American Ornithologists' Union, etc.) v. 79, p. 104, 1962 (THAUC*); Z01 orl-brd TDLo: 140 gm/kg/8D-C The Auk. Bulletin of the Nuttall Ornithological Club. (Washington, D.C. American Ornithologists' Union, etc.) v. 79, p. 104, 1962 (THAUC*); L50 orl-rat TDLo: 3650 mg/kg/26W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 68, 1994 (VCVGK*); Z01 ihl-rat TCLo: 300 mg/m3/4H/2W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 69, 1994 (VCVGK*); Z01 ihl-rat TCLo: 15 mg/m3/90W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 69, 1994 (VCVGK*); Z01 ihl-gpg TCLo: 1000 mg/m3/3D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 69, 1994 (VCVGK*); Z01 ihl-rbt TCLo: 1000 mg/m3/4H/14D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 69, 1994 (VCVGK*); Z01 ihl-dog TCLo: 300 mg/m3/2W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 69, 1994 (VCVGK*); N17 ipr-ckn TDLo: 187.5 mg/kg/3D-I Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 162, p. 371, 1968 (SCIEAS); N17 ipr-qal TDLo: 1875 mg/kg/3D-I Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 162, p. 371, 1968 (SCIEAS); N16-N17-Y07 ipr-rat TDLo: 500 mg/kg/10D-I Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 14, p. 727, 1976 (CLPTAT); L30-Y37 ims-rat TDLo: 630 mg/kg/12W-C Lipids. (American Oil Chemists' Soc., POB 5037, Stn. A., Champaign, IL 61820) V.1- 1966- v. 7, p. 182, 1972 (LPDSAP) TR: ACGIH TLV-TWA 1 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 5, p. 83, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 179, 1991 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 5, p. 83, 1974 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 179, 1991 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 179, 1991 (IMEMDT); TOXICOLOGY REVIEW Journal of Scientific and Industrial Research. (Pub. and Information Directorate, CSIR, Hillside Rd., New Delhi 110012, India) V.1-4, 1942-45: V.22- 1963- v. 34, p. 462, 1975 (JSIRAC); TOXICOLOGY REVIEW Annals of Applied Biology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1914- v. 35, p. 505, 1948 (AABIAV); TOXICOLOGY REVIEW Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 29, p. 1, 1972 (ATXKA8); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 1, p. 160, 1950 (ADCSAJ); TOXICOLOGY REVIEW Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 7, p. 243, 1974 (ENVRAL); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 48, p. 141, 1973 (RREVAH); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 59, p. 119, 1975 (RREVAH); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 1, p. 160, 1950 (ADCSAJ); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 61, p. 37, 1975 (RREVAH); TOXICOLOGY REVIEW Nova Acta Leopoldina. (Johann Ambrosius Barth Verlag, Postfach 109, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1932- v. 41, p. 271, 1975 (NOALA4); TOXICOLOGY REVIEW Meditsinskii Zhurnal Uzbekistana. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1957- v. (8), p. 90, 1973 (MZUZA8); TOXICOLOGY REVIEW Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- v. 10(3), p. 43, 1975 (CNDQA8); TOXICOLOGY REVIEW Economie et Medecine Animales. (Paris, France) V.1-17, 1960-76. Discontinued. v. 14, p. 141, 1973 (ECMAAI); TOXICOLOGY REVIEW Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970. v. 80, p. 485, 1973 (DTTIAF); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 56, p. 107, 1975 (RREVAH); TOXICOLOGY REVIEW American Journal of Digestive Diseases. (New York, NY) V.5-22, 1938-55: New series: V.1-23, 1956-78. For publisher information, see DDSCDJ. v. 20, p. 331, 1953 (AJDDAL); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ); TOXICOLOGY REVIEW Essays in Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 7, p. 1, 1976 (ETOXAC); TOXICOLOGY REVIEW Internationales Archiv fuer Gewerbepathologie und Gewerbehygiene. (Heidelberg, Fed. Rep. Ger.) V.19-25, 1962-69. For publisher information, see IAEHDW. v. 24, p. 193, 1968 (IRGGAJ); TOXICOLOGY REVIEW BioScience. (American Institute of Biological Sciences, 1401 Wilson Blvd., Arlington, VA 22209) V.14- 1964- v. 20, p. 958, 1970 (BISNAS); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,250,1970 (85CVA2); TOXICOLOGY REVIEW Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.4- 1979- v. 7, p. 513, 1979 (PHTHDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 13, p. 231, 1978 (CTOXAO); TOXICOLOGY REVIEW Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 1, p. 89, 1977 (EESADV); TOXICOLOGY REVIEW Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 1, p. 503, 1978 (EESADV); TOXICOLOGY REVIEW Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 42(9), p. 66, 1977 (GISAAA); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-922903 (NTIS**); TOXICOLOGY REVIEW Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- v. 54, p. 413, 1978 (BNYMAM) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA (1 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 67, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 1 mg/m3, JAN 1993; OEL-AUSTRALIA: TWA 1 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 1 mg/m3, Skin, JAN 1999; OEL-BELGIUM: TWA 1 mg/m3, JAN 1993; OEL-DENMARK: TWA 1 mg/m3, JAN 1999; OEL-FINLAND: TWA 1 mg/m3, STEL 3 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 1 mg/m3, C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 1 mg/m3 (total dust), Skin, JAN 1999; OEL-HUNGARY: STEL 0.1 mg/m3, Skin, Carcinogen, JAN 1993; OEL-INDIA: TWA 1 mg/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 1 mg/m3, JAN 1999; OEL-NORWAY: TWA 1 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 1 mg/m3, Skin, JAN 1993; OEL-POLAND: MAC(TWA) 0.1 mg/m3, STEL 0.8 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.1 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 1 mg/m3, Skin, JAN 1999; OEL-THAILAND: TWA 1 mg/m3, JAN 1993; OEL-TURKEY: TWA 1 mg/m3, Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 1 mg/m3, STEL 3 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DDT-air: 10H CA TWA 0.5 mg/m3 (0.1 mg/m3 LOQ) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 73750; NIS 1; TNF 160; NOS 2; TNE 160 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/100137/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, In vitro cytogenetics-nonhuman; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-partial sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Negative: Host-mediated assay, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: D melanogaster Sex-linked lethal, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-nondisjunction, Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), no evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-131, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 752 of 1119 in RTECS (through 2003/06) AN: KJ3975000 PN: Ethane,-1,1,1-trichloro-2,2,2-trifluoro- SY: CFC-113a-; Freon-FT-; F-113a-; FC-113a-; 1,1,1-Trichlorotrifluoroethane-; 1,1,1-Trifluorotrichloroethane-; T-WD602- RN: Current: 354-58-5 BRN: 1699455 BHR: 4-01-00-00142 UD: 200012 MF: C2-Cl3-F3 MW: 187.37 WL: GXGGXFFF CC: Tumorigen (C) AT: F11-F12-J25 ihl-rat LC50: 13 pph/15M Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- v. 1, p. 239, 1982 (HUTODJ); T/E unlistd ipr-mus LD50: 8600 mg/kg European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 7, p. 247, 1974 (EJTXAZ) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-45, October 2000 Record 753 of 1119 in RTECS (through 2003/06) AN: KJ6500000 PN: Ethanol, 2-(4-amino-2-nitroanilino)- SY: 2-(4-Amino-2-nitroanilino)ethanol; 2-((4-Amino-2-nitrophenyl)amino)ethanol; Ethanol, 2-((4-amino-2-nitrophenyl)amino)-; HC Red No. 3; 4-(2-Hydroxyethyl)amino-3-nitroaniline; N(sup 1)-(2-Hydroxyethyl)-2-nitro-p-phenylenediamine; NCI-C54922- RN: Current: 2871-01-4 BRN: 2110120 UD: 200210 MF: C8-H11-N3-O3 MW: 197.22 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 100 ug/plate (+S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-281, 1986 (NTPTR*) TE: V03-L60 orl-mus TDLo: 130 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-281, 1986 (NTPTR*); V02-R60 orl-rat TDLo: 131250 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-188075/AS (NTIS**); V03-L60 orl-mus TDLo: 130000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-188075/AS (NTIS**) AT: T/E unlistd orl-rat LD50: >1 gm/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 11, p. 509, 1992 (JACTDZ); T/E unlistd orl-mus LD50: >500 mg/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 11, p. 509, 1992 (JACTDZ) MD: M03-N30 orl-rat TDLo: 65 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-281, 1986 (NTPTR*) TR: IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 153, 1993 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 153, 1993 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 153, 1993 (IMEMDT) ND: NOES 1983: HZD X2688; NIS 1; TNF 4235; NOS 1; TNE 42485; TFE 32059 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse; NCI Carcinogenesis Studies (gavage), no evidence: rat Record 754 of 1119 in RTECS (through 2003/06) AN: KJ8575000 PN: Ethanol,-2-butoxy- SY: 2-Butossi-etanolo- (Italian); 2-Butoxy-1-ethanol-; 2-Butoxy-aethanol- (German); 2-Butoxyethanol-; 2-Butoxyethanol- (ACGIH:OSHA); 3-Oxa-1-heptanol-; BUCS-; Butoksyetylowy-alkohol- (Polish); Butoxyethanol-; Butyl-cellosolve-; Butyl-cellosolve- (OSHA); Butyl-oxitol-; Butylcelosolv- (Czech); Butylglycol- (French,German); Dowanol-EB-; Ektasolve-EB-; Ethylene-glycol-monobutyl-ether-; Ethylene-glycol-n-butyl-ether-; Ethylene-glycol,-monobutyl-ether-; Gafcol-EB-; Glycol-butyl-ether-; Glycol-ether-EB-; Glycol-monobutyl-ether-; Jeffersol-EB-; Monobutyl-ether-of-ethylene-glycol-; Monobutyl-glycol-ether-; O-Butyl-ethylene-glycol-; Poly-Solv-EB-; n-Butoxyethanol- RN: Current: 111-76-2 BRN: 1732511 BHR: 4-01-00-02380 UD: 200305 MF: C6-H14-O2 MW: 118.20 WL: Q2O4 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) (UCDS**); eye-rbt 100 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,629,1986 (85JCAE) ME: mmo-sat 19 umol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 281, 1995 (MUREAV) RE: T01 orl-rat TDLo: 6279 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3349 (NTPTR*); T13-T25-T26 ihl-rat TCLo: 200 ppm/6H (6-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 47, 1984 (EVHPAZ); T46 ihl-rat TCLo: 25 ppm/6H (6-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 47, 1984 (EVHPAZ); T25 ihl-rat TCLo: 12 mg/kg/4H (1-19D preg) Fiziologicheski Aktivnye Veshchestva. Physiologically Active Substances. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1966- v. 21, p. 30, 1989 (FAVUAI); T19-T25-T46 ihl-rat TCLo: 200 ppm/6H (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571237 (NTIS**); T25 orl-mus TDLo: 9440 mg/kg (7-14D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); T25 orl-mus TDLo: 7 gm/kg (8-14D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 55, 1987 (TCMUD8); T26 orl-mus TDLo: 9440 mg/kg (6-13D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 29, 1987 (TCMUD8); T13-T24 ihl-rbt TCLo: 200 ppm/6H (6-18D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 47, 1984 (EVHPAZ); T47 ihl-rbt TCLo: 100 ppm/6H (6-18D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 47, 1984 (EVHPAZ); T72 orl-mus TDLo: 9440 mg/kg (7-14D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); T24-T25-T46 ihl-rat TCLo: 483 mg/m3 (6H/6-15D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); T24-T25-T46 ihl-rbt TCLo: 483 mg/m3 (6H/6-15D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); T81 orl-mus TDLo: 25.2 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); T72 orl-mus TDLo: 47.25 gm/kg (7D male/7D pre/21D preg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); T51-T53-T81 orl-mus TDLo: 0.72 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); T51 orl-mus TDLo: 0.72 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); T26-T81 orl-mus TDLo: 198.45 gm/kg (21W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); T35 orl-rat TDLo: 600 mg/kg (9-11D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89-165849 (NTIS**) TE: V03-N60 ihl-rat TCLo: 125 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-484, 2000 (NTPTR*); V01-L60 ihl-mus TCLo: 250 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-484, 2000 (NTPTR*); V03-N61 ihl-rat TCLo: 3250 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB#2000-105865 (NTIS**); V01-L60 ihl-mus TCLo: 15600 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB#2000-105865 (NTIS**); V03-K60 ihl-mus TCLo: 15600 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB#2000-105865 (NTIS**) ORNG: 470000000 ng/kg. [470.000000 mg/kg] T/E unlistd SRNG: 220000000 ng/kg. [220.000000 mg/kg] T/E unlistd IHPB: 450000 ppb/4H. [450.000000 ppm/4H] F19-U01 AT: F24-J22-U20 orl-wmn TDLo: 600 mg/kg Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- v. 7, p. 187, 1988 (HUTODJ); F24-H02-U20 orl-wmn TDLo: 7813 uL/kg Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- v. 8, p. 243, 1989 (HUTODJ); K13 ihl-hmn TCLo: 195 ppm/8H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); D07-D35-J30 ihl-hmn TCLo: 100 ppm Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 50, 1974 (NPIRI*); T/E unlistd orl-rat LD50: 470 mg/kg Dow Chemical Company Reports. (Dow Chemical USA, Health and Environment Research, Toxicology Research Lab., Midland, MI 48640) MSD-46 (DOWCC*); F19-U01 ihl-rat LC50: 450 ppm/4H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 68, p. 405, 1983 (TXAPA9); T/E unlistd ipr-rat LD50: 220 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,67,1982 (85GMAT); T/E unlistd ivn-rat LD50: 307 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); F07-F13-J30 unr-rat LD50: 917 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(11), p. 7, 1976 (GISAAA); F05-F07-R21 orl-mus LD50: 1230 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); F29-J22-M14 ihl-mus LC50: 700 ppm/7H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 157, 1943 (JIHTAB); T/E unlistd ipr-mus LD50: 536 mg/kg Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 2, 1961 (SCCUR*); T/E unlistd scu-mus LDLo: 500 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 42, p. 355, 1931 (JPETAB); T/E unlistd ivn-mus LD50: 1130 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); F07-F13-J30 unr-mus LD50: 1050 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(11), p. 7, 1976 (GISAAA); T/E unlistd orl-rbt LD50: 300 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 32, p. 1241, 1981 (YKYUA6); T/E unlistd skn-rbt LD50: 220 mg/kg Dow Chemical Company Reports. (Dow Chemical USA, Health and Environment Research, Toxicology Research Lab., Midland, MI 48640) MSD-46 (DOWCC*); T/E unlistd ipr-rbt LD50: 220 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,67,1982 (85GMAT); T/E unlistd ivn-rbt LD50: 252 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); F01-K30-M30 orl-gpg LD50: 1200 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); T/E unlistd ihl-gpg LC :>633 ppm/1H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572613 (NTIS**); T/E unlistd skn-gpg LD50: 230 uL/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 7, p. 559, 1965 (TXAPA9); T/E unlistd unr-mam LD50: 1500 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(5), p. 61, 1986 (GISAAA); L30-M30-P23 orl-mus LD50: 1167 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); L30-M30-P23 orl-rat LD50: 917 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); L30-M30-P23 orl-rbt LD50: 320 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); N04 ipr-mam TDLo: 100 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); L30-M30-P23 ihl-mus LC50: 3380 mg/m3/7H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); L30-M30-P23 ihl-rat LC50: 2900 mg/m3/7H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); L30-M30-P23 ihl-rat LCLo: 1800 mg/m3/7H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); T/E unlistd orl-hmn LDLo: 143 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); D25-L30-M30 ihl-hmn TCLo: 1500 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1984 (VCVGK*); P23-L30-M30 skn-rbt TDLo: 0.56 ml/kg/1H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1984 (VCVGK*) MD: L70-M70-U01 orl-rat TDLo: 139 gm/kg/90D-C AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); F16-U01 orl-rat TDLo: 9324 mg/m3/21D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 16, p. 830, 1991 (FAATDF); P71 ihl-rat TCLo: 1540 mg/m3/7H/5W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 374, 1943 (JIHTAB); M14-P30-Z01 ihl-rat TCLo: 432 ppm/7H/30D-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); L70-P08-P71 ihl-rat TCLo: 245 ppm/6H/9D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 68, p. 405, 1983 (TXAPA9); P08-P30-P71 orl-rat TDLo: 1500 mg/kg/12D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 112, p. 198, 1992 (TXAPA9); N22-P71-Y15 ihl-rat TCLo: 10 mg/m3/24H/13W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(11), p. 7, 1976 (GISAAA); L70-P71-Y03 orl-rat TDLo: 13290 mg/kg/6W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 349, 1986 (FAATDF); N74 orl-mus TDLo: 5180 mg/kg/2W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3349 (NTPTR*); L70-M14-P30 ihl-mus TCLo: 396 ppm/7H/30D-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); N73-P27-S05 skn-mus TDLo: 6 gm/kg/4D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 42, p. 209, 1998 (TOXID9); L70-M14-P30 ihl-mus TCLo: 401 ppm/7H/90D-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); P06-M16 ihl-dog TCLo: 415 ppm/7H/12W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 409, 1943 (JIHTAB); P30-P71-Z01 ihl-dog TCLo: 385 ppm/7H/28D-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); L70-P08-P71 skn-rbt TDLo: 4500 uL/kg/9D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516797 (NTIS**); J16-M70-U01 ihl-gpg TCLo: 376 ppm/7H/30D-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); Z01 orl-mus TDLo: 9440 mg/kg/8D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); N74-P26-Z71 orl-rat TDLo: 14000 mg/kg/4W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1994 (VCVGK*); P28-P71 orl-rat TDLo: 2170 mg/kg/4W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 166, 1994 (VCVGK*); L30-M30-Z01 skn-rbt TDLo: 6.3 mL/kg/2W-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); Z01 ihl-gpg TCLo: 2500 mg/m3/8H/12D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); A03-M02-Z01 ihl-rat TCLo: 900 mg/m3/4H/25D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); Z01 skn-rat TDLo: 17.5 mL/kg/10D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); A30-L30-M30 orl-rat TDLo: 46.5 mg/kg/60D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); M16-P28 ihl-dog TCLo: 2000 mg/m3/7H/12W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); P05-P28 ihl-mky TCLo: 500 mg/m3/7H/12W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); P23 ihl-rat TCLo: 421 mg/m3/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); L30-M30 ihl-rat TCLo: 516 mg/m3/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); N22-P05-U01 ihl-rat TCLo: 10 mg/m3/90D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 167, 1994 (VCVGK*); N73-P27 skn-mus TDLo: 6000 mg/kg/4D-C International Journal of Toxicology (Continous: Journal of the American College of Toxicology,Taylor and Francis Health Sciences) V.16- 1997- v. 20, p. 383, 2001 (IJOTO*); S02 skn-mus TDLo: 2000 mg/kg/4D-C International Journal of Toxicology (Continous: Journal of the American College of Toxicology,Taylor and Francis Health Sciences) V.16- 1997- v. 20, p. 383, 2001 (IJOTO*); Z01 orl-mus TDLo: 198.45 gm/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); U01 orl-mus TDLo: 37.8 gm/kg/4W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); F16 orl-mus TDLo: 20.16 gm/kg/4W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); L70-M71-U01 orl-mus TDLo: 198.45 gm/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); M71-T02-U01 orl-mus TDLo: 198.45 gm/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85226827 (NTIS**); U01-M71-N73 orl-rat TDLo: 300 mg/kg/3D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89-165849 (NTIS**); P05-P23 orl-rat TDLo: 300 mg/kg/3D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89-165849 (NTIS**) TR: ACGIH TLV-TWA 20 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 50 ppm (240 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 29, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 50 ppm (240 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 50 ppm (240 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 50 ppm (240 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 50 ppm (240 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 25 ppm (120 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 20 ppm (100 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 25 ppm (121 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 25 ppm (120 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 25 ppm (120 mg/m3), STEL 75 ppm (350 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 25 ppm (120 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 20 ppm (100 mg/m3), Skin, JAN 1999; OEL-HUNGARY: TWA 100 mg/m3, STEL 200 mg/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 20 ppm (100 mg/m3), STEL 40 ppm, Skin, JAN 1999; OEL-NORWAY: TWA 20 ppm (100 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 50 ppm (240 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 360 mg/m3, JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWEDEN: NGV 10 ppm (50 mg/m3), KTV 20 ppm (100 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 20 ppm (100 mg/m3), KZG-W 40 ppm (200 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 50 ppm (240 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 25 ppm (123 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ETHYLENE GLYCOL MONOBUTYL ETHER-air: 10H TWA 5 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 29930; NIS 398; TNF 141929; NOS 199; TNE 1547951; NOES 1983: HZD 29930; NIS 402; TNF 130413; NOS 239; TNE 2139297; TFE 585932 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/102527/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Alcohols IV, 1403; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NTP Carcinogenisis Studies (inhalation): some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-484, 2000 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: mouse, rat; NTP Toxicity studies, RPT# TOX-26, October 2000; OSHA ANALYTICAL METHOD #83 Record 755 of 1119 in RTECS (through 2003/06) AN: KK0875000 PN: Ethanol,-2-chloro- SY: 2-Chloorethanol- (Dutch); 2-Chloraethanol- (German); 2-Chlorethanol- (German); 2-Chloroethanol-; 2-Chloroethanol- (OSHA); 2-Chloroethyl-alcohol-; 2-Cloroetanolo- (Italian); 2-Monochloroethanol-; Aethylenechlorhydrin- (German); Chloroethanol-; Chloroethylowy-alkohol- (Polish); Ethyleen-chloorhydrine- (Dutch); Ethylene-chlorhydrin-; Ethylene-chlorohydrin-; Ethylene-chlorohydrin- (ACGIH:OSHA); Ethylene-glycol,-chlorohydrin-; Glicol-monocloridrina- (Italian); Glycol-chlorohydrin-; Glycol-monochlorohydrin-; Glycolmonochloorhydrine- (Dutch); Glycomonochlorhydrin-; Monochlorhydrine-du-glycol- (French); NCI-C50135-; beta-Chloroethyl-alcohol-; delta-Chloroethanol- RN: Current: 107-07-3 BRN: 878139 BHR: 4-01-00-01372 UD: 200305 MF: C2-H5-Cl-O MW: 80.52 WL: Q2G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 200 mg/2H MLD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 382, 1970 (TXAPA9); eye-rbt 2 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 33 mg MOD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 382, 1970 (TXAPA9); eye-rbt 9 mg/6H MOD Bulletin of Parenteral Drug Association. (Philadelphia, PA) V.1-31, 1946-77. v. 31, p. 25, 1977 (BUYRAI) ME: mmo-sat 20 umol/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 367, 1974 (MUREAV); mmo-sat 3333 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); oms-esc 2914 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19, p. 98, 1992 (EMMUEG); dnr-esc 10 umol/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 367, 1974 (MUREAV); mmo-klp 15 mmol/L (-S9) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 25, p. 85, 1969 (EXPEAM); mmo-asn 40 gm/L (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 30, p. 9, 1980 (CBINA8); sln-asn 74500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 138, p. 33, 1984 (MUREAV); oms-rat-orl 20 mg/L Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 37, 1982 (JACTDZ); oms-rat-lvr 12 gm/L Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 37, 1982 (JACTDZ); oms-rat-ihl 1 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 36(11), p. 9, 1971 (GISAAA); cyt-rat-ihl 1 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 36(11), p. 9, 1971 (GISAAA); cyt-mus-orl 500 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(8), p. 13, 1978 (GISAAA); mmo-mus-lym 80 mg/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); cyt-ham-ovr 980 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 165, 1989 (EMMUEG); sce-ham-ovr 1200 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) RE: T34-T51 orl-mus TDLo: 1100 mg/kg (6-16D preg) Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 17, p. 381, 1982 (JPFCD2); T34 ivn-mus TDLo: 180 mg/kg (8-10D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-172104/AS (NTIS**); T35 ivn-mus TDLo: 360 mg/kg (4-6D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-172104/AS (NTIS**); T35-T39 ivn-mus TDLo: 360 mg/kg (8-10D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-172104/AS (NTIS**); T35 ivn-mus TDLo: 360 mg/kg (10-12D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-172104/AS (NTIS**) TE: V03-J60-P60 skn-mus TDLo: 156000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-145513/AS (NTIS**) ORNG: 71000000 ng/kg. [71.000000 mg/kg] F07-J22 SRNG: 67000000 ng/kg. [67.000000 mg/kg] T/E unlistd SKNG: 293000000 ng/kg. [293.000000 mg/kg] T/E unlistd AT: L30-M30 ihl-man LCLo: 305 ppm/2H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 26, p. 277, 1944 (JIHTAB); F07-J22 orl-rat LD50: 71 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 36(4-6), p. 376, 1971 (HYSAAV); F07-J22 ihl-rat LC50: 290 mg/m3 Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 36(4-6), p. 376, 1971 (HYSAAV); T/E unlistd skn-rat LD50: 293 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-275, 1985 (NTPTR*); F07-J22 scu-rat LD50: 84 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 36(4-6), p. 376, 1971 (HYSAAV); A11 unr-rat LD50: 71 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(8), p. 13, 1978 (GISAAA); T/E unlistd orl-mus LD50: 81 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 60, p. 568, 1971 (JPMSAE); F07-J22 ihl-mus LC50: 385 mg/m3 Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 36(4-6), p. 376, 1971 (HYSAAV); T/E unlistd skn-mus LD50: 18 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,66,1982 (85GMAT); T/E unlistd ipr-mus LD50: 97 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 19, 1972 (JPMSAE); T/E unlistd scu-mus LD50: 98 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 15(2), p. 54, 1971 (GTPZAB); A11 unr-mus LD50: 91 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(8), p. 13, 1978 (GISAAA); T/E unlistd skn-rbt LD50: 67 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 19, 1972 (JPMSAE); T/E unlistd ipr-rbt LD50: 80 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 19, 1972 (JPMSAE); T/E unlistd scu-rbt LD50: 100 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 15(2), p. 54, 1971 (GTPZAB); G08-J25-U28 ivn-rbt LDLo: 100 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 1, p. 207, 1944 (BJIMAG); F01-K30-M30 orl-gpg LD50: 110 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); T/E unlistd ihl-gpg LC50: 870 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 15(2), p. 54, 1971 (GTPZAB); T/E unlistd skn-gpg LDLo: 70 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 27, p. 93, 1945 (JIHTAB); T/E unlistd ipr-gpg LD50: 85 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 19, 1972 (JPMSAE); T/E unlistd scu-gpg LD50: 75 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 15(2), p. 54, 1971 (GTPZAB); T/E unlistd scu-frg LDLo: 250 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 1, p. 207, 1944 (BJIMAG); T/E unlistd orl-man LDLo: 330 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 39, p. 587, 2001 (JTCTDW); T/E unlistd orl-chd LDLo: 396 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 39, p. 587, 2001 (JTCTDW); G08-K13 orl-wmn TDLo: 99 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 39, p. 587, 2001 (JTCTDW) MD: L70-N71-Z01 orl-rat TDLo: 5670 mg/kg/12W-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 313, 1975 (FCTXAV); L03-P01-Z01 ihl-rat TCLo: 3400 mg/m3/15M/11D-I British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 1, p. 207, 1944 (BJIMAG); P28-P30-Y15 ihl-rat TCLo: 1 mg/m3/4H/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 36(6), p. 37, 1971 (GISAAA); K02 orl-rat TDLo: 91 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(7), p. 102, 1976 (GISAAA); Z01 skn-rat TDLo: 6188 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-275, 1985 (NTPTR*); J16-Z01 skn-rat TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-275, 1985 (NTPTR*); U01-Z01 ipr-rat TDLo: 384 mg/kg/30D-I Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 60, p. 1163, 1971 (JPMSAE); Z01 ipr-rat TDLo: 1152 mg/kg/12W-I Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 60, p. 1163, 1971 (JPMSAE); L30-M30-P28 unr-rat TDLo: 910 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(8), p. 13, 1978 (GISAAA); Z01 skn-mus TDLo: 1411 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-275, 1985 (NTPTR*); Z01 skn-mus TDLo: 1154 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-275, 1985 (NTPTR*); K12-K13-U01 orl-dog TDLo: 1932 mg/kg/15W-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 313, 1975 (FCTXAV); Z01 ivn-rbt TDLo: 81 mg/kg/9D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-170959/AS (NTIS**); U01-Z01 ivn-mus TDLo: 360 mg/kg/3D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-172104/AS (NTIS**) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-CL 1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS) SR: MSHA STANDARD-air: TWA 5 ppm (16 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 108, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (16 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (16 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (16 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (16 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 1 ppm (3 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 1 ppm (3 mg/m3), Skin, JAN 1993; OEL-BELGIUM: STEL 1 ppm (3.3 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-FINLAND: STEL 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-FRANCE: VLE 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 1 ppm (3 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (16 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 1 mg/m3, STEL 3 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.5 mg/m3, Skin, JAN 1993; OEL-SWEDEN: TGV 1 ppm (3.5 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 1 ppm (3 mg/m3), KZG-W 5 ppm (15 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 5 ppm (16 mg/m3), JAN 1993; OEL-UNITED KINGDOM: STEL 1 ppm (3.4 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ETHYLENE CHLOROHYDRIN-air: CL 1 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X4018; NIS 1; TNF 17; NOS 1; TNE 476; TFE 68 SL: EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Negative: S pombe-forward mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Ethylene chlorohydrin, 2513; NCI Carcinogenesis Studies (derm), no evidence: mouse, rat Record 756 of 1119 in RTECS (through 2003/06) AN: KK2450000 PN: Ethanol,-2-chloro-,-phosphate- (3:1) SY: 2-Chloroethanol-phosphate-; Antiblaze-100-; Celluflex-; Fyrol-CEF-; NCI-C60128-; Niax-flame-retardant-3-CF-; Phosphoric acid, tris(2-chloroethyl)ester; Tri(2-chloroethyl)phosphate; Tri-beta-chloroethyl-phosphate-; Trichlorethyl-phosphate-; Tris(2-chloroethyl) phosphate; Tris(2-chloroethyl)phosphate; Tris(beta-chloroethyl) phosphate; Tris-(2-chlorethyl)fosfat (Czech) RN: Current: 115-96-8 BRN: 1710938 BHR: 4-01-00-01379 UD: 200305 MF: C6-H12-Cl3-O4-P MW: 285.50 WL: G2OPO&O2GO2G CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 1 umol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 373, 1979 (MUREAV); mnt-ham-ipr 125 mg/kg European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 18, p. 1337, 1982 (EJCODS); mtr-ham-emb 400 mg/L European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 18, p. 1337, 1982 (EJCODS); sce-ham-lng 700 mg/L European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 18, p. 1337, 1982 (EJCODS); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T85 orl-rat TDLo: 1800 mg/kg (7-15D preg) Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (101), p. 55, 1983 (ESKHA5); T29-T75 orl-mus TDLo: 24.5 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB920129170 (NTIS**); T26-T73 orl-mus TDLo: 350 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB920129170 (NTIS**); T29-T72 orl-mus TDLo: 6125 mg/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB920129170 (NTIS**) TE: V01-M61 orl-rat TDLo: 45760 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-391, 1991 (NTPTR*); V03-L60-M61 orl-mus TDLo: 182 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-391, 1991 (NTPTR*); V02-M61-N62 orl-rat TDLo: 45760 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-105147/AS (NTIS**); V02-A30-M61 orl-rat TDLo: 45760 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-105147/AS (NTIS**); V03-M03-M61 orl-mus TDLo: 182000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-105147/AS (NTIS**); V03-M03-N60 orl-mus TDLo: 91000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-105147/AS (NTIS**) ORNG: 1230000000 ng/kg. [1230.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1230 mg/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 17, p. 720, 1977 (BECTA6); T/E unlistd orl-mus LD50: 1866 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A067-313 (NTIS**); F05-F12 ipr-mus LDLo: 250 mg/kg "Summary Tables of Biological Tests," National Research Council Chemical-Biological Coordination Center. (National Academy of Science Library, 2101 Constitution Ave., NW, Washington, DC 20418) v. 7, p. 396, 1955 (CBCCT*); D17-F07-K30 skn-rbt LDLo: 2 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0517716 (NTIS**) MD: J70-M70-Z01 orl-rat TDLo: 2100 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-391, 1991 (NTPTR*); A30-L70-M70 orl-rat TDLo: 28 gm/kg/16W-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 6, p. 1, 1990 (TIHEEC); L70-M30-M70 orl-mus TDLo: 56 gm/kg/16W-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 6, p. 1, 1990 (TIHEEC); L70-M03-M70 orl-mus TDLo: 56 gm/kg/16W-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 6, p. 1, 1990 (TIHEEC); U01 orl-mus TDLo: 4900 mg/kg/28D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB920129170 (NTIS**); T01 orl-mus TDLo: 102900 mg/kg/21W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB920129170 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1543, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 109, 1990 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1543, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1543, 1999 (IMEMDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 17, p. 101, 1980 (CTOXAO) ND: NOHS 1974: HZD M0756; NIS 5; TNF 95; NOS 9; TNE 762; NOES 1983: HZD M0756; NIS 6; TNF 278; NOS 5; TNE 5073; TFE 578 SL: EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse Record 757 of 1119 in RTECS (through 2003/06) AN: KK8050000 PN: Ethanol,-2-ethoxy- SY: 2-Ethoxyethanol-; 2-Ethoxyethanol- (ACGIH:OSHA); Athylenglykol-monoathylather- (German); Cellosolve-; Cellosolve- (OSHA); Cellosolve-solvent-; Celosolv- (Czech); Dowanol-8-; Dowanol-EE-; EGEE-; Ektasolve-EE-; Ether-monoethylique-de-l'ethylene-glycol- (French); Ethyl-cellosolve-; Ethylene-glycol-ethyl-ether-; Ethylene-glycol-monoethyl-ether-; Etoksyetylowy-alkohol- (Polish); Glycol-monoethyl-ether- (OSHA); Jeffersol-EE-; NCI-C54853-; Oxitol-; Poly-Solv-EE-; RCRA-waste-number-U227-; RCRA-waste-number-U359- RN: Current: 110-80-5 Previous: 96231-36-6 UD: 200305 MF: C4-H10-O2 MW: 90.14 WL: Q2O2 CC: Tumorigen (C); Hormone (H); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: eye-hmn 6000 ppm Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878- v. 45, p. 1459, 1930 (PHRPA6); skn-rbt 500 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 5/20/1966 (UCDS**); eye-rbt 50 mg MOD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 5/20/1966 (UCDS**); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,624,1986 (85JCAE); eye-gpg 10 ug MLD Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 11, p. 150, 1959 (JPPMAB) ME: spm-rat-orl 23400 mg/kg/5W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 84, p. 576, 1986 (TXAPA9); cyt-ham-ovr 6830 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 3170 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T29 orl-rat TDLo: 500 mg/kg (5D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 182, 1985 (FAATDF); T25-T27 orl-rat TDLo: 7820 mg/kg (1-21D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 880, 1971 (ARZNAD); T34-T46-T47 orl-rat TDLo: 600 mg/kg (10-12D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 87, 1984 (TOXID9); T35 orl-rat TDLo: 1800 mg/kg (7-15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 87, 1984 (TOXID9); T01 orl-rat TDLo: 4500 mg/kg (6W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 348, 1986 (FAATDF); T26-T46 ihl-rat TCLo: 10 ppm/6H (6-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 33, 1984 (EVHPAZ); T34-T46-T47 ihl-rat TCLo: 200 ppm/7H (1-19D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO); T25-T35 ihl-rat TCLo: 600 ppm/7H (7-13D preg) Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 2, p. 231, 1981 (NRTXDN); T16-T85 ihl-rat TCLo: 100 ppm/7H (14-20D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 58A, 1980 (TJADAB); T25-T26-T34 skn-rat TDLo: 50 gm/kg (7-16D preg) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 5, p. 277, 1982 (DCTODJ); T46-T47 skn-rat TDLo: 50 gm/kg (7-16D preg) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 5, p. 277, 1982 (DCTODJ); T13-T41-T53 skn-rat TDLo: 50 gm/kg (7-16D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 69, 1984 (EVHPAZ); T46 scu-rat TDLo: 1955 mg/kg (1-21D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 880, 1971 (ARZNAD); T02 orl-mus TDLo: 25 gm/kg (25D male) Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 21, p. 29, 1979 (SAIGBL); T71-T72 orl-mus TDLo: 252 gm/kg (18W pre) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 85, 1984 (EVHPAZ); T72-T81 orl-mus TDLo: 5600 mg/kg (8-14D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 55, 1987 (TCMUD8); T25-T59 orl-mus TDLo: 12600 mg/kg (8-14D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 33, p. 96C, 1986 (TJADAB); T02 ihl-rbt TCLo: 400 ppm/6H (65D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 157, 1984 (EVHPAZ); T45-T46-T47 ihl-rbt TCLo: 160 ppm/7H (1-18D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO); T46 ihl-rbt TCLo: 175 ppm/6H (6-18D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571396 (NTIS**); T53 ihl-rbt TCLo: 160 ppm/7H (1-18D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO); T13-T29 ihl-rbt TCLo: 617 ppm/7H (1-18D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-208074 (NTIS**); T19-T25-T26 ihl-rbt TCLo: 400 ppm/6H (6-18D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0546094 (NTIS**); T23-T24 orl-rat TDLo: 17500 mg/kg (35D male) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); T72 orl-mus TDLo: 28840 mg/kg (7-14D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); T34 skn-rat TDLo: 12.5 mL/kg (7-16D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); T35-T46-T81 ihl-rat TCLo: 2270 mg/m3 (7H/1-18D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); T23 orl-mus TDLo: 220.5 gm/kg (21W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); T81 orl-mus TDLo: 220.5 gm/kg (21W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); T22 orl-mus TDLo: 382.2 gm/kg (21W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); T29-T72-T81 orl-mus TDLo: 52.5 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**) ORNG: 2125000000 ng/kg. [2125.000000 mg/kg] F07-F31-J25 SRNG: 3600000 ng/kg. [3.600000 mg/kg] T/E unlistd SKNG: 3900000000 ng/kg. [3900.000000 mg/kg] T/E unlistd AT: F07-F31-J25 orl-rat LD50: 2125 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(3), p. 48, 1988 (GTPZAB); T/E unlistd ihl-rat LC50: 2000 ppm/7H Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 54, 1974 (NPIRI*); T/E unlistd skn-rat LD50: 3900 mg/kg Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 180, 1984 (TOXID9); T/E unlistd ipr-rat LD50: 2800 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 880, 1971 (ARZNAD); T/E unlistd scu-rat LD50: 3400 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 880, 1971 (ARZNAD); T/E unlistd ivn-rat LD50: 2400 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 54, 1974 (NPIRI*); T/E unlistd unr-rat LD50: 7750 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 47(5), p. 84, 1982 (GISAAA); T/E unlistd orl-mus LD50: 2451 mg/kg Kodak Company Reports. (343 State St., Rochester, NY 14650) v. MSDS-10, p. 170A, 1982 (KODAK*); F29-J22-M14 ihl-mus LC50: 1820 ppm/7H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 157, 1943 (JIHTAB); J16-M03-P27 ipr-mus LD50: 1707 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 6, p. 342, 1947 (FEPRA7); T/E unlistd scu-mus LDLo: 5 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 42, p. 355, 1931 (JPETAB); F05-F12-J22 ivn-mus LD50: 3900 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 880, 1971 (ARZNAD); T/E unlistd unr-mus LD50: 5799 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 47(5), p. 84, 1982 (GISAAA); T/E unlistd orl-rbt LD50: 1275 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 53(10), p. 78, 1988 (GISAAA); T/E unlistd scu-rbt LD50: 2 gm/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 880, 1971 (ARZNAD); F05-F12-J22 ivn-rbt LD50: 900 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 880, 1971 (ARZNAD); F01-K30-M30 orl-gpg LD50: 1400 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); F07-F18-J22 ihl-gpg LCLo: 3000 ppm/24H Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878- v. 45, p. 1459, 1930 (PHRPA6); T/E unlistd unr-gpg LD50: 3070 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 47(5), p. 84, 1982 (GISAAA); F22-L30-M30 orl-mus LD50: 4000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 162, 1984 (VCVGK*); F22-L30-M30 orl-rat LD50: 2125 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 162, 1984 (VCVGK*); F22-L30-M30 orl-rbt LD50: 1275 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 162, 1984 (VCVGK*); T/E unlistd skn-rbt LD50: 3.6 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 162, 1984 (VCVGK*); J30-K06 ihl-mus LCLo: 6500 mg/m3/7H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 162, 1984 (VCVGK*); A30-L30-M30 orl-wmn TDLo: 0.8 ml/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1984 (VCVGK*); T/E unlistd orl-hmn LDLo: 143 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1984 (VCVGK*) MD: N72-U01-Z73 orl-rat TDLo: 3600 mg/kg/4W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 109, p. 11, 1999 (TOLED5); F15-P08-U01 orl-rat TDLo: 26452 mg/kg/6W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0570960 (NTIS**); Z01 orl-rat TDLo: 25 gm/kg/2W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 147, 1984 (EVHPAZ); N74-U01-Z73 orl-rat TDLo: 18655 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3349 (NTPTR*); U01 ihl-rat TCLo: 4000 ppm/4H/2W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 25, p. 369, 1964 (AIHAAP); P27 ihl-rat TCLo: 1370 mg/m3/7H/5W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 374, 1943 (JIHTAB); Z01 orl-mus TDLo: 25 gm/kg/2W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 147, 1984 (EVHPAZ); N19-N30-P27 orl-mus TDLo: 660 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3349 (NTPTR*); M16-P06-P30 ihl-dog TCLo: 840 ppm/7H/12W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 409, 1943 (JIHTAB); P05-U01-Z73 ihl-rbt TCLo: 400 ppm/6H/13W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 157, 1984 (EVHPAZ); P28-U01-Z73 ihl-rbt TCLo: 400 ppm/6H/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0546061 (NTIS**); T02-U01-Z73 orl-rat TDLo: 17500 mg/kg/5W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); T01 orl-rat TDLo: 8750 mg/kg/5W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); T01-T02-Z73 orl-rat TDLo: 24500 mg/kg/7W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); U01-T01-T02 orl-rat TDLo: 12250 mg/kg/7W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); Z01 orl-mus TDLo: 28840 mg/kg/8D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); P70 ihl-rat TCLo: 1400 mg/m3/7H/25D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); T01 orl-rat TDLo: 7 mg/kg/2W-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); T01 orl-rat TDLo: 2750 mg/kg/11D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); P05-P71-D17 ihl-rat TCLo: 1470 mg/m3/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); P05-P71-D17 ihl-rbt TCLo: 1470 mg/m3/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); T02-P05-D17 ihl-rbt TCLo: 1470 mg/m3/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); L30-M30 orl-rat TDLo: 342.5 mg/kg/137D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); L30-M30-T02 orl-rat TDLo: 342.5 mg/kg/137D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 163, 1994 (VCVGK*); T01 orl-rat TDLo: 4680 mg/kg/5D-I Japanese Journal of Toxicology and Environmental Health. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.38- 1992- v. 13, p. 763, 1984 (JJTHEC); T02 orl-rat TDLo: 9360 mg/kg/5D-I Japanese Journal of Toxicology and Environmental Health. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.38- 1992- v. 13, p. 763, 1984 (JJTHEC); U01 orl-rat TDLo: 14040 mg/kg/5D-I Japanese Journal of Toxicology and Environmental Health. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.38- 1992- v. 13, p. 763, 1984 (JJTHEC); L70 orl-mus TDLo: 220.5 gm/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); A70-T14 orl-mus TDLo: 382.2 gm/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); A70-T01-T02 orl-mus TDLo: 220.5 gm/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); T03-T02 orl-mus TDLo: 382.2 gm/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**) TR: ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 30, p. 307, 2000 (CRTXB2) SR: MSHA STANDARD-air: TWA 100 ppm (370 mg/m3) (skin) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 18, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 200 ppm (740 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 200 ppm (740 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 200 ppm (740 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 200 ppm (740 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 ppm (19 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 20 ppm (75 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 5 ppm (18 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 5 ppm (18.5 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 50 ppm (185 mg/m3), STEL 100 ppm (370 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (19 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 20 ppm (75 mg/m3), Skin, JAN 1999; OEL-HUNGARY: TWA 70 mg/m3, STEL 140 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 5 ppm (18 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (19 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (18 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 200 ppm (740 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 20 mg/m3, MAC(STEL) 80 mg/m3, JAN 1999; OEL-RUSSIA: TWA 5 ppm, STEL 5 mg/m3, JAN 1993; OEL-SWEDEN: NGV 5 ppm (19 mg/m3), KTV 10 ppm (40 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (19 mg/m3), KZG-W 10 ppm (38 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 200 ppm (740 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 10 ppm (37 mg/m3), Skin, SEP 2000; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ETHYLENEGLYCOL MONOETHYL ETHER-air: 10H TWA 0.5 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 31350; NIS 253; TNF 43849; NOS 154; TNE 406097; NOES 1983: HZD 31350; NIS 153; TNF 16505; NOS 106; TNE 264436; TFE 72493 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9072; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN, #39; NIOSH Analytical Method, 1994: Alcohols IV, 1403; NTP Toxicity studies, RPT# TOX-26, October 2000; OSHA ANALYTICAL METHOD #53; OSHA ANALYTICAL METHOD #79 Record 758 of 1119 in RTECS (through 2003/06) AN: KL2860000 PN: Ethanol, 2-((2-(2-hydroxyethoxy)-4-nitrophenyl)amino)- SY: N,O-Di(2-hydroxyethyl)-2-amino-5-nitrophenol; HC-Yellow-4-; 2-((2-(2-Hydroxyethoxy)-4-nitrophenyl)amino)ethanol; 2-(3-Nitro-6-(beta-hydroxyethylamino)phenoxy)ethanol RN: Current: 59820-43-8 UD: 200302 MF: C10-H14-N2-O5 MW: 242.26 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 100 ug/plate (+S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-419, 1992 (NTPTR*); sln-dmg-ipr 10 pph National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-419, 1992 (NTPTR*) TE: V03-N60 orl-rat TDLo: 221 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-419, 1992 (NTPTR*); V03-A60 orl-rat TDLo: 216300 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-123883 (NTIS**) MD: U01 orl-rat TDLo: 7 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-419, 1992 (NTPTR*); U01 orl-rat TDLo: 54600 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-419, 1992 (NTPTR*); U01 orl-mus TDLo: 33600 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-419, 1992 (NTPTR*); U01 orl-mus TDLo: 109 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-419, 1992 (NTPTR*) TR: IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 159, 1993 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 159, 1993 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 159, 1993 (IMEMDT) SL: NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 759 of 1119 in RTECS (through 2003/06) AN: KL2880000 PN: Ethanol, 2,2'-((4-((2-hydroxyethyl)amino)-3-nitrophenyl)imino)di- SY: Ethanol, 2,2'-((4-((2-hydroxyethyl)amino)-3-nitrophenyl)imino)bis- (9CI); HC Blue No. 2; 2,2'-((4-((2-Hydroxyethyl)amino)-3-nitrophenyl)imino)bis(ethanol); NCI-C54897-; 3-Nitro-N(sup 1),N(sup 1),N(sup 4)-tris(2-hydroxyethyl)-; p-Phenylenediamine, 3-nitro-N(sup 1),N(sup 1),N(sup 4)-tris(2-hydroxyethyl)-; N(sup 1),N(sup 4),N(sup 4)-Tris(2-hydroxyethyl)-2-nitro-para-phenylenediamine RN: Current: 33229-34-4 BRN: 2148848 UD: 200210 MF: C12-H19-N3-O5 MW: 285.34 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1250 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 151, 1990 (MUREAV); dns-rat-lvr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); mmo-mus-lym 200 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 151, 1990 (MUREAV); dns-mus-lvr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); cyt-mus-lvr 35 umol/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 6, p. 139, 1990 (CBTOE2); sce-mus-lvr 175 umol/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 6, p. 139, 1990 (CBTOE2); msc-mus-lym 150 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-293, 1985 (NTPTR*); dns-ham-lvr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); sce-ham-ovr 240 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); dns-rbt-lvr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV) TE: V01-M61 orl-rat TDLo: 721000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-108339/AS (NTIS**); V03-P62 orl-mus TDLo: 1630720 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-108339/AS (NTIS**) AT: T/E unlistd orl-rat LD :>500 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-293, 1985 (NTPTR*); M16 orl-mus LD :>1 gm/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-293, 1985 (NTPTR*) MD: M16-U01 orl-rat TDLo: 17500 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-293, 1985 (NTPTR*); M16-U01 orl-mus TDLo: 42 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-293, 1985 (NTPTR*) TR: IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 143, 1993 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 143, 1993 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 143, 1993 (IMEMDT) SL: NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 760 of 1119 in RTECS (through 2003/06) AN: KL2975000 PN: Ethanol,-2,2'-iminodi- SY: 2,2'-Dihydroxydiethylamine-; 2,2'-Iminobisethanol-; 2,2'-Iminodiethanol-; 2-(2-Hydroxyethylamino)ethanol; Bis(2-hydroxyethyl)amine; DEA-; Di(2-hydroxyethyl)amine; Diaethanolamin- (German); Diethanolamin- (Czech); Diethanolamine-; Diethanolamine- (ACGIH); Diethylamine,-2,2'-dihydroxy-; Diethylolamine-; Diolamine-; NCI-C55174- RN: Current: 111-42-2 BRN: 605315 BHR: 4-04-00-01514 UD: 200302 MF: C4-H11-N-O2 MW: 105.16 WL: Q2M2Q CC: Tumorigen (C); Drug (D); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 50 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 12/29/1971 (UCDS**); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,685,1986 (85JCAE); eye-rbt 5500 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 750 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,685,1986 (85JCAE) RE: T01 orl-rat TDLo: 18382 mg/kg (14D male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*); T19-T87 skn-rat TDLo: 15 gm/kg (6-15D preg) Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 30, p. 169, 1999 (RTOPDW); T19 skn-rbt TDLo: 4550 mg/kg (6-18D preg) Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 30, p. 169, 1999 (RTOPDW); T46 skn-rat TDLo: 15000 mg/kg (6-15D preg) Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 30, p. 169, 1999 (RTOPDW); T19 ihl-rat TCLo: 200 mg/m3/6H (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0538412 (NTIS**) TE: V01-L60 skn-mus TDLo: 21 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-478, 1999 (NTPTR*); V01-L60 skn-mus TDLo: 57680 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-167553 (NTIS**); V01-L60 skn-mus TDLo: 28840 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-167553 (NTIS**) ORNL: 620000 nL/kg. [0.620000 mL/kg] D17-F11-R21 SRNL: 7640000 nL/kg. [7.640000 mL/kg] F19-Q30-R03 AT: D17-F11-R21 orl-rat LD50: 620 uL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516797 (NTIS**); T/E unlistd ipr-rat LD50: 120 mg/kg Environmental Space Science. English Translation of Kosmicheskaya Biologiya Meditsina. 1967-70. v. 2, p. 289, 1968 (EVSSAV); T/E unlistd scu-rat LD50: 2200 mg/kg Environmental Space Science. English Translation of Kosmicheskaya Biologiya Meditsina. 1967-70. v. 2, p. 289, 1968 (EVSSAV); T/E unlistd ivn-rat LD50: 778 mg/kg Environmental Space Science. English Translation of Kosmicheskaya Biologiya Meditsina. 1967-70. v. 2, p. 289, 1968 (EVSSAV); T/E unlistd ims-rat LD50: 1500 mg/kg Environmental Space Science. English Translation of Kosmicheskaya Biologiya Meditsina. 1967-70. v. 2, p. 289, 1968 (EVSSAV); F07-F13-F23 orl-mus LD50: 3300 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 29(11), p. 25, 1964 (GISAAA); T/E unlistd ipr-mus LD50: 210 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516742 (NTIS**); T/E unlistd orl-rbt LD50: 2200 mg/kg Environmental Space Science. English Translation of Kosmicheskaya Biologiya Meditsina. 1967-70. v. 2, p. 289, 1968 (EVSSAV); F19-Q30-R03 skn-rbt LD50: 7640 uL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516797 (NTIS**); T/E unlistd orl-gpg LD50: 2 gm/kg "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 5,197,1986 (85INA8); T/E unlistd skn-gpg LD50: 11900 uL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516742 (NTIS**); T/E unlistd orl-mam LDLo: 3 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520710 (NTIS**) MD: M16-P05-Y10 orl-rat TDLo: 52 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*); M70-P05-Z73 orl-rat TDLo: 8827 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*); L30-P05-Z01 orl-rat TDLo: 49 gm/kg/7W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 17, p. 308, 1970 (TXAPA9); M16-P05-Y10 skn-rat TDLo: 1008 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*); L70-M70-P05 skn-rat TDLo: 8125 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*); L70-Y10 orl-mus TDLo: 30366 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*); G70-M70-Y15 orl-mus TDLo: 38402 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*); L70-R03-Z01 skn-mus TDLo: 30 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*); L70-M70-Y15 skn-mus TDLo: 40950 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3343 (NTPTR*) TR: ACGIH TLV-TWA 2 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT) SR: OEL-AUSTRALIA: TWA 3 ppm (15 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 3 ppm (13 mg/m3), JAN 1999; OEL-BELGIUM: TWA 3 ppm (13 mg/m3), JAN 1993; OEL-DENMARK: TWA 3 ppm (15 mg/m3), JAN 1999; OEL-FRANCE: VME 3 ppm (15 mg/m3), JAN 1999; OEL-GERMANY: No MAK Established, JAN 1999; OEL-NORWAY: TWA 3 ppm (15 mg/m3), JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, Skin, JAN 1993; OEL-SWEDEN: TWA 3 ppm (15 mg/m3), STEL 6 ppm (30 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 0.1 mg/m3, JAN 1999; OEL-SWITZERLAND: TWA 3 ppm (13 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 3 ppm (13 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DIETHANOLAMINE-air: 10H TWA 3 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #95-121, 1995 (NIOSH*); NOHS 1974: HZD T0517; NIS 3; TNF 315; NOS 2; TNE 857; NOHS 1974: HZD 24615; NIS 147; TNF 18443; NOS 118; TNE 186455; NOES 1983: HZD 24615; NIS 249; TNF 46466; NOS 171; TNE 828471; TFE 218923 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0293-8736, 8EHQ-0293-8746; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Aminoethanol compounds II, 3509; NCI Carcinogenesis Studies (derm), clear evidence: mouse; NCI Carcinogenesis Studies (derm), no evidence: rat; NTP Toxicity studies, RPT# TOX-20, October 2000 Record 761 of 1119 in RTECS (through 2003/06) AN: KL5775000 PN: Ethanol,-2-methoxy- SY: 2-Methoxy-aethanol- (German); 2-Methoxyethanol-; 2-Methoxyethanol- (ACGIH:OSHA); 2-Metossietanolo- (Italian); Aethylenglykol-monomethylaether- (German); Dowanol-7-; Dowanol-EM-; EGME-; Ether-monomethylique-de-l'ethylene-glycol- (French); Ethylene-glycol-methyl-ether-; Ethylene-glycol-monomethyl-ether-; Glycol-ether-EM-; Glycol-monomethyl-ether-; Glycolmethyl-ether-; Jeffersol-EM-; Methoxyethanol-; Methoxyhydroxyethane-; Methyl-cellosolve-; Methyl-cellosolve- (OSHA); Methyl-cellosolve-methyl-glycol-; Methyl-ethoxol-; Methyl-glycol-; Methyl-oxitol-; Methylcelosolv- (Czech); Methylglykol- (German); Metil-cellosolve- (Italian); Metoksyetylowy-alkohol- (Polish); Monomethyl-ether-of-ethylene-glycol-; Poly-Solv-EM-; Prist- RN: Current: 109-86-4 BRN: 1731074 BHR: 4-01-00-02375 UD: 200305 MF: C3-H8-O2 MW: 76.11 WL: Q2O1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 483 mg/24H MLD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 276, 1971 (TXAPA9); eye-rbt 97 mg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 276, 1971 (TXAPA9); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,623,1986 (85JCAE); eye-gpg 10 ug MLD Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 11, p. 150, 1959 (JPPMAB) ME: cyt-hmn-lym 150 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 125, 1994 (MUREAV); dlt-rat-orl 500 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 390, 1984 (ENMUDM); spm-rat-orl 500 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 390, 1984 (ENMUDM); spm-mus-orl 500 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 390, 1984 (ENMUDM) RE: T47 orl-rat TDLo: 175 mg/kg (7-13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 32, p. 33, 1985 (TJADAB); T16-T83 orl-rat TDLo: 175 mg/kg (7-13D preg) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 9, p. 1, 1986 (DCTODJ); T01 orl-rat TDLo: 15015 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3349 (NTPTR*); T02 orl-rat TDLo: 100 mg/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 69, p. 385, 1983 (TXAPA9); T26-T34-T47 orl-rat TDLo: 350 mg/kg (9-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 86, p. 197, 1986 (TXAPA9); T24-T25 ihl-rat TCLo: 68 mg/kg/4H (1-19D preg) Fiziologicheski Aktivnye Veshchestva. Physiologically Active Substances. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1966- v. 21, p. 30, 1989 (FAVUAI); T02 ihl-rat TCLo: 30 ppm/6H (65D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 49, 1983 (FAATDF); T16-T22-T72 ihl-rat TCLo: 100 ppm/6H (6-17D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 69, p. 43, 1983 (TXAPA9); T75-T81 ihl-rat TCLo: 100 ppm/6H (6-17D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 69, p. 43, 1983 (TXAPA9); T25 ihl-rat TCLo: 30 ppm/6H (13W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 80, 1983 (FAATDF); T22-T35 skn-rat TDLo: 11592 mg/kg (6-17D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 6, p. 165, 1986 (JJATDK); T01-T02-T23 skn-rat TDLo: 4375 mg/kg (7D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 100, p. 145, 1989 (TXAPA9); T25 skn-rat TDLo: 2 gm/kg (10D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 15, p. 448, 1990 (FAATDF); T34-T43-T50 skn-rat TDLo: 1 gm/kg (12D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 15, p. 448, 1990 (FAATDF); T46-T47 ipr-rat TDLo: 330 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 54A, 1984 (TJADAB); T41-T53 ipr-rat TDLo: 190 mg/kg (14D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 4, p. 35, 1984 (JJATDK); T46 ipr-rat TDLo: 190 mg/kg (12D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 4, p. 35, 1984 (JJATDK); T25 ipr-rat TDLo: 190 mg/kg (8D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 4, p. 35, 1984 (JJATDK); T72-T75 scu-rat TDLo: 600 mg/kg (6-20D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 199, 1984 (EVHPAZ); T72 scu-rat TDLo: 440 mg/kg (7-17D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 73, 1987 (TCMUD8); T34-T46 orl-rat TDLo: 250 mg/kg (13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 145, p. 415, 1997 (TXAPA9); T46 orl-mus TDLo: 175 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 31, p. 48A, 1985 (TJADAB); T26-T35-T41 orl-mus TDLo: 2 gm/kg (7-14D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 20, p. 335, 1981 (TXCYAC); T25-T26-T34 orl-mus TDLo: 500 mg/kg (9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 80, p. 108, 1985 (TXAPA9); T34-T46 orl-mus TDLo: 250 mg/kg (11D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 80, p. 108, 1985 (TXAPA9); T02 orl-mus TDLo: 6250 mg/kg (25D male) Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 21, p. 29, 1979 (SAIGBL); T02 ihl-mus TCLo: 1000 ppm/6H (11D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 61, p. 368, 1981 (TXAPA9); T01 ihl-mus TCLo: 500 ppm/7H (5D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 70, p. 303, 1983 (TXAPA9); T26-T53 ihl-mus TCLo: 50 ppm/6H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 75, p. 409, 1984 (TXAPA9); T46-T53 ihl-mus TCLo: 50 ppm/6H (6-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 7, 1984 (EVHPAZ); T34 scu-mus TDLo: 1200 mg/kg (7-13D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 50, p. 263, 1990 (TOLED5); T25 scu-mus TDLo: 3200 mg/kg (7-14D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 50, p. 263, 1990 (TOLED5); T41-T43 scu-mus TDLo: 250 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 54, p. 219, 1996 (TJADAB); T41 ivn-mus TDLo: 250 mg/kg (8D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 101, 1992 (TOXID9); T27-T35 orl-mky TDLo: 930 mg/kg (20-45D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 66A, 1987 (TJADAB); T34 orl-mky TDLo: 633 mg/kg (20-45D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 66A, 1987 (TJADAB); T02 ihl-rbt TCLo: 300 ppm/6H (65D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 49, 1983 (FAATDF); T45-T47-T53 ihl-rbt TCLo: 50 ppm/6H (6-18D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 75, p. 409, 1984 (TXAPA9); T34-T45-T46 ihl-rbt TCLo: 50 ppm/6H (6-18D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 7, 1984 (EVHPAZ); T25-T46 ihl-rbt TCLo: 10 ppm/6H (6-18D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 75, p. 409, 1984 (TXAPA9); T02 orl-gpg TDLo: 6250 mg/kg (25D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 75, 1984 (EVHPAZ); T02 skn-gpg TDLo: 65 gm/kg (65D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 339, 1986 (FAATDF); T02 orl-ham TDLo: 1562 mg/kg (25D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 75, 1984 (EVHPAZ); T72 orl-mus TDLo: 11200 mg/kg (7-14D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); T25-T34-T46 skn-rat TDLo: 2.5 mg/kg (7-16D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1994 (VCVGK*); T16-T75 ihl-rat TCLo: 933 mg/m3 (6-17D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 160, 1994 (VCVGK*); T34-T46 orl-rat TDLo: 1000 mg/kg (6-17D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 160, 1994 (VCVGK*); T34-T46 orl-mus TDLo: 1000 mg/kg (6-17D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 160, 1994 (VCVGK*); T34-T46 orl-rbt TDLo: 1000 mg/kg (6-17D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 160, 1994 (VCVGK*); T25-T26-T34 orl-rat TDLo: 350 mg/kg (9-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 197, 1986 (TXAPA9); T35-T47 orl-rat TDLo: 350 mg/kg (9-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 197, 1986 (TXAPA9); T81 orl-mus TDLo: 2 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89152565 (NTIS**); T17 orl-mus TDLo: 4.45 gm/kg (7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T72 orl-rat TDLo: 5.5 gm/kg (21W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90252321/AS (NTIS**); T72 orl-mus TDLo: 5.6 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T81 orl-mus TDLo: 7.2 gm/kg (7D male/7D pre-1D post) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88192240 (NTIS**); T29 orl-mus TDLo: 8.4 gm/kg (7D male/ 7D pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88192240 (NTIS**); T29-T81 orl-mus TDLo: 11.8 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T23 orl-mus TDLo: 14 gm/kg (14D male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T22 orl-mus TDLo: 14 gm/kg (14D pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T29-T72 orl-mus TDLo: 17.5 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89152565 (NTIS**); T26-T81 orl-mus TDLo: 35.28 gm/kg (15W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T29 orl-rat TDLo: 36.75 gm/kg (21W male/21W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90252321/AS (NTIS**); T75-T81 orl-mus TDLo: 43 gm/kg (15W male/15W pre-3W post) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89152565 (NTIS**); T26-T73 orl-rat TDLo: 30 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90252321 (NTIS**); T72 orl-rat TDLo: 37.5 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90252321/AS (NTIS**); T53 orl-mus TDLo: 50 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89152565 (NTIS**); T21-T29-T72 orl-mus TDLo: 159 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T51 orl-mus TDLo: 159 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T72 orl-mus TDLo: 170 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89152565 (NTIS**); T26-T73 orl-rat TDLo: 1050 mg/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90252321 (NTIS**); T73 orl-rat TDLo: 3570 mg/kg (17W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90252321 (NTIS**); T29 orl-mus TDLo: 19 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88211446 (NTIS**); T81 orl-rat TDLo: 15 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90252321 (NTIS**); T81 orl-mus TDLo: 200 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88211446 (NTIS**); T72 orl-rat TDLo: 262 mg/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB90252321 (NTIS**); T51-T53 orl-mus TDLo: 60 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88211446 (NTIS**) ORNG: 2370000000 ng/kg. [2370.000000 mg/kg] F05-J30 SRNG: 1280000000 ng/kg. [1280.000000 mg/kg] T/E unlistd AT: K05-L30-M30 orl-hmn LDLo: 3380 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28, p. 267, 1946 (JIHTAB); F11-F12-F17 ihl-hmn TCLo: 25 ppm Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 20, p. 134, 1938 (JIHTAB); F05-J30 orl-rat LD50: 2370 mg/kg Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 29, p. 361, 1987 (VHTODE); T/E unlistd ihl-rat LC50: 1500 ppm/7H Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 57, 1974 (NPIRI*); T/E unlistd ipr-rat LD50: 2500 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 57, 1974 (NPIRI*); P23 ivn-rat LD50: 2068 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); F07-F17-G30 orl-mus LD50: 2560 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(3), p. 48, 1988 (GTPZAB); F29-J22-M14 ihl-mus LC50: 1480 ppm/7H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 157, 1943 (JIHTAB); M04-P27-P30 ipr-mus LD50: 2147 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 6, p. 342, 1947 (FEPRA7); F01-P23 orl-rbt LD50: 890 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 114, 1956 (AMIHAB); T/E unlistd skn-rbt LD50: 1280 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 57, 1974 (NPIRI*); F01-K30-M30 orl-gpg LD50: 950 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); Z72 orl-rat TDLo: 250 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 491, 1992 (REPTED); T29 ipr-rat TDLo: 50 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 45, 2000 (REPTED); T01 orl-rat TDLo: 250 mg/kg Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 43, p. 312, 1985 (EXMPA6); P05-T01 orl-rat TDLo: 200 mg/kg Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 61, p. 119, 1994 (EXMPA6); T02 orl-gpg TDLo: 200 mg/kg Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 61, p. 119, 1994 (EXMPA6); P30 orl-gpg TDLo: 300 mg/kg Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 61, p. 119, 1994 (EXMPA6); F07-L30-M30 orl-mus LD50: 2800 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1984 (VCVGK*); F07-L30-M30 orl-rbt LD50: 890 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1984 (VCVGK*); F07-L30-M30 orl-rat LD50: 2460 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1984 (VCVGK*); T01-T02 ipr-rat TDLo: 150 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1984 (VCVGK*); M11 skn-rbt LD50: 2000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1984 (VCVGK*); T/E unlistd orl-hmn LDLo: 143 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1984 (VCVGK*); T01 ihl-rat TCLo: 625 ppm/4H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. Suppl.7, p. 167, 1984 (ARTODN); T02-Z73 ihl-rat TCLo: 1000 ppm/4H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. Suppl.7, p. 167, 1984 (ARTODN); T01-T02 orl-rat TDLo: 150 mg/kg Journal of Andrology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1980- v. 5, p. 369, 1984 (JOAND3) MD: A30-U01-Y20 ihl-rat TCLo: 400 ppm/6H/2W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 22, p. 423, 1980 (ENVRAL); N74-U01-Z73 orl-rat TDLo: 10206 mg/kg/21D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 16, p. 830, 1991 (FAATDF); N74-S05 orl-rat TDLo: 500 mg/kg/10D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 109, p. 494, 1991 (TXAPA9); P72-U01-Z73 ihl-rat TCLo: 300 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 49, 1983 (FAATDF); P26-P27 ihl-rat TCLo: 970 mg/m3/7H/5W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 374, 1943 (JIHTAB); M16-P26-P72 ihl-rat TCLo: 1000 ppm/6H/11D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 61, p. 368, 1981 (TXAPA9); P70-P72-Z73 skn-rat TDLo: 20 gm/kg/4W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 57, p. 209, 1989 (TXCYAC); P70-Y21 ipr-rat TDLo: 450 mg/kg/16D-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 9, p. 617, 1993 (TIHEEC); N74-P73-U01 orl-rat TDLo: 29484 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3349 (NTPTR*); N74-S04 skn-rat TDLo: 3200 mg/kg/4D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 98, p. 215, 1995 (TXCYAC); N74-Z73 orl-mus TDLo: 12110 mg/kg/2W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3349 (NTPTR*); N19-N30-P27 orl-mus TDLo: 82 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3349 (NTPTR*); P72-Z73 ihl-mus TCLo: 1000 ppm/6H/11D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 61, p. 368, 1981 (TXAPA9); P06-P30 ihl-dog TCLo: 750 ppm/7H/12W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 409, 1943 (JIHTAB); N74-P71-Z73 ihl-rbt TCLo: 300 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 49, 1983 (FAATDF); P71-U01-Z73 skn-gpg TDLo: 65 gm/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 339, 1986 (FAATDF); T14 orl-rat TDLo: 900 mg/kg/3D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 142, p. 328, 1997 (TXAPA9); M71 orl-rat TDLo: 4500 mg/kg/15D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 142, p. 328, 1997 (TXAPA9); T11-T29 orl-rat TDLo: 1050 mg/kg/2W-C Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 45, 2000 (REPTED); Z01 orl-mus TDLo: 11200 mg/kg/8D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); T01 orl-rat TDLo: 600 mg/kg/3D-I Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 61, p. 119, 1994 (EXMPA6); T01 orl-gpg TDLo: 600 mg/kg/3D-I Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 61, p. 119, 1994 (EXMPA6); B30-U01 ihl-rat TCLo: 3680 mg/m3/6H/9D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1994 (VCVGK*); B30-U01 ihl-mus TCLo: 3680 mg/m3/6H/9D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1994 (VCVGK*); T02 ihl-rat TCLo: 3680 mg/m3/6H/9D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1994 (VCVGK*); T02 ihl-mus TCLo: 3680 mg/m3/6H/9D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1994 (VCVGK*); U01-C08-A30 ihl-mam TCLo: 1240 mg/m3/6H/5D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 159, 1994 (VCVGK*); T02-T01 ihl-rat TCLo: 1100 mg/m3/10D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 160, 1994 (VCVGK*); T02-T01 orl-rat TDLo: 500 mg/kg/10D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 160, 1994 (VCVGK*); P27-P06 ihl-dog TCLo: 2500 mg/m3/7H/60D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 160, 1994 (VCVGK*); L70-U07-Z74 orl-rat TDLo: 700 mg/kg/7D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 197, 1986 (TXAPA9); Z73 orl-rat TDLo: 1200 mg/kg/8D-I Journal of Andrology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1980- v. 5, p. 369, 1984 (JOAND3); M71 orl-mus TDLo: 8820 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88211446 (NTIS**); L70 orl-mus TDLo: 29400 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88211446 (NTIS**); T01-T02 orl-mus TDLo: 80850 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88211446 (NTIS**); Z01 orl-mus TDLo: 8820 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88211446 (NTIS**); T02-U01 orl-mus TDLo: 126000 mg/kg/15W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89152565 (NTIS**); L70-T02 orl-mus TDLo: 17850 mg/kg/15W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89152565 (NTIS**); L70 orl-mus TDLo: 6300 mg/kg/15W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88192240 (NTIS**); U01 orl-mus TDLo: 4200 mg/kg/7D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88192240 (NTIS**); T02-T03 orl-mus TDLo: 4200 mg/kg/7D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88192240 (NTIS**); L70-T12 orl-mus TDLo: 9800 mg/kg/49D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88192240 (NTIS**); U01 orl-mus TDLo: 21665 mg/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**); T14 orl-mus TDLo: 35280 mg/kg/15W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86163136 (NTIS**) TR: ACGIH TLV-TWA 5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 30, p. 307, 2000 (CRTXB2) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 25 ppm (80 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 158, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 25 ppm (80 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 25 ppm (80 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 25 ppm (80 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 25 ppm (80 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 ppm (16 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 5 ppm (15 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 5 ppm (16 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 5 ppm (16 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 25 ppm (80 mg/m3), STEL 40 ppm (120 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (16 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 5 ppm (15 mg/m3), Skin, JAN 1999; OEL-HUNGARY: TWA 15 mg/m3, STEL 30 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 5 ppm (16 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (16 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (16 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 25 ppm (80 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 15 mg/m3, MAC(STEL) 60 mg/m3, JAN 1999; OEL-RUSSIA: TWA 5 ppm, JAN 1993; OEL-SWEDEN: NGV 5 ppm (16 mg/m3), KTV 10 ppm (30 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (15 mg/m3), KZG-W 10 ppm (30 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 25 ppm (80 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (16 mg/m3), Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ETHYLENEGLYCOL MONOMETHYL ETHER-air: 10H TWA 0.1 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 46240; NIS 128; TNF 11165; NOS 102; TNE 103424; NOES 1983: HZD 46240; NIS 89; TNF 8042; NOS 86; TNE 168180; TFE 53403 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9101; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN, #39; NIOSH Analytical Method, 1994: Alcohols IV, 1403; NTP Toxicity studies, RPT# TOX-26, October 2000; OSHA ANALYTICAL METHOD #53; OSHA ANALYTICAL METHOD #79 Record 762 of 1119 in RTECS (through 2003/06) AN: KL6900000 PN: Ethanol, 2,2'-((4-(methylamino)-3-nitrophenyl)imino)di- SY: 2,2'-((4-(Methylamino)-3-nitrophenyl)imino)diethanol; HC-Blue-1-; HC Blue No. 1; N',N'-Bis(2-hydroxyethyl)-N-methyl-2-nitro-p-phenylenediamine; N-Methyl-amino-2-nitro-4-N',N'-bis-(2-hydroxyethyl)-aminobenzene; NCI-C04159-; p-Phenylenediamine, N,N-bis(2-hydroxyethyl)-N'-methyl-2-nitro- RN: Current: 2784-94-3 BRN: 2134980 UD: 200210 MF: C11-H17-N3-O4 MW: 255.31 WL: WNR BM1 EN2Q2Q CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 333 ug/plate (+S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*); sln-dmg-orl 15 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); dns-rat-lvr 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); mnt-mus-ipr 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 139, 1990 (MUREAV); mmo-mus-lym 10 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 151, 1990 (MUREAV); dns-mus-lvr 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); cyt-mus-lvr 30 umol/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 6, p. 139, 1990 (CBTOE2); sce-mus-lvr 195 umol/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 6, p. 139, 1990 (CBTOE2); msc-mus-lym 30 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*); mtr-ham-emb 31 mg/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 2, p. 103, 1988 (TIVIEQ); dns-ham-lvr 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); cyt-ham-ovr 960 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 119 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 200 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 116, p. 169, 1983 (MUREAV); dns-mky-lvr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); dns-rbt-lvr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV) TE: V01-J60-L60 orl-rat TDLo: 66 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*); V01-L60 orl-mus TDLo: 98280 mg/kg/39W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 703, 1987 (FCTOD7); V01-L60-N62 orl-mus TD :131 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*); V01-L60 orl-rat TDLo: 129780 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-114683/AS (NTIS**); V01-J61 orl-rat TDLo: 129780 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-114683/AS (NTIS**); V01-L60 orl-mus TDLo: 129780 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-114683/AS (NTIS**); V02-N62 orl-mus TDLo: 519120 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-114683/AS (NTIS**); V01-L60 orl-mus TDLo: 259560 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-114683/AS (NTIS**) AT: T/E unlistd orl-rat LD :>500 mg/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 13, p. 344, 1994 (JACTDZ); T/E unlistd orl-mus LD :>1 gm/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 13, p. 344, 1994 (JACTDZ) MD: F05-U03-Z01 orl-rat TDLo: 35 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*); N30 orl-rat TDLo: 28437 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*); M30-U01-Z01 orl-mus TDLo: 84 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*); N30 orl-mus TDLo: 136 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 129, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 129, 1993 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 129, 1993 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), clear evidence: mouse; NTP Carcinogenesis Studies (feed), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-271, 1985 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: rat Record 763 of 1119 in RTECS (through 2003/06) AN: KL9275000 PN: Ethanol,-2,2',2''-nitrilotri- SY: Alkanolamine-244-; Daltogen-; Nitrilo-2,2',2''-triethanol-; 2,2',2''-Nitrilotriethanol-; Sterolamide-; Triaethanolamin-NG-; Sting-Kill-; TEA- (amino alcohol); Thiofaco-T-35-; Triethanolamin-; Triethanolamine-; Triethanolamine- (ACGIH); Triethylamine,-2,2',2''-trihydroxy-; Triethylolamine-; Tri(hydroxyethyl)amine; Trihydroxytriethylamine-; Tris(2-hydroxyethyl)amine; Trolamine- RN: Current: 102-71-6 UD: 200302 MF: C6-H15-N-O3 MW: 149.22 WL: Q2N2Q2Q CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-hmn 15 mg/3D-I MLD "Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar, eds., New York, Academic Press, Inc. 1977 -,127,1977 (85DKA8); skn-rbt 560 mg/24H MLD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 276, 1971 (TXAPA9); eye-rbt 20 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 10 mg MLD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 55, p. 501, 1980 (TXAPA9) ME: cyt-hmn-lym 100 umol/L Biologicheskii Zhurnal Armenii. Biological Journal of Armenia. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.19- 1966- v. 39, p. 422, 1986 (BZARAZ); sce-hmn-lym 1 mmol/L Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 21(6), p. 29, 1987 (CYGEDX) TE: V03-M60 skn-rat TDLo: 129 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-449, 1999 (NTPTR*); V03-M61 skn-rat TDLo: 90125 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-102846 (NTIS**) ORNL: 4920000 nL/kg. [4.920000 mL/kg] D17-K12-R21 AT: D17-K12-R21 orl-rat LD50: 4920 uL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516797 (NTIS**); T/E unlistd skn-rat LD50: >16 mL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516797 (NTIS**); T/E unlistd ipr-rat LD50: 1510 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516797 (NTIS**); F12-K12-M30 orl-mus LD50: 5846 mg/kg Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. (Tohoku University, Research Institute for Tuberculosis and Cancer, 4-1 Seiryo-machi, Sendai, Japan) V.1- 1949- v. 36(1-4), p. 10, 1989 (SRTCAC); T/E unlistd ipr-mus LD50: 1450 mg/kg Russian Chemical Reviws (English Translation). Translation of USKHAB. (Royal Soc. of Chemistry, Distribution Centre, Blackhorse Rd., Letchworth, Herts SG6 1HN, UK) V.29- 1960- v. 38, p. 975, 1969 (RCRVAB); T/E unlistd orl-rbt LD50: 2200 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,114,1982 (85GMAT); T/E unlistd skn-rbt LD50: >20 mL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 3/18/1965 (UCDS**); T/E unlistd orl-gpg LD50: 2200 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,114,1982 (85GMAT); T/E unlistd orl-mam LDLo: 2 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520710 (NTIS**) MD: L70-M70-Z73 orl-rat TDLo: 63028 mg/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520455 (NTIS**); M30 orl-rat TDLo: 96 gm/kg/60D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516740 (NTIS**); L70-M70 orl-rat TDLo: 29700 ug/kg/90D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516797 (NTIS**); L70-M70-N74 ihl-rat TCLo: 2 gm/m3/6H/3W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0533592 (NTIS**); M71-R03-U01 skn-rat TDLo: 65 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-449, 1999 (NTPTR*); U01 orl-mus TDLo: 2296 mL/kg/82W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 25, 1992 (FAATDF); G70-P08-P71 ihl-mus TCLo: 125 mg/m3/6H/3W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0533591 (NTIS**); L70-M71-R03 skn-mus TDLo: 260 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-449, 1999 (NTPTR*); L30-M30 orl-gpg TDLo: 192 gm/kg/17W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516740 (NTIS**); Z01 skn-gpg TDLo: 32 gm/kg/4D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516740 (NTIS**) TR: ACGIH TLV-TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-DENMARK: TWA 0.5 ppm (3.1 mg/m3), JAN 1999; OEL-SWEDEN: NGV 5 mg/m3, KTV 10 mg/m3 JAN 1999 ND: NOHS 1974: HZD M0260; NIS 297; TNF 61500; NOS 201; TNE 821293; NOES 1983: HZD M0260; NIS 311; TNF 70726; NOS 195; TNE 1726272; TFE 573604 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Aminoethanol compounds II, 3509; NCI Carcinogenesis Studies (derm), equivocal evidence: rat; NCI Carcinogenesis Studies (derm), inadequate study: mouse; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 764 of 1119 in RTECS (through 2003/06) AN: KL9550000 PN: Ethanol,-N-nitrosoiminodi- SY: Diethanolnitrosoamine-; Diethylamine,-2,2'-dihydroxy-N-nitroso-; Bis(beta-hydroxyaethyl)nitrosamin (German); Bis(beta-hydroxyethyl)nitrosamine; Diaethanolnitrosamin- (German); NCI-C55583-; Ndela-; RCRA-waste-number-U173-; 2,2'-Iminodi-N-nitrosoethanol-; N-Nitrosoaminodiethanol-; N-Nitrosobis(2-hydroxyethyl)amine; N-Nitrosodiaethanolamin- (German); N-Nitrosodiethanolamine-; 2,2'-(Nitrosoimino)bisethanol; Nitrosoimino-diethanol- RN: Current: 1116-54-7 BRN: 1762620 BHR: 3-04-00-00721 UD: 200204 MF: C4-H10-N2-O3 MW: 134.16 WL: Q2NNO&&2Q CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 100 umol/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 158, p. 141, 1985 (MUREAV); mmo-sat 1 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 91, 1987 (MUREAV); slt-dmg-skn 260 mmol/L Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 4, p. 437, 1984 (TCMUD8); mrc-smc 17 gm/L IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 57, p. 721, 1984 (IAPUDO); mnt-nml-mul 12500 ppb Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 83, 1993 (MUREAV); mtr-rat-orl 60 mg/kg/60W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 607, 1988 (CRNGDP); dnd-rat-lvr 12500 nmol/L Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 111, p. 149, 1986 (JCROD7); dnd-rat-orl 1030 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-mus-ipr 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); hma-mus-esc 450 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 909, 1981 (CRNGDP) TE: V01-D09-L60 orl-rat TDLo: 855 mg/kg/2Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 5167, 1982 (CNREA8); V01-J60 orl-mus TDLo: 295 mg/kg/10W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1475, 1989 (CRNGDP); V02-D09-J60 skn-ham TDLo: 21600 mg/kg/36W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 299, 1982 (IAPUDO); V01-D09-J60 scu-ham TDLo: 6080 mg/kg/27W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2521, 1983 (CNREA8); V01-D09-J60 orl-ham TDLo: 21600 mg/kg/45W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2521, 1983 (CNREA8); V01-D09-J60 scu-ham TD :7200 mg/kg/27W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 299, 1982 (IAPUDO); V01-D09-L60 orl-rat TD :10 gm/kg/50W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 167, 1984 (CRNGDP); V01-D09-L60 orl-rat TD :12 gm/kg/75W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 23, 1984 (FCTOD7); V01-L60 orl-rat TD :3450 mg/kg/2Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 5167, 1982 (CNREA8); V01-D09-L60 orl-rat TD :8 gm/kg/50W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 23, 1984 (FCTOD7); V01-D09-J60 scu-ham TD :10500 mg/kg/42W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 14, p. 23, 1981 (CALEDQ); V01-D09-L60 orl-rat TD :100 gm/kg/1Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 5167, 1982 (CNREA8); V01-D09-J60 scu-ham TD :17920 mg/kg/27W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2521, 1983 (CNREA8); V01-D09-J60 scu-ham TD :15 gm/kg/5W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 4, p. 55, 1977 (CALEDQ); V03-D09-L60 orl-rat TD :1202 mg/kg/2Y-C IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 591, 1982 (IAPUDO) ORNG: 7500000000 ng/kg. [7500.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 7500 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 40(1), p. 81, 1975 (GISAAA); T/E unlistd scu-ham LDLo: 11 gm/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 4, p. 55, 1977 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: 0.001 mg/m3, Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 15, 1976; NCI Carcinogenesis Studies (oral), clear evidence: rat Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 288, p. 589, 1980 (NATUAS); NCI Carcinogenesis Studies (oral), clear evidence: rat Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 23, 1984 (FCTOD7); NCI Carcinogenesis Studies (oral), clear evidence: rat Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1679, 1985 (CRNGDP); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #31 Record 765 of 1119 in RTECS (through 2003/06) AN: KN1575000 PN: Ether, bis(chloromethyl) SY: 1,1'-Dichlorodimethyl-ether-; BCME-; Bis(chloromethyl) ether (ACGIH:OSHA); Bis-CME-; Bis-chloromethyl-ether-; Chloro(chloromethoxy)methane; Chloro(chloromethoxy)methane fume; Chloromethyl-ether-; Dichlordimethylaether- (German); Dimethyl-1,1'-dichloroether-; Methane, oxybis(chloro-; Oxybis(chloromethane); RCRA-waste-number-P016-; sym-Dichloro-dimethyl-ether-; sym-Dichloromethyl-ether- RN: Current: 542-88-1 BRN: 1679223 BHR: 4-01-00-03051 UD: 200210 MF: C2-H4-Cl2-O MW: 114.96 WL: G1O1G CC: Tumorigen (C); Mutagen (M); Human-Data (P) ME: mmo-sat 20 ug/plate (-S9) British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); dns-hmn-fbr 160 ug/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 21, p. 151, 1981 (TXCYAC); dns-mus-skn 360 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 769, 1973 (CNREA8); dni-mus-skn 360 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 769, 1973 (CNREA8); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-mus-fbr 0.001 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V01-D09-J60 ihl-rat TCLo: 100 ppb/6H/4W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 73, 1975 (AEHLAU); V01-V10 scu-rat TDLo: 375 mg/kg/43W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 43, p. 481, 1969 (JNCIAM); V02-J60 ihl-mus TCLo: 100 ppb/6H/26W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 58, p. 269, 1981 (TXAPA9); V03-R60 skn-mus TDLo: 5520 mg/kg/23W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 16, p. 472, 1968 (AEHLAU); V02-V10 ipr-mus TDLo: 50 mg/kg/61W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2553, 1975 (CNREA8); V02-V10 scu-mus TDLo: 384 mg/kg/42W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 352, 1980 (CNREA8); V02-V10 scu-mus TD :640 mg/kg/53W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2553, 1975 (CNREA8); V03-J60 ihl-rat TC :100 ppb/6H/6W-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 106, 1980 (PAACA3); V02-J60-R21 scu-mus TD :12500 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 15, p. 92, 1969 (TXAPA9); V02-D09-J60 ihl-rat TC :100 ppb/6H/26W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 58, p. 269, 1981 (TXAPA9); V03-V08 ihl-mus TC :1 ppm/82D-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 22, p. 663, 1971 (AEHLAU); V01-D09-J60 ihl-rat TC :75 ppb/6H/2Y-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 68, p. 597, 1982 (JJIND8); V01-R60-V10 skn-mus TD :11 gm/kg/44W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 43, p. 481, 1969 (JNCIAM) ORNL: 210000 nL/kg. [0.210000 mL/kg] T/E unlistd SRNL: 280000 nL/kg. [0.280000 mL/kg] T/E unlistd AT: D07-D25-J30 ihl-man TCLo: 3 ppm Tijdschrift Voor Sociale Geneeskunde. (B.V. Uitgeversmaatschappij. Reflex, Mathenesserlaan 310, Rotterdam 3003, Netherlands) V.1- 1923- v. 51, p. 596, 1973 (TJSGA8); J30 ihl-man LCLo: 100 ppm/3M Tijdschrift Voor Sociale Geneeskunde. (B.V. Uitgeversmaatschappij. Reflex, Mathenesserlaan 310, Rotterdam 3003, Netherlands) V.1- 1923- v. 51, p. 596, 1973 (TJSGA8); T/E unlistd orl-rat LD50: 210 uL/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); J16-P01 ihl-rat LC50: 7 ppm/7H Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 61, 1975 (AEHLAU); T/E unlistd ihl-mus LC50: 25 mg/m3/6H Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 22, p. 663, 1971 (AEHLAU); T/E unlistd skn-rbt LD50: 280 uL/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); J16-P01 ihl-ham LC50: 7 ppm/7H Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 61, 1975 (AEHLAU) MD: J02-Z01 ihl-rat TCLo: 4.7 mg/m3/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 280, 1994 (VCVGK*); J60 ihl-mus TCLo: 6 mg/m3/130D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 280, 1994 (VCVGK*); J60 ihl-rat TCLo: 0.5 mg/m3/6H/210D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 280, 1994 (VCVGK*); J60 ihl-ham TCLo: 0.5 mg/m3/6H/210D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 280, 1994 (VCVGK*); J60 ihl-mus TCLo: 5 mg/m3/28W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 280, 1994 (VCVGK*); D09-J30 ihl-rat TCLo: 0.5 mg/m3/659D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 280, 1994 (VCVGK*) TR: ACGIH TLV-TWA 0.001 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.001 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 231, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 231, 1974 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 131, 1987 (IMSUDL); TOXICOLOGY REVIEW Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 166, p. 113, 1978 (ZHPMAT) SR: OSHA PEL (Construc): see CFR 29,1926.1108 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA-cancer suspect agent Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1008, 1987 (CFRGBR); OEL-AUSTRALIA: TWA 0.001 ppm (0.006 mg/m3), Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.001 ppm (0.0047 mg/m3), Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 ppm (0.005 mg/m3), JAN 1999; OEL-FINLAND: TWA 0.001 ppm (0.004 mg/m3), STEL 0.003 ppm, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.001 ppm (0.006 mg/m3), C1 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-INDIA: TWA 0.001 ppm (0.005 mg/m3), Carcinogen, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 0.001 ppm (0.005 mg/m3), Skin, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.001 ppm (0.005 mg/m3), JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.001 ppm (0.005 mg/m3), Carcinogen, JAN 1999; OEL-UNITED KINGDOM: TWA 0.001 ppm (0.005 mg/m3), Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BIS(CHLOROMETHYL) ETHER-air: CA use 29 CFR 1910.1008 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X6315; NIS 1; TNF 3; NOS 1; TNE 14; TFE 5 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/90/168691/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #10 Record 766 of 1119 in RTECS (through 2003/06) AN: KN1750000 PN: Ether, bis(2-chloro-1-methylethyl) SY: (2-Chloro-1-methylethyl) ether; 2,2'-Dichloroisopropyl-ether-; 2,2'-Oxybis(1-chloropropane); 2-(1-Methyl-2-chloroethoxy)-1-chloropropane; 2-(1-Methyl-2-chloroethoxy)-1-chloropropane, fume; Bis(1-chloro-2-propyl) ether; Bis(2-chloro-1-methylethyl) ether; Bis(2-chloroisopropyl) ether; Bis(beta-chloroisopropyl)ether; DCIP-; DCIP- (nematocide); Dichlorodiisopropyl-ether-; Dichloroisopropyl-ether-; Isopropylchlorex-; NCI-C50044-; Nemamol-; Nemamort-; Nemamorte-; Propane, 2,2'-oxybis(1-chloro-; RCRA-waste-number-U027-; beta,beta'-Dichlorodiisopropyl-ether- RN: Current: 108-60-1 Previous: 52438-91-2 BRN: 1735833 BHR: 3-01-00-01470 UD: 200210 MF: C6-H12-Cl2-O MW: 171.08 WL: G1Y1&OY1&1G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 1 gm/plate (+S9) HEW Publication (FDA. United States). (Washington, DC) ?-1979(?). For publisher information, see HPFSDS. FDA-78-1046, 1978 (DHEFDK); mmo-sat 333 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); msc-mus-lym 250 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); cyt-ham-ovr 124 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 11300 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V01-J60-L60 orl-mus TDLo: 103000 mg/kg/180D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-169615 (NTIS**); V01-J60 orl-mus TDLo: 103000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-169615 (NTIS**) ORNG: 240000000 ng/kg. [240.000000 mg/kg] T/E unlistd SRNL: 3000000 nL/kg. [3.000000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 240 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); D27-J22-L30 ihl-rat LCLo: 700 ppm/5H British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 27, p. 1, 1970 (BJIMAG); T/E unlistd skn-rat LD50: >2 gm/kg Pesticide Manual. (The British Crop Protection Council, 20 Bridport Rd., Thornton Heath CR4 7QG, UK) V.1- 1968- v. 9, p. 83, 1991 (PEMNDP); T/E unlistd orl-mus LD50: 296 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 37, p. 597, 1986 (YKYUA6); T/E unlistd skn-rbt LD50: 3 mL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC) MD: P08-P71-P72 orl-rat TDLo: 11250 mg/kg/45D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(5), p. 69, 1985 (GISAAA); P72-Y15-Y21 orl-rat TDLo: 2340 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(5), p. 69, 1985 (GISAAA); F15-P27-U01 orl-rat TDLo: 364 gm/kg/2Y-C Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 2, p. 296, 1977 (JTSCDR); Z01 orl-mus TDLo: 4424 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-239, 1982 (NTPTR*); F15-U01 orl-mus TDLo: 876 gm/kg/2Y-C Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 2, p. 295, 1977 (JTSCDR) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 149, 1986 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1275, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 149, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1275, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1275, 1999 (IMEMDT) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (gavage), no evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-191, 1979 (NCITR*) Record 767 of 1119 in RTECS (through 2003/06) AN: KN1770000 PN: Ether, bis(2-chloro-1-methylethyl), mixed with 2-chloro-1-methylethyl-(2-chloropropyl)ether (7:3) SY: Bis(2-chloro-1-methylethyl)ether mixed with 2-chloro-1-methylethyl-(2-chloropropyl) ether UD: 199904 MF: C6-H12-Cl2-O MW: 171.08 CC: Tumorigen (C) TE: V01-J60-L60 orl-mus TDLo: 51500 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-239, 1982 (NTPTR*); V01-J60-L60 orl-mus TD :103 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-239, 1982 (NTPTR*) SL: NTP Carcinogenesis Bioassay (gavage), clear evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-239, 1983 (NTPTR*) Record 768 of 1119 in RTECS (through 2003/06) AN: KN3525000 PN: Ether, bis(pentabromophenyl) SY: 1,1'-Oxybis(2,3,4,5,6-pentabromobenzene); BR-55N-; Benzene, 1,1'-oxybis(2,3,4,5,6-pentabromo- (9CI); Berkflam-B-10E-; Bis(pentabromophenyl)ether; Bromkal-82-ode-; Bromkal-83-10DE-; DBDPO-; DE-83R-; Dbdpo-; De-83R-; Decabrom-; Decabrominated-diphenyl-ether-; Decabromobiphenyl-ether-; Decabromobiphenyl-oxide-; Decabromodiphenyl-ether-; Decabromodiphenyl-oxide-; Decabromophenyl-ether-; Ether,-decabromodiphenyl-; FR-300-; FR-300BA-; FRP-53-; NCI-C55287-; Pentabromophenyl-ether-; Saytex-102-; Saytex-102E-; Tardex-100- RN: Current: 1163-19-5 BRN: 2188438 BHR: 1-06-00-00108 UD: 200302 MF: C12-Br10-O MW: 959.22 CC: Tumorigen (C); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 100 uL SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0522261 (NTIS**) RE: T25 orl-rat TDLo: 100 mg/kg (6-15D preg) Journal of Fire and Flammability/Combustion Toxicology Supplement. (Westport, CT) V.1-2, 1974-75. For publisher information, see JCTODH. v. 1, p. 52, 1974 (COTODO) TE: V02-L60 orl-rat TDLo: 1092 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-309, 1986 (NTPTR*); V01-L60 orl-rat TDLo: 1081500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-247780/AS (NTIS**); V01-L60 orl-rat TDLo: 1802500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-247780/AS (NTIS**); V03-L60-N62 orl-mus TDLo: 2163000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-247780/AS (NTIS**) AT: T/E unlistd orl-rat LDLo: 500 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0522261 (NTIS**); T/E unlistd skn-rat LD :>3 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 48(8), p. 18, 1983 (GISAAA) MD: L30-N05 orl-rat TDLo: 24 gm/kg/30D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 11, p. 153, 1975 (EVHPAZ); Y07 orl-rat TDLo: 4 mg/kg/4D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 61, p. 76, 2001 (TOSCF2); L70 unr-rat TDLo: 1344 mg/kg/2W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 316, 1994 (VCVGK*); L30-M30-N75 orl-rat TDLo: 24000 mg/kg/30D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 316, 1994 (VCVGK*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 73, 1990 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1365, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1365, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1365, 1999 (IMEMDT) SR: OEL-RUSSIA: STEL 3 mg/m3, JAN 1993 ND: NOES 1983: HZD X4046; NIS 12; TNF 981; NOS 30; TNE 32661; TFE 8875 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (feed), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-309, 1986 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: mouse, rat Record 769 of 1119 in RTECS (through 2003/06) AN: KN6650000 PN: Ether,-chloromethyl-methyl- SY: CMME-; Chlordimethylether- (Czech); Chloromethyl-methyl-ether-; Chloromethyl-methyl-ether- (ACGIH:OSHA); Dimethylchloroether-; Ether-methylique-monochlore- (French); Ether,-dimethyl-chloro-; Methoxychloromethane-; Methylchloromethyl-ether-; Monochlorodimethyl-ether-; RCRA-waste-number-U046- RN: Current: 107-30-2 BRN: 505943 BHR: 4-01-00-03046 UD: 200210 MF: C2-H5-Cl-O MW: 80.52 WL: G1O1 CC: Tumorigen (C); Mutagen (M) ME: dni-hmn-lym 5 mL/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 13, p. 213, 1981 (CALEDQ); mtr-ham-emb 10 mg/L Advances in Modern Environmental Toxicology. (Senate Press, Inc., P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980- v. 1, p. 241, 1980 (AETODY) TE: V03-J60-N60 ihl-rat TCLo: 1 ppm/6H/72W Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 70, 1975 (AEHLAU); V03-J60 ihl-mus TCLo: 2 ppm/82D-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 22, p. 663, 1971 (AEHLAU); V02-V10 scu-mus TDLo: 312 mg/kg/26W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 46, p. 143, 1971 (JNCIAM); V03-J60 ihl-ham TCLo: 1 ppm/6H/90D Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 70, 1975 (AEHLAU); V02-V10 scu-mus TD :852 mg/kg/71W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 48, p. 1431, 1972 (JNCIAM); V03-J60 scu-mus TD :125 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 15, p. 92, 1969 (TXAPA9) AT: J16-P01 ihl-rat LC50: 55 ppm/7H Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 61, 1975 (AEHLAU); T/E unlistd ihl-mus LC50: 1030 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,89,1982 (85GMAT); J16-P01 ihl-ham LC50: 65 ppm/7H Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 61, 1975 (AEHLAU) MD: J02-Z01 ihl-rat TCLo: 32.7 mg/m3/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 278, 1994 (VCVGK*); J30-L30-U01 ihl-rbt TCLo: 3 mg/m3/5H/90D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 278, 1994 (VCVGK*); J60 ihl-mus TCLo: 6 mg/m3/130D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 278, 1994 (VCVGK*); J02-R60 ihl-rat TCLo: 3.27 mg/m3/130W-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 278, 1994 (VCVGK*) TR: ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 239, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 239, 1974 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 131, 1987 (IMSUDL); TOXICOLOGY REVIEW Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 1, p. 289, 1977 (EESADV) SR: OSHA PEL (Construc): see CFR 29,1926.1108 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA-cancer suspect agent Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1006, 1987 (CFRGBR); OEL-AUSTRALIA: Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: Carcinogen, JAN 1993; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-RUSSIA: STEL 0.5 mg/m3, Skin, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHLOROMETHYL METHYL ETHER-air: CA use 29 CFR 1910.1006 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #10 Record 770 of 1119 in RTECS (through 2003/06) AN: KN8400000 PN: Ether,-2,4-dichlorophenyl-p-nitrophenyl- SY: 2',4'-Dichloro-4-nitrobiphenyl-ether-; 2,4-Dechlorophenyl-p-nitrophenyl-ether-; 2,4-Dichloro-1-(4-nitrophenoxy)benzene; 2,4-Dichloro-4'-nitrodiphenyl-ether-; 2,4-Dichlorophenyl-4-nitrophenyl-ether-; 2,4-Dichlorophenyl-p-nitrophenyl-ether-; 2,4-Dichlorphenyl-4-nitrophenylaether- (German); 4'-Nitro-2,4-dichlorodiphenyl-ether-; 4-(2,4-Dichlorophenoxy)nitrobenzene; Benzene, 2,4-dichloro-1-(4-nitrophenoxy)-; FW-925-; Mezotox-; NCI-C00420-; NE-; NIP-; Niclofen-; Nitofen-; Nitrafen-; Nitraphen-; Nitrochlor-; Nitrofen-; Nitrofene- (French); Nitrophen-; Nitrophene-; Preparation-125-; TOK-; TOK-E-; TOK-E-40-; TOK-E-25-; TOK-WP-50-; TOK-2-; Tokkorn-; Trizilin-; Trizilin-25- RN: Current: 1836-75-5 Previous: 51274-07-8 BRN: 1887356 BHR: 4-06-00-01288 UD: 200305 MF: C12-H7-Cl2-N-O3 MW: 284.10 WL: WNR DOR BG DG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 33300 ng/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); pic-esc 4460 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 193, 1987 (MUREAV); mtr-rat-emb 1500 ng/plate JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 190, 1981 (JJATDK); pic-esc 35.7 mmol/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 206, 2000 (EMMUEG) RE: T45-T49-T53 orl-rat TDLo: 62500 ug/kg (6-15D preg) Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 4(1), p. 221, 1985 (JACTDZ); T33 orl-rat TDLo: 150 mg/kg (7-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 339, 1986 (TCMUD8); T86 orl-rat TDLo: 37530 ug/kg (6-18D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 34, p. 285, 1985 (TXCYAC); T34 orl-rat TDLo: 62500 ug/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 213, 1986 (TJADAB); T81 orl-rat TDLo: 100 mg/kg (11D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 20, p. 209, 1981 (TXCYAC); T47-T71-T75 orl-rat TDLo: 80 mg/kg (10-13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 86, p. 22, 1986 (TXAPA9); T42-T49 skn-rat TDLo: 12 mg/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 28, p. 37, 1983 (TXCYAC); T45-T52-T53 skn-rat TDLo: 120 mg/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 28, p. 37, 1983 (TXCYAC); T75-T81 skn-rat TDLo: 120 mg/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 28, p. 37, 1983 (TXCYAC); T45 unr-rat TDLo: 13900 ug/kg (7-16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 45A, 1982 (TJADAB); T42 unr-rat TDLo: 125 mg/kg (7-16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 45A, 1982 (TJADAB); T49 unr-rat TDLo: 220 mg/kg (8-18D preg) Pharmacologist. (American Soc. for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1959- v. 19, p. 178, 1977 (PHMCAA); T75 unr-rat TDLo: 352 mg/kg (8-18D preg) Pharmacologist. (American Soc. for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1959- v. 19, p. 178, 1977 (PHMCAA); T49-T76 orl-mus TDLo: 660 mg/kg (5-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24(1), p. 11A, 1981 (TJADAB); T75-T86-T91 orl-mus TDLo: 1100 mg/kg (7-17D preg) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 215, p. 293, 1982 (SCIEAS); T34-T86 orl-mus TDLo: 660 mg/kg (5-15D preg) Nagoya Medical Journal. (Nagoya City Univ. Medical School, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan) V.1- 1953- v. 31, p. 115, 1986 (NMJOAA); T59-T86 orl-mus TDLo: 68750 ug/kg (7-17D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 67, p. 1, 1983 (TXAPA9); T75 orl-mus TDLo: 550 mg/kg (7-17D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 67, p. 1, 1983 (TXAPA9); T45-T49-T51 orl-mus TDLo: 2520 mg/kg (1-21D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 32, p. 45B, 1985 (TJADAB); T77 skn-mus TDLo: 175 mg/kg (8D preg) Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 21, p. 303, 1986 (JPFCD2); T75 skn-mus TDLo: 160 mg/kg (8D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 40, p. 297, 1986 (TXCYAC); T52 skn-mus TDLo: 286 mg/kg (8D preg) Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 21, p. 303, 1986 (JPFCD2); T75 skn-mus TDLo: 1100 mg/kg (7-17D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 45A, 1982 (TJADAB); T42 unr-mus TDLo: 550 mg/kg (7-17D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 45A, 1982 (TJADAB); T75 unr-mus TDLo: 1100 mg/kg (7-17D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 45A, 1982 (TJADAB); T42-T53 unr-ham TDLo: 500 mg/kg (7-11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 45A, 1982 (TJADAB); T59 unr-rat TDLo: 37.53 mg/kg (8-16D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 740, 2001 (HBPTO*); T26-T53 ihl-rat TCLo: 23 mg/m3 (2-5D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 312, 1994 (VCVGK*); T35 orl-rat TDLo: 825 mg/kg (8-18D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 313, 1994 (VCVGK*); T53-T59-T81 orl-rat TDLo: 1650 mg/kg (8-18D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 313, 1994 (VCVGK*); T75-T49 orl-rat TDLo: 550 mg/kg (8-18D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 313, 1994 (VCVGK*); T52 orl-rat TDLo: 250 mg/kg (11D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 73, p. 323, 1984 (TXAPA9) TE: V01-H60-L60 orl-rat TDLo: 42 gm/kg/94W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-26, 1978 (NCITR*); V01-L60-J60 orl-mus TDLo: 24 gm/kg/12W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 937, 1980 (JJIND8); V01-H60-L60 orl-mus TD :200 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-184, 1979 (NCITR*); V01-H60-L60 orl-mus TD :308 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-26, 1978 (NCITR*); V01-H60-L60 orl-mus TD :114 gm/kg/58W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-26, 1978 (NCITR*); V01-L60-J60 orl-mus TD :47 gm/kg/12W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 937, 1980 (JJIND8) ORNG: 740000000 ng/kg. [740.000000 mg/kg] F13-J26-U25 SKNG: 5000000000 ng/kg. [5000.000000 mg/kg] T/E unlistd AT: F13-J26-U25 orl-rat LD50: 740 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 32(1), p. 20, 1967 (HYSAAV); T/E unlistd skn-rat LD50: 5 gm/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 28, p. 316, 1974 (AEHLAU); T/E unlistd unr-rat LD50: 3 gm/kg "Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971 -,109,1971 (30ZDA9); F13-J26-U25 orl-mus LD50: 450 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 32(1), p. 20, 1967 (HYSAAV); T/E unlistd orl-cat LDLo: 300 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 32(1), p. 20, 1967 (HYSAAV); F13-J22-K01 ihl-cat LCLo: 620 mg/m3/4H Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 32(1), p. 20, 1967 (HYSAAV); T/E unlistd orl-rbt LD50: 1620 mg/kg "Pesticide Index," Frear, E.H., ed., State College, PA, College Science Pub., 1969 5,166,1976 (28ZEAL); T/E unlistd skn-rbt LDLo: 3270 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 29, p. 1, 1983 (TXCYAC); Y07 unr-rat TDLo: 250 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 740, 2001 (HBPTO*); F07-K06-K12 orl-mus LD50: 8250 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 312, 1984 (VCVGK*); F07-K06-K12 orl-rat LD50: 7850 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 312, 1984 (VCVGK*); F07-K06-K12 orl-rbt LD50: 2650 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 312, 1984 (VCVGK*); N30-N08 orl-rat TDLo: 250 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 73, p. 323, 1984 (TXAPA9) MD: L70-M70-Z73 orl-rat TDLo: 13650 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 263, 1971 (TXAPA9); L70-M70 orl-rat TDLo: 40740 mg/kg/13W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 10, p. 427, 1972 (FCTXAV); L70-M70-Z01 orl-rat TDLo: 40740 mg/kg/97W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 263, 1971 (TXAPA9); L70 orl-dog TDLo: 1400 mg/kg/4W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 263, 1971 (TXAPA9); L70 orl-dog TDLo: 36400 mg/kg/2Y-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 10, p. 427, 1972 (FCTXAV); P08-Y11-Z01 ihl-cat TCLo: 26 mg/m3/4H/7W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(1), p. 19, 1967 (GISAAA); N07 unr-rat TDLo: 1500 mg/kg/3D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 740, 2001 (HBPTO*); U01-Z01 ihl-mam TCLo: 18 mg/m3/4H/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 313, 1994 (VCVGK*); U01 orl-rat TDLo: 68320 mg/kg/305D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 313, 1994 (VCVGK*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 30, p. 271, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 30, p. 271, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Archives of Pathology and Laboratory Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-5(2), 1926-28: V.100- 1976- v. 107, p. 54, 1983 (APLMAS) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-RUSSIA: STEL 1 mg/m3, JAN 1993; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL-UNITED KINGDOM: TWA 1 ppm (7.1 mg/m3), SEP 2000 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-26, 1978 (NCITR*); NCI Carcinogenesis Bioassay (feed), clear evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-184, 1979 (NCITR*); NCI Carcinogenesis Bioassay (feed), no evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-184, 1979 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 771 of 1119 in RTECS (through 2003/06) AN: KQ6300000 PN: Ethyl-alcohol- SY: Absolute-ethanol-; Aethanol- (German); Aethylalkohol- (German); Alcohol-; Alcohol-dehydrated-; Alcohol,-anhydrous-; Alcool-ethylique- (French); Alcool-etilico- (Italian); Algrain-; Alkohol- (German); Alkoholu-etylowego- (Polish); Anhydrol-; Cologne-Spirit-; Etanolo- (Italian); Ethanol-; Ethanol- (ACGIH:OSHA); Ethyl-alcohol- (DOT:OSHA); Ethyl-alcohol-anhydrous-; Ethyl-hydrate-; Ethyl-hydroxide-; Etylowy-alkohol- (Polish); Fermentation-alcohol-; Grain-alcohol-; Jaysol-; Jaysol-S-; Methylcarbinol-; Molasses-alcohol-; NCI-C03134-; Potato-alcohol-; SD-alcohol-23-hydrogen-; Spirits-of-wine-; Spirt-; Tecsol- RN: Current: 64-17-5 UD: 200305 MF: C2-H6-O MW: 46.08 WL: Q2 CC: Tumorigen (C); Drug (D); Mutagen (M); Natural-Product (N); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 400 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 7/22/1970 (UCDS**); skn-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,189,1986 (85JCAE); eye-rbt 500 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,189,1986 (85JCAE); eye-rbt 100 mg/4S rinse MOD Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 573, 1982 (FCTOD7) ME: mmo-sat 11 pph (+S9) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 52, p. 225, 1990 (ENVRAL); mmo-esc 140 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 97, 1984 (MUREAV); dnr-esc 5 mg/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); sln-dmg-orl 10 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 268, p. 95, 1992 (MUREAV); mmo-smc 24 pph (-S9) Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 15, p. 927, 1979 (GNKAA5); dnd-smc 850 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 326, p. 165, 1995 (MUREAV); mmo-asn 20 pph (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 51, 1977 (MUREAV); mrc-asn 5 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 51, 1977 (MUREAV); sln-asn 30 gm/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 31, p. 81, 1979 (EVHPAZ); cyt-grh-par 500 mmol/L Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 51, p. 646, 1964 (NATWAY); dni-hmn-lym 220 mmol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 1171, 1982 (PNASA6); cyt-hmn-lym 1160 gm/L Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 85A, p. 25, 1977 (AEMBAP); cyt-hmn-fbr 12000 ppm Acta Cytologica. (Science Printers and Pub., Inc., 2 Jacklynn Ct., St. Louis, MO 63132) V.1- 1957- v. 16, p. 41, 1972 (ACYTAN); cyt-hmn-leu 1 pph/72H-C Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959- v. 20, p. 421, 1978 (TSITAQ); sce-hmn-lym 500 ppm/72H-C Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 27, p. 66, 1980 (CGCGBR); dnd-rat-orl 4 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 345, p. 191, 1995 (MUREAV); oms-rat-ipr 250 gm/kg/16D-C Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 56, p. 195, 1988 (CYTBAI); oms-rat-orl 3 gm/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 49, p. 125, 1981 (APTOA6); cyt-rat-orl 2 gm/kg Tsitologiya i Genetika. Cytology and Genetics. For English translation, see CYGEDX. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967- v. 14(5), p. 48, 1980 (TGANAK); mnt-mus-ipr 1240 mg/kg/2D Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 85A, p. 25, 1977 (AEMBAP); cyt-mus-orl 40 gm/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 302, p. 258, 1983 (NATUAS); sce-mus-orl 420 mg/kg/3W Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 291, 1979 (MUREAV); sln-mus-orl 5 gm/kg Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 44, p. 7, 1987 (CGCGBR); dlt-mus-orl 3720 mg/kg/3D Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 85A, p. 25, 1977 (AEMBAP); spm-mus-orl 1500 mg/kg/50D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 65, p. 229, 1979 (MUREAV); cyt-ham-ovr 100 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 72, 1986 (ENMUDM); cyt-ham-emb 1 pph Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 3, p. 207, 1988 (MUTAEX); cyt-ham-ovr 160 mmol/L Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 106, p. 169, 1987 (BIZNAT); sce-ham-ovr 3900 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 85, 1983 (MUREAV); mnt-dog-lym 400 umol/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A075-605 (NTIS**); dna-rat-orl 5 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 479, p. 81, 2001 (MUREAV); dna-rat-orl 3 gm/kg/7D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 479, p. 81, 2001 (MUREAV) RE: T74-T77-T84 orl-wmn TDLo: 41 gm/kg (41W preg) American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 129, p. 1075, 1975 (AJDCAI); T39 orl-wmn TDLo: 250 mg/kg (37W preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 145, p. 251, 1983 (AJOGAH); T74-T77 ivn-wmn TDLo: 8 gm/kg (32W preg) American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 134, p. 419, 1980 (AJDCAI); T22 iut-wmn TDLo: 200 mg/kg (5D pre) International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS 66044) V.1- 1955- v. 14, p. 280, 1969 (INJFA3); T83 orl-rat TDLo: 78 gm/kg (7-19D preg) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 59, p. 577, 1998 (PBBHAU); T33 orl-rat TDLo: 4 gm/kg (13D preg) Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 15(2), p. 23, 1981 (CYGEDX); T01-T02 orl-rat TDLo: 322 gm/kg (35D male) International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS 66044) V.1- 1955- v. 23, p. 176, 1978 (INJFA3); T34 orl-rat TDLo: 12 gm/kg (9-12D preg) Physiological Psychology. (Austin, TX) V.1-14, 1973-86. v. 7, p. 311, 1979 (PLPSAX); T16-T81-T85 orl-rat TDLo: 132 gm/kg (1-22D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 23, p. 217, 1981 (TJADAB); T41-T59 orl-rat TDLo: 24 gm/kg (14-16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 23, p. 41A, 1981 (TJADAB); T83 orl-rat TDLo: 354 gm/kg (10D post) Research Communications in Psychology, Psychiatry and Behavior. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1976- v. 2, p. 119, 1977 (RCPBDC); T42-T53 orl-rat TDLo: 4 gm/kg (6-15D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 267, 1982 (JTEHD6); T22-T24-T25 orl-rat TDLo: 35295 mg/kg (1-15D preg) Ontogenez (Moscow). For English translation, see SJDBA9. (V/O Mezhdunarodnaya Kniga, 113095, Moscow, USSR) V.1- 1970- v. 22(1), p. 71, 1991 (ONGZAC); T46-T53 orl-rat TDLo: 44 gm/kg (7-17D preg) Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (103), p. 10, 1985 (ESKHA5); T59 ihl-rat TCLo: 20000 ppm/7H (1-22D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 48A, 1984 (TJADAB); T85-T86 ipr-rat TDLo: 15 gm/kg (8-13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 36, p. 31A, 1987 (TJADAB); T31 ipr-rat TDLo: 2240 mg/kg (9-12D preg) Dissertation Abstracts International, B: The Sciences and Engineering. (University Microfilms International, 300 N. Zeeb Rd., Ann Arbor, MI 48106) V.30- 1969- v. 38, p. 5835, 1978 (DABBBA); T34 ipr-rat TDLo: 600 mg/kg (8-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 26(1), p. 12A, 1982 (TJADAB); T25-T31-T34 ipr-rat TDLo: 600 mg/kg (8-15D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 21, p. 108, 1983 (IJEBA6); T43-T46 ipr-rat TDLo: 600 mg/kg (8-15D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 21, p. 108, 1983 (IJEBA6); T85 ipr-rat TDLo: 3600 mg/kg (7-8D preg) Neuroscience Letters. (Elsevier Scientific Publishers Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 289, p. 13, 2000 (NELED5); T31-T39-T46 ivn-rat TDLo: 4 gm/kg (6-7D preg) Revue Roumaine d'Embryologie et de Cytologia, Serie d'Embrologie. (Bucharest, Romania) V.1-8, 1964-71. v. 8, p. 105, 1971 (RECYAR); T25 ivn-rat TDLo: 3 gm/kg (6-7D preg) Revue Roumaine d'Embryologie et de Cytologia, Serie d'Embrologie. (Bucharest, Romania) V.1-8, 1964-71. v. 8, p. 105, 1971 (RECYAR); T34-T46-T59 ivn-rat TDLo: 4 gm/kg (6-7D preg) Revue Roumaine d'Embryologie et de Cytologia, Serie d'Embrologie. (Bucharest, Romania) V.1-8, 1964-71. v. 8, p. 105, 1971 (RECYAR); T29 ice-rat TDLo: 5 mg/kg (1D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 42, p. 199, 1975 (JRPFA4); T25-T35 unr-rat TDLo: 60 gm/kg (9-14D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 45(1), p. 83, 1982 (FATOAO); T23 itt-rat TDLo: 400 mg/kg (1D male) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 24, p. 884, 1973 (FESTAS); T25 iut-rat TDLo: 2400 mg/kg (10D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 14, p. 316, 1976 (IJEBA6); T16-T76-T81 mul-rat TDLo: 642 gm/kg (1-21D preg/23D post) Developmental Psychobiology. (John Wiley and Sons, Inc., 605 Third Ave., New York, NY 10158) V.1- 1968- v. 10, p. 435, 1977 (DEPBA5); T85-T86 mul-rat TDLo: 373 gm/kg (23D post) Developmental Psychobiology. (John Wiley and Sons, Inc., 605 Third Ave., New York, NY 10158) V.1- 1968- v. 10, p. 435, 1977 (DEPBA5); T31 orl-mus TDLo: 162 gm/kg (11-19D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 56A, 1983 (TJADAB); T83-T85 orl-mus TDLo: 21 gm/kg (1-21D preg) Journal of Studies on Alcohol. (P.O. Box 969, Piscataway, NJ 08854) V.36- 1975- v. 38, p. 1696, 1977 (JSALDP); T41-T42 orl-mus TDLo: 5800 mg/kg (7D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 231, 1983 (TJADAB); T53-T72-T81 orl-mus TDLo: 75600 mg/kg (5-11D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 23, p. 127, 1979 (RCOCB8); T34 orl-mus TDLo: 5500 mg/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24(1), p. 53A, 1981 (TJADAB); T01 orl-mus TDLo: 1680 gm/kg (70D male) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 39, p. 542, 1980 (FEPRA7); T34-T46 ipr-mus TDLo: 5800 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 231, 1983 (TJADAB); T41-T42-T43 ipr-mus TDLo: 5800 mg/kg (7D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 231, 1983 (TJADAB); T35-T42-T46 ipr-mus TDLo: 5622 ug/kg (10D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 124, p. 676, 1976 (AJOGAH); T33 ipr-mus TDLo: 4 mg/kg (10D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 193, p. 515, 1979 (ANREAK); T25 ipr-mus TDLo: 4300 mg/kg (10D preg) Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information, see NTOTDY. v. 2, p. 227, 1980 (NETOD7); T71-T72-T81 orl-dog TDLo: 21600 mg/kg (1-60D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 36, p. 285, 1977 (FEPRA7); T75 orl-dog TDLo: 260 gm/kg (1-62D preg) Alcoholism: Clinical and Experimental Research. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1977- v. 4, p. 123, 1980 (ACRSDM); T27 orl-dog TDLo: 221 gm/kg (1-47D preg) Alcoholism: Clinical and Experimental Research. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1977- v. 4, p. 123, 1980 (ACRSDM); T02 itt-dog TDLo: 100 mg/kg (1D male) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 24, p. 884, 1973 (FESTAS); T27 orl-mky TDLo: 78 gm/kg (4-23W preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 345, 1987 (TJADAB); T81 orl-mky TDLo: 400 mg/kg (2-21W preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29, p. 49, 1984 (TJADAB); T14 orl-mky TDLo: 206 gm/kg (90D pre) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 221, p. 677, 1983 (SCIEAS); T34-T41-T43 orl-mky TDLo: 32400 mg/kg (2-19W preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 44, p. 29, 1991 (TJADAB); T31 orl-mky TDLo: 43200 mg/kg (1-24W preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 44, p. 29, 1991 (TJADAB); T22 orl-rbt TDLo: 3945 mg/kg (1D pre) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 34, p. 275, 1966 (JOENAK); T29 orl-rbt TDLo: 3750 mg/kg (1D pre) Indian Journal of Medical Research. (Indian Council of Medical Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913- v. 58, p. 501, 1970 (IJMRAQ); T34-T39 ivn-rbt TDLo: 15 mg/kg (15-29D preg) Journal of Pediatric Surgery. (Grune and Stratton, Inc., Journal Subscription Dept., POB 6280, Duluth, MN 55806) V.1- 1966- v. 29, p. 1030, 1994 (JPDSA3); T72-T81 orl-pig TDLo: 2648 gm/kg (78W pre/1-16W preg) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 5, p. 229, 1983 (NTOTDY); T81-T85 orl-gpg TDLo: 90 gm/kg (1-68D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 127, p. 438, 1957 (ANREAK); T34-T41 orl-gpg TDLo: 240 gm/kg (2-61D preg) Developmental Brain Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1981- v. 106, p. 39, 1998 (DBRRDB); T81-T83-T86 orl-gpg TDLo: 264 gm/kg (2-67D preg) Alcoholism: Clinical and Experimental Research. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1977- v. 23, p. 1816, 1999 (ACRSDM); T43 orl-gpg TDLo: 72 gm/kg (45-62D preg) FASEB Journal. Official Publication of the Federation of American Societies for Experimental Biology. (Federation of American Societies for Experimental Biology, 9650 Rockville Pike, Bethesda, MD 20814) V.1- 1987- v. 14, p. A1447, 2000 (FAJOEC); T34 ivn-dom TDLo: 94 gm/kg (14-21W preg) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 12, p. 329, 1980 (PBBHAU); T34-T83 ivn-dom TDLo: 40 gm/kg (14-17W preg) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 3, p. 105, 1981 (NTOTDY); T49 ivn-dom TDLo: 1 gm/kg (18W preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 151, p. 859, 1985 (AJOGAH); T43 orl-mam TDLo: 31500 mg/kg (15-35D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30, p. 203, 1984 (TJADAB); T19-T77-T39 orl-gpg TDLo: 76000 mg/kg (43-62D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 23, p. 355, 2001 (NETEEC); T41-T85-T87 orl-rat TDLo: 191220 mg/kg (2-20D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 23, p. 453, 2001 (NETEEC); T19-T41-T86 orl-gpg TDLo: 264000 mg/kg (2-67D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 22, p. 183, 2000 (NETEEC); T19-T77-T85 ivn-dom TDLo: 29000 mg/kg (106-134D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 22, p. 205, 2000 (NETEEC); T41-T77 orl-rat TDLo: 30 gm/kg (1-20D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 163, p. 15, 2001 (TJADAB); T51-T53-T81 orl-mus TDLo: 20 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); T81 orl-mus TDLo: 20 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); T53 orl-mus TDLo: 20 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); T41-T87 orl-rat TDLo: 22.5 gm/kg (11-20D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 719, 2002 (NETEEC); T59-T41 orl-rat TDLo: 40 gm/kg (1-20D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 45, p. 68, 1982 (FATOAO); T59 orl-rat TDLo: 42 gm/kg (1-21D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 45, p. 66, 1982 (FATOAO); T72 orl-mus TDLo: 700 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); T53 orl-rat TDLo: 240 gm/kg (30D male) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 82, 1984 (FATOAO); T52 orl-rat TDLo: 65 gm/kg (7-19D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 138, p. 389, 1997 (ENDOAO); T52 orl-rat TDLo: 75 gm/kg (7-21D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 138, p. 389, 1997 (ENDOAO); T83 orl-rat TDLo: 112 mg/kg (14D male) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 86, 1985 (FATOAO); T52-T91 orl-rat TDLo: 147 mg/kg (1-21D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 84, 1984 (FATOAO); T52-T83-T91 orl-rat TDLo: 60000 mg/kg (1-30D post) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 93, 1985 (FATOAO); T41-T81-T83 orl-rat TDLo: 900 mL/kg (19D pre-21D post) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 275, 2002 (NETEEC) TE: V03-L60-P62 orl-mus TDLo: 320 mg/kg/50W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 13, p. 345, 1981 (CALEDQ); V03-K60-L60 rec-mus TDLo: 120 gm/kg/18W-I Zeitschrift fuer Immunitaetsforschung und Experimentelle Therapie. (Stuttgart, Fed. Rep. Ger.) 1924-62. For publisher information, see ZIEKBA. v. 59, p. 203, 1928 (ZIETA2); V03-K60 orl-mus TD :400 gm/kg/57W-I Zeitschrift fuer Immunitaetsforschung und Experimentelle Therapie. (Stuttgart, Fed. Rep. Ger.) 1924-62. For publisher information, see ZIEKBA. v. 59, p. 203, 1928 (ZIETA2) ORNG: 7060000000 ng/kg. [7060.000000 mg/kg] J30 AT: N30-P30 orl-man TDLo: 22500 mg/kg/4W-I Clinical Endocrinology (Oxford). (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1972- v. 25, p. 143, 1986 (CLECAP); F01-G04-J22 orl-inf TDLo: 11712 uL/kg Journal of UOEH (University of Occupational and Environmental Health). (Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu 807, Japan) V.1- 1979- v. 9, p. 53, 1987 (JOUOD4); N04-N30-P30 orl-wmn TDLo: 1200 mg/kg/3H Alcoholism: Clinical and Experimental Research. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1977- v. 7, p. 289, 1983 (ACRSDM); F05-F13-F24 orl-man TDLo: 3371 uL/kg Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 21, p. 272, 1979 (VHTODE); J30-L03-P30 orl-chd LDLo: 2 gm/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 17, p. 183, 1958 (ATXKA8); F24-J22-K13 orl-chd TDLo: 14400 mg/kg/30M-I Acta Paediatrica Scandinavica. (Almqvist and Wiksell International, POB 4627, S-11691 Stockholm, Sweden) V.54-80 1965-91 For publisher information, see APAEEL v. 74, p. 977, 1985 (APSVAM); F42 orl-man TDLo: 700 mg/kg Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 8, p. 77, 1986 (NTOTDY); F04-F27-K13 orl-hmn LDLo: 1400 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 44, 1974 (NPIRI*); K04-K30 orl-man TDLo: 50 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 56, p. 117, 1936 (JPETAB); F17-F19-F25 orl-man TDLo: 1430 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 197, p. 488, 1976 (JPETAB); F08-N19 orl-wmn TDLo: 256 gm/kg/12W JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 238, p. 2143, 1977 (JAMAAP); F12-F24-U28 scu-inf LDLo: 19440 mg/kg American Journal of Clinical Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1931- v. 5, p. 466, 1935 (AJCPAI); J30 orl-rat LD50: 7060 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 718, 1970 (TXAPA9); T/E unlistd ihl-rat LC50: 20000 ppm/10H Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 44, 1974 (NPIRI*); T/E unlistd ipr-rat LD50: 3600 ug/kg Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1968- v. 2, p. 27, 1969 (PHMGBN); J22 ivn-rat LD50: 1440 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 60, 1971 (TXAPA9); J16-J22 iat-rat LD50: 11 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 60, 1971 (TXAPA9); T/E unlistd orl-mus LD50: 3450 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(3), p. 31, 1967 (GISAAA); T/E unlistd ihl-mus LC50: 39 gm/m3/4H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 26(8), p. 53, 1982 (GTPZAB); T/E unlistd ipr-mus LD50: 528 mg/kg Strahlentherapie. (Urban and Schwarzenberg, Postfach 202440, D-8000 Munich 2, Fed. Rep. Ger.) V.1- 1912- v. 127, p. 245, 1965 (STRAAA); T/E unlistd scu-mus LD50: 8285 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 48A, p. 99, 1970 (FAONAU); T/E unlistd ivn-mus LD50: 1973 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 128, 1955 (HBTXAC); T/E unlistd orl-dog LDLo: 5500 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 130, 1955 (HBTXAC); T/E unlistd ipr-dog LDLo: 3 gm/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 1, p. 207, 1944 (BJIMAG); T/E unlistd scu-dog LDLo: 6 gm/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 130, 1955 (HBTXAC); F19-J22-K12 ivn-dog LDLo: 1600 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 60, 1971 (TXAPA9); K05-L01-M05 orl-cat LDLo: 6 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 56, p. 117, 1936 (JPETAB); T/E unlistd ivn-cat LDLo: 3945 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 130, 1955 (HBTXAC); T/E unlistd orl-rbt LD50: 6300 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 130, 1955 (HBTXAC); T/E unlistd skn-rbt LDLo: 20 gm/kg "Alcohols: Their Chemistry, Properties and Manufacture," Monick, J.A., New York, Reinhold Book, 1968 -,72,1968 (31ZTAS); T/E unlistd ipr-rbt LD50: 963 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 61, p. 321, 1985 (EVHPAZ); T/E unlistd scu-rbt LDLo: 20 gm/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 651, 1980 (YAKUD5); T/E unlistd ivn-rbt LD50: 2374 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 61, p. 321, 1985 (EVHPAZ); T/E unlistd orl-gpg LD50: 5560 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); T/E unlistd ihl-gpg LCLo: 21900 ppm FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 48A, p. 99, 1970 (FAONAU); T/E unlistd ipr-gpg LD50: 3414 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 61, p. 321, 1985 (EVHPAZ); T/E unlistd ipr-ham LD50: 5068 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 61, p. 321, 1985 (EVHPAZ); T/E unlistd scu-pgn LDLo: 5 gm/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931 v. -, p. -, 1931 (FDWU**); T/E unlistd scu-ckn LDLo: 5 gm/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931 v. -, p. -, 1931 (FDWU**); H30 ivn-ckn LDLo: 8216 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 60, p. 312, 1937 (JPETAB); T/E unlistd scu-frg LDLo: 7100 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 128, 1955 (HBTXAC); C06-F07 par-frg LDLo: 36 gm/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 50, p. 296, 1935 (AIPTAK); F07-F12-F17 ipr-mam LD50: 4300 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 13, p. 358, 1968 (TXAPA9); K04-K06 orl-rat TDLo: 6.4 gm/kg Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 70, p. 17, 2001 (LIFSAK); F17 ipr-mus TDLo: 0.8 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 293, p. 188, 2000 (JPETAB); U28 ipr-mus TDLo: 4.2 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 293, p. 188, 2000 (JPETAB); T/E unlistd ihl-mus LCLo: 117000 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); F40 ihl-mus TCLo: 50000 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); A30 ihl-mus TCLo: 2500 mg/m3/40M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); T/E unlistd orl-rat LD50: 9000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); F19 orl-rat TDLo: 1500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); F01 ihl-rat TCLo: 12000 mg/m3/8H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); F01 ihl-gpg TCLo: 12000 mg/m3/8H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); A30 ihl-rbt TCLo: 2500 mg/m3/40M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); C15 ihl-hmn TCLo: 2500 mg/m3/20M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1984 (VCVGK*); F05 ipr-rat TDLo: 2.45 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 299, p. 698, 2001 (JPETAB); K30 orl-rat TDLo: 2.5 gm/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 365, p. 17, 2002 (AEPPAE); A30-H30-L30 orl-mus TDLo: 5 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 298, p. 737, 2001 (JPETAB); F04 ipr-rat TDLo: 3 gm/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 444, p. 83, 2002 (EJPHAZ); U28 ipr-rat TDLo: 3000 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 21, 1984 (FATOAO); A30-G01-L50 orl-rat TDLo: 8000 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 52, 1987 (FATOAO); P28-Y21 orl-rat TDLo: 3 gm/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 319, 1981 (FATOAO); F17 orl-rat TDLo: 5 gm/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 319, 1981 (FATOAO) MD: L03-L70-U01 orl-rat TDLo: 1825 gm/kg/1Y-C Digestive Diseases and Sciences. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.24- 1979- v. 25, p. 587, 1980 (DDSCDJ); Y07 orl-rat TDLo: 19 gm/kg/21D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 12, p. 265, 1982 (TOLED5); G70-P28-Z73 orl-rat TDLo: 280 gm/kg/5W-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 8, p. 243, 1983 (JTSCDR); Y07-Y10 orl-rat TDLo: 851 gm/kg/10W-C Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 38, p. 260, 1976 (APTOA6); L30-Y25 orl-rat TDLo: 7 mL/kg/7D-I Journal of Drug Research. (National Organization for Drug Research and Control, POB 29, Cairo, Egypt) V.2- 1969- v. 10(1-2), p. 25, 1978 (JDGRAX); L30-L70-Y16 orl-rat TDLo: 6300 mg/kg/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 64(1), p. 46, 1999 (GISAAA); A30-G30-L30 orl-dog TDLo: 560 mL/kg/10W-C Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 128, p. 1021, 1968 (PSEBAA); L03 orl-mky TDLo: 210 gm/kg/5W-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 8, p. 243, 1983 (JTSCDR); F42 orl-rat TDLo: 45 gm/kg/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 64, 1993 (GISAAA); T23 orl-mus TDLo: 3500 gm/kg/10W-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 225, p. 479, 1983 (JPETAB); T23 orl-mus TDLo: 2100 gm/kg/5W-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 225, p. 479, 1983 (JPETAB); T01 orl-mus TDLo: 1750 gm/kg/5W-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 225, p. 479, 1983 (JPETAB); A30-N30-S05 ihl-mus TCLo: 8000 mg/m3/4H/17W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1994 (VCVGK*); A30-N30-S05 ihl-rat TCLo: 8000 mg/m3/4H/17W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1994 (VCVGK*); A30-N30-S05 ihl-rbt TCLo: 8000 mg/m3/4H/17W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 93, 1994 (VCVGK*); A30-N19-N04 orl-rat TDLo: 62.5 gm/kg/5D-C Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 37, p. 1089, 1987 (BIREBV); N19 orl-rat TDLo: 62.5 gm/kg/6D-C Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 37, p. 1089, 1987 (BIREBV); F16 orl-mus TDLo: 448 gm/kg/4W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118651 (NTIS**); N30 orl-rat TDLo: 65 gm/kg/13D-C Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 138, p. 389, 1997 (ENDOAO); F16-U01 orl-rat TDLo: 900 mL/kg/62D-C Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 275, 2002 (NETEEC); T01 orl-rat TDLo: 240000 mg/kg/30D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 82, 1984 (FATOAO); L01-L03-Y55 ims-rat TDLo: 420 gm/kg/6W-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 299, p. 832, 2001 (JPETAB); Y15-L30 ims-mus TDLo: 42 gm/kg/14D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 46, p. 103, 1983 (FATOAO); L03-L14 ims-mus TDLo: 63 gm/kg/21D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 46, p. 103, 1983 (FATOAO) TR: ACGIH TLV-TWA 1000 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1000 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 44, p. 35, 1988 (IMEMDT); TOXICOLOGY REVIEW International Review of Experimental Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 11, p. 177, 1972 (IRXPAT); TOXICOLOGY REVIEW Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 56, p. 291, 1975 (AEMBAP); TOXICOLOGY REVIEW Archivos del Instituto de Cardiologia de Mexico. (Instituto de Cardiologia de Mexico, Juan Badiano No.1, 14080 Mexico City, Mexico) V.14- 1944- v. 44, p. 874, 1974 (AICMA2); TOXICOLOGY REVIEW Methods and Achievements in Experimental Pathology. (S. Karger AG, Postfach, CH-4009, Basel, Switzerland) V.1- 1966- v. 6, p. 81, 1972 (MAEPBU); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 8, p. 433, 1970 (FCTXAV); TOXICOLOGY REVIEW Clinical Chemistry (Winston-Salem, NC). (American Assoc. for Clinical Chemistry, 1725 K St., NW, Washington, DC 20006) V.1- 1955- v. 19, p. 361, 1973 (CLCHAU); TOXICOLOGY REVIEW Pharmacological Reviews. (Williams and Wilkins, 428 E. Preston St., Baltimore, MD 21202) V.1- 1949- v. 4, p. 1, 1952 (PAREAQ); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6); TOXICOLOGY REVIEW Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 209, p. 353, 1980 (SCIEAS); TOXICOLOGY REVIEW JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 235, p. 1458, 1976 (JAMAAP); TOXICOLOGY REVIEW Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 157, 1980 (TJADAB); TOXICOLOGY REVIEW Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 16, p. 53, 1977 (TJADAB) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 1000 ppm (1900 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 103, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1000 ppm (1900 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1000 ppm (1900 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1000 ppm (1900 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1000 ppm (1900 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 1000 ppm (1900 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 1000 ppm (1900 mg/m3), JAN 1999; OEL-BELGIUM: TWA 1000 ppm (1880 mg/m3), JAN 1993; OEL-DENMARK: TWA 1000 ppm (1900 mg/m3), JAN 1999; OEL-FINLAND: TWA 1000 ppm (1900 mg/m3), STEL 1250 ppm (2400 mg/m3), JAN 1999; OEL-FRANCE: VME 1000 ppm (1900 mg/m3), VLE 5000 ppm, JAN 1999; OEL-GERMANY: MAK 1000 ppm (1900 mg/m3), JAN 1999; OEL-HUNGARY: TWA 1000 mg/m3, STEL 3000 mg/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 500 ppm (950 mg/m3), JAN 1999; OEL-NORWAY: TWA 500 ppm (950 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1000 ppm (1900 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 1000 mg/m3, MAC(STEL) 3000 mg/m3, JAN 1999; OEL-RUSSIA: STEL 1000 mg/m3, JAN 1993; OEL-SWEDEN: NGV 500 ppm (1000 mg/m3), KTV 1000ppm (1900 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 1000 ppm (1900 mg/m3), JAN 1999; OEL-THAILAND: TWA 1000 ppm (1900 mg/m3), JAN 1993; OEL-TURKEY: TWA 1000 ppm (1900 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 1000 ppm (1950 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ETHYL ALCOHOL-air: 10H TWA 1000 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 31500; NIS 430; TNF 157709; NOS 242; TNE 2088926; NOES 1983: HZD 31500; NIS 334; TNF 86077; NOS 222; TNE 2069125; TFE 1014002 SL: EPA GENETOX PROGRAM 1988, Positive: Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Negative: Aspergillus-forward mutation, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-nonhuman, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Negative: N crassa-aneuploidy, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: In vitro SCE-human lymphocytes, In vitro SCE-human; EPA GENETOX PROGRAM 1988, Negative: In vitro SCE-nonhuman, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative/limited: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Ethanol in blood, 8002; NIOSH Analytical Method, 1994: Alcohols I, 1400; NTP Carcinogenesis studies, on test (two year studies), October 2000; OSHA ANALYTICAL METHOD #100 Record 772 of 1119 in RTECS (through 2003/06) AN: KR5919600 PN: Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (Z)- SY: (Z)-2-(4-(1,2-Diphenyl-1-butenyl)-phenoxy)-N,N-dimethylethanamine(tamoxifen); (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene-; ICI-47699-; Tamoxifen-; Tamoxifen- (Z); Z-Tamoxifen-; trans-Tamoxifen- RN: Current: 10540-29-1 UD: 200305 MF: C26-H29-N-O MW: 371.56 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mnt-hmn-lym 1 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 5, 1994 (CRNGDP); dna-hmn-lym 10 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 16, p. 1661, 1995 (CRNGDP); dni-hmn-mmr 1 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 1727, 1982 (CNREA8); cyt-hmn-lym 500 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 303, 1997 (CRNGDP); sln-hmn-lym 250 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 303, 1997 (CRNGDP); mtr-rat-orl 840 mg/kg/6W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 195, 1989 (CALEDQ); dna-rat-lvr 10 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 19, p. 861, 1998 (CRNGDP); dna-rat-orl 60 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 1487, 1994 (CRNGDP); dna-rat-ipr 35 mg/kg/7D-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1785, 1996 (CRNGDP); oms-rat-scu 2500 ug/kg/5D-I Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 656, p. 45, 1981 (BBACAQ); dni-rat-scu 500 ug/kg Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 656, p. 45, 1981 (BBACAQ); cyt-rat-orl 35 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 303, 1997 (CRNGDP); sln-rat-orl 35 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 303, 1997 (CRNGDP); msc-rat-orl 840 mg/kg/6W-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 28, p. 430, 1996 (EMMUEG); dna-mus-ipr 480 umol/kg/4D-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 2087, 1994 (CRNGDP); dna-mus-orl 480 umol/kg/4D-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2197, 1992 (CRNGDP); dna-mus-lvr 10 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 89, 1996 (CRNGDP); dna-rat-orl 147 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 171, p. 27, 2001 (CALEDQ); dns-rat-orl 367.5 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 171, p. 27, 2001 (CALEDQ); hma-rat-orl 1680 mg/kg/12W Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 162, p. 117, 2001 (CALEDQ); dna-mus-orl 840 mg/kg/7D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 1737, 2000 (CRNGDP); dna-rat-orl 140 mg/kg/7D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 22, p. 1307, 2001 (CRNGDP); dna-rat-ipr 140 mg/kg/7D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 22, p. 1307, 2001 (CRNGDP); dna-rat-orl 140 mg/kg/7D Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 13, p. 200, 2000 (CRTOEC); dna-rat-orl 245 mg/kg/1W Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 75, p. 375, 2001 (ATSUDG) RE: T17 orl-wmn TDLo: 4 mg/kg (5D post) British Journal of Obstetrics and Gynaecology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.82- 1975- v. 85, p. 134, 1978 (BJOGAS); T22 orl-rat TDLo: 2250 ug/kg (1-3D preg) Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 14, p. 952, 1971 (JMCMAR); T25-T34-T39 orl-rat TDLo: 6 mg/kg (9-11D preg) British Journal of Obstetrics and Gynaecology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.82- 1975- v. 103, p. 630, 1996 (BJOGAS); T24 orl-rat TDLo: 50 ug/kg (4D preg) Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 64, p. 741, 1980 (CTRRDO); T19 orl-rat TDLo: 330 mg/kg (30D pre) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 114, p. 127, 1992 (TXAPA9); T86-T87 scu-rat TDLo: 600 ug/kg (15-20D preg) Clinical Cancer Research. (Clinical Cancer Research, POB 3000, Denville, NJ 07834) V.1- 1995- v. 6, p. 305, 2000 (CCREF4); T22 scu-rat TDLo: 2250 ug/kg (1-3D preg) Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 14, p. 952, 1971 (JMCMAR); T24 scu-rat TDLo: 100 ug/kg (3D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 5, p. 473, 1972 (CCPTAY); T13 scu-rat TDLo: 500 ug/kg (1D pre) Journal of Steroid Biochemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1969- v. 12, p. 47, 1980 (JSTBBK); T12-T13-T14 scu-rat TDLo: 75 ug/kg (3D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 21, p. 1087, 1979 (BIREBV); T13-T14-T19 ims-rat TDLo: 3500 ug/kg (14D pre) Nippon Funin Gakkai Zasshi. Japanese Journal of Fertility and Sterility. (Nippon Funin Gakkai, 1-1 Sadohara-cho, Ichigaya, Shinjuku-ku, Toyko 162, Japan) V.1- 1956- v. 30, p. 1, 1985 (NFGZAD); T22 orl-mus TDLo: 2400 ug/kg (1-3D preg) Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 14, p. 952, 1971 (JMCMAR); T11 orl-mus TDLo: 1 mg/kg (3D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 5, p. 209, 1982 (ATSUDG); T29 orl-mus TDLo: 50 ug/kg (3D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 5, p. 209, 1982 (ATSUDG); T22 scu-mus TDLo: 7200 ug/kg (1-3D preg) Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 14, p. 952, 1971 (JMCMAR); T12-T13 scu-mus TDLo: 25 mg/kg (5D preg) In Vivo. (POB 51359, Kiffisia, GR-145 10, Greece) V.1- 1987- v. 4, p. 175, 1990 (IVIVE4); T91 par-mus TDLo: 480 ug/kg (15-20D preg) Oncology Reports. (Oncology Reports, POB 18179, Athens, 116 10, Greece) V.1- 1994- v. 5, p. 609, 1998 (OCRPEW); T31-T34 orl-rbt TDLo: 3250 ug/kg (6-18D preg) Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- v. 6, p. 217, 1980 (JZKEDZ); T13-T24 scu-ham TDLo: 6 mg/kg (1-3D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 41, p. 93, 1990 (CCPTAY); T52-T85-T86 scu-gpg TDLo: 7500 ug/kg (29-54D preg) Hormones and Behavior. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 21, p. 402, 1987 (HOBEAO); T91 scu-gpg TDLo: 7500 ug/kg (29-54D preg) Hormones and Behavior. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 21, p. 402, 1987 (HOBEAO) TE: V03-L60 orl-rat TDLo: 6825 mg/kg/65W-C Breast Cancer Research and Treatment. (Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1981- v. 31, p. 11, 1994 (BCTRD6); V01-T64 orl-rat TDLo: 4 mg/kg/4D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 793, 2000 (CRNGDP); V01-L60 orl-rat TDLo: 2.94 gm/kg/12W-C Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 75, p. 375, 2001 (ATSUDG) ORNG: 4100000000 ng/kg. [4100.000000 mg/kg] T/E unlistd AT: R25 orl-wmn TDLo: 5600 ug/kg/1W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 291, p. 1172, 1985 (BMJOAE); K13-P14-P17 unr-wmn TDLo: 200 ug/kg/D Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 1431, 1976 (CTRRDO); P05-Q15 unr-wmn TDLo: 5600 ug/kg/2W-I British Journal of Rheumatology. (Bailliere Tindall, 33 The Avenue, Eastborn BN21 3UN, UK) v. 33, p. 583, 1994 (BJRHDF); T/E unlistd orl-rat LD50: 4100 mg/kg Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- v. 9, p. 186, 1984 (DRFUD4); T/E unlistd ipr-rat LD50: 700 mg/kg Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- v. 9, p. 186, 1984 (DRFUD4); T/E unlistd orl-mus LD50: 2150 mg/kg Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- v. 9, p. 186, 1984 (DRFUD4); T/E unlistd ipr-mus LD50: 575 mg/kg Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52: V.21- 1968- v. 43, p. 1533, 1990 (JANTAJ); N17 ipr-ckn TDLo: 10 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 267, p. 434, 1977 (NATUAS) MD: Y15-Y40 orl-rat TDLo: 330 mg/kg/30D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 114, p. 127, 1992 (TXAPA9); P28-Y15-Y40 orl-rat TDLo: 1001 mg/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 114, p. 127, 1992 (TXAPA9); N13 orl-rat TDLo: 308 mg/kg/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 114, p. 127, 1992 (TXAPA9); Y15 orl-rat TDLo: 84 mg/kg/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 114, p. 127, 1992 (TXAPA9); L70 orl-rat TDLo: 147 mg/kg/1W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 171, p. 27, 2001 (CALEDQ); L70 orl-rat TDLo: 1911 mg/kg/13W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 171, p. 27, 2001 (CALEDQ); U01 orl-rat TDLo: 1575 mg/kg/5W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 249, 2000 (ARTODN); L70-L30 orl-rat TDLo: 3780 mg/kg/12W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 249, 2000 (ARTODN); L60-V05 orl-rat TDLo: 15120 mg/kg/1Y-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 249, 2000 (ARTODN); L60 orl-rat TDLo: 7560 mg/kg/26W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 249, 2000 (ARTODN); Y07 orl-rat TDLo: 630 mg/kg/14D-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 249, 2000 (ARTODN); N73-N74-Z74 scu-mus TDLo: 14.5 mg/kg/5D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 60, p. 185, 2000 (JTEHD6); U01 scu-mus TDLo: 0.3 mg/kg/5D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 60, p. 185, 2000 (JTEHD6); Z74-N17 scu-mus TDLo: 300 ug/kg/3D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 104, p. 1296, 1996 (EVHPAZ); T13 orl-rat TDLo: 980 mg/kg/4W-C Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 75, p. 375, 2001 (ATSUDG); N17-T13 scu-rat TDLo: 178.5 ug/kg/5D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 56, p. 1239, 1997 (BIREBV); N17-T13-Z74 scu-rat TDLo: 1085 ug/kg/5D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 56, p. 1239, 1997 (BIREBV); N04 orl-wmn TDLo: 5.6 mg/kg/1W-I Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 54, p. 404, 1982 (JCEMAZ); R60-V30 orl-wmn TDLo: 112 mg/kg/20W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 92, p. 903, 2000 (JJIND8); L70-U01-Z73 scu-rat TDLo: 336 mg/kg/40W-I Prostate (New York). (John Wiley and Sons, Inc., 605 Third Avenue, New York, NY 10158). V.1- 1980- v. 31, p. 9, 1997 (PRSTDS); N30-Z74 scu-rat TDLo: 4 mg/kg/4D-I Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 65, p. 151, 1975 (JOENAK); U01 scu-rat TDLo: 333.2 mg/kg/28W-I Prostate (New York). (John Wiley and Sons, Inc., 605 Third Avenue, New York, NY 10158). V.1- 1980- v. 31, p. 9, 1997 (PRSTDS); L70-M71-Z72 scu-rat TDLo: 714 mg/kg/60W-I Prostate (New York). (John Wiley and Sons, Inc., 605 Third Avenue, New York, NY 10158). V.1- 1980- v. 31, p. 9, 1997 (PRSTDS); Z74 scu-rat TDLo: 50 ug/kg/5D-I Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 117, p. 2238, 1985 (ENDOAO); T13 scu-rat TDLo: 150 ug/kg/5D-I Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 117, p. 2238, 1985 (ENDOAO); Z74-T13 scu-rat TDLo: 1 mg/kg/5D-I Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 117, p. 2238, 1985 (ENDOAO); T12-Y09 ims-rat TDLo: 348 ug/kg/2D-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 63, p. 15, 1987 (CBINA8) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 253, 1996 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 253, 1996 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 253, 1996 (IMEMDT); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 363, 1978 (JTEHD6); TOXICOLOGY REVIEW Clinical Endocrinology (Oxford). (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1972- v. 4, p. 551, 1975 (CLECAP) ND: NOES 1983: HZD X7229; NIS 1; TNF 9; NOS 1; TNE 339; TFE 170 SL: EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-human; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 773 of 1119 in RTECS (through 2003/06) AN: KR7000000 PN: Ethylamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride SY: 2-(Benzhydryloxy)-N,N-dimethylethylamine hydrochloride; 2-Diphenylmethoxy-N,N-dimethylethanamine-hydrochloride-; 2-Diphenylmethoxy-N,N-dimethylethylamine-hydrochloride-; Allergan-; Allergival-; Bena-; Benadryl-; Benzhydramine-hydrochloride-; Benzhydrol,-beta-dimethylaminoethyl-ether-hydrochloride-; Denydryl-; Difenhydramine-hydrochloride-; Dimedrol-hydrochloride-; Diphenhydramine-hydrochloride-; Eldadryl-; Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride; Ethylamine, N,N-dimethyl-2-(diphenylmethoxy)-, hydrochloride; NCI-C56075-; Resmin-; Restamin-; Vena-; alpha-Hydroxydiphenylmethane-beta-dimethylaminoethyl-ether-hydrochloride-; beta-Dimethylaminoethyl-benzhydryl-ether-hydrochloride-; sk-Diphenhydramine- RN: Current: 147-24-0 Previous: 8052-21-9 UD: 200305 MF: C17-H21-N-O.Cl-H MW: 291.85 WL: 1N1&2OYR&R &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: dnd-rat-lvr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); mnt-ham-lng 200 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 411, p. 235, 1998 (MUREAV); cyt-ham-ovr 100 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 60, 1989 (EMMUEG) RE: T25 orl-rat TDLo: 39 mg/kg (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 971, 1971 (TXAPA9); T43-T46-T53 par-rat TDLo: 12 mg/kg (10D preg) Archivos de Farmacologia y Toxicologia. (Universidad Complutense, Facultad de Medicina, Departamento Coordinado de Farmacologia, Ciudad Universitaria, Madrid 3, Spain) V.1- 1975- v. 3, p. 157, 1977 (AFTOD7); T76 par-rat TDLo: 48 mg/kg (13-16D preg) Archivos de Farmacologia y Toxicologia. (Universidad Complutense, Facultad de Medicina, Departamento Coordinado de Farmacologia, Ciudad Universitaria, Madrid 3, Spain) V.1- 1975- v. 3, p. 157, 1977 (AFTOD7); T25 par-rat TDLo: 12 mg/kg (5D preg) Archivos de Farmacologia y Toxicologia. (Universidad Complutense, Facultad de Medicina, Departamento Coordinado de Farmacologia, Ciudad Universitaria, Madrid 3, Spain) V.1- 1975- v. 3, p. 157, 1977 (AFTOD7); T71-T75 orl-mus TDLo: 420 mg/kg (1-21D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 18, p. 188, 1968 (ARZNAD); T76 orl-mus TDLo: 4200 mg/kg (1-21D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 18, p. 188, 1968 (ARZNAD); T34 orl-mus TDLo: 320 mg/kg (11-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-148684 (NTIS**); T81 orl-mus TDLo: 800 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 361, 1986 (TCMUD8); T34 scu-mus TDLo: 50 mg/kg (8D preg) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 60, p. 420, 1971 (JPMSAE); T53 scu-mus TDLo: 100 mg/kg (8D preg) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 60, p. 420, 1971 (JPMSAE); T34 unr-mus TDLo: 1600 mg/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 53A, 1983 (TJADAB); T34-T43 orl-mus TDLo: 1.6 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-163055 (NTIS**); T34-T43 orl-mus TDLo: 640 mg/kg (11-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-148684 (NTIS**); T34-T53 orl-rat TDLo: 1000 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-180612 (NTIS**) TE: V03-A60 orl-rat TDLo: 27037 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-355, 1989 (NTPTR*); V03-A60-J60 orl-rat TDLo: 19467 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219437/AS (NTIS**); V03-A60-L60 orl-rat TDLo: 10815 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219437/AS (NTIS**) ORNG: 500000000 ng/kg. [500.000000 mg/kg] T/E unlistd AT: F12-G04-T25 orl-chd TDLo: 12500 ug/kg Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 90, p. 1017, 1977 (JOPDAB); E16-F08-H01 orl-man TDLo: 10714 ug/kg American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- v. 4, p. 369, 1986 (AJEMEN); F12-F24-G04 orl-wmn TDLo: 83 mg/kg Critical Care Medicine. (Williams and Wilkins, 428 E. Preston Street, Baltimore, MD 21202) V.1- 1973- v. 16, p. 1161, 1988 (CCMDC7); D35-F08-F19 skn-chd TDLo: 60 mg/kg/6H-I Clinical Pediatrics (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1962- v. 25, p. 163, 1986 (CPEDAM); T/E unlistd orl-rat LD50: 500 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 334, 1982 (NIIRDN); T/E unlistd ipr-rat LD50: 82 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 102, p. 250, 1951 (JPETAB); T/E unlistd scu-rat LD50: 201 mg/kg Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- v. 81, p. 261, 1961 (YKKZAJ); F05-F12-J22 ivn-rat LD50: 35 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 12, p. 2769, 1984 (YACHDS); T/E unlistd orl-mus LD50: 164 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 550, 1995 (NIIRDN); F12-F13 ipr-mus LD50: 56 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 112, p. 318, 1954 (JPETAB); F07-F12-R21 scu-mus LD50: 99200 ug/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 54, p. 33, 1958 (NYKZAU); F12-F17-F19 ivn-mus LD50: 20 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 5, p. 72, 1955 (ARZNAD); F07-F12-F13 ivn-dog LD50: 24 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 89, p. 227, 1947 (JPETAB); F12-F13-J22 ivn-rbt LD50: 10 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 4, p. 150, 1945 (FEPRA7); T/E unlistd orl-gpg LD50: 280 mg/kg Journal of Allergy. (St. Louis, MO) V.1-47, 1929-71. For publisher information, see JACIBY. v. 27, p. 57, 1956 (JOALAS); T/E unlistd ipr-gpg LD50: 75 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 83, p. 120, 1945 (JPETAB); F11-F12-F23 scu-gpg LD50: 40 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 113, p. 72, 1955 (JPETAB); F11-F12-F13 ivn-ham LD50: 18 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 97, p. 371, 1949 (JPETAB); K13 ims-pgn LD50: 63 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 46, p. 140, 1957 (JAPMA8); T/E unlistd ipr-mam LD50: 80 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 3, p. 328, 1953 (ARZNAD); C04 orl-mus TDLo: 50 mg/kg Biological and pharmaceutical bulletin. (Pharmaceutical Society of Japan, 2-12-15, Shibuya, Shibuya-ku, Tokyo 150-0002, Japan) V.1- 1993- v. 25, p. 260, 2002 (BIPBU*) MD: Z01 orl-rat TDLo: 1750 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-355, 1989 (NTPTR*); L03 orl-rat TDLo: 5687 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-355, 1989 (NTPTR*); U01-Z71-Z74 scu-rat TDLo: 6796 ug/kg/14D-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 133, p. 886, 1970 (PSEBAA); Z01 orl-mus TDLo: 3706 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-355, 1989 (NTPTR*); Z01 orl-mus TDLo: 3418 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-355, 1989 (NTPTR*); F13-F19 orl-dog TDLo: 1440 mg/kg/5W-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 89, p. 227, 1947 (JPETAB); U01 orl-mus TDLo: 1600 mg/kg/10D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-163055 (NTIS**); F04-Z01 orl-mus TDLo: 8000 mg/kg/4D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-148684 (NTIS**); F11-F12 orl-mus TDLo: 8000 mg/kg/4D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-148684 (NTIS**); L70-U01 orl-mus TDLo: 640 mg/kg/4D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-148684 (NTIS**); F07-L70-U01 orl-rat TDLo: 1000 mg/kg/10D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-180612 (NTIS**); F15-F19-J25 orl-rat TDLo: 1000 mg/kg/10D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-180612 (NTIS**) ND: NOHS 1974: HZD M0624; NIS 4; TNF 1150; NOS 9; TNE 4626; NOES 1983: HZD M0624; NIS 7; TNF 679; NOS 9; TNE 28929; TFE 23779 SL: NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 774 of 1119 in RTECS (through 2003/06) AN: KU9625000 PN: Ethylene,-chloro- SY: Chloroethene-; Chloroethylene-; Chlorure-de-vinyle- (French); Cloruro-di-vinile- (Italian); Ethene,-chloro-; Ethylene-monochloride-; Monochloroethene-; Monochloroethylene-; RCRA-waste-number-U043-; VCM-; Vinile (cloruro di) (Italian); Vinyl-C-monomer-; Vinyl-chloride-; Vinyl-chloride- (ACGIH:OSHA); Vinyl-chloride-monomer-; Vinylchlorid- (German); Vinyle(chlorure de) (French); Winylu-chlorek- (Polish) RN: Current: 75-01-4 BRN: 1731576 BHR: 4-01-00-00700 UD: 200210 MF: C2-H3-Cl MW: 62.50 WL: G1U1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 2000 ppm/48H (+S9) Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 63, p. 363, 1975 (BBRCA9); mmo-sat 1 pph (-S9) Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 1(3), p. 159, 1985 (CBTOE2); mmo-esc 10600 umol/L (+S9) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 24, p. 2013, 1975 (BCPCA6); dnr-esc 100 ug/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 101, 1978 (MUREAV); slt-dmg-ihl 48500 ppm Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1083, 1996 (CRNGDP); sln-dmg-ihl 1 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 307, 1978 (MUREAV); mrc-smc 48 mmol/L/3H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 85, 1976 (MUREAV); mmo-ssp 16 mmol/L/30M (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 85, 1976 (MUREAV); cyt-hmn-hla 10 mmol/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 9, p. 21, 1978 (TXCYAC); msc-hmn-lym 7500 ppt Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 31, 1997 (CRNGDP); mtr-rat-ihl 2000 ppm/14W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 47, p. 71, 1981 (ARTODN); dna-rat-orl 18 gm/kg/2Y-C Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 211, 1978 (CBINA8); dnd-rat-ihl 205 ppm/5H Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 37, p. 219, 1981 (CBINA8); dns-rat-lvr 2100 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1629, 1984 (CRNGDP); dni-rat-ivn 9500 ug/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 17, p. 239, 1977 (CBINA8); cyt-rat-ihl 150 ug/m3/14W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(7), p. 111, 1978 (GISAAA); hma-rat-smc 1 pph/24H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 381, 1981 (MUREAV); mnt-mus-ihl 5 pph/4H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 75, p. 191, 1980 (MUREAV); mtr-mus-emb 75 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 28, p. 85, 1985 (CALEDQ); hma-mus-ssp 700 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 85, 1976 (MUREAV); hma-mus-smc 700 mg/kg Toxicological European Research. (S.P.E., 10, Ave. de Messine, 75008 Paris, France) V.1- 1978- v. 3, p. 131, 1981 (TOERD9); mnt-ham-emb 30 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 397, 1988 (MUREAV); mmo-ham-lng 20 pph/5H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 173, 1979 (MUREAV); cyt-ham-ihl 12500 ppm/6H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 1, 1980 (ARTODN); cyt-ham-mul 600 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 187, 1978 (MUREAV); sce-ham-ihl 12500 ppm/6H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 1, 1980 (ARTODN); msc-ham-ovr 10 pph Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 25, p. 91, 1982 (EVSRBT) RE: T01 ihl-man TCLo: 30 mg/m3 (5Y male) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(5), p. 28, 1980 (GTPZAB); T02 ihl-rat TCLo: 100 ppm/6H (26W male) Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 10, p. 281, 1985 (EESADV); T34 ihl-rat TCLo: 500 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 33, p. 134, 1975 (TXAPA9); T25 ihl-rat TCLo: 1500 ppm/24H (1-9D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 11, p. 45, 1978 (TXCYAC); T34-T46 ihl-rat TCLo: 500 ppm/7H (6-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 41, p. 171, 1981 (EVHPAZ); T22 ihl-rat TCLo: 250 ppm/6H (55D pre) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 965, 1977 (JTEHD6); T24 ihl-mus TCLo: 30000 ppm/6H (5D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 21, p. 71, 1977 (EVHPAZ); T34-T46 ihl-mus TCLo: 500 ppm/7H (6-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 41, p. 171, 1981 (EVHPAZ); T26-T46 ihl-rbt TCLo: 500 ppm/7H (6-18D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 41, p. 171, 1981 (EVHPAZ) TE: V01-L60 ihl-man TCLo: 200 ppm/14Y-I Virchows Archiv A: Pathological Anatomy and Histology. (Berlin, Fed. Rep. Ger.) V.362-397, 1974-82. v. 372, p. 195, 1976 (VAPHDQ); V01-L60-M61 orl-rat TDLo: 3463 mg/kg/52W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 41, p. 3, 1981 (EVHPAZ); V01-R60 ihl-rat TCLo: 1 ppm/4H/52W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 41, p. 3, 1981 (EVHPAZ); V01-T65-N60 ihl-rat TCLo: 10000 ppm/4H (12-18D preg) Cold Spring Harbor Conferences on Cell Proliferation. (Cold Spring Harbor, NY) V.1-10, 1974-83. v. 4, p. 119, 1977 (CSHCAL); V03-R60-K60 ipr-rat TDLo: 21 mg/kg/65W-I Advances in Tumour Prevention, Detection and Characterization. (New York, NY) V.1-5, 1974-80. Discontinued. v. 3, p. 216, 1976 (APDCDT); V03-R60 scu-rat TDLo: 21 mg/kg/67W-I Advances in Tumour Prevention, Detection and Characterization. (New York, NY) V.1-5, 1974-80. Discontinued. v. 3, p. 216, 1976 (APDCDT); V01-H60-R60 ihl-mus TCLo: 50 ppm/30W-I Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 271, p. 431, 1976 (ANYAA9); V01-P62-R60 ihl-ham TCLo: 50 ppm/4H/30W-I Advances in Tumour Prevention, Detection and Characterization. (New York, NY) V.1-5, 1974-80. Discontinued. v. 3, p. 216, 1976 (APDCDT); V01-H60-R60 ihl-rat TC :50 ppm/7H/26W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 68, p. 120, 1983 (TXAPA9); V01-L60-R60 ihl-rat TC :100 ppm/7H/26W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 68, p. 120, 1983 (TXAPA9); V01-J60-L60 ihl-mus TC :50 ppm/47W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 15, 1978 (JTEHD6); V01-L61-M61 orl-rat TD :34 gm/kg/3Y-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 21, p. 1, 1977 (EVHPAZ); V01-J60-R60 ihl-mus TC :50 ppm/6H/4W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 7, p. 909, 1981 (JTEHD6); V01-L60-R60 ihl-mus TC :50 ppm/4H/30W-I Cold Spring Harbor Conferences on Cell Proliferation. (Cold Spring Harbor, NY) V.1-10, 1974-83. v. 4, p. 119, 1977 (CSHCAL); V01-D45-L61 ihl-rat TC :250 ppm/2Y-I Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti. (Academia Nazionale dei Lincei, Via della Lungara, 10, I-00165 Rome, Italy) 1892-1939: Ser. 8: V.1- 1946- v. 56, p. 1, 1974 (AANLAW); V01-P60 ihl-hmn TC :300 mg/m3/1W-C Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 26(1), p. 28, 1982 (GTPZAB); V01-R60 ihl-rat TC :5 ppm/4H/52W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 41, p. 3, 1981 (EVHPAZ); V01-R60 ihl-rat TC :50 ppm/6H/43W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 7, p. 909, 1981 (JTEHD6); V03-L61 ihl-rat TCLo: 128 mg/m3/1Y-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 422, 1990 (VCVGH*); V03-Q60-J60 ihl-rat TCLo: 77000 mg/m3/6M "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 422, 1990 (VCVGH*) ORNG: 500000000 ng/kg. [500.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 500 mg/kg Dow Chemical Company Reports. (Dow Chemical USA, Health and Environment Research, Toxicology Research Lab., Midland, MI 48640) (DOWCC*); F11-F12-J25 ihl-rat LC50: 18 pph/15M Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- v. 1, p. 239, 1982 (HUTODJ); F01 ihl-mus LCLo: 20 pph/30M American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 21, p. 394, 1960 (AIHAAP); F01 ihl-gpg LCLo: 30 pph/30M American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 21, p. 394, 1960 (AIHAAP); T/E unlistd ihl-mam LCLo: 200 ppm/18M International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3) MD: L70-P30-Y15 orl-rat TDLo: 23400 mg/kg/13W-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 633, 1975 (FCTXAV); G04-G06-G08 ihl-rat TCLo: 30 mg/m3/4H/26W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 16(2), p. 24, 1972 (GTPZAB); L70-M70-N73 ihl-rat TCLo: 5000 ppm/7H/52W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 13, p. 25, 1979 (TXCYAC); F23-P28-L70 ihl-rat TCLo: 400 mg/m3/24H/14W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(11), p. 74, 1979 (GISAAA); U01-Y07-Y16 ihl-rat TCLo: 28000 ppm/7H/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 1, 1982 (TXAPA9); L70-N73-P72 ihl-rat TCLo: 2000 ppm/8H/92D-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 265, 1963 (AIHAAP); G04-G06-G08 ihl-rbt TCLo: 9 gm/m3/4H/22W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 12(7), p. 47, 1968 (GTPZAB); A11-P30-Q02 ihl-rbt TCLo: 30 mg/m3/26W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 16(2), p. 24, 1972 (GTPZAB); G06 ihl-rat TCLo: 30 mg/m3/4H/20D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 422, 1990 (VCVGH*); G04 ihl-rat TCLo: 30 mg/m3/4H/18W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 422, 1990 (VCVGH*); E08 ihl-rat TCLo: 300 mg/m3/4H/28W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 422, 1990 (VCVGH*); G04-Q30 ihl-rbt TCLo: 30 mg/m3/4H/4W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 422, 1990 (VCVGH*); G06-H01-H06 ihl-rbt TCLo: 900 mg/m3/8W-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 422, 1990 (VCVGH*) TR: ACGIH TLV-TWA 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 377, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 377, 1979 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 373, 1987 (IMSUDL); TOXICOLOGY REVIEW Fortschritte der Arzneimittelforschung. Progress in Drug Research. (Birkhauser Boston, Inc., c/o Springer-Verlag New York, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1959- v. 18, p. 365, 1974 (FAZMAE); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 1, p. 47, 1975 (JTEHD6); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS); TOXICOLOGY REVIEW Chemisch-Weekblad. (The Hague, Netherlands) V.1-71, 1903-75. v. 70(28/29), p. 5, 1974 (CHWEAP); TOXICOLOGY REVIEW Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 39, p. 1792, 1977 (CANCAR); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 32, p. 93, 1975 (MUREAV); TOXICOLOGY REVIEW Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 166, p. 113, 1978 (ZHPMAT); TOXICOLOGY REVIEW Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- v. 54, p. 413, 1978 (BNYMAM); TOXICOLOGY REVIEW Archives Belges de Medecine Sociale, Hygiene, Medecine du Trevail et Medecine Legale. (Quartier Esplanade no.6, 1010 Brussels, Belgium) V.4- 1946- v. 35, p. 585, 1977 (ABMHAM); TOXICOLOGY REVIEW Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 117, 1978 (CBINA8); TOXICOLOGY REVIEW Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 20(4), p. 46, 1976 (GTPZAB); TOXICOLOGY REVIEW Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 22, p. 31, 1980 (VHTODE); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 131, 1976 (MUREAV) SR: MSHA STANDARD-air: TWA 200 ppm (510 mg/m3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 31, 1973 (DTLWS*); OSHA PEL (Construc): see CFR 29,1926.1117 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 500 ppm (13 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OSHA-cancer suspect agent Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1017, 1987 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 2.5 mg/m3, JAN 1993; OEL-AUSTRALIA: TWA 5 ppm (10 mg/m3), Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 5 ppm (13 mg/m3), Carcinogen JAN 1993; OEL-DENMARK: TWA 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 5 ppm (15 mg/m3), STEL 10 ppm (30 mg/m3), Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 10 mg/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL(C) 2.5 ppm (6.5 mg/m3), Group I Carcinogen, JAN 1999; OEL-THE NETHERLANDS: Carcinogen, JAN 1999; OEL-NORWAY: TWA 1 ppm (3 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 50 ppm (100 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 30 mg/m3, JAN 1999; OEL-RUSSIA: TWA 1 mg/m3, STEL 2.5 ppm (5 mg/m3), JAN 1993; OEL-SWEDEN: NGV 1 ppm (2.5 mg/m3), KTV 5 ppm (13 mg/m3), Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 2 ppm (5.2 mg/m3), Carcinogen, JAN 1999; OEL-THAILAND: TWA 1 ppm (2.8 mg/m3), JAN 1993; OEL-TURKEY: TWA 500 ppm (1300 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 7 ppm, Carcubigen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO VINYL CHLORIDE-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 76445; NIS 22; TNF 1459; NOS 36; TNE 29836; NOES 1983: HZD 76445; NIS 63; TNF 3711; NOS 59; TNE 81314; TFE 28398 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101132/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-human lymphocyte, E coli polA with S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S pombe-forward mutation; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal, Mouse spot test; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 28, 1978; NIOSH Analytical Method, 1994: Vinyl chloride, 1007; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #04 Record 775 of 1119 in RTECS (through 2003/06) AN: KV9275000 PN: Ethylene,-1,1-dichloro- SY: 1,1-Dichloroethene-; 1,1-Dichloroethene- (9CI); 1,1-Dichloroethylene-; Chlorure-de-vinylidene- (French); Ethene,-1,1-dichloro-; NCI-C54262-; RCRA-waste-number-U078-; VDC-; Vinylidene-chloride-; Vinylidene-chloride- (ACGIH); Vinylidene-chloride- (II); Vinylidene-dichloride-; Vinylidine-chloride- RN: Current: 75-35-4 UD: 200305 MF: C2-H2-Cl2 MW: 96.94 WL: GYGU1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 5 pph (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 141, 1978 (MUREAV); mmo-sat 3 pph/2H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 183, 1978 (MUREAV); mmo-esc 2500 umol/L (+S9) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 24, p. 2013, 1975 (BCPCA6); mmo-smc 30 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 179, 1981 (MUREAV); mrc-smc 30 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 179, 1981 (MUREAV); dnd-smc 75 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 209, 1988 (MUREAV); sln-smc 50 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 209, 1988 (MUREAV); sln-asn 500 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 266, p. 117, 1992 (MUREAV); dnd-rat-ihl 10 ppm Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 357, 1980 (TXAPA9); slt-mus-lym 160 ppm/48H-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17, p. 122, 1991 (EMMUEG); dnd-mus-ihl 50 ppm Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 357, 1980 (TXAPA9); dns-mus-ihl 50 ppm Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 357, 1980 (TXAPA9); dns-mus-orl 200 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 36, p. 199, 1985 (TXCYAC); hma-mus-smc 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 179, 1981 (MUREAV); cyt-ham-lng 250 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 157, 1987 (MUREAV); sce-ham-lng 75 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 157, 1987 (MUREAV) RE: T29-T34 orl-rat TDLo: 200 mg/kg (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 189, 1979 (TXAPA9); T46 ihl-rat TCLo: 80 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 189, 1979 (TXAPA9); T22 ihl-rat TCLo: 55 ppm/6H (55D pre) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 965, 1977 (JTEHD6); T25 ihl-rbt TCLo: 160 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 189, 1979 (TXAPA9) TE: V03-L60-P62 ihl-rat TCLo: 55 ppm/6H/52W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 15, 1978 (JTEHD6); V01-M61-P61 ihl-mus TCLo: 25 ppm/4H/52W-I Medicina del Lavoro. Industrial Medicine. (Via S. Barnaba, 8, 20122 Milan, Italy) V.16- 1925- v. 68, p. 241, 1977 (MELAAD); V02-J60-R60 skn-mus TDLo: 4840 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 1433, 1979 (JJIND8); V03-P61-R60 ihl-rat TC :150 ppm/4H/52W-I Medicina del Lavoro. Industrial Medicine. (Via S. Barnaba, 8, 20122 Milan, Italy) V.16- 1925- v. 68, p. 241, 1977 (MELAAD); V03-J60-L60 ihl-mus TC :55 ppm/6H/13W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 7, p. 909, 1981 (JTEHD6); V03-L60 ihl-mus TC :55 ppm/6H/52W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 21, p. 25, 1977 (EVHPAZ); V03-P60 ihl-rat TC :55 ppm/6H/52W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 21, p. 25, 1977 (EVHPAZ); V03-K60-L60 ihl-rat TC :150 ppm/4H/52W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 21, p. 45, 1977 (EVHPAZ); V03-L60-R60 ihl-rat TC :55 ppm/6H/28W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 7, p. 909, 1981 (JTEHD6); V03-L61 ihl-mus TCLo: 220 mg/m3/40W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 432, 1990 (VCVGH*) ORNG: 200000000 ng/kg. [200.000000 mg/kg] T/E unlistd IHPB: 6350000 ppb/4H. [6350.000000 ppm/4H] F24 AT: F01-L30-M30 ihl-hmn TCLo: 25 ppm Chemistry and Industry (London). (Royal Soc. of Chemistry, Distribution Centre, Blackhorse Rd., Letchworth, Herts SG6 1HN, UK) V.1- 1923- v. (11), p. 463, 1976 (CHINAG); T/E unlistd orl-rat LD50: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-143766 (NTIS**); F24 ihl-rat LC50: 6350 ppm/4H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 168, 1971 (TXAPA9); T/E unlistd orl-mus LD50: 194 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 411, 1978 (BJCAAI); T/E unlistd orl-dog LDLo: 5750 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd ivn-dog LDLo: 225 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd skn-rbt LD :>2426 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A180-198 (NTIS**); T/E unlistd scu-rbt LDLo: 3700 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); J30 ipr-mus TDLo: 50 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 297, p. 1193, 2001 (JPETAB) MD: L30-Y16-Y38 orl-rat TDLo: 1300 mg/kg/4W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 3, p. 90, 1983 (JJATDK); L01-P01-Z01 orl-rat TDLo: 7 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-228, 1982 (NTPTR*); L03-M03-Y03 ihl-rat TCLo: 189 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); J26-L01-Z01 orl-mus TDLo: 7 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-228, 1982 (NTPTR*); L03-L30-Z01 orl-mus TDLo: 6500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-228, 1982 (NTPTR*); L02-L03-U01 ihl-dog TCLo: 189 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); L03-U01-Z01 ihl-mky TCLo: 189 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); U01 ihl-rbt TCLo: 101 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); L30-Y15-Z01 ihl-gpg TCLo: 189 mg/m3/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); F18-F21-U01 ihl-rat TCLo: 143 mg/m3/6H/1Y-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 432, 1990 (VCVGH*); L30 ihl-rat TCLo: 158 mg/m3/6H/5W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 432, 1990 (VCVGH*); L30-M03-P27 ihl-rbt TCLo: 500 mg/m3/3H/16W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 433, 1990 (VCVGH*) TR: ACGIH TLV-TWA 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 195, 1986 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1163, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 195, 1986 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1163, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1163, 1999 (IMEMDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 8, p. 633, 1975 (CTOXAO); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. ORNL/TIRC-77/3 (NTIS**); TOXICOLOGY REVIEW Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 22, p. 31, 1980 (VHTODE) SR: OEL-AUSTRALIA: TWA 5 ppm (20 mg/m3), STEL 20 ppm, JAN 1993; OEL-AUSTRIA: MAK 2 ppm (8 mg/m3), Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 5 ppm (20 mg/m3), STEL 20 ppm (79 mg/m3), JAN 1993; OEL-DENMARK: TWA 2 ppm (8 mg/m3), JAN 1999; OEL-FINLAND: TWA 10 ppm (40 mg/m3), STEL 20 ppm (80 mg/m3), Carcinogen, JAN 1999; OEL-FRANCE: VME 5 ppm (20 mg/m3), JAN 1999; OEL-GERMANY: MAK 2 ppm (8 mg/m3), Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (20 mg/m3), JAN 1999; OEL-NORWAY: TWA 1 ppm (4 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 50 mg/m3, MAC(STEL) 80 mg/m3, JAN 1999; OEL-RUSSIA: STEL 50 mg/m3, JAN 1993; OEL-SWEDEN: NGV 5 ppm (20 mg/m3), KTV 10 ppm (40 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 2 ppm (8 mg/m3), KZG-W 4 ppm (16 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 10 ppm (40 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO VINYLIDENE CHLORIDE-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 83011; NIS 22; TNF 879; NOS 23; TNE 10947; NOES 1983: HZD 83011; NIS 2; TNF 97; NOS 13; TNE 2679; TFE 291 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/100152/AS); EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 28, 1978; NIOSH Analytical Method, 1994: Vinylidene chloride, 1015; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat; OSHA ANALYTICAL METHOD #19 Record 776 of 1119 in RTECS (through 2003/06) AN: KV9400000 PN: Ethylene, 1,2-dichloro-, (E)- SY: (E)-1,2-Dichloroethene; (E)-1,2-Dichloroethylene; 1,2-Dichloroethylene,-trans-; Ethene, 1,2-dichloro-, (E)- (9CI); HCC-1130t-; R-1130t-; RCRA-waste-number-U079-; t-DCE-; trans-1,2-Dichloroethylene-; trans-Acetylene-dichloride-; trans-Dichloroethylene- RN: Current: 156-60-5 BRN: 1420761 BHR: 4-01-00-00709 UD: 200302 MF: C2-H2-Cl2 MW: 96.94 WL: G1U1G -T CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MOD Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 11, 1990 (ATDAEI); eye-rbt 10 mg MOD Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 11, 1990 (ATDAEI) ME: mmo-sat 50 ug/plate (+S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 15, p. 101, 1987 (TECSDY); mrc-smc 80 mmol/L Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 4, p. 365, 1984 (TCMUD8); dnd-smc 22 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 209, 1988 (MUREAV); sln-smc 51500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 209, 1988 (MUREAV); sln-ham-lng 6500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 135, 1987 (MUREAV) RE: T25 ihl-rat TCLo: 6000 ppm/6H (7-16D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 225, 1993 (FAATDF); T25-T34 ihl-rat TCLo: 12000 ppm/6H (7-16D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 225, 1993 (FAATDF); T19-T25-T39 ihl-rat TCLo: 12000 ppm (7-16D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 40, p. 41, 1990 (TOXID9) ORNG: 1235000000 ng/kg. [1235.000000 mg/kg] T/E unlistd AT: F04-F08 ihl-hmn TCLo: 4800 mg/m3/10M Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); T/E unlistd orl-rat LD50: 1235 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 7, p. 141, 1977 (TXCYAC); F07 ihl-rat LC50: 24100 ppm Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 17, 2000 (TOXID9); G30-J30-L03 ipr-rat LD50: 7411 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 7, p. 141, 1977 (TXCYAC); F05-F07-F19 orl-mus LD50: 2122 mg/kg Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 8, p. 373, 1985 (DCTODJ); F01-F12-J22 ihl-mus LCLo: 75 gm/m3/2H Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); T/E unlistd ipr-mus LD50: 3952 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 7, p. 141, 1977 (TXCYAC); F01-F12-K13 ihl-cat LCLo: 43 gm/m3/6H Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); R02-U01 skn-rbt LD50: >5 gm/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 10, 1990 (ATDAEI) MD: M70 orl-rat TDLo: 113 gm/kg/90D-C Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 6(4), p. 471, 1987 (JACTDZ); J30-L30-N70 ihl-rat TCLo: 200 ppm/8H/16W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 7(2), p. 141, 1977 (TXCYAC); D17-D25-F15 ihl-rat TCLo: 2000 ppm/10D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 225, 1993 (FAATDF) TR: ACGIH TLV-TWA 200 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: OEL-DENMARK: TWA 200 ppm (790 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 200 ppm (806 mg/m3), STEL 250 ppm, SEP 2000 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 777 of 1119 in RTECS (through 2003/06) AN: KW2975000 PN: Ethylene-glycol- SY: 1,2-Dihydroxyethane-; 1,2-Ethandiol-; 1,2-Ethanediol-; Athylenglykol- (German); Dowtherm-SR-1-; Ethane-1,2-diol-; Ethylene-alcohol-; Ethylene-dihydrate-; Ethylene-glycol- (ACGIH); Ethylene-glycol,-aerosol-; Glycol-alcohol-; Lutrol-9-; M.E.G.; Macrogol-400-BPC-; Monoethylene-glycol-; NCI-C00920-; Norkool-; Tescol-; Ucar-17- RN: Current: 107-21-1 Previous: 71767-64-1 UD: 200305 MF: C2-H6-O2 MW: 62.08 WL: Q2Q CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-rat 0.012%/3D Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 646, 1970 (TXAPA9); skn-rbt 555 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 7/21/1965 (UCDS**); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,205,1986 (85JCAE); eye-rbt 100 mg/1H MLD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. LMF-69 (NTIS**); eye-rbt 0.012 ppm/3D Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 646, 1970 (TXAPA9); eye-rbt 1440 mg/6H MOD Bulletin of Parenteral Drug Association. (Philadelphia, PA) V.1-31, 1946-77. v. 31, p. 25, 1977 (BUYRAI) ME: dni-hmn-lym 320 mmol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 1171, 1982 (PNASA6); cyt-rat-orl 1200 mg/kg Tsitologiya i Genetika. Cytology and Genetics. For English translation, see CYGEDX. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967- v. 19, p. 436, 1985 (TGANAK); msc-mus-lym 100 mmol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 74, 1980 (PAACA3) RE: T44-T46-T48 orl-rat TDLo: 50 gm/kg (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 113, 1985 (TXAPA9); T34-T46 orl-rat TDLo: 8580 mg/kg (6-15D preg) Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 20, p. 289, 1986 (CHYCDW); T43-T46 orl-rat TDLo: 12500 mg/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 52A, 1984 (TJADAB); T13-T26-T34 orl-rat TDLo: 25 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-104594 (NTIS**); T02 orl-rat TDLo: 51948 mg/kg (13W male) Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 8, p. 12, 1994 (WDZAEK); T19-T46-T59 ihl-rat TCLo: 2500 mg/m3/6H (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 24, p. 57, 1995 (FAATDF); T34-T46 orl-mus TDLo: 7500 mg/kg (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 113, 1985 (TXAPA9); T43-T46 orl-mus TDLo: 7500 mg/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 52A, 1984 (TJADAB); T72-T81-T91 orl-mus TDLo: 84 gm/kg (1-21D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 136, 1984 (TOXID9); T25-T71-T72 orl-mus TDLo: 88720 mg/kg (7-14D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); T13-T24-T29 orl-mus TDLo: 15 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-105385 (NTIS**); T13-T19-T24 ihl-mus TCLo: 1000 mg/m3/6H (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 24, p. 57, 1995 (FAATDF); T25-T34-T73 ihl-mus TCLo: 1000 mg/m3/6H (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 24, p. 57, 1995 (FAATDF); T19-T24-T25 ihl-mus TCLo: 2100 mg/m3/6H (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 27, p. 49, 1995 (FAATDF); T26-T34-T46 ihl-mus TCLo: 2100 mg/m3/6H (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 27, p. 49, 1995 (FAATDF); T19 orl-rbt TDLo: 28 gm/kg (6-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-211219 (NTIS**); T72-T75-T81 orl-mus TDLo: 88720 mg/kg (7-14D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); T34-T59-T81 unr-rat TDLo: 50000 mg/kg (6-15D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); T34-T59-T81 unr-mus TDLo: 7500 mg/kg (6-15D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); T34-T59-T81 unr-rat TDLo: 5000 mg/kg (multigenerations) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); T34-T59-T81 unr-mus TDLo: 750 mg/kg (multigenerations) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); T72-T43-T46 orl-mus TDLo: 413 gm/kg (15W male/15W pre-3W post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 100, 1985 (TXAPA9); T91 orl-mus TDLo: 413 gm/kg (15W male/15W pre-3W post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 100, 1985 (TXAPA9); T46-T81 orl-mus TDLo: 1.7 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB84241108 (NTIS**); T41 orl-mus TDLo: 1.7 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB84241108 (NTIS**); T51 orl-mus TDLo: 1.7 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB84241108 (NTIS**); T34 orl-mus TDLo: 7.5 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105385 (NTIS**); T43-T46-T59 orl-mus TDLo: 7.5 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105385 (NTIS**); T81 orl-mus TDLo: 29.75 gm/kg (7D male/7D pre/21D preg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB84241108 (NTIS**); T26-T29 orl-mus TDLo: 59.5 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB84241108 (NTIS**); T26 orl-mus TDLo: 98 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86177383 (NTIS**); T81 orl-mus TDLo: 294 gm/kg (15W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86177383 (NTIS**); T29-T25-T34 orl-mus TDLo: 15 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105385 (NTIS**); T35 orl-mus TDLo: 15 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105385 (NTIS**); T16-T53 orl-rat TDLo: 18.8 gm/kg (6-20D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88-204326/AS (NTIS**); T81 orl-mus TDLo: 850 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86177383 (NTIS**); T53 orl-mus TDLo: 850 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86177383 (NTIS**); T34-T46-T72 orl-rat TDLo: 25000 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-274528 (NTIS**); T27-T71 orl-rbt TDLo: 28000 mg/kg (6-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91-211219 (NTIS**); T26-T75-T81 orl-rat TDLo: 33750 mg/kg (6-20D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88-204326/AS (NTIS**); T41-T46 orl-rat TDLo: 33750 mg/kg (6-20D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88-204326/AS (NTIS**) ORNG: 4700000000 ng/kg. [4700.000000 mg/kg] T/E unlistd SRNL: 9530000 nL/kg. [9.530000 mL/kg] T/E unlistd AT: A11-D16-J30 orl-man TDLo: 24 gm/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 38, p. 445, 2000 (JTCTDW); C04-K08-M12 orl-man TDLo: 15 gm/kg Annals of Emergency Medicine. (American College of Emergency Physicians, 1125 Executive Circle, Irving, TX 75038) v. 20, p. 208, 1991 (AEMED3); C04-M12 orl-man TDLo: 1195 mg/kg Annals of Emergency Medicine. (American College of Emergency Physicians, 1125 Executive Circle, Irving, TX 75038) v. 20, p. 208, 1991 (AEMED3); F01-J26-M30 orl-chd TDLo: 5500 mg/kg Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1925- v. 52, p. 598, 1976 (PGMJAO); F12-F24-K12 orl-hmn LDLo: 786 mg/kg European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 373, 1976 (EJTXAZ); F27-K13-L30 orl-hmn LDLo: 398 mg/kg Sudebno-Meditsinskaya Ekspertiza. Forensic Medical Examination. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1958- v. 26(2), p. 48, 1983 (SMEZA5); D17-J21-J30 ihl-hmn TCLo: 10000 mg/m3 Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 5, p. 1, 1933 (AGGHAR); F24-M12-U20 orl-man TDLo: 16 gm/kg Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 9, p. 317, 1990 (HETOEA); T/E unlistd unr-man LDLo: 1637 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd ihl-rat LC :>200 mg/m3/4H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(11), p. 57, 1981 (GTPZAB); T/E unlistd ipr-rat LD50: 5010 mg/kg Kriobiologiya i Kriomeditsina. Cryobiology and Cryomedicine. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1975- v. 9, p. 36, 1981 (KRKRDT); T/E unlistd scu-rat LD50: 2800 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 49, 1974 (NPIRI*); T/E unlistd ivn-rat LD50: 3260 mg/kg Kriobiologiya i Kriomeditsina. Cryobiology and Cryomedicine. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1975- v. 9, p. 36, 1981 (KRKRDT); F07-F24-J26 ims-rat LDLo: 3300 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 41, p. 387, 1931 (JPETAB); F07-F13-K13 unr-rat LD50: 13 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(3), p. 16, 1968 (GISAAA); T/E unlistd orl-mus LD50: 5500 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(3), p. 31, 1967 (GISAAA); T/E unlistd ihl-mus LC :>200 mg/m3/2H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(11), p. 57, 1981 (GTPZAB); J16-M04-P27 ipr-mus LD50: 5614 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 6, p. 342, 1947 (FEPRA7); T/E unlistd scu-mus LDLo: 2700 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 1, p. 207, 1944 (BJIMAG); F07-F13-K13 unr-mus LD50: 8050 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(3), p. 16, 1968 (GISAAA); M30 orl-dog LD50: 5500 mg/kg Recueil de Medecine Veterinaire. (Masson Pub. USA, Inc., Year Book Medical Pub., 35 E. Wacker Dr., Chicago IL 60601) V.1- 1824- v. 154, p. 137, 1978 (RMVEAG); M30 orl-cat LD50: 1650 mg/kg Recueil de Medecine Veterinaire. (Masson Pub. USA, Inc., Year Book Medical Pub., 35 E. Wacker Dr., Chicago IL 60601) V.1- 1824- v. 154, p. 137, 1978 (RMVEAG); F12-F18-P30 scu-cat LDLo: 2 gm/kg Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 5, p. 1, 1933 (AGGHAR); T/E unlistd skn-rbt LD50: 9530 uL/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,731,1969 (34ZIAG); F07-F11-F12 ivn-rbt LDLo: 5 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 41, p. 387, 1931 (JPETAB); F07-F24-J26 ims-rbt LDLo: 5500 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 41, p. 387, 1931 (JPETAB); F07-F13-K13 unr-rbt LD50: 5017 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(3), p. 16, 1968 (GISAAA); F07-K30-M30 orl-gpg LD50: 6610 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); F07-F13-K13 unr-gpg LD50: 11150 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(3), p. 16, 1968 (GISAAA); M13 ihl-hmn TCLo: 22 mg/m3 International Archives of Occupational and Environmental Health. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.35- 1975- v. 69, p. 255, 1997 (IAEHDW); T/E unlistd scu-mus LD50: 2700 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd ipr-mus LD50: 1700 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd ivn-mus LD50: 300 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd orl-rat LD50: 4700 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd ivn-rat LDLo: 2800 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd ims-rat LDLo: 3300 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd orl-gpg LD50: 6600 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd scu-gpg LDLo: 5000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd scu-rbt LD50: 19500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd ipr-rbt LDLo: 1000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd ivn-rbt LDLo: 5000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd ims-rbt LDLo: 5500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd orl-cat LD50: 2000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); T/E unlistd scu-cat LDLo: 2000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); F40 ihl-rbt TCLo: 4 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); A30-M16-P28 orl-rat TDLo: 1110 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); A30-F22-Y15 orl-rat TDLo: 5000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); A03-L30-M30 orl-rat TDLo: 1000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 139, 1984 (VCVGK*); P28 ipr-mky LDLo: 4000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1984 (VCVGK*); G10-J15-L30 unr-hmn LDLo: 70 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1984 (VCVGK*); P26 orl-rat TDLo: 120 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1984 (VCVGK*); D25 eye-rbt TDLo: 10 pph "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 141, 1984 (VCVGK*); D25 ihl-rbt TCLo: 12 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 141, 1984 (VCVGK*) MD: L30-L70-M70 orl-rat TDLo: 14 mL/kg/2W-C Journal of UOEH (University of Occupational and Environmental Health). (Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu 807, Japan) V.1- 1979- v. 13, p. 13, 1991 (JOUOD4); F16-M03-Z01 orl-rat TDLo: 438 gm/kg/2Y-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 3, p. 229, 1965 (FCTXAV); M70-P28-U08 orl-rat TDLo: 85230 mg/kg/90D-C Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 13, p. 43, 1990 (DCTODJ); U07-U08-Y03 orl-rat TDLo: 12 mL/kg/6D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 39, p. 543, 1977 (TXAPA9); M03-P28-Y10 orl-rat TDLo: 26150 mg/kg/10D-C Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 13, p. 43, 1990 (DCTODJ); A70-M11-U01 ihl-rat TCLo: 8400 ug/m3/24H/12W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(9), p. 106, 1974 (GISAAA); D26-Z01 ihl-rat TCLo: 12 mg/m3/8H/90D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 646, 1970 (TXAPA9); J30-L14-M03 ihl-rat TCLo: 1 mg/m3/32W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 7, p. 102, 1965 (TPKVAL); L02-M03-U01 orl-mus TDLo: 546 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-413, 1993 (NTPTR*); L02-M03 orl-mus TDLo: 1081 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-413, 1993 (NTPTR*); M03 orl-mky TDLo: 5751 gm/kg/22W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 15, p. 624, 1969 (TXAPA9); D26-D35-Z01 ihl-rbt TCLo: 12 mg/m3/8H/90D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 646, 1970 (TXAPA9); Z01 orl-mus TDLo: 88720 mg/kg/8D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 57, p. 141, 1984 (EVHPAZ); D26 ihl-rat TCLo: 120 mg/m3/8D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); A30-F01 ihl-cat TCLo: 500000 mg/m3/6H/28H-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); A30-F01 ihl-mky TCLo: 500000 mg/m3/6H/28H-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); L14 ihl-mam TCLo: 256 mg/m3/28D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); J21 ihl-hmn TCLo: 140 mg/m3/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); G30-L14-M30 ihl-rat TCLo: 198 mg/m3/4H/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); Z01 ihl-mus TCLo: 10 mg/m3/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); D25-F33-J21 ihl-mus TCLo: 1 mg/m3/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); D25-F33-J21 ihl-rat TCLo: 1 mg/m3/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); D25-F33-J21 ihl-gpg TCLo: 1 mg/m3/122D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); H02-J30-L30 ihl-mus TCLo: 1 mg/m3/154D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); H02-J30-L30 ihl-rat TCLo: 1 mg/m3/154D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); H02-J30-L30 ihl-gpg TCLo: 1 mg/m3/154D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 140, 1994 (VCVGK*); T02-Y20 unr-rat TDLo: 9.1 mg/kg/26W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 141, 1994 (VCVGK*); G30-H30-M30 ihl-mam TCLo: 20 mg/m3/5Y-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 141, 1994 (VCVGK*); Z01 orl-mus TDLo: 29.4 gm/kg/7D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 100, 1985 (TXAPA9); Z01 orl-mus TDLo: 117.6 gm/kg/14D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 100, 1985 (TXAPA9); Z01 orl-mus TDLo: 82.3 gm/kg/14W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 100, 1985 (TXAPA9); R21-U01-L70 orl-mus TDLo: 15000 mg/kg/10D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105385 (NTIS**); M71-T13 orl-rat TDLo: 33750 mg/kg/15D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105385 (NTIS**); M30 orl-rat TDLo: 18750 mg/kg/15D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105385 (NTIS**); M03-Z01 orl-rbt TDLo: 28000 mg/kg/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91-211219 (NTIS**); U01 orl-rat TDLo: 25000 mg/kg/10D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-274528 (NTIS**); M03-T02-U01 orl-mus TDLo: 294000 mg/kg/15W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86177383 (NTIS**) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-CL 100 mg/m3 (H) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF); TOXICOLOGY REVIEW Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 8, p. 99, 1994 (REPTED) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 10 mg/m3 (particulate) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 19, 1973 (DTLWS*); OEL-AUSTRALIA: TWA 60 mg/m3, STEL 120 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 10 ppm (26 mg/m3), Skin, JAN 1999; OEL-BELGIUM: STEL 50 ppm (127 mg/m3), JAN 1993; OEL-DENMARK: TWA 50 ppm (130 mg/m3), JAN 1999; OEL-FINLAND: TWA 10 mg/m3, STEL 20 mg/m3, JAN 1993; OEL-FRANCE: VLE 50 ppm (125 mg/m3), JAN 1999; OEL-GERMANY: MAK 10 ppm (26 mg/m3), Skin, JAN 1999; OEL-HUNGARY: STEL 50 mg/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 50 ppm (125 mg/m3), JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 50 ppm (125 mg/m3), JAN 1999; OEL-NORWAY: TWA 25 ppm (63 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 15 mg/m3, MAC(STEL) 50 mg/m3, JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWEDEN: NGV 10 ppm (25 mg/m3), KTV 20 ppm (50 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (125 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 10 mg/m3, Particulate, SEP 2000; OEL-UNITED KINGDOM: TWA 60 mg/m3, STEL 125 mg/m3, Vapor, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 32385; NIS 308; TNF 69314; NOS 174; TNE 743782; NOES 1983: HZD 32385; NIS 340; TNF 102395; NOS 214; TNE 1511087; TFE 446607 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101108/AS); EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-nondisjunction; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9100, 8EHQ-0892-9252; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Ethylene glycol, 5500; NIOSH Analytical Method, 1996: Glycols, 5523; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 778 of 1119 in RTECS (through 2003/06) AN: KX2450000 PN: Ethylene-oxide- SY: 1,2-Epoxyaethan- (German); 1,2-Epoxyethane-; Aethylenoxid- (German); Amprolene-; Anprolene-; Anproline-; Dihydrooxirene-; Dimethylene-oxide-; E.O.; ENT-26263-; EO-; ETO-; Epoxyethane-; Ethene-oxide-; Ethox-; Ethyleenoxide- (Dutch); Ethylene (oxyde d') (French); Ethylene-oxide- (ACGIH:OSHA); Etilene (ossido di) (Italian); Etylenu-tlenek- (Polish); FEMA No. 2433; Merpol-; NCI-C50088-; Oxacyclopropane-; Oxane-; Oxidoethane-; Oxiraan- (Dutch); Oxiran-; Oxirane-; Oxirene,-dihydro-; Oxyfume-; Oxyfume-12-; RCRA-waste-number-U115-; Sterilizing gas ethylene oxide 100%; T-Gas-; alpha,beta-Oxidoethane- RN: Current: 75-21-8 Previous: 19034-08-3; 99932-75-9 UD: 200305 MF: C2-H4-O MW: 44.06 WL: T3OTJ CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-hmn 1%/7S AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 2, p. 549, 1950 (AMIHBC); eye-rbt 18 mg/6H MOD Bulletin of Parenteral Drug Association. (Philadelphia, PA) V.1-31, 1946-77. v. 31, p. 25, 1977 (BUYRAI) ME: mmo-sat 40 umol/plate (+S9) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 115, 1980 (FCTXAV); mmo-sat 20 ppm (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 65, 1988 (EMMUEG); mmo-esc 3500 umol/10H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 24, p. 83, 1974 (MUREAV); mmo-omi 540 mg/L (-S9) "Sporulation and Germination, Proceedings of the Eighth International Spore Conference, 1980," Washington, DC, American Soc. of Microbiology, 1981 8,273,1981 (47YKAF); slt-dmg-par 114 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 195, 1970 (CNREA8); slt-dmg-ihl 750 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 405, p. 259, 1998 (MUREAV); cyt-dmg-par 55 mmol/L Zeitschrift fuer Vererbungslehre. (Berlin, Fed. Rep. Ger.) V.89-98, 1958-66. For publisher information, see MGGEAE. v. 92, p. 457, 1961 (ZEVBA5); sln-dmg-par 55 mmol/L Zeitschrift fuer Vererbungslehre. (Berlin, Fed. Rep. Ger.) V.89-98, 1958-66. For publisher information, see MGGEAE. v. 92, p. 457, 1961 (ZEVBA5); mmo-nsc 140 mmol/L/10M (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 101, p. 185, 1968 (MGGEAE); mmo-smc 25 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 250, p. 229, 1991 (MUREAV); mrc-smc 25 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 250, p. 229, 1991 (MUREAV); sce-smc 25 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 250, p. 229, 1991 (MUREAV); dnd-hmn-fbr 5 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 161, 1994 (EMMUEG); dns-hmn-leu 4 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 47, p. 265, 1983 (CBINA8); cyt-hmn-ihl 5 ppm/1Y Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 170, p. 55, 1986 (MUREAV); sce-hmn-lym 4 pph Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 15, 1986 (TCMUD8); sce-hmn-fbr 36 ppm/24H Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 170, p. 548, 1980 (ZHPMAT); sce-hmn-lym 10 mg/L Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1968- v. 25, p. 214, 1982 (PHMGBN); sce-hmn-ihl 380 ppb/6H/4Y-I Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 17, p. 60, 1991 (SWEHDO); sce-hmn-ihl 60 ppm/12W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 281, p. 31, 1992 (MUREAV); msc-hmn-fbr 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 283, 1993 (MUREAV); mnt-rat-ivn 200 mg/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 43, p. 69, 1978 (APTOA6); mnt-rat-ihl 200 ppm/6H/4W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 324, p. 87, 1994 (MUREAV); cyt-rat-bmr 30 ug/L/2D Toxicology of New Industrial Chemical Substances. English translation of TPKVAL. (USSR Academy of Medical Sciences, Meditsina, Moscow, USSR) v. 13, p. 47, 1973 (TNICS*); cyt-rat-ihl 1 ug/L/17W Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 13, p. 51, 1973 (TPKVAL); cyt-rat-orl 9 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 12, p. 72, 1971 (TPKVAL); sce-rat-ihl 50 ppm/6H/3D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 120, p. 37, 1983 (MUREAV); dlt-rat-ihl 1000 ppm/4H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 40, p. 261, 1977 (TXAPA9); dlt-rat-scu 40 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 48(1), p. 23, 1983 (GISAAA); mnt-mus-ipr 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 75, p. 191, 1980 (MUREAV); mnt-mus-ivn 200 mg/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 43, p. 69, 1978 (APTOA6); mnt-mus-ihl 380 ppm/3H-C Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (102), p. 84, 1984 (ESKHA5); mtr-mus-emb 2500 umol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 58, 1989 (MUTAEX); dnd-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 197, p. 93, 1988 (MUREAV); dnd-mus-ihl 1800 ppm/1H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 209, p. 177, 1988 (MUREAV); dns-mus-ihl 300 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 166, 1979 (ENMUDM); cyt-mus-ihl 400 ppm/6H-C Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 59, p. 332, 1987 (ARTODN); cyt-mus-ipr 88120 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 288, p. 223, 1993 (MUREAV); sce-mus-ipr 88120 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 288, p. 223, 1993 (MUREAV); dlt-mus-ihl 204 ppm/6H/48D-I Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 16, p. 126, 1990 (EMMUEG); dlt-mus-ipr 150 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 252, 1980 (ENMUDM); msc-mus-ipr 200 mg/kg/3D-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 288, p. 151, 1993 (MUREAV); msc-mus-lym 5 umol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 74, 1980 (PAACA3); msc-mus-ihl 200 ppm/6H/4W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 392, p. 211, 1997 (MUREAV); trn-mus-ipr 30 mg/kg/25D-I Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 252, 1980 (ENMUDM); trn-mus-ihl 165 ppm/6H/48D-I Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 16, p. 126, 1990 (EMMUEG); mtr-ham-emb 625 ppm/2H-C Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 67, 1986 (ENMUDM); cyt-ham-fbr 250 ppm Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (102), p. 77, 1984 (ESKHA5); msc-ham-ovr 5 mg/L/1H Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 12, p. 27, 1983 (JTEHD6); msc-ham-lng 7500 ppm/2H-C Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 67, 1986 (ENMUDM); cyt-mky-ihl 100 ppm/7H/2Y-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 76, p. 85, 1984 (TXAPA9); sce-mky-ihl 50 ppm/7H/2Y-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 76, p. 85, 1984 (TXAPA9); sce-rbt-ihl 50 ppm/12W-I Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 121, 1982 (ENMUDM); cyt-mky-ihl 100 ppm/104W Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 59, 2001 (MUREAV); mnt-rat-ipr 50 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 59, 2001 (MUREAV); sce-rat-ihl 50 ppm/4W Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 59, 2001 (MUREAV); sce-rbt-ihl 250 ppm/12W Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 59, 2001 (MUREAV); sce-rat-ipr 50 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 59, 2001 (MUREAV) RE: T01 ihl-rat TCLo: 50 ppm/6H (91D male) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 45, p. 592, 1990 (NEZAAQ); T34 ihl-rat TCLo: 100 ppm/6H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A84, 1979 (TXAPA9); T72 ihl-rat TCLo: 100 ppm/6H (12W male/9W pre-3W preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A84, 1979 (TXAPA9); T02-T24 ihl-rat TCLo: 3600 ug/m3/24H (60D male) Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 14, p. 11, 1975 (TPKVAL); T24-T72 ihl-rat TCLo: 100 ppm/6H (12W pre-21D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 63, p. 382, 1982 (TXAPA9); T34-T43-T46 ihl-rat TCLo: 150 ppm/7H (7-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-258038 (NTIS**); T35 ihl-mus TCLo: 255 ppm/6H (10D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 119, p. 377, 1983 (MUREAV); T25-T35-T55 ihl-mus TCLo: 1200 ppm/90M (1D preg) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 176, p. 269, 1987 (MUREAV); T25-T35-T39 ihl-mus TCLo: 1200 ppm/90M (1D pre) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 39, p. 563, 1989 (TJADAB); T39 ihl-mus TCLo: 2700 ppm/6H (7D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 57, p. 231, 1998 (TJADAB); T72-T91 ipr-mus TDLo: 750 mg/kg (25D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 73, p. 133, 1980 (MUREAV); T35 ipr-mus TDLo: 150 mg/kg (1D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 73, p. 133, 1980 (MUREAV); T25-T26-T42 ipr-mus TDLo: 125 mg/kg (1D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 53, p. 1, 1996 (TJADAB); T46-T59 ipr-mus TDLo: 125 mg/kg (1D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 53, p. 1, 1996 (TJADAB); T25 ivn-mus TDLo: 225 mg/kg (10-12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 34A, 1979 (TJADAB); T46 ivn-mus TDLo: 450 mg/kg (8-10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 34A, 1979 (TJADAB); T26-T34 ivn-mus TDLo: 450 mg/kg (10-12D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 56, p. 16, 1980 (TXAPA9); T01 ihl-mky TCLo: 50 ppm/7H (96W male) AAMI Technology Assessment Report. (Assoc. for the Advancement of Medical Instrumentation, 1901 N. Ft. Myer Dr., Suite 602, Arlington, VA 22209) No.1-81- 1981- v. 8-84, p. 7, 1984 (ATAREK); T01 ihl-mky TCLo: 50 ppm/7H (2Y male) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 3, p. 60, 1983 (TOXID9); T25 ivn-rbt TDLo: 324 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-242016 (NTIS**); T34 ihl-mus TCLo: 1800 ppm/1.5H (7D preg) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 50, p. 259, 1999 (TOSCF2); T26-T34-T35 ivn-rbt TDLo: 81 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-242016 (NTIS**); T73 ivn-rbt TDLo: 81 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-242016 (NTIS**) TE: V01-K60-L60 orl-rat TDLo: 1186 mg/kg/2Y-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 46, p. 924, 1982 (BJCAAI); V01-A60-P61 ihl-rat TCLo: 33 ppm/6H/2Y-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 75, p. 105, 1984 (TXAPA9); V01-J60 ihl-mus TDLo: 50 ppm/6H/2Y National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-326, 1987 (NTPTR*); V01-P62-V10 scu-mus TDLo: 292 mg/kg/95W-I Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 174, p. 383, 1981 (ZHPMAT); V02-P62-V10 scu-mus TD :1090 mg/kg/91W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 39, p. 588, 1979 (BJCAAI); V01-P62-V10 scu-mus TD :908 mg/kg/95W-I Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 174, p. 383, 1981 (ZHPMAT); V01-P62-V10 scu-mus TD :2576 mg/kg/95W-I Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 174, p. 383, 1981 (ZHPMAT); V01-K60-L60 orl-rat TD :5112 mg/kg/2Y-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 46, p. 924, 1982 (BJCAAI); V01-P60 ihl-rat TC :50 ppm/7H/2Y-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 76, p. 69, 1984 (TXAPA9); V03-A60 ihl-rat TC :33 ppm/6H/2Y-I Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 6, p. 117, 1985 (NRTXDN); V01-A60 ihl-rat TC :33 ppm/6H/2Y-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 24, p. 145, 1986 (FCTOD7); V01-J60 ihl-mus TCLo: 3060 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-169859 (NTIS**); V01-J60-T64 ihl-mus TCLo: 3060 mg/kg/102W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-169859 (NTIS**) ORNG: 72000000 ng/kg. [72.000000 mg/kg] T/E unlistd IHPB: 800000 ppb/4H. [800.000000 ppm/4H] J30-L30-M30 AT: D07 ihl-hmn TCLo: 12500 ppm/10S Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 32, p. 409, 1932 (JOHYAY); F12-K13-J30 ihl-wmn TCLo: 500 ppm/2M Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969- v. 15, p. 384, 1981 (DICPBB); T/E unlistd orl-rat LD50: 72 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 17, 1978 (SPEADM); J30-L30-M30 ihl-rat LC50: 800 ppm/4H "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,258,1969 (34ZIAG); T/E unlistd scu-rat LD50: 187 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 48(1), p. 23, 1983 (GISAAA); J30-L30-M30 unr-rat LDLo: 200 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,258,1969 (34ZIAG); T/E unlistd ihl-mus LC50: 836 ppm/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-270 (NTIS**); T/E unlistd ipr-mus LD50: 175 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 48(1), p. 23, 1983 (GISAAA); T/E unlistd ivn-mus LD50: 290 mg/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 43, p. 69, 1978 (APTOA6); D17-K13-K12 ihl-dog LC50: 960 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 237, 1956 (AMIHAB); D35-F12-K13 ivn-dog LD50: 330 mg/kg Journal of Thoracic and Cardiovascular Surgery. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.38- 1959- v. 61, p. 309, 1971 (JTCSAQ); T/E unlistd scu-cat LDLo: 100 mg/kg "Beitrage zur Toxikologie des Athylenoxyds und der Glykole, Dissertation," Hofbauer, A., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1933 v. -, p. -, 1933 (HDWU**); D35-F18-F21 ivn-rbt LDLo: 175 mg/kg Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 32, p. 409, 1932 (JOHYAY); T/E unlistd orl-gpg LD50: 270 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); T/E unlistd ihl-gpg LC50: 1500 mg/m3/4H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,67,1982 (85GMAT) MD: U01-Z01 ihl-rat TCLo: 406 ppm/6H/6W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 237, 1956 (AMIHAB); F23-P30-U06 ihl-rat TCLo: 300 ug/m3/24H/83D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(10), p. 3, 1966 (GISAAA); F15-L30 ihl-rat TCLo: 500 ppm/6H/13W-I Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 43, p. 1053, 1988 (NEZAAQ); Z01 ihl-mus TCLo: 800 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-326, 1987 (NTPTR*); M70-P05-Y07 ihl-mus TCLo: 400 ppm/6H/13W-I Journal of UOEH (University of Occupational and Environmental Health). (Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu 807, Japan) V.1- 1979- v. 14, p. 33, 1992 (JOUOD4); D07-N30-Z01 ihl-mus TCLo: 600 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-326, 1987 (NTPTR*); L70-N73-Z73 ihl-mus TCLo: 450 mg/m3/6H/10W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534608 (NTIS**); P08-P71 ihl-dog TCLo: 290 ppm/6H/6W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 237, 1956 (AMIHAB); P08-P71 ihl-dog TCLo: 102 ppm/26W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 237, 1956 (AMIHAB); D35 ihl-mky TCLo: 100 ppm/7H/2Y-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 354, 1992 (TOXID9); Z01 ivn-rbt TDLo: 81 mg/kg/9D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-242016 (NTIS**); U01 ivn-rbt TDLo: 72 mg/kg/4D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-242016 (NTIS**); Y55 ivn-rbt TDLo: 144 mg/kg/4D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB83-242016 (NTIS**) TR: ACGIH TLV-TWA 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 189, 1985 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 205, 1987 (IMSUDL); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 73, 1994 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 73, 1994 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 73, 1994 (IMEMDT); TOXICOLOGY REVIEW JOM, Journal of Occupational Medicine. (American Occupational Medicine Assoc., 150 N. Wacker Dr., Chicago, IL 60606) V.10- 1968- v. 15, p. 808, 1973 (JJOMDZ); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS); TOXICOLOGY REVIEW Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 8, p. 700, 1964 (AEHLAU); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 30, p. 595, 2000 (CRTXB2) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 50 ppm (90 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 112, 1971 (DTLVS*); OSHA PEL (Construc): see CFR 29,1926.1147 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 50 ppm (90 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OSHA-cancer hazard Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1047, 1987 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 10 ppm (20 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 1 ppm (2 mg/m3), Carcinogen, JAN 1993; OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-BELGIUM: TWA 1 ppm (1.8 mg/m3), Carcinogen, JAN 1993; OEL-DENMARK: TWA 1 ppm (1.8 mg/m3), JAN 1999; OEL-FINLAND: TWA 1 ppm (2.8 mg/m3), Carcinogen, JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-HUNGARY: STEL 1 mg/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 1 ppm (1.8 mg/m3), Group 1 Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 50 ppm (90 mg/m3), Carcinogen, JAN 1999; OEL-NORWAY: TWA 1 ppm, JAN 1999; OEL-POLAND: MAC(TWA) 1 mg/m3, MAC(STEL) 3 mg/m3, JAN 1999; OEL-RUSSIA: TWA 50 ppm, STEL 1 mg/m3, JAN 1993; OEL-SWEDEN: NGV 1 ppm (2 mg/m3), KTV 5 ppm (9 mg/m3), Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 1 ppm (2 mg/m3), Skin, Carcinogen, JAN 1999; OEL-TURKEY: TWA 50 ppm (90 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (9.2 mg/m3), Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ETHYLENE OXIDE-air: 8H CA TWA 0.1 ppm, CL 5 ppm/10M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 32550; NIS 67; TNF 7411; NOS 74; TNE 107450; NOES 1983: HZD 32550; NIS 89; TNF 10657; NOS 104; TNE 270683; TFE 120086 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/91/180554/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Rodent dominant lethal, Rodent heritable translocation; EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal, UDS in mouse germ cells; EPA GENETOX PROGRAM 1988, Negative: Mouse specific locus; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9104; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 35, MAY 1981; NIOSH CURRENT INTELLIGENCE BULLETIN 52, JULY 1989; NIOSH Analytical Method, 1994: Ethylene oxide, 1614 or by portable GC, 3702; NCI Carcinogenesis Studies (inhal), clear evidence: mouse; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #30, SUPERSEDED BY #50; PASSIVE MONITOR, OSHA ANALYTICAL METHOD #49 Record 779 of 1119 in RTECS (through 2003/06) AN: KX3850000 PN: Ethylene,-tetrachloro- SY: 1,1,2,2-Tetrachloroethylene-; Ankilostin-; Antisol-1-; Carbon-bichloride-; Carbon-dichloride-; Czterochloroetylen- (Polish); Didakene-; Dilatin-PT-; Dow-per-; ENT-1,860-; Ethene,-tetrachloro-; Ethylene-tetrachloride-; Ethylenetetrachloride-; Fedal-UN-; NCI-C04580-; PER-; PERK-; Per-; Perawin-; Perc-; Perchloorethyleen,-per- (Dutch); Perchlor-; Perchloraethylen,-per- (German); Perchlorethylene-; Perchloroethylene-; Perchloroethylene- (ACGIH:OSHA); Perclene-; Perclene-D-; Percloroetilene- (Italian); Percosolve-; Perk-; Perklone-; Persec-; RCRA-waste-number-U210-; Tetlen-; Tetracap-; Tetrachlooretheen- (Dutch); Tetrachloraethen- (German); Tetrachlorethylene-; Tetrachloroethene-; Tetrachloroethylene-; Tetrachloroethylene- (DOT:OSHA); Tetrachloroethylene- (IUPAC); Tetracloroetene- (Italian); Tetraleno-; Tetralex-; Tetravec-; Tetroguer-; Tetropil- RN: Current: 127-18-4 BRN: 1361721 BHR: 4-01-00-00715 UD: 200305 MF: C2-Cl4 MW: 165.82 WL: GYGUYGG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 810 mg/24H SEV European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 171, 1976 (EJTXAZ); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,108,1986 (85JCAE); eye-rbt 162 mg MLD European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 171, 1976 (EJTXAZ); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,108,1986 (85JCAE) ME: mmo-sat 50 uL/plate (+S9) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. 5AUG1977 (NIOSH*); dns-hmn-lng 100 mg/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-185075 (NTIS**); mtr-rat-emb 97 umol/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 14, p. 290, 1978 (ITCSAF); cyt-rat-ihl 500 ppm National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-185075 (NTIS**); dnd-mus-ipr 4 mmol/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31, p. 31, 1986 (TOLED5); oms-mus-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); hma-mus-sat 100 ppm National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-185075 (NTIS**); spm-mus-ihl 500 ppm National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-185075 (NTIS**); sln-ham-lng 190 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 135, 1987 (MUREAV) RE: T46 ihl-rat TCLo: 1000 ppm/24H (14D pre/1-22D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A21, 1980 (APTOD9); T34 ihl-rat TCLo: 1000 ppm/24H (1-22D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A21, 1980 (APTOD9); T72-T83-T85 ihl-rat TCLo: 900 ppm/7H (7-13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 41A, 1979 (TJADAB); T25 ihl-rat TCLo: 300 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 84, 1975 (TXAPA9); T72-T75-T81 ihl-rat TCLo: 1000 ppm/6H (multigeneration) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0557702 (NTIS**); T34-T46-T55 ihl-mus TCLo: 300 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 84, 1975 (TXAPA9); T01 ihl-mus TCLo: 500 ppm/7H (5D male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-185075 (NTIS**) TE: V01-P61-T61 ihl-rat TCLo: 200 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-311, 1986 (NTPTR*); V01-L60 orl-mus TDLo: 195 gm/kg/50W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-13, 1977 (NCITR*); V01-L60 ihl-mus TCLo: 100 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-311, 1986 (NTPTR*); V01-L60 orl-mus TD :240 gm/kg/62W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-13, 1977 (NCITR*); V02-M61-P61 ihl-rat TC :200 ppm/6H/2Y-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31(Suppl), p. 16, 1986 (TOLED5); V02-L60 ihl-mus TC :100 ppm/6H/2Y-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31(Suppl), p. 16, 1986 (TOLED5); V01-P61 ihl-rat TCLo: 6180 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-147054/AS (NTIS**); V01-P61 ihl-rat TCLo: 5150 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-147054/AS (NTIS**); V01-L60 ihl-mus TCLo: 6180 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-147054/AS (NTIS**); V03 ihl-mus TCLo: 2100 mg/m3/6H/78W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 459, 1990 (VCVGH*) ORNG: 2629000000 ng/kg. [2629.000000 mg/kg] T/E unlistd AT: C17-D25-F08 ihl-hmn TCLo: 96 ppm/7H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB257-185 (NTIS**); F24 orl-chd TDLo: 545 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 23, p. 103, 1985 (JTCTDW); D25-F01 ihl-man TCLo: 600 ppm/10M AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 5, p. 566, 1952 (AMIHBC); T/E unlistd orl-rat LD50: 2629 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 20, p. 364, 1959 (AIHAAP); T/E unlistd ihl-rat LC50: 34200 mg/m3/8H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 20, p. 364, 1959 (AIHAAP); T/E unlistd ipr-rat LD50: 4678 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); T/E unlistd itr-rat LDLo: 450 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520615 (NTIS**); F01 orl-mus LD50: 8100 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB257-185 (NTIS**); T/E unlistd ihl-mus LC50: 5200 ppm/4H Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 9, p. 303, 1953 (APTOA6); T/E unlistd ipr-mus LD :>500 mg/kg "Summary Tables of Biological Tests," National Research Council Chemical-Biological Coordination Center. (National Academy of Science Library, 2101 Constitution Ave., NW, Washington, DC 20418) v. 4, p. 378, 1952 (CBCCT*); F04-F19 scu-mus LD50: 65 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 123, p. 224, 1958 (JPETAB); F04-F07 orl-dog LDLo: 4 gm/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 9, p. 430, 1929 (AJHYA2); L14 ipr-dog LD50: 2100 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 119, 1967 (TXAPA9); T/E unlistd ivn-dog LDLo: 85 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); F04-F07 orl-cat LDLo: 4 gm/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 9, p. 430, 1929 (AJHYA2); F04-F07 orl-rbt LDLo: 5 gm/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 9, p. 430, 1929 (AJHYA2); T/E unlistd skn-rbt LD :>3228 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A180-198 (NTIS**); T/E unlistd scu-rbt LDLo: 2200 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); F02 orl-rat TDLo: 50 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 170, p. 201, 2002 (TXCYAC) MD: M16 orl-rat TDLo: 14 gm/kg/4W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 59, p. 427, 1992 (ENVRAL); U01-Y03 orl-rat TDLo: 36 gm/kg/90D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 119, 1986 (FAATDF); L30-L70-Y37 orl-rat TDLo: 3 gm/kg/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 78, p. 105, 1985 (TXAPA9); Z01 ihl-rat TCLo: 1750 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-311, 1986 (NTPTR*); A11-Y01 ihl-rat TCLo: 19300 mg/m3/24H/94D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 42(8), p. 50, 1977 (GISAAA); Y07-Y12-Y15 ihl-rat TCLo: 200 ppm/4W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 54, p. 207, 1990 (TOLED5); L01-M01-P27 ihl-rat TCLo: 7000 ppm/8H/50D-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 19, p. 323, 1937 (JIHTAB); P28-L30 ipr-rat TDLo: 49750 ug/kg/3D-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 8, p. 191, 1992 (TIHEEC); S20 orl-mus TDLo: 23215 mg/kg/8W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 74, 2000 (TOXID9); L03 ihl-mus TCLo: 200 ppm/4H/8W-I Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 22, p. 379, 1965 (APTOA6); L03 ihl-mus TCLo: 1750 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-311, 1986 (NTPTR*); M03-M30-Z01 ihl-mus TCLo: 1600 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-311, 1986 (NTPTR*); F07 ihl-rbt TCLo: 2500 ppm/7H/39D-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 5, p. 566, 1952 (AMIHBC); L70-U01 ihl-gpg TCLo: 200 ppm/7H/32W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 5, p. 566, 1952 (AMIHBC); A30-Y37 ihl-grb TCLo: 120 ppm/24H/1Y-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 22, p. 343, 1984 (TOLED5); F02-F29 orl-rat TDLo: 200 mg/kg/40D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 170, p. 201, 2002 (TXCYAC); F02-F17-U01 orl-rat TDLo: 2000 mg/kg/40D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 170, p. 201, 2002 (TXCYAC); M30-P27 ihl-rat TCLo: 1500 mg/m3/8H/28W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 459, 1990 (VCVGH*); K01-F07-F19 ihl-rat TCLo: 10900 mg/m3/2W-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 459, 1990 (VCVGH*); L70 ihl-gpg TCLo: 680 mg/m3/200D-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 460, 1990 (VCVGH*); A30-Y37 ims-rat TDLo: 320 ppm/90D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 52, p. 279, 1990 (TOLED5); A70-U01-Y37 ims-rat TDLo: 320 ppm/30D-C Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 14, p. 91, 1988 (SWEHDO); A30-A70-Y37 ims-grb TDLo: 320 ppm/90D-C Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 60, p. 397, 1987 (ARTODN); A30-Y37 ims-grb TDLo: 120 ppm/1Y-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 22, p. 343, 1984 (TOLED5) TR: ACGIH TLV-TWA 25 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 25 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 355, 1987 (IMSUDL); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 159, 1995 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 159, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 355, 1987 (IMSUDL); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 355, 1987 (IMSUDL); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 159, 1995 (IMEMDT); TOXICOLOGY REVIEW Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 6, p. 517, 1977 (CMSHAF); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 100 ppm (670 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 201, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm;CL 200;Pk 300/5M/3H Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (670 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (670 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (670 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 5 ppm (35 mg/m3), Skin, JAN 1993; OEL-AUSTRALIA: TWA 50 ppm (335 mg/m3), STEL 150 ppm, Carcinogen, JAN 1993; OEL-AUSTRIA: MAK 50 ppm (345 mg/m3), Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 50 ppm (339 mg/m3), STEL 200 ppm (1368 mg/m3), JAN 1993; OEL-DENMARK: TWA 10 ppm (70 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 50 ppm (335 mg/m3), STEL 75 ppm (520 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 50 ppm (335 mg/m3), C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 50 ppm (345 mg/m3), Carcinogen, JAN 1999; OEL-HUNGARY: STEL 50 mg/m3, Skin, Carcinogen, JAN 1993; OEL-JAPAN: OEL 50 ppm (340 mg/m3), 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 35 ppm (240 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 20 ppm (130 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (670 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 60 mg/m3, MAC(STEL) 480 mg/m3, JAN 1999; OEL-RUSSIA: TWA 50 ppm, STEL 10 mg/m3, JAN 1993; OEL-SWEDEN: NGV 10 ppm (70 mg/m3), KTV 25 ppm (170 mg/m3), Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (345 mg/m3), STEL 100 ppm, Skin, JAN 1999; OEL-THAILAND: TWA 100 ppm, STEL 200 ppm, JAN 1993; OEL-UNITED KINGDOM: TWA 50 ppm (345 mg/m3), STEL 199 ppm, SEP 2000; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO TETRACHLOROETHYLENE-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 54790; NIS 288; TNF 52013; NOS 155; TNE 549154; NOES 1983: HZD 54790; NIS 268; TNF 49025; NOS 151; TNE 688110; TFE 177342 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101181/AS); EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-1292-8618, 8EHQ-0393-8618; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0294-8618, 8EHQ-0393-8762; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 20, 1978; NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP Carcinogenesis Studies (inhalation), clear evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-311, 1986 (NTPTR*); NCI Carcinogenesis Bioassay (gavage), inadequate studies: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-13, 1977 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #1001 Record 780 of 1119 in RTECS (through 2003/06) AN: KX4000000 PN: Ethylene,-tetrafluoro- SY: Perfluoroethene-; Perfluoroethylene-; Tetrafluorethylene-; Tetrafluoroethene- (9CI); Tetrafluoroethylene-; 1,1,2,2-Tetrafluoroethylene-; TFE- RN: Current: 116-14-3 UD: 200302 MF: C2-F4 MW: 100.02 WL: FYFUYFF CC: Tumorigen (C); Drug (D); Reproductive-Effector (T) RE: T02 ihl-ham TCLo: 2489 ppm/6H (2W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571191 (NTIS**) TE: V01-L60-M61 ihl-rat TCLo: 625 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-450, 1997 (NTPTR*); V01-L60-L61 ihl-mus TCLo: 312 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-450, 1997 (NTPTR*); V01-L60 ihl-rat TCLo: 9640.8 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-208508 (NTIS**); V01-L61-P61 ihl-rat TCLo: 16093.75 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-208508 (NTIS**); V03-M61 ihl-rat TCLo: 19312.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-208508 (NTIS**); V03-M61 ihl-rat TCLo: 32187.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-208508 (NTIS**); V01-L61 ihl-mus TCLo: 17784 mg/kg/95W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-208508 (NTIS**) IHPB: 40000000 ppb/4H. [40000.000000 ppm/4H] J30 AT: J30 ihl-rat LC50: 40000 ppm/4H Journal of Occupational Medicine. (Chicago, IL) V.1-9, 1957-67. For publisher information, see:JJOMDZ v. 4, p. 262, 1962 (JOCMA7); F07-L30-M30 ihl-mus LC50: 143 gm/m3/4H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 21(5), p. 36, 1977 (GTPZAB); F07-L30-M30 ihl-gpg LC50: 116 gm/m3/4H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 21(5), p. 36, 1977 (GTPZAB) MD: M13-M16-Y15 ihl-rat TCLo: 500 ppm/6H/2W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571191 (NTIS**); M03-L70-M13 ihl-rat TCLo: 625 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-450, 1997 (NTPTR*); M03-L70-M70 ihl-mus TCLo: 5000 ppm/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-450, 1997 (NTPTR*); M03-M10 ihl-mus TCLo: 2500 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-450, 1997 (NTPTR*); M16-P28 ihl-ham TCLo: 991 ppm/6H/2W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571191 (NTIS**); L70-M16-M70 ihl-ham TCLo: 2000 ppm/6H/90D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555226 (NTIS**); A11 ihl-rat TCLo: 100 mg/m3/5H/8W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 291, 1990 (VCVGH*); U01-Y01-Y03 ihl-rat TCLo: 100 mg/m3/16W-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 291, 1990 (VCVGH*); U01-Y20 ihl-rbt TCLo: 0.09 pph/6H/100D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 291, 1990 (VCVGH*) TR: ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1143, 1999 (IMEMDT); IARC Cancer Review: Animal No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 285, 1979 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 285, 1979 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1143, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1143, 1999 (IMEMDT) ND: NOHS 1974: HZD 83760; NIS 24; TNF 622; NOS 32; TNE 5326; NOES 1983: HZD 83760; NIS 7; TNF 870; NOS 9; TNE 14963; TFE 325 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, PROPOSED RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 27009, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9106; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 781 of 1119 in RTECS (through 2003/06) AN: KX4550000 PN: Ethylene,-trichloro- SY: 1,1,2-Trichloroethylene-; 1,1-Dichloro-2-chloroethylene-; 1,2,2-Trichloroethylene-; 1-Chloro-2,2-dichloroethylene-; Acetylene-trichloride-; Algylen-; Anamenth-; Benzinol-; Blacosolv-; Blancosolv-; Cecolene-; Chlorilen-; Chlorylen-; Circosolv-; Crawhaspol-; Densinfluat-; Dow-tri-; Dukeron-; Ethinyl-trichloride-; Ethylene-trichloride-; Fleck-flip-; Flock-FLIP-; Fluate-; Germalgene-; Lanadin-; Lethurin-; NCI-C04546-; Narcogen-; Narkosoid-; Nialk-; Perm-A-chlor-; Petzinol-; Philex-; RCRA-waste-number-U228-; TCE-; Threthylen-; Threthylene-; Trethylene-; Tri-; Tri-clene-; Tri-plus-; Tri-plus-M-; Triad-; Trial-; Triasol-; Trichlooretheen- (Dutch); Trichloorethyleen,-tri- (Dutch); Trichloraethen- (German); Trichloraethylen,-tri- (German); Trichloran-; Trichloren-; Trichlorethylene,-tri- (French); Trichloroethene-; Trichloroethylene-; Trichloroethylene- (ACGIH:OSHA); Trichloroethylene- (IUPAC); Tricloretene- (Italian); Tricloroetilene- (Italian); Trielene-; Trielin-; Trielina- (Italian); Trieline-; Trilen-; Trilene-; Trilene-TE-141-; Triline-; Trimar-; Triol-; Vestrol-; Vitran-; Westrosol- RN: Current: 79-01-6 Previous: 52037-46-4 BRN: 1736782 BHR: 4-01-00-00712 UD: 200305 MF: C2-H-Cl3 MW: 131.38 WL: GYGU1G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,106,1986 (85JCAE); eye-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,106,1986 (85JCAE) ME: mmo-sat 10 ug/plate (+/-S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 15, p. 101, 1987 (TECSDY); mmo-esc 3300 umol/L (+S9) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 24, p. 2013, 1975 (BCPCA6); pic-esc 18 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); mmo-smc 40 mmol/L (+S9) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(4), p. 411, 1978 (JEPTDQ); mrc-smc 20 mmol/L Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(4), p. 411, 1978 (JEPTDQ); dnd-smc 22 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 209, 1988 (MUREAV); sln-smc 11 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 209, 1988 (MUREAV); mmo-asn 2500 ppm (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 155, p. 105, 1985 (MUREAV); sln-asn 17500 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 155, p. 105, 1985 (MUREAV); mnt-ofs-mul 3 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 399, p. 125, 1998 (MUREAV); cyt-ofs-mul 3 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 399, p. 125, 1998 (MUREAV); dns-hmn-lng 100 mg/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-185075 (NTIS**); dni-hmn-lym 5 mL/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 13, p. 213, 1981 (CALEDQ); sce-hmn-lym 178 mg/L Annales de Genetique. (Expansion Scientifique Francaise, 15 rue Saint-Benoit, F-75278, Paris Cedex 06, France) V.1- 1958- v. 24, p. 105, 1981 (AGTQAH); mnt-rat-ihl 5 ppm/6H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 87, 1994 (MUREAV); mnt-rat-orl 4 mmol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 413, p. 1, 1998 (MUREAV); mtr-rat-emb 1100 umol/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 14, p. 290, 1978 (ITCSAF); dnd-rat-lvr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 1145, 1983 (CNREA8); dns-rat-lvr 2800 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1629, 1984 (CRNGDP); dns-rat-orl 16500 mg/kg/3W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 137, 1982 (TXAPA9); mnt-mus-ipr 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 413, p. 151, 1998 (MUREAV); mmo-mus-lym 146 mg/L (+S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); slt-mus-ipr 140 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 38, p. 87, 1977 (ARTODN); mtr-mus-emb 20 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 28, p. 85, 1985 (CALEDQ); dnd-mus-ipr 6 mmol/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31, p. 31, 1986 (TOLED5); dnd-mus-lvr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 1145, 1983 (CNREA8); dns-mus-orl 2500 mg/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A080-636 (NTIS**); dns-mus-bmr 1 mmol/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A080-636 (NTIS**); oms-mus-orl 600 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); hma-mus-smc 400 mg/kg Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(4), p. 411, 1978 (JEPTDQ); spm-mus-ihl 100 ppm National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-185075 (NTIS**); mtr-ham-emb 5 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 291, 1983 (CRNGDP); oms-ham-fbr 1 pph Anesthesiology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1940- v. 43, p. 21, 1975 (ANESAV); sce-ham-ovr 401 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sln-ham-lng 1150 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 135, 1987 (MUREAV); dna-mam-lym 1 mmol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 11, p. 243, 1982 (TOLED5); cyt-mus-skn 7 gm/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 185, 2001 (EMMUEG) RE: T85 orl-rat TDLo: 2688 mg/kg (1-22D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 179, 1984 (TOXID9); T76 orl-rat TDLo: 36 gm/kg (15D pre/1-21D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 32, p. 229, 1984 (TXCYAC); T41 orl-rat TDLo: 1140 mg/kg (14D pre-21D post) Brain Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1966- v. 488, p. 403, 1989 (BRREAP); T46-T59 ihl-rat TCLo: 1800 ppm/24H (1-20D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A22, 1980 (APTOD9); T25-T34 ihl-rat TCLo: 100 ppm/4H (6-22D preg) Journal of Physiology. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1878- v. 276, p. 24P, 1978 (JPHYA7); T53 ihl-rat TCLo: 1800 ppm/6H (1-20D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 14, p. 153, 1979 (TXCYAC); T46 ihl-rat TCLo: 100 ppm/4H (8-21D preg) British Journal of Anesthesia. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1923- v. 54, p. 337, 1982 (BJANAD); T01 ihl-mus TCLo: 100 ppm/7H (5D male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-185075 (NTIS**); T41 ihl-mus TCLo: 150 ppm/24H (4W male/4W pre-3W preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 23, p. 223, 1984 (TOLED5); T25 orl-mus TDLo: 176 gm/kg (15W male/15W pre-3W post) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86173150 (NTIS**); T81 orl-rat TDLo: 19 gm/kg (15W male/15W pre-3W post) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86190782 (NTIS**); T81 orl-mus TDLo: 24.5 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86173150 (NTIS**); T26 orl-rat TDLo: 5.5 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86190782 (NTIS**); T51-T53-T81 orl-rat TDLo: 76 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86190782 (NTIS**); T53 orl-rat TDLo: 156 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86190782 (NTIS**); T29 orl-rat TDLo: 10115 mg/kg (7D male/7D pre/21D preg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86190782 (NTIS**); T51-T53 orl-mus TDLo: 700 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86173150 (NTIS**) TE: V01-J60-R60 ihl-rat TCLo: 150 ppm/7H/2Y-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 21, p. 243, 1983 (INHEAO); V01-L60 orl-mus TDLo: 455 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-2, 1976 (NCITR*); V01-H60-J60 ihl-mus TCLo: 150 ppm/7H/2Y-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 21, p. 243, 1983 (INHEAO); V03-P62-L60 ihl-ham TCLo: 100 ppm/6H/77W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 43, p. 237, 1980 (ARTODN); V01-L60 orl-mus TD :912 gm/kg/78W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-2, 1976 (NCITR*); V03-P62 ihl-mus TC :500 ppm/6H/77W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 43, p. 237, 1980 (ARTODN); V01-J60-R60 ihl-mus TC :150 ppm/7H/2Y-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 21, p. 243, 1983 (INHEAO); V01-L60-P60 orl-mus TD :515 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-243, 1990 (NTPTR*); V03-M61 orl-rat TDLo: 515000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-111815 (NTIS**); V01-L60 orl-mus TDLo: 515000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-111815 (NTIS**); V03-L60 unr-mus TDLo: 456 gm/kg/28W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 446, 1990 (VCVGH*); V03-L60 unr-mus TDLo: 912 gm/kg/78W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 446, 1990 (VCVGH*) ORNG: 4920000000 ng/kg. [4920.000000 mg/kg] T/E unlistd AT: F07-F11-F24 orl-man TDLo: 1 mL/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 41, p. 157, 1998 (TOSCF2); T/E unlistd orl-hmn LDLo: 7 gm/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 35, p. 295, 1976 (ARTODN); K30 orl-man TDLo: 2143 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,602,1969 (34ZIAG); F07-F08 ihl-hmn TCLo: 6900 mg/m3/10M Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); F08 ihl-hmn TCLo: 160 ppm/83M American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 167, 1962 (AIHAAP); F07-K30-L12 ihl-hmn TCLo: 812 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 689, 1945 (BMJOAE); D35-F08 ihl-man TCLo: 110 ppm/8H British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 28, p. 293, 1971 (BJIMAG); T/E unlistd ihl-man LCLo: 2900 ppm New Zealand Medical Journal. (New Zealand Medical Assoc., P.O. Box 156, Wellington, New Zealand) V.1- 1900- v. 50, p. 119, 1951 (NZMJAX); M04-M13-Y16 ihl-hmn TCLo: 500 ppm/16.1Y-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 73, p. 246, 1999 (ARTODN); T/E unlistd orl-rat LD50: 4920 mg/kg Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 32, p. 145, 1994 (INHEAO); T/E unlistd ihl-rat LCLo: 4800 ppm/4H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 469, 1951 (AMIHBC); T/E unlistd ipr-rat LD50: 1282 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); T/E unlistd itr-rat LDLo: 150 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520615 (NTIS**); F05-F19-R21 orl-mus LD50: 2402 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A080-636 (NTIS**); T/E unlistd ihl-mus LC50: 8450 ppm/4H Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 9, p. 303, 1953 (APTOA6); F04-F19 scu-mus LD50: 16 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 123, p. 224, 1958 (JPETAB); T/E unlistd ivn-mus LD50: 33900 ug/kg "Summary Tables of Biological Tests," National Research Council Chemical-Biological Coordination Center. (National Academy of Science Library, 2101 Constitution Ave., NW, Washington, DC 20418) v. 6, p. 141, 1954 (CBCCT*); L14 ipr-dog LD50: 1900 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 119, 1967 (TXAPA9); T/E unlistd scu-dog LDLo: 150 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 76, 1959 (HBTXAC); T/E unlistd ivn-dog LDLo: 150 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd orl-cat LDLo: 5864 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 76, 1959 (HBTXAC); C06-F01-F17 ihl-cat LCLo: 32500 mg/m3/2H Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); T/E unlistd orl-rbt LDLo: 7330 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 76, 1959 (HBTXAC); T/E unlistd ihl-rbt LCLo: 11000 ppm FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 48A, p. 121, 1970 (FAONAU); T/E unlistd skn-rbt LD50: >20 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A062-138 (NTIS**); T/E unlistd scu-rbt LDLo: 1800 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd ihl-gpg LCLo: 37200 ppm/40M "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 76, 1959 (HBTXAC); F41 ihl-rat TCLo: 2000 ppm/70M Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 22, p. 221, 2000 (NETEEC); Y35 orl-rat TDLo: 250 mg/kg Acta Biochimica Polonica (Published by Polish Biochemical Society and the Committee of Biochemistry and Biophysics, Polish Academy of Sciences, Warszawa Panstwowe Wydawnictwo Naukowe, L.Pasteura 3 02-093 Warszawa, Poland) V.1- 1954- v. 47, p. 1129, 2000 (ABCPO*) MD: A06 orl-rat TDLo: 1160 mg/kg/8W-I Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 12, p. 375, 1990 (NETEEC); L70-M70-Y07 orl-rat TDLo: 84 gm/kg/2W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 5, p. 228, 1985 (TOXID9); U01-Z01 orl-rat TDLo: 130 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-273, 1988 (NTPTR*); L70-Y03 orl-rat TDLo: 24 gm/kg/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 78, p. 105, 1985 (TXAPA9); F19-F42 ihl-rat TCLo: 4380 ppm/4H/2W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 25, p. 369, 1964 (AIHAAP); A11-D40 ihl-rat TCLo: 3200 ppm/12H/14W-I Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 13, p. 83, 1991 (NETEEC); L70 ihl-rat TCLo: 150 ppm/24H/30D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 10, p. 1, 1982 (TOLED5); D40 ihl-rat TCLo: 2400 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 38, p. 101, 1997 (FAATDF); A11-M16 ihl-rat TCLo: 50 mg/m3/5H/26W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 5(3), p. 9, 1961 (GTPZAB); P28-L70-Y37 ihl-rat TCLo: 300 ppm/24H/12W-C Experimental and Toxicologic Pathology. (Gustav Fischer Verlag Jena, Postfach 100537, D-07705 Jena, Germany) V.44- 1992- v. 46, p. 133, 1994 (ETPAEK); L30-L70-Y40 scu-rat TDLo: 60 gm/kg/15W-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 25, p. 89, 1987 (INHEAO); L70-P08-Y03 orl-rat TDLo: 28 gm/kg/28D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0590061 (NTIS**); L02-Y10-Y15 orl-mus TDLo: 48 gm/kg/4W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 9, p. 15, 1986 (JJATDK); P26-S04 orl-mus TDLo: 49080 mg/kg/17W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A080-636 (NTIS**); L70-U01-Y03 ihl-mus TCLo: 150 ppm/24H/30D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 10, p. 1, 1982 (TOLED5); L70-M70-U01 orl-mus TDLo: 182 gm/kg/26W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 351, 1982 (TXAPA9); U01-Y07-Z01 orl-mus TDLo: 13 gm/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 351, 1982 (TXAPA9); L70 orl-mus TDLo: 3360 mg/kg/14D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 315, 1982 (TXAPA9); N73 ipr-mus TDLo: 3941 mg/kg/3D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 70, p. 231, 1991 (TXCYAC); J25-J30-Z01 ihl-mus TCLo: 10000 ppm/1H/12D-I British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 4, p. 177, 1949 (BJPCAL); U01 ihl-dog TCLo: 3825 mg/m3/8H/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 270, 1967 (TXAPA9); L30 ihl-dog TCLo: 500 ppm/4H/8W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 26(7), p. 250, 1944 (JIHTAB); A11 ihl-rbt TCLo: 350 ppm/4H/12W-I Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 13, p. 203, 1992 (NRTXDN); M16-P72-Y02 ihl-rbt TCLo: 100 mg/m3/4H/39W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(5), p. 55, 1973 (GTPZAB); L70-U01 ihl-gpg TCLo: 400 ppm/7H/35W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 469, 1951 (AMIHBC); A30-L70-Y03 ihl-grb TCLo: 150 ppm/24H/30D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 10, p. 1, 1982 (TOLED5); A30-Y37 ihl-grb TCLo: 320 ppm/24H/90D-C Neurochemical Pathology. (Humana Press Inc., 999 Riverview Dr., Suite 208, Totowa, NJ 07512) V.1- 1983- v. 3, p. 151, 1985 (NEPADD); F41-F30 ihl-rat TCLo: 2000 ppm/1H/10D-I Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 23, p. 617, 2001 (NETEEC); F30-F41 ihl-rat TCLo: 2000 ppm/5D-I Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 22, p. 221, 2000 (NETEEC); L02-N30-S04 ihl-mus TCLo: 500 ppm/4W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 20, p. 471, 2000 (JJATDK); F17 ihl-rat TCLo: 376 ppm/30D-I Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 441, 2001 (JAPTO*); L70 ihl-mus TCLo: 810 mg/m3/2D-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 444, 1990 (VCVGH*); L70-N73-U01 orl-rat TDLo: 14000 mg/kg/7D-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 451, 2001 (JTPAE7); L15-P28 ihl-man TCLo: 5 ppm/17Y-I British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 49, p. 700, 1992 (BJIMAG); L70-T02-T03 orl-mus TDLo: 102900 mg/kg /21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86161999 (NTIS**); M03-T01 orl-mus TDLo: 102900 mg/kg /21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86173150 (NTIS**); L70-M03 orl-mus TDLo: 102900 mg/kg /21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86173150 (NTIS**); U01 orl-rat TDLo: 2128 mg/kg /28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86190782 (NTIS**); L70-M71-U01 orl-rat TDLo: 42483 mg/kg /21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86190782 (NTIS**); M04-M16 ihl-rat TCLo: 500 ppm/6H/26W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. -, p. 247, 2002 (TOLED5); A30-Y37-Y40 ihl-grb TCLo: 510 ppm/8H/24W-I Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 10, p. 89, 1984 (SWEHDO); A30-Y37-Y40 ihl-grb TCLo: 170 ppm/8H/24W-C Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 10, p. 89, 1984 (SWEHDO); C18-Y37 ims-rat TDLo: 125 gm/kg/10W-I Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 13, p. 601, 1992 (NRTXDN); A30-Y37 ims-rat TDLo: 1720 mg/m3/5D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 85, p. 145, 1986 (TXAPA9) TR: ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not suspected as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 545, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 75, 1995 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 75, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 545, 1979 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 364, 1987 (IMSUDL); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 75, 1995 (IMEMDT); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 671, 1977 (JTEHD6); TOXICOLOGY REVIEW Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 8, p. 91, 1967 (CLPTAT); TOXICOLOGY REVIEW JOM, Journal of Occupational Medicine. (American Occupational Medicine Assoc., 150 N. Wacker Dr., Chicago, IL 60606) V.10- 1968- v. 16, p. 194, 1974 (JJOMDZ); TOXICOLOGY REVIEW JOM, Journal of Occupational Medicine. (American Occupational Medicine Assoc., 150 N. Wacker Dr., Chicago, IL 60606) V.10- 1968- v. 17, p. 603, 1975 (JJOMDZ); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6); TOXICOLOGY REVIEW Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- v. 54, p. 413, 1978 (BNYMAM); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF); TOXICOLOGY REVIEW Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 3, p. 417, 1981 (NTOTDY); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 30, p. 253, 2000 (CRTXB2) SR: MSHA STANDARD-air: TWA 100 ppm (535 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 263, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm;CL 200;Pk 300/5M/2H Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (535 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (535 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (535 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 50 ppm (270 mg/m3), STEL 200 ppm, JAN 1993; OEL-AUSTRIA: MAK 50 ppm (270 mg/m3), Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 50 ppm (269 mg/m3), STEL 200 ppm (1070 mg/m3), JAN 1993; OEL-DENMARK: TWA 10 ppm (55 mg/m3), JAN 1999; OEL-FINLAND: TWA 30 ppm (160 mg/m3), STEL 45 ppm (240 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 75 ppm (405 mg/m3), VLE 200 ppm (1080 mg/m3), C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 50 ppm (270 mg/m3), Carcinogen, JAN 1999; OEL-HUNGARY: TWA 10 mg/m3, STEL 40 mg/m3, JAN 1993; OEL-JAPAN: OEL 50 ppm (270 mg/m3), 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 35 ppm (190 mg/m3), MAC-K 100 ppm (538 mg/m3), JAN 1999; OEL-NORWAY: TWA 20 ppm (110 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (535 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 50 mg/m3, MAC(STEL) 400 mg/m3, JAN 1999; OEL-RUSSIA: TWA 50 ppm, STEL 10 mg/m3, JAN 1993; OEL-SWEDEN: NGV 10 ppm (50 mg/m3), KTV 25 ppm (140 mg/m3), Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (260 mg/m3), KZG-W 250 ppm (1300 mg/m3), JAN 1999; OEL-THAILAND: TWA 100 ppm, STEL 200 ppm, JAN 1993; OEL-TURKEY: TWA 100 ppm (535 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 100 ppm (550 mg/m3), STEL 150 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO TRICHLOROETHYLENE-air: 10H CA TWA 25 ppm, CL 2 ppm/1H National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NIOSH REL TO WASTE ANESTHETIC GASES AND VAPORS-air: CL 2 ppm/1H MMWR. Morbidity and Mortality Weekly Report. (Centers for Disease Control, Atlanta, GA 30333) V.25(10)- 1976- for RTECS citation, only V.34(Suppl 1S), 1985 is used. v. 37(S-7), p. 28, 1988 (MMWR**); NOHS 1974: HZD 73790; NIS 251; TNF 37699; NOS 141; TNE 446588; NOES 1983: HZD 73790; NIS 192; TNF 23225; NOS 143; TNE 401373; TFE 175316 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101165/AS); EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: Mouse spot test, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 2, 1975; NIOSH Analytical Method, 1994: Trichloroethylene, 1022, by portable GC, 3701; NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NTP Carcinogenesis Studies (gavage), clear evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-243, 1983 (NTPTR*); NCI Carcinogenesis Bioassay (gavage), no evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-2, 1976 (NCITR*); NCI Carcinogenesis Studies (gavage), inadequate study: rat; NCI Carcinogenesis Studies (gavage), inadequate studies: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-243, 1983 (NTPTR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #1001 Record 782 of 1119 in RTECS (through 2003/06) AN: LJ8225000 PN: Ferrate(3-), hexacyano-, tripotassium SY: Ferrate(3-), hexakis(cyano-kappa-C)-, tripotassium, (OC-6-11); Iron-potassium-cyanide-; Potassium-cyanoferrate-; Red-prussiate-; Potassium-ferricyanate-; Potassium-ferricyanide-; Tripotassium-ferriccyanide-; Tripotassium-ferric-hexacyanide-; Tripotassium-hexacyanoferrate-; Tripotassium hexacyanoferrate(3-); Tripotassium-iron-hexacyanide- RN: Current: 13746-66-2 Previous: 409-16-5; 2002-18-8 UD: 200012 MF: C6-Fe-N6.3 K MW: 329.27 WL: NC-FE-CN&CN&CN&CN&CN &-KA- 3 CC: Tumorigen (C); Mutagen (M) ME: oms-esc 750 nmol/tube LARC Medical. (19 bis, rue d'Inkermann, 59000 Lille, France) V.1- 1981- v. 6, p. 252, 1986 (LAMEDS); mmo-smc 100 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 149, 1983 (MUREAV); mrc-smc 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 149, 1983 (MUREAV) AT: T/E unlistd orl-rat LDLo: 1600 mg/kg Kodak Company Reports. (343 State St., Rochester, NY 14650) 21MAY1971 (KODAK*); T/E unlistd orl-mus LD50: 2970 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(4), p. 23, 1986 (GISAAA) MD: M16-P71-Y11 ihl-rat TCLo: 510 ug/m3/24H/26W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(4), p. 23, 1986 (GISAAA) ND: NOHS 1974: HZD 81080; NIS 50; TNF 5391; NOS 41; TNE 27467; NOES 1983: HZD 81080; NIS 55; TNF 3468; NOS 58; TNE 85385; TFE 20227 SL: EPA GENETOX PROGRAM 1988, Negative: B subtilis rec assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, selected, October 2000 Record 783 of 1119 in RTECS (through 2003/06) AN: LK5060000 PN: Firemaster-BP-6- SY: Biphenyl,-hexabromo- (technical grade); FireMaster-BP-6-; Firemaster-; Firemaster (FM) BP-6; Hexabromobiphenyl- (technical grade); Polybrominated-biphenyls- RN: Current: 59536-65-1 UD: 200305 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: pic-esc 3100 ng/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); dnd-sal-oth 8 umol/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 23, p. 51, 1978 (EVHPAZ); dni-rat-orl 800 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 23, p. 334, 1980 (ENVRAL) RE: T76-T81-T86 orl-rat TDLo: 215 mg/kg (8-22D preg/28D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 59, p. 300, 1981 (TXAPA9); T35 orl-rat TDLo: 22500 ug/kg (7-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 23, p. 295, 1978 (EVHPAZ); T34 orl-rat TDLo: 11250 ug/kg (7-15D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 23, p. 295, 1978 (EVHPAZ); T51 orl-rat TDLo: 21500 ug/kg (8-22D preg/28D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 59, p. 300, 1981 (TXAPA9); T45 orl-rat TDLo: 400 mg/kg (11D preg) Advances in the Study of Birth Defects. (Baltimore, MD) V.1-7, 1979-82. Discontinued. v. 2, p. 211, 1979 (ASBDD9); T85 orl-rat TDLo: 24600 ug/kg (6-22D preg/24D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 86, 1984 (TOXID9); T72 orl-mus TDLo: 108 mg/kg (8-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 37, p. 171, 1976 (TXAPA9); T41-T43 orl-mus TDLo: 144 mg/kg (7-18D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 10, p. 390, 1975 (ENVRAL); T34 orl-mus TDLo: 216 mg/kg (8-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 37, p. 171, 1976 (TXAPA9); T51 orl-mus TDLo: 90 mg/kg (15D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 23, p. 233, 1978 (EVHPAZ); T25-T35 orl-mus TDLo: 312 mg/kg (4-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 37, p. 171, 1976 (TXAPA9); T81 orl-mky TDLo: 5700 ug/kg (30W pre/24W preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 23, p. 139, 1978 (EVHPAZ); T83 orl-pig TDLo: 4 mg/kg (8-16W preg/28D post) American Journal of Veterinary Research. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.1- 1940- v. 42, p. 183, 1981 (AJVRAH); T87 orl-pig TDLo: 41 mg/kg (8-16W preg/28D post) American Journal of Veterinary Research. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.1- 1940- v. 42, p. 183, 1981 (AJVRAH); T81 orl-ctl TDLo: 37500 ug/kg (1-60D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 23, p. 83, 1978 (EVHPAZ); T51-T52-T81 orl-rat TDLo: 92.5 mg/kg (1D preg-15D post) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 48, p. 715, 1992 (BECTA6); T81-T86 orl-rat TDLo: 5 mg/kg (multigenerations) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 56, p. 240, 1980 (TXAPA9) TE: V01-L60 orl-rat TDLo: 1 gm/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 66, p. 535, 1981 (JJIND8); V01-L60 orl-mus TDLo: 1217 mg/kg/2Y-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 21, p. 451, 1993 (FAATDF); V03-L60 orl-rat TD :1000 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 23, p. 265, 1978 (EVHPAZ); V01-L60 orl-rat TD :1200 mg/kg/18W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 66, p. 535, 1981 (JJIND8); V02-L60 orl-rat TD :365 mg/kg/2Y-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 21, p. 451, 1993 (FAATDF); V01-L60 orl-rat TDLo: 432.6 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-184066 (NTIS**); V01-L60 orl-rat TDLo: 360.5 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-184066 (NTIS**); V01-L60 orl-mus TDLo: 865.2 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-184066 (NTIS**) AT: L30-Y07 par-nml TDLo: 150 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 7, p. 817, 1981 (JTEHD6); L30-S02-Y20 ipr-rat TDLo: 90 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 64, p. 187, 1982 (TXAPA9); L30-L70-Y20 ipr-rat TDLo: 90 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 555, 1985 (FAATDF) MD: L30-L70 orl-rat TDLo: 36 mg/kg/60D-C Journal of the American Veterinary Medical Association. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.48- 1915- v. 169, p. 1231, 1976 (JAVMA4); L70-U01-Y07 orl-rat TDLo: 455 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 44, p. 539, 1978 (TXAPA9); L70-P28-Y07 orl-rat TDLo: 66 mg/kg/22D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 769, 1977 (JTEHD6); L30-L70 orl-rat TDLo: 105 mg/kg/5W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(3), p. 241, 1978 (JEPTDQ); N08-N74-P28 orl-rat TDLo: 37500 ug/kg/25W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 68, p. 1, 1983 (TXAPA9); L70 orl-mus TDLo: 336 mg/kg/28D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 5, p. 605, 1979 (JTEHD6); L70-Y07 orl-mus TDLo: 550 mg/kg/11D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 10, p. 390, 1975 (ENVRAL); L30-L70-P71 orl-mus TDLo: 37500 ug/kg/25W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 68, p. 1, 1983 (TXAPA9); L03-U01-Z01 orl-gpg TDLo: 18 mg/kg/30D-C Journal of the American Veterinary Medical Association. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.48- 1915- v. 169, p. 1231, 1976 (JAVMA4); F07-F15-Z01 orl-qal TDLo: 43800 ug/kg/8D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 33, p. 308, 1984 (BECTA6); N08-N75-P28 orl-rat TDLo: 180 mg/kg/30D-C Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1, p. 23, 1982 (JACTDZ); N30 orl-rat TDLo: 18 mg/kg/30D-C Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1, p. 23, 1982 (JACTDZ); N08-Y53 orl-rat TDLo: 35 mg/kg/140D-C Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 121, p. 520, 1987 (ENDOAO); N30 orl-rat TDLo: 10.5 mg/kg/5W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1, p. 587, 1978 (JEPTDQ) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 18, p. 107, 1978 (IMEMDT); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 44, p. 175, 1982 (EVHPAZ); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 24, p. 173, 1978 (EVHPAZ) SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264388); EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 784 of 1119 in RTECS (through 2003/06) AN: LK5065000 PN: Firemaster-FF-1- SY: 2,4,5,2',4',5'-Hexabromobiphenyl-; PBB-; Polybrominated-biphenyl-; Polybrominated-biphenyl- (FF-1); Polybrominated-biphenyl-mixture- RN: Current: 67774-32-7 UD: 200302 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: dns-rat-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 189, 1994 (MUREAV); mtr-ham-emb 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 356, p. 85, 1996 (MUREAV) RE: T76-T81 orl-rat TDLo: 1600 mg/kg (7-14D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 14, p. 695, 1984 (JTEHD6); T85 orl-rat TDLo: 10 mg/kg (20D pre) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 24, p. 229, 1985 (TOLED5); T81-T86 orl-rat TDLo: 50 mg/kg (60D pre-28D post) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-398, 1993 (NTPTR*); T41-T43 orl-mus TDLo: 360 mg/kg (6-15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 87, 1984 (TOXID9); T29 orl-mus TDLo: 900 mg/kg (6-15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 87, 1984 (TOXID9); T81-T86 orl-mus TDLo: 13080 ug/kg (60 pre-28D post) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-398, 1993 (NTPTR*); T35 orl-mky TDLo: 3.21 mg/kg (30W pre) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. -, p. 419, 1979 (ANYAA9) TE: V01-L60 orl-rat TDLo: 375 mg/kg/26W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-244, 1983 (NTPTR*); V01-J60-L60 orl-mus TDLo: 1250 mg/kg/26W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-244, 1983 (NTPTR*); V02-L60 orl-rat TD :1000 mg/kg Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 602, 1977 (LANCAO); V01-L60 orl-rat TD :1250 mg/kg/26W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-244, 1983 (NTPTR*); V01-L60 orl-rat TD :1314 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-398, 1993 (NTPTR*); V01-L60 orl-mus TD :876 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-398, 1993 (NTPTR*); V01-L60 orl-rat TDLo: 37.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-240473 (NTIS**); V01-L60 orl-mus TDLo: 37.5 mg/kg/25W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-240473 (NTIS**) MD: F17-F18 orl-rat TDLo: 660 mg/kg/30D-I Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 320, p. 325, 1979 (ANYAA9); F07-F17-F18 orl-rat TDLo: 390 mg/kg/26W-I Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 320, p. 325, 1979 (ANYAA9); L50-N74-P73 orl-mus TDLo: 660 mg/kg/30D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 57, p. 99, 1981 (TXAPA9); A70-U01-Z01 orl-mam TDLo: 216 mg/kg/74D-C Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 8, p. 487, 1979 (AECTCV); N19 orl-mky TDLo: 2.74 mg/kg/26W-C Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. -, p. 419, 1979 (ANYAA9); T16-T29 orl-mky TDLo: 3.21 mg/kg/30W-C Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. -, p. 419, 1979 (ANYAA9) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 261, 1986 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 261, 1986 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 321, 1987 (IMSUDL) SL: NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP Carcinogenesis Studies (feed), clear evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-398, 1993 (NTPTR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 785 of 1119 in RTECS (through 2003/06) AN: LK8750000 PN: Flavone,-3,3',4',5,7-pentahydroxy- SY: C.I. 75670; C.I. Natural Yellow 10; Cyanidelonon-1522-; Flavin-meletin-; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy- (9CI); 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; Kvercetin- (Czech); Meletin-; NCI-C60106-; 3,3',4',5,7-Pentahydroxyflavone-; 3,5,7,3',4'-Pentahydroxyflavone-; Quercetin-; Quercetine-; Quercetol-; Quercitin-; Quertine-; Sophoretin-; 3',4',5,7-Tetrahydroxyflavan-3-ol-; T-Gelb bzw. grun 1; Xanthaurine- RN: Current: 117-39-5 Previous: 73123-10-1; 74893-81-5 BRN: 317313 BHR: 5-18-05-00494 UD: 200305 MF: C15-H10-O7 MW: 302.25 WL: T66 BO EVJ CR CQ DQ& DQ GQ IQ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Natural-Product (N) ME: mmo-sat 8 nmol/plate (+/-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 315, 1988 (EMMUEG); oms-sat 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); oms-esc 4 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 55, 1987 (MUREAV); dnr-esc 16 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); pic-esc 12500 ng/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); mrc-smc 2 mg/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 231, 1978 (MUREAV); mnt-hmn-lym 3 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 85, 1995 (MUREAV); dnd-hmn-lvr 600 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 141, 1997 (MUREAV); dnd-hmn-lym 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 141, 1997 (MUREAV); dnd-hmn-hla 400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 141, 1997 (MUREAV); dni-hmn-fbr 50 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 33, p. 3823, 1984 (BCPCA6); oms-hmn-fbr 200 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 33, p. 3823, 1984 (BCPCA6); cyt-hmn-fbr 5 mg/L Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 56, p. 443, 1980 (PJABDW); cyt-hmn-lym 10 mg/L Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 56, p. 443, 1980 (PJABDW); sce-hmn-fbr 1 mg/L Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 56, p. 443, 1980 (PJABDW); sce-hmn-lym 8 mg/L Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 56, p. 443, 1980 (PJABDW); msc-hmn-emb 3 mg/L Kokuritsu Idengaku Kenkyusho Nenpo. Annual Report of the National Institute of Genetics. (Kokuritsu Idengaku Kenkyusho, 1111 Yata, Mishima, Shizuoka-ken 411, Japan) No. 1- 1949- v. (32), p. 51, 1981 (KIKNAJ); dnd-rat-lvr 20 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 58, p. 75, 1991 (CALEDQ); bfa-rat-sat 500 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 9, 1987 (FCTOD7); mnt-mus-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 69, 1981 (MUREAV); mmo-mus-lym 20 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 88, p. 317, 1981 (MUREAV); mtr-mus-emb 25 mg/L Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 78, p. 819, 1987 (JJCREP); mtr-mus-lym 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 88, p. 317, 1981 (MUREAV); dnd-mus-lym 10 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 230, 1980 (ENMUDM); msc-mus-lym 20 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 230, 1980 (ENMUDM); spm-mus-ipr 16 mg/kg/5D-C Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 79, 1987 (ENMUDM); mnt-ham-orl 1 gm/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 231, 1980 (ENMUDM); mnt-ham-ipr 33 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 231, 1980 (ENMUDM); mnt-ham-lng 3 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 85, 1995 (MUREAV); mmo-ham-lng 50 mg/L (+S9) Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 70, p. 273, 1979 (GANNA2); mtr-ham-emb 5 mg/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 1, p. 175, 1977 (TOLED5); cyt-ham-fbr 1 mg/L Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 56, p. 443, 1980 (PJABDW); cyt-ham-ovr 9 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 231, 1980 (ENMUDM); sce-ham-fbr 5 mg/L Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 56, p. 443, 1980 (PJABDW); sce-ham-ovr 15 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 45, 1983 (MUREAV); msc-ham-lng 20 mg/L Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 70, p. 273, 1979 (GANNA2); msc-ham-ovr 9 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 231, 1980 (ENMUDM); oms-ctl-oth 5 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 44, p. 882, 1988 (EXPEAM); dni-ctl-oth 12 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 44, p. 882, 1988 (EXPEAM); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG); dnd-hmn-oth 50 umol/L/15M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 519, p. 151, 2002 (MUREAV) RE: T34 orl-rat TDLo: 20 mg/kg (6-15D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 75, 1982 (FCTOD7); T01-T02 ipr-mus TDLo: 16 mg/kg (5D male) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 79, 1987 (ENMUDM) TE: V01-K60-M60 orl-rat TDLo: 33610 mg/kg/58W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 3468, 1980 (CNREA8); V03-J60 orl-mus TDLo: 966 gm/kg/23W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 72, p. 327, 1981 (GANNA2); V01-K60-M60 orl-rat TD :38235 mg/kg/58W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 3468, 1980 (CNREA8); V02-L60 orl-rat TD :243 gm/kg/3Y-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 95, 1984 (PAACA3); V02-L60 orl-rat TD :487 gm/kg/3Y-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 95, 1984 (PAACA3); V02-L60-V16 orl-rat TDLo: 12600 mg/kg/6W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 143, p. 173, 1999 (CALEDQ); V02-M61 orl-rat TDLo: 1747200 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-147478 (NTIS**) ORNG: 161000000 ng/kg. [161.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 161 mg/kg Reviews of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.98- 1987- v. 113, p. 47, 1990 (RCTOE4); F07-F18-J25 orl-mus LD50: 159 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 77, p. 269, 1951 (PSEBAA); F05-F07-J22 ipr-mus LD50: 3 gm/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 64, p. 186, 1968 (NYKZAU); F07-F18-J25 scu-mus LD50: 97 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 77, p. 269, 1951 (PSEBAA); T/E unlistd ivn-mus LD50: 18 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#02589 (CSLNX*); T/E unlistd ivn-rbt LD50: 100 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 46A, p. 18, 1969 (FAONAU); P28-Y53 ivn-mus TDLo: 3 mg/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 446, p. 187, 2002 (EJPHAZ) MD: K61-V25-V30 orl-mus TDLo: 134400 mg/kg/8W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 1655, 2000 (CRNGDP); R60-V30 orl-rat TDLo: 364000 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-147478 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 31, p. 213, 1983 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 497, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 31, p. 213, 1983 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 497, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 497, 1999 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Inconclusive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis Studies (feed), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-409, 1992 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: rat Record 786 of 1119 in RTECS (through 2003/06) AN: LL9100000 PN: Fluoren-9-one,-2,4,7-trinitro- SY: 2,4,7-Trinitro-9-fluorenon-; 2,4,7-Trinitro-9-fluorenone-; 2,4,7-Trinitro-9H-fluoren-9-one-; 2,4,7-Trinitrofluoren-9-one-; 2,4,7-Trinitrofluorenone-; 2,4,7-Trinitrofluorone-; TNF-; TNF- (ketone) RN: Current: 129-79-3 UD: 200305 MF: C13-H5-N3-O7 MW: 315.21 WL: L B656 HVJ CNW ENW KNW CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0480-0339 (EPASR*); eye-rbt 100 mg MLD United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0480-0339 (EPASR*) ME: mmo-sat 1 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 63, p. 1, 1979 (MUREAV); mmo-sat 10 uL/plate (-S9) United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0280-0333 (EPASR*); mmo-esc 300 nmol/L (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); oms-esc 625 ng/tube Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 41, 1991 (EMMUEG); dni-hmn-oth 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); cyt-hmn-lym 3 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 138, p. 181, 1984 (MUREAV); sce-hmn-lym 3 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 138, p. 181, 1984 (MUREAV); sce-hmn-oth 10 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); dns-rat-orl 100 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 488, 1983 (ENMUDM); dns-rat-lvr 1 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); dni-rat-oth 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); sce-rat-oth 10 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); mmo-mus-lym 7810 ug/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 167, 1983 (MUREAV); dni-mus-tes 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); sce-mus-tes 10 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); sce-mus-oth 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 465, 1989 (MUREAV); sce-mus-bmr 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 465, 1989 (MUREAV); msc-mus-lym 1950 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 167, 1983 (MUREAV); dni-ham-ovr 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); sce-ham-ovr 900 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 167, 1983 (MUREAV); msc-ham-ovr 1 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); mmo-sat 0.01 ug/plate/72H (-S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 303, 2001 (MUTAEX); sce-ham-ovr 9 mg/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 176, 1983 (MUREAV); msc-mus-oth 1.95 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 176, 1983 (MUREAV) TE: V03-R60 orl-rat TDLo: 1000 mg/kg Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 137, p. 257, 1962 (SCIEAS) ORNG: 9910000000 ng/kg. [9910.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 9910 mg/kg Pesticide and Toxic Chemical News. (Food Chemical News, Inc., 400 Wyatt Bldg., 777 14th St., NW, Washington, DC 20005) V.1- 1972- v. 8, p. 4, 1980 (PESTC*); T/E unlistd ihl-mus LC :>3500 mg/m3/6H United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0480-0339 (EPASR*); T/E unlistd skn-rbt LD50: >2 gm/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0480-0339 (EPASR*) MD: U01 orl-rat TDLo: 5026 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3132 (NTPTR*); P71-Y03-Z73 orl-rat TDLo: 22295 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3132 (NTPTR*); L70-N74 orl-mus TDLo: 319 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3132 (NTPTR*) SR: OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: 2, 4, 7-Trinitrofluoren-9-one, 5018; NTP Toxicity studies, RPT# TOX-13, October 2000 Record 787 of 1119 in RTECS (through 2003/06) AN: LP8925000 PN: Formaldehyde- SY: Aldehyde-formique- (French); Aldehyd-mravenci- (Czech); Aldeide-formica- (Italian); Fannoform-; Formaldehyd- (Czech, Polish); BFV-; Formalin-40-; Formalina- (Italian); Formalin-loesungen- (German); Formalith-; Formic-aldehyde-; FYDE-; Lysoform-; Methaldehyde-; Methanal-; Methyl-aldehyde-; Methylene-oxide-; NCI-C02799-; RCRA-waste-number-U122-; Formaldehyde- (ACGIH:OSHA); Formaldehyde,-gas-; Formalin-; Formaline- (German); Formol-; Morbicid-; Oplossingen- (Dutch); Oxomethane-; Oxymethylene-; Paraform-; Superlysoform- RN: Current: 50-00-0 Previous: 8005-38-7; 8006-07-3; 8013-13-6; 112068-71-0 UD: 200305 MF: C-H2-O MW: 30.03 WL: VHH CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-hmn 150 ug/3D-I MLD "Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar, eds., New York, Academic Press, Inc. 1977 -,127,1977 (85DKA8); eye-hmn 4 ppm/5M International Journal of Air and Water Pollution. (London, UK) V.4(1-4), 1961. For publisher information, see ATENBP. v. 4, p. 79, 1961 (IAPWAR); eye-hmn 1 ppm/6M rinse MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 44, p. 463, 1983 (AIHAAP); skn-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,264,1986 (85JCAE); skn-rbt 540 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 4/21/1967 (UCDS**); skn-rbt 50 mg/24H MOD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 369, 1972 (TXAPA9); eye-rbt 750 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,264,1986 (85JCAE); eye-rbt 750 ug SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 10 mg SEV Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 55, p. 501, 1980 (TXAPA9); eye-rbt 37% SEV Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 187, 2001 (JTPAE7) ME: mmo-sat 100 umol/L (+/-S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 427, 1986 (MUTAEX); oms-sat 19 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 100 ppm/3H (-S9) American Naturalist. (Univ. of Chicago Press, Journals Div., POB 37005, Chicago, IL 60637) V.1- 1867- v. 85, p. 119, 1951 (AMNTA4); oms-esc 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 81, 1988 (MUREAV); dnr-esc 1950 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 189, 1981 (CRNGDP); dna-esc 5 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dni-esc 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 153, 1985 (MUREAV); pic-esc 25 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); mmo-srm 5 gm/L (-S9) Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 93, 1971 (ATXKA8); mmo-omi 1 pph/5M-C (-S9) Mycopathologia et Mycologia Applicata. (The Hague, Netherlands) V.5-54(4), 1950-74. For publisher information, see MYCPAH. v. 49, p. 205, 1973 (MMAPAP); mmo-omi 10 ppm (-S9) Proceedings of the Oklahoma Academy of Science. (Oklahoma Academy of Science, c/o Executive Secretary-Treasurer, Southwestern Oklahoma State Univ., Weatherford, OK 73096) V.1- 1910/1920- v. 34, p. 114, 1953 (POASAD); mmo-omi 200 ppm (-S9) Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. v. 6, p. 45, 1958 (APMBAY); mmo-omi 1000 ppm (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 63, p. 1, 1952 (JOBAAY); mmo-omi 250 ppm (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 8, p. 412, 1972 (SOGEBZ); mmo-omi 1 pph/15M (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 19, 1969 (MUREAV); mmo-omi 200 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 62, p. 239, 1979 (MUREAV); slt-dmg-orl 12500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 243, 1987 (MUREAV); sln-dmg-unr 10 pph/3H-C American Naturalist. (Univ. of Chicago Press, Journals Div., POB 37005, Chicago, IL 60637) V.1- 1867- v. 90, p. 377, 1956 (AMNTA4); sln-dmg-ihl 7 pph/24H Theoretical and Applied Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.38- 1968- v. 39, p. 330, 1969 (THAGA6); sln-dmg-orl 250 ppm Theoretical and Applied Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.38- 1968- v. 39, p. 330, 1969 (THAGA6); sln-dmg-par 2000 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 677, 1985 (ENMUDM); dlt-dmg-orl 1300 ppm Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 106, p. 286, 1970 (MGGEAE); mmo-nsc 10 mmol/plate (-S9) Cold Spring Harbor Symposia on Quantitative Biology. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1933- v. 16, p. 245, 1952 (CSHSAZ); mrc-smc 24 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 33, p. 179, 1975 (MUREAV); sln-asn 20 mg/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 31, p. 81, 1979 (EVHPAZ); slt-nml-unr 700 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 273, 1981 (MUREAV); oms-nml-oth 40 mmol/L Comptes Rendus de l'Association des Anatomistes. (Nancy, France) V.1-56, 1899-1972. For publisher information, see ANOBAU. v. 56, p. 712, 1972 (CAANAT); oms-nml-oth 25 mmol/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 95, p. 233, 1975 (ECREAL); cyt-nml-oth 40 mmol/L Comptes Rendus de l'Association des Anatomistes. (Nancy, France) V.1-56, 1899-1972. For publisher information, see ANOBAU. v. 56, p. 712, 1972 (CAANAT); cyt-grh-oth 750 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 401, 1986 (ENMUDM); sln-nml-mul 700 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 201, p. 137, 1988 (MUREAV); dnd-hmn-lym 10 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 121, 1996 (CRNGDP); dnd-hmn-fbr 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 267, 1985 (ENMUDM); dnd-hmn-lng 100 umol/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 220, p. 216, 1983 (SCIEAS); dnd-hmn-oth 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 2522, 1985 (CNREA8); dnd-hmn-leu 12500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 93, 2000 (MUREAV); dns-hmn-hla 10 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dni-hmn-oth 210 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 2522, 1985 (CNREA8); oms-hmn-oth 210 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 2522, 1985 (CNREA8); dni-hmn-hla 400 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); oms-hmn-lym 10 mg/L Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959- v. 24, p. 1056, 1982 (TSITAQ); cyt-hmn-lym 10 mg/L Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959- v. 24, p. 1056, 1982 (TSITAQ); cyt-hmn-fbr 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 119, p. 309, 1983 (MUREAV); sce-hmn-lym 125 umol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 427, 1986 (MUTAEX); msc-hmn-lym 130 umol/L "Formaldehyde: Toxicology, Epidemiology, Mechanisms, Papers of a Meeting, 2nd, 1982," Clary, J.J., et al., eds., New York, Marcel Dekker, 1983 2,173,1983 (50RXAH); mnt-rat-orl 200 mg/kg/30H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 327, 1989 (MUTAEX); mtr-rat-kdy 100 umol/L/3H European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 22, p. 671, 1986 (EJCODS); dnd-rat-lvr 1 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 991, 1994 (CRNGDP); dnd-rat-ihl 35 ug/m3/8W-I Problemi na Khigienata. Problems in Hygiene. (Durzhavno Izdatel'stvo Meditsina i Fizkultura, Pl. Slaveikov 11, Sofia, Bulgaria) V.1- 1975- v. 4, p. 101, 1979 (PRKHDK); dnd-rat-orl 10 umol/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 317, 1982 (ENMUDM); dnd-rat-oth 500 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 11, 1986 (ENMUDM); dnd-rat-oth 200 umol/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 51, p. 309, 1988 (TXCYAC); dns-rat-oth 50 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 11, 1986 (ENMUDM); dns-rat-orl 55 mg/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 79, p. 917, 1988 (JJCREP); dns-rat-lvr 400 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 221, p. 263, 1989 (MUREAV); dni-rat-oth 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 11, 1986 (ENMUDM); oms-rat-oth 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 11, 1986 (ENMUDM); cyt-rat-ihl 500 ug/m3/17W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 53(5), p. 75, 1988 (GISAAA); cyt-rat-ihl 15 ppm/5D-I Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 53, 1985 (ENMUDM); dlt-rat-ipr 625 ug/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 141, 1997 (MUREAV); spm-rat-orl 200 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 71, 1983 (ARTODN); spm-rat-ipr 625 ug/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 141, 1997 (MUREAV); mmo-mus-lym 25 mg/L (+S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 23, p. 115, 1985 (FCTOD7); mtr-mus-emb 1 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 357, 1982 (ENMUDM); dnd-mus-lvr 250 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 991, 1994 (CRNGDP); dnd-mus-leu 125 umol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 217, 1981 (JJIND8); cyt-mus-orl 100 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 317, 1982 (ENMUDM); cyt-mus-ipr 15 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 381, 1983 (ENMUDM); msc-mus-lym 74 mg/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 23, p. 115, 1985 (FCTOD7); hma-mus-esc 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 161, 1992 (MUREAV); mtr-ham-emb 125 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 356, p. 85, 1996 (MUREAV); mtr-ham-kdy 4 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 457, 1983 (CRNGDP); dnd-ham-ovr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 143, 1996 (MUREAV); pic-ham-emb 3 ul/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 474, 1984 (ENMUDM); cyt-ham-lng 18 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); cyt-ham-ovr 200 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 1, 1985 (ENMUDM); sce-ham-lng 67 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 10, 1985 (ARTODN); sce-ham-ovr 110 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 1, 1985 (ENMUDM); msc-ham-ovr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 143, 1996 (MUREAV); dnd-ckn-leu 500 ppm Cell (Cambridge, Mass.). (MIT Press, 28 Carleton St., Cambridge, MA 02142) V.1- 1974- v. 5, p. 45, 1975 (CELLB5); spm-dom-itt 23 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 11, p. 143, 1973 (IJEBA6); dna-mam-lym 500 ppm Molecular Biology. English translation of Molekuliarnaia Biologiia. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 7, p. 201, 1973 (MOLBBJ); dnd-mam-lym 660 mmol/L Biochemistry (English Translation). Translation of BIOHAO. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.21- 1956- v. 39, p. 436, 1974 (BIORAK); dnd-mus-oth 62.5 umol/L/2H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 183, 2002 (MUTAEX); slt-mus-oth 125 umol/L/2H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 183, 2002 (MUTAEX); cyt-mus-oth 125 umol/L/2H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 183, 2002 (MUTAEX); sce-hmn-unr 0.4 ppm/15Y-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 514, p. 115, 2002 (MUREAV); mmo-sat 0.25 umol/L/20M (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 514, p. 133, 2002 (MUREAV); mnt-ham-fbr 3 mmol/L/15M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 514, p. 133, 2002 (MUREAV) RE: T51 orl-rat TDLo: 168 mg/kg (1-21D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(3), p. 89, 1990 (GISAAA); T01 orl-rat TDLo: 200 mg/kg (1D male) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 26(3), p. 14A, 1982 (TJADAB); T83 orl-rat TDLo: 168 mg/kg (1-21D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(4), p. 36, 1990 (GISAAA); T33 ihl-rat TCLo: 1 mg/m3/24H (1-22D preg) Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 34(5), p. 266, 1969 (HYSAAV); T81-T87 ihl-rat TCLo: 12 ug/m3/24H (15D pre/1-22D preg) Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(1-3), p. 327, 1968 (HYSAAV); T83 ihl-rat TCLo: 12 ug/m3/24h (1-22D preg) Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 33(7-9), p. 112, 1968 (HYSAAV); T01-T09 ihl-rat TCLo: 35 ug/m3/8H (60D male) Problemi na Khigienata. Problems in Hygiene. (Durzhavno Izdatel'stvo Meditsina i Fizkultura, Pl. Slaveikov 11, Sofia, Bulgaria) V.1- 1975- v. 4, p. 101, 1979 (PRKHDK); T83 ihl-rat TCLo: 12 ug/m3/24H (20D pre/1-22D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 66, p. 868, 1968 (BEXBAN); T46-T85 ihl-rat TCLo: 500 ug/m3/4H (1-19D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 56(9), p. 35, 1991 (GISAAA); T02-T03 ipr-rat TDLo: 80 mg/kg (10D male) Journal of Reproductive Biology and Comparative Endocrinology. (P.G. Institute of Basic Medical Sciences, Dept. of Endocrinology, Taramani, 600 113, India) V.1- 1981- v. 7, p. 42, 1987 (JRBED2); T02 scu-rat TDLo: 46243 mg/kg (20D male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 28, p. 129, 1941 (ENDOAO); T23 itt-rat TDLo: 400 mg/kg (1D male) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 24, p. 884, 1973 (FESTAS); T51 orl-rat TDLo: 168 mg/kg (1-21D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 54(3), p. 89, 1989 (GISAAA); T34-T43-T46 ipr-mus TDLo: 240 mg/kg (7-14D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 28, p. 37A, 1983 (TJADAB); T35 ipr-mus TDLo: 240 mg/kg (7-14D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30(1), p. 34A, 1984 (TJADAB); T59 ipr-mus TDLo: 160 mg/kg (7-14D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30(1), p. 34A, 1984 (TJADAB); T01 ipr-mus TDLo: 500 mg/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 417, 1984 (MUREAV); T25-T35 ims-mus TDLo: 259 mg/kg (11D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 142, p. 479, 1962 (ANREAK); T02 itt-dog TDLo: 7 mg/kg (1D male) Acta Europaea Fertilitatis. (COFESE Eds., Piazzale Ungheria 73, 90141 Palermo, Italy) V.1- 1969- v. 6, p. 349, 1975 (AEFTAA); T01 itt-mky TDLo: 4 mg/kg (1D male) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 41, p. 465, 1984 (FESTAS); T01-T02 itt-dom TDLo: 6667 ug/kg (1D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 11, p. 143, 1973 (IJEBA6); T34 ihl-rat TCLo: 40 ppm (6-20D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 341, 1994 (VCVGK*); T34 orl-rat TDLo: 17.6 mg/kg (1-22D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 341, 1994 (VCVGK*); T51-T53 orl-rat TDLo: 176 mg/kg (1-22D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 341, 1994 (VCVGK*); T51-T53-T49 orl-rat TDLo: 10.5 mg/kg (1-21D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 6, p. 31, 1994 (GISAAA) TE: V01-K60-P61 orl-rat TDLo: 109 gm/kg/2Y-C Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 5, p. 699, 1989 (TIHEEC); V01-D09 ihl-rat TCLo: 14300 ppb/6H/2Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4382, 1983 (CNREA8); V03-V10 scu-rat TDLo: 1170 mg/kg/65W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 45, p. 451, 1954 (GANNA2); V03-D09 ihl-mus TCLo: 14300 ppb/6H/2Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4382, 1983 (CNREA8); V01-D09 ihl-rat TC :15 ppm/6H/78W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 3398, 1980 (CNREA8); V03-R60-V10 scu-rat TD :350 mg/kg/78W-I FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 50A, p. 71, 1972 (FAONAU); V03-D09 ihl-rat TC :6 ppm/6H/2Y-I Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 25, p. 353, 1982 (EVSRBT); V01-D09 ihl-rat TC :15 ppm/6H/86W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 401, 1985 (TXAPA9); V01-D09 ihl-rat TC :14 ppm/6H/84W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 68, p. 597, 1982 (JJIND8); V03-D09 ihl-rat TC :18750 ug/m3/2Y-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 48(4), p. 60, 1983 (GISAAA); V03-D09 ihl-mus TC :15 ppm/6H/104W-I Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 25, p. 353, 1982 (EVSRBT); V01-D09 ihl-rat TC :15 ppm/6H/2Y-I Chemical Industry Institute of Toxicology, Docket Reports. (POB 12137, Research Triangle Park, NC 27709) DOCKET #10992, 1982 (CIIT**); V03-D09 ihl-rat TC :5600 ppb/6H/2Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4382, 1983 (CNREA8); V03-D09 ihl-rat TC :14300 ppb/6H/2Y-I "Formaldehyde Toxicity, Conference, 1980," Gibson, J.E., ed., New York, NY, Hemisphere Pub. Corp., 1983 -,111,1983 (50EXAK) ORNG: 100000000 ng/kg. [100.000000 mg/kg] T/E unlistd SRNL: 270000 nL/kg. [0.270000 mL/kg] T/E unlistd AT: J20-K06-K13 orl-man TDLo: 643 mg/kg Japanese Journal of Toxicology. (Yakugyo Jihosha, Hokushin Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo, 101, Japan) V.1- 1988- v. 4, p. 261, 1991 (JJTOEX); T/E unlistd orl-wmn LDLo: 108 mg/kg "Practical Toxicology of Plastics," Lefaux, R., Cleveland, OH, Chemical Rubber Co., 1968 -,328,1968 (29ZWAE); D17-J30 ihl-hmn TCLo: 17 mg/m3/30M JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 165, p. 1908, 1957 (JAMAAP); K05-K06-K13 orl-man TDLo: 646 mg/kg Japanese Journal of Toxicology. (Yakugyo Jihosha, Hokushin Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo, 101, Japan) V.1- 1988- v. 4, p. 261, 1991 (JJTOEX); F24-G30-K04 orl-wmn LDLo: 1 mL/kg Intensive Care Medicine. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.3- 1977- v. 23, p. 708, 1997 (ICMED9); D07-F43 ihl-man TCLo: 300 ug/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 12(7), p. 20, 1968 (GTPZAB); T/E unlistd unr-man LDLo: 477 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 100 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 447, 1988 (FCTOD7); C06-F12-F13 ihl-rat LC50: 203 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(2), p. 55, 1974 (GTPZAB); J15-J04 scu-rat LD50: 420 mg/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 6, p. 299, 1950 (APTOA6); F07-F12-F13 orl-mus LD50: 42 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A125-539 (NTIS**); T/E unlistd ihl-mus LC50: 454 gm/m3/4H Current Toxicology. (Nova Science Publishers, Inc., 6080 Jericho Turnpike, Suite 207, Commack, NY 11725) V.1 1993- v. 1, p. 47, 1993 (CUTOEX); T/E unlistd ipr-mus LDLo: 16 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 288, 1972 (TXAPA9); J15-J04 scu-mus LD50: 300 mg/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 6, p. 299, 1950 (APTOA6); T/E unlistd scu-dog LDLo: 350 mg/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3); T/E unlistd ivn-dog LDLo: 70 mg/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3); T/E unlistd ihl-cat LCLo: 400 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,69,1982 (85GMAT); P30 ivn-cat LDLo: 30 mg/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 8, p. 275, 1952 (APTOA6); T/E unlistd skn-rbt LD50: 270 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 4/21/1967 (UCDS**); Y55 scu-rbt LDLo: 240 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 62, p. 984, 1914 (JAMAAP); T/E unlistd ivn-rbt LDLo: 48 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 5, p. 213, 1955 (ARZNAD); T/E unlistd par-frg LDLo: 800 ug/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3); D20-D21-D35 par-rbt TDLo: 0.05 mg/kg Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 89, p. 74, 2001 (PHTOEH); G04 par-rbt TDLo: 0.5 mg/kg Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 89, p. 74, 2001 (PHTOEH); F42 scu-mus TDLo: 16 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 292, p. 331, 2000 (JPETAB); F22-F24-J15 ihl-mus LC :155 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); F22-F24-J15 ihl-mus LC50: 505 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); T/E unlistd orl-mus LD50: 385 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); T/E unlistd scu-mus LD50: 300 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); F22-F24-J15 ihl-rat LC :308 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); F22-F24-J15 ihl-rat LC50: 578 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); F22-F24-J15 ihl-rat LC50: 250 ppm/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); T/E unlistd orl-rat LD16: 284 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); T/E unlistd orl-rat LD84: 729 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 335, 1984 (VCVGK*); T/E unlistd ivn-rat LD50: 87 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); T/E unlistd orl-gpg LD50: 260 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); T/E unlistd skn-rbt LD50: 270 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); D09-J23-K14 ihl-rat TCLo: 15 ppm "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); D07 ihl-rat TCLo: 2 ppm/10M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); J30-Y09 ihl-rat TCLo: 0.5 ppm/6H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); F13-K01 ihl-cat TCLo: 140 mg/m3/1M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); K13 ihl-cat TCLo: 140 mg/m3/3M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); J22-K01 ihl-cat TCLo: 20 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); J02-J22-J30 ihl-mky TCLo: 2.55 ppm/2M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); F11-L30-M30 orl-mus LD50: 500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); F11-L30-M30 orl-rat LD50: 500 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 336, 1984 (VCVGK*); J25-J30 ihl-hmn TCLo: 2 ppm/40M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 337, 1984 (VCVGK*); K06-L30-M30 orl-hmn LDLo: 70 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1984 (VCVGK*); D07 ihl-rat TCLo: 15 ppm/6H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1984 (VCVGK*); F27 ihl-hmn TCLo: 20 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 341, 1984 (VCVGK*); J21 ihl-hmn TCLo: 2.5 ppm "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 341, 1984 (VCVGK*); D25 ihl-hmn TCLo: 0.2 ppm "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 341, 1984 (VCVGK*); D25-J21 ihl-hmn TCLo: 1 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 345, 1984 (VCVGK*); D25 ihl-hmn TCLo: 1 ppm/6M "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 345, 1984 (VCVGK*); B03-Y40-Y55 scu-rat TDLo: 3.76 mg/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 441, p. 67, 2002 (EJPHAZ); U25 scu-rat TDLo: 1.25 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 45, p. 81, 1982 (FATOAO); Y55 par-rat TDLo: 10 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 94, 1987 (FATOAO) MD: F15-M70-Y39 orl-rat TDLo: 3500 mg/kg/4W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 447, 1988 (FCTOD7); K05-K06-M30 orl-rat TDLo: 60 gm/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 27, p. 77, 1989 (FCTOD7); J30-U01-Y12 ihl-rat TCLo: 15 ppm/6H/24W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 49, p. 50, 1989 (ENVRAL); D07 ihl-rat TDLo: 4 ppm/30M/13W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 47, p. 287, 1989 (TOLED5); P72-S04-U01 ihl-rat TCLo: 99 ppm/6H/30D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 3, p. 73, 1983 (TOXID9); D07-Y12 ihl-rat TCLo: 3200 ppb/6H/3D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 29, p. 208, 1996 (FAATDF); L70-N72-N74 ivn-rat TDLo: 2730 mg/kg/13W-I Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 24, p. 1175, 1993 (IYKEDH); D02 ihl-mam TCLo: 42 mg/m3/6H/2W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1994 (VCVGK*); S05 ihl-mus TCLo: 15 ppm/6H/5D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1994 (VCVGK*); D07 ihl-rat TCLo: 5 ppm/4W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1994 (VCVGK*); J30 ihl-gpg TCLo: 1.2 mg/m3/6H/8W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1994 (VCVGK*); D07-J02 ihl-mky TCLo: 7.2 mg/m3/6H/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1994 (VCVGK*); D25-L70 ihl-rat TCLo: 9.6 mg/m3/22H/60D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1994 (VCVGK*); J30-Y09 ihl-mam TCLo: 0.5 ppm/6H/4D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 338, 1994 (VCVGK*); P28-Y15 ihl-rat TCLo: 20 mg/m3/40D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); L30 ihl-rat TCLo: 0.7 mg/m3/60D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); S18 ihl-rat TCLo: 2 mg/m3/50H-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); S18 ihl-gpg TCLo: 2 mg/m3/50H-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); S01 ihl-gpg TCLo: 0.011 mg/m3/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); U01 orl-rat TDLo: 13650 mg/kg/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); U01 orl-dog TDLo: 9100 mg/kg/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); P28-Y20 unr-rat TDLo: 380 mg/kg/20D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); P71-U01 unr-rat TDLo: 1540 mg/kg/20D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); L30-P27 orl-rat TDLo: 962.5 mg/kg/11W-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); K05 orl-rat TDLo: 3500 mg/kg/4W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); Y15 orl-rat TDLo: 500 mg/kg/20D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); J02-U01-Z01 ihl-mus TCLo: 1 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); T12-T13 ihl-mus TCLo: 40 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); J02 ihl-mus TCLo: 50 mg/m3/1H/35W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); F19 ihl-rat TCLo: 1 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 339, 1994 (VCVGK*); L30-Y20 ihl-rat TCLo: 20 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); L30-Y20-Y39 ihl-rat TCLo: 20 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); J02 ihl-rat TCLo: 10 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); Y01 ihl-rat TCLo: 3 mg/m3/2W-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); J02-L50-M01 ihl-rat TCLo: 3 mg/m3/90D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); A30 ihl-rat TCLo: 0.035 mg/m3/98D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); J30 ihl-rat TCLo: 0.012 mg/m3/98D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); S18 ihl-rat TCLo: 0.5 mg/m3/182D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); Z01 ihl-rat TCLo: 40 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); Z01 ihl-mus TCLo: 40 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); T12-Z01 ihl-rat TCLo: 40 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); T12-Z01 ihl-mus TCLo: 40 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); J30-L14-U01 ihl-rat TCLo: 20 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); J30-L14-U01 ihl-mus TCLo: 20 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); D07 ihl-rat TCLo: 10 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); D07 ihl-mus TCLo: 10 ppm/6H/13W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 340, 1994 (VCVGK*); D35 ihl-hmn TCLo: 14 pph/168D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 341, 1994 (VCVGK*); F27-F33 ihl-wmn TCLo: 5 mg/m3/5Y-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 342, 1994 (VCVGK*); D09 ihl-rat TCLo: 5.6 ppm/6H/2Y-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 343, 1994 (VCVGK*); D09 ihl-mus TCLo: 14.3 ppm/6H/2Y-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 343, 1994 (VCVGK*); D09 ihl-rat TCLo: 0.36 mg/m3/6H/122W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 343, 1994 (VCVGK*); J60-K60-Z01 ihl-man TCLo: 3 pph/30D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 343, 1994 (VCVGK*); R13 skn-mus TDLo: 15 mg/kg/3D-I Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975- v. 45, p. 89, 2001 (CODEDG) TR: ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-CL 0.3 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 345, 1982 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 62, p. 217, 1995 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 211, 1987 (IMSUDL); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 62, p. 217, 1995 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 211, 1987 (IMSUDL); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 62, p. 217, 1995 (IMEMDT); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 11, p. 163, 1975 (EVHPAZ); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 34, p. 17, 2001 (RTOPDW) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD: air-CL 2 ppm (3 mg/m3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 19, 1973 (DTLWS*); OSHA PEL (Gen Indu): see 1910.1048 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): see CFR 29,1926.1148 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Fed Cont): CL 5 ppm (6 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 2 ppm (3 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 1 ppm (1.5 mg/m3), STEL 2 ppm, Carcinogen, JAN 1993; OEL-AUSTRIA: MAK 0.5 ppm (0.6 mg/m3), Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 1 ppm (1.2 mg/m3), STEL 2 ppm, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.3 ppm (0.4 mg/m3), JAN 1999; OEL-FRANCE: VME 0.5 ppm, VLE 1 ppm, C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 0.5 ppm (0.6 mg/m3), Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.6 mg/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.5 ppm (0.61 mg/m3), 2A Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (1.5 mg/m3), MAC-K 2 ppm (3 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.5 ppm (0.6 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (6 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 0.5 mg/m3, MAC(STEL) 1 mg/m3, JAN 1999; OEL-RUSSIA: TWA 0.5 ppm, STEL 0.5 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 0.5 ppm (0.6 mg/m3), TGV 1 ppm (1.2 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 ppm (0.6 mg/m3), KZG-W 1 ppm (1.2 mg/m3), JAN 1999; OEL-THAILAND: TWA 3 ppm, STEL 5 ppm, JAN 1993; OEL-TURKEY: TWA 5 ppm (6 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 2 ppm (2.5mg/m3), Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO FORMALDEHYDE-air: 8H CA TWA 0.016 ppm, CL 0.1 ppm/15M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M1529; NIS 72; TNF 10311; NOS 67; TNE 66921; NOHS 1974: HZD 33640; NIS 213; TNF 33243; NOS 155; TNE 394660; NOES 1983: HZD M1529; NIS 87; TNF 11309; NOS 69; TNE 207013; TFE 104994; NOES 1983: HZD 33640; NIS 309; TNF 65738; NOS 193; TNE 1329322; TFE 441902 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/166654); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: N crassa-reversion, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Inconclusive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 34, APRIL 1981; NIOSH Analytical Method, 1994: Aldehydes, screening, 2539; NIOSH Analytical Method, 1994: Formaldehyde by on dust (textile or wood), 5700; NIOSH Analytical Method, 1994: Formaldehyde by GC, 2541, by VIS, 3500; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #ID-102; OSHA ANALYTICAL METHOD #52; OSHA ANALYTICAL METHOD #ID205 Record 788 of 1119 in RTECS (through 2003/06) AN: LQ0525000 PN: Formamide- SY: Amid-kyseliny-mravenci- (Czech); Carbamaldehyde-; Formamide- (ACGIH); Methanamide-; Methanoic-acid,-amide-; Formimidic-acid- RN: Current: 75-12-7 UD: 200305 MF: C-H3-N-O MW: 45.05 WL: ZVH CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 100 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA) ME: oms-nml-oth 500 mmol/L Comptes Rendus de l'Association des Anatomistes. (Nancy, France) V.1-56, 1899-1972. For publisher information, see ANOBAU. v. 56, p. 712, 1972 (CAANAT); cyt-nml-oth 500 mmol/L Comptes Rendus de l'Association des Anatomistes. (Nancy, France) V.1-56, 1899-1972. For publisher information, see ANOBAU. v. 56, p. 712, 1972 (CAANAT) RE: T25-T34 orl-rat TDLo: 2 gm/kg (7D preg) "Malformations Congenitales des Mammiferes," Tuchmann-Duplessis, H., Paris, Masson et Cie, 1971 -,95,1971 (85DJA5); T43-T46 orl-rat TDLo: 7980 mg/kg (7-12D preg) "Malformations Congenitales des Mammiferes," Tuchmann-Duplessis, H., Paris, Masson et Cie, 1971 -,95,1971 (85DJA5); T35 skn-rat TDLo: 1200 mg/kg (10-11D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 35, 1977 (TXAPA9); T25-T34-T46 orl-rbt TDLo: 910 mg/kg (6-18D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 30, p. 1557, 1980 (ARZNAD); T14-T26-T29 orl-mus TDLo: 200 mg/kg (multigeneration)) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 13, p. 76, 1993 (TOXID9); T34 orl-rat TDLo: 1.4 gm/kg (6-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB99-139701 (NTIS**); T27-T34-T71 orl-rbt TDLo: 2.88 gm/kg (6-29D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2001-104060 (NTIS**); T26 orl-rbt TDLo: 3.36 gm/kg (6-29D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2001-104060 (NTIS**); T26-T29 orl-mus TDLo: 6.8 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-109213 (NTIS**); T14-T16 orl-mus TDLo: 6.8 gm/kg (7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-109213 (NTIS**); T26-T81 orl-mus TDLo: 195 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-109213 (NTIS**) ORNG: 5577000000 ng/kg. [5577.000000 mg/kg] E08-F19-M29 SRNG: 17000000000 ng/kg. [17000.000000 mg/kg] T/E unlistd AT: E08-F19-M29 orl-rat LD50: 5577 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 9, p. 163, 1967 (TPKVAL); T/E unlistd ihl-rat LC50: >3900 ppm/6H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528421 (NTIS**); T/E unlistd skn-rat LD :>13500 mg/kg Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001, 00-068 Warsaw 1, Poland) V.25-44, 1973-92. For publisher information, see PJPAE3 v. 32, p. 223, 1980 (PJPPAA); T/E unlistd ipr-rat LD50: 5700 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 26, p. 596, 1973 (TXAPA9); T/E unlistd scu-rat LD50: >4 gm/kg Naunyn-Schmiedebergs Archiv fuer Pharmakologie und Experimentelle Pathologie. (Berlin, Ger.) V.254-263, 1966-69. For publisher information, see NSAPCC. v. 257, p. 296, 1967 (APEPA2); T/E unlistd unr-rat LD50: 3 gm/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 29, p. 225, 1973 (EXPEAM); T/E unlistd orl-mus LD50: 3150 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 11, p. 86, 1969 (TPKVAL); T/E unlistd ipr-mus LD50: 2450 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 230, p. 559, 1957 (AEPPAE); T/E unlistd ivn-dog LDLo: 1500 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd skn-rbt LD50: 17 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528421 (NTIS**); E08-F07-F12 ipr-gpg LD50: 1250 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 9, p. 163, 1967 (TPKVAL); T/E unlistd scu-frg LDLo: 30 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-mam LD50: 3150 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(4), p. 86, 1974 (GISAAA) MD: A11-L14-M13 orl-rat TDLo: 910 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 52(3), p. 72, 1987 (GISAAA); P72-P73-U01 ihl-rat TCLo: 1500 ppm/6H/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 702, 1989 (FAATDF); P08-R03-Z01 skn-rat TDLo: 27 gm/kg/90D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535890 (NTIS**); K14 orl-rbt TDLo: 2880 mg/kg/24D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2001-104060 (NTIS**); U01 orl-rbt TDLo: 910 mg/kg/13D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB99-139701 (NTIS**); F15 orl-rbt TDLo: 840 mg/kg/7D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB99-139701 (NTIS**); F15-F16-Z01 orl-rat TDLo: 3500 mg/kg/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB99-139701 (NTIS**); U01 orl-rat TDLo: 800 mg/kg/4D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB99-139701 (NTIS**) TR: ACGIH TLV-TWA 10 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: OEL-AUSTRALIA: TWA 10 ppm (15 mg/m3), Skin, JAN 1993; OEL-BELGIUM: TWA 10 ppm (18 mg/m3), Skin, JAN 1993; OEL-FINLAND: TWA 20 ppm (37 mg/m3), STEL 30 ppm (55 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 20 ppm (30 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 20 ppm (30 mg/m3), JAN 1999; OEL-NORWAY: TWA 10 ppm (18 mg/m3), JAN 1999; OEL-RUSSIA: STEL 3 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 10 ppm (18 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 20 ppm (37 mg/m3), STEL 30 ppm (56 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO FORMAMIDE-air: 10H TWA 10 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84454; NIS 6; TNF 227; NOS 14; TNE 3195; NOES 1983: HZD 84454; NIS 3; TNF 42; NOS 5; TNE 2724; TFE 556 SL: EPA GENETOX PROGRAM 1988, Negative: Cell transform.-RLV F344 rat embryo; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 789 of 1119 in RTECS (through 2003/06) AN: LQ2100000 PN: Formamide,-N,N-dimethyl- SY: DMF-; DMFA-; Dimethyl-formamide-; Dimethylamid-kyseliny-mravenci- (Czech); Dimethylformamid- (German); Dimethylformamide-; Dimethylformamide- (ACGIH:OSHA); Dimetilformamide- (Italian); Dimetylformamidu- (Czech); Dwumetyloformamid- (Polish); N,N-Dimethyl-formamide-; N,N-Dimethylformamide-; N,N-Dimethylmethanamide-; N-Formyldimethylamine-; NCI-C60913-; NSC-5356-; U-4224- RN: Current: 68-12-2 UD: 200210 MF: C3-H7-N-O MW: 73.11 WL: VHN1&1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-hmn 100%/24H MLD British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 13, p. 51, 1956 (BJIMAG); eye-rbt 100 mg rinse SEV Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 9, p. 147, 1986 (DCTODJ) ME: mmo-sat 600 ug/plate (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 343, 1981 (PMRSDJ); dnr-smc 300 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); sln-smc 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); cyt-hmn-ihl 12300 ug/m3/1Y Zeitschrift fuer die Gesamte Hygiene und Ihre Grenzgebiete. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1955- v. 31, p. 366, 1985 (ZHYGAM); cyt-hmn-lym 100 nmol/L Chemicky Prumysl. Chemical Industry. (SNTL-Statni Nakladatelstvi Technicke Literatury, Spalena 51, 113 02 Prague 1, Czechoslovakia) V.1- 1951- v. 31, p. 548, 1981 (CHPUA4); dlt-rat-ihl 10700 ug/m3 Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 15, p. 21, 1979 (TPKVAL); mnt-mus-ipr 500 ug/kg/24H Dongwuxue Yanjiu. Zoological Research. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1980- v. 8, p. 27, 1987 (DOYADI); cyt-mus-ipr 40 umol/kg Chemicky Prumysl. Chemical Industry. (SNTL-Statni Nakladatelstvi Technicke Literatury, Spalena 51, 113 02 Prague 1, Czechoslovakia) V.1- 1951- v. 31, p. 548, 1981 (CHPUA4); msc-mus-lym 5 gm/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); hma-mus-sat 4250 ug/kg Chemicky Prumysl. Chemical Industry. (SNTL-Statni Nakladatelstvi Technicke Literatury, Spalena 51, 113 02 Prague 1, Czechoslovakia) V.1- 1951- v. 31, p. 548, 1981 (CHPUA4) RE: T34-T46 orl-rat TDLo: 5330 uL/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0521149 (NTIS**); T25-T31-T34 orl-rat TDLo: 5030 mg/kg (6-15D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 29, p. 193, 1991 (FCTOD7); T19-N19 ihl-rat TCLo: 800 ppm/6H (13W pre) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3345 (NTPTR*); T01 ihl-rat TCLo: 50 ppm/6H (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3345 (NTPTR*); T24-T34-T35 ihl-rat TCLo: 4 mg/m3/4H (1-19D preg) Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 14, p. 32, 1975 (TPKVAL); T85 ihl-rat TCLo: 600 mg/m3/24H (1-19D preg) Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 13, p. 75, 1973 (TPKVAL); T25-T31-T34 ihl-rat TCLo: 287 ppm/6H (0-19D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- 29,,193, 1991 (FCTOD7); T34 ihl-rat TCLo: 300 ppm/6H (6-15D preg) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 15, p. 1, 1992 (DCTODJ); T35 skn-rat TDLo: 3600 mg/kg (11-13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 35, 1977 (TXAPA9); T34-T39 skn-rat TDLo: 7552 mg/kg (6-15D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 29, p. 193, 1991 (FCTOD7); T24-T25-T34 skn-rat TDLo: 20 gm/kg (6-15D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 10, p. 333, 1990 (JJATDK); T22-T91 skn-rat TDLo: 20 gm/kg (1-20D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 10, p. 333, 1990 (JJATDK); T34 orl-mus TDLo: 1820 mg/kg (6-15D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 29, p. 193, 1991 (FCTOD7); T19-N19 ihl-mus TCLo: 200 ppm/6H (13W pre) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3345 (NTPTR*); T25-T34 ipr-mus TDLo: 2100 mg/kg (11D preg) Deutsche Gesundheitswesen. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 30, p. 455, 1975 (DEGEA3); T46-T43-T59 ipr-mus TDLo: 15120 mg/kg (1-14D preg) Deutsche Gesundheitswesen. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 30, p. 455, 1975 (DEGEA3); T41-T45-T46 orl-rbt TDLo: 2600 mg/kg (6-18D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 30, p. 1557, 1980 (ARZNAD); T34 orl-rbt TDLo: 2600 mg/kg (6-18D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 30, p. 1557, 1980 (ARZNAD); T34-T45-T46 ihl-rbt TCLo: 450 ppm/6H (7-19D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 29, p. 193, 1991 (FCTOD7); T19-T46-T50 ihl-rbt TCLo: 450 ppm/8H (7-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535254 (NTIS**); T39 skn-rbt TDLo: 5200 mg/kg (6-18D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 29, p. 193, 1991 (FCTOD7); T34 orl-rat TDLo: 1500 mg/kg (6-20D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 39, p. 33, 1997 (FAATDF); T46 orl-rat TDLo: 3000 ug/kg (6-20D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 39, p. 33, 1997 (FAATDF) ORNG: 2800000000 ng/kg. [2800.000000 mg/kg] T/E unlistd SRNG: 4720000000 ng/kg. [4720.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2800 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); T/E unlistd ihl-rat LCLo: 5000 ppm/6H United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #5122301 (USXXAM); T/E unlistd skn-rat LD :>3160 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516779 (NTIS**); F07-F18-U01 ipr-rat LD50: 1400 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 13, p. 51, 1956 (BJIMAG); T/E unlistd scu-rat LD50: 3800 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 15, p. 618, 1965 (ARZNAD); T/E unlistd ivn-rat LD50: 2 gm/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); T/E unlistd unr-rat LD50: >3 gm/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 18, p. 645, 1968 (ARZNAD); T/E unlistd orl-mus LD50: 2900 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0521148 (NTIS**); F12-F18-J22 ihl-mus LC50: 9400 mg/m3/2H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 1, p. 54, 1961 (TPKVAL); T/E unlistd ipr-mus LD50: 650 mg/kg Cancer Chemotherapy Reports. (Bethesda, MD) V.1-52, 1959-68. For publisher information, see CTRRDO. v. 30, p. 9, 1963 (CNCRA6); T/E unlistd scu-mus LD50: 4500 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 15, p. 618, 1965 (ARZNAD); T/E unlistd ivn-mus LD50: 2500 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 15, p. 618, 1965 (ARZNAD); T/E unlistd ims-mus LD50: 3900 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 15, p. 618, 1965 (ARZNAD); T/E unlistd ivn-dog LD50: 470 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 15, p. 618, 1965 (ARZNAD); L30-M16-P20 ipr-cat LD50: 500 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 13, p. 51, 1956 (BJIMAG); T/E unlistd orl-rbt LD50: 5 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520699 (NTIS**); T/E unlistd skn-rbt LD50: 4720 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); L30-M16-P20 ipr-rbt LD50: 1 gm/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 13, p. 51, 1956 (BJIMAG); T/E unlistd ivn-rbt LD50: 1800 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 15, p. 618, 1965 (ARZNAD); L03 ipr-gpg LDLo: 4 gm/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 35, p. 21, 1974 (AIHAAP); T/E unlistd ivn-gpg LD50: 1050 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 15, p. 618, 1965 (ARZNAD) MD: L01-L70-Y03 orl-rat TDLo: 9 mL/kg/12W-I Acta Pathologica Japonica. (Japan Publications Trading Co., Ltd., POB 5030, Tokyo International, Tokyo 101-31, Japan) V.1- 1951- v. 37, p. 1879, 1987 (APJAAG); F15-L70-U01 orl-rat TDLo: 13 gm/kg/15W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 3, p. 128, 1983 (TOXID9); L70-P71-P72 orl-rat TDLo: 5400 mg/kg/90D-C Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 9, p. 147, 1986 (DCTODJ); L70-P71-Y15 ihl-rat TCLo: 400 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3345 (NTPTR*); A11-F05 ihl-rat TCLo: 300 mg/m3/4H/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 23(5), p. 31, 1958 (GISAAA); M16-Y01-Y36 ihl-rat TCLo: 500 ug/m3/24H/60D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 27(4), p. 3, 1962 (GISAAA); Z01 ihl-rat TCLo: 2523 ppm/6H/5D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 9, p. 147, 1986 (DCTODJ); L30-M30-U30 orl-rat TDLo: 4500 mg/kg/10D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572893 (NTIS**); L70-M70-U01 ihl-mus TCLo: 800 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3345 (NTPTR*); U01-Z01 skn-rbt TDLo: 18 gm/kg/2W-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 9, p. 147, 1986 (DCTODJ) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 47, p. 171, 1989 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 47, p. 171, 1989 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 545, 1999 (IMEMDT); IARC Cancer Review: Animal No Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 545, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 545, 1999 (IMEMDT); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS) SR: MSHA STANDARD-air: TWA 10 ppm (30 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 90, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 10 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 10 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 10 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 10 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 ppm (30 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: 10 ppm (30 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 10 ppm (30 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 10 ppm (30 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 10 ppm (30 mg/m3), STEL 20 ppm (60 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 10 ppm (30 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 20 ppm (60 mg/m3), Skin, JAN 1999; OEL-HUNGARY: TWA 10 mg/m3, STEL 20 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 10 ppm (30 mg/m3), Skin, 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 10 ppm (30 mg/m3), Skin, JAN 1999; OEL-THE PHILIPPINES: TWA 10 ppm (30 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 10 mg/m3, MAC(STEL) 60 mg/m3, JAN 1999; OEL-RUSSIA: TWA 10 ppm, STEL 10 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 10 ppm (30 mg/m3), KTV 15 ppm (45 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 10 ppm (30 mg/m3), KZG-W 20 ppm (60 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 10 ppm (30 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 10 ppm (30 mg/m3), STEL 20 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DIMETHYLFORMAMIDE-air: 10H TWA 10 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 26560; NIS 64; TNF 3115; NOS 71; TNE 69191; NOES 1983: HZD 26560; NIS 85; TNF 6209; NOS 93; TNE 124683; TFE 16011 SL: EPA GENETOX PROGRAM 1988, Negative: SHE-clonal assay, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS in rat liver; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Dimethylformamide, 2004; NTP Toxicity studies, RPT# TOX-22, October 2000; OSHA ANALYTICAL METHOD #ID-66 Record 790 of 1119 in RTECS (through 2003/06) AN: LQ4900000 PN: Formic-acid- SY: Acide-formique- (French); Acido-formico- (Italian); Ameisensaeure- (German); Aminic-acid-; Formylic-acid-; Kwas-metaniowy- (Polish); Kyselina-mravenci- (Czech); Methanoic-acid-; RCRA-waste-number-U123-; Formic-acid- (ACGIH:OSHA); Hydrogen-carboxylic-acid-; Mierenzuur- (Dutch) RN: Current: 64-18-6 UD: 200210 MF: C-H2-O2 MW: 46.03 WL: VHQ CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 610 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 8/5/1968 (UCDS**); eye-rbt 122 mg SEV Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 8/5/1968 (UCDS**) ME: mmo-esc 70 ppm/3H (-S9) American Naturalist. (Univ. of Chicago Press, Journals Div., POB 37005, Chicago, IL 60637) V.1- 1867- v. 85, p. 119, 1951 (AMNTA4); pic-esc 100 mmol/L Medycyna Doswiadczalna i Mikrobiologia. For English translation, see EXMMAV. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1949- v. 31, p. 11, 1979 (MDMIAZ); sln-dmg-ihl 1000 ppm/24H Theoretical and Applied Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.38- 1968- v. 39, p. 330, 1969 (THAGA6); sln-dmg-orl 1000 ppm Theoretical and Applied Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.38- 1968- v. 39, p. 330, 1969 (THAGA6); oms-nml-oth 100 mmol/L Comptes Rendus de l'Association des Anatomistes. (Nancy, France) V.1-56, 1899-1972. For publisher information, see ANOBAU. v. 56, p. 712, 1972 (CAANAT); cyt-nml-oth 100 mmol/L Comptes Rendus de l'Association des Anatomistes. (Nancy, France) V.1-56, 1899-1972. For publisher information, see ANOBAU. v. 56, p. 712, 1972 (CAANAT); sce-hmn-lym 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 279, p. 75, 1992 (MUREAV); cyt-ham-ovr 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 195, 1990 (MUREAV) ORNG: 1100000000 ng/kg. [1100.000000 mg/kg] F07-J22 AT: J23-M14-U20 orl-wmn TDLo: 2200 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 32, p. 199, 1994 (JTCTDW); M16 ihl-man TCLo: 7300 ug/m3/8H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 66, p. 522, 1992 (ARTODN); H08-P23-U20 orl-wmn LDLo: 2440 ug/kg American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- v. 7, p. 286, 1989 (AJEMEN); F07-J22 orl-rat LD50: 1100 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(12), p. 49, 1979 (GTPZAB); F07-J22 ihl-rat LC50: 15 gm/m3/15M Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(12), p. 49, 1979 (GTPZAB); F07-J22 orl-mus LD50: 700 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(12), p. 49, 1979 (GTPZAB); F07-J22 ihl-mus LC50: 6200 mg/m3/15M Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(12), p. 49, 1979 (GTPZAB); T/E unlistd ipr-mus LD50: 940 mg/kg Igiena. (Bucharest, Romania) V.5-23, 1956-74(?). For publisher information, see RABIDH. v. 11, p. 507, 1962 (IGIBA5); T/E unlistd ivn-mus LD50: 145 mg/kg Zeitschrift fuer Ernaehrungswissenschaft. (Dr. Dietrich Steinkopff Verlag, Postfach 111008, D-6100 Darmstadt 11, Fed. Rep. Ger.) V.1- 1960- v. 9, p. 332, 1969 (ZERNAL); T/E unlistd orl-dog LD50: 4 gm/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 20, p. 517, 1959 (AMIHAB); T/E unlistd ivn-dog LDLo: 3 gm/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 146, 1955 (HBTXAC); T/E unlistd ivn-rbt LDLo: 239 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 146, 1955 (HBTXAC) MD: F15-U01 orl-rat TDLo: 22680 mg/kg/9W-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 16, p. 463, 1921 (JPETAB); D07-J30-Z01 ihl-rat TCLo: 500 ppm/6H/12D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3342 (NTPTR*); J70-L70-Y03 ihl-rat TCLo: 64 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3342 (NTPTR*); A11-L14-M13 ihl-rat TCLo: 50 mg/m3/16W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(12), p. 49, 1975 (GTPZAB); D07-J30-Z01 ihl-mus TCLo: 500 ppm/6H/12D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3342 (NTPTR*); L70-M70-U01 ihl-mus TCLo: 64 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3342 (NTPTR*) TR: ACGIH TLV-TWA 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 20, p. 517, 1959 (AMIHAB); TOXICOLOGY REVIEW Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 39, p. 299, 1978 (ARTODN) SR: MSHA STANDARD-air: TWA 5 ppm (9 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 119, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (9 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (9 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (9 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (9 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 5 ppm (9 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 5 ppm (9 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 5 ppm (9 mg/m3), JAN 1999; OEL-BELGIUM: TWA 5 ppm (9.4 mg/m3), JAN 1993; OEL-DENMARK: TWA 5 ppm (9 mg/m3), JAN 1999; OEL-FRANCE: VLE 5 ppm (9 mg/m3), JAN 1999; OEL-GERMANY: MAK 5 ppm (9 mg/m3), JAN 1999; OEL-HUNGARY: TWA 5 mg/m3, STEL 8 mg/m3, JAN 1993; OEL-JAPAN: OEL 5 ppm (9.4 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (9 mg/m3), JAN 1999; OEL-NORWAY: TWA 5 ppm (9 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (9 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 15 mg/m3, JAN 1999; OEL-RUSSIA: TWA 5 ppm, STEL 1 mg/m3, Skin, JAN 1993; OEL-SWEDEN: TWA 3 ppm (5 mg/m3), STEL 15 ppm (45 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (9 mg/m3), STEL 10 ppm (18 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 5 ppm (9.6 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO FORMIC ACID-air: 10H TWA 5 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 33720; NIS 59; TNF 3537; NOS 48; TNE 34087; NOES 1983: HZD 33720; NIS 95; TNF 6368; NOS 77; TNE 158933; TFE 37338 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Formic acid, 2011; NTP Toxicity studies, RPT# TOX-19, October 2000; OSHA ANALYTICAL METHOD #ID-112 Record 791 of 1119 in RTECS (through 2003/06) AN: LT7000000 PN: 2-Furaldehyde- SY: Artificial-ant-oil-; Artificial-oil-of-ants-; 2-Formylofuran- (Polish); 2-Formylfuran-; Fural-; Furfural-; 2-Furfural-; Furfural- (ACGIH:OSHA); Furfuraldehyde-; Furfurale- (Italian); Furfurol-; Furfurole-; 2-Furil-metanale- (Italian); 2-Furylaldehyde-; 2-Furylcarboxaldehyde-; 2-Furyl-methanal-; NCI-C56177-; RCRA-waste-number-U125-; 2-Furanaldehyde-; Furale-; 2-Furancarbonal-; 2-Furancarboxaldehyde-; 2-Furankarbaldehyd- (Czech); Furole-; alpha-Furole-; Pyromucic-aldehyde- RN: Current: 98-01-1 BRN: 105755 BHR: 5-17-09-00292 UD: 200302 MF: C5-H4-O2 MW: 96.09 WL: T5OJ BVH CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,788,1986 (85JCAE); skn-rbt 500 mg/24H MLD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,788,1986 (85JCAE) ME: mmo-sat 8094 ug/plate (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 205, 1978 (MUREAV); dnr-bcs 1700 ug/disc Developments in Food Science. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 13, p. 353, 1986 (DFSCDX); slt-dmg-orl 5000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 75, 1992 (MUREAV); sln-dmg-par 100 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 677, 1985 (ENMUDM); sln-dmg-orl 5000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 75, 1992 (MUREAV); sln-dmg-ipr 5000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 75, 1992 (MUREAV); dni-hmn-hla 3 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); sce-hmn-lym 70 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 233, 1985 (MUREAV); oms-mus-orl 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); msc-mus-lym 200 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); oms-ham-lng 1 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 227, p. 117, 1989 (MUREAV); cyt-ham-lng 1 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 227, p. 117, 1989 (MUREAV); cyt-ham-ovr 2500 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 13, p. 89, 1981 (CALEDQ); sce-ham-ovr 11700 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. NTP-TR, p. 382, 1990 (NTPTR*); dns-hmn-lvr 2 nmol/L/24H Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 999, 2001 (FCTOD7) RE: T34 ipr-rat TDLo: 150 mg/kg (6-15D preg) Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 6, p. 290, 1992 (WDZAEK); T01 ipr-mus TDLo: 360 mg/kg (6D male) Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 8, p. 129, 1994 (WDZAEK) TE: V03-L60 orl-rat TDLo: 30900 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. NTP-TR, p. 382, 1990 (NTPTR*); V01-L60 orl-mus TDLo: 90125 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. NTP-TR, p. 382, 1990 (NTPTR*); V01-L61 orl-rat TDLo: 30900 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-108662 (NTIS**); V01-L60-M61 orl-mus TDLo: 90125 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-108662 (NTIS**); V02-L60-M61 orl-mus TDLo: 90125 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-108662 (NTIS**) ORNG: 65000000 ng/kg. [65.000000 mg/kg] T/E unlistd AT: T/E unlistd ihl-hmn TCLo: 310 ug/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 26(6), p. 3, 1961 (GISAAA); T/E unlistd orl-rat LD50: 65 mg/kg Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 13, p. 371, 1980 (BCTKAG); J30-U01 ihl-rat LC50: 175 ppm/6H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 50, p. A359, 1989 (AIHAAP); T/E unlistd ipr-rat LD50: 20 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); F12 scu-rat LD50: 148 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,279,1969 (34ZIAG); V30 orl-mus LD50: 400 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 34, p. 1196, 1940 (BIJOAK); T/E unlistd ihl-mus LCLo: 370 ppm/6H "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,279,1969 (34ZIAG); T/E unlistd ipr-mus LD50: 102 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); T/E unlistd scu-mus LD50: 119 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); T/E unlistd ivn-mus LD50: 152 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); F12-F19-K13 orl-dog LD50: 950 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,279,1969 (34ZIAG); T/E unlistd ihl-dog LC50: 370 ppm/6H "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,279,1969 (34ZIAG); T/E unlistd scu-dog LD50: 214 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); T/E unlistd ivn-dog LD50: 250 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); C08-D16-J26 orl-rbt LDLo: 800 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 21, p. 65, 1923 (JPETAB); T/E unlistd skn-rbt LDLo: 620 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); T/E unlistd scu-rbt LDLo: 500 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 32(5), p. 158, 1967 (HYSAAV); T/E unlistd ims-rbt LD50: 78 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); L02-M03-P01 orl-gpg LD50: 541 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 32(5), p. 158, 1967 (HYSAAV); T/E unlistd scu-gpg LDLo: 100 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 759, 1978 (FCTXAV); T/E unlistd par-frg LDLo: 23 gm/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 21, p. 65, 1923 (JPETAB) MD: L04-L30-L70 orl-rat TDLo: 4190 mL/kg/17W-C Acta Pathologica Japonica. (Japan Publications Trading Co., Ltd., POB 5030, Tokyo International, Tokyo 101-31, Japan) V.1- 1951- v. 36, p. 1027, 1986 (APJAAG); L30-M30-Y21 orl-rat TDLo: 91 mg/kg/14D-I Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 15, p. 241, 1982 (BCTKAG); E01-N30 ihl-rat TCLo: 200 mg/m3/5H/12W-I Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 11, p. 403, 1978 (BCTKAG); F23-Y01-Z01 ihl-rat TCLo: 10140 ug/m3/24H/60D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 26(6), p. 3, 1961 (GISAAA); M04 ihl-rat TCLo: 500 mg/m3/4H/4W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 7, p. 574, 1963 (AEHLAU); M03-P08-P71 scu-rat TDLo: 75 mg/kg/6W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 7, p. 574, 1963 (AEHLAU); M03-P05-P14 scu-rat TDLo: 33 mg/kg/13W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 7, p. 574, 1963 (AEHLAU); Z01 orl-mus TDLo: 4800 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-382, 1990 (NTPTR*); L70 orl-mus TDLo: 4875 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-382, 1990 (NTPTR*) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 409, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 409, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 409, 1995 (IMEMDT) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 5 ppm (20 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 120, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (20 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (20 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (20 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (20 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2 ppm (8 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 5 ppm (20 mg/m3), JAN 1999; OEL-BELGIUM: TWA 2 ppm (7.9 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 2 ppm (7.9 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 2 ppm (8 mg/m3), Skin, JAN 1999; OEL-FRANCE: VLE 2 ppm (8 mg/m3), JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-JAPAN: OEL 2.5 ppm (9.8 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 2 ppm (8 mg/m3), JAN 1999; OEL-NORWAY: TWA 2 ppm (8 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (20 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 10 mg/m3, MAC(STEL) 40 mg/m3, JAN 1999; OEL-RUSSIA: TWA 2.5 ppm, STEL 10 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 2 ppm (8 mg/m3), KTV 5 ppm (20 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 2 ppm (8 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 5 ppm (20 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 2 ppm (8 mg/m3), STEL 5 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 34120; NIS 11; TNF 333; NOS 30; TNE 5904; NOES 1983: HZD 34120; NIS 79; TNF 6447; NOS 66; TNE 135914; TFE 6706 SL: EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Aldehydes, screening, 2539; NIOSH Analytical Method, 1994: Furfural, 2529; NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NTP Carcinogenesis Studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-382, 1990 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; OSHA ANALYTICAL METHOD #ID-72 Record 792 of 1119 in RTECS (through 2003/06) AN: LT7031100 PN: 2-Furaldehyde, 5-(hydroxymethyl)- SY: HMF-; 2-Furancarboxaldehyde, 5-(hydroxymethyl)- (9CI); 5-Hydroxymethylfuraldehyde-; 5-(Hydroxymethyl)-2-furancarboxaldehyde; 5-(Hydroxymethyl)furfural; Hydroxymethylfurfurole-; 5-Oxymethylfurfurole- RN: Current: 67-47-0 BRN: 110889 BHR: 5-18-01-00130 UD: 200012 MF: C6-H6-O3 MW: 126.12 WL: T5OJ BVH E1Q CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 165 nmol/plate (-S9) Developments in Food Science. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 13, p. 353, 1986 (DFSCDX); dnr-bcs 2500 ug/disc Developments in Food Science. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 13, p. 353, 1986 (DFSCDX); oms-ham-lng 1 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 227, p. 117, 1989 (MUREAV); cyt-ham-lng 2 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 227, p. 117, 1989 (MUREAV) TE: V03-M61 scu-rat TDLo: 200 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 47, p. 1037, 1971 (JNCIAM) ORNG: 2500000000 ng/kg. [2500.000000 mg/kg] F12 AT: F12 orl-rat LD50: 2500 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0544683 (NTIS**) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 793 of 1119 in RTECS (through 2003/06) AN: LT7700000 PN: 2-Furaldehyde,-5-nitro-,-semicarbazone- SY: (5-Nitro-2-furfurylideneamino)urea; 1-(5-Nitro-2-furfurylidene)semicarbazide; 2((5-Nitro-2-furanyl)methylene)hydrazinecarboxamide; 2-((5-Nitro-2-furanyl)methylene)hydrazine carboximide; 5-Nitro-2-furaldehyde-semicarbazone-; 5-Nitro-2-furancarboxaldehyde-semicarbazone-; 5-Nitro-2-furfural-semicarbazone-; 5-Nitro-2-furfuraldehyde-semicarbazone-; 5-Nitrofuraldehyde-semicarbazide-; 5-Nitrofuran-2-aldehyde-semicarbazone-; 5-Nitrofurfural-semicarbazone-; 6-Nitrofuraldehyde-semicarbazide-; Acutol-; Aldomycin-; Alfucin-; Amifur-; Babrocid-; Becafurazone-; Biofuracina-; Biofurea-; Chemofuran-; Chixin-; Cocafurin-; Coxistat-; Dermofural-; Dynazone-; Eldezol-; Eldezol-F-6-; Fedacin-; Flavazone-; Fracine-; Furacilin-; Furacillin-; Furacin-; Furacin-E-; Furacin-HC-; Furacine-; Furacinetten-; Furacoccid-; Furacort-; Furacycline-; Furaldon-; Furalone-; Furametral-; Furan-ofteno-; Furaplast-; Furaseptyl-; Furaskin-; Furaziline-; Furazin-; Furazina-; Furazol-W-; Furazone-; Furesol-; Furfurin-; Furosem-; Fuvacillin-; Hemofuran-; Hydrazinecarboxamide, 2-((5-nitro-2-furanyl)methylene)-; Ibiofural-; Mammex-; Mastofuran-; Monofuracin-; NCI-C56064-; NF-7-; NFS-; NFZ-; NSC-2100-; Nefco-; Nifucin-; Nifuzon-; Nitrofural-; Nitrofuraldehyde-semicarbazone-; Nitrofurazan-; Nitrofurazone-; Nitrozone-; Otofuran-; Semikarbazon-5-nitrofurfuralu- (Polish); Spray-dermis-; Spray-foral-; U-6421-; USAF-EA-4-; Vabrocid-; Veterinary-nitrofurazone-; Yatrocin- RN: Current: 59-87-0 BRN: 86403 BHR: 5-17-09-00335 UD: 200305 MF: C6-H6-N4-O4 MW: 198.16 WL: T5OJ BNW E1UNMVZ CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 300 ng/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9(Suppl 9), p. 1, 1987 (ENMUDM); mmo-sat 2 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 15, 1987 (MUREAV); oms-sat 300 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 91, 1992 (MUREAV); dnr-sat 1 ug/disc Bratislavske Lekarske Listy. (PNS-Ustredna Expedicia a Dovoz Tlace, Gottwaldovo nam. 6, 813 81 Bratislava, Czechoslovakia) V.1- 1921- v. 84, p. 645, 1985 (BLLIAX); mmo-esc 40 ug/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 175, p. 149, 1986 (MUREAV); mmo-esc 10 mg/L (+S9) British Journal of Cancer, Supplement. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2ZS, UK) No.1- 1973- v. 3, p. 124, 1978 (BJCSB5); dnr-esc 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 133, 1979 (MUREAV); oms-esc 50 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 14, p. 81, 1976 (CBINA8); pic-esc 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 3, 1974 (MUREAV); mmo-bcs 5 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 19, 1977 (MUREAV); dnr-bcs 10 ug/disc Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 17, p. 70, 1983 (KSRNAM); pic-omi 1 mg/L Comptes Rendus des Seances de l'Academie des Sciences, Serie D: Sciences Naturelles. (Paris, France) V.262-291, 1966-80. For publisher information, see CRASEV. v. 272, p. 886, 1971 (CHDDAT); mmo-nsc 1 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 13, 1977 (MUREAV); mmo-eug 50 mg/L (-S9) Journal of Protozoology. (Soc. of Protozoologists, P.O. Box 368, Lawrence, KS 66044) V.1- 1954- v. 17, p. 129, 1970 (JPROAR); dnd-hmn-oth 250 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 781, 1975 (CNREA8); dnd-mus-ast 80 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 781, 1975 (CNREA8); dnd-mus-lym 500 umol/L/90M-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 40, p. 94, 1979 (BJCAAI); dnd-mus-fbr 250 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 781, 1975 (CNREA8); dnd-mus-oth 500 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 16, p. 223, 1977 (CBINA8); dni-mus-lym 500 umol/L/90M-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 40, p. 94, 1979 (BJCAAI); dni-mus-oth 100 mg/L Revista de Chirurgui, Oncologie, Radiologie, ORL, Oftalmologie, Stomatologie, Seria: Oncologia. (Rompresfilatelia, POB 12-201, Bucharest, Romania) V.13(4)- 1974- v. 19, p. 183, 1980 (ONCODU); msc-mus-lym 100 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-337, 1988 (NTPTR*); dnd-ham-kdy 250 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 781, 1975 (CNREA8); dni-ham-lng 10 umol/L/6D-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 40, p. 94, 1979 (BJCAAI); cyt-ham-ovr 100 mg/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 23, p. 1091, 1985 (FCTOD7); cyt-ham-lng 100 mg/L/27H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 277, 1979 (MUREAV); sce-ham-ovr 250 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-337, 1988 (NTPTR*); msc-ham-ovr 23 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-337, 1988 (NTPTR*) RE: T02 orl-rat TDLo: 700 mg/kg (7D male) Acta Pathologica Japonica. (Japan Publications Trading Co., Ltd., POB 5030, Tokyo International, Tokyo 101-31, Japan) V.1- 1951- v. 14, p. 261, 1964 (APJAAG); T02-T09 orl-rat TDLo: 840 mg/kg (14D male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 53, p. 585, 1953 (ENDOAO); T02 orl-rat TDLo: 529 mg/kg (14D male) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 27, p. 129, 1989 (FCTOD7); T01-T02 orl-rat TDLo: 1792 mg/kg (28D male) Andrologia. (Grosse Verlag GmbH, Kurfuerstenstr. 112-113, D-1000 Berlin 30, Fed. Rep. Ger.) V.6- 1974- v. 10, p. 107, 1978 (ANDRDQ); T02 unr-rat TDLo: 700 mg/kg (14D male) Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 24, p. 348, 1999 (JTSCDR); T34-T35 orl-mus TDLo: 817 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-145844 (NTIS**); T26-T81 orl-mus TDLo: 800 mg/kg (6-13D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 29, 1987 (TCMUD8); T29-T72-T75 orl-mus TDLo: 11340 mg/kg (multigeneration) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 34, p. 56, 1996 (FAATDF); T35-T46 scu-mus TDLo: 300 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 12, p. 206, 1975 (TJADAB); T35-T59 unr-mus TDLo: 900 mg/kg (9-11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 14, p. 250, 1976 (TJADAB); T53 orl-mus TDLo: 12 mg/kg (multigeneration) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 199, 1992 (TOXID9); T51-T81-T82 orl-mus TDLo: 45 mg/kg (multigeneration) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 199, 1992 (TOXID9); T26-T29-T72 orl-mus TDLo: 45 mg/kg (multigeneration) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 199, 1992 (TOXID9); T16 orl-mus TDLo: 1.73 gm/kg (7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T29 orl-mus TDLo: 1.73 gm/kg (7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T23 orl-mus TDLo: 18.2 gm/kg (21W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T26-T81 orl-mus TDLo: 18.2 gm/kg (21W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T53 orl-mus TDLo: 15 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T72-T75-T81 orl-mus TDLo: 61.9 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T16-T73 orl-mus TDLo: 61.9 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T29 orl-mus TDLo: 433.3 mg/kg (7D male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**) TE: V01-R60 orl-rat TDLo: 8652 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-337, 1988 (NTPTR*); V01-N60 orl-mus TDLo: 10094 mg/kg/2Y-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 25, p. 419, 1966 (FEPRA7); V03-J60 scu-mus TDLo: 300 mg/kg/18D-I Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 15, p. 234, 1975 (SEIJBO); V03-R60 orl-rat TD :4500 mg/kg/27D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 28, p. 924, 1968 (CNREA8); V02-M61-R60 orl-rat TD :31 gm/kg/45W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 25, p. 419, 1966 (FEPRA7); V02-R60 orl-rat TD :11176 mg/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 27, p. 129, 1989 (FCTOD7); V02-R60 orl-rat TDLo: 26821.2 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-102388/AS (NTIS**); V03-T69 orl-rat TDLo: 13410.6 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-102388/AS (NTIS**); V02-R60 orl-rat TDLo: 11175.5 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-102388/AS (NTIS**); V02-T63 orl-mus TDLo: 12978 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-102388/AS (NTIS**) ORNG: 590000000 ng/kg. [590.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 590 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 133, p. 299, 1947 (JAMAAP); T/E unlistd ipr-rat LDLo: 150 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 13, p. 285, 1964 (BCPCA6); T/E unlistd scu-rat LD50: 3 gm/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 133, p. 299, 1947 (JAMAAP); T/E unlistd orl-mus LD50: 249 mg/kg Transactions of the Royal Society of Tropical Medicine and Hygiene. (Royal Soc. of Tropical Medicine and Hygiene, Manson House, 26 Portland Pl., London W1N 4EY, UK) V.14- 1920- v. 74, p. 43, 1980 (TRSTAZ); T/E unlistd ipr-mus LD50: 96 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 10, p. 530, 1967 (JMCMAR); T/E unlistd scu-mus LD50: 753 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 102, p. 185, 1951 (JPETAB) MD: Z01 orl-rat TDLo: 1170 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-337, 1988 (NTPTR*); L70-Q02 orl-rat TDLo: 11375 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-337, 1988 (NTPTR*); F12-R03-Z01 orl-mus TDLo: 2710 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-337, 1988 (NTPTR*); L70-Z01 orl-mus TDLo: 6770 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-337, 1988 (NTPTR*); Z71 orl-rat TDLo: 3325 mg/kg/19W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 156, p. 177, 2000 (CALEDQ); L30-M71-N72 orl-mus TDLo: 4340 mg/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); M71-T02 orl-mus TDLo: 433.3 mg/kg/7D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T02 orl-mus TDLo: 525 mg/kg/7D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T12 orl-mus TDLo: 420 mg/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); N16-T02 orl-mus TDLo: 868 mg/kg/7D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**); T29 orl-mus TDLo: 1733.2 mg/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-217694 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 195, 1990 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 171, 1974 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 171, 1974 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 195, 1990 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 195, 1990 (IMEMDT); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 2, p. 365, 1973 (CRTXB2); TOXICOLOGY REVIEW Carcinogenesis--A Comprehensive Survey. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1976- v. 4, p. 171, 1978 (CCSUDL) ND: NOHS 1974: HZD 84410; NIS 3; TNF 305; NOS 5; TNE 3806; NOES 1983: HZD X2857; NIS 1; TNF 697; NOS 5; TNE 6091; TFE 2898; NOES 1983: HZD 84410; NIS 1; TNF 978; NOS 5; TNE 6652; TFE 2898 SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: B subtilis rec assay, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive/dose response: TRP reversion; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: In vivo cytogenetics-nonhuman bone marrow; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, TRP reversion; EPA GENETOX PROGRAM 1988, Negative: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: mouse, rat Record 794 of 1119 in RTECS (through 2003/06) AN: LT8524000 PN: Furan- SY: Axole-; Divinylene-oxide-; 1,4-Epoxy-1,3-butadiene-; NCI-C56202-; RCRA-waste-number-U124-; Furfuran-; Oxacyclopentadiene-; Oxole-; Tetrole- RN: Current: 110-00-9 BRN: 103221 BHR: 5-17-01-00291 UD: 200302 MF: C4-H4-O MW: 68.08 WL: T5OJ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 825 nmol/plate (+/-S9) Developments in Food Science. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 13, p. 353, 1986 (DFSCDX); dnr-bcs 3500 ug/disc Developments in Food Science. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 13, p. 353, 1986 (DFSCDX); msc-mus-lym 1139 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); cyt-ham-ovr 184 mmol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 13, p. 89, 1981 (CALEDQ) RE: T02-T12 orl-rat TDLo: 3900 mg/kg (13W male/13W pre) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-402, 1993 (NTPTR*) TE: V01-L60-L61 orl-rat TDLo: 1040 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-402, 1993 (NTPTR*); V01-L60 orl-mus TDLo: 4160 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-402, 1993 (NTPTR*); V01-L60-L61 orl-rat TDLo: 1950 mg/kg/36W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-228419 (NTIS**); V01-L60-L61 orl-rat TDLo: 1030 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-228419 (NTIS**); V01-L60 orl-rat TDLo: 1030 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-228419 (NTIS**); V01-P61 orl-rat TDLo: 2060 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-228419 (NTIS**); V01-L60 orl-mus TDLo: 4120 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-228419 (NTIS**) AT: D28-F07-J22 ihl-rat LC50: 3398 ppm/1H Hazelton Laboratories, Reports. (Falls Church, VA) HLA468-102, 1987 (HAZL**); T/E unlistd ipr-rat LD50: 5200 ug/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 310, 1979 (AIHAAP); J15-J30 ihl-mus LC50: 120 mg/m3/1H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 310, 1979 (AIHAAP); T/E unlistd ipr-mus LD50: 7 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 40, p. 310, 1979 (AIHAAP); K01-K13-P01 orl-dog LDLo: 234 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 26, p. 281, 1926 (JPETAB); F12-P01 ivn-dog LDLo: 140 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 26, p. 281, 1926 (JPETAB); K01-K13-P01 orl-rbt LDLo: 234 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 26, p. 281, 1926 (JPETAB) MD: L30-Z01 orl-rat TDLo: 600 mg/kg/2W-I American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 145, p. 375, 1994 (AJPAA4); L30-U01 orl-rat TDLo: 240 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-402, 1993 (NTPTR*); L02-M03-N74 orl-rat TDLo: 3900 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-402, 1993 (NTPTR*); J02-L30-Z01 ihl-rat TCLo: 200 mg/m3/4H/60D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 9, p. 106, 1967 (TPKVAL); L12-U01-Z01 ihl-rat TCLo: 500 mg/m3/2H/9W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 10, p. 35, 1968 (TPKVAL); A11-H02 ihl-rat TCLo: 5 mg/m3/4H/26W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 10, p. 35, 1968 (TPKVAL); L30-Z01 ihl-rat TCLo: 500 mg/m3/2H/30D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 9, p. 106, 1967 (TPKVAL); L30-L70-U01 orl-mus TDLo: 1950 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-402, 1993 (NTPTR*); L02-M03-U01 orl-mus TDLo: 2730 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-402, 1993 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 393, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 393, 1995 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 393, 1995 (IMEMDT) SR: OEL-RUSSIA: STEL 0.5 mg/m3, Skin, JAN 1993 ND: NOHS 1974: HZD 34185; NIS 2; TNF 25; NOS 3; TNE 244; NOES 1983: HZD 34185; NIS 2; TNF 14; NOS 2; TNE 35; TFE 7 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 795 of 1119 in RTECS (through 2003/06) AN: LU3482000 PN: 2(5H)-Furanone, 3-chloro-4-dichloromethyl-5-hydroxy- SY: 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone; 3-Chloro-4-dichloromethyl-5-hydroxy-2(5H)-furanone; Chloro(dichloromethyl)-5-hydroxy-2(5H)-furanone; MX- RN: Current: 77439-76-0 BRN: 3606116 UD: 200210 MF: C5-H3-Cl3-O3 MW: 217.43 WL: T5OVJ CG DYGG EQ CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 6250 pg/plate (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10, p. 411, 1987 (EMMUEG); mmo-esc 50 ng/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 413, p. 219, 1998 (MUREAV); dnr-esc 4 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 317, 1994 (EMMUEG); pic-esc 50 nmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 270, 1995 (EMMUEG); dnd-hmn-lym 44100 nmol/L Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 11, p. 103, 1991 (TCMUD8); dnd-hmn-leu 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 133, 1994 (MUREAV); dns-hmn-lvr 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 373, p. 67, 1997 (MUREAV); mnt-rat-orl 300 mg/kg/3D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 151, 1995 (MUREAV); dnd-rat-lvr 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 55, 1991 (MUREAV); dnd-rat-tes 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 55, 1991 (MUREAV); dns-rat-lvr 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 373, p. 67, 1997 (MUREAV); cyt-rat-lym 60 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 299, p. 25, 1993 (MUREAV); sce-rat-lym 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 299, p. 25, 1993 (MUREAV); sce-rat-orl 75 mg/kg/3D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 151, 1995 (MUREAV); dnd-mus-orl 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 393, p. 47, 1997 (MUREAV); dns-mus-lvr 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 373, p. 67, 1997 (MUREAV); cyt-mus-lym 750 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 348, p. 105, 1995 (MUREAV); msc-mus-lym 750 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 348, p. 105, 1995 (MUREAV); hma-mus-esc 200 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 317, 1994 (EMMUEG); dnd-ham-lng 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 55, 1991 (MUREAV); oms-ham-ovr 8500 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10, p. 411, 1987 (EMMUEG); cyt-ham-ovr 4 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10, p. 411, 1987 (EMMUEG); sce-ham-lng 2 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 55, 1991 (MUREAV); sce-ham-ovr 190 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 310, p. 117, 1994 (MUREAV); msc-ham-ovr 2 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 310, p. 117, 1994 (MUREAV); dnd-dom-kdy 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 441, p. 145, 1999 (MUREAV); mmo-sat 0.005 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 490, p. 89, 2001 (MUREAV); slt-hmn-lym 3 mg/L/72H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 495, p. 157, 2001 (MUREAV); mmo-sat 32 ug/plate/20M (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 106, 2000 (EMMUEG) AT: T/E unlistd orl-mus LD50: 120 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 363, 1987 (MUREAV); T/E unlistd skn-mus LD50: 130 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-238126 (NTIS**) MD: M16-Y11-Y35 orl-rat TDLo: 256 mg/kg/4D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 110, p. 59, 1996 (TXCYAC); M70-P28-Y03 orl-rat TDLo: 4050 mg/kg/14W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. (Suppl), p. 307, 1992 (TOLED5); M16-P28-P72 orl-rat TDLo: 200 mg/kg/14D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 33, p. 1027, 1995 (FCTOD7); L70-M16-M70 orl-rat TDLo: 2700 mg/kg/18W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 33, p. 1027, 1995 (FCTOD7); N03 orl-rat TDLo: 7 mg/kg/7D-I Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 8, p. 267, 2000 (ETOPFR); N07-Z01 orl-rat TDLo: 420 mg/kg/7D-I Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 8, p. 267, 2000 (ETOPFR) SL: NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 796 of 1119 in RTECS (through 2003/06) AN: LU3500000 PN: 2(3H)-Furanone, dihydro- SY: 1,2-Butanolide-; 1,4-Butanolide-; 2-Oxolanone-; 4-Butanolide-; 4-Butyrolactone-; 4-Deoxytetronic-acid-; 4-Hydroxybutanoic-acid-lactone-; 4-Hydroxybutanoic-acid,-gamma-lactone-; 4-Hydroxybutyric-acid-lactone-; 4-Hydroxybutyric-acid,-gamma-lactone-; Agrisynth-BLO-; Butyric-acid-lactone-; Butyric-acid,-4-hydroxy-,-gamma-lactone-; Butyrolactone-; Butyryl-lactone-; Butyrylactone-; C-1070-; Dihydro-2(3H)-furanone; NCI-C55878-; Tetrahydro-2-furanone-; gamma-6480-; gamma-BL-; gamma-Butyrolactone-; gamma-Hydroxybutyric-acid-cyclic-ester-; gamma-Hydroxybutyric-acid-lactone-; gamma-Hydroxybutyrolactone-; gamma-butyrolactone- RN: Current: 96-48-0 UD: 200302 MF: C4-H6-O2 MW: 86.10 WL: T5OVTJ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 uL SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0536954 (NTIS**) ME: dnd-bcs 20 uL/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); mtr-ham-kdy 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 638, 1981 (PMRSDJ); cyt-ham-ovr 2580 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 60, 1989 (EMMUEG); sce-ham-ovr 4940 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 60, 1989 (EMMUEG) RE: T02 orl-rat TDLo: 25 gm/kg (20D male) Archives of Andrology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 10, p. 239, 1983 (ARANDR); T34 orl-rat TDLo: 500 mg/kg (6-15D preg) Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 62, p. 57, 1988 (PHTOEH) TE: V03-N61 orl-mus TDLo: 191 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-406, 1992 (NTPTR*); V03-R60-V10 skn-mus TDLo: 50 gm/kg/42W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 31, p. 41, 1963 (JNCIAM); V02-N61 orl-mus TDLo: 134930 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-189323 (NTIS**) ORNG: 1540000000 ng/kg. [1540.000000 mg/kg] F05-F07-J25 AT: F05-F07-J25 orl-rat LD50: 1540 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 31(1), p. 49, 1987 (GTPZAB); T/E unlistd ihl-rat LC50: >5100 mg/m3/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534527 (NTIS**); F01-J30 ipr-rat LD50: 1 gm/kg Archivum Immunologiae et Therapiae Experimentalis. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.10- 1962- v. 13, p. 70, 1965 (AITEAT); F01-F07-J25 orl-mus LD50: 1460 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 64(2), p. 3, 1999 (GISAAA); F01-J30 ipr-mus LD50: 1100 mg/kg Archivum Immunologiae et Therapiae Experimentalis. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.10- 1962- v. 13, p. 70, 1965 (AITEAT); T/E unlistd par-mus LDLo: 1600 mg/kg "Summary Tables of Biological Tests," National Research Council Chemical-Biological Coordination Center. (National Academy of Science Library, 2101 Constitution Ave., NW, Washington, DC 20418) v. 7, p. 687, 1955 (CBCCT*); T/E unlistd ivn-rbt LDLo: 500 mg/kg Archivum Immunologiae et Therapiae Experimentalis. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.10- 1962- v. 13, p. 70, 1965 (AITEAT); T/E unlistd skn-gpg LD50: >5 gm/kg GAF Material Safety Data Sheet. (GAF Chemicals Corporation, 1361 Alps Road, Wayne, NJ 07470) (GAFCC*) MD: P08-P71 orl-rat TDLo: 9600 mg/kg/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 64(2), p. 3, 1999 (GISAAA); U01-Z01 orl-rat TDLo: 9600 mg/kg/16D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-406, 1992 (NTPTR*); U01 orl-rat TDLo: 40950 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-406, 1992 (NTPTR*); A30-L30-Y01 ihl-rat TCLo: 5030 ug/m3/24H/17W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 64(2), p. 3, 1999 (GISAAA); U01-Z01 orl-mus TDLo: 68 gm/kg/16W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-406, 1992 (NTPTR*); R60-V30 orl-rat TDLo: 115875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-189323 (NTIS**); L60-V30 orl-mus TDLo: 134930 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-189323 (NTIS**) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 231, 1976 (IMEMDT); IARC Cancer Review: Animal No Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 367, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 231, 1976 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 367, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 367, 1999 (IMEMDT) ND: NOHS 1974: HZD M1130; NIS 12; TNF 1476; NOS 18; TNE 5155; NOES 1983: HZD M1130; NIS 38; TNF 4447; NOS 42; TNE 44126; TFE 11013 SL: EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), equivocal evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat Record 797 of 1119 in RTECS (through 2003/06) AN: LU5950000 PN: Furan,-tetrahydro- SY: 1,4-Epoxybutane-; Agrisynth-THF-; Butane,-1,4-epoxy-; Butane,-alpha,delta-oxide-; Cyclotetramethylene-oxide-; Diethylene-oxide-; Furanidine-; NCI-C60560-; Oxacyclopentane-; Oxolane-; RCRA-waste-number-U213-; Tetrahydrofuraan- (Dutch); Tetrahydrofuran-; Tetrahydrofuran- (ACGIH:OSHA); Tetrahydrofuranne- (French); Tetraidrofurano- (Italian); Tetramethylene-oxide- RN: Current: 109-99-9 UD: 200302 MF: C4-H8-O MW: 72.12 WL: T5OTJ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-esc 1 umol/L (-S9) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 26(1), p. 43, 1982 (GTPZAB) RE: T34 ihl-rat TCLo: 5000 ppm/6H (6-19D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 255, 1992 (FAATDF); T25 ihl-mus TCLo: 1800 ppm/6H (6-17D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 255, 1992 (FAATDF) TE: V03-M60 ihl-rat TCLo: 1800 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-475, 1998 (NTPTR*); V01-L60 ihl-mus TCLo: 1800 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-475, 1998 (NTPTR*); V03-M61 ihl-rat TCLo: 18900 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB98-164544 (NTIS**); V01-L60 ihl-mus TCLo: 113400 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB98-164544 (NTIS**) ORNG: 1650000000 ng/kg. [1650.000000 mg/kg] T/E unlistd AT: F01 ihl-hmn TCLo: 25000 ppm "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,580,1969 (34ZIAG); T/E unlistd orl-rat LD50: 1650 mg/kg GAF Material Safety Data Sheet. (GAF Chemicals Corporation, 1361 Alps Road, Wayne, NJ 07470) (GAFCC*); F04-J26-K13 ihl-rat LC50: 21000 ppm/3H Sumitomo Sangyo Eisei. Sumitomo Industrial Health. (Sumitomo Byoin Sangyo Eisei Kenkyushitsu, 5-2-2, Nakanoshima, Kita-ku, Osaka 530, Japan) No.1- 1965- v. 20, p. 141, 1984 (SSEIBV); T/E unlistd ipr-rat LD50: 2900 mg/kg Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 24, p. 373, 1982 (SAIGBL); F07-F18-J22 ihl-mus LCLo: 24000 mg/m3/2H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 5, p. 21, 1963 (TPKVAL); T/E unlistd ipr-mus LD50: 1900 mg/kg Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 24, p. 373, 1982 (SAIGBL); D07 ihl-rbt LC :>1200 ppm/4H Sumitomo Sangyo Eisei. Sumitomo Industrial Health. (Sumitomo Byoin Sangyo Eisei Kenkyushitsu, 5-2-2, Nakanoshima, Kita-ku, Osaka 530, Japan) No.1- 1965- v. 18, p. 89, 1982 (SSEIBV); T/E unlistd orl-gpg LD50: 2300 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 34(9), p. 114, 1969 (GISAAA); L03 ipr-gpg LDLo: 500 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 35, p. 21, 1974 (AIHAAP) MD: P02-P72-U01 orl-rat TDLo: 4550 mg/kg/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(2), p. 99, 1967 (GISAAA); D01 ihl-rat TCLo: 1000 ppm/4H/12W-I Seikatsu Eisei. Living and Health. (Osaka Seikatsu Eisei Kyokai, c/o Osaka-shiritsu Kankyo Kagaku Kenkyusho, 8-34 Tojo-cho, Tennoji-ku, Osaka, 543, Japan) V.1- 1957- v. 25, p. 176, 1981 (SEEIAY); N73-N74-P71 ihl-rat TCLo: 5000 ppm/6H/91D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 14, p. 338, 1990 (FAATDF); L30-Q30-Y20 ihl-rat TCLo: 200 ppm/6H/18W-I Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 54, p. 221, 1984 (APTOA6); G70-J70-L70 ihl-rat TDLo: 5000 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-475, 1998 (NTPTR*); P02-P72-U01 orl-mus TDLo: 4550 mg/kg/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(2), p. 99, 1967 (GISAAA); L70-N13-N74 ihl-mus TCLo: 5000 ppm/6H/91D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 14, p. 338, 1990 (FAATDF); J30-Z01 ihl-mus TCLo: 8 gm/m3/2H/60D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 5, p. 21, 1963 (TPKVAL); L70 ihl-mus TCLo: 200 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-475, 1998 (NTPTR*) TR: ACGIH TLV-TWA 200 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 250 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 200 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: MSHA STANDARD-air: TWA 200 ppm (590 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 252, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 200 ppm (590 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 200 ppm (590 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 200 ppm (590 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 200 ppm (590 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 200 ppm (590 mg/m3), STEL 250 ppm, JAN 1993; OEL-AUSTRIA: MAK 200 ppm (590 mg/m3), JAN 1999; OEL-BELGIUM: TWA 200 ppm (590 mg/m3), STEL 250 ppm (738 mg/m3), JAN 1993; OEL-DENMARK: TWA 100 ppm (295 mg/m3), JAN 1999; OEL-FINLAND: TWA 100 ppm (290 mg/m3), STEL 150 ppm (440 mg/m3), JAN 1999; OEL-FRANCE: VME 200 ppm (590 mg/m3), JAN 1999; OEL-GERMANY: MAK 200 ppm (590 mg/m3), JAN 1993; OEL-HUNGARY: TWA 200 mg/m3, STEL 400 mg/m3, JAN 1999; OEL-JAPAN: OEL 200 ppm (590 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 100 ppm (300 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 50 ppm (150 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 200 ppm (590 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 600 mg/m3, MAC(STEL) 750 mg/m3, JAN 1999; OEL-RUSSIA: TWA 200 ppm, STEL 100 mg/m3, JAN 1993; OEL-SWEDEN: NGV 50 ppm (150 mg/m3), KTV 80 ppm (250 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 200 ppm (590 mg/m3), STEL 1000 ppm, JAN 1999; OEL-TURKEY: TWA 200 ppm (590 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 100 ppm (300 mg/m3), STEL 200 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO TETRAHYDROFURAN-air: 10H TWA 200 ppm, STEL 250 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 71695; NIS 72; TNF 4141; NOS 60; TNE 95003; NOES 1983: HZD 71695; NIS 101; TNF 17866; NOS 83; TNE 356038; TFE 47382 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Tetrahydrofuran, 1609; NCI Carcinogenesis Studies (inhal), clear evidence: mouse; NTP Carcinogenesis Studies (inhalation): some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-475, 1998 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: rat Record 798 of 1119 in RTECS (through 2003/06) AN: LU9100000 PN: Furfuryl-alcohol- SY: 2-Furancarbinol-; 2-Furanmethanol-; Furfural-alcohol-; Furfuralcohol-; 2-Furfurylalkohol- (Czech); Furyl-alcohol-; alpha-Furylcarbinol-; 2-Furylcarbinol-; Methanol, (2-furyl)-; NCI-C56224-; Furfuryl-alcohol- (ACGIH:OSHA); 2-Furylmethanol-; 2-Hydroxymethylfuran- RN: Current: 98-00-0 BRN: 106291 BHR: 5-17-03-00338 UD: 200302 MF: C5-H6-O2 MW: 98.11 WL: T5OJ B1Q CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,787,1986 (85JCAE) ME: dnr-bcs 2 mg/disc Developments in Food Science. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 13, p. 353, 1986 (DFSCDX); cyt-ham-ovr 2500 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 13, p. 89, 1981 (CALEDQ) TE: V01-D09 ihl-rat TCLo: 32 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-482, 1999 (NTPTR*); V01-M61 ihl-mus TCLo: 32 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-482, 1999 (NTPTR*); V03-D09 ihl-rat TCLo: 1008 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-151482 (NTIS**); V03-M61 ihl-mus TCLo: 2016 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-151482 (NTIS**) ORNG: 177000000 ng/kg. [177.000000 mg/kg] F13-F19-J24 SRNG: 400000000 ng/kg. [400.000000 mg/kg] F12 SKNG: 3825000000 ng/kg. [3825.000000 mg/kg] T/E unlistd IHPB: 233000 ppb/4H. [233.000000 ppm/4H] T/E unlistd AT: F13-F19-J24 orl-rat LD50: 177 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(9), p. 52, 1981 (GTPZAB); T/E unlistd ihl-rat LC50: 233 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 91, 1958 (AIHAAP); T/E unlistd skn-rat LD50: 3825 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(9), p. 52, 1981 (GTPZAB); T/E unlistd ipr-rat LD50: 650 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 64, 1974 (NPIRI*); F12 scu-rat LD50: 85 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,280,1969 (34ZIAG); T/E unlistd unr-rat LD50: 460 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(6), p. 73, 1990 (GISAAA); V30 orl-mus LD50: 160 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 34, p. 1196, 1940 (BIJOAK); T/E unlistd ihl-mus LCLo: 597 ppm/6H "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,280,1969 (34ZIAG); T/E unlistd unr-mus LD50: 338 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(6), p. 73, 1990 (GISAAA); F12 skn-rbt LD50: 400 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,280,1969 (34ZIAG); T/E unlistd ivn-rbt LD50: 650 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 8, p. 294, 1949 (FEPRA7); T/E unlistd unr-rbt LD50: 632 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(6), p. 73, 1990 (GISAAA); T/E unlistd orl-mam LD50: 360 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(4), p. 86, 1974 (GISAAA) MD: D07-Z01 ihl-rat TCLo: 250 mg/m3/2W-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 19, p. 617, 1991 (TOPADD); A30-Y10-Y16 ihl-rat TCLo: 50 ppm/6H/16W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 31, p. 420, 1983 (ENVRAL); D07 ihl-rat TCLo: 16 ppm/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-482, 1999 (NTPTR*); D07 ihl-rat TCLo: 2 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-482, 1999 (NTPTR*); D07 ihl-mus TCLo: 16 ppm/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-482, 1999 (NTPTR*); D07 ihl-mus TCLo: 2 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-482, 1999 (NTPTR*); A11-P28-Y15 ihl-mam TCLo: 22 mg/m3/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(9), p. 52, 1981 (GTPZAB) TR: ACGIH TLV-STEL 15 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: MSHA STANDARD-air: TWA 5 ppm (20 mg/m3) (skin) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 19, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 50 ppm (200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 50 ppm (200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 50 ppm (200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 50 ppm (200 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 ppm (40 mg/m3), STEL 15 ppm, Skin, JAN 1993; OEL-AUSTRIA: MAK 5 ppm (20 mg/m3), JAN 1999; OEL-BELGIUM: TWA 10 ppm (40 mg/m3), STEL 15 ppm, Skin, JAN 1993; OEL-DENMARK: TWA 5 ppm (20 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 5 ppm (20 mg/m3), STEL 10 ppm (40 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 10 ppm (40 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 10 ppm (40 mg/m3), JAN 1999; OEL-HUNGARY: STEL 8 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 5 ppm (20 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (20 mg/m3), MAC-K 50 ppm, Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (20 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 50 ppm (200 mg/m3), JAN 1993; OEL-RUSSIA: TWA 5 ppm, STEL 0.5 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 5 ppm (20 mg/m3), KTV 10 ppm (40 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 10 ppm (40 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 50 ppm (200 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (20 mg/m3), STEL 15 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO FURFURYL ALCOHOL-air: TWA 10 ppm (Sk), STEL 15 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 34370; NIS 29; TNF 2939; NOS 38; TNE 11577; NOES 1983: HZD 34370; NIS 46; TNF 2827; NOS 63; TNE 77710; TFE 14624 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Furfuryl alcohol, 2505; NTP Carcinogenesis Studies (inhalation): some evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-482, 1999 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: mouse, rat Record 799 of 1119 in RTECS (through 2003/06) AN: LV1400000 PN: 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-methoxy- SY: 5-Benzofuranacrylic-acid,-6-hydroxy-7-methoxy-,-delta-lactone-; 6-Hydroxy-7-methoxy-5-benzofuranacrylic-acid-delta-lactone-; 8-MP-; 8-Methoxy-(furano-3'.2':6.7-coumarin); 8-Methoxy-2',3',6,7-furocoumarin-; 8-Methoxy-4',5',6,7-furocoumarin-; 8-Methoxypsoralen-; 8-Methoxypsoralene-; 8-MoP-; 8-Mop-; 9-Methoxy-7H-furo(3,2-g)benzopyran-7-one; 9-Methoxypsoralen-; Ammoidin-; Geroxalen-; Meladinin-; Meladinine-; Meloxine-; Methoxa-dome-; Methoxsalen-; NCI-C55903-; New-meladinin-; Oxsoralen-; Oxypsoralen-; Proralone-mop-; Xanthotoxin- RN: Current: 298-81-7 Previous: 12692-94-3 BRN: 196453 BHR: 5-19-06-00015 UD: 200210 MF: C12-H8-O4 MW: 216.20 WL: T C566 DO LVOJ BO1 CC: Tumorigen (C); Drug (D); Mutagen (M); Natural-Product (N); Reproductive-Effector (T) ME: mmo-sat 600 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 49, 1984 (MUREAV); mmo-sat 666 ug/plate (-S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-359, 1989 (NTPTR*); mmo-esc 10 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 44, p. 305, 1977 (MUREAV); mmo-smc 50 umol/L (-S9) Bulletin du Cancer. (SPPIF, B.P.22, F-41353 Vineuil, France) V.53- 1966- v. 67, p. 245, 1980 (BUCABS); mrc-smc 50 umol/L Bulletin du Cancer. (SPPIF, B.P.22, F-41353 Vineuil, France) V.53- 1966- v. 67, p. 245, 1980 (BUCABS); cyt-hmn-lym 100 umol/L Planta Medica. (Georg Thieme Verlag, Postfach 732, D-7000 Stuttgart 1, Fed. Rep. Ger.) V.1- 1953- v. 42, p. 333, 1981 (PLMEAA); sce-hmn-lym 100 umol/L Planta Medica. (Georg Thieme Verlag, Postfach 732, D-7000 Stuttgart 1, Fed. Rep. Ger.) V.1- 1953- v. 42, p. 333, 1981 (PLMEAA); dns-rat-lvr 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); msc-mus-lym 20 mg/L Clinical and Experimental Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1976- v. 5, p. 147, 1980 (CEDEDE); cyt-ham-ovr 100 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-359, 1989 (NTPTR*); sce-ham-ovr 33300 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-359, 1989 (NTPTR*); mtr-mus-fbr 1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T19 orl-rat TDLo: 800 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-219666 (NTIS**); T25-T34-T46 orl-rat TDLo: 1600 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-219666 (NTIS**); T41 orl-rat TDLo: 1600 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-219666 (NTIS**) TE: V02-M61-D09 orl-rat TDLo: 18025 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-359, 1989 (NTPTR*); V01-M61-N60 orl-rat TDLo: 19312.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-110164/AS (NTIS**) ORNG: 791000000 ng/kg. [791.000000 mg/kg] F12-F17-F19 AT: F12-F17-F19 orl-rat LD50: 791 mg/kg Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 2, p. 309, 1979 (DCTODJ); T/E unlistd ipr-rat LD50: 158 mg/kg Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 2, p. 309, 1979 (DCTODJ); T/E unlistd scu-rat LD50: 1880 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 1372, 1995 (NIIRDN); F12-F17-F19 orl-mus LD50: 423 mg/kg Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 2, p. 309, 1979 (DCTODJ); F12-F17-F19 ipr-mus LD50: 250 mg/kg Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 2, p. 309, 1979 (DCTODJ); T/E unlistd scu-mus LD50: 860 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 837, 1982 (NIIRDN); T/E unlistd orl-gpg LD50: 505 mg/kg "Psoralens in Cosmetics and Dermatology, Proceedings of the International Symposium, Paris, 1981," Cahn, J., et al., eds., Paris, Pergamon Press France, 1981 -,303,1981 (48PRAW); R14 skn-gpg TDLo: 1989 mg/kg Farmaco. (Societa Chimica Italiana, Corso Strada Nova, 86, Casella Postale 227, 27100 Pavia, Italy) V.44- 1989- v. 55, p. 650, 2000 (FRMCE8) MD: N71-Z72 orl-rat TDLo: 900 mg/kg/30D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 387, 1999 (TOXID9); L30-T03-Z01 orl-rat TDLo: 26 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-359, 1989 (NTPTR*); Z01 orl-rat TDLo: 2400 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-359, 1989 (NTPTR*); K12-L02-P01 ipr-rat TDLo: 690 mg/kg/15D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 131, p. 394, 1961 (JPETAB); K13 orl-mky TDLo: 1404 mg/kg/26W-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 12, p. 21, 1989 (DCTODJ) TR: IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 24, p. 101, 1980 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 24, p. 101, 1980 (IMEMDT); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 1(1), p. 93, 1971 (CRTXB2) SL: EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Negative: Aspergillus-aneuploidy; EPA GENETOX PROGRAM 1988, Inconclusive: Aspergillus-forward mutation; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro SCE-human lymphocytes, In vitro SCE-human; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro SCE-nonhuman; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 800 of 1119 in RTECS (through 2003/06) AN: LW8400000 PN: Gallic-acid,-propyl-ester- SY: 2,4,5-Trihydroxybenzoic-acid-propyl-ester-; 3,4,5-Trihydroxybenzene-1-propylcarboxylate-; 3,4,5-Trihydroxybenzoic-acid-n-propyl-ester-; Benzoic-acid,-3,4,5-trihydroxy-,-propyl-ester-; Gallic-acid-propyl-ester-; NIPA-49-; Nipagallin-P-; Progallin-P-; Propyl-3,4,5-trihydroxybenzoate-; Propyl-gallate-; Propylester-kyseliny-gallove- (Czech); Tennox-PG-; Tenox-PG-; n-Propyl-3,4,5-trihydroxybenzoate-; n-Propyl-ester-of-3,4,5-trihydroxybenzoic-acid-; n-Propyl-gallate- RN: Current: 121-79-9 UD: 200302 MF: C10-H12-O5 MW: 212.22 WL: QR BQ CQ EVO3 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 200 ug/plate (+/-S9) Shiyan Shengwu Xuebao. Journal of Experimental Biology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1953- Suspended 1966-77. v. 12, p. 41, 1979 (SYSWAE); mnt-mus-ipr 900 mg/kg/72H-I Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 25, p. 302, 1995 (EMMUEG); msc-mus-lym 12500 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); cyt-ham-ovr 5 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-fbr 40 mg/L Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (96), p. 55, 1978 (ESKHA5); cyt-ham-lng 10 mg/L Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 41, 1980 (ATSUDG); sce-ham-ovr 5 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); dnd-mus-orl 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 519, p. 103, 2002 (MUREAV); sce-ham-ovr 0.5 mmol/L/3H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 117, 2001 (MUREAV); cyt-ham-ovr 0.5 mmol/L/3H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 117, 2001 (MUREAV) RE: T46 orl-rat TDLo: 45 gm/kg (1-22D preg) Shokuhin Eiseigaku Zasshi. Food Hygiene Journal. (Nippon Shokuhin Eisei Gakkai c/o Shokuhin Eisei Senta, 2-6-1 Jingumae, Shibuya-ku, Tokyo 150, Japan) V.1- 1960- v. 20, p. 378, 1979 (SKEZAP); T75 orl-rat TDLo: 19 gm/kg (1-22D preg) Shokuhin Eiseigaku Zasshi. Food Hygiene Journal. (Nippon Shokuhin Eisei Gakkai c/o Shokuhin Eisei Senta, 2-6-1 Jingumae, Shibuya-ku, Tokyo 150, Japan) V.1- 1960- v. 20, p. 378, 1979 (SKEZAP); T25 orl-rat TDLo: 2500 mg/kg (1-22D preg) American Journal of Anatomy. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1-192, 1901-91. v. 110, p. 29, 1962 (AJANA2) TE: V03-J60-L60 orl-mus TDLo: 168 gm/kg/2Y-C Nippon Koshu Eisei Zasshi. Japanese Journal of Public Health. (Nippon Koshu Eisei Gakkai, 1-29-8 Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1954- v. 29, p. 25, 1982 (NKEZA4); V02-K60-N61 orl-rat TDLo: 259560 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-180042 (NTIS**); V01-P62 orl-mus TDLo: 1038240 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-180042 (NTIS**); V02-L60 orl-mus TDLo: 1038240 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-180042 (NTIS**) ORNG: 2100000000 ng/kg. [2100.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2100 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB245-441 (NTIS**); F12-J22-J30 ipr-rat LD50: 380 mg/kg Food Technology (Chicago). (Institute of Food Technolgists, 221 N. La Salle St., Chicago, IL 60601) V.1- 1947- v. 2, p. 308, 1948 (FOTEAO); T/E unlistd unr-rat LD50: 2500 mg/kg Voprosy Pitaniya. Problems of Nutrition. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1932-41: V.11- 1952- v. 25(6), p. 47, 1966 (VPITAR); T/E unlistd orl-mus LD50: 1700 mg/kg Journal of the American Oil Chemists' Society. (Champaign, IL) V.24-56, 1947-79. v. 54, p. 239, 1977 (JAOCA7); T/E unlistd orl-rbt LD50: 2750 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-840 (NTIS**); M30 orl-pig LD50: >6 gm/kg Voeding. (Stichting TOT Wetenchappelijke Voorlichting OP Voedings Gebied, LAAN Copes Van Catenburch 44,2585 GB's Gravenhage, Netherlands) V.26- 1965- v. 16, p. 683, 1955 (VOEDAK); T/E unlistd orl-ham LD50: 2480 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-840 (NTIS**) MD: Z01 orl-rat TDLo: 42 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-240, 1982 (NTPTR*); L30 orl-rat TDLo: 700 mg/kg/7D-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 3, p. 457, 1965 (FCTXAV); K30 orl-rat TDLo: 113750 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-240, 1982 (NTPTR*); Z01 orl-mus TDLo: 84 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-240, 1982 (NTPTR*) TR: TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 4(3), p. 23, 1985 (JACTDZ) ND: NOHS 1974: HZD 82907; NIS 6; TNF 1188; NOS 8; TNE 5592; NOES 1983: HZD 82907; NIS 18; TNF 1806; NOS 29; TNE 42475; TFE 23494 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat; NTP Carcinogenesis Bioassay (feed), no evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-240, 1982 (NTPTR*) Record 801 of 1119 in RTECS (through 2003/06) AN: LW8800000 PN: Gallium-arsenide- SY: Gallium-monoarsenide- RN: Current: 1303-00-0 UD: 200305 MF: As-Ga MW: 144.64 CC: Tumorigen (C); Reproductive-Effector (T) RE: T19-T34 ihl-rat TCLo: 37 mg/m3/6H (4-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE91-005300 (NTIS**); T01 itr-rat TDLo: 123 mg/kg (8W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 72, 1996 (FAATDF); T01-T02 itr-rat TDLo: 123 mg/kg (8W male) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 50, p. 135, 1995 (NEZAAQ); T01-T02 itr-rat TDLo: 128 mg/kg (8W male) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 52, p. 184, 1997 (NEZAAQ); T19-T34 ihl-mus TCLo: 37 mg/m3/6H (4-17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE91-005300 (NTIS**); T25-T29-T43 ihl-mus TCLo: 75 mg/m3/6H (4-17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE91-005300 (NTIS**); T34-T46 ihl-rat TCLo: 37 mg/m3 (4-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE91-005300/XAB (NTIS**); T34-T35 ihl-mus TCLo: 75 mg/m3 (4-17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE91-005300/XAB (NTIS**) TE: V01-J60 ihl-rat TCLo: 1 mg/m3/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-492, 2000 (NTPTR*) AT: F13-F19-J26 ipr-rat LD30: 10 gm/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 45, 1980 (GTPZAB); C08-F07-F15 ipr-mus LD50: 4700 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 13, 1980 (GISAAA); T/E unlistd ipr-mus LD50: 4700 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 226, 1988 (VCVN1*); D25 eye-mam TDLo: 200 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 228, 1988 (VCVN1*); T/E unlistd ipr-mus LD40: 10000 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 232, 1988 (VCVN1*) MD: J70-L70-N74 ihl-rat TCLo: 1 mg/m3/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-492, 2000 (NTPTR*); A11-P28-U01 ihl-rat TCLo: 12 mg/m3/17W Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 45, 1980 (GTPZAB); J30 ihl-rat TCLo: 100 ug/m3/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-492, 2000 (NTPTR*); J70-P28-U01 itr-rat TDLo: 123 mg/kg/8W-I Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 50, p. 133, 1995 (NEZAAQ); J30-J70 ihl-mus TCLo: 10 mg/m3/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-492, 2000 (NTPTR*); J30-J70-P08 ihl-mus TCLo: 1 mg/m3/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-492, 2000 (NTPTR*); L70-Y01 orl-gpg TDLo: 9870 mg/kg/21D-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 10(5), p. 30, 1966 (GTPZAB); P71-U07-U08 ihl-gpg TCLo: 12 mg/m3/17W Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 45, 1980 (GTPZAB); J12-L70-M03 itr-ham TDLo: 123 mg/kg/8W-I Fukuoka Igaku Zasshi. (c/o Kyushu Daigaku Igakubu, Tatekasu, Fukuoka-shi, Fukuoka, Japan) V.33- 1940- v. 91, p. 21, 2000 (FKIZA4); P71 ihl-mam TCLo: 12 mg/m3/22W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 13, 1980 (GISAAA); N73-N74-Y53 orl-rat TDLo: 750 mg/kg/15D-I Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 2, p. 315, 1996 (ETOPFR); L30-M03-U01 ihl-rat TCLo: 12 mg/m3/17W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 228, 1988 (VCVN1*); L30-M03-U01 ihl-gpg TCLo: 12 mg/m3/17W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 228, 1988 (VCVN1*); P71-Y39 ihl-rat TCLo: 12 mg/m3/8W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 228, 1988 (VCVN1*); P71-Y39 ihl-gpg TCLo: 12 mg/m3/8W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 228, 1988 (VCVN1*); P28 ihl-rat TCLo: 12 mg/m3/4W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 228, 1988 (VCVN1*); P28 ihl-gpg TCLo: 12 mg/m3/4W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 228, 1988 (VCVN1*); J22-J30 ihl-rat TCLo: 75 mg/m3/6H/16D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE91-005300/XAB (NTIS**); Z01-U01 ihl-mus TCLo: 37 mg/m3/6H/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE91-005300/XAB (NTIS**); J30 ihl-mus TCLo: 10 mg/m3/6H/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE91-005300/XAB (NTIS**) SR: OSHA-cancer hazard Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1018, 1987 (CFRGBR) ND: NIOSH REL TO GALLIUM ARSENIDE-air: CA CL 0.002 (As)/m3/15M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X3179; NIS 3; TNF 12; NOS 4; TNE 320; TFE 165 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9185; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (inhal), clear evidence: rat; NCI Carcinogenesis Studies (inhal), no evidence: mouse; NTP Carcinogenesis studies, test completed (camera copy in progress), October 2000 Record 802 of 1119 in RTECS (through 2003/06) AN: LY9520000 PN: Ginkgo biloba L., root extract SY: Yajiaotong- (Chinese) RN: Current: 90045-36-6 UD: 200012 CC: Tumorigen (C); Human-Data (P); Natural-Product (N) AT: D21-D26 orl-man TDLo: 8 mg/kg/1W-I New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 336, p. 1108, 1997 (NEJMAG); T/E unlistd ivn-mus LD50: 162 gm/kg Zhongcaoyao. Chinese Traditional and Herbal Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.11- 1980- v. 20, p. 22, 1989 (CTYAD8) SL: NTP Carcinogenesis studies, selected, October 2000 Record 803 of 1119 in RTECS (through 2003/06) AN: LY9531500 PN: Ginseng- SY: Prosapogenin (Ginseng) (9CI); Panax-; Panax-ginseng-; Panax-schinseng- RN: Current: 50647-08-0 UD: 200302 CC: Tumorigen (C); Drug (D); Reproductive-Effector (T) RE: T09 orl-rat TDLo: 352 gm/kg (60D male) Archives of Andrology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 8, p. 261, 1982 (ARANDR) ORNG: 750000000 ng/kg. [750.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 750 mg/kg Farmatsiya (Moscow). Pharmacy. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.16- 1967- v. 31(6), p. 45, 1982 (FRMTAL); T/E unlistd orl-mus LD50: 200 mg/kg Farmatsiya (Moscow). Pharmacy. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.16- 1967- v. 31(6), p. 45, 1982 (FRMTAL); T/E unlistd ipr-mus LD50: 54 mg/kg Farmatsiya (Moscow). Pharmacy. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.16- 1967- v. 31(6), p. 45, 1982 (FRMTAL); K14 orl-mus TDLo: 90 mg/kg Biological and Pharmaceutical Bulletin. (Pharmaceutical Society of Japan, 2-12-15-201 Shibuya Shibuya-ku, Tokyo 150, Japan) V.16- 1993- v. 24, p. 1122, 2001 (BPBLEO) SL: NTP Carcinogenesis studies, selected, October 2000 Record 804 of 1119 in RTECS (through 2003/06) AN: LZ1950000 PN: Glasswool- SY: Glasswool-fibres- (ACGIH) CD: Fibrous inorganic substances made from short length glass fibres (IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 43, p. 39, 1988 - IMEMDT) UD: 200006 CC: Tumorigen (C) TR: ACGIH TLV-TWA 10 mg/m3, total dust The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 43, p. 39, 1988 (IMEMDT); IARC Cancer Review: Human Inadequat Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 43, p. 39, 1988 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 43, p. 39, 1988 (IMEMDT) SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 805 of 1119 in RTECS (through 2003/06) AN: LZ5758000 PN: Glucopyranose, 2-deoxy-2-(3-(2-chloroethyl)-3-nitrosoureido)-, D- SY: 1-(2-Chloroethyl)-3-(D-glucopyranos-2-yl)-1-nitrosourea; 2-((((2-Chloroethyl)nitrosoamino)carbonyl)amino)-2-deoxy-D-glucose; 2-(3-(2-Chloroethyl)-3-nitrosoureido)-2-deoxy-D-glucosopyranose; 2-(3-(2-Chloroethyl)-3-nitrosoureido)-D-gluco-pyranose; CHLZ-; CLC-; Chlorozotocin-; D-Glucopyranose, 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-2-deoxy-; D-Glucose, 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-2-deoxy- (9CI); DCNU-; NSC-178248-; Urea, 1-(2-chloroethyl)-3-(D-glucopyranos-2-yl)-1-nitroso- RN: Current: 54749-90-5 UD: 200204 MF: C9-H16-Cl-N3-O7 MW: 313.73 WL: T6OTJ BQ CMVNNO&2G DQ EQ F1Q CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: mmo-sat 100 nmol/plate (+S9) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 149, 1980 (JJIND8); sln-dmg-orl 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 297, 1978 (MUREAV); dnd-rat-ipr 100 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 514, 1984 (CNREA8); dnd-rat-mmr 100 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 1171, 1986 (BCPCA6); sce-rat-mmr 5 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 1171, 1986 (BCPCA6); sce-rat-oth 1 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 473, 1983 (CNREA8); dnd-mus-leu 50 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 3197, 1978 (CNREA8); dnd-mus-bmr 100 umol/L INSERM Symposium. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) No.1- 1975- v. 19, p. 49, 1981 (INSSDM); dni-mus-oth 15 mg/kg INSERM Symposium. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) No.1- 1975- v. 19, p. 85, 1981 (INSSDM); dni-mus-leu 20 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 3723, 1980 (CNREA8); oms-mus-leu 15 mg/kg INSERM Symposium. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) No.1- 1975- v. 19, p. 85, 1981 (INSSDM); dnd-mus-bmr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2605, 1982 (CNREA8); sce-mus-leu 350 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 207, p. 179, 1988 (MUREAV); dnd-ham-lng 12800 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 3379, 1978 (CNREA8); msc-ham-lng 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 2719, 1980 (CNREA8); dnd-mam-lym 10 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1887, 1984 (CNREA8); dnd-oin-orl 0.05 mmol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 476, p. 149, 2001 (MUREAV) TE: V01-K60 ipr-rat TDLo: 34 mg/kg/85W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 8, p. 133, 1979 (CALEDQ); V03-K60 ivn-rat TDLo: 16 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V03-J60-K60 ivn-rat TD :64 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V01-J60 ipr-rat TD :80 mg/kg/8W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 57, p. 469, 1988 (BJCAAI) AT: P14-P17-P26 ivn-hmn TDLo: 2027 ug/kg/5D Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 63, p. 17, 1979 (CTRRDO); F14-K13-P17 ivn-man TDLo: 500 mg/kg Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 46, p. 2365, 1980 (CANCAR); J12-J15-K30 ipr-rat LD50: 28 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 8, p. 133, 1979 (CALEDQ); T/E unlistd scu-rat LDLo: 40 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 540, 1986 (TXAPA9); J16-K06-P26 ivn-rat LD50: 22500 ug/kg Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 37, p. 177, 1980 (ONCOBS); V30 ipr-mus LD50: 35 mg/kg INSERM Symposium. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) No.1- 1975- v. 19, p. 123, 1981 (INSSDM); T/E unlistd scu-mus LD50: 66230 ug/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); M03-P27 ivn-mus LD50: 24900 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 12, p. 31, 1979 (TXCYAC); K03-M03-P28 orl-dog LDLo: 3 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 12, p. 31, 1979 (TXCYAC); F15-K13-U01 orl-mky LDLo: 400 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 12, p. 31, 1979 (TXCYAC) MD: M03-Z01 ivn-dog TDLo: 7500 ug/kg/5D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 12, p. 31, 1979 (TXCYAC); K02-M03-N24 ivn-mky TDLo: 200 mg/kg/5D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 12, p. 31, 1979 (TXCYAC) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 65, 1990 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 65, 1990 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 65, 1990 (IMEMDT) ND: NOES 1983: HZD X5397; NIS 1; TNF 45; NOS 1; TNE 267; TFE 223 SL: EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 806 of 1119 in RTECS (through 2003/06) AN: LZ5775000 PN: Glucopyranose, 2-deoxy-2-(3-methyl-3-nitrosoureido)-, D- SY: 2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose; 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose; 2-Deoxy-2-(3-methyl-3-nitrosoureido)-alpha(and beta)-D-glucopyranose; D-Glucopyranose, 2-deoxy-2-(((methylnitrosoamino)carbonyl)amino)-; D-Glucose, 2-deoxy-2-(((methylnitrosoamino)carbonyl)amino)- (9CI); D-Glucose, 2-deoxy-2-(3-methyl-3-nitrosoureido)-; N-D-Glucosyl-(2)-N'-nitrosomethylurea; N-d-Glucosyl(2)-N'-nitrosomethylharnstoff (German); NCI-C03167-; NSC-85598-; NSC-85998-; RCRA-waste-number-U206-; STRZ-; STZ-; Streptozocin-; Streptozotocin-; U-9889-; Zanosar- RN: Current: 18883-66-4 UD: 200305 MF: C8-H15-N3-O7 MW: 265.26 WL: T6OTJ BQ CMVN1&NO DQ EQ F1Q -D,GLU CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ME: mmo-sat 20 ng/plate (+S9) Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- v. 44, p. 96, 1985 (TAKHAA); mmo-sat 1 nmol/plate (-S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 309, 1984 (CRNGDP); oms-sat 130 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 20 ng/plate (-S9) Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- v. 44, p. 96, 1985 (TAKHAA); mmo-esc 1 mg/L (+S9) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 16, p. 523, 1977 (RCOCB8); pic-esc 1 mg/L Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. v. 12, p. 234, 1964 (APMBAY); mmo-bcs 50 mg/L (-S9) Chemical Mutagens. Principles and Methods for Their Detection. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1971- v. 9, p. 165, 1984 (CMMUAO); dnr-bcs 2500 ng/plate Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- v. 44, p. 96, 1985 (TAKHAA); mmo-smc 7500 mg/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 174, p. 39, 1979 (MGGEAE); mmo-asn 50 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 293, 1982 (MUREAV); cyt-oin 4 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 418, p. 35, 1998 (MUREAV); sce-oin-mul 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 447, p. 221, 2000 (MUREAV); dnd-hmn-oth 50 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 37, p. 3441, 1988 (BCPCA6); dnd-hmn-kdy 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 41, 1996 (MUREAV); dni-hmn-hla 100 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); dni-hmn-lng 1 gm/L/3H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 12, p. 183, 1971 (MUREAV); cyt-hmn-lng 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 12, p. 183, 1971 (MUREAV); sce-hmn-oth 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3100, 1988 (CNREA8); mtr-rat-oth 2 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 14, p. 1027, 1993 (CRNGDP); dnd-rat-kdy 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 41, 1996 (MUREAV); dnd-rat-oth 1 mmol/L Diabetes. (American Diabetes Assoc., 2 Park Ave., New York, NY 10016) V.1- 1952- v. 35, p. 866, 1986 (DIAEAZ); dnd-rat-orl 20 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-lvr 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); dns-rat-ipr 250 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 889, 1985 (ENMUDM); dns-rat-lvr 50 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); dns-rat-oth 2 mmol/L Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 53, p. 203, 1990 (EXMPA6); sce-rat-oth 200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3100, 1988 (CNREA8); hma-rat-sat 111 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 51, p. 151, 1978 (MUREAV); dna-mus-ipr 150 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 231, 1984 (CRNGDP); dnd-mus-leu 500 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 82, 1979 (CNREA8); oms-mus-leu 200 mg/kg INSERM Symposium. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) No.1- 1975- v. 19, p. 85, 1981 (INSSDM); dni-mus-oth 200 mg/kg INSERM Symposium. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) No.1- 1975- v. 19, p. 85, 1981 (INSSDM); bfa-mus-sat 12 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 1, 1977 (MUREAV); msc-mus-lym 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 291, 1984 (MUREAV); hma-mus-sat 500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 1, 1977 (MUREAV); hma-mus-esc 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 93, 1992 (MUREAV); dnd-ham-lng 250 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 13, p. 173, 1976 (CBINA8); cyt-ham-ovr 38 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 326, p. 227, 1995 (MUREAV); sce-ham-ovr 189 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 326, p. 227, 1995 (MUREAV); sce-ham-lng 189 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 347, p. 79, 1995 (MUREAV); msc-ham-ovr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 326, p. 227, 1995 (MUREAV); msc-ham-lng 500 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 2719, 1980 (CNREA8); dnd-oin-orl 1.5 mmol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 476, p. 149, 2001 (MUREAV); mnt-hmn-lym 0.5 mmol/L/30M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 503, p. 63, 2002 (MUREAV); cyt-hmn-lym 1 mmol/L/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 503, p. 63, 2002 (MUREAV); slt-ham-ovr 5 mg/L/9D Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 16, p. 260, 1990 (EMMUEG) RE: T31 ipr-rat TDLo: 50 mg/kg (1D pre) Diabetologia. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 10, p. 89, 1974 (DBTGAJ); T31-T34-T47 ipr-rat TDLo: 50 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 419, 1986 (TJADAB); T34-T43 ipr-rat TDLo: 50 mg/kg (7D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 1, p. 117, 1987/1988 (REPTED); T47 ipr-rat TDLo: 50 mg/kg (12D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 1, p. 117, 1987/1988 (REPTED); T12 ivn-rat TDLo: 70 mg/kg (1D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 174, p. 123, 1983 (PSEBAA); T31-T34 ivn-rat TDLo: 35 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 14, p. 373, 1976 (TJADAB); T34-T81 ivn-rat TDLo: 30 mg/kg (5D preg) Metabolism, Clinical and Experimental. (Grune and Stratton, Inc., Journal Subscriptions Dept., POB 6280, Duluth, MN 55806) V.1- 1952- v. 19, p. 1014, 1970 (METAAJ); T52-T83 ivn-rat TDLo: 40 mg/kg (5D preg) Diabetes. (American Diabetes Assoc., 2 Park Ave., New York, NY 10016) V.1- 1952- v. 19, p. 610, 1970 (DIAEAZ); T25-T41-T47 ivn-rat TDLo: 40 mg/kg (1D preg) Journal of Embryology and Experimental Morphology. (Essex, UK) V.1-98, 1953-86. For Publisher information, see DEVPED v. 41, p. 93, 1977 (JEEMAF); T29 ivn-rat TDLo: 60 mg/kg (1D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 171, p. 207, 1982 (PSEBAA); T25-T34-T59 par-rat TDLo: 40 mg/kg (1D pre) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 62A, 1987 (TJADAB); T46 unr-rat TDLo: 65 mg/kg (5D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(3), p. 13A, 1984 (TJADAB); T14-T24-T25 ipr-ham TDLo: 150 mg/kg (3D pre) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(2), p. 22A, 1984 (TJADAB); T19-N21 ivn-dom TDLo: 100 mg/kg (85-95D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 165, p. 1673, 1991 (AJOGAH) TE: V02-L60-M61 ipr-rat TDLo: 470 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V02-M61 ivn-rat TDLo: 25 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 36, p. 692, 1977 (BJCAAI); V02-J60-M61 ipr-mus TDLo: 470 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V01-M61 ivn-mus TDLo: 250 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 703, 1985 (CNREA8); V03-L60-M61 ipr-ham TDLo: 100 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1287, 1973 (JNCIAM); V03-K60-M61 ivn-rat TD :65 mg/kg Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 68, p. 397, 1977 (GANNA2); V02-M61 ivn-rat TD :50 mg/kg Cancer Chemotherapy Reports. (Bethesda, MD) V.1-52, 1959-68. For publisher information, see CTRRDO. v. 52, p. 563, 1968 (CNCRA6); V02-K60-M61 ivn-rat TD :30 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2144, 1978 (CNREA8); V03-L60 ivn-rat TD :65 mg/kg Transplantation. (Williams and Wilkins, Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1963- v. 24, p. 152, 1977 (TRPLAU); V03-L60-M61 ivn-rat TD :50 mg/kg Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 59, p. 891, 1975 (CCROBU); V02-M61 ivn-rat TD :50 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 151, p. 356, 1976 (PSEBAA); V03-M61 ivn-rat TD :65 mg/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 38, p. 129, 1982 (EXPEAM); V02-K60 ivn-rat TD :30 mg/kg Nippon Naibumpi Gakkai Zasshi. Journal of the Japan Endocrine Society. (Nippon Naibumpi Gakkai, c/o Kyoto-Furitsu Ika Daigaku, Kojinbashi Nishizume-Sagaru, Kamigyo-ku, Kyoto 602, Japan) V.1- 1925- v. 54, p. 1070, 1978 (NNGZAZ); V03-K60 ivn-rat TD :65 mg/kg Nippon Naibumpi Gakkai Zasshi. Journal of the Japan Endocrine Society. (Nippon Naibumpi Gakkai, c/o Kyoto-Furitsu Ika Daigaku, Kojinbashi Nishizume-Sagaru, Kamigyo-ku, Kyoto 602, Japan) V.1- 1925- v. 54, p. 1290, 1978 (NNGZAZ) AT: F10-H02-U25 ivn-wmn TDLo: 13513 ug/kg New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 311, p. 798, 1984 (NEJMAG); K07-M10-U10 ivn-wmn LDLo: 440 mg/kg/65W-I Gut. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1960- v. 12, p. 717, 1971 (GUTTAK); K13-L14-M30 ivn-hmn TDLo: 1044 mg/kg/5D Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 34, p. 993, 1974 (CANCAR); T/E unlistd ivn-rat LD50: 138 mg/kg Cancer Chemotherapy Reports. (Bethesda, MD) V.1-52, 1959-68. For publisher information, see CTRRDO. v. 29, p. 91, 1963 (CNCRA6); V30 ipr-mus LD50: 360 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 19, p. 918, 1976 (JMCMAR); T/E unlistd scu-mus LD50: 335 mg/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); V30 ivn-mus LD50: 275 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 19, p. 918, 1976 (JMCMAR); V30 par-mus LD50: 264 mg/kg Cancer Chemotherapy Reports. (Bethesda, MD) V.1-52, 1959-68. For publisher information, see CTRRDO. v. 48, p. 1, 1965 (CNCRA6); V30 ivn-dog LD50: 50 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 19, p. 918, 1976 (JMCMAR); F07-J25-U01 ivn-mky LDLo: 80 mg/kg Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 3, p. 201, 1980 (DCTODJ); K02-N21-N24 ipr-mus TDLo: 100 mg/kg Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 9, p. 71, 2001 (ETOPFR); Y37 ipr-mus TDLo: 200 mg/kg Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 9, p. 71, 2001 (ETOPFR); N21-N24 ipr-rat TDLo: 65 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 71, p. 181, 1992 (TXCYAC); N21-Y07 ipr-rat TDLo: 60 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 294, p. 473, 2000 (JPETAB); N60 ivn-rat LDLo: 50 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 137, p. 280, 1970 (PSEBAA); N21-N24-U01 ivn-rat TDLo: 65 mg/kg Diabetologia. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 9, p. 178, 1973 (DBTGAJ); T/E unlistd unr-rbt LD10: 75 mg/kg Diabetes. (American Diabetes Assoc., 2 Park Ave., New York, NY 10016) V.1- 1952- v. 21, p. 129, 1972 (DIAEAZ); K02 unr-rbt LD60: 150 mg/kg Diabetes. (American Diabetes Assoc., 2 Park Ave., New York, NY 10016) V.1- 1952- v. 21, p. 129, 1972 (DIAEAZ); N24-N21 unr-rbt TDLo: 300 mg/kg Diabetes. (American Diabetes Assoc., 2 Park Ave., New York, NY 10016) V.1- 1952- v. 21, p. 129, 1972 (DIAEAZ); K02-N21-Y12 scu-rat TDLo: 100 mg/kg Canadian Journal of Physiology and Pharmacology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.42- 1964- v. 66, p. 663, 1988 (CJPPA3); K02-N21-Y17 ivn-rat TDLo: 65 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 140, p. 1418, 1972 (PSEBAA); N24-M13-Y20 ivn-rat TDLo: 50 mg/kg Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 767, 2000 (CEXPB9); N24 ivn-rat TDLo: 30 mg/kg Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 270, 2000 (CEXPB9); F16-M10-N24 ipr-rat TDLo: 60 mg/kg Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 358, 2000 (CEXPB9); G30-N21 ivn-rat TDLo: 55 mg/kg Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- v. 27, p. 618, 2000 (CEXPB9); G70-N21-U01 ivn-rat TDLo: 40 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 298, p. 1161, 2001 (JPETAB); K02-N24-P28 ivn-pig TDLo: 125 mg/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 451, p. 217, 2002 (EJPHAZ); N24 ivn-mus TDLo: 200 mg/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 448, p. 39, 2002 (EJPHAZ) MD: K02-M30-Z01 ivn-dog TDLo: 125 mg/kg/5D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 3, p. 201, 1980 (DCTODJ); K02-P26-Z01 ivn-mky TDLo: 200 mg/kg/5D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 3, p. 201, 1980 (DCTODJ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 337, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 337, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 1(1), p. 93, 1971 (CRTXB2); TOXICOLOGY REVIEW Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 22, p. 830, 1972 (ARZNAD) ND: NOES 1983: HZD X5492; NIS 1; TNF 87; NOS 4; TNE 2074; TFE 1713 SL: EPA GENETOX PROGRAM 1988, Positive: Body fluid assay, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; NCI Carcinogenesis Studies (ipr), clear evidence: mouse, rat Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 807 of 1119 in RTECS (through 2003/06) AN: MA2450000 PN: Glutaraldehyde- SY: Aldehyd-glutarowy- (Polish); Cidex-; 1,3-Diformylpropane-; Glutaraldehyd- (Czech); Glutaral-; Glutaric-dialdehyde-; Glutaraldehyde- (ACGIH); Glutardialdehyde-; NCI-C55425-; 1,5-Pentanedial-; 1,5-Pentanedione-; Potentiated-acid-glutaraldehyde-; Sonacide- RN: Current: 111-30-8 BRN: 605390 BHR: 4-01-00-03659 UD: 200302 MF: C5-H8-O2 MW: 100.13 WL: VH3VH CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-hmn 6 mg/3D-I SEV "Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar, eds., New York, Academic Press, Inc. 1977 -,127,1977 (85DKA8); skn-rbt 13 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 1/30/1970 (UCDS**); skn-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,272,1986 (85JCAE); eye-rbt 1 mg SEV Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 1/30/1970 (UCDS**); eye-rbt 250 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,272,1986 (85JCAE) ME: mmo-sat 500 nmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 148, p. 25, 1985 (MUREAV); mmo-sat 150 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-esc 62500 ng/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 412, p. 17, 1998 (MUREAV); dnr-bcs 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 193, p. 21, 1988 (MUREAV); oms-nml-oth 50 mmol/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 95, p. 233, 1975 (ECREAL); oms-nml-oth 50 mmol/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 95, p. 233, 1975 (ECREAL); dnd-hmn-lym 10 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17(Suppl 19), p. 71, 1991 (EMMUEG); dnd-hmn-leu 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 93, 2000 (MUREAV); msc-mus-lym 8 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); dnd-ham-fbr 2500 ppm Collection of Papers Presented at the Annual Symposium on Fundamental Cancer Research. (Baltimore, MD) V.1-29, 1946-76. For publisher information, see AFCPDR. v. 23, p. 346, 1970 (SFCRAO); cyt-ham-ovr 160 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 1, 1985 (ENMUDM); sce-ham-ovr 110 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 1, 1985 (ENMUDM); dnd-ckn-leu 8 pph Cell (Cambridge, Mass.). (MIT Press, 28 Carleton St., Cambridge, MA 02142) V.1- 1974- v. 5, p. 45, 1975 (CELLB5); dnd-mam-lym 2500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 131, 1992 (MUREAV); mmo-sat 0.05 mg/plate/48H (+S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 22, p. 45, 2001 (JAPTO*) RE: T02-T03 orl-rat TDLo: 875 mg/kg (35D male) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 12, p. 11, 1976 (OYYAA2); T13 orl-rat TDLo: 4370 mg/kg (35D pre) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 12, p. 11, 1976 (OYYAA2); T34 orl-rat TDLo: 1 gm/kg (6-15D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 63, p. 147, 1992 (TOLED5); T41-T43-T46 orl-mus TDLo: 50 gm/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 22, p. 51, 1980 (TJADAB); T34 orl-mus TDLo: 8 gm/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 22, p. 51, 1980 (TJADAB); T19-T25-T34 orl-rbt TDLo: 585 mg/kg (7-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0526410 (NTIS**); T81-T87-T91 orl-rat TDLo: 5.3 gm/kg (84D male/70D pre-4W post) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 61, p. 107, 2000 (JTEHD6); T81-T91 orl-rat TDLo: 167.4 mg/kg (multigenerations) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 61, p. 107, 2000 (JTEHD6) ORNG: 134000000 ng/kg. [134.000000 mg/kg] T/E unlistd SRNL: 560000 nL/kg. [0.560000 mL/kg] T/E unlistd IHNG: 480000000 ng/m3/4H. [480.000000 mg/m3/4H] T/E unlistd AT: T/E unlistd orl-rat LD50: 134 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 19, p. 503, 1980 (OYYAA2); T/E unlistd ihl-rat LC50: 480 mg/m3/4H United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-1290-1008 (EPASR*); R03 skn-rat LD50: >2500 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 12, p. 11, 1976 (OYYAA2); T/E unlistd ipr-rat LD50: 17900 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 10, p. 232, 1979 (IYKEDH); T/E unlistd scu-rat LD50: >750 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 395, 1995 (NIIRDN); T/E unlistd ivn-rat LD50: 9800 ug/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-1290-1008 (EPASR*); T/E unlistd orl-mus LD50: 100 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 19, p. 503, 1980 (OYYAA2); R03 skn-mus LD50: >5840 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 12, p. 11, 1976 (OYYAA2); T/E unlistd ipr-mus LD50: 13900 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 10, p. 232, 1979 (IYKEDH); T/E unlistd scu-mus LD50: >590 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 395, 1995 (NIIRDN); T/E unlistd ivn-mus LD50: 15400 ug/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 19, p. 503, 1980 (OYYAA2); T/E unlistd skn-rbt LD50: 560 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 11/4/1971 (UCDS**); F05-F07-F13 orl-gpg LD50: 50 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 52(3), p. 77, 1987 (GISAAA); F07-F15 orl-dck LD50: 820 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0526410-1 (NTIS**); J30-L30-M30 orl-mus LD50: 231 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 404, 1984 (VCVGK*); J30-L30-M30 orl-rat LD50: 140 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 404, 1984 (VCVGK*); D25-J21 ihl-rbt TCLo: 500 ppm "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 404, 1984 (VCVGK*) MD: M16-M70-U01 orl-rat TDLo: 12376 mg/kg/2Y-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 203, 1995 (TOXID9); L03-U01-Y01 orl-rat TDLo: 54600 ug/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 52(3), p. 77, 1987 (GISAAA); U01 orl-rat TDLo: 11410 mg/kg/7D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535072 (NTIS**); D07-J30-Z01 ihl-rat TCLo: 5 ppm/6H/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3348 (NTPTR*); D07-U01 ihl-rat TCLo: 1000 ppb/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3348 (NTPTR*); D07-U01-Z01 ihl-rat TCLo: 500 ppb/6H/2Y-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 341, 1999 (TOXID9); L70-N73-P05 scu-rat TDLo: 175 mg/kg/35D-C Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 12, p. 11, 1976 (OYYAA2); D07-J30-Z01 ihl-mus TCLo: 16 ppm/6H/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3348 (NTPTR*); D07-U01-Z01 ihl-mus TCLo: 1000 ppb/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3348 (NTPTR*); D07-U01 ihl-mus TCLo: 250 ppb/6H/2Y-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 341, 1999 (TOXID9); F16 orl-rat TDLo: 122.5 mg/kg/1W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 61, p. 107, 2000 (JTEHD6); F15 orl-rat TDLo: 967 mg/kg/2W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 61, p. 107, 2000 (JTEHD6); F15 orl-rat TDLo: 688.8 mg/kg/1W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 61, p. 107, 2000 (JTEHD6); N74-P05-P70 orl-rat TDLo: 117.5 mg/kg/235D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 404, 1994 (VCVGK*) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-CL 0.05 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Dangerous Properties of Industrial Materials Report. (Van Nostrand Reinhold, 115 Fifth Ave., New York, NY 10003) V.1- 1981- v. 1(7), p. 2, 1981 (DPIRDU); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 22, p. 143, 1992 (CRTXB2); TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 98, 1996 (JACTDZ) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-AUSTRALIA: TWA 0.2 ppm (0.7 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 0.2 ppm (0.8 mg/m3), JAN 1999; OEL-BELGIUM: TWA 0.2 mg/m3, STEL 0.82 mg/m3, JAN 1993; OEL-DENMARK: TWA 0.2 ppm (0.8 mg/m3), JAN 1999; OEL-FINLAND: CEILING 0.1 ppm, JAN 1999; OEL-FRANCE: VLE 0.2 ppm (0.8 mg/m3), JAN 1999; OEL-GERMANY: MAK 0.21ppm (0.4 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.2 ppm (0.8 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 0.4 mg/m3, MAC(STEL) 0.6 mg/m3, JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWEDEN: STEL 0.2 ppm (0.8 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 0.2 ppm (0.8 mg/m3), KZG-W 0.4 ppm (1.6 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 0.05 ppm (0.2 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO GLUTARALDEHYDE-air: CL 0.2 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84349; NIS 11; TNF 2069; NOS 25; TNE 12954; NOES 1983: HZD 84349; NIS 35; TNF 9475; NOS 63; TNE 367330; TFE 265564 SL: EPA GENETOX PROGRAM 1988, Negative: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN #55, September 1991; NIOSH Analytical Method, 1994: Glutaraldehyde, 2532; NCI Carcinogenesis Studies (inhal), no evidence: mouse, rat; NTP Toxicity studies, RPT# TOX-25, October 2000; OSHA ANALYTICAL METHOD #ID-64 Record 808 of 1119 in RTECS (through 2003/06) AN: MA5599000 PN: Glutaronitrile, 2-bromo-2-(bromomethyl)- SY: 1,2-Dibromo-2,4-dicyanobutane-; 2-Bromo-2-(bromomethyl)glutaronitrile; Methyldibromoglutaronitrile-; Pentanedinitrile, 2-bromo-2-(bromomethyl)- RN: Current: 35691-65-7 UD: 200302 MF: C6-H6-Br2-N2 MW: 265.96 CC: Tumorigen (C); Drug (D); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 500 mg MOD Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 140, 1996 (JACTDZ); eye-rbt 100 mg SEV Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 140, 1996 (JACTDZ); skn-gpg 1%/24H Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975- v. 28, p. 149, 1993 (CODEDG) RE: T25 orl-rat TDLo: 1750 mg/kg (6-15D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 18(Suppl 1), p. 158, 1983 (TOLED5) ORNG: 515000000 ng/kg. [515.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 515 mg/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 140, 1996 (JACTDZ); T/E unlistd ihl-rat LC50: >13 gm/m3/4H Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 140, 1996 (JACTDZ); T/E unlistd skn-rbt LD50: >5 gm/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 140, 1996 (JACTDZ); R13 skn-gpg TDLo: 10 pph Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975- v. 28, p. 149, 1993 (CODEDG) MD: P08-P71-R03 skn-rat TDLo: 84 gm/kg/3W-I Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 140, 1996 (JACTDZ); N75 orl-dog TDLo: 380 mg/kg/13W-C Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 140, 1996 (JACTDZ); P08 skn-rbt TDLo: 120 mg/kg/4W-I Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 15, p. 140, 1996 (JACTDZ) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOES 1983: HZD X1017; NIS 9; TNF 512; NOS 10; TNE 17713; TFE 3345 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 809 of 1119 in RTECS (through 2003/06) AN: MC1075000 PN: Glycine, N-(phosphonomethyl)- SY: Glyphosate-; MON-0573-; MON-2139-; N-(Phosphonomethyl)glycine RN: Current: 1071-83-6 BRN: 2045054 UD: 200305 MF: C3-H8-N-O5-P MW: 169.09 WL: QV1M1PQQO CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P); Reproductive-Effector (T) ME: oms-ctl-lym 17 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 403, p. 13, 1998 (MUREAV); cyt-ctl-lym 17 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 403, p. 13, 1998 (MUREAV); sce-ctl-lym 17 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 403, p. 13, 1998 (MUREAV); slt-dmg 2 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 40, 2000 (EMMUEG) RE: T53 unr-mam TDLo: 30 mg/kg (multigenerations) Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 63, p. 54060, 1998 (FEREAC); T34-T46-T72 orl-rat TDLo: 49 gm/kg (6-19D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 61, p. 446, 2000 (TJADAB) ORNG: 4873000000 ng/kg. [4873.000000 mg/kg] F12-J26-U25 SRNG: 7940000000 ng/kg. [7940.000000 mg/kg] T/E unlistd AT: H02-J13-J14 orl-man LDLo: 2143 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 29, p. 91, 1991 (JTCTDW); G10-H02-K12 orl-man TDLo: 1214 mg/kg Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 10, p. 103, 1991 (HETOEA); G04-H02-J25 orl-wmn LDLo: 4 gm/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 29, p. 91, 1991 (JTCTDW); F12-J26-U25 orl-rat LD50: 4873 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 319, 1978 (TXAPA9); T/E unlistd ihl-rat LC50: >12200 mg/m3/4H "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A222,1984 (85JFAN); F12-J26-U25 ipr-rat LD50: 235 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 1000(Sp Iss 1), p. 148, 1980 (TOLED5); F12-J26-U25 orl-mus LD50: 1568 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 319, 1978 (TXAPA9); F12-J26-U25 ipr-mus LD50: 130 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 1000(Sp Iss 1), p. 148, 1980 (TOLED5); T/E unlistd orl-rbt LD50: 3800 mg/kg Pesticide and Toxic Chemical News. (Food Chemical News, Inc., 400 Wyatt Bldg., 777 14th St., NW, Washington, DC 20005) V.1- 1972- v. 7, p. 6, 1978 (PESTC*); T/E unlistd skn-rbt LD50: 7940 mg/kg "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A222,1984 (85JFAN); T/E unlistd orl-qal LD50: >4640 mg/kg Pesticide Manual. (The British Crop Protection Council, 20 Bridport Rd., Thornton Heath CR4 7QG, UK) V.1- 1968- v. 9, p. 459, 1991 (PEMNDP) MD: L70-P71-Y15 orl-rat TDLo: 153 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3135 (NTPTR*); F07-F15-K12 orl-rat TDLo: 22500 mg/kg/90D-I Huanjing Kexue. Environmental Sciences. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) 1976- Adopted vol. no. with Vol. 1, 1980. v. 5(2), p. 52, 1984 (HCKHDV); K01-L70-M70 orl-mus TDLo: 435 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3135 (NTPTR*); U01-Z01 orl-rat TDLo: 49000 mg/kg/14D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 61, p. 446, 2000 (TJADAB) SL: On EPA IRIS database; NTP Toxicity studies, RPT# TOX-16, October 2000 Record 810 of 1119 in RTECS (through 2003/06) AN: MC5250000 PN: Glycolic-acid- SY: Acetic-acid,-hydroxy-; Kyselina-glykolova- (Czech); Kyselina-hydroxyoctova- (Czech); Hydroxyacetic-acid-; alpha-Hydroxyacetic-acid-; 2-Hydroxyacetic-acid-; Hydroxyethanoic-acid- RN: Current: 79-14-1 BRN: 1209322 BHR: 4-03-00-00571 UD: 200012 MF: C2-H4-O3 MW: 76.06 WL: QV1Q CC: Tumorigen (C); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 2 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA) RE: T19-T34-T46 orl-rat TDLo: 9 gm/kg (7-12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 53, p. 117, 1996 (TJADAB); T34 orl-rat TDLo: 5250 mg/kg (7-21D preg) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 22, p. 569, 1999 (DCTODJ); T19-T34-T46 orl-rat TDLo: 7500 mg/kg (7-21D preg) International Journal of Toxicology. (Taylor and Francis, 47 Runway Rd., Suite g, Levittown, PA 19057) V.16- 1997- v. 17(Suppl 1), p. 71, 1998 (IJTOFN) ORNG: 1950000000 ng/kg. [1950.000000 mg/kg] F07-K30-M30 IHNG: 7100000 ng/m3/4H. [7.100000 mg/m3/4H] D07-J22-U01 AT: F07-K30-M30 orl-rat LD50: 1950 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); D07-J22-U01 ihl-rat LC50: 7100 ug/m3/4H Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 9, p. 435, 1997 (INHTE5); T/E unlistd ivn-cat LD50: 1 gm/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,656,1986 (85JCAE); F07-K30-M30 orl-gpg LD50: 1920 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB) MD: M30-U01-Z01 orl-rat TDLo: 2480 gm/kg/35W-C Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.31- 1951- v. 84, p. 183, 1959 (ABBIA4); M30-U07 orl-rat TDLo: 52500 mg/kg/3W-C Investigative Urology. (Baltimore, MD) V.1-19, 1963-81. For publisher information, see JOURAA. v. 13, p. 113, 1975 (INURAQ); D07-J22-U01 ihl-rat TCLo: 2 gm/m3/6H/2W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0546415 (NTIS**); P30-U01-Z01 orl-cat TDLo: 970 mg/kg/7D-I Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 34, p. 86, 1944 (JAPMA8) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 35260; NIS 27; TNF 2991; NOS 29; TNE 29291; NOES 1983: HZD 35260; NIS 64; TNF 5782; NOS 63; TNE 191563; TFE 98538 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 811 of 1119 in RTECS (through 2003/06) AN: MF0875000 PN: Guanidine,-1,3-diphenyl- SY: Accelerator-D-; Denax-; Denax-DPG-; 1,3-Difenylguanid- (Czech); Diphenylguanidine-; sym-Diphenylguanidine-; N,N'-Diphenylguanidine-; 1,3-Diphenylguanidine-; DPG-accelerator-; Dwufenyloguanidyna- (Polish); Melaniline-; NCI-C60924-; Nocceler-D-; USAF-B-19-; USAF-EK-1270-; Vulcafor-DPG-; Vulkacit-D-; Vulkacit D/C; Vulkazit- RN: Current: 102-06-7 UD: 200210 MF: C13-H13-N3 MW: 211.29 WL: MUYMR&MR CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-hmn 1%/48H Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975- v. 11, p. 256, 1984 (CODEDG) ME: mmo-sat 360 ng/plate (+S9) Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 6(1-2), p. 293, 1985 (JEPOEC); mmo-sat 33 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); bfa-mus-sat 36 ng/kg Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 6(1-2), p. 293, 1985 (JEPOEC) RE: T46 orl-mus TDLo: 76 mg/kg (1-19D preg) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(1), p. 451, 1980 (JEPTDQ); T24 orl-mus TDLo: 190 mg/kg (1-19D preg) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 4(1), p. 451, 1980 (JEPTDQ); T23-T24 orl-mus TDLo: 56 mg/kg (7D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 11, p. 869, 1983 (JTEHD6); T01 orl-mus TDLo: 196 mg/kg (49D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 11, p. 869, 1983 (JTEHD6); T02 orl-mus TDLo: 140 mg/kg (35D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 11, p. 869, 1983 (JTEHD6); T01 orl-ham TDLo: 224 mg/kg (56D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 11, p. 869, 1983 (JTEHD6) ORNG: 323000000 ng/kg. [323.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 323 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3933 (NTPTR*); T/E unlistd ipr-rat LD50: 75 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 16, p. 35, 1965 (MEPAAX); P05 unr-rat LD50: 323 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(7), p. 35, 1978 (GISAAA); C08-F19 orl-mus LD50: 150 mg/kg Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. (Tohoku University, Research Institute for Tuberculosis and Cancer, 4-1 Seiryo-machi, Sendai, Japan) V.1- 1949- v. 36(1-4), p. 10, 1989 (SRTCAC); T/E unlistd ipr-mus LD50: 25 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); P05 unr-mus LD50: 258 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(7), p. 35, 1978 (GISAAA); F05-F22 ivn-dog LDLo: 25 mg/kg Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 143, p. 815, 1949 (CRSBAW); T/E unlistd orl-rbt LD50: 250 mg/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,974,1986 (85JCAE); T/E unlistd skn-rbt LD50: >794 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3933 (NTPTR*); P05 unr-rbt LD50: 246 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(7), p. 35, 1978 (GISAAA); T/E unlistd orl-gpg LD50: 250 mg/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,974,1986 (85JCAE); F05-F22 scu-gpg LDLo: 200 mg/kg Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 143, p. 815, 1949 (CRSBAW); F12-F23-J22 orl-mam LDLo: 250 mg/kg Journal of Industrial Hygiene. (Cambridge, MA) V.1-17, 1919-35. For publisher information, see AEHLAU. v. 13, p. 87, 1931 (JIDHAN) MD: P08-P71-Y11 orl-rat TDLo: 3808 mg/kg/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(7), p. 35, 1978 (GISAAA); L30-P30 orl-rat TDLo: 1313 mg/kg/7D-I Khigiena i Zdraveopazvane. Hygiene and Sanitation. (Hemus, Blvd. Russki 6, Sofia, Bulgaria) V.9- 1966- v. 15, p. 234, 1972 (KHZDAN); L30-P30 orl-rat TDLo: 1500 mg/kg/20D-I Khigiena i Zdraveopazvane. Hygiene and Sanitation. (Hemus, Blvd. Russki 6, Sofia, Bulgaria) V.9- 1966- v. 15, p. 234, 1972 (KHZDAN) ND: NOHS 1974: HZD 27760; NIS 10; TNF 326; NOS 21; TNE 14344; NOES 1983: HZD 27760; NIS 14; TNF 874; NOS 40; TNE 28146; TFE 4339 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9186, 8EHQ-0892-9256; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-42, October 2000 Record 812 of 1119 in RTECS (through 2003/06) AN: MF4200000 PN: Guanidine,-1-methyl-3-nitro-1-nitroso- SY: 1-Methyl-1-nitroso-3-nitroguanidine-; 1-Methyl-3-nitro-1-nitrosoguanidine-; Guanidine,-N-methyl-N'-nitro-N-nitroso- (9CI); MNNG-; Methylnitronitrosoguanidine-; N'-Nitro-N-nitroso-N-methylguanidine-; N-Methyl-N'-nitro-N-nitrosoguanidine-; N-Methyl-N-nitro-N-nitrosoguanidine-; N-Methyl-N-nitroso-N'-nitroguanidine-; N-Methyl-N-nitrosonitroguanidin- (German); N-Metylo-N'-nitro-N-nitrozoguanidyny- (Polish); N-Nitroso-N-methylnitroguanidine-; NSC-9369-; Nitrosoguanidine-; RCRA-waste-number-U163- RN: Current: 70-25-7 Previous: 100234-53-5 UD: 200305 MF: C2-H5-N5-O3 MW: 147.12 WL: WNMYUM&N1&NO CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 310 ng/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 79, 1984 (MUREAV); mmo-sat 2 ug/plate (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 5135, 1975 (PNASA6); dnd-sat 8 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 327, 1982 (CRNGDP); pic-sat 22 nmol/plate Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 9, p. 337, 1979 (PPTCBY); mmo-esc 20 nmol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 87, 1984 (MUREAV); dnr-esc 10 ug/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 101, 1978 (MUREAV); dnd-esc 3400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 52, p. 161, 1978 (MUREAV); dns-esc 2 mmol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 92, p. 177, 1978 (ZKKOBW); pic-esc 20 ug/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 141, 1984 (MUREAV); mmo-bcs 20 mg/L (-S9) Chemical Mutagens. Principles and Methods for Their Detection. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1971- v. 9, p. 165, 1984 (CMMUAO); dnr-bcs 20 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); mrc-bcs 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 31, 1979 (MUREAV); dnd-bcs 240 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); mmo-omi 100 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 135, p. 748, 1978 (JOBAAY); mmo-omi 160 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 137, p. 415, 1979 (JOBAAY); mmo-omi 20 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 135, p. 911, 1978 (JOBAAY); mmo-omi 10 mg/L (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 89, p. 695, 1978 (GENTAE); mmo-omi 4 gm/L (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 128, p. 1441, 1982 (JGMIAN); mmo-omi 250 mg/L (-S9) Journal of General and Applied Microbiology. (Microbiology Research Foundation, c/o Japan Academic Soc. Center Bldg., 2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113, Japan) V.1- 1955- v. 19, p. 467, 1973 (JGAMA9); mmo-omi 250 mg/L (-S9) Journal of General and Applied Microbiology. (Microbiology Research Foundation, c/o Japan Academic Soc. Center Bldg., 2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113, Japan) V.1- 1955- v. 19, p. 467, 1973 (JGAMA9); mmo-omi 250 mg/L (-S9) Journal of General and Applied Microbiology. (Microbiology Research Foundation, c/o Japan Academic Soc. Center Bldg., 2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113, Japan) V.1- 1955- v. 19, p. 467, 1973 (JGAMA9); mmo-omi 250 mg/L (-S9) Journal of General and Applied Microbiology. (Microbiology Research Foundation, c/o Japan Academic Soc. Center Bldg., 2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113, Japan) V.1- 1955- v. 19, p. 467, 1973 (JGAMA9); mmo-omi 25 mg/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 37, p. 936, 1981 (JOVIAM); mmo-omi 50 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 50, p. 37, 1978 (MUREAV); mmo-omi 4 gm/L (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 98, p. 265, 1977 (JGMIAN); mmo-omi 100 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 94, p. 1, 1982 (MUREAV); mmo-omi 10 mg/L (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 128, p. 1401, 1982 (JGMIAN); pic-bcs 10 mmol/L Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 22, p. 338, 1984 (IJEBA6); mmo-omi 100 mg/L (-S9) Developmental Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 43, p. 213, 1975 (DEBIAO); mmo-klp 100 mg/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 157, p. 189, 1977 (MGGEAE); mmo-omi 1 gm/L (-S9) Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 59, p. 865, 1974 (BBRCA9); mmo-omi 10 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 37, p. 1, 1976 (MUREAV); dnd-omi 4 mmol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 37, 1977 (ZKKOBW); mmo-omi 100 mg/L (-S9) Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 19, p. 571, 1981 (AMACCQ); mmo-omi 5 mg/L (-S9) Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 35, p. 439, 1968 (JMOBAK); mmo-omi 20 ug/plate (-S9) Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 35, p. 439, 1968 (JMOBAK); dns-omi 1 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 417, 1981 (CRNGDP); mmo-omi 100 mg/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 15, p. 1, 1975 (JOVIAM); mmo-omi 100 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 102, p. 784, 1970 (JOBAAY); mmo-omi 5 mg/L (-S9) Intervirology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.1- 1973- v. 10, p. 181, 1978 (IVRYAK); mmo-omi 1 gm/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 15, p. 41, 1975 (JOVIAM); mmo-omi 100 mg/L (-S9) Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 19, p. 571, 1981 (AMACCQ); mmo-omi 5 mg/L (-S9) Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 49, p. 815, 1972 (VIRLAX); mmo-omi 25 mg/L (-S9) Doklady Bolgarskoi Akademii Nauk. (Hemus, Blvd. Russki 6, Sofia, Bulgaria) V.1- 1948- v. 33, p. 1401, 1980 (DBANAD); mmo-omi 10 mg/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 167, p. 65, 1978 (MGGEAE); mmo-omi 30 mg/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 167, p. 65, 1978 (MGGEAE); mmo-omi 1 gm/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 104, p. 378, 1969 (MGGEAE); mmo-omi 1 gm/L (-S9) Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52: V.21- 1968- v. 31, p. 662, 1978 (JANTAJ); mmo-omi 100 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 135, p. 748, 1978 (JOBAAY); mmo-omi 100 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 73, p. 1, 1980 (MUREAV); mmo-omi 100 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 101, p. 921, 1970 (JOBAAY); mmo-omi 500 ppm/72H-C (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 522, 1974 (SOGEBZ); mmo-hmi 1 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 30, p. 9, 1975 (MUREAV); mmo-omi 25 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 120, p. 106, 1974 (JOBAAY); mmo-omi 50 mg/L/30M-C (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 121, p. 349, 1980 (JGMIAN); mmo-omi 17 mg/L (-S9) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 34, p. 664, 1979 (NEZAAQ); mmo-omi 10 mg/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 10, p. 760, 1972 (JOVIAM); mmo-omi 30 mg/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 7, p. 673, 1971 (JOVIAM); mmo-omi 10 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 9, p. 261, 1970 (MUREAV); mmo-omi 100 mg/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 121, p. 57, 1973 (MGGEAE); pic-omi 10 ug/plate Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe A: Medizinische Mikrobiologie und Parasitologie. (Stuttgart, Fed. Rep. Ger.) V.217-245, 1971-79. v. 231, p. 369, 1975 (ZMMPAO); mmo-omi 1 gm/L (-S9) Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52: V.21- 1968- v. 35, p. 94, 1982 (JANTAJ); dnd-hmi 1700 umol/L/10M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 289, 1971 (MUREAV); pic-hmi 68 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 37, p. 1, 1976 (MUREAV); pic-omi 10 ug/L Bulletin de l'Academie Polonaise des Sciences, Series des Sciences Biologiques. (Warsaw, Poland) V.5-30, 1957-82. For publisher information, see BPABEN. v. 18, p. 445, 1970 (BAPBAN); mmo-omi 30 ppm (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 11, p. 183, 1975 (SOGEBZ); mmo-omi 2000 ppm/20M-C (-S9) Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.25- 1961- v. 41, p. 615, 1977 (ABCHA6); mmo-omi 100 mg/L (-S9) Canadian Journal of Microbiology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1954- v. 20, p. 1479, 1975 (CJMIAZ); mmo-omi 10 ng/disc (-S9) Issledovaniya po Genetike. (Izdatel'stvo Leningradskogo Universiteta, Leningrad, USSR) No.1- 1961- v. 8, p. 82, 1979 (ISGEAK); mmo-omi 100 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 8, p. 531, 1969 (MUREAV); mmo-omi 50 mg/L (+S9) K'o Hsueh Fa Chan Yueh K'an. Progress in Sciences. (Kuo Chia K'o Hsueh Wei Yuan Hui, 2 Canton St., Taipei 107, Taiwan) V.1- 1973- v. 8, p. 297, 1980 (KHFKDF); mmo-omi 500 ppm/20M-C (-S9) Microbiology (Moscow). (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.26- 1957- v. 42, p. 265, 1973 (MIBLAO); mmo-omi 1 gm/L (-S9) Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 9, p. 682, 1976 (AMACCQ); mmo-omi 10 mg/L (-S9) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 25, p. 85, 1969 (EXPEAM); mmo-omi 200 mg/L (-S9) Zeitschrift fuer Allgemeine Mikrobiologie. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086 Ger. Dem. Rep.) V.1- 1960- v. 17, p. 451, 1977 (ZAPOAK); mmo-omi 10 mg/L (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 83, p. 489, 1976 (GENTAE); mmo-omi 1 gm/L (-S9) Science and Culture. (Indian Science News Assoc., 92 Acharya Prafulla Chandra Rd., Calcutta 700009, India) V.1- 1935- v. 37, p. 52, 1971 (SCINAL); mmo-omi 15 mg/L/70M-C (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 55, p. 121, 1969 (JGMIAN); mmo-omi 7 umol/L/24H-C (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 33, p. 135, 1975 (MUREAV); mmo-omi 50 mg/L (-S9) Journal of Protozoology. (Soc. of Protozoologists, P.O. Box 368, Lawrence, KS 66044) V.1- 1954- v. 24, p. 313, 1977 (JPROAR); mmo-omi 10 mg/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 16, p. 197, 1971 (FOMIAZ); mmo-omi 1 gm/L/30M-C (-S9) Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52: V.21- 1968- v. 31, p. 247, 1978 (JANTAJ); mmo-omi 1 gm/L (-S9) Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 12, p. 383, 1977 (AMACCQ); mmo-omi 1 gm/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 22, p. 12, 1977 (FOMIAZ); mmo-omi 1 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 35, p. 65, 1976 (MUREAV); mmo-omi 2 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 28, p. 9, 1975 (MUREAV); mmo-omi 1 gm/L (-S9) Genetical Research. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1960- v. 29, p. 65, 1977 (GENRA8); mmo-omi 400 ug/plate (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 297, 1978 (CBINA8); mmo-omi 50 ug/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 113, 1980 (MUREAV); dnr-omi 100 ug/plate Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 95, p. 463, 1976 (BIZNAT); dni-omi 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 85, p. 275, 1981 (MUREAV); mmo-omi 10 mg/L (-S9) Journal of Dairy Science. (American Dairy Science Assoc., 309 W. Clark St., Champaign, IL 61820) V.1- 1917- v. 54, p. 331, 1970 (JDSCAE); mmo-omi 100 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 133, p. 631, 1978 (JOBAAY); mmo-omi 25 mg/L (-S9) Journal of Infectious Diseases. (Univ. of Chicago Press, Journals Div., POB 37005, Chicago, IL 60637) V.1- 1904- v. 124, p. 179, 1971 (JIDIAQ); mmo-omi 100 mg/L (-S9) Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905- v. 252, p. 6294, 1977 (JBCHA3); mmo-omi 1 gm/L (-S9) Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. 113, 1972 (BBRCA9); mmo-omi 50 mg/L (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 70, p. 1335, 1973 (PNASA6); mmo-omi 400 mg/L (-S9) Acta Microbiologica Polonica, Series B: Microbiologica Applicata. (Warsaw, Poland) V.1-7, 1969-75. For publisher information, see AMPOAX. v. 6, p. 15, 1974 (AMBBBR); mmo-omi 400 mg/L (-S9) Acta Microbiologica Polonica, Series B: Microbiologica Applicata. (Warsaw, Poland) V.1-7, 1969-75. For publisher information, see AMPOAX. v. 6, p. 15, 1974 (AMBBBR); mmo-omi 30 mg/L (-S9) Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.25- 1961- v. 41, p. 1667, 1977 (ABCHA6); slt-dmg-orl 500 ppm/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 202, 1977 (MUREAV); slt-dmg-par 2500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 19, 1971 (MUREAV); sln-dmg-orl 500 ppm/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 44, p. 145, 1977 (MUREAV); mmo-nsc 20 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 297, 1978 (MUREAV); dnd-omi 125 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 25, p. 235, 1974 (MUREAV); mmo-smc 1000 ppm (-S9) Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 4, p. 286, 1974 (AGACBH); mmo-smc 1 mg/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 200, p. 313, 1985 (MGGEAE); dnr-smc 2 umol/well Japanese Journal of Genetics. Idengaku Zasshi. (Genetics Soc. of Japan, 111 Tanida, Mishima, Shizuoka-ken, Japan) V.1- 1921- v. 50, p. 403, 1975 (IDZAAW); mrc-smc 1 ppm JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 901, 1979 (JJIND8); mmo-asn 50 mmol/L (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 63, p. 317, 1969 (GENTAE); sln-asn 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 155, p. 105, 1985 (MUREAV); mmo-ssp 10 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 2, p. 312, 1965 (MUREAV); mmo-clr 1 mg/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 121, p. 99, 1973 (MGGEAE); dnr-ssp 180 nmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 24, p. 771, 1982 (CNJGA8); mrc-ssp 1 mmol/L/5M Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 110, p. 348, 1971 (MGGEAE); mmo-eug 5 mg/L (-S9) Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 9, p. 682, 1976 (AMACCQ); mmo-omi 300 mg/L (-S9) Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 12(5), p. 56, 1978 (CYGEDX); oms-grh-oth 1250 nmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 279, 1982 (ENMUDM); cyt-grh-oth 1250 nmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 279, 1982 (ENMUDM); cyt-ofs-oth 200 ug/L/24H Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 181, 1982 (ENMUDM); sce-ofs-emb 1 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 381, 1979 (MUREAV); msc-ofs-fbr 4 mg/L Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 10, p. 663, 1981 (AECTCV); mnt-hmn-lng 10 ug/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 735, 1990 (TIVIEQ); dnr-hmn-fbr 5 umol/L/2H Colloques Internationaux du Centre National de la Recherche Scientifique. (Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1946- v. 256, p. 175, 1977 (COINAV); mtr-hmn-fbr 200 ug/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 75, p. 1334, 1978 (PNASA6); dnd-hmn-leu 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 346, p. 49, 1995 (MUREAV); mtr-hmn-oth 400 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 5096, 1981 (CNREA8); dnd-hmn-fbr 20 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 267, 1985 (ENMUDM); dnd-hmn-hla 300 ug/L/1H Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 103, p. 175, 1976 (ECREAL); dnd-hmn-lym 50 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 38, p. 87, 1981 (CBINA8); dns-hmn-oth 100 umol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 69, p. 557, 1982 (JJIND8); dns-hmn-lng 100 ug/L Journal of Cell Biology. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10003) V.12- 1962- v. 39, p. 72a, 1968 (JCLBA3); dns-hmn-fbr 10 umol/L/3H International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 16, p. 284, 1975 (IJCNAW); dns-hmn-hla 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-leu 90 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 38, p. 87, 1981 (CBINA8); dns-hmn-lym 140 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 38, p. 87, 1981 (CBINA8); dni-hmn-hla 2 umol/L/30M-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(1), p. 65, 1978 (JEPTDQ); dni-hmn-lng 1 mg/L/3H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 12, p. 183, 1971 (MUREAV); dni-hmn-fbr 10 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 984, 1980 (CNREA8); dni-hmn-lym 3 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 38, p. 87, 1981 (CBINA8); oms-hmn-lng 500 ug/L Journal of Cell Biology. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10003) V.12- 1962- v. 39, p. 72a, 1968 (JCLBA3); dns-hmn-lvr 10 umol/L Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959- v. 22, p. 1346, 1980 (TSITAQ); dns-hmn-kdy 100 umol/L Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 28(11), p. 53, 1982 (VOONAW); dns-hmn-oth 100 umol/L Zhonghua Zhongliu Zazhi. Chinese Journal of Oncology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1978- v. 13, p. 90, 1991 (CCLCDY); cyt-hmn-oth 700 nmol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 353, 1991 (TIVIEQ); cyt-hmn-lng 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 12, p. 183, 1971 (MUREAV); cyt-hmn-fbr 6800 nmol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 297, 1977 (MUREAV); cyt-hmn-leu 100 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 30, p. 103, 1974 (BJCAAI); cyt-hmn-lym 340 nmol/L/24H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 61, 1980 (ARTODN); cyt-hmn-hla 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 369, 1978 (MUREAV); sce-hmn-fbr 1 nmol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 1387, 1977 (JTEHD6); sce-hmn-lym 1 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 24, p. 107, 1979 (CBINA8); sce-hmn-oth 1 nmol/L ICN-UCLA Symposia on Molecular and Cellular Biology. (Menlo Park, CA) V.1-23, 1974-81. v. 7, p. 341, 1977 (IUSMDJ); sce-hmn-hla 300 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 593, 1984 (CRNGDP); sce-hmn-leu 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 346, p. 49, 1995 (MUREAV); msc-hmn-fbr 225 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 29, 1978 (MUREAV); msc-hmn-emb 40 umol/L/3H-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 58, p. 1873, 1977 (JNCIAM); msc-hmn-oth 3 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1114, 1981 (CNREA8); msc-hmn-hla 1 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 30, p. 3039, 1981 (BCPCA6); mnt-rat-ipr 18750 ug/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 188, p. 45, 1987 (MUREAV); mnt-rat-orl 20 mg/kg/16H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 327, 1989 (MUTAEX); mnt-rat-lvr 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 213, 1993 (MUREAV); mtr-rat-orl 1 mmol/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 43, p. 313, 1983 (CBINA8); mtr-rat-ipr 30 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 1157, 1980 (CNREA8); mtr-rat-emb 100 ug/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 79, 1978 (JTEHD6); mtr-rat-lvr 10 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 28, p. 215, 1973 (BJCAAI); dnd-rat-lng 10 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 58, p. 57, 1991 (CALEDQ); dnd-rat-orl 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 213, p. 227, 1989 (MUREAV); dnd-rat-lvr 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 69, 1987 (MUREAV); dnd-rat-ipr 25 mg/kg Experimental Cell Biology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.44- 1976- v. 47, p. 92, 1979 (ECEBDI); dns-rat-orl 12500 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1425, 1989 (CRNGDP); dns-rat-orl 50 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 553, 1982 (ENMUDM); dns-rat-lvr 147 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 381, 1985 (PMRSDJ); dns-rat-oth 3200 umol/L Shika Kiso Igakkai Zasshi. Journal of the Japanese Association for Basic Dentistry. (Shika Kiso Igakkai, Hanayama Bldg., 1-44-2 Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1959- v. 22, p. 300, 1980 (SHKKAN); dni-rat-orl 8183 mg/kg/70W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 64, p. 373, 1973 (GANNA2); bfa-rat-ovr 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 263, 1985 (MUREAV); cyt-rat-orl 50 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 86, p. 47, 1976 (ZKKOBW); cyt-rat-lvr 10 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1077, 1987 (CRNGDP); sce-rat-lvr 400 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 47, 1981 (MUREAV); msc-rat-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 159, 1978 (MUREAV); msc-rat-orl 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 159, 1978 (MUREAV); msc-rat-par 2400 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 99, 1987 (MUREAV); msc-rat-emb 1 mg/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 79, 1978 (JTEHD6); msc-rat-oth 250 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 34, p. 481, 1976 (MUREAV); msc-rat-lvr 50 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 259, 1980 (ENMUDM); hma-rat-smc 412 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 3, p. 41, 1983 (TCMUD8); mnt-mus-ipr 75 mg/kg Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 2, p. 199, 1987 (MUTAEX); mnt-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 151, 1986 (MUREAV); mnt-mus-orl 150 mg/kg Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 2, p. 199, 1987 (MUTAEX); mmo-mus-lym 200 ug/L/4H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); slt-mus-ipr 35 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 38, p. 87, 1977 (ARTODN); dnd-mus-fbr 50 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 143, 1982 (ENMUDM); mtr-mus-emb 300 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 659, 1985 (PMRSDJ); mtr-mus-fbr 20 ug/L Advances in Modern Environmental Toxicology. (Senate Press, Inc., P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980- v. 1, p. 133, 1980 (AETODY); mtr-mus-oth 50 ug/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 68, p. 1098, 1971 (PNASA6); dnd-mus-leu 6 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 23, p. 387, 1974 (MUREAV); dnd-mus-orl 15 mg/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 17, p. 765, 1976 (IJCNAW); dnd-mus-ipr 400 umol/kg "Biology of Radiation Carcinogenesis, Symposium, 1975," Yuhas, J.M., et al., eds., New York, Raven Press, 1976 -,165,1976 (33AQAA); dnd-mus-emb 2 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 131, 1979 (CNREA8); dnd-mus-oth 100 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 10, p. 223, 1980 (CALEDQ); dnd-mus-ast 50 mg/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 192, p. 191, 1969 (BBACAQ); dns-mus-tes 1 umol/L/3H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 37, p. 195, 1977 (ARTODN); dns-mus-emb 500 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 3, p. 49, 1971 (CBINA8); dns-mus-fbr 10 umol/L Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959- v. 22, p. 1346, 1980 (TSITAQ); dni-mus-lym 2 umol/L Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 28, p. 560, 1985 (MOPMA3); dni-mus-emb 2 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 682, 1980 (CNREA8); dni-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); dni-mus-oth 500 umol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 68, p. 1015, 1982 (JJIND8); dns-mus-lvr 1 umol/L Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 12, p. 119, 1984 (TOPADD); cyt-mus-ivn 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 60, p. 329, 1979 (MUREAV); sce-mus-ipr 300 ug/kg/6H-I Human Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.31- 1976- v. 35, p. 299, 1977 (HUGEDQ); sce-mus-ivn 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 60, p. 329, 1979 (MUREAV); sce-mus-lym 100 ug/L Journal of Clinical Hematology and Oncology. (Cancer Center at Wadley Institutes, POB 35988, Dallas, TX 75235) V.5(3)- 1975- v. 13, p. 1, 1983 (JCHODP); sce-mus-fbr 250 ug/L Human Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.31- 1976- v. 63, p. 53, 1983 (HUGEDQ); sce-mus-emb 2500 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 593, 1984 (CRNGDP); msc-mus-lvr 500 ug/L Somatic Cell Genetics. (New York, NY) V.1-9, 1975-83. For publisher information, see SCMGDN. v. 7, p. 373, 1981 (SCGTDW); msc-mus-oth 1 mg/L Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 73, p. 167, 1982 (GANNA2); msc-mus-oth 3 mg/L Journal of Experimental Medicine. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1896- v. 152, p. 1175, 1980 (JEMEAV); dlt-mus-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 155, 1973 (MUREAV); msc-mus-mmr 3 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 125, 1983 (CNREA8); msc-mus-emb 1 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 332, 1982 (ENMUDM); msc-mus-tes 3 mg/L "Teratomas and Differentiation, a Symposium, Nutley, NJ, 1975," Sherman, M.I. ed., New York, Academic Press, Inc., 1975 -,161,1975 (32YLA6); msc-mus-oth 250 ug/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 108, 1980 (PAACA3); msc-mus-lym 5 ug/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); msc-mus-fbr 250 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 215, 1980 (CRNGDP); msc-mus-leu 250 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 3073, 1974 (CNREA8); hma-mus-srm 60 mg/kg/2H Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 117, p. 197, 1972 (MGGEAE); hma-mus-sat 5 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); hma-mus-esc 60 mg/kg Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 117, p. 197, 1972 (MGGEAE); hma-mus-smc 2 mmol/kg Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 3, p. 99, 1973 (AGACBH); hma-mus-leu 25 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 3073, 1974 (CNREA8); mnt-ham-lng 80 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 273, 1984 (MUREAV); mnt-ham-ovr 40 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 295, 1990 (MUREAV); mmo-ham-ovr 60 nmol/L (+S9) Molecular Toxicology. (Taylor and Francis, Inc., 242 Cherry St., Philadelphia, PA USA 19106) V.1- 1987- v. 1, p. 217, 1987 (MOTOEX); mtr-ham-emb 500 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 3508, 1977 (CNREA8); mtr-ham-lng 68 umol/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 48, p. 1409, 1972 (JNCIAM); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-ham-fbr 500 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 1274, 1982 (CNREA8); dnd-ham-lng 3 umol/L/30M Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 732, 1976 (BBRCA9); dnd-ham-fbr 50 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 143, 1982 (ENMUDM); dns-ham-lng 20 umol/L/1H Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 3, p. 49, 1971 (CBINA8); dns-ham-emb 10 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); dns-ham-kdy 500 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 3, p. 49, 1971 (CBINA8); dns-ham-ovr 1 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 515, 1983 (ENMUDM); dni-ham-lng 20 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 682, 1980 (CNREA8); cyt-ham-fbr 4 mg/L Yichuan. Heredity. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1979- v. 6(6), p. 26, 1984 (ICHUDW); cyt-ham-lng 500 ug/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 59, p. 289, 1977 (JNCIAM); cyt-ham-ovr 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 141, p. 95, 1984 (MUREAV); sce-ham-ovr 180 nmol/L Molecular Toxicology. (Taylor and Francis, Inc., 242 Cherry St., Philadelphia, PA USA 19106) V.1- 1987- v. 1, p. 217, 1987 (MOTOEX); sce-ham-lng 100 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3270, 1984 (CNREA8); sce-ham-unr 7 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 166, 1980 (MUREAV); sce-ham-fbr 30 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 104, p. 141, 1982 (MUREAV); sce-ham-ipr 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); sce-ham-orl 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); msc-ham-lng 200 ug/L/3H British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 39, p. 540, 1979 (BJCAAI); msc-ham-emb 1 umol/L/3H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 351, 1976 (MUREAV); msc-ham-ovr 500 ug/L/16H Journal of Cellular Physiology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.67- 1966- v. 74, p. 245, 1969 (JCLLAX); msc-ham-kdy 500 ug/L Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 77, p. 309, 1974 (GENTAE); msc-ham-fbr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 389, 1982 (CNREA8); dnd-gpg-orl 14700 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1443, 1982 (CRNGDP); msc-dog-kdy 500 ug/L Somatic Cell Genetics. (New York, NY) V.1-9, 1975-83. For publisher information, see SCMGDN. v. 4, p. 609, 1978 (SCGTDW); dnd-mam-kdy 100 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); dnd-mam-lym 8 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 327, 1982 (CRNGDP); dns-frg-fbr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 49, p. 407, 1978 (MUREAV); dns-mam-kdy 50 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); cyt-dom-oth 1 mg/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 16, p. 791, 1980 (ITCSAF); msc-mam-lvr 1 mg/L Somatic Cell Genetics. (New York, NY) V.1-9, 1975-83. For publisher information, see SCMGDN. v. 4, p. 647, 1978 (SCGTDW); mmo-sat 1 ug/plate (+/-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 38, p. 1, 2000 (FCTOD7); mmo-sat 5 ug/plate/20M (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 13, 2001 (MUREAV); mmo-esc 0.5 ug/plate/20M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 91, 2001 (MUREAV); cyt-ham-ovr 0.6 mg/L/20H (-S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 20, p. 491, 2000 (JAPTO*); dnd-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); dnd-hmn-oth 33 umol/l/30M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 185, 2001 (MUREAV); mmo-sat 5 ug/plate/20M (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 19, 2001 (MUREAV); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG); cyt-hmn-spr 1 mg/L/120M (-S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 504, p. 183, 2002 (MUTAEX); msc-mus-imp 10 mg/kg/42W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 182, p. 127, 2002 (CALEDQ); mnt-rat-skn 0.02 pph/3D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 513, p. 93, 2002 (MUREAV); mnt-mus-skn 0.02 pph/3D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 513, p. 93, 2002 (MUREAV); dnd-hmn-oth 10 mg/L/60M Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 9, 2000 (EMMUEG); slt-ham-ovr 0.01 mg/L/9D Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 16, p. 260, 1990 (EMMUEG) RE: T34-T46 ipr-mus TDLo: 25 mg/kg (11D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 3, p. 335, 1983 (TCMUD8); T41-T43-T46 ipr-mus TDLo: 40 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 18, p. 263, 1978 (TJADAB); T25 ipr-mus TDLo: 40 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 18, p. 263, 1978 (TJADAB); T26-T29 ipr-mus TDLo: 50 mg/kg (1D pre) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 171, 1971 (MUREAV); T33-T46 ipr-mus TDLo: 50 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 60A, 1982 (TJADAB) TE: V01-K60 orl-rat TDLo: 500 ug/kg Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 69, p. 805, 1978 (GANNA2); V01-R60-V10 skn-rat TDLo: 720 mg/kg/60W-I Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 55, p. 117, 1985 (ARGEAR); V01-G30-M61 scu-rat TDLo: 400 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 227, 1980 (ARTODN); V03-T65-A60 ivn-rat TDLo: 25 mg/kg (15D preg) Kyoto-furitsu Ika Daigaku Zasshi. Journal of the Kyoto Prefectural School of Medicine. (Kyoto-furitsu Ika Daigaku Igakkai, Hirokoji, Kawaramachi-dori, Kamigyo-ku, Kyoto 602, Japan) V.1- 1927- v. 84, p. 23, 1975 (KFIZAO); V03-J61-P61 ivn-rat TDLo: 60 mg/kg European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 16, p. 395, 1980 (EJCAAH); V01-V10 par-rat TDLo: 400 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 227, 1980 (ARTODN); V01-K61 rec-rat TDLo: 128 mg/kg/32W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 50, p. 927, 1973 (JNCIAM); V01-K60 orl-mus TDLo: 1984 mg/kg/70W-I Zhonghua Zhongliu Zazhi. Chinese Journal of Oncology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1978- v. 4, p. 161, 1982 (CCLCDY); V01-R60 skn-mus TDLo: 54 mg/kg/30W-I Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 12, p. 397, 1982 (BANRDU); V03-J60-L60 scu-mus TDLo: 48 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 23, p. 757, 1969 (BJCAAI); V03-K60-P62 orl-dog TDLo: 725 mg/kg/45W-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 97, p. 51, 1980 (JCROD7); V03-K60 orl-mky TDLo: 800 mg/kg/5Y-I Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 36, p. 129, 1989 (NEOLA4); V03-J60 orl-rbt TDLo: 743 mg/kg/26W-C Haigan. Lung Cancer. (Nippon Haigan Gakkai, c/o Chiba Daigaku Igakubu Haigan Kenkyusho, 1-8-1 Inohona, Chiba 280, Japan) v. 16, p. 321, 1976 (HGANAO); V03-K60 orl-ham TDLo: 592 mg/kg/27W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 1444, 1970 (CNREA8); V01-K60 orl-grb TDLo: 1400 uL/kg/20W-I Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 89, p. 97, 1998 (JJCREP); V01-K60 orl-rat TD :697 mg/kg/12W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 22, p. 315, 1984 (CALEDQ); V01-K60 orl-rat TD :280 mg/kg/8W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 1335, 1983 (CNREA8); V01-K60 orl-rat TD :107 mg/kg/35W-C Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 100, p. 1, 1981 (JCROD7); V01-K60 orl-mus TD :6220 mg/kg/88W-C Zhonghua Zhongliu Zazhi. Chinese Journal of Oncology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1978- v. 4, p. 161, 1982 (CCLCDY); V01-K60 orl-rat TD :438 mg/kg/25W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 32, p. 253, 1983 (IJCNAW); V01-R60-V10 par-rat TD :125 mg/kg/10W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 26(2), p. 62, 1980 (VOONAW); V01-K60 orl-rat TD :651 mg/kg/34W-C Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 28(9), p. 34, 1982 (VOONAW); V01-K60 orl-rat TD :13500 mg/kg/78W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 70, p. 1067, 1983 (JJIND8); V01-K60 orl-rat TD :155 mg/kg/11W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2469, 1975 (CNREA8); V01-K60 orl-rat TD :250 mg/kg Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 75, p. 362, 1984 (GANNA2); V03-Q60-V08 ivn-rat TDLo: 437.5 mg/kg/25W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 477, p. 173, 2001 (MUREAV); V01-K60 orl-rat TDLo: 840 mg/kg/12W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 145, p. 85, 1999 (CALEDQ); V01-K60 orl-rat TDLo: 437.5 mg/kg/25W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 137, p. 131, 1999 (CALEDQ); V01-K60 orl-rat TDLo: 2600 mg/kg/52W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 138, p. 23, 1999 (CALEDQ); V01-K60 orl-rat TDLo: 700 mg/kg/25W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 141, p. 117, 1999 (CALEDQ) ORNG: 90000000 ng/kg. [90.000000 mg/kg] F12-J15-K06 AT: F12-J15-K06 orl-rat LD50: 90 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 91, p. 183, 1978 (ZKKOBW); T/E unlistd scu-rat LD50: 420 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); J15-F12 ivn-rat LD50: 80 mg/kg European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 16, p. 395, 1980 (EJCAAH); T/E unlistd ipr-mus LD50: 66 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); T/E unlistd ivn-mus LD50: 37300 ug/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); T/E unlistd orl-ham LD50: 1070 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 4, p. 241, 1978 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 183, 1974 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 248, 1987 (IMSUDL); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 248, 1987 (IMSUDL); TOXICOLOGY REVIEW Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 135, 1971 (ATXKA8); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY); TOXICOLOGY REVIEW Nutrition and Cancer. (Franklin Institute Press, POB 2266, Phildelphia, PA 19103) V.1- 1978- v. 3, p. 109, 1981 (NUCADQ) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-UNITED KINGDOM: Carcinogen, SEP 2000 ND: NOES 1983: HZD B0070; NIS 1; TNF 75; NOS 2; TNE 523 SL: EPA GENETOX PROGRAM 1988, Positive: Aspergillus-recombination, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/F344 rat, Cell transform.-BALB/c-3T3; EPA GENETOX PROGRAM 1988, Positive: SHE-focus assay, Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, In vitro cytogenetics-nonhuman; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Rodent dominant lethal, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test, Mouse spot test; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: B subtilis rec assay, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS in rat liver, V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive: TRP reversion, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion, S pombe-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: SHE-clonal assay, Cell transform.-C3H/10T1/2; EPA GENETOX PROGRAM 1988, Positive/dose response: Cell transform.-mouse prostate; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human, In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive/dose response: In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-human, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, UDS in mouse germ cells; EPA GENETOX PROGRAM 1988, Inconclusive: Cytogenetics-male germ cell, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro SCE-human lymphocytes, Mouse specific locus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 813 of 1119 in RTECS (through 2003/06) AN: MG0185000 PN: Guar-gum- SY: 1212A-; A-20D-; Cyamopsis-gum-; Dealca-TP1-; Dealca-TP2-; Decorpa-; Galactasol-; Gendriv-162-; Guar-; Guaran-; Guar-flour-; Burtonite-V-7-E-; Jaguar-; Jaguar-6000-; Jaguar-A-20-B-; Jaguar-A-20D-; Jaguar-A-40F-; Jaguar-gum-A-20-D-; Jaguar No.124; Jaguar-plus-; J-2Fp-; Gum-cyamopsis-; Gum-guar-; Indalca-AG-; Indalca-AG-BV-; Indalca-AG-HV-; Lycoid-DR-; NCI-C50395-; Regonol-; Rein-guarin-; Supercol G.F.; Supercol-U-powder-; Syngum-D-46D-; Uni-Guar- RN: Current: 9000-30-0 Previous: 57406-68-5; 57406-71-0 UD: 200302 CC: Tumorigen (C); Mutagen (M) TE: V02-A60 orl-rat TDLo: 1081500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-202813 (NTIS**); V02-N61 orl-rat TDLo: 901250 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-202813 (NTIS**) ORNG: 6770000000 ng/kg. [6770.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 6770 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 287, 1981 (FCTXAV); T/E unlistd orl-mus LD50: 8100 mg/kg Food and Drug Research Laboratories, Inc., Papers. (P.O. Box 107, Rt. 17C, Waverly, NY 14892-0107) v. 124, p. -, 1976 (FDRLI*); T/E unlistd orl-rbt LD50: 7 gm/kg Food and Drug Research Laboratories, Inc., Papers. (P.O. Box 107, Rt. 17C, Waverly, NY 14892-0107) v. 124, p. -, 1976 (FDRLI*); T/E unlistd orl-ham LD50: 6 gm/kg Food and Drug Research Laboratories, Inc., Papers. (P.O. Box 107, Rt. 17C, Waverly, NY 14892-0107) v. 124, p. -, 1976 (FDRLI*) MD: Z01 orl-rat TDLo: 228 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-229, 1982 (NTPTR*); M70-N22-U01 orl-rat TDLo: 451 gm/kg/91D-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 287, 1981 (FCTXAV); Z01 orl-mus TDLo: 1092 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-229, 1982 (NTPTR*); L60-V30 orl-mus TDLo: 2163000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-202813 (NTIS**) ND: NOHS 1974: HZD 83111; NIS 10; TNF 208; NOS 20; TNE 3024; NOES 1983: HZD 83111; NIS 20; TNF 2264; NOS 41; TNE 44736; TFE 6883 SL: EPA GENETOX PROGRAM 1988, Negative: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 814 of 1119 in RTECS (through 2003/06) AN: MG1017000 PN: Gum-tara- SY: NCI-C54364-; Tara-gum- RN: Current: 39300-88-4 UD: 200302 CC: Tumorigen (C) TE: V01-T61 orl-rat TDLo: 1081500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-195546 (NTIS**) AT: T/E unlistd orl-rat LD :>630 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NTP-TR-224, 1982 (NTIS**); T/E unlistd orl-mus LD :>630 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NTP-TR-224, 1982 (NTIS**) MD: U01 orl-rat TDLo: 70 gm/kg/14D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NTP-TR-224, 1982 (NTIS**); U01 orl-mus TDLo: 168 gm/kg/14D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NTP-TR-224, 1982 (NTIS**); K60-V30 orl-rat TDLo: 1081500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-195546 (NTIS**); J60-L60-V30 orl-mus TDLo: 2163000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-195546 (NTIS**) SL: NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 815 of 1119 in RTECS (through 2003/06) AN: MI5230000 PN: 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)- SY: C.I. 75300; C.I. Natural Yellow 3; Curcuma-; Curcumin-; Diferuloylmethane-; E-100-; Golden-seal-; Haidr-; Halad-; Haldar-; Halud-; Hydrastis-; Kacha-haldi-; Kurkumin- (Czech); Indian-saffron-; Indian-turmeric-; Merita-earth-; NCI-C61325-; Orange-Root-; Souchet-; Turmeric-Yellow-; Yellow-ginger-; Yellow-puccoon-; Yellow-root-; Yo-kin-; Zlut-prirodni-3- (Czech) RN: Current: 458-37-7 Previous: 33171-04-9 BRN: 2306965 BHR: 4-08-00-03697 UD: 200302 MF: C21-H20-O6 MW: 368.41 CC: Tumorigen (C); Mutagen (M); Natural-Product (N) ME: mnt-hmn-emb 73600 ug/L Senshokutai. Chromosome. (Sensyokutai Gakkai, Kaokusai Kirisutokyo Daigaku, Mitaka, Tokyo-to, Japan) No.1- 1946- Adopted new numbering in 1976. v. (20), p. 574, 1980 (SNSHBT); dni-hmn-hla 1 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 83, 1997 (CRNGDP); oms-hmn-hla 500 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 83, 1997 (CRNGDP); cyt-hmn-emb 36800 ug/L Senshokutai. Chromosome. (Sensyokutai Gakkai, Kaokusai Kirisutokyo Daigaku, Mitaka, Tokyo-to, Japan) No.1- 1946- Adopted new numbering in 1976. v. (20), p. 574, 1980 (SNSHBT); cyt-rat-bmr 7980 mg/kg/38W-C Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 62, p. 111, 1990 (CYTBAI); sce-mus-bmr 25 mg/kg Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 62, p. 111, 1990 (CYTBAI); mnt-hmn-lng 73600 ug/L Senshokutai. Chromosome. (Sensyokutai Gakkai, Kaokusai Kirisutokyo Daigaku, Mitaka, Tokyo-to, Japan) No.1- 1946- Adopted new numbering in 1976. v. (20), p. 574, 1980 (SNSHBT); cyt-ham-lng 20 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); dnd-ham-lng 10 umol/L/3H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 503, p. 21, 2002 (MUREAV); mnt-ham-lng 41 umol/L/3H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 503, p. 21, 2002 (MUREAV) TE: V02-L60-V16 orl-rat TDLo: 12600 mg/kg/6W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 143, p. 173, 1999 (CALEDQ) AT: T/E unlistd orl-rat LD :>2 gm/kg Planta Medica. (Georg Thieme Verlag, Postfach 732, D-7000 Stuttgart 1, Fed. Rep. Ger.) V.1- 1953- v. 64, p. 353, 1998 (PLMEAA); T/E unlistd orl-mus LD50: >2 gm/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 25, p. 447, 1973 (JPPMAB); T/E unlistd ipr-mus LD50: 1500 mg/kg Indian Journal of Medical Research. (Indian Council of Medical Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913- v. 64, p. 601, 1976 (IJMRAQ); Y15 orl-mus TDLo: 50 mg/kg Biological and pharmaceutical bulletin. (Pharmaceutical Society of Japan, 2-12-15, Shibuya, Shibuya-ku, Tokyo 150-0002, Japan) V.1- 1993- v. 25, p. 627, 2002 (BIPBU*) MD: L60-V25-V30 orl-mus TDLo: 62160 mg/kg/37W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 331, 2000 (CRNGDP); K60-V25-V30 orl-mus TDLo: 7000 mg/kg/10W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 921, 2000 (CRNGDP); R60-V25 orl-mus TDLo: 1000 mg/kg/10D-I Journal of Ethnopharmacology. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1979- v. 79, p. 27, 2002 (JOETD7); R60-V25 skn-mus TDLo: 1200 mg/kg/12D-I Journal of Ethnopharmacology. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1979- v. 79, p. 27, 2002 (JOETD7); J60-V25-V30 orl-mus TDLo: 737 mg/kg/10D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 141, p. 159, 1999 (CALEDQ) ND: NOES 1983: HZD X4425; NIS 3; TNF 145; NOS 3; TNE 690 SL: EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 816 of 1119 in RTECS (through 2003/06) AN: MN9275000 PN: Hexane- SY: Esani- (Italian); Gettysolve-B-; Heksan- (Polish); Hexanen- (Dutch); Hexyl-hydride-; NCI-C60571-; n-Hexane-; n-Hexane- (ACGIH:OSHA) RN: Current: 110-54-3 UD: 200210 MF: C6-H14 MW: 86.20 WL: 6H CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 10 mg MLD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 55, p. 501, 1980 (TXAPA9) ME: sln-smc 132 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 83, 1994 (MUREAV); cyt-ham-fbr 500 mg/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 623, 1984 (FCTOD7) RE: T85 ihl-rat TCLo: 10000 ppm/7H (15D pre/1-18D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 1, p. 152, 1981 (TOXID9); T81 ihl-rat TCLo: 1000 ppm/6H (8-16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 22A, 1979 (TJADAB); T34 ihl-rat TCLo: 5000 ppm/20H (6-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE88-006812 (NTIS**); T34 orl-mus TDLo: 238 gm/kg (6-15D preg) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 3, p. 393, 1980 (DCTODJ) TE: V01-T61 ihl-rat TCLo: 1000 ppm/4H/59W-I Journal of Occupational Health. (Japan Society for Occupational Health, 1-29-8 Shinjuku, Shinjuku-ku, Tokyo, 160, Japan) V.38- 1996- v. 41, p. 261, 1999 (JOCHFV); V02-L60 ihl-mus TCLo: 9018 ppm/6H/2Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0537874 (NTIS**) ORNG: 25000000000 ng/kg. [25000.000000 mg/kg] T/E unlistd IHPB: 48000000 ppb/4H. [48000.000000 ppm/4H] T/E unlistd AT: C18 ihl-hmn TCLo: 190 ppm/8W American Journal of Industrial Medicine. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 111, 1986 (AJIMD8); T/E unlistd orl-rat LD50: 25 gm/kg Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 32, p. 145, 1994 (INHEAO); T/E unlistd ihl-rat LC50: 48000 ppm/4H Annual Review of Pharmacology and Toxicology. (Annual Reviews, Inc., POB 10139, Palo Alto, CA 94303) V.16- 1976- v. 22, p. 145, 1982 (ARPTDI); T/E unlistd ipr-rat LDLo: 9100 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 1, p. 156, 1959 (TXAPA9); F01-J25-G30 ihl-mus LCLo: 120 gm/m3 Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 143, p. 223, 1929 (AEPPAE); F05 ivn-mus LDLo: 831 mg/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 37, p. 56, 1975 (APTOA6); T/E unlistd ivn-rbt LDLo: 132 mg/kg Haematologica. (Il Pensiero Scientifico Editore, Via Panama 48, I-00198, Rome, Italy) V.1- 1920- v. 58, p. 491, 1973 (HAEMAX); T01-T03 orl-rat TDLo: 20000 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 491, 1992 (REPTED); F13-D25 ihl-mam LC50: 126 gm/m3 "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 71, 1998 (VCVPS*) MD: B30-C16-Y40 ihl-rat TCLo: 2000 ppm/12H/24W-I Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 11, p. 323, 1992 (HETOEA); U01 orl-rat TDLo: 40 gm/kg/4W-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 1(3), p. 67, 1985 (TIHEEC); A11-F18-U01 ihl-rat TCLo: 1000 ppm/24H/11W-C Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 5, p. 69, 1983 (NTOTDY); A70-U01 ihl-rat TCLo: 1 pph/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 4, p. 191, 1984 (FAATDF); J30-Y03-Y10 ihl-rat TCLo: 476 ppm/6H/4W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 12, p. 13, 1982 (TOLED5); U01 ihl-rat TCLo: 3000 ppm/6H/2Y-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 14, p. 317, 1994 (TOXID9); C06-U01 ihl-rat TCLo: 500 ppm/24H/9W-C Journal of the Neurological Sciences. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) No.1- 1964- v. 57, p. 209, 1982 (JNSCAG); C15-C16-U01 ipr-rat TDLo: 18900 mg/kg/35D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 13, p. 835, 1984 (JTEHD6); L30-P28-Y20 ipr-rat TDLo: 4788 mg/kg/7D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 14, p. 169, 1982 (TOLED5); C16-U01-Y40 ihl-rat TCLo: 1200 ppm/12H/16W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 63, p. 381, 1989 (ARTODN); D07-F17-P70 ihl-mus TCLo: 10000 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-91-3121 (NTPTR*); C18-F19-Z01 ipr-ckn TDLo: 18 gm/kg/90D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 369, 1982 (TXAPA9); U01 orl-rat TDLo: 100000 mg/kg/5D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 491, 1992 (REPTED); J30-Y03-Y37 ihl-rat TCLo: 1700 mg/m3/6H/4W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 31, 1990 (VCVGH*); C10 ihl-hmn TCLo: 190 mg/m3/6Y-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 32, 1990 (VCVGH*); A10 ihl-gpg TCLo: 150000 mg/m3/1H/30D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 32, 1990 (VCVGH*) TR: ACGIH TLV-TWA 50 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: MSHA STANDARD-air: TWA 500 ppm (1800 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 126, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 500 ppm (1800 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 500 ppm (1800 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 500 ppm (1800 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 500 ppm (1800 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 50 ppm (180 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 50 ppm (180 mg/m3), JAN 1999; OEL-BELGIUM: TWA 50 ppm (176 mg/m3), JAN 1993; OEL-DENMARK: TWA 25 ppm (90 mg/m3), JAN 1999; OEL-FINLAND: TWA 50 ppm (180 mg/m3), STEL 150 ppm (530 mg/m3), JAN 1999; OEL-FRANCE: VME 50 ppm (170 mg/m3), JAN 1999; OEL-GERMANY: MAK 50 ppm (180 mg/m3), JAN 1999; OEL-HUNGARY: TWA 100 mg/m3, STEL 200 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 40 ppm (140 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 25 ppm (90 mg/m3), JAN 1999; OEL-NORWAY: TWA 25 ppm (90 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 500 ppm (1800 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 400 mg/me, JAN 1999; OEL-RUSSIA: TWA 40 ppm, STEL 300 mg/m3, JAN 1993; OEL-SWEDEN: NGV 25 ppm (90 mg/m3), KTV 50 ppm (180 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (180 mg/m3), KZG-W 100 ppm (360 mg/m3), JAN 1999; OEL-TURKEY: TWA 500 ppm (1800 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 20 ppm (72 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO HEXANE-air: 10H TWA 50 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 36955; NIS 281; TNF 72257; NOS 168; TNE 763261; NOES 1983: HZD 36955; NIS 221; TNF 40256; NOS 161; TNE 643101; TFE 138726 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/166688); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-1292-8628, 8EHQ-0893-8628; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrocarbons, BP 36-126 degree C, 1500; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NTP Toxicity studies, RPT# TOX-02, October 2000 Record 817 of 1119 in RTECS (through 2003/06) AN: MO1312000 PN: 1,6-Hexanediamine,-dihydrochloride- SY: 1,6-Diaminohexane-dihydrochloride-; 1,6-Hexamethylenediamine-dihydrochloride-; Hexamethylenediamine-dihydrochloride-; Hexanediamine-dihydrochloride- RN: Current: 6055-52-3 UD: 200012 MF: C6-H16-N2.2 Cl-H MW: 189.16 CC: Tumorigen (C) MD: L70 orl-rat TDLo: 3682 mg/kg/2W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3347 (NTPTR*); D07-J30-P72 ihl-rat TCLo: 50 mg/m3/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 348, 1993 (FAATDF); D07-J30-Z01 ihl-rat TCLo: 800 mg/m3/6H/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 348, 1993 (FAATDF); J02-N74-Z01 ihl-mus TCLo: 800 mg/m3/6H/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 348, 1993 (FAATDF); D07-J70-L70 ihl-mus TCLo: 160 mg/m3/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 348, 1993 (FAATDF) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Toxicity studies, RPT# TOX-24, October 2000 Record 818 of 1119 in RTECS (through 2003/06) AN: MP0770000 PN: 1-Hexanol,-2-ethyl-,-phosphate- SY: 2-Ethyl-1-hexanol-phosphate-; Disflamoll-TOF-; Flexol-TOF-; Kronitex-TOF-; Kronitexreg-; NCI-C54751-; Phosphoric acid tri(2-ethylhexyl) ester; Phosphoric acid, tris(2-ethylhexyl) ester; TOF-; Tri(2-ethylhexyl)phosphate; Triethylhexyl-phosphate-; Trioctyl-phosphate-; Tris(2-ethylhexyl)phosphate; Tris-(2-ethylhexyl)fosfat (Czech) RN: Current: 78-42-2 BRN: 1715839 BHR: 4-01-00-01786 UD: 200210 MF: C24-H51-O4-P MW: 434.72 WL: 4Y2&1OPO&O1Y4&2&O1Y4&2 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 250 mg MOD "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,606,1969 (34ZIAG); eye-rbt 500 mg MLD American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA) ME: mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V01-L60 orl-mus TDLo: 520 gm/kg/2Y-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 271, 1986 (EVHPAZ); V02-N61 orl-rat TDLo: 1030000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-171502/AS (NTIS**); V02-N62 orl-mus TDLo: 257500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-171502/AS (NTIS**); V01-L60 orl-mus TDLo: 515000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-171502/AS (NTIS**) ORNG: 37000000000 ng/kg. [37000.000000 mg/kg] T/E unlistd SRNG: 20000000000 ng/kg. [20000.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 37 gm/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30, p. 63, 1948 (JIHTAB); T/E unlistd ipr-rat LD50: 30 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528341 (NTIS**); T/E unlistd unr-rat LD50: 40 gm/kg "Practical Toxicology of Plastics," Lefaux, R., Cleveland, OH, Chemical Rubber Co., 1968 -,337,1968 (29ZWAE); T/E unlistd orl-mus LD50: 12800 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528341 (NTIS**); T/E unlistd ipr-mus LD50: 3200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528341 (NTIS**); T/E unlistd orl-rbt LD50: 46 gm/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1133,1986 (85JCAE); T/E unlistd skn-rbt LD50: 20 gm/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1133,1986 (85JCAE); T/E unlistd ihl-gpg LC50: 450 mg/m3/30M "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1133,1986 (85JCAE); T/E unlistd orl-mam LD50: 7600 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(4), p. 86, 1974 (GISAAA) MD: L70-M70-P28 orl-rat TDLo: 18900 mg/kg/9W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 13, p. 29, 1982 (TOLED5); U01 orl-rat TDLo: 46500 mg/kg/30D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528359 (NTIS**); U01 orl-rat TDLo: 4200 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-274, 1984 (NTPTR*); K30 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-274, 1984 (NTPTR*); F07-R21 orl-mus TDLo: 10080 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-274, 1984 (NTPTR*) ND: NOHS 1974: HZD 80228; NIS 6; TNF 108; NOS 22; TNE 3565; NOES 1983: HZD 80228; NIS 1; TNF 40; NOS 1; TNE 1209; TFE 725 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-274, 1984 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 819 of 1119 in RTECS (through 2003/06) AN: MU1050000 PN: Hydantoin,-5,5-diphenyl- SY: 5,5-Diphenyl-2,4-imidazolidinedione-; 5,5-Diphenylhydantoin-; 5,5-Diphenylhydantoin- (IUPAC); 5,5-Diphenylimidazolidin-2,4-dione-; 5,5-Dwufenylohydantoina- (Polish); Aleviatin-; DPH-; Danten-; Dantoinal-; Dantoinal-klinos-; Dantoine-; Denyl-; Di-Hydan-; Di-Lan-; Difenilhidantoina- (Spanish); Dilabid-; Dintoina-; Diphantoin-; Diphedan-; Diphenylhydantoin-; Diphenylhydantoine- (French); Ekko-capsules-; Elepsindon-; Enkelfel-; Epamin-; Epdantoine-simple-; Fenitoina-; Fentoin-; Gerot-epilan-D-; Hidantal-; Hidantilo-; Ictalis-simple-; Kessodanten-; Lepsin-; Minetoin-; NCI-C55765-; Neos-hidantoina-; Neosidantoina-; Novantoina-; OM-hidantoina-simple-; OM-Hydantoine-; Phentoin-; Phenytoin-; Ritmenal-; Silantin-; Sodanton-; Zentropil- RN: Current: 57-41-0 Previous: 125-59-7 UD: 200302 MF: C15-H12-N2-O2 MW: 252.29 WL: T5MVMV EHJ ER& ER CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: dna-esc 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 100 mg/L Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 99, p. 257, 1979 (VIRLAX); dni-hmn-lym 360 umol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 33, p. 38, 1975 (TXAPA9); cyt-hmn-lym 40 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 623, 1988 (MUREAV); cyt-hmn-leu 100 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 109, p. 961, 1971 (AJOGAH); mtr-rat-orl 1260 mg/kg/6W Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 387, 1988 (CRNGDP); sce-mus-ipr 10 mg/kg Archivos de Investigacion Medica. (POB 12,631, Col. Narvarte, Deleg. Benito Juarez, 03020 Mexico City, DF, Mexico) V.1- 1970- v. 21, p. 211, 1990 (AIVMBU); mtr-ham-emb 100 mg/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 2, p. 103, 1988 (TIVIEQ); sce-ham-ovr 1600 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T43 orl-wmn TDLo: 1080 mg/kg (1-39W preg) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 702, 1971 (LANCAO); T42-T43-T47 orl-wmn TDLo: 1620 mg/kg (1-39W preg) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 481, 1980 (LANCAO); T81-T85-T86 orl-wmn TDLo: 3240 mg/kg (1-39W preg) Clinical Genetics. (Munksgaard International Publishers, POB2148, DK-1016 Copenhagen K, Denmark) V.1- 1970- v. 51, p. 343, 1997 (CLGNAY); T43-T86-T91 orl-wmn TDLo: 1365 mg/kg (1-39W preg) Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 89, p. 662, 1976 (JOPDAB); T44-T46-T59 orl-wmn TDLo: 540 mg/kg (1-39W preg) Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 87, p. 285, 1975 (JOPDAB); T44-T86-T91 unr-wmn TDLo: 3675 mg/kg (1-35W preg) Obstetrics and Gynecology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1953- v. 52, p. 682, 1978 (OBGNAS); T47-T87 unr-wmn TDLo: 1620 mg/kg (1-39W preg) Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 89, p. 662, 1976 (JOPDAB); T81 unr-wmn TDLo: 540 mg/kg (1-39W preg) Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 89, p. 662, 1976 (JOPDAB); T42 orl-rat TDLo: 800 mg/kg (11-14D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 30, p. 309, 1990 (CGANE7); T83 orl-rat TDLo: 50 mg/kg (7-16D preg) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 28, p. 2585, 1979 (BCPCA6); T75-T81-T85 orl-rat TDLo: 2400 mg/kg (7-18D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 11, p. 295, 1989 (NETEEC); T46-T81-T85 orl-rat TDLo: 1300 mg/kg (7-19D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24, p. 115, 1981 (TJADAB); T26-T35 orl-rat TDLo: 540 mg/kg (9-17D preg) East African Medical Journal. (P.O. Box 41632, Nairobi, Kenya) V.9- 1932- v. 60, p. 407, 1983 (EAMJAV); T41-T81 orl-rat TDLo: 2400 mg/kg (7-18D preg) International Journal of Developmental Neuroscience. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1983- v. 8, p. 283, 1990 (IJDND6); T85 orl-rat TDLo: 600 mg/kg (7-18D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 20, p. 123, 1998 (NETEEC); T19-T72-T85 orl-rat TDLo: 2400 mg/kg (7-18D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 21, p. 567, 1999 (NETEEC); T14-T29 ipr-rat TDLo: 50 mg/kg (1D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 119, p. 982, 1965 (PSEBAA); T45-T53 ipr-rat TDLo: 338 mg/kg (12-14D preg) Dissertation Abstracts International, B: The Sciences and Engineering. (University Microfilms International, 300 N. Zeeb Rd., Ann Arbor, MI 48106) V.30- 1969- v. 36, p. 2145, 1975 (DABBBA); T41-T53 ipr-rat TDLo: 150 mg/kg (11D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 22, p. 193, 1972 (TXAPA9); T34-T35 ipr-rat TDLo: 100 mg/kg (11D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 22, p. 193, 1972 (TXAPA9); T46 ipr-rat TDLo: 150 mg/kg (14D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 22, p. 193, 1972 (TXAPA9); T25-T31-T34 scu-rat TDLo: 900 mg/kg (10-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 12, p. 291, 1975 (TJADAB); T46 scu-rat TDLo: 900 mg/kg (10-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 12, p. 291, 1975 (TJADAB); T43 scu-rat TDLo: 600 mg/kg (13-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 22, p. 193, 1972 (TXAPA9); T85 scu-rat TDLo: 120 mg/kg (15-22D preg) Psychological Reports. (Southern Univ. Press, Baton Rouge, LA 70813) V.1- 1952- v. 47, p. 1163, 1980 (PYRTAZ); T87 scu-rat TDLo: 1050 mg/kg (1-21D preg) Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 58, p. 78, 1982 (PJABDW); T23 scu-rat TDLo: 4800 mg/kg (60D male) Journal of Neurology, Neurosurgery and Psychiatry. (British Medical Journal, POB 560B, Kennebunkport, ME 04046) V.7- 1944- v. 41, p. 858, 1978 (JNNPAU); T23 par-rat TDLo: 4800 mg/kg (60D male) Israel Journal of Medical Sciences. (POB 1435, Jerusalem 91013, Israel) V.1- 1965- v. 15, p. 615, 1979 (IJMDAI); T27 orl-mus TDLo: 85 mg/kg (10D preg) Journal of Dental Research. (International Assoc. for Dental Research, 734 15th St., NW, Suite 809, Washington, DC 20005) V.1- 1919- v. 57, p. 362, 1978 (JDREAF); T47-T53 orl-mus TDLo: 640 mg/kg (14D pre/1-18D preg) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 211, p. 483, 1981 (SCIEAS); T46 orl-mus TDLo: 150 mg/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 6, p. 323, 1976 (TXCYAC); T42-T54 orl-mus TDLo: 400 mg/kg (9-18D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 33A, 1982 (TJADAB); T43 orl-mus TDLo: 45 mg/kg (12D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 53, 1975 (TXAPA9); T72-T75-T81 orl-mus TDLo: 630 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 361, 1986 (TCMUD8); T33 ipr-mus TDLo: 58 mg/kg (13D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 18(Suppl 1), p. 109, 1983 (TOLED5); T83 ipr-mus TDLo: 88 mg/kg (9D preg) Pediatric Research. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1967- v. 11, p. 528, 1977 (PEREBL); T24-T25-T43 ipr-mus TDLo: 150 mg/kg (11-13D preg) Journal of Dental Research. (International Assoc. for Dental Research, 734 15th St., NW, Suite 809, Washington, DC 20005) V.1- 1919- v. 58, p. 1918, 1979 (JDREAF); T39 ipr-mus TDLo: 75 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 32A, 1976 (TJADAB); T46 ipr-mus TDLo: 50 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 2, p. 305, 1969 (TJADAB); T25-T41-T53 ipr-mus TDLo: 88 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 45, 1979 (TJADAB); T25 scu-mus TDLo: 100 mg/kg (11D preg) Carcinogenesis--A Comprehensive Survey. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1976- v. 3, p. 401, 1978 (CCSUDL); T43 ims-mus TDLo: 100 mg/kg (10D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 173, p. 82, 1983 (PSEBAA); T39 par-mus TDLo: 88 mg/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 17, p. 34A, 1978 (TJADAB); T43 par-mus TDLo: 263 mg/kg (11-13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 15, p. 17A, 1977 (TJADAB); T46 unr-mus TDLo: 75 mg/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 33, p. 41C, 1986 (TJADAB); T46-T47 unr-mus TDLo: 106 mg/kg (8-10D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 38, p. 438, 1979 (FEPRA7); T53 unr-mky TDLo: 210 mg/kg (25-45D preg) "Medical Primatology, Selected Papers from the 3rd Conference on Experimental Medicine and Surgery in Primates, Lyons, France, 1972," Goldsmith, E.I. and J. Moor-Jankowski, eds., White Plains, NY, Albert J. Phiebig Inc., 1972 Pt III,286,1972 (27CWAL); T46 orl-rbt TDLo: 300 mg/kg (16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 45, p. 247, 1992 (TJADAB); T43-T46 orl-rbt TDLo: 450 mg/kg (14-16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 46, p. 485, 1992 (TJADAB); T43 unr-rbt TDLo: 450 mg/kg (6-8D preg) "Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, Proceedings of a Symposium, Nottingham, UK, 1975," Legg, N.J., et al., eds., Kent, UK, MCS Consultants, 1976 -,105,1976 (36DLAV); T25-T35 orl-mam TDLo: 330 mg/kg (8-18D preg) Experimental Animals. Jikken Dobutso Iho. (Nippon Jikken Dobutsu Gakkai, c/o Keio Gijuku Daigaku Igakubu Jikken Dobutsu Senta, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.1- 1952- v. 35, p. 387, 1986 (JIDOAA) TE: V01-T65-M61 orl-wmn TDLo: 1620 mg/kg (1-39W preg) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 481, 1980 (LANCAO); V01-T65-A60 orl-wmn TDLo: 1620 mg/kg (1-39W preg) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 244, p. 1464, 1980 (JAMAAP); V01-P62 orl-wmn TDLo: 730 mg/kg/1Y-C Nippon Ketsueki Gakkai Zasshi. Journal of Japan Haematological Society. (Nippon Ketsueki Gakkai, Kyoto Daigaku Igakubu, Fuzoku Byoin, 54 Kawara-machi, Shogoin, Sakyo-ku, Kyoto 606, Japan) V.1- 1937- v. 46, p. 1, 1983 (NKGZAE); V01-T65-A60 unr-wmn TDLo: 1620 mg/kg (1-39W preg) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 244, p. 1464, 1980 (JAMAAP); V01-T65-M61 unr-wmn TDLo: 1620 mg/kg (1-39W preg) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 481, 1980 (LANCAO); V03-R60 orl-rat TDLo: 1500 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 26, p. 619, 1966 (CNREA8); V01-L60 orl-mus TDLo: 52560 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-404, 1993 (NTPTR*); V03-R60 orl-rat TD :1500 mg/kg/27D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 28, p. 924, 1968 (CNREA8); V01-P62 orl-wmn TD :730 mg/kg/1Y-C Nippon Ketsueki Gakkai Zasshi. Journal of Japan Haematological Society. (Nippon Ketsueki Gakkai, Kyoto Daigaku Igakubu, Fuzoku Byoin, 54 Kawara-machi, Shogoin, Sakyo-ku, Kyoto 606, Japan) V.1- 1937- v. 43, p. 711, 1980 (NKGZAE); V02-P62-R60 orl-chd TD :6023 mg/kg/1Y-C Australasian Journal of Dermatology. (Australasian College of Dermatologists, 271 Bridge Rd., Glebe, N.S.W., Australia) V.9- 1967- v. 22, p. 28, 1981 (AJDEBP); V03-L60 orl-rat TD :105 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-404, 1993 (NTPTR*); V03-P60-P62 orl-mus TD :5284 mg/kg/17W-C Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 78, p. 290, 1972 (ZKKOBW); V02-L60 orl-rat TDLo: 103824 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-216009 (NTIS**); V01-L60 orl-mus TDLo: 17304 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-216009 (NTIS**) ORNG: 1635000000 ng/kg. [1635.000000 mg/kg] F04-F05-F18 AT: F07-F08-F19 orl-wmn TDLo: 200 mg/kg Annals of Emergency Medicine. (American College of Emergency Physicians, 1125 Executive Circle, Irving, TX 75038) v. 16, p. 1387, 1987 (AEMED3); R03 orl-chd TDLo: 3 mg/kg/3W Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 20, p. 48, 1976 (CLPTAT); P16-J02-J30 orl-wmn TDLo: 540 mg/kg/90D-I American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 87, p. 93, 1989 (AJMEAZ); T/E unlistd orl-chd LDLo: 100 mg/kg Neurology. (Modern Medicine Pub., Inc., 1 E. First St., Duluth, MN 55802) V.1- 1951- v. 11, p. 138, 1961 (NEURAI); F17-F19 orl-chd TDLo: 11 mg/kg/D American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 130, p. 75, 1976 (AJDCAI); A05-F08-F33 orl-man TDLo: 31 mg/kg/4D-I Journal of Clinical Gastroenterology. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) v. 9, p. 337, 1987 (JCGADC); A05-F08-F19 orl-wmn TDLo: 106 mg/kg/2W-I Journal of Clinical Gastroenterology. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) v. 9, p. 337, 1987 (JCGADC); P30 orl-man TDLo: 1300 mg/kg Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 69, p. 557, 1968 (AIMEAS); L12-P30-R03 orl-chd TDLo: 140 mg/kg/2W-I Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 28, p. 943, 1961 (PEDIAU); F17 ivn-chd TDLo: 15 mg/kg Clinical Pediatrics (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1962- v. 24, p. 467, 1985 (CPEDAM); F05-F13-F23 ivn-chd TDLo: 15 mg/kg Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 72, p. 831, 1983 (PEDIAU); F13-F23 unr-chd TDLo: 18 mg/kg/3D-I Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 72, p. 831, 1983 (PEDIAU); F04-F05-F18 orl-rat LD50: 1635 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 33, p. 1168, 1983 (ARZNAD); T/E unlistd ipr-rat LD50: 352 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 193, p. 37, 1971 (AIPTAK); T/E unlistd scu-rat LD50: >1500 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 30, p. 477, 1980 (ARZNAD); F05 ivn-rat LD50: 101 mg/kg Japanese Kokai Tokyo Koho Patents. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) #79-163823 (JKXXAF); F02 orl-mus LD50: 150 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 18, p. 383, 1975 (JMCMAR); T/E unlistd ipr-mus LD50: 100 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 24, p. 465, 1981 (JMCMAR); T/E unlistd scu-mus LD50: 110 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 4, p. 723, 1954 (ARZNAD); T/E unlistd ivn-mus LD50: 92 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 4, p. 723, 1954 (ARZNAD); T/E unlistd unr-mus LD50: 800 mg/kg Acta Pharmaceutica Suecica. (Apotekarsocieteten-Farmacevtiska Foereningen, Box 1136, S-111, 81 Stockholm, Sweden) V.1- 1964- v. 2, p. 155, 1965 (APSXAS); T/E unlistd ivn-dog LD50: 90 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 -,224,1972 (27ZQAG); T/E unlistd orl-rbt LD50: >3 gm/kg French Medicament Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Discontinued. #2292M (FMXXAJ); F12-J26 ivn-rbt LD50: 56400 ug/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 33, p. 1168, 1983 (ARZNAD); F02 orl-mam LD50: 250 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 8, p. 836, 1965 (JMCMAR); F23 ipr-mus TDLo: 20 mg/kg Journal of Ethnopharmacology. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1979- v. 78, p. 73, 2001 (JOETD7) MD: L70-P28-Y21 ipr-rat TDLo: 21500 ug/kg/5D-I Clinica Chimica Acta. (Elsevier Science B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1956- v. 289, p. 1, 1999 (CCATAR); U01 orl-mus TDLo: 1865 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-404, 1993 (NTPTR*); A30-Y21 ipr-mus TDLo: 1 gm/kg/5D-I British Journal of Pharmacology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.34- 1968- v. 126, p. 1634, 1999 (BJPCBM); L30-N30-Y07 orl-rat TDLo: 700 mg/kg/7D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 111, p. 263, 1991 (TXAPA9); Y16 orl-rat TDLo: 1400 mg/kg/14D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 111, p. 263, 1991 (TXAPA9) TR: IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 13, p. 201, 1977 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 319, 1987 (IMSUDL); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 175, 1996 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 175, 1996 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 319, 1987 (IMSUDL); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 175, 1996 (IMEMDT); TOXICOLOGY REVIEW Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969- v. 8, p. 690, 1974 (DICPBB); TOXICOLOGY REVIEW Australian Journal of Hospital Pharmacy. (B.R. Miller, POB 125, Heidelberg, Vic., Australia) V.1- 1971- v. 4(1), p. 5, 1974 (AUHPAI); TOXICOLOGY REVIEW Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. (ADIS Press International Inc., Suite B-30, Oxford Ct. Business Center, 582 Middletown Blvd., Langhorne, PA 19047) V.1- 1971- v. 8, p. 354, 1974 (DRUGAY); TOXICOLOGY REVIEW Internist. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1960- v. 15, p. 7, 1974 (INTEAG); TOXICOLOGY REVIEW Epilepsia (New York). (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) Ser.1-3: 1909-55: Ser.4: V.1- 1959- v. 16, p. 159, 1975 (EPILAK); TOXICOLOGY REVIEW Clinical Chemistry (Winston-Salem, NC). (American Assoc. for Clinical Chemistry, 1725 K St., NW, Washington, DC 20006) V.1- 1955- v. 19, p. 361, 1973 (CLCHAU); TOXICOLOGY REVIEW Proceedings of the Royal Society of Medicine. (New York, NY) V.1-70, 1907-77. For publisher information, see JRSMD9. v. 63, p. 48, 1970 (PRSMA4); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6); TOXICOLOGY REVIEW British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 442, 1973 (BMJOAE); TOXICOLOGY REVIEW Deutsche Medizinische Wochenschrift. (Stuttgart, Fed. Rep. Ger.) V.1-104, 1875-1979. v. 105, p. 719, 1980 (DMWOAX); TOXICOLOGY REVIEW Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 18A, 1979 (TJADAB); TOXICOLOGY REVIEW Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 8, p. 259, 1973 (BIREBV); TOXICOLOGY REVIEW "Phenytoin-Induced Teratology and Gingival Pathology," Hassell, T.M., et al., eds., New York, Raven Press, 1980 -,83,1980 (43VSAU); TOXICOLOGY REVIEW Journal of the American Dental Association. (American Dental Assoc., 211 E. Chicago Ave., Chicago, IL 60611) V.9- 1922- v. 99, p. 652, 1979 (JADSAY) ND: NOHS 1974: HZD 80404; NIS 2; TNF 182; NOS 8; TNE 3344; NOES 1983: HZD 80404; NIS 5; TNF 1154; NOS 10; TNE 23400; TFE 16795 SL: EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-human; NCI Carcinogenesis Studies (feed), clear evidence: mouse; NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 820 of 1119 in RTECS (through 2003/06) AN: MU2800000 PN: Hydantoin, 1-((5-nitrofurfurylidene)amino)- SY: 1-(((5-Nitro-2-furanyl)methylene)amino-2,4-imidazolidinedione); 1-((5-Nitrofurfurylidene)amino)hydantoin; 1-(5-Nitro-2-furfurylideneamino)-hydantoin; 2,4-Imidazolidinedione, 1-(((5-nitro-2-furanyl)methylene)amino)-; Berkfurin-; Chemiofuran-; Cyantin-; Dantafur-; Furadantin-; Furadantoin-; Furadonin-; Furadonine-; Furantoin-; Furatoin-; Furobactina-; Ituran-; Macrobid-; Macrodantin-; N-(5-Nitro-2-furfurlidene)-1-aminohydantoin; N-(5-Nitro-2-furfurylidene)-1-aminohydantoin; N-(5-Nitro-2-furfurylideno)-1-aminohydantoina (Polish); N-(5-Nitrofurfurylidene)-1-aminohydantoin; NCI-C55196-; NSC-2107-; Nifurantin-; Nitrofurantoin-; Orafuran-; USAF-EA-2-; Urizept-; Welfurin-; Zoofurin- RN: Current: 67-20-9 UD: 200305 MF: C8-H6-N4-O5 MW: 238.18 WL: T5OJ BNW E1UN- AT5NVMV EHJ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 100 ng/plate (+S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); mmo-sat 300 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); dnr-sat 500 nmol/well Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 2266, 1974 (CNREA8); mmo-esc 100 ug/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 175, p. 149, 1986 (MUREAV); oms-esc 3200 nmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 58, p. 69, 1986 (CBINA8); mmo-esc 10 mg/L (+S9) British Journal of Cancer, Supplement. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2ZS, UK) No.1- 1973- v. 3, p. 124, 1978 (BJCSB5); dnr-esc 2 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); pic-esc 2 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 244, p. 55, 1990 (MUREAV); dnr-bcs 2 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); mrc-smc 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 145, 1979 (MUREAV); dnd-omi 120 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 244, p. 55, 1990 (MUREAV); pic-omi 500 ug/L Comptes Rendus des Seances de l'Academie des Sciences, Serie D: Sciences Naturelles. (Paris, France) V.262-291, 1966-80. For publisher information, see CRASEV. v. 272, p. 886, 1971 (CHDDAT); slt-dmg-orl 5 mmol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 359, 1989 (MUREAV); sln-asn 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 159, 1974 (MUREAV); mmo-eug 10 mg/L (-S9) Journal of Protozoology. (Soc. of Protozoologists, P.O. Box 368, Lawrence, KS 66044) V.1- 1954- v. 17, p. 129, 1970 (JPROAR); dnd-ofs-ims 10 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 80, p. 317, 1991 (CBINA8); dnd-hmn-oth 112 gm/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 45, p. 77, 1983 (CBINA8); bfa-hmn-sat 1400 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 58, p. 871, 1977 (JNCIAM); dnd-rat-ipr 56 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 45, p. 77, 1983 (CBINA8); dnd-rat-lvr 112 gm/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 45, p. 77, 1983 (CBINA8); bfa-rat-smc 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 145, 1979 (MUREAV); bfa-rat-sat 1 gm/kg/4D-C Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 15, p. 69, 1976 (CBINA8); hma-rat-smc 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 145, 1979 (MUREAV); spm-rat-unr 16 mg/kg/8D Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 112, p. 348, 1974 (JOURAA); dnd-mus-ipr 64 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 45, p. 77, 1983 (CBINA8); dnd-mus-oth 430 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 16, p. 223, 1977 (CBINA8); dni-mus-oth 50 mg/L Revista de Chirurgui, Oncologie, Radiologie, ORL, Oftalmologie, Stomatologie, Seria: Oncologia. (Rompresfilatelia, POB 12-201, Bucharest, Romania) V.13(4)- 1974- v. 19, p. 183, 1980 (ONCODU); sce-mus-ipr 64 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 45, p. 77, 1983 (CBINA8); msc-mus-lym 100 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); mmo-ham-ovr 200 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 225, p. 181, 1989 (MUREAV); cyt-ham-ovr 900 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); cyt-ham-lng 100 mg/L Applied Methods in Oncology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 3, p. 253, 1980 (AMONDS); cyt-ham-fbr 60 mg/L Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (96), p. 55, 1978 (ESKHA5); sce-ham-ovr 33 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); msc-ham-ovr 200 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 225, p. 181, 1989 (MUREAV); mmo-esc 150 gm/L/40M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 479, p. 37, 2001 (MUREAV); cyt-hmn-orl 80 mg/kg/30D Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 31, 2002 (MUTAEX); sce-hmn-orl 170 mg/kg/90D Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 31, 2002 (MUTAEX); cyt-hmn-lym 5 umol/L/24H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 31, 2002 (MUTAEX); sce-hmn-lym 40 umol/L/24H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 31, 2002 (MUTAEX); mtr-mus-fbr 1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T01 orl-man TDLo: 140 mg/kg (14D male) Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 77, p. 275, 1957 (JOURAA); T02-T09 orl-rat TDLo: 2100 mg/kg (14D male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 53, p. 585, 1953 (ENDOAO); T25 orl-rat TDLo: 1740 mg/kg (8W male/2W pre-2W preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 13, p. 811, 1984 (JTEHD6); T75-T81 orl-rat TDLo: 1920 mg/kg (8W male/2W pre-3W preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 13, p. 811, 1984 (JTEHD6); T12 orl-mus TDLo: 105 gm/kg (43W pre) Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 17, p. 774, 1989 (TOPADD); T24 orl-mus TDLo: 87500 ug/kg (5D male) Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. v. 17, p. 405, 1976 (PESTD5); T44 scu-mus TDLo: 75 mg/kg (9-11D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 16, p. 250, 1976 (SEIJBO); T59 unr-mus TDLo: 750 mg/kg (9-11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 14, p. 250, 1976 (TJADAB); T72-T81 orl-mus TDLo: 5.04 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-175354 (NTIS**); T26-T53 orl-mus TDLo: 144 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-175354 (NTIS**) TE: V02-M60 orl-rat TDLo: 10815 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); V01-T63 orl-mus TDLo: 21630 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); V02-R60 orl-rat TD :135 gm/kg/2Y-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 21, p. 303, 1984 (CALEDQ); V02-M61-N10 orl-rat TDLo: 5460 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-197930/AS (NTIS**); V02-T69 orl-rat TDLo: 21630 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-197930/AS (NTIS**); V01-Q60 orl-rat TDLo: 79310 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-197930/AS (NTIS**); V01-L60-P62 orl-mus TDLo: 216300 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-197930/AS (NTIS**) ORNG: 604000000 ng/kg. [604.000000 mg/kg] T/E unlistd AT: J13-J22-L14 orl-wmn TDLo: 365 mg/kg/1Y-I Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1925- v. 73, p. 519, 1997 (PGMJAO); M05-M13-P72 orl-man TDLo: 40 mg/kg/2W-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 348, p. 1177, 1996 (LANCAO); C16-F19 orl-hmn TDLo: 80 mg/kg Archives of Neurology (Chicago). (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.3- 1960- v. 18, p. 680, 1968 (ARNEAS); A03-D14-F07 orl-man TDLo: 29 mg/kg/20D-I Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969- v. 22, p. 345, 1988 (DICPBB); P23 orl-wmn TDLo: 24 mg/kg American Journal of Clinical Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1931- v. 58, p. 408, 1972 (AJCPAI); L01-L12-L14 orl-wmn TDLo: 42 mg/kg/6W-I Medical Journal of Australia. (Australasian Medical Pub. Co. Ltd., 71-79 Arundel St., Glebe, N.S.W., Australia) V.1- 1914- v. 156, p. 347, 1992 (MJAUAJ); M16 unr-hmn TDLo: 60 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 1044, 1976 (BMJOAE); T/E unlistd orl-rat LD50: 604 mg/kg Research Progress in Organic-Biological and Medicinal Chemistry. (New York, NY) V.1-3, 1964-72. Discontinued. v. 2, p. 303, 1970 (RPOBAR); T/E unlistd ipr-rat LD50: 112 mg/kg Research Progress in Organic-Biological and Medicinal Chemistry. (New York, NY) V.1-3, 1964-72. Discontinued. v. 2, p. 303, 1970 (RPOBAR); T/E unlistd orl-mus LD50: 360 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 16, p. 312, 1973 (JMCMAR); T/E unlistd ipr-mus LD50: 100 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd orl-ckn LD50: 53 mg/kg Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 112, p. 1741, 1982 (JONUAI); T/E unlistd orl-mam LDLo: 250 mg/kg Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- v. 102, p. 505, 1963 (BCFAAI) MD: F15-U01 orl-rat TDLo: 3500 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); L70-Z01 orl-rat TDLo: 45500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); F15-Z01 orl-mus TDLo: 63 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); L70-Z01 orl-mus TDLo: 3276 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); T14-U01 orl-mus TDLo: 4032 mg/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-175354 (NTIS**); M71-T14 orl-mus TDLo: 21168 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-175354 (NTIS**); M71-T02 orl-mus TDLo: 21168 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB93-175354 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 211, 1990 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 211, 1990 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 211, 1990 (IMEMDT); TOXICOLOGY REVIEW Carcinogenesis--A Comprehensive Survey. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1976- v. 4, p. 171, 1978 (CCSUDL); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 2, p. 365, 1973 (CRTXB2); TOXICOLOGY REVIEW Texas Reports on Biology and Medicine. (Galveston, TX) V.1-41(2), 1943-81/82. Discontinued. v. 25, p. 270, 1967 (TRBMAV) ND: NOES 1983: HZD 84411; NIS 1; TNF 171; NOS 5; TNE 3756; TFE 2239 SL: EPA GENETOX PROGRAM 1988, Positive: Body fluid assay, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: TRP reversion, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive/dose response: TRP reversion; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat, Sperm morphology-human; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), clear evidence: mouse; NTP Carcinogenesis Studies (feed), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-341, 1989 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: rat Record 821 of 1119 in RTECS (through 2003/06) AN: MU7175000 PN: Hydrazine- SY: Hydrazine- (ACGIH:OSHA); Hydrazine-fume-; Hydrazyna- (Polish); Levoxine-; Nitrogen-hydride-; Oxytreat-35-; RCRA-waste-number-U133- RN: Current: 302-01-2 UD: 200305 MF: H4-N2 MW: 32.06 WL: ZZ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 120 ug/plate (-S9) Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 97, p. 137, 1978 (BIZNAT); mmo-esc 4300 umol/L (+S9) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31, p. 131, 1986 (TOLED5); oms-esc 80 pmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); dna-esc 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); oms-bcs 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 5, p. 343, 1968 (MUREAV); mmo-hmi 2 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 30, p. 9, 1975 (MUREAV); mmo-omi 70 ug/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 173, p. 233, 1986 (MUREAV); sln-dmg-orl 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 16, p. 363, 1972 (MUREAV); mmo-smc 200 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 339, 1982 (MUREAV); mtr-hmn-lvr 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-hmn-oth 35 mg/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 17, p. 719, 1981 (ITCSAF); dni-hmn-hla 50 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 59, 1984 (CNREA8); dnd-rat-lvr 3 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 357, 1983 (MUREAV); dns-rat-orl 60 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 953, 1983 (CRNGDP); dns-rat-lng 250 ug/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A075-605 (NTIS**); dni-rat-orl 60 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 953, 1983 (CRNGDP); dnd-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 415, p. 1, 1998 (MUREAV); dnd-mus-orl 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 415, p. 1, 1998 (MUREAV); dni-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); msc-mus-lym 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 321, 1981 (MUREAV); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); dnd-ham-orl 15 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 59, 1983 (PAACA3); dns-ham-ovr 250 ug/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A075-605 (NTIS**); dns-ham-lng 250 ug/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A075-605 (NTIS**); dnd-mam-lym 95 pph Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 174, p. 591, 1969 (BBACAQ) RE: T25 ihl-rat TCLo: 4 mg/m3/2H (7-20D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(10), p. 23, 1974 (GISAAA); T34-T35 ihl-rat TCLo: 1 mg/m3/24H (1-11D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(10), p. 23, 1974 (GISAAA); T25 skn-rat TDLo: 50 mg/kg (9D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A119-706 (NTIS**); T25 ipr-rat TDLo: 100 mg/kg (6-15D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A21, 1980 (APTOD9); T34 ipr-rat TDLo: 50 mg/kg (6-15D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A21, 1980 (APTOD9); T41-T46-T53 ipr-rat TDLo: 30 mg/kg (7-9D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A119-706 (NTIS**); T25-T34 ipr-rat TDLo: 30 mg/kg (7-9D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A119-706 (NTIS**); T34-T35-T75 scu-rat TDLo: 80 mg/kg (11-20D preg) Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 21, p. 615, 1970 (AEHLAU); T34-T46 ipr-mus TDLo: 48 mg/kg (6-9D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A084-023 (NTIS**); T41-T53 ipr-mus TDLo: 80 mg/kg (6-9D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A084-023 (NTIS**); T02 ihl-ham TCLo: 1 ppm/6H (1Y male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 1050, 1985 (FAATDF); T34 ihl-rat TCLo: 1 mg/m3 (1-22D preg) "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1989 (VCVN5*) TE: V02-L60 orl-rat TDLo: 900 mg/kg/2Y-C Experimental Pathology (1981). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.19- 1981- v. 33, p. 133, 1988 (EXPADD); V01-N62 ihl-rat TCLo: 5 ppm/6H/1Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 1050, 1985 (FAATDF); V02-J60-P62 orl-mus TDLo: 1951 mg/kg/2Y-C International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 9, p. 109, 1972 (IJCNAW); V03-D09 ihl-mus TCLo: 1 ppm/6H/1Y-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 74, 1980 (PAACA3); V01-P60-P61 ipr-mus TDLo: 400 mg/kg/5W-I UICC Monograph Series. International Union Against Cancer. (Secaucus, NJ) V.1-12, 1967-69(?). v. 7, p. 180, 1967 (UICMAI); V03-K61 ihl-ham TCLo: 1 ppm/6H/1Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 1050, 1985 (FAATDF); V03-D09 ihl-rat TC :5 ppm/6H/1Y-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 74, 1980 (PAACA3); V03-D09 ihl-rat TC :1 ppm/6H/1Y-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 74, 1980 (PAACA3); V03-D09 ihl-ham TC :5 ppm/6H/1Y-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 74, 1980 (PAACA3) ORNG: 60000000 ng/kg. [60.000000 mg/kg] T/E unlistd SRNG: 91000000 ng/kg. [91.000000 mg/kg] T/E unlistd IHPB: 570000 ppb/4H. [570.000000 ppm/4H] D35-F12-J22 AT: T/E unlistd orl-rat LD50: 60 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); D35-F12-J22 ihl-rat LC50: 570 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 12, p. 609, 1955 (AMIHAB); T/E unlistd ipr-rat LD50: 59 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); T/E unlistd ivn-rat LD50: 55 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); T/E unlistd ims-rat LD50: 53500 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 16(6), p. 53, 1972 (GISAAA); T/E unlistd orl-mus LD50: 59 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); D35-F12-J22 ihl-mus LC50: 252 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 12, p. 609, 1955 (AMIHAB); T/E unlistd ipr-mus LD50: 62 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); T/E unlistd ivn-mus LD50: 57 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); T/E unlistd unr-mus LD50: 200 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 6, p. 160, 1952 (BJCAAI); T/E unlistd skn-dog LDLo: 96 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 186, 1972 (TXAPA9); T/E unlistd ivn-dog LD50: 25 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); T/E unlistd ims-dog LD50: 16500 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 16(6), p. 53, 1972 (GISAAA); T/E unlistd skn-rbt LD50: 91 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 9, p. 199, 1954 (AMIHBC); T/E unlistd ivn-rbt LD50: 20 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 9, p. 199, 1954 (AMIHBC); T/E unlistd ims-rbt LD50: 38500 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 16(6), p. 53, 1972 (GISAAA); F12 skn-gpg LD50: 190 mg/kg U.S. Army Chemical Warfare Laboratories. (Army Chemical Center, MD) CWL 2-10, 1958 (XAWPA2); T/E unlistd ihl-rat LC50: 130 mg/m3/2H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); T/E unlistd ihl-mus LC50: 1000 mg/m3/2H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); T/E unlistd ihl-mus LC50: 320 mg/m3/4H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); J02-F13-F22 ihl-rat TCLo: 20000 mg/m3/4H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); J15-M71 orl-mus LD50: 59 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); J15-M71 orl-rat LD50: 60 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); F40 ipr-rat TDLo: 20 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); F22 ipr-cat TDLo: 20 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); F22-F40 skn-dog TDLo: 3 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); F22-F40 skn-dog TDLo: 100 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1993 (VCVN5*); U01 orl-rat TDLo: 75 mg/kg Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 975, 2001 (CRTOEC); M16-P72-P70 orl-rat TDLo: 90 mg/kg Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 975, 2001 (CRTOEC); L02-L03-L30 orl-rat TDLo: 120 mg/kg Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 975, 2001 (CRTOEC) MD: Z01 ihl-rat TCLo: 1 ppm/24H/90D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A086-341 (NTIS**); F18-Z01 ihl-rat TCLo: 5 ppm/6H/26W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 476, 1954 (AMIHBC); L14-M16-P26 ihl-rat TCLo: 10 mg/m3/4H/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 40(3), p. 29, 1975 (GISAAA); Z01 ihl-mus TCLo: 1 ppm/24H/90D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A086-341 (NTIS**); Z01 ihl-mus TCLo: 14 ppm/6H/5W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 476, 1954 (AMIHBC); F15-F18-Z01 ihl-dog TCLo: 14 ppm/6H/26W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 476, 1954 (AMIHBC); Z01 ihl-mky TCLo: 1 ppm/24H/90D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A086-341 (NTIS**); Z01 ihl-gpg TCLo: 14 ppm/6H/14W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 476, 1954 (AMIHBC); L30-M30-N30 ihl-ham TCLo: 1 ppm/6H/1Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A086-341 (NTIS**); P05-P72 ihl-mus TCLo: 130 mg/m3/1H/17W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1989 (VCVN5*); J30 ihl-gpg TCLo: 5 mg/m3/24H/59D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 20, 1989 (VCVN5*) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.01 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 127, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 991, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 223, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 991, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 991, 1999 (IMEMDT); TOXICOLOGY REVIEW AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 9, p. 199, 1954 (AMIHBC); TOXICOLOGY REVIEW Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 135, 1971 (ATXKA8) SR: MSHA STANDARD-air: TWA 1 ppm (1.3 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 127, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 ppm (1.3 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 ppm (1.3 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 ppm (1.3 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 ppm (1.3 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.1 ppm (0.1 mg/m3), Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-DENMARK: TWA 0.1 ppm (0.13 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 0.1 ppm, STEL 0.3 ppm, Skin, Carcinogen, JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-JAPAN: OEL 0.01 ppm (0.013 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 0.1 ppm (0.13 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1 ppm (1.3 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 0.05 mg/m3, MAC(STEL) 0.1 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.1 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 0.1 ppm, KTV 0.3 ppm, Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.1 ppm (0.13 mg/m3), Skin, Carcinogen, JAN 1999; OEL-TURKEY: TWA 1 ppm (1.3 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 0.03 mg/m3, STEL 0.13 mg/m3, Skin, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO HYDRAZINES-air: CA CL 0.03 ppm/120M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 38110; NIS 37; TNF 2134; NOS 27; TNE 11185; NOES 1983: HZD 38110; NIS 44; TNF 2515; NOS 46; TNE 60490; TFE 2841 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101025/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-1292-8619, 8EHQ-0593-9056; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrazine, 3503; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #20; OSHA ANALYTICAL METHOD #108 Record 822 of 1119 in RTECS (through 2003/06) AN: MV2450000 PN: Hydrazine,-1,1-dimethyl- SY: 1,1-Dimethylhydrazin- (German); 1,1-Dimethylhydrazine-; 1,1-Dimethylhydrazine- (ACGIH:OSHA); Dimazin-; Dimazine-; Dimethylhydrazine-; N,N-Dimethylhydrazine-; Niesymetryczna-dwu-metylohydrazyna- (Polish); RCRA-waste-number-U098-; Unsymmetrical-dimethylhydrazine-; as-Dimethyl-hydrazine-; asymmetric-Dimethylhydrazine-; uns-Dimethylhydrazine- RN: Current: 57-14-7 BRN: 605261 BHR: 4-04-00-03322 UD: 200210 MF: C2-H8-N2 MW: 60.12 WL: ZN1&1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 42 umol/plate (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1469, 1981 (CNREA8); mmo-sat 500 ug/plate (-S9) Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 21, p. 319, 1979 (CNJGA8); mmo-esc 20 umol/L (-S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); dnr-esc 600 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dnd-esc 1 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); pic-esc 17 gm/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 532, 1981 (CNREA8); dnr-bcs 6 mg/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); mmo-asn 198 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mtr-hmn-oth 50 mg/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 17, p. 719, 1981 (ITCSAF); mtr-hmn-fbr 167 umol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 80, p. 7219, 1983 (PNASA6); dnd-hmn-fbr 300 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 267, 1985 (ENMUDM); mtr-rat-orl 200 umol/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 43, p. 313, 1983 (CBINA8); dnd-rat-lvr 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 357, 1983 (MUREAV); dns-rat-ipr 60 mg/kg Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 36, p. 2364, 1975 (CANCAR); mnt-mus-ipr 28 mg/kg/24H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 216, p. 321, 1989 (MUREAV); dnr-mus-lvr 100 umol/L Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 79, p. 204, 1988 (JJCREP); dnd-mus-ipr 3500 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1469, 1981 (CNREA8); dnd-mus-orl 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 415, p. 1, 1998 (MUREAV); dni-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); dni-mus-ast 1100 umol/L JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 243, 1981 (JJATDK); oms-mus-ast 900 umol/L JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 243, 1981 (JJATDK); sce-mus-ipr 10 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 579, 1986 (ENMUDM); msc-mus-lym 5 mmol/L/24H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A075-605 (NTIS**); hma-mus-sat 125 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); spm-mus-ipr 2300 mg/kg/5D-C Chemical Mutagens. Principles and Methods for Their Detection. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1971- v. 5, p. 257, 1978 (CMMUAO); msc-ham-lng 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 121, 1984 (MUREAV) RE: T25-T34 ipr-rat TDLo: 600 mg/kg (6-15D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 13, p. 125, 1984 (JTEHD6) TE: V03-D45-K61 orl-rat TDLo: 150 mg/kg/7W-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 246, p. 491, 1973 (NATUAS); V03-K60-K61 scu-rat TDLo: 21 mg/kg Surgical Forum. (American College of Surgeons, 55 E. Erie St., Chicago, IL 60611) V.1- 1950- v. 31, p. 413, 1980 (SUFOAX); V01-H60-J60 orl-mus TDLo: 5880 mg/kg/42W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 50, p. 181, 1973 (JNCIAM); V03-J60 ipr-mus TDLo: 144 mg/kg/8W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 337, 1969 (JNCIAM); V02-K61 scu-mus TDLo: 420 mg/kg/21W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 39, p. 69, 1988 (CALEDQ); V01-H60-K61 orl-ham TDLo: 228 gm/kg/48W-C Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 2427, 1977 (CANCAR); V01-C60 scu-ham TDLo: 2686 mg/kg/72W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 35, p. 303, 1987 (CALEDQ); V03-J60 orl-mus TD :288 mg/kg/8W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 337, 1969 (JNCIAM); V03-K60-K61 scu-rat TD :400 mg/kg/20W-I Surgical Forum. (American College of Surgeons, 55 E. Erie St., Chicago, IL 60611) V.1- 1950- v. 31, p. 413, 1980 (SUFOAX); V03-D45-K61 orl-rat TD :300 mg/kg/14W-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 246, p. 491, 1973 (NATUAS); V03-K60 scu-mus TD :200 mg/kg/25W-I Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 92, p. 1681, 1981 (BEXBAN) ORNG: 122000000 ng/kg. [122.000000 mg/kg] T/E unlistd SRNG: 1060000000 ng/kg. [1060.000000 mg/kg] T/E unlistd SKNG: 770000000 ng/kg. [770.000000 mg/kg] A11-F12-P26 IHPB: 252000 ppb/4H. [252.000000 ppm/4H] D35-F12-J22 AT: F27-J30-L14 unr-hmn TDLo: 10 mg/kg "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 71, 1999 (STGNBT); T/E unlistd orl-rat LD50: 122 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); D35-F12-J22 ihl-rat LC50: 252 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 12, p. 609, 1955 (AMIHAB); A11-F12-P26 skn-rat LD50: 770 mg/kg "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 71, 1999 (STGNBT); F12 ipr-rat LD50: 102 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 6, p. 371, 1964 (TXAPA9); T/E unlistd ivn-rat LD50: 119 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); F12 ice-rat LDLo: 27 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 14, p. 1901, 1965 (BCPCA6); A11-F12-M03 orl-mus LD50: 155 mg/kg "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 71, 1999 (STGNBT); D35-F12-J22 ihl-mus LC50: 172 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 12, p. 609, 1955 (AMIHAB); D15-F12-R21 ipr-mus LD50: 113 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 124, p. 172, 1967 (PSEBAA); T/E unlistd ivn-mus LD50: 250 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); K12-F11-F12 ihl-dog LC50: 3580 ppm/15M American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 137, 1963 (AIHAAP); F12 skn-dog LDLo: 301 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 649, 1971 (TXAPA9); F12-K13-J30 ipr-dog LD50: 60 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD292-689 (NTIS**); T/E unlistd ivn-dog LD50: 60 mg/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 24, p. 71, 1973 (MEPAAX); F12-K13 ipr-mky LD50: 60 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD292-689 (NTIS**); F07-H05-J24 ipr-cat LDLo: 30 mg/kg European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 7, p. 238, 1974 (EJTXAZ); T/E unlistd skn-rbt LD50: 1060 mg/kg "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 5,210.1(89),1986 (85INA8); T/E unlistd ihl-gpg LC50: 100 mg/m3/4H Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (6), p. 39, 1999 (TOVEFN); F12 skn-gpg LD50: 1329 mg/kg U.S. Army Chemical Warfare Laboratories. (Army Chemical Center, MD) CWL 2-10, 1958 (XAWPA2); F12 ihl-ham LC50: 392 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 12, p. 609, 1955 (AMIHAB); T/E unlistd scu-ham LD50: 325 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 35, p. 303, 1987 (CALEDQ) MD: J16 ihl-rat TCLo: 34 gm/m3/13M/40D European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 7, p. 242, 1974 (EJTXAZ); M10-Z01 ipr-rat TDLo: 630 mg/kg/3W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 15, p. 62, 1969 (TXAPA9) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.01 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 137, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1425, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 137, 1974 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1425, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1425, 1999 (IMEMDT); TOXICOLOGY REVIEW Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 135, 1971 (ATXKA8) SR: MSHA STANDARD-air: TWA 0.5 ppm (1 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 91, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.5 ppm (1 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.5 ppm (1 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.5 ppm (1 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.5 ppm (1 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.5 ppm (1 mg/m3), Skin, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.1 ppm (0.25 mg/m3), Skin, JAN 1999; OEL-FINLAND: STEL 0.1 ppm (0.25 mg/m3), Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.1 ppm (0.2 mg/m3), C2 Carcinogen, JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 0.5 ppm (1 mg/m3), Skin, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.1 ppm (0.25 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 0.5 ppm (1 mg/m3), Skin, JAN 1993; OEL-SWEDEN: NGV 0.1 ppm, KTV 0.5 ppm, Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 ppm (1.2 mg/m3), Skin, Carcinogen, JAN 1999; OEL-TURKEY: TWA 0.5 ppm (1 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 1,1-DIMETHYLHYDRAZINE-air: CA CL 0.06 ppm/120M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84395; NIS 2; TNF 14; NOS 3; TNE 25; NOES 1983: HZD 84395; NIS 1; TNF 43; NOS 3; TNE 2917 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101025/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal, L5178Y cells in vitro-TK test; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: 1, 1-Dimethylhydrazine, 3515; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 823 of 1119 in RTECS (through 2003/06) AN: MV9625000 PN: Hydrazine,-sulfate- (1:1) SY: Hydrazine-monosulfate-; Hydrazine-sulfate-; Hydrazine-sulphate-; Hydrazinium-sulfate-; Hydrazonium-sulfate-; Idrazina-solfato- (Italian); NSC-150014-; Siran-hydrazinu- (Czech) RN: Current: 10034-93-2 UD: 200302 MF: H4-N2.H2-O4-S MW: 130.14 WL: ZZ &S-O4 CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 20 mg/24H MOD "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,15,1972 (28ZPAK); skn-hmn 0.25% Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975- v. 15, p. 244, 1986 (CODEDG) ME: mmo-sat 5 ug/plate (+/-S9) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); oms-sat 35 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-sat 50 ug/plate (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 351, 1981 (PMRSDJ); mmo-esc 100 ug/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 387, 1981 (PMRSDJ); dnr-esc 250 ug/disc JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); dnr-bcs 200 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dnd-bcs 200 ug/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); mmo-omi 1500 ug/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 173, p. 233, 1986 (MUREAV); mmo-smc 133 mg/L (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 414, 1981 (PMRSDJ); dnr-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 385 ppm Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 481, 1981 (PMRSDJ); sln-smc 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mmo-ssp 5 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 424, 1981 (PMRSDJ); dns-hmn-fbr 1 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 528, 1981 (PMRSDJ); dnd-rat-lvr 1 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 181, 1994 (EMMUEG); dnr-mus-lvr 10 umol/L Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 79, p. 204, 1988 (JJCREP); dni-mus-ipr 180 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 19, p. 939, 1981 (IJEBA6); hma-mus-sat 3100 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 16, p. 189, 1972 (MUREAV); mtr-ham-emb 1 gm/L Advances in Modern Environmental Toxicology. (Senate Press, Inc., P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980- v. 1, p. 241, 1980 (AETODY); mtr-ham-kdy 2500 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 638, 1981 (PMRSDJ); dna-ham-orl 1035 mg/kg/9W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 70, p. 324, 1983 (TXAPA9); cyt-ham-ovr 1167 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 551, 1981 (PMRSDJ); sce-ham-lng 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 103, 1983 (MUREAV); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) TE: V01-J60-L60 orl-rat TDLo: 43 gm/kg/85W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 41, p. 331, 1968 (JNCIAM); V01-T65-J60 orl-mus TDLo: 1892 mg/kg (multigenerations) Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 105, p. 258, 1983 (JCROD7); V01-J60-L60 orl-mus TDLo: 19 gm/kg/61W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 41, p. 331, 1968 (JNCIAM); V03-J60 ipr-mus TDLo: 832 mg/kg/8W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 337, 1969 (JNCIAM); V01-L60 orl-ham TDLo: 29702 mg/kg/2Y-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 439, 1987 (CRNGDP); V02-J60-L60 orl-rat TD :38 gm/kg/68W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 41, p. 331, 1968 (JNCIAM); V02-J60 orl-mus TD :1664 mg/kg/8W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 337, 1969 (JNCIAM); V02-J60-L60 orl-mus TD :1280 mg/kg/4w-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 18, p. 543, 1964 (BJCAAI); V03-J60 orl-mus TD :11 gm/kg/46W-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 194, p. 488, 1962 (NATUAS); V03-J60 ipr-mus TD :950 mg/kg/10W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 4, p. 318, 1969 (IJCNAW); V03-J60 ipr-mus TD :475 mg/kg/5W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 4, p. 318, 1969 (IJCNAW); V03-J60-L60 orl-mus TD :14080 mg/kg/64W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 17, p. 75, 1982 (CALEDQ); V01-J60 orl-mus TD :18524 mg/kg/84W-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 105, p. 258, 1983 (JCROD7); V02-J60 orl-mus TD :18480 mg/kg/84W-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 105, p. 258, 1983 (JCROD7); V02-J60 orl-mus TD :226 mg/kg Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 72, p. 125, 1986 (TUMOAB) ORNG: 601000000 ng/kg. [601.000000 mg/kg] T/E unlistd AT: C10-F07-K13 orl-hmn TDLo: 201 mg/kg/8D Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 59, p. 1151, 1975 (CCROBU); T/E unlistd orl-rat LD50: 601 mg/kg "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,15,1972 (28ZPAK); T/E unlistd ipr-rat LD50: 230 mg/kg Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 41, p. 74, 1978 (RPTOAN); T/E unlistd orl-mus LD50: 434 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 28(12), p. 56, 1984 (GTPZAB); L01-M03 ipr-mus LD50: 152 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 17, p. 315, 1968 (AEHLAU); T/E unlistd scu-mus LD50: 455 mg/kg Acta Biologica et Medica Germanica. (Berlin, Ger. Dem. Rep.) V.1-41, 1958-82. For publisher information, see BBIADT. v. 21, p. 635, 1968 (ABMGAJ); T/E unlistd orl-dog LDLo: 100 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-rbt LDLo: 100 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd ihl-mam LC :>6400 ug/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 28(12), p. 56, 1984 (GTPZAB); N08-N30-P30 par-mus TDLo: 80 mg/kg Journal of Experimental Medicine. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1896- v. 173, p. 357, 1991 (JEMEAV) MD: U01 orl-rat TDLo: 1500 mg/kg/15D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 41, p. 203, 1978 (FATOAO); N74-U01-Z71 ipr-rat TDLo: 1200 mg/kg/30D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 41, p. 203, 1978 (FATOAO); U01 orl-mus TDLo: 1500 mg/kg/15D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 41, p. 203, 1978 (FATOAO) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 127, 1974 (IMEMDT) ND: NIOSH REL TO HYDRAZINES-air: CA CL 0.03 ppm/120M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X4065; NIS 4; TNF 223; NOS 5; TNE 945; TFE 259 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, E coli polA without S9; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: SHE-clonal assay, Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 824 of 1119 in RTECS (through 2003/06) AN: MW2625000 PN: Hydrazobenzene- SY: (sym)-Diphenylhydrazine; 1,2-Diphenylhydrazine-; 1,2-Diphenylhydrazine- (9CI); Benzene,-hydrazodi-; Hydrazine,-1,2-diphenyl-; Hydrazobenzen- (Czech); N,N'-Bianiline-; N,N'-Diphenylhydrazine-; NCI-C01854-; RCRA-waste-number-U109- RN: Current: 122-66-7 BRN: 639793 BHR: 4-15-00-00056 UD: 200210 MF: C12-H12-N2 MW: 184.26 WL: RMMR CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 10 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); dni-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); cyt-ham-ovr 14 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 5 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); dnd-mus-ipr 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); dnd-mus-orl 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV) TE: V01-L60-R60 orl-rat TDLo: 2620 mg/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-92, 1978 (NCITR*); V01-L60-R60 scu-rat TDLo: 5200 mg/kg/52W-C Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 19(6), p. 28, 1975 (GTPZAB); V01-L60 orl-mus TDLo: 26 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-92, 1978 (NCITR*); V03-L60 skn-mus TDLo: 5280 mg/kg/26W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 20(4), p. 53, 1974 (VOONAW); V03-L60-V10 scu-mus TDLo: 8400 mg/kg/38W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 20(4), p. 53, 1974 (VOONAW); V01-L60-R60 orl-rat TD :9820 mg/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-92, 1978 (NCITR*); V03-R60-T64 orl-rat TD :36 gm/kg/53W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 20(4), p. 53, 1974 (VOONAW); V03-D45 scu-rat TD :16 gm/kg/1Y-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 3, p. 789, 1950 (CANCAR); V03-R60-T64 scu-rat TD :6 gm/kg/27W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 20(4), p. 53, 1974 (VOONAW) ND: NOES 1983: HZD X5870; NIS 1; TNF 7; NOS 1; TNE 977; TFE 154 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/91/180356/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-92, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 825 of 1119 in RTECS (through 2003/06) AN: MW5775000 PN: Hydrocoumarin- SY: 2-Chromanone-; Chroman,-2-oxo-; Coumarin,-3,4-dihydro-; 3,4-Dihydro-2H-1-benzopyran-2-one-; Dihydrocoumarin-; 3,4-Dihydrocoumarin-; 1,2-Benzodihydropyrone-; Hydrocinnamic-acid,-o-hydroxy-,-delta-lactone-; O-Hydroxycinnamic-acid-; Melilotin-; Melilotine-; Melilotol-; NCI-C55890-; Oxochroman-; USAF-DO-12- RN: Current: 119-84-6 BRN: 4584 BHR: 5-17-10-00013 UD: 200302 MF: C9-H8-O2 MW: 148.17 WL: T66 BOVT&J CC: Tumorigen (C); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MOD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 12, p. 521, 1974 (FCTXAV); skn-gpg 1%/48H MOD Journal of the Society of Cosmetic Chemists. (Soc. of Cosmetic Chemists, 1995 Broadway, Suite 1701, New York, NY 10023) V.1- 1947- v. 28, p. 357, 1977 (JSCCA5) TE: V02-M61 orl-rat TDLo: 433 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-423, 1993 (NTPTR*); V02-L60 orl-mus TDLo: 144 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-423, 1993 (NTPTR*); V02-K06-M61 orl-rat TDLo: 39000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-103925 (NTIS**); V02-L60 orl-mus TDLo: 13000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-103925 (NTIS**) ORNG: 1460000000 ng/kg. [1460.000000 mg/kg] F07 AT: F07 orl-rat LD50: 1460 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV); T/E unlistd ipr-mus LD50: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd skn-rbt LD50: >5 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 12, p. 521, 1974 (FCTXAV); F07 orl-gpg LD50: 1760 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV) MD: Z01 orl-rat TDLo: 18 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-423, 1993 (NTPTR*); L30-P71-Y01 orl-rat TDLo: 19500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-423, 1993 (NTPTR*); Z01 orl-mus TDLo: 27 gm/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-423, 1993 (NTPTR*); L70-Z01 orl-mus TDLo: 104 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-423, 1993 (NTPTR*) TR: TOXICOLOGY REVIEW Progress in Medical Chemistry. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1961- v. 10, p. 85, 1974 (PMDCAY) ND: NOHS 1974: HZD 83169; NIS 1; TNF 21; NOS 2; TNE 456; NOES 1983: HZD 83169; NIS 3; TNF 65; NOS 8; TNE 2054; TFE 276 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies (gavage), some evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-423, 1993 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 826 of 1119 in RTECS (through 2003/06) AN: MX2450000 PN: Hydroperoxide,-alpha,alpha-dimethylbenzyl- SY: 7-Hydroperoxykumen- (Czech); CHP-; Cumeenhydroperoxyde- (Dutch); Cumene-hydroperoxide-; Cumenyl-hydroperoxide-; Cumolhydroperoxid- (German); Cumyl-hydroperoxide-; Hydroperoxyde-de-cumene- (French); Hydroperoxyde-de-cumyle- (French); Idroperossido-di-cumene- (Italian); Idroperossido-di-cumolo- (Italian); Isopropylbenzene-hydroperoxide-; Kumenylhydroperoxid- (Czech); RCRA-waste-number-U096-; alpha,alpha-Dimethylbenzyl-hydroperoxide-; alpha-Cumyl-hydroperoxide- RN: Current: 80-15-9 BRN: 1908117 BHR: 4-06-00-03221 UD: 200210 MF: C9-H12-O2 MW: 152.21 WL: QOX1&1&R CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); skn-rbt 500 mg MLD Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 3, 1961 (SCCUR*); eye-rbt 1 mg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); eye-rbt 70% "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 533, 1994 (VCVGK*) ME: mmo-sat 100 ug/plate (+S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 7445, 1982 (PNASA6); mmo-sat 100 ug/plate (-S9) Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.25- 1961- v. 44, p. 1989, 1980 (ABCHA6); mmo-esc 12500 ng/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 41, 2000 (MUREAV); oms-esc 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 81, 1988 (MUREAV); mrc-smc 47 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 308, p. 159, 1994 (MUREAV); dlt-mus-ipr 750 umol/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 444, p. 145, 1999 (MUREAV); mmo-sat 50 ug/plate/44H Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 105, 2002 (FCTOD7); dnd-ofs-spr 20 umol/L/2H Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 1205, 2001 (FCTOD7); mmo-esc 40 ug/plate/20M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 91, 2001 (MUREAV) TE: V03-V10 scu-mus TDLo: 8844 mg/kg/67W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 37, p. 825, 1966 (JNCIAM); V03-P62-R60 unr-mus TDLo: 304 mg/kg Radiation Research, Supplement. (New York, NY) No.1-7, 1959-67. Discontinued. v. 3, p. 193, 1963 (RARSAM) ORNG: 382000000 ng/kg. [382.000000 mg/kg] M14 SKNG: 500000000 ng/kg. [500.000000 mg/kg] F12-M14 IHPB: 220000 ppb/4H. [220.000000 ppm/4H] J22 AT: M14 orl-rat LD50: 382 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); J22 ihl-rat LC50: 220 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); F12-M14 skn-rat LD50: 500 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 30, p. 1, 1975 (AEHLAU); F18-F19 ipr-rat LD50: 95 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); T/E unlistd scu-rat LD50: 382 mg/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,242,1986 (85JCAE); T/E unlistd orl-mus LDLo: 5 gm/kg Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 3, 1961 (SCCUR*); J22 ihl-mus LC50: 200 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); T/E unlistd ipr-mus LD50: 270 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 26(12), p. 22, 1961 (GISAAA); F07-F13-J22 scu-mus LD50: 490 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 26(12), p. 22, 1961 (GISAAA); G07-P71-U28 skn-rbt LDLo: 1200 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 8(8), p. 12, 1964 (GTPZAB) MD: Z01 orl-rat TDLo: 1604 mg/kg/7W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP); J30-M30-Z01 ihl-rat TCLo: 50 ppm/4H/3D-I British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 27, p. 1, 1970 (BJIMAG); Z01 ipr-rat TDLo: 399 mg/kg/7W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 19, p. 205, 1958 (AIHAAP) SR: OEL-RUSSIA: STEL 1 mg/m3, JAN 1993 ND: NOHS 1974: HZD A1346; NIS 80; TNF 4311; NOS 53; TNE 95676; NOES 1983: HZD A1346; NIS 125; TNF 10989; NOS 85; TNE 234305; TFE 69933 SL: EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 827 of 1119 in RTECS (through 2003/06) AN: MX3500000 PN: Hydroquinone- SY: Arctuvin-; 1,4-Dihydroxy-benzeen- (Dutch); 1,4-Dihydroxybenzen- (Czech); Dihydroxybenzene-; Dihydroxybenzene- (OSHA); p-Dihydroxybenzene-; 1,4-Dihydroxybenzene-; 1,4-Dihydroxy-benzol- (German); 1,4-Diidrobenzene- (Italian); p-Dioxobenzene-; p-Dioxybenzene-; Eldopaque-; Eldoquin-; Hydroquinol-; Hydroquinole-; Benzene,-p-dihydroxy-; p-Benzenediol-; 1,4-Benzenediol-; Benzohydroquinone-; Benzoquinol-; Black-and-white-bleaching-cream-; Hydrochinon- (Czech, Polish); alpha-Hydroquinone-; p-Hydroquinone-; p-Hydroxyphenol-; NCI-C55834-; Phiaquin-; Quinol-; beta-Quinol-; Hydroquinone- (ACGIH:OSHA); Idrochinone- (Italian); Pyrogentistic-acid-; Tenox-HQ-; Tequinol-; Tecquinol-; USAF-EK-356- RN: Current: 123-31-9 UD: 200305 MF: C6-H6-O2 MW: 110.12 WL: QR DQ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-hmn 2% MLD Archives of Dermatology. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.82- 1960- v. 93, p. 589, 1966 (ARDEAC); skn-hmn 5% SEV Archives of Dermatology. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.82- 1960- v. 93, p. 589, 1966 (ARDEAC); skn-hmn 3% "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 230, 1994 (VCVGK*) ME: mmo-sat 2 umol/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 91, 1981 (MUREAV); mmo-sat 750 nmol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 371, p. 293, 1996 (MUREAV); mmo-esc 100 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 41, 2000 (MUREAV); dnd-omi 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); sln-dmg-orl 6 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 469, p. 215, 2000 (MUREAV); mrc-asn 1 mmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 2, p. 235, 1987 (MUTAEX); sln-asn 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 215, p. 187, 1989 (MUREAV); mnt-hmn-lym 75 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 249, p. 201, 1991 (MUREAV); dna-hmn-bmr 500 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1181, 1991 (CRNGDP); dnd-hmn-lng 800 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 81, p. 197, 1992 (CBINA8); dnd-hmn-lym 100 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 305, 1995 (EMMUEG); dni-hmn-hla 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); oms-hmn-lym 5 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 2471, 1985 (CNREA8); sce-hmn-lym 5 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 2471, 1985 (CNREA8); sln-hmn-lym 6 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 57, 1993 (MUREAV); sln-hmn-lym 75 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 9, 1994 (MUREAV); dnd-rat-lvr 400 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 63, p. 47, 1992 (CALEDQ); dns-rat-orl 8 gm/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 74, p. 1283, 1985 (JJIND8); mnt-mus-ipr 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 29, 1994 (MUREAV); mnt-mus-scu 240 mg/kg/6D-C Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 39, p. 129, 1982 (CBINA8); mmo-mus-lym 2500 ug/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); oms-mus-orl 120 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); dni-mus-lym 10 umol/L Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 28, p. 560, 1985 (MOPMA3); oms-mus-lym 10 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 29, p. 161, 1985 (TOLED5); oms-mus-oth 25 umol/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 2, p. 231, 1986 (CBTOE2); cyt-mus-ipr 40 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 263, p. 223, 1991 (MUREAV); sln-mus-ipr 80 mg/kg Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 208, 1989 (MUTAEX); msc-mus-lym 1250 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); mnt-ham-lng 17500 nmol/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 82, p. 81, 1989 (EVHPAZ); mtr-ham-emb 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 373, p. 113, 1997 (MUREAV); dns-ham-emb 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 373, p. 113, 1997 (MUREAV); dni-ham-lng 500 umol/L Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 4, p. 151, 1991 (CRTOEC); oms-ham-emb 2 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 47, 1993 (MUREAV); cyt-ham-ovr 20 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); cyt-ham-emb 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 373, p. 113, 1997 (MUREAV); sce-ham-emb 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 373, p. 113, 1997 (MUREAV); sce-ham-ovr 500 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-lng 20 umol/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 82, p. 81, 1989 (EVHPAZ); sln-ham-emb 1250 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 287, p. 47, 1993 (MUREAV); msc-ham-emb 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 373, p. 113, 1997 (MUREAV); oms-rbt-bmr 6 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 50, p. 203, 1984 (CBINA8); mnt-mus-ipr 3 mg/kg/6D Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 121, p. 15, 2001 (TOLED5); cyt-hmn-leu 2 umol/L/48H Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 1485, 2000 (CRNGDP); mtr-mus-fbr 10 ug/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG); sce-mus-ivn 600 mg/kg/3D "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 230, 1994 (VCVGK*); mnt-mus-orl 80 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 208, p. 61, 1988 (MUREAV) RE: T25 orl-rat TDLo: 2500 mg/kg (1-22D preg) American Journal of Anatomy. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1-192, 1901-91. v. 110, p. 29, 1962 (AJANA2); T25 orl-rat TDLo: 667 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 41, p. 43, 1990 (TJADAB); T26 orl-rat TDLo: 1 gm/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 41, p. 43, 1990 (TJADAB); T12 scu-rat TDLo: 5 mg/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 57, p. 466, 1955 (ENDOAO); T14 scu-rat TDLo: 550 mg/kg (11D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 57, p. 466, 1955 (ENDOAO); T02-T03-T23 scu-rat TDLo: 5100 mg/kg (51D male) Sbornik Vysoke Skoly Zemedelske v Brne, Rada B: Spisy Veterinarni. Publications of the Agricultural University in Brno, Series B: Works of the Faculty of Vetinerary Science. (Brno, Czechoslovakia) 1953-66. For publisher information, see AUAAB7. v. 12, p. 491, 1965 (SSZBAC); F19-T43-T46 orl-rbt TDLo: 1950 mg/kg (6-18D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571419 (NTIS**) TE: V01-M61 orl-rat TDLo: 25750 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-366, 1989 (NTPTR*); V02-L60 orl-mus TDLo: 25750 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-366, 1989 (NTPTR*); V02-M61 orl-rat TD :256 gm/kg/2Y-C United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0491-1210 (EPASR*); V02-M61 orl-rat TD :349 gm/kg/2Y-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 82, p. 1211, 1991 (JJCREP); V02-L60 orl-mus TD :699 gm/kg/2Y-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 82, p. 1211, 1991 (JJCREP); V01-L60 orl-mus TD :26 gm/kg/2Y-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 30, p. 737, 1992 (FCTOD7); V01-J60-L60 orl-mus TDLo: 174720 mg/kg/26W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 143, p. 71, 1999 (CALEDQ); V01-V16-J60 orl-mus TDLo: 174720 mg/kg/26W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 143, p. 71, 1999 (CALEDQ); V02-M61 orl-rat TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-240389 (NTIS**); V01-P61 orl-rat TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-240389 (NTIS**); V02-L60-N05 orl-mus TDLo: 25750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-240389 (NTIS**) ORNG: 302000000 ng/kg. [302.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-hmn LDLo: 29 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,321,1969 (34ZIAG); F24-G07-J24 orl-hmn TDLo: 170 mg/kg Annales de Medecine Legale. Criminologie, Police Scientifique et Toxicologie. (Paris, France) V.1, 1920-51: V.39-47, 1958-67. For publisher information, see MLDCAS. v. 7, p. 79, 1927 (AMILAN); T/E unlistd orl-rat LD50: 302 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555537 (NTIS**); T/E unlistd ipr-rat LD50: 170 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 19, p. 327, 1990 (EESADV); T/E unlistd scu-rat LDLo: 300 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 162, 1955 (HBTXAC); F11-F12-F13 ivn-rat LD50: 115 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 8, p. 348, 1949 (FEPRA7); T/E unlistd unr-rat LD50: 720 mg/kg Gigiena Truda i Professional'naya Patologiya v Estonskoi SSR. Labor Hygiene and Occupational Pathology in the Estonian SSR. (Institut Eksperimental'noi i Klinicheskoi Meditsiny Ministerstva Zdravookhraneniya Estonskoi SSR, Tallinn, USSR) V.8- 1972- v. 8, p. 145, 1972 (GTPPAF); T/E unlistd orl-mus LD50: 245 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 38(8), p. 6, 1973 (GISAAA); T/E unlistd ipr-mus LD50: 100 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD414-344 (NTIS**); T/E unlistd scu-mus LD50: 182 mg/kg Zeitschrift fuer die Gesamte Innere Medizin und Ihre Grenzgebiete. (Buchexport, Postfach 160, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1946- v. 2, p. 333, 1947 (ZGIMAL); T/E unlistd unr-mus LD50: 150 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 6, p. 160, 1952 (BJCAAI); F12-F13-K13 orl-dog LD50: 200 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 8, p. 348, 1949 (FEPRA7); T/E unlistd scu-dog LDLo: 100 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 183, p. 319, 1936 (AEPPAE); T/E unlistd ivn-dog LDLo: 80 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 162, 1955 (HBTXAC); T/E unlistd orl-cat LD50: 50 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555537 (NTIS**); F11-H05-P24 scu-cat LDLo: 50 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 72, p. 241, 1913 (AEXPBL); T/E unlistd orl-rbt LD50: 200 mg/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3); T/E unlistd ipr-rbt LD50: 125 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 19, p. 327, 1990 (EESADV); T/E unlistd ivn-rbt LDLo: 100 mg/kg Agressologie. Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees aux Effets de l'Agression. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1960- v. 3, p. 311, 1962 (AGSOA6); F11-F12-F13 orl-gpg LD50: 550 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 8, p. 348, 1949 (FEPRA7); T/E unlistd ipr-gpg LDLo: 200 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 162, 1955 (HBTXAC); T/E unlistd scu-gpg LDLo: 300 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 162, 1955 (HBTXAC); F12-F13-K13 orl-pgn LD50: 300 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 8, p. 348, 1949 (FEPRA7); T/E unlistd scu-frg LDLo: 190 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 160, 1955 (HBTXAC); C06-F12-G30 par-frg LDLo: 190 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 166, p. 437, 1932 (AEPPAE); F17-F23-J22 orl-mam LD50: 480 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 15, p. 136, 1979 (TPKVAL); T/E unlistd skn-mam LD50: 5970 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 16, 1980 (GISAAA); P26 orl-mus TDLo: 80 mg/kg/12H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 208, p. 61, 1988 (MUREAV) MD: K06-P26-U01 orl-rat TDLo: 236 gm/kg/9W-C Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 84, p. 684, 1953 (PSEBAA); L70-Z01 orl-rat TDLo: 13 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-366, 1989 (NTPTR*); Z01 orl-rat TDLo: 6 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-366, 1989 (NTPTR*); P05-P28-P71 ihl-rat TCLo: 10 mg/m3/4H/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(9), p. 35, 1978 (GTPZAB); L70-Z01 orl-mus TDLo: 13 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-366, 1989 (NTPTR*); A70-L70-P20 orl-mus TDLo: 32500 mg/kg/65W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-366, 1989 (NTPTR*); Z01 orl-mus TDLo: 3 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-366, 1989 (NTPTR*); F19-U30-Z01 orl-cat TDLo: 220 mg/kg/14D-I Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 183, p. 319, 1936 (AEPPAE); M03-Y21 orl-rat TDLo: 1500 mg/kg/6W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 23, p. 391, 1994 (FAATDF); Y03 orl-rat TDLo: 250 mg/kg/1W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 23, p. 397, 1994 (FAATDF); M03-Y20 orl-rat TDLo: 1500 mg/kg/6W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 23, p. 397, 1994 (FAATDF); U01-Z01 orl-rat TDLo: 1802500 mg/kg/103W-C Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. -, p. 684, 1953 (PSEBAA) TR: ACGIH TLV-TWA 2 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 691, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 155, 1977 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 155, 1977 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 691, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 691, 1999 (IMEMDT); TOXICOLOGY REVIEW Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 23, p. 6, 1971 (AEHLAU); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 75, 1978 (MUREAV) SR: MSHA STANDARD-air: TWA 2 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 133, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 2 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 2 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 2 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 2 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 2 mg/m3, JAN 1999; OEL-BELGIUM: TWA 2 mg/m3, JAN 1993; OEL-DENMARK: TWA 2 mg/m3, JAN 1999; OEL-FINLAND: TWA 2 mg/m3, STEL 4 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 2 mg/m3, JAN 1999; OEL-GERMANY: Carcinogenm, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 2 mg/m3, JAN 1999; OEL-NORWAY: TWA 0.5 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 2 mg/m3, JAN 1993; OEL-POLAND: MAC(TWA) 2 mg/m3, MAC(STEL) 4 mg/m3, JAN 1999; OEL-SWEDEN: NGV 0.5 mg/m3, KTV 1.5 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 2 mg/m3, KZG-W 4 mg/m3, JAN 1999; OEL-TURKEY: TWA 2 mg/m3, JAN 1993; OEL-UNITED KINGDOM: LTEL 2 mg/m3, STEL 4 mg/m3, JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO HYDROQUINONE-air: CL 2 mg/m3/15M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M0747; NIS 143; TNF 24380; NOS 88; TNE 116192; NOES 1983: HZD M0747; NIS 177; TNF 40917; NOS 136; TNE 442749; TFE 144063 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydroquinone, 5004; NTP Carcinogenesis Studies (gavage), some evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-366, 1989 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 828 of 1119 in RTECS (through 2003/06) AN: MX4375000 PN: Hydroquinone,-tert-butyl- SY: 1,4-Benzenediol, 2-(1,1-dimethylethyl)- (9CI); 2-(1,1-Dimethylethyl)-1,4-benzenediol; Banox-20BA-; MTBHQ-; Mono-tertiarybutylhydroquinone-; Sustane-; TBHQ-; Tenox-TBHQ-; t-Butylhydroquinone-; tert-Butyl-1,4-benzenediol-; tert-Butylhydroquinone- RN: Current: 1948-33-0 BRN: 637923 BHR: 4-06-00-06013 UD: 200207 MF: C10-H14-O2 MW: 166.24 WL: QR DQ BX1&1&1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-esc 150 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 41, 2000 (MUREAV); dns-rat-orl 33600 mg/kg/4W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 99, p. 37, 1989 (TXAPA9); cyt-mus-ipr 200 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 459, 1984 (FCTOD7); sce-mus-ipr 20 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 234, 1989 (EMMUEG); mmo-ham-lng 170 ug/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 17, 1992 (MUREAV); cyt-ham-lng 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 125, 1990 (MUREAV); sce-ham-lng 170 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 17, 1992 (MUREAV); msc-ham-lng 1700 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 17, 1992 (MUREAV) RE: T19-T75 orl-rat TDLo: 32500 mg/kg (13W pre) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-459, 1997 (NTPTR*); T02 orl-mus TDLo: 39 gm/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-459, 1997 (NTPTR*); T21 orl-mus TDLo: 39 gm/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-459, 1997 (NTPTR*) ORNG: 700000000 ng/kg. [700.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 700 mg/kg Journal of the American Oil Chemists' Society. (Champaign, IL) V.24-56, 1947-79. v. 52, p. 53, 1975 (JAOCA7); D35-F19-J22 ihl-rat LCLo: 2900 mg/m3/4H Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 753, 1992 (ATDAEI); T/E unlistd ipr-rat LD50: 300 mg/kg Journal of the American Oil Chemists' Society. (Champaign, IL) V.24-56, 1947-79. v. 52, p. 53, 1975 (JAOCA7); T/E unlistd orl-mus LD50: 1 gm/kg Kodak Company Reports. (343 State St., Rochester, NY 14650) 21MAY1971 (KODAK*); F11-F18 ipr-mus LD50: 144 mg/kg Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 7, p. 335, 1984 (DCTODJ); T/E unlistd orl-gpg LD50: 790 mg/kg WHO Food Additives Series. (Geneva, Switzerland) No.1-8, 1972-75. Discontinued. v. 8, p. 26, 1975 (WHFAAC) MD: P27-U01 orl-rat TDLo: 16250 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-459, 1997 (NTPTR*); L30-L70-Y07 orl-mus TDLo: 10054 ng/kg/12D-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 45, p. 935, 1982 (BJCAAI); D07-K30-R03 orl-mus TDLo: 78 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-459, 1997 (NTPTR*) ND: NOES 1983: HZD X7157; NIS 12; TNF 892; NOS 21; TNE 18166; TFE 3687 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 829 of 1119 in RTECS (through 2003/06) AN: NC4725000 PN: Hydroxylamine,-N-nitroso-N-phenyl-,-ammonium-salt- SY: Ammonium-N-nitrosophenylhydroxylamine-; Cupferon- (Czech); Cupferron-; Kupferron- (Czech); NCI-C03258-; N-Hydroxy-N-nitroso-benzenamine,-ammonium-salt-; N-Nitrosofenylhydroxylamin-amonny- (Czech); N-Nitrosophenylhydroxylamin-ammonium-salz- (German); N-Nitrosophenylhydroxylamine-ammonium-salt- RN: Current: 135-20-6 UD: 200210 MF: C6-H6-N2-O2.H3-N MW: 155.18 WL: QNR&NO &ZH CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: eye-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,510,1986 (85JCAE) ME: mmo-sat 100 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); mmo-esc 333 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); cyt-grh-orl 1 pph Journal of Cytology and Genetics. (Soc. of Cytologists and Geneticists, Treasurer, Karnatak Univ., Dept. of Botany, Dharwad, 580003, India) V.1- 1966- v. 1, p. 75, 1966 (JCGEDO); dni-hmn-hla 2 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V01-H60-L60 orl-rat TDLo: 123 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-100, 1978 (NCITR*); V01-H60-L60 orl-mus TDLo: 437 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-100, 1978 (NCITR*); V03-J60 orl-rat TD :9040 mg/kg/65W-C Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI) ORNG: 199000000 ng/kg. [199.000000 mg/kg] F18-J22-R03 AT: F18-J22-R03 orl-rat LD50: 199 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(3), p. 48, 1988 (GTPZAB); T/E unlistd ipr-rat LDLo: 50 mg/kg Kodak Company Reports. (343 State St., Rochester, NY 14650) 21MAY1971 (KODAK*); T/E unlistd ivn-mus LD50: 180 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#04968 (CSLNX*); T/E unlistd skn-gpg LD50: >5 gm/kg Kodak Company Reports. (343 State St., Rochester, NY 14650) 21MAY1971 (KODAK*) ND: NOHS 1974: HZD A1044; NIS 1; TNF 6; NOS 1; TNE 23; NOES 1983: HZD A1044; NIS 1; TNF 10; NOS 1; TNE 136; TFE 39 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-100, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 830 of 1119 in RTECS (through 2003/06) AN: NC4900000 PN: Hydroxylamine,-N-phenyl- SY: Aniline,-N-hydroxy-; N-Hydroxyaniline-; Benzenamine,-N-hydroxy- (9CI); N-Hydroxybenzenamine-; NCI-C60093-; Phenylhydroxyamine-; Phenylhydroxylamine-; beta-Phenylhydroxylamine-; N-Phenylhydroxylamine- RN: Current: 100-65-2 BRN: 507174 BHR: 4-15-00-00004 UD: 199712 MF: C6-H7-N-O MW: 109.14 WL: QMR CC: Mutagen (M); Human-Data (P) ME: mmo-sat 100 ug/plate (-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) JAN1982 (NTPTB*); mrc-esc 2 umol/L Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 86, p. 155, 1995 (JJCREP) ORNG: 100000000 ng/kg. [100.000000 mg/kg] T/E unlistd AT: R10 skn-hmn TDLo: 500 ug/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 35, p. 401, 1895 (AEXPBL); T/E unlistd orl-rat LD50: 100 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(3), p. 68, 1979 (GISAAA); M14-P24 scu-rat LDLo: 40 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 182, p. 118, 1936 (AEPPAE); T/E unlistd orl-mus LD50: 247 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(3), p. 68, 1979 (GISAAA); T/E unlistd orl-dog LDLo: 30 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-rbt LD50: 125 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(3), p. 68, 1979 (GISAAA); F08-F17-J22 scu-rbt LDLo: 50 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 35, p. 401, 1895 (AEXPBL) MD: F15-P27-U01 orl-rat TDLo: 1060 mg/kg/13W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 10, p. 671, 1972 (FCTXAV); P30-U30 orl-rat TDLo: 34 gm/kg/50D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(3), p. 68, 1979 (GISAAA) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 Record 831 of 1119 in RTECS (through 2003/06) AN: NI2200000 PN: Imferon- SY: A-100- (Pharmaceutical); B-75-; Chinofer-; Eisendextran- (German); Fe-Dextran-; Fenate-; Ferdex-100-; Ferric-dextran-; Ferridextran-; Ferrodextran-; Ferroglucin-; Ferroglukin-75-; A-100-; Dextran-iron-complex-; Dextrofer-75-; Iro-Jex-; Iron-dextran-; Iron-dextran-complex-; Iron-dextran-injection-; Iron-hydrogenated-dextran-; Ironorm-injection-; RCRA-waste-number-U139-; Imposil-; Myofer-100-; Polyfer-; Prolongal-; Ursoferran- RN: Current: 9004-66-4 Previous: 8050-93-9; 53858-58-5 UD: 200006 CC: Tumorigen (C); Drug (D); Reproductive-Effector (T); Human-Data (P) RE: T81 ivn-rat TDLo: 2580 gm/kg (17-20D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 5, p. 147, 1975 (TXCYAC); T81-T85 ims-rat TDLo: 240 mg/kg (6W pre) Bulletin of the Psychonomic Society. (Psychonomic Soc., 2904 Guadalupe St., Austin, TX 78705) V.1- 1973- v. 10, p. 49, 1977 (BPNSBY); T13 iut-rat TDLo: 52500 ug/kg (1D pre) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 19, p. 1124, 1981 (IJEBA6); T34 ims-rbt TDLo: 650 mg(Fe)/kg (6-18D preg) Scandinavian Journal of Haematology, Supplementum. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) No.1- 1967- v. 32, p. 69, 1977 (SJHSBD); T13-T22 iut-rat TDLo: 5250 ug/kg (1D pre) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 19, p. 1124, 1981 (IJEBA6) TE: V02-V10 ims-wmn TDLo: 20 mg/kg/3Y-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 277, 1973 (BMJOAE); V01-V10 scu-rat TDLo: 750 mg(Fe)/kg/4W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 2, p. 370, 1967 (IJCNAW); V02-V10 ims-rat TDLo: 1150 mg/kg/17W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 15, p. 838, 1961 (BJCAAI); V03-P62-V10 scu-mus TDLo: 2300 mg/kg Annual Report--Cancer Research Campaign. (Cancer Research Campaign, 2 Carlton House Terrace, London SW1Y 5AR, UK) V.1- 1924- v. 40, p. 30, 1962 (BECCAN); V03-V10 ims-mus TDLo: 2 gm(Fe)/kg/9W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 21, p. 448, 1967 (BJCAAI); V03-V10 ims-rbt TDLo: 28 gm/kg/27W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 1593, 1964 (BMJOAE); V03-L60 scu-ham TDLo: 40 gm/kg/10W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 24, p. 109, 1960 (JNCIAM); V03-V10 scu-mus TD :1120 mg(Fe)/kg/28W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 1800, 1962 (BMJOAE); V02-V10 ims-rat TD :3760 mg(Fe)/kg/47W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 947, 1959 (BMJOAE); V03-V10 scu-rat TD :104 gm/kg/26W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 24, p. 109, 1960 (JNCIAM); V01-V10 scu-rat TD :1500 mg(Fe)/kg/8W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 2, p. 370, 1967 (IJCNAW); V01-V10 ims-wmn TD :52 mg(Fe)/kg/6W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 1411, 1960 (BMJOAE); V01-V10 scu-rat TD :2400 mg(Fe)/kg/24W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 18, p. 801, 1964 (BJCAAI); V03-J61-V10 scu-mus TD :104 gm/kg/13W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 24, p. 109, 1960 (JNCIAM) AT: T/E unlistd ipr-rat LD50: 3 gm(Fe)/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 185, 1971 (TXAPA9); T/E unlistd ims-rat LDLo: 1617 mg(Fe)/kg Acta Veterinaria (Belgrade). (Jugoslovenska Knjiga, POB 36, YU-11001, Belgrade, Yugoslavia) V.1- 1951- v. 29, p. 21, 1979 (ACVTA8); T/E unlistd orl-mus LD50: 1 gm(Fe)/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 24, p. 352, 1965 (BJPCAL); T/E unlistd ivn-mus LD50: 460 mg(Fe)/kg Acta Poloniae Pharmaceutica. For English translation, see APPFAR. (Ars Polona, POB 1001, 00-680 Warsaw 1, Poland) V.1- 1937- v. 18, p. 149, 1961 (APPHAX); T/E unlistd ims-mus LD :>450 mg(Fe)/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 10, p. 375, 1955 (BJPCAL); T/E unlistd ivn-rbt LDLo: 500 mg(Fe)/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 10, p. 375, 1955 (BJPCAL); T/E unlistd ims-rbt LD :>690 mg(Fe)/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 10, p. 375, 1955 (BJPCAL) MD: G30-L30-Y12 ipr-rat TDLo: 700 mg/kg/7D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 51, p. 235, 1997 (JTEHD6) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 2, p. 161, 1973 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 2, p. 161, 1973 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 226, 1987 (IMSUDL); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 683, 1978 (BMJOAE); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR) ND: NOES 1983: HZD X4721; NIS 1; TNF 39; NOS 2; TNE 1157; TFE 573 SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 832 of 1119 in RTECS (through 2003/06) AN: NI3950000 PN: Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)- SY: Biocarbazine-R-; Dacarbazine-; Deticene-; (Dimethyltriazeno)imidazolecarboxamide; 4-(Dimethyltriazeno)imidazole-5-carboxamide; 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide; 4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide; 5-(Dimethyltriazeno)imidazole-4-carboxamide; 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide; 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; DTIC-dome-; NCI-C04717-; 1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)- (9CI); NSC-45388- RN: Current: 4342-03-4 UD: 200006 MF: C6-H10-N6-O MW: 182.22 WL: T5M CNJ DVZ ENUNN1&1 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 100 ug/plate (+/-S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 467, 1982 (CRNGDP); mmo-esc 100 ug/plate (+/-S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 467, 1982 (CRNGDP); dnr-esc 600 pg/plate Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 28, p. 159, 1985 (NULSAK); sln-dmg-orl 500 umol/L/3D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 202, p. 251, 1988 (MUREAV); mrc-smc 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 239, 1988 (MUREAV); dni-mus-fbr 10 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 24, p. 615, 1975 (BCPCA6); oms-mus-fbr 100 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 24, p. 615, 1975 (BCPCA6); dnd-rat-ipr 6 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 285, 1991 (CRNGDP); dni-rat-ipr 37500 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 21, p. 2817, 1972 (BCPCA6); dni-rat-oth 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 2827, 1976 (CNREA8); oms-rat-oth 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 2827, 1976 (CNREA8); mnt-mus-ipr 225 mg/kg/48H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); mmo-mus-lym 75 mg/L (+S9) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 1, p. 277, 1978 (DCTODJ); dnd-mus-orl 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 465, p. 11, 2000 (MUREAV); oms-mus-ipr 9 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 259, 1989 (MUREAV); cyt-mus-ipr 9 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 259, 1989 (MUREAV); msc-mus-lym 75 mg/L Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 1, p. 277, 1978 (DCTODJ); sce-ham-ovr 200 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 577, 1983 (CNREA8); msc-ham-lng 20 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 467, 1982 (CRNGDP); msc-ham-ovr 400 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 577, 1983 (CNREA8) RE: T34 ipr-rat TDLo: 50 mg/kg (12D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 2231, 1973 (CNREA8); T53 ipr-rat TDLo: 200 mg/kg (12D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 186, p. 461, 1976 (ANREAK); T46 ipr-rat TDLo: 100 mg/kg (12D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 2231, 1973 (CNREA8); T41-T43 ipr-rat TDLo: 400 mg/kg (12D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 2231, 1973 (CNREA8) TE: V01-P62-R60 orl-rat TDLo: 1730 mg/kg/15W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 951, 1975 (JNCIAM); V03-T65-A60 ipr-rat TDLo: 25 mg/kg (20D preg) Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 50, p. 306, 1980 (ARGEAR); V01-P62-R60 ipr-rat TDLo: 3900 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V01-J60-P62 ipr-mus TDLo: 1950 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V01-P62-R60 orl-rat TD :3700 mg/kg/14W-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 11, p. 73, 1970 (PAACA3) ORNG: 2147000000 ng/kg. [2147.000000 mg/kg] F17-F25 AT: K13-P14-Y10 ivn-hmn TDLo: 3500 ug/kg Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 57, p. 83, 1973 (CCROBU); F17-F25 orl-rat LD50: 2147 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 9, p. 3105, 1981 (YACHDS); T/E unlistd ipr-rat LD50: 350 mg/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 50, p. 306, 1980 (ARGEAR); F17-F25 ivn-rat LD50: 411 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 9, p. 3105, 1981 (YACHDS); F17-F25 orl-mus LD50: 2032 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 9, p. 3105, 1981 (YACHDS); T/E unlistd ipr-mus LD50: 567 mg/kg Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 62, p. 721, 1978 (CTRRDO); F17-F25 ivn-mus LD50: 466 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 9, p. 3105, 1981 (YACHDS); V30 par-ham LD10: 250 mg/kg Journal of Surgical Oncology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1969- v. 15, p. 355, 1980 (JSONAU) MD: Z01 ipr-mus TDLo: 1568 mg/kg/14D-I Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 62, p. 693, 1978 (CTRRDO) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 203, 1981 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 203, 1981 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 184, 1987 (IMSUDL) ND: NOES 1983: HZD X3246; NIS 1; TNF 412; NOS 9; TNE 17273; TFE 12863 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; NCI Carcinogenesis Studies (ipr), clear evidence: mouse, rat Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 833 of 1119 in RTECS (through 2003/06) AN: NI5600000 PN: Imidazole-1-ethanol,-2-methyl-5-nitro- SY: 1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole; 1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole; 1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole; 1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole; 1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole; 1-(hidroxyethyl)-2-methyl-5-nitro-imidazole; 1-Hydroxyethyl-2-methyl-5-nitroimidazole-; 2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole; 2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole; 2-Methyl-5-nitroimidazole-1-ethanol-; Acromona-; Anagiardil-; Atrivyl-; Bayer-5360-; Bexon-; CONT-; Clont-; Danizol-; Deflamon-wirkstoff-; Efloran-; Elyzol-; Entizol-; Eumin-; Flagemona-; Flagesol-; Flagil-; Flagyl-; Flegyl-; Giatricol-; Gineflavir-; Klion-; MTZ-; Meronidal-; Metronidaz-; Metronidazol-; Metronidazole-; Metronidazolo-; Monagyl-; NIDA-; NSC-50364-; Nalox-; Neo-tric-; Novonidazol-; Orvagil-; RP-8823-; SC-10295-; Sanatrichom-; Takimetol-; Trichazol-; Trichex-; Trichocide-; Trichomol-; Trichomonacid-'pharmachim'-; Trichopal-; Trichopol-; Tricocet-; Tricom-; Tricowas-B-; Trikacide-; Trikamon-; Trikojol-; Trikozol-; Trimeks-; Trivazol-; Vagilen-; Vagimid-; Vertisal- RN: Current: 443-48-1 BRN: 611683 BHR: 5-23-05-00063 UD: 200204 MF: C6-H9-N3-O3 MW: 171.18 WL: T5N CNJ A2Q B1 ENW CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ID: skn-hmn 0.75% Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975- v. 135, p. 93, 1999 (CODEDG) ME: mmo-sat 25 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 38, p. 203, 1976 (MUREAV); mmo-sat 50 ug/plate (-S9) European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- v. 25, p. 241, 1990 (EJMCA5); mmo-esc 100 umol/L (-S9) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(3), p. 657, 1979 (JEPTDQ); oms-esc 4 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 55, 1987 (MUREAV); mmo-esc 1 gm/L (+S9) British Journal of Cancer, Supplement. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2ZS, UK) No.1- 1973- v. 3, p. 124, 1978 (BJCSB5); dnr-esc 200 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dna-esc 2 umol Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 13, p. 872, 1977 (MOPMA3); pic-esc 500 ug/plate Acta Microbiologica Polonica. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1-17(4), 1952-68: V.25- 1976- v. 34, p. 111, 1985 (AMPOAX); dnr-bcs 200 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); mmo-klp 20 umol/L/20H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 207, 1979 (MUREAV); mmo-omi 25 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 483, 1974 (MUREAV); dni-omi 1 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 1421, 1974 (BCPCA6); oms-omi 1 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 1421, 1974 (BCPCA6); dni-omi 5 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 1421, 1974 (BCPCA6); oms-omi 5 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 1421, 1974 (BCPCA6); dni-omi 5 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 1421, 1974 (BCPCA6); oms-omi 5 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 1421, 1974 (BCPCA6); mmo-nsc 8800 mg/L (-S9) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(4), p. 1109, 1979 (JEPTDQ); bfa-hmn-sat 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 357, 1980 (MUREAV); cyt-hmn-unr 86 mg/kg/30D Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 802, 1976 (LANCAO); cyt-hmn-lym 500 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 467, 1984 (ENMUDM); cyt-hmn-orl 250 mg/kg/10D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 370, p. 75, 1996 (MUREAV); dnd-rat-lvr 3 mmol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); bfa-rat-sat 800 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 171, 1982 (MUREAV); dnd-mus-lym 30 mmol/L/4H-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 40, p. 94, 1979 (BJCAAI); dnd-mus-fbr 300 umol/L British Journal of Cancer, Supplement. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2ZS, UK) No.1- 1973- v. 3, p. 124, 1978 (BJCSB5); dni-mus-lym 30 mmol/L/1H-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 40, p. 94, 1979 (BJCAAI); dni-mus-oth 100 mg/L Revista de Chirurgui, Oncologie, Radiologie, ORL, Oftalmologie, Stomatologie, Seria: Oncologia. (Rompresfilatelia, POB 12-201, Bucharest, Romania) V.13(4)- 1974- v. 19, p. 183, 1980 (ONCODU); bfa-rat-sat 100 mg/kg Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 61, p. 1595, 1985 (BSIBAC); cyt-mus-orl 1200 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 25, p. 240, 1987 (IJEBA6); hma-mus-sat 400 mg/kg/5D Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 188, p. 1118, 1975 (SCIEAS); hma-mus-esc 4 mg/kg/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 164, p. 9, 1986 (MUREAV); hma-mus-smc 25 mmol/kg Drugs under Experimental and Clinical Research. (Bioscience Ediprint, Blvd. James-Fazy 13, 1201 Geneva 1, Switzerland) V.1- 1977- v. 11, p. 755, 1985 (DECRDP); dni-ham-lng 1 mmol/L/6D-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 40, p. 94, 1979 (BJCAAI); cyt-ham-lng 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 78, p. 201, 1980 (MUREAV); sce-ham-orl 125 mg/kg Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 29B, p. 613, 1984 (BLFSBY); hma-ham-emb 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 289, 1987 (MUREAV); dna-mam-lym 60 umol/L Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 13, p. 872, 1977 (MOPMA3); dnd-hmn-orl 214.3 mg/kg/10D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 478, p. 153, 2001 (MUREAV) RE: T23 orl-rat TDLo: 16800 mg/kg (42D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 386, 1989 (FAATDF); T01-T02 orl-rat TDLo: 22400 mg/kg (56D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 386, 1989 (FAATDF); T13 unr-rat TDLo: 750 mg/kg (30D pre) Recent Progress In Hormone Research. Proceedings of the Laurentian Hormone Conference. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1947- v. 20, p. 395, 1964 (RPHRA6); T35-T59 ipr-mus TDLo: 60 mg/kg (8-14D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 19, p. 37, 1983 (TOLED5) TE: V01-L60-R60 orl-rat TDLo: 219 gm/kg/2Y-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 863, 1979 (JJIND8); V01-J60-P62 orl-mus TDLo: 181 gm/kg/72W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 48, p. 721, 1972 (JNCIAM); V03-R60-T64 orl-rat TD :27 gm/kg/35W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 403, 1973 (JNCIAM); V02-J60-P62 orl-mus TD :8 gm/kg/14W-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 69, p. 379, 1983 (TUMOAB); V02-R60 orl-rat TD :3 gm/kg/14W-C Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 70, p. 307, 1984 (TUMOAB); V01-L60 orl-mus TD :21800 mg/kg/2Y-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 112, p. 135, 1986 (JCROD7); V01-T65-J60 orl-mus TD :1680 mg/kg (1-21D preg) Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 112, p. 135, 1986 (JCROD7) ORNG: 3000000000 ng/kg. [3000.000000 mg/kg] F07-J24-U28 AT: F08 orl-wmn TDLo: 40 mg/kg Southern Medical Journal. (Southern Medical Assoc., POB 2446, Birmingham, AL 35205) V.1- 1908- v. 78, p. 627, 1985 (SMJOAV); L12-L30-U25 orl-man TDLo: 3570 ug/kg/D JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 193, p. 1128, 1965 (JAMAAP); D35-F11 orl-wmn TDLo: 12 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 292, p. 174, 1986 (BMJOAE); C10-C18 orl-man TDLo: 1030 mg/kg/8W British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 610, 1977 (BMJOAE); C04-D50-F27 orl-hmn TDLo: 39600 mg/kg/4W-I International Journal of Clinical Pharmacology Research. (Bioscience Ediprint Inc., 16 Rue A. - Gavard, 1227 Carouge - Geneva, Switzerland) V.1- 1981- v. 19, p. 83, 1999 (CPHRDE); F08-F10-F33 ivn-wmn TDLo: 100 mg/kg/5D-I American Journal of Psychiatry. (American Psychiatric Assoc., Circulation Dept., 1400 K St., NW, Washington, DC 20005) V.78- 1921- v. 154, p. 1169, 1997 (AJPSAO); F07-J24-U28 orl-rat LD50: 3 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 8, p. 1089, 1974 (OYYAA2); Y12 orl-mus LD50: 3800 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 20, p. 1522, 1977 (JMCMAR); T/E unlistd ipr-mus LD50: 870 mg/kg Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001, 00-068 Warsaw 1, Poland) V.25-44, 1973-92. For publisher information, see PJPAE3 v. 42, p. 471, 1990 (PJPPAA); F07-F11-F12 scu-mus LD50: 3640 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 8, p. 1089, 1974 (OYYAA2); T02-Z73 orl-rat TDLo: 2500 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 491, 1992 (REPTED) MD: M14-Z01-Z73 orl-rat TDLo: 34 gm/kg/34D-C Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 8, p. 1089, 1974 (OYYAA2); A30-U01-Z01 orl-dog TDLo: 6500 mg/kg/26D-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 28, p. 612, 1978 (ARZNAD) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 13, p. 113, 1977 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 250, 1987 (IMSUDL); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 250, 1987 (IMSUDL); TOXICOLOGY REVIEW Journal of Antimicrobial Chemotherapy. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1975- v. 3, p. 205, 1977 (JACHDX); TOXICOLOGY REVIEW Advances in Chemotherapy. (New York, NY) V.1-3, 1964-68. For publisher information, see AVPCAQ. v. 3, p. 39, 1968 (ADCMAZ) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOES 1983: HZD X4277; NIS 1; TNF 216; NOS 4; TNE 5262; TFE 2655 SL: EPA GENETOX PROGRAM 1988, Positive: Body fluid assay, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive/dose response: TRP reversion; EPA GENETOX PROGRAM 1988, Negative: Mammalian micronucleus, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-human; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 834 of 1119 in RTECS (through 2003/06) AN: NI7175000 PN: Imidazole,-2-methyl- SY: 2-Methylimidazole- RN: Current: 693-98-1 UD: 200012 MF: C4-H6-N2 MW: 82.12 WL: T5M CNJ B1 CC: Tumorigen (C) AT: F12 orl-mus LD50: 1400 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 301, 1969 (TXAPA9); F12 ipr-mus LD50: 480 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 301, 1969 (TXAPA9) MD: N30-P28-U01 orl-rat TDLo: 13500 mg/kg/90D-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 202, 1995 (TOXID9); N07-P28-U01 orl-rat TDLo: 11250 mg/kg/90D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 30, p. 203, 1996 (TOXID9); U01 orl-mus TDLo: 54 gm/kg/90D-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 202, 1995 (TOXID9); N07-U01 orl-mus TDLo: 108 gm/kg/90D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 30, p. 203, 1996 (TOXID9) ND: NOHS 1974: HZD A1324; NIS 4; TNF 67; NOS 6; TNE 418; NOES 1983: HZD A1324; NIS 11; TNF 318; NOS 22; TNE 7023; TFE 3073 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, on test (two year studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 835 of 1119 in RTECS (through 2003/06) AN: NI7350000 PN: Imidazole,-4-methyl- SY: 4-Methylimidazole- RN: Current: 822-36-6 UD: 200012 MF: C4-H6-N2 MW: 82.12 WL: T5M CNJ D1 CC: Tumorigen (C) ORNG: 751000000 ng/kg. [751.000000 mg/kg] F11-F12-K30 AT: F11-F12-K30 orl-rat LD50: 751 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 89, p. 175, 1987 (TXAPA9); F12 orl-mus LD50: 370 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 301, 1969 (TXAPA9); F12 ipr-mus LD50: 165 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 301, 1969 (TXAPA9); F12 ipr-rbt LDLo: 120 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 301, 1969 (TXAPA9); F12 orl-ckn LD50: 590 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 301, 1969 (TXAPA9); F12 ipr-ckn LD50: 210 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 301, 1969 (TXAPA9) MD: F11-F19-Z01 orl-rat TDLo: 45 gm/kg/90D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 30, p. 203, 1996 (TOXID9); U01-Z01 orl-mus TDLo: 108 gm/kg/90D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 30, p. 203, 1996 (TOXID9) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, on test (two year studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 836 of 1119 in RTECS (through 2003/06) AN: NI9625000 PN: 2-Imidazolidinethione- SY: 1,3-Ethylene-2-thiourea-; 1,3-Ethylenethiourea-; 2-Imadazoline-2-thiol-; 2-Mercaptoimidazoline-; 2-Merkaptoimidazolin- (Czech); 2-Thiol-dihydroglyoxaline-; 4,5-Dihydroimidazole-2(3H)-thione; Akrochem-etu-22-; ETU-; Ethylene-thiourea-; Ethylene-thiouree- (French); Ethylenethiourea-; Imidazole-2(3H)-thione, 4,5-dihydro-; Imidazoline,-2-mercapto-; Imidazoline-2-thiol-; N,N'-Ethylenethiourea-; NA-22-; NA-22-D-; NCI-C03372-; Pennac-CRA-; RCRA-waste-number-U116-; Robac-22-; Rodanin-S-62- (Czech); Sanceller-22-; Sodium-22-neoprene-accelerator-; USAF-EL-62-; Urea,-1,3-ethylene-2-thio-; Vulkacit npv/C2; Warecure-C- RN: Current: 96-45-7 Previous: 96-46-8 UD: 200302 MF: C3-H6-N2-S MW: 102.17 WL: T5MYMTJ BUS CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Hormone (H); Mutagen (M); Primary-Irritant (S); Reproductive-Effector (T) ID: eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,988,1986 (85JCAE) ME: mmo-sat 1 mmol/L (+S9) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 31, p. 214, 1975 (EXPEAM); mmo-sat 20 ug/plate (-S9) British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); dnr-sat 20 mg/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 38, p. 122, 1976 (MUREAV); mmo-esc 200 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 396, 1981 (PMRSDJ); dnr-esc 500 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 195, 1981 (PMRSDJ); pic-esc 10 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 224, 1981 (PMRSDJ); dnd-bcs 2 mg/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); slt-dmg-mul 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 395, p. 229, 1997 (MUREAV); mmo-smc 5 mmol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 174, p. 39, 1979 (MGGEAE); dnr-smc 300 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 491, 1981 (PMRSDJ); sln-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); sln-asn 39200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 139, 1986 (MUREAV); cyt-rat-par 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 38, p. 349, 1976 (MUREAV); cyt-rat-orl 200 mg/kg Cold Spring Harbor Conferences on Cell Proliferation. (Cold Spring Harbor, NY) V.1-10, 1974-83. v. 4, p. 267, 1977 (CSHCAL); mmo-mus-lym 1800 mg/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); dnd-mus-ipr 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 391, p. 201, 1997 (MUREAV); hma-mus-sat 6 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 111, 1977 (MUREAV); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mrc-dmg-orl 1 mmol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 518, p. 95, 2002 (MUREAV) RE: T34 orl-rat TDLo: 84 mg/kg (11-14D preg) Journal of Health Science. (Pharmaceutical Society of Japan, 2-12-15 Shibuya, Shibuya-Ku, Tokyo 150-0002, Japan) V. 45- 1999- v. 45, p. 184, 1999 (JHSCFD); T53 orl-rat TDLo: 60 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24, p. 131, 1981 (TJADAB); T50 orl-rat TDLo: 100 mg/kg (13D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 18, p. 241, 1978 (SEIJBO); T43 orl-rat TDLo: 60 mg/kg (13D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 273, 1982 (FCTOD7); T75-T76 orl-rat TDLo: 10 mg/kg (17D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 292, 1980 (ATSUDG); T34-T46 orl-rat TDLo: 50 mg/kg (12D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 18, p. 241, 1978 (SEIJBO); T41-T76 orl-rat TDLo: 30 mg/kg (15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 415, 1987 (FAATDF); T34-T35 ihl-rat TCLo: 120 mg/m3/3H (7-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB277-077 (NTIS**); T46 ihl-rat TCLo: 27200 ug/m3/3H (7-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB277-077 (NTIS**); T41-T43-T46 skn-rat TDLo: 100 mg/kg (12-13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 35, 1977 (TXAPA9); T16-T71-T81 skn-rat TDLo: 2800 mg/kg (7D pre/1-21D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 102, 1992 (TOXID9); T41-T76 ipr-rat TDLo: 30 mg/kg (17D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 449, 1986 (TJADAB); T75 ipr-rat TDLo: 30 mg/kg (19D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 449, 1986 (TJADAB); T26-T41-T75 ipr-rat TDLo: 30 mg/kg (12D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 30, p. 121, 1990 (CGANE7); T81 ipr-rat TDLo: 30 mg/kg (13D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 30, p. 121, 1990 (CGANE7); T34-T41-T43 scu-rat TDLo: 80 mg/kg (13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. 229, 1979 (TXAPA9); T46-T55 scu-rat TDLo: 80 mg/kg (13D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. 229, 1979 (TXAPA9); T41-T43-T46 unr-rat TDLo: 300 mg/kg (12D preg) Anatomia, Histologia, Embryologia. (Paul Parey Scientific Pub., 35 W. 38th St., Suite 3W, New York, NY 10018) V.2- 1973- v. 9, p. 89, 1980 (AHEMA5); T73 orl-mus TDLo: 1600 mg/kg (12D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 13, p. 747, 1984 (JTEHD6); T46 orl-mus TDLo: 2 gm/kg (7-16D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 5, p. 821, 1979 (JTEHD6); T43 orl-mus TDLo: 2 gm/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 23, p. 335, 1981 (TJADAB); T25-T35-T46 orl-mus TDLo: 2 gm/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 57A, 1983 (TJADAB); T34 orl-mus TDLo: 2400 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 57A, 1983 (TJADAB); T42-T45-T43 orl-cat TDLo: 600 mg/kg (16-35D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 18, p. 311, 1978 (TJADAB); T25 orl-rbt TDLo: 1120 mg/kg (7-20D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 7, p. 243, 1973 (TJADAB); T41 orl-rbt TDLo: 140 mg/kg (7-20D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 7, p. 243, 1973 (TJADAB); T46 orl-ham TDLo: 600 mg/kg (11D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 11, p. 287, 1983 (JTEHD6); T43-T46-T50 orl-ham TDLo: 6480 mg/kg (6-18D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 18, p. 11, 1978 (SEIJBO); T25-T35 orl-ham TDLo: 2400 mg/kg (11D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 11, p. 287, 1983 (JTEHD6); T34 orl-ham TDLo: 2160 mg/kg (6-13D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 18, p. 11, 1978 (SEIJBO); T41-T43 orl-ham TDLo: 1200 mg/kg (11D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 11, p. 287, 1983 (JTEHD6) TE: V01-N62 orl-rat TDLo: 10920 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-388, 1992 (NTPTR*); V01-J60-N62 orl-rat TDLo: 5306 mg/kg/77W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 49, p. 583, 1972 (JNCIAM); V01-L60-N62 orl-mus TDLo: 87360 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-388, 1992 (NTPTR*); V01-L60-P62 orl-mus TDLo: 77 gm/kg/82W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 1101, 1969 (JNCIAM); V01-N62 orl-rat TD :11466 mg/kg/78W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 75, 1981 (JJIND8); V01-N62-T61 orl-rat TD :44 gm/kg/2Y-C European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 303, 1976 (EJTXAZ); V01-N62 orl-rat TD :146 gm/kg/2Y-C European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 303, 1976 (EJTXAZ); V01-N60-N62 orl-rat TD :9125 mg/kg/2Y-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 493, 1975 (FCTXAV); V03-L60 orl-rat TD :5470 mg/kg/26W-C Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(2), p. 25, 1988 (GTPZAB); V02-N62 orl-rat TDLo: 2737.5 mg/kg/1Y-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); V01-N62 orl-rat TDLo: 5475 mg/kg/1Y-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); V01-N62 orl-rat TDLo: 9125 mg/kg/1Y-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); V01-N62 orl-rat TDLo: 10815 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191618 (NTIS**); V01-N62 orl-rat TDLo: 9012.5 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191618 (NTIS**); V01-L60-N62 orl-mus TDLo: 86520 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191618 (NTIS**) ORNG: 1832000000 ng/kg. [1832.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1832 mg/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 7, p. 19, 1972 (BECTA6); T/E unlistd orl-mus LD50: 3 gm/kg Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 71, 1980 (TJADAB); T/E unlistd ipr-mus LD50: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd unr-mus LD50: 7800 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 30(5), p. 59, 1986 (GTPZAB); N30 ipr-rat TDLo: 1000 mg/kg Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. Suppl.8, p. 253, 1985 (ATSUDG) MD: N30-P28 orl-rat TDLo: 297 mg/kg/28D-C Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 9, p. 339, 1986 (ATSUDG); N30-N75-P28 orl-rat TDLo: 764 mg/kg/90D-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(1), p. 147, 1977 (JEPTDQ); F15-N75-U01 orl-rat TDLo: 220 mg/kg/7W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 67, p. 264, 1983 (TXAPA9); N30-N75-U01 orl-rat TDLo: 3600 mg/kg/17W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 7, p. 19, 1972 (BECTA6); L70 orl-rat TDLo: 450 mg/kg/8W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); N75-U01 orl-rat TDLo: 900 mg/kg/8W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); M71 orl-rat TDLo: 1800 mg/kg/8W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); N73 orl-rat TDLo: 5475 mg/kg/26W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); N08 orl-rat TDLo: 10950 mg/kg/1Y-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); U01 orl-rat TDLo: 75 mg/kg/8W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); L70-N75 orl-rat TDLo: 375 mg/kg/8W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); N08 orl-rat TDLo: 1140.6 mg/kg/26W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); N07 orl-rat TDLo: 2281 mg/kg/1Y-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); G70 orl-rat TDLo: 2281 mg/kg/26W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU); M71-N73 orl-rat TDLo: 1500 mg/kg/8W-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 21, p. 324, 1973 (JAFCAU) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); TOXICOLOGY REVIEW Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 7, p. 243, 1974 (ENVRAL); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 39(6), p. A34, 1978 (AIHAAP); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,250,1970 (85CVA2); TOXICOLOGY REVIEW Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- v. 14, p. 49, 1979 (CNDQA8) SR: OEL-FINLAND: TWA 0.2 mg/m3, STEL 0.6 mg/m3, Carcinogen, JAN 1993; OEL-FRANCE: Carcinogen, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999 ND: NIOSH REL TO ETHYLENE THIOUREA-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 82079; NIS 13; TNF 1100; NOS 39; TNE 7475; NOES 1983: HZD 82079; NIS 11; TNF 462; NOS 24; TNE 10749; TFE 1804 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: TRP reversion; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 22, 1978; NIOSH Analytical Method, 1994: Ethylene thiourea, 5011; NCI Carcinogenesis Studies (feed), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #95 Record 837 of 1119 in RTECS (through 2003/06) AN: NK9300000 PN: Indeno(1,2,3-cd)pyrene SY: IP-; RCRA-waste-number-U137-; o-Phenylenepyrene-; 1,10-(ortho-Phenylene)pyrene; 1,10-(1,2-Phenylene)pyrene; 2,3-Phenylenepyrene-; 2,3-o-Phenylenepyrene- RN: Current: 193-39-5 BRN: 1879312 BHR: 4-05-00-02765 UD: 200210 MF: C22-H12 MW: 276.34 WL: L E6 C5666 B6 3ABC VJ CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 3 ug/plate/48H (-S9) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 141, 1979 (FCTXAV); msc-hmn-lym 50 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 371, p. 123, 1996 (MUREAV); mtr-ham-lng 100 ug/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 17, p. 149, 1980 (TXCYAC); dnd-esc 952.5 ug/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 515, p. 85, 2002 (MUREAV) TE: V01-J60-V10 imp-rat TDLo: 4150 ug/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 71, p. 539, 1983 (JJIND8); V03-R60 skn-mus TDLo: 40 mg/kg/20D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 1761, 1986 (CRNGDP); V01-V10 scu-mus TDLo: 72 mg/kg/9W-I Acta Unio Internationalis Contra Cancrum. (Louvain, Belgium) V.1-20, 1936-64. For publisher information, see IJCNAW. v. 19, p. 490, 1963 (AICCA6); V01-J60-V10 imp-rat TD :20750 ug/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 71, p. 539, 1983 (JJIND8); V03-J60-V10 imp-rat TD :5 mg/kg "Polynuclear Aromatic Hydrocarbons, International Symposium, 7th, 1982," Cooke, M., and A.J. Dennis, eds., Columbus, OH, Battelle Press, 1983 7,571,1983 (50NNAZ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 373, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 373, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Pc,4,1972 (85DHAX) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264370); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Polynuclear aromatic hydrocarbons by HPLC, 5506, by GC, 5515; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 838 of 1119 in RTECS (through 2003/06) AN: NL1800000 PN: Indium-phosphide- SY: Indium-monophosphide- RN: Current: 22398-80-7 UD: 200207 MF: In-P MW: 145.79 CC: Tumorigen (C); Reproductive-Effector (T) RE: T02-T03 itr-ham TDLo: 48 mg/kg (8W male) Journal of Occupational Health. (Japan Society for Occupational Health, 1-29-8 Shinjuku, Shinjuku-ku, Tokyo, 160, Japan) V.38- 1996- v. 42, p. 196, 2000 (JOCHFV) AT: J30-P70-Y10 itr-rat LD :>100 mg/kg Journal of Occupational Health. (Japan Society for Occupational Health, 1-29-8 Shinjuku, Shinjuku-ku, Tokyo, 160, Japan) V.38- 1996- v. 38, p. 205, 1997 (JOCHFV); P28 orl-mus LD :>5 gm/kg Journal of Occupational Health. (Japan Society for Occupational Health, 1-29-8 Shinjuku, Shinjuku-ku, Tokyo, 160, Japan) V.38- 1996- v. 38, p. 6, 1996 (JOCHFV); J70-N73-P28 ipr-mus LD :>5 gm/kg Journal of Occupational Health. (Japan Society for Occupational Health, 1-29-8 Shinjuku, Shinjuku-ku, Tokyo, 160, Japan) V.38- 1996- v. 38, p. 6, 1996 (JOCHFV) MD: J13-J70-P28 itr-ham TDLo: 48 mg/kg/8W-I Journal of Occupational Health. (Japan Society for Occupational Health, 1-29-8 Shinjuku, Shinjuku-ku, Tokyo, 160, Japan) V.38- 1996- v. 42, p. 169, 2000 (JOCHFV) SR: OSHA PEL (Construc): 8H TWA 0.1 mg(In)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OEL-UNITED KINGDOM: TWA 0.1 mg(In)/m3, STEL 0.3 mg(In)/m3, SEP 2000 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP Carcinogenesis studies, test completed (post peer review), October 2000 Record 839 of 1119 in RTECS (through 2003/06) AN: NL9483000 PN: Indole-3-methanol- SY: 1H-Indole-3-methanol- (9CI); 3-Hydroxymethylindole-; 3-Indolylcarbinol-; I-3COH-; Indole-3-carbinol-; Indole-3-carbinol- RN: Current: 700-06-1 BRN: 121323 BHR: 5-21-03-00045 UD: 200302 MF: C9-H9-N-O MW: 147.19 WL: T56 BMJ D1Q CC: Tumorigen (C); Mutagen (M); Natural-Product (N); Human-Data (P); Reproductive-Effector (T) ME: dna-hmn-fbr 25 umol/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 484, p. 3, 2001 (MUREAV) RE: T91 orl-rat TDLo: 1 mg/kg (15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 141, p. 68, 1996 (TXAPA9); T34 scu-rat TDLo: 400 mg/kg (8-9D preg) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 159, 1980 (FCTXAV) AT: F24 scu-rat LDLo: 500 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 159, 1980 (FCTXAV); Y53 orl-rat TDLo: 250 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 82, p. 947, 1990 (JJIND8) MD: L30-L70 orl-rat TDLo: 9100 mg/kg/13W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 292, 1995 (TOXID9); L30-Y03-Y16 orl-rat TDLo: 24500 mg/kg/28W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 375, 2000 (TOXID9); U01 orl-dog TDLo: 5600 mg/kg/13W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 292, 1995 (TOXID9); L70-Y07 orl-rat TDLo: 200 mg/kg/2D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 38, p. 15, 2000 (FCTOD7); L70-Y07 orl-rat TDLo: 280 mg/kg/2W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 38, p. 15, 2000 (FCTOD7); S02 orl-rat TDLo: 5250 mg/kg/35D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 59, p. 271, 2000 (JTEHD6); Y07 orl-rat TDLo: 1520 mg/kg/10D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 294, p. 473, 2000 (JPETAB); Y07 orl-mus TDLo: 1750 mg/kg/1W-C Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 83, p. 155, 1992 (CBINA8); Y53 orl-mus TDLo: 3500 mg/kg/1W-C Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 83, p. 155, 1992 (CBINA8); Y53 orl-man TDLo: 42 mg/kg/7D-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 82, p. 947, 1990 (JJIND8) SL: NTP Carcinogenesis studies, selected, October 2000; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 840 of 1119 in RTECS (through 2003/06) AN: NM7263000 PN: Ink- SY: Black-newsprint-ink- CD: A complex mixture of carbon black in a mineral oil vehicle with various other petroleum-based additives (National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3340 - NTPTR*) UD: 200012 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 6666 ug/plate (-S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3340 (NTPTR*) MD: L70 skn-mus TDLo: 20800 uL/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3340 (NTPTR*) SL: NTP Toxicity studies, RPT# TOX-17, October 2000 Record 841 of 1119 in RTECS (through 2003/06) AN: NM7461240 PN: Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3) SY: Aviral-; Delimmun-; Imunovir-; Inosiplex-; Isoprinosin-; Isoprinosine-; Inosine-pranobex-; Isoviral-; Methisoprinol-; NP-113-; NTP-10381-; Viruxan- RN: Current: 36703-88-5 UD: 199109 MF: C10-H12-N4-O5.3 C9-H9-N-O3.3 C5-H13-N-O MW: 1019.40 CC: Z Other (Z) ORNG: 9150000000 ng/kg. [9150.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 9150 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 19, p. 906, 1988 (IYKEDH); T/E unlistd ipr-rat LD50: 2960 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 124, 1990 (NIIRDN); T/E unlistd scu-rat LD50: 3460 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 19, p. 906, 1988 (IYKEDH); T/E unlistd ivn-rat LD50: 1970 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 19, p. 906, 1988 (IYKEDH); T/E unlistd orl-mus LD50: 9410 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 19, p. 906, 1988 (IYKEDH); T/E unlistd ipr-mus LD50: 2300 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 124, 1990 (NIIRDN); T/E unlistd scu-mus LD50: 2960 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 19, p. 906, 1988 (IYKEDH); T/E unlistd ivn-mus LD50: 1570 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 19, p. 906, 1988 (IYKEDH) Record 842 of 1119 in RTECS (through 2003/06) AN: NQ9490000 PN: Isocyanic-acid,-methyl-m-phenylene-ester- SY: 1,3-Diisocyanatomethylbenzene-; 2,4 (80%)- and 2,6 (20%)-Toluene diisocyanate; Benzene,-1,3-diisocyanatomethyl- (9CI); Desmodur-T100-; Diisocyanatomethylbenzene-; Diisocyanatotoluene-; Hylene-T-; Methyl-m-phenylene-isocyanate-; Methyl-meta-phenylene-diisocyanate-; Methylphenylene-isocyanate-; Mondur-TD-; Mondur-TD-80-; Nacconate-100-; Niax-isocyanate-TDI-; RCRA-waste-number-U223-; Rubinate-TDI-; Rubinate TDI 80/20; TDI-; TDI-80-20-; Toluene-diisocyanate-; Toluene-diisocyanate- (80:20 mixture of 2,4:2,6 isomers); Tolylene-diisocyanate-; Tolylene-isocyanate- RN: Current: 26471-62-5 Previous: 1321-39-7; 25321-34-0; 29033-29-2; 50853-47-9; 50985-24-5; 71215-63-9; 72214-34-7; 80498-23-3; 89698-92-0; 104213-33-4 UD: 200210 MF: C9-H6-N2-O2 MW: 174.17 CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg open SEV Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 7/11/1967 (UCDS**) ME: mmo-sat 100 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9(Suppl 9), p. 1, 1987 (ENMUDM); sln-dmg-orl 15 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); trn-dmg-orl 15 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); cyt-hmn-lym 92 mg/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 36, p. 37, 1987 (TOLED5); mmo-mus-lym 50 mg/L (+S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); msc-mus-lym 50 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 800 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 50 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V01-P61-R60 orl-rat TDLo: 31800 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-251, 1986 (NTPTR*); V01-P60-P62 orl-mus TDLo: 63 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-251, 1986 (NTPTR*); V02-K60-L60 orl-rat TD :63600 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-251, 1986 (NTPTR*); V01-R60-K60 orl-rat TDLo: 31500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-115176 (NTIS**); V01-R60 orl-rat TDLo: 63000 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-115176 (NTIS**); V02-K60-L60 orl-rat TDLo: 31500 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-115176 (NTIS**); V01-H60-L60 orl-mus TDLo: 63000 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-115176 (NTIS**) ORNG: 4130000000 ng/kg. [4130.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 4130 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 43, p. 89, 1982 (AIHAAP); T/E unlistd ihl-rat LCLo: 600 ppm/6H Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 1/11/1967 (UCDS**); T/E unlistd orl-mus LD50: 1950 mg/kg Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- v. 39, p. 202, 1980 (TAKHAA); F13-J22-K01 ihl-mus LC50: 9700 ppb/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 447, 1962 (AIHAAP); F13-J22-K01 ihl-rbt LC50: 11 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 447, 1962 (AIHAAP); T/E unlistd skn-rbt LD50: >10 mL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 1/11/1967 (UCDS**); F13-J22-K01 ihl-gpg LC50: 12700 ppb/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 447, 1962 (AIHAAP); R01 ihl-gpg TCLo: 8.5 mg/m3/4H Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 121, p. 79, 2001 (TOLED5); R01 itr-gpg TDLo: 0.6 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 121, p. 79, 2001 (TOLED5); J04-J20 ihl-hmn TCLo: 0.014 ppm/30M American Review of Respiratory Disease. (American Lung Assoc., 1740 Broadway, New York, NY 10019) V.80- 1959- v. 136, p. 1403, 1987 (ARDSBL) MD: U01-Z01 orl-rat TDLo: 7 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-251, 1986 (NTPTR*); J02-Z01 orl-rat TDLo: 15600 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-251, 1986 (NTPTR*); A11-P26-Y01 ihl-rat TCLo: 10 ug/m3/24H/22W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(6), p. 96, 1978 (GISAAA); J30 ihl-rat TCLo: 100 ppb/6H/81D-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 26, p. 143, 1965 (AIHAAP); Z01 ihl-rat TCLo: 2 ppm/6H/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571057 (NTIS**); J02-P71-U01 ihl-rat TCLo: 2830 ppb/6H/3W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0545399 (NTIS**); Z01 orl-mus TDLo: 7800 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-251, 1986 (NTPTR*); U01-Z01 orl-mus TDLo: 7 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-251, 1986 (NTPTR*); U01-Z01 ihl-mus TCLo: 1 ppm/6H/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571057 (NTIS**); J02 ihl-gpg TCLo: 46 ppb/1W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 114, p. 91, 1996 (TXCYAC); Z01 ihl-gpg TCLo: 1 ppm/6H/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571057 (NTIS**); J02 ihl-gpg TCLo: 29 ppb/8W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 116, p. 17, 1997 (TXCYAC) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 287, 1986 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 865, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 287, 1986 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 865, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 865, 1999 (IMEMDT) SR: OEL-FRANCE: VME 0.01 ppm (0.08 mg/m3), VLE 0.02 ppm (0.16 mg/m3), JAN 1999; OEL-SWEDEN: TWA 0.005 ppm, CEILING 0.01 ppm, JAN 1999; OEL-UNITED KINGDOM: TWA 0.02 mg(NCO)/m3, STEL 0.07 mg(NCO)/m3, SEP 2000 ND: NIOSH REL TO TOLUENE DIISOCYANATE-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X3117; NIS 32; TNF 2226; NOS 45; TNE 38881; TFE 4723 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 53, DECEMBER 1989; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 843 of 1119 in RTECS (through 2003/06) AN: NT4037000 PN: Isoprene- SY: 1,3-Butadiene,-2-methyl-; Isopentadiene-; beta-Methylbivinyl-; 2-Methylbutadiene-; 2-Methyl-1,3-butadiene-; NSC-9237- RN: Current: 78-79-5 Previous: 78006-92-5 UD: 200305 MF: C5-H8 MW: 68.13 WL: 1UY1&1U1 CC: Tumorigen (C); Mutagen (M) ME: mnt-mus-ihl 438 ppm/6H/12D-C Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 3, p. 141, 1988 (MUTAEX); sce-mus-ihl 438 ppm/6H/12D-C Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 3, p. 141, 1988 (MUTAEX); dnd-mus-ihl 700 ppm/26W-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 373, 2001 (CBINA8) RE: T34 ihl-mus TCLo: 280 ppm (6-17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE89008095/XAD (NTIS**); T46 ihl-rat TCLo: 7000 ppm (6-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE89008095/XAD (NTIS**); T43-T46-T53 ihl-mus TCLo: 7000 ppm (6-17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE89008095/XAD (NTIS**) TE: V01-R60 ihl-rat TCLo: 220 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-486, 1999 (NTPTR*); V01-J60-L60 ihl-mus TCLo: 7000 ppm/6H/26W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 54, p. 5333, 1994 (CNREA8); V02-K60-V08 ihl-mus TCLo: 700 ppm/6H/26W -I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 373, 2001 (CBINA8); V02-M61-T61 ihl-rat TCLo: 22050 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-101651 (NTIS**); V02-R60 ihl-rat TCLo: 220500 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-101651 (NTIS**); V02-R60 ihl-rat TCLo: 5775 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-101651 (NTIS**) IHNG: 180000000000 ng/m3/4H. [180000.000000 mg/m3/4H] F01-J25 AT: F01-J25 ihl-rat LC50: 180 gm/m3/4H Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 31, p. 162, 1968 (RPTOAN); J30 ihl-mus LC50: 139 gm/m3/2H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 9(1), p. 36, 1965 (GTPZAB) MD: F40 orl-rat TDLo: 157 mg/kg/9W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 24(6), p. 8, 1959 (GISAAA); A70-J70-M71 ihl-rat TCLo: 3400 mg/m3/22W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 9(1), p. 36, 1965 (GTPZAB); F42 ihl-mus TCLo: 3400 mg/m3/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 9(1), p. 36, 1965 (GTPZAB); K30 ihl-mus TCLo: 700 ppm/6H/13W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 54, p. 5333, 1994 (CNREA8); F40-P72 ihl-gpg TCLo: 3400 mg/m3/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 9(1), p. 36, 1965 (GTPZAB); T11 ipr-mus TDLo: 14973.6 mg/kg/30D-I Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 8, p. 963, 1995 (CRTOEC); M71 ihl-rat TCLo: 7000 ppm/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE89008095/XAD (NTIS**); M71-U01 ihl-mus TCLo: 7000 ppm/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE89008095/XAD (NTIS**); L70 ihl-mus TCLo: 1400 ppm/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #DE89008095/XAD (NTIS**) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 215, 1994 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1015, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 215, 1994 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1015, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1015, 1999 (IMEMDT); TOXICOLOGY REVIEW Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 27, 2001 (CBINA8); TOXICOLOGY REVIEW Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 135-136, p. 65, 2001 (CBINA8) SR: OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 300 mg/m3, JAN 1999; OEL-RUSSIA: STEL 40 mg/m3, JAN 1993 ND: NOHS 1974: HZD 40940; NIS 36; TNF 2278; NOS 43; TNE 58102; NOES 1983: HZD 40940; NIS 6; TNF 123; NOS 15; TNE 3703; TFE 578 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0293-8707; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (inhal), clear evidence: rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Toxicity studies, RPT# TOX-31, October 2000 Record 844 of 1119 in RTECS (through 2003/06) AN: NT8400000 PN: Isopropylamine- SY: 2-Amino-propaan- (Dutch); 2-Aminopropan- (German); 2-Aminopropane-; 2-Amino-propano- (Italian); Isopropilamina- (Italian); Isopropylamine- (ACGIH:OSHA); 1-Methylethylamine-; Monoisopropylamine-; 2-Propanamine-; Propane,-2-amino-; sec-Propylamine-; 2-Propylamine- RN: Current: 75-31-0 UD: 200210 MF: C3-H9-N MW: 59.13 WL: ZY1&1 CC: Tumorigen (C); Primary-Irritant (S) ID: skn-rbt 345 mg open MOD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 11/15/1971 (UCDS**); skn-rbt 10 mg/24H open SEV AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); eye-rbt 100 uL SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0542011 (NTIS**) ORNG: 111000000 ng/kg. [111.000000 mg/kg] F07-J22-K30 SRNG: 380000000 ng/kg. [380.000000 mg/kg] T/E unlistd IHPB: 4000000 ppb/4H. [4000.000000 ppm/4H] T/E unlistd AT: F07-J22-K30 orl-rat LD50: 111 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0542011 (NTIS**); T/E unlistd ihl-rat LC50: 4000 ppm/4H Interagency Collaborative Group on Environmental Carcinogenesis, National Cancer Institute, Memorandum, June 17, 1974 17JUN1974 (IAEC**); T/E unlistd ipr-rat LDLo: 50 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 31, p. 238, 1968 (FATOAO); T/E unlistd orl-mus LD50: 2200 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(3), p. 79, 1980 (GISAAA); T/E unlistd ihl-mus LCLo: 7000 ppm/40M Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 7, 1961 (SCCUR*); K12-R21-U28 orl-rbt LD50: 3200 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(3), p. 79, 1980 (GISAAA); T/E unlistd skn-rbt LD50: 380 mg/kg Interagency Collaborative Group on Environmental Carcinogenesis, National Cancer Institute, Memorandum, June 17, 1974 17JUN1974 (IAEC**); T/E unlistd orl-gpg LD50: 2700 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(3), p. 79, 1980 (GISAAA); T/E unlistd ihl-mam LC50: 1800 mg/m3 Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 14, p. 80, 1975 (TPKVAL); T/E unlistd unr-mam LD50: 500 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 14, p. 80, 1975 (TPKVAL) TR: ACGIH TLV-TWA 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW Chemical Reviews. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1924- v. 9, p. 389, 1931 (CHREAY) SR: MSHA STANDARD-air: TWA 5 ppm (12 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 141, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (12 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (12 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (12 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (12 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 ppm (12 mg/m3), STEL 10 ppm, JAN 1993; OEL-AUSTRIA: MAK 5 ppm (12 mg/m3), JAN 1999; OEL-BELGIUM: TWA 5 ppm (12 mg/m3), STEL 10 ppm (24 mg/m3), JAN 1993; OEL-DENMARK: TWA 5 ppm (12 mg/m3), JAN 1999; OEL-FRANCE: VME 5 ppm (12 mg/m3), JAN 1999; OEL-GERMANY: MAK 5 ppm (12 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (12 mg/m3), JAN 1999; OEL-NORWAY: TWA 5 ppm (12 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (12 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 12 mg/m3, MAC(STEL) 24 mg/m3, JAN 1999; OEL-RUSSIA: STEL 1 mg/m3, JAN 1993; OEL-SWEDEN: TWA 5 ppm (12 mg/m3), STEL 10 ppm (25 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (12 mg/m3), KZG-W 10 ppm (24 mg/m3), JAN 1999; OEL-TURKEY: TWA 5 ppm (12 mg/m3), JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 40990; NIS 10; TNF 808; NOS 14; TNE 13196; NOES 1983: HZD 40990; NIS 6; TNF 235; NOS 7; TNE 8134; TFE 3174 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 845 of 1119 in RTECS (through 2003/06) AN: NX8225000 PN: Isothiocyanic-acid,-allyl-ester- SY: 2-Propenyl-isothiocyanate-; 3-Isothiocyanato-1-propene-; Allyl-isorhodanide-; Allyl-isosulfocyanate-; Allyl-isosulphocyanate-; Allyl-isothiocyanate-; Allyl-mustard-oil-; Allyl-sevenolum-; Allyl-thiocarbonimide-; Allyl-isothiocyanate-; Allylisothiokyanat- (Czech); Allylsenevol-; Allylsenfoel- (German); Artificial-mustard-oil-; Artificial-oil-of-mustard-; Carbospol-; FEMA No. 2034; Isothiocyanate-d'allyle- (French); Mustard-oil-; NCI-C50464-; Oil-of-mustard-BPC-1949-; Oil-of-mustard,-artificial-; Oleum-sinapis-volatile-; Propene,-3-isothiocyanato-; Redskin-; Senf-oel- (German); Synthetic-mustard-oil-; Volatile-oil-of-mustard- RN: Current: 57-06-7 Previous: 50888-64-7; 50978-48-8; 58391-87-0; 107231-30-1 BRN: 773748 BHR: 4-04-00-01081 UD: 200302 MF: C4-H5-N-S MW: 99.16 WL: SCN2U1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 2 mg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 219, p. 119, 1953 (AEPPAE) ME: mmo-sat 100 ug/plate (+S9) Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.25- 1961- v. 44, p. 3017, 1980 (ABCHA6); mmo-esc 5 ug/plate (-S9) Kanagawa-ken Eisei Kenkyusho Kenkyu Hokoku. Bulletin of Kanagawa Prefectural Public Health Laboratories. (Kanagawa-ken Eisei Kenkyusho, 52-2, Nakao-cho, Asahi-ku, Yokohama 241, Japan) No.1- 1971- v. (9), p. 11, 1979 (KEKHB8); mmo-esc 5 mmol/L (+S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 27, p. 25, 1982 (FOMIAZ); sln-dmg-ihl 100 pph/8M Proceedings of the Royal Society of Edinburgh, Section B. (Edinburgh, Scotland, UK) V.61-74, 1943-74. v. 62, p. 284, 1946/1947 (PREBA3); msc-mus-lym 400 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); mtr-ham-fbr 5 nmol/L Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 10, p. 177, 1985 (JTSCDR); cyt-ham-fbr 4 mg/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 623, 1984 (FCTOD7); cyt-ham-ovr 5 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 160 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); oms-mam-skn 800 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 111, 1993 (MUREAV) RE: T34 scu-rat TDLo: 100 mg/kg (8-9D preg) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 159, 1980 (FCTXAV); T25 scu-rat TDLo: 200 mg/kg (8-9D preg) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 159, 1980 (FCTXAV) TE: V02-M60 orl-rat TDLo: 12875 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-234, 1982 (NTPTR*); V03-V08-V16 skn-mus TDLo: 12 gm/kg/12W-I Acta Unio Internationalis Contra Cancrum. (Louvain, Belgium) V.1-20, 1936-64. For publisher information, see IJCNAW. v. 11, p. 699, 1955 (AICCA6); V01-M60 orl-rat TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-144238 (NTIS**); V03-R60 orl-rat TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-144238 (NTIS**) ORNG: 112000000 ng/kg. [112.000000 mg/kg] J30-K30 SRNG: 88000000 ng/kg. [88.000000 mg/kg] T/E unlistd AT: J30-K30 orl-rat LD50: 112 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 219, p. 119, 1953 (AEPPAE); T/E unlistd ipr-rat LDLo: 80 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 16, p. 870, 1966 (ARZNAD); F24-R03 scu-rat LD50: 92 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 159, 1980 (FCTXAV); T/E unlistd orl-mus LD50: 308 mg/kg Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) TR-73-83, 1973 (AMRL**); T/E unlistd ipr-mus LDLo: 4 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 288, 1972 (TXAPA9); F12 scu-mus LD50: 80 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 5, p. 505, 1955 (ARZNAD); T/E unlistd skn-rbt LD50: 88 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 42, p. 417, 1977 (TXAPA9); F23-J30-U28 ivn-rbt LDLo: 12 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 4, p. 107, 1909 (BIJOAK); T/E unlistd skn-mus LDLo: 19.83 mg/kg/12H Xenobiotica. (Taylor and Francis Ltd., 4 John St., London WC1N 2ET, UK) V.1- 1971- v. 23, p. 889, 1993 (XENOBH) MD: F07-R21-Z01 orl-rat TDLo: 5600 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-234, 1982 (NTPTR*); L70-P28-Y07 orl-rat TDLo: 300 mg/kg/3D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 44, p. 65, 1988 (TOLED5); Z01 orl-mus TDLo: 700 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-234, 1982 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 55, 1985 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 37, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 55, 1985 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 37, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 37, 1999 (IMEMDT); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 225, 1974 (MUREAV) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-RUSSIA: TWA 0.3 mg/m3, STEL 0.6 mg/m3, JAN 1993 SL: EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 846 of 1119 in RTECS (through 2003/06) AN: NY1412000 PN: Isovaleric-acid,-allyl-ester- SY: Allyl-isovalerate-; Allyl-isovalerianate-; Allyl-3-methylbutyrate-; FEMA No. 2045; Butanoic-acid,-3-methyl-,-2-propenyl-ester-; Butyric-acid,-3-methyl-,-allyl-ester-; 3-Methylbutanoic-acid,-2-propenyl-ester-; 3-Methylbutyric-acid,-allyl-ester-; NCI-C54717-; 2-Propenyl-isovalerate-; 2-Propenyl-3-methylbutanoate- RN: Current: 2835-39-4 BRN: 1750520 BHR: 4-02-00-00899 UD: 200210 MF: C8-H14-O2 MW: 142.22 WL: 1Y1&1VO2U1 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MOD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 703, 1979 (FCTXAV) ME: msc-mus-lym 100 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 300 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 500 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V01-P61-P62 orl-rat TDLo: 31930 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-253, 1983 (NTPTR*); V01-P62 orl-mus TDLo: 31930 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-253, 1983 (NTPTR*); V03-N60-P61 orl-rat TD :15965 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-253, 1983 (NTPTR*); V02-T69 orl-rat TDLo: 15965 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-218214 (NTIS**); V01-P61 orl-rat TDLo: 15965 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-218214 (NTIS**); V02-K60 orl-mus TDLo: 31930 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-218214 (NTIS**); V01-P62 orl-mus TDLo: 15965 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-218214 (NTIS**) ORNG: 230000000 ng/kg. [230.000000 mg/kg] T/E unlistd SRNG: 560000000 ng/kg. [560.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 230 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 703, 1979 (FCTXAV); F07-R21 orl-mus LDLo: 500 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-253, 1983 (NTPTR*); T/E unlistd skn-rbt LD50: 560 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 703, 1979 (FCTXAV) MD: K12-U01-Z01 orl-rat TDLo: 3500 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-253, 1983 (NTPTR*); L30-U01 orl-rat TDLo: 11375 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-253, 1983 (NTPTR*); F07-R21-U01 orl-mus TDLo: 3500 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-253, 1983 (NTPTR*); F07-K30-M20 orl-mus TDLo: 11375 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-253, 1983 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 69, 1985 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1241, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 69, 1985 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1241, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1241, 1999 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat Record 847 of 1119 in RTECS (through 2003/06) AN: NY9350000 PN: JP-5-jet-fuel- SY: JP-5-; JP-5-; JP-5-Navy-Fuel-; JP-5-navy-fuel-; MIL-T-5624M- UD: 200210 CC: Tumorigen (C); Human-Data (P) TE: V03-R60 skn-mus TDLo: 130000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-131678/AS (NTIS**) ORNL: 26000000 nL/kg. [26.000000 mL/kg] G30-J15-L03 AT: G30-J15-L03 orl-rat LD50: 26 mL/kg "Toxicology of Petroleum Hydrocarbons, Proceedings of the Symposium, 1st, 1982," MacFarland, H.N., et al., eds., Washington, DC, American Petroleum Institute, 1983 1,46,1983 (52MLA2) MD: M03-U01-Y15 orl-rat TDLo: 67500 mg/kg/90D-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 11, p. 423, 1995 (TIHEEC); F16 ihl-rat TCLo: 1125 mg/m3/6H/35D-I "Toxicology of Petroleum Hydrocarbons, Proceedings of the Symposium, 1st, 1982," MacFarland, H.N., et al., eds., Washington, DC, American Petroleum Institute, 1983 1,46,1983 (52MLA2); Z01 skn-mus TDLo: 270 gm/kg/9D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-310, 1986 (NTPTR*); P27-R03-Z01 skn-mus TDLo: 260 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-310, 1986 (NTPTR*); A10-F42 ihl-hmn TCLo: 300 mg/m3/17Y-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 61, 1998 (VCVPS*); F42-A30-Y65 ihl-rat TCLo: 1200 mg/m3/180H/I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 63, p. 397, 2001 (JTEHD6) TR: IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 45, p. 203, 1989 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 45, p. 203, 1989 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 45, p. 203, 1989 (IMEMDT) SL: NCI Carcinogenesis Studies (derm), no evidence: mouse Record 848 of 1119 in RTECS (through 2003/06) AN: OA0137500 PN: Kava-Kava-resin- SY: Kava-Kava-extract-; Resin-Kava-kava- RN: Current: 9000-38-8 UD: 200012 CC: Tumorigen (C) SL: NTP Carcinogenesis Studies, Selected, October 2000 Record 849 of 1119 in RTECS (through 2003/06) AN: OB5310000 PN: Ketone,-methyl-2-pyridyl- SY: 2-Acetylpyridine-; Ethanone, 1-(2-pyridinyl)- (9CI); FEMA-3251-; Methyl-2-pyridyl-ketone-; 1-(2-Pyridinyl)ethanone; 2-Pyridyl-methyl-ketone- RN: Current: 1122-62-9 UD: 200012 MF: C7-H7-N-O MW: 121.15 WL: T6NJ BV1 CC: Tumorigen (C); Mutagen (M) ME: sln-smc 6000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 163, p. 23, 1986 (MUREAV) ORNG: 2280000000 ng/kg. [2280.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2280 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 487, 1975 (FCTXAV); T/E unlistd orl-bwd LD50: 1 gm/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV) SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 850 of 1119 in RTECS (through 2003/06) AN: OB6465000 PN: Ketone, 3-pyridyl 3-(N-methyl-N-nitrosamino)propyl SY: 1-Butanone, 4-(methylnitrosoamino)-1-(3-pyridinyl)-; NNK- (carcinogen); 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone; 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; 4-(N-Methyl-N-nitrosoamino)-4-(3-pyridyl)-1-butanone; N-Methyl-N-nitroso-4-oxo-4-(3-pyridyl)butyl amine; 4-(Nitrosoamino-N-methyl)-1-(3-pyridyl)-1-butanone; 4-(N-Nitroso-N-methylamino)-1-(3-pyridyl)-1-butanone; NNK- RN: Current: 64091-91-4 Previous: 64142-44-5; 64173-37-1; 87876-94-6; 96552-68-0; 121268-99-3 BRN: 3548355 BHR: 5-22-14-00731 UD: 200302 MF: C10-H13-N3-O2 MW: 207.26 WL: T6NJ CV3N1&NO CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 1 mg/plate (+S9) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 173, 1989 (CALEDQ); mmo-sat 1 umol/plate (-S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 305, 1983 (CRNGDP); cyt-hmn-lym 100 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 173, 1989 (CALEDQ); sce-hmn-lym 100 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 173, 1989 (CALEDQ); msc-hmn-lym 50 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1197, 1991 (CRNGDP); mnt-rat-oth 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 249, 1991 (MUREAV); mnt-rat-ipr 150 mg/kg/3D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 249, 1991 (MUREAV); mtr-rat-oth 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 249, 1991 (MUREAV); mtr-rat-ipr 150 mg/kg/3D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 249, 1991 (MUREAV); dnd-rat-ipr 1200 mg/kg/12D-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 1280, 1986 (CNREA8); dnd-rat-lvr 1 mmol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 27, p. 97, 1986 (PAACA3); dna-rat-scu 4 mg/kg/4D-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4215, 1988 (CNREA8); dna-rat-ipr 150 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 2183, 1996 (CRNGDP); mnt-mus-ipr 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 210, p. 249, 1989 (MUREAV); mtr-mus-emb 200 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 324, p. 93, 1994 (MUREAV); dnd-rat-lvr 5 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 51, p. 3946, 1991 (CNREA8); hma-mus-esc 48 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 263, 1994 (CRNGDP); mnt-ham-lng 10 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 2319, 1988 (CRNGDP); mnt-ham-oth 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 65, 1989 (MUREAV); mtr-ham-oth 500 nmol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 44, p. 173, 1989 (CALEDQ); mtr-ham-oth 20 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 2461, 1994 (CRNGDP); dnd-ham-ipr 390 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 389, 1994 (CRNGDP); cyt-ham-lng 20 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 2319, 1988 (CRNGDP); sce-ham-lng 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 25, 1990 (MUREAV); msc-ham-ovr 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 430, p. 145, 1999 (MUREAV); dnd-rbt-oth 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 285, p. 303, 1993 (MUREAV); dnd-rbt-oth 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 285, p. 303, 1993 (MUREAV); dns-rbt-oth 2 mmol/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 6, p. 399, 1990 (CBTOE2); sce-hmn-leu 0.24 mmol/L/3H Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 159, p. 63, 2000 (CALEDQ); msc-mus-ipr 100 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 113, 2000 (CRNGDP); mmo-sat 500 ug/plate/20M (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 13, 2001 (MUREAV); mmo-omi 0.195 mg/L/18H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 13, 2001 (MUREAV); msc-mus-orl 840 mg/kg/5W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 22, p. 203, 2000 (CRNGDP); mmo-sat 0.5 mg/plate/48H (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 479, 2002 (MUTAEX) RE: T65 itr-ham TDLo: 50 mg/kg (15D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 53, p. 2498, 1993 (CNREA8) TE: V01-J60 orl-rat TDLo: 2156 mg/kg/61W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 60, p. 153, 1991 (CALEDQ); V01-J60 scu-rat TDLo: 68396 ug/kg/20W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 291, 1987 (CRNGDP); V03-J60-K60 orl-mus TDLo: 880 mg/kg/95W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1977, 1989 (CRNGDP); V01-J60 ipr-mus TDLo: 41452 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 11, p. 1017, 1990 (CRNGDP); V03-J60-K60 orl-ham TDLo: 960 mg/kg/95W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1977, 1989 (CRNGDP); V01-D09-T65 scu-ham TDLo: 20 mg/kg (15D preg) Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 120, p. 200, 1994 (JCROD7); V01-D09-J60 scu-ham TDLo: 1504 mg/kg/25W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 309, 1982 (IAPUDO); V01-K60-T65 itr-ham TDLo: 50 ug/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 120, p. 200, 1994 (JCROD7); V02-J60 ipr-mus TD :880 mg/kg/7W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 60, p. 819, 1978 (JNCIAM); V02-D09-J60 scu-ham TD :93 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 1287, 1983 (CRNGDP); V01-D09-L60 scu-rat TD :2700 mg/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 298, 1980 (CNREA8); V01-D09-J60 scu-rat TD :68396 ug/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 498, 1986 (CNREA8); V01-D09-L60 scu-rat TD :2700 mg/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 298, 1980 (CNREA8); V03-L60-J60 scu-rat TD :106 mg/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 549, 1989 (CNREA8); V01-J60 ipr-mus TD :166 mg/kg/7W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 47, p. 111, 1989 (CALEDQ); V01-L60-T65 ipr-mus TD :300 mg/kg/3D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 3770, 1989 (CNREA8); V01-T65-L60 ipr-mus TD :300 mg/kg/3D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 3770, 1989 (CNREA8); V03-J60 scu-ham TD :400 mg/kg/16W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 50, p. 1960, 1990 (CNREA8); V01-J30 ipr-mus TDLo: 41.4 mg/kg/5D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 159, p. 113, 2000 (CALEDQ); V01-J30 ipr-mus TDLo: 100 mg/kg/8W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 155, p. 115, 2000 (CALEDQ); V01-J30 ipr-mus TDLo: 240 mg/kg/2W Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 175, p. 9, 2002 (CALEDQ); V01-J60 ipr-mus TDLo: 82.8 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 174, p. 141, 2001 (CALEDQ); V01-J60 ipr-mus TDLo: 100 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 113, 2000 (CRNGDP); V01-J60 ipr-mus TDLo: 82.8 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 174, p. 141, 2001 (CALEDQ); V01-J60 ipr-mus TDLo: 56 mg/kg/28W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 915, 2000 (CRNGDP); V01-J60 ipr-mus TDLo: 82.9 ug/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 135, p. 123, 1999 (CALEDQ) AT: T/E unlistd ipr-mus LD50: 1 gm/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 173, 1989 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 37, p. 209, 1985 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 37, p. 209, 1985 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SL: EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro UDS in rat liver; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 851 of 1119 in RTECS (through 2003/06) AN: OD2800000 PN: Lactic-acid- SY: Ethylidenelactic-acid-; 1-Hydroxyethanecarboxylic-acid-; 2-Hydroxypropanoic-acid-; alpha-Hydroxypropionic-acid-; 2-Hydroxypropionic-acid-; DL-Lactic-acid-; Kyselina-2-hydroxypropanova- (Czech); Kyselina-mlecna- (Czech); Milchsaure- (German); Milk-acid-; Ordinary-lactic-acid-; Propanoic-acid,-2-hydroxy-; Propel-; Propionic-acid,-2-hydroxy-; Racemic-lactic-acid-; SY-83- RN: Current: 50-21-5 BRN: 5238667 UD: 200204 MF: C3-H6-O3 MW: 90.09 WL: QY1&VQ CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 5 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,656,1986 (85JCAE); skn-rbt 100 mg/24H MOD International Journal of Toxicology. (Taylor and Francis, 47 Runway Rd., Suite g, Levittown, PA 19057) V.16- 1997- v. 17(Suppl 1), p. 71, 1998 (IJTOFN); eye-rbt 750 ug SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); skn-hmn 10%/48H British Journal of Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.63- 1951- v. 17, p. 294, 1987 (BJDEAZ) ME: mmo-esc 210 ppm/3H (-S9) American Naturalist. (Univ. of Chicago Press, Journals Div., POB 37005, Chicago, IL 60637) V.1- 1867- v. 85, p. 119, 1951 (AMNTA4); cyt-ham-ovr 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 195, 1990 (MUREAV) RE: T19-T46 orl-mus TDLo: 5700 mg/kg (6-15D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 77, p. 95, 1992 (RCOCB8) ORNG: 3543000000 ng/kg. [3543.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 3543 mg/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C252, 1991 (FMCHA2); T/E unlistd orl-mus LD50: 4875 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 40, p. 144, 1967 (FAONAU); T/E unlistd orl-rbt LDLo: 5 gm/kg Industrial and Engineering Chemistry. (Washington, DC) V.15-62, 1923-70. For publisher information, see CHMTBL. v. 15, p. 628, 1923 (IECHAD); T/E unlistd skn-rbt LD50: >2 gm/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C252, 1991 (FMCHA2); T/E unlistd rec-rbt LDLo: 600 mg/kg Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 83, p. 136, 1920 (CRSBAW); T/E unlistd orl-gpg LD50: 1810 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 259, 1941 (JIHTAB); T/E unlistd orl-qal LD50: >2250 mg/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C252, 1991 (FMCHA2) MD: A70-M70-P30 skn-rat TDLo: 57590 mg/kg/13W-I International Journal of Toxicology. (Taylor and Francis, 47 Runway Rd., Suite g, Levittown, PA 19057) V.16- 1997- v. 17(Suppl 1), p. 71, 1998 (IJTOFN) ND: NOHS 1974: HZD 80595; NIS 56; TNF 10707; NOS 50; TNE 68982; NOES 1983: HZD 80595; NIS 39; TNF 10134; NOS 58; TNE 107962; TFE 63436 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 852 of 1119 in RTECS (through 2003/06) AN: OF8850000 PN: Lead, bis(dimethyldithiocarbamato)- SY: Bis(dimethylcarbamodithioato-S,S')lead; Bis(dimethyldithiocarbamato)lead; Carbamic-acid,-dimethyldithio-,-lead-salt-; Lead, bis(dimethylcarbamodithioato-S,S')-, (T-4)- (9CI); Lead-dimethyldithiocarbamate-; Methyl-ledate-; NCI-C02891- RN: Current: 19010-66-3 UD: 199904 MF: C6-H12-N2-S4.Pb MW: 447.63 WL: 1N1&YUS&S 2-PB- CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 100 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-sat 33 ug/plate (-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) JAN1982 (NTPTB*) TE: V03-J60-P60 scu-mus TDLo: 1000 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-159 (NTIS**) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 131, 1976 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 230, 1987 (IMSUDL); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 230, 1987 (IMSUDL) ND: NOHS 1974: HZD 83298; NIS 1; TNF 27; NOS 14; TNE 1346; NOES 1983: HZD 83298; NIS 1; TNF 16; NOS 3; TNE 4428; TFE 80 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Bioassay (feed), no evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-151, 1979 (NCITR*) Record 853 of 1119 in RTECS (through 2003/06) AN: OG3675000 PN: Lead(II) phosphate (3:2) SY: C.I. 77622; Collodial-lead-phosphate-; Bleiphosphat- (German); Lead-orthophosphate-; Lead-phosphate-; Lead-phosphate- (3:2); Lead(2+) phosphate; Normal-lead-orthophosphate-; Perlex-paste-500-; Perlex-paste-600A-; Phosphoric acid, lead(2+) salt (2:3); Plumbous-phosphate-; RCRA-waste-number-U145-; Trilead-phosphate- RN: Current: 7446-27-7 UD: 200007 MF: O8-P2.3 Pb MW: 811.51 WL: PB3 P-O4*2 CC: Tumorigen (C); Mutagen (M) TE: V03-M61 scu-rat TDLo: 540 mg/kg/6W-I Virchows Archiv fuer Pathologische, Anatomie und Physiologie, und fuer Klinische Medizin. (Berlin, Ger.) V.1-343, 1847-1967. For publisher information, see VAAPB7. v. 323, p. 694, 1953 (APAVAY); V01-M61 par-rat TDLo: 580 mg/kg/34W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 19, p. 860, 1965 (BJCAAI) TR: ACGIH TLV-TWA 0.05 mg(Pb)/m3; animal carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 325, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 325, 1980 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 230, 1987 (IMSUDL); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 230, 1987 (IMSUDL); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Pb,259,1972 (85DHAX) SR: OEL-ARAB Republic of Egypt: TWA 0.05 mg(Pb)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.15 mg(Pb)/m3, JAN 1993; OEL-AUSTRIA: MAK 0.1 mg(Pb)/m3, JAN 1993; OEL-BELGIUM: TWA 0.15 mg(Pb)/m3, JAN 1993; OEL-DENMARK: TWA 0.1 mg(Pb)/m3, JAN 1999; OEL-FINLAND: TWA 0.1 mg(Pb)/m3, JAN 1999; OEL-FRANCE: VME 0.15 mg(Pb)/m3, JAN 1999; OEL-GERMANY: MAK 0.1 mg(Pb)/m3, JAN 1999; OEL-HUNGARY: STEL 0.04 mg(Pb)/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.1 mg(Pb)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.15 mg(Pb)/m3, JAN 1999; OEL-NORWAY: TWA 0.05 mg(Pb)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.15 mg(Pb)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.05 mg(Pb)/m3, JAN 1999; OEL-RUSSIA: STEL 0.005 ppm (0.01 mg(Pb)/m3), JAN 1993; OEL-SWEDEN: NGV 0.05 mg(Pb)/m3 (resp. dust), JAN 1999; OEL-SWEDEN: NGV 0.1 mg(Pb)/m3 (total dust), JAN 1999; OEL-SWITZERLAND: MAK-W 0.1 mg(Pb)/m3, JAN 1999; OEL-THAILAND: TWA 0.2 mg(Pb)/m3, JAN 1993; OEL-TURKEY: TWA 0.2 mg(Pb)/m3, JAN 1993; OEL-UNITED KINGDOM: LTEL 0.15 mg(Pb)/m3, JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO LEAD, INORGANIC-air: 10H TWA <0.1 mg(Pb)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 83915; NIS 2; TNF 54; NOS 4; TNE 1134 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 854 of 1119 in RTECS (through 2003/06) AN: ON8930000 PN: Malonaldehyde, ion(1-), sodium SY: 3-Hydroxy-2-propenal-sodium-salt-; Malonaldehyde-sodium-salt-; Malonaldehyde, sodium deriv. (6CI); Malonaldehyde,-sodium-salt-; Propanedial-sodium-; Propanedial, ion(1-), sodium (9CI); Sodium-beta-oxyacrolein-; Sodium-malondialdehyde- RN: Current: 24382-04-5 Previous: 1977-31-7; 5388-46-5; 76888-01-2; 82995-28-6; 122129-91-3; 128766-18-7; 133767-33-6; 143413-46-1; 219517-51-8 UD: 200210 MF: C3-H3-O2.Na MW: 94.05 CC: Tumorigen (C); Mutagen (M); Natural-Product (N) ME: mmo-sat 4 umol/plate (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 276, 1980 (CNREA8); dna-omi 10 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 16, p. 93, 1995 (CRNGDP); mnt-rat-fbr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 101, p. 237, 1982 (MUREAV); cyt-rat-fbr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 101, p. 237, 1982 (MUREAV); dna-ctl-oth 25 mmol/L/24H Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 13, p. 1235, 2000 (CRTOEC); mmo-sat 2.5 umol/plate/48H Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 13, p. 1235, 2000 (CRTOEC) TE: V01-N62 orl-rat TDLo: 51500 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-331, 1988 (NTPTR*); V01-N62 orl-rat TDLo: 51500 mg/kg/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-204010/AS (NTIS**); V02-K60 orl-rat TDLo: 25750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-204010/AS (NTIS**) ORNG: 824000000 ng/kg. [824.000000 mg/kg] F18-J22-J24 AT: F18-J22-J24 orl-rat LD50: 824 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 7, p. 826, 1965 (TXAPA9) MD: M16-R03-Z01 orl-rat TDLo: 10500 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-331, 1988 (NTPTR*); D35-R03-Z01 orl-rat TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-331, 1988 (NTPTR*); M16-Z01 orl-mus TDLo: 10500 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-331, 1988 (NTPTR*); Z01 orl-mus TDLo: 8125 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-331, 1988 (NTPTR*) SL: NIOSH CURRENT INTELLIGENCE BULLETIN #55, September 1991; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 855 of 1119 in RTECS (through 2003/06) AN: OO3675000 PN: Malononitrile,-o-chlorobenzylidene- SY: (o-Chlorobenzal)malononitrile; 2-Chlorobenzalmalononitrile-; 2-Chlorobenzylidene-malononitrile-; 2-Chlorobmn-; CS-; NCI-C55118-; Propanedinitrile,- ((2-chlorophenyl)methylene); TL-238-; USAF-KF-11-; beta,beta-Dicyano-o-chlorostyrene-; o-Chlorobenzalmalononitrile-; o-Chlorobenzylidene-malonitrile-; o-Chlorobenzylidene-malononitrile-; o-Chlorobenzylidene-malononitrile- (ACGIH:OSHA) RN: Current: 2698-41-1 BRN: 1866635 BHR: 2-09-00-00641 UD: 200302 MF: C10-H5-Cl-N2 MW: 188.62 WL: NCYCN&U1R BG CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-hmn 10 mg/1H MLD British Journal of Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.63- 1951- v. 90, p. 657, 1974 (BJDEAZ); eye-man 0.005 ppm/20S SEV Military Medicine. (Assoc. of Military Surgeons of the United States, Box 104, Kensington, MD 20795) V.116- 1955- v. 134, p. 219, 1969 (MMEDA9); eye-man 624 ng Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 35, p. 412, 1974 (APTOA6); skn-rat 12%/6H open MLD Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); skn-rbt 12%/6H open MLD Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); eye-rbt 5 mg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 656, 1962 (TXAPA9); eye-rbt 1 mg MLD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 17, p. 295, 1970 (TXAPA9); eye-rbt 1150 ng Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 35, p. 412, 1974 (APTOA6); skn-gpg 12%/6H open MLD Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); eye-gpg 429 ng Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 35, p. 412, 1974 (APTOA6) ME: mmo-sat 100 ug/plate (+/-S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 49, p. 15, 1981 (ARTODN); msc-mus-lym 2500 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); mnt-ham-lng 19 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 63, p. 314, 1989 (ARTODN); cyt-ham-ovr 6 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-377, 1990 (NTPTR*); cyt-ham-lng 9400 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 282, p. 231, 1992 (MUREAV); sce-ham-ovr 10 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-377, 1990 (NTPTR*); sce-ham-lng 18800 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 282, p. 231, 1992 (MUREAV) RE: T34 ihl-rat TCLo: 6 mg/m3/5M (6-15D preg) "Current Approaches in Toxicology," Ballantyne, B., ed., Bristol, UK, John Wright and Sons, Ltd., 1977 -,79,1977 (37QLAZ) ORNG: 178000000 ng/kg. [178.000000 mg/kg] K05 AT: D25-J21-J30 ihl-hmn TCLo: 1500 ug/m3/90M Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 6, p. 366, 1963 (AEHLAU); K05 orl-rat LD50: 178 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 24, p. 449, 1972 (AEHLAU); D07-J15-P01 ihl-rat LCLo: 1806 mg/m3/45M Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); T/E unlistd ipr-rat LD50: 48 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 24, p. 45, 1973 (TXAPA9); F12-J26-M30 ivn-rat LD50: 28 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); T/E unlistd orl-mus LD50: 282 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD837-111 (NTIS**); D07-J15-P01 ihl-mus LCLo: 2753 mg/m3/20M Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); S04 ipr-mus LD50: 32320 ug/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 8, p. 73, 1981 (TOLED5); T/E unlistd scu-mus LD :>800 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 656, 1962 (TXAPA9); F12-J30 ivn-mus LD50: 47700 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 25, p. 111, 1973 (TXAPA9); J30 ihl-dog LCLo: 2600 mg/m3/23M Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 30(1), p. 86, 1971 (FEPRA7); F24-J30-R21 orl-rbt LD50: 143 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); D07-J15-P01 ihl-rbt LCLo: 1802 mg/m3/10M Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); P30 ipr-rbt LD50: 32065 ug/kg Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 3, p. 64, 1983 (TOXID9); D17-F07-K12 ivn-rbt LD50: 8 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 656, 1962 (TXAPA9); F24-J30-R21 orl-gpg LD50: 212 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); D07-J15-P01 ihl-gpg LCLo: 2326 mg/m3/10M Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN); F24-J30-R21 ipr-gpg LD50: 73 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 75, 1978 (ARTODN) MD: D17-Z01 ihl-rat TCLo: 100 mg/m3/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-377, 1990 (NTPTR*); D07-N74-U01 ihl-rat TCLo: 1500 ug/m3/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-377, 1990 (NTPTR*); Z01 ihl-mus TCLo: 10 mg/m3/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-377, 1990 (NTPTR*); D07-U01-Z01 ihl-mus TCLo: 3 mg/m3/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-377, 1990 (NTPTR*); L70-N74-S04 ipr-mus TDLo: 160 mg/kg/10D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 26, p. 571, 1981 (BECTA6) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-CL 0.05 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: MSHA STANDARD-air: TWA 0.05 ppm (0.4 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 50, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.05 ppm (0.4 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.05 ppm (0.4 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.05 ppm (0.4 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.05 ppm (0.4 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.05 ppm (0.4 mg/m3), Skin, JAN 1993; OEL-BELGIUM: STEL 0.05 ppm (0.4 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 0.05 ppm (0.4 mg/m3), Skin, JAN 1999; OEL-FRANCE: STEL 0.05 ppm (0.4 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.05 ppm (0.4 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 0.05 ppm (0.4 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 05 ppm (0.4 mg/m3), JAN 1993; OEL-SWITZERLAND: MAK-W 0.05 ppm (0.4 mg/m3), Skin, JAN 1999; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO o-CHLOROBENZYLIDENEMALONONITRILE-air: CL 0.05 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #95-121, 1995 (NIOSH*) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (inhal), no evidence: mouse, rat Record 856 of 1119 in RTECS (through 2003/06) AN: OP0893500 PN: Manganese,-monosulfate,-monohydrate- SY: Manganese (II) sulfate monohydrate; Manganese-sulfate-monohydrate-; Manganese(2+) sulfate monohydrate; Manganous-sulfate-monohydrate-; Sulfuric acid, manganese(2+) salt (1:1), monohydrate RN: Current: 10034-96-5 UD: 200302 MF: O4-S.Mn.H2-O MW: 169.02 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-smc 40 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 137, p. 47, 1984 (MUREAV); mrc-smc 40 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 137, p. 47, 1984 (MUREAV); mnt-mus-orl 205 mg/kg/24H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 159, 1990 (MUREAV); cyt-mus-orl 718 mg/kg/7D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 159, 1990 (MUREAV); spm-mus-orl 513 mg/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 159, 1990 (MUREAV); cyt-ham-ovr 180 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 5 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T01 orl-mus TDLo: 513 mg/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 159, 1990 (MUREAV) TE: V03-N62 orl-mus TDLo: 1314 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-428, 1993 (NTPTR*); V03-N62 orl-mus TDLo: 1297800 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-217148 (NTIS**); V03-N62 orl-mus TDLo: 1622250 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-217148 (NTIS**) MD: L70-P70-P72 orl-rat TDLo: 42 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-428, 1993 (NTPTR*); J70-P72-U01 orl-rat TDLo: 28437 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-428, 1993 (NTPTR*); L70-P08-P30 orl-mus TDLo: 546 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-428, 1993 (NTPTR*) TR: ACGIH TLV-TWA 0.2 mg(Mn)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: OSHA PEL (Gen Indu): CL 5 mg(Mn)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 5 mg(Mn)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 5 mg(Mn)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 5 mg(Mn)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 mg(Mn)/m3, JAN 1993; OEL-BELGIUM: TWA 5 mg(Mn)/m3, JAN 1993; OEL-DENMARK: TWA 2.5 mg(Mn)/m3, JAN 1999; OEL-FINLAND: TWA 0.5 mg(Mn)/m3, JAN 1999; OEL-HUNGARY: TWA 0.3 mg(Mn)/m3, STEL 0.6 mg(Mn)/m3, JAN 1993; OEL-JAPAN: OEL 0.3 mg(Mn)/m3, respirable dust, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 mg(Mn)/m3, MAC-K 3 mg(Mn)/m3, JAN 1999; OEL-NORWAY: TWA 2.5 mg(Mn)/m3, JAN 1999; OEL-POLAND: MAC(TWA) 0.3 mg(Mn)/m3, MAC(C) 5 mg(Mn)/m3, JAN 1999; OEL-SWEDEN: NGV 1 mg(Mn)/m3, TGV 2.5 mg(Mn)/m3 (resp. dust), JAN 1993; OEL-SWEDEN: NGV 2.5 mg(Mn)/m3, TGV 5 mg(Mn)/m3 (total dust), JAN 1993; OEL-UNITED KINGDOM: TWA 5 mg(Mn)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOES 1983: HZD X1601; NIS 3; TNF 60; NOS 6; TNE 893; TFE 398 SL: NCI Carcinogenesis Studies (feed), equivocal evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat Record 857 of 1119 in RTECS (through 2003/06) AN: OP2060000 PN: Mannitol,-D- SY: 1,2,3,4,5,6-Hexanehexol-; Manna-sugar-; Mannite-; NCI-C50362-; D-Mannitol-; Osmitrol- RN: Current: 69-65-8 BRN: 1721898 BHR: 4-01-00-02841 UD: 200207 MF: C6-H14-O6 MW: 182.20 WL: Q1YQYQ 2 -BBAA -D CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: oms-omi 1 mol/L Archiv fuer Mikrobiologie. (Berlin, Fed. Rep. Ger.) V.1-94, 1930-73. For publisher information, see AMICCW. v. 91, p. 305, 1973 (ARMKA7); dni-hmn-lym 50 mmol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 1171, 1982 (PNASA6) ORNG: 13500000000 ng/kg. [13500.000000 mg/kg] T/E unlistd AT: H01-K13-M03 ivn-man TDLo: 17143 mg/kg/2D-C Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 144, p. 2053, 1984 (AIMDAP); T/E unlistd orl-rat LD50: 13500 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 32, p. 1367, 1981 (YKYUA6); T/E unlistd ivn-rat LD50: 9690 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 32, p. 1367, 1981 (YKYUA6); F07-K08 orl-mus LD50: 22 gm/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 40, p. 160, 1967 (FAONAU); T/E unlistd ipr-mus LD50: 14 gm/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 35, p. 98, 1936 (PSEBAA); T/E unlistd ivn-mus LD50: 7470 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 32, p. 1367, 1981 (YKYUA6) MD: K12-U01 orl-rat TDLo: 84 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-236, 1982 (NTPTR*); U01 orl-rat TDLo: 273 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-236, 1982 (NTPTR*) ND: NOES 1983: HZD X4308; NIS 14; TNF 1555; NOS 31; TNE 41268; TFE 28689 SL: EPA GENETOX PROGRAM 1988, Negative: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 858 of 1119 in RTECS (through 2003/06) AN: OS0700000 PN: Melamine- SY: Aero-; DG-002- (amine); Cyanuramide-; Cyanuric-triamide-; Cyanurotriamide-; Cyanurotriamine-; Hicophor-PR-; Isomelamine-; NCI-C50715-; 2,4,6-Triamino-s-triazine-; 2,4,6-Triamino-1,3,5-triazine-; 1,3,5-Triazine-2,4,6-triamine-; s-Triazine,-2,4,6-triamino-; Pluragard-; Pluragard-C-133-; Teoharn-; Theoharn-; Virset-656-4- RN: Current: 108-78-1 Previous: 504-18-7; 65544-34-5; 67757-43-1; 68379-55-5; 70371-19-6; 94977-27-2 BRN: 124341 BHR: 4-26-00-01253 UD: 200302 MF: C3-H6-N6 MW: 126.15 WL: T6N CN ENJ BZ DZ FZ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 500 mg/24H MLD "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,153,1972 (28ZPAK) ME: pic-esc 78 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); mnt-mus-orl 1 gm/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 342, 1982 (ENMUDM); mtr-mus-fbr 10 ug/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T01-T24-T35 ihl-rat TCLo: 500 ug/m3 (17W male) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 58(2), p. 14, 1993 (GISAAA) TE: V01-M60 orl-rat TDLo: 195 gm/kg/2Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 292, 1984 (TXAPA9); V01-M60 orl-rat TD :197 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-245, 1983 (NTPTR*); V03-M60 orl-rat TD :162 gm/kg/2Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 292, 1984 (TXAPA9); V01-M60 orl-rat TDLo: 194670 mg/kg/25W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-202630 (NTIS**) ORNG: 3161000000 ng/kg. [3161.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 3161 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 292, 1984 (TXAPA9); T/E unlistd ihl-rat LC50: 3248 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 58(2), p. 14, 1993 (GISAAA); D17-F11-J24 ipr-rat LDLo: 3200 mg/kg "Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley and Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979: pub. as 2nd rev. ed. in 1985. 2A,2769,1981 (38MKAJ); T/E unlistd unr-rat LD50: 6 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 58(2), p. 14, 1993 (GISAAA); T/E unlistd orl-mus LD50: 3296 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 292, 1984 (TXAPA9); D17-F11-J24 ipr-mus LDLo: 800 mg/kg "Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley and Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979: pub. as 2nd rev. ed. in 1985. 2A,2769,1981 (38MKAJ); T/E unlistd unr-mus LD50: 1 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 58(2), p. 14, 1993 (GISAAA); T/E unlistd skn-rbt LD50: >1 gm/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 110, 1990 (ATDAEI) MD: F15-M30-U01 orl-rat TDLo: 21840 mg/kg/4W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535236 (NTIS**); M30-Z01 orl-rat TDLo: 32760 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-245, 1983 (NTPTR*); M20-U01 orl-rat TDLo: 21 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-245, 1983 (NTPTR*); L30-P28-Y15 ihl-rat TCLo: 58 ug/m3/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 58(2), p. 14, 1993 (GISAAA); M30 orl-mus TDLo: 93600 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-245, 1983 (NTPTR*); M20 orl-mus TDLo: 50400 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-245, 1983 (NTPTR*); P30-Y01 ihl-rat TCLo: 58 ug/m3/45D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 14, 1993 (GISAAA); P30-Y15 ihl-rat TCLo: 58 ug/m3/120D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 14, 1993 (GISAAA); P30-Y15-Y39 ihl-rat TCLo: 0.5 mg/m3/90D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 14, 1993 (GISAAA); Y39 ihl-rat TCLo: 58 ug/m3/105D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 14, 1993 (GISAAA); L14 ihl-rat TCLo: 0.5 mg/m3/45D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 14, 1993 (GISAAA); L14 ihl-rat TCLo: 58 ug/m3/90D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 14, 1993 (GISAAA); T01 ihl-rat TCLo: 0.5 mg/m3/120D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 14, 1993 (GISAAA) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 329, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 333, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 333, 1986 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 329, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 329, 1999 (IMEMDT); TOXICOLOGY REVIEW European Chemical Industry Ecology and Toxicology Centre. Joint Assessment of Commodity Chemicals. (Avenue Louise 250, B-63, B-1050 Brussels, Belgium) v. (1), p. -, 1983 (ECIET*) ND: NOHS 1974: HZD 81887; NIS 32; TNF 1043; NOS 49; TNE 31892; NOES 1983: HZD 81887; NIS 27; TNF 2132; NOS 44; TNE 43104; TFE 6239 SL: EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 859 of 1119 in RTECS (through 2003/06) AN: OS8670000 PN: p-Mentha-6,8-dien-2-one, (S)-(+)- SY: Carvone, (+)-; (+)-Carvone; d-Carvone-; D(+)-Carvone; (S)-Carvone; (S)-(+)-Carvone; 2-Cyclohexen-1-one, 2-methyl-5-(1-methylethenyl)-, (S)-; d-p-Mentha-6,8,(9)-dien-2-one; (S)-d-p-Mentha-6,8,(9)-dien-2-one; d-1-Methyl-4-isopropenyl-6-cyclohexen-2-one-; (S)-(+)-p-Mentha-6,8-dien-2-one RN: Current: 2244-16-8 UD: 200207 MF: C10-H14-O MW: 150.24 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 673, 1978 (FCTXAV) ME: dnr-esc 30 umol/disc Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 37, p. 813, 1999 (FCTOD7); cyt-ham-ovr 12500 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-381, 1990 (NTPTR*); sce-ham-ovr 167 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-381, 1990 (NTPTR*) ORNL: 3710000 nL/kg. [3.710000 mL/kg] T/E unlistd SRNL: 4000000 nL/kg. [4.000000 mL/kg] R03 AT: T/E unlistd orl-rat LD50: 3710 uL/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 673, 1978 (FCTXAV); R03 skn-rbt LD50: 4 mL/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 673, 1978 (FCTXAV) MD: Z01 orl-mus TDLo: 19080 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-381, 1990 (NTPTR*); L70 orl-mus TDLo: 48750 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-381, 1990 (NTPTR*) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 860 of 1119 in RTECS (through 2003/06) AN: OT0261000 PN: p-Menth-4(8)-en-3-one, (R)-(+)- SY: Cyclohexanone, 5-methyl-2-(1-methylethylidene)-, (R)-; Pulegon-; Pulegone-; (+)-Pulegone; d-Pulegone-; (R)-(+)-Pulegone; (+)-(R)-Pulegone RN: Current: 89-82-7 UD: 200012 MF: C10-H16-O MW: 152.26 CC: Tumorigen (C) AT: G10-H02 ivn-dog LDLo: 330 mg/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 236, p. 633, 1953 (COREAF) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, selected, October 2000 Record 861 of 1119 in RTECS (through 2003/06) AN: OV9100000 PN: Mercury(II) chloride SY: Abavit-B-; Bichloride-of-mercury-; Bichlorure-de-mercure- (French); Calochlor-; Chlorid-rtutnaty- (Czech); Chlorure-mercurique- (French); Cloruro-di-mercurio- (Italian); Corrosive-mercury-chloride-; Corrosive-sublimate-; Dichloromercury-; Fungchex-; Mercuric-bichloride-; Mercuric-chloride-; Mercury-bichloride-; Mercury-dichloride-; Mercury-perchloride-; Mercury(2+) chloride; NCI-C60173-; Perchloride-of-mercury-; Quecksilber-chlorid- (German); Sublimat- (Czech); Sublimate-; Sulem-; Sulema- (Russian); TL-898- RN: Current: 7487-94-7 UD: 200305 MF: Cl2-Hg MW: 271.49 WL: HG G2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Organometallic (O); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 500 mg/24H SEV "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,12,1972 (28ZPAK); eye-rbt 50 ug/24H SEV "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,12,1972 (28ZPAK) ME: mmo-sat 1 mg/L (+S9) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 40, p. 597, 1988 (BECTA6); dnd-esc 33 pph Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 67, p. 1390, 1970 (PNASA6); dnr-bcs 50 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 109, 1980 (MUREAV); dnd-omi 33 pph Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 67, p. 1390, 1970 (PNASA6); sln-smc 15 umol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 21, 1986 (MUTAEX); mnt-ofs-leu 2 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 157, 1994 (MUREAV); mnt-nml-mul 12 ppb Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 83, 1993 (MUREAV); mnt-nml-mul 1 ppb Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 83, 1993 (MUREAV); cyt-oin 1 ug/L Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 53, p. 263, 1988 (CYTOAN); cyt-oin-par 12500 ug/kg Environment and Ecology. (Environment and Ecology, C/o Dr. S.K. Konar, Dept. of Zoology, Kalyani University, Kalyani 741253, West Bengal, India) V.1- 1983- v. 4, p. 320, 1989 (ENECEV); mnt-hmn-lym 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 340, p. 175, 1996 (MUREAV); dnd-hmn-leu 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 470, p. 19, 2000 (MUREAV); dnd-hmn-leu 3500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 93, 2000 (MUREAV); oms-hmn-lym 2 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 340, p. 175, 1996 (MUREAV); cyt-hmn-hla 10 mg/L Japanese Journal of Experimental Medicine. (Kinokuniya Book-Stores of America Co., Ltd., West Bldg., Japan Cultural and Trade Center, 1581 Webster St., San Francisco, CA 94115) V.7- 1928- v. 39, p. 47, 1969 (JJEMAG); cyt-hmn-lym 2 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 340, p. 175, 1996 (MUREAV); dnd-rat-ast 500 umol/L Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905- v. 261, p. 3370, 1986 (JBCHA3); dnd-rat-emb 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 163, 1983 (MUREAV); dni-rat-scu 8 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 67, p. 185, 1988 (CBINA8); oms-rat-scu 8 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 67, p. 185, 1988 (CBINA8); dlt-rat-orl 250 ng/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 163, 1983 (MUREAV); dlt-rat-unr 2500 ug/kg Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 16(2), p. 25, 1982 (CYGEDX); dni-mus-ipr 1 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 194, p. 171, 1975 (JPETAB); dni-mus-oth 50 umol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 24, 1980 (TXAPA9); dni-mus-spr 10 umol/L Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 194, p. 171, 1975 (JPETAB); mmo-mus-lym 6 mg/L (+S9) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 367, 1982 (JTEHD6); dnd-mus-lym 100 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 24, p. 489, 1975 (BCPCA6); dnd-mus-emb 50 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 163, 1983 (MUREAV); dns-mus-oth 1 umol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 24, 1980 (TXAPA9); dni-mus-oth 10 umol/L Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 41, p. 371, 1984 (EXMPA6); dni-mus-lym 100 nmol/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 36, p. 297, 1985 (TXCYAC); oms-mus-lym 10 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 24, p. 489, 1975 (BCPCA6); oms-mus-orl 3 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 29, p. 777, 1991 (FCTOD7); cyt-mus-orl 3 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 29, p. 777, 1991 (FCTOD7); dlt-mus-ipr 2 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 30, p. 365, 1975 (MUREAV); msc-mus-lym 400 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); trn-mus-ipr 2 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 30, p. 365, 1975 (MUREAV); mtr-ham-emb 50 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 193, 1979 (CNREA8); dnd-ham-lng 10 umol/L Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 12, p. 173, 1986 (TECSDY); dnd-ham-ovr 2500 nmol/L/1H-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 74, 1983 (PAACA3); dnd-ham-ovr 25 umol/L/1H-C Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 108, p. 614, 1982 (BBRCA9); dni-ham-ovr 40 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 18, p. 205, 1977 (CBINA8); oms-ham-ovr 2700 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 290, p. 281, 1993 (MUREAV); cyt-ham-scu 6400 ug/kg Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25, p. 381, 1982 (TJADAB); sce-ham-ovr 1100 nmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 381, 1985 (ENMUDM); sce-ham-ipr 1 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE83-770037 (NTIS**); dnd-ckn-oth 3 umol/L Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 12, p. 173, 1986 (TECSDY); dnd-mam-lym 33 pph Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 67, p. 1390, 1970 (PNASA6); dni-ctl-kdy 10 umol/L Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 14, p. 509, 1985 (AECTCV); dnd-rat-orl 0.0054 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 167, p. 191, 2001 (TXCYAC); mtr-mus-fbr 1 ug/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T27 orl-wmn TDLo: 50 ug/kg (10W preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 80, p. 145, 1960 (AJOGAH); T01 orl-rat TDLo: 126 mg/kg (84D male) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 33, 2000 (TOXID9); T25-T46 orl-rat TDLo: 240 mg/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(1), p. 26A, 1982 (TJADAB); T31-T34 orl-rat TDLo: 120 mg/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(1), p. 26A, 1982 (TJADAB); T33 orl-rat TDLo: 2470 ug/kg (7D preg) Current Science. (Current Science Assoc., Sadashivanagar P.O., Bangalore 560 080, India) V.1- 1932- v. 55, p. 734, 1986 (CUSCAM); T02-T03-T23 orl-rat TDLo: 919 mg/kg (12W male/2W pre) Biomedical and Environmental Sciences. (Academic Press, 525 B St., Suite 1900, San Diego, CA 92101) V.1- 1988- v. 9, p. 437, 1996 (BESCE5); T25-T34-T35 ihl-rat TCLo: 2720 ng/m3/24H (1-22D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 46(5), p. 67, 1981 (GISAAA); T24-T31 ihl-rat TCLo: 19540 ng/m3/24H (1-22D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 46(5), p. 67, 1981 (GISAAA); T48 ihl-rat TCLo: 276 ng/m3/24H (1-22D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 46(5), p. 67, 1981 (GISAAA); T02 ipr-rat TDLo: 60 mg/kg (30D male) Indian Journal of Physiology and Pharmacology. (All India Institute of Medical Sciences, Dept. of Physiology, Ansari Nagar, New Delhi 110 029, India) V.1- 1957- v. 26, p. 246, 1982 (IJPPAZ); T02-T09 ipr-rat TDLo: 4500 ug/kg (90D male) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 27, p. 45, 1985 (TOLED5); T01-T02 ipr-rat TDLo: 4500 ug/kg (90D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 25, p. 542, 1987 (IJEBA6); T02 scu-rat TDLo: 5430 ug/kg (1D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 7, p. 21, 1964 (JRPFA4); T34-T76-T81 scu-rat TDLo: 80 mg/kg (13-22D preg/10D post) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE85-015022 (NTIS**); T39 scu-rat TDLo: 400 ug/kg (11-12D preg) Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 6, p. 38, 1992 (WDZAEK); T41 ivn-rat TDLo: 1069 ug/kg (10D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 243, 1986 (ARTODN); T48 ivn-rat TDLo: 1069 ug/kg (14D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 243, 1986 (ARTODN); T01-T02 itt-rat TDLo: 21719 ug/kg (1D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 7, p. 21, 1964 (JRPFA4); T29-T72 orl-mus TDLo: 25 mg/kg (40D male/16D pre-3W post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 388, 1999 (TOXID9); T29-T72-T75 orl-mus TDLo: 49 mg/kg (40D male/16D pre-3W post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 388, 1999 (TOXID9); T25-T34-T35 ihl-mus TCLo: 230 ug/m3/4H (9-12D preg) Collection de Medecine Legale et de Toxicologie Medicale. (Masson Editeur, 120 Blvd. Saint- Germain, F-75280 Paris Cedex 06, France) No.53- 1970- v. 125, p. 65, 1984 (CMLMDW); T46 ihl-mus TCLo: 230 ug/m3/4H (9-12D preg) Collection de Medecine Legale et de Toxicologie Medicale. (Masson Editeur, 120 Blvd. Saint- Germain, F-75280 Paris Cedex 06, France) No.53- 1970- v. 125, p. 65, 1984 (CMLMDW); T02 ipr-mus TDLo: 30 mg/kg (30D male) Indian Journal of Physiology and Pharmacology. (All India Institute of Medical Sciences, Dept. of Physiology, Ansari Nagar, New Delhi 110 029, India) V.1- 1957- v. 26, p. 246, 1982 (IJPPAZ); T02 scu-mus TDLo: 5430 ug/kg (30D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 7, p. 21, 1964 (JRPFA4); T33 ivn-mus TDLo: 2030 ug/kg (1D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 33, p. 231, 1986 (TJADAB); T59 ivn-mus TDLo: 3384 ug/kg (1D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 32, p. 27B, 1985 (TJADAB); T26 ivn-mus TDLo: 1353 ug/kg (5D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 49, p. 541, 1992 (BECTA6); T24-T34 ivn-mus TDLo: 2706 ug/kg (12D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 49, p. 541, 1992 (BECTA6); T02 ipr-gpg TDLo: 60 mg/kg (30D male) Indian Journal of Physiology and Pharmacology. (All India Institute of Medical Sciences, Dept. of Physiology, Ansari Nagar, New Delhi 110 029, India) V.1- 1957- v. 26, p. 246, 1982 (IJPPAZ); T02 ipr-ham TDLo: 30 mg/kg (30D male) Indian Journal of Physiology and Pharmacology. (All India Institute of Medical Sciences, Dept. of Physiology, Ansari Nagar, New Delhi 110 029, India) V.1- 1957- v. 26, p. 246, 1982 (IJPPAZ); T11 scu-ham TDLo: 8660 ug/kg (1D pre) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25, p. 381, 1982 (TJADAB); T29 scu-ham TDLo: 24 mg/kg (3D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 11, p. 180, 1974 (BIREBV); T11 scu-ham TDLo: 34648 ug/kg (1D pre) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 18, p. 166, 1978 (SEIJBO); T13 par-ham TDLo: 8 mg/kg (1D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 8, p. 378, 1973 (BIREBV) TE: V02-D07-K60 orl-rat TDLo: 2575 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-101649 (NTIS**); V03-M61 orl-mus TDLo: 5150 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-101649 (NTIS**) ORNG: 1000000 ng/kg. [1.000000 mg/kg] T/E unlistd SKNG: 41000000 ng/kg. [41.000000 mg/kg] T/E unlistd AT: F13-M03-P72 orl-man LDLo: 143 mg/kg Igaku to Seibutsugaku. Medicine and Biology. (c/o Ogato Igaku Kagaku Kenkyusho, 2-3-5 Bakuro-cho, Nihonbashi, Chuo-ku, Tokyo 103, Japan) V.1- 1942- v. 2, p. 48, 1942 (IGSBAL); K05-L14-M03 orl-man TDLo: 57 mg/kg Japanese Journal of Toxicology. (Yakugyo Jihosha, Hokushin Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo, 101, Japan) V.1- 1988- v. 8, p. 157, 1995 (JJTOEX); K30-M05-M16 orl-man TDLo: 21 mg/kg Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 11, p. 309, 1977 (CTOXAO); H07-K06-K20 orl-man LDLo: 86 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 26, p. 189, 1988 (JTCTDW); M11-P30 orl-wmn TDLo: 18 mg/kg Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 11, p. 53, 1992 (HETOEA); K13-K30-M11 orl-wmn TDLo: 50 mg/kg American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 80, p. 145, 1960 (AJOGAH); K07-K09-K13 orl-hmn LDLo: 29 mg/kg New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 244, p. 459, 1951 (NEJMAG); J20-K13-M11 orl-man TDLo: 29 mg/kg Medical Journal of Australia. (Australasian Medical Pub. Co. Ltd., 71-79 Arundel St., Glebe, N.S.W., Australia) V.1- 1914- v. 2, p. 125, 1978 (MJAUAJ); J22-K13-M11 orl-man LDLo: 14286 ug/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 41, p. 2383, 1999 (YAKUD5); T/E unlistd unr-man LDLo: 7253 ug/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 1 mg/kg Pesticide Manual. (The British Crop Protection Council, 20 Bridport Rd., Thornton Heath CR4 7QG, UK) V.1- 1968- v. 9, p. 550, 1991 (PEMNDP); T/E unlistd skn-rat LD50: 41 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(7), p. 27, 1981 (GTPZAB); M03 ipr-rat LD50: 3210 ug/kg Proceedings of the European Society for the Study of Drug Toxicity. (Princeton, NJ 08540) V.1-15, 1963-74. For publisher information, see PESTD5. v. 12, p. 247, 1971 (PSDTAP); T/E unlistd scu-rat LD50: 14 mg/kg Japanese Journal of Experimental Medicine. (Kinokuniya Book-Stores of America Co., Ltd., West Bldg., Japan Cultural and Trade Center, 1581 Webster St., San Francisco, CA 94115) V.7- 1928- v. 39, p. 47, 1969 (JJEMAG); T/E unlistd ivn-rat LD50: 1272 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 243, 1986 (ARTODN); F07-F18 orl-mus LD50: 6 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(1), p. 76, 1986 (GISAAA); T/E unlistd ihl-mus LCLo: 300 mg/m3/10M National Defense Research Committee, Office of Scientific Research and Development, Progress Report. No.9-4-1-9, 1943 (NDRC**); T/E unlistd ipr-mus LD50: 3900 ug/kg Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- v. 25, p. 891, 1991 (PCJOAU); T/E unlistd scu-mus LD50: 4500 ug/kg Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 34, p. 193, 1979 (NEZAAQ); T/E unlistd ivn-mus LD50: 4992 ug/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 21, p. 364, 1948 (QJPPAL); T/E unlistd orl-dog LDLo: 10 mg/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931 v. -, p. -, 1931 (FDWU**); T/E unlistd ivn-dog LDLo: 2710 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 44, p. 423, 1932 (JPETAB); T/E unlistd orl-rbt LDLo: 20 mg/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931 v. -, p. -, 1931 (FDWU**); T/E unlistd scu-rbt LDLo: 10 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); F12-F18-J26 ivn-rbt LDLo: 2 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 35, p. 343, 1929 (JPETAB); T/E unlistd ims-rbt LD50: 7300 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 87, p. 119, 1946 (JPETAB); T/E unlistd skn-gpg LDLo: 345 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 11, p. 201, 1965 (AEHLAU); T/E unlistd ipr-gpg LDLo: 345 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 11, p. 201, 1965 (AEHLAU); T/E unlistd orl-pgn LDLo: 2200 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1389, 1935 (HBAMAK); T/E unlistd scu-pgn LDLo: 1100 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1389, 1935 (HBAMAK); F11-F19 orl-qal LD50: 36 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 20, p. 105, 1987 (JTEHD6); F11-F19 ims-qal LD50: 34 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 20, p. 105, 1987 (JTEHD6); T/E unlistd orl-frg LDLo: 2424 mg/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931 v. -, p. -, 1931 (FDWU**); T/E unlistd scu-frg LDLo: 2 gm/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931 v. -, p. -, 1931 (FDWU**); Y03-Y10-Y16 ims-frg LD50: 7579 ug/kg Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- v. 85, p. 253, 1986 (CBPCEE); K12-M30-Q01 orl-hmn LDLo: 14.3 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1371, 2001 (HBPTO*) MD: M30-M70-U11 orl-rat TDLo: 412 mg/kg/61D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 102(Suppl 3), p. 305, 1994 (EVHPAZ); M16-N72-Y15 orl-rat TDLo: 420 mg/kg/4W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 125, 1993 (FCTOD7); M16-M70-U01 orl-rat TDLo: 675 mg/kg/27W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 36, p. 319, 1992 (JTEHD6); M03-M70-U01 orl-rat TDLo: 160 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-408, 1993 (NTPTR*); M16-M30-M70 orl-rat TDLo: 2600 mg/kg/2Y-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 36, p. 319, 1992 (JTEHD6); N08-U01 orl-rat TDLo: 455 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. 49, 1979 (TXAPA9); G30-H01 orl-rat TDLo: 592 mg/kg/50W-C Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 13, p. 353, 1989 (ATSUDG); M30-Y03 ipr-rat TDLo: 5950 ug/kg/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 28(5), p. 46, 1984 (GTPZAB); M04-U11-Y03 ipr-rat TDLo: 44955 ug/kg/45D-I Zhongguo Yaolixue Yu Dulixue Zazhi. (Chinese Pharmacological Society, 27 Tai-Ping Road, Beijing 100850, China) V.1- 1986- v. 1, p. 147, 1987 (ZYYZEW); M13 scu-rat TDLo: 17647 ug/kg/5W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 79, p. 119, 1993 (TXCYAC); P08-P71-P72 ihl-rat TCLo: 3520 mg/m3/24H/17W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 49(9), p. 11, 1984 (GISAAA); Y16 ipr-rat TDLo: 30 ug/kg/6D-I Toxicological European Research. (S.P.E., 10, Ave. de Messine, 75008 Paris, France) V.1- 1978- v. 1, p. 263, 1978 (TOERD9); L30 skn-rat TDLo: 128 mg/kg/13W-I Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (4), p. 24, 1996 (TOVEFN); M03-M13-M71 scu-rat TDLo: 32 mg/kg/21W-I Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 28, p. 305, 1986 (VHTODE); L70-M70-N74 orl-mus TDLo: 320 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-408, 1993 (NTPTR*); M70 orl-mus TDLo: 650 mg/kg/26W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-408, 1993 (NTPTR*); L30-M30-Y37 ipr-mus TDLo: 10 mg/kg/10D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 6, p. 319, 1980 (TOLED5); M30-N30-P30 scu-mus TDLo: 18 mg/kg/12W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 144, p. 163, 1997 (TXAPA9); A30 ivn-mky TDLo: 25 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 129, p. 196, 1994 (TXAPA9); M05-M30-Z01 skn-rbt TDLo: 2800 mg/kg/4W-I Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 7, p. 522, 1984 (ATSUDG); P70-P71-U01 orl-ckn TDLo: 4260 ug/kg/6W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 12, p. 46, 1974 (BECTA6); F15-Z01 orl-qal TDLo: 560 mg/kg/5D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 20, p. 105, 1987 (JTEHD6); M03-M13-M14 ivn-dom TDLo: 250 ug/kg/5D-C Cornell Veterinarian. (Cornell Univ. New York State College of Veterinary Medicine, Ithaca, NY 14853) V.1- 1911- v. 76, p. 306, 1986 (COVEAZ); T01-T02-Z73 orl-mus TDLo: 94.08 mg/kg/12W-C European Journal of Obstetrics, Gynecology and Reproductive Biology. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.3- 1973- v. 95, p. 92, 2001 (EOGRAL); N12-N72 orl-rat TDLo: 90 mg/kg/60D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 43, p. 481, 1989 (BECTA6); R60-V30 orl-rat TDLo: 1287.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-101649 (NTIS**); Z01 orl-rat TDLo: 210 mg/kg/2W-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1371, 2001 (HBPTO*); Z01 orl-mus TDLo: 210 mg/kg/2W-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1371, 2001 (HBPTO*); M30 orl-rat TDLo: 520 mg/kg/2Y-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1371, 2001 (HBPTO*); M71-U01 orl-mus TDLo: 6.8 mg/kg/5W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 630, 2001 (JTPAE7); T01-U01-Z73 ipr-rat TDLo: 0.75 mg/kg/15D-I Biomedica Biochimica Acta. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086, Ger. Dem. Rep.) V.42- 1983- v. 45, p. 949, 1986 (BBIADT); P30-U11-Z01 orl-rbt TDLo: 15 mg/kg/5D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 191, 1981 (FATOAO) TR: ACGIH TLV-TWA 0.025 mg(Hg)/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 239, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 239, 1993 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 239, 1993 (IMEMDT); TOXICOLOGY REVIEW American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 126, p. 390, 1976 (AJOGAH); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 491, 1977 (JTEHD6); TOXICOLOGY REVIEW Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 34, p. 1858, 1975 (FEPRA7); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 0.05 mg(Hg)/m3 "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 22, 1973 (DTLWS*); OEL-AUSTRALIA: TWA 0.05 mg(Hg)/m3, Skin, JAN 1993; OEL-BELGIUM: TWA 0.05 mg(Hg)/m3, Skin, JAN 1993; OEL-DENMARK: TWA 0.05 mg(Hg)/m3, Skin, JAN 1999; OEL-FINLAND: TWA 1 mg(Hg)/m3, JAN 1999; OEL-FRANCE: VME 0.1 mg(Hg)/m3, JAN 1999; OEL-GERMANY: MAK 0.01 ppm (0.1 mg(Hg)/m3), JAN 1999; OEL-HUNGARY: TWA 0.02 mg(Hg)/m3, STEL 0.04 mg(Hg)/m3, JAN 1993; OEL-JAPAN: OEL 0.05 mg(Hg)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG O.05 mg(Hg)/m3, MAC-K 0.15 mg(Hg)/m3, Skin, JAN 1999; OEL-NORWAY: TWA 0.05 mg(Hg)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.05 mg(Hg)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.05 mg(Hg)/m3, MAC(STEL) 0.15 mg(Hg)/m3, JAN 1999; OEL-RUSSIA: TWA 0.05 mg(Hg)/m3, STEL 0.01 mg(Hg)/m3, JAN 1993; OEL-SWEDEN: NGV 0.05 mg(Hg)/m3, Skin, JAN 1999; OEL-THAILAND: STEL 0.05 mg(Hg)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.025 mg(Hg)/mg, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO MERCURY, ARYL AND INORGANIC-air: CL 0.1 mg/m3 (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84274; NIS 22; TNF 1553; NOS 19; TNE 9791; NOES 1983: HZD 84274; NIS 24; TNF 2012; NOS 24; TNE 45491; TFE 18717 SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, B subtilis rec assay; EPA GENETOX PROGRAM 1988, Negative: N crassa-aneuploidy; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 862 of 1119 in RTECS (through 2003/06) AN: OZ5075000 PN: Methacrylic-acid,-methyl-ester- SY: 2-(Methoxycarbonyl)-1-propene; 2-Methyl-2-propenoic-acid-methyl-ester-; 2-Propenoic-acid,-2-methyl-,-methyl-ester-; Acrylic-acid,-2-methyl-,-methyl-ester-; MME-; Metakrylan-metylu- (Polish); Methacrylate-de-methyle- (French); Methacrylsaeuremethyl-ester- (German); Methyl-2-methyl-2-propenoate-; Methyl-alpha-methylacrylate-; Methyl-methacrylate-; Methyl-methacrylate- (ACGIH:OSHA); Methyl-methacrylate-monomer-; Methyl-methylacrylate-; Methyl-2-methyl-2-propenoate-; Methyl-2-methylpropenoate-; Methyl-methacrylat- (German); Methylester-kyseliny-methakrylove- (Czech); Methylmethacrylaat- (Dutch); Metil-metacrilato- (Italian); NCI-C50680-; Pegalan-; RCRA-waste-number-U162- RN: Current: 80-62-6 BRN: 605459 BHR: 4-02-00-01519 UD: 200302 MF: C5-H8-O2 MW: 100.13 WL: 1UY1&VO1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 10 gm open Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 343, 1941 (JIHTAB); eye-rbt 150 mg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF) ME: mmo-sat 34 mmol/L (-S9) Journal of Bone and Joint Surgery, American Volume. (10 Shattuck St., Boston, MA 02115) V.30- 1948- v. 61A, p. 1203, 1979 (JBJSA3); cyt-rat-ihl 4 mg/m3/16W Biologicheskii Zhurnal Armenii. Biological Journal of Armenia. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.19- 1966- v. 27(6), p. 102, 1974 (BZARAZ); mnt-mus-lym 2202 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 191, 1989 (MUREAV); mmo-mus-lym 500 mg/L (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 4, 1986 (ENMUDM); cyt-mus-lym 2799 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 49, 1988 (EMMUEG); cyt-mus-lym 2202 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 191, 1989 (MUREAV); msc-mus-lym 704 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-314, 1986 (NTPTR*); cyt-ham-ovr 1600 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-314, 1986 (NTPTR*); sce-ham-ovr 1500 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-314, 1986 (NTPTR*) RE: T19-T31-T91 ihl-wmn TCLo: 10 mg/m3 (9Y preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 62(4), p. 19, 1997 (GISAAA); T34-T46 ihl-rat TCLo: 109 gm/m3/17M (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 50, p. 451, 1979 (TXAPA9); T35-T59 ihl-rat TCLo: 109 gm/m3/54M (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 50, p. 451, 1979 (TXAPA9); T14 ihl-rat TCLo: 54 mg/m3/24H (8W pre) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 21(2), p. 49, 1977 (GTPZAB); T25 ihl-rat TCLo: 4480 mg/m3/2H (6-18D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31(Suppl), p. 80, 1986 (TOLED5); T34-T59 ipr-rat TDLo: 405 mg/kg (5-15D preg) Journal of Dental Research. (International Assoc. for Dental Research, 734 15th St., NW, Suite 809, Washington, DC 20005) V.1- 1919- v. 51, p. 1632, 1972 (JDREAF); T59 ipr-rat TDLo: 801 mg/kg (5-15D preg) Journal of Dental Research. (International Assoc. for Dental Research, 734 15th St., NW, Suite 809, Washington, DC 20005) V.1- 1919- v. 51, p. 1632, 1972 (JDREAF); T25-T34-T46 ihl-mus TCLo: 116 ppm/6H (4-13D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555600 (NTIS**); T59 ihl-rat TCLo: 500 mg/m3 (122D pre) Problemi Endocrinologii. (Endocrinology problems, 117819, Nauchnii proesd, 6, Moscow, Russia) V36- 1991- v. 37, p. 51, 1991 (PREND*); T24-T25-T59 ihl-rat TCLo: 500 mg/m3 (119D pre) Problemy Endokrinologii. Problems of Endocrinology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-6, 1936-41: 13- 1967- v. 37, p. 51, 1991 (PROEAS); T59 ihl-rat TCLo: 500 mg/m3 (98D pre/21D preg) Problemy Endokrinologii. Problems of Endocrinology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-6, 1936-41: 13- 1967- v. 37, p. 51, 1991 (PROEAS) TE: V03-V10 imp-rat TDLo: 1620 mg/kg Clinical Orthopaedics and Related Research. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) No.26- 1963- v. 88, p. 223, 1972 (CORTBR) ORNG: 7872000000 ng/kg. [7872.000000 mg/kg] F18-F24-J25 IHNG: 78000000000 ng/m3/4H. [78000.000000 mg/m3/4H] T/E unlistd AT: F04-F13-F14 ihl-hmn TCLo: 125 ppm Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 19(10), p. 25, 1954 (GISAAA); F04-F13-H02 ihl-hmn TCLo: 60 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 1, p. 56, 1957 (GTPZAB); F18-F24-J25 orl-rat LD50: 7872 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 343, 1941 (JIHTAB); T/E unlistd ihl-rat LC50: 78000 mg/m3/4H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 20(6), p. 5, 1976 (GTPZAB); T/E unlistd ipr-rat LD50: 1328 mg/kg Journal of Dental Research. (International Assoc. for Dental Research, 734 15th St., NW, Suite 809, Washington, DC 20005) V.1- 1919- v. 51, p. 1632, 1972 (JDREAF); F07 scu-rat LD50: 7088 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); T/E unlistd orl-mus LD50: 3625 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(4), p. 6, 1976 (GISAAA); T/E unlistd ihl-mus LC50: 18500 mg/m3/2H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 20(6), p. 5, 1976 (GTPZAB); F07 ipr-mus LD50: 945 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); F07 scu-mus LD50: 5954 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); F07-F19-K01 orl-dog LD50: 4725 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); F07-F19-K01 ihl-dog LCLo: 41200 mg/m3/3H Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); F07 scu-dog LD50: 4252 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); T/E unlistd ivn-dog LDLo: 120 uL/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 63, p. 376, 1974 (JPMSAE); C06-M02-Y36 scu-cat LDLo: 7 mL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520933 (NTIS**); T/E unlistd orl-rbt LD50: 8700 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(4), p. 6, 1976 (GISAAA); F18-F24-J25 ihl-rbt LCLo: 17500 mg/m3/4.5H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 343, 1941 (JIHTAB); R03 skn-rbt LD50: >5 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0544282 (NTIS**); F07-J30-M14 scu-rbt LDLo: 14 mL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520933 (NTIS**); F07-F19-K01 orl-gpg LD50: 5954 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); F18-F24-J25 ihl-gpg LCLo: 19000 mg/m3/5H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 23, p. 343, 1941 (JIHTAB); F07 ipr-gpg LD50: 1890 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); F07 scu-gpg LD50: 5954 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); T/E unlistd ihl-mam LC50: 20 gm/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(5), p. 61, 1986 (GISAAA) MD: C18-F07-Y37 orl-rat TDLo: 10500 mg/kg/21D-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 27, p. 121, 1989 (INHEAO); K06-L30 orl-rat TDLo: 17896 mg/kg/35W-I Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 32, p. 653, 1971 (AMPMAR); P28-U08-Y15 ihl-rat TCLo: 116 ppm/8H/26W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 11, p. 66, 1976 (ENVRAL); A04-D07-Z01 ihl-rat TCLo: 5000 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-314, 1986 (NTPTR*); L03-M30-Y38 ihl-rat TCLo: 34500 mg/m3/16W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 74, 1980 (GISAAA); F23-Y01-Y36 ihl-rat TCLo: 1 mg/m3/24H/60D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 27(11), p. 3, 1962 (GISAAA); G06-P30 ihl-rat TCLo: 115 mg/m3/3H/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(1), p. 34, 1980 (GISAAA); D07-J12 ihl-rat TCLo: 500 ppm/6H/2Y-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 52, p. 237, 1988 (TXCYAC); Z01 ihl-mus TCLo: 41 gm/m3/90M/15D-I Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); D07-L02-Z01 ihl-mus TCLo: 5000 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-314, 1986 (NTPTR*); D07-J12 ihl-mus TCLo: 500 ppm/6H/2Y-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 52, p. 237, 1988 (TXCYAC); Z01 ipr-mus TDLo: 19665 mL/kg/15W-I Journal of Biomedical Materials Research. (John Wiley and Sons, Inc., 605 Third Ave., New York, NY 10158) V.1- 1967- v. 8, p. 11, 1974 (JBMRBG); N73 orl-dog TDLo: 1825 mg/kg/2Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 6, p. 29, 1964 (TXAPA9); L03-Z01 ihl-dog TCLo: 47 gm/m3/90M/15D-I Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); Z01 ihl-cat TCLo: 15 gm/m3/7H/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520933 (NTIS**); A30-L30-Y15 orl-rbt TDLo: 97500 ug/kg/39W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(4), p. 6, 1976 (GISAAA); M16-Y36 ihl-rbt TCLo: 15 gm/m3/7H/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520933 (NTIS**); L03-Z01 ihl-gpg TCLo: 65 gm/m3/3H/3D-I Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 14, p. 292, 1945 (INMEAF); U01-Z01 ihl-ham TCLo: 400 ppm/6H/78W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0521056 (NTIS**); N02-N04-Z71 ihl-rat TCLo: 50 mg/m3/4H/4W-I Problemy Endokrinologii. Problems of Endocrinology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-6, 1936-41: 13- 1967- v. 37, p. 51, 1991 (PROEAS); A30 ihl-rat TCLo: 50 mg/m3/4H/17W-I Problemy Endokrinologii. Problems of Endocrinology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-6, 1936-41: 13- 1967- v. 37, p. 51, 1991 (PROEAS) TR: ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 187, 1979 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 187, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 445, 1994 (IMEMDT); IARC Cancer Review: Animal LACK CARCINOGENICITY IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 445, 1994 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 445, 1994 (IMEMDT); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 11, p. 141, 1975 (EVHPAZ); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS) SR: MSHA STANDARD-air: TWA 100 ppm (410 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 168, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm (410 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (410 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (410 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (410 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 100 ppm (410 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 50 ppm (210 mg/m3), JAN 1999; OEL-BELGIUM: TWA 100 ppm (410 mg/m3), JAN 1993; OEL-FINLAND: TWA 100 ppm (410 mg/m3), STEL 150 ppm (615 mg/m3), JAN 1999; OEL-FRANCE: VME 100 ppm (410 mg/m3), VLE 200 ppm (820 mg/m3), JAN 1999; OEL-GERMANY: MAK 50 ppm (210 mg/m3), JAN 1999; OEL-HUNGARY: TWA 50 mg/m3, STEL 150 mg/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 100 ppm (410 mg/m3), JAN 1999; OEL-NORWAY: TWA 25 ppm (100 mg/m), JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (410 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 50 mg/m3, MAC(STEL) 400 mg/m3, JAN 1999; OEL-RUSSIA: STEL 10 mg/m3, JAN 1993; OEL-SWEDEN: NGV 50 ppm (200 mg/m3), KTV 150 ppm (600 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (210 mg/m3), KZG-W 100 ppm (420 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 50 ppm (208 mg/m3), STEL 100 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO METHYL METHACRYLATE-air: 10H TWA 100 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 47700; NIS 89; TNF 11522; NOS 73; TNE 89435; NOES 1983: HZD 47700; NIS 76; TNF 6757; NOS 80; TNE 170079; TFE 59519 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Methyl methacrylate, 2537; NCI Carcinogenesis Studies (inhal), no evidence: mouse, rat; OSHA ANALYTICAL METHOD #94 Record 863 of 1119 in RTECS (through 2003/06) AN: PA3675000 PN: Methane, bis(2-chloroethoxy)- SY: Dichloroethyl-formal-; Di-2-chloroethyl-formal-; Ethane, 1,1'-(methylenebis(oxy))bis(2-chloro-; Formaldehyde bis(beta-chloroethyl) acetal; Bis(2-chloroethoxy)-methane; Bis(beta-chloroethyl)formal; Bis(2-chloroethyl)formal; RCRA-waste-number-U024- RN: Current: 111-91-1 BRN: 1698909 BHR: 4-01-00-03028 UD: 200012 MF: C5-H10-Cl2-O2 MW: 173.05 WL: G2O1O2G CC: Tumorigen (C); Primary-Irritant (S) ID: skn-rbt 10 mg/24H open Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30, p. 63, 1948 (JIHTAB); eye-rbt 500 mg MLD American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA) ORNG: 65000000 ng/kg. [65.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 65 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30, p. 63, 1948 (JIHTAB); T/E unlistd ihl-rat LCLo: 62 ppm/4H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 31, p. 343, 1949 (JIHTAB); T/E unlistd skn-gpg LD50: 170 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30, p. 63, 1948 (JIHTAB) MD: G30-L14-U01 orl-rat TDLo: 10920 mg/kg/13W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0526337 (NTIS**) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 864 of 1119 in RTECS (through 2003/06) AN: PA4900000 PN: Methane,-bromo- SY: Bercema-; Brom-O-Gas-; Brom-O-Sol-; Brom-methan- (German); Bromometano- (Italian); Bromomethane-; Bromure-de-methyle- (French); Bromuro-di-metile- (Italian); Broommethaan- (Dutch); Celfume-; Curafume-; Dawson-100-; Detia-gas-EX-M-; Dowfume-MC-2-; Dowfume-MC-2-soil-fumigant-; Dowfume-MC-33-; Embafume-; Fumigant-1- (Obs.); Halon-1001-; Haltox-; Iscobrome-; Kayafume-; Metafume-; Methogas-; Methyl-bromide-; Methyl-bromide- (ACGIH:OSHA); Methylbromid- (German); Metylu-bromek- (Polish); Monobromomethane-; Pestmaster- (Obs.); Profume- (Obs.); R-40B1-; RCRA-waste-number-U029-; Terabol-; Terr-O-Cide-II-; Terr-O-Gas-100-; Terr-O-Gas-67-; Zytox- RN: Current: 74-83-9 UD: 200210 MF: C-H3-Br MW: 94.95 WL: E1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 400 ppm (+S9) HEW Publication (FDA. United States). (Washington, DC) ?-1979(?). For publisher information, see HPFSDS. FDA-78-1046, 1978 (DHEFDK); mmo-sat 5000 mg/m3 (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 116, p. 185, 1983 (MUREAV); oms-sat 3 pph Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 171, 1987 (ENMUDM); mmo-klp 4750 mg/m3 (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 155, p. 41, 1985 (MUREAV); slt-dmg-ihl 8 mg/L/1H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 131, 1987 (MUREAV); sln-dmg-ihl 150 mg/m3/6H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 272, 1983 (MUREAV); cyt-hmn-lym 95 mg/L Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 21, 1990 (TCMUD8); sce-hmn-lym 43000 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 48, 1985 (ENMUDM); sce-hmn-lym 5 mg/L Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 21, 1990 (TCMUD8); mnt-rat-ihl 338 ppm/6H/14D-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 164, p. 269, 1986 (MUREAV); mnt-mus-ihl 100 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-385, 1992 (NTPTR*); sce-mus-ihl 200 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-385, 1992 (NTPTR*); msc-mus-lym 300 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 155, p. 41, 1985 (MUREAV) RE: T19 orl-rat TDLo: 300 mg/kg (6-15D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 36, p. 421, 1998 (FCTOD7); T19 orl-rbt TDLo: 130 mg/kg (6-18D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 36, p. 421, 1998 (FCTOD7) TE: V01-K17-K60 orl-rat TDLo: 3250 mg/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 262, 1984 (TXAPA9); V01-D09 ihl-rat TCLo: 30 ppm/6H/2.5Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0559186 (NTIS**) ORNG: 214000000 ng/kg. [214.000000 mg/kg] T/E unlistd AT: F12-J26-K13 ihl-man LCLo: 60000 ppm/2H British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 2, p. 24, 1945 (BJIMAG); P02 ihl-chd LCLo: 1 gm/m3/2H Nippon Hoigaku Zasshi. Japanese Journal of Legal Medicine. (Nippon Hoi Gakkai, c/o Tokyo Daigaku Igakubu Hoigaku Kyoshitsu, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113, Japan) V.1- 1944- v. 23, p. 241, 1969 (NHOZAX); F14-K13-R11 ihl-hmn TCLo: 35 ppm Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 11, p. 575, 1942 (INMEAF); R02 skn-hmn TDLo: 35 gm/m3/40M-I Archives of Dermatology. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.82- 1960- v. 124, p. 917, 1988 (ARDEAC); T/E unlistd orl-rat LD50: 214 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 262, 1984 (TXAPA9); F17-U01-U28 ihl-rat LC50: 302 ppm/8H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 183, 1985 (TXAPA9); T/E unlistd scu-rat LD50: 135 mg/kg Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 26, p. 101, 1988 (INHEAO); T/E unlistd ihl-mus LC50: 1540 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,81,1982 (85GMAT); G07-K13-U28 orl-dog LDLo: 500 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528834 (NTIS**); T/E unlistd ihl-rbt LC50: 28900 mg/m3/30M Farmakologiya i Toksikologiya (Kiev). Pharmacology and Toxicology. (Kievskii Nauchno- Issledovatel'skii Institut Farmakologii i Toksikologii, Kiev, USSR) No.1- 1964- v. 8, p. 140, 1973 (FATOBP); F18-J12-R21 ihl-gpg LCLo: 300 ppm/9H U.S. Public Health Service, Public Health Bulletin. (Washington, DC) v. 185, p. 1, 1929 (XPHBAO) MD: M16-R21-U01 orl-rat TDLo: 21840 mg/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 28, p. 109, 1990 (FCTOD7); P08-P71-U01 ihl-rat TCLo: 120 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-385, 1992 (NTPTR*); Y16-Y38 ihl-rat TCLo: 150 ppm/6H/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 112, p. 120, 1992 (TXAPA9); A30-D07-G30 ihl-rat TCLo: 160 ppm/6H/6W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 594, 1988 (FAATDF); F07-F19-Z01 ihl-rat TCLo: 300 ppm/4H/3W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 6, p. 293, 1980 (TOLED5); Z01 ihl-mus TCLo: 200 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-385, 1992 (NTPTR*); F23-U01-Z01 ihl-mus TCLo: 120 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-385, 1992 (NTPTR*); M03-N30-P27 ihl-mus TCLo: 160 ppm/6H/6W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 594, 1988 (FAATDF); C06-F12 ihl-mky TCLo: 250 mg/m3/8H/26W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 22, p. 218, 1940 (JIHTAB); C06-J12-Z01 ihl-rbt TCLo: 130 mg/m3/8H/26W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 22, p. 218, 1940 (JIHTAB); C06-J16-J22 ihl-gpg TCLo: 850 mg/m3/8H/26W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 22, p. 218, 1940 (JIHTAB) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 187, 1986 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 721, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 187, 1986 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 721, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 721, 1999 (IMEMDT) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 15 ppm (60 mg/m3) (skin) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 23, 1973 (DTLWS*); OSHA PEL (Gen Indu): CL 20 ppm (80 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 20 ppm (80 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 20 ppm (80 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 20 ppm (80 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 5 ppm (20 mg/m3), Skin, JAN 1993; OEL-AUSTRALIA: TWA 5 ppm (20 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-DENMARK: TWA 5 ppm (20 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 5 ppm (20 mg/m3), STEL 10 ppm (40 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (20 mg/m3), JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-HUNGARY: TWA 10 mg/m3, STEL 20 mg/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 0.55 ppm (1 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (20 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 20 ppm (80 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 40 mg/m3, JAN 1999; OEL-RUSSIA: STEL 1 mg/m3, JAN 1993; OEL-SWEDEN: NGV 5 ppm (19 mg/m3), KTV 10 ppm (40 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (20 mg/m3), KZG-W 10 ppm (40 mg/m3), Skin, JAN 1999; OEL-THAILAND: TWA 20 ppm (80 mg/m3), JAN 1993; OEL-TURKEY: TWA 20 ppm (80 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (20 mg/m3), STEL 15 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO METHYL BROMIDE-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M0420; NIS 10; TNF 597; NOS 14; TNE 15899; NOES 1983: HZD M0420; NIS 4; TNF 513; NOS 5; TNE 5603; TFE 975 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110682/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0493-8835; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 43, 1984; NIOSH Analytical Method, 1994: Methyl bromide, 2520; NCI Carcinogenesis Studies (inhal), no evidence: mouse Record 865 of 1119 in RTECS (through 2003/06) AN: PA5310000 PN: Methane,-bromodichloro- SY: BDCM-; Bromo-dichloromethane-; Bromodichloromethane-; Dichlorobromomethane-; Dichloromonobromomethane-; Monobromodichloromethane-; NCI-C55243- RN: Current: 75-27-4 BRN: 1697005 BHR: 4-01-00-00076 UD: 200302 MF: C-H-Br-Cl2 MW: 163.83 WL: GYGE CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 50 mg/plate (+S9) HEW Publication (FDA. United States). (Washington, DC) ?-1979(?). For publisher information, see HPFSDS. FDA-78-1046, 1978 (DHEFDK); mmo-sat 10 ug/plate (-S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 13, p. 205, 1987 (TECSDY); sce-hmn-lym 400 umol/L Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 72, 1983 (ENVRAL); cyt-rat-ipr 164 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 111, 1990 (MUREAV); sce-rat-leu 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 241, 1993 (MUREAV); mmo-mus-lym 180 mg/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); sce-mus-orl 200 mg/kg/4D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 72, 1983 (ENVRAL); msc-mus-lym 180 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); cyt-ham-lng 10 umol/L Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 13, p. 205, 1987 (TECSDY); mnt-mus-ihl 100 ppm/6H/7D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 171, 2002 (MUREAV); mnt-mus-ihl 15 ppm/6H/13W Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 171, 2002 (MUREAV) RE: T25 orl-rat TDLo: 750 mg/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 40, p. 30, 1997 (FAATDF) TE: V01-K60-M61 orl-rat TDLo: 25500 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-321, 1987 (NTPTR*); V01-M61 orl-mus TDLo: 25500 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-321, 1987 (NTPTR*); V01-K60-M61 orl-rat TD :51 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-321, 1987 (NTPTR*); V01-L60 orl-mus TD :38250 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-321, 1987 (NTPTR*); V01-K61-M61 orl-rat TDLo: 51500 mg/kg/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-168687 (NTIS**); V01-M61 orl-mus TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-168687 (NTIS**); V01-L60 orl-mus TDLo: 38625 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-168687 (NTIS**) ORNG: 430000000 ng/kg. [430.000000 mg/kg] F07-F11-L30 AT: F07-F11-L30 orl-rat LD50: 430 mg/kg Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. (Tohoku University, Research Institute for Tuberculosis and Cancer, 4-1 Seiryo-machi, Sendai, Japan) V.1- 1949- v. 36(1-4), p. 10, 1989 (SRTCAC); A04-L03-P01 orl-mus LD50: 450 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 44, p. 213, 1978 (TXAPA9); L30-Y20 ihl-rat TCLo: 100 ppm/4H Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 161, p. 67, 2001 (TXCYAC) MD: L70-M70-Y07 orl-rat TDLo: 750 mg/kg/5D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 94, p. 3, 1994 (TXCYAC); L70-P28-U01 orl-rat TDLo: 5670 mg/kg/4W-C Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 17, p. 119, 1992 (JTSCDR); Z01 orl-rat TDLo: 19500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-321, 1987 (NTPTR*); P71-U01-Y15 orl-rat TDLo: 9828 mg/kg/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(4), p. 80, 1985 (GISAAA); L03-L30-L70 orl-rat TDLo: 20075 mg/kg/2Y-C Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 17, p. 51, 1992 (JTSCDR); L70-N73-U01 orl-mus TDLo: 3500 mg/kg/14D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 46, p. 117, 1982 (EVHPAZ); L70-Y10-Y15 orl-mus TDLo: 750 mg/kg/5D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 94, p. 3, 1994 (TXCYAC); M03-M30 ihl-mus TCLo: 10 ppm/6H/3W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 221, 2000 (TOXID9); M03-U01 orl-mus TDLo: 6500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-321, 1987 (NTPTR*); U01-F15 orl-rat TDLo: 742 mg/kg/14D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-111728 (NTIS**); Y21 orl-rat TDLo: 1232 mg/kg/14D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-111728 (NTIS**); L30 orl-rat TDLo: 742 mg/kg/14D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-111728 (NTIS**) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 179, 1991 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1295, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 179, 1991 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1295, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1295, 1999 (IMEMDT) ND: NOES 1983: HZD X5772; NIS 1; TNF 7; NOS 1; TNE 3266; TFE 502 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/90/167461/AS); EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Carcinogenesis studies, on test (two year studies), October 2000; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 866 of 1119 in RTECS (through 2003/06) AN: PA6360000 PN: Methane,-chlorodibromo- SY: Chlorodibromomethane-; Dibromochloromethane-; CDBM-; NCI-C55254-; Monochlorodibromomethane- RN: Current: 124-48-1 BRN: 1731046 BHR: 4-01-00-00081 UD: 200302 MF: C-H-Br2-Cl MW: 208.29 WL: GYEE CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 10 mg/plate (+S9) HEW Publication (FDA. United States). (Washington, DC) ?-1979(?). For publisher information, see HPFSDS. FDA-78-1046, 1978 (DHEFDK); mrc-smc 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 155, p. 53, 1985 (MUREAV); sce-hmn-lym 400 umol/L Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 72, 1983 (ENVRAL); cyt-rat-ipr 20800 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 111, 1990 (MUREAV); sce-rat-leu 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 241, 1993 (MUREAV); oms-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); sce-mus-orl 100 mg/kg/4D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 72, 1983 (ENVRAL); msc-mus-lym 100 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 740 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sln-ham-lng 720 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 369, p. 243, 1996 (MUREAV) TE: V01-L60 orl-mus TDLo: 52500 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-282, 1985 (NTPTR*); V01-L60 orl-mus TDLo: 52500 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-166675/AS (NTIS**); V03-L60 orl-mus TDLo: 52500 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-166675/AS (NTIS**) ORNG: 370000000 ng/kg. [370.000000 mg/kg] C08-F07-F11 AT: C08-F07-F11 orl-rat LD50: 370 mg/kg Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. (Tohoku University, Research Institute for Tuberculosis and Cancer, 4-1 Seiryo-machi, Sendai, Japan) V.1- 1949- v. 36(1-4), p. 10, 1989 (SRTCAC); A04-L03-P01 orl-mus LD50: 800 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 44, p. 213, 1978 (TXAPA9) MD: L30-M30-Z01 orl-rat TDLo: 14 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-282, 1985 (NTPTR*); L70-M70-U01 orl-rat TDLo: 10 gm/kg/4W-C Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 17, p. 119, 1992 (JTSCDR); P71-U01-Y15 orl-rat TDLo: 8568 mg/kg/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 50(4), p. 80, 1985 (GISAAA); L03-M03-Z01 orl-rat TDLo: 16250 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-282, 1985 (NTPTR*); L70-N73-U01 orl-mus TDLo: 3500 mg/kg/14D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 46, p. 117, 1982 (EVHPAZ); L03-M03-U01 orl-mus TDLo: 16250 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-282, 1985 (NTPTR*); L30-Y03-Y21 orl-rat TDLo: 199.5 mg/kg/35D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-111728 (NTIS**); F15 orl-rat TDLo: 1410.5 mg/kg/35D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-111728 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 243, 1991 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1331, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 243, 1991 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1331, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1331, 1999 (IMEMDT) SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/91/180323/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-282, 1985 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse; NCI Carcinogenesis Studies (gavage), no evidence: rat Record 867 of 1119 in RTECS (through 2003/06) AN: PA8050000 PN: Methane,-dichloro- SY: Aerothene-MM-; Chlorure-de-methylene- (French); Dichloromethane-; Dichloromethane- (DOT:OSHA); F-30- (chlorocarbon); Freon-30-; HCC-30-; Khladon-30-; Methane-dichloride-; Methylene-bichloride-; Methylene-chloride-; Methylene-chloride- (ACGIH:OSHA); Methylene-dichloride-; Metylenu-chlorek- (Polish); NCI-C50102-; Narkotil-; R-30-; R30- (refrigerant); RCRA-waste-number-U080-; Solaesthin-; Soleana-VDA-; Solmethine- RN: Current: 75-09-2 BRN: 1730800 BHR: 4-01-00-00035 UD: 200302 MF: C-H2-Cl2 MW: 84.93 WL: G1G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 810 mg/24H SEV European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 171, 1976 (EJTXAZ); skn-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,88,1986 (85JCAE); eye-rbt 162 mg MOD European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 9, p. 171, 1976 (EJTXAZ); eye-rbt 10 mg MLD Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 6, p. 173, 1976 (TXCYAC); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,88,1986 (85JCAE) ME: mmo-sat 5700 ppm (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 245, 1978 (MUREAV); mmo-esc 6300 ppm (+/-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 20, p. 211, 1992 (EMMUEG); pic-esc 8250 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); sln-dmg-orl 125 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 91, 1981 (MUREAV); dni-hmn-fbr 5000 ppm/1H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 81, p. 203, 1981 (MUREAV); mtr-rat-emb 160 umol/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 14, p. 290, 1978 (ITCSAF); dnd-rat-orl 1275 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 61, 1989 (TCMUD8); dnd-rat-lvr 30 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 991, 1994 (CRNGDP); mnt-mus-ihl 27760 mg/m3/6H/2W-I Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 15, p. 221, 1990 (EMMUEG); dnd-mus-lvr 400 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 991, 1994 (CRNGDP); dnd-mus-ihl 4000 ppm/6H-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 991, 1994 (CRNGDP); dnd-mus-orl 1720 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 13, 1998 (MUREAV); cyt-mus-ihl 27760 mg/m3/6H/2W-I Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 15, p. 221, 1990 (EMMUEG); sce-mus-ihl 13880 mg/m3/6H/2W-I Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 15, p. 221, 1990 (EMMUEG); mtr-ham-emb 1300 uL/plate Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 25, p. 75, 1982 (EVSRBT); dnd-ham-ovr 3000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 143, 1996 (MUREAV); dni-ham-lng 5000 ppm/1H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 81, p. 203, 1981 (MUREAV); oms-ham-ovr 6628 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 116, p. 361, 1983 (MUREAV); cyt-ham-lng 1 umol/L Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 13, p. 205, 1987 (TECSDY); cyt-ham-ovr 6628 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 116, p. 361, 1983 (MUREAV); sce-ham-lng 5000 ppm/1H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 81, p. 203, 1981 (MUREAV); msc-ham-ovr 3000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 143, 1996 (MUREAV); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T85 ihl-rat TCLo: 4500 ppm/24H (1-17D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 52, p. 29, 1980 (TXAPA9); T46-T53 ihl-rat TCLo: 1250 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 84, 1975 (TXAPA9); T46 ihl-mus TCLo: 1250 ppm/7H (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 84, 1975 (TXAPA9) TE: V01-N60 ihl-rat TCLo: 3500 ppm/6H/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 4, p. 30, 1984 (FAATDF); V01-J60 ihl-mus TCLo: 2000 ppm/5H/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-306, 1986 (NTPTR*); V02-R60 ihl-rat TCLo: 122400 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-187903/AS (NTIS**); V02-R60-P61 ihl-rat TCLo: 102000 mg/kg/102W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-187903/AS (NTIS**); V01-J60-L60 ihl-mus TCLo: 122400 mg/kg/102W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-187903/AS (NTIS**) ORNG: 1600000000 ng/kg. [1600.000000 mg/kg] F19 AT: M03-P05-U09 orl-man TDLo: 1429 uL/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 36, p. 575, 1994 (YAKUD5); C10-F07-F12 orl-hmn LDLo: 357 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,390,1969 (34ZIAG); F05-F07-G10 ihl-hmn TCLo: 500 ppm/1Y-I Abstracts on Hygiene. (Bureau of Hygiene and Tropical Diseases, Keppel St., London WC1E 7HT, UK) V.1- 1926- v. 43, p. 1123, 1968 (ABHYAE); F06 ihl-hmn TCLo: 500 ppm/8H Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 176, p. 295, 1972 (SCIEAS); F19 orl-rat LD50: 1600 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 48A, p. 94, 1970 (FAONAU); T/E unlistd ihl-rat LC50: 52 gm/m3 Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 15, p. 64, 1979 (TPKVAL); T/E unlistd ipr-rat LD50: 916 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); J02-J15 itr-rat LDLo: 350 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0520615 (NTIS**); T/E unlistd unr-rat LD50: 5350 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 53(6), p. 78, 1988 (GISAAA); T/E unlistd orl-mus LD50: 873 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 106(Suppl 2), p. 497, 1998 (EVHPAZ); T/E unlistd ihl-mus LC50: 14400 ppm/7H National Institutes of Health, Bulletin. (Bethesda, MD) v. 191, p. 1, 1949 (NIHBAZ); T/E unlistd ipr-mus LD50: 437 mg/kg Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 18, p. 109, 1960 (AGGHAR); T/E unlistd scu-mus LD50: 6460 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 354, 1962 (TXAPA9); K06-K08 unr-mus LD50: 4770 mg/kg Eisei Kagaku. Hygienic Chemistry. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1953- v. 28, p. P31, 1982 (ESKGA2); T/E unlistd orl-dog LDLo: 3 gm/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); D15-H02-J22 ihl-dog LCLo: 14108 ppm/7H National Institutes of Health, Bulletin. (Bethesda, MD) v. 191, p. 1, 1949 (NIHBAZ); T/E unlistd ipr-dog LD50: 1274 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 119, 1967 (TXAPA9); T/E unlistd ivn-dog LDLo: 200 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); F01-F19-U28 ihl-cat LCLo: 43400 mg/m3/4.5H Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 116, p. 131, 1936 (AHBAAM); T/E unlistd orl-rbt LDLo: 1900 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 94, 1955 (HBTXAC); T/E unlistd ihl-rbt LCLo: 10000 ppm/7H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 26, p. 8, 1944 (JIHTAB); T/E unlistd scu-rbt LDLo: 2700 mg/kg Quarterly Journal of Pharmacy and Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. v. 7, p. 205, 1934 (QJPPAL); T/E unlistd unr-rbt LD50: 1225 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 53(6), p. 78, 1988 (GISAAA); T/E unlistd ihl-gpg LCLo: 5000 ppm/2H Fluorine Chemistry Reviews. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1967- v. 1, p. 197, 1967 (FLCRAP) MD: L02-L03 orl-rat TDLo: 14940 mg/kg/90D-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 24, p. 943, 1986 (FCTOD7); F16-L03-U01 orl-rat TDLo: 91 gm/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 24, p. 951, 1986 (FCTOD7); J30-Y03-Y10 ihl-rat TCLo: 3700 ppm/5H/4W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 41, 1980 (TOLED5); L30-M03-M70 ihl-rat TCLo: 5000 ppm/24H/14W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD746-295 (NTIS**); L70-Z01 ihl-rat TCLo: 8400 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-306, 1986 (NTPTR*); M30-P24-Y21 ihl-rat TCLo: 500 ppm/6H/2W-I Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 32, p. 535, 1981 (RCOCB8); L30-L70 skn-rat TDLo: 39270 mg/kg/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 26(5), p. 41, 1982 (GTPZAB); F15-L30-P30 ihl-rat TCLo: 1000 ppm/2H/3W-I Hochudoku. (Nippon Hochudoku Gakkai, c/o Kyushu Daigaku Igakubu Hoigaku Kyoshitsu, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812, Japan) V.8- 1990- v. 8, p. 64, 1990 (HOCHE8); A30-Y65 ihl-rat TCLo: 1000 ppm/6H/3D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 29, p. 293, 1984 (TXCYAC); M03 orl-mus TDLo: 1862 mg/kg/2W-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 6, p. 563, 1983 (DCTODJ); L02-L03 orl-mus TDLo: 52740 mg/kg/90D-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 24, p. 943, 1986 (FCTOD7); Z01 ihl-mus TCLo: 13000 ppm/6H/19D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-306, 1986 (NTPTR*); L70-N73-Y02 ihl-mus TCLo: 150 ppm/24H/30D-C Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 59, p. 73, 1986 (APTOA6); L70-U01 ihl-mus TCLo: 5000 ppm/24H/7D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 660, 1972 (TXAPA9); L70-N73-Y02 ihl-mus TCLo: 300 ppm/24H/90D-C Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 59, p. 73, 1986 (APTOA6); F15-Q30-Z01 ihl-dog TCLo: 1000 ppm/24H/7W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD746-295 (NTIS**); F08-F19-F25 ihl-dog TCLo: 5000 ppm/6H/12W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555748 (NTIS**); F15-U01-Z01 ihl-mky TCLo: 5000 ppm/24H/32D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD746-295 (NTIS**); L30-Y37 ihl-gpg TCLo: 552 ppm/6H/5D-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 345, 1976 (AIHAAP) TR: ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 43, 1986 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 251, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 43, 1986 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 251, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 251, 1999 (IMEMDT); TOXICOLOGY REVIEW Fortschritte der Arzneimittelforschung. Progress in Drug Research. (Birkhauser Boston, Inc., c/o Springer-Verlag New York, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1959- v. 18, p. 365, 1974 (FAZMAE) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 500 ppm (1750 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 171, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 500 ppm;CL 1000 ppm;Pk 2000 ppm/5M/2H Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): see 56 FR 57036 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 500 ppm (1740 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 500 ppm (1740 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 100 ppm (350 mg/m3), Carcinogen, JAN 1993; OEL-AUSTRIA: MAK 100 ppm (360 mg/m3), Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 50 ppm (174 mg/m3), Carcinogen, JAN 1993; OEL-DENMARK: TWA 35 ppm (122 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 100 ppm (350 mg/m3), STEL 250 ppm (870 mg/m3), JAN 1999; OEL-FRANCE: VME 50 ppm (180 mg/m3), VLE 100 ppm, C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 100 ppm (360 mg/m3), Carcinogen, JAN 1999; OEL-HUNGARY: STEL 10 mg/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 50 ppm (170 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 100 ppm (350 mg/m3), MAC-K 500 ppm (1750 mg/m3), JAN 1999; OEL-NORWAY: TWA 35 ppm (125 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 500 ppm (1740 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 20 mg/m3, STEL 50 mg/m3, JAN 1999; OEL-RUSSIA: TWA 100 ppm, STEL 50 mg/m3, JAN 1993; OEL-SWEDEN: NGV 35 ppm (120 mg/m3), KTV 70 ppm (250 mg/m3), Skin JAN 1999; OEL-SWITZERLAND: MAK-W 100 ppm (360 mg/m3), KZG-W 500 ppm (1800 mg/m3), JAN 1999; OEL-THAILAND: TWA 500 mg/m3, STEL 1000 mg/m3, JAN 1993; OEL-TURKEY: TWA 500 ppm (1740 mg/m3), JAN 1993; OEL-UNITED KINgDOM: TWA 100 ppm (350 mg/m3), STEL 300 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO METHYLENE CHLORIDE-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 47270; NIS 374; TNF 89025; NOS 192; TNE 975696; NOES 1983: HZD 47270; NIS 363; TNF 87086; NOS 212; TNE 1438196; TFE 352536 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/2000/108026); EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Negative: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 46, 1986; NIOSH Analytical Method, 1994: Methylene chloride, 1005; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #80 Record 868 of 1119 in RTECS (through 2003/06) AN: PA9800000 PN: Methane,-nitro- SY: Nitrocarbol-; Nitrometan- (Polish); Nitromethane-; Nitromethane- (ACGIH:OSHA) RN: Current: 75-52-5 UD: 200302 MF: C-H3-N-O2 MW: 61.05 WL: WN1 CC: Tumorigen (C) TE: V01-R60 ihl-rat TCLo: 188 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-461, 1997 (NTPTR*); V01-D29-L60 ihl-mus TCLo: 750 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-461, 1997 (NTPTR*); V01-R60 ihl-rat TCLo: 9656.25 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-205967 (NTIS**); V01-J60-N60 ihl-mus TCLo: 46350 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-205967 (NTIS**); V01-J60-N60 ihl-mus TCLo: 23175 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-205967 (NTIS**) ORNG: 940000000 ng/kg. [940.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 940 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(9), p. 9, 1967 (GISAAA); T/E unlistd ihl-rat LCLo: 12750 mg/m3/1H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516767 (NTIS**); T/E unlistd ipr-rat LDLo: 1500 mg/kg Bulletin de la Societe de Pharmacie de Lille. (Societe de Pharmacie du Lille, 3, rue du Professeur Laguesse, 59045 Lille, Franch) V.1- 1945- v. (1), p. 29, 1973 (BSPLA9); T/E unlistd orl-mus LD50: 950 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(9), p. 9, 1967 (GISAAA); T/E unlistd ihl-mus LCLo: 18 gm/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,93,1982 (85GMAT); T/E unlistd ipr-mus LD50: 110 mg/kg Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967- v. 10(6), p. 53, 1976 (KHFZAN); M04-L02 orl-dog LDLo: 125 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 102, 1955 (AMIHAB); L02-J25 ivn-dog LDLo: 800 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 102, 1955 (AMIHAB); T/E unlistd ihl-mky LCLo: 1000 ppm Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 16, p. 441, 1947 (INMEAF); F07-F19-J26 orl-rbt LDLo: 750 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 22, p. 315, 1940 (JIHTAB); T/E unlistd ihl-rbt LCLo: 5000 ppm/6H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 22, p. 315, 1940 (JIHTAB); T/E unlistd skn-rbt LD :>2 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0516767 (NTIS**); T/E unlistd ivn-rbt LDLo: 750 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 102, 1955 (AMIHAB); T/E unlistd ihl-gpg LCLo: 5000 ppm/3H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 22, p. 315, 1940 (JIHTAB) MD: F40-P28-Y15 orl-rat TDLo: 2275 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(9), p. 9, 1967 (GISAAA); L30-U01-Z01 orl-rat TDLo: 10500 uL/kg/15W-C AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 11, p. 102, 1955 (AMIHAB); U01 ihl-rat TCLo: 100 ppm/7H/2Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530024 (NTIS**); C18-D01 ihl-rat TCLo: 375 ppm/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-461, 1997 (NTPTR*); P05-U01 ihl-rat TCLo: 1500 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-461, 1997 (NTPTR*); F07-J26-L70 ihl-mus TCLo: 1500 ppm/6H/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-461, 1997 (NTPTR*); D01-J30-M70 ihl-mus TCLo: 188 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-461, 1997 (NTPTR*); F40-P28-Y15 orl-rbt TDLo: 2275 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(9), p. 9, 1967 (GISAAA) TR: ACGIH TLV-TWA 20 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 20 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT) SR: MSHA STANDARD-air: TWA 100 ppm (250 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 187, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm (250 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (250 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (250 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (250 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 100 ppm (250 mg/m3), JAN 1999; OEL-DENMARK: TWA 100 ppm (250 mg/m3), JAN 1999; OEL-FINLAND: TWA 100 ppm (250 mg/m3), STEL 150 ppm (375 mg/m3), JAN 1999; OEL-FRANCE: VME 100 ppm (250 mg/m3), JAN 1999; OEL-GERMANY: MAK 100 ppm (250 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 100 ppm (250 mg/m3), JAN 1999; OEL-NORWAY: TWA 50 ppm (125 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (250 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 30 mg/m3, MAC(STEL) 240 mg/m3, JAN 1999; OEL-SWEDEN: NGV 20 ppm (50 mg/m3), KTV 50 ppm (125 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 100 ppm (250 mg/m3), JAN 1999; OEL-TURKEY: TWA 100 ppm (250 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 100 ppm (254 mg/m3), STEL 150 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 50910; NIS 19; TNF 849; NOS 22; TNE 14084; NOES 1983: HZD 50910; NIS 108; TNF 5853; NOS 92; TNE 134803; TFE 46338 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Nitromethane, 2527; NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 869 of 1119 in RTECS (through 2003/06) AN: PB2100000 PN: Methanesulfonic-acid,-ethyl-ester- SY: EMS-; ENT-26396-; Ethylester-kyseliny-methansulfonove- (Czech); Ethyl-ester-of-methanesulfonic-acid-; Ethyl-ester-of-methanesulphonic-acid-; Ethyl-ester-of-methylsulfonic-acid-; Ethyl-ester-of-methylsulphonic-acid-; Ethyl-methanesulfonate-; Ethyl-methanesulphonate-; Ethyl-methansulfonate-; Ethyl-methansulphonate-; Half-myleran-; RCRA-waste-number-U119-; Methanesulphonic-acid-ethyl-ester-; Methylsulfonic-acid,-ethyl-ester-; NSC-26805- RN: Current: 62-50-0 BRN: 773969 BHR: 4-04-00-00012 UD: 200305 MF: C3-H8-O3-S MW: 124.17 WL: WS1&O2 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 10 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 188, p. 197, 1987 (MUREAV); mmo-sat 300 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); oms-sat 2300 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); dnr-sat 12 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 39, p. 285, 1977 (MUREAV); pic-sat 10 umol/plate Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 9, p. 337, 1979 (PPTCBY); mmo-esc 100 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); oms-esc 490 nmol/tube Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 5971, 1982 (PNASA6); mmo-esc 1 ug/L (+S9) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 16, p. 523, 1977 (RCOCB8); dnr-esc 2 mg/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dnd-esc 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 52, p. 161, 1978 (MUREAV); pic-esc 400 mmol/L Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 150, p. 497, 1959 (PRLBA4); mmo-bcs 450 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 93, 1971 (MUREAV); mmo-omi 10 pph (-S9) Biochimie. (SPPIF, B.P.22, F-41353 Vineuil, France) V.53- 1971- v. 56, p. 1471, 1974 (BICMBE); dnr-bcs 2 mg/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dnd-bcs 290 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 9, p. 141, 1970 (MUREAV); pic-bcs 50 mmol/L Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 22, p. 338, 1984 (IJEBA6); mmo-srm 25 mg/L (-S9) Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 30, p. 67, 1972 (ATXKA8); mmo-hmi 160 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 30, p. 9, 1975 (MUREAV); mmo-omi 150 uL (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 128, p. 427, 1982 (JGMIAN); mmo-omi 1 gm/L/4H-C (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 121, p. 349, 1980 (JGMIAN); mmo-omi 150 uL (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 112, p. 356, 1972 (JOBAAY); mmo-omi 50 mmol/L/18H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 19, 1969 (MUREAV); mmo-omi 15 mmol/L/48H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 19, p. 313, 1973 (MUREAV); mmo-omi 3000 ppm/1H (-S9) Journal of Parasitology. (American Soc. of Parasitologists, 1041 New Hamphsire St., Lawrence, KS 60044) V.1- 1914- v. 69, p. 239, 1983 (JOPAA2); mmo-omi 200 mmol/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 17, p. 81, 1972 (FOMIAZ); mmo-omi 250 mmol/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 29, p. 99, 1984 (FOMIAZ); mmo-omi 1 pph (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 160, p. 288, 1984 (JOBAAY); mmo-omi 100 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 162, p. 137, 1986 (MUREAV); dnd-hmi 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 15, 1984 (MUREAV); pic-hmi 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 15, 1984 (MUREAV); mmo-omi 1 mmol/L (-S9) Current Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1979- v. 5, p. 119, 1982 (CUGED5); mmo-omi 20 mmol/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 37, p. 936, 1981 (JOVIAM); mmo-omi 150 uL (-S9) Archives of Microbiology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secacus, NJ 07094) V.95- 1974- v. 103, p. 141, 1975 (AMICCW); mmo-omi 50 mmol/L/18H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 4, p. 409, 1967 (MUREAV); mmo-omi 400 mmol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 141, p. 23, 1975 (MGGEAE); mmo-omi 258 mmol/L (-S9) Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 145, p. 85, 1975 (BIJOAK); mmo-omi 200 mmol/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 14, p. 194, 1969 (FOMIAZ); mmo-omi 1 pph/60M-C (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 16, p. 197, 1971 (FOMIAZ); mmo-omi 190 mmol/L/4H-C (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 33, p. 135, 1975 (MUREAV); mmo-omi 50 nmol/L (-S9) Genetical Research. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1960- v. 29, p. 65, 1977 (GENRA8); mmo-omi 150 mmol/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 15, p. 34, 1970 (FOMIAZ); mmo-omi 10 mmol/L (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 70, p. 1335, 1973 (PNASA6); mmo-omi 200 mmol/L (-S9) Acta Microbiologica Polonica, Series B: Microbiologica Applicata. (Warsaw, Poland) V.1-7, 1969-75. For publisher information, see AMPOAX. v. 6, p. 15, 1974 (AMBBBR); mmo-omi 200 mmol/L (-S9) Acta Microbiologica Polonica, Series B: Microbiologica Applicata. (Warsaw, Poland) V.1-7, 1969-75. For publisher information, see AMPOAX. v. 6, p. 15, 1974 (AMBBBR); dnr-omi 620 ug/plate Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 95, p. 463, 1976 (BIZNAT); mmo-omi 1 mL (-S9) Journal of Medical Microbiology. (Longman Group UK Ltd., Longman House, Burnt Mill, Harlow, Essex CM20 2JE, UK) V.1- 1968- v. 8, p. 265, 1975 (JMMIAV); mmo-omi 1 pph (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 133, p. 345, 1974 (MGGEAE); mmo-omi 4 pph (-S9) Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 9, p. 352, 1964 (JMOBAK); mmo-omi 4 pph (-S9) Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 9, p. 352, 1964 (JMOBAK); mmo-omi 19 gm/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 101, p. 921, 1970 (JOBAAY); dnd-omi 20 mmol Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 174, p. 674, 1969 (BBACAQ); dnd-omi 258 mmol/L Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 145, p. 85, 1975 (BIJOAK); dnd-omi 250 mmol/L Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 35, p. 601, 1968 (VIRLAX); dns-omi 1 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 417, 1981 (CRNGDP); dni-omi 5 mmol/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 150, p. 301, 1977 (MGGEAE); pic-omi 400 mmol/L Nature (London), New Biology. (Basingstoke, Hants., UK) V.229-246, 1971-73. For publisher information, see NATUAS. v. 234, p. 186, 1971 (NNBYA7); mmo-omi 1 gm/L (-S9) Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52: V.21- 1968- v. 31, p. 662, 1978 (JANTAJ); mmo-omi 20 mg/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 135, p. 911, 1978 (JOBAAY); mmo-omi 200 mmol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 179, p. 191, 1980 (MGGEAE); mmo-omi 25 gm/L (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 128, p. 1401, 1982 (JGMIAN); mmo-omi 100 mmol/L (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 128, p. 1529, 1982 (JGMIAN); mrc-omi 2000 ppm/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 51, p. 181, 1978 (MUREAV); pic-omi 400 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 36, p. 265, 1976 (MUREAV); slt-dmg-orl 1 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 9, p. 323, 1970 (MUREAV); mmo-omi 100 mmol/L (-S9) Microbios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 35, p. 39, 1982 (MCBIA7); mmo-omi 45 nmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 178, p. 195, 1987 (MUREAV); dns-dmg-orl 25 mmol/L Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 104, p. 279, 1983 (GENTAE); cyt-dmg-orl 25 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 10, p. 597, 1970 (MUREAV); sln-dmg-orl 500 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 76, 1985 (ENMUDM); sln-dmg-par 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 4, p. 90, 1967 (MUREAV); sln-dmg-unr 20 mmol/L Nature (London), New Biology. (Basingstoke, Hants., UK) V.229-246, 1971-73. For publisher information, see NATUAS. v. 241, p. 15, 1973 (NNBYA7); mmo-nsc 1 pph/330M (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 63, p. 281, 1969 (GENTAE); mmo-smc 6 pph (-S9) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE84-002180 (NTIS**); mmo-smc 8 gm/L/1H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 173, 1977 (MUREAV); dnr-smc 2500 nmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 24, p. 771, 1982 (CNJGA8); mrc-smc 5 pph National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE84-002180 (NTIS**); sln-smc 2 pph/10M EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 31, p. 97, 1979 (EVHPAZ); mmo-asn 100 mmol/L/30M (-S9) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 210, p. 593, 1966 (NATUAS); mmo-ssp 25 mmol/L (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 25, p. 197, 1974 (MUREAV); mmo-clr 270 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 14, p. 381, 1972 (MUREAV); dnr-ssp 2500 nmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 24, p. 771, 1982 (CNJGA8); slt-slw-par 100 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 425, 1969 (MUREAV); slt-oin-skn 25 mmol/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 187, p. 760, 1975 (SCIEAS); dlt-slw-par 500 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 299, 1978 (MUREAV); spm-slw-oth 500 ppm Japanese Journal of Genetics. Idengaku Zasshi. (Genetics Soc. of Japan, 111 Tanida, Mishima, Shizuoka-ken, Japan) V.1- 1921- v. 50, p. 179, 1975 (IDZAAW); cyt-grh-par 100 mmol/L Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 24, p. 460, 1986 (IJEBA6); sce-ofs-emb 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 381, 1979 (MUREAV); mnt-nml-mul 24 ppm/8D-C Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 211, 1986 (MUTAEX); mnt-nml-mul 10 ppm/12D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 164, p. 245, 1986 (MUREAV); mnt-ofs-lym 8 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 104, p. 147, 1982 (MUREAV); slt-oin-oth 100 umol/L Somatic Cell Genetics. (New York, NY) V.1-9, 1975-83. For publisher information, see SCMGDN. v. 4, p. 179, 1978 (SCGTDW); slt-nml-skn 600 ppm/20H-C Nematologica. (E.J. Brill, POB 9000, 2300 PA Leiden, Netherlands) V.1- 1956- v. 19, p. 117, 1973 (NEMAAT); slt-nml-unr 50 mmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 22, p. 295, 1980 (CNJGA8); sln-nml-mul 4 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 110, p. 39, 1983 (MUREAV); dnd-sal-spr 200 mmol/L European Journal of Biochemistry. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1967- v. 31, p. 103, 1972 (EJBCAI); dna-sal-spr 39 umol/6H-C Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 145, p. 73, 1975 (BIJOAK); dnd-ofs-tes 170 mmol/L Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.31- 1951- v. 97, p. 80, 1962 (ABBIA4); dns-ofs-lvr 10 mmol/L Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 14, p. 555, 1985 (AECTCV); dni-oin-skn 1 ug Ciencia e Cultura (Sao Paulo). Science and Culture. (Sociedade Brasileira para o Progresso da Ciencia, Caixa Postal 1 1008, 05420 Sao Paulo, Brazil) V.1- 1949- v. 28, p. 352, 1976 (CCUPAD); sce-ofs-mul 24 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 35, 1982 (MUREAV); sce-ofs-mul 24 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 35, 1982 (MUREAV); sce-ofs-leu 62 mg/L "Water Chlorination: Environmental Impact and Health Effects, Proceedings of the Conferences on the Environment," Jolley, R.L., et al., eds., Ann Arbor, MI, Ann Arbor Science Pub. Inc., 1975- 3,835,1980 (37KXA7); cyt-ofs-skn 8 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 347, 1981 (MUREAV); cyt-oin-skn 1 ug Ciencia e Cultura (Sao Paulo). Science and Culture. (Sociedade Brasileira para o Progresso da Ciencia, Caixa Postal 1 1008, 05420 Sao Paulo, Brazil) V.1- 1949- v. 28, p. 352, 1976 (CCUPAD); cyt-ofs-skn 8 mg/L Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 5, p. 261, 1981 (EESADV); sln-oin-unr 2000 ppm Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 128, p. 117, 1974 (MGGEAE); sln-oin-orl 5 mmol/L Genetical Research. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1960- v. 23, p. 63, 1974 (GENRA8); dlt-oin-orl 5000 ppm Annals of the Entomological Society of America. (Entomological Soc. of America, 4603 Calvert Rd., College Park, MD 20740) V.1- 1908- v. 62, p. 790, 1969 (AESAAI); dlt-oin-skn 5000 ppm Annals of the Entomological Society of America. (Entomological Soc. of America, 4603 Calvert Rd., College Park, MD 20740) V.1- 1908- v. 62, p. 790, 1969 (AESAAI); spm-oin-skn 1 ug Ciencia e Cultura (Sao Paulo). Science and Culture. (Sociedade Brasileira para o Progresso da Ciencia, Caixa Postal 1 1008, 05420 Sao Paulo, Brazil) V.1- 1949- v. 28, p. 352, 1976 (CCUPAD); dlt-oin-par 20 ug Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 63, 1969 (MUREAV); cyt-nml-ipr 248 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 165, 1986 (MUREAV); sce-nml-ipr 124 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 165, 1986 (MUREAV); sce-oin-oth 40 mg/L Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 46, p. 181, 1986 (CYTBAI); dnr-hmn-fbr 20 umol/L "Biology of Radiation Carcinogenesis, Symposium, 1975," Yuhas, J.M., et al., eds., New York, Raven Press, 1976 -,103,1976 (33AQAA); mtr-hmn-oth 10 mg/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 17, p. 719, 1981 (ITCSAF); dnd-hmn-oth 3 mmol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 149, 1992 (TIVIEQ); dna-hmn-hla 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dnd-hmn-fbr 50 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 7, 1982 (CRNGDP); dns-hmn-oth 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 271, p. 201, 1992 (MUREAV); dns-hmn-fbr 1 mmol/L/3H International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 16, p. 284, 1975 (IJCNAW); dns-hmn-hla 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-lng 400 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 177, 1983 (ENMUDM); dns-hmn-oth 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 140, p. 43, 1984 (MUREAV); dni-hmn-hla 10 mmol/L/30M-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(1), p. 65, 1978 (JEPTDQ); dns-hmn-oth 1 mmol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 79, p. 28, 1985 (TXAPA9); oms-hmn-lym 400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 155, p. 75, 1985 (MUREAV); cyt-hmn-fbr 1 umol/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 433, 1981 (EVSRBT); cyt-hmn-lym 250 mg/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 4066, 1975 (PNASA6); sce-hmn-oth 3 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 139, 1991 (EMMUEG); sce-hmn-lym 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 375, 1977 (MUREAV); sce-hmn-fbr 1 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 1387, 1977 (JTEHD6); sce-hmn-lng 60 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 317, 1983 (MUREAV); msc-hmn-lym 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 128, p. 221, 1984 (MUREAV); msc-hmn-fbr 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 22, p. 281, 1974 (MUREAV); msc-hmn-oth 150 mg/L Somatic Cell Genetics. (New York, NY) V.1-9, 1975-83. For publisher information, see SCMGDN. v. 4, p. 531, 1978 (SCGTDW); mnt-rat-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 79, 1978 (MUREAV); dnd-rat-ivn 31 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 175, 1987 (TCMUD8); dnd-rat-ipr 33800 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 283, 1984 (MUREAV); dnd-rat-par 110 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 11, p. 199, 1980 (CALEDQ); dnd-rat-orl 500 mg/kg/2D-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 14, p. 28, 1973 (PAACA3); dnd-rat-lvr 30 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); dns-rat-orl 20 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 553, 1982 (ENMUDM); dns-rat-lvr 200 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 29, p. 303, 1980 (CBINA8); dns-rat-oth 32 mmol/L Shika Kiso Igakkai Zasshi. Journal of the Japanese Association for Basic Dentistry. (Shika Kiso Igakkai, Hanayama Bldg., 1-44-2 Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1959- v. 22, p. 300, 1980 (SHKKAN); dns-rat-oth 1 mmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 481, 1983 (ENMUDM); dns-rat-ipr 50 mg/kg Journal of Cell Biology. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10003) V.12- 1962- v. 92(2, p. Pt 2), 171a,1982 (JCLBA3); dns-rat-spr 1 mmol/L Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- v. 13, p. 101, 1982 (BANRDU); dni-rat-spr 1 gm/L Hereditas (Lund, Sweden). (Gjoerloffsgatan 121, S-261 34 Landskrona, Sweden) V.1- 1947- v. 99, p. 269, 1983 (HEREAY); cyt-rat-orl 300 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 11, p. 566, 1980 (IYKEDH); cyt-rat-ipr 125 mg/kg/48H-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 235, 1988 (EMMUEG); sce-rat-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 107, p. 131, 1983 (MUREAV); dlt-rat-ipr 50 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 497, 1987 (TCMUD8); msc-rat-oth 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 34, p. 481, 1976 (MUREAV); msc-rat-oth 300 mg/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 2967, 1982 (PNASA6); msc-rat-lvr 600 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 107, p. 433, 1983 (MUREAV); trn-rat-ipr 75 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 153, 1983 (ENMUDM); mnt-mus-par 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 164, 1978 (MUREAV); mnt-mus-ivn 800 mg/kg/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 23, p. 239, 1974 (MUREAV); mnt-mus-ipr 200 mg/kg Proceedings of the European Society for the Study of Drug Toxicity. (Princeton, NJ 08540) V.1-15, 1963-74. For publisher information, see PESTD5. v. 15, p. 275, 1974 (PSDTAP); mnt-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 43, p. 441, 1977 (MUREAV); mmo-mus-bmr 300 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 81, p. 215, 1981 (MUREAV); mmo-mus-lym 10 mg/L/4H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); slt-mus-ipr 50 mg/kg Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 138, p. 309, 1975 (MGGEAE); slt-mus-unr 100 mg/kg Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 92, p. S153, 1979 (GENTAE); slt-mus-par 100 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 24, p. 113, 1978 (EVHPAZ); mtr-mus-emb 2 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 21, 1988 (EMMUEG); mtr-mus-fbr 50 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 459, 1984 (CRNGDP); dnd-mus-lym 2500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 155, 1988 (MUREAV); dnd-mus-ipr 150 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17(Suppl 19), p. 19, 1991 (EMMUEG); dnd-mus-unr 240 mg/kg Pure and Applied Chemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1960- v. 42, p. 209, 1975 (PACHAS); dna-mus-ast 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dns-mus-ipr 100 mg/kg Japanese Journal of Genetics. Idengaku Zasshi. (Genetics Soc. of Japan, 111 Tanida, Mishima, Shizuoka-ken, Japan) V.1- 1921- v. 54, p. 405, 1979 (IDZAAW); dns-mus-tes 1 mmol/L/3H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 37, p. 195, 1977 (ARTODN); dns-mus-oth 100 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1197, 1988 (CRNGDP); cyt-mus-ast 250 mg/kg Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 64(Suppl), p. 12, 1970 (GENTAE); dni-mus-ipr 300 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); dni-mus-emb 5 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 682, 1980 (CNREA8); oms-mus-lym 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 299, p. 19, 1993 (MUREAV); cyt-mus-ipr 360 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 30, p. 107, 1974 (TXAPA9); cyt-mus-orl 300 mg/kg Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 76, p. 109, 1974 (GENTAE); cyt-mus-scu 175 mg/kg Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 12, p. 33, 1987 (JTSCDR); cyt-mus-lym 5 mmol/L Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 24, p. 703, 1982 (OYYAA2); sce-mus-ivn 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 60, p. 329, 1979 (MUREAV); sce-mus-lym 5 mmol/L Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 24, p. 703, 1982 (OYYAA2); sce-mus-oth 100 mg/L Journal of Clinical Hematology and Oncology. (Cancer Center at Wadley Institutes, POB 35988, Dallas, TX 75235) V.5(3)- 1975- v. 13, p. 1, 1983 (JCHODP); sce-mus-ipr 90 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 408, 1984 (ENMUDM); sln-mus-ipr 400 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 20, p. 106, 1992 (EMMUEG); dlt-mus-ipr 76 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 288, 1972 (TXAPA9); dlt-mus-orl 300 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 21, 1978 (MUREAV); hma-mus-leu 250 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 501, 1974 (MUREAV); msc-mus-fbr 10 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 3095, 1981 (CNREA8); msc-mus-lym 100 umol/L/30H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 377, 1976 (MUREAV); msc-mus-mmr 500 umol/L/18H-C Cell (Cambridge, Mass.). (MIT Press, 28 Carleton St., Cambridge, MA 02142) V.1- 1974- v. 9, p. 383, 1976 (CELLB5); msc-mus-leu 5 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 3073, 1974 (CNREA8); msc-mus-ovr 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 51, p. 77, 1978 (MUREAV); hma-mus-smc 14 mmol/kg Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 3, p. 99, 1973 (AGACBH); hma-mus-ssp 600 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 25, p. 197, 1974 (MUREAV); spm-mus-ipr 625 mg/kg/5D Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 4425, 1975 (PNASA6); hma-mus-ovr 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 51, p. 77, 1978 (MUREAV); hma-mus-sat 35 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 30, p. 107, 1974 (TXAPA9); trn-mus-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 32, 1973 (MUREAV); msc-mus-lvr 250 mg/L Somatic Cell Genetics. (New York, NY) V.1-9, 1975-83. For publisher information, see SCMGDN. v. 7, p. 373, 1981 (SCGTDW); msc-mus-oth 420 mg/L "Microsomes, Drug Oxidations, and Chemical Carcinogenesis, International Symposium on Microsomes and Drug Oxidations, 4th, 1979," Coon, M.J., et al., eds., New York, Academic Press, Inc., 1980 4,1149,1980 (43VMAC); mnt-ham-lng 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 273, 1984 (MUREAV); slt-ham-ovr 280 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 594, 1981 (PMRSDJ); mtr-ham-emb 400 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 3508, 1977 (CNREA8); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); dnd-ham-lng 1 mmol/L/1H Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 732, 1976 (BBRCA9); dnd-ham-ovr 25 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 361, 1982 (MUREAV); dns-ham-lng 8 mg/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 77, p. 6072, 1980 (PNASA6); dns-ham-emb 10 mmol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); dni-ham-ovr 30 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 400, p. 169, 1998 (MUREAV); dni-ham-lng 4 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 682, 1980 (CNREA8); oms-ham-lng 20 mmol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 717, 1990 (TIVIEQ); cyt-mus-lym 200 mg/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 394, 1989 (MUTAEX); cyt-ham-ovr 200 mg/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 394, 1989 (MUTAEX); cyt-ham-fbr 1 mmol/L Cell Structure and Function. (Japan Soc. for Cell Biology, Nakanishi Printing Co., Shimotachiuri-ogawa, Kamigyo-Ku, Kyoto 602, Japan) V.1- 1975- v. 5, p. 175, 1980 (CSFUDY); cyt-ham-lng 200 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 249, 1979 (MUREAV); sce-ham-orl 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); sce-ham-ovr 10 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 343, 1976 (MUREAV); sce-ham-kdy 300 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 271, p. 662, 1978 (NATUAS); sce-ham-fbr 1 mmol/L Cell Structure and Function. (Japan Soc. for Cell Biology, Nakanishi Printing Co., Shimotachiuri-ogawa, Kamigyo-Ku, Kyoto 602, Japan) V.1- 1975- v. 5, p. 175, 1980 (CSFUDY); sce-ham-ipr 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); sce-ham-lng 1 mmol/L Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 73, p. 912, 1982 (GANNA2); sce-ham-oth 200 umol/L Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 18, p. 210, 1982 (SOGEBZ); msc-ham-ipr 100 mg/kg Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 2, p. 201, 1977 (DTESD7); msc-ham-ovr 100 ug/L/16H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 91, 1977 (MUREAV); msc-ham-lng 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 177, p. 283, 1987 (MUREAV); msc-ham-kdy 300 mg/L Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 77, p. 309, 1974 (GENTAE); msc-ham-fbr 200 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 389, 1982 (CNREA8); spm-ham-ipr 25 mg/kg/5D Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 8, p. 929, 1981 (JTEHD6); dns-dom-kdy 1 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 13, p. 243, 1976 (CBINA8); cyt-ckn-ipr 133 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 96, p. 53, 1982 (MUREAV); mnt-frg-mul 50 ppm Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 12, 1989 (MUTAEX); mnt-dog-lym 2 mmol/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A075-605 (NTIS**); dnd-mam-kdy 100 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); dns-mam-lym 1 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 8, p. 113, 1974 (CBINA8); oms-mam-lym 49 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 46, p. 179, 1983 (CBINA8); sce-rbt-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 333, 1976 (MUREAV); sce-ckn-ipr 50 ug/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 435, 1980 (ENMUDM); sce-frg-mul 300 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 30, 1986 (ENMUDM); dlt-frg-mul 400 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 719, 1984 (ENMUDM); mnt-ham-oth 6 mmol/L/20H (+/-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 843, 2001 (FCTOD7); mnt-ham-oth 12.5 mmol/L/3H (+/-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 843, 2001 (FCTOD7); dnd-ham-oth 5 mmol/L/3H (+/-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 843, 2001 (FCTOD7); mmo-esc 200 ug/plate/20M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 91, 2001 (MUREAV); slt-mus-oth 0.25 mL/L/4H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 41, 2001 (MUREAV); slt-ham-ovr 0.2 gm/L/24H (-S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 22, p. 45, 2001 (JAPTO*); mnt-hmn-lym 120 mg/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 495, p. 1, 2001 (MUREAV); slt-mus-oth 200 mg/L/4H (+/-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 38, p. 69, 2001 (EMMUEG); mrc-dmg-orl 2 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 70, 2001 (EMMUEG); slt-mus-oth 200 mg/L/4H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 201, 2002 (MUTAEX); sce-ham-ovr 100 mg/L/4H (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 13, 2000 (EMMUEG); dnd-dmg-orl 1 mmol/L/12H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 503, p. 11, 2002 (MUTAEX); sce-ham-ovr 100 mL/L/5H (-S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 449, 2001 (JAPTO*); slt-esc 29 gm/L/75M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 508, p. 107, 2002 (MUREAV); slt-hmn-fbr 10 mmol/L/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 513, p. 159, 2002 (MUREAV); slt-dmg 1 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 40, 2000 (EMMUEG); slt-ham-ovr 50 mg/L/9D Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 16, p. 260, 1990 (EMMUEG) RE: T23-T24 orl-rat TDLo: 500 mg/kg (5D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 70, p. 303, 1983 (TXAPA9); T25-T34-T35 orl-rat TDLo: 500 ug/kg (5D male) Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 25, p. 25, 2000 (JTSCDR); T23 ipr-rat TDLo: 300 mg/kg (1D male) "Antifertility Compounds in the Male and Female," Jackson, H., Springfield, IL, Charles C. Thomas, 1966 -,55,1966 (85GUAJ); T46 ipr-rat TDLo: 200 mg/kg (13D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 17, p. 325, 1968 (JRPFA4); T35 ipr-rat TDLo: 200 mg/kg (1D male) Kobe Daigaku Igakubu Kiyo. Journal of the Medical Faculty of Kobe University. (Kobe Daigaku Igakubu, 7-chome, Kusumoto-cho, Chuo-ku, Kobe 650, Japan) V.30- 1968- v. 41, p. 141, 1980 (KDIKAX); T25 ipr-rat TDLo: 50 mg/kg (1D male) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 497, 1987 (TCMUD8); T82-T91 ipr-rat TDLo: 200 mg/kg (15D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 18, p. 15, 1969 (JRPFA4); T39 ivn-rat TDLo: 62 mg/kg (18D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 157, 1989 (TCMUD8); T21-T23-T35 orl-mus TDLo: 1 gm/kg (5D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 21, p. 71, 1977 (EVHPAZ); T23-T72 orl-mus TDLo: 1750 mg/kg (7D male) Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 2(2), p. 209, 1983 (JACTDZ); T82 ipr-mus TDLo: 625 mg/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 70, p. 109, 1980 (MUREAV); T35 ipr-mus TDLo: 200 mg/kg (1D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 5, p. 417, 1968 (MUREAV); T26 ipr-mus TDLo: 200 mg/kg (1D pre) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 171, 1971 (MUREAV); T25-T34-T46 ipr-mus TDLo: 175 mg/kg (11D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 51, p. 1, 1982 (ARTODN); T43 ipr-mus TDLo: 195 mg/kg (11D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 51, p. 1, 1982 (ARTODN); T24 ipr-mus TDLo: 200 mg/kg (1D male) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 11, p. 559, 1980 (IYKEDH); T35 scu-mus TDLo: 350 mg/kg (1D male) Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 4, p. 127, 1979 (JTSCDR); T59 par-mus TDLo: 100 mg/kg (10D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 24, p. 113, 1978 (EVHPAZ); T25 unr-mus TDLo: 1250 mg/kg (5D male) Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 3(2), p. 158, 1984 (JACTDZ); T01-T02 ipr-ham TDLo: 25 mg/kg (5D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 8, p. 929, 1981 (JTEHD6) TE: V01-R60 orl-rat TDLo: 1043 gm/kg/12W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 56, p. 225, 1991 (CALEDQ); V01-M61-R60 ipr-rat TDLo: 300 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 29, p. 50, 1974 (BJCAAI); V03-T65-A60 ivn-rat TDLo: 100 mg/kg (21D preg) Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967-80. For publisher information, see EXPADD. v. 16, p. 157, 1978 (EXPTAX); V03-A60 ivn-rat TDLo: 1650 mg/kg/2W-I "Brain Tumors and Chemical Injuries to the Central Nervous System, Proceedings of the International Neuropathological Symposium, Warsaw, 1976," Mossakowski, M.J., ed., Warsaw, Poland, Panstwowy Zaklad Wydawnictw Lekarskich, 1978 -,15,1978 (43XWAI); V03-J60-R60 par-rat TDLo: 800 mg/kg/3W-I Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 7, p. 25, 1974 (RCOCB8); V02-J60 ipr-mus TDLo: 373 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 3, p. 117, 1971 (CBINA8); V02-M61 ipr-rat TD :825 mg/kg/10D-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 223, p. 947, 1969 (NATUAS); V03-M61 ipr-rat TD :413 mg/kg/10D-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 223, p. 947, 1969 (NATUAS); V01-R60 orl-rat TD :3353 mg/kg/13W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 1223, 1981 (CRNGDP); V03-J60-M61 ipr-mus TD :600 mg/kg/6W-I Annual Report--Cancer Research Campaign. (Cancer Research Campaign, 2 Carlton House Terrace, London SW1Y 5AR, UK) V.1- 1924- v. 39, p. 77, 1961 (BECCAN); V03-A60 ivn-rat TD :1650 mg/kg/30W-I Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967-80. For publisher information, see EXPADD. v. 16, p. 157, 1978 (EXPTAX); V01-R60 orl-rat TD :1050 gm/kg/12W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 7, p. 79, 1979 (CALEDQ) AT: T/E unlistd ipr-rat LD50: 350 mg/kg Chemical and Pharmaceutical Bulletin. (Japan Pub. Trading Co., USA, 1255 Howard St., San Francisco, CA 94103) V.6- 1958- v. 8, p. 807, 1960 (CPBTAL); T/E unlistd orl-mus LD50: 470 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 373, 1989 (MUREAV); T/E unlistd ipr-mus LD50: 435 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 3, p. 117, 1971 (CBINA8); T02 ipr-rat TDLo: 125 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 144, p. 93, 1998 (MUREAV) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 245, 1974 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 245, 1974 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 135, 1971 (ATXKA8) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999 ND: NOES 1983: HZD X6247; NIS 1; TNF 75; NOS 2; TNE 971; TFE 448 SL: EPA GENETOX PROGRAM 1988, Positive: Aspergillus-forward mutation, Aspergillus-reversion; EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: SHE-focus assay, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-nonhuman bone marrow; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, L5178Y cells in vitro-TK test; EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: In vitro human lymphocyte micronucleus, Mouse spot test; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, In vitro SCE-human lymphocytes; EPA GENETOX PROGRAM 1988, Positive: Mouse specific locus, Sperm morphology-mouse F1; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse, D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: UDS in mouse germ cells, V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive: TRP reversion, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-aneuploidy, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Positive: S pombe-forward mutation, S pombe-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Positive/dose response: Rodent heritable translocation; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human, In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive/dose response: In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Negative: N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Inconclusive: Cytogenetics-male germ cell; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 870 of 1119 in RTECS (through 2003/06) AN: PB2625000 PN: Methanesulfonic-acid,-methyl-ester- SY: as-Dimethyl-sulphite-; Methylester-kyseliny-methansulfonove- (Czech); Methyl-ester-of-methanesulfonic-acid-; Methyl-ester-of-methanesulphonic-acid-; Methyl-mesylate-; Methylmethansulfonat- (German); Methyl-methanesulfonate-; Methyl-methanesulphonate-; Methyl-methansulfonate-; Methyl-methansulphonate-; Methanesulphonic-acid-methyl-ester-; MMS-; NSC-50256- RN: Current: 66-27-3 BRN: 1098586 BHR: 4-04-00-00011 UD: 200305 MF: C2-H6-O3-S MW: 110.14 WL: WS1&O1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 1300 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 188, p. 275, 1987 (MUREAV); oms-sat 27 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); pic-sat 5 umol/plate Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 9, p. 337, 1979 (PPTCBY); mmo-esc 1 ug/plate (-S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 56, p. 267, 1985 (ARTODN); oms-esc 19 nmol/tube Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 5971, 1982 (PNASA6); mmo-esc 33300 ng/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); dnr-esc 600 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dnd-esc 2 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 52, p. 161, 1978 (MUREAV); dns-esc 6500 umol/L/30M European Journal of Biochemistry. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1967- v. 56, p. 433, 1975 (EJBCAI); pic-esc 100 mmol/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 145, p. 219, 1976 (MGGEAE); mmo-bcs 100 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 19, 1977 (MUREAV); dnr-bcs 1 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 49, 1981 (MUREAV); oms-bcs 5000 ppm Microbiology Series. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1973- v. 5, p. 131, 1981 (MSERDS); dnd-bcs 23 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); pic-bcs 50 mmol/L Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 22, p. 338, 1984 (IJEBA6); dnd-hmi 31 mmol/L/10M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 289, 1971 (MUREAV); pic-hmi 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 15, 1984 (MUREAV); mmo-omi 4 mg/plate (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 297, 1978 (CBINA8); mmo-omi 47 mmol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 141, p. 23, 1975 (MGGEAE); mmo-omi 2 gm/L (-S9) Zeitschrift fuer Allgemeine Mikrobiologie. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086 Ger. Dem. Rep.) V.1- 1960- v. 16, p. 279, 1976 (ZAPOAK); mmo-omi 10 mmol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 179, p. 191, 1980 (MGGEAE); mmo-omi 1200 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); dnd-omi 2 mmol/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 150, p. 301, 1977 (MGGEAE); dnd-omi 50 mmol/L Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 35, p. 601, 1968 (VIRLAX); dnd-omi 12500 umol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 73, p. 2629, 1976 (PNASA6); dnd-omi 12500 umol/L Cold Spring Harbor Symposia on Quantitative Biology. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1933- v. 33, p. 277, 1968 (CSHSAZ); dni-omi 1 mmol/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 150, p. 301, 1977 (MGGEAE); dni-omi 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 85, p. 275, 1981 (MUREAV); slt-dmg-orl 100 ppm/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 44, p. 145, 1977 (MUREAV); dns-dmg-emb 4500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 112, p. 215, 1983 (MUREAV); cyt-dmg-unr 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); cyt-dmg-par 7500 umol/L Genetical Research. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1960- v. 24, p. 1, 1974 (GENRA8); sln-dmg-par 4500 umol/L Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 68, p. 731, 1958 (ANYAA9); sln-dmg-orl 100 ppm/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 44, p. 145, 1977 (MUREAV); sln-dmg-unr 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); dlt-dmg-unr 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); trn-dmg-unr 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); mmo-nsc 2 mmol/L (-S9) Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 109, 1981 (EVSRBT); mmo-smc 400 ppm/10M (-S9) Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 23, p. 73, 1981 (CNJGA8); mmo-smc 2500 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); dnr-smc 900 nmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 24, p. 771, 1982 (CNJGA8); mrc-smc 1340 umol/L Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 3, p. 99, 1973 (AGACBH); dnd-smc 4000 ppm Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 2, p. 229, 1987 (MUTAEX); sln-smc 13 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 231, 1990 (MUREAV); mmo-asn 1294 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 1, 1981 (MUREAV); mmo-asn 130 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); mrc-asn 260 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); sln-asn 1800 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 138, p. 33, 1984 (MUREAV); mmo-ssp 600 umol/L (-S9) Colloques Internationaux du Centre National de la Recherche Scientifique. (Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1946- v. 256, p. 315, 1977 (COINAV); mmo-clr 13 mmol/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 118, p. 59, 1974 (JOBAAY); mmo-ssp 1 mmol/L (+S9) Colloques Internationaux du Centre National de la Recherche Scientifique. (Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1946- v. 256, p. 315, 1977 (COINAV); dnr-ssp 900 nmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 24, p. 771, 1982 (CNJGA8); mrc-ssp 2500 umol/L Colloques Internationaux du Centre National de la Recherche Scientifique. (Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1946- v. 256, p. 315, 1977 (COINAV); slt-slw-par 100 umol/kg Nippon Sanshigaku Zasshi. Journal of Sericultural Science of Japan. (Nippon Sanshi Gakkai, 1-2 Owashi, Yatabe-machi, Tsukuba-gun, Ibaraki-ken, Japan) V.1- 1930- v. 46, p. 205, 1977 (NISZAQ); dlt-slw-par 100 umol/kg Nippon Sanshigaku Zasshi. Journal of Sericultural Science of Japan. (Nippon Sanshi Gakkai, 1-2 Owashi, Yatabe-machi, Tsukuba-gun, Ibaraki-ken, Japan) V.1- 1930- v. 46, p. 205, 1977 (NISZAQ); dnd-sal-spr 10 mmol/L Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 13, p. 1, 1974 (JOVIAM); dnd-ofs-tes 140 mmol/L Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.31- 1951- v. 97, p. 80, 1962 (ABBIA4); sce-ofs-leu 5500 ug/L "Water Chlorination: Environmental Impact and Health Effects, Proceedings of the Conferences on the Environment," Jolley, R.L., et al., eds., Ann Arbor, MI, Ann Arbor Science Pub. Inc., 1975- 3,835,1980 (37KXA7); sce-nml-skn 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 105, p. 235, 1982 (MUREAV); sce-ofs-emb 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 381, 1979 (MUREAV); sce-oin-oth 3 mg/L Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 46, p. 181, 1986 (CYTBAI); dlt-ofs-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 263, 1978 (MUREAV); dlt-ofs-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 221, 1984 (MUREAV); mnt-hmn-lym 176 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 292, 1995 (EMMUEG); dnd-hmn-oth 100 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 149, 1992 (TIVIEQ); mtr-hmn-oth 100 ug/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 17, p. 719, 1981 (ITCSAF); dnd-hmn-lym 1 mmol/L Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 125, 1982 (JACTDZ); dnd-hmn-oth 2 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 1, p. 89, 1969/1970 (CBINA8); dnd-hmn-hla 1 mmol/L/1H-C Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 353, p. 215, 1974 (BBACAQ); dnd-hmn-oth 100 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 23, p. 31, 1978 (CBINA8); dnd-hmn-fbr 2400 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 267, 1985 (ENMUDM); dns-hmn-oth 1 mmol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 69, p. 557, 1982 (JJIND8); dns-hmn-fbr 100 umol/L/90M International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 16, p. 284, 1975 (IJCNAW); dns-hmn-hla 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-leu 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 14, p. 413, 1972 (MUREAV); dns-hmn-oth 100 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 377, 1991 (TIVIEQ); dni-hmn-hla 500 umol/L/30M-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(1), p. 65, 1978 (JEPTDQ); dni-hmn-fbr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 335, 1982 (CNREA8); dns-hmn-oth 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 122, p. 377, 1983 (MUREAV); dns-hmn-oth 100 umol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 79, p. 28, 1985 (TXAPA9); dns-hmn-lym 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 281, p. 17, 1992 (MUREAV); dns-hmn-oth 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 291, p. 105, 1993 (MUREAV); cyt-hmn-spr 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 326, p. 185, 1995 (MUREAV); cyt-hmn-lym 200 umol/L/24H-C Hereditas (Lund, Sweden). (Gjoerloffsgatan 121, S-261 34 Landskrona, Sweden) V.1- 1947- v. 77, p. 205, 1974 (HEREAY); sce-hmn-emb 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); sce-hmn-lym 100 umol/L/15H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 375, 1977 (MUREAV); sce-hmn-fbr 100 nmol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 1387, 1977 (JTEHD6); sce-hmn-oth 100 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 139, 1991 (EMMUEG); msc-hmn-lym 160 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 1595, 1978 (CNREA8); msc-hmn-fbr 500 mg/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 21, p. 435, 1979 (CNJGA8); dns-mus-par 16300 ug/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 24, p. 117, 1978 (EVHPAZ); mnt-rat-ipr 80 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 1053, 1986 (CRNGDP); dnr-rat-oth 100 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 511, 1991 (TIVIEQ); dnd-rat-oth 1 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 77, p. 25, 1991 (CBINA8); dnd-rat-ivn 28 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 175, 1987 (TCMUD8); dnd-rat-tes 6 mg/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 1(3), p. 181, 1985 (CBTOE2); mtr-rat-lvr 500 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5087, 1983 (CNREA8); dns-rat-oth 100 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 511, 1991 (TIVIEQ); dnd-rat-oth 7 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 44, p. 63, 1983 (CBINA8); dnd-rat-ipr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 283, 1984 (MUREAV); dnd-rat-lvr 4 mmol/L/20M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 25, p. 391, 1974 (MUREAV); dnd-rat-par 40 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 11, p. 199, 1980 (CALEDQ); dnd-rat-orl 20 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 667, 1982 (ENMUDM); dns-rat-orl 10 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 553, 1982 (ENMUDM); dns-rat-lvr 100 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 33, p. 269, 1986 (CALEDQ); dns-rat-oth 320 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 2898, 1980 (CNREA8); dns-rat-oth 100 umol/l Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 481, 1983 (ENMUDM); dns-rat-ipr 10 mg/kg Journal of Cell Biology. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10003) V.12- 1962- v. 92(2, p. Pt 2), 171a,1982 (JCLBA3); dni-rat-ipr 66 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 27, p. 81, 1979 (CBINA8); dns-rat-spr 10 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 273, 1984 (ENMUDM); dns-rat-oth 1 mmol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 106, 1984 (PAACA3); dns-rat-oth 100 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-rat-oth 1 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1453, 1984 (CRNGDP); cyt-rat-lvr 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 64, p. 329, 1979 (MUREAV); cyt-rat-orl 156 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 347, 1981 (FCTXAV); cyt-rat-ipr 63 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 347, 1981 (FCTXAV); cyt-rat-unr 33 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 239, 1983 (MUREAV); msc-rat-lvr 3 mmol/L/30M Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 4, p. 277, 1978 (CALEDQ); hma-rat-smc 2203 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 31, p. 381, 1975 (MUREAV); spm-rat-ipr 50 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 393, 1984 (ENMUDM); spm-rat-orl 100 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 71, 1983 (ARTODN); mnt-mus-oth 2500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 223, 1993 (MUREAV); mnt-mus-orl 40 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 383, 1989 (MUREAV); mnt-mus-ipr 25 mg/kg/24H Proceedings of the European Society for the Study of Drug Toxicity. (Princeton, NJ 08540) V.1-15, 1963-74. For publisher information, see PESTD5. v. 15, p. 275, 1974 (PSDTAP); mnt-mus-unr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); mnt-mus-ihl 2190 mg/m3 Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 40, p. 280, 1985 (NEZAAQ); mmo-mus-lym 1 mg/L/4H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); slt-mus-unr 50 mg/kg Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 92, p. S153, 1979 (GENTAE); slt-mus-ipr 40 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 123, 1980 (ARTODN); slt-mus-par 50 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 24, p. 113, 1978 (EVHPAZ); dnd-mus-oth 1250 nmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 52, p. 311, 1985 (CBINA8); cyt-mus-unr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); dnd-mus-emb 250 nmol/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 148, p. 929, 1984 (AJOGAH); dns-mus-oth 100 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dna-rat-ihl 50 ppm/2H Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 88, 1984 (PAACA3); mtr-mus-emb 21200 ug/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 9, p. 301, 1981 (TOLED5); dnd-mus-lvr 7 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 44, p. 63, 1983 (CBINA8); dnd-mus-oth 7 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 44, p. 63, 1983 (CBINA8); dnd-mus-ipr 300 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 319, 1984 (CRNGDP); dnd-mus-unr 50 mg/kg Pure and Applied Chemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1960- v. 42, p. 209, 1975 (PACHAS); dnd-mus-leu 1 mmol/L/1H-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2780, 1975 (CNREA8); dnd-mus-lym 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 8, p. 629, 1969 (MUREAV); dna-mus-ast 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dns-mus-tes 10 umol/L/3H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 37, p. 195, 1977 (ARTODN); dns-mus-oth 100 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1197, 1988 (CRNGDP); dns-mus-mmr 3 mmol/L/3H-C Nucleic Acids Research. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1974- v. 4, p. 2619, 1977 (NARHAD); dns-mus-spr 50 umol/L/1H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 201, 1981 (MUREAV); dns-mus-ipr 2 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 281, 1987 (ENMUDM); dns-mus-scu 500 umol/l Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 5216, 1982 (CNREA8); dni-mus-ipr 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); dni-mus-emb 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 682, 1980 (CNREA8); dni-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); dni-mus-oth 30 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 11, p. 501, 1975 (CBINA8); dns-mus-lvr 750 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 1, 1983 (ENMUDM); dni-mus-oth 400 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 5, p. 253, 1978 (CALEDQ); dns-mus-leu 2 mmol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 18, p. 21, 1983 (CALEDQ); dns-mus-oth 100 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); cyt-mus-lym 15 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 323, 1988 (MUREAV); cyt-mus-ipr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 160, 1980 (MUREAV); sce-mus-ipr 170 umol/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 219, 1989 (TCMUD8); cyt-mus-ast 120 mg/kg Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 64(Suppl), p. 12, 1970 (GENTAE); sce-mus-unr 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); sce-mus-ipr 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 103, p. 191, 1982 (MUREAV); dns-mus-orl 2 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 281, 1987 (ENMUDM); sln-mus-ipr 80 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 20, p. 106, 1992 (EMMUEG); hma-mus-esc 50 mg/kg Commission of the European Communities, Report EUR. (Office for Official Pub., 5 rue du Commerce, Luxembourg L-2985, Luxembourg) 1967- v. 6388, p. 328, 1980 (CECED9); dlt-mus-orl 10 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 55, p. 411, 1980 (TXAPA9); dlt-mus-ipr 25 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 288, 1972 (TXAPA9); dlt-mus-ivn 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 33, p. 239, 1975 (MUREAV); dlt-mus-unr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); dlt-mus-ims 100 mg/kg Therapie der Gegenwart. (Urban and Schwarzenberg, Postfach 202440, D-8000 Munich 2, Fed. Rep. Ger.) V.36- 1895- v. 115, p. 832, 1976 (THGEAU); msc-mus-unr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); msc-mus-lym 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 291, 1984 (MUREAV); hma-mus-sat 150 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 23, p. 746, 1973 (ARZNAD); hma-mus-smc 2 umol/kg Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 3, p. 99, 1973 (AGACBH); hma-mus-ssp 100 mg/kg Colloques Internationaux du Centre National de la Recherche Scientifique. (Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1946- v. 256, p. 315, 1977 (COINAV); hma-mus-esc 132 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 25, p. 187, 1974 (MUREAV); spm-mus-ivn 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 33, p. 239, 1975 (MUREAV); spm-mus-par 500 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 159, 1980 (ARTODN); spm-mus-unr 100 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 324, 1982 (ENMUDM); trn-mus-ipr 40 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 75, 1977 (MUREAV); trn-mus-unr 40 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); hma-mus-srm 150 umol/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 353, 1981 (EVSRBT); hma-mus-leu 65 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 31, p. 5, 1975 (MUREAV); mnt-ham-unr 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); mnt-ham-lng 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 273, 1984 (MUREAV); mmo-ham-lng 1 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); mmo-ham-ovr 1 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); mnt-ham-emb 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 397, 1988 (MUREAV); mnt-ham-ovr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 517, 1989 (MUREAV); dnr-ham-oth 100 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 511, 1991 (TIVIEQ); mtr-ham-emb 25 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 3508, 1977 (CNREA8); mtr-ham-kdy 10 mg/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 19, p. 55, 1981 (TXCYAC); dnd-ham-lng 100 umol/L/1H Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 732, 1976 (BBRCA9); dnd-ham-ovr 1 mmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 23, p. 17, 1981 (CNJGA8); dna-ham-oth 100 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 2605, 1981 (CNREA8); dns-ham-oth 100 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 511, 1991 (TIVIEQ); dns-ham-lng 3 mmol/L/1H Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 3, p. 49, 1971 (CBINA8); dns-ham-oth 700 umol/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 1142, 1968 (NATUAS); dns-ham-emb 50 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); dns-ham-lvr 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 1, 1984 (ENMUDM); dni-ham-oth 1500 umol/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 1142, 1968 (NATUAS); dns-ham-oth 320 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dni-ham-lng 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 682, 1980 (CNREA8); dns-ham-oth 100 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dni-ham-ovr 600 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 400, p. 169, 1998 (MUREAV); cyt-ham-ovr 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); cyt-mus-lym 4 mg/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 394, 1989 (MUTAEX); cyt-ham-lng 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 128, p. 31, 1984 (MUREAV); sce-ham-ipr 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 169, 1977 (MUREAV); sce-ham-ovr 6500 ug/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 255, 1982 (JTEHD6); sce-ham-unr 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); sce-ham-fbr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 121, 1981 (MUREAV); sce-ham-emb 100 umol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 28, p. 71, 1981 (IJCNAW); msc-ham-orl 6250 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); sce-ham-lng 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 128, p. 31, 1984 (MUREAV); sce-ham-oth 360 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1627, 1985 (CRNGDP); sln-ham-ovr 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 517, 1989 (MUREAV); msc-ham-ovr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 217, 1978 (MUREAV); msc-ham-lng 250 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 169, p. 159, 1986 (MUREAV); msc-ham-kdy 20 mg/L Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 77, p. 309, 1974 (GENTAE); dns-gpg-oth 100 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-gpg-oth 1 mmol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-mky-lvr 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); mnt-dog-lym 200 umol/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A075-605 (NTIS**); dnd-rbt-oth 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 285, p. 303, 1993 (MUREAV); dnd-rbt-oth 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 285, p. 303, 1993 (MUREAV); dns-rbt-lvr 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 145, 1990 (MUREAV); dnd-mam-kdy 100 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); dna-mam-lym 2500 umol/L Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 80, p. 496, 1961 (BIJOAK); dnd-ckn-emb 1 mmol/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 697, p. 278, 1982 (BBACAQ); dns-rbt-oth 5 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 661, 1985 (CRNGDP); dns-rbt-ivn 22500 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 37, 1978 (ARTODN); dns-mam-lym 1 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 8, p. 113, 1974 (CBINA8); dns-mam-kdy 500 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 333, 1980 (JTEHD6); oms-mam-lym 12 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 46, p. 179, 1983 (CBINA8); dns-pig-oth 100 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-pig-oth 10 mmol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-ctl-oth 100 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-ctl-oth 1 mmol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); cyt-ctl-spr 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 326, p. 185, 1995 (MUREAV); sce-rbt-ipr 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 333, 1976 (MUREAV); sce-ckn-par 212 ug/kg "Cytogenetic Assays of Environmental Mutagens," Hsu, T.C., ed., Totowa, NJ, Allanheld, Osmun and Co., 1982 -,137,1982 (47JMAE); dlt-ofs-spr 5 mmol/L Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 25, p. 375, 1987 (IJEBA6); dnd-omi 0.03 pph/20M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 474, p. 93, 2002 (MUREAV); cyt-hmn-lym 0.02 mg/L/24H Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 485, 2001 (FCTOD7); sce-hmn-lym 0.015 mg/L/24H Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 485, 2001 (FCTOD7); mmo-esc 0.03 pph/15M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 480-481, p. 77, 2001 (MUREAV); dna-hmn-fbr 10 mmol/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 484, p. 3, 2001 (MUREAV); dnd-ham-oth 20 mg/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 471, p. 29, 2000 (MUREAV); mmo-esc 150 gm/L/40M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 479, p. 37, 2001 (MUREAV); mmo-sat 25 uL/plate/20M (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 13, 2001 (MUREAV); mmo-esc 10 ug/plate/20M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 91, 2001 (MUREAV); dnd-mus-ipr 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 1, 2001 (MUREAV); dnd-mus-orl 160 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); mnt-hmn-lym 0.067 mg/L/48H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 177, 2001 (MUREAV); mnt-hmn-lym 0.67 mg/L/3H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 177, 2001 (MUREAV); sce-hmn-lym 0.033 mg/L/48H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 177, 2001 (MUREAV); sce-hmn-lym 0.17 mg/L/3H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 177, 2001 (MUREAV); cyt-hmn-lym 0.1 nmol/L/72H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 13, 2001 (MUREAV); sce-hmn-lym 0.1 nmol/L/48H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 13, 2001 (MUREAV); mmo-sat 0.4 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 490, p. 89, 2001 (MUREAV); cyt-ham-fbr 0.04 mg/L/3H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 29, 2001 (MUREAV); spm-mus-ipr 500 mg/kg/5D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 131, 2001 (MUREAV); mnt-ham-fbr 400 umol/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 139, 2001 (MUREAV); cyt-hmn-oth 1.3 mmol/L/1H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 121, 2001 (MUTAEX); dnd-hmn-oth 0.4 mmol/L/1H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 121, 2001 (MUTAEX); slt-mus-oth 5 mg/L/4H (+/-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 38, p. 69, 2001 (EMMUEG); mnt-mus-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 516, p. 23, 2002 (MUREAV); mnt-hmn-lym 195 umol/L/72H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 516, p. 23, 2002 (MUREAV); slt-mus-oth 5 mg/L/4H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 201, 2002 (MUTAEX); cyt-mus-fbr 1 mmol/L/1H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 233, 2001 (MUTAEX); mrc-dmg-orl 12 mmol/L/2H Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 195, 2000 (EMMUEG); mrc-dmg-orl 0.05 mmol/L/48H Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 195, 2000 (EMMUEG); dnd-dmg-orl 0.5 mmol/L/12H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 503, p. 11, 2002 (MUTAEX); cyt-hmn-spr 100 mg/L/120M (-S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 504, p. 183, 2002 (MUTAEX); dnd-mus-oth 100 mg/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 161, 2002 (MUREAV); sce-ham-ovr 5 mg/L/26H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 161, 2002 (MUREAV); mnt-mus-ipr 100 mg/kg/5D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 171, 2002 (MUREAV); slt-ham-oth 100 umol/L/24H Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 114, 2000 (EMMUEG); slt-ham-ovr 5 mg/L/9D Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 16, p. 260, 1990 (EMMUEG) RE: T01 orl-rat TDLo: 100 mg/kg (1D male) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 26(3), p. 14A, 1982 (TJADAB); T23 orl-rat TDLo: 50 mg/kg (1D male) "Agents Affecting Fertility, a Symposium, 1964," Austin, C.R., and J.S. Perry, eds., Boston, Little, Brown and Co., 1965 -,62,1965 (15QWAW); T82-T91 ipr-rat TDLo: 100 mg/kg (15D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 18, p. 15, 1969 (JRPFA4); T43-T46 ipr-rat TDLo: 100 mg/kg (13D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 17, p. 325, 1968 (JRPFA4); T23 ipr-rat TDLo: 50 mg/kg (1D male) Biochemical Society Transactions. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1973- v. 1, p. 523, 1973 (BCSTB5); T01 ipr-rat TDLo: 100 mg/kg (1D male) Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 33, p. 78, 1964 (ECREAL); T01-T02 ipr-rat TDLo: 100 mg/kg (1D male) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 26(3), p. 14A, 1982 (TJADAB); T35 orl-mus TDLo: 20 mg/kg (1D male) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 24, p. 711, 1982 (OYYAA2); T11 ipr-mus TDLo: 80 mg/kg (1D pre) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 67, p. 370, 1983 (TXAPA9); T22-T75 ipr-mus TDLo: 50 mg/kg (1D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 157, p. 205, 1985 (MUREAV); T25 ipr-mus TDLo: 25 mg/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 288, 1972 (TXAPA9); T35-T43 ipr-mus TDLo: 50 mg/kg (12D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 5, p. 713, 1973 (RCOCB8); T01-T33 ipr-mus TDLo: 20 mg/kg (1D male) Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 31, p. 145, 1981 (CGCGBR); T91 ipr-mus TDLo: 50 mg/kg (1D male) British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 23, p. 521, 1964 (BJPCAL); T35 ims-mus TDLo: 100 mg/kg (1D pre) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 29, p. 209, 1975 (MUREAV); T59 par-mus TDLo: 100 mg/kg (10D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 24, p. 113, 1978 (EVHPAZ); T01 ipr-ham TDLo: 75 mg/kg (5D male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. CONF-771017 (NTIS**); T02 ipr-ham TDLo: 250 mg/kg (5D male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. CONF-771017 (NTIS**); T33 ipr-ham TDLo: 20 mg/kg (17D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 22, 1980 (ATSUDG) TE: V03-D45-K60 orl-rat TDLo: 420 mg/kg/2W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1529, 1985 (CRNGDP); V01-D07 ihl-rat TCLo: 50 ppm/6H/6W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 33, p. 175, 1986 (CALEDQ); V03-A60-B60 ipr-rat TDLo: 72 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 223, p. 947, 1969 (NATUAS); V03-M61-V10 scu-rat TDLo: 184 mg/kg/46W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); V03-T65-C60 ivn-rat TDLo: 30 mg/kg (21D preg) "Brain Tumors and Chemical Injuries to the Central Nervous System, Proceedings of the International Neuropathological Symposium, Warsaw, 1976," Mossakowski, M.J., ed., Warsaw, Poland, Panstwowy Zaklad Wydawnictw Lekarskich, 1978 -,15,1978 (43XWAI); V03-A60 ivn-rat TDLo: 96 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 163, p. 717, 1969 (ANYAA9); V03-T65-A60 ivn-rat TDLo: 20 mg/kg (15D preg) European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 8, p. 641, 1972 (EJCAAH); V01-T65-A60 unr-rat TDLo: 20 mg/kg (15D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 143, 1973 (IARCCD); V02-J60 orl-mus TDLo: 300 mg/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 19, 1986 (TXAPA9); V03-R60-V10 skn-mus TDLo: 11280 mg/kg/64W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3402, 1987 (CNREA8); V01-R60-V10 scu-mus TDLo: 5640 mg/kg/64W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3402, 1987 (CNREA8); V03-M60 unr-rat TD :75 mg/kg/10W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 50, p. 63, 1984 (BJCAAI); V02-J60-P62 orl-mus TD :14 gm/kg/78W-C Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 161, p. 913, 1968 (SCIEAS); V01-D09 ihl-rat TC :50 ppm/6H/30D-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 79, p. 285, 1987 (JJIND8); V03-T65-A60 ivn-rat TD :30 mg/kg (21D preg) Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967-80. For publisher information, see EXPADD. v. 16, p. 157, 1978 (EXPTAX); V03-A60 ivn-rat TD :850 mg/kg/30W-I Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967-80. For publisher information, see EXPADD. v. 16, p. 157, 1978 (EXPTAX) ORNG: 225000000 ng/kg. [225.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 225 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 347, 1981 (FCTXAV); T/E unlistd ipr-rat LD50: 114 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 665, 1984 (FCTOD7); T/E unlistd scu-rat LD50: 125 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); T/E unlistd ivn-rat LD50: 175 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); T/E unlistd orl-mus LD50: 290 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 383, 1989 (MUREAV); T/E unlistd ipr-mus LD50: 180 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 383, 1989 (MUREAV); P14-P30 ivn-dog LDLo: 22 mg/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 203, 1965 (CCSUBJ); T/E unlistd orl-qal LD50: 75 mg/kg Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 48, p. 371, 1976 (JRPFA4); T/E unlistd orl-bwd LD50: 56200 ug/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 253, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1059, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 253, 1974 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1059, 1999 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1059, 1999 (IMEMDT); TOXICOLOGY REVIEW Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 135, 1971 (ATXKA8) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Aspergillus-reversion, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: SHE-focus assay, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Positive: Cytogenetics-male germ cell; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, Rodent heritable translocation; EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: In vitro human lymphocyte micronucleus, Mouse spot test; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: In vitro SCE-human lymphocytes, Mouse specific locus; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse, D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS in rat liver, UDS in mouse germ cells; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion, S pombe-forward mutation; EPA GENETOX PROGRAM 1988, Positive: S pombe-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: In vivo cytogenetics-mammalian oocyte; EPA GENETOX PROGRAM 1988, Positive/dose response: Rodent dominant lethal, In vitro SCE-human; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman, In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro UDS-human fibroblast, TRP reversion; EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-mouse F1, Sperm morphology-rabbit; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 871 of 1119 in RTECS (through 2003/06) AN: PB4025000 PN: Methane,-tetranitro- SY: NCI-C55947-; RCRA-waste-number-P112-; TNM-; Tetan-; Tetranitromethane-; Tetranitromethane- (ACGIH:OSHA) RN: Current: 509-14-8 UD: 200302 MF: C-N4-O8 MW: 196.05 WL: WNXNWNWNW CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 2 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9(Suppl 9), p. 1, 1987 (ENMUDM); mmo-esc 500 ug/plate (+S9) Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 29, p. 34, 1987 (SAIGBL); dnd-rat-lvr 70 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); cyt-ham-ovr 20 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-386, 1990 (NTPTR*); sce-ham-ovr 1700 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-386, 1990 (NTPTR*) TE: V01-J60-J61 ihl-rat TCLo: 2 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-386, 1990 (NTPTR*); V01-J60-J61 ihl-mus TCLo: 500 ppb/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-386, 1990 (NTPTR*); V01-J61 ihl-rat TC :2 ppm/6H/2Y-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 57, p. 95, 1991 (CALEDQ); V01-J61 ihl-mus TC :500 ppb/6H/2Y-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 57, p. 95, 1991 (CALEDQ); V01-J60 ihl-rat TCLo: 61.8 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-113373 (NTIS**); V01-J60 ihl-rat TCLo: 51.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-113373 (NTIS**); V01-J60 ihl-mus TCLo: 30.9 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-113373 (NTIS**) ORNG: 130000000 ng/kg. [130.000000 mg/kg] D07-D35-F07 IHPB: 18000 ppb/4H. [18.000000 ppm/4H] P24 AT: D07-D35-F07 orl-rat LD50: 130 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A051-334 (NTIS**); P24 ihl-rat LC50: 18 ppm/4H Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) TR-77-25, 1977 (AMRL**); P24 ivn-rat LD50: 12600 ug/kg Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) TR-77-25, 1977 (AMRL**); D07-D35-F07 orl-mus LD50: 375 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A051-334 (NTIS**); P24 ihl-mus LC50: 54 ppm/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A051-334 (NTIS**); T/E unlistd ipr-mus LD50: 53 mg/kg Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967- v. 10(6), p. 53, 1976 (KHFZAN); P24 ivn-mus LD50: 63100 ug/kg Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) TR-77-25, 1977 (AMRL**); T/E unlistd ihl-cat LC50: 100 ppm/20M "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,403,1986 (85JCAE); P24 ipr-mam LDLo: 500 mg/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 171, p. 1396, 1920 (COREAF) MD: D07-J12-Z01 ihl-rat TCLo: 6350 ppb/6H/26W-I AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 213, 1954 (AMIHBC); Z01 ihl-rat TCLo: 25 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-386, 1990 (NTPTR*); J30-L70-U01 ihl-rat TCLo: 10 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-386, 1990 (NTPTR*); Z01 ihl-mus TCLo: 25 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-386, 1990 (NTPTR*); D07-J30-L70 ihl-mus TCLo: 10 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-386, 1990 (NTPTR*) TR: ACGIH TLV-TWA 0.005 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.005 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 437, 1996 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 437, 1996 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 437, 1996 (IMEMDT) SR: MSHA STANDARD-air: TWA 1 ppm (8 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 254, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 ppm (8 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 ppm (8 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 ppm (8 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 ppm (8 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 1 ppm (8 mg/m3), JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 1 ppm (8 mg/m3), JAN 1993; OEL-DENMARK: TWA 1 ppm (8 mg/m3), JAN 1999; OEL-FINLAND: TWA 1 ppm (8 mg/m3), STEL 3 ppm (24 mg/m3), JAN 1999; OEL-FRANCE: VME 1 ppm (8 mg/m3), JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.005 ppm (0.04 mg/m3), JAN 1999; OEL-NORWAY: TWA 1 ppm (8 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1 ppm (8 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 0.04 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.3 mg/m3, JAN 1993; OEL-SWEDEN: NGV 0.05 ppm (0.4 mg/,3), KTV 0.2 ppm (0.8 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 1 ppm (8 mg/m3), Carcinogen, JAN 1999; OEL-TURKEY: TWA 1 ppm (8 mg/m3), JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO TETRANITROMETHANE-air: 10H TWA 1 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X7237; NIS 1; TNF 7; NOS 1; TNE 1445; TFE 230 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Tetranitromethane, 3513; NCI Carcinogenesis Studies (inhal), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 872 of 1119 in RTECS (through 2003/06) AN: PB5600000 PN: Methane,-tribromo- SY: Bromoform-; Bromoform- (ACGIH:OSHA); Bromoforme- (French); Bromoformio- (Italian); Methenyl-tribromide-; Methyl-tribromide-; NCI-C55130-; RCRA-waste-number-U225-; Tribrommethaan- (Dutch); Tribrommethan- (German); Tribromometan- (Italian); Tribromomethane- RN: Current: 75-25-2 BRN: 1731048 BHR: 4-01-00-00082 UD: 200305 MF: C-H-Br3 MW: 252.75 WL: EYEE CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P); Reproductive-Effector (T) ME: mmo-sat 666 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-sat 100 ug/plate (-S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); slt-dmg-orl 3000 ppm National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); sln-dmg-orl 3000 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 677, 1985 (ENMUDM); mnt-nml-mul 5 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 83, 1993 (MUREAV); sce-hmn-lym 80 umol/L Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 72, 1983 (ENVRAL); cyt-rat-ipr 25300 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 111, 1990 (MUREAV); cyt-rat-orl 1265 mg/kg/5D-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 111, 1990 (MUREAV); sce-rat-leu 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 241, 1993 (MUREAV); mnt-mus-itr 800 mg/kg/48H-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); sce-mus-orl 100 mg/kg/4D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 72, 1983 (ENVRAL); sce-mus-itr 800 gm/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); msc-mus-lym 200 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); cyt-ham-ovr 110 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 1, 1985 (ENMUDM); sce-ham-ovr 290 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 1, 1985 (ENMUDM); mtr-mus-fbr 0.05 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T17 orl-mus TDLo: 5.6 gm/kg (7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89169254 (NTIS**); T75-T81 orl-mus TDLo: 47 gm/kg (15W male/15W pre-4D post) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89169254 (NTIS**); T51-T53 orl-mus TDLo: 200 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89169254 (NTIS**); T81 orl-mus TDLo: 200 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89169254 (NTIS**) TE: V01-K60 orl-rat TDLo: 10400 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); V02-J60 ipr-mus TDLo: 1100 mg/kg/8W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2717, 1977 (CNREA8); V03-K60 orl-rat TDLo: 103000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-110149/AS (NTIS**); V01-K60 orl-rat TDLo: 103000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-110149/AS (NTIS**) ORNG: 933000000 ng/kg. [933.000000 mg/kg] J22 AT: T/E unlistd orl-hmn LDLo: 143 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,141,1969 (34ZIAG); J22 orl-rat LD50: 933 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); T/E unlistd ihl-rat LCLo: 45 gm/m3/4H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,28,1982 (85GMAT); D17-F07-F25 ipr-rat LD50: 414 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 15, p. 251, 1983 (TOLED5); J22 orl-mus LD50: 1072 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); T/E unlistd ipr-mus LD50: 1274 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 20(12), p. 52, 1976 (GTPZAB); T/E unlistd scu-mus LD50: 1820 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 354, 1962 (TXAPA9); T/E unlistd scu-rbt LDLo: 410 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 28, p. 201, 1891 (AEXPBL); T/E unlistd ihl-mam LC50: 12100 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(4), p. 55, 1974 (GTPZAB) MD: L30-L70-P28 orl-rat TDLo: 6230 mg/kg/4W-C Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 17, p. 119, 1992 (JTSCDR); L30 orl-rat TDLo: 13 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); Z01 orl-rat TDLo: 5600 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); M16 orl-rat TDLo: 5840 mg/kg/1Y-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 14, p. 281, 1994 (TOXID9); L70-N73-U01 orl-mus TDLo: 3500 mg/kg/14D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 46, p. 117, 1982 (EVHPAZ); Z01 orl-mus TDLo: 6500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-350, 1989 (NTPTR*); M02-M03-P28 orl-mus TDLo: 296 mg/kg/14D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 581, 1990 (VCVGH*); F16 orl-mus TDLo: 21000 mg/kg/15W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89169254 (NTIS**) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 213, 1991 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1309, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 52, p. 213, 1991 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1309, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1309, 1999 (IMEMDT) SR: MSHA STANDARD-air: TWA 0.5 ppm (5 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 28, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.5 ppm (5 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.5 ppm (5 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.5 ppm (5 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.5 ppm (5 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.5 ppm (5 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 0.5 ppm (5 mg/m3), JAN 1999; OEL-BELGIUM: TWA 0.5 ppm (5.2 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 0.5 ppm (5 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 0.5 ppm (5 mg/m3), STEL 1.5 ppm (15 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 0.5 ppm (5 mg/m3), Skin, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC -TGG 0.5 ppm (5 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 0.5 ppm (5 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 0.5 ppm (5 mg/m3), Skin, JAN 1993; OEL-POLAND: TWA 5 mg/m3, JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 1000 ppm (5600 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 0.5 ppm (5.3 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BROMOFORM-air: 10H TWA 0.5 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 13160; NIS 3; TNF 43; NOS 3; TNE 242; NOES 1983: HZD 13160; NIS 1; TNF 14; NOS 2; TNE 1473; TFE 230 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/91/180323/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 873 of 1119 in RTECS (through 2003/06) AN: PC8225000 PN: 1,3,4-Metheno-1H-cyclobuta(cd)pentalene, 1,1a,2,2,3,3a,4,5,5,5a,5b,6-dodecachlorooctahydro- SY: 1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachlorooctahydro-1,3,4-metheno-1H-cyclobta(cd)pentalene; 1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachlorooctahydro-1,3,4-metheno-1H-cyclobuta(cd)pentalene; 1,2,3,4,5,5-Hexachloro-1,3-cyclopentadiene-dimer-; 1,3,4-Metheno-1H-cyclobuta(cd)pentalene, dodecachlorooctahydro-; Bichlorendo-; CG-1283-; Cyclopentadiene,-hexachloro-,-dimer-; Decane,perchloropentacyclo-; Dechlorane-; Dechlorane-4070-; Dechloranereg-; Dodecachlorooctahydro-1,3,4-metheno-2H-cyclobuta(c,d)pentalene; Dodecachloropentacyclo(3.2.2.0(sup 2,6),0(sup 3,9),0(sup 5,10))decane; Dodecachloropentacyclodecane-; ENT-25,719-; Ferriamicide-; Ferriamicidereg-; GC-1283-; HRS-l276-; Hexachlorocyclopentadiene-dimer-; Hexachloropentadiene-dimer-; Mirex-; NCI-C06428-; Perchlorodihomocubane-; Perchloropentacyclo(5.2.1.0(sup 2,6).0(sup 3,9).0(sup 5,8))decane; Perchloropentacyclodecane- RN: Current: 2385-85-5 UD: 200305 MF: C10-Cl12 MW: 545.50 WL: L545 B4 C5 D 4ABCE JTJ-/G 1 2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: oms-rat-orl 100 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 23, p. 127, 1984 (TOLED5); oms-mus-orl 60 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV) RE: T12-T13-T34 orl-rat TDLo: 50 mg/kg (5-9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 401, 1983 (TJADAB); T71-T76 orl-rat TDLo: 23750 ug/kg (4-22D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 263, 1979 (TOLED5); T26-T55-T46 orl-rat TDLo: 60 mg/kg (6-15D preg) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 25, 1976 (FCTXAV); T25-T47-T59 orl-rat TDLo: 56 mg/kg (8-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 22, p. 167, 1980 (TJADAB); T48-T55 orl-rat TDLo: 48 mg/kg (8-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 40A, 1980 (TJADAB); T23 orl-rat TDLo: 60 mg/kg (10D male) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 25, 1976 (FCTXAV); T42 orl-rat TDLo: 18750 ug/kg (1-15D post) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 263, 1979 (TOLED5); T81 orl-rat TDLo: 10 mg/kg (1-8D post) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 263, 1979 (TOLED5); T13 scu-rat TDLo: 10 mg/kg (2D pre) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 16, p. 131, 1978 (ENVRAL); T29 scu-rat TDLo: 2 mg/kg (1D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 148, p. 414, 1975 (PSEBAA); T47-T49-T76 unr-rat TDLo: 8 mg/kg (8-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 26(3), p. 17A, 1982 (TJADAB); T71-T75 unr-rat TDLo: 48 mg/kg (8-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 26(3), p. 17A, 1982 (TJADAB); T81-T85 orl-mus TDLo: 22 mg/kg (1-21D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 37, p. 938, 1978 (FEPRA7); T29 orl-mus TDLo: 58 mg/kg (4W male/4W pre-2W post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 54, 1967 (TXAPA9); T72-T75-T81 orl-mus TDLo: 37500 ug/kg (8-12D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 541, 1982 (JTEHD6); T72-T75 orl-mus TDLo: 1775 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 7, 1987 (TCMUD8); T42-T47-T49 unr-mam TDLo: 7 mg/kg (15-21D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 44A, 1982 (TJADAB); T71-T75 unr-mam TDLo: 7 mg/kg (15-21D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 44A, 1982 (TJADAB); T42-T51-T52 orl-rat TDLo: 68 mg/kg (15W male/15W pre-21D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 549, 1981 (TXAPA9); T21-T26 orl-rat TDLo: 68 mg/kg (15W male/15W pre-21D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 549, 1981 (TXAPA9); T76 orl-rat TDLo: 546 mg/kg (15W male/15W pre-21D post Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 549, 1981 (TXAPA9); T26-T29 orl-mus TDLo: 388.7 mg/kg (91D male/91D pre) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 21, p. 397, 1979 (BECTA6); T26-T29 orl-mus TDLo: 157.7 mg/kg (1Y male/1Y pre) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 21, p. 397, 1979 (BECTA6) TE: V02-L60 orl-rat TDLo: 1635 mg/kg/78W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 58, p. 133, 1977 (JNCIAM); V01-L60 orl-mus TDLo: 2222 mg/kg/58W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 1101, 1969 (JNCIAM); V03-L60 orl-rat TD :2340 mg/kg/56W-C Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 38, p. 271, 1983 (EXMPA6); V01-L60 orl-rat TD :2184 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-313, 1990 (NTPTR*); V01-L60 orl-rat TDLo: 546 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-241084 (NTIS**); V02-N61 orl-rat TDLo: 1419.6 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-241084 (NTIS**); V01-L60-P61 orl-rat TDLo: 2839.2 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-241084 (NTIS**) ORNG: 235000000 ng/kg. [235.000000 mg/kg] T/E unlistd SRNG: 800000000 ng/kg. [800.000000 mg/kg] F07-K12 AT: T/E unlistd orl-rat LD50: 235 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 14, 1978 (SPEADM); T/E unlistd skn-rat LD50: >2 gm/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 515, 1969 (TXAPA9); F07-K12 skn-rbt LD50: 800 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535785 (NTIS**); T/E unlistd orl-ham LD50: 125 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A192, 1979 (TXAPA9); T/E unlistd orl-dck LD50: 2400 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 14, p. 212, 1977 (ENVRAL); T/E unlistd ihl-brd LC50: 1400 ppm Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 14, p. 212, 1977 (ENVRAL) MD: L70-N05-Y07 orl-rat TDLo: 84 mg/kg/28D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 58, p. 105, 1981 (TXAPA9); L70-U01-Z01 orl-rat TDLo: 6989 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 271, 1979 (TXAPA9); L30 orl-rat TDLo: 207 mg/kg/24W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 631, 1969 (TXAPA9); L70-Y37-Y40 orl-rat TDLo: 16800 ug/kg/7D-C Pesticide Biochemistry and Physiology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1971- v. 38, p. 273, 1990 (PCBPBS); L70-Y07-Y40 orl-rat TDLo: 84 mg/kg/2W-I Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 4, p. 469, 1976 (AECTCV); F07-K12-Z01 orl-rat TDLo: 562 mg/kg/18D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535785 (NTIS**); L70-Y07 ipr-rat TDLo: 200 mg/kg/4D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 15, p. 219, 1983 (TOLED5); L70-Z01 orl-mus TDLo: 294 mg/kg/70W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 33, p. 70, 1975 (TXAPA9); L70-U01-Y07 orl-mus TDLo: 40 mg/kg/4D-I Environmental Toxicology and Chemistry. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1982- v. 2, p. 49, 1983 (ETOCDK); L30-L70-Y03 orl-mus TDLo: 328 mg/kg/26W-C Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 1, p. 327, 1977 (EESADV); N73-P72-U01 orl-dog TDLo: 227 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 49, p. 271, 1979 (TXAPA9); L70 orl-rbt TDLo: 33600 ug/kg/8W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 19, p. 223, 1978 (BECTA6); L02-L03-L30 orl-ckn TDLo: 63 mg/kg/2W-I Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 4, p. 469, 1976 (AECTCV); L30-N30-Y07 orl-rat TDLo: 36.7 mg/kg/21W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 549, 1981 (TXAPA9); Z01 orl-rat TDLo: 147 mg/kg/21W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 549, 1981 (TXAPA9); F11-L70-U01 orl-rat TDLo: 294 mg/kg/21W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 549, 1981 (TXAPA9); F07-F11-F33 orl-rat TDLo: 252 mg/kg/15W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 549, 1981 (TXAPA9); Z01 orl-mus TDLo: 128.16 mg/kg/60D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 21, p. 397, 1979 (BECTA6); T03 orl-rat TDLo: 12.6 mg/kg/1W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 37, p. 501, 1978 (FEPRA7); N02 orl-rat TDLo: 105 mg/kg/10W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 37, p. 501, 1978 (FEPRA7) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 283, 1979 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 283, 1979 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,250,1970 (85CVA2); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 13, p. 231, 1978 (CTOXAO) ND: NOHS 1974: HZD M1939; NIS 3; TNF 33; NOS 9; TNE 929 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264354); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 874 of 1119 in RTECS (through 2003/06) AN: PC8575000 PN: 1,3,4-Metheno-2H-cyclobuta(cd)pentalen-2-one, 1,1a,3,3a,4,5,5,5a,5b,6-decachloroctahydro- SY: Chlordecone-; Ciba-8514-; Clordecone-; Compound-1189-; 1,2,3,5,6,7,8,9,10,10-Decachloro(5.2.1.0(sup 2,6).0(sup 3,9).0(sup 5,8))decano-4-one; Decachloroketone-; Decachloro-1,3,4-metheno-2H-cyclobuta(cd)pentalen-2-one; Decachlorooctahydro-1,3,4-metheno-2H-cyclobuta(cd)pentalen-2-one; 1,1a,3,3a,4,5,5,5a,5b,6-Decachlorooctahydro-1,3,4-metheno-2H-cyclobuta(cd)pentalen-2-one; Decachloropentacyclo(5.2.1.0(sup 2,6).0(sup 3,9).0(sup 5,8))decan-4-one; Decachloropentacyclo(5.3.0.0(sup 2,6).0(sup 4,10).0(sup 5,9))decan-3-one; Decachlorotetracyclodecanone-; Decachlorotetrahydro-4,7-methanoindeneone-; ENT-16,391-; GC-1189-; General-chemicals-1189-; Kepone-; NCI-C00191-; RCRA-waste-number-U142- RN: Current: 143-50-0 UD: 200305 MF: C10-Cl10-O MW: 490.60 WL: L545 BH C5 D 4ABCE J DVTJ AG BG CG EG FG GG HG HG IG JG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: oms-rat-lvr 100 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 179, 1990 (TIVIEQ); sce-ham-ovr 1700 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); spm-qal-orl 200 ppm/42D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 43, p. 535, 1978 (TXAPA9) RE: T83 orl-rat TDLo: 63 mg/kg (2-22D preg/21D post) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 247, 1979 (TOLED5); T87 orl-rat TDLo: 42 mg/kg (2-22D preg/21D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 142, 1977 (TXAPA9); T41-T53-T55 orl-rat TDLo: 100 mg/kg (7-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 38, p. 189, 1976 (TXAPA9); T34-T46 orl-rat TDLo: 60 mg/kg (7-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 38, p. 189, 1976 (TXAPA9); T85 orl-rat TDLo: 17 mg/kg (1-22D preg/12D post) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 40, p. 667, 1981 (FEPRA7); T24-T26 orl-rat TDLo: 18 mg/kg (5D male) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 30, p. 237, 1986 (TOLED5); T19 ipr-rat TDLo: 25 mg/kg (1D pre) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 65, 1991 (REPTED); T14-T21-T22 ipr-rat TDLo: 50 mg/kg (1D pre) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 8, p. 121, 1986 (NTOTDY); T24 ipr-rat TDLo: 50 mg/kg (1D pre) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 1, p. 105, 1987/1988 (REPTED); T13 ipr-rat TDLo: 75 mg/kg (1D pre) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 65, 1991 (REPTED); T13 scu-rat TDLo: 2 mg/kg (2D pre) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 16, p. 131, 1978 (ENVRAL); T12 scu-rat TDLo: 10 mg/kg (2D pre) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 16, p. 131, 1978 (ENVRAL); T29 orl-mus TDLo: 16500 ug/kg (4W male/4W pre) Journal of Economic Entomology. (Entomological Soc. of America, 4603 Calvert Rd., College Park, MD 20740) V.1- 1908- v. 58, p. 754, 1965 (JEENAI); T35-T46 orl-mus TDLo: 120 mg/kg (7-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 38, p. 189, 1976 (TXAPA9); T72-T81 orl-mus TDLo: 100 mg/kg (8-12D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 541, 1982 (JTEHD6); T72-T75-T81 orl-mus TDLo: 120 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 361, 1986 (TCMUD8); T26 orl-mus TDLo: 72 mg/kg (30D male/30D pre) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 732, 2001 (HBPTO*); T86 ipr-rat TDLo: 60 mg/kg (18-22D preg/7D post) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 733, 2001 (HBPTO*); T52-T53-T91 orl-rat TDLo: 105 mg/kg (14-20D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 18, p. 437, 1979 (ENVRAL); T81 orl-rat TDLo: 40 mg/kg (1D pre) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 483, 1994 (VCVGK*); T35 orl-rat TDLo: 25 mg/kg (7-16D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 484, 1994 (VCVGK*); T35 orl-mus TDLo: 60 mg/kg (7-16D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 484, 1994 (VCVGK*); T52-T85-T91 orl-rat TDLo: 47 mg/kg (60D pre-12D post) Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 3, p. 131, 1982 (NRTXDN); T52-T91 orl-rat TDLo: 30.9 mg/kg (60D pre-21D post) Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 3, p. 119, 1982 (NRTXDN); T26 orl-rat TDLo: 88.2 mg/kg (7W male) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 37, p. 501, 1978 (FEPRA7) TE: V01-L60 orl-rat TDLo: 200 mg/kg/2Y-C Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 26, p. 231, 1979 (NEOLA4); V01-L60 orl-mus TDLo: 1200 mg/kg/80W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-b, 1976 (NCITR*); V01-L60 orl-rat TD :670 mg/kg/80W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-b, 1976 (NCITR*); V01-L60 orl-mus TD :1340 mg/kg/80W-C American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 680, 1976 (AIHAAP); V01-L60 orl-mus TD :1550 mg/kg/80W-C American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 680, 1976 (AIHAAP); V01-L60-R60 orl-rat TD :504 mg/kg/80W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 895, 1978 (JTEHD6); V01-L60 orl-mus TD :1344 mg/kg/80W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 895, 1978 (JTEHD6) ORNG: 91300000 ng/kg. [91.300000 mg/kg] T/E unlistd SRNG: 345000000 ng/kg. [345.000000 mg/kg] T/E unlistd SKNG: 2000000000 ng/kg. [2000.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 91300 ug/kg Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 5, p. 91, 1983 (NTOTDY); F11 orl-dog LD50: 250 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 331, 1978 (TXAPA9); T/E unlistd orl-rbt LD50: 65 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 642, 1966 (PCOC**); T/E unlistd skn-rbt LD50: 345 mg/kg Guide to the Chemicals Used in Crop Protection. (Information Canada, 171 Slater St., Ottawa, Ont., Canada) v. 6, p. 96, 1973 (GUCHAZ); T/E unlistd orl-qal LD50: 237 mg/kg Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 48, p. 371, 1976 (JRPFA4); T/E unlistd unr-mam LD50: 126 mg/kg "Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971 -,65,1971 (30ZDA9); T01-T02 ipr-rat TDLo: 500 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 733, 2001 (HBPTO*); A30-B30 ipr-rat TDLo: 80 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 483, 1994 (VCVGK*); A30 unr-mam TDLo: 25 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 483, 1994 (VCVGK*); T/E unlistd skn-rat LD50: 2000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 483, 1994 (VCVGK*); F11 scu-rat TDLo: 100 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 3, p. 111, 1982 (NRTXDN); A30-F11-N30 scu-rat TDLo: 100 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 3, p. 111, 1982 (NRTXDN); N30-Y21 ipr-rat TDLo: 50 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 8, p. 15, 1987 (NRTXDN); N72 ipr-rat TDLo: 75 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 8, p. 15, 1987 (NRTXDN); N30 scu-rat TDLo: 75 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 100, p. 506, 1989 (TXAPA9); F11 ipr-rat TDLo: 40 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 195, p. 44, 1990 (PSEBAA); N30-P30 ipr-rat TDLo: 60 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 195, p. 44, 1990 (PSEBAA) MD: F41-U01-U25 orl-rat TDLo: 307 mg/kg/15W-I Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 5, p. 91, 1983 (NTOTDY); L70-M70-U01 orl-rat TDLo: 912 mg/kg/2Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. 29, 1979 (TXAPA9); N73-P70-S05 orl-rat TDLo: 100 mg/kg/10D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 15, p. 561, 1985 (JTEHD6); Y64 orl-rat TDLo: 162 mg/kg/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 59, p. 262, 1981 (TXAPA9); L30-L70 orl-rat TDLo: 287 mg/kg/35D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 58, p. 132, 1981 (TXAPA9); F11-Q30-Y03 orl-rat TDLo: 75 mg/kg/3D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 25, p. 262, 1980 (BECTA6); Y07 ipr-rat TDLo: 12500 ug/kg/5D-I Pesticide Biochemistry and Physiology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1971- v. 18, p. 113, 1982 (PCBPBS); F19-U01-Z01 orl-mus TDLo: 180 mg/kg/18D-I Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 2, p. 113, 1981 (NRTXDN); A30-F11-Y03 orl-mus TDLo: 150 mg/kg/3D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 6, p. 275, 1980 (TOLED5); L70 orl-mus TDLo: 320 mg/kg/10W-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 39, p. 615, 1987 (BECTA6); G70-L70-M70 orl-dog TDLo: 560 mg/kg/2.5Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. 29, 1979 (TXAPA9); L70-Z01-Z73 orl-qal TDLo: 1470 mg/kg/42D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 43, p. 535, 1978 (TXAPA9); T02 orl-rat TDLo: 126 mg/kg/12W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 732, 2001 (HBPTO*); T13 unr-mus TDLo: 6 mg/kg/10D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 732, 2001 (HBPTO*); N17 orl-ham TDLo: 12 mg/kg/2D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 732, 2001 (HBPTO*); N17-N19 orl-mus TDLo: 240 mg/kg/30D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 732, 2001 (HBPTO*); T01 orl-rat TDLo: 81 mg/kg/90D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 733, 2001 (HBPTO*); F11 unr-rat TDLo: 700 mg/kg/4W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 484, 1994 (VCVGK*); L70 unr-rat TDLo: 2250 mg/kg/90D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 484, 1994 (VCVGK*); Z74-N17 scu-mus TDLo: 3 mg/kg/3D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 104, p. 1296, 1996 (EVHPAZ); Z01 orl-rat TDLo: 9 mg/kg/15D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 880, 2001 (HBPTO*); A30 orl-rat TDLo: 31.5 mg/kg/105D-C Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 3, p. 119, 1982 (NRTXDN); N16 orl-rat TDLo: 50.4 mg/kg/4W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 37, p. 501, 1978 (FEPRA7); N19 orl-rat TDLo: 84 mg/kg/8W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 37, p. 501, 1978 (FEPRA7); N17-N02-Z74 orl-rat TDLo: 105 mg/kg/10W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 37, p. 501, 1978 (FEPRA7) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 67, 1979 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 67, 1979 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 9, p. 1, 1978 (STEVA8); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 895, 1978 (JTEHD6); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 13, p. 231, 1978 (CTOXAO); TOXICOLOGY REVIEW Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(3), p. 671, 1979 (JEPTDQ) SR: OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: MAK 0.5 ppm (0.9 mg/m3), JAN 1999 ND: NIOSH REL TO KEPONE-air: 10H CA TWA 0.001 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M2969; NIS 1; TNF 280; NOS 2; TNE 12600 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264354); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-human; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-8899; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Kepone, 5508; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 875 of 1119 in RTECS (through 2003/06) AN: PY8030000 PN: Mineral-oil- SY: Adepsine-oil-; Alboline-; Bayol-55-; Bayol-F-; Blandlube-; Crystol-325-; Crystosol-; Glymol-; Kondremul-; Liquid-paraffin-; Neo-cultol-; Nujol-; Oil-mist,-mineral-; Oil-mist,-mineral- (ACGIH:OSHA); Paraffin-oil-; Paroleine-; Petrogalar-; Primol-355-; Primol-D-; Saxol-; USP-mineral-oil- RN: Current: 8012-95-1 Previous: 39355-35-6; 79956-36-8; 83046-05-3 UD: 200210 CC: Tumorigen (C); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 100 mg/24H MLD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); eye-rbt 500 mg MOD American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); skn-gpg 100 mg/24H MLD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG) TE: V01-K60-T61 ihl-man TCLo: 5 mg/m3/5Y-I JOM, Journal of Occupational Medicine. (American Occupational Medicine Assoc., 150 N. Wacker Dr., Chicago, IL 60606) V.10- 1968- v. 23, p. 333, 1981 (JJOMDZ); V03-R60 skn-mus TDLo: 332 gm/kg/20W-I Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 132, p. 439, 1965 (ANYAA9); V03-P61-J61 ipr-mus TDLo: 14 gm/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 193, p. 1086, 1962 (NATUAS); V03-P60 ipr-mus TD :60 gm/kg/17W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 703, 1978 (CNREA8); V03-P62 ipr-mus TD :60 gm/kg/17W-I Immunology. (Blackwell Scientific Pub., 52 Beacon St., Boston, MA 02108) V.1- 1958- v. 17, p. 481, 1969 (IMMUAM); V03-P60-S05 ipr-mus TD :50 gm/kg/9W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 6, p. 422, 1970 (IJCNAW); V03-P60 ipr-mus TD :72 gm/kg/26W-I Journal of Immunology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1916- v. 92, p. 747, 1962 (JOIMA3) AT: T/E unlistd orl-mus LD50: 22 gm/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 30, p. 243, 1973 (ATXKA8) MD: L70-M70 skn-rat TDLo: 5200 uL/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3340 (NTPTR*); L70 skn-mus TDLo: 20800 uL/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3340 (NTPTR*); U01-J30 ihl-mam TCLo: 70 mg/m3/2W-C "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 91, 1998 (VCVPS*) TR: ACGIH TLV-TWA 5 mg/m3 (O) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 10 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 mg/m3 (k) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW Publication of the American Association for the Advancement of Science. (Washington, DC) No.1-94, 1934-73. Discontinued. v. 54, p. 171, 1959 (PAASAH) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 5 mg/m3 (particulate) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 25, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 mg/m3, STEL 10 mg/m3, JAN 1993; OEL-BELGIUM: TWA 5 mg/m3, STEL 10 mg/m3, JAN 1993; OEL-FINLAND: TWA 5 mg/m3, JAN 1999; OEL-HUNGARY: STEL 5 mg/m3, Carcinogen, JAN 1993; OEL-JAPAN: OEL 3 mg/m3, Group 1 Carcinogen, JAN 1999; OEL-THE PHILIPPINES: TWA 5 mg/m3, JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 10 mg/m3, JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWEDEN: NGV 1 mg/m3, KTV 3 mg/m3 (mist or fume), JAN 1999; OEL-SWEDEN: NGV 3 mg/m3, STEL 5 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 5 mg/m3, JAN 1999; OEL-UNITED KINGDOM: LTEL 5 mg/m3, STEL 10 mg/m3, JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD T1542; NIS 3; TNF 22; NOS 7; TNE 698; NOES 1983: HZD T1542; NIS 275; TNF 49328; NOS 178; TNE 1100229; TFE 433405 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Oil mist, mineral, 5026; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 876 of 1119 in RTECS (through 2003/06) AN: QA4725000 PN: Molybdenum-trioxide- SY: Molybdenum(VI) oxide; Molybdenumperoxide-; Molybdic-acid-anhydride-; Molybdic-anhydride-; Molybdic-trioxide-; Natural-molybdite- RN: Current: 1313-27-5 UD: 200207 MF: Mo-O3 MW: 143.94 WL: MO O3 CC: Tumorigen (C); Mutagen (M); Human-Data (P) ME: mnt-ham-emb 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 392, p. 61, 1997 (MUREAV) TE: V03-J60 ihl-rat TCLo: 100 mg/m3/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-462, 1997 (NTPTR*); V03-J60 ihl-mus TCLo: 10 mg/m3/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-462, 1997 (NTPTR*); V02-J60 ipr-mus TDLo: 4750 mg/kg/7W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 1744, 1976 (CNREA8) ORNG: 2689000000 ng/kg. [2689.000000 mg/kg] T/E unlistd AT: J12-J21 ihl-man TCLo: 6 mg/m3/4Y National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AEC-TR-6710 (NTIS**); T/E unlistd orl-rat LD50: 2689 mg/kg Cyprus Copper Company. (9100 East Mineral Circle, P.O. Box 3299, Englewood, CO 80155) 18 JUN 1991 (PerDW#); T/E unlistd ihl-rat LC50: >5840 mg/m3/4H Cyprus Copper Company. (9100 East Mineral Circle, P.O. Box 3299, Englewood, CO 80155) 18 JUN 1991 (PerDW#); T/E unlistd skn-rat LD50: >2 gm/kg Cyprus Copper Company. (9100 East Mineral Circle, P.O. Box 3299, Englewood, CO 80155) 18 JUN 1991 (PerDW#); J30 ipr-mus LD50: 141 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 9(6), p. 40, 1965 (GTPZAB); T/E unlistd scu-mus LD50: 94 mg/kg Zhurnal Vsesoyuznogo Khimicheskogo Obshchestva im. D.I. Mendeleeva. Journal of the D.I. Mendeleeva All-Union Chemical Society. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.5- 1960- v. 19, p. 186, 1974 (ZVKOA6); T/E unlistd ipr-gpg LD75: 400 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX) MD: L03 ihl-rat TCLo: 10 mg/m3/2H/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 17(3), p. 23, 1952 (GISAAA); U01 ihl-rat TCLo: 100 mg/m3/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-462, 1997 (NTPTR*); U02 ihl-mus TCLo: 300 mg/m3/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-462, 1997 (NTPTR*) TR: ACGIH TLV-TWA 10 mg(Mo)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: MSHA STANDARD-air: TWA 5 mg(Mo)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 173, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 mg(Mo)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 mg(Mo)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 mg(Mo)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 mg(Mo)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 mg(Mo)/m3, JAN 1993; OEL-AUSTRIA: MAK 15 mg(Mo)/m3, JAN 1999; OEL-BELGIUM: TWA 5 mg(Mo)/m3, JAN 1993; OEL-DENMARK: TWA 5 mg(Mo)/m3, JAN 1999; OEL-FINLAND: TWA 5 mg(Mo)/m3, JAN 1999; OEL-FRANCE: VME 5 mg(Mo)/m3, VLE 10 mg(Mo)/m3, JAN 1999; OEL-GERMANY: MAK 15 mg(Mo)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 mg(Mo)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 5 mg(Mo)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 4 mg(Mo)/m3, MAC(STEL) 10 mg(Mo)/m3, JAN 1999; OEL-SWEDEN: NGV 10 mg(Mo)/m3 (total dust), JAN 1999; OEL-SWEDEN: NGV 5 mg(Mo)/m3 (resp. dust), JAN 1999; OEL-SWITZERLAND: MAK-W 10 mg(Mo)/m3, JAN 1999; OEL-TURKEY: TWA 5 mg(Mo)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 10 mg(Mo)/m3, STEL 20 mg(Mo)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 84549; NIS 6; TNF 175; NOS 14; TNE 5269; NOES 1983: HZD 84549; NIS 16; TNF 1346; NOS 28; TNE 48418; TFE 1530 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (inhalation), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-462, 1997 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: mouse, rat Record 877 of 1119 in RTECS (through 2003/06) AN: QA5076000 PN: Molybdic-acid,-hexaammonium-salt- SY: Ammonium-heptamolybdate-; Ammonium molybdate(II) ((NH4)6Mo7O24); Ammonium-paramolybdate-; Molybdate,-hexaammonium- (9CI) RN: Current: 12027-67-7 Previous: 12501-45-0 UD: 200302 MF: Mo7-O24.6 H4-N MW: 1163.88 CC: Tumorigen (C); Mutagen (M) ME: mmo-esc 2 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 31, p. 185, 1975 (MUREAV); dnr-bcs 50 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 31, p. 185, 1975 (MUREAV) MD: P71-P72-Y10 ihl-rat TCLo: 60 ug/m3/24H/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 58(1), p. 11, 1993 (GISAAA); L01-M04-U01 orl-rat TDLo: 20 gm/kg/20D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 317, 1989 (VCVN5*); A30-L30-P23 orl-rat TDLo: 595 mg/kg/17W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 318, 1989 (VCVN5*) ND: NOHS 1974: HZD 80790; NIS 31; TNF 1606; NOS 27; TNE 12930; NOES 1983: HZD 80790; NIS 34; TNF 2676; NOS 33; TNE 30922; TFE 15271 SL: EPA GENETOX PROGRAM 1988, Positive: B subtilis rec assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, selected, October 2000 Record 878 of 1119 in RTECS (through 2003/06) AN: QE7525000 PN: Morpholine,-N-nitroso- SY: Morpholine,-4-nitroso-; Nitrosomorpholine-; N-Nitrosomorfolin- (Czech); N-Nitrosomorpholin- (German); N-Nitrosomorpholine-; 4-Nitrosomorpholine-; NMOR- RN: Current: 59-89-2 BRN: 112139 BHR: 4-27-00-00627 UD: 200207 MF: C4-H8-N2-O2 MW: 116.14 WL: T6N DOTJ ANO CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 20 ug/plate (+S9) IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 31, p. 677, 1980 (IAPUDO); oms-esc 430 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); mmo-esc 100 ug/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 387, 1981 (PMRSDJ); pic-esc 250 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 224, 1981 (PMRSDJ); dnr-bcs 2 mg/disc Applied and Environmental Microbiology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.31- 1976- v. 43, p. 177, 1982 (AEMIDF); dnd-bcs 1 mg/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); slt-dmg-orl 210 umol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 144, p. 177, 1985 (MUREAV); sln-dmg-orl 4 mmol/L/3D-I "In Vitro Metabolic Activation in Mutagenic Testing, Proceedings of the Symposium, Research Triangle Park, NC, 1976," De Serres, F.J., et al., eds., New York, Elsevier Science Pub. Co., Inc., 1976 -,63,1976 (35WYAM); sln-dmg-par 1 pph Biophysik (Berlin). (Berlin, Ger.) V.1-10, 1963-73. For publisher information, see REBPAT. v. 1, p. 418, 1964 (BPYKAU); mmo-smc 89 mg/L (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 414, 1981 (PMRSDJ); sln-smc 150 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mmo-asn 10 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mrc-asn 10 mg/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mmo-ssp 5 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 424, 1981 (PMRSDJ); dnd-hmn-lvr 3200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dns-hmn-fbr 160 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 528, 1981 (PMRSDJ); dns-hmn-lvr 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); sce-hmn-lym 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 211, p. 77, 1989 (MUREAV); mnt-rat-orl 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 225, p. 143, 1989 (MUREAV); mtr-rat-ipr 100 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 1157, 1980 (CNREA8); mtr-rat-orl 200 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 1219, 1994 (CRNGDP); dnd-rat-ipr 100 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 3209, 1973 (CNREA8); dnd-rat-orl 400 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-lvr 3200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dns-rat-lvr 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dns-rat-orl 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 225, p. 143, 1989 (MUREAV); cyt-rat-ipr 250 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 39, 1977 (MUREAV); mnt-mus-ipr 6400 ug/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 686, 1981 (PMRSDJ); dnd-mus-ipr 100 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 6, p. 221, 1979 (CALEDQ); dni-mus-orl 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); sce-mus-ipr 37500 ug/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 408, 1984 (ENMUDM); msc-mus-lym 1200 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 580, 1981 (PMRSDJ); hma-mus-sat 50 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 4572, 1977 (CNREA8); mnt-ham-orl 500 mg/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 24, p. 365, 1979 (IJCNAW); mmo-ham-lng 10 umol/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 406, 1980 (CNREA8); mtr-ham-orl 100 mg/kg Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 310, 1978 (BBRCA9); mtr-ham-kdy 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 638, 1981 (PMRSDJ); cyt-ham-orl 200 mg/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 24, p. 365, 1979 (IJCNAW); sce-ham-ovr 1 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 538, 1981 (PMRSDJ); msc-ham-orl 200 mg/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 24, p. 365, 1979 (IJCNAW); msc-ham-ovr 500 umol/L Topics in Chemical Mutagenesis. (Plenum Pub. Corp., 233 Spring Street, New York, NY 10013) V.1- 1984- v. 1, p. 129, 1984 (TCMUE9) TE: V01-L60-M61 orl-rat TDLo: 320 mg/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 94, p. 233, 1979 (JCROD7); V03-L60 ivn-rat TDLo: 286 mg/kg/57W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 66, p. 138, 1964 (ZEKBAI); V01-J60 orl-mus TDLo: 251 mg/kg/10W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1475, 1989 (CRNGDP); V02-J60-L60 orl-mus TDLo: 3140 mg/kg/28W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 46, p. 1029, 1971 (JNCIAM); V01-J60-K60 orl-ham TDLo: 365 mg/kg/61W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 17, p. 333, 1983 (CALEDQ); V01-D09-J60 scu-ham TDLo: 861 mg/kg/35W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1295, 1973 (JNCIAM); V03-D09-J60 orl-ham TD :1080 mg/kg/26W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 875, 1984 (CRNGDP); V02-J60 orl-mus TD :5600 mg/kg/50W-C Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 66, p. 303, 1964 (ZEKBAI); V03-L60 orl-rat TD :420 mg/kg/4W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 65, p. 123, 1974 (GANNA2); V03-L60 orl-rat TD :1400 mg/kg/8W-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 82, p. 987, 1991 (JJCREP); V03-M61-T63 orl-rat TD :180 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 66, p. 1, 1964 (ZEKBAI); V01-L60-P61 orl-rat TD :80 gm/kg/50W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 911, 1982 (CRNGDP); V01-K60-L60 orl-rat TD :200 gm/kg/50W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 911, 1982 (CRNGDP); V03-D09-J60 orl-ham TD :1161 mg/kg/35W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 57, p. 617, 1984 (IAPUDO); V03-D09-L60 ivn-rat TD :290 mg/kg/58W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); V01-D09-J60 scu-ham TD :1514 mg/kg/32W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1295, 1973 (JNCIAM); V02-J30 orl-rat TDLo: 980 mg/kg/8W Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 152, p. 31, 2000 (CALEDQ) ORNG: 282000000 ng/kg. [282.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 282 mg/kg Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 48, p. 134, 1961 (NATWAY); T/E unlistd ipr-rat LD50: 282 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 19, p. 276, 1962 (BJIMAG); T/E unlistd scu-rat LD50: 170 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 80, p. 17, 1973 (ZKKOBW); T/E unlistd ivn-rat LD50: 98 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); T/E unlistd ihl-mus LCLo: 1000 mg/m3/10M National Defense Research Committee, Office of Scientific Research and Development, Progress Report. NDCrc-132, SEP1942 (NDRC**); T/E unlistd ipr-mus LD50: 64 mg/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 682, 1981 (PMRSDJ); T/E unlistd orl-ham LD50: 956 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 17, p. 333, 1983 (CALEDQ); J30-L30-P01 scu-ham LD50: 491 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 81, p. 251, 1974 (ZKKOBW) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 263, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 263, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 64, p. 77, 1976 (RREVAH) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.001 mg/m3, Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-nonhuman lymphocyte; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-human lymphocyte, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus, D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS in rat liver, V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Nitrosamines, 2522; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #27; OSHA ANALYTICAL METHOD #17, SUPERSEDED BY #27 Record 879 of 1119 in RTECS (through 2003/06) AN: QH4377000 PN: Myristic acid, 9-ester with 1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b- alpha,9-beta,9a-alpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-alpha-tetramethyl-5H- cyclopropa(3,4)benz(1,2-e)azulen-5-one, 9a-acetate SY: 12-O-Tetradecanoyl-phorbol-acetate-; 12-O-Tetradecanoylphorbol-13-acetate-; 12-Tetradecanoylphorbol-13-acetate-; 12-Tetradecanoylphorbol-13-monoacetate-; 12-o-Tetradekanoylphorbol-13-acetat- (German); 13-O-Acetylphorbol-12-myristate-; 4beta-Phorbol-12-myristate-13-acetate-; Factor-A1-; Factor-A1- (croton oil); PMA-; PMA- (tumor promoter); Pentahydroxy-tigliadienone-monoacetate(c)monomyristate(b); Phorbol-12-myristate-13-acetate-; Phorbol-12-tetradecanoate-13-acetate-; Phorbol-acetate,-myristate-; Phorbol-monoacetate-monomyristate-; Phorbol-myristate-acetate-; Phorbol-12-myristate-13-acetate-; TPA-; TPA- (phorbol derivative) RN: Current: 16561-29-8 Previous: 11016-13-0; 11019-85-5; 20839-11-6; 26894-58-6; 27534-73-2 BRN: 2407201 UD: 200305 MF: C36-H56-O8 MW: 616.92 WL: L E3 B675 MV IU NUTJ BQ C1 DOV13 EOV1 F1 F1 J1Q LQ N1 CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-mus 7 ng OPEN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 44, p. 279, 1980 (ARTODN); skn-mus 2.5 ug/4H Biological and pharmaceutical bulletin. (Pharmaceutical Society of Japan, 2-12-15, Shibuya, Shibuya-ku, Tokyo 150-0002, Japan) V.1- 1993- v. 24, p. 470, 2001 (BIPBU*); skn-mus 1 ug/6H open European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 438, p. 189, 2002 (EJPHAZ) ME: mmo-esc 1 mg/L (-S9) Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 31, p. 69P, 1979 (JPPMAB); cyt-smc 20 ug/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 294, p. 263, 1981 (NATUAS); dnd-hmn-fbr 1300 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1667, 1985 (CRNGDP); dnd-hmn-leu 25 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 50, p. 4619, 1990 (CNREA8); dns-hmn-oth 10 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 4078, 1984 (CNREA8); dns-hmn-fbr 100 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 4477, 1979 (CNREA8); dni-hmn-leu 500 pmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 51, p. 4279, 1991 (CNREA8); dni-hmn-oth 100 ng/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 875, 1984 (CNREA8); dni-hmn-fbr 20 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 55, p. 801, 1975 (JNCIAM); dni-hmn-lym 10 nmol/L Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 40, p. 273, 1983 (ONCOBS); dni-hmn-oth 500 pmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 2421, 1984 (CNREA8); oms-hmn-oth 1 umol/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 191, p. 129, 1990 (ECREAL); cyt-ham-hla 100 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 11, p. 2067, 1990 (CRNGDP); cyt-hmn-hla 10 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 2345, 1989 (CRNGDP); cyt-hmn-lym 100 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 1313, 1983 (CRNGDP); sce-hmn-fbr 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 393, 1982 (MUREAV); mtr-rat-oth 10 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 2059, 1986 (CRNGDP); dns-rat-lvr 100 pmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1547, 1984 (CRNGDP); dns-rat-rec 16200 pmol/kg Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 75, p. 29, 1984 (GANNA2); dni-rat-oth 25 nmol/L Journal of Neurochemistry. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1956- v. 46, p. 1561, 1986 (JONRA9); dni-rat-oth 10 ug/L Journal of Investigative Dermatology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1938- v. 88, p. 624, 1987 (JIDEAE); sce-rat-fbr 100 gm/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 1909, 1982 (CNREA8); mtr-mus-fbr 100 ug/L Food Additives and Contaminants. (Taylor and Francis Inc., 242 Cherry St., Philadelphia, PA 19106) V.1- 1984- v. 1, p. 179, 1984 (FACOEB); mtr-mus-oth 160 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 1507, 1983 (CRNGDP); mtr-mus-emb 300 ug/L Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 79, p. 921, 1988 (JJCREP); dnd-mus-oth 100 nmol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 26, p. 142, 1985 (PAACA3); dns-mus-emb 1 ug/plate Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 79, p. 921, 1988 (JJCREP); dns-mus-skn 72 nmol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 135, 1984 (CRNGDP); dns-mus-oth 1 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 262, p. 402, 1976 (NATUAS); dns-mus-fbr 1 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 604, 1986 (CNREA8); oms-mus-fbr 16 nmol/L In Vitro Cellular and Developmental Biology. (Tissue Culture Assoc., 19110 Montgomery Village Ave., Suite 300, Gaithersburg, MD 20879) V.21- 1985- v. 22, p. 253, 1986 (ICDBEO); dni-mus-skn 680 nmol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4126, 1983 (CNREA8); dni-mus-fbr 170 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1367, 1985 (CRNGDP); dni-mus-oth 1 umol/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 191, p. 129, 1990 (ECREAL); cyt-mus-oth 10 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1207, 1988 (CRNGDP); cyt-mus-oth 1 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1447, 1985 (CRNGDP); sce-mus-emb 1 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 601, 1981 (CRNGDP); sln-mus-oth 10 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1207, 1988 (CRNGDP); mtr-ham-emb 100 ug/L Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 259, 1980 (DTESD7); dns-ham-oth 160 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4108, 1983 (CNREA8); dni-ham-oth 160 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4108, 1983 (CNREA8); sce-ham-ovr 1 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 625, 1987 (CRNGDP); sce-ham-lng 10 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 45, p. 769, 1982 (BJCAAI); msc-ham-lng 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 169, p. 159, 1986 (MUREAV); dns-gpg-oth 100 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 1975, 1982 (CNREA8); mtr-ckn-emb 10 ug/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 76, p. 348, 1979 (PNASA6); dns-ckn-emb 100 ug/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 76, p. 348, 1979 (PNASA6); dns-ckn-oth 100 ug/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 76, p. 348, 1979 (PNASA6); mtr-mam-fbr 100 ng/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 177, p. 47, 1988 (ECREAL); dnd-rbt-oth 15 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 285, p. 303, 1993 (MUREAV); oms-ckn-emb 50 nmol/L Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 41, p. 120, 1984 (ONCOBS); dni-rbt-oth 100 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 703, 1982 (CRNGDP); dni-ctl-lym 10 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 409, 1982 (CRNGDP); sce-hmn-leu 1 pph/24H Cancer Genetics and Cytogenetics. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1979- v. 123, p. 51, 2000 (CGCYDF); mtr-mus-fbr 0.01 ug/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T34-T35 ipr-mus TDLo: 30 ug/kg (11-13D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 49, p. 17, 1985 (RCOCB8); T81 scu-mus TDLo: 640 ug/kg (2D post) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 165, p. 394, 1980 (PSEBAA) TE: V03-K60-R60 orl-mus TDLo: 10 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 1293, 1979 (CNREA8); V01-R60 skn-mus TDLo: 30204 ug/kg/72W-I Acta Pathologica, Microbiologica et Immunologica Scandinavica, Section A: Pathology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.90-95, 1982-87. v. 91, p. 103, 1983 (ACPADQ); V03-J60-P61 ivg-mus TDLo: 51 mg/kg/52W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 707, 1980 (CRNGDP); V03-V10 imp-dog TDLo: 798 ng/kg/21W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 921, 1980 (JJIND8); V03-K60-R60 skn-ham TDLo: 7800 ug/kg/26W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 155, 1980 (CNREA8); V03-R60 skn-mus TD :1680 ug/kg/16W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 34, p. 523, 1976 (BJCAAI); V03-R60 skn-mus TD :2960 mg/kg/24W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 4183, 1979 (CNREA8); V02-R60 skn-mus TD :1234 ug/kg/25W-I Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1968- v. 30, p. 33, 1979 (VAAZA2); V03-R60 skn-mus TD :7200 ug/kg/24W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 921, 1978 (CNREA8); V03-R60 skn-mus TD :22 mg/kg/52W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 39, p. 376, 1979 (BJCAAI); V02-R60 skn-mus TD :20 mg/kg/25W-I Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 54, p. 282, 1967 (NATWAY); V03-R60 skn-mus TD :21 mg/kg/26W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 642, 1980 (CNREA8); V03-R60 skn-mus TD :4520 ug/kg/67W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 19, p. 21, 1983 (CALEDQ); V03-R60 skn-mus TD :19 mg/kg/47W-I Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 26, p. 128, 1983 (PEXTAR); V02-R60 skn-ham TD :14 mg/kg/22W-I Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 26, p. 128, 1983 (PEXTAR); V01-K60-L60 orl-rat TDLo: 5.6 mg/kg/20W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 541, 2001 (FCTOD7); V01-R60-V16 skn-mus TDLo: 22.2 mg/kg/30W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 145, p. 57, 1999 (CALEDQ); V01-R60-V16 skn-mus TDLo: 10.192 mg/kg/7W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 135, p. 151, 1999 (CALEDQ); V01-R60-V10 skn-mus TDLo: 0.8 mg/kg/10W-I Biological and pharmaceutical bulletin. (Pharmaceutical Society of Japan, 2-12-15, Shibuya, Shibuya-ku, Tokyo 150-0002, Japan) V.1- 1993- v. 24, p. 1440, 2001 (BIPBU*); V01-R60-V10 skn-mus TDLo: 1.6 mg/kg Biological and pharmaceutical bulletin. (Pharmaceutical Society of Japan, 2-12-15, Shibuya, Shibuya-ku, Tokyo 150-0002, Japan) V.1- 1993- v. 24, p. 1282, 2001 (BIPBU*); V01-R60 skn-mus TDLo: 11.808 mg/kg/24W-I Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 42, p. 82, 1996 (VOONC*); V01-R60 skn-mus TDLo: 27.36 mg/kg/114W-I Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 37, p. 297, 1991 (VOONC*) AT: T/E unlistd ipr-mus LD :>1 mg/kg Toxicon. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.1- 1962- v. 38, p. 123, 2000 (TOXIA6); F07-R21-U28 ivn-mus LD50: 309 ug/kg Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 16, p. 535, 1985 (AGACBH); J30-P72-P73 ivn-dom LDLo: 40 ug/kg Journal of Applied Physiology. (Bethesda, MD) V.1-41, 1948-76. v. 54, p. 267, 1983 (JAPYAA) MD: J30-P01-P14 ivn-dog TDLo: 160 ug/kg/4D-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 17, p. 211, 1992 (JTSCDR); J13-J15-Z01 ivn-rbt TDLo: 1680 ug/kg/6W-I American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 111, p. 258, 1983 (AJPAA4); S06-Y12-Y55 ims-mus TDLo: 0.2 mg/kg/9D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 298, p. 376, 2001 (JPETAB) TR: TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 253, 1983 (BLFSBY); TOXICOLOGY REVIEW Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 1171, 1976 (CTRRDO) SL: EPA GENETOX PROGRAM 1988, Positive: In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Negative: SHE-clonal assay, Cell transform.-C3H/10T1/2; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: V79 cell culture-gene mutation, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 880 of 1119 in RTECS (through 2003/06) AN: QI8225000 PN: 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a- hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride SY: 5-Hydroxytetracycline-hydrochloride-; Aquacycline-; Biosolvmycin-; Biosolvomycin-; Engemycin-; Hydrocyclin-; Liquamycin-; Liquamycin-injectable-; Mepatar-; NSC-9169-; Otetryn-; Oxlopar-; Oxyject-100-; Oxytetracycline-hydrochloride-; Oxytetrin-; TM-5-; Terramycin-hydrochloride-; Tetramine-; Tetran-hydrochloride- RN: Current: 2058-46-0 UD: 200210 MF: C22-H24-N2-O9.Cl-H MW: 496.94 WL: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 KQ MQ M1 RQ &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: dna-bcs 10 umol/L Biochemistry (English Translation). Translation of BIOHAO. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.21- 1956- v. 39, p. 587, 1974 (BIORAK); dna-omi 10 mg/L Biochemistry (English Translation). Translation of BIOHAO. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.21- 1956- v. 39, p. 587, 1974 (BIORAK); dna-omi 10 umol/L Biochemistry (English Translation). Translation of BIOHAO. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.21- 1956- v. 39, p. 587, 1974 (BIORAK); mnt-mus-orl 100 mg/kg/24H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 193, 1983 (MUREAV); slt-mus-lym 200 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17, p. 196, 1991 (EMMUEG); dna-mam-lym 20 mg/L Biochemistry (English Translation). Translation of BIOHAO. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.21- 1956- v. 39, p. 587, 1974 (BIORAK); dns-mam-lym 20 mg/L Biochemistry (English Translation). Translation of BIOHAO. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.21- 1956- v. 39, p. 587, 1974 (BIORAK) RE: T27 par-wmn TDLo: 20 mg/kg (20W preg) Gynecologic and Obstetric Investigation. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.9- 1978- v. 26, p. 177, 1988 (GOBIDS); T25-T34 orl-rat TDLo: 11250 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-182469 (NTIS**); T34 orl-rat TDLo: 12 gm/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 434, 1986 (FAATDF); T13 orl-mus TDLo: 21 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-151027 (NTIS**); T75-T81 scu-mus TDLo: 900 mg/kg (10-18D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 161, p. 300, 1967 (CRSBAW) TE: V03-N60 orl-rat TDLo: 1802 gm/kg/2Y National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-315, 1987 (NTPTR*); V02-N61 orl-rat TDLo: 2163000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-204103/AS (NTIS**); V03-A60 orl-rat TDLo: 1802500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-204103/AS (NTIS**) AT: T/E unlistd scu-rat LD50: 800 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 9, p. 711, 1959 (ARZNAD); T/E unlistd ivn-rat LD50: 302 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 99, p. 234, 1950 (JPETAB); T/E unlistd orl-mus LD50: 6696 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 53, p. 238, 1950 (ANYAA9); T/E unlistd scu-mus LD50: 600 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 53, p. 245, 1950 (ANYAA9); T/E unlistd ivn-mus LD50: 100 mg/kg "Index of Antibiotics from Actinomycetes," Umezawa, H. et al., eds., Tokyo, Univ. of Tokyo Press, 1967 -,490,1967 (85FZAT); C08-F12-J30 ivn-dog LDLo: 100 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 53, p. 238, 1950 (ANYAA9); F11-F12-F13 ivn-rbt LDLo: 80 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 99, p. 234, 1950 (JPETAB) MD: F15-U01 orl-rat TDLo: 108 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-315, 1987 (NTPTR*); F15-U01 orl-mus TDLo: 129 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-315, 1987 (NTPTR*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 83236; NIS 2; TNF 49; NOS 6; TNE 9441; NOES 1983: HZD 83236; NIS 2; TNF 763; NOS 10; TNE 20845; TFE 16524 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 881 of 1119 in RTECS (through 2003/06) AN: QI9100000 PN: 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a- pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride SY: Achromycin-hydrochloride-; ALA-TET-; Amycin,-hydrochloride-; Artomycin-; Chlorowodorku-tetracykliny- (Polish); Bristacycline-; Cancycline-250-; Cefracycline-tablets-; Chlorhydrate-de-tetracycline- (French); Cyclopar-; Diacycine-; Dumocyclin-; Hostacycline-; Medamycin-; Mephacyclin-; NCI-C55561-; Neocycline-B-; Panmycin-hydrochloride-; Partrex-; Piracaps-; Polycycline-hydrochloride-; Polyotic-ointment-; Qidtet-; Quadracycline-; Quatrex-; Remicyclin-; Ricycline-; Ro-Cycline-; Sanclomycine-; Steclin-; Stilciclina-; Subamycin-; Sumycin-; Supramycin-; Telotrex-; Topicycline-; Paltet-; Tefilin-; Teline-; Tet-Cy-; Tetrabakat-; Tetrabid-; Tetrablet-; Tetracaps-; Tetrachel-; Tetraciclina-cloridrato- (Italian); Tetracompren-; Tetracycline-chlorohydrate-; Tetracycline-hydrochloride-; Tetra-D-; Tetrakap-; Tetralution-; Tetramavan-; Tetra-wedel-; Tetrosol-; Triphacyclin-; Unicin-; Unimycin-; U-5965-; Vetquamycin-324- RN: Current: 64-75-5 Previous: 8017-77-4; 8026-72-0; 90438-83-8; 102030-19-3 UD: 200305 MF: C22-H24-N2-O8.Cl-H MW: 480.94 WL: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Natural-Product (N) ME: dna-esc 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dnd-omi 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 315, p. 33, 1994 (MUREAV); mrc-smc 3 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 12, p. 357, 1971 (MUREAV); dnd-hmn-fbr 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 315, p. 33, 1994 (MUREAV); dns-hmn-fbr 750 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 315, p. 33, 1994 (MUREAV); dni-hmn-fbr 1250 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 348, p. 7, 1995 (MUREAV); dnd-rat-lvr 200 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 181, 1994 (EMMUEG); dni-mus-mmr 31600 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 261, 1976 (MUREAV); oms-mus-mmr 31600 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 261, 1976 (MUREAV); cyt-mus-mmr 31600 ug/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 261, 1976 (MUREAV); msc-mus-lym 120 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-344, 1989 (NTPTR*); msc-mus-mmr 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 261, 1976 (MUREAV); sce-ham-emb 3 mg/L Shigaku. Ondotology. (Nippon Shika Daigaku Shigakkai, 1-9-20 Fujimi, Chiyodaku, Tokyo 102, Japan) V.38- 1949- v. 74, p. 1385, 1987 (SHIGAZ) RE: T46-T53 orl-rat TDLo: 14 gm/kg (3D male/3D pre-22D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 7, p. 409, 1965 (TXAPA9); T25 orl-rat TDLo: 6 gm/kg (9-14D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 4, p. 516, 1970 (KSRNAM); T27-T31 ipr-rat TDLo: 425 mg/kg (14-18D preg) Laboratory Investigation. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1952- v. 14, p. 1456, 1965 (LAINAW); T39 scu-rat TDLo: 240 mg/kg (16-20D preg) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 17, p. 1479, 1968 (BCPCA6); T34 ims-rat TDLo: 240 mg/kg (10-15D preg) Biologia Neonatorum. (Basel, Switzerland) V.1-14, 1956-69. For publisher information, see BNEOBV. v. 4, p. 365, 1962 (BINEAA); T25-T34 unr-rat TDLo: 450 mg/kg (7-15D preg) Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. v. 16, p. 923, 1971 (ANTBAL); T27 unr-rat TDLo: 765 mg/kg (7-15D preg) Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. v. 16, p. 923, 1971 (ANTBAL); T13 iut-rat TDLo: 100 mg/kg (1D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 29, p. 553, 1984 (CCPTAY); T25-T35-T46 ipr-mus TDLo: 900 mg/kg (8-13D preg) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 3, p. 75, 1972 (IYKEDH); T34 ipr-mus TDLo: 600 mg/kg (8-13D preg) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 3, p. 75, 1972 (IYKEDH); T46 ipr-mus TDLo: 150 mg/kg (10D preg) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 3, p. 82, 1972 (IYKEDH); T53-T75-T81 scu-mus TDLo: 2250 mg/kg (10-18D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 161, p. 300, 1967 (CRSBAW); T27 scu-mus TDLo: 750 mg/kg (1-6D preg) Archives des Sciences Physiologique. (Paris, France) V.1-28, 1947-74. Discontinued. v. 23, p. 481, 1969 (ASPHAK); T81 par-mus TDLo: 2250 mg/kg (10-18D preg) Journal de Physiologie (Paris). (SPPIF, B.P.22, F-41353 Vineuil, France) V.39- 1946- v. 57, p. 567, 1965 (JOPHAN); T25 orl-rbt TDLo: 9 gm/kg (8-16D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 4, p. 516, 1970 (KSRNAM); T52 ims-rat TDLo: 150 mg/kg (1-6D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 66, 1984 (FATOAO); T52 ims-rat TDLo: 150 mg/kg (8-13D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 66, 1984 (FATOAO); T52 ims-rat TDLo: 150 mg/kg (14-19D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 66, 1984 (FATOAO); T48-T54 ims-rat TDLo: 150 mg/kg (1-6D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 70, 1984 (FATOAO); T48 ims-rat TDLo: 150 mg/kg (8-13D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 70, 1984 (FATOAO); T48 ims-rat TDLo: 150 mg/kg (14-19D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 70, 1984 (FATOAO) ORNG: 6443000000 ng/kg. [6443.000000 mg/kg] T/E unlistd AT: D50 orl-man TDLo: 200 mg/kg/7D-I Clinical Pharmacy. (American Soc. of Hospital Pharmacists, 4630 Montgomery Ave., Bethesda, MD 20814) V.1- 1982- v. 4, p. 455, 1985 (CPHADV); T/E unlistd orl-rat LD50: 6443 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 185, 1971 (TXAPA9); T/E unlistd ipr-rat LD50: 318 mg/kg Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). v. 2, p. 26, 1968 (GNRIDX); K12 scu-rat LD50: 700 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 9, p. 445, 1966 (TXAPA9); T/E unlistd ivn-rat LD50: 128 mg/kg Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 v. 10, p. 197, 1955 (FRPSAX); T/E unlistd orl-mus LD50: 2759 mg/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 16, p. 33, 1964 (JPPMAB); T/E unlistd ipr-mus LD50: 368 mg/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 16, p. 33, 1964 (JPPMAB); T/E unlistd ivn-mus LD50: 157 mg/kg Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 v. 10, p. 197, 1955 (FRPSAX); T/E unlistd unr-mus LD50: 105 mg/kg "Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks In New Drugs, Proceedings of the Symposium on Toxicological Testing for Safety of New Drugs, 3rd, Prague, 1976," Benesova, O., et al., eds., Prague, Czechoslovakia, Univerzita Karlova, 1979 -,55,1979 (40YJAX); J13-J30 ipl-rbt LDLo: 35 mg/kg Lung. (Springer-Verlag New York, POB 2485, Secaucus, NJ 07096) V.154- 1976- v. 174, p. 373, 1996 (LUNGD9) MD: M70-P28-Y03 ims-rat TDLo: 210 mg/kg/7D-I Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221 005, India) V.1- 1968(?)- v. 18, p. 110, 1986 (INJPD2); P08-P71-U01 ivn-dog TDLo: 1287 mg/kg/30D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 11, p. 128, 1967 (TXAPA9); P28-P30-Y40 ims-rbt TDLo: 500 mg/kg/20D-I Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. v. 26, p. 374, 1981 (ANTBAL) ND: NOHS 1974: HZD 83550; NIS 2; TNF 474; NOS 2; TNE 1795; NOES 1983: HZD 83550; NIS 4; TNF 680; NOS 15; TNE 22901; TFE 17276 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 882 of 1119 in RTECS (through 2003/06) AN: QI9295900 PN: 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10- tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- SY: ADM-hydrochloride-; Adriacin-; Adriamycin,-hydrochloride-; FI-106-; FI-6804-; Adriblastina-; Adriblastina-RD-; Doxorubicin-hydrochloride-; Hydroxydaunorubicin-hydrochloride-; KW-125- RN: Current: 25316-40-9 UD: 200302 MF: C27-H29-N-O11.Cl-H MW: 580.03 WL: L E6 C666 BV MVT&&&J DQ HV1Q HQ KQ RO1 FO- FT6OTJ B1 CQ DZ &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Natural-Product (N); Human-Data (P); Reproductive-Effector (T) ME: mmo-sat 700 ng/plate (+S9) American Journal of Hospital Pharmacy. (American Soc. of Hospital Pharmacists, 4630 Montgomery Ave., Bethesda, MD 20814) V.15- 1958- v. 43, p. 344, 1986 (AJHPA9); mmo-esc 40 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 41, 2000 (MUREAV); dnr-esc 1250 ng/plate Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 28, p. 159, 1985 (NULSAK); pic-esc 350 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 197, 1980 (MUREAV); oms-omi 1 gm/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 30, p. 67, 1980 (CBINA8); slt-dmg-orl 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 209, p. 1, 1988 (MUREAV); slt-dmg-orl 500 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 211, p. 153, 1989 (MUREAV); mnt-nml-tes 2 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 247, p. 29, 1991 (MUREAV); cyt-nml-tes 2 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 247, p. 29, 1991 (MUREAV); cyt-nml-oth 200 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 247, p. 29, 1991 (MUREAV); sln-nml-tes 2 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 247, p. 29, 1991 (MUREAV); sln-nml-oth 200 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 247, p. 29, 1991 (MUREAV); dnd-hmn-oth 1 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 32, p. 2255, 1983 (BCPCA6); dni-hmn-oth 400 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 4076, 1987 (CNREA8); oms-hmn-oth 300 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 4076, 1987 (CNREA8); bfa-hmn-sat 714 ug/kg American Journal of Hospital Pharmacy. (American Soc. of Hospital Pharmacists, 4630 Montgomery Ave., Bethesda, MD 20814) V.15- 1958- v. 43, p. 344, 1986 (AJHPA9); sce-hmn-lym 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 343, 1977 (MUREAV); dnd-rat-lvr 300 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); dnd-mus-leu 1 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 37, p. 1763, 1988 (BCPCA6); dni-mus-leu 1500 nmol/L Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 22, p. 912, 1979 (JMCMAR); oms-mus-leu 580 nmol/L Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 22, p. 912, 1979 (JMCMAR); dni-mus-ipr 15 mg/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 80, p. 1000, 1989 (JJCREP); oms-mus-ipr 15 mg/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 80, p. 1000, 1989 (JJCREP); dnd-ham-lng 1500 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 725, 1988 (CNREA8); cyt-ham-lng 5 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 249, p. 7, 1991 (MUREAV); cyt-ham-ovr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 31, 1992 (MUREAV); dni-ckn-emb 900 nmol/L Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 26, p. 638, 1983 (JMCMAR) RE: T01-T02-T03 ipr-rat TDLo: 6 mg/kg (2W male) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 2, p. 117, 1988 (REPTED); T03 scu-rat TDLo: 1500 ug/kg (5W male) Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 91, p. 197, 1988 (NYKZAU); T01-T02 ipr-mus TDLo: 1 mg/kg (5W male) Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- v. 38, p. 462, 1991 (TOIZAG); T22-T24 ipr-mus TDLo: 7 mg/kg (5W male) Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- v. 38, p. 462, 1991 (TOIZAG); T01-T02 scu-mus TDLo: 4500 ug/kg (5W male) Andrologia. (Grosse Verlag GmbH, Kurfuerstenstr. 112-113, D-1000 Berlin 30, Fed. Rep. Ger.) V.6- 1974- v. 26, p. 151, 1994 (ANDRDQ); T02 ipr-rbt TDLo: 30 mg/kg (30D male) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1063, 1973 (KSRNAM); T12 ipr-rbt TDLo: 60 mg/kg (30D pre) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1063, 1973 (KSRNAM); T02 ivn-rbt TDLo: 18 mg/kg (30D male) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1063, 1973 (KSRNAM); T12 ivn-rbt TDLo: 600 ug/kg (30D pre) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1063, 1973 (KSRNAM) TE: V03-P61 ivn-mky TDLo: 27 mg/kg/2Y-I Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1968- v. 20, p. 9, 1980 (PHMGBN) AT: M03 ivn-man LDLo: 2571 ug/kg/3W-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 137, p. 385, 1977 (AIMDAP); G01-J15 ivn-man TDLo: 12 mg/kg/26W-I Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 106, p. 814, 1987 (AIMEAS); K12-R12-U01 ipr-rat LD50: 16030 ug/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1052, 1973 (KSRNAM); K12-R12-U01 scu-rat LD50: 21840 ug/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1052, 1973 (KSRNAM); K12-R12-U01 ivn-rat LD50: 12510 ug/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1052, 1973 (KSRNAM); T/E unlistd ims-rat LD50: 16 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 506, 1982 (NIIRDN); D17-F18-K12 orl-mus LD50: 698 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1052, 1973 (KSRNAM); T/E unlistd ipr-mus LD50: 11160 ug/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); T/E unlistd scu-mus LD50: 7678 ug/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); T/E unlistd ivn-mus LD50: 1245 ug/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); T/E unlistd ims-mus LD50: 13700 ug/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 506, 1982 (NIIRDN); F15-F18 ivn-rbt LD50: 5980 ug/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1052, 1973 (KSRNAM); P30 orl-mus LD50: 570 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); P30 ipr-mus LD50: 4.6 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); P30 ivn-mus LD50: 12.5 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); P30 scu-mus LD50: 13.5 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); H02-J20 ivn-cat LDLo: 20 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); H02-J22 ivn-cat LDLo: 2 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*) MD: L70-N73-P05 ipr-rat TDLo: 60 mg/kg/30D-C Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1063, 1973 (KSRNAM); Y15 ipr-rat TDLo: 18900 ug/kg/21D-I Egyptian Journal of Veterinary Science. (National Information and Documentation Centre, A1-Tahrir St., Awqaf P.O. Dokki, Cairo, Egypt) V.9- 1972- v. 26, p. 71, 1989 (EJVSAU); Y15 ipr-rat TDLo: 6300 ug/kg/3D-I Egyptian Journal of Veterinary Science. (National Information and Documentation Centre, A1-Tahrir St., Awqaf P.O. Dokki, Cairo, Egypt) V.9- 1972- v. 26, p. 71, 1989 (EJVSAU); G06-M16-P28 ipr-rat TDLo: 38 mg/kg/14W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 34, p. 1298, 1984 (ARZNAD); G70-P14-Y03 ivn-rat TDLo: 12480 ug/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 79, p. 412, 1985 (TXAPA9); G30-U01 ivn-rat TDLo: 15 mg/kg/5W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 102, p. 292, 1990 (TXAPA9); G06-U01-Z01 ivn-rat TDLo: 9 mg/kg/3W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 70, p. 243, 1991 (TXCYAC); M13-P05-P72 ivn-rat TDLo: 22400 ug/kg/4W-I Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 24, p. 7196, 1990 (KSRNAM); G30-Z01 ivn-rat TDLo: 12 mg/kg/6W-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 19, p. 176, 1991 (TOPADD); G30-M04-P30 scu-rat TDLo: 26 mg/kg/13W-I Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1968- v. 54, p. 182, 1987 (VAAZA2); G30-U01 ivn-mus TDLo: 40 mg/kg/7W-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 21, p. 362, 1993 (TOPADD); P05-P14-Y40 ivn-dog TDLo: 15600 ug/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 79, p. 412, 1985 (TXAPA9); N74-P05-Z01 ivn-rbt TDLo: 18 mg/kg/30D-C Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 1063, 1973 (KSRNAM); P26-S02 unr-mus TDLo: 4 mg/kg/10D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); P26-S02 unr-rat TDLo: 6 mg/kg/10D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); Z01 ivn-rat TDLo: 20 mg/kg/4D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); Z01 ivn-rat TDLo: 18.75 mg/kg/5D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); M03-P14-P17 ivn-rat TDLo: 18.75 mg/kg/5D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); U01 ivn-rat TDLo: 6.25 mg/kg/5D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); N73-N74-P20 ivn-rat TDLo: 7.5 mg/kg/3D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); G04-P26-Z01 ivn-dog TDLo: 5 mg/kg/10D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); G04-P26-R21 ivn-dog TDLo: 6.25 mg/kg/25D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*); G06-R21 ivn-dog TDLo: 1.875 mg/kg/15D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 460, 1998 (VCVPS*) ND: NOES 1983: HZD X3746; NIS 1; TNF 275; NOS 8; TNE 7597; TFE 4972 SL: EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 883 of 1119 in RTECS (through 2003/06) AN: QJ0525000 PN: Naphthalene- SY: Albocarbon-; Naftalen- (Polish); Camphor-tar-; Mighty-150-; Mighty-RD1-; Moth-balls-; Moth-flakes-; Naphthalene- (ACGIH:OSHA); Naphthalin-; Naphthaline-; Naphthene-; NCI-C52904-; RCRA-waste-number-U165-; Tar-camphor-; White-tar- RN: Current: 91-20-3 UD: 200305 MF: C10-H8 MW: 128.18 WL: L66J CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 495 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 1/11/1968 (UCDS**); eye-rbt 100 mg MLD BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 16-4/1970 (BIOFX*) ME: slt-dmg-orl 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 235, 1995 (MUREAV); mnt-hmn-lym 30 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 393, p. 23, 1997 (MUREAV); cyt-ham-ovr 30 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-410, 1992 (NTPTR*); sce-ham-ovr 15 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-410, 1992 (NTPTR*); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T34-T59 orl-rat TDLo: 4500 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-135623 (NTIS**); T46-T47 ipr-rat TDLo: 5925 mg/kg (1-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A35, 1979 (TXAPA9); T72-T75 orl-mus TDLo: 2400 mg/kg (7-14D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 15, p. 25, 1985 (JTEHD6) TE: V03-P62-T64 scu-rat TDLo: 3500 mg/kg/12W-I Virchows Archiv fuer Pathologische, Anatomie und Physiologie, und fuer Klinische Medizin. (Berlin, Ger.) V.1-343, 1847-1967. For publisher information, see VAAPB7. v. 329, p. 141, 1956 (APAVAY); V02-J60 ihl-mus TCLo: 30 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-410, 1992 (NTPTR*); V01-D09 ihl-rat TCLo: 1890 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2001-103699 (NTIS**); V01-D09 ihl-rat TCLo: 1575 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2001-103699 (NTIS**); V02-D07-J60 ihl-mus TCLo: 1854 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-224260/AS (NTIS**) ORNG: 490000000 ng/kg. [490.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-chd LDLo: 100 mg/kg "Toxicology and Biochemistry of Aromatic Hydrocarbons," Gerarde, H., New York, Elsevier, 1960 -,228,1960 (28ZRAQ); T/E unlistd unr-hmn LDLo: 29 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 31, p. 1499, 1980 (YKYUA6); T/E unlistd unr-man LDLo: 74 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 490 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,89,1982 (85GMAT); D17-F07 ihl-rat LC50: >340 mg/m3/1H BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 16-4/1970 (BIOFX*); T/E unlistd skn-rat LD50: >2500 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 515, 1969 (TXAPA9); T/E unlistd orl-mus LD50: 316 mg/kg Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 4, p. 243, 1990 (WDZAEK); T/E unlistd ipr-mus LD50: 150 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD691-490 (NTIS**); F11 scu-mus LD50: 969 mg/kg Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- v. 20, p. 772, 1973 (TOIZAG); T/E unlistd ivn-mus LD50: 100 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#00203 (CSLNX*); T/E unlistd orl-dog LDLo: 400 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-cat LDLo: 1 gm/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-rbt LDLo: 3 gm/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd skn-rbt LD50: >20 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A062-138 (NTIS**); F07-F17 orl-gpg LD50: 1200 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 47(11), p. 78, 1982 (GISAAA) MD: D35 orl-rat TDLo: 20 gm/kg/11W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 115, p. 195, 2000 (TOLED5); L30-L70-Y37 orl-rat TDLo: 10 gm/kg/10D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 8, p. 311, 1981 (TOLED5); N72 orl-rat TDLo: 1680 mg/kg/28D-C BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 16-4/1970 (BIOFX*); L30-U01-Y12 orl-rat TDLo: 12450 mg/kg/9W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 61, p. 480, 1988 (ARTODN); P27-U01 orl-mus TDLo: 3738 mg/kg/14D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 4, p. 406, 1984 (FAATDF); P27 orl-mus TDLo: 11970 mg/kg/90D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 4, p. 406, 1984 (FAATDF); D35-K30-P01 orl-rbt TDLo: 10 gm/kg/10D-I Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 102, p. 842, 1967 (BIJOAK); D35 ipr-rbt TDLo: 2 gm/kg/2D-I Lens and Eye Toxicity Research. (Marcel Dekker, Journal Customer Service, POB 5017, Monticello, NY 12701) V.6n.1-2- 1989- v. 6, p. 203, 1989 (LETRET) TR: ACGIH TLV-TWA 10 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 15 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 1(1), p. 93, 1971 (CRTXB2); TOXICOLOGY REVIEW Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 59, p. 1, 1961 (JOPDAB); TOXICOLOGY REVIEW Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 180, p. 1, 2002 (TXCYAC) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 10 ppm (50 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 177, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 10 ppm (50 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 10 ppm (50 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 10 ppm (50 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 10 ppm (50 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 10 ppm (50 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 10 ppm (50 mg/m3), JAN 1999; OEL-BELGIUM: TWA 10 ppm (52 mg/m3), STEL 15 ppm (79 mg/m3), JAN 1993; OEL-DENMARK: TWA 10 ppm (50 mg/m3), JAN 1999; OEL-FINLAND: TWA 10 ppm (50 mg/m3), STEL 20 ppm (100 mg/m3), JAN 1999; OEL-FRANCE: VME 10 ppm (50 mg/m3), JAN 1999; OEL-GERMANY: MAK 10 ppm (50 mg/m3), JAN 1999; OEL-HUNGARY: TWA 40 mg/m3, STEL 80 mg/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 10 ppm (50 mg/m3), JAN 1999; OEL-NORWAY: TWA 10 ppm (50 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 10 ppm (50 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 20 mg/m3, MAC(STEL) 75 mg/m3, JAN 1999; OEL-RUSSIA: STEL 20 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 10 ppm (50 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 10 ppm (53 mg/m3), STEL 15 ppm (80 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO NAPHTHALENE-air: 10H TWA 10 ppm, STEL 15 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 49600; NIS 71; TNF 4341; NOS 68; TNE 44297; NOES 1983: HZD 49600; NIS 83; TNF 7209; NOS 87; TNE 112696; TFE 5220 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264362); EPA GENETOX PROGRAM 1988, Negative: Cell transform.-mouse embryo; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrocarbons, aromatic, 1501; NIOSH Analytical Method, 1994: Polynuclear aromatic hydrocarbons by HPLC, 5506, by GC, 5515; NCI Carcinogenesis Studies (inhal), clear evidence: rat; NTP Carcinogenesis Studies (inhalation), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-410, 1992 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: mouse; NTP Carcinogenesis studies, test completed (camera copy in progress), October 2000; OSHA ANALYTICAL METHOD #35 Record 884 of 1119 in RTECS (through 2003/06) AN: QJ1897000 PN: 2-Naphthalenecarboxamide, 3-hydroxy-4-((2-methoxy-5-nitrophenyl)azo)-N-(3-nitrophenyl)- SY: 2-Naphthanilide, 3-hydroxy-4-((2-methoxy-5-nitrophenyl)azo)-3'-nitro-; Alkali-Resistant-Red-Dark-; C.I. 12355; C.I. Pigment Red 157; C.I. Pigment Red 23; Calcotone-Red-3B-; Carnation-Red-Toner-B-; Congo-Red-R-138-; Fenalac-Red-FKB-Extra-; Malta-Red-X-2284-; NCI-C60377-; Naphthol-Red-B-; Naphthol-Red-B-20-7575-; Naphthol-Red-D-Toner-35-6001-; Naphthol-Red-Deep-10459-; Pigment-Red-23-; Pigment-Red-BH-; Rubescence-Red-MT-21-; Sanyo-Fast-Red-10B-; Sapona-Red-Lake-RL-6280-; Segnale-Light-Rubine-RG-; Textile-Red-WD-263- RN: Current: 6471-49-4 UD: 200302 MF: C24-H17-N5-O7 MW: 487.46 WL: L66J BNUNR BO1 ENW& CQ DVMR CNW CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 33 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); mmo-sat 10 ug/plate (-S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-411, 1992 (NTPTR*) TE: V03-M61 orl-rat TDLo: 2163000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-228435 (NTIS**) MD: P05 orl-rat TDLo: 273 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-411, 1992 (NTPTR*); P08-P71-U01 orl-mus TDLo: 102 gm/kg/17D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-411, 1992 (NTPTR*); L70-N74 orl-mus TDLo: 136 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-411, 1992 (NTPTR*); P61-V30 orl-rat TDLo: 360500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-228435 (NTIS**) ND: NOHS 1974: HZD M2113; NIS 16; TNF 495; NOS 34; TNE 21254; NOES 1983: HZD M2113; NIS 11; TNF 548; NOS 24; TNE 15233; TFE 2716 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 885 of 1119 in RTECS (through 2003/06) AN: QJ3150000 PN: Naphthalene,-decahydro- SY: Naphthalane-; Bicyclo(4.4.O)decane; Decalin-; De-kalin-; Dekalina- (Polish); Naphthane-; Perhydronaphthalene- RN: Current: 91-17-8 BRN: 878165 BHR: 3-05-00-00245 UD: 200012 MF: C10-H18 MW: 138.28 WL: L66TJ CC: Tumorigen (C); Human-Data (P) TE: V02-N60 ihl-rat TCLo: 5 ppm/24H/90D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 785, 1985 (FAATDF); V01-N60 ihl-mus TCLo: 50 ppm/24H/90D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 785, 1985 (FAATDF) ORNG: 4170000000 ng/kg. [4170.000000 mg/kg] T/E unlistd SRNL: 5900000 nL/kg. [5.900000 mL/kg] T/E unlistd IHPB: 710000 ppb/4H. [710.000000 ppm/4H] T/E unlistd AT: D07-D25-J30 ihl-hmn TCLo: 100 ppm "Handbook of Organic Industrial Solvents," 2nd ed., Chicago, National Assoc. of Mutual Casualty Companies, 1961 v. 2, p. 40, 1961 (TGNCDL); T/E unlistd orl-rat LD50: 4170 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); T/E unlistd ihl-rat LC50: 710 ppm/4H Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 215, 1992 (ATDAEI); T/E unlistd ihl-mus LCLo: 993 ppm/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A062-138 (NTIS**); T/E unlistd skn-rbt LD50: 5900 uL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); J16-L30-M30 ihl-gpg LCLo: 319 ppm/8H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A086-341 (NTIS**) MD: L70-M03-M70 orl-rat TDLo: 1500 mg/kg/5D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 345, 1987 (FCTOD7); L70-M70 orl-rat TDLo: 6 gm/kg/4W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 345, 1987 (FCTOD7); L70-M03-U01 ihl-rat TCLo: 5 ppm/24H/90D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 785, 1985 (FAATDF); L70-M03-M70 ihl-rat TCLo: 125 ppm/22H/31D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 53, 1987 (FCTOD7); J30-L30-N07 ihl-mus TCLo: 5 ppm/24H/90D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 785, 1985 (FAATDF) SR: OEL-HUNGARY: TWA 100 mg/m3, STEL 200 mg/m3, Skin, JAN 1993; OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 300 mg/m3, JAN 1999; OEL-RUSSIA: STEL 100 mg/m3, JAN 1993 ND: NOHS 1974: HZD 84339; NIS 3; TNF 46; NOS 3; TNE 934; NOES 1983: HZD 84339; NIS 2; TNF 81; NOS 2; TNE 249; TFE 74 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-8815, 8EHQ-0892-8816; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 886 of 1119 in RTECS (through 2003/06) AN: QJ5775000 PN: 1,4-Naphthalenedione,-5-hydroxy- SY: Akhnot-; C.I. 75500; C.I. Natural Brown 7; 5-Hydroxy-1,4-naftochinon- (Czech); 5-Hydroxy-1,4-naphthoquinone-; Juglon-; Juglone-; 1,4-Naphthoquinone,-5-hydroxy-; 1,4-Naphthoquinone,-8-hydroxy-; Regianin-; Nucin-; Walnut-extract- RN: Current: 481-39-0 BRN: 1909764 BHR: 4-08-00-02368 UD: 200012 MF: C10-H6-O3 MW: 174.16 WL: L66 BV EVJ GQ CC: Tumorigen (C); Drug (D); Mutagen (M); Natural-Product (N) ME: mmo-sat 30 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 25, 1983 (MUREAV); slt-dmg-mul 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 440, p. 139, 1999 (MUREAV); sln-dmg-orl 10 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 89, 1982 (MUREAV); oms-mus-ast 10 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 126, p. 583, 1967 (PSEBAA) TE: V02-R60 skn-mus TDLo: 394 mg/kg/53W-I Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 21, p. 26, 1978 (JMCMAR) ORNG: 112000000 ng/kg. [112.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 112 mg/kg Voprosy Pitaniya. Problems of Nutrition. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1932-41: V.11- 1952- v. 42(5), p. 67, 1984 (VPITAR); F07 orl-mus LD50: 2500 ug/kg Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 134, p. 1617, 1961 (SCIEAS); T/E unlistd ipr-mus LD50: 25 mg/kg "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980- 8(1),74,1982 (85GDA2); T/E unlistd ivn-dog LDLo: 10 mg/kg Toxicon. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.1- 1962- v. 6, p. 99, 1968 (TOXIA6) SL: NTP Carcinogenesis studies, selected, October 2000 Record 887 of 1119 in RTECS (through 2003/06) AN: QJ6160000 PN: 2,7-Naphthalenedisulfonic acid, 4-amino-3-((4'-((2,4-diaminophenyl)azo)(1,1'-biphenyl)-4-yl) azo)-5-hydroxy-6-(phenylazo)-, disodium salt SY: ATul-Direct-Black-E-; Ahco-Direct-Black-GX-; Airedale-Black-ED-; Aizen-Direct-Deep-Black-EH-; Aizen-Direct-Deep-Black-GH-; Aizen-Direct-Deep-Black-RH-; Amanil-Black-GL-; Amanil-Black-WD-; Apomine-Black-GX-; Atlantic-Black-BD-; Atlantic-Black-C-; Atlantic-Black-E-; Atlantic-Black-EA-; Atlantic-Black-GAC-; Atlantic-Black-GG-; Atlantic-Black-GXCW-; Atlantic-Black-GXOO-; Atlantic-Black-SD-; Azine-Deep-Black-EW-; Azocard-Black-EW-; Azomine-Black-EWO-; Belamine-Black-GX-; Bencidal-Black-E-; Benzanil-Black-E-; Benzo-Deep-Black-E-; Benzo-Leather-Black-E-; Benzoform-Black-BCN-CF-; Black-2EMBL-; Black-4EMBL-; Brasilamina-Black-GN-; Brilliant-Chrome-Leather-Black-H-; C.I. 30235; C.I. Direct Black 38; CERN-prima-38- (Czech); Calcomine-Black-; Calcomine-Black-EXL-; Carbide-Black-E-; Chloramine-Black-C-; Chloramine-Black-EC-; Chloramine-Black-ERT-; Chloramine-Black-EX-; Chloramine-Black-EXR-; Chloramine-Black-XO-; Chloramine-Carbon-Black-S-; Chloramine-Carbon-Black-SJ-; Chloramine-Carbon-Black-SN-; Chlorazol-Black-E-; Chlorazol-Black-E- (biological stain); Chlorazol-Black-EA-; Chlorazol-Black-EN-; Chlorazol-Burl-Black-E-; Chlorazol-Leather-Black-ENP-; Chlorazol-Silk-Black-G-; Chlorazol-black-E-; Chrome-leather-Black-E-; Chrome-leather-Black-EC-; Chrome-leather-Black-EM-; Chrome-leather-Black-G-; Chrome-leather-Brilliant-Black-ER-; Coir-Deep-Black-C-; Columbia-Black-EP-; Diacotton-Deep-Black-; Diacotton-Deep-Black-RX-; Diamine-Deep-Black-EC-; Diamine-Direct-Black-E-; Diaphtamine-Black-V-; Diazine-Black-E-; Diazine-Direct-Black-E-; Diazine-Direct-Black-G-; Diazol-Black-2V-; Diphenyl-deep-Black-G-; Direct-Black-3-; Direct-Black-38-; Direct-Black-A-; Direct-Black-BRN-; Direct-Black-CX-; Direct-Black-CXR-; Direct-Black-E-; Direct-Black-EW-; Direct-Black-EX-; Direct-Black-FR-; Direct-Black-GAC-; Direct-Black-GW-; Direct-Black-GX-; Direct-Black-GXR-; Direct-Black-JET-; Direct-Black-Meta-; Direct-Black-Methyl-; Direct-Black-N-; Direct-Black-RX-; Direct-Black-SD-; Direct-Black-WS-; Direct-Black-Z-; Direct-Deep-Black-E-; Direct-Deep-Black-EW-; Direct-Deep-Black-EX-; Enianil-Black-CN-; Erie-Black-B-; Erie-Black-BF-; Erie-Black-GAC-; Erie-Black-GXOO-; Erie-Black-JET-; Erie-Black-NUG-; Erie-Black-RXOO-; Erie-Brilliant-Black-S-; Erie-Fibre-Black-VP-; Fenamin-Black-E-; Fibre-Black-VF-; Fixanol-Black-E-; Formaline-Black-C-; Formic-Black-C-; Formic-Black-CW-; Formic-Black-MTG-; Formic-Black-TG-; Hispamin-Black-EF-; Interchem-Direct-Black-Z-; Kayaku-Direct-Deep-Black-EX-; Kayaku-Direct-Deep-Black-GX-; Kayaku-Direct-Deep-Black-S-; Kayaku-Direct-Leather-Black-EX-; Kayaku-Direct-Special-Black-AAX-; Lurazol-Black-BA-; META-Black-; Mitsui-Direct-Black-EX-; Mitsui-Direct-Black-GX-; NCI-C54557-; Nippon-Deep-Black-; Nippon-Deep-Black-GX-; Paper-Black-BA-; Paper-Black-T-; Paper-Deep-Black-C-; Paramine-Black-B-; Paramine-Black-E-; Peeramine-Black-E-; Peeramine-Black-GXOO-; Phenamine-Black-BCN-CF-; Phenamine-Black-CL-; Phenamine-Black-E-; Phenamine-Black-E-200-; Pheno-Black-EP-; Pheno-Black-SGN-; Pontamine-Black-E-; Pontamine-Black-EBN-; Sandopel-Black-EX-; Seristan-Black-B-; Telon-Fast-Black-E-; Tertrodirect-Black-E-; Tetrazo-Deep-Black-G-; Tetrodirect-Black-EFD-; Union-Black-EM-; Vondacel-Black-N- RN: Current: 1937-37-7 UD: 200204 MF: C34-H25-N9-O7-S2.2 Na MW: 781.78 WL: L66J BZ CNUNR DR DNUNR DR DNUNR BZ DZ&&& DSWO HSWO INUNR JQ &-NA- 2 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 100 mg MOD Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*) ME: mmo-sat 10 ug/plate (+/-S9) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 519, 1979 (TOLED5); mnt-rat-orl 500 mg/kg/36H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 227, 1987 (MUREAV); dns-rat-orl 500 mg/kg/12H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 227, 1987 (MUREAV); bfa-rat-sat 300 mg/kg International Archives of Occupational and Environmental Health. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.35- 1975- v. 49, p. 177, 1981 (IAEHDW); dnd-mus-orl 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 465, p. 11, 2000 (MUREAV) RE: T87 orl-mus TDLo: 5 gm/kg (8-12D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 177, 1993 (FAATDF); T53 orl-mus TDLo: 3 gm/kg (8-10D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 177, 1993 (FAATDF) TE: V01-L60 orl-rat TDLo: 6825 mg/kg/13W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); V03-M60 orl-mus TDLo: 34 mg/kg/60W-C Tokyo Jikeikai Ika Daigaku Zasshi. Tokyo Jikeikai Medical Journal. (3-25-8, Nishi Shinbashi, Minato-ku, Tokyo 105, Japan) V.66- 1951- v. 88, p. 467, 1973 (TJIDAH); V03-M60 imp-mus TDLo: 80 mg/kg Tokyo Jikeikai Ika Daigaku Zasshi. Tokyo Jikeikai Medical Journal. (3-25-8, Nishi Shinbashi, Minato-ku, Tokyo 105, Japan) V.66- 1951- v. 88, p. 467, 1973 (TJIDAH); V01-L60 orl-rat TD :13286 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 54, p. 431, 1980 (TXAPA9) ORNG: 7600000000 ng/kg. [7600.000000 mg/kg] F12-F19-K12 AT: F12-F19-K12 orl-rat LD50: 7600 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*); T/E unlistd ihl-rat LCLo: 180 gm/m3/1H Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*); M16-M30-U01 orl-rbt LDLo: 1262 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 295, 1982 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 295, 1982 (IMEMDT) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993 ND: NOHS 1974: HZD M1410; NIS 10; TNF 704; NOS 27; TNE 16432; NOES 1983: HZD M1410; NIS 7; TNF 298; NOS 12; TNE 11374; TFE 5821 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 24, 1978; NIOSH Analytical Method, 1994: Dyes, 5013; NCI Carcinogenesis Bioassay (feed), clear evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); NCI Carcinogenesis Bioassay (feed), no evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; NTP Toxicity studies, RPT# TR-108, October 2000 Record 888 of 1119 in RTECS (through 2003/06) AN: QJ6400000 PN: 2,7-Naphthalenedisulfonic acid, 3,3'-((4,4'-biphenylylene)bis(azo))bis(5-amino-4-hydroxy-, tetrasodium salt SY: Airedale-Blue-2BD-; Aizen-Direct-Blue-2BH-; Amanil-Blue-2BX-; Atlantic-Blue-2B-; Atul-Direct-Blue-2B-; Azocard-Blue-2B-; Azomine-Blue-2B-; Belamine-Blue-2B-; Bencidal-Blue-2B-; Chrome-Leather-Blue-2B-; C.I. 22610; C.I. Direct Blue 6; C.I. Direct Blue 6, tetrasodium salt; Cresotine-Blue-2B-; Diphenyl-Blue-2B-; Diphenyl-Blue-KF-; Diphenyl-Blue-M2B-; Fenamin-Blue-2B-; Fixanol-Blue-2B-; Indigo-Blue-2B-; Naphtamine-Blue-2B-; Benzanil-Blue-2B-; Benzo-Blue-BBA-CF-; Benzo-Blue-BBN-CF-; Benzo-Blue-GS-; Blue-2B-; Blue-2B-salt-; Brasilamina-Blue-2B-; Calcomine-Blue-2B-; Chloramine-Blue-2B-; Chlorazol-Blue-B-; Chlorazol-Blue-BP-; Diacotton-Blue-BB-; Diamine-Blue-2B-; Diamine-Blue-BB-; Diaphtamine-Blue-BB-; Diazine-Blue-2B-; Diazol-Blue-2B-; Direct-Blue-6-; Direct-Blue-A-; Direct-Blue-2B-; Direct-Blue-BB-; Direct-Blue-GS-; Direct-Blue-K-; Enianil-Blue-2BN-; Hispamin-Blue-2B-; Kayaku-Direct-; Mitsui-Direct-Blue-2BN-; Modr-Prima-6- (Czech); NCI-C54579-; Niagara-Blue-2B-; Nippon-Blue-BB-; Paramine-Blue-2B-; Phenamine-Blue-BB-; Pontamine-Blue-BB-; Sodium-diphenyl-4,4'-bis-azo-2-8-amino-1-naphthol-3,6-disulphonate-; Pheno-Blue-2B-; Tertrodirect-Blue-2B-; Vondacel-Blue-2B- RN: Current: 2602-46-2 UD: 200012 MF: C32-H20-N6-O14-S4.4 Na MW: 932.78 WL: L66J BQ DSWQ HSWQ JZ CNUNR DR DNUN- CL66J BQ DSWQ HSWQ JZ &-NA- 4 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 100 ug/plate (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 22, p. 188, 1993 (EMMUEG); mmo-sat 100 nmol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 33, 1984 (MUREAV); dna-rat-ipr 61200 ug/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 32, p. 315, 1984 (TXCYAC); dnd-mus-orl 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 465, p. 11, 2000 (MUREAV) RE: T41-T42-T34 ipr-rat TDLo: 200 mg/kg (8D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 127, p. 215, 1968 (PSEBAA); T25 ipr-rat TDLo: 140 mg/kg (8D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 127, p. 215, 1968 (PSEBAA); T39 ipr-rat TDLo: 200 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 2, p. 85, 1969 (TJADAB); T25 scu-rat TDLo: 100 mg/kg (8D preg) Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 91, p. 14P, 1964 (BIJOAK); T59 scu-rat TDLo: 150 mg/kg (8D preg) Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 91, p. 14P, 1964 (BIJOAK); T41-T42 scu-rat TDLo: 167 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 4, p. 327, 1971 (TJADAB) TE: V01-L60 orl-rat TDLo: 5250 mg/kg/5W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); V03-L60 scu-rat TDLo: 750 mg/kg/27W-I British Journal of Experimental Pathology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1920- v. 38, p. 291, 1957 (BJEPA5); V03-M60 orl-mus TDLo: 34 gm/kg/60W-C Tokyo Jikeikai Ika Daigaku Zasshi. Tokyo Jikeikai Medical Journal. (3-25-8, Nishi Shinbashi, Minato-ku, Tokyo 105, Japan) V.66- 1951- v. 88, p. 467, 1973 (TJIDAH); V03-M60 imp-mus TDLo: 80 mg/kg Tokyo Jikeikai Ika Daigaku Zasshi. Tokyo Jikeikai Medical Journal. (3-25-8, Nishi Shinbashi, Minato-ku, Tokyo 105, Japan) V.66- 1951- v. 88, p. 467, 1973 (TJIDAH); V02-L60 orl-rat TD :2310 mg/kg/4W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); V01-L60 orl-rat TD :13650 mg/kg/13W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 54, p. 431, 1980 (TXAPA9) ORNG: 8760000000 ng/kg. [8760.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 8760 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*); T/E unlistd orl-rbt LDLo: 4 gm/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*); T/E unlistd skn-rbt LDLo: 2 gm/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) OTS 215154 (TSCAT*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 311, 1982 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 311, 1982 (IMEMDT); TOXICOLOGY REVIEW Advances in Teratology. (New York, NY) V.1-5, 1966-72. Discontinued. v. 1, p. 131, 1966 (ADTEAS) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993 ND: NOHS 1974: HZD M1416; NIS 4; TNF 94; NOS 10; TNE 1333; NOES 1983: HZD M1416; NIS 4; TNF 70; NOS 6; TNE 3450; TFE 394 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 24, 1978; NIOSH Analytical Method, 1994: Dyes, 5013; NCI Carcinogenesis Bioassay (feed), clear evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); NCI Carcinogenesis Bioassay (feed), no evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-108, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; NTP Toxicity studies, RPT# TR-108, October 2000 Record 889 of 1119 in RTECS (through 2003/06) AN: QJ6420000 PN: 2,7-Naphthalenedisulfonic acid, 3,3'-((3,3'-dimethoxy-4,4'-biphenylylene)bis(azo))bis(5-amino- 4-hydroxy-, tetrasodium salt SY: Airedale-Blue-D-; Aizen-Direct-Sky-Blue-5BH-; Aizen-Direct-Sky-Blue-5B-; Amanil-Sky-Blue-; Atlantic-Sky-Blue-A-; Atul-Direct-Sky-Blue-; Azine-Sky-Blue-5B-; Belamine-Sky-Blue-A-; Chrome-Leather-Pure-Blue-; C.I. 24400; C.I. Direct Blue 15; C.I. Direct Blue 15, tetrasodium salt; Cresotine-Pure-Blue-; Diphenyl-Brilliant-Blue-; Diphenyl-Sky-Blue-6B-; Fenamin-Sky-Blue-; Benzanil-Sky-Blue-; Benzo-Sky-Blue-S-; Benzo-Sky-Blue-A-CF-; Cartasol-Blue-2GF-; Chloramine-Sky-Blue-A-; Chloramine-Sky-Blue-4B-; Diacotton-Sky-Blue-5B-; Diamine-Blue-; Diamine-Blue-6B-; Diamine-Sky-Blue-; Diamine-Sky-Blue-CI-; Diaphtamine-Pure-Blue-; Diazol-Pure-Blue-4B-; Direct-Blue-15-; Direct-Blue-10G-; Direct-Blue-HH-; Direct-Pure-Blue-; Direct-Pure-Blue-M-; Direct-Sky-Blue-A-; Direct-Sky-Blue-5B-; Enianil-Pure-Blue-AN-; Hispamin-Sky-Blue-3B-; Kayafect-Blue-Y-; Kayaku-Direct-Sky-Blue-5B-; Mitsui-Direct-Sky-Blue-5B-; Modr-Prima-15- (Czech); Naphtamine-Blue-10G-; NCI-C61290-; Niagara-Blue-4B-; Niagara-Sky-Blue-; Nippon-Direct-Sky-Blue-; Nippon-Sky-Blue-; Phenamine-Sky-Blue-A-; Pontamine-Sky-Blue-5BX-; Pontacyl-Sky-Blue-4BX-; Shikiso-Direct-Sky-Blue-5B-; Sky-Blue-4B-; Sky-Blue-5B-; Nitto-Direct-Sky-Blue-5B-; Oxamine-Sky-Blue-5B-; Paper-Blue-S-; Tertrodirect-Blue-F-; Vondacel-Blue-HH- RN: Current: 2429-74-5 Previous: 51568-94-6; 95032-75-0 UD: 200302 MF: C34-H24-N6-O16-S4.4 Na MW: 992.84 WL: L66J BQ DSWO HSWO JZ CNUNR CO1 DR BO1 DNUN- CL66J BQ DSWO HSWO JZ &-NA- 4 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 500 ug/plate (+S9) Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 22, p. 413, 1980 (VHTODE); mmo-sat 100 ug/plate (-S9) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 18, p. 111, 1986 (JTEHD6); dnd-mus-orl 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 465, p. 11, 2000 (MUREAV) RE: T25 ipr-rat TDLo: 70 mg/kg (8D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 127, p. 215, 1968 (PSEBAA); T41-T42 ipr-rat TDLo: 200 mg/kg (8D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 127, p. 215, 1968 (PSEBAA); T39 ipr-rat TDLo: 140 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 2, p. 85, 1969 (TJADAB); T87 orl-mus TDLo: 5 gm/kg (8-12D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 177, 1993 (FAATDF) TE: V01-A60-P61 orl-rat TDLo: 168 gm/kg/96W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-397, 1992 (NTPTR*); V01-K60-R60 orl-rat TDLo: 23284.8 mg/kg/88W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-126373 (NTIS**); V01-K60-R60 orl-rat TDLo: 19404 mg/kg/88W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-126373 (NTIS**) MD: L30-N74-U01 orl-rat TDLo: 52500 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-397, 1992 (NTPTR*); L03-M03-U01 orl-rat TDLo: 10 gm/kg/13W National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-397, 1992 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 235, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 235, 1993 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 235, 1993 (IMEMDT); TOXICOLOGY REVIEW Advances in Teratology. (New York, NY) V.1-5, 1966-72. Discontinued. v. 1, p. 131, 1966 (ADTEAS) ND: NOHS 1974: HZD M4514; NIS 1; TNF 10; NOS 2; TNE 69; NOES 1983: HZD M4514; NIS 7; TNF 485; NOS 7; TNE 4527; TFE 201 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (water), clear evidence: rat Record 890 of 1119 in RTECS (through 2003/06) AN: QJ6475500 PN: 1,3-Naphthalenedisulfonic acid, 8-((3,3'-dimethyl-4'-((4-(((4-methylphenyl)sulfonyl)oxy) phenyl)azo)(1,1'-biphenyl)-4-yl)azo)-7-hydroxy-, disodium salt SY: Acid-Leather-Red-BG-; Acid-Red-114-; Amacid-Milling-Red-PRS-; C.I. 23635; C.I. Acid Red 114; C.I. Acid Red 114, disodium salt; Fenafor-Red-PB-; Benzyl-Fast-Red-BG-; Benzyl-Red-BR-; Cerven-kysela-114- (Czech); Elcacid-Milling-Fast-Red-RS-; Erionyl-Red-RS-; Folan-Red-B-; Intrazone-Red-BR-; Kayanol-Milling-Red-RS-; Leather-Fast-Red-B-; Levanol-Red-GG-; Midlon-Red-PRS-; Milling-Fast-Red-B-; Milling-Red-B-; Milling-Red-BB-; Milling-Red-SWB-; NCI-C61096-; Polar-Red-RS-; Sandolan-Red-N-RS-; Sella-Fast-Red-RS-; Sulphonol-Fast-Red-R-; Sulphonol-Red-R-; Suminol-Milling-Red-RS-; Supranol-Fast-Red-3G-; Supranol-Fast-Red-GG-; Supranol-Red-PBX-CF-; Supranol-Red-R-; Telon-Fast-Red-GG-; Tetracid-Milling-Red-B-; Tetracid-Milling-Red-G-; Vondamol-Fast-Red-RS- RN: Current: 6459-94-5 UD: 200302 MF: C37-H28-N4-O10-S3.2 Na MW: 830.85 WL: L66J BNUNR B1 DR C1 DNUNR DOSWR D1&&&& CQ HSWO JSWO &-NA- 2 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 300 nmol/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 33, 1984 (MUREAV); mmo-sat 125 ug/plate (-S9) Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 22, p. 413, 1980 (VHTODE) TE: V01-D09-R60 orl-rat TDLo: 15 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-405, 1991 (NTPTR*); V01-R60-N60 orl-rat TDLo: 3028.2 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-189380 (NTIS**); V01-N60-T69 orl-rat TDLo: 5407.5 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-189380 (NTIS**) MD: N74-U01 orl-rat TDLo: 26 gm/kg/13D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NPT-TR-405, 1991 (NTPTR*); L70-M70-Y15 orl-rat TDLo: 10920 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-405, 1991 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 247, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 247, 1993 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 247, 1993 (IMEMDT) ND: NOHS 1974: HZD M1427; NIS 3; TNF 116; NOS 14; TNE 2855; NOES 1983: HZD M1427; NIS 9; TNF 331; NOS 12; TNE 18511; TFE 352 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (water), clear evidence: rat Record 891 of 1119 in RTECS (through 2003/06) AN: QJ6500000 PN: 1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-(phenylazo)-, disodium salt SY: Acidal-Fast-Orange-; Acid-Fast-Orange-EGG-; Acid-Fast-Orange-G-; Acid-Leather-Orange-KG-; Acid-Leather-Orange-PGW-; Acid-Light-Orange-G-; Acid-Light-Orange-J-; Acid-Light-Orange-JA-Export-; Acid-Light-Orange-SX-; Acid-Orange-10-; Acid-Orange-G-; Acid-Orange-2G-; Acid-Orange-GG-; Acilan-Orange-GX-; Apocid-Orange-2G-; Atul-Acid-Crystal-Orange-G-; C.I. 27; C.I. 16230; C.I. Acid Orange 10; C.I. Acid Orange 10, disodium salt; C.I. Food Orange 4; Colacid-Orange-G-; Crystal-Orange-2G-; Fast-Light-Orange-GA-; Fast-Light-Orange-GA-CF-; Brasilan-Orange-2G-; Bucacid-Fast-Orange-G-; Calcocid-Fast-Light-Orange-2G-; Certicol-Orange-GS-; Cetil-Light-Orange-GG-; D&C Orange No. 3; Eniacid-Light-Orange-G-; Erio-Fast-Orange-AS-; Hexacol-Orange-GG-Crystals-; Hidacid-Fast-Orange-G-; Hidacid-Fast-Orange-2G-; Hispacid-Fast-Orange-2G-; 7-Hydroxy-8-(phenylazo)-1,3-naphthalenedisulfonic acid, disodium salt; 7-Hydroxy-8-(phenylazo)-1,3-naphthalenedisulphonic acid, disodium salt; Java-Orange-2G-; Kiton-Fast-Orange-G-; Ink-Orange-JSN-; Intracid-Fast-Orange-G-; Naphthalene-Fast-Orange-2G-; Naphthalene-Fast-Orange-2GS-; Naphthalene-Orange-Solide-GG-; NCI-C53838-; Neklacid-Fast-Light-Orange-GG-; Neklacid-Fast-Orange-2G-; Schultz No. 39; Solar-Light-Orange-GX-; Standacol-Orange-G-; Straight-Orange-G-; Sulfacid-Light-Orange-J-; Orange #10; 1370-Orange-; Orange-BPC-; Orange-2G-; Orange-G- (biological stain); Orange-G-BPC-; Orange-G-DYE-; Orange-GG-; Orange-G- (indicator); Orange-GMP-; Oranz-G- (Polish); Oranz-GG- (Czech); Oranz-kysela-10- (Czech); Oranz-potravinarska-4- (Czech); 1-Phenylazo-2-naphthol-6,8-disulfonic-acid,-disodium-salt-; 1-Phenylazo-2-naphthol-6,8-disulphonic-acid,-disodium-salt-; Tertracid-Light-Orange-G-; Unitertracid-Light-Orange-G-; Vondacid-Light-Orange-2G-; Wool-Orange-G-; Wool-Orange-2G-; Xylene-Fast-Orange-G- RN: Current: 1936-15-8 UD: 200302 MF: C16-H10-N2-O7-S2.2 Na MW: 452.38 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: pic-esc 100 mmol/L Medycyna Doswiadczalna i Mikrobiologia. For English translation, see EXMMAV. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1949- v. 31, p. 11, 1979 (MDMIAZ); slt-mus-lym 1 gm/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17, p. 196, 1991 (EMMUEG); cyt-ham-ovr 1250 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 165, 1989 (EMMUEG); cyt-ham-ovr 20 umol/L/5H-C Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 27, 1979 (ENMUDM) RE: T02 orl-pig TDLo: 28 gm/kg (16W male) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 367, 1973 (FCTXAV) TE: V02-L60 orl-rat TDLo: 129780 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-169347/AS (NTIS**) MD: L70-N73-P05 orl-rat TDLo: 26250 mg/kg/15W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 329, 1971 (FCTXAV); P27 orl-rat TDLo: 27300 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-211, 1987 (NTPTR*); P27 orl-mus TDLo: 136 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-211, 1987 (NTPTR*); N73-P05-P30 orl-pig TDLo: 2800 mg/kg/16W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 367, 1973 (FCTXAV) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 8, p. 181, 1975 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 8, p. 181, 1975 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) ND: NOHS 1974: HZD M2138; NIS 9; TNF 613; NOS 24; TNE 11575; NOES 1983: HZD M2138; NIS 11; TNF 588; NOS 32; TNE 27936; TFE 12401 SL: EPA GENETOX PROGRAM 1988, Inconclusive: B subtilis rec assay, Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 892 of 1119 in RTECS (through 2003/06) AN: QU7175550 PN: Naphthalene,-1,2,3,4,6,7-hexachloro- SY: 1,2,3,4,6,7-Hexachlorinated-naphthalane-; 1,2,3,4,6,7-Hexachloronaphthalene- RN: Current: 103426-96-6 UD: 200210 MF: C10-H2-Cl6 MW: 334.82 CC: Tumorigen (C); Reproductive-Effector (T) RE: T87 orl-rat TDLo: 3 ug/kg (14-16D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 108, p. 539, 2000 (EVHPAZ); T53-T82-T91 orl-rat TDLo: 3 ug/kg (14-16D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 108, p. 539, 2000 (EVHPAZ) SL: NTP Carcinogenesis studies, selected, October 2000 Record 893 of 1119 in RTECS (through 2003/06) AN: QJ7400000 PN: Naphthalene,-1,2,3,5,6,7-hexachloro- SY: 1,2,3,5,6,7-Hexachloronaphthalene- RN: Current: 103426-97-7 UD: 200012 MF: C10-H2-Br6 MW: 601.58 CC: Tumorigen (C) AT: T/E unlistd orl-gpg LD50: >3610 ug/kg Pergamon Series on Environmental Science. (Oxford, UK) V.1-7, 1978-82. Discontinued. v. 5, p. 367, 1982 (PSSID2) SL: NTP Carcinogenesis studies, selected, October 2000 Record 894 of 1119 in RTECS (through 2003/06) AN: QK1925000 PN: 1-Naphthalenesulfonic-acid,-4-hydroxy-3,4'-azodi-,-disodium-salt- SY: 11959-Red-; 2-(4-Sulfo-1-naphthylazo)-1-naphthol-4-sulfonic acid, disodium salt; 2-(4-Sulpho-1-naphthylazo)-1-naphthol-4-sulphonic acid, disodium salt; 4-Hydroxy-3,4'-azodi-1-naphthalenesulfonic-acid,-disodium-salt-; 4-Hydroxy-3,4'-azodi-1-naphthalenesulphonic-acid,-disodium-salt-; 4-Hydroxy-3-((4-sulfo-1-naphthalenyl)azo)-1-naphthalenesulfonic acid, disodium salt; 4-Hydroxy-3-((4-sulpho-1-naphthalenyl)azo)-1-naphthalenesulphonic acid, disodium salt; Acetacid-Red-B-; Acid-Brilliant-Rubine-2G-; Acid-Brilliant-Rubine-2GT-; Acid Brilliant Rubine A2G conc.; Acid-Chrome-Blue-2R-; Acid-Chrome-Blue-BA-; Acid-Chrome-Blue-BA-CF-; Acid-Chrome-Blue-FBS-; Acid-Fast-Red-FB-; Acid-Red-14-; Acid-Red-2C-; Acid-Rubine-; Acid-Rubine-Extra-; Airedale-carmoisine-; Amacid-Chrome-Blue-R-; Amacid-carmoisine-B-; Atul-Acid-Crystal-Red-; Atul-Crystal-Red-F-; Azo-Rubin-Extra-; Azo-Rubine-; Azo-Rubine- (biological stain); Azo-Rubine-AF-; Azo-Rubine-Extra-LC-; Azo-Rubine-LZ-; Azo-Rubine-S-; Azo-Rubine-S-Specially-Pure-; Azo-Rubine-XX-; Azo-Rubine-for-food-; Azo-rubin-S-; Azo-rubin-XX-; Azorubin-; Brasilan-Azo-Rubine-2NS-; Brilliant-Acid-Rubine-M-; Brilliant Crimson 2R. FQ; Brilliant-Crimson-Red-; Brilliant-carmoisine-; Bucacid-Azo-Rubine-; C.I. 14720; C.I. Acid Red 14; C.I. Acid Red 14, disodium salt; C.I. Food Red 3; Calcocid-Rubine-XX-; Carmoisin- (German); Carmoisine-; Carmoisine-Aluminum-Lake-; Carmoisine-BA-; Carmoisine-BA-CF-; Carmoisine-BSS-; Carmoisine-FU-; Carmoisine-GRN-; Carmoisine-LAS-; Carmoisine-S-; Carmoisine-Supra-; Carmoisine-W-; Carmoisine-WS-; Certicol-carmoisine-S-; Cerven-kysela-14- (Czech); Cerven-potravinarska-3- (Czech); Chrome-Fast-Blue-2R-; Chromotrop-FB-; Chromotrope-FB-; Cilefa-Rubine-R-; Crimson-2EMBL-; Crimson-EMBL-; Diadem-Chrome-Blue-G-; Diadem-Chrome-Blue-R-; Disodium 2-(4-sulfo-1-naphthylazo)-1-naphthol-4-sulfonate; Disodium 2-(4-sulpho-1-naphthylazo)-1-naphthol-4-sulphonate; Disodium salt of 2-(4-sulpho-1-naphthylazo)-1-naphthol-4-sulphonic acid; E122-; Edicol-Supra-Carmoisine-W-; Edicol-Supra-Carmoisine-WS-; Eniacid-Brilliant-Rubine-3B-; Erio-Rubine-B-; Eurocert-Azorubine-; Ext D & C Red No. 10; Extract D and C Red No. 10; Fenazo-Red-C-; Food-Red-5-; Fruit-Red-A-Extra-Yellowish-Geigy-; HD-Carmoisine-Supra-; HD-carmoisine-; Hexacol-carmoisine-; Hexacol carmoisine conc.; Hidacid-Azo-Rubine-; Hispacid-Rubine-F-; Java-Rubine-N-; Karmesin-; Kenachrome-Blue-2R-; Kiton-Crimson-2R-; Kiton-Rubine-R-; L. Red Z 3040; Lighthouse-Chrome-Blue-2R-; NCI-C53849-; Nacarat-; Nacarat-A-export-; Nacarat-Extra-Pure-A-; Neklacid-Azorubine-W-; Neklacid-Rubine-W-; Nylomine-Acid-Red-P4B-; Omega-Chrome-Blue-FB-; Poloxal-Red-2B-; Pontacyl-Rubine-R-; Red #14; Schultz Nr. 208 (German); Solar-Rubine-; Solochrome-Blue-FB-; Standacol-carmoisine-; Tertracid-Red-CA-; Tertrochrome-Blue-FB- RN: Current: 3567-69-9 Previous: 65721-85-9 UD: 200302 MF: C20-H12-N2-O7-S2.2 Na MW: 502.44 WL: L66J BSWQ ENUN- CL66J BQ ESWQ &-NA- 2 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1 gm/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 289, 1978 (MUREAV); mmo-esc 100 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 289, 1978 (MUREAV); mtr-ham-emb 300 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 356, p. 85, 1996 (MUREAV); sce-ham-ovr 300 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 133, 1989 (EMMUEG) TE: V03-T64 orl-rat TDLo: 901250 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-201468 (NTIS**) AT: F07-F12-F24 orl-rat LD50: >10 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 5, p. 179, 1967 (FCTXAV); F07-F12-F24 ipr-rat LD50: 900 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 5, p. 179, 1967 (FCTXAV); T/E unlistd ivn-rat LD50: 800 mg/kg Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- v. 15, p. 402, 1957 (APFRAD); F07-F12-F24 orl-mus LD50: >8 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 5, p. 179, 1967 (FCTXAV); F07-F12-F24 ipr-mus LD50: 900 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 5, p. 179, 1967 (FCTXAV); T/E unlistd ivn-mus LD50: 800 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 413, 1981 (FCTXAV) MD: M70 orl-rat TDLo: 74 gm/kg/90D-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 5, p. 179, 1967 (FCTXAV); U01 orl-rat TDLo: 70 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-220, 1982 (NTPTR*); U01 orl-mus TDLo: 168 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-220, 1982 (NTPTR*); M20-U10 orl-mus TDLo: 135 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-220, 1982 (NTPTR*) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 8, p. 83, 1975 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 8, p. 83, 1975 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) ND: NOHS 1974: HZD M1431; NIS 3; TNF 92; NOS 14; TNE 1771; NOES 1983: HZD M1431; NIS 39; TNF 2819; NOS 49; TNE 38995; TFE 8194 SL: EPA GENETOX PROGRAM 1988, Negative: Carcinogenicity-mouse/rat, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Inconclusive: B subtilis rec assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 895 of 1119 in RTECS (through 2003/06) AN: QK3850000 PN: Naphthalene,-1,2,3,4-tetrahydro- SY: Naphthalene-1,2,3,4-tetrahydride-; Delta(sup 5,7,9)-naphthantriene; Tetrahydronaphthalene-; 1,2,3,4-Tetrahydronaphthalene-; Tetralin-; Tetralina- (Polish); Tetraline-; Tetranap- RN: Current: 119-64-2 UD: 200204 MF: C10-H12 MW: 132.22 WL: L66&TJ CC: Tumorigen (C); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg open SEV Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 1/12/1972 (UCDS**); skn-hmn 2.5%/24H Journal of Investigative Dermatology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1938- v. 24, p. 303, 1991 (JIDEAE) ORNL: 1620000 nL/kg. [1.620000 mL/kg] T/E unlistd SRNL: 17300000 nL/kg. [17.300000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1620 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 1/12/1972 (UCDS**); T/E unlistd skn-rbt LD50: 17300 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 1/12/1972 (UCDS**); T/E unlistd ihl-gpg LC50: 275 ppm "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,47,1986 (85JCAE) SR: OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 300 mg/m3, JAN 1999 ND: NOHS 1974: HZD 84671; NIS 11; TNF 622; NOS 13; TNE 2237; NOES 1983: HZD 84671; NIS 2; TNF 117; NOS 3; TNE 504; TFE 146 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 896 of 1119 in RTECS (through 2003/06) AN: QK4247000 PN: 2-Naphthalenol, 1-((4-methyl-2-nitrophenyl)azo)- SY: Adc-Toluidine-Red-B-; Atlasol-Spirit-Red-3-; Chromatex-Red-J-; C.I.12120; C.I. Pigment Red 3; C.P. Toluidine Toner A-2989; C.P. Toluidine Toner A-2990; C.P. Toluidine Toner Dark RS-3340; C.P. Toluidine Toner Deep X-1865; C.P. Toluidine Toner Light RS-3140; C.P. Toluidine Toner RT-6101; C.P. Toluidine Toner RT-6104; Fastona-Red-B-; Fastona-Scarlet-RL-; Fastona-Scarlet-YS-; Fast-Red-AB-; Fast-Red-A- (pigment); Fast-Red-J-; Fast-Red-JE-; Fast-Red-R-; Independence-Red-; Accosperse-Toluidine-Red-XL-; Calcotone-Toluidine-Red-YP-; Carnelio-Helio-Red-; Cerven-pigment-3- (Czech); Dainichi-Permanent-Red-4-R-; D and C Red No. 35; Deep-Fastona-Red-; Duplex-Toluidine-Red-L-20-3140-; Eljon-Fast-Scarlet-PV-Extra-; Eljon-Fast-Scarlet-RN-; Enialit-Light-Red-RL-; Graphtol-Red-A-4RL-; Hansa-Red-B-; Hansa-Red-G-; Hansa-Scarlet-RB-; Hansa-Scarlet-RN-; Hansa-Scarlet-RNC-; Helio-Fast-Red-BN-; Helio-Fast-Red-RL-; Helio-Fast-Red-RN-; Helio-Red-RL-; Helio-Red-Toner-; Hispalit-Fast-Scarlet-RN-; Irgalite-Fast-Red-P4R-; Irgalite-Fast-Scarlet-RND-; Irgalite-Red-PV2-; Irgalite-Red-RNPX-; Irgalite-Scarlet-RB-; Isol-Fast-Red-HB-; Isol-Fast-Red-RNB-; Isol-Fast-Red-RN2B-; Isol-Fast-Red-RNG-; Isol-Fast-Red-RN2G-; Isol-Toluidine-Red-HB-; Isol-Toluidine-Red-RNB-; Isol-Toluidine-Red-RN2B-; Isol-Toluidine-Red-RNG-; Isol-Toluidine-Red-RN2G-; Kromon-Helio-Fast-Red-; Kromon-Helio-Fast-Red-YS-; Lake-Red-4R-; Lake-Red-4RII-; Lithol-Fast-Scarlet-RN-; Lutetia-Fast-Red-3R-; Lutetia-Fast-Scarlet-RF-; Lutetia-Fast-Scarlet-RJN-; 1-((4-Methyl-2-nitrophenyl)azo)-2-naphthalenol; Monolite-Fast-Scarlet-CA-; Monolite-Fast-Scarlet-GSA-; Monolite-Fast-Scarlet-RB-; Monolite-Fast-Scarlet-RBA-; Monolite-Fast-Scarlet-RN-; Monolite-Fast-Scarlet-RNA-; Monolite-Fast-Scarlet-RNV-; Monolite-Fast-Scarlet-RT-; NCI-C60366-; 1-((2-Nitro-4-methylphenyl)azo)-2-naphthol; Permanent-Red-4R-; Pigment-Red-3-; Pigment-Red-RL-; Pigment-Ruby-; Pigment-Scarlet-; Pigment-Scarlet- (Russian); Pigment-Scarlet-B-; Pigment-Scarlet-N-; Pigment-Scarlet-R-; Polymo-Red-FGN-; Recolite-Fast-Red-RBL-; Recolite-Fast-Red-BL-; Recolite-Fast-Red-RYL-; Sanyo-Scarlet-Pure-; Sanyo Scarlet Pure No. 1000; Scarlet-pigment-RN-; Segnale-Light-Red-B-; Segnale-Light-Red-2B-; Segnale-Light-Red-BR-; Segnale-Light-Red-C4R-; Segnale-Light-Red-RL-; Siegle-Red-1-; Siegle-Red-B-; Siegle-Red-BB-; Silogomma-Red-RLL-; Silosol-Red-RBN-; Silosol-Red-RN-; Siloton-Red-BRLL-; Siloton-Red-RLL-; Symuler-Fast-Scarlet-4R-; Syton-Fast-Scarlet-RB-; Syton-Fast-Scarlet-RD-; Syton-Fast-Scarlet-RN-; Toluidine-Red-; Toluidine-Red-10451-; Toluidine-Red-3B-; Toluidine-Red-BFB-; Toluidine-Red-BFGG-; Toluidine-Red-D-28-3930-; Toluidine-Red-Light-; Toluidine-Red-M-20-3785-; Toluidine-Red-R-; Toluidine-Red-4R-; Toluidine-Red-RT-115-; Toluidine-Red-Toner-; Toluidine-Red-XL-20-3050-; Toluidine-Toner-; Toluidine-Toner-Dark-5040-; Toluidine-Toner-4R-X-2700-; Toluidine-Toner-HR-X-2741-; Toluidine-Toner-Keep-HR-X-2742-; Toluidine-Toner-L-20-3300-; Toluidine-Toner-RT-252-; 1-(o-Nitro-p-tolylazo)-2-naphthol; No. 2 Forthfast Scarlet; Oralith-Red-P4R-; Tertropigment-Red-HAB-; Tertropigment-Scarlet-LRN-; Versal-Scarlet-PRNL-; Versal-Scarlet-RNL-; Vulcafor-Scarlet-A- RN: Current: 2425-85-6 Previous: 12238-48-1; 12240-01-6; 12240-02-7; 39310-30-0 UD: 200302 MF: C17-H13-N3-O3 MW: 307.33 WL: L66J BNUNR D1 BNW& CQ CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 3333 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); dnd-mus-orl 2 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 465, p. 11, 2000 (MUREAV) TE: V02-L60 orl-rat TDLo: 910 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-407, 1992 (NTPTR*); V02-L60-M60 orl-mus TDLo: 4368 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-407, 1992 (NTPTR*); V02-N61 orl-rat TDLo: 540750 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191634/AS (NTIS**); V03-R60 orl-rat TDLo: 1081500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191634/AS (NTIS**); V02-L60 orl-rat TDLo: 901250 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191634/AS (NTIS**); V02-M61-N62 orl-mus TDLo: 4326000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191634/AS (NTIS**) MD: P05-P70 orl-rat TDLo: 42 gm/kg/14D-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 27, p. 793, 1989 (FCTOD7); L70-M70-P26 orl-rat TDLo: 68 gm/kg/90D-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 27, p. 793, 1989 (FCTOD7); L70-P71-U30 orl-mus TDLo: 84 gm/kg/2W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-407, 1992 (NTPTR*); L70-Z01 orl-mus TDLo: 273 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-407, 1992 (NTPTR*); P61-T69-V30 orl-rat TDLo: 216300 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-191634/AS (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 259, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 259, 1993 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 259, 1993 (IMEMDT) ND: NOHS 1974: HZD M2109; NIS 78; TNF 6944; NOS 56; TNE 47730; NOES 1983: HZD M2109; NIS 57; TNF 4689; NOS 53; TNE 51931; TFE 11615 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (feed), some evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-407, 1992 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 897 of 1119 in RTECS (through 2003/06) AN: QK4275000 PN: 1(4H)-Naphthalenone, 4-(p-bis(2-chloroethyl)aminophenyl)imino- SY: 4-(p-Bis(2-chloroethyl)aminophenyl)imino-1(4H)-naphthalenone RN: Current: 63979-13-5 UD: 199406 MF: C20-H18-Cl2-N2-O MW: 373.30 WL: L66 BV EYJ EUNR DN2G2G CC: Z Other (Z) AT: T/E unlistd ipr-rat LD50: 70 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 13, p. 969, 1964 (BCPCA6) MD: P26 orl-rat TDLo: 210 gm/kg/12W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-208, 1981 (NTPTR*) Record 898 of 1119 in RTECS (through 2003/06) AN: QL0175000 PN: Naphtho(1,2,3,4-def)chrysene SY: DB(a,e)P; Dibenzo(a,e)pyrene; 1,2,4,5-Dibenzopyrene- RN: Current: 192-65-4 BRN: 2054070 BHR: 4-05-00-02803 UD: 200007 MF: C24-H14 MW: 302.38 WL: L D66 L666 B6 2AB A&J CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 5 nmol/plate (-S9) Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 3, p. 580, 1990 (CRTOEC); msc-hmn-lym 25 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 342, p. 9, 1995 (MUREAV) TE: V02-R60-V10 skn-mus TDLo: 312 mg/kg/52W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 68, p. 137, 1966 (ZEKBAI); V03-V10 scu-mus TDLo: 72 mg/kg/9W-I Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 259, p. 3899, 1964 (COREAF) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 3, p. 201, 1973 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 327, 1983 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 32, p. 327, 1983 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SR: OEL-FRANCE: Carcinogen, JAN 1993 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 899 of 1119 in RTECS (through 2003/06) AN: QL4900000 PN: 2-Naphthol, 1-(phenylazo)- SY: Atul-Orange-R-; Benzeneazo-beta-naphthol-; Benzene-1-azo-2-naphthol-; 1-Benzeneazo-2-naphthol-; 1-Benzoazo-2-naphthol-; C.I. 12055; C.I. Solvent Yellow 14; Dispersol-Yellow-PP-; Dunkelgelb-; Enial-Orange-I-; Fast-Oil-Orange-I-; Fast-Orange-; Fat-Orange-4A-; Fat-Orange-G-; Fat-Orange-I-; Fat-Orange-R-; Fat-Orange-RS-; Morton-Orange-Y-; Brasilazina-Oil-Orange-; Brilliant-Oil-Orange-R-; Calcogas-M-; Calcogas-Orange-NC-; Calco-Oil-Orange-7078-; Calco-Oil-Orange-7078-Y-; Calco-Oil-Orange-Z-7078-; Campbelline-Oil-Orange-; Carminaph-; Ceres-Orange-R-; Cerotinorange-G-; Grasal-Orange-; Grasan-Orange-R-; Hidaco-Oil-Orange-; Lacquer-Orange-VG-; Plastoresin-Orange-F4A-; Toyo-Oil-Orange-; NCI-C53929-; Oleal-Orange-R-; Oil-Orange-; Oil-Orange-31-; Oil-Orange-2311-; Oil-Orange-2B-; Oil-Orange-E-; Oil-Orange-EP-; Oil-Orange-PEL-; Oil-Orange-PS-; Oil-Orange-R-; Oil-Orange-R-14-; Oil-Orange-7078-V-; Oil-Orange-Z-7078-; Oil-Soluble-Orange-; Orange-a-l'huile-; Orange-2-insoluble-; Orange-PEL-; Orange-3RA-soluble-in-grease-; Orange Resenole No. 3; Orange-R-Fat-Soluble-; Orange-soluble-a-l'huile-; Organol-Orange-; Orient-Oil-Orange-PS-; Petrol-Orange-Y-; 1-(Phenylazo)-2-naphthalenol; 1-Phenylazo-beta-naphthol-; 1-Phenylazo-2-naphthol-; Pyronalorange-; Resinol-Orange-R-; Resoform-Orange-G-; Scharlach-B-; Sansel-Orange-G-; Silotras-Orange-TR-; Solvent-Yellow-14-; Somalia-Orange-I-; Spirit-Orange-; Spirit-Yellow-I-; Stearix-Orange-; Sudan-1-; Sudan-I-; Sudan-Orange-R-; Sudan-Orange-RA-; Sudan-Orange-RA-New-; Tertrogras-Orange-SV-; Waxakol-Orange-GL-; Waxoline-Yellow-I-; Waxoline-Yellow-IM-; Waxoline-Yellow-IP-; Waxoline-Yellow-IS-; Zlut-rozpoustedlova-14- (Czech) RN: Current: 842-07-9 BRN: 651992 BHR: 4-16-00-00228 UD: 200302 MF: C16-H12-N2-O MW: 248.30 WL: L66J BNUNR& CQ CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 300 ng/plate (-S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); mnt-rat-orl 250 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1403, 1991 (CRNGDP); dns-rat-orl 500 mg/kg Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 3, p. 193, 1987 (CBTOE2); mmo-mus-lym 4 mg/L (+S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); slt-mus-lym 8 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17, p. 196, 1991 (EMMUEG); dnd-mus-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 465, p. 11, 2000 (MUREAV); msc-mus-lym 37 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 223, 1987 (MUREAV); sce-ham-ovr 8200 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V02-L60 orl-rat TDLo: 10815 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-226, 1982 (NTPTR*); V02-L60 orl-mus TDLo: 21630 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-226, 1982 (NTPTR*); V03-L60-V10 scu-mus TDLo: 6000 mg/kg/57W-I Glasgow Medical Journal. (Glasgow, Scotland) 1828-1955. For publisher information, see SMDJAK. v. 30, p. 364, 1949 (GMJOAZ); V01-M60 imp-mus TDLo: 80 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 22, p. 825, 1968 (BJCAAI); V03-M60 imp-mus TD :75 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 6, p. 21, 1979 (CALEDQ); V01-M60 imp-mus TD :96 mg/kg Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 17, p. 383, 1975 (GMCRDC); V01-L60 orl-rat TDLo: 21630 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-126474 (NTIS**); V01-L60 orl-rat TDLo: 18025 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-126474 (NTIS**); V01-P61-P62 orl-mus TDLo: 43260 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-126474 (NTIS**) MD: Z01 orl-rat TDLo: 4200 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-226, 1982 (NTPTR*); Z01 orl-mus TDLo: 87360 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-226, 1982 (NTPTR*); P61-P62-V30 orl-rat TDLo: 9012.5 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-126474 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 8, p. 225, 1975 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 8, p. 225, 1975 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 23, p. 6, 1971 (AEHLAU); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 13, p. 271, 1970 (ADCSAJ) ND: NOES 1983: HZD M2105; NIS 34; TNF 1715; NOS 32; TNE 44358; TFE 6755 SL: EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 900 of 1119 in RTECS (through 2003/06) AN: QL6200000 PN: 1H-Naphtho(2,1-b)pyran-1-one, 3-phenyl- SY: beta-Naphthoflavone-; beta-NF-; 3-Phenyl-1H-naphtho(2,1-b)pyran-1-one RN: Current: 6051-87-2 BRN: 18991 BHR: 5-17-10-00728 UD: 200302 MF: C19-H12-O2 MW: 272.31 WL: T B666 CV FOJ ER CC: Tumorigen (C); Reproductive-Effector (T) RE: T25-T35 ipr-rat TDLo: 120 mg/kg (8-10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24, p. 1, 1981 (TJADAB); T25 scu-mus TDLo: 80 mg/kg (11D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 159, 1987 (TCMUD8) TE: V02-L60 orl-rat TDLo: 109 gm/kg/26W-C Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 13, p. 37, 2000 (JTPAE7) AT: T/E unlistd ivn-mus LD50: 180 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#03239 (CSLNX*); T03-Y07 ipr-rat TDLo: 80 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 29, p. 61, 1983 (TXCYAC) MD: L30-Y07 orl-rat TDLo: 1120 mg/kg/14D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 155, p. 1, 1999 (TXAPA9); L70-Y07-Y40 ipr-rat TDLo: 450 mg/kg/3D-I Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 11, p. 580, 1992 (HETOEA); L30-L70-Y07 ipr-rat TDLo: 960 mg/kg/12D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0590101 (NTIS**); L30 orl-mus TDLo: 1120 mg/kg/14D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 155, p. 1, 1999 (TXAPA9); L30-Y07-Y12 ipr-qal TDLo: 600 mg/kg/4D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 15, p. 93, 1985 (JTEHD6); L70-N08-Y16 ipr-rat TDLo: 300 mg/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 111, p. 99, 1991 (TXAPA9); N04-N16-Y09 ipr-nml TDLo: 50 mg/kg/10W-I Molecular and cellular endocrinology (Amsterdam, North-Holland) V.1- 1954- v. 91, p. 99, 1993 (MOCEN*) SL: NTP Carcinogenesis studies, selected, October 2000 Record 901 of 1119 in RTECS (through 2003/06) AN: QM2100000 PN: 2-Naphthylamine- SY: 2-AN-; 2-Aminonaftalen- (Czech); 2-Aminonaphthalene-; 2-Naftylamin- (Czech); 2-Naftylamine- (Dutch); 2-Naphthalamine-; 2-Naphthalenamine-; 2-Naphthylamin- (German); 2-Naphthylamine-mustard-; 6-Naphthylamine-; C.I. 37270; Fast-Scarlet-Base-B-; RCRA-waste-number-U168-; USAF-CB-22-; beta-Naftalamin- (Czech); beta-Naftilamina- (Italian); beta-Naftylamin- (Czech); beta-Naftyloamina- (Polish); beta-Naphthylamin- (German); beta-Naphthylamine-; beta-Naphthylamine- (ACGIH:OSHA) RN: Current: 91-59-8 UD: 200302 MF: C10-H9-N MW: 143.20 WL: L66J CZ CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 2500 ng/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 261, 1981 (PMRSDJ); mmo-sat 2 ug/plate (-S9) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 17, p. 739, 1977 (BECTA6); oms-esc 7 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); mmo-esc 1 ug/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 387, 1981 (PMRSDJ); dnr-esc 25 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); dna-esc 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 25 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 532, 1981 (CNREA8); mmo-bcs 5 gm/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 19, 1977 (MUREAV); dnr-bcs 5 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 19, 1977 (MUREAV); dnd-bcs 2 mg/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); dnd-omi 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); slt-dmg-orl 700 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 195, 1970 (CNREA8); mmo-nsc 200 umol/L (-S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 32, p. 1890, 1972 (CNREA8); mmo-smc 698 umol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 174, p. 39, 1979 (MGGEAE); mmo-smc 89 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 414, 1981 (PMRSDJ); dnr-smc 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 50 ppm Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 481, 1981 (PMRSDJ); sln-smc 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mnt-nml-mul 2500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 157, 1992 (MUREAV); cyt-nml-mul 2500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 319, p. 223, 1993 (MUREAV); mtr-hmn-oth 68 mg/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 17, p. 719, 1981 (ITCSAF); dnd-hmn-fbr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 127, p. 107, 1984 (MUREAV); dns-hmn-fbr 800 ug/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 21, p. 151, 1981 (TXCYAC); dni-hmn-hla 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); dni-hmn-hla 20 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 447, 1982 (MUREAV); mtr-rat-orl 400 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 1157, 1980 (CNREA8); mtr-rat-emb 5 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 799, 1973 (JNCIAM); dnd-rat-ipr 1390 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 1317, 1981 (CRNGDP); dnd-rat-lvr 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 357, 1983 (MUREAV); dns-rat-lvr 10 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); dni-rat-lvr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 337, 1985 (CNREA8); bfa-rat-sat 250 umol/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 16, p. 113, 1980 (TXCYAC); cyt-rat-ipr 6 mg/kg/72H Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 23, p. 36, 1980 (NULSAK); cyt-rat-lvr 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 570, 1981 (PMRSDJ); mnt-mus-ipr 100 mg/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 698, 1981 (PMRSDJ); mnt-mus-orl 300 mg/kg/3D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 234, p. 161, 1990 (MUREAV); mmo-mus-lym 4720 ug/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 37, 1988 (EMMUEG); slt-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 121, p. 267, 1983 (MUREAV); mtr-mus-emb 1 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 52, p. 1167, 1974 (JNCIAM); mtr-mus-mmr 1 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 1784, 1979 (CNREA8); dnd-mus-orl 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 440, p. 1, 1999 (MUREAV); dna-mus-ast 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dni-mus-ipr 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); sce-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 108, p. 225, 1983 (MUREAV); msc-mus-lym 225 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 580, 1981 (PMRSDJ); hma-mus-esc 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 161, 1992 (MUREAV); mtr-ham-emb 1600 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 323, 1980 (CRNGDP); mtr-ham-kdy 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 638, 1981 (PMRSDJ); dns-ham-lvr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 255, 1984 (MUREAV); cyt-ham-ovr 3330 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 551, 1981 (PMRSDJ); sce-ham-ovr 5 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 551, 1981 (PMRSDJ); msc-ham-ovr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 94, p. 449, 1982 (MUREAV); dna-dog-orl 60 umol/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 49, p. 125, 1983 (EVHPAZ); dna-dog-orl 8 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 467, 1981 (CRNGDP); dnd-mam-lym 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); mmo-sat 20 ug/plate/20M (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 19, 2001 (MUREAV); mmo-sat 1 nmol/plate/20M Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 38, p. 268, 2001 (EMMUEG) TE: V01-M60 orl-rat TDLo: 17100 mg/kg/57W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 46, p. 646, 1982 (BJCAAI); V03-P62-V10 ipr-rat TDLo: 1300 mg/kg/13W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 28, p. 535, 1968 (CNREA8); V03-P62-V10 scu-rat TDLo: 6 gm/kg/60W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 20(8), p. 69, 1974 (VOONAW); V02-J60 orl-mus TDLo: 600 mg/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 19, 1986 (TXAPA9); V02-J60 ipr-mus TDLo: 1500 mg/kg/8W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1299, 1981 (JJIND8); V03-R60-V10 scu-mus TDLo: 1600 mg/kg/40W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 15(2), p. 71, 1969 (VOONAW); V01-J60-P62 par-mus TDLo: 18 mg/kg Annual Report--Cancer Research Campaign. (Cancer Research Campaign, 2 Carlton House Terrace, London SW1Y 5AR, UK) V.1- 1924- v. 40, p. 42, 1962 (BECCAN); V03-M60 imp-mus TDLo: 100 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 10, p. 539, 1956 (BJCAAI); V01-M60 orl-dog TDLo: 18 gm/kg/2Y-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 49, p. 193, 1972 (JNCIAM); V03-M60 unr-dog TDLo: 40 gm/kg/81W Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 15(2), p. 71, 1969 (VOONAW); V03-M60 mul-dog TDLo: 3077 mg/kg/78W-C American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 13, p. 656, 1937 (AJPAA4); V03-M60 orl-mky TDLo: 17 gm/kg/5Y-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 825, 1969 (JNCIAM); V01-M60 orl-rbt TDLo: 40 gm/kg/5Y Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 286, 1951 (LANCAO); V01-L60-M60 orl-ham TDLo: 217 mg/kg/45W-C "Bladder Cancer, A Symposium, Fifth Inter-American Conference on Toxicology and Occupational Medicine, Coral Gables, FL," Lampe, K.F., et al., eds., Coral Gables, FL, Aesculapius Pub., 1966 5,129,1966 (85DAAC); V01-L60-M60 orl-ham TD :365 gm/kg/43W-C Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 35, p. 564, 1966 (IMSUAI); V03-M60 orl-dog TD :108 mg/kg/4Y Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 286, 1951 (LANCAO); V03-L60 orl-mus TD :31 gm/kg/2Y Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 286, 1951 (LANCAO); V03-M60 orl-rbt TD :30 gm/kg/5Y Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 286, 1951 (LANCAO); V03-M60 mul-dog TD :4379 mg/kg/80W-C Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 20, p. 46, 1938 (JIHTAB); V03-V10 scu-mus TD :80 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 58, p. 56, 1951 (ZEKBAI); V03-R60-T61 orl-rat TD :13 gm/kg/1Y-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 41, p. 985, 1968 (JNCIAM); V03-M60 mul-dog TD :5169 mg/kg/91W-C Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 20, p. 46, 1938 (JIHTAB); V02-M61-R60 orl-rat TD :16 gm/kg/52W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2943, 1977 (CNREA8); V01-M60 orl-dog TD :94500 mg/kg/9Y-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 44, p. 892, 1981 (BJCAAI); V01-M60 orl-dog TDLo: 33600 mg/kg/168W-I Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 37, p. 60, 1991 (VOONC*) ORNG: 727000000 ng/kg. [727.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 727 mg/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,466,1986 (85JCAE); T/E unlistd ipr-mus LD50: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); J24-M14-P24 unr-dog LDLo: 500 mg/kg U.S. Public Health Service, Public Health Bulletin. (Washington, DC) v. 271, p. 176, 1941 (XPHBAO) TR: ACGIH TLV-Confirmed Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 97, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 97, 1974 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 261, 1987 (IMSUDL); TOXICOLOGY REVIEW Khimiya i Zhizn. Chemistry and Life. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1965- v. 12(2), p. 85, 1976 (KHZHAZ); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 13, p. 271, 1970 (ADCSAJ); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 253, 1983 (BLFSBY) SR: OSHA PEL (Construc): see CFR 29,1926.1109 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA-cancer suspect agent Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1009, 1987 (CFRGBR); OEL-AUSTRALIA: Carcinogen, JAN 1993; OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-BELGIUM: Carcinogen, JAN 1993; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: VME 0.001 ppm (0.005 mg/m3), C1 Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-POLAND: MAC(TWA) 0 mg/m3, MAC(STEL) 0 mg/m3, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: Skin, Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO beta-NAPHTHYLAMINE-air: CA use 29 CFR 1910.1009 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 50065; NIS 1; TNF 10; NOS 5; TNE 420; NOES 1983: HZD 50065; NIS 1; TNF 10; NOS 1; TNE 275; TFE 265 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-mouse embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: E coli polA with S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-BALB/c-3T3, E coli polA without S9; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Naphthylamines, 5518; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #93 Record 902 of 1119 in RTECS (through 2003/06) AN: QM4550000 PN: 2-Naphthylamine,-N-phenyl- SY: Aceto-PBN-; AgeRite-Powder-; AK-1-; AK-1- (stabilizer); 2-Anilinonaphthalene-; Antioxidant-PBN-; Antioxidant-116-; Antioxidant-D-; N-Fenyl-2-aminonaftalen- (Czech); Fenyl-beta-naftylamin- (Czech); Naftam-2-; N-(2-Naphthyl)aniline; beta-Naphthylphenylamine-; 2-Naphthylphenylamine-; NCI-C02915-; Neozon-D-; Neozone-; Neozone-D-; Nilox-PbNa-; Noclizer-D-; Nocrac-D-; Nonox-D-; PBNA-; 2-Phenylaminonaphthalene-; Phenyl-beta-naphthylamine-; N-Phenyl-beta-naphthylamine-; Phenyl-2-naphthylamine-; N-Phenyl-2-naphthylamine-; N-Phenyl-beta-naphthylamine- (ACGIH); Stabilizator-AR-; Stabilizer-AR-; Vulkanox-PBN- RN: Current: 135-88-6 BRN: 2211188 BHR: 4-12-00-03128 UD: 200302 MF: C16-H13-N MW: 219.30 WL: L66J CMR CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 50 pph (+S9) Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 21(6), p. 29, 1987 (CYGEDX); mtr-hmn-oth 23100 ug/L In Vitro. (Rockville, MD) V.1-20, 1965-85. For publisher information, see ICDBEO. v. 17, p. 719, 1981 (ITCSAF); cyt-mus-orl 360 mg/kg/18D Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(9), p. 57, 1979 (GTPZAB) TE: V03-M61 orl-mus TDLo: 433 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-333, 1988 (NTPTR*); V01-J60-L60 orl-mus TDLo: 208 gm/kg/97W-C Shiyan Shengwu Xuebao. Journal of Experimental Biology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1953- Suspended 1966-77. v. 14, p. 129, 1981 (SYSWAE); V02-L60 scu-mus TDLo: 464 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-159 (NTIS**); V03-J60-L60 orl-mus TD :264 gm/kg/99W-C Shiyan Shengwu Xuebao. Journal of Experimental Biology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1953- Suspended 1966-77. v. 14, p. 129, 1981 (SYSWAE); V02-L60 orl-mus TD :135 gm/kg/78W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-159 (NTIS**); V01-J60-M61 orl-mus TD :17280 mg/kg/9W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3098, 1984 (CNREA8); V03-M04-M61 orl-mus TDLo: 648900 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-216270/AS (NTIS**) ORNG: 8730000000 ng/kg. [8730.000000 mg/kg] F07 AT: F07 orl-rat LD50: 8730 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 31(1-3), p. 183, 1966 (HYSAAV); A30-J15-L30 unr-rat LD50: 8700 mg/kg Tijdschrift Voor Sociale Geneeskunde. (B.V. Uitgeversmaatschappij. Reflex, Mathenesserlaan 310, Rotterdam 3003, Netherlands) V.1- 1923- v. 53, p. 415, 1975 (TJSGA8); F07 orl-mus LD50: 1450 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 31(1-3), p. 183, 1966 (HYSAAV) MD: M13-P71-U01 orl-rat TDLo: 19 gm/kg/19D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 12, p. 86, 1971 (TPKVAL); L14-Z01 orl-rat TDLo: 52 gm/kg/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(2), p. 25, 1966 (GISAAA); L70-M03-Z01 orl-rat TDLo: 182 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-333, 1988 (NTPTR*); L14-M10-M13 orl-rat TDLo: 36400 mg/kg/1Y-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 12, p. 86, 1971 (TPKVAL); L70-M03-Z01 orl-mus TDLo: 437 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-333, 1988 (NTPTR*); R60-V25 scu-rat TDLo: 30000 mg/kg/60W-I Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 37, p. 60, 1991 (VOONC*) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 16, p. 325, 1978 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 16, p. 325, 1978 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 318, 1987 (IMSUDL) SR: OEL-AUSTRALIA: Carcinogen, JAN 1993; OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-BELGIUM: Carcinogen, JAN 1993; OEL-FINLAND: Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-POLAND: MAC(TWA) 0.03 mg/m3, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO N-PHENYL-beta-NAPHTHYLAMINE-air: CA lowest concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 80313; NIS 15; TNF 751; NOS 32; TNE 16148; NOES 1983: HZD 80313; NIS 2; TNF 33; NOS 4; TNE 1356; TFE 41 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 16, 1976; NCI Carcinogenesis Studies (feed), equivocal evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat; OSHA ANALYTICAL METHOD #96 Record 903 of 1119 in RTECS (through 2003/06) AN: QN2885000 PN: 1,8-Naphthyridine-3-carboxylic-acid,-1-ethyl-1,4-dihydro-7-methyl-4-oxo- SY: Acide-1-etil-7-metil-1,8-naftiridin-4-one-3-carbossilico- (Italian); Acide-nalidixico- (Italian); Acide-nalidixique- (French); 1-Aethyl-7-methyl-1,8-naphthyridin-4-on-3-karbonsaeure- (German); Betaxina-; 1,4-Dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic-acid-; Dixiben-; 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxilic-acid-; 1-Ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylic-acid-; 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic-acid-; Eucisten-; Nalidic-acid-; Nalidicron-; Nalidixan-; Nalidixic-acid-; Nalidixin-; Nalidixinic-acid-; Nalitucsan-; Nalix-; Nalurin-; 3-Carboxy-1-ethyl-7-methyl-1,8-naphthidin-4-one-; Cybis-; Innoxalon-; Kusnarin-; NCI-C56199-; Narigix-; Naxuril-; Neggram-; Nevigramon-; Nicelate-; Nogram-; NSC-82174-; Poleon-; Specifen-; Uralgin-; Uriben-; Uriclar-; Urisal-; Urodixin-; Uroman-; Uroneg-; Uropan-; WIN-18,320-; Wintomylon- RN: Current: 389-08-2 BRN: 750515 BHR: 5-25-07-00384 UD: 200305 MF: C12-H12-N2-O3 MW: 232.26 WL: T66 BN EV JNJ B2 DVQ I1 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 8 mg/L (+S9) Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 37, p. 213, 1993 (AMACCQ); mmo-sat 10 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 416, p. 169, 1998 (MUREAV); mmo-esc 100 mg/L (-S9) Kanagawa-ken Eisei Kenkyusho Kenkyu Hokoku. Bulletin of Kanagawa Prefectural Public Health Laboratories. (Kanagawa-ken Eisei Kenkyusho, 52-2, Nakao-cho, Asahi-ku, Yokohama 241, Japan) No.1- 1971- v. (8), p. 47, 1978 (KEKHB8); oms-esc 5 mg/L Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 37, p. 213, 1993 (AMACCQ); dnr-esc 6 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dnd-esc 25 mg/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 70, p. 1955, 1973 (PNASA6); dni-esc 2300 ug/L Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 17, p. 763, 1980 (AMACCQ); oms-esc 50 mg/L European Journal of Biochemistry. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1967- v. 62, p. 491, 1976 (EJBCAI); pic-esc 5 mg/L Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 41, p. 244, 1970 (VIRLAX); mmo-bcs 100 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 95, p. 191, 1982 (MUREAV); dnr-bcs 6 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dni-srm 2200 ug/L Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 17, p. 763, 1980 (AMACCQ); mmo-omi 50 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 113, 1980 (MUREAV); mmo-omi 40 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 25, p. 25, 1974 (MUREAV); oms-omi 20 mg/L Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 75, p. 99, 1973 (JMOBAK); dni-omi 100 mg/L Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 116, p. 1398, 1973 (JOBAAY); dni-omi 50 mg/L Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 24, p. 716, 1977 (JOVIAM); dni-omi 200 mg/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 150, p. 301, 1977 (MGGEAE); dni-omi 2200 ug/L Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 17, p. 763, 1980 (AMACCQ); dni-omi 3700 ug/L Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 17, p. 763, 1980 (AMACCQ); pic-omi 30 ug/plate Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe A: Medizinische Mikrobiologie und Parasitologie. (Stuttgart, Fed. Rep. Ger.) V.217-245, 1971-79. v. 231, p. 369, 1975 (ZMMPAO); sln-dmg-orl 20 mg/3D Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 128, 1974 (SOGEBZ); dni-smc 500 mg/L Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 3, p. 562, 1973 (AMACCQ); oms-smc 500 mg/L Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 3, p. 562, 1973 (AMACCQ); dns-ssp 100 mg/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 187, p. 96, 1982 (MGGEAE); dni-ssp 100 mg/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 187, p. 96, 1982 (MGGEAE); dni-clr 300 mg/L Colloques Internationaux du Centre National de la Recherche Scientifique. (Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1946- v. 240, p. 167, 1975 (COINAV); mmo-eug 50 mg/L (-S9) Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.31- 1951- v. 165, p. 548, 1974 (ABBIA4); dnd-eug 50 mg/L Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.31- 1951- v. 165, p. 548, 1974 (ABBIA4); dni-eug 50 mg/L Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.31- 1951- v. 165, p. 548, 1974 (ABBIA4); dni-hmn-oth 500 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 2929, 1986 (CNREA8); sce-hmn-lym 25 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 205, 1996 (MUREAV); dni-mus-oth 10 mmol/L Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 106, p. 1448, 1982 (BBRCA9); dni-ham-lng 21 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 243, p. 213, 1990 (MUREAV); sce-ham-ovr 500 mg/L Chromosoma. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1939- v. 85, p. 603, 1982 (CHROAU); dni-dom-oth 27 mg/L Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 34, p. 1955, 1990 (AMACCQ) RE: T46 orl-rat TDLo: 1320 mg/kg (9-14D preg) Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 19, p. 422, 1971 (NKRZAZ); T26-T31-T34 orl-rat TDLo: 3300 mg/kg (7-17D preg) Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 28(Suppl 4), p. 484, 1980 (NKRZAZ); T35-T46-T71 orl-rat TDLo: 3300 mg/kg (7-17D preg) Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 28(Suppl 4), p. 484, 1980 (NKRZAZ); T72-T75-T81 orl-rat TDLo: 3300 mg/kg (7-17D preg) Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 28(Suppl 4), p. 484, 1980 (NKRZAZ); T34-T46 orl-mus TDLo: 3960 mg/kg (7-12D preg) Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 19, p. 422, 1971 (NKRZAZ); T26-T35 orl-rbt TDLo: 10400 mg/kg (6-18D preg) Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 28(Suppl 4), p. 508, 1980 (NKRZAZ) TE: V01-R60-T69 orl-rat TDLo: 173 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-368, 1989 (NTPTR*); V03-J60-R60 orl-mus TDLo: 173 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-368, 1989 (NTPTR*); V01-D20-T69 orl-rat TDLo: 86520 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB 90-256389 (NTIS**); V01-D20-T69 orl-rat TDLo: 72100 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB 90-256389 (NTIS**); V01-K60 orl-rat TDLo: 173040 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB 90-256389 (NTIS**); V01-R60 orl-mus TDLo: 173040 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB 90-256389 (NTIS**) ORNG: 2040000000 ng/kg. [2040.000000 mg/kg] F07-F12-R21 AT: A03-F24 orl-wmn TDLo: 40 mg/kg Acta Medica Scandinavica. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.52-224, 1919-88. v. 216, p. 237, 1984 (AMSVAZ); F12-N24-R20 orl-wmn TDLo: 160 mg/kg/2D British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 1518, 1977 (BMJOAE); F24-G06-U20 orl-wmn TDLo: 560 mg/kg Intensive Care Medicine. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.3- 1977- v. 5, p. 141, 1979 (ICMED9); P30 unr-chd TDLo: 1200 mg/kg/20D "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,414,1969 (34ZIAG); F07-F12-R21 orl-rat LD50: 2040 mg/kg Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 28(Suppl 4), p. 406, 1980 (NKRZAZ); T/E unlistd ipr-rat LD50: 319 mg/kg Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher information, see AMACCQ. v. -, p. 117, 1970 (AACHAX); T/E unlistd scu-rat LD50: 1584 mg/kg Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher information, see AMACCQ. v. -, p. 117, 1970 (AACHAX); T/E unlistd ivn-rat LD50: 1160 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 908, 1995 (NIIRDN); T/E unlistd orl-mus LD50: 572 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 185, 1971 (TXAPA9); T/E unlistd ipr-mus LD50: 600 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #4552882 (USXXAM); T/E unlistd scu-mus LD50: 500 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 185, 1971 (TXAPA9); T/E unlistd ivn-mus LD50: 101 mg/kg Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher information, see AMACCQ. v. -, p. 117, 1970 (AACHAX) MD: U01-Z01 orl-rat TDLo: 44800 mg/kg/4W-I Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher information, see AMACCQ. v. -, p. 117, 1970 (AACHAX); L70-N30-Z01 orl-rat TDLo: 24 gm/kg/30D-C Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 19, p. 404, 1971 (NKRZAZ); L70-U01 orl-rat TDLo: 21840 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-368, 1989 (NTPTR*); J30-P28-P72 orl-rat TDLo: 31200 mg/kg/26W-I Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- v. 19, p. 404, 1971 (NKRZAZ); D20 orl-rat TDLo: 1400 mg/kg/2W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 42, p. 398, 1992 (ARZNAD); L70-U01 orl-mus TDLo: 43680 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-368, 1989 (NTPTR*); K13 orl-dog TDLo: 400 mg/kg/2D-I Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher information, see AMACCQ. v. -, p. 117, 1970 (AACHAX); P61-R60-V30 orl-rat TDLo: 86520 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB 90-256389 (NTIS**); A60-T69-V30 orl-rat TDLo: 72100 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB 90-256389 (NTIS**) TR: TOXICOLOGY REVIEW Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 127, p. 269, 2002 (TOLED5) ND: NOES 1983: HZD X3708; NIS 1; TNF 348; NOS 7; TNE 6188; TFE 4169 SL: EPA GENETOX PROGRAM 1988, Positive: B subtilis rec assay, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse Record 904 of 1119 in RTECS (through 2003/06) AN: QR5950000 PN: Nickel- SY: Alcan-756-; C.I. 77775; Carbonyl-nickel-powder-; EL12-; Fibrex-; Fibrex-P-; NP-2-; Ni-0901-S-; Ni-270-; Ni-4303T-; Nichel- (Italian); Nickel-270-; Nickel-particles-; Nickel-sponge-; Nickel,-metal-; Nickel,-metal- (ACGIH:OSHA); Raney-alloy-; Raney-nickel- RN: Current: 7440-02-0 UD: 200302 MF: Ni MW: 58.71 WL: NI CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mtr-ham-kdy 400 mg/L IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 53, p. 193, 1984 (IAPUDO); mtr-ham-emb 5 umol/L Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 1, p. 132, 1981 (TOXID9) RE: T34-T35 orl-rat TDLo: 158 mg/kg (multigenerations) Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 23, p. 102, 1971 (AEHLAU) TE: V03-R60-V10 scu-rat TDLo: 3000 mg/kg/6W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 16, p. 55, 1955 (JNCIAM); V01-Q60-V10 ims-rat TDLo: 56 mg/kg IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 53, p. 127, 1984 (IAPUDO); V03-V10 ipl-rat TDLo: 100 mg/kg/21W-I Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 16, p. 150, 1973 (PWPSA8); V03-J60-T64 par-rat TDLo: 40 mg/kg/52W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 5, p. 445, 1962 (AEHLAU); V01-R60-V10 imp-rat TDLo: 250 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 16, p. 55, 1955 (JNCIAM); V02-V10 ims-mus TDLo: 200 mg/kg Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V02-T64-V10 imp-rbt TDLo: 165 mg/kg/2Y-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 16, p. 55, 1955 (JNCIAM); V03-J60-J61 ihl-gpg TCLo: 15 mg/m3/91W-I AMA Archives of Pathology. (Chicago, IL) V.50(4)-69, 1950-60. For publisher information, see APLMAS. v. 65, p. 600, 1958 (AMPLAO); V03-Q60-V10 ims-ham TDLo: 200 mg/kg/21W-I Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 14, p. 68, 1971 (PWPSA8); V03-V10 ims-rat TD :58 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 17, p. 11, 1976 (PAACA3); V03-V10 imp-rat TD :23 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 16, p. 55, 1955 (JNCIAM); V02-V10 ims-rat TD :125 mg/kg/13W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V02-V10 ims-mus TD :800 mg/kg/13W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V03-V10 ims-rat TD :90 mg/kg/18W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V03-Q60-V10 ims-rat TD :889 ug/kg Journal of Pathology. (John Wiley and Sons, Inc., 605 Third Ave., New York, NY 10158) V.97- 1969- v. 97, p. 375, 1969 (JPTLAS); V03-Q60-V10 ipl-rat TD :1250 mg/kg/17W-I Texas Reports on Biology and Medicine. (Galveston, TX) V.1-41(2), 1943-81/82. Discontinued. v. 10, p. 167, 1952 (TRBMAV); V03-V10 ipl-rat TD :125 mg/kg/21W-I Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 16, p. 150, 1973 (PWPSA8); V02-Q60-V10 ims-rat TD :200 mg/kg/21W-I Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 14, p. 68, 1971 (PWPSA8); V01-V10 ims-rat TD :1 gm/kg/17W-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 9, p. 28, 1968 (PAACA3) AT: T/E unlistd orl-rat LDLo: 5 gm/kg Food and Drug Research Laboratories, Inc., Papers. (P.O. Box 107, Rt. 17C, Waverly, NY 14892-0107) 7684D, 1983 (FDRLI*); H05-L30-P30 ipr-rat LD50: 250 mg/kg Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 15, p. 482, 1946 (INMEAF); T/E unlistd itr-rat LDLo: 12 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AEC-TR-6710 (NTIS**); F07-F16-M13 ivn-mus LDLo: 50 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 23, p. 549, 1960 (FATOAO); T/E unlistd scu-cat LDLo: 12500 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd ipr-rbt LDLo: 7 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd scu-rbt LDLo: 7500 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd orl-gpg LDLo: 5 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 455, 1980 (YAKUD5) MD: J12-Z01 orl-rat TDLo: 500 mg/kg/5D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 23, p. 549, 1960 (FATOAO); L14-P28-P71 ihl-rat TCLo: 100 ug/m3/24H/17W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(11), p. 8, 1974 (GISAAA); J12-Z01 ivn-rat TDLo: 50 mg/kg/5D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 23, p. 549, 1960 (FATOAO); J12-Z01 orl-mus TDLo: 500 mg/kg/5D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 23, p. 549, 1960 (FATOAO); J12-Z01 ivn-mus TDLo: 100 mg/kg/5D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 23, p. 549, 1960 (FATOAO); J30-J70-Y37 ihl-rbt TCLo: 1700 ug/m3/6H/5W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 26, p. 353, 1981 (ENVRAL); J30-Y37 ihl-rbt TCLo: 130 ug/m3/6H/35W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 30, p. 89, 1983 (ENVRAL); J30 ihl-rbt TCLo: 1 mg/m3/6H/26W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 23, p. 170, 1980 (ENVRAL); J30-J70-P01 ihl-rbt TCLo: 1 mg/m3/6H/13W-I Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 41, p. 26, 1984 (EXMPA6); J12-Z01 ivn-rbt TDLo: 50 mg/kg/5D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 23, p. 549, 1960 (FATOAO) TR: ACGIH TLV-TWA 1.5 mg(Ni)/m3 (I) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not suspected as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 264, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); TOXICOLOGY REVIEW Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 3, p. 156, 1973 (ACLSCP); TOXICOLOGY REVIEW Kogai to Taisaku. Journal of Environmental Pollution Control. (Kogai Taisaku Gijutsu Dokokai, Shuwa-Akasaka Bldg., 9-1-244, Akasaka, Minato-ku, Tokyo 107, Japan) V.1- 1965- v. 11, p. 1300, 1975 (KOTTAM); TOXICOLOGY REVIEW Mikrobiyoloji Bulteni. Bulletin of Microbiology. (c/o Dr. A. Tevfik Cenqiz, Ankara Universitesi Tip Fakultesi Mikrobiyoloji Ana Bilim Dah, Ankara, Turkey) V.1- 1967- v. 9, p. 321, 1975 (MIBUBI); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Ni,168,1975 (85DHAX); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,63,1970 (85CVA2); TOXICOLOGY REVIEW "Experimental Lung Cancer: Carcinogenesis and Bioassays, International Symposium, 1974," Karbe, E., and J.F. Park, eds., Springer-Verlag New York, Inc., 1974 -,93,1974 (31BYAP); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. CONF-691001 (NTIS**); TOXICOLOGY REVIEW Memoir--Geological Society of America. (POB 9140, Boulder, CO 80302) No.1- 1934- v. 123, p. 109, 1971 (GSAMAQ); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR); TOXICOLOGY REVIEW Diseases of the Chest. (Chicago, IL) V.1-56, 1935-69. For publisher information, see CHETBF. v. 54, p. 527, 1968 (DICHAK); TOXICOLOGY REVIEW Advances in Modern Toxicology. (John Wiley and Sons, Inc., 605 Third Ave., New York, NY 10016) V.1, 1976-79. Discontinued. v. 3, p. 209, 1977 (AMTODM); TOXICOLOGY REVIEW Critical Reviews in Oncology/Hematology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1983- v. 42, p. 93, 2002 (CREOH*) SR: MSHA STANDARD-air: TWA 1 mg/m3 "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 24, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.1 mg/m3, JAN 1993; OEL-AUSTRALIA: TWA 1 mg/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-DENMARK: TWA 0.5 mg/m3, JAN 1999; OEL-FINLAND: TWA 0.1 mg/m3, Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 1 mg/m3, C3 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.005 mg(Ni)/m3, Carcinogen (insoluble compounds), JAN 1993; OEL-JAPAN: OEL 1 mg/m3, 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 mg/m3, Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 mg/m3 (insoluble compounds), JAN 1993; OEL-THE PHILIPPINES: TWA 1 mg/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.25 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.05 mg/m3, JAN 1993; OEL-SWEDEN: NGV 0.5 mg/m3 (dust), JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 mg/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 1 mg/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.1 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO NICKEL, INORGANIC-air: 10H CA TWA 0.015 mg(Ni)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 50420; NIS 55; TNF 1867; NOS 52; TNE 23272; NOES 1983: HZD X5096; NIS 2; TNF 7; NOS 4; TNE 110; NOES 1983: HZD X5918; NIS 14; TNF 678; NOS 17; TNE 6440; TFE 611; NOES 1983: HZD X5986; NIS 14; TNF 1124; NOS 15; TNE 10233; TFE 80; NOES 1983: HZD X8294; NIS 1; TNF 9; NOS 1; TNE 611; NOES 1983: HZD 50420; NIS 260; TNF 32771; NOS 116; TNE 507681; TFE 19673 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101199/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Elements by ICP, 7300; NIOSH Analytical Method, 1994: Metals in urine, 8310; NIOSH Analytical Method, 1994: Elements in blood or tissue, 8005; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #ID125G Record 905 of 1119 in RTECS (through 2003/06) AN: QR6125000 PN: Nickel(II) acetate (1:2) SY: Acetic acid, nickel(2+) salt; Nickel-acetate-; Nickel-diacetate-; Nickelous-acetate- RN: Current: 373-02-4 Previous: 17593-69-0 UD: 200302 MF: C4-H6-O4.Ni MW: 176.81 WL: QV1 &-NI- CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: pic-esc 40 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 59, 1984 (ENMUDM); mtr-hmn-fbr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3815, 1987 (CNREA8); dns-rat-ipr 129 umol/kg/5D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1819, 1985 (CRNGDP); mtr-ham-kdy 225 mg/L IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 53, p. 193, 1984 (IAPUDO) RE: T25 ivn-ham TDLo: 10 mg/kg (8D preg) Advances in Teratology. (New York, NY) V.1-5, 1966-72. Discontinued. v. 5, p. 51, 1972 (ADTEAS) TE: V01-T65-N60 ipr-rat TDLo: 15912 ug/kg (16-18D preg) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 1351, 1992 (CRNGDP); V02-V10 ims-rat TDLo: 420 mg/kg/47W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V03-V10 imp-rat TDLo: 95 mg/kg/78W-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 5, p. 50, 1964 (PAACA3); V02-J60 ipr-mus TDLo: 360 mg/kg/8W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 1744, 1976 (CNREA8); V03-V10 ims-rat TD :225 mg/kg/46W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V01-T65-N60 ipr-rat TD :15912 ug/kg (17D preg) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 1351, 1992 (CRNGDP) ORNG: 350000000 ng/kg. [350.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 350 mg/kg Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 11, p. 39, 1968 (PWPSA8); F07-J22-K12 ipr-rat LD50: 23 mg/kg Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 11, p. 39, 1968 (PWPSA8); T/E unlistd orl-mus LD50: 410 mg/kg Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 11, p. 39, 1968 (PWPSA8); F07-J22-K12 ipr-mus LD50: 32 mg/kg Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 11, p. 39, 1968 (PWPSA8); C08-J22-J30 scu-gpg LDLo: 20 mg/kg Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 8, p. 565, 1908 (JOHYAY) MD: P08-U09-Y03 orl-rat TDLo: 1581 mg/kg/6W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 25, p. 323, 1973 (TXAPA9); L30-U01-Y09 orl-mus TDLo: 25297 mg/kg/4W-C Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 28, p. 620, 1969 (JANSAG); U09-U11 orl-rat TDLo: 840 mg/kg/4W-C American Journal of Physiology. (American Physiological Soc., 9650 Rockville Pike, Bethesda, MD 20814) V.1- 1898- v. 238, p. 53, 1980 (AJPHAP) TR: ACGIH TLV-TWA 0.1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 264, 1987 (IMSUDL); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); TOXICOLOGY REVIEW Advances in Teratology. (New York, NY) V.1-5, 1966-72. Discontinued. v. 5, p. 51, 1972 (ADTEAS); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Ni,168,1975 (85DHAX); TOXICOLOGY REVIEW Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 3, p. 156, 1973 (ACLSCP) SR: MSHA STANDARD-air: TWA 1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 178, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR) ND: NIOSH REL TO NICKEL, INORGANIC-air: 10H CA TWA 0.015 mg(Ni)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 81906; NIS 6; TNF 128; NOS 13; TNE 2489; NOES 1983: HZD 81906; NIS 18; TNF 481; NOS 12; TNE 6772; TFE 281 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 906 of 1119 in RTECS (through 2003/06) AN: QR6200000 PN: Nickel(II) carbonate (1:1) SY: C.I. 77779; Nickel(2+) carbonate; Carbonic-acid,-nickel-salt- (1:1); Nickel-monocarbonate-; Nickelous-carbonate- RN: Current: 3333-67-3 UD: 200012 MF: C-Ni-O3 MW: 118.72 WL: QVQ &-NI- CC: Tumorigen (C); Mutagen (M) ME: dnd-rat-ipr 10 mg/kg/3H Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3544, 1982 (CNREA8); oms-rat-ipr 40 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3892, 1984 (CNREA8) TE: V03-V10 imp-rat TDLo: 95 mg/kg/78W-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 5, p. 50, 1964 (PAACA3) AT: C08-J22-J30 scu-gpg LDLo: 32 mg/kg Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 8, p. 565, 1908 (JOHYAY) TR: ACGIH TLV-TWA 1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 75, 1976 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); TOXICOLOGY REVIEW Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 3, p. 156, 1973 (ACLSCP); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Ni,168,1975 (85DHAX) SR: MSHA STANDARD-air: TWA 1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 178, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-DENMARK: TWA 1 mg(Ni)/m3, JAN 1999; OEL-FINLAND: TWA 5 mg(Ni)/m3, Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 1 mg/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWEDEN: NGV 0.1 mg(nI)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 mg/m3, Carcinogen, JAN 1999; OEL-UNITED KINGDOM: TWA 0.1 mg(Ni)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO NICKEL, INORGANIC-air: 10H CA TWA 0.015 mg(Ni)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 81905; NIS 12; TNF 349; NOS 9; TNE 4696; NOES 1983: HZD 81905; NIS 28; TNF 864; NOS 23; TNE 13040; TFE 2017 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 907 of 1119 in RTECS (through 2003/06) AN: QR6300000 PN: Nickel-carbonyl- SY: Nickel-carbonyl- (ACGIH:OSHA); Nickel-carbonyle- (French); Nichel-tetracarbonile- (Italian); Nikkeltetracarbonyl- (Dutch); Nickel-tetracarbonyle- (French); RCRA-waste-number-P073-; Nickel-tetracarbonyl-; Tetracarbonyl-nickel- RN: Current: 13463-39-3 UD: 200302 MF: C4-Ni-O4 MW: 170.75 WL: NI C-O*4 CC: Tumorigen (C); Reproductive-Effector (T); Human-Data (P) RE: T42 ihl-rat TCLo: 60 mg/m3/15M (8D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 345, 1978 (TXAPA9); T26-T35-T34 ihl-rat TCLo: 120 mg/m3/15M (8D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 345, 1978 (TXAPA9); T81 ihl-rat TCLo: 160 mg/m3/15M (7D preg) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 203, p. 550, 1979 (SCIEAS); T23-T26-T34 ivn-rat TDLo: 25 mg/kg (7D preg) "Reproduction and Developmental Toxicity of Metals, Proceedings of a Joint Meeting, Rochester, 1982," Clarkson, T.W., et al., eds., New York, Plenum Pub. Corp., 1983 -,399,1983 (50WKA3); T35 ivn-rat TDLo: 25 mg/kg (7D preg) "Reproduction and Developmental Toxicity of Metals, Proceedings of a Joint Meeting, Rochester, 1982," Clarkson, T.W., et al., eds., New York, Plenum Pub. Corp., 1983 -,399,1983 (50WKA3); T41-T49-T59 ihl-ham TCLo: 60 mg/m3/15M (5D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DOE/EV/03140-5 (NTIS**); T75 ihl-ham TCLo: 60 mg/m3/15M (5D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DOE/EV/03140-5 (NTIS**); T35-T45-T49 ihl-ham TCLo: 60 mg/m3/15M (4D preg) "Spurenelement-Symposium: Nickel, 3rd," Jena, Anke, M., et al., eds., Jena, Ger. Dem. Rep., Friedrich-Schiller-Universitaet, 1980 3,301,1980 (48ECAY) TE: V03-J60 ihl-rat TCLo: 250 mg/m3/30M/1Y American Journal of Clinical Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1931- v. 35, p. 203, 1961 (AJCPAI); V01-J60-L60 ivn-rat TDLo: 54 mg/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 32, p. 2253, 1972 (CNREA8); V03-J60 ihl-rat TC :4 ppm/30M/2Y-I American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 46, p. 1027, 1965 (AJPAA4) AT: F07-J30-U25 ihl-hmn TCLo: 7 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 22(11), p. 30, 1957 (GISAAA); T/E unlistd ihl-hmn LCLo: 30 ppm/30M Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 23, p. 373, 1971 (AEHLAU); T/E unlistd ihl-rat LC50: 35 ppm/30M American Journal of Clinical Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1931- v. 26, p. 107, 1956 (AJCPAI); F18-J26-U01 ipr-rat LD50: 39 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 14, p. 604, 1967 (AEHLAU); F18-J26-U01 scu-rat LD50: 63 mg/kg Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 14, p. 604, 1967 (AEHLAU); Y53 ivn-rat LD50: 64 mg/kg Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 2, p. 545, 1971 (RCOCB8); J16-L30 ihl-mus LC50: 67 mg/m3/30M AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 48, 1953 (AMIHBC); T/E unlistd ihl-dog LCLo: 360 ppm/90M Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 7, p. 525, 1907 (JOHYAY); T/E unlistd ihl-cat LC50: 1890 mg/m3/30M Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd ihl-rbt LCLo: 300 mg/m3/30M Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 455, 1980 (YAKUD5) MD: J02-U01-Z01 ihl-rat TCLo: 30 mg/m3/30M/52W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 16, p. 480, 1957 (AMIHAB); Z01 ihl-mus TCLo: 2500 ug/m3/4D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. (10), p. 144, 1968 (TPKVAL) TR: ACGIH TLV-TWA 0.05 (Ni)ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.05 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 264, 1987 (IMSUDL); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); TOXICOLOGY REVIEW Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 3, p. 156, 1973 (ACLSCP); TOXICOLOGY REVIEW Annals of Allergy. (American College of Allergists, POB 20671, Bloomington, MN 55420) V.1- 1943- v. 35, p. 165, 1975 (ANAEA3); TOXICOLOGY REVIEW Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 35, p. 89, 1976 (FEPRA7); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Ni,168,1975 (85DHAX); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR); TOXICOLOGY REVIEW Diseases of the Chest. (Chicago, IL) V.1-56, 1935-69. For publisher information, see CHETBF. v. 54, p. 527, 1968 (DICHAK); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 12, p. 601, 1978 (CTOXAO); TOXICOLOGY REVIEW Critical Reviews in Oncology/Hematology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1983- v. 42, p. 35, 2002 (CREOH*) SR: MSHA STANDARD-air: TWA 0.001 ppm (0.007 mg/m3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 24, 1973 (DTLWS*); MSHA STANDARD: HUMAN CARCINOGEN "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 24, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 0.001 ppm (0.007 mg(Ni)/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.001 ppm (0.007 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.001 ppm (0.007 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.001 ppm (0.007 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.007 ppm (0.001 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 0.05 ppm (0.1 mg/m3), JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 ppm (0.007 mg(Ni)/m3, Skin, JAN 1999; OEL-FINLAND: TWA 0.001 ppm (0.007 mg/m3), STEL 0.003 ppm, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.05 ppm (0.23 mg(Ni)/m3), JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1993; OEL-HUNGARY: STEL 0.007 mg/m3, Skin, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.001 ppm (0.007 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.001 ppm (0.007 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 0.001 ppm (0.007 mg/m3), JAN 1993; OEL-RUSSIA: TWA 0.001 ppm, STEL 0.0005 mg/m3, Carcinogen, JAN 1993; OEL-SWEDEN: NGV 0.001 ppm (0.007 mg/m3), Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 ppm (0.35 mg/m3), Skin, Carcinogen, JAN 1999; OEL-THAILAND: TWA 0.001 ppm (0.007 mg/m3), JAN 1993; OEL-TURKEY: TWA 0.001 ppm (0.007 mg/m3), JAN 1993; OEL-UNITED KINGDOM: STEL 0.1 ppm (0.24 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO NICKEL CARBONYL-air: 10H CA TWA 0.001 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Nickel carbonyl, 6007; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 908 of 1119 in RTECS (through 2003/06) AN: QR6500000 PN: Nickel,-compd-with-pi-cyclopentadienyl- (1:2) SY: Di-pi-cyclopentadienylnickel-; pi-Cyclopentadienyl compd. with nickel; Nickel-biscyclopentadiene-; Nickelocene-; Nikelocen- (Czech) RN: Current: 1271-28-9 UD: 200006 MF: C10-H10-Ni MW: 188.91 WL: L50J 0-NI- 0L50J CC: Tumorigen (C) TE: V02-V10 ims-rat TDLo: 600 mg/kg/52W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V02-Q60-V10 ims-ham TDLo: 200 mg/kg Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 14, p. 68, 1971 (PWPSA8); V02-P62-V10 ims-rat TD :600 mg/kg/47W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V02-Q60-V10 ims-rat TD :650 mg/kg/1Y-I Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 14, p. 68, 1971 (PWPSA8); V02-V10 ims-rat TD :1260 mg/kg/56W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V03-Q60-R60 ims-rat TD :50 mg/kg Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V02-V10 ims-rat TD :50 mg/kg/46W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*) ORNG: 490000000 ng/kg. [490.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 490 mg/kg Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 11, p. 39, 1968 (PWPSA8); T/E unlistd ipr-rat LD50: 50 mg/kg Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); T/E unlistd ims-rat LD50: 82 mg/kg Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); F07-J22-K12 orl-mus LD50: 600 mg/kg Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 11, p. 39, 1968 (PWPSA8); T/E unlistd ipr-mus LD50: 86 mg/kg Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 11, p. 39, 1968 (PWPSA8) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 75, 1976 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Ni,168,1975 (85DHAX); TOXICOLOGY REVIEW Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 3, p. 156, 1973 (ACLSCP); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 909 of 1119 in RTECS (through 2003/06) AN: QR7030000 PN: Nickel-hydroxide- RN: Current: 11113-74-9 Previous: 37280-71-0 UD: 200006 MF: H-O.Ni MW: 75.72 CC: Tumorigen (C) SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 910 of 1119 in RTECS (through 2003/06) AN: QR7040000 PN: Nickel(II) hydroxide SY: Nickel-dihydroxide-; Nickelous-hydroxide- RN: Current: 12054-48-7 UD: 200012 MF: H2-Ni-O2 MW: 92.73 WL: .NI..Q2 CC: Tumorigen (C) TE: V01-J60-Q60 ims-rat TDLo: 480 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 275, 1983 (CRNGDP); V03-Q60-V10 ims-rat TD :60 mg/kg "Nickel Toxicology, 2nd International Conference on Nickel Toxicology, Swansea, Wales, 1980," London, Academic Press Inc., Ltd., 1980 -,59,1980 (45ICAX) ORNG: 1515000000 ng/kg. [1515.000000 mg/kg] F07-F19-K12 IHNG: 1200000000 ng/m3/4H. [1200.000000 mg/m3/4H] F13-J22-R21 AT: F07-F19-K12 orl-rat LD50: 1515 mg/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 684, 1992 (ATDAEI); F13-J22-R21 ihl-rat LC50: 1200 mg/m3/4H Research and Consulting Company, Technical Reports. (RCC NOTOX B.V., Hambakenwetering 7, 5231 DD 's-Hertogenbosch, Netherlands) NOTOX1074, 1988 (RCCRC*); T/E unlistd skn-rat LD50: >2 gm/kg Research and Consulting Company, Technical Reports. (RCC NOTOX B.V., Hambakenwetering 7, 5231 DD 's-Hertogenbosch, Netherlands) NOTOX1074/1338, 1988 (RCCRC*); T/E unlistd scu-mus LD50: 50 mg/kg Zhurnal Vsesoyuznogo Khimicheskogo Obshchestva im. D.I. Mendeleeva. Journal of the D.I. Mendeleeva All-Union Chemical Society. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.5- 1960- v. 19, p. 186, 1974 (ZVKOA6) TR: ACGIH TLV-TWA 1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 75, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Ni,168,1975 (85DHAX); TOXICOLOGY REVIEW Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 3, p. 156, 1973 (ACLSCP) SR: MSHA STANDARD-air: TWA 1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 178, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.1 mg(Ni)/m3, JAN 1993; OEL-AUSTRALIA: TWA 1 mg(Ni)/m3, JAN 1993; OEL-BELGIUM: TWA 1 mg(Ni)/m3 (insoluble compounds), JAN 1993; OEL-BELGIUM: TWA 1 mg(Ni)/m3, JAN 1993; OEL-DENMARK: TWA 1 mg(Ni)/m3, JAN 1999; OEL-FINLAND: TWA 0.1 mg(Ni)/m3, Skin, Carcinogen, JAN 1999; OEL-FRANCE: CME 1 mg(Ni)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.005 mg(Ni)/m3, Carcinogen (insoluble compounds), JAN 1993; OEL-THE PHILIPPINES: TWA 1 mg(Ni)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.25 mg(Ni)/m3, JAN 1999; OEL-RUSSIA: STEL 0.05 mg(Ni)/m3, JAN 1993; OEL-SWEDEN: NGV 0.1 mg(Ni)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 mg(Ni)/m3 (insoluble compounds), JAN 1999; OEL-THAILAND: TWA 1 mg(Ni)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.5 mg(Ni)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO NICKEL, INORGANIC-air: 10H CA TWA 0.015 mg(Ni)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X7142; NIS 1; TNF 53; NOS 2; TNE 106 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 911 of 1119 in RTECS (through 2003/06) AN: QR8400000 PN: Nickel(II) oxide (1:1) SY: Black-nickel-oxide-; Bunsenite-; C.I. 77777; Green-nickel-oxide-; Mononickel-oxide-; Nickel-monoxide-; Nickel-oxide-; Nickel-oxide-sinter-75-; Nickel-protoxide-; Nickel(II) oxide; Nickelous-oxide- RN: Current: 1313-99-1 UD: 200302 MF: Ni-O MW: 74.71 WL: NI O CC: Tumorigen (C); Mutagen (M); Natural-Product (N) ME: mtr-hmn-fbr 50 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3815, 1987 (CNREA8); mtr-rat-oth 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 179, 1993 (MUREAV); mtr-mus-emb 500 umol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 100, 1983 (PAACA3); mtr-ham-kdy 100 mg/L IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 53, p. 193, 1984 (IAPUDO); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V02-J60 ihl-rat TCLo: 1250 ug/m3/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-451, 1996 (NTPTR*); V01-Q60-V10 ims-rat TDLo: 71264 ug/kg IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 53, p. 127, 1984 (IAPUDO); V03-J60 ipl-rat TDLo: 40 mg/kg "Progress in Nickel Toxicology, Proceedings of the International Conference on Nickel Metabolism and Toxicology, 3rd, 1984," Brown, S.S., and F.W. Sunderman, Jr., eds., Oxford, UK, Blackwell Scientific Pub. Ltd., 1985 -,37,1985 (55DXAE); V03-J60 itr-rat TDLo: 90 mg/kg Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 24(4), p. 44, 1978 (VOONAW); V03-V10 imp-rat TDLo: 95 mg/kg/78W-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 5, p. 50, 1964 (PAACA3); V03-J60 ihl-mus TCLo: 5 mg/m3/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-451, 1996 (NTPTR*); V03-V10 ims-mus TDLo: 400 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 22, p. 158, 1962 (CNREA8); V03-Q60-V10 ims-rat TD :180 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 22, p. 158, 1962 (CNREA8) AT: T/E unlistd orl-rat LDLo: 5 gm/kg Food and Drug Research Laboratories, Inc., Papers. (P.O. Box 107, Rt. 17C, Waverly, NY 14892-0107) 7684B, 1983 (FDRLI*); T/E unlistd itr-rat LDLo: 20 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AEC-TR-6710 (NTIS**); T/E unlistd scu-mus LD50: 50 mg/kg Zhurnal Vsesoyuznogo Khimicheskogo Obshchestva im. D.I. Mendeleeva. Journal of the D.I. Mendeleeva All-Union Chemical Society. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.5- 1960- v. 19, p. 186, 1974 (ZVKOA6); T/E unlistd ivn-dog LDLo: 9 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd ivn-cat LDLo: 12700 ug/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX) MD: J30-P70-Y10 ihl-rat TCLo: 600 ug/m3/6H/13W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 57, p. 255, 1989 (TXCYAC); J30-J70 ihl-rat TCLo: 30032 ug/m3/6H/12D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 50, p. 145, 1988 (TXCYAC); J30-S04 ihl-rat TCLo: 200 mg/m3/24H/4W-C Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 8, p. 516, 1984 (EESADV); J30-S04 ihl-rat TCLo: 25 mg/m3/24H/4W-C Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 8, p. 516, 1984 (EESADV); J70-M70-Y03 ihl-rat TCLo: 200 ug/m3/24H/17W-C Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 555, 1980 (DTESD7); J30-P30-S03 ihl-mus TCLo: 2460 ug/m3/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 15, p. 476, 1990 (FAATDF); J30 ihl-mus TCLo: 30032 ug/m3/6H/12D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 50, p. 145, 1988 (TXCYAC) TR: ACGIH TLV-TWA 1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 75, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); TOXICOLOGY REVIEW Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 3, p. 156, 1973 (ACLSCP); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Ni,168,1975 (85DHAX); TOXICOLOGY REVIEW Diseases of the Chest. (Chicago, IL) V.1-56, 1935-69. For publisher information, see CHETBF. v. 54, p. 527, 1968 (DICHAK); TOXICOLOGY REVIEW Critical Reviews in Oncology/Hematology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1983- v. 42, p. 35, 2002 (CREOH*) SR: MSHA STANDARD-air: TWA 1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 178, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.1 mg(Ni)/m3, JAN 1993; OEL-AUSTRALIA: TWA 1 mg(Ni)/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 1 mg(Ni)/m3 (insoluble compounds), JAN 1993; OEL-DENMARK: TWA 1 mg(Ni)/m3, JAN 1999; OEL-FINLAND: TWA 0.1 mg(Ni)/m3, Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 1 mg(Ni)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.005 mg(Ni)/m3, Carcinogen (insoluble compounds), JAN 1993; OEL-THE PHILIPPINES: TWA 1 mg(Ni)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.25 mg(Ni)/m3, JAN 1999; OEL-RUSSIA: STEL 0.05 mg(Ni)/m3, JAN 1993; OEL-SWEDEN: NGV 0.1 mg/m3, Carcinogen, JAN 1999; OEL-SWEDEN: NGV 0.5 mg(Ni)/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 0.5 mg(Ni)/m3 (insoluble compounds), JAN 1999; OEL-THAILAND: TWA 1 mg(Ni)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.5 mg(Ni)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO NICKEL, INORGANIC-air: 10H CA TWA 0.015 mg(Ni)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84269; NIS 11; TNF 311; NOS 14; TNE 4916; NOES 1983: HZD 84269; NIS 22; TNF 702; NOS 31; TNE 18166; TFE 5820 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies (inhalation), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-451, 1996 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 912 of 1119 in RTECS (through 2003/06) AN: QR9800000 PN: Nickel-sulfide- (3:2) SY: Nickel-sesquisulfide-; Nickel-subsulfide-; Nickel-subsulphide-; alpha-Nickel sulfide (3:2) crystalline; Nickel-sulphide-; Nickel-tritadisulphide-; Trinickel-disulphide- RN: Current: 12035-72-2 UD: 200305 MF: Ni3-S2 MW: 240.25 WL: NI3 S2 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: dlt-omi 5 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 621, 1986 (ENMUDM); mtr-hmn-fbr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3815, 1987 (CNREA8); sce-hmn-lym 1 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4136, 1981 (CNREA8); mtr-rat-oth 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 179, 1993 (MUREAV); dnd-rat-lvr 3 mmol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); msc-rat-emb 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 420, p. 85, 1998 (MUREAV); mtr-mus-emb 1 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4136, 1981 (CNREA8); dnd-mus-lng 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 420, p. 85, 1998 (MUREAV); dnd-mus-ihl 24 mg/m3/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 420, p. 85, 1998 (MUREAV); dnd-mus-oth 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 420, p. 85, 1998 (MUREAV); mtr-ham-kdy 10 mg/L Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 12, p. 185, 1986 (TECSDY); mtr-ham-emb 5 umol/plate Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 1, p. 132, 1981 (TOXID9); dnd-ham-ovr 10 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 657, 1982 (CRNGDP); dns-ham-emb 10 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 17, p. 273, 1983 (CALEDQ); cyt-ham-ovr 5 mg/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 84, p. 278, 1986 (TXAPA9); dna-mam-lym 4800 mg/L Biochemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1962- v. 21, p. 771, 1982 (BICHAW) RE: T26-T35 ims-rat TDLo: 80 mg/kg (6D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 43, p. 381, 1978 (TXAPA9); T81 irn-rat TDLo: 50 mg/kg (1D pre) "Reproduction and Developmental Toxicity of Metals, Proceedings of a Joint Meeting, Rochester, 1982," Clarkson, T.W., et al., eds., New York, Plenum Pub. Corp., 1983 -,399,1983 (50WKA3) TE: V01-J60-N60 ihl-rat TCLo: 1 mg/m3/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-453, 1996 (NTPTR*); V01-J60 ihl-rat TCLo: 970 ug/m3/6H/76W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 1165, 1975 (JNCIAM); V03-V10 scu-rat TDLo: 25 mg/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 79, p. 212, 1988 (JJCREP); V01-D29-V10 ivn-rat TDLo: 10 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 39, p. 330, 1980 (FEPRA7); V01-J60-Q60 ims-rat TDLo: 115 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 275, 1983 (CRNGDP); V03-J60 ipl-rat TDLo: 40 mg/kg "Progress in Nickel Toxicology, Proceedings of the International Conference on Nickel Metabolism and Toxicology, 3rd, 1984," Brown, S.S., and F.W. Sunderman, Jr., eds., Oxford, UK, Blackwell Scientific Pub. Ltd., 1985 -,37,1985 (55DXAE); V01-D29 ocu-rat TDLo: 2500 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DOE/EV/03140-5 (NTIS**); V01-T61 par-rat TDLo: 40 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 268, 1978 (CNREA8); V03-V10 imp-rat TDLo: 40 mg/kg Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 18, p. 353, 1988 (ACLSCP); V03-T61 itt-rat TDLo: 5 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 18, p. 52, 1977 (PAACA3); V01-M61 irn-rat TDLo: 25 mg/kg Laboratory Investigation. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1952- v. 35, p. 71, 1976 (LAINAW); V03-V10 ims-mus TDLo: 200 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 22, p. 158, 1962 (CNREA8); V03-Q60-V10 imp-rbt TDLo: 27 mg/kg European Journal of Cell Biology. (Wissenschaftliche Verlagsgesellschaft, Postfach 40, D-7000, Stuttgart l, Fed. Rep. Ger.) V.19- 1979- v. 19, p. 276, 1979 (EJCBDN); V01-Q60-V10 ims-ham TDLo: 80 mg/kg Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 91, p. 57, 1978 (AEMBAP); V02-R60-V10 mul-ham TDLo: 272 gm/kg/18W-I Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 91, p. 57, 1978 (AEMBAP); V01-Q60-V10 ims-rat TD :229 mg/kg IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 53, p. 127, 1984 (IAPUDO); V01-D29 ocu-rat TD :10 mg/kg Investigative Ophthalmology and Visual Science. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.16- 1977- v. 22, p. 768, 1982 (IOVSDA); V01-J60-V10 ims-rat TD :10 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 461, 1983 (CRNGDP); V01-J60 ihl-rat TCLo: 970 ug/m3/6H/76W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 1165, 1975 (JNCIAM); V02-Q60-V10 ims-ham TD :40 mg/kg Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 91, p. 57, 1978 (AEMBAP); V02-M61 irn-rat TD :23 mg/kg Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(6), p. 1511, 1979 (JEPTDQ); V01-M61 irn-rat TD :45 mg/kg Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(6), p. 1511, 1979 (JEPTDQ); V01-J60-V10 ims-rat TDLo: 100 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1005, 1987 (CRNGDP); V03-T61 itt-rat TD :40 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 18, p. 52, 1977 (PAACA3); V01-J60-V10 ims-rat TD :4800 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 461, 1983 (CRNGDP) AT: T/E unlistd orl-rat LD50: >5 gm/kg Personal Communication from F.W. Schaller, Inco Ltd., Park 80 West Plaza Two, Saddle Brook, NJ 07662, May 16, 1986 16 MAY 1986 (SchF##); T/E unlistd itr-mus LD50: 4 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 313, 1986 (ENVRAL); C08-J22-J30 ipr-gpg LDLo: 102 ug/kg Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 8, p. 565, 1908 (JOHYAY) MD: D07-J70-U01 ihl-rat TCLo: 14732 ug/m3/6H/12D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 50, p. 145, 1988 (TXCYAC); J70-D07-U01 ihl-rat TCLo: 1800 ug/m3/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 584, 1989 (FAATDF); D07-J70-Z01 ihl-mus TCLo: 29872 ug/m3/6H/12D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 50, p. 145, 1988 (TXCYAC); D07-J30-J70 ihl-mus TCLo: 1800 ug/m3/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 584, 1989 (FAATDF) TR: ACGIH TLV-TWA 0.1 mg(Ni)/m3 (I) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 mg/m3 (i) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 75, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 49, p. 257, 1990 (IMEMDT); TOXICOLOGY REVIEW Annals of Clinical and Laboratory Science. (1833 Delancey Pl., Philadelphia, PA 19103) V.1- 1971- v. 3, p. 156, 1973 (ACLSCP); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Ni,168,1975 (85DHAX); TOXICOLOGY REVIEW Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 12, p. 102, 1969 (PEXTAR); TOXICOLOGY REVIEW Diseases of the Chest. (Chicago, IL) V.1-56, 1935-69. For publisher information, see CHETBF. v. 54, p. 527, 1968 (DICHAK); TOXICOLOGY REVIEW Patologia Polska. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 23, p. 135, 1972 (PAPOAC); TOXICOLOGY REVIEW Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 127, p. 69, 2002 (TOLED5) SR: MSHA STANDARD-air: TWA 1 mg(Ni)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 178, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 mg(Ni)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.1 mg(Ni)/m3, JAN 1993; OEL-AUSTRALIA: TWA 1 mg(Ni)/m3, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 1 mg(Ni)/m3 (insoluble compounds), JAN 1993; OEL-DENMARK: TWA 1 mg(Ni)/m3, JAN 1999; OEL-FINLAND: TWA 0.1 mg(Ni)/m3, Skin, Carcinogen, JAN 1999; OEL-FINLAND: TWA 0.1 mg(Ni)/m3, Skin, Carcinogen (insoluble compounds), JAN 1993; OEL-FINLAND: Carcinogen, JAN 1993; OEL-FRANCE: VME 1 mg(Ni)/m3, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.005 mg(Ni)/m3, Carcinogen (insoluble compounds), JAN 1993; OEL-THE PHILIPPINES: TWA 1 mg(Ni)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.25 mg(Ni)/m3, JAN 1999; OEL-RUSSIA: STEL 0.05 mg(Ni)/m3, JAN 1993; OEL-SWEDEN: NGV 0.01 mg/m3, Carcinogen, JAN 1999; OEL-SWEDEN: NGV 0.5 mg(Ni)/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 0.5 mg(Ni)/m3 (insoluble compounds), JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 mg(Ni)/m3, Carcinogen, JAN 1999; OEL-THAILAND: TWA 1 mg(Ni)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.5 mg(Ni)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO NICKEL, INORGANIC-air: 10H CA TWA 0.015 mg(Ni)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (inhal), clear evidence: rat; NCI Carcinogenesis Studies (inhal), no evidence: mouse; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 913 of 1119 in RTECS (through 2003/06) AN: QS6550000 PN: Nicotine,-1'-demethyl-1'-nitroso- SY: 1'-Nitroso-1'-demethylnicotine-; 1-Nitroso-2-(3-pyridyl)pyrrolidine; 3-(1-Nitroso-2-pyrrolidinyl)pyridine; N'-Nitrosonornicotine-; Nicotine,-1'-nitroso-1'-demethyl-; Nitrosonornicotine-; Pyridine, 3-(1-nitroso-2-pyrrolidinyl)-, (S)- RN: Current: 16543-55-8 Previous: 53759-22-1 UD: 200207 MF: C9-H11-N3-O MW: 177.23 WL: T6NJ C- BT5NTJ ANO CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1 mg/plate (+S9) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 173, 1989 (CALEDQ); mmo-sat 200 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 210, p. 249, 1989 (MUREAV); cyt-hmn-lym 100 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 173, 1989 (CALEDQ); sce-hmn-lym 100 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 173, 1989 (CALEDQ); dna-rat-ivn 360 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2877, 1982 (CNREA8); dns-rat-lvr 10 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 465, 1987 (CRNGDP); mnt-mus-ipr 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 210, p. 249, 1989 (MUREAV); hma-mus-esc 48 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 263, 1994 (CRNGDP); msc-mus-orl 840 mg/kg/5W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 22, p. 203, 2000 (CRNGDP) TE: V03-D09-K60 orl-rat TDLo: 2552 mg/kg/36W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 20, p. 333, 1983 (CALEDQ); V03-K60 ipr-rat TDLo: 880 mg/kg/8W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 6, p. 365, 1979 (CALEDQ); V01-D09 scu-rat TDLo: 567 mg/kg/22W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 2285, 1984 (CNREA8); V03-J60-K60 orl-mus TDLo: 2880 mg/kg/69W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1977, 1989 (CRNGDP); V02-J60 ipr-mus TDLo: 880 mg/kg/7W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 60, p. 819, 1978 (JNCIAM); V03-D09-J60 orl-ham TDLo: 2694 mg/kg/31W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 20, p. 333, 1983 (CALEDQ); V01-D09-J60 ipr-ham TDLo: 1422 mg/kg/25W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 2849, 1981 (CNREA8); V02-J60 scu-ham TDLo: 1288 mg/kg/6W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 309, 1982 (IAPUDO); V01-D09-J60 unr-ham TDLo: 2836 mg/kg/25W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 635, 1982 (IAPUDO); V02-J60-M61 ipr-mus TD :3300 mg/kg/41W-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 202, p. 1126, 1964 (NATUAS); V01-D09-J60 ipr-ham TD :2850 mg/kg/25W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 2849, 1981 (CNREA8); V02-D09-J60 scu-ham TD :3100 mg/kg/25W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 2, p. 169, 1977 (CALEDQ); V02-J60 scu-ham TD :1290 mg/kg/6W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 2386, 1981 (CNREA8); V03-A60-D09 scu-rat TD :1640 mg/kg/14W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 499, 1982 (IAPUDO); V02-D09-J60 unr-ham TD :1418 mg/kg/25W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 635, 1982 (IAPUDO); V01-D09-L60 scu-rat TD :3160 mg/kg/20W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 298, 1980 (CNREA8); V03-K60 orl-rat TD :3 gm/kg/30W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 1237, 1975 (JNCIAM); V02-J60 ipr-mus TD :354 mg/kg/7W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 71, p. 25, 1993 (CALEDQ); V01-D09 scu-mam TDLo: 926 mg/kg/38W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 1957, 1992 (CRNGDP) AT: T/E unlistd ipr-mus LD50: 1 gm/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 173, 1989 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 281, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 281, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SR: OEL-FRANCE: Carcinogen, JAN 1993 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, In vitro UDS in rat liver; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 914 of 1119 in RTECS (through 2003/06) AN: RA0805000 PN: Nitrous-acid,-isobutyl-ester- SY: Blackjack-; Isobutyl-nitrite-; NCI-C61052-; Nitrous-acid,-2-methylpropyl-ester- (9CI) RN: Current: 542-56-3 BRN: 1699518 BHR: 4-01-00-01595 UD: 200302 MF: C4-H9-N-O2 MW: 103.14 WL: ONO1Y1&1 CC: Tumorigen (C); Mutagen (M); Human-Data (P) ME: mmo-sat 1 mg/plate (+S9) Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 56, p. 816, 1980 (BSIBAC); mmo-sat 333 ug/plate (-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) APR1982 (NTPTB*); msc-mus-lym 75900 nmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 115, 1989 (EMMUEG) TE: V01-J60 ihl-rat TCLo: 150 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-448, 1996 (NTPTR*); V02-J60 ihl-mus TCLo: 150 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-448, 1996 (NTPTR*); V01-J60 ihl-rat TCLo: 4635 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-120232 (NTIS**); V03-J60 ihl-rat TCLo: 3862.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-120232 (NTIS**); V03-J60 ihl-mus TCLo: 9270 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-120232 (NTIS**) ORNG: 410000000 ng/kg. [410.000000 mg/kg] F01 IHPB: 777000 ppb/4H. [777.000000 ppm/4H] F05-F13-J24 AT: P24-H02-G10 orl-man TDLo: 120 mg/kg Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 92, p. 637, 1980 (AIMEAS); F01 orl-rat LD50: 410 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 41, p. 1583, 1982 (FEPRA7); F05-F13-J24 ihl-rat LC50: 777 ppm/4H Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 101, 1987 (FAATDF); L30-P24 orl-mus LD50: 205 mg/kg Research Communications in Substances Abuse. (PJD Pub. Ltd., P.O.Box 966, Westbury, NY 11590) V.1- 1980- v. 3, p. 233, 1982 (RCSADO); F17-J24-M10 ihl-mus LC50: 1033 ppm/1H Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 1, p. 448, 1981 (FAATDF); L30 ipr-mus LD50: 184 mg/kg Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 26, p. 75, 1979 (RCOCB8); N30 ihl-mus TCLo: 900 ppm/45M Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 116, p. 151, 2000 (TOLED5) MD: J30-L30-Z01 ihl-rat TCLo: 600 ppm/6H/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 19, p. 169, 1992 (FAATDF); D07-P24-P71 ihl-rat TCLo: 150 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 19, p. 169, 1992 (FAATDF); L70-M70-N73 ihl-mus TCLo: 400 ppm/7H/60D-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 5, p. 134, 1985 (JJATDK); J70-U01-Z01 ihl-mus TCLo: 800 ppm/6H/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 19, p. 169, 1992 (FAATDF); J02-P71-P72 ihl-mus TCLo: 300 ppm/6H/14W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 19, p. 169, 1992 (FAATDF); L70-P24-P72 ihl-mus TCLo: 300 ppm/6.5H/18W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 15, p. 823, 1985 (JTEHD6) ND: NOES 1983: HZD X4720; NIS 1; TNF 13; NOS 4; TNE 290; TFE 13 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (inhal), clear evidence: rat; NTP Carcinogenesis studies (inhalation), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-448, 1996 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: mouse Record 915 of 1119 in RTECS (through 2003/06) AN: RA1225000 PN: Nitrous-acid,-sodium-salt- SY: Anti-rust-; Diazotizing-salts-; Dusitan-sodny- (Czech); Erinitrit-; Filmerine-; Azotyn-sodowy- (Polish); Natrium-nitrit- (German); NCI-C02084-; Nitrite-de-sodium- (French); Sodium-nitrite- RN: Current: 7632-00-0 UD: 200305 MF: N-O2.Na MW: 69.00 WL: NA N-O-O CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 500 mg/24H MLD "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,15,1972 (28ZPAK) ME: mmo-sat 250 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 28, p. 31, 1975 (MUREAV); mmo-sat 1 mg/plate (-S9) Mikrobiyoloji Bulteni. Bulletin of Microbiology. (c/o Dr. A. Tevfik Cenqiz, Ankara Universitesi Tip Fakultesi Mikrobiyoloji Ana Bilim Dah, Ankara, Turkey) V.1- 1967- v. 25, p. 94, 1991 (MIBUBI); oms-sat 2200 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 50 mmol/L (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 61, p. 376, 1969 (GENTAE); dnr-esc 625 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); pic-esc 215 ug/well Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 463, p. 347, 1986 (ANYAA9); mmo-bcs 400 mol (-S9) Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 4, p. 411, 1968 (MOPMA3); oms-hmi 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 61, p. 129, 1979 (MUREAV); mmo-omi 2 mol/L (-S9) Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 37, p. 335, 1969 (VIRLAX); dnd-omi 100 mmol/L Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 116, p. 31, 1977 (JMOBAK); mmo-omi 17 mmol/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 15, p. 48, 1970 (FOMIAZ); mmo-omi 4 pph (-S9) Zeitschrift fuer Allgemeine Mikrobiologie. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086 Ger. Dem. Rep.) V.1- 1960- v. 16, p. 279, 1976 (ZAPOAK); mmo-omi 1 mol/L (-S9) Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 2, p. 324, 1960 (BBRCA9); mmo-omi 50 mmol/L (-S9) Tsitologiya i Genetika. Cytology and Genetics. For English translation, see CYGEDX. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967- v. 3, p. 87, 1968 (TGANAK); mmo-omi 3350 mmol/L (-S9) Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 81, p. 192, 1977 (VIRLAX); mmo-omi 50 mmol/L (-S9) Archives of Microbiology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secacus, NJ 07094) V.95- 1974- v. 103, p. 141, 1975 (AMICCW); mmo-omi 2 mol/L (-S9) Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 74, p. 154, 1976 (VIRLAX); mmo-omi 50 mol/L (-S9) Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung II. Naturwissenschaftliche: Allgemeine, Landwirtschaftliche und Technische Mikrobiologie. (Jena, Ger. Dem. Rep.) V.107-132, 1952-77. v. 128, p. 678, 1974 (ZBPIA9); mmo-omi 700 mmol/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 15, p. 1, 1975 (JOVIAM); mmo-omi 1 mmol/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 15, p. 41, 1975 (JOVIAM); mmo-omi 10 mmol/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 23, p. 177, 1978 (FOMIAZ); mmo-omi 4 mol/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 7, p. 295, 1971 (JOVIAM); mmo-omi 1 mol/L (-S9) Acta Virologica (English Edition). (Academic Press Inc. Ltd., 24-28 Oval Rd., London NW1 7DX, UK) V.1- 1957- v. 21, p. 397, 1977 (AVIRA2); mmo-omi 50 mmol/L (-S9) Journal of General Microbiology. (Soc. for General Microbiology, Journal Sales, 62 London Rd., Reading, RG1 5AS, UK) V.1- 1947- v. 128, p. 1401, 1982 (JGMIAN); dnd-omi 1 mol/L Journal de Chimie Physique et de Physico-Chimie Biologique. (CDR-Centrale des Revues, 11, rue Gossin, F-92543 Montrouge Cedex, France) V.1- 1903- v. 58, p. 1005, 1961 (JCPBAN); oms-omi 1 mol/L Journal de Chimie Physique et de Physico-Chimie Biologique. (CDR-Centrale des Revues, 11, rue Gossin, F-92543 Montrouge Cedex, France) V.1- 1903- v. 58, p. 1005, 1961 (JCPBAN); mmo-omi 5 mol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 141, p. 207, 1975 (MGGEAE); mmo-omi 200 mg/kg (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 37, p. 936, 1981 (JOVIAM); dnd-omi 1 mol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 25, p. 235, 1974 (MUREAV); slt-dmg-orl 72500 umol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 359, 1989 (MUREAV); mmo-nsc 5 umol/L/2H (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 111, p. 159, 1971 (MGGEAE); mmo-smc 72500 umol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 102, p. 290, 1968 (MGGEAE); mrc-smc 100 umol/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 168, p. 125, 1979 (MGGEAE); sln-asn 500 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 10, p. 111, 1970 (MUREAV); mmo-ssp 34 mmol/L (-S9) Abhandlungen der Deutschen Akademie der Wissenschaften zu Berlin, Klasse fuer Medizin. (Berlin, Ger. Dem. Rep.) 1950-68. Discontinued. v. -, p. 193, 1962 (ADWMAX); bfa-ofs-sat 450 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 20, p. 147, 1983 (CALEDQ); bfa-ofs-esc 450 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 20, p. 147, 1983 (CALEDQ); dns-hmn-hla 6 mmol/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 551, 1983 (FCTOD7); dni-hmn-fbr 2000 ppm Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 32, p. 341, 1985 (NEOLA4); dni-hmn-oth 725 umol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 47, p. 396, 1991 (IJCNAW); bfa-hmn-sat 200 mmol/L Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 47, p. 889, 1981 (CANCAR); cyt-ham-hla 265 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 333, 1987 (MUREAV); cyt-rat-par 100 mg/kg/5D-I Problemi na Khigienata. Problems in Hygiene. (Durzhavno Izdatel'stvo Meditsina i Fizkultura, Pl. Slaveikov 11, Sofia, Bulgaria) V.1- 1975- v. 4, p. 151, 1979 (PRKHDK); cyt-rat-orl 2730 mg/kg/13D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 13, p. 643, 1984 (JTEHD6); cyt-rat-ipr 69 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 281, 1990 (MUREAV); mtr-mus-fbr 10 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 11, p. 595, 1990 (CRNGDP); dnd-mus-lym 105 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 155, 1988 (MUREAV); cyt-mus-orl 60 mg/kg/30D-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 30, p. 315, 1986 (CALEDQ); cyt-mus-mmr 10 mmol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 119, 1976 (MUREAV); sce-mus-ipr 5 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 31, p. 299, 1986 (CALEDQ); msc-mus-lym 70400 umol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 3, p. 193, 1988 (MUTAEX); msc-mus-mmr 1 mmol/L/2D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 119, 1976 (MUREAV); hma-mus-ssp 362 umol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 21, 1983 (MUREAV); spm-mus-orl 840 mg/kg/2W Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 689, 1988 (MUREAV); mnt-ham-orl 500 mg/kg International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 24, p. 365, 1979 (IJCNAW); mtr-ham-orl 100 mg/kg Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 81, p. 310, 1978 (BBRCA9); mtr-ham-oth 100 mmol/L/24H Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 55, p. 1117, 1973 (BBRCA9); mtr-ham-fbr 50 mmol/L/3H Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 67, p. 165, 1976 (GANNA2); dni-ham-lng 100 ppm Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 32, p. 341, 1985 (NEOLA4); cyt-ham-fbr 530 mg/L/34H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); cyt-ham-emb 20 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 69, 1977 (MUREAV); cyt-ham-lng 400 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); sce-ham-fbr 3 mmol/L Proceedings of the Japan Academy. (Tokyo, Japan) V.21-53, 1945-77. For publisher information, see PJABDW. v. 53, p. 46, 1977 (PJACAW); msc-ham-orl 100 mg/kg IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 585, 1982 (IAPUDO); msc-ham-lng 1000 ppm Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 32, p. 341, 1985 (NEOLA4); cyt-mky-lvr 265 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 333, 1987 (MUREAV); dnd-mam-lym 1 mol Journal de Chimie Physique et de Physico-Chimie Biologique. (CDR-Centrale des Revues, 11, rue Gossin, F-92543 Montrouge Cedex, France) V.1- 1903- v. 58, p. 1005, 1961 (JCPBAN); mrc-dmg-orl 36 mmol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 518, p. 95, 2002 (MUREAV); mmo-sat 5 mg/plate Experimental Oncology (Journal of ucrainian section of European institute of ecology and cancer, Kiev-22, Vaselkovskaya str., 25, Kiev-22) V.1- 1979- v. 15, p. 25, 1992 (EXONC*) RE: T35-T81 orl-rat TDLo: 660 mg/kg (1-22D preg) American Journal of Public Health. (American Public Health Assoc., 1015 15th St., NW, Washington, DC 20005) V.2-17, 1912-27: V.61- 1971- v. 62, p. 1045, 1972 (AJHEAA); T81-T83-T87 orl-rat TDLo: 11 gm/kg (1-22D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 89, 1984 (TOXID9); T76 orl-rat TDLo: 10280 mg/kg (1-22D preg/20D post) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 668, 1987 (FAATDF); T81-T87 orl-rat TDLo: 6080 mg/kg (20D post) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 668, 1987 (FAATDF); T41-T48-T85 ipr-rat TDLo: 400 mg/kg (10-19D preg) Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I. P. Pavlova. (Izdatelstvo Nauka, 21 Garibaldi Street, 117335 Moscow, Russia) V.1- 1951- v. 43, p. 613, 1993 (ZVNDAM); T48 orl-mus TDLo: 280 mg/kg (1-14D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 18, p. 367, 1978 (TJADAB); T24-T35 orl-mus TDLo: 1200 mg/kg (6-15D preg) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 42, p. 836, 1987 (NEZAAQ); T23 orl-mus TDLo: 1680 mg/kg (14D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 689, 1988 (MUREAV); T01 orl-mus TDLo: 840 mg/kg (14D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 689, 1988 (MUREAV); T39 ivn-ctl TDLo: 36 mg/kg (30-31W preg) Theriogenology. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022) V.1- 1974- v. 33, p. 1075, 1990 (THGNBO); T34 scu-pig TDLo: 1890 mg/kg (15-105D preg) "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 41, 1989 (VCVN5*); T81 orl-mus TDLo: 480 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91132027 (NTIS**); T53 orl-mus TDLo: 480 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91132027 (NTIS**) TE: V01-K60 orl-rat TDLo: 2190 gm/kg/2Y-C Huanjing Kexue Xuebao. Environmental Sciences Journal. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1981- v. 6, p. 246, 1986 (HKXUDL); V01-T65-J60 orl-mus TDLo: 2149 mg/kg (2W male/2W pre-3W post) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 3561, 1985 (CNREA8); V03-K60 orl-rat TD :63 gm/kg/95W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 64, p. 1435, 1980 (JJIND8); V03-R60-T61 orl-rat TD :91 gm/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 25, 1982 (FCTOD7); V03-R60-T61 orl-rat TD :183 gm/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 25, 1982 (FCTOD7); V02-L60 orl-rat TD :100 gm/kg/2Y-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 1189, 1983 (CRNGDP); V02-L60 orl-rat TD :40 gm/kg/56W-C Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 87, 1977 (ZKKOBW); V01-K60 orl-rat TD :365 gm/kg/2Y-I Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 8, p. 35, 1988 (TCMUD8); V03-K60 orl-mus TDLo: 118965 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2001-107676 (NTIS**); V01-M60-V16 orl-rat TDLo: 27300 mg/kg/273D-C Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 37, p. 203, 1991 (VOONC*) ORNG: 180000000 ng/kg. [180.000000 mg/kg] T/E unlistd IHNG: 5500000 ng/m3/4H. [5.500000 mg/m3/4H] T/E unlistd AT: F17-H05-K13 orl-hmn TDLo: 14 mg/kg Deutsche Medizinische Wochenschrift. (Stuttgart, Fed. Rep. Ger.) V.1-104, 1875-1979. v. 74, p. 961, 1949 (DMWOAX); F24-J24-P24 orl-man LDLo: 321 mg/kg Israel Journal of Medical Sciences. (POB 1435, Jerusalem 91013, Israel) V.1- 1965- v. 28, p. 289, 1992 (IJMDAI); G07-H02 orl-man TDLo: 1714 ug/kg/70M Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1924- v. 16, p. 73, 1937 (JCINAO); F24-K13-P24 orl-hmn LDLo: 71 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,543,1969 (34ZIAG); H30 orl-chd LDLo: 22 mg/kg Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 162, 1917 (LANCAO); T/E unlistd orl-rat LD50: 180 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); T/E unlistd scu-rat LD50: 96600 ug/kg Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 14, p. 231, 1991 (ATSUDG); T/E unlistd ivn-rat LD50: 65 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 13, p. 320, 1963 (ARZNAD); H02-H05 orl-mus LD50: 175 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 53A, p. 97, 1974 (FAONAU); T/E unlistd ipr-mus LD50: 158 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 165, p. 30, 1969 (JPETAB); F13-J26-K13 scu-mus LDLo: 150 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 35, p. 480, 1929 (AIPTAK); T/E unlistd orl-dog LDLo: 330 mg/kg "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973 -,245,1973 (27ZIAQ); C08-F12-K13 scu-dog LDLo: 60 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 21, p. 425, 1911 (AIPTAK); T/E unlistd ivn-dog LDLo: 15 mg/kg "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973 -,245,1973 (27ZIAQ); T/E unlistd orl-cat LDLo: 1500 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1372, 1935 (HBAMAK); J22-J24-K01 scu-cat LDLo: 35 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 126, p. 209, 1927 (AEPPAE); T/E unlistd orl-rbt LD50: 186 mg/kg Southwestern Veterinarian. (College of Veterinary Medicine, Texas A and M Univ., College Station, TX 77843) V.1- 1948- v. 27, p. 246, 1974 (SOVEA7); T/E unlistd scu-rbt LDLo: 60 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1372, 1935 (HBAMAK); C06-F24-M10 ivn-rbt LDLo: 80 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 41, p. 121, 1931 (JPETAB); T/E unlistd orl-ckn LD50: 28944 ug/kg American Journal of Veterinary Research. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.1- 1940- v. 30, p. 2185, 1969 (AJVRAH); T/E unlistd scu-frg LDLo: 1 gm/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1372, 1935 (HBAMAK); S02 orl-mus TDLo: 25 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 119, 2001 (FCTOD7); P70-S02 orl-mus TDLo: 100 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 119, 2001 (FCTOD7); T/E unlistd ihl-rat LC50: 5.5 mg/m3/4H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 40, 1993 (VCVN5*); Y03-Y11 ihl-rat TCLo: 1.2 mg/m3/4H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 40, 1993 (VCVN5*); P24-P71-P72 orl-dog TDLo: 150 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 41, 1993 (VCVN5*); P24-P71-P72 ivn-dog TDLo: 150 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 41, 1993 (VCVN5*); P24-P71-P72 scu-dog TDLo: 150 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 41, 1993 (VCVN5*); F24-J25-P24 unr-hmn LDLo: 0.036 gm/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 41, 1993 (VCVN5*); J22-P30 scu-rat LD :120 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 45, p. 76, 1982 (FATOAO); U30 scu-mus TDLo: 300 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 74, 1987 (FATOAO); A10-G06 scu-cat LDLo: 100 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 210, 1981 (FATOAO); T/E unlistd scu-rat LDLo: 100 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 210, 1981 (FATOAO); T/E unlistd scu-mus LDLo: 100 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 210, 1981 (FATOAO) MD: L30 orl-rat TDLo: 180 mg/kg/8D-I Khigiena i Zdraveopazvane. Hygiene and Sanitation. (Hemus, Blvd. Russki 6, Sofia, Bulgaria) V.9- 1966- v. 25, p. 558, 1982 (KHZDAN); L30-P28-Y16 orl-rat TDLo: 22500 mg/kg/90D-C Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 13, p. 41, 1980 (BCTKAG); A10-F07-P24 orl-rat TDLo: 17080 mg/kg/61D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 5, p. 409, 1972 (ENVRAL); P24-Y10-Y15 orl-rat TDLo: 4477 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(7), p. 8, 1979 (GISAAA); U01 orl-rat TDLo: 134 gm/kg/64W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(3), p. 687, 1979 (JEPTDQ); Y03-Y11 ihl-rat TCLo: 300 ug/m3/4H/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(3), p. 41, 1972 (GISAAA); A11-P30-Y03 ihl-rat TCLo: 125 ug/m3/22W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 16(10), p. 36, 1972 (GTPZAB); L30-Y11-Z01 ipr-rat TDLo: 960 mg/kg/30D-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 34(6), p. 29, 1990 (GTPZAB); J70-L70-U01 orl-rat TDLo: 185 gm/kg/61W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 6, p. 199, 1980 (TOLED5); K30 orl-mus TDLo: 3600 mg/kg/90D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 60, p. 185, 1998 (BECTA6); S02 orl-mus TDLo: 175 mg/kg/1W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 119, 2001 (FCTOD7); S04 orl-mus TDLo: 700 mg/kg/1W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 119, 2001 (FCTOD7); P24-Z01 scu-pig TDLo: 1890 mg/kg/90D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 41, 1989 (VCVN5*); Y03-Y04-Y16 orl-rat TDLo: 27 mg/kg/10D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 41, 1989 (VCVN5*); L14 orl-rat TDLo: 100 mg/kg/10D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 41, 1989 (VCVN5*); P24-Y41 orl-rat TDLo: 110 mg/kg/22D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 42, 1989 (VCVN5*); C16-Y03 ihl-rat TCLo: 0.125 mg/m3/4H/22W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 42, 1989 (VCVN5*); F40-P24-T01 orl-rat TDLo: 912.5 mg/kg/26W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 42, 1989 (VCVN5*); G30-M30-Y10 orl-gpg TDLo: 53.5 gm/kg/9W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 42, 1989 (VCVN5*); F16 orl-mus TDLo: 16800 mg/kg/35D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91132027 (NTIS**) TR: TOXICOLOGY REVIEW Journal of the Science of Food and Agriculture. (Blackwell Scientific Pub. Inc., 52 Beacon St., Boston, MA 02108) V.1- 1950- v. 26, p. 1761, 1975 (JSFAAE); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-HUNGARY: STEL 1 mg/m3, Skin, JAN 1993 ND: NOHS 1974: HZD 69230; NIS 229; TNF 40763; NOS 127; TNE 389731; NOES 1983: HZD 69230; NIS 250; TNF 47686; NOS 169; TNE 928532; TFE 274167 SL: EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay, In vivo cytogenetics-mammalian oocyte; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test, In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro cytogenetics-nonhuman; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal, Host-mediated assay; EPA GENETOX PROGRAM 1988, Inconclusive: Rodent heritable translocation, Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (water), equivocal evidence: mouse; NCI Carcinogenesis Studies (water), no evidence: rat; NTP Carcinogenesis studies, test completed (post peer review), October 2000 Record 916 of 1119 in RTECS (through 2003/06) AN: RB9000000 PN: 5-Norbornene-2,3-dicarboxylic-acid,-1,4,5,6,7,7-hexachloro- SY: Bicyclo(2.2.1)hept-5-ene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexachloro- (9CI); Chlorendic-acid-; HET-acid-; 1,4,5,6,7,7-Hexachlorobicyclo(2.2.1)-5-heptene-2,3-dicarboxylic acid; Hexachloro-endo-methylenetetrahydrophthalic-acid-; 1,4,5,6,7,7-Hexachloro-5-norbornene-2,3-dicarboxylic-acid-; Kyselina 3,6-endomethylen-3,4,5,6,7,7-hexachlor-delta(sup 4)-tetrahydroftalova (Czech); Kyselina 1,2,3,4,7,7-hexachlorbicyklo(2,2,1)hept-2-en-5,6-dikarboxylova (Czech); NCI-C55072- RN: Current: 115-28-6 UD: 200210 MF: C9-H4-Cl6-O4 MW: 388.83 WL: L55 A CUTJ AG AG BG EG FG GG CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,581,1986 (85JCAE); eye-rbt 250 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,581,1986 (85JCAE) ME: msc-mus-lym 1700 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-304, 1987 (NTPTR*); cyt-ham-lng 975 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 369, p. 243, 1996 (MUREAV); mtr-mus-fbr 0.05 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V01-L60 orl-rat TDLo: 45063 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-304, 1987 (NTPTR*); V01-L60 orl-mus TDLo: 108 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-304, 1987 (NTPTR*); V01-K60-L60 orl-rat TDLo: 19467 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-206835/AS (NTIS**); V01-L60 orl-rat TDLo: 47586 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-206835/AS (NTIS**); V01-L60 orl-mus TDLo: 64169 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-206835/AS (NTIS**) AT: T/E unlistd orl-rat LD :>1 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535786 (NTIS**); T/E unlistd ihl-rat LC :>790 mg/m3/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0537100 (NTIS**) MD: U01-Z01 orl-rat TDLo: 35 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-304, 1987 (NTPTR*); L30 orl-rat TDLo: 45500 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-304, 1987 (NTPTR*); Z01 orl-mus TDLo: 84 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-304, 1987 (NTPTR*); L01-U01 orl-mus TDLo: 218 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-304, 1987 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 45, 1990 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 45, 1990 (IMEMDT) ND: NOHS 1974: HZD T0695; NIS 1; TNF 21; NOS 2; TNE 166; NOES 1983: HZD T0695; NIS 1; TNF 3; NOS 1; TNE 55; TFE 29 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 917 of 1119 in RTECS (through 2003/06) AN: RC8925000 PN: 19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol SY: (17-alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17,diol; 17-Ethinyl-3,17-estradiol-; 17-Ethinyl-3,17-oestradiol-; 17-Ethinylestradiol-; 17-Ethynyl-3,17-dihydroxy-1,3,5-oestratriene-; 17-Ethynyloestradiol-; 17-alpha-Ethinyl-17-beta-estradiol-; 17-alpha-Ethinyl-3,17-dihydroxy-delta(sup 1,3,5)-estratriene; 17-alpha-Ethinyl-delta(sup 1,3,5(10))oestratriene-3,17-beta-diol; 17-alpha-Ethinylestra-1,3,5(10)-triene-3,17-beta-diol; 17-alpha-Ethinylestradiol-; 17-alpha-Ethinyloestra-1,3,5(10)-triene-3,17-beta-diol; 17-alpha-Ethynyl-1,3,5(10)-estratriene-3,17-beta-diol; 17-alpha-Ethynyl-1,3,5(10)-oestratriene-3,17-beta-diol; 17-alpha-Ethynyl-1,3,5-oestratriene-3,17-beta-diol-; 17-alpha-Ethynyl-17-beta-oestradiol-; 17-alpha-Ethynylestra-1,3,5(10)-triene-3,17-beta-diol; 17-alpha-Ethynylestradiol-; 17-alpha-Ethynylestradiol-17-beta-; 17-alpha-Ethynyloestra-1,3,5(10)-triene-3,17-beta-diol; 17-alpha-Ethynyloestradiol-; 17-alpha-Ethynyloestradiol-17-beta-; 17alpha-Ethynyl-oestradiol-; 19-Nor-17-alpha-pregna-1,3,5(10)-triene-20-yne-3,17-diol; 3,17-beta-Dihydroxy-17-alpha-ethynyl-1,3,5(10)-estratriene; 3,17-beta-Dihydroxy-17-alpha-ethynyl-1,3,5(10)-oestratriene; Aethinyoestradiol- (German); Amenoron-; Anovlar-; Chee-O-Gen-; Chee-O-Genf-; Diognat-E-; Diogyn-E-; Diprol-; Dyloform-; EE-; EE(sub 2); EED-; EO-; Esteed-; Estigyn-; Estinyl-; Eston-E-; Estoral-; Estoral- (orion); Estorals-; Estra-1,3,5(10)-triene-3,17-beta-diol, 17-alpha-ethynyl-; Estradiol,-17-ethynyl-; Ethidol-; Ethinoral-; Ethinyl-estradiol-; Ethinyl-oestranol-; Ethinylestradiol-; Ethinylestriol-; Ethinyloestradiol-; Ethinyloestriol-; Ethynyl-estradiol-; Ethynylestradiol-; Ethynyloestradiol-; Eticyclin-; Eticyclol-; Etinestrol-; Etinestryl-; Etinoestryl-; Etistradiol-; Feminone-; Follicoral-; Ginestrene-; Inestra-; Linoral-; Lynoral-; Menolyn-; Microfollin-; NSC-10973-; Novestrol-; Oradiol-; Orestralyn-; Palonyl-; Perovex-; Primogyn-; Primogyn-C-; Primogyn-M-; Progynon-C-; Spanestrin- RN: Current: 57-63-6 Previous: 77538-56-8 BRN: 2419975 BHR: 4-06-00-06877 UD: 200305 MF: C20-H24-O2 MW: 296.44 WL: L E5 B666TTT&J E1 FQ F1UU1 OQ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Hormone (H) ME: mmo-sat 500 ug/plate (+S9) Shiyan Shengwu Xuebao. Journal of Experimental Biology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1953- Suspended 1966-77. v. 12, p. 41, 1979 (SYSWAE); dnr-bcs 5 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 19, 1977 (MUREAV); mmo-ssp 50 ug/plate (-S9) Egyptian Journal of Botany. (National Information and Documentation Centre, Al-Tahrir St., Awqaf P.O. Dokki, Cairo, Egypt) V.1- 1958- v. 20, p. 29, 1977 (EGJBAY); dna-sal-spr 10 nmol/L Journal of Steroid Biochemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1969- v. 3, p. 515, 1972 (JSTBBK); dns-hmn-mmr 5 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 1727, 1982 (CNREA8); dni-hmn-lym 50 umol/L Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 146, p. 401, 1974 (PSEBAA); cyt-hmn-lym 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 173, 1997 (MUREAV); sce-hmn-lym 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 173, 1997 (MUREAV); mtr-rat-orl 12600 ug/kg/6W Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 387, 1988 (CRNGDP); mtr-rat-emb 10700 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dna-rat-orl 1390 nmol/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 23, p. 13, 1978 (CBINA8); dna-rat-oth 10 nmol/L Journal of Steroid Biochemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1969- v. 3, p. 515, 1972 (JSTBBK); dns-rat-lvr 15 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 3574, 1989 (CNREA8); dns-rat-orl 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 189, 1994 (MUREAV); dns-rat-scu 3500 ug/kg/7D-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 1224, 1986 (CNREA8); dni-rat-lvr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 337, 1985 (CNREA8); mnt-mus-ipr 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 173, 1997 (MUREAV); mtr-mus-fbr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 2583, 1987 (CNREA8); dns-mus-scu 400 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 14, 1988 (CNREA8); dns-mus-emb 1 mg/L Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 33, p. 327, 1973 (JRPFA4); oms-mus-oth 740 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH); sce-mus-ipr 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 173, 1997 (MUREAV); cyt-ham-lng 10 mg/L Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 19(Suppl 4), p. S1065, 1991 (YACHDS); cyt-ham-ovr 50 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 29, p. 201, 1985 (TOLED5); cyt-ham-scu 160 mg/kg/20W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 311, p. 191, 1994 (MUREAV); sce-ham-ovr 10 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 44, p. 62, 1988 (EXPEAM); sln-ham-fbr 75 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 171, p. 31, 1986 (MUREAV); oms-dom-oth 74100 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH); oms-ctl-oth 7410 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH); cyt-ctl-oth 7410 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH); cyt-dom-oth 74100 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH) RE: T13-T29 orl-wmn TDLo: 500 ug/kg (5D pre) Progress in Reproductive Biology. (Basel, Switzerland) V.1-8, 1976-81. v. 7, p. 310, 1980 (PRBIDC); T14-T22 orl-wmn TDLo: 500 ug/kg (5D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 14, p. 375, 1976 (CCPTAY); T29 orl-wmn TDLo: 160 ug/kg (57W pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 105, p. 7, 1966 (ACEDAB); T22 unr-wmn TDLo: 20 ug/kg (4D preg) International Congress Series--Excerpta Medica. (Excerpta Medica, Inc., POB 3085, Princeton, NJ 08540) No.1- 1952- v. (133), p. 406, 1967 (EXMDA4); T22 unr-wmn TDLo: 500 ug/kg (1-5D preg) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 244, p. 1336, 1980 (JAMAAP); T02-T03 orl-rat TDLo: 560 ug/kg (14D male) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 500, 1958 (ANYAA9); T25 orl-rat TDLo: 4500 ng/kg (1-9D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T26-T29 orl-rat TDLo: 250 ug/kg (1-4D preg) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 41, p. 351, 1962 (ACENA7); T13 orl-rat TDLo: 860 ng/kg (1D pre) Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 23, p. 329, 1980 (JMCMAR); T44 orl-rat TDLo: 750 ug/kg (15-17D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 21, p. 591, 1983 (IJEBA6); T22 orl-rat TDLo: 55 ug/kg (11D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 116, p. 343, 1964 (PSEBAA); T02-T03 scu-rat TDLo: 1 mg/kg (10D male) International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS 66044) V.1- 1955- v. 8, p. 589, 1963 (INJFA3); T22 scu-rat TDLo: 1 mg/kg (1D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 43, p. 505, 1975 (JRPFA4); T12-T13-T29 scu-rat TDLo: 5 ug/kg (1D pre) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 49, p. 193, 1965 (ACENA7); T03 scu-rat TDLo: 4 ug/kg (1D male) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 49, p. 193, 1965 (ACENA7); T24 scu-rat TDLo: 28 ug/kg (3-9D preg) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 47, p. 444, 1964 (ACENA7); T53 scu-rat TDLo: 600 ug/kg (17-20D preg) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 240, p. 104, 1981 (ACEDAB); T12-T13-T29 imp-rat TDLo: 10 mg/kg (24D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 2, p. 315, 1970 (BIREBV); T02 unr-rat TDLo: 130 ug/kg (13D male) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 36, p. 1069, 1986 (ARZNAD); T12 unr-rat TDLo: 26 ug/kg (13D pre) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 36, p. 1069, 1986 (ARZNAD); T13 orl-mus TDLo: 300 ng/kg (3D pre) Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 6, p. 1321, 1978 (YACHDS); T27 orl-mus TDLo: 40 ug/kg (3-4D preg) Acta Pharmacologica et Toxicologica, Supplementun. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) No.1- 1947- v. 26(1), p. 1, 1968 (APTSAI); T22 orl-mus TDLo: 120 ug/kg (1D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 19, p. 787, 1968 (FESTAS); T35-T46 orl-mus TDLo: 200 ug/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 23, p. 233, 1981 (TJADAB); T53 orl-mus TDLo: 70 ug/kg (11-17D preg) Development, Growth and Differentiation. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.11- 1969- v. 19, p. 241, 1977 (DGDFA5); T91 orl-mus TDLo: 70 ug/kg (11-17D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 127, p. 832, 1977 (AJOGAH); T22 ipr-mus TDLo: 280 mg/kg (28D pre) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 70, p. 60, 1981 (JPMSAE); T13 scu-mus TDLo: 1200 ng/kg (3D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T61 scu-mus TDLo: 400 ug/kg (11-12D preg) British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 62, p. 599, 1990 (BJCAAI); T53 scu-mus TDLo: 180 ug/kg (11-19D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 39, p. 193, 1999 (CGANE7); T22 ivg-mus TDLo: 280 mg/kg (28D pre) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 70, p. 60, 1981 (JPMSAE); T22 orl-mky TDLo: 500 ug/kg (1-6D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 115, p. 101, 1973 (AJOGAH); T29 orl-rbt TDLo: 4 ug/kg (1D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 78, p. 860, 1966 (ENDOAO); T25 orl-rbt TDLo: 100 ug/kg (6-15D preg) AMI-Berichte. (Berlin, Fed. Rep. Ger.) No. 1-2, 1978-82. v. (1), p. 127, 1988 (AMBED4); T29 scu-rbt TDLo: 25 ug/kg (1D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 79, p. 939, 1966 (ENDOAO); T24 scu-rbt TDLo: 6 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T24-T34 unr-rbt TDLo: 19 ug/kg (1-19D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 2, p. 85, 1970 (CCPTAY); T29 unr-rbt TDLo: 125 ug/kg (1D pre) Indian Journal of Pharmacy. (Bombay, India) V.1-40(1), 1939-78. For publisher information, see IJSIDW. v. 32, p. 164, 1970 (IJPAAO); T21-T22 orl-ham TDLo: 20 mg/kg (4D pre) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 70, p. 582, 1972 (ACENA7); T24-T25 orl-ham TDLo: 90 mg/kg (1-9D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T13 orl-ham TDLo: 70 ug/kg (7D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T22-T25 imp-ham TDLo: 20 mg/kg (10D pre) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 70, p. 385, 1972 (ACENA7); T21 imp-ham TDLo: 4 mg/kg (10D pre) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 70, p. 385, 1972 (ACENA7); T02 imp-ham TDLo: 160 mg/kg (55W male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 57, p. 255, 1955 (ENDOAO); T83 orl-rat TDLo: 0.1 mg/kg (multigeneration)) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 53, 2002 (FCTOD7); T51 orl-rat TDLo: 2.5 mg/kg (multigeneration)) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 53, 2002 (FCTOD7) TE: V01-L61 orl-wmn TDLo: 2738 ug/kg/10Y-I Medical Journal of Australia. (Australasian Medical Pub. Co. Ltd., 71-79 Arundel St., Glebe, N.S.W., Australia) V.1- 1914- v. 1, p. 473, 1981 (MJAUAJ); V03-N60-R60 orl-rat TDLo: 6 ug/kg/2Y-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 885, 1980 (JTEHD6); V01-R60 imp-rat TDLo: 5 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 455, 1981 (JJIND8); V02-M61 imp-ham TDLo: 621 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 12, p. 274, 1952 (CNREA8); V03-T63-T64 orl-rat TD :245 mg/kg/35W-C Experimental Medicine and Surgery. (Brooklyn, NY) V.1-29, 1943-71. Suspended. v. 22, p. 28, 1964 (EMSUA8); V03-M60 imp-ham TD :800 mg/kg/34W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5200, 1983 (CNREA8); V01-L60 orl-wmn TD :102 mg/kg/5Y-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 273, 1980 (LANCAO); V03-R60 imp-rat TD :5 mg/kg Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 63, p. 1180, 1979 (CTRRDO) ORNG: 960000000 ng/kg. [960.000000 mg/kg] T/E unlistd AT: J22-K13-U25 orl-wmn TDLo: 21 mg/kg/21D-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 1479, 1973 (LANCAO); T/E unlistd orl-rat LD50: 960 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 222, 1995 (NIIRDN); F12-F19-M30 ipr-rat LD50: 471 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 18, p. 2583, 1990 (YACHDS); F07-P01 scu-rat LD50: >2 gm/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 18, p. 2583, 1990 (YACHDS); T/E unlistd orl-mus LD50: 950 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 222, 1995 (NIIRDN); F12-F19-M30 ipr-mus LD50: 250 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 18, p. 2583, 1990 (YACHDS); F07-P01 scu-mus LD50: >3 gm/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 18, p. 2583, 1990 (YACHDS) MD: N30-Y10 orl-rat TDLo: 500 ug/kg/5D-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 297, 1981 (JJATDK); L70-P05-U01 orl-rat TDLo: 270 mg/kg/27D-I Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 7, p. 3340, 1979 (YACHDS); P05-U01-Z71 orl-rat TDLo: 108 mg/kg/90D-I Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 7, p. 3355, 1979 (YACHDS); P01-P05-P14 orl-dog TDLo: 475 mg/kg/95D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 20, p. 319, 1971 (TXAPA9); Z74 orl-rat TDLo: 0.03 mg/kg/3D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); T13-T19 scu-rat TDLo: 6 ug/kg/3D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 170, p. 21, 2002 (TXCYAC); T62-V25-V30 imp-rat TDLo: 25.200 mg/kg/40W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 150, p. 33, 2000 (CALEDQ); T13 orl-rat TDLo: 0.14 mg/kg/14D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); T14 orl-rat TDLo: 0.25 mg/kg/25D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); P02 orl-wmn TDLo: 672 ug/kg/96W-I Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 21, p. 505, 1980 (CCPTAY); P28-Y37 ipr-rat TDLo: 750 ug/kg/3D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 51, 1986 (FATOAO) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 21, p. 233, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 6, p. 77, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 72, p. 49, 1999 (IMEMDT); TOXICOLOGY REVIEW Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 185, p. 169, 1974 (ACEDAB); TOXICOLOGY REVIEW Research on Steroids. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1964- v. 6, p. 455, 1975 (RSTEBF); TOXICOLOGY REVIEW Current Medical Research and Opinion. (Clayton-Wray Pub. Ltd., 1a High St., Alton, Hants., UK) V.1- 1972- v. 4, p. 309, 1976 (CMROCX); TOXICOLOGY REVIEW Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 34, p. 53, 2001 (RTOPDW); TOXICOLOGY REVIEWS Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 14, p. 79, 2001 (TOPADD) ND: NOHS 1974: HZD 84691; NIS 1; TNF 68; NOS 6; TNE 2770; NOES 1983: HZD 84691; NIS 1; TNF 26; NOS 2; TNE 853; TFE 692 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-BALB/c-3T3, SHE-clonal assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 918 of 1119 in RTECS (through 2003/06) AN: RC8960000 PN: 17-alpha-19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy- SY: Compound-33355-; Delta-mve-; 3,17-beta-Dihydroxy-17-alpha-ethynyl-1,3,5(10)-estratriene-3-methyl ether; EE3ME-; Estra-1,3,5(10)-trien-17-beta-ol, 17-alpha-ethynyl-3-methoxy-; 17-alpha-Ethinyl-estradiol-3-methyl-ether-; Ethinylestradiol-3-methyl-ether-; 17-alpha-Ethinyl-oestradiol-3-methyl-ether-; Ethinyloestradiol-3-methyl-ether-; Ethynylestradiol-3-methyl-ether-; 17-Ethynylestradiol-3-methyl-ether-; 17-alpha-Ethynylestradiol-3-methyl-ether-; 17-alpha-Ethynyl-3-methoxy-1,3,5(10)-estratrien-17-beta-ol; (+)-17-alpha-Ethynyl-17-beta-hydroxy-3-methoxy-1,3,5(10)-estratriene; (+)-17-alpha-Ethynyl-17-beta-hydroxy-3-methoxy-1,3,5(10)-oestratriene; 17-Ethynyl-3-methoxy-1,3,5(10)-estratrien-17-beta-ol; 17-alpha-Ethynyl-3-methoxy-17-beta-hydroxy-delta-1,3,5(10)-estratriene; 17-alpha-Ethynyl-3-methoxy-17-beta-hydroxy-delta-1,3,5(10)-oestratriene; 17-Ethynyl-3-methoxy-1,3,5(10)-oestratien-17-beta-ol; Ethynyloestradiol-3-methyl-ether-; Ethynyloestradiol-methyl-ether-; 17-Ethynyloestradiol-3-methyl-ether-; 17-alpha-Ethynyloestradiol-3-methyl-ether-; 17-alpha-Ethynyloestradiol-methyl-ether-; Mestranol-; 3-Methoxy-17-alpha-ethinylestradiol-; 3-Methoxy-17-alpha-ethinyloestradiol-; 3-Methoxyethynylestradiol-; 3-Methoxy-17-alpha-ethynylestradiol-; 3-Methoxy-17-alpha-ethynyl-1,3,5(10)-estratrien-17-beta-ol; 3-Methoxyethynyloestradiol-; 3-Methoxy-17-alpha-ethynyloestradiol-; 3-Methoxy-17-ethynyloestradiol-17-beta-; 3-Methoxy-17-alpha-ethynyl-1,3,5(10)-oestratrien-17-beta-ol; 3-Methoxy-19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-ol; 3-Methoxy-17-alpha-19-norpregna-1,3,5(10)-trien-20-yn-17-ol; (17-alpha)-3-Methoxy-19-norpregna-1,3,5(10)-trien-20-yn-17-ol; 3-Methylethynylestradiol-; 3-Methylethynyloestradiol-; SC-4725- RN: Current: 72-33-3 Previous: 43085-54-7; 53445-46-8 BRN: 2625905 BHR: 4-06-00-06877 UD: 200006 MF: C21-H26-O2 MW: 310.47 WL: L E5 B666TTT&J E1 FQ F1UU1 OO1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Hormone (H) ME: cyt-hmn-lym 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 173, 1994 (MUREAV); sce-hmn-lym 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 173, 1994 (MUREAV); dns-rat-scu 5 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 2007, 1986 (CRNGDP); mnt-mus-ipr 1 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 173, 1994 (MUREAV); oms-mus-scu 120 ug/kg American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH); cyt-mus-par 30 ug/kg/48H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 173, 1994 (MUREAV); sce-mus-ipr 100 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 173, 1994 (MUREAV) RE: T29 orl-wmn TDLo: 20 ug/kg (20D pre) International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS 66044) V.1- 1955- v. 9, p. 57, 1964 (INJFA3); T12 orl-wmn TDLo: 25600 ng/kg (16D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 24, p. 19, 1973 (FESTAS); T29 orl-wmn TDLo: 160 ug/kg (57W pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 105, p. 7, 1966 (ACEDAB); T12 orl-rat TDLo: 2500 ug/kg (10D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 119, p. 340, 1965 (PSEBAA); T29 orl-rat TDLo: 150 ug/kg (2-4D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 77, p. 873, 1965 (ENDOAO); T53-T91 orl-rat TDLo: 430 ug/kg (1-22D preg/21D post) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 80, p. 447, 1967 (ENDOAO); T22 orl-rat TDLo: 700 ug/kg (7D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 10, p. 105, 1965 (JRPFA4); T13 orl-rat TDLo: 690 ng/kg (1D pre) Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 23, p. 329, 1980 (JMCMAR); T02-T03 orl-rat TDLo: 336 ug/kg (14D male) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 500, 1958 (ANYAA9); T24 orl-rat TDLo: 1 mg/kg (2-3D preg) Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 4, p. 801, 1964 (STEDAM); T24 scu-rat TDLo: 1050 ug/kg (3-9D preg) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 47, p. 444, 1964 (ACENA7); T29 scu-rat TDLo: 60 ug/kg (2-4D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 77, p. 873, 1965 (ENDOAO); T12-T13-T29 scu-rat TDLo: 500 ng/kg (1D pre) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 49, p. 193, 1965 (ACENA7); T02-T03 scu-rat TDLo: 400 ng/kg (1D male) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 49, p. 193, 1965 (ACENA7); T22 scu-rat TDLo: 35 ug/kg (35D pre) Recent Progress In Hormone Research. Proceedings of the Laurentian Hormone Conference. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1947- v. 20, p. 395, 1964 (RPHRA6); T13 unr-rat TDLo: 150 ug/kg (30D pre) Recent Progress In Hormone Research. Proceedings of the Laurentian Hormone Conference. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1947- v. 20, p. 395, 1964 (RPHRA6); T29 orl-mus TDLo: 3 mg/kg (1D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 248, 1980 (ATSUDG); T26 orl-mus TDLo: 250 ug/kg (4-8D preg) Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 30, p. 53, 1975 (PHARAT); T13 scu-mus TDLo: 132 ng/kg (3D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T29 unr-mus TDLo: 2 mg/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 12, p. 346, 1961 (FESTAS); T29-T72 orl-dog TDLo: 5 mg/kg (6D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 1, p. 282, 1969 (BIREBV); T29 orl-rbt TDLo: 50 ug/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 73, p. 17, 1963 (ACEDAB); T21 orl-rbt TDLo: 500 ug/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 73, p. 17, 1963 (ACEDAB); T24 scu-rbt TDLo: 30 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T34 scu-rbt TDLo: 15 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T29 scu-rbt TDLo: 25 ug/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 73, p. 3, 1963 (ACEDAB); T24-T34 unr-rbt TDLo: 95 ug/kg (1-19D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 2, p. 85, 1970 (CCPTAY) TE: V03-L30 orl-rat TDLo: 2400 ug/kg/17W-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 76, 1980 (PAACA3); V03-T63-T64 ipr-rat TDLo: 61 mg/kg/84W-C Oncologia (Tokyo). (Onkorojia Sha, 1-9-11 Horidome-cho, Nihonbashi, Chuo-ku, Tokyo 103, Japan) V.1- 1982- v. 20(4), p. 93, 1987 (ONCOEV); V02-R60 orl-mus TDLo: 19 mg/kg/30W-C Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 168, p. 1190, 1974 (CRSBAW); V02-R60 orl-mus TD :20 mg/kg/28W-C Revue Europeenne d'Etudes Cliniques et Biologiques. European Journal of Clinical and Biological Research. (Paris, France) V.15-17, 1970-72. For publisher information, see BIMDB3. v. 16, p. 425, 1971 (REEBB3) AT: T/E unlistd orl-rat LD50: >10 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 217, 1970 (OYYAA2); F07-K01-R21 ipr-rat LD50: >3 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 217, 1970 (OYYAA2); F07-K01-R21 scu-rat LD50: >5 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 217, 1970 (OYYAA2); D28-F07-R21 orl-mus LD50: >10 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 217, 1970 (OYYAA2); D17-F07-R21 ipr-mus LD50: >3200 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 217, 1970 (OYYAA2); D17-D28-R21 scu-mus LD50: 2500 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 217, 1970 (OYYAA2) MD: N74-P05-U01 orl-rat TDLo: 300 mg/kg/30D-C Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 217, 1970 (OYYAA2); F41 orl-mus TDLo: 5490 mg/kg/17W-C Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 7, p. 541, 1984 (DCTODJ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 21, p. 257, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 6, p. 87, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 72, p. 49, 1999 (IMEMDT); TOXICOLOGY REVIEW Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 185, p. 169, 1974 (ACEDAB); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 1(1), p. 93, 1971 (CRTXB2); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 197, 1977 (JTEHD6); TOXICOLOGY REVIEW Current Medical Research and Opinion. (Clayton-Wray Pub. Ltd., 1a High St., Alton, Hants., UK) V.1- 1972- v. 4, p. 309, 1976 (CMROCX) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 919 of 1119 in RTECS (through 2003/06) AN: RC8975000 PN: 19-Nor-17-alpha-pregn-4-en-20-yn-3-one,-17-hydroxy- SY: Noralutin-; Norethisterone-; Norethynodron-; Norethynodrone-; 19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one-; 19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one-; Norluton-; Anhydrohydroxynorprogesterone-; 17-alpha-Ethinylestra-4-en-17-beta-ol-3-one-; 17-alpha-Ethinyl-17-beta-hydroxy-delta(sup:4)-estren-3-one; Ethinylnortestosterone-; Ethinyl-19-nortestosterone-; 17-Ethinyl-19-nortestosterone-; 17-alpha-Ethinyl-19-nortestosterone-; 17-alpha-Ethynyl-4-estren-17-ol-3-one-; 17-alpha-Ethynyl-17-hydroxy-4-estren-3-one-; 17-alpha-Ethynyl-17-beta-hydroxyestr-4-en-3-one-; 17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one-; 17-alpha-Ethynyl-17-beta-hydroxy-19-norandrost-4-en-3-one-; 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one-; 17-alpha-Ethynyl-19-nor-4-androsten-17-beta-ol-3-one-; 17-alpha-Ethynyl-19-nortestosterone-; Gestest-; (17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one; 17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one-; 17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one-; 17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one-; Micronett-; Micronor-; Norethindrone-; 19-Nor-ethindrone-; 19-Norethinyltestosterone-; 19-Nor-ethinyl--4,5-testosterone-; Norethisteron-; 19-Norethisterone-; 19-Nor-17-ethinyltestosterone-; 19-Nor-17-alpha-ethynyltestosterone-; Norlutin-; Norpregneninlone-; 17-alpha-19-Norpregn-4-en-20-yn-3-one,-17-hydroxy-; Nor-Q.D.; Primolut-N-; Proluteasi-; SC-4640-; Triella- RN: Current: 68-22-4 BRN: 1915671 BHR: 4-08-00-01221 UD: 200204 MF: C20-H26-O2 MW: 298.46 WL: L E5 B666 OV MUTJ E FQ F1UU1 -A&F CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Hormone (H) ME: dni-hmn-lym 50 umol/L Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 146, p. 401, 1974 (PSEBAA); mtr-rat-orl 600 mg/kg/6W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 33, 1998 (MUREAV); dns-rat-lvr 50 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1201, 1985 (CRNGDP); oms-mus-oth 10 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH); cyt-mus-orl 45 mg/kg/15D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 215, 1993 (MUREAV); cyt-ham-lng 100 mg/L Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 19(Suppl 4), p. S1065, 1991 (YACHDS); oms-dom-oth 100 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH); oms-mam-oth 100 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH); cyt-mam-oth 100 ug/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 120, p. 390, 1974 (AJOGAH) RE: T13-T29 orl-wmn TDLo: 4 mg/kg (20D pre) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 85, p. 427, 1963 (AJOGAH); T01-T04-T09 orl-man TDLo: 7143 ug/kg (25D male) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 37, p. 75, 1961 (ACENA7); T14-T29 orl-wmn TDLo: 4200 ug/kg (21D pre) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 124, p. 891, 1956 (SCIEAS); T53 orl-wmn TDLo: 37800 ug/kg (7-24W preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 19, p. 1369, 1959 (JCEMAZ); T22-T29 orl-wmn TDLo: 210 ug/kg (30D pre) Obstetrics and Gynecology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1953- v. 41, p. 585, 1973 (OBGNAS); T01-T02-T04 orl-man TDLo: 18 mg/kg (42D male) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 18, p. 1057, 1959 (FEPRA7); T05 orl-man TDLo: 18 mg/kg (42D male) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 18, p. 1057, 1959 (FEPRA7); T53 orl-wmn TDLo: 28 mg/kg (5-25W preg) American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 106, p. 586, 1963 (AJDCAI); T53 orl-wmn TDLo: 63 mg/kg (10-39W preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 84, p. 962, 1962 (AJOGAH); T14 orl-wmn TDLo: 2190 ug/kg (52W pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 144, p. 7, 1970 (ACEDAB); T17 orl-wmn TDLo: 7 ug/kg (1D post) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 127, p. 245, 1977 (AJOGAH); T53 orl-wmn TDLo: 37800 ug/kg (7-24W preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 19, p. 1369, 1959 (JCEMAZ); T22 imp-wmn TDLo: 230 ug/kg (26W pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 18, p. 411, 1978 (CCPTAY); T29 unr-wmn TDLo: 131 ug/kg (52W pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 22, p. 259, 1980 (CCPTAY); T46-T53 unr-wmn TDLo: 4200 ug/kg (6-8W preg) New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 268, p. 255, 1963 (NEJMAG); T53 unr-wmn TDLo: 14 mg/kg (6-39W preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 11, p. 148, 1960 (FESTAS); T85 unr-wmn TDLo: 12 mg/kg (6-20W preg) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 211, p. 1171, 1981 (SCIEAS); T53 unr-wmn TDLo: 76 mg/kg (6-32W preg) Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 26, p. 151, 1960 (PEDIAU); T12 unr-wmn TDLo: 84 ug/kg (12D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 23, p. 739, 1972 (FESTAS); T29 orl-rat TDLo: 50 mg/kg (5D pre) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 33, p. 231, 1983 (ARZNAD); T03 orl-rat TDLo: 28 mg/kg (14D male) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 500, 1958 (ANYAA9); T34-T44-T46 orl-rat TDLo: 188 mg/kg (15-17D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 21, p. 591, 1983 (IJEBA6); T53 orl-rat TDLo: 100 mg/kg (17-20D preg) Endocrinologia Japonica. (Japan Pub. Trading Co., Ltd., POB 5030, Tokyo International, Tokyo, Japan) V.1- 1954- v. 24, p. 77, 1977 (ECJPAE); T34 orl-rat TDLo: 20 mg/kg (6-9D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 15, p. 955, 1978 (OYYAA2); T22 orl-rat TDLo: 50 mg/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 59, p. 695, 1956 (ENDOAO); T14 orl-rat TDLo: 60 mg/kg (12D pre) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 29, p. 95, 1979 (ARZNAD); T22 scu-rat TDLo: 17500 ug/kg (7D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 12, p. 511, 1975 (CCPTAY); T12 scu-rat TDLo: 400 ug/kg (10D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 119, p. 340, 1965 (PSEBAA); T34 scu-rat TDLo: 2 mg/kg (6-9D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 15, p. 955, 1978 (OYYAA2); T16 scu-rat TDLo: 15 mg/kg (15-24D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 123, p. 867, 1966 (PSEBAA); T53 scu-rat TDLo: 17500 ug/kg (15-21D preg) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 38, p. 128, 1961 (ACENA7); T29 scu-rat TDLo: 500 ug/kg (2D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 105, p. 7, 1966 (ACEDAB); T02-T03 scu-rat TDLo: 15750 ug/kg (21D male) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 119, p. 340, 1965 (PSEBAA); T23 scu-rat TDLo: 5250 ug/kg (7D male) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 12, p. 511, 1975 (CCPTAY); T16-T53 par-rat TDLo: 62500 ug/kg (15-19D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 78, p. 965, 1966 (ENDOAO); T13 unr-rat TDLo: 1500 ug/kg (30D pre) Recent Progress In Hormone Research. Proceedings of the Laurentian Hormone Conference. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1947- v. 20, p. 395, 1964 (RPHRA6); T25-T35 orl-mus TDLo: 80 mg/kg (8-15D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 121, p. 455, 1966 (PSEBAA); T34 orl-mus TDLo: 200 mg/kg (6-7D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 15, p. 955, 1978 (OYYAA2); T13 orl-mus TDLo: 360 ug/kg (1D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 119, p. 340, 1965 (PSEBAA); T25 scu-mus TDLo: 2 mg/kg (6-7D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 15, p. 955, 1978 (OYYAA2); T24 scu-mus TDLo: 50 mg/kg (4D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 3, p. 239, 1962 (JRPFA4); T13 scu-mus TDLo: 120 ug/kg (1D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 119, p. 340, 1965 (PSEBAA); T26-T29 par-mus TDLo: 12 mg/kg (1-3D preg) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 20, p. 299, 1960 (JOENAK); T34 imp-mus TDLo: 6500 ug/kg (6-18D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 28A, 1987 (TJADAB); T13 ivg-mus TDLo: 6400 ng/kg (1D pre) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 20, p. 198, 1960 (JOENAK); T01-T02 ihl-mky TCLo: 30 ug/kg/30M (60D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 22, p. 935, 1980 (BIREBV); T29 ihl-mky TDLo: 18 ug/kg (10D pre) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 270, p. 532, 1977 (NATUAS); T14 ihl-mky TDLo: 34 ug/kg (10D pre) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 270, p. 532, 1977 (NATUAS); T14 ims-mky TDLo: 3 mg/kg (3D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 30, p. 886, 1984 (BIREBV); T29 ims-mky TDLo: 800 ug/kg (8D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 39(Suppl), p. 419, 1983 (FESTAS); T27 imp-mky TDLo: 186 ug/kg (1-31D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 25, p. 97, 1982 (CCPTAY); T01-T09 unr-mky TDLo: 270 ug/kg (45D male) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 44, p. 120, 1985 (FESTAS); T12 ivg-mky TDLo: 2847 ug/kg (52W pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 20, p. 339, 1979 (CCPTAY); T25-T35 orl-rbt TDLo: 39 mg/kg (8-20D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 121, p. 455, 1966 (PSEBAA); T29 orl-rbt TDLo: 150 ug/kg (1D pre) "Control of Ovulation, Proceedings of the Conference, Dedham, MA, 1960," Villee, C.A., ed., Oxford, UK, Pergamon Press Ltd., 1961 -,37,1961 (13OPAL); T29 orl-rbt TDLo: 125 ug/kg (1D pre) "The Control of Fertility," Pincus, G., New York, Academic Press, 1965 -,57,1965 (85GRAA); T21 orl-rbt TDLo: 313 ug/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 73, p. 17, 1963 (ACEDAB); T24 skn-rbt TDLo: 500 ug/kg (1D pre) Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 7, p. 341, 1966 (STEDAM); T29 skn-rbt TDLo: 500 ug/kg (1D pre) Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 5, p. 699, 1965 (STEDAM); T22 scu-rbt TDLo: 1250 ug/kg (5D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 12, p. 189, 1975 (CCPTAY); T13 scu-rbt TDLo: 2500 ug/kg (5D pre) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 142, p. 469, 1962 (ANREAK); T24 scu-rbt TDLo: 15 mg/kg (5-7D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 3, p. 246, 1962 (JRPFA4); T21-T29 scu-rbt TDLo: 37500 ng/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 73, p. 3, 1963 (ACEDAB); T29 scu-rbt TDLo: 5 mg/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 28, p. 18, 1956 (ACEDAB); T24 unr-rbt TDLo: 300 ug/kg (1-3D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 2, p. 85, 1970 (CCPTAY); T52-T53 scu-gpg TDLo: 86 mg/kg (18-60D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 19, p. 606, 1968 (FESTAS); T19-T21 par-ham TDLo: 2400 ug/kg (3D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 37, p. 269, 1974 (JRPFA4) TE: V03-T63 scu-mus TDLo: 163 mg/kg/78W-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 21, p. 153, 1967 (BJCAAI); V03-T63 par-mus TDLo: 168 mg/kg/78W-C Pakistan Medical Forum. (Karachi, Pakistan) V.1-8, 1966-73(?) Disc ontinued. v. 7, p. 21, 1972 (PMDFA9); V03-V08 imp-mus TDLo: 166 mg/kg/77W-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 212, p. 686, 1966 (NATUAS) AT: N16-R03 orl-wmn TDLo: 42 mg/kg American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 84, p. 962, 1962 (AJOGAH); T/E unlistd orl-mus LD50: 6 gm/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 809, 1990 (NIIRDN) MD: P28-Y37 ims-rat TDLo: 30 mg/kg/15D-I Shengzhi Yu Biyun. Reproduction and Contraception. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) 1980- v. 11(3), p. 17, 1991 (SCYYDZ); T13 scu-rat TDLo: 60 mg/kg/3D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 170, p. 21, 2002 (TXCYAC); T13-U01 scu-rat TDLo: 600 mg/kg/3D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 170, p. 21, 2002 (TXCYAC) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 294, 1987 (IMSUDL); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 72, p. 49, 1999 (IMEMDT); TOXICOLOGY REVIEW Clinical Obstetrics and Gynecology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1958- v. 16(4), p. 37, 1973 (COGYAK); TOXICOLOGY REVIEW Pediatric Clinics of North America. (W.B. Saunders Co., W. Washington Sq., Philadelphia, PA 19105) V.1- 1954- v. 8, p. 413, 1961 (PCNAA8); TOXICOLOGY REVIEW Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 5, p. 447, 1965 (ARVPAX); TOXICOLOGY REVIEW Current Medical Research and Opinion. (Clayton-Wray Pub. Ltd., 1a High St., Alton, Hants., UK) V.1- 1972- v. 4, p. 309, 1976 (CMROCX); TOXICOLOGY REVIEW Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 51, p. 671, 1960 (ACEDAB) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Sperm morphology-human; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 920 of 1119 in RTECS (through 2003/06) AN: RG2240000 PN: 9-Octadecenamide, N,N-bis(2-hydroxyethyl)-, (Z)- SY: (Z)-N,N-Bis(2-hydroxyethyl)-9-octadecenamide; Alrosol-O-; Amisol-ode-; Clindrol-2000-; Clindrol-2020-; Comperlan-OD-; Diethanololeamide-; EMID-6545-; Emulsifier-WHC-; Lauridit-OD-; Mackamide-O-; Marlamid-D-1885-; N,N-Diethanololeamide-; Nitrene-NO-; Oleamide-dea-; Oleamide, N,N-bis(2-hydroxyethyl)-; Oleic-acid-diethanolamide-; Oleic-acid-diethanolamine-condensate-; Oleic-diethanolamide-; Schercomid-ODA-; Stafoam-DO-; Steinamid-DO-280SE-; Witcamide-511C- RN: Current: 93-83-4 BRN: 1985420 UD: 200207 MF: C22-H43-N-O3 MW: 369.66 CC: Tumorigen (C); Primary-Irritant (S) ID: skn-rbt 300 uL MOD Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(5), p. 415, 1986 (JACTDZ) ORNL: 12400000 nL/kg. [12.400000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 12400 uL/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-481, 1999 (NTPTR*); T/E unlistd orl-mus LD50: >10 gm/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(5), p. 415, 1986 (JACTDZ) MD: J70-R02-Y03 skn-rat TDLo: 13 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-481, 1999 (NTPTR*); R03 skn-rat TDLo: 26 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-481, 1999 (NTPTR*); G70-M70-R02 skn-rat TDLo: 3250 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-481, 1999 (NTPTR*); R03 skn-mus TDLo: 7875 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-481, 1999 (NTPTR*) ND: NOES 1983: HZD X9293; NIS 74; TNF 6868; NOS 73; TNE 103140; TFE 24322 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (derm), no evidence: mouse, rat Record 921 of 1119 in RTECS (through 2003/06) AN: RG5075000 PN: 2,6-Octadienal,-3,7-dimethyl- SY: Citral-; 3,7-Dimethyl-2,6-octadienal-; Lemsyn-GB-; NCI-C56348- RN: Current: 5392-40-5 BRN: 1721871 BHR: 3-01-00-03053 UD: 200207 MF: C10-H16-O MW: 152.26 WL: VH1UY1&3Y1&U1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Natural-Product (N); Primary-Irritant (S) ID: skn-hmn 40 mg/24H MLD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 259, 1979 (FCTXAV); skn-man 16 mg/48H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-rbt 500 mg/24H MOD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 259, 1979 (FCTXAV); skn-rbt 100 mg/24H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-pig 50 mg/48H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-gpg 1%/48H MOD Journal of the Society of Cosmetic Chemists. (Soc. of Cosmetic Chemists, 1995 Broadway, Suite 1701, New York, NY 10023) V.1- 1947- v. 28, p. 357, 1977 (JSCCA5); skn-gpg 100 mg/24H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG) ME: dnr-bcs 2222 ug/disc Osaka-shi Igakkai Zasshi. Journal of Osaka City Medical Association. (Osaka-shi Igakkai, c/o Osaka-shiritsu Daigaku Igakubu, 1-4-54 Asahi-cho, Abeno-ku, Osaka, 545, Japan) V.24- 1975- v. 34, p. 267, 1985 (OIGZDE) RE: T34 orl-rat TDLo: 1250 mg/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 96, p. 105, 1995 (TXCYAC); T22-T59 orl-rat TDLo: 2500 mg/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 96, p. 105, 1995 (TXCYAC); T19-T24-T35 orl-rat TDLo: 10 gm/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 96, p. 105, 1995 (TXCYAC); T46-T73 orl-rat TDLo: 10 gm/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 96, p. 105, 1995 (TXCYAC); T11-T24-T25 skn-rat TDLo: 28 gm/kg (60D pre) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 547, 1980 (FCTXAV); T75 skn-rat TDLo: 46 gm/kg (14W pre) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 547, 1980 (FCTXAV); T12-T29-T75 skn-rat TDLo: 46 gm/kg (14W pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 55, p. 347, 1979 (JRPFA4); T72 skn-rat TDLo: 27600 mg/kg (60D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 55, p. 347, 1979 (JRPFA4); T11-T24-T25 ipr-rat TDLo: 1800 mg/kg (22W pre) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 547, 1980 (FCTXAV); T12-T72 ipr-rat TDLo: 1800 mg/kg (6D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 55, p. 347, 1979 (JRPFA4); T25-T87 ipr-rat TDLo: 1800 mg/kg (6D pre) "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 286, 1998 (VCVPS*); T25-T87 skn-rat TDLo: 27.6 gm/kg (60D pre) "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 286, 1998 (VCVPS*) ORNG: 4960000000 ng/kg. [4960.000000 mg/kg] F07 SRNG: 2250000000 ng/kg. [2250.000000 mg/kg] T/E unlistd AT: F07 orl-rat LD50: 4960 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV); T/E unlistd ipr-rat LD50: 460 mg/kg Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 55, p. 347, 1979 (JRPFA4); V30 orl-mus LD50: 6 gm/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 34, p. 1196, 1940 (BIJOAK); T/E unlistd skn-rbt LD50: 2250 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 505, 1987 (FCTOD7); T/E unlistd orl-mus LD50: 1.67 gm/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 291, 1998 (VCVPS*); L70-M71 orl-rat LD50: 3.45 gm/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 291, 1998 (VCVPS*) MD: L70-Y07-Y26 orl-rat TDLo: 24 gm/kg/10D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 505, 1987 (FCTOD7); N30 skn-rat TDLo: 5550 mg/kg/30D-I Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- v. 115, p. 169, 1996 (CBPCEE); L30-L70-Z01 orl-mus TDLo: 14952 mg/kg/14D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 463, 1993 (FCTOD7); M05-M13-P30 orl-rbt TDLo: 255 mg/kg/13W-I FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 44A, p. 1, 1967 (FAONAU); T12-Z71 ipr-rat TDLo: 1800 mg/kg/6D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 291, 1998 (VCVPS*); T12-Z71 skn-rat TDLo: 27.6 gm/kg/60D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 291, 1998 (VCVPS*) ND: NOHS 1974: HZD 83184; NIS 5; TNF 353; NOS 33; TNE 68051; NOES 1983: HZD 83184; NIS 98; TNF 12505; NOS 84; TNE 200484; TFE 83180 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9204; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), equivocal evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 922 of 1119 in RTECS (through 2003/06) AN: RG5365000 PN: 1,6-Octadiene,-7-methyl-3-methylene- SY: Myrcene-; beta-Myrcene-; 3-Methylene-7-methyl-1,6-octadiene-; 7-Methyl-3-methylene-1,6-octadiene- RN: Current: 123-35-3 BRN: 1719990 BHR: 4-01-00-01108 UD: 200012 MF: C10-H16 MW: 136.26 WL: 1Y1&U3YU1&1U1 CC: Tumorigen (C); Reproductive-Effector (T); Natural-Product (N); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MOD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 615, 1976 (FCTXAV) RE: T24-T34-T46 orl-rat TDLo: 12 gm/kg (6-15D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 31, 1993 (FCTOD7); T76 orl-rat TDLo: 14 mg/kg (15-21D preg/21D post) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 623, 1993 (FCTOD7) AT: T/E unlistd orl-rat LD50: >5 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 615, 1976 (FCTXAV); T/E unlistd skn-rbt LD50: >5 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 14, p. 615, 1976 (FCTXAV) ND: NOHS 1974: HZD M1662; NIS 1; TNF 200; NOS 1; TNE 801; NOES 1983: HZD M1662; NIS 14; TNF 2650; NOS 29; TNE 25154; TFE 12898 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 923 of 1119 in RTECS (through 2003/06) AN: RG5920000 PN: 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (E)- SY: 2,6-Octadien-1-ol,-3,7-dimethyl-,-acetate,-trans-; 3,7-Dimethyl-2-trans,-6-octadienyl-acetate-; Acetic-acid,-geraniol-ester-; Food-grade-geranyl-acetate-; Geraniol-acetate-; Geranyl-acetate-; NCI-C54728-; trans-2,6-Dimethyl-2,6-octadien-8-yl-ethanoate-; trans-3,7-Dimethyl-2,6-octadien-1-ol,-acetate-; trans-3,7-Dimethyl-2,6-octadien-1-yl-acetate- RN: Current: 105-87-3 BRN: 1722815 BHR: 4-02-00-00204 UD: 200210 MF: C12-H20-O2 MW: 196.32 WL: 1Y&U3YU2OV1 -T CC: Tumorigen (C); Mutagen (M); Natural-Product (N); Primary-Irritant (S) ID: skn-man 16 mg/48H MLD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-rbt 100 mg/24H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-gpg 100 mg/24H MOD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG) ME: pic-esc 25 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); dnd-rat-lvr 250 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); dns-rat-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 189, 1994 (MUREAV); mmo-mus-lym 18 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 196, p. 61, 1988 (MUREAV); mtr-ham-emb 200 mg/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 2, p. 103, 1988 (TIVIEQ); sce-ham-ovr 70 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V02-M61-R60 orl-rat TDLo: 515000 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-174313/AS (NTIS**) ORNG: 6330000000 ng/kg. [6330.000000 mg/kg] F07-F24 AT: F07-F24 orl-rat LD50: 6330 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV); F07 orl-mus LDLo: 8 gm/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-252, 1987 (NTPTR*) MD: Z01 orl-rat TDLo: 260 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-252, 1987 (NTPTR*); Z01 orl-mus TDLo: 28 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-252, 1987 (NTPTR*); L30-Z01 orl-mus TDLo: 130 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-252, 1987 (NTPTR*) ND: NOHS 1974: HZD 83198; NIS 3; TNF 53; NOS 35; TNE 7388; NOES 1983: HZD 83198; NIS 19; TNF 3954; NOS 25; TNE 48026; TFE 33271 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP CARCINOGENESIS STUDIES (GAVAGE), NO EVIDENCE: MOUSE, RAT National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-252, 87 (NTPTR*); NTP Carcinogenesis Studies (gavage), no evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-252, 1986 (NTPTR*) Record 924 of 1119 in RTECS (through 2003/06) AN: RN8640000 PN: 7-Oxabicyclo(4.1.0)heptane, 3-(epoxyethyl)- SY: 1,2-Epoxy-4-(epoxyethyl)cyclohexane; 1-Epoxyethyl-3,4-epoxycyclohexane-; 1-Ethyleneoxy-3,4-epoxycyclohexane-; 1-Vinyl-3-cyclohexene-dioxide-; 3-(1,2-Epoxyethyl)-7-oxabicyclo(4.1.0)heptane; 3-Oxiranyl-7-oxabicyclo(4.1.0)heptane; 4-(1,2-Epoxyethyl)-7-oxabicyclo(4.1.0)heptane; 4-Vinlycyclohexene-dioxide-; 4-Vinyl-1,2-cyclohexene-diepoxide-; 4-Vinyl-1-cyclohexene-diepoxide-; 4-Vinyl-1-cyclohexene-dioxide-; 4-Vinylcyclohexene-; 4-Vinylcyclohexene-diepoxide-; NCI-C60139-; UCET-textile-finish-11-74- (Obs.); Vinyl-cyclohexene-diepoxide-; Vinyl-cyclohexene-dioxide-; Vinylcyclohexene-diepoxide- RN: Current: 106-87-6 Previous: 25550-49-6 BRN: 106071 BHR: 5-19-01-00295 UD: 200302 MF: C8-H12-O2 MW: 140.20 WL: T36 BOTJ A- BT3OTJ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 mg SEV Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 9, 1961 (SCCUR*) ME: mmo-sat 50 ug/plate (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 367, 1979 (MUREAV); mmo-klp 1 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 269, 1981 (MUREAV); mmo-smc 25 mmol/L (-S9) Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 56, p. 1803, 1980 (BSIBAC); mrc-smc 25 mmol/L Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 56, p. 1803, 1980 (BSIBAC); dnd-rat-ipr 960 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 139, p. 394, 1996 (TXAPA9); cyt-rat-ipr 125 mg/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 6, p. 235, 1951 (BJPCAL); msc-mus-lym 25 ng/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-362, 1989 (NTPTR*); cyt-ham-ovr 37800 pg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-362, 1989 (NTPTR*); sce-ham-ovr 3730 pg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-362, 1989 (NTPTR*) RE: T02-T03-T09 ipr-mus TDLo: 4800 mg/kg (30D male) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 435, 1992 (TOXID9); T34-T53 orl-mus TDLo: 13468 mg/kg (6-18D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 14, p. 164, 1994 (TOXID9) TE: V01-R60 skn-rat TDLo: 31500 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-362, 1989 (NTPTR*); V03-J60-V10 ipr-rat TDLo: 5000 mg/kg/10W-I British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 6, p. 235, 1951 (BJPCAL); V01-R60-V10 skn-mus TDLo: 56 gm/kg/47W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 31, p. 41, 1963 (JNCIAM); V03-P62-R60 unr-mus TDLo: 2800 mg/kg Radiation Research, Supplement. (New York, NY) No.1-7, 1959-67. Discontinued. v. 3, p. 193, 1963 (RARSAM); V03-R60-V10 skn-mus TD :90 gm/kg/74W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 24, p. 305, 1963 (AIHAAP); V03-J60-R60 skn-mus TD :12 gm/kg/9W-I British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 6, p. 235, 1951 (BJPCAL); V01-R60-T63 skn-mus TD :10300 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-362, 1989 (NTPTR*); V01-R60 skn-mus TDLo: 60000 mg/kg/60W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219957/AS (NTIS**); V01-R60-T12 skn-mus TDLo: 60000 mg/kg/60W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219957/AS (NTIS**); V01-R60 skn-rat TDLo: 31500 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219957/AS (NTIS**); V01-R60 skn-rat TDLo: 39375 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219957/AS (NTIS**); V01-R60 skn-mus TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219957/AS (NTIS**); V01-T63 skn-mus TDLo: 103000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219957/AS (NTIS**) ORNG: 2130000000 ng/kg. [2130.000000 mg/kg] T/E unlistd SRNL: 620000 nL/kg. [0.620000 mL/kg] T/E unlistd IHPB: 800000 ppb/4H. [800.000000 ppm/4H] T/E unlistd AT: T/E unlistd orl-rat LD50: 2130 mg/kg Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 9, 1961 (SCCUR*); T/E unlistd ihl-rat LC50: 800 ppm/4H Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 9, 1961 (SCCUR*); F07-J26-R03 skn-mus LDLo: 3216 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-362, 1989 (NTPTR*); T/E unlistd skn-rbt LD50: 620 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 9/19/1972 (UCDS**); J16-J30 unr-rbt LD50: 680 ug/kg Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 56, p. 1803, 1980 (BSIBAC) MD: K30-L70-M70 orl-rat TDLo: 32500 mg/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 14, p. 745, 1990 (FAATDF); A70-M70-N74 skn-rat TDLo: 6552 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NPT-TR-362, 1989 (NTPTR*); R03-R30 skn-rat TDLo: 19500 mg/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 14, p. 745, 1990 (FAATDF); P26-P72-U01 ims-rat TDLo: 400 mg/kg/10D-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 2, p. 50, 1961 (AEHLAU); K30-L70-M70 orl-mus TDLo: 65 gm/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 14, p. 745, 1990 (FAATDF); L70-N74-R03 skn-mus TDLo: 6832 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-362, 1989 (NTPTR*); L70-M70-R03 skn-mus TDLo: 26 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-362, 1989 (NTPTR*); T01-Z73 ipr-mus TDLo: 4000 mg/kg/5D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 9, p. 359, 1995 (REPTED); T12 ipr-mus TDLo: 300 mg/kg/30D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 379, 1991 (REPTED) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 141, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 361, 1994 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 141, 1976 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 361, 1994 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 361, 1994 (IMEMDT) SR: OEL-AUSTRALIA: TWA 10 ppm (60 mg/m3), Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 10 ppm (57 mg/m3), Skin, Carcinogen, JAN 1993; OEL-DENMARK: TWA 10 ppm (60 mg/m3), JAN 1999; OEL-FINLAND: TWA 10 ppm (60 mg/m3), STEL 20 ppm (120 mg/m3), Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 10 ppm (60 mg/m3), JAN 1999; OEL-NORWAY: TWA 10ppm (60 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 10 ppm (60 mg/m3), Carcinogen, JAN 1999; OEL-UNITED KINGDOM: LTEL 10 ppm (60 mg/m3), JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO VINYL CYCLOHEXENE DIOXIDE-air: 10H CA TWA 10 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M1392; NIS 7; TNF 181; NOS 11; TNE 2028; NOES 1983: HZD M1392; NIS 14; TNF 107; NOS 24; TNE 6224; TFE 1718 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 925 of 1119 in RTECS (through 2003/06) AN: RP4489165 PN: 1,2,3-Oxathiazin-4(3H)-one, 6-methyl-, 2,2-dioxide, potassium salt SY: Acesulfame-K-; Acesulfame-potassium-; 6-Methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide-potassium-salt-; Potassium-acesulfame-; Sunett- RN: Current: 55589-62-3 Previous: 124030-40-6 UD: 200012 MF: C4-H4-N-O4-S.K MW: 201.25 CC: Tumorigen (C) SL: NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 926 of 1119 in RTECS (through 2003/06) AN: RP5425000 PN: 1,2-Oxathiolane-2,2-dioxide- SY: 1,3-Propane-sultone-; 1-Propanesulfonic-acid-3-hydroxy-gamma-sultone-; 3-Hydroxy-1-propanesulfonic-acid-gamma-sultone-; 3-Hydroxy-1-propanesulphonic-acid-sultone-; Propane-sultone-; Propane-sultone- (ACGIH); Propanesultone-; RCRA-waste-number-U193-; gamma-Propane-sultone- RN: Current: 1120-71-4 BRN: 109782 BHR: 5-19-01-00005 UD: 200210 MF: C3-H6-O3-S MW: 122.15 WL: T5OSWTJ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 mg MLD "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,498,1969 (34ZIAG) ME: mmo-sat 5 ug/plate (+S9) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 893, 1979 (JJIND8); mmo-sat 70 ug/plate (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 5135, 1975 (PNASA6); oms-sat 16 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 1 gm/L (-S9) Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 93, 1971 (ATXKA8); dnr-esc 500 ug/disc JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); dna-esc 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); oms-bcs 50 mmol/L Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 136, p. 854, 1978 (JOBAAY); dnd-bcs 50 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); mmo-srm 25 mg/L (-S9) Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 30, p. 67, 1972 (ATXKA8); mmo-omi 1600 mg/L (-S9) Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 6, p. 667, 1970 (MOPMA3); dnr-omi 610 ug/plate Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 95, p. 463, 1976 (BIZNAT); mrc-smc 1000 ppm JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 901, 1979 (JJIND8); mmo-ssp 7900 umol/L (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 14, p. 195, 1976 (CBINA8); mtr-hmn-oth 7500 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 5096, 1981 (CNREA8); dnd-hmn-fbr 5 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 185, 1978 (CBINA8); dns-hmn-fbr 200 umol/L/2H "Biology of Radiation Carcinogenesis, Symposium, 1975," Yuhas, J.M., et al., eds., New York, Raven Press, 1976 -,103,1976 (33AQAA); cyt-hmn-lym 1 mmol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 28, p. 139, 1985 (TOLED5); sce-hmn-lym 500 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 28, p. 139, 1985 (TOLED5); msc-hmn-fbr 30 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1620, 1981 (CNREA8); mtr-rat-emb 5 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 799, 1973 (JNCIAM); dnd-rat-ivn 31 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 175, 1987 (TCMUD8); mnt-mus-ipr 18 mg/kg/48H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); mtr-mus-fbr 30 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 377, 1982 (CRNGDP); mtr-mus-emb 50 mg/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 9, p. 301, 1981 (TOLED5); dnd-mus-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dns-mus-skn 2 mmol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 769, 1973 (CNREA8); dni-mus-skn 2 mmol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 769, 1973 (CNREA8); dni-mus-orl 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); hma-mus-sat 12 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); mtr-ham-ipr 1 gm/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 95, p. 380, 1973 (ARPAAQ); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-ham-emb 1 mg/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); cyt-ham-fbr 125 mg/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); cyt-ham-lng 10 mg/L Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 41, 1980 (ATSUDG) RE: T35 ivn-rat TDLo: 80 mg/kg (15D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD) TE: V01-A60-R60 orl-rat TDLo: 7840 mg/kg/60W-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 230, p. 460, 1971 (NATUAS); V03-V10 scu-rat TDLo: 10 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 75, p. 69, 1970 (ZEKBAI); V01-T65-A60 ivn-rat TDLo: 20 mg/kg (15D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD); V01-J60-P62 skn-mus TDLo: 1000 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 6, p. 139, 1976 (TXCYAC); V02-V10 scu-mus TDLo: 756 mg/kg/63W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 46, p. 143, 1971 (JNCIAM); V03-C60 orl-rat TD :1100 mg/kg/37W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 75, p. 69, 1970 (ZEKBAI); V01-A60-R60 orl-rat TD :12 gm/kg/60W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 75, 1981 (JJIND8); V01-A60-R60 orl-rat TD :13 gm/kg/32W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 75, 1981 (JJIND8); V03-J60 scu-rat TD :166 mg/kg International Surgery. (International College of Surgeons, 1516 N. Lake Shore Dr., Chicago, IL 60610) V.45- 1966- v. 66, p. 161, 1981 (INTSAO); V03-J60 scu-rat TD :559 mg/kg/17W-I International Surgery. (International College of Surgeons, 1516 N. Lake Shore Dr., Chicago, IL 60610) V.45- 1966- v. 66, p. 161, 1981 (INTSAO); V03-J60 scu-rat TD :434 mg/kg/15W-I International Surgery. (International College of Surgeons, 1516 N. Lake Shore Dr., Chicago, IL 60610) V.45- 1966- v. 66, p. 161, 1981 (INTSAO); V01-R60-V10 skn-mus TD :50 mg/kg/1W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 37, p. 93, 1976 (TXAPA9) ORNG: 100000000 ng/kg. [100.000000 mg/kg] F12-J22-K12 AT: F12-J22-K12 orl-rat LD50: 100 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555330 (NTIS**); D17-H05-R21 ihl-rat LCLo: 2140 mg/m3/6H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555330 (NTIS**); F12-J22-K12 ipr-rat LD50: 100 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555330 (NTIS**); T/E unlistd scu-rat LD50: 135 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 75, p. 69, 1970 (ZEKBAI); F07-F12-R21 orl-mus LD50: 400 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555330 (NTIS**); T/E unlistd skn-mus LDLo: 1000 gm/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 6, p. 139, 1976 (TXCYAC); D35-F07-R21 ipr-mus LD50: 100 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555330 (NTIS**) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 253, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1095, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 253, 1974 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1095, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1095, 1999 (IMEMDT) SR: OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-GERMANY: Skin Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO PROPANE SULTONE-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S pombe-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Inconclusive: SHE-clonal assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 927 of 1119 in RTECS (through 2003/06) AN: RP5950000 PN: 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide SY: 2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide; 2-H-1,3,2-Oxazaphosphorinane-; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide (9CI); ASTA-B518-; B-518-; Bis(2-chloroethyl)phosphoramide-cyclic propanolamide ester; CB-4564-; CP-; CYP-; Clafen-; Claphene-; Cyclophosphamid-; Cyclophosphamide-; Cyclophosphamidum-; Cyclophosphan-; Cyclophosphane-; Cyclophosphoramide-; Cyclostin-; Cyklofosfamid- (Czech); Cytophosphan-; Cytoxan-; Endoxan-; Endoxan-asta-; Endoxana-; Endoxanal-; Endoxane-; Genoxal-; N,N-Bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide; N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide; N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid (German); N,N-Di(2-chloroethyl)-N,O-propylene-phosphoric acid ester diamide; NCI-C04900-; NSC-26271-; Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester; Procytox-; RCRA-waste-number-U058-; SK-20501-; Sendoxan-; Zyklophosphamid- (German) RN: Current: 50-18-0 BRN: 11744 BHR: 4-27-00-09750 UD: 200305 MF: C7-H15-Cl2-N2-O2-P MW: 261.11 WL: T6MPOTJ BO BN2G2G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Natural-Product (N); Human-Data (P); Reproductive-Effector (T) ME: mmo-sat 1 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); dns-sat 2 ug Experimental Cell Biology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.44- 1976- v. 50, p. 271, 1982 (ECEBDI); mmo-esc 5 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 28, p. 405, 1975 (MUREAV); mmo-esc 10 mmol/L (+S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 33, p. 225, 1975 (ARTODN); dnr-esc 1250 ug/plate Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 28, p. 159, 1985 (NULSAK); pic-esc 100 ug/plate Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2819, 1983 (CNREA8); dnr-bcs 1 gm/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 19, 1981 (EVSRBT); dnd-bcs 2 mg/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); dnd-omi 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); slt-dmg-orl 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 252, p. 305, 1991 (MUREAV); sln-dmg-orl 2 mmol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 33, p. 221, 1975 (MUREAV); sln-dmg-par 19200 umol/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 175, 1981 (EVSRBT); trn-dmg-orl 8000 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); mmo-smc 26700 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 309, 1977 (MUREAV); dnr-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 111, p. 295, 1983 (MUREAV); sln-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mmo-asn 20 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mmo-ssp 1 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 111, p. 295, 1983 (MUREAV); oms-grh-emb 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 119, p. 71, 1983 (MUREAV); cyt-grh-emb 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 119, p. 71, 1983 (MUREAV); cyt-grh-oth 20 umol/L Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 33, p. 114, 1982 (CGCGBR); mnt-nml-tes 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 125, 1988 (MUREAV); mnt-nml-mul 5 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 298, p. 25, 1992 (MUREAV); mnt-nml-mul 5 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 298, p. 25, 1992 (MUREAV); mnt-ofs-mul 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 438, p. 155, 1999 (MUREAV); cyt-nml-ipr 15600 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 165, 1986 (MUREAV); cyt-nml-mul 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 319, p. 223, 1993 (MUREAV); sce-nml-ipr 2600 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 165, 1986 (MUREAV); sce-ofs-mul 2500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 35, 1982 (MUREAV); mnt-hmn-lym 800 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 227, p. 167, 1989 (MUREAV); mmo-hmn-lym 7 mg/L (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 335, 1989 (MUTAEX); mmo-hmn-fbr 475 nmol/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1873, 1981 (CNREA8); dnd-hmn-ivn 750 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 3452, 1989 (CNREA8); dnd-hmn-leu 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 346, p. 49, 1995 (MUREAV); dnd-hmn-oth 900 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 213, 2000 (MUREAV); dns-hmn-hla 100 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-lym 1 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 1059, 1980 (JTEHD6); dns-hmn-oth 300 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 271, p. 201, 1992 (MUREAV); dni-hmn-hla 600 umol/L/1H-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(1), p. 65, 1978 (JEPTDQ); dni-hmn-oth 200 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3676, 1982 (CNREA8); oms-hmn-hla 840 mg/L Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. v. 4, p. 362, 1967 (HUMAA7); bfa-hmn-smc 6200 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 257, 1973 (MUREAV); bfa-hmn-sat 14 mg/kg Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 38, p. 1253, 1976 (CANCAR); sce-hmn-oth 500 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 26, 1985 (ENMUDM); cyt-hmn-unr 60 mg/kg/8W-I Human Heredity. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.19- 1969- v. 29, p. 100, 1979 (HUHEAS); cyt-chd-unr 4 mg/kg/4W Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. v. 22, p. 221, 1974 (HUMAA7); cyt-hmn-leu 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 101, 1977 (MUREAV); cyt-hmn-hla 210 mg/L/48H Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. v. 4, p. 362, 1967 (HUMAA7); cyt-hmn-lym 10 ug/L/72H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 61, 1980 (ARTODN); cyt-hmn-oth 50 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 11, p. 258, 1971 (MUREAV); sce-hmn-orl 31 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 289, 1979 (MUREAV); sce-hmn-lym 10 umol/L Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 56, p. 568, 1980 (PJABDW); sce-hmn-fbr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 3626, 1985 (CNREA8); sce-hmn-leu 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 346, p. 49, 1995 (MUREAV); mnt-rat-ipr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 79, 1978 (MUREAV); mnt-rat-lvr 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 213, 1993 (MUREAV); mtr-rat-emb 5 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dns-rat-ipr 25 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 278, 1980 (ENMUDM); dns-rat-lvr 500 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); dni-rat-ivn 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 275, 1979 (MUREAV); dns-rat-orl 25 mg/kg JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 2, p. 172, 1982 (JJATDK); bfa-rat-sat 50 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 155, 1979 (ENMUDM); bfa-rat-emb 100 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 28, p. 23, 1985 (TOLED5); cyt-rat-lvr 2 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 64, p. 329, 1979 (MUREAV); cyt-rat-ipr 3300 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 38, p. 35, 1977 (ARTODN); cyt-rat-orl 9 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 29, p. 1871, 1979 (ARZNAD); cyt-rat-ivn 3300 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 42(8), p. 27, 1977 (GISAAA); cyt-rat-unr 9 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 3, p. 122, 1979 (EESADV); sce-rat-ipr 5 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 301, 1980 (ENMUDM); sce-rat-lym 5 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 229, 1981 (TOLED5); sce-rat-lvr 1 mg/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 13, p. 95, 1982 (TOLED5); sce-rat-oth 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); sce-rat-orl 240 mg/kg/10D-C Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 79, 1985 (ENMUDM); dlt-rat-orl 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 267, 1977 (MUREAV); hma-rat-smc 2611 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 31, p. 381, 1975 (MUREAV); spm-rat-ipr 100 mg/kg/5D-I Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 393, 1984 (ENMUDM); mnt-mus-fbr 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 279, p. 217, 1992 (MUREAV); mnt-mus-ivn 60 ug/kg Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 6, 1989 (MUTAEX); mnt-mus-unr 20 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 3, p. 122, 1979 (EESADV); mnt-mus-ipr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 311, 1978 (MUREAV); mnt-mus-orl 30 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 234, p. 155, 1990 (MUREAV); mnt-mus-scu 20 mg/kg/24H Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 36, p. 297, 1980 (EXPEAM); mmo-mus-lym 250 ug/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 295, 1989 (MUREAV); slt-mus-ipr 5 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 38, p. 87, 1977 (ARTODN); dnd-mus-scu 15 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 83, 1989 (CRNGDP); mtr-mus-emb 10 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2922, 1978 (CNREA8); dnd-mus-ivn 160 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 3452, 1989 (CNREA8); dnd-mus-lym 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 155, 1988 (MUREAV); dnd-mus-ipr 20 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 2, p. 47, 1982 (TCMUD8); dnd-mus-unr 60 mg/kg Pure and Applied Chemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1960- v. 42, p. 209, 1975 (PACHAS); dna-mus-ast 120 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 1048, 1973 (CNREA8); dnd-mus-leu 1 mmol/L Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 62, p. 23, 1978 (CTRRDO); dns-mus-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 50, p. 229, 1978 (MUREAV); dns-mus-orl 100 mg/kg Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 7, p. 174, 1984 (ATSUDG); dni-mus-ipr 150 mg/kg British Journal of Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.63- 1951- v. 94, p. 1, 1976 (BJDEAZ); dni-mus-scu 80 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 22, p. 3181, 1973 (BCPCA6); oms-mus-scu 80 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 22, p. 3181, 1973 (BCPCA6); oms-mus-ipr 20 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 105, 1989 (MUREAV); cyt-mus-lym 35 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 252, p. 221, 1991 (MUREAV); cyt-mus-ihl 1 mg/m3/2H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 1, 1988 (MUREAV); bfa-mus-sat 50 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 521, 1980 (ENMUDM); bfa-mus-lym 1 gm/kg Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 12, p. 1425, 1976 (SOGEBZ); cyt-mus-unr 150 mg/kg Genetika (Zemun, Yugoslavia). (Unija Bioloskih Naucnih Drustava Jugoslavije, Postanski fah 12 7, Zemun, Yugoslavia) V.1- 1969- v. 11, p. 203, 1979 (GNTKDF); cyt-mus-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 140, p. 49, 1984 (MUREAV); cyt-mus-emb 50 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2922, 1978 (CNREA8); cyt-mus-ivn 45 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 60, p. 329, 1979 (MUREAV); sce-mus-ihl 1 mg/m3/2H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 1, 1988 (MUREAV); sce-mus-par 2500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 233, 1978 (MUREAV); sce-mus-scu 5 mg/kg Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 18, p. 231, 1977 (CGCGBR); sce-mus-ipr 3 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3820, 1984 (CNREA8); sce-mus-ivn 10 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 246, 1980 (ENMUDM); sce-mus-unr 12500 ug/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 260, p. 448, 1976 (NATUAS); sce-mus-emb 10 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2922, 1978 (CNREA8); sln-mus-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 144, p. 27, 1985 (MUREAV); sce-mus-ast 15 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 177, 1979 (ENMUDM); sce-mus-oth 4 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 465, 1989 (MUREAV); dlt-mus-ipr 100 mg/kg Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 25, p. 523, 1978 (NEOLA4); dlt-mus-orl 160 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 26, p. 427, 1974 (MUREAV); dlt-mus-unr 40 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 3, p. 122, 1979 (EESADV); msc-mus-lym 80 mg/L Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 1, p. 277, 1978 (DCTODJ); hma-mus-ast 10 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 321, 1990 (TCMUD8); hma-mus-lng 1600 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 64, p. 259, 1979 (MUREAV); hma-mus-sat 200 mg/kg Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 96, p. 151, 1977 (BIZNAT); hma-mus-srm 870 mg/kg/2H Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 117, p. 197, 1972 (MGGEAE); hma-mus-smc 225 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 111, p. 295, 1983 (MUREAV); hma-mus-lym 150 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 13, p. 267, 1977 (ENVRAL); spm-mus-ipr 100 mg/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 100, p. 345, 1982 (MUREAV); spm-mus-unr 50 mg/kg Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 16, p. 1397, 1980 (GNKAA5); trn-mus-ipr 350 mg/kg Radiation and Environmental Biophysics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.11- 1974- v. 13, p. 1, 1976 (REBPAT); mnt-ham-lng 2 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 63, 1989 (MUREAV); mmo-ham-lng 10 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 157, p. 189, 1985 (MUREAV); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); mtr-ham-emb 50 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); cyt-ham-ihl 1 mg/m3/2H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 1, 1988 (MUREAV); cyt-ham-lng 100 umol/L Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 52, p. 97, 1982 (ARGEAR); cyt-ham-ovr 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 191, 1989 (MUREAV); cyt-ham-orl 320 mg/kg/2W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 99, 1969 (MUREAV); cyt-ham-oth 10 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2922, 1978 (CNREA8); cyt-ham-fbr 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 51, p. 397, 1978 (MUREAV); cyt-ham-ipr 3300 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 38, p. 35, 1977 (ARTODN); sce-ham-ipr 1 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 29, p. 1871, 1979 (ARZNAD); sce-ham-ovr 100 umol/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 343, 1976 (MUREAV); sce-ham-orl 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 164, 1980 (MUREAV); sce-ham-lng 625 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 37, 1980 (CRNGDP); sce-ham-unr 1 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 3, p. 122, 1979 (EESADV); sce-ham-oth 10 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2922, 1978 (CNREA8); sce-ham-fbr 3 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); sln-ham-lvr 2 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 397, 1985 (PMRSDJ); sce-ham-lvr 26 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 207, p. 69, 1988 (MUREAV); sce-ham-ihl 1 mg/m3/2H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 1, 1988 (MUREAV); msc-ham-lvr 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 271, p. 79, 1992 (MUREAV); spm-ham-orl 400 mg/kg/24H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 39, p. 187, 1978 (ARTODN); spm-ham-ipr 200 mg/kg/5D Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 38, p. 35, 1977 (ARTODN); cyt-gpg-ipr 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 268, p. 211, 1992 (MUREAV); sce-mky-ivn 18400 ug/kg Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 22, p. 1213, 1986 (GNKAA5); dna-dog-orl 6600 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1483, 1991 (CRNGDP); cyt-mam-orl 25 mg/kg Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 39, p. 142, 1974 (JANSAG); cyt-mam-ipr 50 mg/kg Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 17, p. 1639, 1981 (GNKAA5); cyt-mky-ivn 18400 ug/kg Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 22, p. 1213, 1986 (GNKAA5); sce-mky-kdy 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 3626, 1985 (CNREA8); dns-rbt-ivn 20 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 139, 1980 (ARTODN); oms-ckn-emb 3 ug Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 241, 1986 (ENMUDM); bfa-rbt-lym 20 mg/kg Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 101, p. 461, 1986 (BEBMAE); cyt-ckn-par 8 ug/kg "Cytogenetic Assays of Environmental Mutagens," Hsu, T.C., ed., Totowa, NJ, Allanheld, Osmun and Co., 1982 -,137,1982 (47JMAE); sce-ckn-par 8 ug/kg "Cytogenetic Assays of Environmental Mutagens," Hsu, T.C., ed., Totowa, NJ, Allanheld, Osmun and Co., 1982 -,137,1982 (47JMAE); sce-rbt-ipr 35 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 333, 1976 (MUREAV); sce-rbt-par 35 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 176, 1979 (ENMUDM); sce-rbt-lym 5 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 229, 1981 (TOLED5); cyt-rbt-ivn 20 mg/kg Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 101, p. 461, 1986 (BEBMAE); sce-rbt-ivn 20 mg/kg Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 101, p. 461, 1986 (BEBMAE); mnt-mus-ipr 40 mg/kg/2D Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 121, p. 159, 2001 (TOLED5); spm-mus-ipr 40 mg/kg Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 10, p. 81, 2001 (ETOPFR); cyt-hmn-lym 6 mg/L/20H (+S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 1, 2002 (FCTOD7); mnt-rat-orl 1.4 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 478, p. 211, 2001 (MUREAV); mnt-ham-oth 17.5 umol/L/3H (+/-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 843, 2001 (FCTOD7); cyt-ham-oth 10 gm/L/2H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 472, p. 75, 2000 (MUREAV); spm-mus-orl 500 mg/kg/10D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 1, 2001 (MUREAV); mnt-mus-orl 40 mg/kg/2D-I (-S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 20, p. 491, 2000 (JAPTO*); mnt-mus-orl 20 mg/kg (-S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 20, p. 491, 2000 (JAPTO*); dnd-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); mnt-ham-fbr 10 mg/L/6H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 75, 2001 (MUREAV); cyt-mus-orl 20 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 144, p. 137, 1999 (CALEDQ); cyt-hmn-lym 10 mg/L/18H International Journal of Toxicology (Continous: Journal of the American College of Toxicology,Taylor and Francis Health Sciences) V.16- 1997- v. 19, p. 69, 2000 (IJOTO*); mnt-hmn-lym 28 mg/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 177, 2001 (MUREAV); sce-hmn-lym 1.4 mg/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 177, 2001 (MUREAV); sce-hmn-lym 50 nmol/L/90M (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 13, 2001 (MUREAV); cyt-hmn-lym 50 nmol/L/6H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 13, 2001 (MUREAV); cyt-ham-ovr 25 mg/L/4H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 41, 2001 (MUREAV); mnt-mus-ipr 120 mg/kg/3D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 41, 2001 (MUREAV); mmo-sat 0.5 mg/plate (+S9) Journal of Ethnopharmacology. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1979- v. 77, p. 30, 2001 (JOETD7); mnt-mus-orl 40 mg/kg/48H-I Journal of Ethnopharmacology. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1979- v. 77, p. 30, 2001 (JOETD7); spm-hmn-spr 20 mg/L/2H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 491, p. 57, 2001 (MUREAV); mnt-hmn-lym 28 mg/L/2H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 89, 2001 (MUREAV); cyt-hmn-lym 28 mg/L/2H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 89, 2001 (MUREAV); sce-hmn-lym 28 mg/L/2H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 89, 2001 (MUREAV); mnt-hmn-oth 12 mg/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 517, p. 39, 2002 (MUREAV); sce-hmn-oth 12 mg/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 517, p. 39, 2002 (MUREAV); slt-hmn-ivn 71.4 mg/kg Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 197, 2001 (MUTAEX); mtr-mus-fbr 10 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG); cyt-ham-ovr 50 mg/L/2H (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 201, 2002 (MUTAEX); mrc-dmg-orl 0.5 mmol/L/48H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 385, 2001 (MUTAEX); mmo-sat 100 ug/plate/48H (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 523, 2001 (MUTAEX); cyt-ham-ovr 20 mg/L/4H Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 13, 2000 (EMMUEG); cyt-ham-ovr 6 mg/L/3H (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 261, 2002 (MUTAEX); cyt-hmn-spr 20 mg/L/120M (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 504, p. 183, 2002 (MUTAEX); cyt-oin-ipr 2 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 141, 2002 (MUREAV); sce-ham-ovr 0.009 mmol/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 117, 2001 (MUREAV); cyt-ham-ovr 0.009 mmol/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 117, 2001 (MUREAV); cyt-rat-ipr 30 mg/kg (+S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 449, 2001 (JAPTO*); spm-rat-ipr 200 mg/kg/5D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 513, p. 193, 2002 (MUREAV); mmo-sat 500 ug/plate/20M (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 514, p. 19, 2002 (MUREAV); mnt-ham-fbr 2.5 mg/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 514, p. 133, 2002 (MUREAV) RE: T14 orl-wmn TDLo: 60 mg/kg (60D pre) New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 289, p. 1159, 1973 (NEJMAG); T41-T46-T50 orl-wmn TDLo: 980 mg/kg (2W pre-33W preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 13, p. 139, 1993 (TCMUD8); T01 orl-man TDLo: 107 mg/kg (21W male) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 156, 1975 (LANCAO); T14 orl-wmn TDLo: 168 ug/kg (20W pre) Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 39, p. 1403, 1977 (CANCAR); T02 unr-chd TDLo: 180 mg/kg (90D male) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 426, 1972 (LANCAO); T01 unr-chd TDLo: 586 mg/kg (89D male) Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 88, p. 206, 1976 (JOPDAB); T14 unr-wmn TDLo: 24 mg/kg (30D pre) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 693, 1972 (LANCAO); T01-T02 unr-man TDLo: 130 mg/kg (26W male) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 568, 1972 (LANCAO); T01 unr-man TDLo: 24286 ug/kg (17D male) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 1290, 1972 (LANCAO); T01-T02 unr-man TDLo: 281 mg/kg (39W male) Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 840, 1972 (LANCAO); T43-T46 mul-wmn TDLo: 382 mg/kg (1-39W preg) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 188, p. 423, 1964 (JAMAAP); T43-T46 mul-wmn TDLo: 502 mg/kg (1-37W preg) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 188, p. 423, 1964 (JAMAAP); T46-T47 mul-wmn TDLo: 215 mg/kg (43-70D preg) Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 74, p. 87, 1971 (AIMEAS); T23 orl-rat TDLo: 100 mg/kg (1D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 267, 1977 (MUREAV); T01-T25-T34 orl-rat TDLo: 91800 ug/kg (18D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 37, p. 317, 1987 (BIREBV); T33 orl-rat TDLo: 168 mg/kg (4W male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 50, p. 55, 1994 (BIREBV); T71-T41-T43 orl-rat TDLo: 110 mg/kg (7-17D preg) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 7, p. 367, 1976 (IYKEDH); T45-T46-T53 orl-rat TDLo: 110 mg/kg (7-17D preg) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 7, p. 367, 1976 (IYKEDH); T50 orl-rat TDLo: 5 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 28, p. 11A, 1983 (TJADAB); T02-T03 orl-rat TDLo: 122 mg/kg (18D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 37, p. 317, 1987 (BIREBV); T01 ipr-rat TDLo: 140 mg/kg (1D male) Hinyokika Kiyo. Journal of Urology. (Kyoto Daigaku Igakubu, Hinyokikagaku Kyoshitsu, 54 Kawara-machi, Shogain, Sakyo-ku, Kyoto 606, Japan) V.1- 1955- v. 12, p. 1339, 1966 (HIKYAJ); T85 ipr-rat TDLo: 91 mg/kg (17-22D preg/20D post) Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 703, 1982 (YACHDS); T25-T35 ipr-rat TDLo: 7500 ug/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24, p. 1, 1981 (TJADAB); T24 ipr-rat TDLo: 30 mg/kg (3D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 417, 1990 (TCMUD8); T22 ipr-rat TDLo: 250 mg/kg (5W pre) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 211, p. 80, 1981 (SCIEAS); T41-T46 ipr-rat TDLo: 10 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24, p. 1, 1981 (TJADAB); T42-T43-T45 ipr-rat TDLo: 20 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24, p. 1, 1981 (TJADAB); T41-T46 scu-rat TDLo: 10 mg/kg (12D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 9, p. 445, 1966 (TXAPA9); T25-T39 scu-rat TDLo: 20 mg/kg (3D preg) Advances in the Study of Birth Defects. (Baltimore, MD) V.1-7, 1979-82. Discontinued. v. 2, p. 95, 1979 (ASBDD9); T13 scu-rat TDLo: 60 mg/kg (3D preg) Bibliotheca Anatomica. (S. Karger AG, Postfach, CH-4009 Basel, Switzerland) No.1- 1961- v. 19, p. 247, 1981 (BIANA6); T31-T35-T39 scu-rat TDLo: 60 mg/kg (3D preg) Journal of Embryology and Experimental Morphology. (Essex, UK) V.1-98, 1953-86. For Publisher information, see DEVPED v. 41, p. 65, 1977 (JEEMAF); T46 ivn-rat TDLo: 55 mg/kg (7-17D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 20, p. 143, 1980 (SEIJBO); T85 par-rat TDLo: 10 mg/kg (1D male) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24(1), p. 52A, 1981 (TJADAB); T41-T42-T43 par-rat TDLo: 20 mg/kg (14D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 20, p. 838, 1982 (IJEBA6); T46-T55 par-rat TDLo: 20 mg/kg (14D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 20, p. 838, 1982 (IJEBA6); T31 par-rat TDLo: 20 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30(1), p. 42A, 1984 (TJADAB); T41 unr-rat TDLo: 20 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 68A, 1983 (TJADAB); T24 unr-rat TDLo: 100 mg/kg (1D male) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 47A, 1983 (TJADAB); T25 unr-rat TDLo: 15 mg/kg (13D preg) Archiv fuer Experimentelle Veterinaermedizin. (S. Hirzel Verlag, Postfach 506, Leipzig DDR-7010, Ger. Dem. Rep.) V.6- 1952- v. 36, p. 179, 1982 (AXVMAW); T42 unr-rat TDLo: 20 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24(1), p. 42A, 1981 (TJADAB); T25-T26-T34 orl-mus TDLo: 20 mg/kg (10D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 344, 1978 (TXAPA9); T42-T46-T47 orl-mus TDLo: 20 mg/kg (10D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 155, 1980 (JTEHD6); T24-T35 orl-mus TDLo: 100 mg/kg (1D male) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 317, 1975 (FCTXAV); T01 orl-mus TDLo: 97 mg/kg (1D male) Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 2, p. 180, 1972 (AGACBH); T72-T75 ipr-mus TDLo: 20 mg/kg (12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 7, 1987 (TCMUD8); T01 ipr-mus TDLo: 100 mg/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 100, p. 345, 1982 (MUREAV); T41-T43 ipr-mus TDLo: 20 mg/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 42, p. 473, 1990 (TJADAB); T54 ipr-mus TDLo: 1 mg/kg (12D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 18, p. 25, 1986 (JTEHD6); T25-T34 ipr-mus TDLo: 5 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 4, p. 141, 1971 (TJADAB); T46 ipr-mus TDLo: 5 mg/kg (7D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 22, p. 122, 1972 (ARZNAD); T43-T53 ipr-mus TDLo: 20 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 4, p. 141, 1971 (TJADAB); T26 ipr-mus TDLo: 5 mg/kg (10D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 28, p. 475, 1968 (CNREA8); T25 scu-mus TDLo: 20 mg/kg (2D preg) Advances in the Study of Birth Defects. (Baltimore, MD) V.1-7, 1979-82. Discontinued. v. 2, p. 95, 1979 (ASBDD9); T39 scu-mus TDLo: 20 mg/kg (3D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 23, 1986 (TCMUD8); T43-T46 scu-mus TDLo: 200 mg/kg (11-14D preg) Journal of the Faculty of Science, Hokkaido University, Series 6: Zoology. (Hokkaido Univ., Faculty of Science, Nishi-8 chome, Kita-10jo, Kita-ku, Sapporo 060, Japan) V.1- 1930- v. 15, p. 662, 1965 (JFHZA8); T35 scu-mus TDLo: 100 mg/kg (11-14D preg) Journal of the Faculty of Science, Hokkaido University, Series 6: Zoology. (Hokkaido Univ., Faculty of Science, Nishi-8 chome, Kita-10jo, Kita-ku, Sapporo 060, Japan) V.1- 1930- v. 15, p. 662, 1965 (JFHZA8); T33 scu-mus TDLo: 4 mg/kg (3D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 115, 1986 (TCMUD8); T33 ivn-mus TDLo: 10 mg/kg (13D preg) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 279, p. 531, 1979 (NATUAS); T76 ivn-mus TDLo: 5 mg/kg (12D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 18, p. 25, 1986 (JTEHD6); T31-T34-T46 ims-mus TDLo: 32 mg/kg (11-15D preg) Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 26, p. 529, 1979 (NEOLA4); T25-T35 ims-mus TDLo: 106 mg/kg (11-15D preg) Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 26, p. 529, 1979 (NEOLA4); T33 par-mus TDLo: 20 mg/kg (4D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24(2), p. 49A, 1981 (TJADAB); T46 unr-mus TDLo: 20 mg/kg (11D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A89, 1980 (APTOD9); T42 unr-mus TDLo: 20 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 28, p. 46A, 1983 (TJADAB); T81-T91 unr-mus TDLo: 65 mg/kg (6-18D preg) Immunopharmacology and Immunotoxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.9- 1987- v. 11, p. 193, 1989 (IITOEF); T35 ipc-mus TDLo: 80 ug/kg (11D preg) "Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks In New Drugs, Proceedings of the Symposium on Toxicological Testing for Safety of New Drugs, 3rd, Prague, 1976," Benesova, O., et al., eds., Prague, Czechoslovakia, Univerzita Karlova, 1979 -,207,1979 (40YJAX); T34 orl-rbt TDLo: 93 mg/kg (6-20D preg) Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 40, p. 45, 1993 (NEOLA4); T43-T46 orl-rbt TDLo: 279 mg/kg (6-20D preg) Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 40, p. 45, 1993 (NEOLA4); T39 scu-rbt TDLo: 4 mg/kg (10-13D preg) Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 258, p. 2899, 1964 (COREAF); T42 scu-rbt TDLo: 60 mg/kg (10-13D preg) Archives d'Anatomie, d'Histologie and d'Embryologie. (Editions Alsatia, B.P. 9, 68001 Colmar, France) V.1- 1922- v. 53, p. 209, 1970 (AAHEAF); T41-T42-T45 ivn-rbt TDLo: 30 mg/kg (7D preg) Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 2, p. 83, 1971 (AGACBH); T34-T46 ivn-rbt TDLo: 20 mg/kg (9D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 30, p. 1585, 1980 (ARZNAD); T43 ivn-rbt TDLo: 30 mg/kg (12D preg) Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 2, p. 83, 1971 (AGACBH); T26-T35 ivn-rbt TDLo: 65 mg/kg (6-18D preg) Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 695, 1982 (YACHDS); T31 ivn-rbt TDLo: 80 mg/kg (9D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24(2), p. 36A, 1981 (TJADAB); T42 par-rbt TDLo: 48 mg/kg (10-13D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 164, p. 1344, 1970 (CRSBAW); T53 par-rbt TDLo: 10 mg/kg (10-13D preg) Archives d'Anatomie, d'Histologie and d'Embryologie. (Editions Alsatia, B.P. 9, 68001 Colmar, France) V.1- 1922- v. 58, p. 147, 1975 (AAHEAF); T01 orl-ham TDLo: 16 mg/kg (2D male) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 25, p. 1889, 1975 (ARZNAD); T02 ipr-ham TDLo: 1 gm/kg (4D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 22, p. 29, 1987 (JTEHD6); T33 ipr-ham TDLo: 5 mg/kg (17D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 22, 1980 (ATSUDG); T01 ipr-ham TDLo: 200 mg/kg (4D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 22, p. 29, 1987 (JTEHD6); T25 ipr-ham TDLo: 15 mg/kg (9D preg) Journal of Craniofacial Genetics and Developmental Biology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 381, 1989 (JCGBDF); T34-T43 ipr-ham TDLo: 30 mg/kg (10D preg) Journal of Craniofacial Genetics and Developmental Biology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 381, 1989 (JCGBDF); T46 unr-ham TDLo: 30 mg/kg (10D preg) Anti-Cancer Drugs. (Rapid Communications of Oxford Ltd., The Old Malthous, Paradise St., Oxford OX1 1LD, UK) V.1- 1990- v. 7, p. 204, 1996 (ANTDEV); T21 orl-dom TDLo: 30 mg/kg (1D male) Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 34, p. 903, 1972 (JANSAG); T34-T35 orl-mam TDLo: 528 mg/kg (8-18D preg) Experimental Animals. Jikken Dobutso Iho. (Nippon Jikken Dobutsu Gakkai, c/o Keio Gijuku Daigaku Igakubu Jikken Dobutsu Senta, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.1- 1952- v. 35, p. 387, 1986 (JIDOAA); T34-T46 ipr-mam TDLo: 275 mg/kg (8-18D preg) Experimental Animals. Jikken Dobutso Iho. (Nippon Jikken Dobutsu Gakkai, c/o Keio Gijuku Daigaku Igakubu Jikken Dobutsu Senta, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.1- 1952- v. 35, p. 387, 1986 (JIDOAA); T25-T35-T59 ipr-mam TDLo: 550 mg/kg (8-18D preg) Experimental Animals. Jikken Dobutso Iho. (Nippon Jikken Dobutsu Gakkai, c/o Keio Gijuku Daigaku Igakubu Jikken Dobutsu Senta, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.1- 1952- v. 35, p. 387, 1986 (JIDOAA); T34-T46-T59 ivn-mam TDLo: 50 mg/kg (12D preg) Experimental Animals. Jikken Dobutso Iho. (Nippon Jikken Dobutsu Gakkai, c/o Keio Gijuku Daigaku Igakubu Jikken Dobutsu Senta, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.1- 1952- v. 35, p. 387, 1986 (JIDOAA); T72-T81 orl-rat TDLo: 336 mg/kg (multigeneration) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 27, p. 602, 1974 (TXAPA9); T21-T26 orl-rat TDLo: 504 mg/kg (multigeneration) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 27, p. 602, 1974 (TXAPA9); T29 ipr-mus TDLo: 100 mg/kg (1D pre) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 73, 1991 (REPTED); T24 orl-rat TDLo: 61.2 mg/kg (3W male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 34, p. 275, 1986 (BIREBV); T25 orl-rat TDLo: 8.4 mg/kg (1W male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 34, p. 275, 1986 (BIREBV); T29-T35 orl-rat TDLo: 40.8 mg/kg (2W male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 34, p. 275, 1986 (BIREBV); T29-T35 orl-rat TDLo: 25.2 mg/kg (3W male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 34, p. 275, 1986 (BIREBV); T59 orl-rat TDLo: 91.8 mg/kg (3W male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 34, p. 275, 1986 (BIREBV); T34 orl-rat TDLo: 214.2 mg/kg (7W male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 34, p. 275, 1986 (BIREBV); T25 orl-rat TDLo: 61.2 mg/kg (14D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 316, p. 144, 1985 (NATUAS); T43-T59 orl-rat TDLo: 91.8 mg/kg (21D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 316, p. 144, 1985 (NATUAS); T24 orl-rat TDLo: 153 mg/kg (35D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 316, p. 144, 1985 (NATUAS); T34 orl-rat TDLo: 214.2 mg/kg (49D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 316, p. 144, 1985 (NATUAS); T25-T34 ipr-mus TDLo: 20 mg/kg (12D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 69, 1985 (FATOAO); T34-T35 ipr-rat TDLo: 30 mg/kg (10D preg) Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 45, p. 79, 1982 (JPETAB) TE: V01-P61 orl-wmn TDLo: 1890 mg/kg/3Y-I Johns Hopkins Medical Journal. (Baltimore, MD) V.120-151, 1967-82. Discontinued. v. 142, p. 211, 1978 (JHMJAX); V01-K60 orl-man TDLo: 2310 mg/kg/4.5Y-C British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 280, p. 524, 1980 (BMJOAE); V01-P60 unr-man TDLo: 857 mg/kg/3Y-C Journal of Clinical Pathology. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1947- v. 26, p. 649, 1973 (JCPAAK); V01-P60 unr-wmn TDLo: 1050 mg/kg/69W-C Journal of Clinical Pathology. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1947- v. 26, p. 649, 1973 (JCPAAK); V01-M60-P62 orl-rat TDLo: 475 mg/kg/100W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 23, p. 706, 1979 (IJCNAW); V01-A60-M61 ivn-rat TDLo: 676 mg/kg/1Y-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 20, p. 1461, 1970 (ARZNAD); V02-J60-M60 ipr-mus TDLo: 1950 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V01-R60-T63 scu-mus TDLo: 1352 mg/kg/1Y-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 20, p. 1461, 1970 (ARZNAD); V01-M60 orl-wmn TD :2700 mg/kg/6Y-C Urologe Ausgabe A. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.9- 1970- v. 17, p. 105, 1978 (URGABW); V01-M60-P62 orl-rat TD :1270 mg/kg/87W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 23, p. 706, 1979 (IJCNAW); V01-M60-P62 orl-rat TD :698 mg/kg/89W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 23, p. 706, 1979 (IJCNAW); V01-M60 orl-man TD :1078 mg/kg/3Y-C Rinsho Hinyokika. Clinical Urology. (Igaku Shoin, 5-24-3 Hongo, Bunkyo-ku, Tokyo 113-91, Japan) V.21- 1967- v. 32, p. 1073, 1978 (RIHYAC); V01-P61-J61 scu-mus TD :3600 mg/kg/76W-I Arthritis and Rheumatism. (Arthritis Foundation, 1314 Spring St., NW, Atlanta, GA 30309) V.1- 1958- v. 22, p. 1338, 1979 (ARHEAW); V01-M60 orl-man TD :1800 mg/kg/6Y-C Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 126, p. 544, 1981 (JOURAA); V01-M60 orl-hmn TD :920 mg/kg/3Y-C Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 91, p. 221, 1979 (AIMEAS); V01-M60-P60 orl-rat TD :1075 mg/kg/86W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 51, p. 606, 1983 (CANCAR); V01-P61 orl-man TD :1190 mg/kg/4Y-I Medicine. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1922- v. 58, p. 32, 1979 (MEDIAV); V01-M60 orl-wmn TD :1760 mg/kg/4Y-C Scandinavian Journal of Rheumatology. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.1- 1972- v. 12, p. 73, 1983 (SJRHAT) ORNG: 100000000 ng/kg. [100.000000 mg/kg] T/E unlistd AT: M30 orl-wmn TDLo: 45 mg/kg Arthritis and Rheumatism. (Arthritis Foundation, 1314 Spring St., NW, Atlanta, GA 30309) V.1- 1958- v. 15, p. 530, 1972 (ARHEAW); L12-L14-L30 orl-man TDLo: 579 mg/kg/2Y-I American Journal of Gastroenterology. (American College of Gastroenterology, Inc., 428 E. Preston St., Baltimore, MD 21202) V.21- 1954- v. 95, p. 845, 2000 (AJGAAR); P15 orl-man TDLo: 56 mg/kg/26D-I American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 81, p. 1059, 1986 (AJMEAZ); F12-U30 orl-chd TDLo: 2500 ug/kg American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 140, p. 1094, 1986 (AJDCAI); L30 orl-man TDLo: 56 mg/kg/4W-I Southern Medical Journal. (Southern Medical Assoc., POB 2446, Birmingham, AL 35205) V.1- 1908- v. 78, p. 222, 1985 (SMJOAV); K30-M30-R21 orl-hmn TDLo: 20 mg/kg Arthritis and Rheumatism. (Arthritis Foundation, 1314 Spring St., NW, Atlanta, GA 30309) V.1- 1958- v. 12, p. 663, 1969 (ARHEAW); P30 orl-wmn LDLo: 16 mg/kg/4D-I American Journal of the Medical Sciences. (Slack Inc., 6900 Grove Rd., Thorofare, NJ 08086) New series: V.1- 1841- v. 254, p. 48, 1967 (AJMSA9); U30 ivn-wmn TDLo: 60 mg/kg/9W-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 145, p. 548, 1985 (AIMDAP); D14 ivn-wmn TDLo: 13500 ug/kg Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 116, p. 92, 1992 (AIMEAS); P30 mul-man LDLo: 45 mg/kg/26W-I American Journal of the Medical Sciences. (Slack Inc., 6900 Grove Rd., Thorofare, NJ 08086) New series: V.1- 1841- v. 254, p. 48, 1967 (AJMSA9); T/E unlistd orl-rat LD50: 100 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 516, 1995 (NIIRDN); T/E unlistd ipr-rat LD50: 40 mg/kg Clinical Proceedings of the Children's Hospital of the District of Columbia. (Washington, DC) V.1-27, 1971. For publisher information, see CPNMAQ. v. 18, p. 307, 1962 (CPCHAO); P05-U01 scu-rat LD50: 144 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 431, 1982 (KSRNAM); P05-U01 ivn-rat LD50: 148 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 431, 1982 (KSRNAM); T/E unlistd ice-rat LD50: >400 ug/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 18, p. 760, 1966 (JPPMAB); T/E unlistd unr-rat LD50: 190 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 64(4), p. 157S, 1968 (NYKZAU); T/E unlistd orl-mus LD50: 137 mg/kg Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 36, p. 240, 1973 (RPTOAN); T/E unlistd ipr-mus LD50: 110 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 41, p. 90, 1978 (FATOAO); T/E unlistd scu-mus LD50: 200 mg/kg Advances in the Study of Birth Defects. (Baltimore, MD) V.1-7, 1979-82. Discontinued. v. 2, p. 95, 1979 (ASBDD9); T/E unlistd ivn-mus LD50: 140 mg/kg "Radiation-Induced Cancer, Proceedings of a Symposium, Athens, 1969," Lanham, MD, Bernan-UNIPUB, 1969 -,97,1969 (17TVAO); T/E unlistd par-mus LD50: 315 mg/kg Transplantation. (Williams and Wilkins, Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1963- v. 13, p. 316, 1972 (TRPLAU); U01 itr-mus LDLo: 200 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 30, p. 63, 1986 (TOLED5); T/E unlistd unr-mus LD50: 480 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 64(4), p. 157S, 1968 (NYKZAU); F07-J25 ipr-dog LDLo: 50 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 431, 1982 (KSRNAM); F07-P26-U01 ivn-dog LDLo: 11 mg/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 191, 1965 (CCSUBJ); F07-P26-U01 ivn-mky LDLo: 45 mg/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 191, 1965 (CCSUBJ); F19-J22-U28 ipr-cat LDLo: 50 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 431, 1982 (KSRNAM); D15-F18-J25 ipr-rbt LDLo: 200 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 431, 1982 (KSRNAM); T/E unlistd ivn-rbt LDLo: 300 mg/kg Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 34, p. 308, 1999 (JTSCDR); D28-F18-F19 ipr-gpg LDLo: 200 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 431, 1982 (KSRNAM); F17-F18-F19 orl-ham LD50: 763 mg/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 37, p. 401, 1981 (EXPEAM); T/E unlistd ipr-ham LD50: 429 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 2, p. 267, 1977 (CALEDQ); V30 par-ham LD10: 110 mg/kg Journal of Surgical Oncology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1969- v. 15, p. 355, 1980 (JSONAU); G30-L30-M30 ivn-dom LD50: 45100 ug/kg Dongbei Nongxueyuan Xuebao. Journal of Northeast Agricultural College. (Dongbei Nongxueyuan Xuebao Beinjibu, Majia Huayuan, Xiangfangqu Harbin, Peop. Rep. China) History not known. v. 34, p. 56, 1980 (DNXUDW); T12 ipr-mus TDLo: 75 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 379, 1991 (REPTED); N04-Z71 ipr-rat TDLo: 150 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 481, 1991 (REPTED); T11 ipr-mus TDLo: 75 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 411, 1992 (REPTED); N17 ipr-mus TDLo: 500 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 411, 1992 (REPTED); T01 ipr-mus TDLo: 20 mg/kg Pharmacological Research. (Academic Press, 24-28 Oval Rd. London NW1 7DX, UK) V.21- 1989- v. 35, p. 457, 1997 (PHMREP); R60-V25-V30 ipr-rat TDLo: 50 mg/kg Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 45, p. 650, 1999 (VOONC*); Y15 orl-rat TDLo: 100 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 51, 1986 (FATOAO); J30-L15-Y53 orl-rat TDLo: 10 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 51, 1986 (FATOAO); S04 ipr-mus TDLo: 250 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO) MD: N74-P72-S02 ipr-mus TDLo: 875 mg/kg/35D-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 25, p. 189, 2000 (JTSCDR); Z01 orl-rat TDLo: 660 mg/kg/80D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); N73-P72-Y15 orl-rat TDLo: 87500 ug/kg/5W-C Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 5, p. 444, 1974 (IYKEDH); N73-P72-Y15 orl-rat TDLo: 910 mg/kg/26W-C Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 5, p. 444, 1974 (IYKEDH); N74-P72-S05 orl-rat TDLo: 15 mg/kg/10D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 15, p. 561, 1985 (JTEHD6); U30-Y03-Y15 ipr-rat TDLo: 300 mg/kg/30D-C Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 439, 1982 (KSRNAM); N73-P28-P71 ivn-rat TDLo: 87500 ug/kg/5W-C Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 5, p. 444, 1974 (IYKEDH); N73-S04 ivn-rat TDLo: 21 mg/kg/7D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 107, p. 47, 1996 (TXCYAC); N74-P08-U01 ipr-mus TDLo: 100 mg/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 165, p. 237, 2000 (TXAPA9); S02-S04 ipr-mus TDLo: 50 mg/kg/10D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 13, p. 129, 1982 (TOLED5); P14 orl-dog TDLo: 150 mg/kg/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); P14-Z01 orl-dog TDLo: 150 mg/kg/15D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); M14-P05-P26 ivn-dog TDLo: 140 mg/kg/35D-I Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 462, 1982 (KSRNAM); P72 orl-rat TDLo: 168 mg/kg/56D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 27, p. 602, 1974 (TXAPA9); N73-S06-U01 ipr-mus TDLo: 200 mg/kg/4D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 1087, 2001 (FCTOD7); S04 orl-mus TDLo: 150 mg/kg/3D-I Journal of Ethnopharmacology. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1979- v. 78, p. 133, 2001 (JOETD7); P30 orl-rat TDLo: 26.1 mg/kg/10D-I Journal of Environmental Science and Health, Part A: Environmental Science and Engineering. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.A11- 1976- v. A22, p. 639, 1987 (JESEDU); N19-T12-T29 ipr-mus TDLo: 3744 mg/kg/52W-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 133, p. 190, 1970 (PSEBAA); T01-T02 orl-rat TDLo: 336.6 mg/kg/11W-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 34, p. 275, 1986 (BIREBV); N02-U01-Z71 ipr-rat TDLo: 200 mg/kg/30D-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 61, p. 861, 1990 (BJCAAI); R60-V30-V25 ipr-mus TDLo: 200 mg/kg/2D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 147, p. 17, 1999 (CALEDQ); J60-V25-V30 ipr-mus TDLo: 120 mg/kg/5D-I Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 43, p. 313, 1997 (VOONC*); V25-V30 ipr-mus TDLo: 100 mg/kg/5D-I Experimental Oncology (Journal of ucrainian section of European institute of ecology and cancer, Kiev-22, Vaselkovskaya str., 25, Kiev-22) V.1- 1979- v. 18, p. 276, 1996 (EXONC*); T02 orl-man TDLo: 210 mg/kg/12W-I American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 129, p. 315, 1975 (AJDCAI); T01 orl-man TDLo: 430180 mg/kg/274D-I American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 129, p. 315, 1975 (AJDCAI); T01 orl-man TDLo: 120 mg/kg/60D-I American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 129, p. 315, 1975 (AJDCAI); T02 orl-man TDLo: 338.6 mg/kg/60D-I American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 129, p. 315, 1975 (AJDCAI); N19 ipr-rat TDLo: 15 mg/kg/15D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 2340, 1987 (CNREA8); Z74-Z71-T12 ipr-rat TDLo: 750 mg/kg/15D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 2340, 1987 (CNREA8); Z01 ipr-rat TDLo: 1500 mg/kg/15D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 2340, 1987 (CNREA8); N30-U01 ipr-rat TDLo: 2250 mg/kg/15D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 2340, 1987 (CNREA8); T01-T02-Y10 orl-mus TDLo: 378 mg/kg/21D-I Pharmacological Research. (Academic Press, 24-28 Oval Rd. London NW1 7DX, UK) V.21- 1989- v. 35, p. 457, 1997 (PHMREP); T01-N04 orl-hmn TDLo: 42.8 mg/kg/30W-I Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 36, p. 76, 1981 (FESTAS) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 165, 1981 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 165, 1981 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 182, 1987 (IMSUDL); TOXICOLOGY REVIEW Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 88, p. 185, 1977 (ZKKOBW); TOXICOLOGY REVIEW Minnesota Medicine. (Minnesota Medical Assoc., 2221 University Ave., SE, Suite 400, Minneapolis, MN 55414) V.1- 1918- v. 57, p. 19, 1974 (MIMDAL); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 144, p. 429, 1964 (JPETAB); TOXICOLOGY REVIEW Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 5, p. 447, 1965 (ARVPAX); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 2, p. 159, 1973 (CRTXB2); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY); TOXICOLOGY REVIEW Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 174, p. 1, 2002 (TXCYAC) ND: NOES 1983: HZD X3688; NIS 2; TNF 991; NOS 9; TNE 30026; TFE 20745 SL: EPA GENETOX PROGRAM 1988, Positive: Body fluid assay, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-human; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-human bone marrow; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Positive: Cytogenetics-male germ cell, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: Rodent heritable translocation; EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: Mouse spot test, E coli polA with S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test, Mouse specific locus; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-rat, Sperm morphology-mouse F1; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-human, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal, UDS in mouse germ cells; EPA GENETOX PROGRAM 1988, Positive: TRP reversion, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: Cell transform.-C3H/10T1/2; EPA GENETOX PROGRAM 1988, Positive/dose response: In vivo cytogenetics-nonhuman bone marrow; EPA GENETOX PROGRAM 1988, Positive/dose response: In vivo cytogenetics-mammalian oocyte; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Positive/dose response: Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman, In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-BALB/c-3T3; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro SCE-human lymphocytes; EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-rabbit, In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (ipr), clear evidence: mouse, rat Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 928 of 1119 in RTECS (through 2003/06) AN: RP6157750 PN: 2H-1,3,2-Oxazaphosphorine, tetrahydro-2-(bis(2-chloroethyl)amino)-, 2-oxide, monohydrate SY: N,N-Bis(beta-cloraethyl) N'-O-propylenphosphorildiamid monohydratum (Romanian); 2-(Bis(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphocyclohexane 2-oxide monohydrate; 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridine monohydrate; (Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,4,5,6-oxazaphosphorine-1,3,2-oxide-2 monohydrate; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester monohydrate; N,N-Bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester amide monohydrate; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxaphosphorin-2-amine, 2-oxide monohydrate; N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide monohydrate; Cyclic N',O-propylene ester of N,N-bis(2-chloroethyl)phosphorodiamidic acid monohydrate; Cyclophosphamide-hydrate-; Cyclophosphamide-monohydrate-; 2-(Di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane-2-oxide monohydrate; N,N-Di(2-chloroethyl)amino-N,O-propylene phosphoric acid ester diamide monohydrate; Endoxan-monohydrate- RN: Current: 6055-19-2 UD: 200302 MF: C7-H15-Cl2-N2-O2-P.H2-O MW: 279.13 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: sln-smc 42 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 231, 1990 (MUREAV); mnt-nml-mul 500 ppb Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 83, 1993 (MUREAV); mnt-nml-mul 5 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 83, 1993 (MUREAV); cyt-hmn-lym 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 412, p. 55, 1998 (MUREAV); dns-rat-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 135, 1988 (MUREAV); mnt-mus-orl 15 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 234, p. 169, 1990 (MUREAV); mnt-mus-ipr 12500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 278, p. 99, 1992 (MUREAV); dnd-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); oms-mus-ipr 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 299, p. 19, 1993 (MUREAV); cyt-mus-ipr 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 299, p. 19, 1993 (MUREAV); sce-mus-ipr 50 umol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 271, 1989 (MUREAV); spm-mus-ipr 100 mg/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 69, p. 149, 1980 (MUREAV); cyt-ham-ovr 0.02 gm/L/4H (+S9) Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 22, p. 45, 2001 (JAPTO*); cyt-rat-ipr 30 mg/kg Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 22, p. 45, 2001 (JAPTO*); dnd-rat-lvr 5 umol/L/12H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 519, p. 163, 2002 (MUREAV); dnd-hmn-lvr 5 umol/L/12H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 519, p. 163, 2002 (MUREAV); mnt-hmn-lym 28 mg/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 519, p. 179, 2002 (MUREAV); sce-hmn-lym 1.4 mg/L/3H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 519, p. 179, 2002 (MUREAV) RE: T48-T51 ipr-mus TDLo: 40 mg/kg (14D preg) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 1, 1991 (EMMUEG); T24 orl-rat TDLo: 321 mg/kg (9W male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 229, p. 129, 1990 (MUREAV); T25 orl-rat TDLo: 88 mg/kg (9W male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 229, p. 129, 1990 (MUREAV); T24-T43-T46 ivn-rat TDLo: 5 mg/kg (11D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 38, p. 39, 1998 (CGANE7); T12-T31-T34 ivn-rat TDLo: 27500 ug/kg (7-17D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 517, 1982 (KSRNAM); T41-T46-T47 ivn-rat TDLo: 27500 ug/kg (7-17D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 517, 1982 (KSRNAM); T81-T85 ivn-rat TDLo: 27500 ug/kg (7-17D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 16, p. 517, 1982 (KSRNAM) ORNG: 94000000 ng/kg. [94.000000 mg/kg] F19-M10-P01 AT: F19-M10-P01 orl-rat LD50: 94 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); T/E unlistd ipr-rat LD50: 121 mg/kg Farmacia (Bucharest). (Rompresfilatelia, POB 12-201, Bucharest, Romania) V.1- 1953- v. 18, p. 409, 1970 (FRMBAZ); F19-M10-P01 orl-mus LD50: 350 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); T/E unlistd ivn-mus LD50: 275 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); F07-F19-K13 orl-dog LD50: 44 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); T/E unlistd ivn-dog LD50: 40 mg/kg Deutsche Medizinische Wochenschrift. (Stuttgart, Fed. Rep. Ger.) V.1-104, 1875-1979. v. 83, p. 453, 1958 (DMWOAX); T/E unlistd ivn-rbt LD50: 130 mg/kg Deutsche Medizinische Wochenschrift. (Stuttgart, Fed. Rep. Ger.) V.1-104, 1875-1979. v. 83, p. 453, 1958 (DMWOAX); T/E unlistd ivn-gpg LD50: 400 mg/kg Deutsche Medizinische Wochenschrift. (Stuttgart, Fed. Rep. Ger.) V.1-104, 1875-1979. v. 83, p. 453, 1958 (DMWOAX) MD: M14-P72-Z01 orl-rat TDLo: 240 mg/kg/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); P71-P72-Z01 orl-rat TDLo: 480 mg/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); L70-P72-S04 orl-mus TDLo: 480 mg/kg/24D-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 30, p. 103, 1984 (TXCYAC); P72-Z01 orl-dog TDLo: 150 mg/kg/9W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); P72-Z01 orl-dog TDLo: 150 mg/kg/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 324, 1962 (TXAPA9); N73-P72-S04 ipr-brd TDLo: 60 mg/kg/3D-I Journal of Wildlife Diseases. (Wildlife Disease Assoc., POB 886, Ames, IA 50010) V.6- 1970- v. 30, p. 328, 1994 (JWIDAW) TR: IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 135, 1975 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 135, 1975 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 165, 1981 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 165, 1981 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 929 of 1119 in RTECS (through 2003/06) AN: RQ7350000 PN: 2-Oxetanone- SY: 1,3-Propiolactone-; 3-Hydroxypropionic-acid-lactone-; 3-Propanolide-; 3-Propiolactone-; BPL-; Betaprone-; Hydracrylic-acid-beta-lactone-; Propanolide-; Propiolactone-; Propionic-acid,-3-hydroxy-,-beta-lactone-; beta-PL-; beta-Propiolactone-; beta-Propiolactone- (ACGIH:OSHA); beta-Propiolakton- (Czech); beta-Propionolactone-; beta-Proprolactone- RN: Current: 57-57-8 BRN: 1360 BHR: 5-17-09-00003 UD: 200210 MF: C3-H4-O2 MW: 72.07 WL: T4OVTJ CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 1 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); oms-sat 8300 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); pic-sat 500 ppm Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 830, 1970 (CNREA8); mmo-esc 1 uL/plate (+/-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 387, 1981 (PMRSDJ); dnr-esc 10 ug/disc JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); dna-esc 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dns-esc 15 mmol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 92, p. 177, 1978 (ZKKOBW); pic-esc 340 nmol/plate Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 5971, 1982 (PNASA6); oms-bcs 50 mmol/L Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 136, p. 854, 1978 (JOBAAY); dnd-bcs 110 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); mmo-srm 2 gm/L (-S9) Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 93, 1971 (ATXKA8); mmo-omi 2 gm/L (-S9) Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 6, p. 667, 1970 (MOPMA3); mmo-omi 450 umol/L (-S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3480, 1982 (CNREA8); mmo-omi 667 ppm/1H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 34, p. 175, 1976 (MUREAV); dnd-omi 10 mmol/L Journal of General and Applied Microbiology. (Microbiology Research Foundation, c/o Japan Academic Soc. Center Bldg., 2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113, Japan) V.1- 1955- v. 19, p. 339, 1973 (JGAMA9); dnd-omi 1000 ppm Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 10, p. 41, 1975 (CBINA8); dnd-omi 2 pph Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 10, p. 41, 1975 (CBINA8); dnd-omi 1600 umol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 73, p. 2629, 1976 (PNASA6); dni-omi 5 mmol/L Journal of General and Applied Microbiology. (Microbiology Research Foundation, c/o Japan Academic Soc. Center Bldg., 2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113, Japan) V.1- 1955- v. 19, p. 339, 1973 (JGAMA9); oms-omi 5 mmol/L Journal of General and Applied Microbiology. (Microbiology Research Foundation, c/o Japan Academic Soc. Center Bldg., 2-4-16 Yayoi, Bunkyo-ku, Tokyo, 113, Japan) V.1- 1955- v. 19, p. 339, 1973 (JGAMA9); pic-omi 1 mg/plate Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe A: Medizinische Mikrobiologie und Parasitologie. (Stuttgart, Fed. Rep. Ger.) V.217-245, 1971-79. v. 231, p. 369, 1975 (ZMMPAO); slt-dmg-orl 200 mmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 153, 1984 (ENMUDM); sln-dmg-orl 250 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 189, 1984 (ENMUDM); sln-dmg-par 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 55, 1979 (MUREAV); trn-dmg-par 25 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 55, 1979 (MUREAV); mmo-nsc 2 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 297, 1978 (MUREAV); mmo-smc 89 mg/L (+/-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 414, 1981 (PMRSDJ); mrc-smc 1 ug/plate Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 456, 1981 (PMRSDJ); sln-smc 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mmo-ssp 100 ug/L (+/-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 424, 1981 (PMRSDJ); mtr-hmn-oth 7500 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 5096, 1981 (CNREA8); mtr-hmn-fbr 28 umol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 80, p. 7219, 1983 (PNASA6); dnd-hmn-lym 1 mmol/L Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 125, 1982 (JACTDZ); dns-hmn-fbr 160 ug/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 21, p. 151, 1981 (TXCYAC); dni-hmn-hla 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); cyt-hmn-fbr 13 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 4720, 1986 (CNREA8); cyt-hmn-hla 100 nmol/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 9, p. 21, 1978 (TXCYAC); dnd-rat-lvr 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); dnd-rat-orl 100 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 1589, 1978 (CNREA8); cyt-rat-leu 250 umol/L/5H Laboratory Animals. (Laboratory Animals Ltd., 1 Thrifts Mead, Theydon Bois, Essex CM16 7NF, UK) V.1- 1967- v. 3, p. 157, 1969 (LBANAX); mnt-mus-ipr 54 mg/kg/24H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 216, p. 321, 1989 (MUREAV); mmo-mus-lym 15 mg/L/4H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); mtr-mus-emb 100 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 659, 1985 (PMRSDJ); oms-mus-oth 57 gm/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 937, 1974 (BCPCA6); dnd-mus-skn 8 nmol/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 163, p. 751, 1969 (ANYAA9); dnd-mus-ast 12 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 3025, 1976 (CNREA8); dna-mus-lvr 1600 umol/L/20H Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 18, p. 327, 1977 (CBINA8); dns-mus-skn 8600 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 769, 1973 (CNREA8); dns-mus-oth 500 umol/L Journal of Investigative Dermatology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1938- v. 62, p. 480, 1974 (JIDEAE); dns-mus-fbr 500 umol/L Journal of Investigative Dermatology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1938- v. 62, p. 480, 1974 (JIDEAE); dni-mus-skn 8600 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 769, 1973 (CNREA8); oms-mus-oth 57 gm/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 937, 1974 (BCPCA6); msc-mus-lym 2 mg/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); hma-mus-sat 405 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); mtr-ham-ipr 250 mg/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 95, p. 380, 1973 (ARPAAQ); mtr-ham-emb 2500 ug/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 13, p. 105, 1976 (CBINA8); mtr-ham-kdy 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); dnd-ham-lng 100 umol/L/1H Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 732, 1976 (BBRCA9); dnd-ham-emb 2500 ug/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 13, p. 105, 1976 (CBINA8); cyt-ham-fbr 30 mg/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); cyt-ham-lng 18 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); cyt-ham-ovr 200 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 1, 1985 (ENMUDM); sce-ham-ovr 100 umol/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 258, p. 121, 1975 (NATUAS); sce-ham-lng 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 118, p. 103, 1983 (MUREAV); msc-ham-ovr 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 94, p. 449, 1982 (MUREAV); msc-ham-lng 2 mmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 426, 1984 (ENMUDM); dna-mam-lym 1600 umol/L/20H Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 18, p. 327, 1977 (CBINA8); dnd-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); dnd-mus-orl 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV) TE: V01-K60-L60 orl-rat TDLo: 2868 mg/kg/1Y-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 46, p. 924, 1982 (BJCAAI); V01-D09 ihl-rat TCLo: 5 ppm/6H/30D-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 79, p. 285, 1987 (JJIND8); V01-V10 scu-rat TDLo: 22 mg/kg/25W-I British Medical Bulletin. (Longman Group UK Ltd., Longman House, Burnt Mill, Harlow, Essex CM20 2JE, UK) V.1- 1943- v. 20, p. 96, 1964 (BMBUAQ); V03-J60-J61 itr-rat TDLo: 72 mg/kg/30W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 20, p. 134, 1966 (BJCAAI); V03-K61 rec-rat TDLo: 857 mg/kg/6W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 2740, 1988 (CNREA8); V01-K60 orl-mus TDLo: 3080 mg/kg/77W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 1433, 1979 (JJIND8); V01-R60 skn-mus TDLo: 6200 mg/kg/15W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 9, p. 177, 1955 (BJCAAI); V02-V10 scu-mus TDLo: 69 mg/kg/43W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 19, p. 392, 1965 (BJCAAI); V03-R60-V10 ivn-mus TDLo: 40 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 10, p. 357, 1956 (BJCAAI); V03-L60-R60 skn-gpg TDLo: 56 mg/kg/141W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 20, p. 200, 1966 (BJCAAI); V02-V10 scu-rat TD :50 mg/kg/25W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 15, p. 85, 1961 (BJCAAI); V03-N60-R60 skn-mus TD :8100 mg/kg/27W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 10, p. 357, 1956 (BJCAAI); V02-V10 scu-mus TD :648 mg/kg/54W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 1433, 1979 (JJIND8); V01-R60-V10 skn-mus TD :11 gm/kg/56W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 6, p. 139, 1976 (TXCYAC); V02-V10 scu-mus TD :408 mg/kg/34W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 53, p. 695, 1974 (JNCIAM); V03-K60 orl-rat TD :3050 mg/kg/61W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 37, p. 825, 1966 (JNCIAM); V02-V10 scu-mus TD :1168 mg/kg/40W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 37, p. 825, 1966 (JNCIAM); V01-V10 scu-rat TD :1080 mg/kg/54W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 39, p. 1213, 1967 (JNCIAM); V03-K60 orl-mus TD :320 mg/kg/8W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4747, 1983 (CNREA8); V01-R60-V10 skn-mus TD :37772 mg/kg/2Y-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 23, p. 1081, 1985 (FCTOD7) AT: T/E unlistd ihl-rat LC50: 25 ppm/6H "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 5,497,1986 (85INA8); T/E unlistd ipr-mus LD50: 405 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8) TR: ACGIH TLV-TWA 0.5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 259, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1103, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 259, 1974 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1103, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1103, 1999 (IMEMDT); TOXICOLOGY REVIEW Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 7, p. 243, 1974 (ENVRAL); TOXICOLOGY REVIEW "Microbial Toxins, 1970-72," Ajil, S.J., et al., eds., New York, Academic Press, Inc., 1970-72 6,409,1971 (22HAAD) SR: MSHA STANDARD: SUSPECTED CARCINOGEN "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 27, 1972 (DTLWS*); OSHA PEL (Construc): see CFR 29,1926.1113 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA-cancer suspect agent Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1013, 1987 (CFRGBR); OEL-AUSTRALIA: TWA 0.5 ppm (1.5 mg/m3), Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.5 ppm (1.5 mg/m3), Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.1 ppm (1.5 mg/m3), JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.5 ppm (1.5 mg/m3), Carcinogen, JAN 1999; OEL-POLAND: MAC(TWA) 1 mg/m3, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.5 ppm (1.5 mg/m3), Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO beta-PROPIOLACTONE-air: CA use 29 CFR 1910.1013 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 62270; NIS 1; TNF 19; NOS 1; TNE 38 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-focus assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, L5178Y cells in vitro-TK test; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 930 of 1119 in RTECS (through 2003/06) AN: RR0875000 PN: Oxirane, ((2-propenyloxy)methyl)- SY: 1,2-Epoxy-3-allyloxypropane-; 1-(Allyloxy)-2,3-epoxypropane; 1-Allilossi-2,3-epossipropano- (Italian); 1-Allyloxy-2,3-epoxy-propaan- (Dutch); 1-Allyloxy-2,3-epoxypropan- (German); AGE- (OSHA); Allil-glicidil-etere- (Italian); Allyl-2,3-epoxypropyl-ether-; Allyl-glycidol-ether-; Allyl-glycidyl-ether-; Allyl-glycidyl-ether- (ACGIH:OSHA); Allylglycidaether- (German); Ether,-allyl-2,3-epoxypropyl-; Glycidyl-allyl-ether-; NCI-C56666-; Oxyde-d'allyle-et-de-glycidyle- (French); Propane, 1-(allyloxy)-2,3-epoxy- RN: Current: 106-92-3 BRN: 105871 BHR: 5-17-03-00012 UD: 200302 MF: C6-H10-O2 MW: 114.16 WL: T3OTJ B1O2U1 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 485 mg/3D MOD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); skn-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,772,1986 (85JCAE); eye-rbt 97 mg SEV AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); eye-rbt 750 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,772,1986 (85JCAE) ME: mmo-sat 100 ug/plate (+S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-376, 1990 (NTPTR*); mmo-esc 20 umol/L (-S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); oms-esc 3300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 231, p. 205, 1990 (MUREAV); dnd-esc 1 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); mmo-klp 500 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 269, 1981 (MUREAV); sln-dmg-orl 5500 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); cyt-ham-ovr 64800 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-376, 1990 (NTPTR*); sce-ham-ovr 3300 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-376, 1990 (NTPTR*); sce-ham-lng 625 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 249, p. 55, 1991 (MUREAV); mtr-mus-fbr 0.00001 pph/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V03-D09 ihl-rat TCLo: 10 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-376, 1990 (NTPTR*); V02-D09 ihl-mus TCLo: 10 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-376, 1990 (NTPTR*); V03-D09 ihl-rat TCLo: 309 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-260027 (NTIS**); V03-D09 ihl-mus TCLo: 618 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-260027 (NTIS**) ORNG: 1600000000 ng/kg. [1600.000000 mg/kg] A11-F17-F19 SRNG: 2550000000 ng/kg. [2550.000000 mg/kg] T/E unlistd AT: A11-F17-F19 orl-rat LD50: 1600 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); D26-J15-K01 ihl-rat LC50: 670 ppm/8H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); A11-F07-F19 orl-mus LD50: 390 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); D17-J22-K01 ihl-mus LC50: 270 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); T/E unlistd skn-rbt LD50: 2550 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB) MD: J06-M70-U01 ihl-rat TCLo: 400 ppm/7H/10W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); D07-J02-J30 ihl-rat TCLo: 200 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-376, 1990 (NTPTR*); P26-P72-U01 ims-rat TDLo: 400 mg/kg/8D-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 2, p. 50, 1961 (AEHLAU); Z01 ihl-mus TCLo: 50 ppm/6H/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-376, 1990 (NTPTR*); L60-V30 ihl-mus TCLo: 309 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-260027 (NTIS**); A60-V30 ihl-mus TCLo: 309 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-260027 (NTIS**) TR: ACGIH TLV-TWA 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: MSHA STANDARD-air: TWA 5 ppm (22 mg/m3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 9, 1971 (DTLWS*); OSHA PEL (Gen Indu): CL 10 ppm (45 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 10 ppm (45 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 10 ppm (45 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 10 ppm (45 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 ppm (22 mg/m3), STEL 10 ppm, Skin, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 5 ppm (23 mg/m3), STEL 10 ppm (47 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-FINLAND: STEL 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (22 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 10 ppm (45 mg/m3), JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.1 ppm (0.5 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 5 ppm (22 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 10 ppm (45 mg/m3), JAN 1993; OEL-SWITZERLAND: MAK-W 0.05 ppm (0.1 mg/m3), JAN 1999; OEL-THAILAND: TWA 10 ppm (45 mg/m3), JAN 1993; OEL-TURKEY: TWA 10 ppm (45 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (24 mg/m3), STEL 10 ppm (47 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO ALLYL GLYCIDYL ETHER-air: 10H TWA 5 ppm, STEL 10 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 04530; NIS 9; TNF 153; NOS 24; TNE 2769; NOES 1983: HZD 04530; NIS 6; TNF 23; NOS 11; TNE 2457; TFE 29 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 29, 1978; NIOSH Analytical Method, 1994: Allyl glycidyl ether, 2545; NTP Carcinogenesis Studies (inhalation), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-376, 1990 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: mouse, rat Record 931 of 1119 in RTECS (through 2003/06) AN: RS8225000 PN: Ozone- SY: Ozon- (Polish); Ozone- (ACGIH:OSHA); Triatomic-oxygen- RN: Current: 10028-15-6 UD: 200305 MF: O3 MW: 48.00 WL: O3 CC: Tumorigen (C); Mutagen (M); Natural-Product (N); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: eye-rbt 2 ppm/4H Journal of the Air Pollution Control Association. (Air Pollution Control Assoc., POB 2861, Pittsburgh, PA 15230) V.5- 1955- v. 10, p. 17, 1960 (JPCAAC) ME: mmo-sat 19 ppb/35M (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17(Suppl 19), p. 22, 1991 (EMMUEG); mmo-sat 3 mg/L (-S9) Ozone: Science and Engineering. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1979- v. 8, p. 217, 1986 (OZSEDS); mmo-esc 50 ppm (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 197, p. 472, 1984 (MGGEAE); dnr-esc 50 ppm/30M Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 77, p. 220, 1977 (BBRCA9); dnd-esc 500 ug/L Annales de l'Institut Pasteur (Paris). (Paris, France) V.1-123, 1887-1972. For publisher information, see ANMBCM. v. 114, p. 595, 1968 (AIPAAV); pic-esc 50 ppm Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 26, p. 706, 1984 (CNJGA8); dnd-omi 70 pph Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 78, p. 199, 1977 (JOHYAY); dlt-oin-ihl 30 ppm/3H-C Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 657, 1982 (ENMUDM); cyt-hmn-ihl 500 ppb/6H Medical Hypotheses. (Churchill Livingstone Inc., 1560 Broadway, New York, NY 10036) V.1- 1975- v. 4, p. 165, 1978 (MEHYDY); cyt-hmn-leu 7230 ppb/1H Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 12, p. 188, 1976 (ENVRAL); cyt-hmn-oth 8 ppm/5M-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 194, p. 793, 1962 (NATUAS); sce-hmn-lng 250 ppb/1H-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 18, p. 336, 1979 (ENVRAL); cyt-rat-ihl 28 mg/m3/5D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(9), p. 12, 1979 (GISAAA); mtr-mus-fbr 5 ppm Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 1611, 1986 (CRNGDP); dnd-mus-fbr 25 mmol/L Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 247, p. 69, 1987 (BIJOAK); mtr-ham-emb 5 ppm Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 1611, 1986 (CRNGDP); dni-ham-lng 2 ppm/1H Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 17, p. 119, 1986 (JTEHD6); cyt-ham-ihl 200 ppb/5H Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 4, p. 262, 1971 (ENVRAL); cyt-ckn-fbr 1 ug/L/30M Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 67, p. 113, 1965 (ZEKBAI); dna-gpg-ihl 0.4 ppm/2H Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 9, p. 811, 1997 (INHTE5); dna-hmn-ihl 0.4 ppm/2H Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 9, p. 811, 1997 (INHTE5); dnd-hmn-oth 0.9 mmol/L/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 517, p. 13, 2002 (MUREAV); dnd-mus-ihl 1 ppm/90M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 63, 2002 (MUREAV); cyt-ham-ihl 0.38 ug/L/5H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 166, 1989 (VCVN5*) RE: T24-T34-T46 ihl-rat TCLo: 1040 ppb/24H (6-9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. 19, 1979 (TXAPA9); T85-T86 ihl-rat TCLo: 1500 ppb/24H (17-20D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 5, p. 3, 1980 (TOLED5); T81-T85 ihl-mam TCLo: 2 mg/m3 (9-12D preg) "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 166, 1989 (VCVN5*); T81-T85 ihl-mam TCLo: 2 mg/m3 (17-20D preg) "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 166, 1989 (VCVN5*) TE: V02-J60 ihl-mus TCLo: 5 ppm/2H/75D-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 20, p. 16, 1970 (AEHLAU); V03-J60 ihl-mus TC :608 ug/m3/24W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 75, p. 771, 1985 (JJIND8); V02-J60 ihl-mus TC :1 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-440, 1994 (NTPTR*); V03-J60 ihl-mus TCLo: 44.1 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-226999 (NTIS**); V03-J60 ihl-mus TCLo: 88.2 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-226999 (NTIS**) IHPB: 4800 ppb/4H. [4.800000 ppm/4H] J15-P01 AT: F27-H02-J22 ihl-hmn LCLo: 50 ppm/30M "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,446,1969 (34ZIAG); J21-J25-J30 ihl-man TCLo: 80 ppb/6.6H Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 46, p. 145, 1991 (AEHLAU); J30-R03 ihl-hmn TCLo: 100 ppm/1M News Edition, American Chemical Society. (Easton, PA) V.18-19, 1940-41. For publisher information, see CENEAR. v. 19, p. 686, 1941 (NEACA9); D17-G08-J21 ihl-man TCLo: 1860 ppb/75M Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 10, p. 517, 1965 (AEHLAU); J25-J30 ihl-wmn TCLo: 350 ppb/75M Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 12, p. 151, 2000 (INHTE5); J21-J22-J30 ihl-hmn TCLo: 1 ppm Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 10, p. 295, 1965 (AEHLAU); G08-J30 ihl-hmn TCLo: 200 ppb/4H/4D-I American Journal of Respiratory and Critical Care Medicine. (American Lung Association, 1740 Broadway, New Youk, NY 10019) V. 149- 1994- v. 161, p. 1855, 2000 (AJCMED); J21-J22-J30 ihl-hmn TCLo: 600 ppb/2H American Review of Respiratory Disease. (American Lung Assoc., 1740 Broadway, New York, NY 10019) V.80- 1959- v. 118, p. 287, 1978 (ARDSBL); J15-P01 ihl-rat LC50: 4800 ppb/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 15, p. 181, 1957 (AMIHAB); J15-P01 ihl-mus LC50: 12600 ppb/3H Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 16, p. 22, 1957 (FEPRA7); F07-J22-J30 ihl-cat LC50: 34500 ppb/3H Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 25, p. 301, 1956 (IMSUAI); F07-J22-J30 ihl-rbt LC50: 36 ppm/3H Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 25, p. 301, 1956 (IMSUAI); J30 ihl-gpg LC50: 24800 ppb/3H Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 26, p. 63, 1957 (IMSUAI); T/E unlistd ihl-ham LC50: 10500 ppb/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 15, p. 181, 1957 (AMIHAB); J02-J30 ihl-rat TCLo: 0.8 ppm/3H Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 46, p. 329, 1995 (JTEHD6); J02-J30-Y55 ihl-rat TCLo: 0.8 ppm/3H Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 46, p. 329, 1995 (JTEHD6); T/E unlistd ihl-mus LC50: 46 mg/m3/2H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-mus LC50: 40 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-mus LC50: 7.6 mg/m3/4H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-mus LC50: 4 mg/m3/24H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-rat LC50: 28 mg/m3/2H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-rat LC50: 4.5 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-rat LC50: 1 mg/m3/44H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-rat LC :0.5 mg/m3/1H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); J15 ihl-rat TCLo: 1.2 mg/m3/18H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-gpg LC50: 7 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); J15 ihl-gpg TCLo: 1 mg/m3/2H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-rbt LC50: 7.4 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); T/E unlistd ihl-cat LC50: 7 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); J70-L70-Y16 ihl-mus TCLo: 1.6 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); Y02-Y10 ihl-rat TCLo: 0.65 mg/m3/6H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); F40-J25-P05 ihl-rat TCLo: 6.5 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); N30 ihl-rat TCLo: 2 mg/m3/24H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); A30-J30-Y02 ihl-gpg TCLo: 0.2 mg/m3/1H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); N30 ihl-dog TCLo: 0.2 mg/m3/1H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); P24-Y02 ihl-dom TCLo: 1 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); F40 ihl-mus TCLo: 0.1 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); D25-J21-J25 ihl-hmn TCLo: 0.2 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); P30-Y10 ihl-hmn TCLo: 0.6 mg/m3/3H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); D04 ihl-hmn TCLo: 0.0004 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); F40 ihl-hmn TCLo: 0.4 mg/m3/1H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); D12-D14-D35 ihl-hmn TCLo: 0.4 mg/m3/4H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); D25-J21 ihl-hmn TCLo: 0.2 mg/m3/30M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); J25 ihl-hmn TCLo: 2 mg/m3/1H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); J15 ihl-hmn TCLo: 8 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); F21-F27-G07 ihl-hmn TCLo: 20 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 163, 1993 (VCVN5*); J30-Y37 ihl-rat TCLo: 2 ppm/4H Experimental Lung Research. (Hemisphere Publishing, c/o Taylor and Francis 1900 Frost Road, Suite 101, Bristol, PA 19007) V.1- 1980- v. 14, p. 477, 1988 (EXLRDA); J30-U28-Y37 ihl-rat TCLo: 0.4 ppm/4H Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 6, p. 267, 1994 (INHTE5) MD: J02-J30 ihl-rat TCLo: 950 ppb/8H/90D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 106, p. 384, 1990 (TXAPA9); J30-J70-Y12 ihl-rat TCLo: 1600 ug/m3/24H/7D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 24, p. 515, 1988 (JTEHD6); Y10-Y12-Y40 ihl-rat TCLo: 800 ug/m3/24H/3D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 116, p. 209, 1992 (TXAPA9); J25-U01 ihl-rat TCLo: 700 ppb/2H/28D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 17, p. 143, 1986 (JTEHD6); J30-Y09-Y12 ihl-rat TCLo: 200 ppb/24H/12W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 42, p. 425, 1987 (ENVRAL); J30-P30-U01 ihl-rat TCLo: 750 ppb/24H/14D-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(5-6), p. 247, 1980 (JEPTDQ); J70-N74-S04 ihl-mus TCLo: 400 ppb/24H/14D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 35, p. 490, 1984 (ENVRAL); N74-S04-U01 ihl-mus TCLo: 1 ppm/24H/4W-C Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 9, p. 243, 1989 (JEPOEC); N73 ihl-mus TCLo: 608 ug/m3/26W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 26, p. 139, 1985 (TOLED5); J30-Y10 ihl-mus TCLo: 300 ppb/3D-C Experimental Lung Research. (Hemisphere Publishing, c/o Taylor and Francis 1900 Frost Road, Suite 101, Bristol, PA 19007) V.1- 1980- v. 20, p. 579, 1994 (EXLRDA); J30-Y37 ihl-mky TCLo: 1500 pph/8H/21D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 29, p. 207, 1985 (TOLED5); J02-J13 ihl-mky TCLo: 400 ppb/8H/90D-I Experimental Lung Research. (Hemisphere Publishing, c/o Taylor and Francis 1900 Frost Road, Suite 101, Bristol, PA 19007) V.1- 1980- v. 12, p. 57, 1987 (EXLRDA); J30 ihl-rbt TCLo: 100 ppb/2H/13D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 21, p. 27, 1987 (JTEHD6); J02-J70-U01 ihl-gpg TCLo: 2 ppm/2D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 521, 1977 (JTEHD6); J70-Y10-Y40 ihl-gpg TCLo: 800 ug/m3/24H/3D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 116, p. 209, 1992 (TXAPA9); J02-J30-Y10 ihl-qal TCLo: 3 mg/m3/24H/7D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 54, p. 39, 1991 (ENVRAL); J70-L70-M71 ihl-mus TCLo: 2 mg/m3/24H/3D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 164, 1989 (VCVN5*); J70-L70-M71 ihl-rat TCLo: 2 mg/m3/24H/3D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 164, 1989 (VCVN5*); P28 ihl-rat TCLo: 1.96 mg/m3/5H/10D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 164, 1989 (VCVN5*); J02-J13-J22 ihl-rat TCLo: 1.4 mg/m3/24H/7D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); K30-P05 ihl-rat TCLo: 0.4 mg/m3/24H/3D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); F15-J70-P28 ihl-gpg TCLo: 0.6 mg/m3/24H/2W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J02-J30-Y20 ihl-mky TCLo: 1.2 mg/m3/4H/4D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); S05 orl-rat TDLo: 4 mg/kg/40D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J30-S05 ihl-mus TCLo: 0.2 mg/m3/5H/100D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J02-P71 ihl-mus TCLo: 0.7 mg/m3/8H/1Y-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J02-J13-U01 ihl-rat TCLo: 0.25 mg/m3/24H/13W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J70-N75-Z73 ihl-rat TCLo: 9 mg/m3/6H/13W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J02 ihl-dom TCLo: 9.5 mg/m3/4H/6W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); P30 ihl-mky TCLo: 1.2 mg/m3/8H/1Y-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); P30-Y16 ihl-mky TCLo: 0.3 mg/m3/8H/90D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J06-J15-Z01 ihl-gpg TCLo: 0.7 mg/m3/24H/90D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J06-J15-Z01 ihl-rat TCLo: 0.7 mg/m3/24H/90D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); J06-J15-Z01 ihl-mky TCLo: 0.7 mg/m3/24H/90D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 165, 1989 (VCVN5*); Z01 ihl-mam TCLo: 8 mg/m3/24H/14D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 166, 1989 (VCVN5*); T02 ihl-rat TCLo: 3.9 mg/m3/24H/13W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 166, 1989 (VCVN5*); J02-U01 ihl-rat TCLo: 2.4 mg/m3/6H/4W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 166, 1989 (VCVN5*); J70-P28 ihl-gpg TCLo: 0.6 mg/m3/24H/2W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 166, 1989 (VCVN5*); G04-G08-F18 ihl-hmn TCLo: 0.5 mg/m3/7Y-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 167, 1989 (VCVN5*); N30 ihl-dog TCLo: 0.75 ppm/2D/24H-C Experimental Pathology (1981). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.19- 1981- v. 28, p. 105, 1985 (EXPADD); J06-Y21 ihl-rat TCLo: 0.48 ppm/4H/4W-I Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 39, p. 757, 1984 (NEZAAQ); J30-Y37 ihl-mky TCLo: 0.15 ppm/8H/90D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 24, p. 125, 1985 (TOLED5); J30-Y16-Y37 ihl-mky TCLo: 0.3 ppm/8H/90D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 24, p. 125, 1985 (TOLED5); P30 ihl-mky TCLo: 0.64 ppm/8H/1Y-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 32, p. 445, 1983 (ENVRAL) TR: ACGIH TLV-TWA 0.05 ppm (heavy work) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.2 ppm (< 2 hours) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 ppm (light work) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.08 ppm (moderate work) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 ppm, light work The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-TWA 0.08 ppm, mod work The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-TWA 0.05 ppm, heavy work The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 35, p. 89, 1976 (FEPRA7); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB228-002 (NTIS**); TOXICOLOGY REVIEW Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 16, p. 903, 1968 (AEHLAU); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. CONF-691001 (NTIS**) SR: MSHA STANDARD-air: TWA 0.1 ppm (0.2 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 194, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.1 ppm (0.2 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.1 ppm (0.2 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.1 ppm (0.2 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.1 ppm (0.2 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.1 ppm (0.02 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 0.1 ppm (0.2 mg/m3), STEL 0.3 ppm, JAN 1993; OEL-AUSTRIA: MAK 0.1 ppm (0.2 mg/m3), JAN 1999; OEL-BELGIUM: STEL 0.1 ppm (0.2 mg/m3), JAN 1993; OEL-DENMARK: TWA 0.1 ppm (0.2 mg/m3), JAN 1999; OEL-FINLAND: TWA 0.1 ppm (0.2 mg/m3), STEL 0.3 ppm (0.6 mg/m3), JAN 1999; OEL-FRANCE: VME 0.1 ppm (0.2 mg/m3), VLE 0.2 ppm (0.4 mg/m3), JAN 1999; OEL-GERMANY: MAK 0.1 ppm (0.2 mg/m3), JAN 1999; OEL-HUNGARY: TWA 0.2 mg/m3, STEL 0.4 mg/m3, JAN 1993; OEL-JAPAN: OEL 0.1 ppm (0.2 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-K 0.6 ppm (0.120 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.1 ppm (0.2 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 0.1 ppm (0.2 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 0.1 mg/m3, MAC(STEL) 0.6 mg/m3, JAN 1999; OEL-RUSSIA: TWA 0.1 ppm, STEL 0.1 mg/m3, JAN 1993; OEL-SWEDEN: NGV 0.1 ppm (0.2 mg/m3), TGV 0.3 ppm (0.6 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 0.1 ppm (0.2 mg/m3), KZG-W 0.2 ppm (0.4 mg/m3), JAN 1999; OEL-TURKEY: TWA 0.1 ppm (0.2 mg/m3), JAN 1993; OEL-UNITED KINGDOM: STEL 0.2 ppm (0.4 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO OZONE-air: CL 0.1 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 81651; NIS 54; TNF 6329; NOS 53; TNE 32552; NOES 1983: HZD 81651; NIS 70; TNF 5347; NOS 67; TNE 72134; TFE 32361 SL: EPA GENETOX PROGRAM 1988, Negative: In vivo cytogenetics-nonhuman bone marrow; EPA GENETOX PROGRAM 1988, Negative: In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Inconclusive: In vivo cytogenetics-nonhuman lymphocyte; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Inconclusive: In vivo cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Inconclusive: Cytogenetics-male germ cell; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (inhalation), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-440, 1994 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: mouse; NCI Carcinogenesis Studies (inhal), no evidence: rat; OSHA ANALYTICAL METHOD # ID214 Record 932 of 1119 in RTECS (through 2003/06) AN: RV0480000 PN: Paraffin-waxes-and-hydrocarbon-waxes,-chlorinated- (C12, 60% chlorine) SY: Chlorinated-paraffins- (C12, 60% Chlorine); Chlorinated-paraffins- (C12, 60% chlorine) RN: Current: 108171-26-2 Previous: 63449-39-8 UD: 200210 CC: Tumorigen (C) TE: V01-L60 orl-rat TDLo: 227 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-308, 1986 (NTPTR*); V01-J60 orl-mus TDLo: 182 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-308, 1986 (NTPTR*); V02-M61-N62 orl-rat TD :227 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-308, 1986 (NTPTR*); V02-K60 orl-rat TD :227 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-308, 1986 (NTPTR*); V02-L60-R60 orl-mus TD :917 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-308, 1986 (NTPTR*); V01-L60-P61 orl-rat TD :228 gm/kg/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); V02-L60 orl-mus TD :91250 mg/kg/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); V02-N62 orl-mus TD :183 gm/kg/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); V01-L60-P61 orl-rat TDLo: 160680 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-248101/AS (NTIS**); V03-N62 orl-rat TDLo: 160680 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-248101/AS (NTIS**); V01-L60 orl-mus TDLo: 64375 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-248101/AS (NTIS**); V03-N62 orl-mus TDLo: 64375 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-248101/AS (NTIS**) AT: T/E unlistd orl-rat LD :>13600 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); T/E unlistd orl-mus LD :>27200 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF) MD: K12-Z01 orl-rat TDLo: 120 gm/kg/16D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); L70-M03 orl-rat TDLo: 325 gm/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); K12-Z01 orl-mus TDLo: 30 gm/kg/16D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); L70 orl-mus TDLo: 32 gm/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 55, 1990 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 55, 1990 (IMEMDT) SL: NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 933 of 1119 in RTECS (through 2003/06) AN: RV0490000 PN: Paraffin-waxes-and-hydrocarbon-waxes,-chlorinated- (C23, 43% chlorine) SY: Chlorinated-paraffins- (C23, 43% Chlorine); Chlorinated-paraffins- (C23, 43% chlorine) RN: Current: 108171-27-3 Previous: 56509-64-9; 56730-95-1; 63449-39-8 UD: 200210 CC: Tumorigen (C) TE: V02-N61 orl-rat TDLo: 657 gm/kg/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); V01-P62 orl-mus TDLo: 2575 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-305, 1986 (NTPTR*); V01-P62 orl-mus TD :3750 gm/kg/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); V02-N61 orl-rat TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-248093/AS (NTIS**); V01-P62 orl-mus TDLo: 1287500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-248093/AS (NTIS**); V03-L60 orl-mus TDLo: 2575000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-248093/AS (NTIS**) AT: T/E unlistd orl-rat LD :>11700 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF); T/E unlistd orl-mus LD :>23400 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 454, 1987 (FAATDF) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 55, 1990 (IMEMDT) ND: NOES 1983: HZD X2994; NIS 4; TNF 245; NOS 7; TNE 2350 SL: NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NCI Carcinogenesis Studies (gavage), equivocal evidence: rat Record 934 of 1119 in RTECS (through 2003/06) AN: RZ2620000 PN: Pentaerythritol,-tetranitrate- SY: Angicap-; Angitet-; Antora-; Arcotrate-; Baritrate-; CHOT-; 1,3-Dinitrato-2,2-bis(nitratomethyl)propane; Mycardol-; Myotrate-10-; 2,2-Bis((nitrooxy)methyl)-1,3-propanediol dinitrate (ester); 2,2-Bis(hydroxymethyl)-1,3-propanediol tetranitrate; C-2- (explosive); Cardiacap-; C-Hot-; Deltrate-20-; Dilcoran-80-; Dipentrate-; Duotrate-; El-PETN-; Erinit-; Extex-; Hasethrol-; Kaytrate-; Lentrat-; Lowetrate-; LX-02-1-; LX-08-0-; LX-16- (explosive); Martrate-45-; Metranil-; Mikardol-; NCI-C55743-; Neo-corovas-; Neopentanetetrayl-nitrate-; Niperyt-; Niperyth-; Nitrinol-; Nitropenta-; Nitropentaerythrite-; Nitropentaerythritol-; Pencard-; Pentanitrine-; Pentarit-; Penthrit-; Penthrite-; Pentrate-; Pentriol-; Pentritol-; Pentryate-; Pentryate-80-; Prevangor-; 1,3-Propanediol, 2,2-bis((nitrooxy)methyl)-, dinitrate (ester); Quintrate-; Rythritol-; SDM No. 23; SDM No. 35; Tranite-D-lay-; Pentafin-; Pentestan-80-; Pentetrate-unicelles-; Pentitrate-; PETN-; Pergitral-; Peridex-LA-; Peritrate-; Perityl-; Subicard-; Tanipent-; Tentrate-20-; Tetranitropentaerythrite-; Tetrasule-; Vasitol-; Vasodiatol-; Vaso-80-unicelies- RN: Current: 78-11-5 Previous: 103842-90-6; 108736-71-6 BRN: 1716886 BHR: 4-01-00-02816 UD: 200305 MF: C5-H8-N4-O12 MW: 316.17 WL: WNO1X1ONW1ONW1ONW CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: sce-ham-ovr 160 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-365, 1989 (NTPTR*) TE: V03-D09-N62 orl-rat TDLo: 12875 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-365, 1989 (NTPTR*); V02-N60 orl-rat TDLo: 1092000 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219452/AS (NTIS**); V02-N60 orl-rat TDLo: 225680 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-219452/AS (NTIS**) ORNG: 1660000000 ng/kg. [1660.000000 mg/kg] T/E unlistd AT: R03 orl-man TDLo: 1669 mg/kg/8Y-C British Journal of Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.63- 1951- v. 87, p. 498, 1972 (BJDEAZ); T/E unlistd orl-rat LD50: 1660 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 9, p. 759, 1967 (YAKUD5); T/E unlistd ivn-rat LD50: 926 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 9, p. 759, 1967 (YAKUD5); T/E unlistd orl-mus LDLo: 7 gm/kg Farmatsevtichnii Zhurnal (Kiev). (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.3- 1930- v. 16(2), p. 63, 1961 (FRZKAP); H05 ipr-mus LD50: >5 gm/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 131, p. 187, 1961 (AIPTAK); H02 orl-rbt TDLo: 50 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 364, p. 269, 2001 (AEPPAE) MD: H30 orl-rbt TDLo: 126 mg/kg/21D-I Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 364, p. 269, 2001 (AEPPAE) ND: NOHS 1974: HZD 83538; NIS 1; TNF 68; NOS 6; TNE 2770; NOES 1983: HZD 83538; NIS 4; TNF 59; NOS 8; TNE 2650; TFE 1267 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis Studies (feed), equivocal evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-365, 1989 (NTPTR*); NTP Carcinogenesis Studies (feed), no evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-365, 1989 (NTPTR*) Record 935 of 1119 in RTECS (through 2003/06) AN: SA9275000 PN: 2-Pentanone,-4-methyl- SY: 2-Methyl-4-pentanone-; 4-Methyl-2-pentanon- (Czech); 4-Methyl-2-pentanone-; 4-Methyl-pentan-2-on- (Dutch, German); 4-Metilpentan-2-one- (Italian); Hexon- (Czech); Hexone-; Hexone- (OSHA); Isobutyl-methyl-ketone-; Isobutyl-methylketon- (Czech); Isopropylacetone-; Ketone,-isobutyl-methyl-; MIBK-; MIK-; Methyl-isobutyl-ketone-; Methyl-isobutyl-ketone- (ACGIH:OSHA); Methyl-isobutyl-cetone- (French); Methylisobutylketon- (Dutch, German); Metilisobutilchetone- (Italian); Metyloizobutyloketon- (Polish); RCRA-waste-number-U161-; Shell-MIBK- RN: Current: 108-10-1 BRN: 605399 BHR: 4-01-00-03305 UD: 200305 MF: C6-H12-O MW: 100.18 WL: 1Y1&1V1 CC: Tumorigen (C); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-hmn 200 ppm/15M Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28, p. 262, 1946 (JIHTAB); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,284,1986 (85JCAE); eye-rbt 40 mg SEV Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 4/25/1958 (UCDS**); eye-rbt 100 uL/24H MOD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535383 (NTIS**) RE: T34-T46 ihl-rat TCLo: 300 ppm/6H (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 310, 1987 (FAATDF); T34-T35 ihl-mus TCLo: 3000 ppm/6H (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 310, 1987 (FAATDF); T41-T46-T47 ihl-mus TCLo: 3000 ppm/6H (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 310, 1987 (FAATDF) ORNG: 2080000000 ng/kg. [2080.000000 mg/kg] T/E unlistd AT: D07 ihl-man TCLo: 2290 mg/m3 National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535383 (NTIS**); T/E unlistd orl-rat LD50: 2080 mg/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 4/25/1958 (UCDS**); T/E unlistd ihl-rat LC50: 100 gm/m3 National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535383 (NTIS**); T/E unlistd ipr-rat LD50: 400 mg/kg "Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley and Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979: pub. as 2nd rev. ed. in 1985. 2C,4748,1982 (38MKAJ); T/E unlistd orl-mus LD50: 1900 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535383 (NTIS**); T/E unlistd ihl-mus LC50: 23300 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(11), p. 52, 1973 (GTPZAB); T/E unlistd ipr-mus LD50: 268 mg/kg Shell Chemical Company. Unpublished Report. (2401 Crow Canyon Rd., San Romon, CA 94583) v. -, p. 7, 1961 (SCCUR*); T/E unlistd skn-rbt LD :>3 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535383 (NTIS**); T/E unlistd orl-gpg LD50: 1600 mg/kg "Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley and Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979: pub. as 2nd rev. ed. in 1985. 2C,4748,1982 (38MKAJ); D35-G08-J30 ihl-gpg LCLo: 68900 mg/m3/3H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535383 (NTIS**); T/E unlistd ipr-gpg LD50: 800 mg/kg "Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley and Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979: pub. as 2nd rev. ed. in 1985. 2C,4748,1982 (38MKAJ); T/E unlistd unr-mam LD50: 1396 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(5), p. 61, 1986 (GISAAA); D07-J21 ihl-hmn TCLo: 800 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 426, 1994 (VCVGK*); A30-F01 ihl-hmn TCLo: 4100 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 426, 1994 (VCVGK*); D07-D25-J21 ihl-hmn TCLo: 12 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 5, p. 8, 1994 (GISAAA) MD: F12-Z01 orl-rat TDLo: 9350 mg/kg/24D-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(11), p. 52, 1973 (GTPZAB); L70-M70 ihl-rat TCLo: 1996 ppm/6H/11D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 380, 1987 (FAATDF); L70-P28-M16 ihl-rat TCLo: 1002 ppm/6H/14W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 380, 1987 (FAATDF); A11-U28-Y12 skn-rat TDLo: 35700 mg/kg/17W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 53(10), p. 79, 1988 (GISAAA); L70-M30-M70 ihl-rat TCLo: 410 mg/m3/2W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535383 (NTIS**); L70-M30-M70 ihl-rat TCLo: 410 mg/m3/90D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535383 (NTIS**); N72 ihl-rat TCLo: 4210 mg/m3/6H/4W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572858 (NTIS**); L70-M70 ihl-mus TCLo: 1996 ppm/6H/11D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 380, 1987 (FAATDF); L70 ihl-mus TCLo: 1002 ppm/6H/14W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 380, 1987 (FAATDF) TR: ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 75 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 100 ppm (410 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 126, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm (410 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (410 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (410 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (410 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 100 ppm (400 mg/m3), JAN 1999; OEL-DENMARK: TWA 25 ppm (100 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 50 ppm (205 mg/m3), JAN 1999; OEL-JAPAN: OEL 50 ppm (105 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 25 ppm (104 mg/m3), MAC-K 50 ppm (208 mg/m3), JAN 1999; OEL-NORWAY: TWA 25 ppm (105 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 200 mg/m3, MAC(STEL) 300 mg/m3, JAN 1999; OEL-SWEDEN: NGV 25 ppm (100 mg/m3), KTV 50 ppm (200 mg/m3), JAN 1999 ND: NIOSH REL TO METHYL ISOBUTYL KETONE-air: 10H TWA 50 ppm, STEL 75 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 37510; NIS 258; TNF 42735; NOS 149; TNE 435266; NOES 1983: HZD 37510; NIS 253; TNF 47027; NOS 150; TNE 612921; TFE 110397 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0293-8704; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Ketones I, 1300; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NTP Carcinogenesis studies, on test (two year studies), October 2000; OSHA ANALYTICAL METHOD #1004 Record 936 of 1119 in RTECS (through 2003/06) AN: SD9450000 PN: Peroxybenzoic-acid,-tert-butyl-ester- SY: Novox-; terc.Butylester kyseliny peroxybenzoove (Czech); terc.Butylperbenzoan (Czech); t-Butyl-perbenzoate-; t-Butyl-peroxy-benzoate-; Esperox-10-; Perbenzoate-de-butyle-tertiaire- (French); Trigonox-C- RN: Current: 614-45-9 BRN: 1342734 BHR: 4-09-00-00715 UD: 200210 MF: C11-H14-O3 MW: 194.25 WL: 1X1&1&OOVR CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,381,1986 (85JCAE); eye-rbt 100 mg/1M rinse MLD Zentralblatt fuer Arbeitsmedizin und Arbeitsschutz. (Darmstadt, Fed. Rep. Ger.) V.1-25, 1951-75. v. 8, p. 25, 1958 (ZAARAM); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,381,1986 (85JCAE); skn-rbt 0.1 mL/4H MLD "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 545, 1994 (VCVGK*); skn-rbt 0.1 mL/5D-I MOD "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 545, 1994 (VCVGK*); eye-rbt 0.05 mL "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 545, 1994 (VCVGK*) ME: mmo-sat 67 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM) TE: V03-P62 unr-mus TDLo: 311 mg/kg Radiation Research, Supplement. (New York, NY) No.1-7, 1959-67. Discontinued. v. 3, p. 193, 1963 (RARSAM) ORNG: 1012000000 ng/kg. [1012.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1012 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,30,1982 (85GMAT); T/E unlistd ihl-rat LC :>57 mg/m3/4H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 10, p. 55, 1968 (TPKVAL); F18-J22-K20 orl-mus LD50: 914 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 10, p. 55, 1968 (TPKVAL); T/E unlistd ihl-mus LC :>57 mg/m3/4H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 10, p. 55, 1968 (TPKVAL) MD: K30-N73-Z73 orl-rat TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3134 (NTPTR*); M11-M16 ihl-rat TCLo: 6 mg/m3/4H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 10, p. 55, 1968 (TPKVAL); K30-N73 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-92-3134 (NTPTR*) SR: OEL-RUSSIA: STEL 1 mg/m3, JAN 1993 ND: NOHS 1974: HZD 82135; NIS 6; TNF 140; NOS 16; TNE 8562; NOES 1983: HZD 82135; NIS 25; TNF 1326; NOS 26; TNE 27644; TFE 10655 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-15, October 2000 Record 937 of 1119 in RTECS (through 2003/06) AN: SF7950000 PN: Phenanthridinium,-3,8-diamino-5-ethyl-6-phenyl-,-bromide- SY: Ethidium-bromide-; 2,7-Diamino-10-ethyl-9-phenylphenanthridinium-bromide-; 3,8-Diamino-5-ethyl-6-phenylphenanthridinium-bromide-; 2,7-Diamino-9-phenyl-10-ethylphenanthridinium-bromide-; 2,7-Diamino-9-phenylphenanthridine-ethobromide-; Dromilac-; Homidium-bromide-; RD-1572- RN: Current: 1239-45-8 UD: 200302 MF: C21-H20-N3.Br MW: 394.35 WL: T B666 HKJ EJ H2 IR& LZ &E &9/26 CC: Tumorigen (C); Drug (D); Mutagen (M) ME: mmo-sat 200 ng/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 127, p. 31, 1984 (MUREAV); mmo-sat 100 ng/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 439, p. 37, 1999 (MUREAV); oms-sat 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); dnr-sat 1 pph Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 4, p. 286, 1974 (AGACBH); mmo-esc 10 mg/L (-S9) Comptes Rendus des Seances de l'Academie des Sciences, Serie D: Sciences Naturelles. (Paris, France) V.262-291, 1966-80. For publisher information, see CRASEV. v. 269, p. 1708, 1969 (CHDDAT); dnr-esc 250 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 41, p. 61, 1976 (MUREAV); dna-esc 15 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); oms-esc 500 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 20, p. 2921, 1971 (BCPCA6); pic-esc 10 ug/plate Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2819, 1983 (CNREA8); dnr-bcs 6 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); mmo-omi 50 ug/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 113, 1980 (MUREAV); mmo-omi 10 gm/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 126, p. 959, 1976 (JOBAAY); mmo-omi 5 umol/L (-S9) Journal of Dental Research. (International Assoc. for Dental Research, 734 15th St., NW, Suite 809, Washington, DC 20005) V.1- 1919- v. 55, p. 266, 1976 (JDREAF); mmo-omi 25 mg/L (-S9) Current Microbiology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1978- v. 8, p. 201, 1983 (CUMIDD); dnd-omi 100 ug/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 55, p. 248, 1969 (ECREAL); dnd-omi 2 mg/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 55, p. 248, 1969 (ECREAL); dnd-omi 600 mg/L Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 33, p. 141, 1968 (JMOBAK); dnd-omi 300 mg/L Journal of Molecular Biology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 77, p. 479, 1973 (JMOBAK); dnd-nml 1 mol Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 561, p. 77, 1979 (BBACAQ); dni-omi 2 mg/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 150, p. 301, 1977 (MGGEAE); dni-omi 100 ug/L Nature (London), New Biology. (Basingstoke, Hants., UK) V.229-246, 1971-73. For publisher information, see NATUAS. v. 232, p. 143, 1971 (NNBYA7); oms-omi 50 mg/L Indian Journal of Biochemistry and Biophysics. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.8- 1971- v. 19, p. 285, 1982 (IJBBBQ); dni-omi 2500 ug/L Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 26, p. 75, 1979 (CYTBAI); sln-dmg-orl 3 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 203, 1982 (MUREAV); slt-dmg-orl 3 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 138, p. 169, 1984 (MUREAV); dlt-dmg-orl 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 203, 1982 (MUREAV); mmo-smc 5 umol/L (-S9) Chemical and Pharmaceutical Bulletin. (Japan Pub. Trading Co., USA, 1255 Howard St., San Francisco, CA 94103) V.6- 1958- v. 34, p. 1735, 1986 (CPBTAL); mrc-smc 1 pph Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 4, p. 286, 1974 (AGACBH); dna-smc 50 umol/L Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905- v. 249, p. 6617, 1974 (JBCHA3); mmo-ssp 2 mg/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 144, p. 75, 1976 (MGGEAE); dni-eug 1 mg/L Journal of Cell Science. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1966- v. 13, p. 567, 1973 (JNCSAI); mnt-nml-mul 63400 nmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 17, 1989 (MUTAEX); dni-nml-oth 50 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 222, p. 193, 1969 (NATUAS); cyt-nml-oth 10 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 222, p. 193, 1969 (NATUAS); cyt-nml-oth 10 mmol/L Archives d'Anatomie Microscopique et de Morphologie Experimentale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.36-76, 1947-1987. For publisher information, see BSTME2. v. 62, p. 365, 1973 (AAMMAU); cyt-nml-oth 10 mmol/L Archives d'Anatomie Microscopique et de Morphologie Experimentale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.36-76, 1947-1987. For publisher information, see BSTME2. v. 62, p. 365, 1973 (AAMMAU); dna-hmn-fbr 2 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 11, p. 101, 1975 (CBINA8); dnd-hmn-leu 5 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 263, p. 679, 1976 (NATUAS); dni-hmn-hla 40 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); dnd-rat-oth 40 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 77, p. 25, 1991 (CBINA8); dna-rat-lvr 200 umol/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 100, p. 223, 1976 (ECREAL); dns-rat-lvr 2500 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 393, 1989 (CRNGDP); dni-rat-lvr 500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 145, 1983 (MUREAV); sce-rat-lvr 10 mg/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 2, p. 379, 1986 (CBTOE2); dnd-mus-ast 117 umol/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 374, p. 96, 1974 (BBACAQ); dnd-mus-mmr 100 nmol/L Journal of Biochemistry (Tokyo). (Japanese Biochemical Soc., c/o Japan Academic Soc. Center, 2-4-16 Yayoi, Bunkyo-ku, Tokyo 113, Japan) V.1- 1922- v. 84, p. 145, 1978 (JOBIAO); dni-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); dni-mus-oth 500 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 40, p. 869, 1984 (EXPEAM); dni-mus-leu 500 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 20, p. 2921, 1971 (BCPCA6); oms-mus-leu 500 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 20, p. 2921, 1971 (BCPCA6); dni-mus-lym 100 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 21, p. 1977, 1972 (BCPCA6); oms-mus-lym 100 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 21, p. 1977, 1972 (BCPCA6); cyt-mus-fbr 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 33, p. 417, 1975 (MUREAV); cyt-mus-leu 5 mg/L Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1968- v. 27, p. 79, 1978 (VAAZA2); cyt-mus-oth 10 mg/L Chromosoma. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1939- v. 47, p. 157, 1974 (CHROAU); sce-mus-ivn 80 mg/kg Japanese Journal of Medical Science and Biology. (National Institute of Health, 2-chome, Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.5- 1952- v. 38, p. 207, 1985 (JJMCAQ); dnd-ham-fbr 10 mg/L/30M-C Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 99, p. 7, 1976 (ECREAL); cyt-ham-ovr 10 mg/L Chromosoma. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1939- v. 47, p. 157, 1974 (CHROAU); cyt-ham-fbr 10 mg/L Chromosoma. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1939- v. 47, p. 157, 1974 (CHROAU); cyt-ham-lng 41 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); sce-ham-lng 10 mg/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 2, p. 379, 1986 (CBTOE2); msc-ham-lng 75 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 2303, 1994 (CRNGDP); msc-ham-ovr 45 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 94, p. 449, 1982 (MUREAV); dna-bwd-leu 37500 nmol/L Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 46, p. 1399, 1972 (BBRCA9); dnd-brd-leu 1 mmol/L Nature (London), New Biology. (Basingstoke, Hants., UK) V.229-246, 1971-73. For publisher information, see NATUAS. v. 243, p. 20, 1973 (NNBYA7); dnd-brd-lvr 1 mmol/L Nature (London), New Biology. (Basingstoke, Hants., UK) V.229-246, 1971-73. For publisher information, see NATUAS. v. 243, p. 20, 1973 (NNBYA7); dnd-brd-oth 1 mmol/L Nature (London), New Biology. (Basingstoke, Hants., UK) V.229-246, 1971-73. For publisher information, see NATUAS. v. 243, p. 20, 1973 (NNBYA7); sce-ckn-par 847 ug/kg "Cytogenetic Assays of Environmental Mutagens," Hsu, T.C., ed., Totowa, NJ, Allanheld, Osmun and Co., 1982 -,137,1982 (47JMAE); dnd-ham-lng 15.7 umol/L/3H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 503, p. 21, 2002 (MUREAV) AT: V30 ipr-mus LDLo: 20 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 2699, 1974 (CNREA8); T/E unlistd scu-mus LD50: 110 mg/kg Annals of Tropical Medicine and Parasitology. (Grune and Stratton, Inc., POB 6280, Duluth, MN 55806) V.1- 1907- v. 46, p. 285, 1952 (ATMPA2) ND: NOHS 1974: HZD A1168; NIS 1; TNF 17; NOS 1; TNE 34; NOES 1983: HZD A1168; NIS 1; TNF 7; NOS 3; TNE 21 SL: EPA GENETOX PROGRAM 1988, Positive: In vitro mammalian nonhuman micronucleus; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Inconclusive: Cytogenetics-male germ cell; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; NTP Carcinogenesis studies, selected, October 2000 Record 938 of 1119 in RTECS (through 2003/06) AN: SI1750000 PN: Phenethylamine, alpha-methyl-, sulfate (2:1), (+-)- SY: (+-)-2-Amino-1-phenylpropane sulfate; (+-)-Amphetamine sulfate; (+-)-Phenisopropylamine sulfate; Acetdron-; Adiparthrol-; Alentol-; Amphetamine-sulfate-; Amphetamine-sulphate-; Amphoids-S-; Astedin-; Benzafinyl-; Benzamphetamine-; Benzedryna-; Benzies-; Benzpropamine-; Betafen-; Betaphen-; Bluzedrin-; Cartwheels-; Centramina-; DL-1-Phenyl-2-aminopropane-sulfate-; Dietamine-; Durophet-; Euphodyn-; Fabedrine-; Fenara-; Fenedrin-; Halloo-wach-; Ibiozedrine-; Leodrin-; Levonor-; Mimetina-; Monetamine-; NCI-C55710-; Noclon-; Ortenal-; Peaches-; Phenamine-; Phenamine- (sympathomimetic); Phenisopropylamine-sulfate-; Phenopromin-; Phenpromin-; Propenyl-; Psychedrinum-; Psychedryna-; Psychoton-; Sedolin-; Simpamina-; Synsatedrine-; Theptine-; Vapedrine-; Zedrine-; alpha-Methylphenethylamine sulfate, (+-)-; beta-Phenyl-isopropylamine-sulfate-; dl-Amphetamine-sulfate- RN: Current: 60-13-9 Previous: 156-31-0 UD: 200305 MF: C18-H26-N2.H2-O4-S MW: 368.54 WL: ZY1R & 2WSQQ -R CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: sln-dmg-unr 1500 gm/L Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 5, p. 395, 1972 (CTOXAO); dnd-rat-lvr 4 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 181, 1994 (EMMUEG) RE: T83 scu-rat TDLo: 4 mg/kg (12-15D preg) Brain Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1966- v. 21, p. 460, 1970 (BRREAP); T85 scu-rat TDLo: 11 mg/kg (1-22D preg) Psychopharmacology (Berlin). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.47- 1976- v. 58, p. 171, 1978 (PSCHDL); T35 orl-mus TDLo: 900 mg/kg (1-18D preg) Okajimas Folia Anatomica Japonica. (Keio Univ., School of Medicine, Dept. of Anatomy, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.14- 1936- v. 41, p. 227, 1965 (OFAJAE); T35 orl-mus TDLo: 900 mg/kg (1-18D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 7, p. 66, 1967 (SEIJBO) ORNG: 55000000 ng/kg. [55.000000 mg/kg] D16-F12-K01 AT: F05-F14-G10 orl-hmn TDLo: 41 mg/kg Klinische Wochenscrift. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1922- v. 17, p. 1580, 1938 (KLWOAZ); D16-F12-K01 orl-rat LD50: 55 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 13, p. 711, 1963 (ARZNAD); F12 ipr-rat LD50: 125 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 132, p. 97, 1961 (JPETAB); F13-L30 scu-rat LD50: 160 mg/kg Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 10, p. 1874, 1937 (AIMEAS); D16-F12-K01 orl-mus LD50: 24 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 13, p. 711, 1963 (ARZNAD); T/E unlistd scu-mus LD50: 7 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 170, p. 428, 1967 (AIPTAK); F13-F17 ivn-mus LD50: 31800 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 2, p. 558, 1960 (TXAPA9); T/E unlistd orl-dog LD50: 23 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 118, p. 557, 1965 (PSEBAA); T/E unlistd ivn-dog LD50: 6 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 118, p. 557, 1965 (PSEBAA); D16-F12-J26 scu-mky LDLo: 5 mg/kg American Journal of the Medical Sciences. (Slack Inc., 6900 Grove Rd., Thorofare, NJ 08086) New series: V.1- 1841- v. 198, p. 785, 1939 (AJMSA9); F12 ivn-rbt LDLo: 22 mg/kg Journal de Physiologie et de Pathologie Generale. (Paris, France) V.1-38, 1899-1945. For publisher information, see JOPHAN. v. 37, p. 597, 1939 (JPPGAR); T/E unlistd ipr-gpg LDLo: 50 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 100, p. 267, 1950 (JPETAB); T/E unlistd scu-gpg LD50: 105 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 137, p. 375, 1962 (AIPTAK); F17 ipr-ckn LD50: 125 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 2, p. 558, 1960 (TXAPA9); F17 ivn-ckn LD50: 70 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 2, p. 558, 1960 (TXAPA9); F07 par-frg LD50: 280 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 76, p. 375, 1942 (JPETAB); D16-F05-J26 scu-dom LDLo: 15 mg/kg American Journal of the Medical Sciences. (Slack Inc., 6900 Grove Rd., Thorofare, NJ 08086) New series: V.1- 1841- v. 198, p. 785, 1939 (AJMSA9); F05 ipr-mus TDLo: 5 mg/kg Farmakologiya i Toksikologiya (Kiev). Pharmacology and Toxicology. (Kievskii Nauchno- Issledovatel'skii Institut Farmakologii i Toksikologii, Kiev, USSR) No.1- 1964- v. 159, p. 35, 1986 (FATOBP); F41 unr-rat TDLo: 10 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 55, 1984 (FATOAO); F15 ipr-mus TDLo: 18 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 44, 1986 (FATOAO); F15 ipr-rat TDLo: 1.25 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 44, 1986 (FATOAO); T/E unlistd ipr-mus LD50: 13 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 15, 1985 (FATOAO) MD: F13-U01 orl-rat TDLo: 214 mg/kg/13W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 56, p. 123, 1989 (TXCYAC); N22-P28-Y15 ipr-rat TDLo: 280 mg/kg/4W-I General Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.6- 1975- v. 29, p. 687, 1997 (GEPHDP); F41 imp-rat TDLo: 2520 ug/kg/3W-I Rossiiski Fiziologicheskii Zhurnal imeni I.M. Sechenova. (Mezhdunarodnaya Kniga, Bd'shaya Yakimanka, 39 117049 Moscow, Russia) V.83- 1997- v. 83(8), p. 33, 1997 (RFZSFY); L70 orl-mus TDLo: 210 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-387, 1991 (NTPTR*); Z01 orl-mus TDLo: 5460 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-387, 1991 (NTPTR*); N61-V30 orl-rat TDLo: 865.2 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-107978 (NTIS**); R60-V30 orl-rat TDLo: 721 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-107978 (NTIS**); L60-V30 orl-mus TDLo: 8652 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-107978 (NTIS**); A60-L60-V30 orl-mus TDLo: 8652 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-107978 (NTIS**) TR: TOXICOLOGY REVIEW "International Symposium on Amphetamines and Related Compounds, Proceedings, Mario Negri Institute for Pharmacological Research, Milan, 1969," Costa, E., and S. Garattini, eds., New York, Raven Press, 1970 -,343,1970 (17XKAB) ND: NOES 1983: HZD X7049; NIS 1; TNF 25; NOS 1; TNE 2440; TFE 1459 SL: EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-nondisjunction; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 939 of 1119 in RTECS (through 2003/06) AN: SJ4375000 PN: Phenol,-4-allyl-2-methoxy- SY: 4-Allylcatechol-2-methyl-ether-; p-Allylguaiacol-; 4-Allylguaiacol-; 4-Allyl-1-hydroxy-2-methoxybenzene-; 4-Allyl-2-methoxyphenol-; Eugenic-acid-; Eugenol-; p-Eugenol-; 1,3,4-Eugenol-; FA-100-; FEMA No. 2467; Caryophyllic-acid-; 1-Hydroxy-2-methoxy-4-allylbenzene-; 4-Hydroxy-3-methoxyallylbenzene-; 1-Hydroxy-2-methoxy-4-prop-2-enylbenzene-; 2-Methoxy-4-allylphenol-; 2-Methoxy-1-hydroxy-4-allylbenzene-; 2-Methoxy-4-prop-2-enylphenol-; 2-Methoxy-4-(2-propenyl)phenol; 2-Metoksy-4-allilofenol- (Polish); NCI-C50453-; Phenol, 2-methoxy-4-(2-propenyl)-; Synthetic-eugenol- RN: Current: 97-53-0 BRN: 1366759 BHR: 4-06-00-06337 UD: 200302 MF: C10-H12-O2 MW: 164.22 WL: 1U2R DQ CO1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Natural-Product (N); Primary-Irritant (S) ID: skn-hmn 40 mg/48H MLD Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 545, 1975 (FCTXAV); skn-man 16 mg/48H MOD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-rbt 100 mg/24H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-pig 50 mg/48H MLD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-gpg 100 mg/24H MOD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG) ME: mmo-sat 50 ug/plate (-S9) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A116-715 (NTIS**); mrc-smc 2270 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 427, 1989 (MUREAV); dnd-rat-lvr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); mnt-mus-ipr 296 mg/kg/24H Journal of Oral Pathology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.1- 1972- v. 15, p. 450, 1986 (JOPHBO); mnt-mus-orl 29589 mg/kg/24H Journal of Oral Pathology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.1- 1972- v. 15, p. 450, 1986 (JOPHBO); msc-mus-lym 21300 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); mtr-ham-emb 3 ppm Shigaku. Ondotology. (Nippon Shika Daigaku Shigakkai, 1-9-20 Fujimi, Chiyodaku, Tokyo 102, Japan) V.38- 1949- v. 74, p. 1365, 1987 (SHIGAZ); dns-ham-emb 1 ppm Shigaku. Ondotology. (Nippon Shika Daigaku Shigakkai, 1-9-20 Fujimi, Chiyodaku, Tokyo 102, Japan) V.38- 1949- v. 74, p. 1365, 1987 (SHIGAZ); oms-ham-ovr 400 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 14, p. 251, 1981 (CALEDQ); cyt-ham-fbr 125 mg/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 623, 1984 (FCTOD7); cyt-ham-ovr 300 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 75 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-emb 300 ppb Shigaku. Ondotology. (Nippon Shika Daigaku Shigakkai, 1-9-20 Fujimi, Chiyodaku, Tokyo 102, Japan) V.38- 1949- v. 74, p. 1365, 1987 (SHIGAZ) TE: V03-L60 orl-mus TDLo: 37080 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-223, 1983 (NTPTR*); V01-L60 orl-mus TDLo: 259560 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-186402 (NTIS**); V02-L60 orl-mus TDLo: 519120 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-186402 (NTIS**) ORNG: 1930000000 ng/kg. [1930.000000 mg/kg] F05-F24-J22 AT: F05-F24-J22 orl-rat LD50: 1930 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 73, p. 148, 1950 (PSEBAA); F07 ihl-rat LC :>2580 mg/m3/4H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 62, p. 381, 1988 (ARTODN); F12-F18-M30 ipr-rat LDLo: 800 mg/kg Revue Medicale de la Suisse Romande. (Societe Medicale de La Suisse Romande, 2 rue Bellefontaine, 1003 Lausanne, Switzerland) V.1- 1881- v. 16, p. 449, 1896 (RMSRA6); F12-F18-M30 scu-rat LDLo: 5 gm/kg Revue Medicale de la Suisse Romande. (Societe Medicale de La Suisse Romande, 2 rue Bellefontaine, 1003 Lausanne, Switzerland) V.1- 1881- v. 16, p. 449, 1896 (RMSRA6); J02-J15-J16 itr-rat LD50: 11 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 59, p. 78, 1986 (ARTODN); F07 orl-mus LD50: 3 gm/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV); T/E unlistd ipr-mus LD50: 500 mg/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 250, p. 1148, 1960 (COREAF); F12-J22-J26 ivn-mus LD50: 72 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 164, p. 30, 1966 (AIPTAK); F19-K13 orl-dog LDLo: 500 mg/kg Gastroenterology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1943- v. 15, p. 481, 1950 (GASTAB); F07 orl-gpg LD50: 2130 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV); J02-J15-J16 itr-ham LD50: 17 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 59, p. 78, 1986 (ARTODN) MD: L30-Z01 orl-rat TDLo: 68 gm/kg/34D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 7, p. 18, 1965 (TXAPA9); Z01 orl-rat TDLo: 70 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-223, 1983 (NTPTR*); L02-U01 orl-rat TDLo: 3580 mg/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 6, p. 378, 1964 (TXAPA9); Z01 orl-mus TDLo: 84 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-223, 1983 (NTPTR*); Q15-Q30 orl-rat TDLo: 858 mg/kg/26D-I Toxicology and Clinical Pharmacology of Herbal Products Melanie Johns Cupp ed., Humana press, 2000. v. -, p. 126, 2000 (TCPHP*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 75, 1985 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 545, 1975 (FCTXAV) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 82100; NIS 17; TNF 1034; NOS 31; TNE 37569; NOES 1983: HZD 82100; NIS 82; TNF 9995; NOS 91; TNE 187937; TFE 83766 SL: EPA GENETOX PROGRAM 1988, Inconclusive: Host-mediated assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), equivocal evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat Record 940 of 1119 in RTECS (through 2003/06) AN: SJ6300000 PN: Phenol,-2-amino-4-nitro- SY: 1-Amino-2-hydroxy-5-nitrobenzene-; 3-Amino-4-hydroxynitrobenzene-; 2-Amino-4-nitrofenol- (Czech); 2-Amino-4-nitrophenol-; 1-Hydroxy-2-amino-4-nitrobenzene-; 2-Hydroxy-5-nitroaniline-; NCI-C55958-; p-Nitroaminofenol- (Polish); 4-Nitro-2-aminofenol- (Czech); p-Nitro-o-aminophenol-; 4-Nitro-2-aminophenol-; Rodol-42- RN: Current: 99-57-0 BRN: 776533 BHR: 4-13-00-00896 UD: 200210 MF: C6-H6-N2-O3 MW: 154.14 WL: ZR BQ ENW CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,674,1986 (85JCAE) ME: mmo-sat 20 ug/plate (+S9) Chemical Mutagens. Principles and Methods for Their Detection. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1971- v. 8, p. 151, 1983 (CMMUAO); mmo-sat 100 ug/plate (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 2423, 1975 (PNASA6); pic-esc 100 mmol/L Medycyna Doswiadczalna i Mikrobiologia. For English translation, see EXMMAV. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1949- v. 31, p. 11, 1979 (MDMIAZ); cyt-ham-ovr 249 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-339, 1988 (NTPTR*); sce-ham-ovr 5 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-339, 1988 (NTPTR*); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V02-N60 orl-rat TDLo: 64375 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-339, 1988 (NTPTR*); V02-M61 orl-rat TDLo: 128750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-128623/AS (NTIS**) ORNG: 2400000000 ng/kg. [2400.000000 mg/kg] F07-F19-R21 AT: F07-F19-R21 orl-rat LD50: 2400 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 15, p. 607, 1977 (FCTXAV); T/E unlistd ipr-rat LD50: 246 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 657, 1977 (JTEHD6); T/E unlistd orl-mus LD50: 850 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(8), p. 50, 1981 (GTPZAB); T/E unlistd ipr-mus LD50: 143 mg/kg Genetica Polonica. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1960- v. 26, p. 109, 1985 (GPOLA4) MD: Z01 orl-rat TDLo: 13750 mg/kg/15D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-339, 1988 (NTPTR*); L70-M03-Z01 orl-rat TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-339, 1988 (NTPTR*); Z01 orl-mus TDLo: 13750 mg/kg/15D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-339, 1988 (NTPTR*); L70-Z01 orl-mus TDLo: 65 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-339, 1988 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 167, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 167, 1993 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 167, 1993 (IMEMDT) ND: NOES 1983: HZD E0280; NIS 1; TNF 2232; NOS 1; TNE 20256; TFE 17049 SL: EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-339, 1988 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 941 of 1119 in RTECS (through 2003/06) AN: SJ6302500 PN: Phenol,-2-amino-5-nitro- SY: 2-Amino-5-nitrophenol-; C.I. 76535; 3-Hydroxy-4-aminonitrobenzene-; 2-Hydroxy-4-nitroaniline-; NCI-C55970-; 3-Nitro-6-aminophenol-; 5-Nitro-2-aminophenol-; Rodol-YBA-; Ursol-Yellow-Brown-A- RN: Current: 121-88-0 BRN: 972974 BHR: 4-13-00-00903 UD: 200210 MF: C6-H6-N2-O3 MW: 154.14 WL: ZR BQ DNW CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 20 ug/plate (+S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 2423, 1975 (PNASA6); mmo-sat 100 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9(Suppl 9), p. 1, 1987 (ENMUDM); msc-mus-lym 25 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*); cyt-ham-ovr 905 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*); cyt-ham-lng 1 mg/L Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 41, 1980 (ATSUDG); sce-ham-ovr 1240 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*) TE: V03-K60 orl-rat TDLo: 51500 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*); V02-K60 orl-rat TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-184809/AS (NTIS**); V03-T69 orl-rat TDLo: 103000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-184809/AS (NTIS**) AT: T/E unlistd orl-rat LD50: >4 gm/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 657, 1977 (JTEHD6); T/E unlistd ipr-rat LD50: >800 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 657, 1977 (JTEHD6) MD: Z01 orl-rat TDLo: 3756 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*); K09-L70-Z01 orl-rat TDLo: 52 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*); Z01 orl-mus TDLo: 7500 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*); L70-Z01 orl-mus TDLo: 104 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 177, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 177, 1993 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 177, 1993 (IMEMDT) ND: NOES 1983: HZD X1660; NIS 1; TNF 1339; NOS 1; TNE 14512; TFE 11827 SL: EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal, N crassa-aneuploidy; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-334, 1988 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 942 of 1119 in RTECS (through 2003/06) AN: SK7600000 PN: Phenol,-2,4-diamino-,-dihydrochloride- SY: 2,4-Diaminophenol-dihydrochloride-; 2,4-Diaminophenol-hydrochloride-; Acrol-; Amidol-; Dianol-; NCI-C60026- RN: Current: 137-09-7 UD: 200302 MF: C6-H8-N2-O.2 Cl-H MW: 197.08 WL: ZR CZ DQ &GH 2 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 330 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); msc-mus-lym 2 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 143, 1987 (ENMUDM) TE: V03-M61 orl-mus TDLo: 19570 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-117919 (NTIS**) ORNG: 240000000 ng/kg. [240.000000 mg/kg] D28-F19-K12 AT: D28-F19-K12 orl-rat LD50: 240 mg/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 13, p. 330, 1994 (JACTDZ); T/E unlistd ipr-mus LDLo: 50 mg/kg Revue Belge de Pathologie et de Medecine Experimentale. (Brussels, Belgium) V.18-31, 1947-65. For publisher information, see PTEUA6. v. 22, p. 1, 1952 (RBPMAZ) MD: M70-U01-Z01 orl-rat TDLo: 6500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-401, 1992 (NTPTR*); P71-Y15-Z01 orl-rat TDLo: 800 mg/kg/4D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555385 (NTIS**); L70-Z01 orl-mus TDLo: 800 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-401, 1992 (NTPTR*); L70-M70-Z01 orl-mus TDLo: 325 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-401, 1992 (NTPTR*) ND: NOES 1983: HZD X2516; NIS 1; TNF 809; NOS 1; TNE 6638; TFE 4211 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, PROPOSED RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 27009, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-401, 1992 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse; NCI Carcinogenesis Studies (gavage), no evidence: rat Record 943 of 1119 in RTECS (through 2003/06) AN: SK8575000 PN: Phenol,-2,4-dichloro- SY: 2,4-DCP-; 2,4-Dichlorohydroxybenzene-; 2,4-Dichlorophenol-; NCI-C55345-; RCRA-waste-number-U081- RN: Current: 120-83-2 BRN: 742467 BHR: 4-06-00-00885 UD: 200305 MF: C6-H4-Cl2-O MW: 163.00 WL: QR BG DG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534822 (NTIS**) ME: mmo-sat 333 ug/plate (-S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-353, 1989 (NTPTR*); dnd-rat-lvr 200 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 181, 1994 (EMMUEG); msc-mus-lym 30 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-353, 1989 (NTPTR*); dni-ham-ovr 1200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 400, p. 169, 1998 (MUREAV); cyt-ham-ovr 1400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 400, p. 169, 1998 (MUREAV); sce-ham-ovr 3100 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-353, 1989 (NTPTR*); sln-ham-lng 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 135, 1987 (MUREAV); cyt-mus-ipr 180 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 1, 2001 (MUREAV); spm-mus-ipr 180 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 1, 2001 (MUREAV); mtr-mus-fbr 20 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T59 orl-rat TDLo: 20 mg/kg (1-20D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(11), p. 102, 1976 (GISAAA); T34 orl-rat TDLo: 7500 mg/kg (6-15D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 167, 1984 (TOXID9); T46 orl-rat TDLo: 7500 mg/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 635, 1989 (FAATDF); T34-T46 scu-mus TDLo: 666 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**); T34-T59 orl-rat TDLo: 22 mg/kg (1-22D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 247, 1994 (VCVGK*); T46 orl-rat TDLo: 1650 mg/kg (1-22D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 247, 1994 (VCVGK*); T34-T39 orl-rat TDLo: 22 mg/kg (1-22D preg) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 40, p. 102, 1975 (GISAAA); T86-T87 orl-rat TDLo: 3 mg/kg (multigenerations) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 14, p. 723, 1984 (JTEHD6); T34-T35-T39 orl-rat TDLo: 7500 mg/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 635, 1989 (FAATDF) TE: V01-R60 skn-mus TDLo: 16 gm/kg/39W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 19, p. 413, 1959 (CNREA8) ORNG: 47000000 ng/kg. [47.000000 mg/kg] F15-J22-K30 AT: F15-J22-K30 orl-rat LD50: 47 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534822 (NTIS**); F11-F12-U25 ipr-rat LD50: 430 mg/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 13, p. 20, 1958 (BJPCAL); F05-F19-J22 orl-mus LD50: 1276 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 478, 1985 (FAATDF); T/E unlistd ipr-mus LD50: 153 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 18, p. 868, 1975 (JMCMAR); F15-J27-L30 skn-rbt LDLo: 3160 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534822 (NTIS**); T/E unlistd orl-gpg LDLo: 2 gm/kg Antibiotics Annual. (New York, NY) 1953-60. For publisher information, see AMACCQ. v. 7, p. 321, 1959/1960 (ABANAE); T/E unlistd orl-mam LD50: 464 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 16, 1980 (GISAAA); T/E unlistd skn-mam LD50: 790 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 16, 1980 (GISAAA); F11-F12 orl-mus LD50: 1276 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 29, p. 39, 1985 (TOLED5); T/E unlistd orl-rat LD50: 580 mg/kg Beratergremium fuer umweltrelevante Altstoffe (BUA. Gesellschaft Deutscher Chemiker. Weinheim : New York : VCH) 1992- v. 31, p. 1, 1989 (BFUUA*); T/E unlistd scu-rat LD50: 580 mg/kg Beratergremium fuer umweltrelevante Altstoffe (BUA. Gesellschaft Deutscher Chemiker. Weinheim : New York : VCH) 1992- v. 31, p. 1, 1989 (BFUUA*); T/E unlistd orl-mus LD50: 580 mg/kg Beratergremium fuer umweltrelevante Altstoffe (BUA. Gesellschaft Deutscher Chemiker. Weinheim : New York : VCH) 1992- v. 31, p. 1, 1989 (BFUUA*) MD: P26 orl-rat TDLo: 91 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-353, 1989 (NTPTR*); F16-P20-Y03 orl-mus TDLo: 31770 mg/kg/90D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 478, 1985 (FAATDF); M03-Z01 orl-mus TDLo: 437 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-353, 1989 (NTPTR*); Z01 orl-mus TDLo: 67200 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-353, 1989 (NTPTR*); L30-Y37 ipr-gpg TDLo: 480 mg/kg/2W-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 34, p. 415, 1996 (INHEAO); J30-R21-Z01 ims-rat TDLo: 7500 mg/kg/10D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 635, 1989 (FAATDF); U01 ims-rat TDLo: 2000 mg/kg/10D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 635, 1989 (FAATDF); L30-L70 ims-mus TDLo: 40320 mg/kg/24W-C Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- v. 19, p. 356, 1972 (TOIZAG); U01-Z01 orl-rat TDLo: 7500 mg/kg/10D-I Beratergremium fuer umweltrelevante Altstoffe (BUA. Gesellschaft Deutscher Chemiker. Weinheim : New York : VCH) 1992- v. 31, p. 1, 1989 (BFUUA*) TR: IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 319, 1986 (IMEMDT); IARC Cancer Review: Animal No Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 769, 1999 (IMEMDT); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 2, p. 305, 1974 (STEVA8) ND: NOES 1983: HZD X4154; NIS 1; TNF 6; NOS 1; TNE 63; TFE 23 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110757/AS); EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9261; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat Record 944 of 1119 in RTECS (through 2003/06) AN: SL1945000 PN: Phenol, (1,1-dimethylethyl)-4-methoxy- SY: Antioxyne-B-; Antrancine-12-; BHA-; BOA- (antioxidant); Butylated-hydroxyanisole-; Butylhydroxyanisole-; tert-Butylhydroxyanisole-; tert-Butyl-4-hydroxyanisole-; 2(3)-tert-Butyl-4-hydroxyanisole; 2-terc.Butyl-4-methoxyfenol (Czech); tert-Butyl-4-methoxyphenol-; Butylohydroksyanizol- (Polish); (1,1-Dimethylethyl)-4-methoxyphenol; EEC No. E320; Embanox-; Nipantiox-1-F-; Protex-; Sustane-1-F-; Tenox-BHA- RN: Current: 25013-16-5 Previous: 8003-24-5 UD: 200302 MF: C11-H16-O2 MW: 180.27 WL: QR DO1 XX1&1&1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-omi 12500 ug/L (-S9) FEMS Microbiology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 14, p. 183, 1982 (FMLED7); dni-hmn-hla 400 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); dnd-rat-lvr 250 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); dns-rat-orl 176 gm/kg/21W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 33, p. 119, 1986 (CALEDQ); dni-ham-lng 500 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 549, 1991 (TIVIEQ); sce-ham-fbr 100 umol/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 58, p. 1635, 1977 (JNCIAM); dnd-mus-orl 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 519, p. 103, 2002 (MUREAV) RE: T81 orl-rat TDLo: 30 gm/kg (2W male/2W pre-2W post) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 3, p. 321, 1981 (NTOTDY); T76 orl-rat TDLo: 36 gm/kg (2W male/2W pre-3W post) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 3, p. 321, 1981 (NTOTDY); T85 orl-mus TDLo: 12600 mg/kg (1-21D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 31, p. 596, 1972 (FEPRA7) TE: V01-K60 orl-rat TDLo: 728 gm/kg/2Y-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 73, p. 332, 1982 (GANNA2); V03-K60 orl-mus TDLo: 874 gm/kg/1Y-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 77, p. 1083, 1986 (JJCREP); V01-K60 orl-ham TDLo: 437 gm/kg/1Y-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 77, p. 1083, 1986 (JJCREP); V03-K60 orl-rat TD :182 gm/kg/2Y-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 73, p. 332, 1982 (GANNA2); V01-M60-V05 orl-rat TD :269 gm/kg/32W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 895, 1983 (CRNGDP); V01-K60-N60 orl-rat TD :874 gm/kg/2Y-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 84, p. 237, 1993 (JJCREP); V02-K60 orl-ham TD :202 gm/kg/24W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 74, p. 459, 1983 (GANNA2); V02-J60 orl-rat TD :4200 mg/kg/10W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 165, 1986 (CNREA8); V01-K60 orl-rat TD :728 gm/kg/2Y-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31(Suppl), p. 207, 1986 (TOLED5); V01-K60 orl-rat TD :874 gm/kg/1Y-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 77, p. 1083, 1986 (JJCREP); V02-K60 orl-rat TD :202 gm/kg/24W-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 77, p. 854, 1986 (JJCREP) ORNG: 2000000000 ng/kg. [2000.000000 mg/kg] F05-F19-J26 AT: F05-F19-J26 orl-rat LD50: 2 gm/kg Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 22, p. 231, 1970 (TRENAF); P01 ipr-rat LD50: 881 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 27, p. 15, 1985 (TOLED5); F05-F19-J26 orl-mus LD50: 1100 mg/kg Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 22, p. 231, 1970 (TRENAF); T/E unlistd orl-rbt LD50: 2100 mg/kg Journal of the American Oil Chemists' Society. (Champaign, IL) V.24-56, 1947-79. v. 54, p. 239, 1977 (JAOCA7) MD: L30-U30-Y07 orl-rat TDLo: 3300 mg/kg/12D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 34, p. 787, 1985 (BECTA6); N72-P28 orl-rat TDLo: 63 gm/kg/6W-C Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. v. 39, p. 353, 1961 (AJEBAK); L70-Y03 orl-rat TDLo: 700 mg/kg/7D-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 3, p. 457, 1965 (FCTXAV); L70-N75-P28 orl-rat TDLo: 9900 mg/kg/16W-C Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 22, p. 231, 1970 (TRENAF); L70 orl-rat TDLo: 182 mg/kg/2Y-C Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. v. 37, p. 533, 1959 (AJEBAK); J70-P23-U01 ipr-rat TDLo: 2688 mg/kg/7D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 27, p. 15, 1985 (TOLED5); L30-L70-Y07 orl-mus TDLo: 10900 ng/kg/12D-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 45, p. 935, 1982 (BJCAAI); L30-L70-Y03 orl-mky TDLo: 14 gm/kg/4W-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 10, p. 769, 1972 (FCTXAV); K30-L70-Y21 orl-mky TDLo: 15 gm/kg/84D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 24, p. 1197, 1986 (FCTOD7); J60-V25-V30 orl-mus TDLo: 1154 gm/kg/8W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 137, p. 123, 1999 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 40, p. 123, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 40, p. 123, 1986 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 3(5), p. 83, 1984 (JACTDZ) ND: NOHS 1974: HZD 83660; NIS 6; TNF 547; NOS 12; TNE 4272; NOES 1983: HZD 83660; NIS 30; TNF 3888; NOS 53; TNE 89673; TFE 44061 SL: EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro SCE-nonhuman; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 945 of 1119 in RTECS (through 2003/06) AN: SL6300000 PN: Phenol,-4,4'-isopropylidenedi- SY: 2,2-(4,4'-Dihydroxydiphenyl)propane; 2,2-Bis(4-hydroxyphenyl)propane; 2,2-Bis(p-hydroxyphenyl)propane; 2,2-Bis-4'-hydroxyfenylpropan- (Czech); 2,2-Di(4-hydroxyphenyl)propane; 2,2-Di(4-phenylol)propane; 4,4'-Bisphenol-A-; 4,4'-Dihydroxy-2,2-diphenylpropane-; 4,4'-Dihydroxydiphenyl-2,2-propane-; 4,4'-Dihydroxydiphenyldimethylmethane-; 4,4'-Dihydroxydiphenylpropane-; 4,4'-Isopropylidendiphenol-; 4,4'-Isopropylidendiphenol-dust-; 4,4'-Isopropylidenebisphenol-; Bis(4-hydroxyphenyl) dimethylmethane; Bis(4-hydroxyphenyl)propane; Bisferol-A- (Czech); Bisphenol-; Bisphenol-A-; Bisphenol-A- (OSHA); DIAN-; Dimethyl bis(p-hydroxyphenyl)methane; Dimethylmethylene-p,p'-diphenol-; Diphenylolpropane-; NCI-C50635-; Phenol,-4,4'-dimethylmethylenedi-; Propane, 2,2-bis(p-hydroxyphenyl)-; Ucar-bisphenol-A-; beta-Di-p-hydroxyphenylpropane-; p,p'-Dihydroxydiphenyldimethylmethane-; p,p'-Dihydroxydiphenylpropane-; p,p'-Isopropylidenebisphenol-; p,p'-Isopropylidenediphenol- RN: Current: 80-05-7 BRN: 1107700 BHR: 4-06-00-06717 UD: 200305 MF: C15-H16-O2 MW: 228.31 WL: QR DX1&1&R DQ CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 250 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 7/14/1965 (UCDS**); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,238,1986 (85JCAE); eye-rbt 250 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,238,1986 (85JCAE) ME: dnd-rat-lvr 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); dna-rat-ipr 200 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 60, 1995 (EMMUEG); dna-rat-orl 800 mg/kg/4D-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 60, 1995 (EMMUEG); mnt-ham-lng 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 21, 1997 (MUREAV); dni-ham-ovr 400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 400, p. 169, 1998 (MUREAV); cyt-ham-ovr 400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 400, p. 169, 1998 (MUREAV) RE: T34 orl-rat TDLo: 10 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-205110 (NTIS**); T25 orl-rat TDLo: 15 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-205110 (NTIS**); T85 orl-rat TDLo: 2120 ug/kg (10D pre-21D post) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 64, p. 687, 1999 (PBBHAU); T85 orl-rat TDLo: 6400 ug/kg (13-22D preg/1-6D post) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 64, p. 687, 1999 (PBBHAU); T46 ipr-rat TDLo: 1275 mg/kg (1-15D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO); T34 ipr-rat TDLo: 1275 mg/kg (1-15D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A23, 1980 (APTOD9); T26-T24 ipr-rat TDLo: 1875 mg/kg (1-15D preg) Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A23, 1980 (APTOD9); T26-T34-T41 ipr-rat TDLo: 1275 mg/kg (1-15D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO); T25-T50 ipr-rat TDLo: 1875 mg/kg (1-15D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO); T25-T34-T35 orl-mus TDLo: 12500 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-205102 (NTIS**); T24 orl-mus TDLo: 7500 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-205102 (NTIS**); T13 orl-mus TDLo: 12500 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-205102 (NTIS**); T81-T91 orl-mus TDLo: 16800 ng/kg (11-17D preg) American Zoologist. (American Soc. of Zoologists, Box 2739, California Lutheran College, Thousand Oaks, CA 91360) V.1- 1961- v. 40, p. 429, 2000 (AMZOAF); T53 scu-mus TDLo: 900 mg/kg (11-19D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 39, p. 193, 1999 (CGANE7); T53 orl-mus TDLo: 14000 ng/kg (11-17D preg) Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 14, p. 239, 1998 (TIHEEC); T35-T34-T39 orl-rat TDLo: 20 gm/kg (1-20D preg) Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 2611, 2001 (LIFSAK); T34 unr-rat TDLo: 350 mg/kg (9-15D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 234, 1994 (VCVGK*); T25-T34 orl-mus TDLo: 12500 mg/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 571, 1987 (FAATDF); T75 orl-mus TDLo: 1.75 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86103207 (NTIS**); T26 orl-mus TDLo: 153 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86103207 (NTIS**); T26 orl-mus TDLo: 171.5 gm/kg (98D male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86103207 (NTIS**); T51-T53 orl-mus TDLo: 437 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86103207 (NTIS**) TE: V03-P61-T61 orl-rat TDLo: 43260 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-184060 (NTIS**); V03-P61 orl-rat TDLo: 36050 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-184060 (NTIS**); V03-P61-P62 orl-mus TDLo: 86520 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-184060 (NTIS**) ORNG: 3250000000 ng/kg. [3250.000000 mg/kg] T/E unlistd SRNL: 3000000 nL/kg. [3.000000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 3250 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 28, p. 301, 1967 (AIHAAP); E08-F12-F19 orl-mus LD50: 2400 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(7), p. 25, 1968 (GISAAA); F07-F19-J22 ihl-mus LC :>1700 mg/m3/2H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 2, p. 50, 1961 (TPKVAL); T/E unlistd ipr-mus LD50: 150 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD691-490 (NTIS**); F07-L03-U01 scu-mus LDLo: 2500 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 2, p. 50, 1961 (TPKVAL); T/E unlistd orl-rbt LD50: 2230 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 28, p. 301, 1967 (AIHAAP); T/E unlistd skn-rbt LD50: 3 mL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); E08-F12-F19 orl-gpg LD50: 4 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(7), p. 25, 1968 (GISAAA); T/E unlistd orl-mam LD50: 6500 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,135,1969 (34ZIAG); T22 orl-rat LD50: 1200 mg/kg Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 2611, 2001 (LIFSAK); S02 orl-rat TDLo: 1000 mg/kg Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 2611, 2001 (LIFSAK); N17 scu-rat TDLo: 5.9 mg/kg Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 18, p. 1108, 1970 (JAFCAU) MD: L03-Z01 orl-rat TDLo: 12 mg/kg/12D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 2, p. 50, 1961 (TPKVAL); U01 orl-rat TDLo: 42 gm/kg/8W-C Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 9, p. 9, 1959 (ARZNAD); K30-Z01 orl-rat TDLo: 5460 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-215, 1982 (NTPTR*); M10-L30-P23 orl-rat TDLo: 31500 mg/kg/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(7), p. 25, 1968 (GISAAA); F40-L14-P30 orl-rat TDLo: 455 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(7), p. 25, 1968 (GISAAA); D07-U01 ihl-rat TCLo: 150 mg/m3/6H/13W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 8, p. 248, 1988 (TOXID9); L70-M11-N73 ihl-rat TCLo: 47 mg/m3/2H/19W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 4, p. 43, 1962 (TPKVAL); L30-Z01 orl-mus TDLo: 273 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-215, 1982 (NTPTR*); L03-M30-Z01 ihl-mus TCLo: 200 mg/m3/2H/41D-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 2, p. 50, 1961 (TPKVAL); M16-P71-Y37 orl-rbt TDLo: 31500 mg/kg/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(7), p. 25, 1968 (GISAAA); M16-P28-N30 orl-rbt TDLo: 4550 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(7), p. 25, 1968 (GISAAA); T15 scu-rat TDLo: 0.1 mg/kg/11D-C Journal of Steroid Biochemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1969- v. 60, p. 153, 1997 (JSTBBK); T14 orl-rat TDLo: 300 mg/kg/3D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); Z74 orl-rat TDLo: 600 mg/kg/3D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); U01 scu-rat TDLo: 273 mg/kg/15D-C Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 42, p. 917, 2001 (CMSHAF); U01 orl-rat TDLo: 4.2 gm/kg/14D-I Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 2611, 2001 (LIFSAK); U01 orl-rat TDLo: 7 mg/kg/7D-I Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 2611, 2001 (LIFSAK); F15 orl-rat TDLo: 1.2 gm/kg/4D-I Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 2611, 2001 (LIFSAK); K30 orl-rat TDLo: 20 gm/kg/20D-I Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69: V.14- 1974- v. 69, p. 2611, 2001 (LIFSAK); T14 orl-rat TDLo: 2500 mg/kg/25D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 154, 2000 (TOSCF2); N17-R25-V05 scu-rat TDLo: 1.1 mg/kg/11D-C Journal of Steroid Biochemistry and Molecular Biology. (Pergamon Press, c/o Elsevier Science, POB 945, New York, NY 10159) V.37- 1990- v. 60, p. 153, 1997 (JSBBEZ); U01 orl-rat TDLo: 10.25 gm/kg/22D-C Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 75, p. 42, 2001 (ARTODN); L70 orl-rat TDLo: 20.5 gm/kg/44D-C Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 75, p. 42, 2001 (ARTODN); T01-T09 orl-rat TDLo: 10.34 gm/kg/44D-C Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 75, p. 42, 2001 (ARTODN); T03-Z72 orl-rat TDLo: 41.8 gm/kg/44D-C Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 75, p. 42, 2001 (ARTODN); F15 orl-mus TDLo: 12252 mg/kg/14D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86103207 (NTIS**); L70 orl-mus TDLo: 257250 mg/kg/21W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86103207 (NTIS**); L70-M71-U01 orl-mus TDLo: 257250 mg/kg/21W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB86103207 (NTIS**); T01 orl-mus TDLo: 257250 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB89169254 (NTIS**); T13-Z74 orl-rat TDLo: 600 mg/kg/3D-I Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 149, 2001 (CRTOEC); U01-Z74 scu-rat TDLo: 2400 mg/kg/3D-I Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 149, 2001 (CRTOEC); T13 scu-rat TDLo: 30 mg/kg/3D-I Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 14, p. 149, 2001 (CRTOEC) TR: TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF) SR: OSHA PEL (Shipyard): CL 0.5 ppm (2.8 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OEL-RUSSIA: STEL 5 mg/m3, JAN 1993 ND: NOHS 1974: HZD 12845; NIS 82; TNF 5427; NOS 74; TNE 71597; NOES 1983: HZD T0995; NIS 2; TNF 6; NOS 2; TNE 2180; TFE 49; NOES 1983: HZD 12845; NIS 70; TNF 5987; NOS 78; TNE 92138; TFE 15144 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), equivocal evidence: mouse, rat; NTP Carcinogenesis Bioassay (feed), inadequate studies: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-215, 1982 (NTPTR*) Record 946 of 1119 in RTECS (through 2003/06) AN: SL7875000 PN: Phenol,-2-methoxy-4-propenyl- SY: 1-Hydroxy-2-methoxy-4-propenylbenzene-; 4-Hydroxy-3-methoxy-1-propenylbenzene-; Isoeugenol-; 2-Methoxy-4-propenylphenol-; NCI-C60979-; 4-Propenylguaiacol- RN: Current: 97-54-1 BRN: 1909602 BHR: 3-06-00-04993 UD: 200305 MF: C10-H12-O2 MW: 164.22 WL: 2U1R DQ CO1 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-man 16 mg/48H MOD Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-rbt 100 mg/24H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG); skn-gpg 100 mg/24H SEV Cosmetics and Toiletries. (Allured Pub. Corp., POB 318, Wheaton, IL 60189) V.91- 1976- v. 94(8), p. 41, 1979 (CTOIDG) ME: sce-hmn-lym 250 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 169, p. 129, 1986 (MUREAV) RE: T34 orl-rat TDLo: 7 gm/kg (6-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2000-105138 (NTIS**); T26-T46 orl-rat TDLo: 14 gm/kg (6-19D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2000-105138 (NTIS**) ORNG: 1560000000 ng/kg. [1560.000000 mg/kg] F24 AT: F24 orl-rat LD50: 1560 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 6, p. 378, 1964 (TXAPA9); T/E unlistd ipr-mus LD50: 328 mg/kg Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- v. 104, p. 793, 1984 (YKKZAJ); F07-F24 orl-gpg LD50: 1410 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 2, p. 327, 1964 (FCTXAV) MD: F26 orl-rat TDLo: 14000 mg/kg/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2000-105138 (NTIS**); R21 orl-rat TDLo: 7000 mg/kg/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2000-105138 (NTIS**); F40 orl-rat TDLo: 3500 mg/kg/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2000-105138 (NTIS**); L70-U01 orl-rat TDLo: 1750 mg/kg/7D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2000-105138 (NTIS**); F15 orl-rat TDLo: 1500 mg/kg/6D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB2000-105138 (NTIS**) ND: NOHS 1974: HZD 83233; NIS 5; TNF 94; NOS 25; TNE 5786; NOES 1983: HZD 83233; NIS 10; TNF 3651; NOS 19; TNE 35171; TFE 24980 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, selected, October 2000 Record 947 of 1119 in RTECS (through 2003/06) AN: SM6300000 PN: Phenol,-pentachloro- SY: 1-Hydroxypentachlorobenzene-; 2,3,4,5,6-Pentachlorophenol-; AD-73-; CM-613-; CP-1309-; Chem-Penta-; Chem-Tol-; Chlon-; Chlorophen-; Dow-pentachlorophenol-DP-2-antimicrobial-; Dowicide-7-; Dowicide-EC-7-; Durotox-; EP-30-; Fungifen-; Grundier-arbezol-; Lauxtol-; Lauxtol-A-; Liroprem-; MB-333-; NCI-C54933-; NCI-C55378-; NCI-C56655-; PCP-; PCP- (pesticide); Penchlorol-; Penta-; Penta-WR-; Penta-ready-; Penta-kil-; Pentachloorfenol- (Dutch); Pentachlorofenol-; Pentachlorofenolo-; Pentachlorophenol-; Pentachlorophenol- (ACGIH:OSHA); Pentachlorophenol,-DP-2-; Pentachlorophenol,-EC-7-; Pentachlorophenol,-technical-grade-; Pentachlorphenol-; Pentachlorphenol- (German); Pentaclorofenolo- (Italian); Pentacon-; Penwar-; Peratox-; Permacide-; Permagard-; Permasan-; Permatox-DP-2-; Permatox-penta-; Permite-; Pol-Nu-; Pole-topper-fluid-; Preventol-P-; RCRA-waste-number-U242-; Santophen-20-; Thompson's-wood-fix-; Weedone-; Witophen-P-; Woodtreat-A- RN: Current: 87-86-5 BRN: 1285380 BHR: 4-06-00-01025 UD: 200305 MF: C6-H-Cl5-O MW: 266.32 WL: QR BG CG DG EG FG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 10 mg/24H open MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 95, 1962 (AIHAAP); eye-rbt 100 uL/24H MLD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0546023 (NTIS**) ME: mmo-sat 40 nmol/plate (-S9) Aichi Ika Daigaku Igakkai Zasshi. Journal of the Aichi Medical University Association. (Aichi Ika Daigaku Igakkai, Yazako, Nagakute-machi, Aichi-gun, Aichi-ken, Japan) V.1- 1973- v. 10, p. 305, 1982 (AIDZAC); oms-omi 10 mg/L Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 13, p. 7, 1987 (EESADV); mmo-smc 400 mg/L (-S9) Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 12, p. 325, 1978 (EVSRBT); mrc-smc 190 umol/L IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 10, p. 161, 1974 (IARCCD); slt-mus-ipr 50 mg/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 12, p. 325, 1978 (EVSRBT); oms-mus-orl 30 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); mtr-ham-emb 100 mg/L Advances in Modern Environmental Toxicology. (Senate Press, Inc., P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980- v. 1, p. 241, 1980 (AETODY); cyt-ham-ovr 80 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 3 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG); mmo-omi 40 mg/L Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1491, 2001 (HBPTO*); cyt-ham-fbr 300 mg/L (-S9) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1491, 2001 (HBPTO*) RE: T34 orl-rat TDLo: 60 mg/kg (9D preg) Dissertation Abstracts International, B: The Sciences and Engineering. (University Microfilms International, 300 N. Zeeb Rd., Ann Arbor, MI 48106) V.30- 1969- v. 37, p. 1184, 1976 (DABBBA); T46 orl-rat TDLo: 50 mg/kg (6-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 151, 1974 (TXAPA9); T76-T81 orl-rat TDLo: 4 gm/kg (77D pre-28D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 138, 1977 (TXAPA9); T55 orl-rat TDLo: 120 mg/kg (8-11D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 151, 1974 (TXAPA9); T35 scu-mus TDLo: 450 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**); T91 orl-man TDLo: 124 mg/kg (multigeneration) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 113, p. 95, 1998 (JRPFA4); T81-T87 unr-rat TDLo: 5 mg/kg (8D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 249, 1994 (VCVGK*); T81-T87 unr-rat TDLo: 5 mg/kg (9D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 249, 1994 (VCVGK*); T81-T87 unr-rat TDLo: 5 mg/kg (10D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 249, 1994 (VCVGK*); T81-T87 unr-rat TDLo: 5 mg/kg (11D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 249, 1994 (VCVGK*); T81-T87 unr-rat TDLo: 5 mg/kg (12D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 249, 1994 (VCVGK*); T81-T87 unr-rat TDLo: 5 mg/kg (13D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 249, 1994 (VCVGK*); T25-T87 ihl-mus TCLo: 0.15 mg/m3 (122D pre) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 258, 1994 (VCVGK*); T34-T73-T46 orl-rat TDLo: 50 mg/kg (6-15D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1496, 2001 (HBPTO*); T34-T39 orl-rat TDLo: 5 gm/kg (26W male/26W pre/0-20D preg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1496, 2001 (HBPTO*); T25-T34 orl-rat TDLo: 800 mg/kg (6-15D preg) International Journal of Toxicology (Continous: Journal of the American College of Toxicology,Taylor and Francis Health Sciences) V.16- 1997- v. 20, p. 353, 2001 (IJOTO*) TE: V01-N60 orl-mus TDLo: 8736 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-349, 1989 (NTPTR*); V03-J60-L60 scu-mus TDLo: 46 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-159 (NTIS**); V01-L60-N61 orl-mus TDLo: 8652 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-216536/AS (NTIS**); V01-L60-N61 orl-mus TDLo: 8652 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-216536/AS (NTIS**); V01-L60 orl-mus TDLo: 17304 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-216536/AS (NTIS**); V02-N61-P60 orl-mus TDLo: 51912 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-216536/AS (NTIS**); V02-P60 orl-mus TDLo: 17304 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-216536/AS (NTIS**); V03-D09 orl-rat TDLo: 21840 mg/kg/52W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-152878 (NTIS**); V02 orl-rat TDLo: 21.9 gm/kg/1Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1489, 2001 (HBPTO*) ORNG: 27000000 ng/kg. [27.000000 mg/kg] H01-N24-U25 SKNG: 96000000 ng/kg. [96.000000 mg/kg] F13-F23-J22 AT: F17-R20-U25 orl-man LDLo: 401 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 1, p. 343, 1977 (EESADV); H01-N24-U25 orl-rat LD50: 27 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 76, p. 104, 1942 (JPETAB); F13-F23-J22 ihl-rat LC50: 355 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 13(9), p. 58, 1969 (GTPZAB); F13-F23-J22 skn-rat LD50: 96 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 13(9), p. 58, 1969 (GTPZAB); F12-J22-U25 ipr-rat LD50: 56 mg/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 13, p. 20, 1958 (BJPCAL); T/E unlistd orl-mus LD50: 36 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 63, 1978 (ARTODN); F13-F23-J22 ihl-mus LC50: 225 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 13(9), p. 58, 1969 (GTPZAB); T/E unlistd ipr-mus LD50: 32 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 63, 1978 (ARTODN); T/E unlistd scu-dog LDLo: 135 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 123, 1959 (HBTXAC); T/E unlistd unr-dog LD50: 70 mg/kg Phytiatrie-Phytopharmacie. (Societe Francaise de Phytiatrie et de Phytopharmacie, Etoile de Choisy, Route de St-Cyr, 78000 Versailles, France) V.1- 1952- v. 1, p. 3, 1953 (PHPHA6); F18-H01-M10 orl-rbt LDLo: 70 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 76, p. 104, 1942 (JPETAB); F18-H01-M10 skn-rbt LDLo: 40 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 76, p. 104, 1942 (JPETAB); T/E unlistd ipr-rbt LDLo: 135 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 123, 1959 (HBTXAC); F18-H01-M10 scu-rbt LDLo: 70 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 76, p. 104, 1942 (JPETAB); T/E unlistd unr-gpg LD50: 100 mg/kg Phytiatrie-Phytopharmacie. (Societe Francaise de Phytiatrie et de Phytopharmacie, Etoile de Choisy, Route de St-Cyr, 78000 Versailles, France) V.1- 1952- v. 1, p. 3, 1953 (PHPHA6); T/E unlistd orl-ham LD50: 168 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A192, 1979 (TXAPA9); T/E unlistd orl-grb LD50: 294 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 40, p. 63, 1978 (ARTODN); T/E unlistd orl-dck LD50: 380 mg/kg Down to Earth. (Dow Chemical USA, Agricultural Products Dept., Midland, MI 48640) V.1- 1945- v. 35, p. 25, 1979 (DOEAAH); T/E unlistd unr-frg LD50: 36 mg/kg Phytiatrie-Phytopharmacie. (Societe Francaise de Phytiatrie et de Phytopharmacie, Etoile de Choisy, Route de St-Cyr, 78000 Versailles, France) V.1- 1952- v. 1, p. 3, 1953 (PHPHA6); S04 ipr-mus TDLo: 120 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 36, p. 307, 1985 (TXCYAC); N30 ipr-rat TDLo: 1.86 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 67, p. 107, 1991 (TXCYAC); T/E unlistd orl-rat LD50: 130 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1486, 2001 (HBPTO*); T/E unlistd ipr-rat LD50: 60 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1486, 2001 (HBPTO*); F07 orl-mus LD50: 117 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 29, p. 39, 1985 (TOLED5) MD: L70-P71-U01 orl-rat TDLo: 840 mg/kg/12W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 2, p. 141, 1974 (TXCYAC); N30-P28 orl-rat TDLo: 84 mg/kg/28D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 71, p. 9, 1994 (TOLED5); P28-U01-Y15 orl-rat TDLo: 21840 mg/kg/2Y-C Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 12, p. 301, 1978 (EVSRBT); L70-N73-U01 orl-mus TDLo: 45 gm/kg/30D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-349, 1989 (NTPTR*); L70-S04-Y10 orl-mus TDLo: 1680 mg/kg/8W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 2, p. 90, 1982 (FAATDF); L70-N73-Y15 orl-mus TDLo: 10920 mg/kg/26W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-349, 1989 (NTPTR*); Z74 unr-mus TDLo: 60 mg/kg/3D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 262, 2000 (TOXID9); P28-P72 orl-pig TDLo: 150 mg/kg/30D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 31, p. 599, 1983 (BECTA6); N74-P71-Y07 orl-ctl TDLo: 2610 mg/kg/23W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 52, p. 468, 1980 (TXAPA9); S04 orl-mus TDLo: 420 ppm/6W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 36, p. 307, 1985 (TXCYAC); L30 orl-rat TDLo: 11.76 gm/kg/28W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1489, 2001 (HBPTO*); U01 orl-rat TDLo: 300 mg/kg/10D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1496, 2001 (HBPTO*); T13-U01 orl-rat TDLo: 8643 mg/kg/201D-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1496, 2001 (HBPTO*); S04 orl-mus TDLo: 140 mg/kg/14D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1499, 2001 (HBPTO*); U01 orl-rbt TDLo: 195 mg/kg/13D-I International Journal of Toxicology (Continous: Journal of the American College of Toxicology,Taylor and Francis Health Sciences) V.16- 1997- v. 20, p. 345, 2001 (IJOTO*); F15 orl-rbt TDLo: 390 mg/kg/13D-I International Journal of Toxicology (Continous: Journal of the American College of Toxicology,Taylor and Francis Health Sciences) V.16- 1997- v. 20, p. 345, 2001 (IJOTO*); F15-U01 orl-rat TDLo: 800 mg/kg/10D-I International Journal of Toxicology (Continous: Journal of the American College of Toxicology,Taylor and Francis Health Sciences) V.16- 1997- v. 20, p. 353, 2001 (IJOTO*) TR: ACGIH TLV-TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 319, 1986 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 371, 1991 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 769, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 303, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 371, 1991 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 371, 1991 (IMEMDT); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 2, p. 305, 1974 (STEVA8); TOXICOLOGY REVIEW American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 43, p. 799, 1982 (AIHAAP) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 198, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-DENMARK: TWA 0.005 ppm (0.05 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, STEL 1.5 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 0.5 mg/m3, Skin, C3 Carcinogen, JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-HUNGARY: TWA 0.2 mg/m3, STEL 0.4 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 0.5 mg/m3, Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.06 mg/m3, Skin, JAN 1999; OEL-NORWAY: TWA 0.05 ppm (0.5 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 0.5 mg/m3, MAC(STEL) 1.5 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.1 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 0.5 mg/m3, KTV 1.5 mg/m3, Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 ppm (0.5 mg/m3), STEL 0.1 ppm, Skin, JAN 1999; OEL-TURKEY: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 0.5 mg/m3, STEL 1.5 mg/m3, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO PENTACHLOROPHENOL-air: 10H TWA 0.5 mg/m3 (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 54160; NIS 47; TNF 3548; NOS 42; TNE 29154; NOES 1983: HZD 54160; NIS 29; TNF 2248; NOS 38; TNE 26806; TFE 4191 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/2001/109106/AS); EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation; EPA GENETOX PROGRAM 1988, Negative: Host-mediated assay, Mouse spot test; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test, S cerevisiae-homozygosis; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Pentachlorophenol, 5512, in blood, 8001, in urine, 8303; NCI Carcinogenesis Studies (feed), clear evidence: mouse; NCI Carcinogenesis Studies (feed), equivocal evidence: rat; OSHA ANALYTICAL METHOD #39 Record 948 of 1119 in RTECS (through 2003/06) AN: SM8380000 PN: Phenolphthalein- SY: Alophen-; Agoral-; 3,3-Bis(4-hydroxyphenyl)-1-(3H)-isobenzofuranone; 3,3-Bis(p-hydroxyphenyl)phthalide; Colax-; Correctol-; Dialose-; alpha-Di(p-hydroxyphenyl)phthalide; Dihydroxyphthalophenone-; Doxidan-; Euchessina-; Evac-Q-Kit-; Evac-Q-Kwik-; Evac-U-Gen-; Evac-V-Lax-; Ex-Lax-; Feen-a-mint-gum-; FemiLax-; Fenolftalein- (Czech); alpha-(p-Hydroxyphenyl)-alpha-(4-oxo-2,5-cyclohexadien-1-ylidene)-o-toluic acid; 1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxyphenyl)-; Koprol-; Laxogen-; LaxCaps-; Lax-Pills-; Lilo-; Medilax-; Modane-; NCI-C55798-; Phenolax-; Phthalide 3,3,-bis(p-hydroxyphenyl)-; Phthalimetten-; Phthalin-; Prulet-; Purga-; Purgen-; Purgophen-; Spulmako-lax-; Trilax- RN: Current: 77-09-8 Previous: 467-29-8; 57214-20-7 BRN: 284423 BHR: 5-18-04-00188 UD: 200305 MF: C20-H14-O4 MW: 318.34 WL: T56 BVO DHJ D- D-/R DQ 2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P); Reproductive-Effector (T) ME: mnt-mus-orl 1680 mg/kg/14D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 151, 1995 (MUREAV); cyt-ham-ovr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 151, 1995 (MUREAV) RE: T16-T29 orl-mus TDLo: 29.4 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91178707 (NTIS**); T72 orl-mus TDLo: 123.48 gm/kg (21W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91178707 (NTIS**); T72 orl-mus TDLo: 840 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91178707 (NTIS**); T53 orl-mus TDLo: 840 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91178707 (NTIS**) TE: V01-M60-N61 orl-rat TDLo: 364 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-465, 1996 (NTPTR*); V01-N60-R60 orl-mus TDLo: 281 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-465, 1996 (NTPTR*); V02-N61 orl-rat TDLo: 360500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-169882/AS (NTIS**); V03-N61 orl-rat TDLo: 360500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-169882/AS (NTIS**); V03-M61 orl-rat TDLo: 1442000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-169882/AS (NTIS**); V01-P62 orl-mus TDLo: 432600 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-169882/AS (NTIS**); V01-P62 orl-mus TDLo: 288400 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-169882/AS (NTIS**) AT: K05-K13-M16 orl-man TDLo: 29 mg/kg Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1925- v. 60, p. 491, 1984 (PGMJAO); T/E unlistd orl-rat LD :>1 gm/kg National Academy of Sciences, National Research Council, Chemical-Biological Coordination Center, Review. (Washington, DC) v. 5, p. 25, 1953 (NCNSA6); T/E unlistd ipr-rat LDLo: 500 mg/kg National Academy of Sciences, National Research Council, Chemical-Biological Coordination Center, Review. (Washington, DC) v. 5, p. 30, 1953 (NCNSA6); N17 scu-rat TDLo: 95 mg/kg Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 18, p. 1108, 1970 (JAFCAU) MD: L70-P28-U01 orl-rat TDLo: 324 gm/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 48, 1992 (FAATDF); L70-P71-Z73 orl-mus TDLo: 106 gm/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 48, 1992 (FAATDF); L60-V30 orl-mus TDLo: 288400 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-169882/AS (NTIS**); M71-T02 orl-mus TDLo: 123.48 gm/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB91178707 (NTIS**) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 387, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 387, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 387, 2000 (IMEMDT); TOXICOLOGY REVIEW Deutsche Apotheker. (Postfach 1650, 6370 Oberusel/Taunas, Fed. Rep. Ger.) V.1- 1949- v. 27, p. 151, 1975 (DAPOAG) ND: NOHS 1974: HZD T0011; NIS 1; TNF 8; NOS 1; TNE 31; NOHS 1974: HZD 56240; NIS 102; TNF 6160; NOS 43; TNE 43092; NOES 1983: HZD X9187; NIS 3; TNF 117; NOS 6; TNE 1946; TFE 1408; NOES 1983: HZD 56240; NIS 89; TNF 6900; NOS 57; TNE 73297; TFE 18309 SL: EPA GENETOX PROGRAM 1988, Negative: B subtilis rec assay; EPA GENETOX PROGRAM 1988, Inconclusive: B subtilis rec assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: mouse; NTP Carcinogenesis Studies (feed), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-465, 1996 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 949 of 1119 in RTECS (through 2003/06) AN: SN1575000 PN: Phenol,-2,4,6-trichloro- SY: Dowcide-2S-; Dowicide-2S-; NCI-C02904-; OMAL-; Phenachlor-; RCRA-waste-number-U231-; 2,4,6-Trichlorfenol- (Czech); 2,4,6-Trichlorophenol- RN: Current: 88-06-2 BRN: 776729 BHR: 4-06-00-01005 UD: 200210 MF: C6-H3-Cl3-O MW: 197.44 WL: QR BG DG FG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,525,1986 (85JCAE); eye-rbt 250 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,525,1986 (85JCAE) ME: mmo-sat 10 ug/plate (-S9) Toxicological and Environmental Chemistry. (Gordon and Breach Science Pub. Inc., 1 Park Ave., New York, NY 10016) V.3(3/4)- 1981- v. 14, p. 143, 1987 (TECSDY); dnd-omi 500 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 69, p. 333, 1989 (CBINA8); mmo-smc 400 mg/L (-S9) Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 12, p. 325, 1978 (EVSRBT); slt-mus-ipr 50 mg/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 12, p. 325, 1978 (EVSRBT); msc-mus-lym 80 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); mnt-ham-lng 30 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 175, 1992 (MUREAV); oms-ham-lng 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 303, p. 101, 1993 (MUREAV); cyt-ham-ovr 400 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 303, p. 101, 1993 (MUREAV); cyt-ham-lng 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 303, p. 101, 1993 (MUREAV); sln-ham-lng 30 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 280, p. 175, 1992 (MUREAV); msc-ham-lng 20 mg/L Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 14, p. 1617, 1985 (CMSHAF) RE: T81 orl-rat TDLo: 12500 mg/kg (2W pre/1-21D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 233, 1986 (FAATDF) TE: V01-P61-P62 orl-rat TDLo: 185 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-155, 1979 (NCITR*); V01-L60 orl-mus TDLo: 441 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-155, 1979 (NCITR*); V01-L60 orl-mus TD :882 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-155, 1979 (NCITR*); V01-P61-P62 orl-rat TD :374 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-155, 1979 (NCITR*) ORNG: 820000000 ng/kg. [820.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 820 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 1176, 1966 (PCOC**); F11-F12-U25 ipr-rat LD50: 276 mg/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 13, p. 20, 1958 (BJPCAL); T/E unlistd orl-gpg LD50: 1 gm/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C310, 1991 (FMCHA2); T/E unlistd orl-mam LD50: 454 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 16, 1980 (GISAAA); T/E unlistd skn-mam LD50: 700 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(10), p. 16, 1980 (GISAAA) MD: L70-M70-P28 orl-rat TDLo: 21600 mg/kg/90D-I Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 9(5), p. 497, 1990 (JACTDZ) TR: IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 319, 1986 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 154, 1987 (IMSUDL); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 769, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 349, 1979 (IMEMDT) ND: NOHS 1974: HZD 84393; NIS 1; TNF 14; NOS 2; TNE 112; NOES 1983: HZD 84393; NIS 1; TNF 17; NOS 1; TNE 851; TFE 187 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/91/181545/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, S cerevisiae-forward mutation; EPA GENETOX PROGRAM 1988, Negative: Mouse spot test, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-155, 1979 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 950 of 1119 in RTECS (through 2003/06) AN: SO8225000 PN: Phenothiazine, 10-(2-(dimethylamino)propyl)-, monohydrochloride SY: Atosil-; 10-(3-Dimethylaminoisopropyl)phenothiazine hydrochloride; 10-(2-(Dimethylamino)propyl)phenothiazine monohydrochloride; N-(2-Dimethylaminopropyl-1)phenothiazine hydrochloride; 10-(2-Dimethylaminopropyl)phenothiazine hydrochloride; 10-(2-Dimethylamino-1-propyl)phenothiazine hydrochloride; N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine hydrochloride; Diprasine-; Diprazin-; Dorme-; Fellozine-; Fenergan-; Ganphen-; HL-8700-; Kinetosin-; Phencen-; 10H-Phenothiazine-10-ethanamine,-N,N,alpha-trimethyl-,-monohydrochloride-; Phenergan-hydrochloride-; Pipolfen-; Plletia-; Primine-; Promantine-; Promethiazin- (German); Promethazine-hydrochloride-; Promine-; Pyrethia-; Remsed-; Romegran-hydrochloride-; Promethazine N-(2'-dimethylamino-2'-methylethyl)phenothiazine hydrochloride RN: Current: 58-33-3 Previous: 16639-38-6 UD: 200305 MF: C17-H20-N2-S.Cl-H MW: 320.91 WL: T C666 BN ISJ B1Y1&N1&1 &GH CC: Tumorigen (C); Drug (D); Reproductive-Effector (T); Human-Data (P) RE: T34 orl-rat TDLo: 60 mg/kg (5-16D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 7, p. 701, 1974 (RCOCB8); T29 orl-rat TDLo: 240 mg/kg (5-16D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 7, p. 701, 1974 (RCOCB8); T24-T34 par-rat TDLo: 350 mg/kg (1D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (2D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T25-T34 par-rat TDLo: 350 mg/kg (3D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T24-T25-T34 par-rat TDLo: 350 mg/kg (4D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T25-T34 par-rat TDLo: 350 mg/kg (5D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (6D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (7D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (8D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (9D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T25-T27-T31 par-rat TDLo: 350 mg/kg (10D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T25-T27-T31 par-rat TDLo: 350 mg/kg (11D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T25-T27-T31 par-rat TDLo: 350 mg/kg (12D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T25-T27-T31 par-rat TDLo: 350 mg/kg (13D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (10D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (11D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (12D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (13D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (14D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO); T34 par-rat TDLo: 350 mg/kg (15D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO) AT: F04-F12-F21 orl-hmn TDLo: 3500 ug/kg/D American Journal of Psychiatry. (American Psychiatric Assoc., Circulation Dept., 1400 K St., NW, Washington, DC 20005) V.78- 1921- v. 113, p. 654, 1957 (AJPSAO); F13-F17-F20 orl-chd TDLo: 20 mg/kg Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 368, 1980 (LANCAO); T/E unlistd ipr-rat LD50: 170 mg/kg Cesko-Slovenska Farmacie. (PNS-Ustredni Expedice a Dovoz Tisku, Kafkova 19, 160 00 Prague 6, Czechoslovakia) V.1-42, 1952-93. For publisher information, see CSLFEK v. 15, p. 526, 1966 (CKFRAY); T/E unlistd scu-rat LD50: 400 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 375, 1980 (YAKUD5); T/E unlistd ivn-rat LD50: 15 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 375, 1980 (YAKUD5); F12-J30 orl-mus LD50: 255 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 135, p. 364, 1962 (AIPTAK); T/E unlistd ipr-mus LD50: 160 mg/kg Cesko-Slovenska Farmacie. (PNS-Ustredni Expedice a Dovoz Tisku, Kafkova 19, 160 00 Prague 6, Czechoslovakia) V.1-42, 1952-93. For publisher information, see CSLFEK v. 15, p. 526, 1966 (CKFRAY); T/E unlistd scu-mus LD50: 240 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 375, 1980 (YAKUD5); T/E unlistd ivn-mus LD50: 50 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 108, p. 340, 1953 (JPETAB); T/E unlistd scu-dog LD50: 250 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 54, p. 688, 1958 (NYKZAU); T/E unlistd ipr-gpg LD50: 35 mg/kg Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 38, p. 749, 1983 (PHARAT); T/E unlistd ivn-gpg LD50: 42500 ug/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 113, p. 313, 1958 (AIPTAK); T/E unlistd par-rat LD50: 525 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 89, 1985 (FATOAO) MD: Z01 orl-rat TDLo: 666 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-425, 1993 (NTPTR*); D07-L70 orl-rat TDLo: 2164 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-425, 1993 (NTPTR*); L70-Z01 orl-mus TDLo: 900 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-425, 1993 (NTPTR*); L70-Z01 orl-mus TDLo: 2925 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-425, 1993 (NTPTR*); P28-U01-Y03 ipr-rbt TDLo: 25 mg/kg/5D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 16, p. 51, 1997 (JEPOEC); A60-N61-V30 orl-rat TDLo: 17149.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-210192 (NTIS**); T64-V30 orl-rat TDLo: 17149.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-210192 (NTIS**) ND: NOHS 1974: HZD 81480; NIS 2; TNF 946; NOS 5; TNE 7809; NOES 1983: HZD 81480; NIS 1; TNF 292; NOS 4; TNE 8796; TFE 7472 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat Record 951 of 1119 in RTECS (through 2003/06) AN: SP5740000 PN: Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride, trihydrate SY: 3,7-Bis(dimethylamino)phenothiazin-5-ium chloride trihydrate; C.I. Basic Blue 9, trihydrate (8CI); Methylene-Blue-trihydrate- RN: Current: 7220-79-3 UD: 200012 MF: C16-H18-N3-S.Cl.3 H2-O MW: 373.94 CC: Tumorigen (C) SL: NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 952 of 1119 in RTECS (through 2003/06) AN: SS8850000 PN: o-Phenylenediamine,-4-chloro- SY: 2-Amino-4-chloroaniline-; 1,2-Benzenediamine,-4-chloro- (9CI); C.I. 76015; 4-Chloro-1,2-benzenediamine-; 4-Chloro-1,2-diaminobenzene-; p-Chloro-o-phenylenediamine-; 4-Chloro-o-phenylenediamine-; 4-Chloro-1,2-phenylenediamine-; 4-Cl-o-PD-; 1,2-Diamino--4-chlorobenzene-; 3,4-Diaminochlorobenzene-; 3,4-Diamino-1-chlorobenzene-; NCI-C03292-; Ursol-Olive-6G- RN: Current: 95-83-0 BRN: 508472 BHR: 4-13-00-00068 UD: 200007 MF: C6-H7-Cl-N2 MW: 142.60 WL: ZR BZ DG CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 10 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); oms-esc 274 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19, p. 98, 1992 (EMMUEG); mmo-esc 1 mg/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); dnd-hmn-fbr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 127, p. 107, 1984 (MUREAV); dns-rat-lvr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 183, 1988 (MUREAV); mnt-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 259, p. 43, 1991 (MUREAV); dnd-mus-orl 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 440, p. 1, 1999 (MUREAV); cyt-mus-ipr 100 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 53, 1986 (ENMUDM); sce-mus-ipr 400 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 207, 1989 (EMMUEG); msc-mus-orl 327 gm/kg/26W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 414, p. 149, 1998 (MUREAV) TE: V01-L60-M60 orl-rat TDLo: 135 gm/kg/77W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 495, 1980 (CRNGDP); V01-L60 orl-mus TDLo: 324 gm/kg/77W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 495, 1980 (CRNGDP); V01-K60-M60 orl-rat TD :273 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-63, 1978 (NCITR*); V01-L60 orl-mus TD :917 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-63, 1978 (NCITR*); V01-K60-M60 orl-rat TD :136 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-63, 1978 (NCITR*); V01-L60 orl-mus TD :460 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-63, 1978 (NCITR*); V02-L60 orl-mus TD :40500 gm/kg/96W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 495, 1980 (CRNGDP); V01-L60-M60 orl-rat TD :18750 gm/kg/2Y-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 495, 1980 (CRNGDP) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 81, 1982 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 81, 1982 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SR: OEL-FINLAND: Carcinogen, JAN 1993; OEL-FRANCE: Carcinogen, JAN 1993 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, PROPOSED RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 27009, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-63, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 953 of 1119 in RTECS (through 2003/06) AN: SS9175000 PN: p-Phenylenediamine,-2,6-dichloro- SY: 1,4-Benzenediamine,-2,6-dichloro-; C.I. 37020; Daito-Brown-Salt-RR-; 1,4-Diamino-2,6-dichlorobenzene-; 2,5-Diamino-1,3-dichlorobenzene-; 2,6-Dichloro-1,4-benzenediamine-; 2,6-Dichloro-p-phenylenediamine-; 2,6-Dichloro-1,4-phenylenediamine-; Fast-Brown-RR-Salt-; NCI-C50260- RN: Current: 609-20-1 BRN: 2209257 BHR: 4-13-00-00225 UD: 200302 MF: C6-H6-Cl2-N2 MW: 177.04 WL: ZR DZ BG FG CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1 mg/pLate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); cyt-mus-ipr 100 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 25, p. 302, 1995 (EMMUEG); msc-mus-lym 25 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); mtr-ham-emb 600 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 515, 1986 (ENMUDM); cyt-ham-ovr 250 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 16 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V01-J60-L60 orl-mus TDLo: 87 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-219, 1982 (NTPTR*); V01-J60-L60 orl-mus TD :260 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-219, 1982 (NTPTR*); V01-L60 orl-mus TDLo: 259560 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-184052 (NTIS**) ORNG: 700000000 ng/kg. [700.000000 mg/kg] L30-P27-U01 AT: L30-P27-U01 orl-rat LD50: 700 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-219, 1982 (NTPTR*) MD: M30-U01 orl-rat TDLo: 43680 mg/kg/13W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. UCRL-13701 (NTIS**); U01 orl-mus TDLo: 81900 mg/kg/13W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. UCRL-13701 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 325, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 325, 1986 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), clear evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat Record 954 of 1119 in RTECS (through 2003/06) AN: ST2705000 PN: m-Phenylenediamine,-4-methoxy-,-sulfate- SY: Anisole,-2,4-diamino-,-hydrogen-sulfate-; Anisole,-2,4-diamino-,-sulfate-; BASF-Ursol-SLA-; 1,3-Benzenediamine, 4-methoxy, sulfate (1:1) (9CI); C.I. 76051; C.I. Oxidation Base 12A; 2,4-Diaminoanisole-sulfate-; 2,4-Diaminoanisole-sulphate-; 1,3-Diamino-4-methoxybenzene-sulphate-; 2,4-Diamino-1-methoxybenzene-sulphate-; Durafur-Brown-MN-; Fouramine-BA-; Fourrine-76-; Fourrine-SLA-; Furro-SLA-; 4-Methoxy-1,3-benzenediamine-sulfate- (1:1); 4-Methoxy-1,3-benzenediamine-sulphate-; 4-Methoxy-m-phenylenediamine-sulfate-; p-Methoxy-m-phenylenediamine-sulphate-; 4-Methoxy-m-phenylenediamine-sulphate-; Nako-TSA-; NCI-C01989-; Oxidation-Base-12A-; Pelagol-BA-; Pelagol-Grey-SLA-; Pelagol-SLA-; Renal-SLA-; Ursol-SLA-; Zoba-SLE- RN: Current: 39156-41-7 Previous: 108066-98-4 UD: 200006 MF: C7-H10-N2-O.H2-O4-S MW: 236.27 WL: ZR CZ DO1 &WSQQ CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1 mg/plate (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11(Suppl 12), p. 1, 1988 (EMMUEG); mmo-sat 1 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); sln-dmg-orl 15100 umol/L/3D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 181, 1977 (MUREAV); sln-nsc 150 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 167, p. 35, 1986 (MUREAV); mrc-smc 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 78, p. 243, 1980 (MUREAV); mmo-mus-lym 2110 ug/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 37, 1988 (EMMUEG); msc-mus-lym 10300 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 37, 1988 (EMMUEG) TE: V01-N05-V15 orl-rat TDLo: 18 gm/kg/10W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 197, 1980 (JJIND8); V01-N62 orl-mus TDLo: 157 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-84, 1978 (NCITR*); V03-N62-R60 orl-rat TD :33 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-84, 1978 (NCITR*); V01-N62-R60 orl-rat TD :51 gm/kg/72W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-84, 1978 (NCITR*); V02-N62 orl-mus TD :1310 gm/kg/78W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 103, 1982 (IMEMDT); V01-N60-N62 orl-rat TD :689 gm/kg/82W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 103, 1982 (IMEMDT); V01-N62-R60 orl-rat TD :1377 gm/kg/82W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 103, 1982 (IMEMDT); V01-N62-U01 orl-rat TD :2730 gm/kg/78W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 103, 1982 (IMEMDT); V01-N62-R60 orl-rat TD :2870 gm/kg/82W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 103, 1982 (IMEMDT); V03-N60-N62 orl-rat TD :350 gm/kg/10W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 103, 1982 (IMEMDT) AT: T/E unlistd orl-rat LD50: >4 gm/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 657, 1977 (JTEHD6); T/E unlistd ipr-rat LD50: 372 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 657, 1977 (JTEHD6); T/E unlistd ipr-mus LD50: 160 mg/kg Genetica Polonica. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1960- v. 26, p. 109, 1985 (GPOLA4) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 103, 1982 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 16, p. 51, 1978 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, PROPOSED RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 27009, 82 (FEREAC); NIOSH CURRENT INTELLIGENCE BULLETIN 19, 1978; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-84, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 955 of 1119 in RTECS (through 2003/06) AN: SZ2975000 PN: Phosphine sulfide, tris(1-aziridinyl)- SY: Aziridine,-1,1,1-phosphinothioylidynetris-; Girostan-; NSC-6396-; Oncotepa-; Oncothio-tepa-; Oncotiotepa-; AI-3-24916-; CBC-806495-; Ledertepa-; NCI-C01649-; 1,1',1''-Phosphinothioylidynetrisaziridine-; SK-6882-; Stepa-; Thioplex-; Triaziridinylphosphine-sulfide-; Phosphoric tri(ethyleneamide); Phosphorothioic-acid-triethylenetriamide-; Phosphorothioic-triamide,-N,N',N''-tri-1,2-ethanediyl-; Phosphorothioic-triamide,-N,N',N-triethylene-; Tespa-; Tespamin-; Tespamine-; Thiofozil-; Thiophosphamide-; Thiophosphoramide,-N,N',N''-tri-1,2-ethanediyl-; Thiophosphoramide,-N,N',N-triethylene-; Thiotriethylenephosphoramide-; Thiotef-; Thio-tep-; Thio-tepa-; Thio-tepa-S-; Tifosyl-; Tiofosfamid-; Tiofosyl-; Tiofozil-; Tio-TEF-; N,N',N''-Tri-1,2-ethanediylphosphorothioic-triamide-; N,N',N''-Tri-1,2-ethanediylthiophosphoramide-; Tri(ethyleneimino)thiophosphoramide; N,N',N''-Triethylenephosphorothioic-triamide-; N,N',N-Triethylenethiophosphamide-; Triethylene-thiophosphoramide-; Triethylenethiophosphoramide-; N,N',N-Triethylenethiophosphoramide-; Triethylenethiophosphorotriamide-; Tris(1-aziridinyl)phosphine sulfide; Tris(1-aziridinyl)phosphine sulphide; Tris(ethylenimino)thiophosphate; TSPA-; WR-45312- RN: Current: 52-24-4 Previous: 639-23-6; 85177-92-0 BRN: 145978 BHR: 4-20-00-00052 UD: 200009 MF: C6-H12-N3-P-S MW: 189.24 WL: T3NTJ APS&- AT3NTJ&- AT3NTJ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-hmn 2 mg/3W Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 63, p. 619, 1979 (CTRRDO) ME: mmo-sat 800 ug/plate (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2209, 1977 (CNREA8); mmo-sat 5 ug/plate (-S9) Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 1(1), p. 21, 1984 (CBTOE2); dns-sat 2 ug Experimental Cell Biology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.44- 1976- v. 50, p. 271, 1982 (ECEBDI); mmo-esc 100 ug/plate (-S9) Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- v. 44, p. 96, 1985 (TAKHAA); dnr-esc 600 umol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 92, p. 177, 1978 (ZKKOBW); pic-esc 200 mg/L Archiv fuer Mikrobiologie. (Berlin, Fed. Rep. Ger.) V.1-94, 1930-73. For publisher information, see AMICCW. v. 51, p. 9, 1965 (ARMKA7); slt-dmg-orl 100 umol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 359, 1989 (MUREAV); sln-dmg-orl 12 mmol/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 917, 1981 (EVSRBT); dns-nsc 10 ug/tube Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 44, p. 327, 1987 (ONCOBS); mrc-smc 2250 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 239, 1988 (MUREAV); mmo-asn 250 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 293, 1982 (MUREAV); dns-hmn-lym 1 mg/L Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 17(2), p. 61, 1983 (CYGEDX); dni-hmn-hla 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); cyt-hmn-lym 52 umol/L Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 1580, 1974 (SOGEBZ); cyt-hmn-leu 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 14, p. 345, 1972 (MUREAV); cyt-hmn-emb 50 umol/L/12H Izvestiya Akademii Nauk SSSR, Seriya Biologicheskaya. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1936- v. (4), p. 477, 1967 (IANBAM); sce-hmn-lym 16 umol/L Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 44, p. 209, 1987 (CGCGBR); sce-hmn-lym 1 mg/L Tsitologiya i Genetika. Cytology and Genetics. For English translation, see CYGEDX. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967- v. 16(2), p. 34, 1982 (TGANAK); mnt-rat-orl 4 mg/kg Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. v. 17, p. 405, 1976 (PESTD5); dni-rat-ivn 1600 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 275, 1979 (MUREAV); oms-rat-ipr 5 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 15, p. 804, 1977 (IJEBA6); bfa-rat-sat 200 mg/kg Urological Research. (Springer Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1973- v. 7, p. 119, 1979 (URLRA5); msc-rat-ipr 16800 ug/kg/4W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 403, p. 199, 1998 (MUREAV); mnt-mus-ipr 1 mg/kg Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 20, p. 365, 1984 (GNKAA5); mtr-mus-emb 500 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2202, 1977 (CNREA8); dnd-mus-lym 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 51, p. 4360, 1991 (CNREA8); dnd-mus-unr 5 mg/kg Pure and Applied Chemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1960- v. 42, p. 209, 1975 (PACHAS); dnd-mus-fbr 1 gm/L Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 93, p. 85, 1982 (BEXBAN); dnd-mus-emb 1 gm/L Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 93(1), p. 68, 1982 (BEBMAE); dnd-mus-ipr 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dni-mus-leu 1 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 41, p. 157, 1988 (CALEDQ); cyt-mus-ipr 1250 ug/kg Folia Biologica (Prague). (Academic Press Inc. Ltd., 24-28 Oval Rd., London NW1 7DX, UK) V.1- 1955- v. 27, p. 178, 1981 (FOBLAN); cyt-mus-unr 5 mg/kg Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 11, p. 49, 1975 (SOGEBZ); sce-mus-ipr 2 mg/kg Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 19(1), p. 23, 1985 (CYGEDX); dlt-mus-ipr 500 ug/kg International Journal of Environmental Studies. (Gordon and Breach Science Pub. Inc., c/o STBS Ltd., 1 Bedford St., London WCE 9PP, UK) V.1- 1970- v. 21, p. 317, 1983 (IJEVAW); dlt-mus-orl 5 mg/kg Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. v. 17, p. 405, 1976 (PESTD5); hma-mus-leu 7500 ug/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 6, p. 145, 1973 (EVHPAZ); hma-mus-sat 12400 ug/kg/3H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 291, 1977 (MUREAV); spm-mus-ipr 5 mg/kg/5D Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 4425, 1975 (PNASA6); trn-mus-ipr 5 mg/kg Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 51, 1974 (SOGEBZ); cyt-ham-oth 12500 ng/L Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 16, p. 1307, 1980 (GNKAA5); cyt-ham-ipr 2500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 287, 1994 (MUREAV); cyt-ham-emb 1 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2202, 1977 (CNREA8); cyt-ham-lng 330 umol/L/2H Hereditas (Lund, Sweden). (Gjoerloffsgatan 121, S-261 34 Landskrona, Sweden) V.1- 1947- v. 94, p. 21, 1981 (HEREAY); cyt-ham-fbr 3800 ug/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 917, 1981 (EVSRBT); sce-ham-unr 150 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 166, 1980 (MUREAV); sce-ham-oth 400 ng/L Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 16, p. 2164, 1980 (GNKAA5); sce-ham-oth 5 mg/L Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 16(4), p. 23, 1982 (CYGEDX); sce-ham-lng 10 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3270, 1984 (CNREA8); sce-ham-ipr 250 ug/kg Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 29B, p. 613, 1984 (BLFSBY); sce-ham-oth 1300 nmol/L Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 18, p. 210, 1982 (SOGEBZ); cyt-rbt-ivn 3 mg/kg Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 94, p. 1118, 1982 (BEXBAN); cyt-rbt-lym 30 mg/L Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 94, p. 1118, 1982 (BEXBAN); cyt-mky-ivn 3 mg/kg Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 103, p. 394, 1987 (BEXBAN); cyt-mky-lym 150 mg/L Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 103, p. 394, 1987 (BEXBAN); sce-mky-ivn 3 mg/kg Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 103, p. 394, 1987 (BEXBAN); sce-mky-lym 150 mg/L Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 103, p. 394, 1987 (BEXBAN); dni-rbt-kdy 15 mg/L Experimental Cell Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.10- 1950- v. 36, p. 92, 1964 (ECREAL) RE: T23 ipr-rat TDLo: 2 mg/kg (5D male) "Antifertility Compounds in the Male and Female," Jackson, H., Springfield, IL, Charles C. Thomas, 1966 -,37,1966 (85GUAJ); T34-T46-T41 ipr-rat TDLo: 5 mg/kg (12D preg) Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 23, p. 231, 1959 (PEDIAU); T01 ipr-rat TDLo: 7500 ug/kg (1D male) Hinyokika Kiyo. Journal of Urology. (Kyoto Daigaku Igakubu, Hinyokikagaku Kyoshitsu, 54 Kawara-machi, Shogain, Sakyo-ku, Kyoto 606, Japan) V.1- 1955- v. 12, p. 1339, 1966 (HIKYAJ); T34-T46 ipr-rat TDLo: 2500 ug/kg (12D preg) Nagasaki Igakkai Zasshi. Journal of Nagasaki Medical Association. (Nagasaki Igakkai, c/o Nagasaki Daigaku Igakubu, 12-4 Sakamoto-machi, Nagasaki 852, Japan) V.1- 1923- v. 41, p. 332, 1966 (NAGZAC); T35-T46 ipr-rat TDLo: 500 ug/kg (13D preg) Dopovidi Akademii Nauk Ukrains'koi RSR, Seriya B: Geologichini, Khimichni ta Biologichni Nauki. Transactions of the Academy of Sciences of the Ukranian SSR, Series B. (V/O Mezhdunarodnaya Kniga, 113095, Moscow, USSR) 1976- v. (3), p. 59, 1983 (DANND6); T23-T26 itt-rat TDLo: 8 mg/kg (1D male) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 22, p. 175, 1980 (CCPTAY); T24 orl-mus TDLo: 25 mg/kg (5D male) Proceedings of the European Society of Toxicology. (Amsterdam, Netherlands) V.16-18, 1975-77. Discontinued. v. 17, p. 405, 1976 (PESTD5); T85 ipr-mus TDLo: 625 ug/kg (12D preg) Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 31(1), p. 101, 1995 (GNKAA5); T46 ipr-mus TDLo: 1 mg/kg (10D preg) Okajimas Folia Anatomica Japonica. (Keio Univ., School of Medicine, Dept. of Anatomy, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.14- 1936- v. 44, p. 203, 1968 (OFAJAE); T01-T24 ipr-mus TDLo: 1250 ug/kg (1D male) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 88, p. 1074, 1979 (BEXBAN); T43 ipr-mus TDLo: 5 mg/kg (10D preg) Okajimas Folia Anatomica Japonica. (Keio Univ., School of Medicine, Dept. of Anatomy, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.14- 1936- v. 44, p. 203, 1968 (OFAJAE); T41-T45 ipr-mus TDLo: 7500 ug/kg (7D preg) Okajimas Folia Anatomica Japonica. (Keio Univ., School of Medicine, Dept. of Anatomy, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.14- 1936- v. 44, p. 203, 1968 (OFAJAE); T34 ipr-mus TDLo: 3 mg/kg (10D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 7, p. 66, 1967 (SEIJBO); T01 ipr-ham TDLo: 5 mg/kg (5D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 8, p. 307, 1981 (JTEHD6); T02 ipr-ham TDLo: 1 mg/kg (5D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 8, p. 307, 1981 (JTEHD6); T23-T26 itt-ham TDLo: 16 mg/kg (1D male) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 22, p. 175, 1980 (CCPTAY) TE: V01-P61 par-man TDLo: 33 mg/kg/3Y-I Canadian Medical Association Journal. (Canadian Medical Assoc., POB 8650, Ottawa, ON K1G 0G8, Canada) V.1- 1911- v. 129, p. 578, 1983 (CMAJAX); V01-P61 unr-wmn TDLo: 17 mg/kg/56W-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 775, 1970 (LANCAO); V01-D45-R60 ipr-rat TDLo: 218 mg/kg/1Y-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-58, 1978 (NCITR*); V01-K60-P62 ivn-rat TDLo: 52 mg/kg/1Y-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 20, p. 1461, 1970 (ARZNAD); V03-R60 skn-mus TDLo: 10 gm/kg/17W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 57, p. 295, 1966 (GANNA2); V02-J60 ipr-mus TDLo: 47 mg/kg/8W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 3069, 1973 (CNREA8); V01-P61-P62 ipr-mus TD :360 mg/kg/1Y-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-58, 1978 (NCITR*); V01-D45-R60 ipr-rat TD :218 mg/kg/1Y-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-58, 1978 (NCITR*) ORNG: 23000000 ng/kg. [23.000000 mg/kg] T/E unlistd AT: C10-P26 par-man TDLo: 631 ug/kg Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 38, p. 1471, 1976 (CANCAR); T/E unlistd orl-rat LD50: 23 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 9, p. 759, 1967 (YAKUD5); T/E unlistd ipr-rat LD50: 8 mg/kg Clinical Proceedings of the Children's Hospital of the District of Columbia. (Washington, DC) V.1-27, 1971. For publisher information, see CPNMAQ. v. 18, p. 307, 1962 (CPCHAO); T/E unlistd scu-rat LD50: 7800 ug/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 9, p. 759, 1967 (YAKUD5); T/E unlistd ivn-rat LD50: 9400 ug/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 8, p. 1, 1958 (ARZNAD); T/E unlistd iat-rat LD50: 8750 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 4, p. 344, 1962 (TXAPA9); C08-F07-F19 orl-mus LD50: 38 mg/kg "Imifos," Giller, S.A., ed., Izd, Riga, USSR, 1968 -,129,1968 (21ACAB); T/E unlistd ipr-mus LD50: 11 mg/kg Fiziologicheski Aktivnye Veshchestva. Physiologically Active Substances. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1966- v. 22, p. 36, 1990 (FAVUAI); L02-M03-P27 scu-mus LD50: 16500 ug/kg Farmakologiya i Toksikologiya (Kiev). Pharmacology and Toxicology. (Kievskii Nauchno- Issledovatel'skii Institut Farmakologii i Toksikologii, Kiev, USSR) No.1- 1964- v. 8, p. 73, 1973 (FATOBP); T/E unlistd ivn-mus LD50: 14500 ug/kg Journal of Antibiotics, Series A. (Tokyo, Japan) V.6-20, 1953-67. For publisher information, see JANTAJ. v. 13, p. 19, 1960 (JAJAAA); V30 ims-mus LD50: 11500 ug/kg Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- v. 17, p. 353, 1983 (PCJOAU); P14-P15-P30 ivn-dog LDLo: 760 ug/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 203, 1965 (CCSUBJ); P14-P15-P30 ivn-mky LDLo: 1500 ug/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 203, 1965 (CCSUBJ); L02-M03-P27 ivn-rbt LD50: 5500 ug/kg Farmakologiya i Toksikologiya (Kiev). Pharmacology and Toxicology. (Kievskii Nauchno- Issledovatel'skii Institut Farmakologii i Toksikologii, Kiev, USSR) No.1- 1964- v. 8, p. 73, 1973 (FATOBP); T/E unlistd orl-qal LD50: 237 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 6, p. 149, 1982 (EESADV); T/E unlistd orl-bwd LD50: 5620 ug/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 85, 1975 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 123, 1990 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 123, 1990 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 85, 1975 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 123, 1990 (IMEMDT); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Arquivos de Neuro-Psiquiatria. (Caixa Postal 30.657, 01051 Sao Paulo, Brazil) V.1- 1943- v. 5, p. 447, 1965 (ANPIAM); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 2, p. 159, 1973 (CRTXB2) ND: NOES 1983: HZD X4618; NIS 1; TNF 142; NOS 6; TNE 11452; TFE 8724 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-C3H/10T1/2; EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-nonhuman; EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, Rodent heritable translocation; EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse, D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive/dose response: In vivo cytogenetics-nonhuman bone marrow; EPA GENETOX PROGRAM 1988, Positive/dose response: Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman; NCI Carcinogenesis Bioassay (ipr), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-58, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 956 of 1119 in RTECS (through 2003/06) AN: SZ7710000 PN: Phosphonic-acid,-dimethyl-ester- SY: Bis(hydroxymethyl)phosphine oxide; Dimethoxyphosphine-oxide-; Dimethyl-acid-phosphite-; Dimethyl-hydrogen-phosphite-; Dimethyl-hydrogen-phosphonate-; Dimethyl-phosphite-; Dimethyl-phosphonate-; Dimethyl-phosphorous-acid-; Dimethylester-kyseliny-fosforite- (Czech); Dimethylfosfit- (Czech); Dimethylfosfonat- (Czech); Dimethylhydrogenphosphite-; Hydrogen-dimethyl-phosphite-; Methyl-phosphonate- ((MeO)2HPO); NCI-C54773-; Phosphorous-acid-dimethyl-ester- RN: Current: 868-85-9 UD: 200210 MF: C2-H7-O3-P MW: 110.06 WL: 1OPHO&O1 CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1115,1986 (85JCAE); eye-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1115,1986 (85JCAE) ME: mmo-sat 7500 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); mnt-mus-ipr 1500 mg/kg/3D-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 21, p. 160, 1993 (EMMUEG); mmo-mus-lym 1700 mg/L (+S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); msc-mus-lym 2100 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); cyt-ham-ovr 1600 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 250 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V01-J60-K60 orl-rat TDLo: 103 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-287, 1985 (NTPTR*); V01-J60-K60 orl-rat TDLo: 144200 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-144805/AS (NTIS**); V03-J60 orl-rat TDLo: 72100 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-144805/AS (NTIS**) ORNG: 3040000000 ng/kg. [3040.000000 mg/kg] T/E unlistd SRNG: 681000000 ng/kg. [681.000000 mg/kg] F07-F19 AT: T/E unlistd orl-rat LD50: 3040 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-287, 1985 (NTPTR*); T/E unlistd ihl-rat LC50: >20 gm/m3 Albright and Wilson Inc. (P.O. Box 26229, Richmond, VA 23260-6229) #OPB-3, 1984 (ALBRW*); T/E unlistd scu-rat LD50: 2970 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 36(4), p. 22, 1992 (GTPZAB); E08-J26-K01 orl-mus LD50: 1831 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 36(4), p. 22, 1992 (GTPZAB); D28-J22 ihl-mus LC :>7100 mg/m3/6H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0537047 (NTIS**); T/E unlistd scu-mus LD50: 2610 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 36(4), p. 22, 1992 (GTPZAB); F07-F19 skn-rbt LD50: 681 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0537044 (NTIS**); E08-J26-K01 orl-gpg LD50: 900 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 36(4), p. 22, 1992 (GTPZAB); J30-P01 ihl-gpg LC :>7100 mg/m3/6H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0537047 (NTIS**) MD: F07-Z01 orl-rat TDLo: 7500 mg/kg/15D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-287, 1985 (NTPTR*); D26-U01-Z01 orl-rat TDLo: 26 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-287, 1985 (NTPTR*); Z01 orl-mus TDLo: 30 gm/kg/15D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-287, 1985 (NTPTR*); J16-Z01 orl-mus TDLo: 97500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-287, 1985 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 85, 1990 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1437, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1437, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1437, 1999 (IMEMDT) SR: OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999 ND: NOHS 1974: HZD 84136; NIS 1; TNF 21; NOS 2; TNE 41; NOES 1983: HZD 84136; NIS 1; TNF 7; NOS 1; TNE 1822; TFE 272 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 957 of 1119 in RTECS (through 2003/06) AN: SZ9120000 PN: Phosphonic-acid,-methyl-,-dimethyl-ester- SY: DMMP-; Dimethyl-methanephosphonate-; Dimethyl-methylphosphonate-; Fyrol-DMMP-; Methanephosphonic-acid-dimethyl-ester-; Methyl-phosphonic-acid,-dimethyl-ester-; NCI-C54762- RN: Current: 756-79-6 BRN: 878263 BHR: 4-04-00-03499 UD: 200210 MF: C3-H9-O3-P MW: 124.09 WL: 1OPO&1&O1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: slt-dmg-orl 24 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 51, 1994 (EMMUEG); spm-rat-orl 61250 mg/kg/7W-I Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 41, p. 126, 1984 (EXMPA6); dlt-mus-orl 65 gm/kg/13W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 138, p. 213, 1984 (MUREAV); cyt-ham-ovr 250 mg/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A124-785 (NTIS**); sce-ham-ovr 11 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 15, 1987 (MUREAV) RE: T01-T23 orl-rat TDLo: 63 gm/kg (63D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 379, 1984 (TXAPA9); T02-T03 orl-rat TDLo: 126 gm/kg (63D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 379, 1984 (TXAPA9); T25 orl-rat TDLo: 15750 mg/kg (63D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 379, 1984 (TXAPA9); T01-T02 orl-rat TDLo: 61250 mg/kg (7W male) Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 41, p. 126, 1984 (EXMPA6); T25 orl-mus TDLo: 10 gm/kg (20D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 138, p. 213, 1984 (MUREAV); T81 orl-mus TDLo: 33 gm/kg (7-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-220143 (NTIS**); T81 orl-mus TDLo: 33400 mg/kg (6-13D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 29, 1987 (TCMUD8) TE: V01-M61 orl-rat TDLo: 515 gm/kg/2Y-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 91, 1988 (FAATDF); V01-M61-P61 orl-rat TDLo: 515000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB88-168695 (NTIS**) ORNG: 8210000000 ng/kg. [8210.000000 mg/kg] F18 AT: F18 orl-rat LD50: 8210 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) FYI-OTS-0483-0242 (TSCAT*); T/E unlistd ivn-rat LD50: 1050 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) FYI-OTS-0483-0242 (TSCAT*); T/E unlistd orl-mus LD50: >6810 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-323, 1987 (NTPTR*); F18-J25-J30 ivn-mus LD50: 912 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) FYI-OTS-0483-0242 (TSCAT*); F07-F19 orl-ckn LD50: 3998 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) FYI-OTS-0483-0242 (TSCAT*) MD: M03-M30-M71 orl-rat TDLo: 2500 mg/kg/5D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 24, 2000 (TOSCF2); Z01 orl-rat TDLo: 75 gm/kg/15D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-323, 1987 (NTPTR*); L70-Z01 orl-rat TDLo: 130 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-323, 1987 (NTPTR*); K05-K30-Z01 orl-mus TDLo: 150 gm/kg/15D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-323, 1987 (NTPTR*); Z01 orl-mus TDLo: 260 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-323, 1987 (NTPTR*) ND: NOHS 1974: HZD A1091; NIS 2; TNF 35; NOS 4; TNE 204; NOES 1983: HZD A1091; NIS 5; TNF 53; NOS 8; TNE 2134; TFE 763 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-323, 1987 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; NCI Carcinogenesis Studies (gavage), inadequate study: mouse Record 958 of 1119 in RTECS (through 2003/06) AN: SZ9660000 PN: Phosphonic-acid,-morpholino-,-dimethyl-ester- SY: DMMPA-; Dimethyl-4-morpholinylphosphonate-; Dimethyl-morpholinophosphonate-; Dimethyl-morpholinophosphoramidate-; Dimethylmorpholinophosphonate-; Dmmpa-; HC-1717-; Morpholinophosphonic-acid-dimethyl-ester-; NCI-C54740-; Phosphonic-acid,-4-morpholinyl-,-dimethyl-ester-; Phosphonic-acid,-4-morpholinyl-,-dimethyl-ester- (9CI); Phosphonic-acid,-morpholino,-dimethyl-ester- RN: Current: 597-25-1 BRN: 141995 BHR: 4-27-00-00629 UD: 200210 MF: C6-H14-N-O4-P MW: 195.18 WL: T6N DOTJ APO&O1&O1 CC: Tumorigen (C); Mutagen (M) ME: slt-dmg-orl 37 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 51, 1994 (EMMUEG); msc-mus-lym 2200 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); cyt-ham-ovr 3 gm/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); sce-ham-ovr 3 gm/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*) TE: V01-P61 orl-rat TDLo: 309 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); V01-P61 orl-rat TDLo: 309000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-186491/AS (NTIS**) ORNG: 5910000000 ng/kg. [5910.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 5910 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A044-988 (NTIS**); T/E unlistd ipr-rat LD50: 2370 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A044-988 (NTIS**); J30 ivn-rat LD50: 350 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); T/E unlistd ims-rat LD50: 5200 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); T/E unlistd orl-mus LD50: 3300 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); T/E unlistd ipr-mus LD50: 5 gm/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); T/E unlistd ivn-mus LD50: 400 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); T/E unlistd ims-mus LD50: 4800 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); J24 ivn-rbt LD50: 347 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A044-988 (NTIS**) MD: Z01 orl-rat TDLo: 35 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); L70-Z01 orl-rat TDLo: 52 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); Z01 orl-mus TDLo: 28 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); Z01 orl-mus TDLo: 26 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*) SL: EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-298, 1986 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 959 of 1119 in RTECS (through 2003/06) AN: TA2450000 PN: Phosphonium, tetrakis(hydroxymethyl)-, chloride SY: NCI-C55061-; Tetrahydroxymethylphosphonium-chloride-; Tetrakis-(hydroxymethyl)fosfoniumchlorid (Czech); Tetrakis(hydroxymethyl)phosphonium chloride; THPC- RN: Current: 124-64-1 UD: 200210 MF: C4-H12-O4-P.Cl MW: 190.58 WL: Q1P1Q1Q1Q &G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mtr-mus-emb 5000 ppm Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 259, 1980 (JTEHD6); msc-mus-lym 6 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-296, 1987 (NTPTR*); mtr-ham-kdy 5000 ppm Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 259, 1980 (JTEHD6); cyt-ham-ovr 45 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-296, 1987 (NTPTR*); cyt-ham-lng 87 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); sce-ham-ovr 15 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-296, 1987 (NTPTR*); msc-ham-lng 5000 ppm Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 259, 1980 (JTEHD6) TE: V03-P61 orl-rat TDLo: 1931.25 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-204137/AS (NTIS**) ORNG: 161000000 ng/kg. [161.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 161 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-296, 1987 (NTPTR*); T/E unlistd ipr-mus LDLo: 125 mg/kg "Summary Tables of Biological Tests," National Research Council Chemical-Biological Coordination Center. (National Academy of Science Library, 2101 Constitution Ave., NW, Washington, DC 20418) v. 7, p. 789, 1955 (CBCCT*); T/E unlistd orl-mam LD50: 400 mg/kg Kobunshi. High Polymers. (Kobunshi Gakkai, 5-12-8, Ginza, Chuo-Ku, Tokyo 104, Japan) V.1- 1952- v. 24, p. 788, 1975 (KOBUA3); T/E unlistd skn-mam LD50: 3800 mg/kg Kobunshi. High Polymers. (Kobunshi Gakkai, 5-12-8, Ginza, Chuo-Ku, Tokyo 104, Japan) V.1- 1952- v. 24, p. 788, 1975 (KOBUA3) MD: C02-F18 orl-rat TDLo: 7200 mg/kg/90D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 2, p. 115, 1982 (TOXID9) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 95, 1990 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1529, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1529, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1529, 1999 (IMEMDT); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 17, p. 101, 1980 (CTOXAO) ND: NOHS 1974: HZD T0112; NIS 1; TNF 25; NOS 1; TNE 100 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), no evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-296, 1987 (NTPTR*) Record 960 of 1119 in RTECS (through 2003/06) AN: TA2570000 PN: Phosphonium, tetrakis(hydroxymethyl)-, sulfate (2:1) SY: Octakis(hydroxymethyl)phosphonium sulfate; Bis(tetrakis(hydroxymethyl)phosphonium)sulfate (salt); NCI-C55050-; Pyroset-TKO-; Tetrakis(hydroxymethyl)phosphonium sulfate; THPS- RN: Current: 55566-30-8 UD: 200210 MF: C8-H24-O8-P2.O4-S MW: 406.32 WL: Q1P1Q1Q1Q 2 &WSW CC: Tumorigen (C); Mutagen (M) ME: mtr-mus-emb 5000 ppm Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 259, 1980 (JTEHD6); msc-mus-lym 6 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-296, 1987 (NTPTR*); mtr-ham-kdy 5000 ppm Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 259, 1980 (JTEHD6); msc-ham-lng 5000 ppm Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 259, 1980 (JTEHD6) TE: V03-P61 orl-rat TDLo: 2575 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-204137/AS (NTIS**) ORNG: 248000000 ng/kg. [248.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 248 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-296, 1987 (NTPTR*) MD: L30 orl-rat TDLo: 650 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-296, 1987 (NTPTR*) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 95, 1990 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1529, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1529, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1529, 1999 (IMEMDT) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat Record 961 of 1119 in RTECS (through 2003/06) AN: TC0350000 PN: Phosphoric-acid,-2,2-dichlorovinyl-dimethyl-ester- SY: (2,2-Dichloor-vinyl)-dimethyl-fosfaat (Dutch); (2,2-Dichlor-vinyl)-dimethyl-phosphat (German); (2,2-Dichloro-vinil)dimetil-fosfato (Italian); 2,2-Dichloroethenyl-dimethyl-phosphate-; 2,2-Dichloroethenyl-phosphoric-acid-dimethyl-ester-; 2,2-Dichlorovinyl-dimethyl-phosphate-; 2,2-Dichlorovinyl-dimethyl-phosphoric-acid-ester-; Apavap-; Astrobot-; Atgard-; Atgard-C-; Atgard-V-; BAY-19149-; Bayer-19149-; Benfos-; Bibesol-; Brevinyl-; Brevinyl-E50-; Canogard-; Chlorvinphos-; Cypona-; DDVP-; DDVP- (OSHA); DDVP- (insecticide); Dedevap-; Denkavepon-; Deriban-; Derribante-; Devikol-; Dichlofos-; Dichloorvo- (Dutch); Dichlorfos- (Polish); Dichlorman-; Dichlorovos-; Dichlorvos-; Dichlorvos- (ACGIH:OSHA); Dimethyl-2,2-dichloroethenyl-phosphate-; Dimethyl-2,2-dichlorovinyl-phosphate-; Dimethyl-dichlorovinyl-phosphate-; Divipan-; ENT-20738-; Equigard-; Equigel-; Estrosel-; Estrosol-; Ethenol,-2,2-dichloro-,-dimethyl-phosphate-; Fecama-; Fekama-; Fly-fighter-; Fly-Die-; Insectigas-D-; MAFU-strip-; Marvex-; Mopari-; NCI-C00113-; NO-Pest-; NO-Pest-strip-; NSC-6738-; Nefrafos-; Nerkol-; Nogos-; Nogos-50-; Nogos-50-EC-; Nogos-G-; Novotox-; Nuvan-; Nuvan-100EC-; Nuvan-7-; O,O-Dimethyl-2,2-dichlorovinyl-phosphate-; O,O-Dimethyl-O-2,2-dichlorovinyl-phosphate-; O,O-Dimethyl-dichlorovinyl-phosphate-; O,O-Dimethyl-O-(2,2-dichlor-vinyl)-phosphat (German); O,O-Dwumetylo-O-dwuchlorowinylofosforan- (Polish); O,O-dimethyl-O-(2,2-dichlorovinyl)phosphate; O-(2,2-Dichlorvinyl)-O,O-dimethylphosphat (German); OKO-; OMS-14-; Panaplate-; Phosphate-de-dimethyle-et-de-2,2-dichlorovinyle- (French); Phosphoric-acid,-2,2-dichloroethenyl-dimethyl-ester- (9CI); Phosvit-; SD-1750-; Szklarniak-; TAP-9VP-; Task-; Tetravos-; Unifos-; Unifos- (pesticide); Unifos-50-EC-; Unitox-; Vapona-; Vapona-insecticide-; Vaponite-; Vapora-II-; Vinyl-alcohol,-2,2-dichloro-,-dimethyl-phosphate-; Vinylofos-; Vinylophos-; Winylophos- RN: Current: 62-73-7 Previous: 8023-22-1; 8072-21-7; 8072-39-7; 11095-17-3; 11096-21-2; 12772-40-6; 55819-32-4; 62139-95-1; 95828-55-0; 116788-91-1 BRN: 1709141 BHR: 4-01-00-02063 UD: 200305 MF: C4-H7-Cl2-O4-P MW: 220.98 WL: GYGU1OPO&O1&O1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Organometallic (O); Reproductive-Effector (T) ME: mmo-sat 333 ug/plate (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11(Suppl 12), p. 1, 1988 (EMMUEG); mmo-esc 5 pph (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 19, 1976 (MUREAV); oms-esc 3820 nmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19, p. 98, 1992 (EMMUEG); dnr-esc 60 nmol/plate Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 458, 1973 (CNREA8); dnd-esc 1 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 52, p. 161, 1978 (MUREAV); pic-esc 70 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 193, 1987 (MUREAV); dnr-bcs 10 pph Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 19, 1976 (MUREAV); mmo-srm 25 mg/L (-S9) Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 30, p. 67, 1972 (ATXKA8); mmo-klp 1000 ppm (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 16, p. 413, 1972 (MUREAV); mmo-omi 5600 ug/plate (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 297, 1978 (CBINA8); mmo-omi 1000 ppm (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 16, p. 413, 1972 (MUREAV); mmo-omi 80 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 175, 1973 (MUREAV); dnr-omi 10 umol/plate Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 39, p. 339, 1982 (CBINA8); sln-dmg-orl 750 ppb Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 28, p. 405, 1975 (MUREAV); mrc-smc 19 mmol/L/6H IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 10, p. 161, 1974 (IARCCD); mmo-asn 14 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 395, 1977 (MUREAV); mrc-asn 28 mg/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 395, 1977 (MUREAV); sln-asn 800 mg/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 31, p. 81, 1979 (EVHPAZ); mmo-ssp 5 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 139, 1983 (MUREAV); mmo-ssp 5 mmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 139, 1983 (MUREAV); dnd-sal-spr 14 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 8, p. 171, 1974 (CBINA8); cyt-ofs-mul 10 ppb Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 344, p. 1, 1995 (MUREAV); dnd-hmn-lym 62 mg/L Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 66, p. 425, 1980 (TUMOAB); dnd-hmn-hla 970 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 8, p. 171, 1974 (CBINA8); dns-hmn-oth 65 mmol/L Pesticide Science. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1970- v. 15, p. 439, 1984 (PSSCBG); dni-hmn-lym 62 mg/L Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 66, p. 425, 1980 (TUMOAB); cyt-hmn-lym 1 mg/L Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959- v. 18, p. 1490, 1976 (TSITAQ); mtr-rat-oth 40 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 439, 1988 (MUREAV); cyt-rat-oth 80 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 439, 1988 (MUREAV); sce-rat-oth 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 206, p. 439, 1988 (MUREAV); dnd-mus-ipr 420 ug/kg Acta Pharmacologica et Toxicologica, Supplementun. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) No.1- 1947- v. 49(5), p. 56, 1981 (APTSAI); dnd-mus-ihl 8 mg/kg Pesticide Biochemistry and Physiology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1971- v. 6, p. 101, 1976 (PCBPBS); msc-mus-lym 12500 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-342, 1989 (NTPTR*); hma-mus-smc 4 mg/L Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 30, p. 61, 1972 (ATXKA8); spm-mus-ipr 35 mg/kg/5D Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 4425, 1975 (PNASA6); mtr-ham-emb 110 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 515, 1986 (ENMUDM); dnd-ham-lng 2000 ppm/60M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 24, p. 365, 1974 (MUREAV); cyt-ham-ipr 3 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 152, 1986 (ARTODN); cyt-ham-lng 100 mg/L Applied Methods in Oncology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 3, p. 253, 1980 (AMONDS); cyt-ham-ovr 160 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-342, 1989 (NTPTR*); sce-ham-ovr 30 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 8, p. 939, 1981 (JTEHD6); sce-ham-lng 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 78, p. 177, 1980 (MUREAV); dnd-mam-lym 100 uL Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 57, p. 393, 1970 (NATWAY); pic-esc 0.284 mmol/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 206, 2000 (EMMUEG); msc-mus-ipr 55 mg/kg/22D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 146, p. 155, 1999 (CALEDQ) RE: T83 orl-rat TDLo: 39200 ug/kg (14-21D preg) Neuropatologia Polska. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1963- v. 15, p. 255, 1977 (NUPOBT); T81-T86-T91 orl-rat TDLo: 220 mg/kg (multigeneration) International Journal of Environmental Health Research. (Carfax Publishing Co., POB 25, Abingdon, Oxon. Ox14 3UE, UK) V.1- 1991- v. 5, p. 239, 1995 (IJEREO); T45 ipr-rat TDLo: 15 mg/kg (11D preg) Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 16, p. 805, 1968 (AEHLAU); T01-T02 unr-rat TDLo: 40 mg/kg (2D male) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 15, p. 458, 1976 (BECTA6); T01 orl-mus TDLo: 180 mg/kg (18D male) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 11(5), p. 429, 1974 (BECTA6); T25 orl-rbt TDLo: 65 mg/kg (6-13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 20, p. 383, 1979 (TJADAB); T83 orl-rbt TDLo: 60 mg/kg (22-31D preg) Folia Histochemica et Cytochemica. (Cracow, Poland) V.1-21, 1963-83. v. 16, p. 335, 1978 (FHCYAI); T34 ihl-rbt TCLo: 4 mg/m3/23H (1-28D preg) Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 30, p. 29, 1972 (ATXKA8); T83 unr-rbt TDLo: 60 mg/kg (22-31D preg) Folia Histochemica et Cytochemica. (Cracow, Poland) V.1-21, 1963-83. v. 16, p. 139, 1978 (FHCYAI); T41-T48-T52 orl-pig TDLo: 255 mg/kg (41-70D preg) Zentralblatt fuer Veterinaermedizin, Reihe A. (Verlag Paul Parey, Linderstr. 44-47, D-1000 Berlin 61, Fed. Rep. Ger.) V.10- 1963- v. 27, p. 662, 1980 (ZVRAAX); T83 orl-pig TDLo: 759 mg/kg (1-15W preg/4W post) Canadian Journal of Animal Science. (Agricultural Institute of Canada, 151 Slater St., Suite 907, Ottawa, ON K1P 5H4, Canada) V.37- 1957- v. 71, p. 227, 1991 (CNJNAT); T41 unr-gpg TDLo: 90 mg/kg (42-44D preg) Neurochemical Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1976- v. 19, p. 569, 1994 (NEREDZ) TE: V02-J60-K60 orl-rat TDLo: 4120 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-342, 1989 (NTPTR*); V01-K60-P61 orl-rat TDLo: 2060 mg/kg/2Y-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 82, p. 157, 1991 (JJCREP); V01-K60 orl-mus TDLo: 20600 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-342, 1989 (NTPTR*); V01-K60-P61 orl-rat TDLo: 2060 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-198508 (NTIS**); V02-R60 orl-rat TDLo: 2060 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-198508 (NTIS**); V02-K60 orl-mus TDLo: 10300 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-198508 (NTIS**); V02-K60 orl-mus TDLo: 20600 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-198508 (NTIS**) ORNG: 17000000 ng/kg. [17.000000 mg/kg] T/E unlistd SRNG: 107000000 ng/kg. [107.000000 mg/kg] T/E unlistd SKNG: 750000 ng/kg. [0.750000 mg/kg] T/E unlistd IHNG: 15000000 ng/m3/4H. [15.000000 mg/m3/4H] D17-F11-K01 AT: T/E unlistd orl-rat LD50: 17 mg/kg Japan Pesticide Information. (Japan Plant Protection Assoc., 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For publisher information, see AGJAEP. v. (13), p. 36, 1972 (JPIFAN); D17-F11-K01 ihl-rat LC50: 15 mg/m3/4H Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(12), p. 35, 1968 (GISAAA); T/E unlistd skn-rat LD50: 750 ug/kg Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 35, 1995 (TOVEFN); A30-P30-Y01 ipr-rat LD50: 15 mg/kg Acta Pharmacologica et Toxicologica, Supplementun. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) No.1- 1947- v. 49(5), p. 67, 1981 (APTSAI); T/E unlistd scu-rat LD50: 10800 ug/kg Acta Physiologica Polonica. (Karger-Libri, POB CH-4009, Warszawa, Switzerland) V.1-41, 1950-90. v. 32, p. 507, 1981 (APYPAY); Y01 unr-rat LD50: 57 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(12), p. 35, 1968 (GISAAA); T/E unlistd orl-mus LD50: 61 mg/kg Osaka Shiritsu Daigaku Igaku Zasshi. Journal of the Osaka City Medical Center. (Osaka, Japan) V.4-23, 1955-74. For publisher information, see OIGZDE. v. 15, p. 553, 1966 (OSDIAF); D17-F11-K01 ihl-mus LC50: 13 mg/m3/4H Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(12), p. 35, 1968 (GISAAA); T/E unlistd skn-mus LD50: 206 mg/kg Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.25- 1961- v. 27, p. 684, 1963 (ABCHA6); Y01 ipr-mus LD50: 22 mg/kg Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 11, p. 91, 1963 (JAFCAU); F12-D35-J22 scu-mus LD50: 24 mg/kg Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 31, p. 170, 1962 (IMSUAI); T/E unlistd ivn-mus LD50: 18 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#00004 (CSLNX*); Y01 unr-mus LD50: 75 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(12), p. 35, 1968 (GISAAA); T/E unlistd orl-dog LD50: 100 mg/kg "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A141,1984 (85JFAN); F07-K12-K13 ivn-dog LDLo: 2200 ug/kg Australian Veterinary Journal. (Australian Veterinary Assoc., Executive Director, 134-136 Hampden Road, Artarmon, N.S.W., Australia) V.2- 1927- v. 49, p. 113, 1973 (AUVJA2); E08-Y01 orl-rbt LD50: 10 mg/kg Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 83, p. 32, 1977 (BEXBAN); T/E unlistd skn-rbt LD50: 107 mg/kg Bulletin of the Entomological Society of America. (Entomological Soc. of America, 4603 Calvert Rd., College Park, MD 20740) V.1- 1955- v. 12, p. 117, 1966 (BESAAT); Y01 unr-rbt LD50: 23 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(12), p. 35, 1968 (GISAAA); K13-Y01 orl-pig LD50: 157 mg/kg American Journal of Veterinary Research. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.1- 1940- v. 40, p. 315, 1979 (AJVRAH); T/E unlistd ipr-ham LD50: 30 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 152, 1986 (ARTODN); T/E unlistd orl-pgn LD50: 23700 ug/kg ASTM Special Technical Publication. (American Soc. for Testing Materials, 1916 Race St., Philadelphia, PA 19103) No.1- 1911- v. (680), p. 157, 1979 (ASTTA8); Y01 orl-ckn LD50: 6450 ug/kg Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221 005, India) V.1- 1968(?)- v. 10, p. 323, 1978 (INJPD2); F11-F12-K12 orl-qal LD50: 22010 ug/kg Hokkaidoritsu Eisei Kenkyushoho. Report of the Hokkaido Institute of Public Health. (Nishi- 12-chome, Kita-19-jo, Kita-ku, Sapporo 060, Japan) No.1- 1951- v. 24, p. 35, 1974 (HOEKAN); T/E unlistd orl-dck LD50: 7800 ug/kg Down to Earth. (Dow Chemical USA, Agricultural Products Dept., Midland, MI 48640) V.1- 1945- v. 35, p. 25, 1979 (DOEAAH); T/E unlistd unr-mam LD50: 125 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 41(8), p. 82, 1976 (GISAAA); T/E unlistd orl-bwd LD50: 12 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 315, 1972 (TXAPA9); T01-T02 orl-mus TDLo: 40 mg/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 11, p. 429, 1974 (BECTA6); P28-Y02-Y37 ipr-rat TDLo: 8 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S86, 2002 (TOLED5); T/E unlistd unr-rat LD50: 40 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 97, 1987 (FATOAO); Y23-Y61-Y65 ipr-rat TDLo: 10 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 334, 1981 (FATOAO) MD: L30-P30-Y37 orl-rat TDLo: 360 mg/kg/90D-I Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 21, p. 31, 1988 (BCTKAG); L30-M30-Y04 orl-rat TDLo: 56 mg/kg/14D-I Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 7, p. 201, 1974 (BCTKAG); A10-C16-Y01 orl-rat TDLo: 45 mg/kg/6W-I Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 10, p. 429, 1988 (NETEEC); U01-Y01-Z01 ihl-rat TDLo: 8200 ug/m3/45D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(12), p. 35, 1968 (GISAAA); A30-L30-Y01 skn-rat TDLo: 141 mg/kg/17W-I Acta Physiologica Polonica. (Karger-Libri, POB CH-4009, Warszawa, Switzerland) V.1-41, 1950-90. v. 32, p. 507, 1981 (APYPAY); L30-U01-Y01 scu-rat TDLo: 28 mg/kg/28D-I Acta Physiologica Polonica. (Karger-Libri, POB CH-4009, Warszawa, Switzerland) V.1-41, 1950-90. v. 31, p. 575, 1980 (APYPAY); L30-M03-U01 scu-rat TDLo: 21600 ug/kg/17W-I Acta Physiologica Polonica. (Karger-Libri, POB CH-4009, Warszawa, Switzerland) V.1-41, 1950-90. v. 32, p. 507, 1981 (APYPAY); Z01 orl-mus TDLo: 5200 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-342, 1989 (NTPTR*); A30-F07-Y01 scu-mus TDLo: 100 mg/kg/10D-I Journal of Health Science. (Pharmaceutical Society of Japan, 2-12-15 Shibuya, Shibuya-Ku, Tokyo 150-0002, Japan) V. 45- 1999- v. 45, p. 191, 1999 (JHSCFD); A30-M10-Y01 orl-dog TDLo: 56250 ug/kg/90D-C Nippon Yakuzaishikai Zasshi. Journal of the Japan Pharmaceutical Association. (Nippon Yakuznishikai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1949- v. 26, p. 739, 1974 (NYZZA3); P30-Y01 skn-mky TDLo: 750 mg/kg/10D-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 15, p. 340, 1957 (AMIHAB); Z01 skn-mky TDLo: 400 mg/kg/4D-I Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 30, p. 1229, 1979 (YKYUA6); A30-U01-Y01 orl-ckn TDLo: 2450 mg/kg/28D-C Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221 005, India) V.1- 1968(?)- v. 10, p. 323, 1978 (INJPD2); P28-Y01-Y16 orl-dom TDLo: 112 mg/kg/28D-I Indian Veterinary Journal. (Dr. R. Krishnamurti, G.M.V.C., 8 Avenue Rd., Madras 600 034, India) V.1- 1924- v. 66, p. 821, 1989 (IVEJAC); A30-P30-Y01 orl-rat TDLo: 150 mg/kg/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. -, p. 64, 1993 (GISAAA); T02 orl-mus TDLo: 90 mg/kg/9D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 11, p. 429, 1974 (BECTA6); T01 orl-mus TDLo: 180 mg/kg/18D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 11, p. 429, 1974 (BECTA6); P28-Y02-Y37 ipr-rat TDLo: 16 mg/kg/2D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S86, 2002 (TOLED5); P28-Y02-Y37 ipr-rat TDLo: 24 mg/kg/3D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S86, 2002 (TOLED5) TR: ACGIH TLV-TWA 0.1 mg/m3 (skin) (I,V) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.90 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 267, 1991 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 97, 1979 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 97, 1979 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 267, 1991 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 267, 1991 (IMEMDT); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 46, p. 1, 1973 (RREVAH); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 32, p. 133, 1975 (MUREAV); TOXICOLOGY REVIEW Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- v. 10(3), p. 43, 1975 (CNDQA8); TOXICOLOGY REVIEW Nippon Yakuzaishikai Zasshi. Journal of the Japan Pharmaceutical Association. (Nippon Yakuznishikai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1949- v. 26, p. 739, 1974 (NYZZA3); TOXICOLOGY REVIEW New Scientist. (IPC Magazines Ltd., King's Reach Tower, Stamford St., London SE1 9LS, UK) V.1- 1956- v. 53, p. 489, 1972 (NWSCAL); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 63, p. 1, 1976 (RREVAH); TOXICOLOGY REVIEW Alimentation et la Vie. (Societe Scientifique d'Hygiene Alimentaire, 16, rue de l'Estrapade, 75005 Paris, France) V.39- 1951- v. 50, p. 77, 1962 (ALLVAR) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 0.1 ppm (1.0 mg/m3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 16, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 1 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.1 ppm (1 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 0.1 ppm (1 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 0.1 ppm (1 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 01 ppm (0.9 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 0.1 ppm (1 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 1 mg/m3, STEL 3 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 0.1 ppm (1 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 0.1 ppm (1 mg/m3), Skin, JAN 1999; OEL-HUNGARY: STEL 0.2 mg/m3, Skin, JAN 1993; OEL-INDIA: TWA 0.1 ppm (1 mg/m3), Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 0.1 ppm (1 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 0.1 ppm (1 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1 mg/m3, Skin, JAN 1993; OEL-POLAND: MAC(TWA) 1 mg/m3, STEL 3 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.2 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: MAK-W 0.1 ppm (1 mg/m3), Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 0.1 ppm (0.92 mg/m3), STEL 0.3 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DICHLORVOS-air: 10H TWA 1 mg/m3 (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M0377; NIS 16; TNF 2139; NOS 20; TNE 29515; NOES 1983: HZD M0377; NIS 10; TNF 1356; NOS 17; TNE 24205; TFE 2466 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101124/AS); EPA GENETOX PROGRAM 1988, Positive: B subtilis rec assay, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test, TRP reversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Negative: In vivo cytogenetics-nonhuman bone marrow; EPA GENETOX PROGRAM 1988, Negative: Cytogenetics-male germ cell, Host-mediated assay; EPA GENETOX PROGRAM 1988, Negative: Mammalian micronucleus, In vitro SCE-human lymphocytes; EPA GENETOX PROGRAM 1988, Negative: In vitro SCE-human, D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat, Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-mouse; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NTP Carcinogenesis Studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-342, 1989 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; OSHA ANALYTICAL METHOD #62 Record 962 of 1119 in RTECS (through 2003/06) AN: TD0175000 PN: Phosphoric-acid,-tritolyl-ester- SY: Cresyl-phosphate-; Disflamoll-TKP-; Durad-; Flexol-Plasticizer-TCP-; Fyrquel-150-; IMOL-S-140-; Lindol-; Celluflex-179C-; Kronitex-; NCI-C61041-; Phosflex-179A-; Phosphate-de-tricresyle- (French); Tricresilfosfati- (Italian); Tricresylfosfaten- (Dutch); Tricresyl-phosphate-; Trikresylfosfat- (Czech); Trikresylphosphate- (German); Tris(tolyloxy)phosphine oxide; Tritolylfosfat- (Czech); Tritolyl-phosphate- RN: Current: 1330-78-5 Previous: 73299-28-2 UD: 200302 MF: C21-H21-O4-P MW: 368.39 WL: 1R XOPO&OR X1&OR X1 CC: Tumorigen (C); Organometallic (O); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 500 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 12/29/1964 (UCDS**); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1131,1986 (85JCAE) RE: T01-T02 orl-rat TDLo: 4550 mg/kg (13W male) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 6, p. 292, 1986 (TOXID9); T01-T02 orl-rat TDLo: 13200 mg/kg (66D male) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 46, p. 321, 1987 (TXCYAC); T35 orl-rat TDLo: 16 gm/kg (66D male/24D pre-22D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 46, p. 321, 1987 (TXCYAC); T01-T02-T72 orl-mus TDLo: 1750 mg/kg (7D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 10, p. 344, 1988 (FAATDF); T81 orl-mus TDLo: 4464 mg/kg (7D male/7D pre-22D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 10, p. 344, 1988 (FAATDF); T72 orl-mus TDLo: 7250 mg/kg (7D pre/1-22D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 10, p. 344, 1988 (FAATDF); T82 orl-mus TDLo: 2250 mg/kg (7D male/7D pre-22D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 10, p. 344, 1988 (FAATDF); T72 orl-rat TDLo: 14.4 gm/kg (7D male/7D pre/22D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 22, p. 392, 1994 (FAATDF); T72 orl-rat TDLo: 42.4 gm/kg (106D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 22, p. 392, 1994 (FAATDF) ORNG: 3000000000 ng/kg. [3000.000000 mg/kg] T/E unlistd AT: C08-F17-F18 orl-wmn TDLo: 70 mg/kg/14D Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 88, 1981 (LANCAO); T/E unlistd orl-hmn LDLo: 1800 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 7, p. 585, 1957 (ARZNAD); T/E unlistd orl-rat LD50: 3 gm/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 2, p. 96, 1975 (NPIRI*); T/E unlistd orl-mus LD50: 3900 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,114,1982 (85GMAT); C06-F07-J24 scu-mus LDLo: 12 mg/kg "Practical Toxicology of Plastics," Lefaux, R., Cleveland, OH, Chemical Rubber Co., 1968 -,339,1968 (29ZWAE); T/E unlistd orl-dog LDLo: 500 mg/kg "Practical Toxicology of Plastics," Lefaux, R., Cleveland, OH, Chemical Rubber Co., 1968 -,339,1968 (29ZWAE); C08-F19 skn-cat LD50: 1500 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 1000(Sp Iss 1), p. 141, 1980 (TOLED5); T/E unlistd orl-rbt LDLo: 100 mg/kg "Practical Toxicology of Plastics," Lefaux, R., Cleveland, OH, Chemical Rubber Co., 1968 -,339,1968 (29ZWAE); K01-K12-Y01 skn-rbt LDLo: 1 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534886 (NTIS**); T/E unlistd par-rbt LD50: 100 mg/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3); T/E unlistd orl-ckn LD50: >10 gm/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 291, 1977 (TXAPA9) MD: F17-N74-U01 orl-rat TDLo: 20300 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-433, 1994 (NTPTR*); L70-M70-P28 orl-rat TDLo: 23400 mg/kg/13W-I Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 8, p. 107, 1974 (OYYAA2); S02-S04 orl-rat TDLo: 252 mg/kg/6W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 49, p. 312, 1992 (BECTA6); N30 orl-rat TDLo: 24 gm/kg/60D-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 22, p. 341, 1994 (TOPADD); F07-P28-Y01 orl-mus TDLo: 52 gm/kg/13W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 5, p. 108, 1985 (TOXID9); F17-L70-U01 orl-mus TDLo: 10220 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-433, 1994 (NTPTR*); F11-F13-Z01 orl-cat TDLo: 2100 mg/kg/6W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 7, p. 585, 1957 (ARZNAD); F18-U01-Z01 orl-rat TDLo: 11850 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); N74-U01-Z01 orl-rat TDLo: 37700 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); T01-U01-Z01 orl-rat TDLo: 37700 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); Z01 orl-mus TDLo: 11850 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); F18-U30 orl-mus TDLo: 9490 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); N13-N70 orl-rat TDLo: 4550 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); B30-C18-N13 orl-mus TDLo: 9100 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); B30-N70-U01 orl-mus TDLo: 36400 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); N13-N30-U01 orl-rat TDLo: 20930 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); M04-M30 orl-rat TDLo: 39130 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); F15-M04-M30 orl-rat TDLo: 68250 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); N13-N70 orl-rat TDLo: 47450 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); C18-F18-N13 orl-mus TDLo: 20930 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); C18-F18-U01 orl-mus TDLo: 34580 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); M03 orl-mus TDLo: 81900 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- v. VI:433, p. 325, 1994 (NTPTR*); N72-Z71-Y53 orl-rat TDLo: 16 gm/kg/40D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 122, p. 281, 1993 (TXAPA9); U01 orl-rat TDLo: 24.4 gm/kg/61D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 22, p. 392, 1994 (FAATDF); U01 orl-rat TDLo: 52.4 gm/kg/131D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 22, p. 392, 1994 (FAATDF) TR: TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF) ND: NOHS 1974: HZD 82880; NIS 131; TNF 15911; NOS 79; TNE 146408; NOES 1983: HZD 82880; NIS 132; TNF 15728; NOS 95; TNE 239503; TFE 66405 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 963 of 1119 in RTECS (through 2003/06) AN: TD0875000 PN: Phosphoric-triamide,-hexamethyl- SY: ENT-50882-; Eastman-Inhibitor-HPT-; HMPA-; HMPT-; HPT-; Hempa-; Hexametapol-; Hexamethyl-phosphoramide-; Hexamethyl-phosphoramide- (ACGIH); Hexamethylfosforamid- (Czech); Hexamethylphosphoric-acid-triamide-; Hexamethylphosphoric-triamide-; Hexamethylphosphorotriamide-; Hexamethylphosphotriamide-; Hexmethylphosphoramide-; N,N,N,N,N,N-Hexamethylphosphoric-triamide-; Phosphoric-acid-hexamethyltriamide-; Phosphoric tris(dimethylamide); Phosphoryl-hexamethyltriamide-; Tri(dimethylamino)phosphineoxide; Tris(dimethylamino)phosphine oxide; Tris(dimethylamino)phosphorus oxide; Tris-(dimethylamid) kyseliny fosforecne (Czech) RN: Current: 680-31-9 UD: 200302 MF: C6-H18-N3-O-P MW: 179.24 WL: 1N1&PO&N1&1&N1&1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-gpg 50 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571620 (NTIS**) ME: mmo-sat 4 ug/plate (-S9) British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 36, p. 564, 1977 (BJCAAI); mmo-esc 50 ug/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 351, 1981 (PMRSDJ); dnd-bcs 20 uL/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); slt-dmg-orl 560 umol/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 313, 1985 (PMRSDJ); sln-dmg-mul 250 ppm Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 651, 1981 (PMRSDJ); sln-dmg-par 1000 ppm Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 38, p. 442, 1969 (IMSUAI); sln-dmg-orl 100 ppm Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 666, 1981 (PMRSDJ); dlt-dmg-par 5 mmol/L Folia Biologica (Prague). (Academic Press Inc. Ltd., 24-28 Oval Rd., London NW1 7DX, UK) V.1- 1955- v. 18, p. 139, 1972 (FOBLAN); trn-dmg-par 10 mmol/L Folia Biologica (Prague). (Academic Press Inc. Ltd., 24-28 Oval Rd., London NW1 7DX, UK) V.1- 1955- v. 18, p. 139, 1972 (FOBLAN); trn-dmg-orl 100 ppm Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 51, 1994 (EMMUEG); mmo-smc 100 mg/L (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 414, 1981 (PMRSDJ); mmo-smc 3490 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 257, 1985 (PMRSDJ); dnr-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 2 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 481, 1981 (PMRSDJ); sln-smc 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mnt-nml-mul 30 ppm Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 17, 1989 (MUTAEX); cyt-oin-skn 250 ppm Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 38, p. 21, 1973 (CYTOAN); cyt-oin-par 159 mmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 11, p. 648, 1969 (CNJGA8); dlt-oin-par 159 mmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 11, p. 648, 1969 (CNJGA8); dlt-oin-unr 100 ppm Bulletin of the World Health Organization. (WHO, Pub. Center USA, 49 Sheridan Ave., Albany, NY 12210) v. 47, p. 305, 1972 (BWHOA6); spm-oin-par 200 ug Annales de Biologie Animale, Biochimie, Biophysique. (Versailles, France) V.1-19, 1961-79. v. 17, p. 661, 1977 (ABABAC); mtr-hmn-lvr 80 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 37, p. 873, 1978 (BJCAAI); dnd-hmn-oth 15 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 213, 2000 (MUREAV); dns-hmn-hla 125 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 375, 1985 (PMRSDJ); dns-hmn-fbr 156 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 517, 1981 (PMRSDJ); cyt-hmn-lym 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 19, 1985 (MUREAV); cyt-hmn-leu 5 mmol/L Chromosoma. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1939- v. 24, p. 314, 1968 (CHROAU); mnt-rat-ipr 1800 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 309, 1987 (MUREAV); dns-rat-lvr 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 341, 1985 (PMRSDJ); bfa-rat-ovr 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 263, 1985 (MUREAV); cyt-rat-ipr 1800 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 309, 1987 (MUREAV); sce-rat-lvr 2 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 387, 1985 (PMRSDJ); mnt-mus-orl 600 mg/kg Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 22, p. 60, 1988 (CHYCDW); mnt-mus-ipr 1280 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 122, p. 143, 1983 (MUREAV); mmo-mus-lym 3 mL/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 531, 1985 (PMRSDJ); mtr-mus-emb 1 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 659, 1985 (PMRSDJ); sce-mus-ipr 1700 ug/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 673, 1981 (PMRSDJ); dlt-mus-ipr 250 mg/kg/12H Folia Biologica (Prague). (Academic Press Inc. Ltd., 24-28 Oval Rd., London NW1 7DX, UK) V.1- 1955- v. 16, p. 407, 1970 (FOBLAN); msc-mus-lym 3 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 580, 1981 (PMRSDJ); mtr-ham-emb 400 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 665, 1985 (PMRSDJ); mtr-ham-kdy 2500 ug/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 36, p. 564, 1977 (BJCAAI); cyt-ham-lvr 2 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 397, 1985 (PMRSDJ); cyt-ham-lng 2 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 427, 1985 (PMRSDJ); sce-ham-ovr 5 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 413, 1985 (PMRSDJ); sce-ham-lng 5 mmol/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 469, 1985 (PMRSDJ); sln-ham-lvr 10 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 397, 1985 (PMRSDJ); mtr-mus-fbr 0.1 pph/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T22 orl-rat TDLo: 2430 mg/kg (multigenerations) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 499, 1971 (TXAPA9); T02 orl-rat TDLo: 2 gm/kg (1D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 211, p. 146, 1966 (NATUAS); T01 ipr-rat TDLo: 43750 mg/kg (5W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555525 (NTIS**) TE: V01-D09 ihl-rat TCLo: 50 ppb/52W-C American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 106, p. 8, 1982 (AJPAA4); V01-D09 ihl-rat TC :400 ppb/35W-I Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 190, p. 422, 1975 (SCIEAS); V01-D09 ihl-rat TC :100 ppb/26W-C American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 106, p. 8, 1982 (AJPAA4); V01-D09 ihl-rat TC :50 ppb/6H/1Y-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 68, p. 157, 1982 (JJIND8); V01-D09 ihl-rat TC :4000 ppb/39W-C American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 106, p. 8, 1982 (AJPAA4); V01-D09 ihl-rat TC :100 ppb/6H/26W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 68, p. 157, 1982 (JJIND8); V01-D09 ihl-rat TC :400 ppb/6H/43W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 68, p. 157, 1982 (JJIND8); V03-D09 ihl-rat TC :50 ppb/6H/52W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 90, 1982 (TXAPA9); V03-D09 ihl-rat TC :100 ppb/6H/26W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 90, 1982 (TXAPA9); V03-D09 ihl-rat TC :50 ppb/6H/52W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 33, p. 106, 1984 (ENVRAL) ORNG: 2650000000 ng/kg. [2650.000000 mg/kg] F12-M14-M29 SRNG: 2600000000 ng/kg. [2600.000000 mg/kg] F05-F07-J22 AT: F12-M14-M29 orl-rat LD50: 2650 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 211, p. 146, 1966 (NATUAS); J22-P30 ihl-rat LCLo: 2920 mg/m3/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571242 (NTIS**); C09-F12-M14 skn-rat LDLo: 3500 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 211, p. 146, 1966 (NATUAS); T/E unlistd orl-mus LD50: 2400 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 70, p. 114P, 1974 (NYKZAU); T/E unlistd ipr-mus LD50: 1600 mg/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 682, 1981 (PMRSDJ); T/E unlistd ivn-mus LD50: 800 mg/kg Chemistry and Industry (London). (Royal Soc. of Chemistry, Distribution Centre, Blackhorse Rd., Letchworth, Herts SG6 1HN, UK) V.1- 1923- v. (36), p. 1529, 1966 (CHINAG); T/E unlistd orl-rbt LDLo: 1500 mg/kg Journal of Economic Entomology. (Entomological Soc. of America, 4603 Calvert Rd., College Park, MD 20740) V.1- 1908- v. 48, p. 139, 1955 (JEENAI); F05-F07-J22 skn-rbt LD50: 2600 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 499, 1971 (TXAPA9); T/E unlistd orl-gpg LD50: 1600 mg/kg "Principles of Insect Chemosterilization," Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968 -,315,1968 (85DZAJ); T/E unlistd skn-gpg LD50: 1175 mg/kg "Principles of Insect Chemosterilization," Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968 -,315,1968 (85DZAJ); C08-F19 orl-ckn LD50: 835 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 16, p. 100, 1970 (TXAPA9); T/E unlistd orl-qal LD50: 1 gm/kg Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 48, p. 371, 1976 (JRPFA4) MD: Z01 orl-rat TDLo: 6 gm/kg/60D-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 211, p. 146, 1966 (NATUAS); J05-J12 orl-rat TDLo: 8640 mg/kg/72D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 10, p. 411, 1967 (TXAPA9); Z01 ihl-rat TCLo: 400 ppb/6H/32W-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 36, p. 916, 1975 (AIHAAP); J12-N74-U01 orl-rat TDLo: 4600 mg/kg/92D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 499, 1971 (TXAPA9); K12-U01-Z71 skn-rbt TDLo: 1500 mg/kg/21D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 499, 1971 (TXAPA9) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 211, 1977 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1465, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 211, 1977 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1465, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1465, 1999 (IMEMDT) SR: OEL-AUSTRALIA: Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: Skin, Carcinogen, JAN 1993; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: Skin, Carcinogen JAN 1993; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO THE CHEMICAL-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X4066; NIS 1; TNF 92; NOS 2; TNE 700; TFE 51 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Rodent dominant lethal, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse, Sperm morphology-rabbit; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 6, 1975; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 964 of 1119 in RTECS (through 2003/06) AN: TD2540000 PN: Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, cyclohexylamine salt SY: Cytoxyl-alcohol-cyclohexylammonium-salt-; NSC-52695-; N,N-Bis(2-chloroethyl)-N'-(3-hydroxypropyl)phosphorodiamidate cyclohexylammonium salt; NCI-C04922- RN: Current: 4465-94-5 UD: 199904 MF: C7-H17-Cl2-N2-O3-P.C6-H13-N MW: 378.33 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 100 ug/plate (+/-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) JAN1982 (NTPTB*); dni-hmn-lym 500 umol/L Agents and Actions, A Swiss Journal of Pharmacology. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1969/70- v. 4, p. 117, 1974 (AGACBH) RE: T34-T43-T53 ipr-mus TDLo: 29 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 4, p. 141, 1971 (TJADAB); T46-T25 ipr-mus TDLo: 290 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 4, p. 141, 1971 (TJADAB) TE: V01-M60-R60 ipr-rat TDLo: 2900 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V03-J60-P62 ipr-mus TDLo: 3900 mg/kg/26W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR) AT: T/E unlistd orl-mus LD50: 1618 mg/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); T/E unlistd scu-mus LD50: 966 mg/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); T/E unlistd ivn-mus LD50: 400 mg/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*) SL: NCI Carcinogenesis Studies (ipr), clear evidence: mouse, rat Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU) Record 965 of 1119 in RTECS (through 2003/06) AN: TH8890060 PN: 1,4-Phthalazinedione,-5-amino-2,3-dihydro- SY: 5-Amino-2,3-dihydro-1,4-phthalazinedione-; 3-Aminophthalhydrazide-; 3-Aminophthalic-acid-hydrazide-; Luminol- RN: Current: 521-31-3 UD: 200012 MF: C8-H7-N3-O2 MW: 177.18 CC: Tumorigen (C); Mutagen (M) ME: sce-ham-lng 500 umol/L Chromosoma. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1939- v. 99, p. 360, 1990 (CHROAU) AT: T/E unlistd orl-rat LD :>500 mg/kg National Academy of Sciences, National Research Council, Chemical-Biological Coordination Center, Review. (Washington, DC) v. 5, p. 11, 1953 (NCNSA6) ND: NOES 1983: HZD X7070; NIS 1; TNF 7; NOS 1; TNE 28 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, selected, October 2000 Record 966 of 1119 in RTECS (through 2003/06) AN: TH9990000 PN: Phthalic-acid,-benzyl-butyl-ester- SY: AI3-14777-; BBP-; Palatinol-BB-; 1,2-Benzenedicarboxylic-acid,-butyl-phenylmethyl-ester-; Benzyl-butylester-kyseliny-ftalove- (Czech); Benzyl-butyl-phthalate-; Benzyl-n-butyl-phthalate-; Butyl-benzyl-phthalate-; n-Butyl-benzyl-phthalate-; Butyl-phenylmethyl-1,2-benzenedicarboxylate-; NCI-C54375-; Santicizer-160-; Sicol-160-; Unimoll-BB- RN: Current: 85-68-7 Previous: 58128-78-2 BRN: 2062204 BHR: 4-09-00-03218 UD: 200305 MF: C19-H20-O4 MW: 312.39 WL: QVR BVO1R CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mtr-ham-emb 2 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 356, p. 85, 1996 (MUREAV) RE: T02-T03 orl-rat TDLo: 21 gm/kg (14D male) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 136, 1984 (TOXID9); T13-T19-T35 orl-rat TDLo: 16400 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-115346 (NTIS**); T39-T46 orl-rat TDLo: 16400 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-115346 (NTIS**); T25-T43-T46 orl-rat TDLo: 4900 mg/kg (1-7D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 12, p. 57, 1992 (JJATDK); T01-T02-T23 orl-rat TDLo: 154 gm/kg (10W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-458, 1997 (NTPTR*); T19-T34 orl-rat TDLo: 4500 mg/kg (0-8D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 12, p. 127, 1998 (REPTED); T25-T34 orl-rat TDLo: 1500 mg/kg (6D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 19, p. 357, 1999 (JJATDK); T25-T26-T39 orl-mus TDLo: 9100 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-129999 (NTIS**); T19 orl-mus TDLo: 23300 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-129999 (NTIS**); T53 orl-rat TDLo: 11600 mg/kg (2W pre-22D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T53-T81 orl-rat TDLo: 369.8 mg/kg (1-22D preg/21D post) Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 26, p. 330, 1997 (RTOPDW); T49-T53-T75 orl-rat TDLo: 119 gm/kg (14W male/14W pre-3W post) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); T52-T81-T91 orl-rat TDLo: 24 gm/kg (14W male/14W pre-21D post) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); T47-T85 orl-rat TDLo: 24 gm/kg (14W male/14W pre-21D post) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); T86 orl-rat TDLo: 5 gm/kg (14W male/14W pre-21D post) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); T25-T46-T53 orl-rat TDLo: 2700 mg/kg (6-15D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); T34 orl-rat TDLo: 5800 mg/kg (6-15D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); T42 orl-rat TDLo: 7500 mg/kg (6-15D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); T41-T43 orl-rat TDLo: 11250 mg/kg (6-20D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); T53-T81-T91 orl-rat TDLo: 5700 ug/kg (2W pre-22W post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T53-T81-T91 orl-rat TDLo: 11.3 mg/kg (10W pre-22D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T25-T35 orl-rat TDLo: 1100 mg/kg (1-11D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 8, p. 231, 1994 (REPTED); T25-T59 orl-rat TDLo: 12.8 gm/kg (6-13D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC); T81 orl-rat TDLo: 43 gm/kg (1-29D male/14D pre-6D post Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC); T25-T75 orl-rat TDLo: 85 gm/kg (1-29D male/14D pre-6D post Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC); T25 orl-rat TDLo: 20000 mg/kg (1-20D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC); T34 orl-rat TDLo: 8000 mg/kg (6-13D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC) TE: V01-P61-P62 orl-rat TDLo: 433 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-213, 1982 (NTPTR*); V01-P61 orl-rat TD :437 gm/kg/2Y-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 271, 1986 (EVHPAZ); V01-K60 orl-rat TDLo: 364 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-458, 1997 (NTPTR*); V01-P61 orl-rat TDLo: 117600 mg/kg/28W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-118398 (NTIS**); V03-K60 orl-rat TDLo: 360500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB98-131089 (NTIS**); V03-M60 orl-rat TDLo: 865200 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB98-131089 (NTIS**); V02-K60 orl-rat TDLo: 524160 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB98-131014 (NTIS**) ORNG: 2330000000 ng/kg. [2330.000000 mg/kg] T/E unlistd SKNG: 6700000000 ng/kg. [6700.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2330 mg/kg IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 193, 1982 (IMEMDT); T/E unlistd skn-rat LD50: 6700 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(6), p. 25, 1974 (GISAAA); T/E unlistd orl-mus LD50: 4170 mg/kg IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 193, 1982 (IMEMDT); T/E unlistd skn-mus LD50: 6700 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(6), p. 25, 1974 (GISAAA); T/E unlistd ipr-mus LD50: 3160 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 4, p. 3, 1973 (EVHPAZ); T/E unlistd unr-mus LD50: 13700 ug/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(7), p. 52, 1988 (GTPZAB); T/E unlistd skn-rbt LD50: >10 gm/kg Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 3, p. 79, 1987 (TIHEEC); F07-F31-U01 orl-gpg LD50: 13750 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 25, 1980 (GTPZAB) MD: F15-P01-Z01 orl-rat TDLo: 56 gm/kg/4W-C Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 3, p. 79, 1987 (TIHEEC); L70 orl-rat TDLo: 68250 mg/kg/91D-C Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 11, p. 1, 1992 (JACTDZ); L70-M70 orl-rat TDLo: 38402 mg/kg/13W-C Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 3, p. 79, 1987 (TIHEEC); U01-Z01 ihl-rat TCLo: 2100 mg/m3/6H/4W-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 3, p. 79, 1987 (TIHEEC); L70-M70 ihl-rat TCLo: 789 mg/m3/6H/13W-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 3, p. 79, 1987 (TIHEEC); M70-Z72-Z73 orl-rat TDLo: 21 gm/kg/14D-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 35, p. 189, 1985 (TXCYAC); L30-U01-Z73 orl-rat TDLo: 51450 mg/kg/21D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0536510 (NTIS**); U01 orl-mus TDLo: 273 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-213, 1982 (NTPTR*); K01-M71 orl-rat TDLo: 14100 mg/kg/141D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); N08-Z71 orl-rat TDLo: 70500 mg/kg/141D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); K01-N30 orl-rat TDLo: 9800 mg/kg/14W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); L70-M71-U01 orl-rat TDLo: 49000 mg/kg/14W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); L70-M71-N75 orl-rat TDLo: 10500 mg/kg/21D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); L70-M71-N75 orl-rat TDLo: 32000 mg/kg/64D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 513, 2000 (REPTED); U01-Y15-Z01 orl-rat TDLo: 16000 mg/kg/10D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); L70-M71-Y15 orl-rat TDLo: 7500 mg/kg/10D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); P27 orl-rat TDLo: 2700 mg/kg/10D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); P27-Y15-Z01 orl-rat TDLo: 8700 mg/kg/15D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); U01 orl-rat TDLo: 18750 mg/kg/15D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); L70 orl-rat TDLo: 5250 mg/kg/15D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); Y12 orl-rat TDLo: 4050 mg/kg/15D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); M71 orl-rat TDLo: 6750 mg/kg/15D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 417, 2000 (REPTED); L70-P27 orl-rat TDLo: 117600 mg/kg/28W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-118398 (NTIS**); F15-Z71-Z74 orl-rat TDLo: 700 mg/kg/7D-C Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 8, p. 231, 1994 (REPTED); U01 orl-rat TDLo: 8000 mg/kg/8D-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC); U01 orl-rat TDLo: 13000 mg/kg/20D-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC); T02-Z73 orl-rat TDLo: 29000 mg/kg/29D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC); F15 orl-rat TDLo: 7000 mg/kg/7D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC); F15 orl-rat TDLo: 7000 mg/kg/14D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 99, p. 191, 1995 (TXCYAC) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 115, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 193, 1982 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 193, 1982 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 115, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 115, 1999 (IMEMDT); TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 11, p. 1, 1992 (JACTDZ) SR: OEL-DENMARK: TWA 3 mg/m3, JAN 1999; OEL-RUSSIA: STEL 1 mg/m3, JAN 1993; OEL-SWEDEN: NGV 3 mg/m3, KTV 5 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 5 mg/m3, SEP 2000 ND: NOHS 1974: HZD 80249; NIS 93; TNF 9594; NOS 74; TNE 66289; NOES 1983: HZD 80249; NIS 158; TNF 27154; NOS 119; TNE 331841; TFE 59743 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9016, 8EHQ-0892-9174; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-8845; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: rat; NTP Carcinogenesis Studies (feed), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-458, 1997 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 967 of 1119 in RTECS (through 2003/06) AN: TI0350000 PN: Phthalic acid, bis(2-ethylhexyl) ester SY: 1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester; 2-Ethylhexyl-phthalate-; Bis(2-ethylhexyl)-1,2-benzenedicarboxylate; Bis(2-ethylhexyl)phthalate; Bis-(2-ethylhexyl)ester kyseliny ftalove (Czech); Bisoflex-81-; Bisoflex-DOP-; Compound-889-; DEHP-; Di(2-ethylhexyl)orthophthalate; Di(2-ethylhexyl)phthalate; Di-(2-ehylhexyl) phthalate; Di-(2-ethylhexyl)phthalate; Di-2-ethylhexyl-phthalate-; Di-sec-octyl-phthalate- (ACGIH:OSHA); Dioctyl-phthalate-; Ergoplast-FDO-; Ethylhexyl-phthalate-; Eviplast-80-; Eviplast-81-; Fleximel-; Flexol-DOP-; Flexol-Plasticizer-DOP-; Good-rite-GP-264-; Hatcol-DOP-; Hercoflex-260-; Jayflex-DOP-; Kodaflex-DOP-; Mollan-O-; NCI-C52733-; Nuoplaz-DOP-; Octoil-; Palatinol-AH-; Phthalic-acid-dioctyl-ester-; Pittsburgh-PX-138-; Platinol-AH-; Platinol-DOP-; RC-Plasticizer-DOP-; RCRA-waste-number-U028-; Reomol-D-79P-; Reomol-DOP-; Sicol-150-; Staflex-DOP-; Truflex-DOP-; Vestinol-AH-; Vinicizer-80-; Witcizer-312- RN: Current: 117-81-7 BRN: 1890696 BHR: 4-09-00-03181 UD: 200305 MF: C24-H38-O4 MW: 390.62 WL: 4Y2&1OVR BVO1Y4&2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,389,1986 (85JCAE); eye-rbt 500 mg MLD American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,389,1986 (85JCAE) ME: mmo-sat 5 mg/plate (-S9) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 45, p. 119, 1982 (EVHPAZ); pic-esc 50 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); slt-dmg-orl 200 mmol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 359, 1989 (MUREAV); mmo-smc 1541 mg/L (+/-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 271, 1985 (PMRSDJ); mrc-smc 5 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 217, 1985 (PMRSDJ); cyt-hmn-leu 6 mg/L Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 65, p. 1648, 1976 (JPMSAE); sce-hmn-lym 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 211, p. 77, 1989 (MUREAV); dns-rat-lvr 500 umol/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 371, 1985 (PMRSDJ); dns-rat-orl 670 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 27, p. 148, 1986 (PAACA3); spm-rat-orl 1 pph/60D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 343, 1986 (EVHPAZ); mmo-mus-lym 40 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 569, 1985 (PMRSDJ); dns-mus-orl 202 gm/kg/40W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 96, p. 494, 1988 (TXAPA9); oms-mus-orl 1 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 157, 1995 (MUREAV); dlt-mus-ipr 12780 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 29, p. 35, 1974 (TXAPA9); dlt-mus-scu 2970 mg/kg/10D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 16, p. 71, 1985 (JTEHD6); mtr-ham-orl 750 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 45, p. 119, 1982 (EVHPAZ); mtr-ham-emb 4 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 665, 1985 (PMRSDJ); cyt-ham-orl 7500 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 45, p. 119, 1982 (EVHPAZ); sce-ham-ovr 25 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sln-ham-lvr 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 397, 1985 (PMRSDJ); mtr-mus-fbr 0.01 pph/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T34 orl-rat TDLo: 7140 mg/kg (1-21D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 26, p. 253, 1973 (TXAPA9); T12 orl-rat TDLo: 35 mg/kg (14D pre) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 15, p. 389, 1977 (FCTXAV); T02-T03 orl-rat TDLo: 6 gm/kg (3D male) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 59, p. 290, 1986 (ARTODN); T25 orl-rat TDLo: 17200 mg/kg (multigenerations) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 31, p. 507, 1976 (NEZAAQ); T34-T39-T51 orl-rat TDLo: 10 gm/kg (6-15D preg) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 27, p. 885, 1989 (IJEBA6); T46-T47-T53 orl-rat TDLo: 9766 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 41, 1987 (TJADAB); T86 orl-rat TDLo: 137 mL/kg (1-22D preg/21D post) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 36, p. 963, 1998 (FCTOD7); T24 ipr-rat TDLo: 6 gm/kg (3-9D preg) Journal of Dairy Science. (American Dairy Science Assoc., 309 W. Clark St., Champaign, IL 61820) V.1- 1917- v. 55, p. 696, 1972 (JDSCAE); T25-T42-T59 ipr-rat TDLo: 10 gm/kg (5-15D preg) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 51, 1972 (JPMSAE); T34 ipr-rat TDLo: 5 gm/kg (5-15D preg) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 51, 1972 (JPMSAE); T09 ipr-rat TDLo: 1 gm/kg (10D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 62, p. 121, 1982 (TXAPA9); T16-T24 ipr-rat TDLo: 6 gm/kg (3-9D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); T26 orl-mus TDLo: 78880 mg/kg (6-13D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 29, 1987 (TCMUD8); T01 orl-mus TDLo: 4200 mg/kg (21D male) Osaka-furitsu Koshu Eisei Kenkyusho Kenkyu Hokoku, Koshu Eisei Hen. Research Reports of the Oaka Prefectural Institute of Public Health, Public Health Section. (Osaka-furitsu Koshu Eisei Kenkyusho, 1-3-69 Nakamichi, Higashinari-ku, Osaka, 537, Japan) No.3- 1966- v. 15, p. 129, 1977 (OKEHDW); T35-T46 orl-mus TDLo: 1 gm/kg (7D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 45, p. 71, 1982 (EVHPAZ); T25-T26-T35 orl-mus TDLo: 2040 mg/kg (1-17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-105674 (NTIS**); T41-T42-T47 orl-mus TDLo: 2040 mg/kg (1-17D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 84A, 1983 (TJADAB); T01-T02 ipr-mus TDLo: 30 gm/kg (5D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 255, 1986 (EVHPAZ); T24-T26 ipr-mus TDLo: 25560 mg/kg (1D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 81, 1973 (EVHPAZ); T35 ipr-mus TDLo: 12780 mg/kg (1D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 81, 1973 (EVHPAZ); T23 ipr-mus TDLo: 12780 ug/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 29, p. 35, 1974 (TXAPA9); T27 ipr-mus TDLo: 24 gm/kg (7-9D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 56, p. 263, 1985 (ARTODN); T24-T35 scu-mus TDLo: 2970 mg/kg (3D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 16, p. 71, 1985 (JTEHD6); T02-T23 scu-mus TDLo: 19722 mg/kg (3D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 26, p. 39, 1989 (JTEHD6); T09 scu-mus TDLo: 1972 mg/kg (3D male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 26, p. 39, 1989 (JTEHD6); T19 scu-mus TDLo: 9861 mg/kg (3D pre) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 26, p. 39, 1989 (JTEHD6); T22 ivn-mus TDLo: 50 mg/kg (1D pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB250-102 (NTIS**); T26 ivn-mus TDLo: 350 mg/kg (7D male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB250-102 (NTIS**); T34 ivn-mus TDLo: 15 mg/kg (3-5D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB250-102 (NTIS**); T29 ivn-mus TDLo: 5 mg/kg (8D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB250-102 (NTIS**); T02 orl-gpg TDLo: 20 gm/kg (10D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 45, p. 77, 1982 (EVHPAZ); T02 orl-mam TDLo: 20 gm/kg (10D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 45, p. 77, 1982 (EVHPAZ); T02 orl-mam TDLo: 509 gm/kg (60W male) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 6, p. 341, 1976 (TXCYAC); T25-T34 orl-mus TDLo: 8400 mg/kg (1-21D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 22, p. 245, 1980 (ENVRAL); T34 orl-mus TDLo: 49.2 mg/kg (7D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 113, 1979 (TOLED5); T35 orl-mus TDLo: 98.4 mg/kg (7D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 113, 1979 (TOLED5); T46 orl-mus TDLo: 984.6 mg/kg (7D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 113, 1979 (TOLED5); T26 orl-rat TDLo: 72000 mg/kg (60D male) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 343, 1986 (EVHPAZ); T24-T76 ipr-rat TDLo: 6 mL/kg (3-9D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); T76-T24 ipr-rat TDLo: 2 mL/kg (3D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); T24 ipr-rat TDLo: 2 mL/kg (6D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); T24 ipr-rat TDLo: 4 mL/kg (3-6D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); T25-T26-T75 orl-mus TDLo: 1.6 gm/kg (17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88204300 (NTIS**); T81 orl-mus TDLo: 1.6 gm/kg (17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB88204300 (NTIS**); T34-T35-T39 orl-mus TDLo: 2.04 gm/kg (1-17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105674 (NTIS**); T46-T59 orl-mus TDLo: 2.04 gm/kg (1-17D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105674 (NTIS**); T34 orl-rat TDLo: 10 gm/kg (1-20D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105658 (NTIS**); T81 orl-rat TDLo: 11.46 gm/kg (20D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #87119046 (NTIS**); T35-T59 orl-rat TDLo: 20 gm/kg (1-20D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105658 (NTIS**); T25-T26 orl-rat TDLo: 6260 mg/kg (20D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #87119046 (NTIS**) TE: V01-L60-N60 orl-rat TDLo: 216 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-217, 1982 (NTPTR*); V01-L60 orl-mus TDLo: 260 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-217, 1982 (NTPTR*); V01-L60-T61 orl-rat TD :433 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-217, 1982 (NTPTR*); V01-L60 orl-mus TD :519 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-217, 1982 (NTPTR*); V03-L60 orl-mus TD :120 gm/kg/24W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 1021, 1983 (CRNGDP); V01-L60 orl-rat TD :524 gm/kg/2Y-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 271, 1986 (EVHPAZ); V01-L60 orl-mus TD :262 gm/kg/2Y-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 271, 1986 (EVHPAZ); V01-L60 orl-rat TD :438 gm/kg/2Y-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 38, p. 15, 1987 (CALEDQ); V01-L60 orl-rat TD :91 gm/kg/2Y-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 50, p. 195, 1999 (TOSCF2); V02-K60 orl-rat TDLo: 430.8 gm/kg/78W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); V03 orl-mus TDLo: 98.5 mg/kg Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 58, p. 377, 2000 (TOSCF2); V01-L60 orl-rat TDLo: 519120 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-184011 (NTIS**); V01-L60 orl-rat TDLo: 432600 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-184011 (NTIS**); V01-L60 orl-mus TDLo: 519120 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-184011 (NTIS**); V01-L60 orl-mus TDLo: 259560 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-184011 (NTIS**); V02-L60 orl-mus TDLo: 32760 mg/kg/26W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7) ORNG: 30000000000 ng/kg. [30000.000000 mg/kg] T/E unlistd SRNG: 25000000000 ng/kg. [25000.000000 mg/kg] T/E unlistd AT: K30 orl-man TDLo: 143 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 27, p. 130, 1945 (JIHTAB); T/E unlistd orl-rat LD50: 30 gm/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 2, p. 32, 1975 (NPIRI*); R30 skn-rat LDLo: 4 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(6), p. 35, 1980 (GISAAA); T/E unlistd ipr-rat LD50: 30700 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 27, p. 130, 1945 (JIHTAB); J30 ivn-rat LD50: 250 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 230, 1978 (TXAPA9); F07-J02-P01 itr-rat LDLo: 30 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 2, p. 59, 1961 (TPKVAL); T/E unlistd unr-rat LD50: 47 gm/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(7), p. 52, 1988 (GTPZAB); F07-J02-K20 orl-mus LD50: 1500 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 2, p. 59, 1961 (TPKVAL); R30 skn-mus LDLo: 4 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(6), p. 35, 1980 (GISAAA); H02-F13 ipr-mus LD50: 14 gm/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 55, p. 158, 1966 (JPMSAE); T/E unlistd ivn-mus LD50: 1060 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB250-102 (NTIS**); T/E unlistd unr-mus LD50: 7 gm/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(7), p. 52, 1988 (GTPZAB); T/E unlistd orl-rbt LD50: 34 gm/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 4, p. 3, 1973 (EVHPAZ); T/E unlistd skn-rbt LD50: 25 gm/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 27, p. 130, 1945 (JIHTAB); T/E unlistd ipr-rbt LD :>31 mL/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 259, 1956 (AMIHAB); T/E unlistd orl-gpg LD50: 26 gm/kg IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 269, 1982 (IMEMDT); T/E unlistd skn-gpg LD50: 10 gm/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 4, p. 3, 1973 (EVHPAZ); T/E unlistd unr-gpg LD50: 40500 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(7), p. 52, 1988 (GTPZAB); U01 orl-mus TDLo: 984.6 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 113, 1979 (TOLED5); T/E unlistd orl-mus LD50: 29.5 gm/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 113, 1979 (TOLED5); T16 ipr-rat TDLo: 2 ml/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ) MD: L30-Y10-Z73 orl-rat TDLo: 1500 mg/kg/30D-I Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 37, p. 310, 1995 (VHTODE); L70-M70-U01 orl-rat TDLo: 139 gm/kg/2Y-C AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 8, p. 219, 1953 (AMIHBC); L70-Y10-Z73 orl-rat TDLo: 17500 mg/kg/7D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 61, p. 205, 1981 (TXAPA9); M70-R21-U01 orl-rat TDLo: 59388 mg/kg/6W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 15, p. 389, 1977 (FCTXAV); P30-R21-U01 orl-rat TDLo: 168 gm/kg/17W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 15, p. 389, 1977 (FCTXAV); L70-R21-Z73 orl-rat TDLo: 19796 mg/kg/12W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 15, p. 389, 1977 (FCTXAV); L70-Y03-Y11 orl-rat TDLo: 25200 mg/kg/21D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 77, p. 116, 1985 (TXAPA9); L30-L70 orl-rat TDLo: 14 gm/kg/14D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 66, p. 317, 1993 (TOLED5); J70-L70-P28 ihl-rat TCLo: 940 mg/m3/6H/4W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 30, p. 915, 1992 (FCTOD7); L30-U02-Y16 ipr-rat TDLo: 9 mg/kg/11D-I Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 36, p. 264, 1998 (IJEBA6); L70-U01-Z73 orl-rat TDLo: 42 gm/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530399 (NTIS**); L70-U01-Y07 orl-mus TDLo: 30 gm/kg/15D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 40, p. 209, 1988 (TOLED5); Z01 orl-mus TDLo: 33852 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-217, 1982 (NTPTR*); L30-M03-M30 orl-mus TDLo: 403 gm/kg/40W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 96, p. 494, 1988 (TXAPA9); L70-M70-Z01 orl-mus TDLo: 213 gm/kg/2Y-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0559217 (NTIS**); K17-Z73 ipr-mus TDLo: 10500 mg/kg/6W-I Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 55, p. 158, 1966 (JPMSAE); L70-U01-Z01 orl-rbt TDLo: 30 gm/kg/15D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 40, p. 209, 1988 (TOLED5); L70-Y07-Z01 orl-gpg TDLo: 30 gm/kg/15D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 40, p. 209, 1988 (TOLED5); L70-Y07 orl-ham TDLo: 14 gm/kg/14D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 46, 1984 (TXAPA9); L30-L70-U01 orl-mam TDLo: 509 gm/kg/60W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 6, p. 341, 1976 (TXCYAC); U30-Y37 orl-brd TDLo: 384 mg/kg/30D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 25, p. 345, 1980 (BECTA6); Y21-Z73 scu-mus TDLo: 3 mg/kg/3D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 26, p. 39, 1989 (JTEHD6); L30-N17-P28 orl-rat TDLo: 5040 mg/kg/4W-C International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 58, p. 736, 1994 (IJCNAW); L30-N17-P28 orl-rat TDLo: 10080 mg/kg/8W-C International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 58, p. 736, 1994 (IJCNAW); L30-N17 orl-rat TDLo: 20160 mg/kg/16W-C International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 58, p. 736, 1994 (IJCNAW); U01 orl-mky TDLo: 227500 mg/kg/13W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 78, p. 43, 1998 (ENVRAL); K01-Y09 orl-mus TDLo: 6720 mg/kg/14D-C Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 62, p. 249, 2001 (BCPCA6); L70-N07-P28 orl-rat TDLo: 8400 mg/kg/14D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 121, p. 35, 2001 (TOLED5); U01 orl-rat TDLo: 5.52 gm/kg/7D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); P30-P71 orl-rat TDLo: 143.6 gm/kg/182D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); P05-Y53 orl-rat TDLo: 287.2 gm/kg/364D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); P05-P30-Y53 orl-rat TDLo: 170.8 gm/kg/182D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); Y39 orl-rat TDLo: 26.7 gm/kg/182D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); M30 orl-rat TDLo: 4.2 gm/kg/104W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); T01 orl-rat TDLo: 21.04 gm/kg/104W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); L02-L70-M71 orl-rat TDLo: 106.7 gm/kg/104W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); L70 orl-rat TDLo: 132.3 gm/kg/104W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); M71 orl-rat TDLo: 683.2 gm/kg/104W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 433, 2000 (TOSCF2); Z01-U01 orl-mus TDLo: 921.7 gm/kg/104W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 58, p. 377, 2000 (TOSCF2); M71-L70-Z74 orl-mus TDLo: 1061.6 gm/kg/104W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 58, p. 377, 2000 (TOSCF2); A70-M71-Z73 orl-mus TDLo: 212.7 gm/kg/104W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 58, p. 377, 2000 (TOSCF2); L30-T01-Y55 orl-mus TDLo: 691.3 gm/kg/78W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 58, p. 377, 2000 (TOSCF2); L30-Y55 orl-mus TDLo: 796.2 gm/kg/78W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 58, p. 377, 2000 (TOSCF2); M04 orl-mus TDLo: 193.4 gm/kg/78W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 58, p. 377, 2000 (TOSCF2); T02-Y20 ipr-rat TDLo: 15 mL/kg/10D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 12, p. 131, 1976 (ENVRAL); T12-Y20 ipr-rat TDLo: 15 mL/kg/10D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 12, p. 131, 1976 (ENVRAL); T01 orl-rat TDLo: 1000 mg/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 95, p. 104, 1988 (TXAPA9); T02-U01-Z73 orl-rat TDLo: 2500 mg/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 95, p. 104, 1988 (TXAPA9); Z01 orl-rat TDLo: 5000 mg/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 95, p. 104, 1988 (TXAPA9); T01-Z73 orl-rat TDLo: 5000 mg/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 95, p. 104, 1988 (TXAPA9); Z73 orl-rat TDLo: 10000 mg/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 95, p. 104, 1988 (TXAPA9); T01-T02 orl-rat TDLo: 5000 mg/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 95, p. 104, 1988 (TXAPA9); U01 orl-rat TDLo: 12600 mg/kg/6W-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 343, 1986 (EVHPAZ); F15 orl-rat TDLo: 8400 mg/kg/1W-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 343, 1986 (EVHPAZ); T01-T02-Z73 orl-rat TDLo: 72000 mg/kg/60D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 343, 1986 (EVHPAZ); L70 orl-rat TDLo: 18000 mg/kg/60D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 343, 1986 (EVHPAZ); P28 orl-rat TDLo: 1050 mg/kg/2W-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 343, 1986 (EVHPAZ); U01-Z72-Z73 orl-rat TDLo: 28000 mg/kg/10D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 229, 1986 (EVHPAZ); U01-Z72 orl-rat TDLo: 28000 mg/kg/10D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 229, 1986 (EVHPAZ); U01 orl-mus TDLo: 60480 mg/kg/12W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7); L70-M71 orl-mus TDLo: 32760 mg/kg/26W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7); L70-M71-T02 orl-mus TDLo: 32760 mg/kg/26W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7); L02-L70-M71 orl-mus TDLo: 131040 mg/kg/26W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7); L30-M04-U01 orl-mus TDLo: 131040 mg/kg/26W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7); L30-T02 orl-mus TDLo: 131040 mg/kg/26W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7); T02-T03-Z72 orl-rat TDLo: 12000 mg/kg/10D-I Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 452, 1980 (ATSUDG); L03 orl-rat TDLo: 42000 mg/kg/21D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); L70-Y20-Y26 orl-rat TDLo: 1050 mg/kg/21D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); L30 orl-rat TDLo: 21000 mg/kg/21D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); Y03-Y07-Y21 orl-rat TDLo: 1050 mg/kg/21D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); L30-Y10-Y26 orl-rat TDLo: 4200 mg/kg/21D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); Y04 orl-rat TDLo: 54800 mg/kg/274D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); L70-Y07-Y11 orl-rat TDLo: 21000 mg/kg/21D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); L70-Y07-Y11 orl-rat TDLo: 10153 mg/kg/13D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); Y04 orl-rat TDLo: 1338 mg/kg/3D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); N08-P30 orl-rat TDLo: 3600 mg/kg/3D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); N08-P30 orl-rat TDLo: 12600 mg/kg/21D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 70, p. 195, 1986 (EVHPAZ); L70-U01-Z73 orl-rat TDLo: 28 gm/kg/14D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 36, p. 160, 1985 (ENVRAL); L30-Y07-Y20 orl-mus TDLo: 24000 mg/kg/10D-C Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 36, p. 4221, 1987 (BCPCA6); T16-Z01 ipr-rat TDLo: 6 mL/kg/7D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); T16-Z01 ipr-rat TDLo: 4 mg/kg/3D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); N16 ipr-rat TDLo: 6.25 gm/kg/5D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 21, p. 65, 1979 (BECTA6); U01 orl-rat TDLo: 36000 mg/kg/12D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 128, p. 216, 1994 (TXAPA9); N19 orl-rat TDLo: 16000 mg/kg/8D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 128, p. 216, 1994 (TXAPA9); N02-N04-T12 orl-rat TDLo: 6000 mg/kg/3D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 128, p. 216, 1994 (TXAPA9); N30 orl-rat TDLo: 10000 mg/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 128, p. 216, 1994 (TXAPA9); T02 orl-rat TDLo: 28000 mg/kg/10D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 237, 1986 (EVHPAZ); T02-Z73 orl-rat TDLo: 23800 mg/kg/14D-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 237, 1986 (EVHPAZ); T02 orl-rat TDLo: 14000 mg/kg/14D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 237, 1986 (EVHPAZ); T01-T02 ivn-rat TDLo: 3000 mg/kg/11D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 65, p. 237, 1986 (EVHPAZ); U01 orl-rat TDLo: 6260 mg/kg/20D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #87119046 (NTIS**); F15-U01 orl-rat TDLo: 11460 mg/kg/20D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #87119046 (NTIS**); U01 orl-mus TDLo: 323 mg/kg/17D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #87119046 (NTIS**); U01 orl-mus TDLo: 1440 mg/kg/12D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105674 (NTIS**); L70 orl-mus TDLo: 2040 mg/kg/17D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105674 (NTIS**); F04-R21 orl-mus TDLo: 4250 mg/kg/17D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105674 (NTIS**); U01 orl-rat TDLo: 2000 mg/kg/4D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105658 (NTIS**); F15-L70-R21 orl-rat TDLo: 5000 mg/kg/20D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85-105658 (NTIS**); L30-Y20 orl-rat TDLo: 8400 mg/kg/1W-C Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 65, p. 265, 1989 (PHTOEH); L30-Y07-Y37 orl-rat TDLo: 8400 mg/kg/1W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 76, p. 63, 1995 (TOLED5); U11-Y37-Z73 ims-rat TDLo: 8400 mg/kg/1W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 23, p. 67, 1984 (TOLED5) TR: ACGIH TLV-TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 73, 1973 (EVHPAZ); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 54, p. 1, 1975 (RREVAH); TOXICOLOGY REVIEW JOM, Journal of Occupational Medicine. (American Occupational Medicine Assoc., 150 N. Wacker Dr., Chicago, IL 60606) V.10- 1968- v. 15, p. 808, 1973 (JJOMDZ); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS); TOXICOLOGY REVIEW Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (93), p. 1, 1975 (ESKHA5); TOXICOLOGY REVIEW Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 1, 1978 (TXAPA9); TOXICOLOGY REVIEW Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 141, 1982 (JTEHD6); TOXICOLOGY REVIEW JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 8, p. 75, 1988 (JJATDK); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 96, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 mg/m3, JAN 1993; OEL-AUSTRALIA: TWA 5 mg/m3, STEL 10 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 5 mg/m3, JAN 1999; OEL-BELGIUM: TWA 5 mg/m3, STEL 10 mg/m3, JAN 1993; OEL-DENMARK: TWA 3 mg/m3, JAN 1999; OEL-FINLAND: TWA 5 mg/m3, STEL 10 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 5 mg/m3, JAN 1999; OEL-GERMANY: MAK 10 mg/m3, JAN 1999; OEL-HUNGARY: TWA 5 mg/m3, STEL 10 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 5 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 mg/m3, JAN 1999; OEL-NORWAY: TWA 3 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 5 mg/m3, JAN 1993; OEL-POLAND: MAC(TWA) 1 mg/m3, MAC(STEL) 5 mg/m3, JAN 1999; OEL-RUSSIA: STEL 1 mg/m3, JAN 1993; OEL-SWEDEN: NGV 3 mg/m3, KTV 5 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 5 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 5 mg/m3, STEL 10 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DEHP-air: 10H CA TWA 5 mg/m3, STEL 10 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M0347; NIS 222; TNF 33723; NOS 126; TNE 332356; NOES 1983: HZD M0347; NIS 164; TNF 19879; NOS 116; TNE 340800; TFE 106918 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/182400/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro SCE-nonhuman; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9120; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Di(2-ethylhexyl) phthalate, 5020; NCI Carcinogenesis Studies (feed), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; OSHA ANALYTICAL METHOD #104 Record 968 of 1119 in RTECS (through 2003/06) AN: TI0875000 PN: Phthalic-acid,-dibutyl-ester- SY: Dibutyl-1,2-benzenedicarboxylate-; Di-n-butylester-kyseliny-ftalove- (Czech); Dibutyl-phthalate-; Di-n-butyl-phthalate-; Dibutyl-phthalate- (ACGIH:OSHA); Palatinol-C-; o-Benzenedicarboxylic-acid,-dibutyl-ester-; Benzene-o-dicarboxylic-acid-di-n-butyl-ester-; n-Butylphthalate-; Celluflex-DPB-; DBP- (ester); Dibutyl-o-phthalate-; Elaol-; Ergoplast-FOB-; Genoplast-B-; Hatcol-DBP-; Hexaplas M/B; Kodaflex-DBP-; Monocizer-DBP-; Polycizer-DBP-; PX-104-; RCRA-waste-number-U069-; Staflex-DBP-; Unimoll-DB-; Vestinol-C-; Witcizer-300- RN: Current: 84-74-2 BRN: 1914064 BHR: 4-09-00-03175 UD: 200305 MF: C16-H22-O4 MW: 278.38 WL: 4OVR BVO2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 100 ug/plate (+S9) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 16, p. 61, 1985 (JTEHD6); dnd-hmn-lym 354 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 21, 2000 (MUREAV); dnd-hmn-oth 354 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 21, 2000 (MUREAV); cyt-ham-fbr 30 mg/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); dnd-hmn-oth 216 umol/L/60M Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 9, 2000 (EMMUEG) RE: T01-T02 orl-rat TDLo: 24 gm/kg (20D male) Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 3, p. 153, 1989 (WDZAEK); T13-T25 orl-rat TDLo: 6750 mg/kg (0-8D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 39, p. 189, 1999 (CGANE7); T25-T34-T43 orl-rat TDLo: 2250 mg/kg (7-9D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 86, p. 163, 1994 (TXCYAC); T31 orl-rat TDLo: 2520 mg/kg (1-21D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 26, p. 253, 1973 (TXAPA9); T25-T34-T35 orl-rat TDLo: 8820 mg/kg (7-15D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 69, p. 197, 1993 (TOLED5); T13-T86-T91 orl-rat TDLo: 19 gm/kg (3-22D preg/3-20D post) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 43, p. 47, 1998 (TOSCF2); T34-T43-T46 orl-rat TDLo: 1500 mg/kg (15D preg) JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 17, p. 223, 1997 (JJATDK); T19-T25-T26 orl-rat TDLo: 6750 mg/kg (0-8D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 13, 2000 (REPTED); T25 ipr-rat TDLo: 1017 mg/kg (5-15D preg) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 51, 1972 (JPMSAE); T34-T46 ipr-rat TDLo: 305 mg/kg (5-15D preg) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 51, 1972 (JPMSAE); T76 ipr-rat TDLo: 6 gm/kg (3-9D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); T24-T26-T41 orl-mus TDLo: 7200 mg/kg (1-18D preg) Osaka-furitsu Koshu Eisei Kenkyusho Kenkyu Hokoku, Shokuhin Eisei Hen. Research Reports of the Osaka Prefectural Institute of Public Health, Food Sanitation Section. (Osaka-furitsu Koshu Eisei Kenkyusho, 1-3-69 Nakamichi, Higashinari-ku, Osaka 537, Japan) No.1- 1970- v. 8, p. 29, 1977 (OEKSDJ); T34 orl-mus TDLo: 8640 mg/kg (1-18D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 45, p. 65, 1982 (EVHPAZ); T26 orl-mus TDLo: 20 gm/kg (6-13D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 29, 1987 (TCMUD8); T02-T09 orl-mus TDLo: 16800 mg/kg (7D male) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 5, p. 413, 1980 (TOLED5); T02 orl-gpg TDLo: 14 gm/kg (7D male) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 11, p. 141, 1982 (TOLED5); T53 unr-rat TDLo: 1000 mg/kg (16-19D preg) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 42, p. 176, 1998 (TOXID9); T34 orl-mus TDLo: 46200 mg/kg (1-21D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 22, p. 245, 1980 (ENVRAL); T53-T73 orl-rat TDLo: 2 gm/kg (15D preg) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 45, p. 212, 1998 (TOSCF2); T25-T34 orl-rat TDLo: 1.5 gm/kg (15D preg) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 45, p. 212, 1998 (TOSCF2); T39 orl-rat TDLo: 501 mg/kg (10D preg) Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 89, p. 104, 2001 (PHTOEH); T76 ipr-rat TDLo: 6 mL/kg (3-9D preg) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); T81 orl-rat TDLo: 11.2 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**); T81 orl-rat TDLo: 77.5 gm/kg (17W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**); T72 orl-rat TDLo: 2.3 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**); T81 orl-rat TDLo: 66 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**); T21-T22 orl-rat TDLo: 651 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**); T51-T53-T81 orl-rat TDLo: 651 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**) ORNG: 7499000000 ng/kg. [7499.000000 mg/kg] T/E unlistd AT: F08-K13-M30 orl-hmn TDLo: 140 mg/kg Schweizerische Medizinische Wochenschrift. (Schwabe and Co., Steintorst 13, 4010 Basel, Switzerland) V.50- 1920- v. 84, p. 1243, 1954 (SMWOAS); T/E unlistd orl-rat LD50: 7499 mg/kg Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 5, p. 264, 1991 (WDZAEK); T/E unlistd ihl-rat LC50: 4250 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(8), p. 26, 1973 (GTPZAB); T/E unlistd skn-rat LDLo: 6 gm/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,44,1982 (85GMAT); T/E unlistd ipr-rat LD50: 3050 uL/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 51, 1972 (JPMSAE); T/E unlistd ims-rat LD50: >8 gm/kg "Industrial Hygiene and Toxicology," 2nd ed., Patty, F.A., ed., New York, John Wiley and Sons, Inc., 1958-63 2,1904,1963 (14CYAT); F01-F19-J22 unr-rat LD50: 9410 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(6), p. 86, 1990 (GISAAA); T/E unlistd orl-mus LD50: 3474 mg/kg Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 5, p. 264, 1991 (WDZAEK); T/E unlistd ihl-mus LC50: 25 gm/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,44,1982 (85GMAT); T/E unlistd ipr-mus LD50: 3570 mg/kg Journal of the Society of Cosmetic Chemists. (Soc. of Cosmetic Chemists, 1995 Broadway, Suite 1701, New York, NY 10023) V.1- 1947- v. 28, p. 667, 1977 (JSCCA5); T/E unlistd ivn-mus LD50: 720 mg/kg Kanagawa-ken Eisei Kenkyusho Kenkyu Hokoku. Bulletin of Kanagawa Prefectural Public Health Laboratories. (Kanagawa-ken Eisei Kenkyusho, 52-2, Nakao-cho, Asahi-ku, Yokohama 241, Japan) No.1- 1971- v. (3), p. 19, 1973 (KEKHB8); F01-F19-J22 unr-mus LD50: 8140 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(6), p. 86, 1990 (GISAAA); T/E unlistd skn-rbt LD50: >20 mL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 12/29/1971 (UCDS**); F07-F31-U01 orl-gpg LD50: 10 gm/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 25, 1980 (GTPZAB); T/E unlistd orl-mam LD50: 5 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(4), p. 86, 1974 (GISAAA) MD: N30-U01-Y01 orl-rat TDLo: 96750 mg/kg/45D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(6), p. 102, 1968 (GISAAA); L70-U01-Z73 orl-rat TDLo: 42 gm/kg/28D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530401 (NTIS**); Z73 orl-rat TDLo: 4 gm/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 41, p. 609, 1977 (TXAPA9); L70-M70-P05 orl-rat TDLo: 27300 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3353 (NTPTR*); F15-Z01 orl-rat TDLo: 22750 mg/kg/1Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 26, p. 253, 1973 (TXAPA9); A70-P05-U01 ihl-rat TCLo: 900 mg/m3/6H/35D-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(8), p. 26, 1973 (GTPZAB); L70-M70 orl-mus TDLo: 54600 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-95-3353 (NTPTR*); Z71 orl-rat TDLo: 11250 mg/kg/9D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 13, 2000 (REPTED); F40-N17 orl-rat TDLo: 13500 mg/kg/9D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 13, 2000 (REPTED); F15-U01 orl-rat TDLo: 4500 mg/kg/9D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 13, 2000 (REPTED); U01-Z74 orl-rat TDLo: 6750 mg/kg/9D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 13, 2000 (REPTED); T02-T03 orl-rat TDLo: 28000 mg/kg/10D-I Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 452, 1980 (ATSUDG); T16-Z01 ipr-rat TDLo: 12 mL/kg/7D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 91, 1973 (EVHPAZ); U01 ims-rat TDLo: 4557 mg/kg/1W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**); L70-M71 ims-rat TDLo: 77469 mg/kg/17W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**); L70-M71-T02 ims-rat TDLo: 77469 mg/kg/17W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92111996 (NTIS**); L70-U01 ims-mus TDLo: 151200 mg/kg/18W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85144798 (NTIS**); L70-Z74 ims-mus TDLo: 151200 mg/kg/18W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85144798 (NTIS**) TR: ACGIH TLV-TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 54, p. 1, 1975 (RREVAH); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 4, p. 3, 1973 (EVHPAZ); TOXICOLOGY REVIEW Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail, rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963- v. 10(3), p. 49, 1973 (CMTVAS); TOXICOLOGY REVIEW Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (93), p. 1, 1975 (ESKHA5); TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 4(3), p. 267, 1985 (JACTDZ); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 75, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 5 mg/m3, JAN 1999; OEL-BELGIUM: TWA 5 mg/m3, JAN 1993; OEL-FRANCE: VME 5 mg/m3, JAN 1999; OEL-HUNGARY: TWA 2 mg/m3, STEL 4 mg/m3, Skin, JAN 1993; OEL-INDIA: TWA 5 mg/m3, JAN 1993; OEL-JAPAN: OEL 5 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 mg/m3, JAN 1999; OEL-NORWAY: TWA 3 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 5 mg/m3, JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 10 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.5 mg/m3, JAN 1993; OEL-SWEDEN: NGV 3 mg/m3, KTV 5 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 5 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 5 mg/m3, STEL 10 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DIBUTYL PHTHALATE-air: 10H TWA 5 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 80248; NIS 192; TNF 28100; NOS 114; TNE 258823; NOES 1983: HZD 80248; NIS 199; TNF 31502; NOS 138; TNE 512631; TFE 198249 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/2001/109104/AS); EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro SCE-nonhuman; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Dibutyl phthalate, 5020; NTP Toxicity studies, RPT# TOX-30, October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000; OSHA ANALYTICAL METHOD #104 Record 969 of 1119 in RTECS (through 2003/06) AN: TI1050000 PN: Phthalic-acid,-diethyl-ester- SY: 1,2-Benzenedicarboxylic-acid,-diethyl-ester-; Anozol-; DEP-; DPX-F5384-; Diethyl-1,2-benzenedicarboxylate-; Diethyl-o-phthalate-; Diethyl-phthalate-; Diethyl-phthalate- (ACGIH); Diethylester-kyseliny-ftalove- (Czech); Ethyl-phthalate-; NCI-C60048-; Neantine-; Palatinol-A-; Phthalol-; Phthalsaeurediaethylester- (German); Placidol-E-; RCRA-waste-number-U088-; Solvanol-; Unimoll-DA-; o-Benzenedicarboxylic-acid-diethyl-ester- RN: Current: 84-66-2 BRN: 1912500 BHR: 4-09-00-03172 UD: 200305 MF: C12-H14-O4 MW: 222.26 WL: 2OVR BVO2 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 112 mg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 82, p. 377, 1944 (JPETAB) ME: mmo-sat 200 ug/plate (+S9) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 16, p. 61, 1985 (JTEHD6) RE: T46 orl-rat TDLo: 25 gm/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 48, p. 33, 1993 (TJADAB); T25-T34-T46 ipr-rat TDLo: 506 mg/kg (5-15D preg) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 51, 1972 (JPMSAE); T01-T03-T72 orl-mus TDLo: 171 gm/kg (7D male/7D pre-21D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 88, p. 255, 1987 (TXAPA9); T86 orl-mus TDLo: 171 gm/kg (7D male/7D pre-21D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 88, p. 255, 1987 (TXAPA9); T34-T46 skn-mus TDLo: 101 gm/kg (1-17D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 33, p. 387, 1987 (OYYAA2); T46 skn-rbt TDLo: 26 mL/kg (6-18D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572465 (NTIS**); T26 orl-mus TDLo: 3.64 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118636 (NTIS**); T51-T81 orl-mus TDLo: 3.64 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118636 (NTIS**); T51-T53-T81 orl-mus TDLo: 3.64 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118636 (NTIS**); T53 orl-mus TDLo: 3.64 gm/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118636 (NTIS**); T26 orl-mus TDLo: 11.9 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118636 (NTIS**) TE: V03-L60 skn-mus TDLo: 618 mL/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-429, 1995 (NTPTR*) ORNG: 8600000000 ng/kg. [8600.000000 mg/kg] F07-F31-U01 AT: D15-F01-J22 orl-man TDLo: 357 uL/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 32, p. 1456, 1990 (YAKUD5); D17-J21-J30 ihl-hmn TCLo: 1000 mg/m3 Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 5, p. 1, 1933 (AGGHAR); F07-F31-U01 orl-rat LD50: 8600 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 25, 1980 (GTPZAB); T/E unlistd ipr-rat LD50: 5058 uL/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 51, 1972 (JPMSAE); T/E unlistd unr-rat LD50: 9500 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(7), p. 52, 1988 (GTPZAB); T/E unlistd orl-mus LD50: 6172 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 17(11), p. 51, 1973 (GTPZAB); J15-M03-P27 ipr-mus LD50: 2749 mg/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 6, p. 342, 1947 (FEPRA7); T/E unlistd unr-mus LD50: 8600 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(7), p. 52, 1988 (GTPZAB); T/E unlistd orl-rbt LD50: 1 gm/kg "Industrial Hygiene and Toxicology," 2nd ed., Patty, F.A., ed., New York, John Wiley and Sons, Inc., 1958-63 2,1904,1963 (14CYAT); T/E unlistd ivn-rbt LDLo: 100 mg/kg Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 5, p. 1, 1933 (AGGHAR); F07-F31-U01 orl-gpg LD50: 8600 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 25, 1980 (GTPZAB); T/E unlistd scu-gpg LD50: 3 gm/kg "Industrial Hygiene and Toxicology," 2nd ed., Patty, F.A., ed., New York, John Wiley and Sons, Inc., 1958-63 2,1904,1963 (14CYAT); T/E unlistd unr-gpg LD50: 3 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(9), p. 26, 1990 (GISAAA) MD: L70-U01-Z73 orl-rat TDLo: 44240 mg/kg/14D-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 415, 1978 (FCTXAV); L70-U01-Z73 orl-rat TDLo: 133 gm/kg/6W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 415, 1978 (FCTXAV); K30-L70-Z73 orl-rat TDLo: 354 gm/kg/16W-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 16, p. 415, 1978 (FCTXAV); P28 orl-rat TDLo: 25200 mg/kg/3W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 10, p. 379, 1982 (TOLED5); L70-M70 skn-rat TDLo: 24 mL/kg/4W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-429, 1995 (NTPTR*); L70-U01 skn-mus TDLo: 25 mL/kg/4W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-429, 1995 (NTPTR*) TR: ACGIH TLV-TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 3, p. 73, 1973 (EVHPAZ); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 54, p. 1, 1975 (RREVAH); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 4, p. 3, 1973 (EVHPAZ); TOXICOLOGY REVIEW Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (93), p. 1, 1975 (ESKHA5); TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 4(3), p. 267, 1985 (JACTDZ); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF); TOXICOLOGY REVIEW Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 97, 2001 (FCTOD7) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-AUSTRALIA: TWA 5 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 5 mg/m3, JAN 1999; OEL-BELGIUM: TWA 5 mg/m3, JAN 1993; OEL-DENMARK: TWA 3 mg/m3, JAN 1999; OEL-FINLAND: TWA 5 mg/m3, STEL 10 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 5 mg/m3, JAN 1999; OEL-JAPAN: OEL 5 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 5 mg/m3, JAN 1999; OEL-NORWAY: TWA 3 mg/m3, JAN 1999; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 15 mg/m3, JAN 1999; OEL-RUSSIA: STEL 0.5 mg/m3, JAN 1993; OEL-SWEDEN: NGV 3 mg/m3, KTV 5 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 5 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 5 mg/m3, STEL 10 mg/m3. SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DIETHYL PHTHALATE-air: 10H TWA 5 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #95-121, 1995 (NIOSH*); NOHS 1974: HZD 81806; NIS 30; TNF 1334; NOS 49; TNE 109691; NOES 1983: HZD 81806; NIS 120; TNF 16408; NOS 98; TNE 239149; TFE 108580 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264214/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (derm), equivocal evidence: mouse; NCI Carcinogenesis Studies (derm), no evidence: mouse, rat; OSHA ANALYTICAL METHOD #104 Record 970 of 1119 in RTECS (through 2003/06) AN: TI3450000 PN: Phthalic-anhydride,-tetrachloro- SY: CP-626-; 1,3-Isobenzofurandione,-4,5,6,7-tetrachloro- (9CI); NCI-C61585-; Niagathal-; 4,5,6,7-Tetrachloro-1,3-isobenzofurandione-; Tetrachlorophthalic-anhydride-; Tetrathal- RN: Current: 117-08-8 BRN: 211560 BHR: 5-17-11-00260 UD: 200012 MF: C8-Cl4-O3 MW: 285.88 CC: Tumorigen (C); Primary-Irritant (S) ID: eye-rbt 100 mg MLD National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3351 (NTPTR*) AT: T/E unlistd orl-rat LD50: >15800 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3351 (NTPTR*); T/E unlistd ihl-rat LC :>3600 mg/m3/4H National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3351 (NTPTR*); T/E unlistd skn-rbt LD50: >5 gm/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3351 (NTPTR*) MD: L70-M03-Z01 orl-rat TDLo: 68250 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3351 (NTPTR*); J70-N24-P72 ihl-rat TCLo: 5 mg/m3/6H/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0538630 (NTIS**) ND: NOHS 1974: HZD M3316; NIS 2; TNF 55; NOS 3; TNE 142; NOES 1983: HZD M3316; NIS 4; TNF 43; NOS 6; TNE 2067; TFE 786 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-8912; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-28, October 2000 Record 971 of 1119 in RTECS (through 2003/06) AN: TJ5000000 PN: 3-Picoline- SY: beta-Picoline-; m-Picoline-; beta-Methylpyridine-; m-Methylpyridine-; 3-Methylpyridine-; Pyridine,-3-methyl- (9CI) RN: Current: 108-99-6 UD: 200012 MF: C6-H7-N MW: 93.14 CC: Tumorigen (C); Primary-Irritant (S) ID: skn-rbt 200 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534823 (NTIS**); eye-rbt 100 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534823 (NTIS**) ORNG: 400000000 ng/kg. [400.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 400 mg/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,841,1986 (85JCAE); F07-F18-J22 ihl-rat LCLo: 11820 mg/m3/5H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534823 (NTIS**); F07 ipr-rat LD50: 150 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 5, p. 920, 1985 (FAATDF); T/E unlistd ipr-mus LD50: 596 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 88, p. 82, 1946 (JPETAB); T/E unlistd ivn-mus LD50: 298 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 88, p. 82, 1946 (JPETAB); F15-J27-K30 skn-rbt LDLo: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534823 (NTIS**); T/E unlistd skn-gpg LD50: 1 gm/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,841,1986 (85JCAE); T/E unlistd orl-qal LD50: 1 gm/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV); T/E unlistd orl-bwd LD50: 1 gm/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV) ND: NOES 1983: HZD X2579; NIS 2; TNF 34; NOS 2; TNE 5202; TFE 390 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 972 of 1119 in RTECS (through 2003/06) AN: TM3850000 PN: 2-Piperidineacetic-acid,-alpha-phenyl-,-methyl-ester,-hydrochloride- SY: Centedrin-; Meridil-hydrochloride-; Methyl-alpha-phenyl-2-piperidineacetate-hydrochloride-; Methylphenidate-hydrochloride-; Ritalin-; Ritalin-hydrochloride- RN: Current: 298-59-9 UD: 200305 MF: C14-H19-N-O2.Cl-H MW: 269.80 WL: T6MTJ BYR&VO1 &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: mtr-ham-emb 500 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 4, 1986 (ENMUDM); cyt-ham-ovr 1 gm/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 702 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V02-L60 orl-mus TDLo: 18250 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-439, 1995 (NTPTR*); V02-L60 orl-mus TDLo: 43260 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-162615 (NTIS**) ORNG: 350000000 ng/kg. [350.000000 mg/kg] T/E unlistd AT: F10 orl-chd TDLo: 32 mg/kg/6W-I Biological Psychiatry. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1969- v. 20, p. 1332, 1985 (BIPCBF); T/E unlistd orl-rat LD50: 350 mg/kg Analytical Profiles of Drug Substances. (Academic Press, 525 B Street, Suite 1900, San Diego, CA 92101) V.1-20, 1972-91. v. 10, p. 473, 1981 (APDSB7); T/E unlistd scu-rat LD50: 170 mg/kg Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*); T/E unlistd ivn-rat LD50: 50 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 -,264,1972 (27ZQAG); F17 orl-mus LD50: 60 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 18, p. 71, 1975 (JMCMAR); T/E unlistd ipr-mus LD50: 96500 ug/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #3749765 (USXXAM); T/E unlistd scu-mus LD50: 150 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 241, p. 182, 1961 (AEPPAE); T/E unlistd ivn-mus LD50: 40 mg/kg Klinische Wochenscrift. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1922- v. 32, p. 445, 1954 (KLWOAZ); T/E unlistd orl-rbt LD50: 900 mg/kg Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*); T/E unlistd scu-rbt LD50: 170 mg/kg Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*); T/E unlistd ivn-rbt LD50: 30 mg/kg Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*); F26 orl-mus TDLo: 1 mg/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 420, p. 33, 2001 (EJPHAZ); F42 ipr-rat TDLo: 1.25 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 298, p. 539, 2001 (JPETAB) MD: A70-L70-M70 orl-rat TDLo: 6370 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-439, 1995 (NTPTR*); L70-M70-Y15 orl-rat TDLo: 5320 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-439, 1995 (NTPTR*); L30-L70 orl-mus TDLo: 6370 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-439, 1995 (NTPTR*); L70 orl-mus TDLo: 28 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-439, 1995 (NTPTR*); K01 orl-dog TDLo: 180 mg/kg/30D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 42, p. 373, 1998 (TOXID9); R60-V30 orl-rat TDLo: 18025 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-162615 (NTIS**); S18 ipr-rat TDLo: 4.34 mg/kg/7D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 298, p. 539, 2001 (JPETAB) ND: NOES 1983: HZD X6175; NIS 1; TNF 46; NOS 1; TNE 697; TFE 366 SL: NTP Carcinogenesis Studies (feed), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NPT-TR-439, 1995 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 973 of 1119 in RTECS (through 2003/06) AN: TN2100000 PN: Piperidine,-1-nitroso- SY: Nitrosopiperidin- (German); N-Nitroso-piperidin- (German); N-Nitrosopiperidine-; 1-Nitrosopiperidine-; NO-Pip-; NPIP-; N-N-Pip-; RCRA-waste-number-U179-; Pyridine,-hexahydro-N-nitroso-; TL-266- RN: Current: 100-75-4 Previous: 68374-62-9 BRN: 110253 BHR: 5-20-03-00530 UD: 200207 MF: C5-H10-N2-O MW: 114.17 WL: T6NTJ ANO CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 100 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); oms-esc 440 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); mmo-esc 2 umol/plate (+S9) Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 75, p. 8, 1984 (GANNA2); dnr-esc 6 mg/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); pic-esc 50 mg/L Topics in Chemical Mutagenesis. (Plenum Pub. Corp., 233 Spring Street, New York, NY 10013) V.1- 1984- v. 1, p. 91, 1984 (TCMUE9); dnr-bcs 6 mg/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); slt-dmg-orl 10 mmol/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 359, 1989 (MUREAV); sln-dmg-orl 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 27, 1979 (MUREAV); trn-dmg-orl 425 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); mmo-smc 50 mmol/L/24H (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 155, 1978 (MUREAV); dnd-hmn-lng 100 umol/plate Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 59, p. 1401, 1977 (JNCIAM); dns-hmn-lvr 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); sce-hmn-lym 10 mmol/L Topics in Chemical Mutagenesis. (Plenum Pub. Corp., 233 Spring Street, New York, NY 10013) V.1- 1984- v. 1, p. 129, 1984 (TCMUE9); mtr-rat-ipr 50 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 1157, 1980 (CNREA8); dnd-rat-ipr 50 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 3209, 1973 (CNREA8); dnd-rat-lvr 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2592, 1982 (CNREA8); dnd-rat-orl 2220 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dns-rat-lvr 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dns-rat-oth 100 mmol/L Shika Kiso Igakkai Zasshi. Journal of the Japanese Association for Basic Dentistry. (Shika Kiso Igakkai, Hanayama Bldg., 1-44-2 Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1959- v. 22, p. 300, 1980 (SHKKAN); hma-rat-smc 2603 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 3, p. 41, 1983 (TCMUD8); mmo-mus-lym 5190 umol/L (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 3, p. 193, 1988 (MUTAEX); dnd-mus-lym 12200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 155, 1988 (MUREAV); dnd-mus-ipr 120 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); mmo-ham-emb 1 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 129, p. 111, 1984 (MUREAV); mtr-ham-emb 100 ug/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); dns-ham-emb 3 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 129, p. 111, 1984 (MUREAV); mmo-ham-lng 100 umol/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 406, 1980 (CNREA8) TE: V01-K60-L60 orl-rat TDLo: 350 mg/kg/2Y-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 31, p. 657, 1980 (IAPUDO); V03-D09 scu-rat TDLo: 680 mg/kg/34W-I Xenobiotica. (Taylor and Francis Ltd., 4 John St., London WC1N 2ET, UK) V.1- 1971- v. 3, p. 271, 1973 (XENOBH); V01-K60-L60 ivn-rat TDLo: 400 mg/kg/40W-I Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 50, p. 100, 1963 (NATWAY); V01-K60-L60 orl-mus TDLo: 2160 mg/kg/1Y-C Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 56, p. 142, 1969 (NATWAY); V03-L60 orl-mky TDLo: 540 gm/kg/5Y-I "Medical Primatology, Selected Papers from the 3rd Conference on Experimental Medicine and Surgery in Primates, Lyons, France, 1972," Goldsmith, E.I. and J. Moor-Jankowski, eds., White Plains, NY, Albert J. Phiebig Inc., 1972 Pt III,216,1972 (27CWAL); V01-J60-L60 orl-gpg TDLo: 1326 mg/kg/52W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 665, 1982 (IAPUDO); V01-J60-K60 orl-ham TDLo: 206 mg/kg/1Y-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 21, p. 219, 1983 (CALEDQ); V01-D09-J60 scu-ham TDLo: 1245 mg/kg/25W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 2, p. 169, 1977 (CALEDQ); V02-T65-K60 scu-ham TDLo: 100 mg/kg (14D preg) Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 71, 1977 (ZKKOBW); V03-L60 orl-rat TD :504 mg/kg/4W-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 65, p. 123, 1974 (GANNA2); V02-J60 scu-ham TD :100 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 71, 1977 (ZKKOBW); V01-K60-L60 orl-rat TD :3915 mg/kg/29W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 18, p. 265, 1964 (BJCAAI); V03-K60 scu-rat TD :850 mg/kg/52W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 1077, 1969 (ARZNAD); V02-J60 scu-ham TD :623 mg/kg/44W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1295, 1973 (JNCIAM); V01-K60-L60 orl-rat TD :840 mg/kg/56W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 31, p. 657, 1980 (IAPUDO); V01-K60-L60 orl-rat TD :1400 mg/kg/30W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 1045, 1981 (CRNGDP); V02-J60 scu-ham TD :1047 mg/kg/37W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1295, 1973 (JNCIAM); V03-K60-P62 scu-rat TD :900 mg/kg/1Y-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 66, p. 138, 1964 (ZEKBAI); V02-K60 orl-rat TD :1400 mg/kg/28W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 12, p. 99, 1981 (CALEDQ); V01-D09 scu-rat TDLo: 90 mg/kg/3W-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 15, p. 39, 2002 (TOPADD) ORNG: 200000000 ng/kg. [200.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 200 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); T/E unlistd scu-rat LD50: 100 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 80, p. 17, 1973 (ZKKOBW); T/E unlistd ivn-rat LD50: 60 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); T/E unlistd ihl-mus LC :>500 mg/m3/10M National Defense Research Committee, Office of Scientific Research and Development, Progress Report. v. NDCrc-132, p. June, 1942 (NDRC**); T/E unlistd orl-ham LD50: 617 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 21, p. 219, 1983 (CALEDQ); J30-L30-P01 scu-ham LD50: 324 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 81, p. 251, 1974 (ZKKOBW) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 287, 1978 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 28, p. 151, 1982 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 287, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY) SR: OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.001 mg/m3, Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-partial sex chrom. loss; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Nitrosamines, 2522; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #27 Record 974 of 1119 in RTECS (through 2003/06) AN: TP2450000 PN: Platinum(II), diamminedichloro-, cis- SY: cis-Platinous-diaminodichloride-; cis-Platinous-diammine-dichloride-; cis-Platinum-; cis-Platinum(II); cis-Platinum(II) diamminedichloride; cisPt(II); Biocisplatinum-; Briplatin-; CDDP-; CPDD-; Cis-diamminedichloroplatinum(II); Cis-platinum-; CisPt-; Cisplatin-; Cisplatino- (Spanish); Cisplatyl-; Diamminedichloroplatinum-; NCI-C55776-; NK-801-; NSC-119875-; Neoplatin-; Peyrone's-chloride-; Platiblastin-; Platidiam-; Platidiam-Lachema-BRNO-; Platinol-; Platinum, diamminedichloro-, (SP-4-2)- (9CI); TR-170-; cis-DDP-; cis-Diaminedichloroplatinum-; cis-Diaminodichloroplatinum(II); cis-Diamminedichloroplatinum-; cis-Diamminedichloroplatinum- (II); cis-Dichlorodiammine platinum(II); cis-Dichlorodiammineplatinum-; cis-Dichlorodiamminoplatinum(II); cis-Platin- RN: Current: 15663-27-1 UD: 200305 MF: Cl2-H6-N2-Pt MW: 300.07 WL: Z&2 PT-G2 CC: Tumorigen (C); Drug (D); Mutagen (M); Natural-Product (N); Human-Data (P); Reproductive-Effector (T) ME: mmo-sat 250 ng/plate (+S9) Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- v. 44, p. 96, 1985 (TAKHAA); mmo-sat 300 ng/plate (-S9) American Journal of Hospital Pharmacy. (American Soc. of Hospital Pharmacists, 4630 Montgomery Ave., Bethesda, MD 20814) V.15- 1958- v. 43, p. 344, 1986 (AJHPA9); mmo-sat 1 nmol/plate (-S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 913, 1979 (CNREA8); dnd-sat 10 mg/L/20H-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); mmo-esc 25 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 50, p. 1, 1978 (MUREAV); oms-esc 3 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 171, p. 83, 1986 (MUREAV); slt-esc 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 17, p. 13, 1973 (MUREAV); dnr-esc 125 ng/plate Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 28, p. 159, 1985 (NULSAK); oms-esc 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 94, p. 53, 1982 (MUREAV); dnd-esc 35 mg/L Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 116, p. 1247, 1973 (JOBAAY); dni-esc 26600 nmol/L NATO Advanced Study Institute Series, Series A: Life Sciences. (New York, NY) V.1-52, 1975-82. For publisher information, see NALSDJ. v. 40, p. 521, 1981 (NASSDK); oms-esc 250 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 29, p. 327, 1980 (CBINA8); pic-esc 1 ug/plate Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 90, p. 209, 1979 (BBRCA9); oms-bcs 15 umol/L/3H-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); dnr-bcs 1 ug/plate Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532, Japan) V.29- 1970- v. 44, p. 96, 1985 (TAKHAA); dnd-omi 250 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 3313, 1980 (CNREA8); dnd-omi 1 mmol/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 251, p. 736, 1974 (NATUAS); dnd-omi 60 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4127, 1981 (CNREA8); dnd-omi 1 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 32, p. 321, 1980 (CBINA8); slt-dmg-orl 10 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 40, 1986 (ENMUDM); cyt-dmg-par 200 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 285, 1983 (ENMUDM); sln-dmg-par 830 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 133, 1980 (ENMUDM); trn-dmg-orl 40 ppm Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); spm-dmg-par 200 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 285, 1983 (ENMUDM); mmo-nsc 200 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 43, 1984 (MUREAV); mmo-smc 50 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 127, p. 23, 1984 (MUREAV); mrc-smc 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 127, p. 23, 1984 (MUREAV); dna-sal-spr 10 mg/L Nucleic Acids Research. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1974- v. 10, p. 5345, 1982 (NARHAD); mnt-hmn-lym 8250 nmol/L Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 34, p. 235, 1987 (NEOLA4); mnt-hmn-leu 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 122, p. 111, 1983 (MUREAV); mnt-hmn-fbr 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 310, p. 37, 1994 (MUREAV); dnd-hmn-leu 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 52, p. 878, 1992 (CNREA8); dnd-hmn-ovr 20 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 51, p. 5181, 1991 (CNREA8); dnd-hmn-oth 10 umol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 47, p. 252, 1991 (IJCNAW); dnd-hmn-ovr 40 umol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 41, p. 809, 1988 (IJCNAW); dns-hmn-ovr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 5713, 1988 (CNREA8); dns-hmn-oth 5 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3019, 1988 (CNREA8); dns-hmn-fbr 20 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1809, 1984 (CNREA8); dnd-hmn-oth 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 3347, 1981 (CNREA8); dnd-hmn-oth 45 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 1361, 1987 (CNREA8); dnd-hmn-lym 12 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 897, 1982 (CNREA8); dnd-hmn-hla 5 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 1345, 1974 (BCPCA6); oms-hmn-hla 5 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 1345, 1974 (BCPCA6); dnd-hmn-lng 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 3347, 1981 (CNREA8); dnd-hmn-oth 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 3347, 1981 (CNREA8); dnd-hmn-oth 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 3347, 1981 (CNREA8); dni-hmn-oth 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 5829, 1989 (CNREA8); dnd-hmn-fbr 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 3347, 1981 (CNREA8); dni-hmn-hla 500 nmol/L Journal of Clinical Hematology and Oncology. (Cancer Center at Wadley Institutes, POB 35988, Dallas, TX 75235) V.5(3)- 1975- v. 7, p. 349, 1976 (JCHODP); dni-hmn-lym 10 mg/L Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 59, p. 665, 1975 (CCROBU); dni-hmn-oth 5 umol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 6, p. 207, 1970 (IJCNAW); oms-hmn-oth 5 umol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 6, p. 207, 1970 (IJCNAW); oms-hmn-lym 8250 nmol/L Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 34, p. 235, 1987 (NEOLA4); dni-hmn-ovr 5 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 40, p. 2641, 1990 (BCPCA6); dni-hmn-oth 20 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 42, p. 357, 1991 (BCPCA6); bfa-hmn-sat 24 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 18, p. 329, 1983 (CALEDQ); cyt-hmn-oth 10 umol/L Research in Experimental Medicine. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.157- 1972- v. 189, p. 409, 1989 (REXMAS); sce-hmn-oth 50 mg/L Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 61, p. 1741, 1988 (CANCAR); sce-hmn-oth 3300 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 1361, 1987 (CNREA8); sce-hmn-lym 250 ng/L/96H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 61, 1980 (ARTODN); dnd-rat-ipr 3500 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4127, 1981 (CNREA8); dnd-rat-oth 10 umol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 42, p. 382, 1988 (IJCNAW); dna-rat-ivn 8 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 52, p. 149, 1992 (CNREA8); dna-rat-ipr 5 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1665, 1996 (CRNGDP); dni-rat-ipr 4 mg/kg Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 30, p. 643, 1983 (NEOLA4); dni-rat-ivn 8500 ug/kg Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 70, p. 143, 1992 (PHTOEH); dni-rat-kdy 10 umol/L Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 70, p. 143, 1992 (PHTOEH); bfa-rat-sat 40 mg/kg Hinyokika Kiyo. Journal of Urology. (Kyoto Daigaku Igakubu, Hinyokikagaku Kyoshitsu, 54 Kawara-machi, Shogain, Sakyo-ku, Kyoto 606, Japan) V.1- 1955- v. 26, p. 813, 1980 (HIKYAJ); cyt-rat-ipr 650 ug/kg/5D Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 17, p. 57, 1980 (TXCYAC); sce-rat-oth 1 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 3511, 1983 (CNREA8); mnt-mus-ipr 100 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 181, 1987 (MUREAV); mnt-mus-oth 62500 ng/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 223, 1993 (MUREAV); dnd-mus-ipr 10 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 4719, 1982 (CNREA8); dnd-mus-leu 4 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 39, p. 169, 1982 (CBINA8); dnd-mus-ivn 20 mg/kg Investigational New Drugs. The Journal of New Anticancer Agents. Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1983- v. 8, p. 17, 1990 (INNDDK); dns-mus-oth 1 mg/L Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 29, p. 87, 1986 (NULSAK); dni-mus-oth 1 mg/L In Vitro Cellular and Developmental Biology. (Tissue Culture Assoc., 19110 Montgomery Village Ave., Suite 300, Gaithersburg, MD 20879) V.21- 1985- v. 22, p. 305, 1986 (ICDBEO); dni-mus-mmr 5 mg/L Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 76, p. 289, 1985 (JJCREP); dni-mus-ast 100 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 19, p. 2757, 1970 (BCPCA6); oms-mus-ast 100 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 19, p. 2757, 1970 (BCPCA6); dni-mus-lym 50 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 69, p. 47, 1982 (JJIND8); dni-mus-leu 1 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4484, 1988 (CNREA8); dni-mus-oth 500 ug/L Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 69, p. 37, 1983 (TUMOAB); oms-mus-ipr 12 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 187, 1985 (MUREAV); bfa-mus-sat 2500 ug/kg Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 32, p. 307, 1985 (NEOLA4); cyt-mus-ipr 500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 211, p. 131, 1989 (MUREAV); cyt-mus-oth 8 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 14, p. 383, 1976 (IJEBA6); cyt-mus-leu 5 mg/L Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1968- v. 27, p. 79, 1978 (VAAZA2); cyt-mus-oth 2 mg/L Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 14, p. 383, 1976 (IJEBA6); cyt-mus-ivn 1300 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 22, p. 821, 1991 (IYKEDH); sce-mus-oth 4 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 2025, 1985 (CNREA8); sce-mus-emb 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 264, p. 225, 1991 (MUREAV); dlt-mus-ipr 2500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 230, p. 205, 1990 (MUREAV); hma-mus-esc 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 164, p. 19, 1986 (MUREAV); hma-mus-ast 18200 ug/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 25, p. 1871, 1976 (BCPCA6); spm-mus-ipr 10 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); spm-mus-ivn 10 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); mnt-ham-ipr 1 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE83-770037 (NTIS**); mnt-ham-lng 680 nmol/L Zhongguo Yaolixue Yu Dulixue Zazhi. (Chinese Pharmacological Society, 27 Tai-Ping Road, Beijing 100850, China) V.1- 1986- v. 5, p. 217, 1991 (ZYYZEW); mnt-ham-ovr 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 115, 1990 (MUREAV); mtr-ham-kdy 1 umol/L European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 25, p. 27, 1989 (EJCODS); mtr-ham-emb 100 nmol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 28, p. 71, 1981 (IJCNAW); dna-ham-ovr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 346, p. 221, 1995 (MUREAV); dnd-ham-lng 11 umol/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 271, 1979 (MUREAV); dnd-ham-ovr 1 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 2043, 1984 (CNREA8); dna-ham-oth 1 mmol/L British Journal of Cancer, Supplement. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2ZS, UK) No.1- 1973- v. 3, p. 68, 1978 (BJCSB5); dni-ham-lng 30 umol/L Journal of Clinical Hematology and Oncology. (Cancer Center at Wadley Institutes, POB 35988, Dallas, TX 75235) V.5(3)- 1975- v. 7, p. 349, 1976 (JCHODP); dni-ham-ovr 5 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 35, p. 189, 1981 (CBINA8); oms-ham-ovr 5 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 35, p. 189, 1981 (CBINA8); cyt-ham-lng 680 nmol/L Zhongguo Yaolixue Yu Dulixue Zazhi. (Chinese Pharmacological Society, 27 Tai-Ping Road, Beijing 100850, China) V.1- 1986- v. 5, p. 217, 1991 (ZYYZEW); cyt-ham-ovr 5 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 35, p. 189, 1981 (CBINA8); sce-ham-oth 330 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1627, 1985 (CRNGDP); sce-ham-lng 1 ng/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 267, 1979 (MUREAV); sce-ham-emb 100 nmol/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 28, p. 71, 1981 (IJCNAW); sce-ham-ovr 200 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 577, 1983 (CNREA8); sce-ham-ipr 10 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. DE83-770037 (NTIS**); msc-ham-ovr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 103, 1977 (MUREAV); msc-ham-lng 2 mg/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 267, 1979 (MUREAV); dna-mam-lym 100 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 10, p. 27, 1975 (CBINA8); dni-rbt-kdy 5 mg/L/24H Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 2538, 1988 (CNREA8); oms-rbt-kdy 5 mg/L/24H Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 2538, 1988 (CNREA8); sce-rbt-ivn 1250 ug/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 265, 1981 (ENMUDM); sce-rbt-lym 100 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 265, 1981 (ENMUDM); dna-rat-spr 10 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 151, p. 71, 2000 (CALEDQ); mmo-esc 4 ug/plate/20M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 492, p. 91, 2001 (MUREAV); cyt-hmn-lym 0.5 mg/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 498, p. 89, 2001 (MUREAV); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG); slt-esc 20 mg/L/45M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 508, p. 107, 2002 (MUREAV) RE: T75 ipr-rat TDLo: 4500 ug/kg (17-22D preg/20D post) Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 703, 1982 (YACHDS); T31-T34-T72 ipr-rat TDLo: 2750 ug/kg (7-11D preg) Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 673, 1982 (YACHDS); T02 ipr-rat TDLo: 9 mg/kg (3D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 34, p. 995, 1996 (IJEBA6); T46 ipr-rat TDLo: 300 ug/kg (6D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 69, p. 245, 1983 (TXAPA9); T85-T86 ipr-rat TDLo: 13 mg/kg (17-22D preg/20D post) Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 703, 1982 (YACHDS); T25 ipr-rat TDLo: 3 mg/kg (3D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 10, p. 417, 1990 (TCMUD8); T01-T02-T03 scu-rat TDLo: 10 mg/kg (5D male) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 55, p. 156, 1991 (FESTAS); T01-T02-T03 scu-rat TDLo: 10 mg/kg (5D male) Journal of Andrology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1980- v. 11, p. 436, 1990 (JOAND3); T35-T71-T75 ivn-rat TDLo: 4125 ug/kg (7-17D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 15, p. 5782, 1981 (KSRNAM); T31-T46-T85 ivn-rat TDLo: 660 ug/kg (7-17D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 15, p. 5782, 1981 (KSRNAM); T34-T76 ivn-rat TDLo: 1650 ug/kg (7-17D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 15, p. 5782, 1981 (KSRNAM); T81-T86 ivn-rat TDLo: 4125 ug/kg (7-17D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 15, p. 5782, 1981 (KSRNAM); T85 unr-rat TDLo: 1 mg/kg (multigeneration) Yakubutsu, Seishin, Kodo. Japanese Journal of Psychopharmacology. (Nippon Shinkei, Seishin Yakuri Gakkai, 1433 Nogawa, Miyamae-ku, Kawasaki, 213, Japan) V.1-13, 1981-93. For publisher information, see NSSZEW v. 11, p. 438, 1991 (YSKODB); T41 orl-mus TDLo: 8 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(3), p. 29A, 1984 (TJADAB); T41 ipr-mus TDLo: 8 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 29(3), p. 29A, 1984 (TJADAB); T25-T26-T34 ipr-mus TDLo: 3 mg/kg (8D preg) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 35, p. 647, 1979 (EXPEAM); T01 ipr-mus TDLo: 1100 ug/kg (1D male) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); T33-T41 ipr-mus TDLo: 20 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 28, p. 189, 1983 (TJADAB); T34 ipr-mus TDLo: 300 ug/kg (8D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 69, p. 245, 1983 (TXAPA9); T01-T02 scu-mus TDLo: 350 mg/kg (5W male) Archives of Andrology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 24, p. 113, 1990 (ARANDR); T01 ivn-mus TDLo: 1100 ug/kg (1D male) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); T26-T35 ivn-rbt TDLo: 1625 ug/kg (6-18D preg) Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 695, 1982 (YACHDS) TE: V02-R60-T65 ipr-mus TDLo: 7500 ug/kg (17D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 53, p. 3874, 1993 (CNREA8); V01-J60 ipr-mus TDLo: 16 mg/kg/19W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 913, 1979 (CNREA8); V02-J60 ipr-mus TD :16204 ug/kg/10W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); V02-J60 ipr-mus TD :32408 ug/kg/10W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); V01-J60 ipr-mus TDLo: 16.20 mg/kg/10W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 915, 2000 (CRNGDP) ORNG: 25800000 ng/kg. [25.800000 mg/kg] F17-K12-P05 AT: M03 ivn-man TDLo: 2140 ug/kg/5D-I Japanese Journal of Medicine. (Nankodo Co., Ltd., POB 5272, Tokyo International 100-31, Japan) V.1-30, 1962-1991. For publisher information, see IEDIEP. v. 23, p. 283, 1984 (JJMDAT); D40-M12-P26 ivn-hmn TDLo: 1500 ug/kg/6D-I Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 57, p. 191, 1973 (CCROBU); M03-M12-P30 ivn-hmn TDLo: 500 ug/kg/13D-I Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 62, p. 693, 1978 (CTRRDO); F08-K13-M12 ivn-hmn TDLo: 2500 ug/kg Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 59, p. 647, 1975 (CCROBU); K13 ivn-hmn TDLo: 72 mg/kg/25D-I Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 62, p. 1591, 1978 (CTRRDO); R10-R11 idr-hmn TDLo: 40 ng/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2766, 1975 (CNREA8); M03 par-man TDLo: 2140 ug/kg/5D-I Nippon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine. (Nippon Naika Gakkai, 33-5, 3-chome, Hongo, Bunkyo-ku, Tokyo 113, Japan) V.1- 1913- v. 72, p. 1426, 1983 (NNGAAS); D40 unr-chd TDLo: 19200 ug/kg/12W-I Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 103, p. 1006, 1983 (JOPDAB); F17-K12-P05 orl-rat LD50: 25800 ug/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 723, 1982 (YACHDS); T/E unlistd ipr-rat LD50: 6400 ug/kg Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 18, p. 31, 1993 (JTSCDR); J24-K12-M10 scu-rat LD50: 8100 ug/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 15, p. 5669, 1981 (KSRNAM); M30 ivn-rat LD50: 8 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 201, 1981 (JJIND8); F17-K12-P05 ims-rat LD50: 9200 ug/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 723, 1982 (YACHDS); M03 unr-rat LD :>5 mg/kg Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 24, p. 337, 1999 (JTSCDR); J24-K12-M10 orl-mus LD50: 32700 ug/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 15, p. 5669, 1981 (KSRNAM); T/E unlistd ipr-mus LD50: 6600 ug/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 34, p. 414, 1991 (JMCMAR); T/E unlistd scu-mus LD50: 13 mg/kg Journal de Pharmacie de Belgique. (SPPIF, B.P.22, F-41353 Vineuil, France) New series: V.1- 1945/46- v. 41, p. 286, 1986 (JPBEAJ); T/E unlistd ivn-mus LD50: 11 mg/kg Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 7, p. 90, 1984 (ATSUDG); F17-K12-P05 ims-mus LD50: 17900 ug/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 10, p. 723, 1982 (YACHDS); T/E unlistd par-mus LD50: 22 mg/kg International Journal of Radiation Oncology, Biology, Physics. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1975- v. 5, p. 1417, 1979 (IOBPD3); T/E unlistd unr-mus LD50: 10900 ug/kg Gan to Kagaku Ryoho. Cancer and Chemotherapy. (1-8-9 Yaesu, Chuo-ku, Tokyo 103, Japan) V.1- 1974- v. 13, p. 280, 1986 (GTKRDX); K30-M03-P24 ivn-dog LDLo: 2500 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 25, p. 230, 1973 (TXAPA9); T/E unlistd ivn-mky LDLo: 250 ug/kg Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 33, p. 1219, 1974 (CANCAR); D40 ipr-gpg LD50: 9700 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 33, p. 320, 1975 (TXAPA9); F12-M03 par-frg LD50: 17 mg/kg Journal of Comparative Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.75- 1965- v. 103, p. 387, 1990 (JCVPAR); K13 ivn-mam LDLo: 8 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 28(4), p. 285, 2000 (YACHDS); T01-U01 ipr-mus TDLo: 8 mg/kg Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 112, p. 436, 1986 (ACENA7); M03-M12-P28 ipr-rat TDLo: 7.5 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 293, p. 829, 2000 (JPETAB); N04-N16-Y07 ivn-rat TDLo: 7 mg/kg Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 126, p. 2398, 1990 (ENDOAO); H30-P72-V30 iat-hmn TDLo: 4.25 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 86, p. 196, 2002 (BJCAAI); Y15 iat-rat TDLo: 0.4 mg/kg Biological and Pharmaceutical Bulletin. (Pharmaceutical Society of Japan, 2-12-15-201 Shibuya Shibuya-ku, Tokyo 150, Japan) V.16- 1993- v. 23, p. 344, 2000 (BPBLEO); V30-Y15 iat-rat TDLo: 0.8 mg/kg Biological and Pharmaceutical Bulletin. (Pharmaceutical Society of Japan, 2-12-15-201 Shibuya Shibuya-ku, Tokyo 150, Japan) V.16- 1993- v. 23, p. 344, 2000 (BPBLEO); M04-M10-M12 ipr-rat TDLo: 7.5 mg/kg Naunyn-Schmiedebergs Archiv fuer Pharmakologie. (Berlin, Ger.) V.264-271, 1969-71. For publisher information, see NSAPCC. v. 361, p. 334, 2000 (NNAPBA) MD: L30-M30-U11 ipr-rat TDLo: 24 mg/kg/3D-I Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 86, p. 276, 2000 (PHTOEH); K30-Y21 ipr-rat TDLo: 9 mg/kg/5D-I Anti-Cancer Drugs. (Rapid Communications of Oxford Ltd., The Old Malthous, Paradise St., Oxford OX1 1LD, UK) V.1- 1990- v. 8, p. 853, 1997 (ANTDEV); M70-N74-P05 ipr-rat TDLo: 22680 ug/kg/35D-C Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 15, p. 5687, 1981 (KSRNAM); L70-M16-N74 ipr-rat TDLo: 23296 ug/kg/26W-C Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 15, p. 5719, 1981 (KSRNAM); M03-U01-Z01 ipr-rat TDLo: 14 mg/kg/7D-I Journal of Comparative Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.75- 1965- v. 105, p. 367, 1991 (JCVPAR); C18-Z01 ipr-rat TDLo: 18 mg/kg/5W-I Acta Neuropathologica. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1961- v. 84, p. 364, 1992 (ANPTAL); G30-M30-N30 ivn-rat TDLo: 16200 ug/kg/26W-I Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 22, p. 1038, 1991 (IYKEDH); C18 ipr-rat TDLo: 18 mg/kg/9W-I Acta Neuropathologica. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1961- v. 84, p. 364, 1992 (ANPTAL); M03-P26-Q30 ipr-rat TDLo: 22800 ug/kg/6W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 38, p. 535, 1976 (TXAPA9); P28-P72-P73 ivn-rat TDLo: 22 mg/kg/4W-I Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 30, p. 2131, 1996 (KSRNAM); M30-P28-Y11 ivn-rat TDLo: 18 mg/kg/20D-I Renal Failure. (Marcel Dekker Journals, POB 5005, Monticello, NY 12701) V.10- 1987- v. 17, p. 539, 1995 (REFAE8); C03-U01-Z01 ipr-mus TDLo: 40 mg/kg/8W-I Muscle and Nerve. (John Wiley and Sons, 605 Third Ave., New York, NY 10158) V.1- 1978- v. 22, p. 329, 1999 (MUNEDE); A70-M70-U01 ivn-mus TDLo: 11 mg/kg/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-166281 (NTIS**); P17-U01-Y03 ivn-dog TDLo: 10500 ug/kg/90D Korean Journal of Toxicology. (Korean Society of Toxicology, c/o College of Medicine, Seoul National University, Seoul, 110, S. Korea) V.1- 1985- v. 8, p. 235, 1992 (KJTOEA); M70-P73-Z73 ivn-dog TDLo: 10800 ug/kg/26W-I Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 22, p. 1020, 1991 (IYKEDH); M03-P26-Z01 ivn-dog TDLo: 3750 ug/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 25, p. 230, 1973 (TXAPA9); K30-M03-P26 ivn-mky TDLo: 12500 ug/kg/5D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 25, p. 230, 1973 (TXAPA9); C18-K13-M03 ivn-mky TDLo: 12500 ug/kg/12W-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 46, p. 155, 1998 (TOSCF2); D40-D44-Z01 ipr-gpg TDLo: 7500 ug/kg/15D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 33, p. 320, 1975 (TXAPA9); P28-U01-Z01 ipr-gpg TDLo: 18 mg/kg/9D-I Journal of Comparative Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.75- 1965- v. 105, p. 367, 1991 (JCVPAR); D44 ipr-gpg TDLo: 15 mg/kg/30D-I Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 29, p. 3573, 1995 (KSRNAM); D44-U01 ipr-rat TDLo: 15 mg/kg/1W-I Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 22, p. 163, 2001 (NRTXDN); R60-V30-V25 ipr-mus TDLo: 10 mg/kg/2D-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 147, p. 17, 1999 (CALEDQ); V25-U01 ims-mus TDLo: 22.5 mg/kg/5D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 297, p. 1106, 2001 (JPETAB); V25 ims-mus TDLo: 7.5 mg/kg/5D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 297, p. 1106, 2001 (JPETAB); C16-M12-P72 ims-rat TDLo: 22.5 mg/kg/10D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 297, p. 1106, 2001 (JPETAB) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 151, 1981 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 170, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 170, 1987 (IMSUDL); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 170, 1987 (IMSUDL); TOXICOLOGY REVIEW Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 60, p. 399, 1973 (NATWAY); TOXICOLOGY REVIEW Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 48, p. 124, 1974 (RRCRBU); TOXICOLOGY REVIEW Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 86, p. 803, 1977 (AIMEAS); TOXICOLOGY REVIEW Antibiotics and Chemotherapy (Basel). (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.17- 1971- v. 23, p. 99, 1978 (ANBCB3) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Pt)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Pt)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Pt)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Pt)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR) ND: NOES 1983: HZD X3192; NIS 1; TNF 609; NOS 8; TNE 21216; TFE 15289 SL: EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: In vitro SCE-nonhuman, TRP reversion; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: TRP reversion; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 975 of 1119 in RTECS (through 2003/06) AN: TQ1360000 PN: Polychlorinated-biphenyl- (aroclor 1254) SY: Arochlor-1254-; Aroclor-1254-; Chlorierte biphenyle, chlorgehalt 54% (German); Chlorodiphenyl- (54% Cl); Chlorodiphenyl- (54% chlorine); Chlorodiphenyl (54% chlorine) (ACGIH,OSHA); Clorodifenili, cloro 54% (Italian); Diphenyle chlore, 54% de chlore (French); NCI-C02664-; PCB- (OSHA) RN: Current: 11097-69-1 UD: 200305 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mnt-ofs-ipr 50 mg/kg Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 47, p. 147, 1986 (CYTBAI); mnt-ofs-ipr 50 mg/kg Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 47, p. 147, 1986 (CYTBAI); cyt-ofs-ipr 50 mg/kg Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- v. 82, p. 489, 1985 (CBPCEE); cyt-ofs-ipr 50 mg/kg Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- v. 82, p. 489, 1985 (CBPCEE); cyt-ofs-ipr 50 mg/kg Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- v. 82, p. 489, 1985 (CBPCEE); spm-oin-orl 808 mg Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 11, p. 167, 1974 (CYTBAI); mtr-rat-orl 25 ppm/2Y-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 60, p. 89, 1985 (EVHPAZ); dnd-rat-orl 1295 mg/kg Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 57, p. 407, 1981 (BSIBAC); dnd-rat-ipr 500 mg/kg Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 57, p. 407, 1981 (BSIBAC); dnd-rat-lvr 300 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); dns-rat-lvr 20 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3010, 1982 (CNREA8); mtr-mus-fbr 5 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T81-T86-T91 orl-rat TDLo: 192 mg/kg (6D post) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 31, p. 76, 1983 (ENVRAL); T85 orl-rat TDLo: 148 mg/kg (6-21D preg/21D post) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 33, p. 120, 1996 (FAATDF); T83 orl-rat TDLo: 35 mg/kg (10-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 139, p. 252, 1996 (TXAPA9); T51 orl-rat TDLo: 90 mg/kg (7-15D preg) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 11, p. 471, 1973 (FCTXAV); T91 orl-rat TDLo: 40 mg/kg (5D post) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 38, p. 946, 1987 (BECTA6); T24 orl-rat TDLo: 750 mg/kg (5D male) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 13, p. 507, 1975 (FCTXAV); T85 orl-rat TDLo: 96 mg/kg (6-21D preg) Brain Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1966- v. 850, p. 87, 1999 (BRREAP); T87 orl-rat TDLo: 304 mg/kg (6-22D preg/21D post) Hearing Research. (Elsevier Science B. V., POB 211, 1000 AE Amsterdam, Netherlands) V. 1- 1986- v. 144, p. 196, 2000 (HERED3); T19-T83 ipr-rat TDLo: 250 mg/kg (15D preg) International Journal of Biochemistry. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1970- v. 25, p. 1209, 1993 (IJBOBV); T85 orl-mus TDLo: 59400 ug/kg (3D pre-21D post) Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 3, p. 5, 1981 (NTOTDY); T25-T27-T35 orl-rbt TDLo: 350 mg/kg (1-28D preg) Environmental Physiology. (Copenhagen, Denmark) V.1(1-4), 1971. For publisher information, see ENPBBC. v. 1, p. 67, 1971 (EVPHBI); T83 orl-rbt TDLo: 280 mg/kg (1-28D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 6, p. 120, 1971 (BECTA6); T22 orl-mam TDLo: 14 mg/kg (30D pre) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 83, 1984 (TOXID9); T52 orl-rat TDLo: 380 mg/kg (6-22D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 243, 1995 (TOXID9); T41-T52 orl-rat TDLo: 38 mg/kg (6-22D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 157, 1995 (TOXID9); T72-T81 orl-rat TDLo: 152 mg/kg (6-22D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 157, 1995 (TOXID9); T42 orl-rat TDLo: 38 mg/kg (6-22D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 30, p. 25, 1996 (TOXID9); T52 orl-rat TDLo: 35 mg/kg (10-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 136, p. 269, 1996 (TXAPA9); T51-T53 orl-rat TDLo: 320 ug/kg (5D post) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 66, p. 52, 1994 (ENVRAL); T86 orl-rat TDLo: 160 ug/kg (5D post) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 66, p. 52, 1994 (ENVRAL); T41 orl-rat TDLo: 222 mg/kg (6-22D preg/21D post) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 174, p. 188, 2001 (TXAPA9); T51-T52-T81 orl-rat TDLo: 462.5 mg/kg (1D preg-15D post) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 48, p. 715, 1992 (BECTA6); T41 orl-rat TDLo: 4 gm/kg (12-16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 62A, 1980 (TJADAB); T41-T52 scu-rat TDLo: 90 mg/kg (10-18D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S83, 2001 (TOLED5) TE: V01-L60 orl-rat TDLo: 73500 mg/kg/2Y-C EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 60, p. 89, 1985 (EVHPAZ); V02-L60 orl-mus TDLo: 17 gm/kg/48W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 53, p. 547, 1974 (JNCIAM); V03-R60-V10 skn-mus TDLo: 4 mg/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 18, p. 552, 1977 (BECTA6); V03-T65-J60 ipr-mus TDLo: 500 mg/kg (19D preg) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 71, p. 157, 1983 (JJIND8); V03-K60 orl-rat TD :1 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 5052, 1981 (CNREA8); V03-K60 orl-rat TD :3 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 5052, 1981 (CNREA8); V03-K60-L60 orl-rat TD :4 gm/kg/2Y-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-38, 1978 (NCITR*) ORNG: 1010000000 ng/kg. [1010.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1010 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 60, p. 33, 1981 (TXAPA9); F07-J22-K12 ivn-rat LD50: 358 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 12, p. 63, 1974 (FCTXAV); T/E unlistd ipr-mus LD50: 880 mg/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 8, p. 245, 1972 (BECTA6); T/E unlistd orl-mam LD50: 4 gm/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 6, p. 279, 1977 (AECTCV); T/E unlistd ipr-mam LD50: >1250 mg/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 6, p. 279, 1977 (AECTCV); M30-Y09-Y50 ivn-ckn TDLo: 300 mg/kg Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905- v. 255, p. 8275, 1980 (JBCHA3); Y07 ipr-rat TDLo: 500 mg/kg Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 13, p. 924, 1977 (MOPMA3); L70-N30-Y07 ipr-mus TDLo: 50 mg/kg Environmental Pollution. (Barking, UK) V.1-20, 1970-79. v. 72, p. 57, 1991 (ENVPAF); L30-P30 ipr-mus TDLo: 200 mg/kg Environmental Pollution. (Barking, UK) V.1-20, 1970-79. v. 72, p. 57, 1991 (ENVPAF); P30 ipr-mus TDLo: 50 mg/kg Environmental Pollution. (Barking, UK) V.1-20, 1970-79. v. 72, p. 57, 1991 (ENVPAF); N30-Y07 ipr-mus TDLo: 200 mg/kg Environmental Pollution. (Barking, UK) V.1-20, 1970-79. v. 72, p. 57, 1991 (ENVPAF); L30-Y20-Y07 ipr-mus TDLo: 500 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 71, p. 254, 1983 (TXAPA9); T/E unlistd ivn-rat LD50: 358 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 58, 1984 (VCVGK*) MD: F17-U01 orl-rat TDLo: 600 mg/kg/4W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 40, p. 68, 1997 (FAATDF); L30-Y37-Y40 orl-rat TDLo: 5475 mg/kg/52W-C Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 8, p. 191, 1979 (AECTCV); L30-L70 orl-rat TDLo: 1652 mg/kg/35W-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 25, p. 354, 1972 (AEHLAU); L70-Y37 orl-rat TDLo: 210 mg/kg/20W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 37, p. 112, 1976 (TXAPA9); L70-M70-Q30 orl-rat TDLo: 105 mg/kg/15W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 57, p. 83, 1989 (TXCYAC); L30-Y07-Y40 orl-rat TDLo: 50400 ug/kg/12W-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 12, p. 669, 1974 (BECTA6); L70-P28-Y07 orl-rat TDLo: 60 mg/kg/20D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 769, 1977 (JTEHD6); L70-Y07 orl-rat TDLo: 70 mg/kg/1W-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 12, p. 145, 1974 (BECTA6); L70-P28-Y37 orl-rat TDLo: 1920 ug/kg/4D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 34, p. 427, 1985 (BECTA6); L30-L70-Y21 ipr-rat TDLo: 350 mg/kg/7D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 4, p. 107, 1978 (JTEHD6); L70 orl-mus TDLo: 672 mg/kg/28D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 5, p. 605, 1979 (JTEHD6); F05-L70-N72 orl-mus TDLo: 90 mg/kg/15D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 40, p. 91, 1977 (TXAPA9); S04 orl-mky TDLo: 8365 ug/kg/4.5Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 16, p. 773, 1991 (FAATDF); D35-P27-R22 orl-mky TDLo: 170 mg/kg/2.3Y-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 14, p. 1, 1986 (TOPADD); L70-Y15-Z74 orl-rbt TDLo: 4200 mg/kg/14W-I American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 70, p. 363, 1973 (AJPAA4); J30-M30-Y40 scu-rbt TDLo: 25 mg/kg/20D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 9, p. 283, 1989 (JEPOEC); L30 ims-rbt TDLo: 25 mg/kg/20D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 12, p. 17, 1993 (JEPOEC); L30-Y36 orl-qal TDLo: 588 mg/kg/12W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 51, p. 57, 1997 (JTEHD6); L30 par-dck TDLo: 25 mg/kg/10W-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 12, p. 17, 1993 (JEPOEC); S04-U01 scu-dom TDLo: 20 mg/kg/20D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 9, p. 283, 1989 (JEPOEC); L30 ims-dom TDLo: 5 mg/kg/20D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 12, p. 17, 1993 (JEPOEC); L30 ims-dom TDLo: 7500 ug/kg/12W-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 12, p. 17, 1993 (JEPOEC); U01-Z01 orl-mam TDLo: 119 mg/kg/28D-C Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 15, p. 393, 1986 (AECTCV); G70-U01-Z01 orl-mam TDLo: 180 mg/kg/17W-C Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 6, p. 279, 1977 (AECTCV); E01-L70-Y65 orl-brd TDLo: 431 mg/kg/8W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 53, p. 75, 1980 (TXAPA9); F15-U01 orl-rat TDLo: 1820 mg/kg/52W-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 377, 2000 (TOSCF2); N71-U01 orl-rat TDLo: 1750 mg/kg/10W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 288, 1993 (FAATDF); N71-T01-U01 orl-rat TDLo: 2625 mg/kg/15W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 288, 1993 (FAATDF); L30-M30-N08 orl-rat TDLo: 35 mg/kg/5W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 288, 1993 (FAATDF); N19-U01 orl-rat TDLo: 300 mg/kg/30D-I Comparative Biochemistry and Physiology. (Elmsford, NY) V.1-37, 1960-70. For publisher information, see CBPBB8. v. 77C , p. 65, 1984 (CBCPAI); U01 orl-rat TDLo: 632.4 mg/kg/372D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 377, 2000 (TOSCF2); Q30 orl-rat TDLo: 1055.6 mg/kg/182D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 377, 2000 (TOSCF2); F17 orl-rat TDLo: 309.4 mg/kg/182D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 377, 2000 (TOSCF2); N16-N17-Z71 orl-nml TDLo: 102.9 mg/kg/30D-C Marine Environmental Research. (Kidlington, Oxford : Elsevier) V. 1- 1978- v. 24, p. 179, 1988 (MAERE*); P26-U01 orl-rat TDLo: 750 mg/kg/5D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 13, p. 14, 1975 (BECTA6); Z01 orl-rat TDLo: 1500 mg/kg/5D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 13, p. 14, 1975 (BECTA6); N75 orl-bwd TDLo: 2800 mg/kg/8W-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 8, p. 306, 1972 (BECTA6); S04 orl-rbt TDLo: 5.94 mg/kg/33D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 587, 1975 (TXAPA9); N30 orl-rbt TDLo: 10.26 mg/kg/57D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 587, 1975 (TXAPA9); L70-N73 orl-rbt TDLo: 119.7 mg/kg/57D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 32, p. 587, 1975 (TXAPA9); N08 orl-rat TDLo: 10 mg/kg/40D-C Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 121, p. 520, 1987 (ENDOAO); N08 orl-rat TDLo: 10 mg/kg/20D-C Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 121, p. 520, 1987 (ENDOAO); Y53 orl-rat TDLo: 7.5 mg/kg/150D-C Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 121, p. 520, 1987 (ENDOAO); N07 orl-rat TDLo: 8.4 mg/kg/4W-C Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1968- v. 33, p. 213, 1980 (VAAZA2); N06 orl-rat TDLo: 84 mg/kg/4W-C Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1968- v. 33, p. 213, 1980 (VAAZA2); N30 orl-rat TDLo: 10.5 mg/kg/5W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1, p. 587, 1978 (JEPTDQ); L60-V16 orl-rat TDLo: 756 mg/kg/18W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 66, p. 509, 1981 (JNCIAM); L70-Y53 skn-rat TDLo: 120 ug/kg/4D-I Canadian Journal of Physiology and Pharmacology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.42- 1964- v. 54, p. 23, 1976 (CJPPA3); L70-Y53 orl-rat TDLo: 165 mg/kg/11D-I Canadian Journal of Physiology and Pharmacology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.42- 1964- v. 54, p. 23, 1976 (CJPPA3) TR: ACGIH TLV-TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 18, p. 43, 1978 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 322, 1987 (IMSUDL); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 322, 1987 (IMSUDL); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 1, p. 105, 1972 (EVHPAZ); TOXICOLOGY REVIEW Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 14, p. 139, 1974 (ARVPAX); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 44, p. 1, 1973 (RREVAH); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 2, p. 305, 1974 (STEVA8); TOXICOLOGY REVIEW BioScience. (American Institute of Biological Sciences, 1401 Wilson Blvd., Arlington, VA 22209) V.14- 1964- v. 20, p. 958, 1970 (BISNAS); TOXICOLOGY REVIEW Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 5, p. 249, 1972 (ENVRAL) SR: MSHA STANDARD-air: TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 52, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.5 mg/m3, STEL 1 mg/m3, Skin, Carcinogen JAN 1993; OEL-AUSTRIA: MAK 0.05 ppm (0.5 mg/m3), Skin, Suspected Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.5 mg/m3, STEL 1 mg/m3, Skin, JAN 1993; OEL-FRANCE: VME 0.5 mg/m3, Skin, JAN 1999; OEL-GERMANY: MAK 0.05 ppm (0.5 mg/m3), Skin, Carcinogen, JAN 1999; OEL-JAPAN: OEL 0.1 mg/m3, Skin, 2A Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.5 mg/m3, Skin, JAN 1999; OEL-NORWAY: TWA 0.01 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-POLAND: MAC(TWA) 1 mg/m3, JAN 1999; OEL-SWEDEN: NGV 0.1 mg/m3, KTV 0.3 mg/m3, Skin, Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.05 ppm (0.5 mg/m3), Skin, JAN 1999; OEL-TURKEY: TWA 1 mg/m3, Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 0.1 mg/m3, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHLORODIPHENYL (54% Cl)-air: 10H CA TWA 0.001 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X1181; NIS 5; TNF 170; NOS 7; TNE 3702; TFE 1725 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/2000/108027); EPA GENETOX PROGRAM 1988, Negative: SHE-clonal assay, Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 7, 1976 AND BULLETIN 45, 1986; NIOSH Analytical Method, 1994: Polychlorobiphenyls, 5503, in serum, 8004; NCI Carcinogenesis Bioassay (feed), equivocal evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-38, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 976 of 1119 in RTECS (through 2003/06) AN: TQ1362000 PN: Polychlorinated-biphenyl- (aroclor 1260) SY: Arochlor-1260-; Aroclor-1260-; Chlorodiphenyl- (60% Cl); Clophen-A60-; Phenoclor-DP6- RN: Current: 11096-82-5 UD: 200210 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: cyt-rat-orl 1080 mg/kg/26W-C Abstracts of Papers, Society of Toxicology. Annual Meetings. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) v. 19, p. A16, 1980 (APTOD9) RE: T72 orl-rat TDLo: 1675 mg/kg (multigenerations) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 12, p. 63, 1974 (FCTXAV); T14-T24 orl-mus TDLo: 74 mg/kg (62D pre/1-10D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 6, p. 176, 1973 (ENVRAL); T14 ipr-mus TDLo: 20 mg/kg (1D pre) Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 1, p. 148, 1972 (AMBOCX); T91 scu-mus TDLo: 143 mg/kg (21D post) Environmental Physiology and Biochemistry. (Copenhagen, Denmark) V.2-5, 1972-75. Discontinued. v. 5, p. 54, 1975 (ENPBBC); T53-T91 orl-rat TDLo: 210 mg/kg (14-20D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 18, p. 437, 1979 (ENVRAL) TE: V01-L60 orl-rat TDLo: 4380 mg/kg/83W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 55, p. 1453, 1975 (JNCIAM); V01-L60 orl-rat TD :4992 mg/kg/2Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 75, p. 278, 1984 (TXAPA9); V02-L60 orl-rat TD :360 mg/kg/17W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 39, p. 59, 1988 (CALEDQ) ORNG: 1315000000 ng/kg. [1315.000000 mg/kg] F07-K12 AT: F07-K12 orl-rat LD50: 1315 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 12, p. 63, 1974 (FCTXAV); T/E unlistd skn-rbt LDLo: 2 gm/kg Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 14, p. 139, 1974 (ARVPAX) MD: L30-Y07 orl-rat TDLo: 4200 ug/kg/7D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 26, p. 504, 1973 (TXAPA9); L30-L70 orl-rat TDLo: 340 mg/kg/35W-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 25, p. 354, 1972 (AEHLAU); L70 ipr-rat TDLo: 150 mg/kg/3D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 418, 1974 (TXAPA9); L70-P28-Y03 orl-dog TDLo: 910 mg/kg/1Y-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 5, p. 249, 1972 (ENVRAL); A30-Y65 orl-mky TDLo: 448 mg/kg/20W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 66, p. 145, 1991 (TXCYAC); L70-R21-Y36 skn-rbt TDLo: 960 mg/kg/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 563, 1972 (TXAPA9); L70-N75 orl-qal TDLo: 1260 mg/kg/18W-C Poultry Science. (Poultry Science Assoc., Inc., 309 W. Clark St., Champaign, IL 61820) V.1- 1921- v. 53, p. 125, 1974 (POSCAL); F17 orl-rat TDLo: 273 mg/kg/91D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 53, p. 377, 2000 (TOSCF2) TR: IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 18, p. 43, 1978 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 18, p. 43, 1978 (IMEMDT); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 1, p. 105, 1972 (EVHPAZ); TOXICOLOGY REVIEW Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 14, p. 139, 1974 (ARVPAX); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 2, p. 305, 1974 (STEVA8); TOXICOLOGY REVIEW BioScience. (American Institute of Biological Sciences, 1401 Wilson Blvd., Arlington, VA 22209) V.14- 1964- v. 20, p. 958, 1970 (BISNAS); TOXICOLOGY REVIEW Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 5, p. 249, 1972 (ENVRAL) ND: NIOSH REL TO POLYCHLORINATED BIPHENYLS-air: 10H CA TWA 0.001 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X1180; NIS 2; TNF 55; NOS 2; TNE 991; TFE 44 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/2000/108027); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 7, 1976 AND BULLETIN 45, 1986; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 977 of 1119 in RTECS (through 2003/06) AN: TQ1376000 PN: Polychlorinated-biphenyl- (kanechlor 500) SY: Kanechlor-500-; KC-500- RN: Current: 37317-41-2 Previous: 50922-46-8 UD: 200009 CC: Tumorigen (C); Reproductive-Effector (T) RE: T34 orl-rat TDLo: 550 mg/kg (1-22D preg) Okajimas Folia Anatomica Japonica. (Keio Univ., School of Medicine, Dept. of Anatomy, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.14- 1936- v. 53, p. 93, 1976 (OFAJAE); T85 orl-rat TDLo: 140 mg/kg (15-21D preg) Okajimas Folia Anatomica Japonica. (Keio Univ., School of Medicine, Dept. of Anatomy, 35 Shinano-machi, Shinjuku-ku, Tokyo 160, Japan) V.14- 1936- v. 53, p. 105, 1976 (OFAJAE); T83 orl-rat TDLo: 240 mg/kg (3W pre) Osaka-furitsu Koshu Eisei Kenkyusho Kenkyu Hokoku, Koshu Eisei Hen. Research Reports of the Oaka Prefectural Institute of Public Health, Public Health Section. (Osaka-furitsu Koshu Eisei Kenkyusho, 1-3-69 Nakamichi, Higashinari-ku, Osaka, 537, Japan) No.3- 1966- v. 16, p. 81, 1978 (OKEHDW); T76 orl-mus TDLo: 2520 mg/kg (1-21D preg/21D post) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 16, p. 103, 1977 (TJADAB); T81-T85 orl-mus TDLo: 1260 mg/kg (1-21D preg) Advances in the Study of Birth Defects. (Baltimore, MD) V.1-7, 1979-82. Discontinued. v. 4, p. 163, 1980 (ASBDD9); T25-T35 scu-mus TDLo: 4 gm/kg (6-10D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 19, p. 49, 1981 (TXCYAC); T43 scu-mus TDLo: 800 mg/kg (6-15D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 19, p. 49, 1981 (TXCYAC) TE: V01-L60 orl-mus TDLo: 13 gm/kg/32W-C Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken, Japan) V.1- 1950- v. 25, p. 635, 1974 (NAIZAM); V01-L60 orl-mus TD :23 gm/kg/32W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1637, 1973 (JNCIAM); V03-L60 orl-mus TD :13440 mg/kg/32W-C Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 17, p. 54, 1975 (SAIGBL) MD: F05 orl-rat TDLo: 30 mg/kg/15W-I Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 73, p. 887, 1977 (NYKZAU); L30-L70-P28 orl-rat TDLo: 1050 mg/kg/35D-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 22, p. 139, 1980 (ENVRAL); L30-M30-U05 orl-rat TDLo: 900 mg/kg/30D-C Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 16, p. 516, 1976 (BECTA6) TR: IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 18, p. 43, 1978 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 261, 1974 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 18, p. 43, 1978 (IMEMDT); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 2, p. 305, 1974 (STEVA8) ND: NIOSH REL TO POLYCHLORINATED BIPHENYLS-air: 10H CA TWA 0.001 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: NIOSH CURRENT INTELLIGENCE BULLETIN 7, 1976 AND BULLETIN 45, 1986; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 978 of 1119 in RTECS (through 2003/06) AN: TQ1350000 PN: Polychlorinated-biphenyls- SY: Aroclor-; Chlophen-; Chlorextol-; Chlorinated-biphenyl-; Chlorinated-diphenyl-; Chlorinated-diphenylene-; Chloro-biphenyl-; Chloro-1,1-biphenyl-; Clophen-A-60-; Fenclor-; Fenclor-42-; PCBs-; Phenochlor-; Phenoclor-; Polychlorinated-biphenyl-; Biphenyl,-polychloro-; Kanechlor-; Kanechlor-300-; Kanechlor-400-; Polychlorobiphenyl- RN: Current: 1336-36-3 UD: 200305 CC: Tumorigen (C); Reproductive-Effector (T) RE: T85 orl-rat TDLo: 400 mg/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 440, 1988 (FAATDF); T85 orl-rat TDLo: 420 mg/kg (21D post) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 440, 1988 (FAATDF); T85 ipr-rat TDLo: 700 mg/kg (14D pre) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 440, 1988 (FAATDF); T71-T72-T75 orl-mam TDLo: 325 mg/kg (30D pre/1-36D preg) Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 6, p. 239, 1977 (AMBOCX); T81 orl-mam TDLo: 325 mg/kg (30D pre/1-36D preg) Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 6, p. 239, 1977 (AMBOCX); T12-T22 orl-rat TDLo: 420 mg/kg (34D pre/1-22D preg) Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 3, p. 479, 1976 (AECTCV); T19 orl-rat TDLo: 210 mg/kg (34D pre/1-22D preg) Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 3, p. 479, 1976 (AECTCV); T21-T29-T52 orl-mam TDLo: 0.0125 mg/kg (multigenerations) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 54, p. 343, 1998 (JTEHD6); T75-T77 orl-mam TDLo: 0.025 mg/kg (multigenerations) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 54, p. 343, 1998 (JTEHD6); T83-T86-T87 orl-mam TDLo: 0.05 mg/kg (multigenerations) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 54, p. 343, 1998 (JTEHD6) TE: V03-L60 orl-rat TDLo: 16800 mg/kg/2Y-C Toxicological European Research. (S.P.E., 10, Ave. de Messine, 75008 Paris, France) V.1- 1978- v. 1, p. 159, 1978 (TOERD9); V01-J60-L60 orl-mus TDLo: 1250 mg/kg/25W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 688, 1983 (FCTOD7); V01-L60 orl-rat TD :1250 mg/kg/25W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 21, p. 688, 1983 (FCTOD7) ORNG: 4000000000 ng/kg. [4000.000000 mg/kg] T/E unlistd AT: L30-U01-Y37 orl-mus LD50: 1900 mg/kg Fukuoka Igaku Zasshi. (c/o Kyushu Daigaku Igakubu, Tatekasu, Fukuoka-shi, Fukuoka, Japan) V.33- 1940- v. 60, p. 544, 1969 (FKIZA4); L30-Y04 ipr-rat TDLo: 50 mg/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 53, p. 177, 1983 (ATXKA8); T/E unlistd orl-rat LD50: 4000 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 58, 1984 (VCVGK*); Y04 ipr-rat TDLo: 50 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 177, 1983 (ARTODN) MD: L03-L70-Z01 orl-rat TDLo: 45 gm/kg/5W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 20, p. 97, 1938 (JIHTAB); P28-P30-Y01 orl-rat TDLo: 286 mg/kg/4W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 43, p. 13, 1978 (TXAPA9); L30-Y37-Y40 orl-rat TDLo: 5475 mg/kg/52W-C Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 8, p. 191, 1979 (AECTCV); L30-Z01 orl-rat TDLo: 90 gm/kg/6D-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 20, p. 97, 1938 (JIHTAB); L30 ihl-rat TCLo: 930 ug/m3/8H/20W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 20, p. 97, 1938 (JIHTAB); L02-M03-R03 skn-rbt TDLo: 1148 mg/kg/38D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 617, 1971 (TXAPA9); L70-N75 orl-qal TDLo: 5980 mg/kg/17W-C Poultry Science. (Poultry Science Assoc., Inc., 309 W. Clark St., Champaign, IL 61820) V.1- 1921- v. 53, p. 125, 1974 (POSCAL); N08-Y16 ipr-rat TDLo: 300 mg/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 111, p. 99, 1991 (TXAPA9); N30-Y03 orl-rat TDLo: 84 mg/kg/4W-C American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 89, p. 118, 1977 (AJPAA4); L30-Y36 orl-mus TDLo: 2535 mg/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 138, p. 98, 1996 (TXAPA9); N74-Y20-Y37 orl-rat TDLo: 168 mg/kg/4W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 43, p. 13, 1978 (TXAPA9); L30-S05-Y07 orl-rat TDLo: 88 mg/kg/22D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 59, p. 79, 1985 (EVHPAZ); L30-S05-Y07 orl-mky TDLo: 120 mg/kg/20W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 59, p. 79, 1985 (EVHPAZ); L50-S05 orl-mky TDLo: 140 mg/kg/20W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 24, p. 123, 1982 (TXCYAC) TR: IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 18, p. 43, 1978 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 322, 1987 (IMSUDL); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 322, 1987 (IMSUDL); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 1, p. 105, 1972 (EVHPAZ); TOXICOLOGY REVIEW JOM, Journal of Occupational Medicine. (American Occupational Medicine Assoc., 150 N. Wacker Dr., Chicago, IL 60606) V.10- 1968- v. 18, p. 109, 1976 (JJOMDZ); TOXICOLOGY REVIEW Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 34, p. 1675, 1975 (FEPRA7); TOXICOLOGY REVIEW Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 14, p. 139, 1974 (ARVPAX); TOXICOLOGY REVIEW Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 94, p. 125, 1972 (ARPAAQ); TOXICOLOGY REVIEW Chemistry. (Washington, DC) V.18-52, 1944-79. v. 49(4), p. 14, 1976 (CHRYAQ); TOXICOLOGY REVIEW Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 2, p. 305, 1974 (STEVA8); TOXICOLOGY REVIEW BioScience. (American Institute of Biological Sciences, 1401 Wilson Blvd., Arlington, VA 22209) V.14- 1964- v. 20, p. 958, 1970 (BISNAS); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 21, p. 1, 1990 (CRTXB2) ND: NIOSH REL TO POLYCHLORINATED BIPHENYLS-air: 10H CA TWA 0.001 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X2539; NIS 2; TNF 22; NOS 2; TNE 459 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 7, 1976 AND BULLETIN 45, 1986; NIOSH Analytical Method, 1994: Polychlorobiphenyls, 5503, in serum, 8004; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 979 of 1119 in RTECS (through 2003/06) AN: TS8050000 PN: Potassium-chloride- SY: Chlorid-draselny- (Czech); Chloropotassuril-; Dipotassium-dichloride-; Emplets-potassium-chloride-; Enseal-; K-Dur-; K-Lor-; K-Lyte/Cl; K-Predne-dome-; Kalitabs-; Kaochlor-; Kaon-Cl-; Kaon-Cl-10-; Kaon-Cl-TABS-; Kay-ciel-; Klor-Con-; Klotrix-; Monopotassium-chloride-; Muriate-of-potash-; Pfiklor-; Potassium-monochloride-; Potavescent-; Rekawan-; Slow-K-; Super-K-; Super-K- (salt); Tripotassium-trichloride- RN: Current: 7447-40-7 Previous: 12599-00-7; 59217-68-4 UD: 200305 MF: Cl-K MW: 74.55 WL: KA G CC: Drug (D); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 500 mg/24H MLD "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,8,1972 (28ZPAK) ME: mmo-sat 100 ug/plate (+/-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) APR1982 (NTPTB*); mmo-smc 2500 mmol/L (-S9) Genetical Research. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1960- v. 37, p. 173, 1981 (GENRA8); mrc-smc 400 mmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 21, 1986 (MUTAEX); sln-smc 300 mmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 21, 1986 (MUTAEX); dns-rat-orl 1500 ug/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 80, p. 424, 1989 (JJCREP); mmo-mus-lym 2048 mg/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 37, 1988 (EMMUEG); dnd-ham-ovr 260 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 15, 1987 (MUREAV); cyt-ham-lng 12 gm/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 501, 1984 (FCTOD7); cyt-ham-ovr 140 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 15, 1987 (MUREAV); sce-ham-ovr 180 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 15, 1987 (MUREAV) ORNG: 2600000000 ng/kg. [2600.000000 mg/kg] T/E unlistd AT: J24-J30-U10 orl-inf LDLo: 938 mg/kg/2D JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 240, p. 1339, 1978 (JAMAAP); K13-P02 orl-wmn TDLo: 60 mg/kg/D Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 919, 1980 (LANCAO); G04-K13-P02 orl-man LDLo: 20 mg/kg Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 919, 1980 (LANCAO); T/E unlistd orl-rat LD50: 2600 mg/kg "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,8,1972 (28ZPAK); T/E unlistd ipr-rat LD50: 660 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 3, p. 597, 1965 (FCTXAV); F12-J22 ivn-rat LD50: 142 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 14, p. 1128, 1964 (ARZNAD); T/E unlistd orl-mus LD50: 1500 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 21, p. 257, 1990 (IYKEDH); T/E unlistd ipr-mus LD50: 620 mg/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 256, p. 1043, 1963 (COREAF); T/E unlistd ivn-mus LD50: 117 mg/kg European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76. For publisher information, see TOERD9. v. 8, p. 188, 1975 (EJTXAZ); F17-F24-J30 orl-gpg LDLo: 2500 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 35, p. 1, 1929 (JPETAB); F17-F24-J30 ipr-gpg LDLo: 900 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 35, p. 1, 1929 (JPETAB); T/E unlistd scu-gpg LDLo: 2550 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd ivn-gpg LDLo: 77 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 131, p. 171, 1928 (AEPPAE); T/E unlistd par-gpg LDLo: 40 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 131, p. 171, 1928 (AEPPAE); T/E unlistd iat-gpg LDLo: 130 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 131, p. 171, 1928 (AEPPAE); T/E unlistd scu-pgn LDLo: 2210 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd scu-frg LDLo: 2120 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); K12-K13 orl-man TDLo: 214.29 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 39, p. 641, 2001 (JTCTDW) TR: TOXICOLOGY REVIEW Internist. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1960- v. 15, p. 7, 1974 (INTEAG) ND: NOHS 1974: HZD 60360; NIS 97; TNF 14471; NOS 88; TNE 122749; NOES 1983: HZD 60360; NIS 147; TNF 16061; NOS 125; TNE 387624; TFE 175287 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 Record 980 of 1119 in RTECS (through 2003/06) AN: TU4154100 PN: Pregna-1,4-diene-3,11,20-trione,-17,21-hydroxy- SY: Ancortone-; Colisone-; Cortan-; delta-Cortelan-; Cortidelt-; delta-Cortisone-; delta-1-Cortisone-; delta(sup 1)-Cortisone; delta-Cortone-; 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione-; NSC-10023-; Orasone-; Paracort-; Bicortone-; Dacortin-; Decortancyl-; Decortin-; Decortisyl-; delta-1-Dehydrocortisone-; 1-Dehydrocortisone-; 1,2-Dehydrocortisone-; Dekortin-; Delta-cortelan-; Deltacortisone-; Deltacortone-; Delta-dome-; Delta-E-; Deltasone-; Deltison-; Deltisone-; Deltra-; Di-adreson-; Encorton-; Encortone-; Enkorton-; Hostacortin-; IN-Sone-; Juvason-; Lisacort-; Metacortandracin-; Meticorten-; NCI-C04897-; Precort-; Prednicen-M-; Prednilonga-; Prednison-; Prednisone-; Prednizon-; 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione-; Rectodelt-; Servisone-; SK-Prednisone-; delta-Sone-; Supercortil-; U-6020-; Ultracorten-; Ultracortene-; Wojtab-; Zenadrid-; Zenadrid- (veterinary) RN: Current: 53-03-2 UD: 199904 MF: C21-H26-O5 MW: 358.47 WL: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 3333 ug/plate (+S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) JAN1982 (NTPTB*); mmo-sat 333 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM) RE: T81-T85 scu-mus TDLo: 24 mg/kg (13-18D preg) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 12, p. 213, 1980 (PBBHAU) TE: V03-N60-R60 ipr-rat TDLo: 860 mg/kg/26W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR) AT: C04 orl-wmn TDLo: 2400 ug/kg/2D-I Neurology. (Modern Medicine Pub., Inc., 1 E. First St., Duluth, MN 55802) V.1- 1951- v. 36, p. 729, 1986 (NEURAI); C04 orl-man TDLo: 857 ug/kg Neurology. (Modern Medicine Pub., Inc., 1 E. First St., Duluth, MN 55802) V.1- 1951- v. 36, p. 729, 1986 (NEURAI); R03 orl-man LDLo: 400 ug/kg Irish Journal of Medical Science. (Royal Academy of Medicine, 6 Kildare St., Dublin 2, Ireland) 1922-67: Ser. 7: V.1- 1968- v. 155, p. 234, 1986 (IJMSAT); P01-R03 unr-wmn TDLo: 113 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 243, p. 1260, 1980 (JAMAAP); T/E unlistd ipr-mus LD50: 135 mg/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); T/E unlistd scu-mus LD50: 101 mg/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); T/E unlistd ims-mus LD50: 600 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 293, 1981 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 293, 1981 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 326, 1987 (IMSUDL); TOXICOLOGY REVIEW Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 5, p. 447, 1965 (ARVPAX); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 17, p. 85, 1980 (CTOXAO) ND: NOHS 1974: HZD 80494; NIS 1; TNF 68; NOS 6; TNE 2770; NOES 1983: HZD 80494; NIS 1; TNF 45; NOS 1; TNE 1266; TFE 725 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (ipr), equivocal evidence: rat Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NCI Carcinogenesis Studies (ipr), no evidence: mouse Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR) Record 981 of 1119 in RTECS (through 2003/06) AN: TW0175000 PN: Progesterone- SY: Agolutin-; Corlutin-; Corlutina-; Corluvite-; Corporin-; Corpus-luteum-hormone-; Flavolutan-; Nalutron-; NSC-9704-; Percutacrine-Luteinique-; Piaponon-; delta(sup 4)-Pregnene-3,20-dione; Bio-luton-; Fologenon-; Gesterol-100-; Gestone-; Gestormone-; Glanducorpin-; Gynlutin-; Gynoluton-; Hormoflaveine-; Hormoluton-; Lingusorbs-; Lipo-lutin-; Lucorteum-Sol-; Luteal-hormone-; Luteinique-; Luteodyn-; Luteogan-; Luteohormone-; Luteol-; Luteosan-; Luteostab-; Luteovis-; Lutex-; Lutidon-; Lutocyclin-; Lutocyclin-M-; Lutocylin-; Lutoform-; Lutogyl-; Lutren-; Lutromone-; Pregn-4-ene-3,20-dione- (9CI); 4-Pregnene-3,20-dione-; Primolut-; Progekan-; Progestasert-; Progesterol-; beta-Progesterone-; Prolutone-; Progesteronum-; Progestin-; Progestone-; Prolidon-; Syngesterone-; Syngestrets-; Synovex-S-; Syntolutan- RN: Current: 57-83-0 UD: 200305 MF: C21-H30-O2 MW: 314.51 WL: L E5 B666 OV MUTJ A1 E1 FV1 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Hormone (H) ME: dni-hmn-lym 5 umol/L Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 146, p. 401, 1974 (PSEBAA); dni-hmn-kdy 100 ug/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 10, p. 299, 1968 (CNJGA8); cyt-hmn-kdy 100 ug/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 10, p. 299, 1968 (CNJGA8); sce-hmn-lym 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 191, p. 121, 1987 (MUREAV); mnt-rat-orl 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 33, 1998 (MUREAV); mtr-rat-emb 2600 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); mtr-mus-fbr 80 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dnd-mus-orl 1060 mg/kg Medical Science Research. (Elsevier Applied Science Pub. Ltd., Crown House, Linton Rd., Barking, Essex IG11 8JU, UK) V.15- 1987- v. 15, p. 703, 1987 (MSCREJ); dns-mus-scu 200 mg/kg Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 60, p. 167, 1974 (JOENAK); dni-mus-scu 200 mg/kg Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 60, p. 167, 1974 (JOENAK); cyt-mus-emb 1 mg/L Doklady Akademii Nauk SSSR. Proceedings of the Academy of Sciences of the USSR. For English translation, see DBIOAM and DKBSAS. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1933- v. 282, p. 173, 1985 (DANKAS); mtr-ham-emb 30 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 16, p. 1329, 1995 (CRNGDP); dnd-rbt-ivn 100 ug/kg Nippon Naibumpi Gakkai Zasshi. Journal of the Japan Endocrine Society. (Nippon Naibumpi Gakkai, c/o Kyoto-Furitsu Ika Daigaku, Kojinbashi Nishizume-Sagaru, Kamigyo-ku, Kyoto 602, Japan) V.1- 1925- v. 51, p. 1043, 1975 (NNGZAZ); cyt-dog-iat 100 ug/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 1145, 1968 (NATUAS); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T13 orl-wmn TDLo: 200 mg/kg (20D pre) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 85, p. 427, 1963 (AJOGAH); T53 orl-wmn TDLo: 113 mg/kg (6-32W preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 19, p. 1369, 1959 (JCEMAZ); T29 orl-wmn TDLo: 120 mg/kg (20D pre) Vitamins and Hormones. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1943- v. 17, p. 307, 1959 (VIHOAQ); T13 orl-wmn TDLo: 100 mg/kg (20D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 16, p. 158, 1965 (FESTAS); T14-T22-T29 orl-wmn TDLo: 120 mg/kg (20D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 28, p. 18, 1956 (ACEDAB); T01-T05 ims-man TDLo: 50 mg/kg (70D male) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 649, 1958 (ANYAA9); T04 ims-man TDLo: 15 mg/kg (21D male) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 649, 1958 (ANYAA9); T53 par-wmn TDLo: 600 ug/kg (67-71D preg) Mayo Clinic Proceedings. (Room 1035, Plummer Bldg., Mayo Clinic, Rochester, MN 55905) V.39- 1964- v. 33, p. 200, 1958 (MACPAJ); T14 par-wmn TDLo: 32 mg/kg (3W pre) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 76, p. 626, 1958 (AJOGAH); T53 unr-wmn TDLo: 386 mg/kg (18-34W preg) AMA Journal of Diseases of Children. (Chicago, IL) V.91-99, 1956-60. For publisher information, see AJDCAI. v. 95, p. 9, 1958 (AMDCA5); T14 ivg-wmn TDLo: 210 mg/kg (3W pre) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 76, p. 626, 1958 (AJOGAH); T14 ivg-wmn TDLo: 475 ug/kg (1Y pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 13, p. 559, 1976 (CCPTAY); T21 orl-rat TDLo: 25 mg/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 5, p. 282, 1954 (FESTAS); T03 orl-rat TDLo: 180 mg/kg (9D male) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 100, p. 540, 1959 (PSEBAA); T21 orl-rat TDLo: 50 mg/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 28, p. 18, 1956 (ACEDAB); T13 orl-rat TDLo: 700 mg/kg (14D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 24, p. 284, 1973 (FESTAS); T03-T03 skn-rat TDLo: 240 mg/kg (30D male) Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 10, p. 687, 1967 (STEDAM); T27 scu-rat TDLo: 7 mg/kg (10-16D preg) Journal of Physiology. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1878- v. 164, p. 138, 1962 (JPHYA7); T14 scu-rat TDLo: 188 mg/kg (30D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 108, p. 3, 1961 (PSEBAA); T35 scu-rat TDLo: 420 mg/kg (15-17D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 75, p. 145, 1964 (ENDOAO); T53 scu-rat TDLo: 9 mg/kg (15-20D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 5, p. 331, 1963 (JRPFA4); T41 scu-rat TDLo: 4 mg/kg (9D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 74, p. 1255, 1972 (BEXBAN); T85 scu-rat TDLo: 1 mg/kg (9D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 74, p. 1255, 1972 (BEXBAN); T29 scu-rat TDLo: 500 ug/kg (2D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 105, p. 7, 1966 (ACEDAB); T16-T17-T81 scu-rat TDLo: 20 mg/kg (23D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 145, p. 1047, 1974 (PSEBAA); T91 ims-rat TDLo: 110 mg/kg (1-22D preg) Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1924- v. 41, p. 710, 1962 (JCINAO); T25 ims-rat TDLo: 900 ug/kg (6-14D preg) Folia Biologica (Krakow). (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1953- v. 16, p. 343, 1968 (FOBGA8); T02-T03-T09 ims-rat TDLo: 200 mg/kg (48D male) Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 5, p. 45, 1967 (IJEBA6); T34 ims-rat TDLo: 30 mg/kg (1-6D preg) Folia Biologica (Krakow). (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1953- v. 16, p. 343, 1968 (FOBGA8); T31 ims-rat TDLo: 35 mg/kg (14-20D preg) Folia Biologica (Krakow). (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1953- v. 16, p. 343, 1968 (FOBGA8); T29 ice-rat TDLo: 250 ug/kg (1D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 27, p. 445, 1971 (JRPFA4); T41-T83 par-rat TDLo: 36300 ug/kg (7-17D preg) Brain Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1966- v. 170, p. 194, 1979 (BRREAP); T13 par-rat TDLo: 8750 ug/kg (7D pre) Journal of Experimental Medicine. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1896- v. 102, p. 347, 1955 (JEMEAV); T48 par-rat TDLo: 60 ug/kg (16-19D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 82, p. 1561, 1976 (BEXBAN); T17 imp-rat TDLo: 250 ug/kg (2D post) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 7, p. 109, 1972 (BIREBV); T12 imp-rat TDLo: 30 mg/kg (24D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 2, p. 315, 1970 (BIREBV); T16 unr-rat TDLo: 100 mg/kg (20-24D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 16, p. 479, 1977 (BIREBV); T83-T91 scu-mus TDLo: 240 mg/kg (14-16D preg) Developmental Pharmacology and Therapeutics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.1- 1980- v. 10, p. 385, 1987 (DPTHDL); T29 scu-mus TDLo: 100 mg/kg (1D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 248, 1980 (ATSUDG); T25-T34 scu-mus TDLo: 20 mg/kg (6-9D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 15, p. 955, 1978 (OYYAA2); T13 scu-mus TDLo: 1500 ug/kg (3D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 5, p. 331, 1963 (JRPFA4); T02 scu-mus TDLo: 2400 mg/kg (20D male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 28, p. 129, 1941 (ENDOAO); T13 imp-mus TDLo: 3 gm/kg (5D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 16, p. 357, 1977 (CCPTAY); T29 unr-mus TDLo: 10 mg/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 12, p. 346, 1961 (FESTAS); T13 scu-dog TDLo: 16 mg/kg (5D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 12, p. 529, 1975 (CCPTAY); T29 imp-dog TDLo: 360 mg/kg (34W pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 36, p. 373, 1981 (FESTAS); T15 imp-dog TDLo: 600 mg/kg (60W pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 36, p. 373, 1981 (FESTAS); T01-T02 ihl-mky TCLo: 30 ug/kg/30M (60D male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 22, p. 935, 1980 (BIREBV); T29 ihl-mky TDLo: 4 ug/kg (10D pre) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 270, p. 532, 1977 (NATUAS); T29 scu-mky TDLo: 900 ug/kg (9D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 90, p. 257, 1972 (ENDOAO); T29 ims-mky TDLo: 12 mg/kg (8D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 39(Suppl), p. 419, 1983 (FESTAS); T13-T29 ivg-mky TDLo: 85410 ug/kg (52W pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 20, p. 339, 1979 (CCPTAY); T12 ivg-mky TDLo: 17155 ug/kg (52W pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 20, p. 339, 1979 (CCPTAY); T29 orl-rbt TDLo: 1 mg/kg (1D pre/1D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 79, p. 939, 1966 (ENDOAO); T21-T29 orl-rbt TDLo: 100 mg/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 73, p. 17, 1963 (ACEDAB); T24 skn-rbt TDLo: 500 ug/kg (1D pre) Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 7, p. 341, 1966 (STEDAM); T29 skn-rbt TDLo: 1 mg/kg (1D pre) Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 5, p. 699, 1965 (STEDAM); T13 scu-rbt TDLo: 50 ug/kg (5D pre) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 142, p. 469, 1962 (ANREAK); T29 scu-rbt TDLo: 50 ug/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 73, p. 3, 1963 (ACEDAB); T01-T09 scu-rbt TDLo: 70 mg/kg (14D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 204, p. 261, 1964 (NATUAS); T24 scu-rbt TDLo: 300 ug/kg (2D pre/1D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 117, p. 167, 1973 (AJOGAH); T12 scu-rbt TDLo: 100 ug/kg (1D pre) Journal of Physiology. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1878- v. 181, p. 568, 1965 (JPHYA7); T21 scu-rbt TDLo: 150 ug/kg (1D pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 73, p. 3, 1963 (ACEDAB); T24 ims-rbt TDLo: 8 mg/kg (2-9D preg) Australian Journal of Biological Sciences. (Commonwealth Scientific and Industrial Research Organization, 314 Albert St., E. Melbourne, Vic. 3002, Australia) V.6- 1953- v. 28, p. 291, 1975 (AJBSAM); T17 ims-rbt TDLo: 8 mg/kg (25-32D preg) Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 42, p. 131, 1976 (JANSAG); T22-T24-T59 ims-rbt TDLo: 2500 mg/kg (2D pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 14, p. 451, 1976 (BIREBV); T76 unr-rbt TDLo: 120 ug/kg (6-29D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 17, p. 489, 1978 (CCPTAY); T24 iut-rbt TDLo: 684 ug/kg (14D pre/1-10D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 109, p. 536, 1971 (AJOGAH); T22 iut-rbt TDLo: 105 ug/kg (21D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 17, p. 465, 1978 (CCPTAY); T25 iut-rbt TDLo: 260 ug/kg (21D pre/1-31D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 17, p. 465, 1978 (CCPTAY); T29 scu-pig TDLo: 2250 ug/kg (1-5D preg) Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 18, p. 163, 1959 (JANSAG); T12 scu-pig TDLo: 40 mg/kg (16D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 19, p. 541, 1969 (JRPFA4); T29 scu-pig TDLo: 1667 ug/kg (1D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 17, p. 227, 1968 (JRPFA4); T53 ims-pig TDLo: 18333 ug/kg (15-25D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 52, p. 1389, 1995 (BIREBV); T14 par-pig TDLo: 5833 ug/kg (14D pre) Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 10, p. 665, 1951 (JANSAG); T53 scu-gpg TDLo: 86 mg/kg (18-60D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 19, p. 606, 1968 (FESTAS); T02-T21 ims-gpg TDLo: 1480 mg/kg (70D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 209, p. 1322, 1966 (NATUAS); T29 scu-ham TDLo: 240 ug/kg (1D pre) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 169, p. 189, 1982 (PSEBAA); T13 scu-ham TDLo: 2 mg/kg (1D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 42, p. 341, 1975 (JRPFA4); T16-T72 scu-ham TDLo: 80 mg/kg (1D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 6, p. 281, 1972 (BIREBV); T22 scu-ham TDLo: 32 mg/kg (1D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 16, p. 499, 1968 (JRPFA4); T21 par-ham TDLo: 2400 ug/kg (3D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 37, p. 269, 1974 (JRPFA4); T01-T09 scu-ctl TDLo: 3 mg/kg (30D male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 77, p. 203, 1965 (ENDOAO); T14-T29 scu-dom TDLo: 1273 ug/kg (14D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 43, p. 208, 1948 (ENDOAO); T14-T22 ims-dom TDLo: 2545 ug/kg (7D pre) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 4, p. 57, 1962 (JRPFA4); T16 ims-ctl TDLo: 1700 ug/kg (39-41W preg) Theriogenology. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022) V.1- 1974- v. 20, p. 267, 1983 (THGNBO); T16 par-hor TDLo: 16667 ug/kg (45-47W preg) Journal of Reproduction and Fertility, Supplement. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) No.1- 1966- v. 23, p. 637, 1975 (JRFSAR) TE: V02-R60 scu-mus TDLo: 40 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 19, p. 824, 1965 (BJCAAI); V03-T63-T64 par-mus TDLo: 1289 mg/kg/78W-C Pakistan Medical Forum. (Karachi, Pakistan) V.1-8, 1966-73(?) Disc ontinued. v. 7, p. 21, 1972 (PMDFA9); V02-V08 imp-mus TDLo: 1296 mg/kg/77W-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 212, p. 686, 1966 (NATUAS); V03-R60 ims-dog TDLo: 26643 mg/kg/4Y-I Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 31, p. 340, 1979 (FESTAS); V03-L60 imp-dog TDLo: 270 mg/kg/78W "Pharmacology of Steroid Contraceptive Drugs," Garattini, S. and H.W. Berendes, eds., New York, Raven Press, 1977 -,145,1977 (36PYAS); V02-R60 scu-mus TD :9500 mg/kg/19W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 19, p. 824, 1965 (BJCAAI); V03-P61 scu-mus TD :200 mg/kg/5W-I Indian Journal of Cancer. (Indian Cancer Soc., Parel, Bombay, 400 012, India) V.1- 1963- v. 9, p. 244, 1972 (IJCAAR); V02-T63 imp-mus TD :1300 mg/kg/78W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 21, p. 144, 1967 (BJCAAI); V02-V08 imp-mus TD :2592 mg/kg/77W-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 212, p. 686, 1966 (NATUAS); V02-V08 imp-mus TD :14 gm/kg/77W-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 212, p. 686, 1966 (NATUAS); V03-V08 imp-mus TD :648 mg/kg/77W-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 212, p. 686, 1966 (NATUAS); V03-V08 imp-mus TD :216 mg/kg/77W-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 212, p. 686, 1966 (NATUAS); V03-V08 imp-mus TD :19 gm/kg/77W-C Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 212, p. 686, 1966 (NATUAS) AT: T/E unlistd ipr-rat LD50: 327 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 1183, 1995 (NIIRDN); F12-F19-J22 ivn-mus LDLo: 100 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 11, p. 117, 1968 (JMCMAR); N17 ipr-rat TDLo: 1 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 92, p. 368, 1988 (TXAPA9); F40 ipr-rat TDLo: 65 mg/kg Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 14, p. 727, 1976 (CLPTAT); F01 ipr-mus TDLo: 16 mg/kg Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 14, p. 727, 1976 (CLPTAT); M16-U05 ims-rat TDLo: 1000 ug/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 454, p. 131, 2002 (EJPHAZ) MD: N02-P28-Z72 ipr-rat TDLo: 750 mg/kg/15D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 338, 2000 (TOSCF2); T11-T12 par-mus TDLo: 250000 ug/kg/5D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 29, 1986 (TJADAB); T12 ipr-mus TDLo: 277.5 mg/kg/5D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 29, 1986 (TJADAB); Y53-Y12 ipr-rat TDLo: 3500 mg/kg/2W-I Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 90, p. 1252, 1972 (ENDOAO) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 296, 1987 (IMSUDL); TOXICOLOGY REVIEW Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 185, p. 169, 1974 (ACEDAB); TOXICOLOGY REVIEW Pediatric Clinics of North America. (W.B. Saunders Co., W. Washington Sq., Philadelphia, PA 19105) V.1- 1954- v. 8, p. 413, 1961 (PCNAA8); TOXICOLOGY REVIEW Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 59, p. 1, 1961 (JOPDAB); TOXICOLOGY REVIEW Current Medical Research and Opinion. (Clayton-Wray Pub. Ltd., 1a High St., Alton, Hants., UK) V.1- 1972- v. 4, p. 309, 1976 (CMROCX); TOXICOLOGY REVIEW Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 51, p. 671, 1960 (ACEDAB); TOXICOLOGY REVIEW Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- v. 13, p. 113, 1974 (JRPMAP) ND: NOHS 1974: HZD 84510; NIS 2; TNF 134; NOS 9; TNE 22963; NOES 1983: HZD 84510; NIS 2; TNF 55; NOS 2; TNE 287; TFE 55 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-human; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-BALB/c-3T3, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 982 of 1119 in RTECS (through 2003/06) AN: TX4110000 PN: Propane,-1-bromo- SY: 1-Bromopropane-; Propyl-bromide-; n-Propyl-bromide- RN: Current: 106-94-5 UD: 200012 MF: C3-H7-Br MW: 123.01 WL: E3 CC: Tumorigen (C); Reproductive-Effector (T) RE: T25 orl-rat TDLo: 2 gm/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 101, p. 321, 1982 (MUREAV); T01 ihl-rat TCLo: 821 ppm/8H (12W male) Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 40, p. 414, 1998 (SAIGBL); T03 ihl-rat TCLo: 200 ppm/8H (12W male) Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 54, p. 416, 2000 (TOSCF2) AT: T/E unlistd orl-rat LDLo: 4 gm/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 101, p. 321, 1982 (MUREAV); T/E unlistd ihl-rat LC50: 253 gm/m3/30M Fiziologicheski Aktivnye Veshchestva. Physiologically Active Substances. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1966- v. 7, p. 35, 1975 (FAVUAI); T/E unlistd ipr-rat LD50: 2950 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,102,1982 (85GMAT); T/E unlistd ipr-mus LD50: 2530 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,102,1982 (85GMAT) MD: J30-P01 ihl-rat TCLo: 98408 mg/m3/30M/1W-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 139, 1944 (JPETAB); L70-U01 ihl-rat TCLo: 1800 ppm/6H/8W-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 41, p. A42, 1999 (SAIGBL); C18 ihl-rat TCLo: 400 ppm/8H/12W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 394, 2000 (TOXID9); E05-F07 unr-rat TDLo: 37887 mg/kg/4W-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 41, p. A1, 1999 (SAIGBL); A30 ipr-mus TDLo: 1350 mg/kg/5D-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 40, p. 415, 1998 (SAIGBL) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 983 of 1119 in RTECS (through 2003/06) AN: TX4111000 PN: Propane,-2-bromo- SY: 2-Bromopropane-; Isopropyl-bromide-; sec-Propyl-bromide- RN: Current: 75-26-3 UD: 200302 MF: C3-H7-Br MW: 123.01 WL: EY1&1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mnt-mus-ipr 900 mg/kg Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 15, p. 85, 2000 (REPTED) RE: T26 ihl-rat TCLo: 1000 ppm/6H (2W male/2W pre-3W preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0559611 (NTIS**); T12-T14 ipr-rat TDLo: 18900 mg/kg (14D pre/7D preg) Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 35, p. 278, 1997 (INHEAO); T01 scu-rat TDLo: 6775 mg/kg (5D male) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 104, p. 19, 1999 (TOLED5); T01 scu-rat TDLo: 5 gm/kg (5W male) Human and Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke, Hampshire, RG21 2XS, UK) V.9- 1990- v. 18, p. 683, 1999 (HETOEA) AT: F43-U01 ihl-mus LC50: 31171 ppm/4H Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 34, p. 403, 1996 (INHEAO); T/E unlistd ipr-mus LD50: 4837 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 20(12), p. 52, 1976 (GTPZAB); T/E unlistd ihl-mam LC50: 36 gm/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(4), p. 55, 1974 (GTPZAB) MD: J30-P01 ihl-rat TCLo: 172 gm/m3/30M/1W-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 80, p. 139, 1944 (JPETAB); N30 ihl-rat TCLo: 300 ppm/8H/9W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 159, p. 185, 1999 (TXAPA9); Z73 ihl-rat TCLo: 2000 ppm/6H/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0559163 (NTIS**); E05-F07 unr-rat TDLo: 12744 mg/kg/4W-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 41, p. A1, 1999 (SAIGBL); M71-G70-N24 ipr-rat TDLo: 3000 mg/kg/4W-I Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 23, p. 281, 1997 (SWEHDO); U01 ipr-rat TDLo: 1500 mg/kg/1W-I Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 23, p. 281, 1997 (SWEHDO); N72-T02-Z73 ipr-rat TDLo: 6000 mg/kg/4W-I Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 23, p. 281, 1997 (SWEHDO); A70-J70-L70 ipr-rat TDLo: 12000 mg/kg/4W-I Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 23, p. 281, 1997 (SWEHDO) ND: NOES 1983: HZD X4017; NIS 1; TNF 17; NOS 1; TNE 1582; TFE 323 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 984 of 1119 in RTECS (through 2003/06) AN: TX4900000 PN: Propane,-1-chloro-2,3-epoxy- SY: (Chloromethyl)ethylene oxide; (DL)-alpha-Epichlorohydrin; 1,2-Epoxy-3-chloropropane-; 1-Chloor-2,3-epoxy-propaan- (Dutch); 1-Chlor-2,3-epoxy-propan- (German); 1-Chloro-2,3-epoxypropane-; 1-Chloro-2,3-epoxypropane- (OSHA); 1-Cloro-2,3-epossipropano- (Italian); 2,3-Epoxypropyl-chloride-; 2-(Chloromethyl)oxirane; 3-Chloro-1,2-epoxypropane-; 3-Chloro-1,2-propane-oxide-; 3-Chloro-1,2-propylene-oxide-; Chloromethyloxirane-; Chloropropylene-oxide-; ECH-; Epichloorhydrine- (Dutch); Epichlorhydrin-; Epichlorhydrine- (French); Epichlorohydrin-; Epichlorohydrin- (ACGIH:OSHA); Epichlorohydryna- (Polish); Epichlorophydrin-; Epicloridrina- (Italian); Glycerol-epichlorhydrin-; Oxirane, (chloromethyl)-; Oxirane, 2-(chloromethyl); RCRA-waste-number-U041-; Skekhg-; alpha-Epichlorohydrin-; epi-Chlorohydrin-; gamma-Chloropropylene-oxide- RN: Current: 106-89-8 BRN: 79785 BHR: 5-17-01-00020 UD: 200210 MF: C3-H5-Cl-O MW: 92.53 WL: T3OTJ B1G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 10 mg/24H open Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30, p. 63, 1948 (JIHTAB); eye-rbt 100 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,769,1986 (85JCAE) ME: mmo-sat 33 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 105, 1986 (MUREAV); oms-sat 60 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 1 uL/plate (+/-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 387, 1981 (PMRSDJ); oms-esc 195 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); dnr-esc 4 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 133, p. 161, 1984 (MUREAV); dnd-esc 1 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); dnr-bcs 997 mmol/L "Prevention and Detection of Cancer, Proceedings of the 3rd International Symposium on Detection and Prevention of Cancer," New York, Marcel Dekker, 1977 -,155,1977 (37ATAD); oms-bcs 1 mol/L "Prevention and Detection of Cancer, Proceedings of the 3rd International Symposium on Detection and Prevention of Cancer," New York, Marcel Dekker, 1977 -,155,1977 (37ATAD); dnd-bcs 20 uL/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); mmo-klp 200 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 269, 1981 (MUREAV); sln-dmg-par 5100 umol/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 175, 1981 (EVSRBT); mmo-nsc 150 mmol/L (-S9) Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 11, p. 223, 1979 (STEVA8); mmo-smc 40 mg/L (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 414, 1981 (PMRSDJ); dnr-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 65 mmol/L Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 18, p. 1337, 1980 (IJEBA6); sln-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mmo-ssp 21 mmol/L (-S9) Abhandlungen der Deutschen Akademie der Wissenschaften zu Berlin, Klasse fuer Medizin. (Berlin, Ger. Dem. Rep.) 1950-68. Discontinued. v. -, p. 193, 1962 (ADWMAX); mmo-ssp 800 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 109, p. 41, 1983 (MUREAV); mnt-nml-mul 10800 nmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 17, 1989 (MUTAEX); dns-hmn-fbr 32 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 528, 1981 (PMRSDJ); dns-hmn-lym 500 umol/L Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 69, p. 191, 1983 (TUMOAB); dni-hmn-hla 2700 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); dni-hmn-lym 5 mmol/L Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 69, p. 191, 1983 (TUMOAB); cyt-hmn-lym 10 umol/L/24H Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 11, p. 223, 1979 (STEVA8); cyt-hmn-leu 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 34, p. 279, 1976 (MUREAV); sce-hmn-lym 10 nmol/L Caryologia. (Via G. LaPira 4, 50121 Florence, Italy) V.1- 1948- v. 34, p. 261, 1981 (CARYAB); msc-hmn-oth 500 umol/L Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911- v. 69, p. 191, 1983 (TUMOAB); dnd-rat-lvr 300 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); dns-rat-orl 50 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1425, 1989 (CRNGDP); cyt-rat-lvr 10 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 64, p. 329, 1979 (MUREAV); spm-rat-orl 50 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 71, 1983 (ARTODN); mnt-mus-ipr 120 mg/kg/16D-I "Occupational Health in the Chemical Industry, Proceedings of the International Congress, 11th, Alberta, Canada, 1983," Oxford, R.R., et al., eds., Calgary, Alberta, Canada, Univ. of Calgary, 1984 -,175,1984 (54DEAI); dnd-mus-lym 1040 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 155, 1988 (MUREAV); dnd-mus-ipr 140 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); cyt-mus-ipr 5 mg/kg Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 11, p. 223, 1979 (STEVA8); cyt-mus-orl 20 mg/kg Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 11, p. 223, 1979 (STEVA8); cyt-mus-ihl 5 mg/m3 Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 85, p. 287, 1981 (MUREAV); sce-mus-ipr 5500 ug/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 673, 1981 (PMRSDJ); msc-mus-lym 7500 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 580, 1981 (PMRSDJ); hma-mus-sat 50 mg/kg Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 95, p. 451, 1976 (BIZNAT); hma-mus-esc 180 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 161, 1992 (MUREAV); spm-mus-ihl 5 mg/m3 Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 85, p. 287, 1981 (MUREAV); mtr-ham-kdy 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 638, 1981 (PMRSDJ); cyt-ham-ovr 15 mg/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 432, 1989 (MUTAEX); cyt-ham-lng 47 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); sce-ham-ovr 33 uL/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 551, 1981 (PMRSDJ); sce-ham-lng 100 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3270, 1984 (CNREA8); msc-ham-ovr 30 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 137, 1984 (MUREAV) RE: T23 orl-rat TDLo: 180 mg/kg (12D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 226, p. 87, 1970 (NATUAS); T01 orl-rat TDLo: 25 mg/kg (1D male) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 53, p. 71, 1983 (ARTODN); T01-T02-T23 orl-rat TDLo: 1050 mg/kg (21D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 16, 1989 (FAATDF); T24 orl-rat TDLo: 288 mg/kg (23D male) Journal of Andrology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1980- v. 12, p. 54, 1991 (JOAND3); T23 ihl-rat TCLo: 50 ppm/6H (50D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 68, p. 415, 1983 (TXAPA9); T19-T25 ihl-rat TCLo: 100 ppm/7H (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0545225 (NTIS**); T01-T02 scu-rat TDLo: 75 mg/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 70, p. 67, 1983 (TXAPA9); T34 orl-mus TDLo: 1200 mg/kg (6-15D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 87, 1982 (JTEHD6); T19-T25 ihl-rbt TCLo: 100 ppm/7H (6-18D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0545225 (NTIS**) TE: V01-K60 orl-rat TDLo: 60 gm/kg/81W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 71, p. 922, 1980 (GANNA2); V01-D09-J15 ihl-rat TCLo: 100 ppm/6H/30D-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 751, 1980 (JJIND8); V02-J60 ipr-mus TDLo: 2400 mg/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 19, 1986 (TXAPA9); V03-V10 scu-mus TDLo: 720 mg/kg/18W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 48, p. 1431, 1972 (JNCIAM); V03-P62-R60 unr-mus TDLo: 19 mg/kg Radiation Research, Supplement. (New York, NY) No.1-7, 1959-67. Discontinued. v. 3, p. 193, 1963 (RARSAM); V02-V10 scu-mus TD :2760 mg/kg/69W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 53, p. 695, 1974 (JNCIAM); V03-J60 ihl-rat TC :100 ppm/6H/6W-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 21, p. 106, 1980 (PAACA3); V03-D09 ihl-rat TC :100 ppm Chemical Week. (McGraw-Hill, Inc., 1221 Ave. of the Americas, New York, NY 10020) V.68- 1951- v. 123(24), p. 25, 1978 (CHWKA9); V03-D09-J16 ihl-rat TC :30 ppm/6H/57W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 751, 1980 (JJIND8); V03-K60 orl-rat TD :36 gm/kg/81W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 71, p. 922, 1980 (GANNA2); V02-K60 orl-rat TD :85050 mg/kg/81W-C Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken, Japan) V.1- 1950- v. 32, p. 270, 1981 (NAIZAM); V03-K60 orl-rat TD :42525 mg/kg/81W-C Nara Igaku Zasshi. Journal of the Nara Medical Association. (Nara Igakkai, c/o Narakenritsu Ika Daigaku, Shijo-cho, Kashihara, Nara-ken, Japan) V.1- 1950- v. 32, p. 270, 1981 (NAIZAM); V03-K60-N60 orl-rat TD :5150 mg/kg/2Y-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 36, p. 325, 1985 (TXCYAC) ORNG: 90000000 ng/kg. [90.000000 mg/kg] T/E unlistd SRNG: 515000000 ng/kg. [515.000000 mg/kg] T/E unlistd AT: J30 ihl-hmn TCLo: 40 ppm/2H "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,240,1969 (34ZIAG); D07-D35 ihl-hmn TCLo: 20 ppm "Practical Toxicology of Plastics," Lefaux, R., Cleveland, OH, Chemical Rubber Co., 1968 -,108,1968 (29ZWAE); T/E unlistd orl-rat LD50: 90 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30, p. 63, 1948 (JIHTAB); T/E unlistd ihl-rat LC50: 250 ppm/8H Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 41, 1974 (NPIRI*); F07-J30-R21 skn-rat LDLo: 1 gm/kg University of California, Berkeley, Publications in Pharmacology. (Berkeley, CA) V.1-3, 1938-57. Discontinued. v. 2, p. 69, 1941 (UCPHAQ); T/E unlistd ipr-rat LD50: 113 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 1712, 1972 (JPMSAE); M10 scu-rat LD50: 150 mg/kg Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF, B.P.22, F-41353 Vineuil, France) V.7- 1946- v. 28, p. 505, 1967 (AMPMAR); T/E unlistd ivn-rat LD50: 154 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 41, 1974 (NPIRI*); F07-F11-F19 orl-mus LD50: 195 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 46, 1968 (GISAAA); T/E unlistd ihl-mus LCLo: 72 gm/m3/9M Journal of Biomedical Materials Research. (John Wiley and Sons, Inc., 605 Third Ave., New York, NY 10158) V.1- 1967- v. 8, p. 11, 1974 (JBMRBG); T/E unlistd skn-mus LD50: 250 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,64,1982 (85GMAT); T/E unlistd ipr-mus LD50: 170 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 1712, 1972 (JPMSAE); F18-J22-M03 scu-mus LDLo: 250 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 2, p. 28, 1961 (TPKVAL); T/E unlistd orl-rbt LD50: 345 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 46, 1968 (GISAAA); T/E unlistd skn-rbt LD50: 515 mg/kg Personal Communication from M.A. Wolf, Dow Chemical Co., Midland, MI 48640, Jan. 18, 1977 18 JAN 1977 (WolMA#); T/E unlistd ipr-rbt LD50: 160 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 1712, 1972 (JPMSAE); T/E unlistd orl-gpg LD50: 280 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 46, 1968 (GISAAA); T/E unlistd ipr-gpg LD50: 118 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 1712, 1972 (JPMSAE) MD: K04-M70-U01 orl-rat TDLo: 190 mg/kg/10D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 19, p. 41, 1996 (DCTODJ); L70-N72-Y40 orl-rat TDLo: 1218 mg/kg/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 46, 1968 (GISAAA); F40 orl-rat TDLo: 910 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 46, 1968 (GISAAA); A30-F40-P30 ihl-rat TCLo: 20 mg/m3/24H/14W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(9), p. 7, 1966 (GISAAA); J02-M03-Z01 ihl-rat TCLo: 170 mg/m3/3H/17W-C Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 2, p. 28, 1961 (TPKVAL); J30-M30-Y16 ihl-rat TCLo: 5 ppm/2H/5W-I Hochudoku. (Nippon Hochudoku Gakkai, c/o Kyushu Daigaku Igakubu Hoigaku Kyoshitsu, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812, Japan) V.8- 1990- v. 12, p. 144, 1994 (HOCHE8); M70-P08-U01 ipr-rat TDLo: 341 ug/kg/30D-I Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 1712, 1972 (JPMSAE); A70-F15-P70 ipr-rat TDLo: 2045 ug/kg/12W-I Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 61, p. 1712, 1972 (JPMSAE); A30-L30 scu-rat TDLo: 270 mg/kg/9D-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 6, p. 270, 1992 (WDZAEK); D02-D07-L30 ihl-mus TCLo: 25 ppm/6H/90D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555021 (NTIS**); P05-P06 ipr-mus TDLo: 120 mg/kg/16D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0542017 (NTIS**); N73-U01-Y40 orl-rbt TDLo: 4872 mg/kg/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 46, 1968 (GISAAA); L14-P70-Y39 orl-rbt TDLo: 91 mg/kg/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 33(1), p. 46, 1968 (GISAAA); Z01 ipr-bwd TDLo: 60 mg/kg/3D-I Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 37, p. 774, 1999 (IJEBA6) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.5 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 11, p. 131, 1976 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 603, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 202, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 603, 1999 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 603, 1999 (IMEMDT) SR: MSHA STANDARD-air: TWA 5 ppm (19 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 98, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (19 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (19 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (19 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (19 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 2 ppm (10 mg/m3), Skin, JAN 1993; OEL-AUSTRALIA: TWA 2 ppm (10 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-BELGIUM: TWA 2 ppm (7.6 mg/m3), Skin, JAN 1993; OEL-FINLAND: TWA 0.5 ppm (1.9 mg/m3), Skin, Carcinogen, JAN 1999; OEL-FRANCE: VLE 2 ppm (10 mg/m3), C2 Carcinogen, JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-HUNGARY: STEL 1 mg/m3, Skin, Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (4 mg/m3), MAC-K 4 ppm, Skin, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.5 ppm (1.9 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (19 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 1 mg/m3, STEL 8 mg/m3, JAN 1999; OEL-SWEDEN: NGV 0.5 ppm (1.9 mg/m3), KTV 1 ppm (4 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 2 ppm (8 mg/m3), Skin, Carcinogen, JAN 1999; OEL-TURKEY: TWA 5 ppm (19 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 0.5 ppm (1.9 mg/m3), STEL 1.5 ppm, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO EPICHLOROHYDRIN-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 29010; NIS 40; TNF 2004; NOS 58; TNE 41380; NOES 1983: HZD 29010; NIS 75; TNF 4249; NOS 87; TNE 80170; TFE 14921 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal, S pombe-forward mutation; EPA GENETOX PROGRAM 1988, Positive: S pombe-reversion; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-human, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 30, 1978; NIOSH Analytical Method, 1994: Epichlorohydrin, 1010; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 985 of 1119 in RTECS (through 2003/06) AN: TX8750000 PN: Propane,-1,2-dibromo-3-chloro- SY: (R/S)-1,2-Dibromo-3-chloropropane; 1,2-Dibrom-3-chlor-propan- (German); 1,2-Dibromo-3-chloropropane-; 1,2-Dibromo-3-chloropropane- (DOT:OSHA); 1,2-Dibromo-3-chloropropane-production-grade-; 1,2-Dibromo-3-cloro-propano- (Italian); 1,2-Dibroom-3-chloorpropaan- (Dutch); 1-Chloro-2,3-dibromopropane-; 3-Chloro-1,2-dibromopropane-; BBC-12-; DBCP-; Dibromchlorpropan- (German); Dibromochloropropane-; Fumagon-; Fumazone-; Fumazone-86-; Fumazone-86E-; NCI-C00500-; Nemabrom-; Nemafume-; Nemagon-; Nemagon-20-; Nemagon-206-; Nemagon-20G-; Nemagon-90-; Nemagon-soil-fumigant-; Nemagone-; Nemanax-; Nemapaz-; Nemaset-; Nematocide-; Nematox-; Nemazon-; OS-1897-; Oxy-DBCP-; Propane,-1-chloro-2,3-dibromo-; RCRA-waste-number-U066-; SD-1897- RN: Current: 96-12-8 Previous: 105567-86-0 BRN: 1732077 BHR: 3-01-00-00250 UD: 200305 MF: C3-H5-Br2-Cl MW: 236.35 WL: G1YE1E CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-rbt 10 gm SEV Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); eye-rbt 1% MLD Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9) ME: mmo-sat 10 nL/well (+S9) Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- v. 11, p. 223, 1979 (STEVA8); mmo-sat 500 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 15, 1985 (ENMUDM); oms-esc 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 131, p. 101, 1984 (MUREAV); dnr-esc 20900 ug/disc Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 14, p. 8, 1975 (BECTA6); mmo-bcs 1 nmol/plate (-S9) Microbiology Series. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1973- v. 5, p. 93, 1981 (MSERDS); sln-dmg-ihl 17700 ppb/3H-C Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 681, 1982 (ENMUDM); sln-dmg-orl 100 ppm/3D Huanjing Kexue. Environmental Sciences. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) 1976- Adopted vol. no. with Vol. 1, 1980. v. 5(5), p. 7, 1984 (HCKHDV); trn-dmg-orl 200 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); dni-hmn-hla 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); mnt-rat-orl 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 234, p. 129, 1990 (MUREAV); dnd-rat-tes 173 mg/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 1(3), p. 181, 1985 (CBTOE2); dnd-rat-ipr 35 mg/kg Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 1(3), p. 181, 1985 (CBTOE2); dnd-rat-ipr 1182 ug/kg Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 4, p. 528, 1991 (CRTOEC); dnd-rat-lvr 5 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 49, 1989 (CRNGDP); dns-rat-ipr 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 135, 1988 (MUREAV); cyt-rat-orl 3650 ug/kg/5D Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A46, 1979 (TXAPA9); dlt-rat-orl 50 mg/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 71, 1980 (MUREAV); spm-rat-orl 3650 ug/kg/5D Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A46, 1979 (TXAPA9); mnt-mus-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); mmo-mus-lym 20 mg/L (+S9) Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 3, p. 391, 1987 (CBTOE2); slt-mus-ipr 106 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 174, p. 145, 1986 (MUREAV); dns-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 169, 1979 (MUREAV); dnd-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 13, 1998 (MUREAV); msc-mus-lym 83700 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); mtr-ham-emb 7 mg/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 3, p. 391, 1987 (CBTOE2); cyt-ham-ovr 50 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-lng 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 78, p. 177, 1980 (MUREAV); sce-ham-ovr 10 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-lng 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 78, p. 177, 1980 (MUREAV); dnd-rbt-oth 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 285, p. 303, 1993 (MUREAV); dnd-rbt-oth 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 285, p. 303, 1993 (MUREAV); spm-rbt-orl 375 mg/kg/10W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 628, 1986 (FAATDF); dnd-gpg-ipr 40.2 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 58, p. 133, 1989 (TXCYAC); mnt-mus-orl 51.4 mg/kg/2D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 12, p. 41, 1993 (GISAAA); mnt-rat-orl 12.68 mg/kg/4D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 12, p. 41, 1993 (GISAAA); mnt-mus-orl 20.4 mg/kg/4D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 12, p. 41, 1993 (GISAAA) RE: T09 orl-rat TDLo: 200 mg/kg (1D male) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 135, 1984 (TOXID9); T34 orl-rat TDLo: 500 mg/kg (6-15D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 21, p. 483, 1979 (BECTA6); T25-T26 orl-rat TDLo: 250 mg/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 101, p. 321, 1982 (MUREAV); T35 orl-rat TDLo: 50 mg/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 71, 1980 (MUREAV); T01-T02-T23 orl-rat TDLo: 375 mg/kg (75D male) Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 36(1-3), p. 344, 1971 (HYSAAV); T25 ihl-rat TCLo: 10 ppm/6H (4W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 104, 1983 (FAATDF); T01 ihl-rat TCLo: 1 ppm/6H (4W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 104, 1983 (FAATDF); T02-T09-T53 ipr-rat TDLo: 20090 ug/kg (1D male) Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 4, p. 528, 1991 (CRTOEC); T01-T02-T03 scu-rat TDLo: 50 mg/kg (1D male) Andrologia. (Grosse Verlag GmbH, Kurfuerstenstr. 112-113, D-1000 Berlin 30, Fed. Rep. Ger.) V.6- 1974- v. 23, p. 363, 1991 (ANDRDQ); T23 scu-rat TDLo: 33 mg/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 71, p. 294, 1983 (TXAPA9); T02-T03 scu-rat TDLo: 19 mg/kg (19D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 90, p. 299, 1987 (TXAPA9); T02 scu-rat TDLo: 40 mg/kg (1D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 79, p. 54, 1985 (TXAPA9); T01 unr-rat TDLo: 100 mg/kg (1D male) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 40(6), p. 101, 1975 (GISAAA); T01-T02 orl-rbt TDLo: 92657 ug/kg (10W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 638, 1986 (FAATDF); T01-T24 ihl-rbt TCLo: 1 ppm/6H (70D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 2, p. 241, 1982 (FAATDF); T23 ihl-rbt TCLo: 10 ppm/6H (40D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 2, p. 241, 1982 (FAATDF); T52-T81-T91 unr-rat TDLo: 150 mg/kg (14-19D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 737, 2001 (HBPTO*); T52-T81-T91 unr-rat TDLo: 150 mg/kg (16-19D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 737, 2001 (HBPTO*); T52-T81-T91 unr-rat TDLo: 150 mg/kg (18-19D preg) Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 737, 2001 (HBPTO*); T23 scu-rat TDLo: 1 mg/kg (24W male) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 31, p. 454, 1984 (BIREBV); T26 orl-mus TDLo: 875 mg/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118644/AS (NTIS**); T51-T53 orl-mus TDLo: 100 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118644/AS (NTIS**); T51 orl-mus TDLo: 100 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85118644/AS (NTIS**) TE: V01-K60-R60 orl-rat TDLo: 5475 mg/kg/73W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-28, 1978 (NCITR*); V01-D09 ihl-rat TCLo: 600 ppb/6H/2Y-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 42, p. 772, 1980 (BJCAAI); V01-R60-V10 scu-rat TDLo: 240 mg/kg/12W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31(Suppl), p. 202, 1986 (TOLED5); V01-K60 orl-mus TDLo: 49 gm/kg/47W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-28, 1978 (NCITR*); V01-D09 ihl-mus TCLo: 600 ppb/6H/2Y-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 98, p. 75, 1980 (JCROD7); V01-J60-R60 skn-mus TDLo: 100 gm/kg/74W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 63, p. 1433, 1979 (JJIND8); V01-K60-R60 orl-rat TD :9280 mg/kg/64W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-28, 1978 (NCITR*); V01-D09 ihl-mus TC :3 ppm/6H/2Y-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 98, p. 75, 1980 (JCROD7); V01-D09-N61 ihl-rat TC :600 ppb/6H/76W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 47, p. 365, 1983 (EVHPAZ); V01-D09 ihl-rat TC :3 ppm/6H/2Y-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 42, p. 772, 1980 (BJCAAI); V01-D09-J60 ihl-mus TC :600 ppb/6H/76W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 47, p. 365, 1983 (EVHPAZ); V01-D09-N61 ihl-rat TC :600 ppb/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-206, 1982 (NTPTR*); V01-D09-N61 ihl-rat TC :3 ppm/6H/84W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-206, 1982 (NTPTR*); V01-D09-J60 ihl-mus TC :600 ppb/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-206, 1982 (NTPTR*); V01-D09-J60 ihl-mus TC :3 ppm/6H/76W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-206, 1982 (NTPTR*); V01-M61 scu-rat TD :240 mg/kg/12W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31(Suppl), p. 202, 1986 (TOLED5); V01-D09 ihl-rat TCLo: 18.54 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-225632 (NTIS**); V01-D09-N61 ihl-rat TCLo: 15.45 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-225632 (NTIS**); V01-J60-J61 ihl-mus TCLo: 136.8 mg/kg/76W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-225632 (NTIS**); V01-D09 ihl-mus TCLo: 37.08 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-225632 (NTIS**) ORNG: 170000000 ng/kg. [170.000000 mg/kg] T/E unlistd SRNG: 1400000000 ng/kg. [1400.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 170 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); T/E unlistd ihl-rat LC50: 103 ppm/8H Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 15, p. 448, 1956 (FEPRA7); T/E unlistd scu-rat LD50: 100 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 27, p. 287, 1983 (TXCYAC); T/E unlistd orl-mus LD50: 257 mg/kg Guide to the Chemicals Used in Crop Protection. (Information Canada, 171 Slater St., Ottawa, Ont., Canada) v. 6, p. 172, 1973 (GUCHAZ); T/E unlistd ipr-mus LD50: 123 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 169, 1979 (MUREAV); T/E unlistd orl-rbt LD50: 180 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); T/E unlistd skn-rbt LD50: 1400 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); T/E unlistd orl-gpg LD50: 150 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 797, 1966 (PCOC**); T/E unlistd orl-ckn LD50: 60 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); T02 ipr-rat TDLo: 40.2 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 58, p. 133, 1989 (TXCYAC); T/E unlistd ipr-rat LDLo: 80.4 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 58, p. 133, 1989 (TXCYAC); T02 ipr-mus TDLo: 80.4 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 58, p. 133, 1989 (TXCYAC); T/E unlistd ipr-mus LDLo: 120 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 58, p. 133, 1989 (TXCYAC); T/E unlistd ipr-ham LDLo: 161 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 58, p. 133, 1989 (TXCYAC); T02 ipr-gpg LDLo: 40 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 58, p. 133, 1989 (TXCYAC); M71-U01-Z73 scu-rat TDLo: 100 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 59, p. 84, 1981 (TXAPA9); M04-M16-P28 ipr-rat TDLo: 40 mg/kg Chirality. (New York Ny Wiley-Liss) V.1- 1989- v. 7, p. 359, 1995 (CHIRA*) MD: L01-L04-P27 orl-rat TDLo: 3150 mg/kg/45D-I Meditsinskii Zhurnal Uzbekistana. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1957- v. 1(1), p. 64, 1970 (MZUZA8); L70-M70-U01 orl-rat TDLo: 2025 mg/kg/90D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); F16-U01-Z73 orl-rat TDLo: 602 mg/kg/64D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 804, 1989 (FAATDF); L70-U01-Z73 ihl-rat TDLo: 10 ppm/7H/70D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); L02-M03-P26 ihl-rat TCLo: 25 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-206, 1982 (NTPTR*); J30-M03 ihl-rat TCLo: 10 ppm/24H/14D-C Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 20, p. 315, 1982 (INHEAO); M30-P30 ipr-rat TDLo: 160 mg/kg/2D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 8, p. 317, 1981 (TOLED5); M70-P72-Z73 scu-rat TDLo: 2400 mg/kg/12W-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 27, p. 49, 1989 (INHEAO); Z01 orl-mus TDLo: 11940 mg/kg/6W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-28, 1978 (NCITR*); J02-Z01 ihl-mus TCLo: 5 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-206, 1982 (NTPTR*); Z73 ihl-rat TDLo: 12 ppm/7H/70D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); Z73 ihl-gpg TDLo: 12 ppm/7H/70D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 545, 1961 (TXAPA9); U01 scu-rat TDLo: 175 mg/kg/1W-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 31, p. 454, 1984 (BIREBV); N02-Z73 scu-rat TDLo: 912.5 mg/kg/26W-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 31, p. 454, 1984 (BIREBV); N04-Z72 scu-rat TDLo: 4562 mg/kg/26W-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 31, p. 454, 1984 (BIREBV); Z73 scu-rat TDLo: 912.5 mg/kg/26W-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 31, p. 454, 1984 (BIREBV); N16 scu-rat TDLo: 182.5 mg/kg/26W-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 31, p. 454, 1984 (BIREBV) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 83, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 139, 1977 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 479, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 191, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 479, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 479, 1999 (IMEMDT); TOXICOLOGY REVIEW Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 1259, 1977 (LANCAO); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF) SR: OSHA PEL (Construc): see CFR 29,1926.1144 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA-cancer hazard Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1044, 1987 (CFRGBR); OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000 ND: NIOSH REL TO 1,2-DIBROMO-3-CHLOROPROPANE-air: CA use 29 CFR 1910.1044 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M2705; NIS 1; TNF 8; NOS 6; TNE 176 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test, Sperm morphology-human; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (inhal), clear evidence: rat; NTP Carcinogenesis Bioassay (inhalation), clear evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-206, 1982 (NTPTR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 986 of 1119 in RTECS (through 2003/06) AN: TX9625000 PN: Propane,-1,2-dichloro- SY: 1,2-Dichloropropane-; 1,2-Dichloropropane- (OSHA); Bichlorure-de-propylene- (French); Dwuchloropropan- (Polish); ENT-15,406-; NCI-C55141-; Propylene-chloride-; Propylene-dichloride- (ACGIH:OSHA); RCRA-waste-number-U083-; alpha,beta-Dichloropropane-; alpha,beta-Propylene-dichloride- RN: Current: 78-87-5 BRN: 1718880 BHR: 3-01-00-00225 UD: 200210 MF: C3-H6-Cl2 MW: 112.99 WL: GY1&1G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 500 mg MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP) ME: mmo-sat 100 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-mus-lym 11600 ug/L (+S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 660 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-263, 1986 (NTPTR*); sce-ham-ovr 113 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-lng 3300 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 401, 1987 (ENMUDM) RE: T19 orl-rat TDLo: 1250 mg/kg (6-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 28, p. 18, 1995 (FAATDF); T19 orl-rbt TDLo: 1950 mg/kg (7-19D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 28, p. 18, 1995 (FAATDF) TE: V01-R60 orl-mus TDLo: 130 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-263, 1986 (NTPTR*); V01-R60 orl-rat TDLo: 128750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-114443/AS (NTIS**); V01-L60 orl-mus TDLo: 64375 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-114443/AS (NTIS**) ORNG: 1947000000 ng/kg. [1947.000000 mg/kg] T/E unlistd SRNL: 8750000 nL/kg. [8.750000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1947 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 20, p. 364, 1959 (AIHAAP); T/E unlistd ihl-rat LC50: 14 gm/m3/8H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 20, p. 364, 1959 (AIHAAP); T/E unlistd ipr-rat LD50: 1100 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 63, p. 445, 1989 (ARTODN); T/E unlistd orl-mus LD50: 860 mg/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,98,1986 (85JCAE); T/E unlistd ihl-mus LCLo: 1000 ppm/2H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28, p. 1, 1946 (JIHTAB); K06-K08 unr-mus LD50: 960 mg/kg Eisei Kagaku. Hygienic Chemistry. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1953- v. 28, p. P31, 1982 (ESKGA2); F04-L30 orl-dog LDLo: 5 gm/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 16, p. 325, 1932 (AJHYA2); T/E unlistd skn-rbt LD50: 8750 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 7/28/1966 (UCDS**); T/E unlistd orl-gpg LD50: 2 gm/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C253, 1991 (FMCHA2) MD: P28-Y15-Y21 orl-rat TDLo: 435 mg/kg/30D-I Reviews of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.98- 1987- v. 104, p. 93, 1988 (RCTOE4); M30-Z01 orl-rat TDLo: 28 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-263, 1986 (NTPTR*); K02-Y04 orl-rat TDLo: 109 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(1), p. 94, 1974 (GISAAA); L70-N73-Y15 orl-rat TDLo: 16250 mg/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 713, 1989 (FAATDF); A11-J30-Y01 ihl-rat TCLo: 9 mg/m3/24H/94D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 42(8), p. 50, 1977 (GISAAA); L30-Y03-Y10 ihl-rat TCLo: 10 mg/m3/24H/60D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 47(10), p. 21, 1982 (GISAAA); L03-P27-Z01 ihl-rat TCLo: 1000 ppm/7H/20W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(1), p. 1, 1946 (JIHTAB); L30-Y16 ipr-rat TDLo: 2500 mg/kg/5D-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 63, p. 445, 1989 (ARTODN); L30-Y16 ipr-rat TDLo: 1400 mg/kg/4W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 63, p. 445, 1989 (ARTODN); M30-Z01 orl-mus TDLo: 28 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-263, 1986 (NTPTR*); Z01 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-263, 1986 (NTPTR*); L03-Z01 ihl-mus TCLo: 400 ppm/7H/7W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30(3), p. 189, 1948 (JIHTAB); L03-M03-N30 ihl-dog TCLo: 1000 ppm/7H/26W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(1), p. 1, 1946 (JIHTAB); L03-N30-Z01 ihl-gpg TCLo: 1500 ppm/7H/8W-I Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 28(1), p. 1, 1946 (JIHTAB); Z01 ihl-mus TCLo: 400 ppm/7H/120D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 395, 1990 (VCVGH*); Y03 ihl-rat TCLo: 10 mg/m3/30D-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 395, 1990 (VCVGH*); Y03 ihl-rat TCLo: 10 mg/m3/60D-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 395, 1990 (VCVGH*); J15-J30-P01 ihl-rat TCLo: 10 mg/m3/90D-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 395, 1990 (VCVGH*) TR: ACGIH TLV-TWA 75 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 110 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 75 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 131, 1986 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1393, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 131, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1393, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1393, 1999 (IMEMDT); TOXICOLOGY REVIEW Pharmacological Reviews. (Williams and Wilkins, 428 E. Preston St., Baltimore, MD 21202) V.1- 1949- v. 4, p. 1, 1952 (PAREAQ) SR: MSHA STANDARD-air: TWA 75 ppm (350 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 218, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 75 ppm (350 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 75 ppm (350 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 75 ppm (350 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 75 ppm (350 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 75 ppm (350 mg/m3), STEL 110 ppm, JAN 1993; OEL-AUSTRIA: MAK 75 ppm (350 mg/m3), JAN 1999; OEL-BELGIUM: TWA 75 ppm (347 mg/m3), STEL 110 ppm (509 mg/m3), JAN 1993; OEL-DENMARK: TWA 75 ppm (350 mg/m3), JAN 1999; OEL-FINLAND: TWA 75 ppm (350 mg/m3), STEL 115 ppm (530 mg/m3), JAN 1999; OEL-FRANCE: VME 75 ppm (350 mg/m3), JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: TWA 50 mg/m3, STEL 100 mg/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 75 ppm (350 mg/m3), JAN 1999; OEL-NORWAY: TWA 40 ppm (185 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 75 ppm (350 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 50 mg/m3, MAC(STEL) 400 mg/m3, JAN 1999; OEL-RUSSIA: STEL 10 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 75 ppm (350 mg/m3), KZG-W 375 ppm (1750 mg/m3), JAN 1999; OEL-TURKEY: TWA 74 ppm (350 mg/m3), JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO PROPYLENE DICHLORIDE-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 24390; NIS 13; TNF 653; NOS 15; TNE 9601; NOES 1983: HZD 24390; NIS 6; TNF 116; NOS 15; TNE 2944; TFE 1022 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/90/182122/AS); EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Propylene dichloride, 1013; NTP Carcinogenesis Studies (gavage), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-263, 1986 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 987 of 1119 in RTECS (through 2003/06) AN: TY3195500 PN: 1,3-Propanediol, 2,2-bis(bromomethyl)- SY: 2,2-Bis(bromomethyl)-1,3-propanediol; 2,2-Bis(bromomethyl)propan-1,3-diol; Dibromoneopentyl-glycol-; Dibromopentaerythritol-; FR-1138-; NCI-C55516-; Pentaerythritol-dibromide-; Pentaerythritol-dibromohydrin- RN: Current: 3296-90-0 BRN: 1304582 BHR: 4-01-00-02554 UD: 200302 MF: C5-H10-Br2-O2 MW: 261.97 WL: Q1X1Q1E1E CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 1 mg/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19(Suppl 21), p. 2, 1992 (EMMUEG); cyt-ham-ovr 800 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T16-T26-T87 orl-mus TDLo: 124 gm/kg (15W male/15W pre) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 245, 1989 (FAATDF); T22-T87 orl-mus TDLo: 62 gm/kg (15W pre) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 245, 1989 (FAATDF); T02-T03 orl-mus TDLo: 62 gm/kg (15W male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 245, 1989 (FAATDF) TE: V01-R60 orl-rat TDLo: 72800 mg/kg/1Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-452, 1996 (NTPTR*); V01-J60 orl-mus TDLo: 102 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-452, 1996 (NTPTR*); V01-P61 orl-rat TDLo: 216300 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-120224 (NTIS**); V01-P61 orl-rat TDLo: 180250 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-120224 (NTIS**); V03-J60-N62 orl-rat TDLo: 432600 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-120224 (NTIS**); V03-J60-N62 orl-rat TDLo: 360500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-120224 (NTIS**); V01-J60-N60 orl-mus TDLo: 108150 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-120224 (NTIS**) ORNG: 1880000000 ng/kg. [1880.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1880 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0524337 (NTIS**); T/E unlistd orl-mus LD50: 1200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0524337 (NTIS**) MD: M03-M30-U01 orl-rat TDLo: 109 gm/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 480, 1989 (FAATDF); L70 orl-rat TDLo: 9 gm/kg/30D-I Journal of Combustion Toxicology. (Westport, CT) V.3-9, 1976-82. v. 7, p. 77, 1980 (JCTODH); D35 orl-rat TDLo: 73 gm/kg/2Y-C Journal of Combustion Toxicology. (Westport, CT) V.3-9, 1976-82. v. 7, p. 77, 1980 (JCTODH); M03-M30-U01 orl-mus TDLo: 36 gm/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 480, 1989 (FAATDF); U01 orl-mus TDLo: 3836 mg/kg/14D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86168341 (NTIS**) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); TOXICOLOGY REVIEW Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 747, 1989 (FAATDF) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: mouse, rat; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 988 of 1119 in RTECS (through 2003/06) AN: TZ2975000 PN: Propane,-1,2-epoxy- SY: AD-6- (suspending agent); Epoxypropane-; 1,2-Epoxypropane-; 1,2-Epoxypropane- (ACGIH:OSHA); 2,3-Epoxypropane-; Ethylene-oxide,-methyl-; Methyl-ethylene-oxide-; Methyloxacyclopropane-; Methyl-oxirane-; NCI-C50099-; Oxirane,-methyl-; Oxyde-de-propylene- (French); Propane,-epoxy-; Propene-oxide-; Propylene-epoxide-; Propylene-oxide-; 1,2-Propylene-oxide-; Propylene-oxide- (DOT:OSHA) RN: Current: 75-56-9 BRN: 79763 BHR: 5-17-01-00017 UD: 200210 MF: C3-H6-O MW: 58.09 WL: T3OTJ B1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 415 mg open MOD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 12/13/1963 (UCDS**); skn-rbt 50 mg/6M SEV AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 228, 1956 (AMIHAB); eye-rbt 20 mg SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,768,1986 (85JCAE) ME: mmo-sat 350 ug/plate (+S9) Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.25- 1961- v. 47, p. 2461, 1983 (ABCHA6); mmo-sat 700 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 101, 1979 (MUREAV); oms-sat 1 pph Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 171, 1987 (ENMUDM); mmo-esc 700 ug/plate (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 101, 1979 (MUREAV); dnd-esc 1 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); mmo-klp 500 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 269, 1981 (MUREAV); mmo-omi 25 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 73, p. 1, 1980 (MUREAV); mmo-omi 5 mmol/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 274, 1994 (EMMUEG); dnd-omi 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); slt-dmg-ihl 1500 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 405, p. 259, 1998 (MUREAV); sln-dmg-ihl 645 ppm/24H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 337, 1983 (MUREAV); sln-dmg-orl 1 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); sln-dmg-par 10 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); trn-dmg-par 10 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); mmo-nsc 500 mmol/L (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 40, p. 890, 1955 (GENTAE); mmo-smc 50 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 250, p. 229, 1991 (MUREAV); mrc-smc 25 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 250, p. 229, 1991 (MUREAV); sce-smc 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 250, p. 229, 1991 (MUREAV); mmo-ssp 183 mmol/L (-S9) Abhandlungen der Deutschen Akademie der Wissenschaften zu Berlin, Klasse fuer Medizin. (Berlin, Ger. Dem. Rep.) 1950-68. Discontinued. v. -, p. 193, 1962 (ADWMAX); dnd-sal-spr 5 mL Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.31- 1951- v. 97, p. 80, 1962 (ABBIA4); dnd-ofs-tes 5 gm Archives of Biochemistry and Biophysics. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.31- 1951- v. 97, p. 80, 1962 (ABBIA4); cyt-hmn-lym 1850 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 101, 1979 (MUREAV); sce-hmn-lym 25000 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 48, 1985 (ENMUDM); dnd-rat-lvr 30 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); cyt-rat-lvr 25 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 153, p. 57, 1985 (MUREAV); dlt-rat-ihl 300 ppm/5D-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 117, p. 337, 1983 (MUREAV); mnt-mus-ipr 600 mg/kg/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 101, 1979 (MUREAV); slt-mus-lym 160 ppm/48H-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17, p. 122, 1991 (EMMUEG); dnd-mus-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); cyt-mus-ipr 349 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 288, p. 223, 1993 (MUREAV); sce-mus-ipr 232 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 288, p. 223, 1993 (MUREAV); msc-mus-lym 400 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 160 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 5 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-lng 2500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 249, p. 55, 1991 (MUREAV); dnd-mam-lym 75 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 9, p. 97, 1974 (CBINA8); dna-mam-lym 100 mmol/tube Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 67, p. 275, 1988 (CBINA8); dna-rat-ihl 600 mg/kg/4W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 2011, 2000 (CRNGDP) RE: T34-T46 ihl-rat TCLo: 500 ppm/7H (7-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-258038 (NTIS**); T43 ihl-rat TCLo: 500 ppm/7H (1-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-258038 (NTIS**); T24-T26-T29 ihl-rat TCLo: 500 ppm/7H (15D pre/1-16D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 9, p. 94, 1983 (SWEHDO); T01 ipr-rat TDLo: 47 mg/kg (1D male) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 49, p. 168, 1994 (NEZAAQ); T01-T02 ipr-rat TDLo: 1860 mg/kg (6W male) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 49, p. 168, 1994 (NEZAAQ); T01 ihl-mky TCLo: 100 ppm/7H (2Y male) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 3, p. 60, 1983 (TOXID9) TE: V01-K60 orl-rat TDLo: 10798 mg/kg/2Y-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 46, p. 924, 1982 (BJCAAI); V01-D09 ihl-mus TCLo: 400 ppm/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-267, 1985 (NTPTR*); V02-N60 ihl-rat TCLo: 100 ppm/7H/2Y-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 76, p. 69, 1984 (TXAPA9); V03-V16 scu-rat TDLo: 1500 mg/kg/46W-I Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 68, p. 750, 1958 (ANYAA9); V01-D09 ihl-mus TCLo: 400 ppm/6H/2Y-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 77, p. 573, 1986 (JJIND8); V01-P62-V10 scu-mus TDLo: 272 mg/kg/95W-I Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 174, p. 383, 1981 (ZHPMAT); V02-P62-V10 scu-mus TD :3640 mg/kg/91W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 39, p. 588, 1979 (BJCAAI); V01-P62-V10 scu-mus TD :868 mg/kg/95W-I Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 174, p. 383, 1981 (ZHPMAT); V01-P62-V10 scu-mus TD :2912 mg/kg/95W-I Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 174, p. 383, 1981 (ZHPMAT); V01-P62-V10 scu-mus TD :6616 mg/kg/95W-I Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 174, p. 383, 1981 (ZHPMAT); V03-K60 orl-rat TD :2714 mg/kg/2Y-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 46, p. 924, 1982 (BJCAAI); V03-D09 ihl-rat TC :400 ppm/6H/2Y-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 77, p. 573, 1986 (JJIND8); V02-R60 ihl-rat TC :300 ppm/6H/2.3Y-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 159, 1988 (FCTOD7); V02-D09 ihl-rat TCLo: 12360 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-179653/AS (NTIS**); V02-D09-N62 ihl-rat TCLo: 10300 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-179653/AS (NTIS**); V01-D09 ihl-mus TCLo: 24720 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-179653/AS (NTIS**); V02-D09 ihl-mus TCLo: 24720 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-179653/AS (NTIS**) ORNG: 380000000 ng/kg. [380.000000 mg/kg] F13-F19-J26 SRNL: 1500000 nL/kg. [1.500000 mL/kg] T/E unlistd IHPB: 4000000 ppb/4H. [4000.000000 ppm/4H] D07-D17-J22 AT: F07-F27-K13 ihl-man TCLo: 1400 gm/m3/10M Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 15(2), p. 48, 1971 (GTPZAB); F13-F19-J26 orl-rat LD50: 380 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 14(11), p. 55, 1970 (GTPZAB); D07-D17-J22 ihl-rat LC50: 4000 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 237, 1956 (AMIHAB); T/E unlistd ipr-rat LD50: 150 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,103,1982 (85GMAT); F13-F19-J26 orl-mus LD50: 440 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 14(11), p. 55, 1970 (GTPZAB); D07-J22-K01 ihl-mus LC50: 1740 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 237, 1956 (AMIHAB); T/E unlistd ipr-mus LD50: 175 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,103,1982 (85GMAT); D07-D17-K13 ihl-dog LCLo: 2005 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 237, 1956 (AMIHAB); T/E unlistd skn-rbt LD50: 1500 uL/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); F07-L30-M30 orl-gpg LD50: 660 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 46(7), p. 76, 1981 (GISAAA); D27-F18-J22 ihl-gpg LCLo: 4000 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 228, 1956 (AMIHAB); T/E unlistd orl-mam LD50: 440 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(4), p. 86, 1974 (GISAAA) MD: A30-L30-P30 orl-rat TDLo: 1170 mg/kg/45D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 46(7), p. 76, 1981 (GISAAA); D35-J12-Z01 ihl-rat TCLo: 457 ppm/7H/28W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 228, 1956 (AMIHAB); J22-K12-Z01 ihl-rat TCLo: 1433 ppm/6H/12D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-267, 1985 (NTPTR*); A10-A30-H02 ihl-rat TCLo: 25 mg/m3/4H/26W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 14(11), p. 55, 1970 (GTPZAB); D07 ihl-rat TCLo: 529 ppm/6H/4W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 27, p. 25, 1995 (FAATDF); G70-J02-U01 ihl-rat TCLo: 997 ppm/6H/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- OTS0535203 (NTPTR*); F07-J22 ihl-mus TCLo: 487 ppm/6H/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-267, 1985 (NTPTR*); Z01 ihl-mus TCLo: 125 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-267, 1985 (NTPTR*); D35-J70-U01 ihl-gpg TCLo: 457 ppm/7H/22W-I AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 13, p. 228, 1956 (AMIHAB) TR: ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 20 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 227, 1985 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 181, 1994 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 227, 1985 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 181, 1994 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 181, 1994 (IMEMDT) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 100 ppm (240 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 219, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm (240 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (240 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (240 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (240 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 20 ppm (50 mg/m3), Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 20 ppm (48 mg/m3), JAN 1993; OEL-DENMARK: TWA 5 ppm (12 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 5 ppm (12 mg/m3), Carcinogen, JAN 1999; OEL-FRANCE: VME 20 ppm (50 mg/m3), C2 Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 100 ppm (240 mg/m3), Carcinogen, JAN 1999; OEL-NORWAY: TWA 1 ppm (2 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (240 mg/m3), JAN 1993; OEL-RUSSIA: STEL 1 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 5 ppm (12 mg/m3), KTV 10 ppm (25 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 2.5 ppm (6 mg/m3), Carcinogen, JAN 1999; OEL-TURKEY: TWA 100 ppm (240 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (12 mg/m3), Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO PROPYLENE OXIDE-air: CA lowest feasible concentrtion National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 63550; NIS 78; TNF 9032; NOS 60; TNE 75135; NOES 1983: HZD 63550; NIS 57; TNF 5786; NOS 67; TNE 421140; TFE 317309 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Positive: N crassa-reversion, D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S pombe-reversion; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 51, JULY 1989; NIOSH Analytical Method, 1994: Propylene oxide, 1612; NCI Carcinogenesis Studies (inhal), clear evidence: mouse; NTP Carcinogenesis Studies (inhalation), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-267, 1985 (NTPTR*); NCI Carcinogenesis Studies (inhal), equivocal evidence: rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #88 Record 989 of 1119 in RTECS (through 2003/06) AN: TZ5250000 PN: Propane,-2-nitro- SY: 2-NP-; 2-Nitropropane-; 2-Nitropropane- (ACGIH:OSHA); Dimethylnitromethane-; Isonitropropane-; Nipar-S-20-; Nipar-S-20-solvent-; Nipar-S-30-solvent-; Nitroisopropane-; RCRA-waste-number-U171-; beta-Nitropropane- RN: Current: 79-46-9 UD: 200210 MF: C3-H7-N-O2 MW: 89.11 WL: WNY1&1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 25 umol/L (+S9) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 341, 1989 (FAATDF); mmo-sat 1 mg/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); dnd-sat 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 104, p. 49, 1982 (MUREAV); mmo-esc 2500 ug/plate (+/-S9) Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 29, p. 34, 1987 (SAIGBL); cyt-hmn-lym 60 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 217, 1987 (MUREAV); sce-hmn-lym 7500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 217, 1987 (MUREAV); mnt-rat-orl 25 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 2329, 1989 (CRNGDP); dnr-rat-ipr 20 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 811, 1988 (CRNGDP); dnr-rat-lvr 30 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 811, 1988 (CRNGDP); dnd-rat-orl 44555 ug/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 57, p. 61, 1991 (CALEDQ); dnd-rat-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 391, p. 165, 1997 (MUREAV); dns-rat-lvr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 221, p. 263, 1989 (MUREAV); dns-rat-ipr 20 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 811, 1988 (CRNGDP); dns-rat-orl 50 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 2329, 1989 (CRNGDP); dnr-dom-oth 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 413, p. 69, 1998 (MUREAV) RE: T47 ipr-rat TDLo: 2550 mg/kg (1-15D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A35, 1979 (TXAPA9); T25-T34 ipr-rat TDLo: 2550 mg/kg (1-15D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO) TE: V01-L60 orl-rat TDLo: 4277 mg/kg/16W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1947, 1987 (CRNGDP); V01-L60 ihl-rat TCLo: 207 ppm/7H/26W-I Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(5), p. 233, 1979 (JEPTDQ); V03-L60 ihl-rat TC :207 ppm/26W-I U.S. Public Health Service, Current Intelligence Bulletin. (National Institute for Occupational Safety and Health, 5600 Fishers Lane, Rockville, MD 20857) 25APR1977 (XPHCI*) ORNG: 720000000 ng/kg. [720.000000 mg/kg] T/E unlistd AT: F14-K12-K13 ihl-man TCLo: 20 ppm Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5. v. 16, p. 441, 1947 (INMEAF); T/E unlistd orl-rat LD50: 720 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,430,1969 (34ZIAG); T/E unlistd ihl-rat LC50: 400 ppm/6H Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(5), p. 233, 1979 (JEPTDQ); P24 ipr-rat LDLo: 1100 mg/kg Bulletin de la Societe de Pharmacie de Lille. (Societe de Pharmacie du Lille, 3, rue du Professeur Laguesse, 59045 Lille, Franch) V.1- 1945- v. (2), p. 83, 1972 (BSPLA9); T/E unlistd ihl-mus LC50: 10 gm/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,94,1982 (85GMAT); T/E unlistd ipr-mus LD50: 75 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD691-490 (NTIS**); D17-J22-K01 ihl-cat LCLo: 714 ppm/5H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 5, p. 52, 1952 (AMIHBC); F07-F19-J26 orl-rbt LDLo: 500 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 22, p. 315, 1940 (JIHTAB); F12-J22-J24 ihl-rbt LCLo: 2381 ppm/5H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 5, p. 52, 1952 (AMIHBC); F12-J22-J24 ihl-gpg LCLo: 4622 ppm/5H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 5, p. 52, 1952 (AMIHBC) TR: ACGIH TLV-TWA 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 331, 1982 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1079, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 331, 1982 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1079, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1079, 1999 (IMEMDT) SR: MSHA STANDARD-air: TWA 25 ppm (90 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 188, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 25 ppm (90 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 25 ppm (90 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 25 ppm (90 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 25 ppm (90 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-DENMARK: TWA 5 ppm (18 mg/m3), JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 25 ppm (90 mg/m3), JAN 1999; OEL-NORWAY: TWA 10 ppm (35 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 25 ppm (90 mg/m3), JAN 1993; OEL-SWEDEN: NGV 5 ppm (18 mg/m3), TGV 10 ppm (35 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (18 mg/m3), Carcinogen, JAN 1999; OEL-TURKEY: TWA 25 ppm (90 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (19 mg/m3), Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 2-NITROPROPANE-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 51090; NIS 57; TNF 2335; NOS 42; TNE 29842; NOES 1983: HZD 51090; NIS 15; TNF 345; NOS 19; TNE 9818; TFE 1817 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 17, 1977; NIOSH Analytical Method, 1994: 2-Nitropropane, 2528; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #46; OSHA ANALYTICAL METHOD #15, SUPERSEDED BY #46 Record 990 of 1119 in RTECS (through 2003/06) AN: TZ8350000 PN: 1,2,3-Propanetricarboxylic acid, 1,1'-(1-(12-amino-4,9,11-trihydroxy-2-methyltridecyl)-2-(1- methylpentyl)-1,2-ethanediyl)ester SY: Fumonisin-B1-; Fumonisin-B1-; Macrofusine- RN: Current: 116355-83-0 UD: 200305 MF: C34-H59-N-O15 MW: 721.94 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Natural-Product (N) ME: dni-rat-lvr 12500 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 16, p. 625, 1995 (CRNGDP); oms-rat-lvr 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 391, p. 39, 1997 (MUREAV); cyt-rat-lvr 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 391, p. 39, 1997 (MUREAV); dnd-hmn-fbr 0.1 umol/L/48H Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 25, 2002 (FCTOD7); dnd-hmn-fbr 0.01 umol/L/72H Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 25, 2002 (FCTOD7); mnt-hmn-lvr 50 mg/L/1H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 257, 2002 (MUTAEX); dnd-hmn-lvr 25 mg/L/24H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 257, 2002 (MUTAEX) RE: T46 orl-rat TDLo: 150 mg/kg (8-12D preg) Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 37, p. 126, 1995 (VHTODE); T19-T34 orl-rat TDLo: 210 mg/kg (3-16D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 36, p. 397, 1998 (FCTOD7); T19-T34-T35 orl-rat TDLo: 700 mg/kg (3-16D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 36, p. 673, 1998 (FCTOD7); T24-T25-T34 orl-mus TDLo: 900 mg/kg (7-15D preg) Mycopathologia. (Kluwer Academic Pub. Group, Distribution Centre, POB 322, 3300 AH Dordrecht, Netherlands) V.1- 1938- v. 128, p. 111, 1994 (MYCPAH); T41 orl-mus TDLo: 225 mg/kg (7-15D preg) Mycopathologia. (Kluwer Academic Pub. Group, Distribution Centre, POB 322, 3300 AH Dordrecht, Netherlands) V.1- 1938- v. 128, p. 111, 1994 (MYCPAH); T43 orl-mus TDLo: 900 mg/kg (7-15D preg) Mycopathologia. (Kluwer Academic Pub. Group, Distribution Centre, POB 322, 3300 AH Dordrecht, Netherlands) V.1- 1938- v. 128, p. 111, 1994 (MYCPAH); T19-T25-T26 orl-mus TDLo: 900 mg/kg (7-15D preg) Mycopathologia. (Kluwer Academic Pub. Group, Distribution Centre, POB 322, 3300 AH Dordrecht, Netherlands) V.1- 1938- v. 134, p. 161, 1996 (MYCPAH); T34-T35 orl-ham TDLo: 12 mg/kg (8-9D preg) Mycopathologia. (Kluwer Academic Pub. Group, Distribution Centre, POB 322, 3300 AH Dordrecht, Netherlands) V.1- 1938- v. 128, p. 33, 1994 (MYCPAH); T27-T34-T35 orl-rat TDLo: 700 mg/kg (3-16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 55, p. 56, 1997 (TJADAB) TE: V01-M61 orl-rat TDLo: 1837.5 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NIH No. 01-3955 (NTIS**); V01-M61 orl-rat TDLo: 1837.5 mg/kg/105W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 379, 2001 (JTPAE7); V02-M61 orl-rat TDLo: 2205 mg/kg/105W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 379, 2001 (JTPAE7); V02-L60-L14 orl-rat TDLo: 525 mg/kg/5W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 146, p. 207, 1999 (CALEDQ) AT: P28-Y15-Y37 orl-mky TDLo: 1 mg/kg Toxicon. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.1- 1962- v. 39, p. 273, 2001 (TOXIA6); T/E unlistd orl-mky TDLo: 10 mg/kg Toxicon. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.1- 1962- v. 39, p. 273, 2001 (TOXIA6) MD: F15-P26-P28 orl-rat TDLo: 55 mg/kg/11D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 53, p. 135, 1998 (JTEHD6); L70-P28-U01 orl-rat TDLo: 399 mg/kg/21D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 35, p. 647, 1997 (FCTOD7); M03-M70 orl-rat TDLo: 175 mg/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 24, p. 102, 1995 (FAATDF); P27-U01 orl-rat TDLo: 350 mg/kg/14D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 39, p. 53, 1997 (FAATDF); L30-L70 orl-rat TDLo: 582 mg/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 35, p. 647, 1997 (FCTOD7); M03-M16-Y10 ipr-rat TDLo: 30 mg/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 133, p. 207, 1995 (TXAPA9); L01-P28-Y16 ipr-rat TDLo: 4500 ug/kg/6D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 114, p. 163, 2000 (TOLED5); L50-P28-Y20 orl-mus TDLo: 884 mg/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 24, p. 102, 1995 (FAATDF); L70-P26-U01 orl-mus TDLo: 1050 mg/kg/14D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 35, p. 981, 1997 (FCTOD7); L30-M30-M70 scu-mus TDLo: 1250 ug/kg/5D-I Journal of Comparative Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.75- 1965- v. 117, p. 371, 1997 (JCVPAR); L30-M03-Y15 ivn-rbt TDLo: 16 mg/kg/6D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 14, p. 208, 1994 (TOXID9); G09-G10-G30 orl-pig TDLo: 60 mg/kg/3D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 162, p. 151, 2000 (TXAPA9); G30 ivn-pig TDLo: 4 mg/kg/4D-I Veterinary Pathology. (Waverly Press, Inc., POB 64025, Baltimore, MD 21264) V.8- 1971- v. 36, p. 485, 1999 (VTPHAK); U01-Z01 orl-rat TDLo: 700 mg/kg/14D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 55, p. 56, 1997 (TJADAB); U01 orl-rat TDLo: 280 mg/kg/14D-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 169, p. 127, 2001 (CALEDQ); L70-U01 orl-rat TDLo: 420 mg/kg/14D-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 169, p. 127, 2001 (CALEDQ); L14-M71-Y37 orl-rat TDLo: 13.5 mg/kg/4W-C Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 5, p. 101, 1998 (ETOPFR); R60-V16 orl-mus TDLo: 57.6 mg/kg/20W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 155, p. 1, 2000 (CALEDQ); R60-V16 skn-mus TDLo: 57.6 mg/kg/20W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 155, p. 61, 2000 (CALEDQ); M03 orl-rat TDLo: 5512.5 mg/kg/105W-I Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 379, 2001 (JTPAE7); M16-U01 orl-rat TDLo: 4.48 mg/kg/1W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 135, p. S23, 2002 (TOLED5) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 56, p. 445, 1993 (IMEMDT); TOXICOLOGY REVIEW Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 127, p. 19, 2002 (TOLED5) SL: NCI Carcinogenesis Studies (feed), clear evidence: mouse, rat; NTP Carcinogenesis studies, test completed (post peer review), October 2000 Record 991 of 1119 in RTECS (through 2003/06) AN: TZ9275000 PN: Propane,-1,2,3-trichloro- SY: 1,2,3-Trichloropropane-; 1,2,3-Trichloropropane- (ACGIH:OSHA); Allyl-trichloride-; Glycerol-trichlorohydrin-; Glyceryl-trichlorohydrin-; NCI-C60220-; Trichlorohydrin- RN: Current: 96-18-4 BRN: 1732068 BHR: 4-01-00-00199 UD: 200302 MF: C3-H5-Cl3 MW: 147.43 WL: G1YG1G CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 uL/24H MLD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534994 (NTIS**); eye-rbt 100 uL MOD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534994 (NTIS**) ME: mmo-sat 500 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 15, 1985 (ENMUDM); dnd-hmn-lym 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 371, p. 185, 1996 (MUREAV); dnd-rat-ipr 55361 ug/kg Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB 57/36, West End Station, Washington, DC 20037) V.1- 1988- v. 4, p. 528, 1991 (CRTOEC); cyt-rat-ihl 800 ug/L Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1414, 1974 (BEXBAN); sce-ham-lng 300 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 401, 1987 (ENMUDM) RE: T26 orl-rat TDLo: 400 mg/kg (5D male) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 101, p. 321, 1982 (MUREAV) TE: V01-K60-R60 orl-rat TDLo: 5200 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-384, 1993 (NTPTR*); V01-K60-L60 orl-mus TDLo: 3120 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-384, 1993 (NTPTR*); V01-K60 orl-rat TDLo: 1560 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-207784 (NTIS**); V01-N60-T69 orl-rat TDLo: 15600 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-207784 (NTIS**); V01-R60-T69 orl-rat TDLo: 5200 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-207784 (NTIS**); V01-K60-L60 orl-mus TDLo: 3120 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-207784 (NTIS**); V01-L60-N60 orl-mus TDLo: 31200 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-207784 (NTIS**) ORNL: 108000 nL/kg. [0.108000 mL/kg] K12-L30-R21 SRNL: 372000 nL/kg. [0.372000 mL/kg] K12-J30-K30 AT: K12-L30-R21 orl-rat LD50: 108 uL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534994 (NTIS**); T/E unlistd ihl-rat LCLo: 500 ppm/4H Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 3/20/1973 (UCDS**); F07-F19-P30 orl-mus LD50: 369 mg/kg Trudy Khar'kovskogo Meditsinskogo Instituta. (Khar'kovskii Gosudarstvennyi Meditsinskii Institut, Kharkov, USSR) N.1- 1935- v. 124, p. 27, 1976 (TKGMB8); T/E unlistd ihl-mus LC50: 3400 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,114,1982 (85GMAT); F04-L02-L03 orl-dog LDLo: 200 mg/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 16, p. 325, 1932 (AJHYA2); F07-F19-P30 orl-rbt LD50: 380 mg/kg Trudy Khar'kovskogo Meditsinskogo Instituta. (Khar'kovskii Gosudarstvennyi Meditsinskii Institut, Kharkov, USSR) N.1- 1935- v. 124, p. 27, 1976 (TKGMB8); K12-J30-K30 skn-rbt LD50: 372 uL/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534994 (NTIS**); F07-F19-P30 orl-gpg LD50: 340 mg/kg Trudy Khar'kovskogo Meditsinskogo Instituta. (Khar'kovskii Gosudarstvennyi Meditsinskii Institut, Kharkov, USSR) N.1- 1935- v. 124, p. 27, 1976 (TKGMB8) MD: M70-P28-Y02 orl-rat TDLo: 2720 mg/kg/17W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-384, 1993 (NTPTR*); G30-L70-Y15 orl-rat TDLo: 1179 mg/kg/10D-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 11, p. 179, 1991 (JJATDK); L70-N73-Z71 ihl-rat TCLo: 297 ppm/6H/4W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 25, p. 299, 1988 (JTEHD6); A11-Y01 ihl-rat TCLo: 2 mg/m3/24H/94D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 42(8), p. 50, 1977 (GISAAA); D17-L70-U01 ihl-rat TCLo: 15 ppm/6H/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0542010 (NTIS**); J30-K30 orl-mus TDLo: 5355 mg/kg/17W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-384, 1993 (NTPTR*); P72-U01 ihl-mus TCLo: 3210 mg/m3/5H/23D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 398, 1990 (VCVGH*); A70-L70-U01 unr-rat TDLo: 3210 mg/m3/90D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 398, 1990 (VCVGH*) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 223, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 223, 1995 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 223, 1995 (IMEMDT) SR: MSHA STANDARD-air: TWA 50 ppm (300 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 266, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 50 ppm (300 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 50 ppm (300 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 50 ppm (300 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 50 ppm (300 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 ppm (60 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 50 ppm (300 mg/m3), JAN 1999; OEL-BELGIUM: TWA 10 ppm (60 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 10 ppm (60 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 50 ppm (300 mg/m3), STEL 75 ppm (450 mg/m3), JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 10 ppm (60 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 10 ppm (60 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 50 ppm (300 mg/m3), JAN 1993; OEL-RUSSIA: STEL 2 mg/m3, JAN 1993; OEL-SWITZERLAND: Carcinogen, JAN 1999; OEL-UNITED KINGDOM: TWA 50 ppm (306 mg/m3), STEL 75 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 1,2,3-TRICHLOROPROPANE-air: 10H CA TWA 10 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 73960; NIS 4; TNF 108; NOS 5; TNE 490; NOES 1983: HZD 73960; NIS 1; TNF 3; NOS 7; TNE 492; TFE 10 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110872/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9216; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 992 of 1119 in RTECS (through 2003/06) AN: UA8942000 PN: 2-Propanol,-1-chloro- SY: 1-Chloro-2-hydroxypropane-; 1-Chloro-2-propanol-; 1-Chloro-2-propanol,-technical-grade-; 1-Chloroisopropyl-alcohol-; alpha-Propylene-chlorohydrin-; sec-Propylene-chlorohydrin- RN: Current: 127-00-4 BRN: 773653 BHR: 4-01-00-01490 UD: 200302 MF: C3-H7-Cl-O MW: 94.55 WL: QY1&1G CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 1100 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 381, 1978 (MUREAV); mmo-sat 333 ug/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9(Suppl 9), p. 1, 1987 (ENMUDM); slt-dmg-par 1 ppb Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 51, 1994 (EMMUEG) RE: T16 orl-rat TDLo: 1400 mg/kg (14D pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91158469 (NTIS**); T81 orl-rat TDLo: 910 mg/kg (14D pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91158469 (NTIS**) IHPB: 1000000 ppb/4H. [1000.000000 ppm/4H] T/E unlistd AT: T/E unlistd ihl-rat LC50: 1000 ppm/4H "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,517,1986 (85JCAE); T/E unlistd orl-dog LDLo: 200 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-477, 1998 (NTPTR*); F01 orl-gpg LD50: 720 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-477, 1998 (NTPTR*) MD: K02-P26-P27 orl-rat TDLo: 3640 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-477, 1998 (NTPTR*); K02 orl-rat TDLo: 9800 mg/kg/14W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-477, 1998 (NTPTR*); F07-J15-Z01 ihl-rat TCLo: 1000 ppm/6H/3D-I British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 27, p. 5, 1970 (BJIMAG); L30-L70 orl-mus TDLo: 2450 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-477, 1998 (NTPTR*); K02 orl-mus TDLo: 686 mg/kg/14W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-477, 1998 (NTPTR*); F16-U01 orl-rat TDLo: 910 mg/kg/14D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91158469 (NTIS**) SL: EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (drinking water), no evidence: mice, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-477, 1998 (NTPTR*); NCI Carcinogenesis Studies (water), no evidence: mouse, rat Record 993 of 1119 in RTECS (through 2003/06) AN: UB0175000 PN: 1-Propanol,-2,3-dibromo- SY: 2,3-Dibromo-1-propanol-; 2,3-Dibromopropan-1-ol-; 2,3-Dibromopropanol-; 2,3-Dibromopropyl-alcohol-; Brominex-257-; DBP- (flame retardant); NCI-C55436-; USAF-DO-42- RN: Current: 96-13-9 BRN: 1719127 BHR: 4-01-00-01446 UD: 200302 MF: C3-H6-Br2-O MW: 217.91 WL: Q1YE1E CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: eye-rbt 100 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528368 (NTIS**) ME: mmo-sat 203 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 381, 1978 (MUREAV); mmo-sat 3300 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-esc 313 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 412, p. 17, 1998 (MUREAV); sln-dmg-orl 500 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); trn-dmg-orl 500 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 349, 1985 (ENMUDM); dnd-rat-oth 1 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 705, 1985 (CRNGDP); dns-rat-lvr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 213, 1983 (MUREAV); mtr-ham-emb 500 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 705, 1985 (CRNGDP); msc-ham-lng 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 213, 1983 (MUREAV) TE: V01-K60-R60 skn-rat TDLo: 47940 mg/kg/51W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-400, 1993 (NTPTR*); V01-K60-L60 skn-mus TDLo: 37170 mg/kg/42W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-400, 1993 (NTPTR*); V01-K60-R60 skn-rat TDLo: 45120 mg/kg/48W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-206687 (NTIS**); V01-K60-R60 skn-rat TDLo: 48880 mg/kg/52W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-206687 (NTIS**); V01-K60 skn-mus TDLo: 15840 mg/kg/36W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-206687 (NTIS**); V01-L60-R60 skn-mus TDLo: 31860 mg/kg/36W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-206687 (NTIS**); V01-R60 skn-mus TDLo: 34515 mg/kg/39W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-206687 (NTIS**) ORNG: 681000000 ng/kg. [681.000000 mg/kg] T/E unlistd SRNG: 316000000 ng/kg. [316.000000 mg/kg] T/E unlistd IHNG: 9920000000 ng/m3/4H. [9920.000000 mg/m3/4H] D07-F07-J22 AT: T/E unlistd orl-rat LD50: 681 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528372 (NTIS**); D07-F07-J22 ihl-rat LC50: 9920 mg/m3/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528374 (NTIS**); T/E unlistd ipr-mus LD50: 125 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd skn-rbt LD50: 316 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528372 (NTIS**) MD: F07-L70-Z01 ihl-rat TCLo: 500 mg/m3/4H/3W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528371 (NTIS**); M03 skn-rat TDLo: 11505 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-400, 1993 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (derm), clear evidence: mouse, rat Record 994 of 1119 in RTECS (through 2003/06) AN: UB0350000 PN: 1-Propanol,-2,3-dibromo-,-phosphate- (3:1) SY: (2,3-Dibromopropyl) phosphate; 2,3-Dibromo-1-propanol-phosphate-; APEX-462-5-; Anfram-3PB-; Bromkal-P-67-6HP-; ES685-; Firemaster-LV-T-23P-; Firemaster-T23P-; Firemaster-T23P-LV-; Flacavon-R-; Flamex-T-23P-; Flammex-AP-; Flammex-LV-T-23P-; Flammex-T-23P-; Fyrol-HB32-; NCI-C03270-; Phosphoric acid, tris(2,3-dibromopropyl) ester; RCRA-waste-number-U235-; T-23P-; TDBP-; TDBP- (Czech); TDBPP-; Tris- (flame retardant); Tris(2,3-dibromopropyl) phosphate; Tris(2,3-dibromopropyl) phosphoric acid ester; Tris(2,3-dibromopropyl)phosphate; Tris(dibromopropyl)phosphate; Tris-(2,3-dibrompropyl)fosfat (Czech); Tris-2,3-dibrompropyl-ester-kyseliny-fosforecne- (Czech); Tris-BP-; USAF-DO-41-; Zetifex-ZN- RN: Current: 126-72-7 BRN: 1915153 UD: 200210 MF: C9-H15-Br6-O4-P MW: 697.67 WL: E1YE1OPO&O1YE1EO1YE1E CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1137,1986 (85JCAE); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1137,1986 (85JCAE) ME: mmo-sat 2270 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 381, 1978 (MUREAV); mmo-sat 110 nmol/plate (-S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 2, p. 287, 1987 (MUTAEX); mmo-esc 100 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 5), p. 1, 1985 (ENMUDM); dnr-esc 10 ug/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 107, 1980 (MUREAV); slt-dmg-orl 250 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 1197, 1994 (CRNGDP); sln-dmg-unr 1000 ppm Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(1-2), p. 207, 1979 (JEPTDQ); sln-dmg-orl 500 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 144, 1979 (ENMUDM); trn-dmg-orl 1000 ppm/2D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 385, 1978 (MUREAV); dnd-hmn-oth 2 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 89, 1977 (MUREAV); sce-hmn-emb 69700 ug/L Senshokutai. Chromosome. (Sensyokutai Gakkai, Kaokusai Kirisutokyo Daigaku, Mitaka, Tokyo-to, Japan) No.1- 1946- Adopted new numbering in 1976. v. (20), p. 574, 1980 (SNSHBT); mnt-rat-ipr 250 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 1197, 1994 (CRNGDP); mtr-rat-emb 1270 ng/plate JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 190, 1981 (JJATDK); dnd-rat-ipr 2500 nmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 82, p. 195, 1992 (CBINA8); dnd-rat-lvr 10 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 82, p. 195, 1992 (CBINA8); dns-rat-lvr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 213, 1983 (MUREAV); bfa-rat-sat 500 mg/kg Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 17, p. 101, 1980 (CTOXAO); mnt-mus-ipr 1020 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 66, p. 691, 1981 (JJIND8); mmo-mus-lym 25 mg/L (+S9) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(1-2), p. 207, 1979 (JEPTDQ); mtr-mus-lym 2500 ug/L Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(1-2), p. 207, 1979 (JEPTDQ); bfa-mus-sat 50 mg/kg Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(1-2), p. 207, 1979 (JEPTDQ); cyt-mus-ivn 1500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 60, p. 329, 1979 (MUREAV); cyt-mus-lym 10 mg/L Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(1-2), p. 207, 1979 (JEPTDQ); sce-mus-ivn 1500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 60, p. 329, 1979 (MUREAV); sce-mus-lym 5 mg/L Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(1-2), p. 207, 1979 (JEPTDQ); sce-mus-lng 125 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 60, p. 1179, 1978 (JNCIAM); msc-mus-orl 1200 mg/kg/4D-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 28, p. 342, 1996 (EMMUEG); msc-mus-lym 5 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 160, 1978 (MUREAV); spm-mus-ipr 4085 mg/kg/5D-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 66, p. 691, 1981 (JJIND8); mnt-ham-ipr 400 mg/kg European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 18, p. 1337, 1982 (EJCODS); mmo-ham-lng 20 umol/L (+S9) Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 56, p. 20, 1985 (APTOA6); mtr-ham-emb 25 mg/L European Journal of Cancer and Clinical Oncology. (Pergamon Press, c/o Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.17(7)- 25, 1981-89. For publisher information, see EJCAEL v. 18, p. 1337, 1982 (EJCODS); cyt-ham-lng 100 mg/L Applied Methods in Oncology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1978- v. 3, p. 253, 1980 (AMONDS); sce-ham-lng 5 mg/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 60, p. 1179, 1978 (JNCIAM); msc-ham-lng 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 124, p. 213, 1983 (MUREAV); sce-ckn-par 424 ug/kg "Cytogenetic Assays of Environmental Mutagens," Hsu, T.C., ed., Totowa, NJ, Allanheld, Osmun and Co., 1982 -,137,1982 (47JMAE); slt-rat-orl 12.5 gm/kg/45D-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 1, 2000 (EMMUEG) RE: T13 orl-rat TDLo: 1800 mg/kg (7-15D preg) Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (98), p. 50, 1980 (ESKHA5); T46 orl-rat TDLo: 250 mg/kg (6-15D preg) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 67, 1981 (FCTXAV); T75 orl-rat TDLo: 450 mg/kg (7-15D preg) Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 4, p. 296, 1979 (JTSCDR); T46 orl-rat TDLo: 1800 mg/kg (7-15D preg) Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 8, p. 339, 1983 (JTSCDR); T01-T02 ipr-rat TDLo: 8510 mg/kg (72D male) Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(2), p. 153, 1986 (JACTDZ); T03 ipr-rat TDLo: 4260 mg/kg (72D male) Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(2), p. 153, 1986 (JACTDZ) TE: V01-M61 orl-rat TDLo: 1330 mg/kg/76W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-76, 1978 (NCITR*); V01-J60-L60 orl-mus TDLo: 39 gm/kg/92W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-76, 1978 (NCITR*); V01-J60-K60 skn-mus TDLo: 85 gm/kg/71W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 3236, 1978 (CNREA8); V01-J60-L60 orl-mus TD :87 gm/kg/103W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-76, 1978 (NCITR*); V02-M61 orl-rat TD :3600 mg/kg/103W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-76, 1978 (NCITR*); V02-M61 orl-rat TD :1800 mg/kg/103W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-76, 1978 (NCITR*); V01-J60-L60 orl-mus TD :43 gm/kg/103W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-76, 1978 (NCITR*); V03-M60 orl-rat TD :1820 mg/kg/2Y-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 743, 1980 (FCTXAV); V03-M60 orl-rat TD :43680 mg/kg/2Y-C Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 18, p. 743, 1980 (FCTXAV); V02-K61-U01 orl-rat TD :26 gm/kg/52W-I Laboratory Investigation. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1952- v. 44, p. 74, 1981 (LAINAW) ORNG: 810000000 ng/kg. [810.000000 mg/kg] F07-L30 AT: F07-L30 orl-rat LD50: 810 mg/kg Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. (Tohoku University, Research Institute for Tuberculosis and Cancer, 4-1 Seiryo-machi, Sendai, Japan) V.1- 1949- v. 36(1-4), p. 10, 1989 (SRTCAC); F13 orl-mus LD50: 6800 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 29(12), p. 53, 1985 (GTPZAB); T/E unlistd ipr-mus LD50: 300 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd unr-mus LD50: 1149 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 66, p. 691, 1981 (JJIND8); T/E unlistd skn-rbt LD50: >8 gm/kg JFF/Fire Retardant Chemistry. (Technomic Pub. Co., Inc., 265 W. State St., Westport, CN 06880) V.1- 1974- v. 1, p. 205, 1974 (FRCHD6) MD: M03-M16 orl-rat TDLo: 1400 mg/kg/7D-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 7, p. 23, 1987 (JJATDK); L70-Z73 skn-rbt TDLo: 29510 mg/kg/13W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 979, 1977 (JTEHD6) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 20, p. 575, 1979 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 905, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 369, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 905, 1999 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 905, 1999 (IMEMDT); TOXICOLOGY REVIEW Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 13, p. 74, 1977 (ENVRAL); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 17, p. 101, 1980 (CTOXAO) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999 ND: NOHS 1974: HZD M1916; NIS 2; TNF 18; NOS 7; TNE 206 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse, D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman, In vivo SCE-nonhuman; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-76, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 995 of 1119 in RTECS (through 2003/06) AN: UB3772000 PN: Propanol, (1,1-dimethylethoxy)- SY: tert-Butoxypropanol-; Propanol,-tert-butoxy- (8CI); Propylene-glycol-t-butyl-ether- RN: Current: 57018-52-7 BRN: 1734501 BHR: 3-01-00-02148 UD: 200012 MF: C7-H16-O2 MW: 132.23 CC: Tumorigen (C) ND: NOES 1983: HZD X2424; NIS 13; TNF 874; NOS 18; TNE 20356; TFE 2551 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 996 of 1119 in RTECS (through 2003/06) AN: UB4375000 PN: 1-Propanol,-2,3-epoxy- SY: 2,3-Epoxy-1-propanol- (ACGIH:OSHA); 2,3-Epoxypropanol-; 3-Hydroxy-1,2-epoxypropane-; Epihydrin-alcohol-; Glycide-; Glycidol-; Glycidol- (ACGIH:OSHA); Glycidyl-alcohol-; Methanol,-oxiranyl-; NCI-C55549- RN: Current: 556-52-5 BRN: 383562 BHR: 5-17-03-00009 UD: 200302 MF: C3-H6-O2 MW: 74.09 WL: T3OTJ B1Q CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 558 mg/3D MOD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); skn-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,769,1986 (85JCAE); eye-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,769,1986 (85JCAE) ME: mmo-sat 3 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 105, 1986 (MUREAV); mmo-esc 500 umol/L (-S9) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 4, p. 103, 1979 (TOLED5); oms-esc 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 231, p. 205, 1990 (MUREAV); dnr-esc 10 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 141, 1984 (MUREAV); mmo-klp 200 umol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 269, 1981 (MUREAV); sln-dmg-orl 3690 ppm National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); trn-dmg-orl 1230 ppm National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); mmo-nsc 500 mmol/L (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 40, p. 890, 1955 (GENTAE); mrc-smc 2500 ppm JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 901, 1979 (JJIND8); cyt-hmn-lym 400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 243, 1981 (MUREAV); sce-hmn-lym 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 243, 1981 (MUREAV); cyt-rat-ipr 320 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 665, 1984 (FCTOD7); cyt-rat-orl 600 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 665, 1984 (FCTOD7); msc-mus-lym 1250 ug/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); mtr-ham-emb 10 ug/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); cyt-ham-ovr 12500 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); sce-ham-ovr 10100 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); sce-ham-lng 1250 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 249, p. 55, 1991 (MUREAV); msc-ham-lng 1 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 11, p. 497, 1990 (CRNGDP); mtr-mus-fbr 0.001 pph/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T23 orl-rat TDLo: 180 mg/kg (12D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 226, p. 87, 1970 (NATUAS); T01-T02 orl-rat TDLo: 18200 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); T23 ipr-rat TDLo: 500 mg/kg (5D male) Biochemical Society Transactions. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1973- v. 1, p. 523, 1973 (BCSTB5); T34 orl-mus TDLo: 2 gm/kg (6-15D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 87, 1982 (JTEHD6); T01 orl-mus TDLo: 6825 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*) TE: V01-K60-R60 orl-rat TDLo: 38625 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); V01-K60-R60 orl-mus TDLo: 25750 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); V01-A60-R60 orl-rat TDLo: 19312.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-259094 (NTIS**); V01-K60-R60 orl-rat TDLo: 19312.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-259094 (NTIS**); V01-K60-L60 orl-mus TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-259094 (NTIS**); V01-N60-R60 orl-mus TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-259094 (NTIS**) ORNG: 420000000 ng/kg. [420.000000 mg/kg] T/E unlistd SRNG: 1980000000 ng/kg. [1980.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 420 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 347, 1981 (FCTXAV); J06-J30 ihl-rat LC50: 580 ppm/8H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); T/E unlistd ipr-rat LD50: 200 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 19, p. 347, 1981 (FCTXAV); T/E unlistd orl-mus LD50: 431 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 42, 1980 (GTPZAB); J06-J30 ihl-mus LC50: 450 ppm/4H AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB); T/E unlistd ipr-mus LD50: 500 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 35, p. 98, 1936 (PSEBAA); T/E unlistd skn-rbt LD50: 1980 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 250, 1956 (AMIHAB) MD: Z01 orl-rat TDLo: 9600 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); A30-M03-N30 orl-rat TDLo: 36400 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); A11-J26-U30 ihl-rat TCLo: 125 mg/m3/4H/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 42, 1980 (GTPZAB); Z01 orl-mus TDLo: 9600 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); A06-M03-Z01 orl-mus TDLo: 27300 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-374, 1990 (NTPTR*); A11 ihl-gpg TCLo: 125 mg/m3/4H/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(3), p. 42, 1980 (GTPZAB) TR: ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT) SR: MSHA STANDARD-air: TWA 50 ppm (150 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 121, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 50 ppm (150 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 50 ppm (150 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 50 ppm (150 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 50 ppm (150 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 25 ppm (75 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 50 ppm (150 mg/m3), JAN 1999; OEL-BELGIUM: TWA 25 ppm (76 mg/m3), JAN 1993; OEL-DENMARK: TWA 0.2 ppm (1 mg/m3), JAN 1999; OEL-FINLAND: TWA 50 ppm (150 mg/m3), STEL 75 ppm (225 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 25 ppm (75 mg/m3), JAN 1999; OEL-GERMANY: MAK 50 ppm (150 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 10 ppm (60 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 25 ppm (75 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 50 ppm (150 mg/m3), JAN 1993; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWEDEN: NGV 25 ppm (75 mg/m3), KTV 50 ppm (150 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 25 ppm (75 mg/m3), KZG-W 50 ppm (150 mg/m3), JAN 1999; OEL-TURKEY: TWA 50 ppm (150 mg/m3), JAN 1993; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO GLYCIDOL-air: 10H TWA 25 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD 35120; NIS 3; TNF 88; NOS 10; TNE 4872; TFE 580 SL: EPA GENETOX PROGRAM 1988, Positive: N crassa-reversion, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S pombe-reversion; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Inconclusive: SHE-clonal assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Glycidol, 1608; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 997 of 1119 in RTECS (through 2003/06) AN: UB8765000 PN: Propanol,-oxybis- SY: Dipropylene-glycol- (6CI); Oxybispropanol- RN: Current: 25265-71-8 UD: 200305 MF: C6-H14-O3 MW: 134.20 CC: Tumorigen (C); Reproductive-Effector (T) RE: T19 orl-rat TDLo: 50 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-196179 (NTIS**) ORNG: 14850000000 ng/kg. [14850.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 14850 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,731,1969 (34ZIAG); T/E unlistd skn-rbt LD50: >20 mL/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,731,1969 (34ZIAG); T/E unlistd orl-mam LD50: 15 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(4), p. 86, 1974 (GISAAA) MD: L70-Z01 orl-rat TDLo: 20000 mg/kg/10D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-196179 (NTIS**); F16-U01 orl-rat TDLo: 20000 mg/kg/4D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-196179 (NTIS**); F15 orl-rat TDLo: 8000 mg/kg/4D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-196179 (NTIS**) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 81390; NIS 141; TNF 16331; NOS 94; TNE 162532; NOES 1983: HZD 81390; NIS 162; TNF 22758; NOS 137; TNE 366813; TFE 131449 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 998 of 1119 in RTECS (through 2003/06) AN: UC6740000 PN: Propene- SY: Methylethene-; Methylethylene-; NCI-C50077-; Propylene-; 1-Propylene-; Propylene- (ACGIH); R-1270-; 1-Propene- (9CI) RN: Current: 115-07-1 Previous: 676-63-1; 33004-01-2 UD: 200210 MF: C3-H6 MW: 42.09 WL: 2U1 CC: Tumorigen (C) TE: V02-D09 ihl-rat TCLo: 154500 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-145521/AS (NTIS**); V02-D09 ihl-rat TCLo: 128750 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-145521/AS (NTIS**); V03-T64 ihl-mus TCLo: 865200 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-145521/AS (NTIS**) AT: T/E unlistd ihl-rat LC :>86 gm/m3/4H IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 161, 1994 (IMEMDT) MD: D07 ihl-rat TCLo: 5000 ppm/6H/2Y-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 76, p. 288, 1984 (TXAPA9); Z01 ihl-mus TCLo: 1250 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-272, 1985 (NTPTR*); J61-V30 ihl-mus TCLo: 309000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-145521/AS (NTIS**) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Simple asphyxiant The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 213, 1979 (IMEMDT); IARC Cancer Review: Animal No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 19, p. 213, 1979 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 161, 1994 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 161, 1994 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 161, 1994 (IMEMDT) SR: OEL-AUSTRALIA: Asphyxiant, JAN 1993; OEL-BELGIUM: Asphyxiant, JAN 1993; OEL-HUNGARY: Asphyxiant, JAN 1993; OEL-THE NETHERLANDS: Asphyxiant, JAN 1999; OEL-RUSSIA: STEL 100 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 10000 ppm (17500 mg/m3), JAN 1999; OEL-UNITED KINGDOM: Asphyxiant, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 63495; NIS 16; TNF 493; NOS 32; TNE 7150; NOES 1983: HZD 63495; NIS 7; TNF 162; NOS 25; TNE 7305; TFE 975 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (inhal), no evidence: mouse, rat Record 999 of 1119 in RTECS (through 2003/06) AN: UC7090000 PN: Propene,-3-bromo- SY: Bromallylene-; 1-Bromo-2-propene-; 3-Bromopropene-; 3-Bromopropylene- RN: Current: 106-95-6 BRN: 605308 BHR: 4-01-00-00754 UD: 200012 MF: C3-H5-Br MW: 120.99 WL: E2U1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 1 umol/plate (+S9) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 29, p. 993, 1980 (BCPCA6); dns-hmn-hla 500 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 20, p. 263, 1983 (CALEDQ) ORNG: 120000000 ng/kg. [120.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 120 mg/kg JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 9, p. 235, 1989 (JJATDK); T/E unlistd ihl-rat LC50: 10 gm/m3/30M Fiziologicheski Aktivnye Veshchestva. Physiologically Active Substances. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1966- v. 7, p. 35, 1975 (FAVUAI); T/E unlistd ipr-mus LD50: 48 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 20(12), p. 52, 1976 (GTPZAB); T/E unlistd ihl-mam LC50: 4110 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 18(4), p. 55, 1974 (GTPZAB) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 1000 of 1119 in RTECS (through 2003/06) AN: UC8045000 PN: Propene,-1-chloro-2-methyl- SY: 1-Chloro-2-methyl-1-propene-; 1-Chloro-2-methylpropene-; 1-Chloro-2-methylpropene- (IUPAC); 1-Chloroisobutylene-; 1-Propene,-1-chloro-2-methyl-; 2,2-Dimethylvinyl-chloride-; 2-Methyl-1-propenyl-chloride-; Dimethylvinyl-chloride-; Dimethylvinylchloride-; Isocrotyl-chloride-; NCI-C54819-; alpha-Chloroisobutylene-; beta,-beta-Dimethylvinyl-chloride- RN: Current: 513-37-1 BRN: 1733843 BHR: 4-01-00-00803 UD: 200210 MF: C4-H7-Cl MW: 90.56 WL: G1UY1&1 CC: Tumorigen (C); Mutagen (M) ME: slt-dmg-orl 12800 ppm Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 51, 1994 (EMMUEG); sln-dmg-orl 12750 ppm/3D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); trn-dmg-orl 12750 ppm/3D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); msc-mus-lym 400 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); sce-ham-ovr 500 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) TE: V01-D09 orl-rat TDLo: 51500 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); V01-K60 orl-mus TDLo: 51 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); V02-R60 orl-mus TD :102 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); V01-D09-K60 orl-rat TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-115184 (NTIS**); V01-K60-T69 orl-mus TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-115184 (NTIS**) ORNG: 4465000000 ng/kg. [4465.000000 mg/kg] D35-F18-J22 IHNG: 400000000 ng/m3/4H. [400.000000 mg/m3/4H] T/E unlistd AT: D35-F18-J22 orl-rat LD50: 4465 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); T/E unlistd ihl-rat LC50: 400 mg/m3/4H "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,112,1986 (85JCAE); F07-J22-K12 orl-mus LD50: 3160 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); F01-J25-J30 ihl-mus LC50: 181 gm/m3 University of California, Berkeley, Publications in Pharmacology. (Berkeley, CA) V.1-3, 1938-57. Discontinued. v. 2, p. 39, 1941 (UCPHAQ) MD: F18-Q30-Z01 orl-rat TDLo: 17500 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); F07-K20-Z01 orl-rat TDLo: 48750 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); J22-K12-Z01 orl-mus TDLo: 14 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*); P27-Z01 orl-mus TDLo: 48750 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-316, 1986 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 315, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 315, 1995 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 315, 1995 (IMEMDT) SR: OEL-RUSSIA: STEL 0.3 mg/m3, Skin, JAN 1993 SL: EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1001 of 1119 in RTECS (through 2003/06) AN: UC8050000 PN: Propene,-3-chloro-2-methyl- SY: 1-Chloro-2-methyl-2-propene-; 2-Methallyl-chloride-; 2-Methyl-2-propenyl-chloride-; 2-Methyl-allylchlorid- (German); 2-Methylallyl-chloride-; 3-Chlor-2-methyl-prop-1-en- (German); 3-Chloro-2-methyl-1-propene-; 3-Chloro-2-methylpropene-; 3-Chloro-2-methylpropene- (IUPAC); 3-Chloroisobutylene-; 3-Cloro-2-metil-prop-1-ene- (Italian); Chlorure-de-methallyle- (French); Cloruro-di-metallile- (Italian); Isobutenyl-chloride-; Methallyl-chloride-; Methyl-allyl-chloride-; NCI-C54820-; beta-Methallyl-chloride-; beta-Methylallyl-chloride-; gamma-Chloroisobutylene- RN: Current: 563-47-3 BRN: 878160 BHR: 4-01-00-00803 UD: 200210 MF: C4-H7-Cl MW: 90.56 WL: G1Y1&U1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P) ME: mmo-sat 6 umol/plate (+/-S9) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 29, p. 2611, 1980 (BCPCA6); sln-dmg-orl 4500 ppm Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 23, p. 208, 1994 (EMMUEG); dns-hmn-hla 1 mmol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 20, p. 263, 1983 (CALEDQ); msc-mus-lym 23200 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 200 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*); sce-ham-ovr 16 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 133, 1989 (EMMUEG) TE: V01-N61 orl-rat TDLo: 77250 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*); V03-K60 orl-rat TDLo: 38625 mg/kg/2Y-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 26, p. 95, 1985 (PAACA3); V01-K60 orl-mus TDLo: 51500 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*); V03-K60 orl-mus TDLo: 51500 mg/kg/2Y-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 26, p. 95, 1985 (PAACA3); V02-D29 ihl-mus TCLo: 100 ppm/6H/2Y-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 38, p. 309, 2000 (INHEAO); V02-K60-T61 orl-rat TD :77250 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*); V01-K60 orl-rat TDLo: 38625 mg/kg/2Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-247293/AS (NTIS**); V01-K60 orl-mus TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB86-247293/AS (NTIS**) ORNG: 848000000 ng/kg. [848.000000 mg/kg] F11-K12-P01 AT: T/E unlistd ihl-hmn LCLo: 22000 ppm/10M "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,377,1969 (34ZIAG); F11-K12-P01 orl-rat LD50: 848 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0539687 (NTIS**); T/E unlistd ihl-rat LC50: 34 gm/m3/30M Fiziologicheski Aktivnye Veshchestva. Physiologically Active Substances. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1966- v. 7, p. 35, 1975 (FAVUAI); K30-L30-P27 orl-mus LDLo: 3160 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*) MD: Z01 orl-rat TDLo: 7 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*); Z01 orl-rat TDLo: 19500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*); Z01 ihl-rat TCLo: 16 gm/m3/1H/5W-I Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901- v. 46, p. 217, 1948 (JOHYAY); Z01 orl-mus TDLo: 10500 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*); L30-M03-Z01 orl-mus TDLo: 81250 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-300, 1986 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 325, 1995 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 325, 1995 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 63, p. 325, 1995 (IMEMDT) SR: OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-RUSSIA: STEL 0.3 mg/m3, Skin, JAN 1993 ND: NOHS 1974: HZD 83971; NIS 1; TNF 33; NOS 2; TNE 1683 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1002 of 1119 in RTECS (through 2003/06) AN: UC8310000 PN: Propene,-1,3-dichloro- SY: alpha-Chloroallyl-chloride-; gamma-Chloroallyl-chloride-; 3-Chloroallyl-chloride-; 3-Chloropropenyl-chloride-; D-D-92-; DD-95-; 1,3-Dichloropropene-; 1,3-Dichloropropene-1-; 1,3-Dichloro-2-propene-; 1,3-Dichloropropene- (ACGIH); alpha,gamma-Dichloropropylene-; 1,3-Dichloropropylene-; Dorlone-II-; NCI-C03985-; RCRA-waste-number-U084-; Telone-; Telone-II-; Telone-II-soil-fumigant- RN: Current: 542-75-6 Previous: 8022-76-2 BRN: 1719556 BHR: 3-01-00-00704 UD: 200302 MF: C3-H4-Cl2 MW: 110.97 WL: G2U1G CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Human-Data (P) ME: mmo-sat 33 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-sat 10 umol/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 59, 1980 (ENMUDM); oms-esc 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 81, 1988 (MUREAV); sln-dmg-orl 5750 ppm Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 325, 1985 (ENMUDM); dnd-mus-ipr 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 13, 1998 (MUREAV); msc-mus-lym 3 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 49100 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 60, 1989 (EMMUEG); sce-ham-ovr 900 nmol/L Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 22, p. 681, 1980 (CNJGA8) TE: V01-K60-L60 orl-rat TDLo: 15600 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-269, 1985 (NTPTR*); V01-K60-M60 orl-mus TDLo: 31200 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-269, 1985 (NTPTR*); V02-J60 ihl-mus TCLo: 60 ppm/6H/5D/2Y Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 12, p. 418, 1989 (FAATDF); V01-K60 orl-rat TDLo: 15600 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-230449/AS (NTIS**); V02-L60 orl-rat TDLo: 7800 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-230449/AS (NTIS**); V02-J60-K60 orl-rat TDLo: 7800 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-230449/AS (NTIS**); V03-J60-K60 orl-mus TDLo: 15600 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-230449/AS (NTIS**); V01-K60 orl-mus TDLo: 31200 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-230449/AS (NTIS**); V01-M60 orl-mus TDLo: 15600 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-230449/AS (NTIS**) ORNG: 470000000 ng/kg. [470.000000 mg/kg] T/E unlistd SRNG: 504000000 ng/kg. [504.000000 mg/kg] T/E unlistd SKNG: 775000000 ng/kg. [775.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 470 mg/kg Dow Chemical Company Reports. (Dow Chemical USA, Health and Environment Research, Toxicology Research Lab., Midland, MI 48640) MSD-405 (DOWCC*); D17 ihl-rat LCLo: 1000 ppm/2H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 38, p. 217, 1977 (AIHAAP); T/E unlistd skn-rat LD50: 775 mg/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C103, 1991 (FMCHA2); T/E unlistd ipr-rat LD50: 175 mg/kg Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 5, p. 2, 1985 (TOXID9); T/E unlistd orl-mus LD50: 640 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 562, 1987 (FAATDF); T/E unlistd ihl-mus LC50: 4650 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,48,1982 (85GMAT); T/E unlistd skn-rbt LD50: 504 mg/kg Dow Chemical Company Reports. (Dow Chemical USA, Health and Environment Research, Toxicology Research Lab., Midland, MI 48640) MSD-405 (DOWCC*); T/E unlistd ihl-gpg LCLo: 400 ppm/7H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 38, p. 217, 1977 (AIHAAP) MD: K02-Y04 orl-rat TDLo: 455 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(1), p. 94, 1974 (GISAAA); K04-P28-U01 orl-rat TDLo: 1365 mg/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 224, 1996 (FAATDF); J30-M70-U01 ihl-rat TCLo: 90 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 207, 1988 (FAATDF); G70-L70-U01 orl-mus TDLo: 1365 mg/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 224, 1996 (FAATDF); J30-L70-U01 ihl-mus TCLo: 90 ppm/6H/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 11, p. 207, 1988 (FAATDF); P06-P71-U01 orl-dog TDLo: 3731 mg/kg/13W-C Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 30, p. 233, 1999 (RTOPDW); P06-P26-U01 orl-dog TDLo: 5460 mg/kg/1Y-C Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 30, p. 233, 1999 (RTOPDW) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 113, 1986 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 933, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 41, p. 113, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 933, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 933, 1999 (IMEMDT) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-AUSTRALIA: TWA 1 ppm (5 mg/m3), Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 1 ppm (4.5 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 1 ppm (5 mg/m3), Skin, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-NORWAY: TWA 1 ppm (5 mg/m3), JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWITZERLAND: 1 ppm (5 mg/m3), Skin, Carcinogen, JAN 1999; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO 1,3-DICHLOROPROPENE-air: 8H CA TWA 1 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #95-121, 1995 (NIOSH*); NOES 1983: HZD X3912; NIS 3; TNF 48; NOS 14; TNE 2162; TFE 33 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110765/AS); EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1003 of 1119 in RTECS (through 2003/06) AN: UD1400000 PN: 2-Propenenitrile,-2-methyl- SY: 2-Cyanopropene-1-; Isopropene-cyanide-; Isopropenylnitrile-; Methacrylonitrile-; Methylacrylonitrile-; alpha-Methylacrylonitrile-; Methylacrylonitrile- (ACGIH); 2-Methylpropenenitrile-; RCRA-waste-number-U152-; USAF-ST-40- RN: Current: 126-98-7 UD: 200305 MF: C4-H5-N MW: 67.10 WL: NCY1&U1 CC: Tumorigen (C); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 200 mg MLD Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 31, p. 113, 1949 (JIHTAB); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,901,1986 (85JCAE); eye-rbt 50 mg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 31, p. 113, 1949 (JIHTAB); eye-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,901,1986 (85JCAE) RE: T19-T26 orl-rat TDLo: 350 mg/kg (1-7D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 48, p. 696, 1992 (BECTA6); T34 ihl-rat TCLo: 100 ppm/6H (6-20D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 20, p. 365, 1993 (FAATDF); T39 orl-rat TDLo: 150 mg/kg (10D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 163, p. 149, 2000 (TXAPA9); T81 orl-rat TDLo: 20 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB97-176390 (NTIS**); T53-T85 orl-rat TDLo: 20 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB97-176390 (NTIS**) ORNG: 120000000 ng/kg. [120.000000 mg/kg] T/E unlistd SRNG: 12500000 ng/kg. [12.500000 mg/kg] T/E unlistd SKNG: 2080000000 ng/kg. [2080.000000 mg/kg] T/E unlistd IHPB: 328000 ppb/4H. [328.000000 ppm/4H] F12-J22 AT: T/E unlistd orl-rat LD50: 120 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 29(5), p. 37, 1985 (GTPZAB); F12-J22 ihl-rat LC50: 328 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 29, p. 202, 1968 (AIHAAP); T/E unlistd skn-rat LD50: 2080 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 29(5), p. 37, 1985 (GTPZAB); T/E unlistd orl-mus LD50: 17 mg/kg Juzen Igakkai Zasshi. Journal of Juzen Medical Society. (Kanazawa Daigaku Juzen Igakkai, 13-1 Takara-machi, Kanazawa 920, Japan) V.1- 1896- v. 94, p. 664, 1985 (JUZIAG); F12 ihl-mus LC50: 36 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 29, p. 202, 1968 (AIHAAP); T/E unlistd ipr-mus LDLo: 15 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 31, p. 113, 1949 (JIHTAB); F01-F12-K12 ihl-dog LCLo: 52 ppm/7H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 29, p. 202, 1968 (AIHAAP); T/E unlistd orl-rbt LD50: 16 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 29(5), p. 37, 1985 (GTPZAB); F12 ihl-rbt LC50: 37 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 29, p. 202, 1968 (AIHAAP); T/E unlistd skn-rbt LD50: 12500 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0534646 (NTIS**); F12 ihl-gpg LC50: 88 ppm/4H American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 29, p. 202, 1968 (AIHAAP) MD: U01 orl-rat TDLo: 5400 mg/kg/90D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-176390 (NTIS**); L30-Z01 ihl-rat TCLo: 109 ppm/7H/91D-I American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 29, p. 202, 1968 (AIHAAP); L70 ims-rat TDLo: 2940 mg/kg/21W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB97-176390 (NTIS**); T02 ims-rat TDLo: 294 mg/kg/21W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB97-176390 (NTIS**) TR: ACGIH TLV-TWA 1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: MSHA STANDARD-air: TWA 1 ppm (3 mg/m3) (skin) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 22, 1973 (DTLWS*); OEL-AUSTRALIA: TWA 1 ppm (3 mg/m3), Skin, JAN 1993; OEL-BELGIUM: TWA 1 ppm (2.7 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 1 ppm (3 mg/m3), STEL 3 ppm (9 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (3 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 1 ppm (3 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 1 ppm (3 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: LTEL 1 ppm (3 mg/m3), Skin, JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO METHYLACRYLONITRILE-air: 10H TWA 1 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X5279; NIS 3; TNF 58; NOS 2; TNE 213 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat; NTP Toxicity studies, RPT# TOX-47, October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1004 of 1119 in RTECS (through 2003/06) AN: UD3370000 PN: 2-Propenoic acid, 2-(hydroxymethyl)-2-(((1-oxo-2-propenyl)oxy)methyl)-1,3-propanediyl ester SY: NK-Ester-A-TMM-3-; NK-Ester-A-TMM-3L-; NK-Ester-TMM-50T-; Acrylic-acid,-triester-with-pentaerythritol-; Aronix-M-305-; Gafgard-233-; Kayarad-PET-30-; Light-Acrylate-PE-3A-; P-300- (acrylate); Pentaerythritol-triacrylate-; PETA-; Sartomer-SR-444-; Setalux-UV-2242-; SR-444-; SR-444C-; Tetramethylolmethane-triacrylate- RN: Current: 3524-68-3 UD: 200302 MF: C14-H18-O7 MW: 298.32 WL: 1U1VO1X1Q1OV1U1&1OV1U1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 3/28/1972 (UCDS**); skn-rbt 500 mg MOD Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 19, p. 149, 1986 (JTEHD6); eye-rbt 1 mg SEV Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 3/28/1972 (UCDS**); eye-rbt 100 uL/24H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555713 (NTIS**) ME: mnt-mus-lym 350 ug/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 381, 1989 (MUTAEX); cyt-mus-lym 300 ug/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 381, 1989 (MUTAEX) RE: T19-T25-T35 orl-rat TDLo: 500 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571348 (NTIS**) TE: V03-P62 skn-mus TDLo: 16 gm/kg/80W-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 19, p. 149, 1986 (JTEHD6) ORNG: 1830000000 ng/kg. [1830.000000 mg/kg] K08-K09-K30 SRNL: 4000000 nL/kg. [4.000000 mL/kg] T/E unlistd AT: K08-K09-K30 orl-rat LD50: 1830 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555713 (NTIS**); F19-K30-R21 ipr-rat LD50: 25 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555706 (NTIS**); T/E unlistd skn-rbt LD50: 4 mL/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 313, 1974 (TXAPA9) MD: M03 skn-mus TDLo: 16 gm/kg/80W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0546330 (NTIS**); R03 skn-rbt TDLo: 2 gm/kg/2W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555406 (NTIS**); R13 skn-gpg TDLo: 5 pph/12W-I Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975- v. 9, p. 55, 1983 (CODEDG) ND: NOHS 1974: HZD M1224; NIS 2; TNF 56; NOS 3; TNE 138; NOES 1983: HZD M1224; NIS 1; TNF 21; NOS 1; TNE 62; TFE 41 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1005 of 1119 in RTECS (through 2003/06) AN: UI0209950 PN: 1-Propylamine,-3-chloro-N,N-dimethyl-,-hydrochloride- SY: 3-Chloro-N,N-dimethyl-1-propylamine-hydrochloride-; Dimethylaminopropyl-chloride,-hydrochloride- RN: Current: 5407-04-5 UD: 200012 MF: C5-H12-Cl-N.Cl-H MW: 158.09 WL: G3N1&1 &GH CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 10 mg/L (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 33, 1981 (ENMUDM) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, laboratory assigned, October 2000; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 1006 of 1119 in RTECS (through 2003/06) AN: UK5075000 PN: 2-Propyn-1-ol- SY: 1-Propyne-3-ol-; 2-Propynyl-alcohol-; Acetylene-carbinol-; Agrisynth-PA-; Ethynylcarbinol-; Methanol,-ethynyl-; Propargyl-alcohol-; Propargyl-alcohol- (ACGIH:OSHA); RCRA-waste-number-P102- RN: Current: 107-19-7 BRN: 506003 BHR: 4-01-00-02214 UD: 200302 MF: C3-H4-O MW: 56.07 WL: Q2UU1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M) ME: mmo-sat 10 umol/plate (+S9) University Microfilms International. (300 N. Zeeb Rd., Ann Arbor, MI 48106) DA85-04850 (UNMI**); cyt-ham-ovr 400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 273, 1994 (MUREAV) ORNG: 20000000 ng/kg. [20.000000 mg/kg] T/E unlistd SRNG: 16000000 ng/kg. [16.000000 mg/kg] R03 AT: T/E unlistd orl-rat LD50: 20 mg/kg "Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley and Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979: pub. as 2nd rev. ed. in 1985. 2C,4672,1982 (38MKAJ); T/E unlistd ihl-rat LC50: 873 ppm/2H GAF Material Safety Data Sheet. (GAF Chemicals Corporation, 1361 Alps Road, Wayne, NJ 07470) (GAFCC*); F07-J22-P01 orl-mus LD50: 50 mg/kg Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 8, p. 97, 1966 (TPKVAL); F07-F13-J22 ihl-mus LC50: 2000 mg/m3/2H Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 8, p. 97, 1966 (TPKVAL); R03 skn-rbt LD50: 16 mg/kg "Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley and Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979: pub. as 2nd rev. ed. in 1985. 2C,4672,1982 (38MKAJ); T/E unlistd scu-rbt LDLo: 25 mg/kg "Zur Pharmakologie Ungesattigter Alkohole, Dissertation," Bock, H., Pharmakologischen Institut der Universitat Breslau, Poland, 1930 v. -, p. -, 1930 (BDBU**); T/E unlistd orl-gpg LD50: 60 mg/kg The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 4, p. 346, 1980 (DTLVS*); T/E unlistd orl-mam LD50: 50 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); T/E unlistd ihl-mam LC50: 3 gm/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); T/E unlistd unr-mam LD50: 53 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(5), p. 61, 1986 (GISAAA); J25-L30-M30 ihl-mus LC50: 1750 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 122, 1984 (VCVGK*); J25-L30-M30 ihl-rat LC50: 1800 mg/m3 "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 122, 1984 (VCVGK*); J25-L30-M30 orl-mus LD50: 50 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 122, 1984 (VCVGK*); J25-L30-M30 orl-rat LD50: 55 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 122, 1984 (VCVGK*) MD: A11-P30-Z01 ihl-rat TCLo: 230 mg/m3/2H/3W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 8, p. 97, 1966 (TPKVAL); H02-L14-P72 ihl-rat TCLo: 7 mg/m3/4H/22W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 8, p. 97, 1966 (TPKVAL); A11-P30-Z01 ihl-mus TCLo: 230 mg/m3/2H/3W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 8, p. 97, 1966 (TPKVAL); D07 ihl-mus TCLo: 25300 ppb/6H/14D-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 15, p. 207, 1995 (JJATDK); L30-M30-U01 ihl-mam TCLo: 100 mg/m3/4H/60D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 122, 1994 (VCVGK*); L30-M30-U01 ihl-mam TCLo: 5 mg/m3/4H/28W-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 122, 1994 (VCVGK*) TR: ACGIH TLV-TWA 1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: MSHA STANDARD-air: TWA 1 ppm (2 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 215, 1971 (DTLVS*); OSHA PEL (Construc): 8H TWA 1 ppm (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 ppm (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OEL-AUSTRALIA: TWA 1 ppm (2 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 2 ppm (9 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 1 ppm (2.3 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 1 ppm (2.5 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 1 ppm (2 mg/m3), STEL 3 ppm (6 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 1 ppm (2 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 2 ppm (5 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 ppm (2 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 1 ppm (2.5 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 1 ppm (1 mg/m3), Skin, JAN 1993; OEL-RUSSIA: STEL 1 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 1 ppm (2 mg/m3), Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 1 ppm (2.3 mg/m3), STEL 3 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO PROPARGYL ALCOHOL-air: 10H TWA 1 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 62000; NIS 7; TNF 471; NOS 11; TNE 30791; NOES 1983: HZD 62000; NIS 56; TNF 3447; NOS 38; TNE 54359; TFE 19934 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; OSHA ANALYTICAL METHOD #97 Record 1007 of 1119 in RTECS (through 2003/06) AN: UO3470000 PN: Pteridine,-2,4,7-triamino-6-phenyl- SY: Ademine-; Diren-; Ditak-; Dyrenium-; Dytac-; NCI-C56042-; Noridil-; 6-Phenyl-2,4,7-pteridinetriamine-; 6-Phenyl-2,4,7-triaminopteridine-; Jatropur-; 2,4,7-Pteridinetriamine,-6-phenyl- (9CI); Pterofen-; Pterophene-; SKF-8542-; Taturil-; Teriam-; Teridin-; 2,4,7-Triamino-6-fenilpteridina- (Italian); 2,4,7-Triamino-6-phenylpteridine-; Triampur-; Triamteren-; Triamterene-; Triamteril-; Triamteril-complex-; Tri-Span-; Triteren- RN: Current: 396-01-0 BRN: 266723 BHR: 5-26-17-00447 UD: 200302 MF: C12-H11-N7 MW: 253.30 WL: T66 BN DN GN JNJ CZ EZ HR& IZ CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: mnt-ham-lng 12600 ug/L Senshokutai. Chromosome. (Sensyokutai Gakkai, Kaokusai Kirisutokyo Daigaku, Mitaka, Tokyo-to, Japan) No.1- 1946- Adopted new numbering in 1976. v. (20), p. 574, 1980 (SNSHBT); mtr-ham-emb 25 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 6), p. 4, 1986 (ENMUDM); cyt-ham-lng 2800 ug/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); sce-ham-lng 12600 ug/L Senshokutai. Chromosome. (Sensyokutai Gakkai, Kaokusai Kirisutokyo Daigaku, Mitaka, Tokyo-to, Japan) No.1- 1946- Adopted new numbering in 1976. v. (20), p. 574, 1980 (SNSHBT) TE: V03-L60 orl-rat TDLo: 21840 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-420, 1993 (NTPTR*); V02-L60 orl-mus TDLo: 34944 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-420, 1993 (NTPTR*); V02-L60 orl-rat TDLo: 6489 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-213782 (NTIS**); V03-L60-N05 orl-mus TDLo: 34608 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB94-213782 (NTIS**) ORNG: 400000000 ng/kg. [400.000000 mg/kg] T/E unlistd AT: L02-U25 orl-wmn TDLo: 42 mg/kg/3W-I Medical Journal of Australia. (Australasian Medical Pub. Co. Ltd., 71-79 Arundel St., Glebe, N.S.W., Australia) V.1- 1914- v. 147, p. 262, 1987 (MJAUAJ); T/E unlistd orl-rat LD50: 400 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 21, p. 775, 1979 (YAKUD5); T/E unlistd ipr-rat LD50: 200 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 21, p. 775, 1979 (YAKUD5); T/E unlistd orl-mus LD50: 285 mg/kg French Demande Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) #2314719 (FRXXBL); T/E unlistd ipr-mus LD50: 249 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 519, 1982 (NIIRDN); T/E unlistd scu-mus LD50: 620 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 519, 1982 (NIIRDN); T/E unlistd ivn-mus LD50: 25077 ug/kg Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 50, p. 419, 1995 (PHARAT); T/E unlistd unr-mus LDLo: 25 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 35, p. 1688, 1985 (ARZNAD) MD: M03-Y03 orl-rat TDLo: 157 mg/kg/3W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 31, p. 1257, 1981 (ARZNAD); N30-U01 orl-rat TDLo: 2700 mg/m3/15D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-420, 1993 (NTPTR*); M03-U01 orl-rat TDLo: 6370 mg/m3/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-420, 1993 (NTPTR*); N30-P72-U01 orl-mus TDLo: 8190 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-420, 1993 (NTPTR*) ND: NOES 1983: HZD X5679; NIS 1; TNF 60; NOS 1; TNE 587; TFE 310 SL: NTP Carcinogenesis Studies (feed), some evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-420, 1993 (NTPTR*); NCI Carcinogenesis Studies (feed), equivocal evidence: mouse, rat Record 1008 of 1119 in RTECS (through 2003/06) AN: UO8925000 PN: Purine, 6-((1-methyl-4-nitroimidazol-5-yl)thio)- SY: Azamun- (Czech); Azanin-; Azathioprine-; Imuran-; Imurek-; Imurel-; Methylnitroimidazolylmercaptopurine-; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin (Czech); 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine; 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine; 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purine; 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; Muran-; NCI-C03474-; NSC-39084-; BW-57-322-; 1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)- RN: Current: 446-86-6 UD: 200305 MF: C9-H7-N7-O2-S MW: 277.29 WL: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 500 ug/plate (+S9) Canadian Journal of Genetics and Cytology. (National Research Council of Canada, Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.1- 1959- v. 21, p. 319, 1979 (CNJGA8); mmo-sat 100 ug/plate (-S9) Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 97, p. 137, 1978 (BIZNAT); mmo-klp 200 umol/L/20H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 207, 1979 (MUREAV); sln-dmg-orl 5 mg/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 28, p. 87, 1975 (MUREAV); dlt-dmg-orl 5 mg/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 28, p. 87, 1975 (MUREAV); mmo-nsc 1200 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 28, p. 87, 1975 (MUREAV); mmo-smc 25 mmol/L (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1011, 1988 (CRNGDP); mrc-smc 25 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1011, 1988 (CRNGDP); mnt-hmn-lym 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 291, p. 93, 1993 (MUREAV); dni-hmn-leu 500 mg/L Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 504, 1971 (ARZNAD); oms-hmn-bmr 1 mg/L Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 21, p. 502, 1971 (ARZNAD); cyt-wmn-unr 15 mg/kg/7W Acta Medica Scandinavica. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.52-224, 1919-88. v. 182, p. 445, 1967 (AMSVAZ); cyt-wmn-unr 59 mg/kg Acta Medica Scandinavica. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.52-224, 1919-88. v. 179, p. 249, 1966 (AMSVAZ); cyt-hmn-leu 6 mg/L Zeitschrift fuer Gastroenterologie. (Demeter Verlag, Postfach 1660, D-8032 Graefelfing, Fed. Rep. Ger.) V.1- 1963- v. 9, p. 47, 1971 (ZGASAX); cyt-hmn-lym 83 umol/L Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. v. 21, p. 153, 1974 (HUMAA7); cyt-hmn-unr 11 mg/kg/8D Danish Medical Bulletin. (Copenhagen, Denmark) V.1-18, 1954-71. v. 23, p. 152, 1976 (DMBUAE); sce-hmn-lym 100 ng/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 215, 1978 (MUREAV); mnt-rat-ipr 100 mg/kg/24H Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 34, p. 324, 1978 (EXPEAM); mnt-rat-orl 3 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 291, p. 79, 1993 (MUREAV); dnd-rat-lvr 1 mmol/L Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 117, p. 321, 1991 (JCROD7); dni-rat-par 40 ug/kg Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1320, 1974 (BEXBAN); mnt-mus-ipr 50 mg/kg/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 153, 1979 (MUREAV); mnt-mus-orl 100 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 42, p. 239, 1979 (ARTODN); dns-mus-ipr 100 mg/kg Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 7, p. 174, 1984 (ATSUDG); dni-mus-ast 300 ug/L Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 22, p. 105, 1975 (NEOLA4); oms-mus-ast 300 ug/L Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 22, p. 105, 1975 (NEOLA4); dlt-mus-orl 50 mg/kg/2D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 28, p. 87, 1975 (MUREAV); hma-mus-smc 12500 umol/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1011, 1988 (CRNGDP); spm-mus-ipr 500 mg/kg/5D Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 4425, 1975 (PNASA6); mnt-ham-orl 1 gm/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 42, p. 239, 1979 (ARTODN); cyt-ham-fbr 100 umol/L Studia Biophysica. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086, Ger. Dem. Rep.) V.1- 1966- v. 108, p. 219, 1985 (STBIBN); cyt-ham-orl 1 gm/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 42, p. 239, 1979 (ARTODN) RE: T25 orl-rat TDLo: 15 mg/kg (6-8D preg) Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften. (Schwabe and Co., Steinentorstr. 13, CH-4010 Basel, Switzerland) V.1- 1944- v. 22, p. 153, 1968 (BSAMA5); T27 orl-rat TDLo: 15 mg/kg (6-8D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 158, p. 1984, 1964 (CRSBAW); T34-T35-T46 orl-rat TDLo: 60 mg/kg (10-15D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 2, p. 401, 1968 (OYYAA2); T76 orl-rat TDLo: 120 mg/kg (10-15D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 2, p. 401, 1968 (OYYAA2); T81 orl-rat TDLo: 240 mg/kg (10-15D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 2, p. 401, 1968 (OYYAA2); T01-T02 orl-rat TDLo: 70 mg/kg (14D male) Nippon Hinyokika Gakkai Zasshi. Japanese Journal of Urology. (Japanese Urological Association, c/o Dept. of Urology, Faculty of Medicine, University of Tokyo, 7-3-1 Bunkyo-ku, Tokyo 113 Japan) V.1- 1917- v. 87, p. 42, 1996 (NGKZA6); T25 ipr-rat TDLo: 10 mg/kg (7D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 4, p. 291, 1962 (JRPFA4); T35 ipr-rat TDLo: 20 mg/kg (10-11D preg) Zentralblatt fuer Veterinaermedizin, Reihe A. (Verlag Paul Parey, Linderstr. 44-47, D-1000 Berlin 61, Fed. Rep. Ger.) V.10- 1963- v. 22, p. 38, 1975 (ZVRAAX); T46 ipr-rat TDLo: 40 mg/kg (10-11D preg) Zentralblatt fuer Veterinaermedizin, Reihe A. (Verlag Paul Parey, Linderstr. 44-47, D-1000 Berlin 61, Fed. Rep. Ger.) V.10- 1963- v. 22, p. 38, 1975 (ZVRAAX); T25-T31-T34 ipr-rat TDLo: 14 mg/kg (5-18D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 128, p. 668, 1977 (AJOGAH); T25-T26 unr-rat TDLo: 15 mg/kg (6-8D preg) Union Medicale du Canada. (1440 ouest rue Sainte-Catherine, Montreal H3G 2P9, Quebec, Canada) V.1- 1872- v. 97, p. 283, 1968 (UMCAAA); T46 orl-mus TDLo: 50 mg/kg (10D preg) Naunyn-Schmiedeberg's Archives of Pharmacology. (Springer Verlag, Heidelberger, Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.272- 1972- v. 298, p. 93, 1977 (NSAPCC); T34-T46-T76 orl-mus TDLo: 60 mg/kg (8-13D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 2, p. 401, 1968 (OYYAA2); T81 orl-mus TDLo: 60 mg/kg (8-13D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 2, p. 401, 1968 (OYYAA2); T34-T35-T43 orl-mus TDLo: 50 mg/kg (10D preg) Naunyn-Schmiedeberg's Archives of Pharmacology. (Springer Verlag, Heidelberger, Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.272- 1972- v. 298, p. 93, 1977 (NSAPCC); T27 orl-mus TDLo: 70 mg/kg (6-12D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 158, p. 1984, 1964 (CRSBAW); T42-T46-T48 ipr-mus TDLo: 20 mg/kg (9-10D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 97, p. 387, 1967 (AJOGAH); T25-T34 ipr-mus TDLo: 12 mg/kg (6-8D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 97, p. 387, 1967 (AJOGAH); T35 ipr-mus TDLo: 30 mg/kg (6-8D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 97, p. 387, 1967 (AJOGAH); T43 ipr-mus TDLo: 40 mg/kg (9-10D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 97, p. 387, 1967 (AJOGAH); T35-T43-T46 scu-mus TDLo: 30 mg/kg (10D preg) Zentralblatt fuer Veterinaermedizin, Reihe A. (Verlag Paul Parey, Linderstr. 44-47, D-1000 Berlin 61, Fed. Rep. Ger.) V.10- 1963- v. 22, p. 38, 1975 (ZVRAAX); T34 scu-mus TDLo: 50 mg/kg (10D preg) Naunyn-Schmiedeberg's Archives of Pharmacology. (Springer Verlag, Heidelberger, Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.272- 1972- v. 298, p. 93, 1977 (NSAPCC); T26 unr-mus TDLo: 30 mg/kg (8-10D preg) Union Medicale du Canada. (1440 ouest rue Sainte-Catherine, Montreal H3G 2P9, Quebec, Canada) V.1- 1872- v. 97, p. 283, 1968 (UMCAAA); T25 unr-mus TDLo: 70 mg/kg (6-12D preg) Union Medicale du Canada. (1440 ouest rue Sainte-Catherine, Montreal H3G 2P9, Quebec, Canada) V.1- 1872- v. 97, p. 283, 1968 (UMCAAA); T42-T43-T46 orl-rbt TDLo: 45 mg/kg (6-14D preg) Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 259, p. 3648, 1964 (COREAF); T42 orl-rbt TDLo: 30 mg/kg (8-10D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 160, p. 501, 1966 (CRSBAW); T26 orl-rbt TDLo: 90 mg/kg (6-14D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 159, p. 2290, 1965 (CRSBAW); T35 orl-rbt TDLo: 45 mg/kg (8-10D preg) Zentralblatt fuer Veterinaermedizin, Reihe A. (Verlag Paul Parey, Linderstr. 44-47, D-1000 Berlin 61, Fed. Rep. Ger.) V.10- 1963- v. 22, p. 38, 1975 (ZVRAAX); T35 ipr-rbt TDLo: 4 mg/kg (7-10D preg) Zentralblatt fuer Veterinaermedizin, Reihe A. (Verlag Paul Parey, Linderstr. 44-47, D-1000 Berlin 61, Fed. Rep. Ger.) V.10- 1963- v. 22, p. 38, 1975 (ZVRAAX); T46 ipr-rbt TDLo: 20 mg/kg (7-10D preg) Zentralblatt fuer Veterinaermedizin, Reihe A. (Verlag Paul Parey, Linderstr. 44-47, D-1000 Berlin 61, Fed. Rep. Ger.) V.10- 1963- v. 22, p. 38, 1975 (ZVRAAX); T29 ivn-rbt TDLo: 25 mg/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 38, p. 238, 1982 (FESTAS); T26-T46 unr-rbt TDLo: 45 mg/kg (8-10D preg) Union Medicale du Canada. (1440 ouest rue Sainte-Catherine, Montreal H3G 2P9, Quebec, Canada) V.1- 1872- v. 97, p. 283, 1968 (UMCAAA) TE: V01-P62 orl-wmn TDLo: 273 mg/kg/13W-C British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 4, p. 235, 1972 (BMJOAE); V03-K60 orl-rat TDLo: 1932 mg/kg/46W-C Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (102), p. 66, 1984 (ESKHA5); V03-N60-R60 ipr-rat TDLo: 360 mg/kg/7W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); V02-L60-P62 orl-mus TDLo: 1596 mg/kg/95W-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 80, p. 419, 1989 (JJCREP); V03-J60-P62 ipr-mus TDLo: 585 mg/kg/26W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); V01-P62-R60 scu-mus TDLo: 1200 mg/kg/30W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 29, p. 662, 1979 (ARZNAD); V01-M61-N62 ims-mus TDLo: 3500 mg/kg/26W-I Blood. (Grune and Stratton, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1946- v. 31, p. 396, 1968 (BLOOAW); V01-V10 scu-mus TD :2600 mg/kg/65W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 29, p. 483, 1979 (ARZNAD); V01-D45-P62 orl-rat TD :11 gm/kg/1W-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 91, 1983 (PAACA3); V01-M60 orl-wmn TD :3 gm/kg/3.5Y-C JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 237, p. 152, 1977 (JAMAAP); V01-P61 orl-wmn TD :5460 mg/kg/6Y-I Acta Medica Scandinavica. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.52-224, 1919-88. v. 207, p. 315, 1980 (AMSVAZ); V01-P61 orl-man TD :728 mg/kg/43W-C American Journal of the Medical Sciences. (Slack Inc., 6900 Grove Rd., Thorofare, NJ 08086) New series: V.1- 1841- v. 273, p. 335, 1977 (AJMSA9); V01-P61 orl-man TD :1565 mg/kg/4Y-C American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 57, p. 885, 1974 (AJMEAZ); V01-P61 orl-man TD :3266 mg/kg/3Y-C American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 57, p. 885, 1974 (AJMEAZ); V01-P61 orl-wmn TD :2 gm/kg/3Y-C Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1925- v. 53, p. 173, 1977 (PGMJAO) ORNG: 400000000 ng/kg. [400.000000 mg/kg] T/E unlistd AT: F15-K13 orl-wmn TDLo: 56 mg/kg/4W-I Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1925- v. 56, p. 274, 1980 (PGMJAO); J30-M03-Q15 orl-man TDLo: 15 mg/kg/7D-I American Journal of Kidney Diseases. (Grune and Stratton, Inc., Journal Subscription Dept., POB 6280, Duluth, MN 55806) V.1- 1981- v. 23, p. 874, 1994 (AJKDDP); P14-P17-P20 orl-wmn TDLo: 42 mg/kg/3W-I Annals of the Rheumatic Diseases. (British Medical Journal, Box 560B, Kennebunkport, ME 04041) V.1- 1939- v. 47, p. 503, 1988 (ARDIAO); L30 orl-man LDLo: 395 mg/kg/56W-I Gastroenterology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1943- v. 90, p. 446, 1986 (GASTAB); K12-K13-U25 orl-wmn TDLo: 500 ug/kg Journal of Rheumatology. (920 Yonge St., Suite 608, Toronto, Ont., Canada) V.1- 1974- v. 13, p. 1117, 1986 (JRHUA9); H02-M11 orl-man TDLo: 7500 ug/kg/1W-I Arthritis and Rheumatism. (Arthritis Foundation, 1314 Spring St., NW, Atlanta, GA 30309) V.1- 1958- v. 24, p. 1453, 1981 (ARHEAW); P14 orl-man TDLo: 50 mg/kg/3W-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 342, p. 1245, 1993 (LANCAO); P05-P26 unr-chd TDLo: 2500 ug/kg/D-I American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 134, p. 377, 1980 (AJDCAI); T/E unlistd orl-rat LD50: 400 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 8, 1995 (NIIRDN); T/E unlistd ipr-rat LD50: 300 mg/kg Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 4, p. 297, 1962 (JRPFA4); T/E unlistd scu-rat LD50: >1 gm/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 3, 1982 (NIIRDN); T/E unlistd idu-rat LD50: 630 mg/kg Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 31, p. 223, 1968 (RPTOAN); T/E unlistd orl-mus LD50: 2500 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 8, 1995 (NIIRDN); T/E unlistd ipr-mus LD50: 273 mg/kg Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 34, p. 284, 1971 (RPTOAN); S04 scu-mus LD50: 350 mg/kg Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 18, p. 320, 1975 (JMCMAR); T/E unlistd idu-mus LD50: 2437 mg/kg Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 31, p. 223, 1968 (RPTOAN); T/E unlistd idu-rbt LDLo: 100 mg/kg Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 31, p. 223, 1968 (RPTOAN) MD: N74-U01 orl-rat TDLo: 224 mg/kg/4W-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 27, p. 171, 1999 (TOPADD); P14-P26 orl-mus TDLo: 1400 mg/kg/14D-I Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- v. 39, p. 2690, 1996 (JMCMAR); P72 scu-mus TDLo: 780 mg/kg/26W-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 29, p. 483, 1979 (ARZNAD); U01 ipr-mus TDLo: 900 mg/kg/9D-I Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 31, p. 155, 1981 (RCOCB8) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 47, 1981 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 47, 1981 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 119, 1987 (IMSUDL); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3); TOXICOLOGY REVIEW CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- v. 2, p. 159, 1973 (CRTXB2); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY); TOXICOLOGY REVIEW Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 174, p. 1, 2002 (TXCYAC) ND: NOES 1983: HZD X3947; NIS 1; TNF 65; NOS 2; TNE 1849; TFE 880 SL: EPA GENETOX PROGRAM 1988, Positive: D melanogaster-nondisjunction; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-partial sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: Rodent dominant lethal; NCI Carcinogenesis Studies (ipr), clear evidence: mouse Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NCI Carcinogenesis Studies (ipr), no evidence: rat Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 1009 of 1119 in RTECS (through 2003/06) AN: UQ8225000 PN: 3,5-Pyrazolidinedione,-4-butyl-1,2-diphenyl- SY: Alindor-; Alkabutazona-; Alqoverin-; Antadol-; Anuspiramin-; Artrizone-; Artropan-; Azolid-; Benzone-; Betazed-; Chembutazone-; DA-192-; Digibutina-; Diossidone-; 3,5-Dioxe-4-buty-1,-diphenyl-pyrazolidine-; 3,5-Dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin-; 3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine-; Diozol-; Diphebuzol-; Diphenylbutazone-; 1,2-Diphenyl-4-butyl-3,5-dioxopyrazolidine-; 1,2-Diphenyl-4-butyl-3,5-pyrazolidinedione-; 1,2-Diphenyl-3,5-dioxo-4-butylpyrazolidine-; 1,2-Diphenyl-2,3-dioxo-4-N-butylpyrazoline-; Ecobutazone-; Elmedal-; Equi-bute-; Eributazone-; Febuzina-; Fenartil-; Fenibutasan-; Fenibutazona-; Fenibutol-; Fenilbutazona-; Fenilbutine-; Fenilidina-; Fenotone-; Fenylbutazon-; Flexazone-; G-13,871-; Ia-BuT-; Mephabutazone-; NCI-C56531-; Neo-zoline-; Phebuzine-; Phenylbutazon- (German); Phenylbutazone-; Phenyl-mobuzon-; Bizolin-200-; Butacote-; Butacompren-; Butadion-; Butadione-; Butalidon-; Butapirazol-; Butartrina-; Butazina-; Butazolidin-; Butazolidine-; Butidiona-; Butiwas-simple-; Butoz-; 4-Butyl-1,2-diphenyl-3,5-dioxopyrazolidine-; 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione-; 4-Butyl-1,2-diphenyl-3,5-pyrazolidinedione-; Buvetzone-; Buzon-; Pirarreumol-B-; Pyrabutol-; Rectofasa-; Reudo-; Reudox-; Reumuzol-; Reupolar-; Rubatone-; R-3-ZON-; Scanbutazone-; Schemergin-; Shigrodin-; Tencodyne-; Ticinil-; Todalgil-; VAC-10-; USAF-GE-15-; Uzone-; Zolaphen- RN: Current: 50-33-9 BRN: 290080 BHR: 5-24-05-00400 UD: 200305 MF: C19-H20-N2-O2 MW: 308.41 WL: T5VNNV EHJ BR& CR& E4 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 100 mg MOD Current Medical Research and Opinion. (Clayton-Wray Pub. Ltd., 1a High St., Alton, Hants., UK) V.1- 1972- v. 4, p. 17, 1976 (CMROCX) ME: oms-hmn-emb 20 mg/L Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 74, p. 828, 1972 (BEXBAN); oms-hmn-lym 320 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 14, p. 83, 1972 (MUREAV); cyt-hmn-lym 320 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 14, p. 83, 1972 (MUREAV); hma-rat-oth 100 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 24, p. 219, 1975 (BCPCA6); mnt-mus-orl 75 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 18, p. 869, 1980 (IJEBA6); mnt-mus-ipr 50 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 18, p. 869, 1980 (IJEBA6); dni-mus-ipr 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); sce-mus-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 420, p. 15, 1998 (MUREAV); cyt-ham-orl 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 377, 1971 (MUREAV); cyt-ham-fbr 1 gm/L Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886- v. (96), p. 55, 1978 (ESKHA5); cyt-ham-lng 830 mg/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); cyt-ham-ovr 1600 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); msc-mus-lym 500 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-367, 1990 (NTPTR*) RE: T16 orl-rat TDLo: 360 mg/kg (17-22D preg) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 10, p. 164, 1979 (IYKEDH); T72 orl-rat TDLo: 1140 mg/kg (14D pre/1-22D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 15, p. 46, 1969 (TXAPA9); T47 orl-rat TDLo: 30 mg/kg (21D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 27, p. 117, 1984 (OYYAA2); T34 orl-rat TDLo: 600 mg/kg (5-16D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 7, p. 701, 1974 (RCOCB8); T46-T85 orl-rat TDLo: 1100 mg/kg (7-17D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 20, p. 377, 1980 (OYYAA2); T12-T13 orl-rat TDLo: 25200 mg/kg (84D pre) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 19, p. 1, 1980 (OYYAA2); T25-T34-T46 orl-mus TDLo: 8 gm/kg (6-15D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 20, p. 289, 1980 (OYYAA2); T81 orl-mus TDLo: 8 gm/kg (6-15D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 20, p. 289, 1980 (OYYAA2); T29 orl-rbt TDLo: 1050 mg/kg (1-7D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 10, p. 129, 1965 (JRPFA4); T25-T35 orl-rbt TDLo: 780 mg/kg (6-18D preg) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 10, p. 149, 1979 (IYKEDH); T26 orl-rbt TDLo: 1560 mg/kg (6-18D preg) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 10, p. 149, 1979 (IYKEDH); T29 orl-rbt TDLo: 200 mg/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 38, p. 238, 1982 (FESTAS) TE: V01-P61 orl-man TDLo: 4368 mg/kg/4Y-C British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 744, 1964 (BMJOAE); V01-P61 mul-wmn TDLo: 4200 mg/kg/77W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 1569, 1961 (BMJOAE); V02-M60 orl-rat TDLo: 51500 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-367, 1990 (NTPTR*); V02-L60 orl-mus TDLo: 154 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-367, 1990 (NTPTR*); V01-P20-P61 orl-man TD :140 mg/kg/3W-C British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 1552, 1960 (BMJOAE); V02-K06-M61 orl-rat TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-258765 (NTIS**); V01-K06-M61 orl-rat TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-258765 (NTIS**); V03-L60 orl-mus TDLo: 154500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-258765 (NTIS**) ORNG: 245000000 ng/kg. [245.000000 mg/kg] F29 AT: H30-M02 orl-wmn TDLo: 168 mg/kg/4W-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 145, p. 685, 1985 (AIMDAP); M03-M11 orl-man TDLo: 17500 ug/kg/3W-I Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 41, p. 1075, 1954 (AIMEAS); F12-J22-T24 orl-man TDLo: 2426 mg/kg/24H-I Annals of Emergency Medicine. (American College of Emergency Physicians, 1125 Executive Circle, Irving, TX 75038) v. 20, p. 204, 1991 (AEMED3); H01-M11-M14 unr-man TDLo: 200 mg/kg/5W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 282, p. 950, 1981 (BMJOAE); P14-P15-U25 unr-wmn TDLo: 40 mg/kg/4D-I Problemy Gematologii i Perelivaniia Krovi. Problems of Hematology and Blood Transfusion. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1956- v. 4(5), p. 48, 1959 (PGPKA8); F29 orl-rat LD50: 245 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 123, p. 48, 1959 (AIPTAK); T/E unlistd ipr-rat LD50: 142 mg/kg Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 v. 14, p. 347, 1959 (FRPSAX); F07-F11-F12 scu-rat LD50: 230 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 1285, 1972 (OYYAA2); T/E unlistd ivn-rat LD50: 100 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 10, p. 665, 1960 (ARZNAD); T/E unlistd ims-rat LD50: 220 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 10, p. 665, 1960 (ARZNAD); T/E unlistd orl-mus LD50: 238 mg/kg Pharmacological Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 18, p. 241, 1986 (PLRCAT); T/E unlistd ipr-mus LD50: 128 mg/kg Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- v. 19, p. 33, 1985 (PCJOAU); T/E unlistd scu-mus LD50: 230 mg/kg Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- v. 7, p. 1022, 1955 (JPPMAB); T/E unlistd ivn-mus LD50: 90 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 36, 1969 (ARZNAD); F05-F12-J30 ims-mus LD50: 430 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 13, p. 97, 1977 (OYYAA2); T/E unlistd unr-mus LD50: 128 mg/kg Farmatsevtichnii Zhurnal (Kiev). (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.3- 1930- v. (5), p. 26, 1983 (FRZKAP); F12-F17-J22 orl-dog LD50: 332 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 20, p. 265, 1980 (OYYAA2); F29 ivn-dog LD50: 121 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 149, p. 571, 1964 (AIPTAK); T/E unlistd ivn-cat LD50: 100 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 36, 1969 (ARZNAD); F12-F17-J22 orl-rbt LD50: 781 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 20, p. 265, 1980 (OYYAA2); F12-F19-J22 ivn-rbt LD50: 146 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 10, p. 129, 1960 (ARZNAD); T/E unlistd orl-gpg LD50: 250 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 1207, 1969 (ARZNAD); T/E unlistd orl-ham LD50: 1260 mg/kg Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 7, p. 365, 1984 (ATSUDG); F29 orl-mam LD50: 700 mg/kg European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- v. 21, p. 277, 1986 (EJMCA5); F29 ipr-mam LD50: 300 mg/kg European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- v. 21, p. 277, 1986 (EJMCA5); G02-G30 orl-cat TDLo: 22 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 54, 1985 (FATOAO); Y55 orl-rat TDLo: 30 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 48, p. 44, 1985 (FATOAO); F29 orl-rat TDLo: 13.5 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 94, 1987 (FATOAO); U28 orl-rat TDLo: 72 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 94, 1987 (FATOAO); S02 skn-mus TDLo: 25 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 84, 1984 (FATOAO); Y55 skn-rat TDLo: 50 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 84, 1984 (FATOAO); F29 orl-mam TDLo: 100 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 36, 1986 (FATOAO); Y55 orl-mus TDLo: 56 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 36, 1986 (FATOAO); F29 orl-mus TDLo: 85 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 46, 1982 (FATOAO); T/E unlistd orl-rat LD50: 375 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 46, 1982 (FATOAO); Y55 ipr-rat TDLo: 72 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 94, 1987 (FATOAO); F29-U28 orl-rat TDLo: 72 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 94, 1987 (FATOAO) MD: L70-Z01 orl-rat TDLo: 13 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-367, 1990 (NTPTR*); L14-M10-P72 orl-rat TDLo: 83950 mg/kg/1Y-C Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 10, p. 665, 1960 (ARZNAD); L70-M70-Z71 orl-rat TDLo: 6300 mg/kg/21D-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 22, p. 226, 1972 (ARZNAD); K06-Z01 orl-rat TDLo: 600 mg/kg/4D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 52, p. 454, 1980 (TXAPA9); M10-M70-U30 orl-rat TDLo: 2800 mg/kg/2W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 17, p. 117, 1983 (TOLED5); L70-Z01 orl-mus TDLo: 39 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-367, 1990 (NTPTR*); L70-M70-N73 orl-mky TDLo: 37800 mg/kg/27W-I Current Medical Research and Opinion. (Clayton-Wray Pub. Ltd., 1a High St., Alton, Hants., UK) V.1- 1972- v. 4, p. 17, 1976 (CMROCX); F15-K06-P28 ivn-dom TDLo: 158 mg/kg/12D-I Journal of the American Veterinary Medical Association. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.48- 1915- v. 202, p. 71, 1993 (JAVMA4); K04 ivn-ctl TDLo: 54 mg/kg/4D-I Veterinary Pathology. (Waverly Press, Inc., POB 64025, Baltimore, MD 21264) V.8- 1971- v. 27, p. 244, 1990 (VTPHAK); N30-Y07 ipr-gpg TDLo: 600 mg/kg/10D-I Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 14, p. 727, 1976 (CLPTAT); M16-N30 unr-man TDLo: 24600 mg/kg/41D-I Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 14, p. 727, 1976 (CLPTAT); N30-P30 orl-rat TDLo: 5000 mg/kg/10D-I Farmakologiya i Toksikologiya (Kiev). Pharmacology and Toxicology. (Kievskii Nauchno- Issledovatel'skii Institut Farmakologii i Toksikologii, Kiev, USSR) No.1- 1964- v. 159, p. 75, 1986 (FATOBP); K06 ipr-rat TDLo: 300 mg/kg/3D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 81, 1986 (FATOAO); Y55 orl-rat TDLo: 216 mg/kg/3D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 94, 1987 (FATOAO) TR: IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 13, p. 183, 1977 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 13, p. 183, 1977 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 316, 1987 (IMSUDL); TOXICOLOGY REVIEW Antibiotics and Chemotherapy (Washington, DC). (Washington, DC) V.1-12, 1951-62. For publisher information, see CLMEA3. v. 3, p. -, 1953 (ANTCAO); TOXICOLOGY REVIEW American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- v. 38, p. 409, 1965 (AJMEAZ); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6) ND: NOES 1983: HZD X3730; NIS 2; TNF 58; NOS 3; TNE 755; TFE 488 SL: EPA GENETOX PROGRAM 1988, Negative: Cytogenetics-male germ cell, Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus, Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavage), some evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-367, 1990 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse, rat Record 1010 of 1119 in RTECS (through 2003/06) AN: UR2455000 PN: Pyrene,-1,6-dinitro- SY: 1,6-Dinitropyrene- RN: Current: 42397-64-8 BRN: 3413178 BHR: 3-05-00-02287 UD: 200204 MF: C16-H8-N2-O4 MW: 292.26 WL: L666 B6 2AB PJ DNW KNW CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 600 pg/plate (+S9) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 73, p. 1359, 1984 (JJIND8); mmo-sat 10 ng/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 170, p. 31, 1986 (MUREAV); oms-sat 5 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 5 ng/plate (-S9) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 73, p. 1359, 1984 (JJIND8); oms-esc 5 ng/tube Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 41, 1991 (EMMUEG); dnr-bcs 20 ng/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 174, p. 89, 1986 (MUREAV); mmo-smc 2900 ng/L (+S9) Progress in Clinical and Biological Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1975- v. 109, p. 249, 1982 (PCBRD2); mrc-smc 1400 ng/L Progress in Clinical and Biological Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1975- v. 109, p. 249, 1982 (PCBRD2); dna-hmn-mmr 500 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1769, 1996 (CRNGDP); dna-hmn-lng 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); dns-hmn-oth 500 nmol/L Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 79, p. 28, 1985 (TXAPA9); dns-hmn-lvr 50 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 1075, 1989 (CNREA8); oms-hmn-lym 1250 ug/L/3H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 209, p. 135, 1988 (MUREAV); oms-hmn-fbr 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 213, p. 141, 1989 (MUREAV); cyt-hmn-lym 1250 ug/L/3H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 209, p. 135, 1988 (MUREAV); msc-hmn-lym 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 233, 1994 (MUREAV); dna-rat-lvr 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); dns-rat-lvr 10 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 159, 1987 (MUREAV); dns-rat-oth 80 nmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 489, 1983 (ENMUDM); cyt-rat-lvr 1250 mg/L Progress in Clinical and Biological Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1975- v. 109, p. 249, 1982 (PCBRD2); dns-mus-lvr 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 159, 1987 (MUREAV); hma-mus-sat 2 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 253, p. 181, 1991 (MUREAV); mmo-ham-ovr 2 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 119, p. 387, 1983 (MUREAV); dnd-ham-lng 15 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 24, p. 121, 1984 (CALEDQ); oms-ham-lng 250 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 208, p. 213, 1988 (MUREAV); cyt-ham-ovr 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 158, p. 209, 1985 (MUREAV); cyt-ham-lng 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 208, p. 213, 1988 (MUREAV); sce-ham-ovr 500 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 158, p. 209, 1985 (MUREAV); sln-ham-lng 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 208, p. 213, 1988 (MUREAV); msc-ham-lng 100 ug/L Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 75, p. 574, 1984 (GANNA2); msc-ham-ovr 50 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 158, p. 209, 1985 (MUREAV); dns-rbt-lng 2500 ng/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 175, p. 259, 1986 (MUREAV); dna-hmn-mmr 5 umol/L/22H Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 155, p. 47, 2000 (CALEDQ) TE: V01-K60-R60 ipr-rat TDLo: 23 mg/kg/4W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 13, p. 279, 1986 (DTESD7); V01-V10 scu-rat TDLo: 9206 ug/kg/8W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 13, p. 279, 1986 (DTESD7); V01-J60 ipl-rat TDLo: 600 ug/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 76, p. 693, 1986 (JJIND8); V01-J60-R60 itr-rat TDLo: 120 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1285, 1989 (CRNGDP); V01-V10 scu-mus TDLo: 80 mg/kg/20W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 13, p. 253, 1986 (DTESD7); V01-J60 itr-ham TDLo: 104 mg/kg/26W-I Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 76, p. 457, 1985 (JJCREP); V01-V10 scu-rat TD :16 mg/kg/10W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 25, p. 239, 1985 (CALEDQ) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 215, 1989 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 215, 1989 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 215, 1989 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1011 of 1119 in RTECS (through 2003/06) AN: UR2456000 PN: Pyrene,-1,8-dinitro- SY: 1,8-DNP-; 1,8-Dinitropyrene- RN: Current: 42397-65-9 BRN: 3413165 BHR: 3-05-00-02287 UD: 200210 MF: C16-H8-N2-O4 MW: 292.26 WL: L666 B6 2AB PJ DNW KNW CC: Tumorigen (C); Drug (D); Mutagen (M) ME: mmo-sat 300 pg/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 7, 1993 (MUREAV); mmo-sat 200 ng/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 321, 1981 (MUREAV); oms-sat 3 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); dnd-sat 2 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 457, 1983 (ENMUDM); mmo-esc 25 ng/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 142, p. 163, 1985 (MUREAV); oms-esc 5 ng/tube Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 41, 1991 (EMMUEG); dnr-bcs 10 ng/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 174, p. 89, 1986 (MUREAV); mmo-smc 2900 ng/L (+S9) Progress in Clinical and Biological Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1975- v. 109, p. 249, 1982 (PCBRD2); mrc-smc 1400 ng/L Progress in Clinical and Biological Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1975- v. 109, p. 249, 1982 (PCBRD2); dna-hmn-mmr 500 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1769, 1996 (CRNGDP); dns-hmn-lvr 1 mg/L Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 78, p. 807, 1987 (JJCREP); msc-hmn-lym 100 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 457, 1983 (ENMUDM); dnd-rat-lvr 20 umol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 110, 1984 (PAACA3); dns-rat-lvr 100 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 159, 1987 (MUREAV); cyt-rat-lvr 1250 mg/L Progress in Clinical and Biological Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1975- v. 109, p. 249, 1982 (PCBRD2); dns-mus-lvr 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 159, 1987 (MUREAV); msc-mus-lym 500 ug/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 25, p. 397, 1982 (EVSRBT); hma-mus-sat 100 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 253, p. 181, 1991 (MUREAV); mmo-ham-ovr 2 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 119, p. 387, 1983 (MUREAV); mtr-ham-emb 1700 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 357, 1983 (CRNGDP); dnd-ham-lng 15 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 24, p. 121, 1984 (CALEDQ); cyt-ham-ovr 50 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 158, p. 209, 1985 (MUREAV); cyt-ham-lng 25 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 259, p. 103, 1991 (MUREAV); sce-ham-ovr 1 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 1, 1982 (ENMUDM); msc-ham-lng 100 ug/L Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 75, p. 574, 1984 (GANNA2); msc-ham-ovr 50 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 158, p. 209, 1985 (MUREAV); dna-rbt-oth 25 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 10, p. 1323, 1989 (CRNGDP); dns-rbt-lng 1250 ng/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 175, p. 259, 1986 (MUREAV); sce-ham-ovr 0.05 mg/L/24H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 515, p. 181, 2002 (MUREAV); cyt-ham-ovr 0.0086 mg/L/24H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 515, p. 181, 2002 (MUREAV) TE: V03-R60 orl-rat TD :35071 ug/kg/4W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1187, 1991 (CRNGDP); V01-K60-R60 ipr-rat TDLo: 23 mg/kg/4W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 13, p. 279, 1986 (DTESD7); V01-V10 scu-rat TDLo: 16 mg/kg/10W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 583, 1984 (CRNGDP); V01-V10 scu-mus TDLo: 40 mg/kg/20W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 13, p. 253, 1986 (DTESD7); V01-V10 scu-rat TD :160 ug/kg/10W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 25, p. 239, 1985 (CALEDQ); V01-J60-V10 scu-mus TD :40 mg/kg/20W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 79, p. 185, 1987 (JJIND8); V01-R60 ipr-rat TD :35071 ug/kg/4W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1187, 1991 (CRNGDP) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 231, 1989 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 231, 1989 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 231, 1989 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1012 of 1119 in RTECS (through 2003/06) AN: UR2480000 PN: Pyrene,-1-nitro- SY: 1-Nitropyrene-; 3-Nitropyrene- RN: Current: 5522-43-0 BRN: 1882811 BHR: 4-05-00-02471 UD: 200207 MF: C16-H9-N-O2 MW: 247.26 WL: L666 B6 2AB PJ DNW CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 30 ng/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 216, p. 211, 1989 (MUREAV); mmo-sat 1 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 321, 1981 (MUREAV); oms-sat 20 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); dna-sat 26 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2052, 1983 (CNREA8); mmo-esc 3 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 142, p. 163, 1985 (MUREAV); oms-esc 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 131, p. 101, 1984 (MUREAV); pic-esc 20 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1153, 1988 (CRNGDP); dnr-bcs 200 ng/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 174, p. 89, 1986 (MUREAV); mtr-hmn-fbr 3 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 353, 1983 (CRNGDP); dna-hmn-lym 30 umol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 85, p. 3513, 1988 (PNASA6); dna-hmn-mmr 500 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 1769, 1996 (CRNGDP); dns-hmn-oth 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 161, p. 109, 1986 (MUREAV); dns-hmn-lvr 3500 ug/L Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 78, p. 807, 1987 (JJCREP); dni-hmn-oth 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); msc-hmn-fbr 1 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 89, 1986 (CRNGDP); msc-hmn-oth 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 161, p. 109, 1986 (MUREAV); msc-hmn-lym 4 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 233, 1994 (MUREAV); mtr-rat-orl 600 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 45, p. 21, 1989 (CALEDQ); mtr-rat-itr 30 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 412, p. 283, 1998 (MUREAV); dnd-rat-lvr 200 umol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 110, 1984 (PAACA3); dna-rat-ipr 8200 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 357, 1988 (CRNGDP); dns-rat-lvr 1 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 1, 1984 (ENMUDM); dns-rat-oth 10 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 773, 1984 (CRNGDP); dni-rat-oth 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); bfa-rat-sat 10 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 36, p. 233, 1987 (TOLED5); sce-rat-orl 5 gm/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 373, 1982 (JTEHD6); mtr-mus-emb 20 mg/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 32, p. 611, 1994 (FCTOD7); dnd-mus-lvr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 151, p. 137, 1985 (MUREAV); dnd-mus-itr 100 umol/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 42, p. 159, 1988 (TOLED5); dns-mus-lvr 35 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 190, p. 159, 1987 (MUREAV); dni-mus-tes 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); mmo-ham-ovr 2 mg/L (+S9) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 373, 1982 (JTEHD6); mtr-ham-emb 4100 nmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 357, 1983 (CRNGDP); dnd-ham-lng 15 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 24, p. 121, 1984 (CALEDQ); dna-ham-ovr 10 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 2317, 1991 (CRNGDP); dns-ham-lvr 10 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 1, 1984 (ENMUDM); dni-ham-ovr 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 73, 1990 (MUREAV); oms-ham-lng 15 mg/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 2, p. 23, 1987 (MUTAEX); cyt-ham-lng 15 mg/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 2, p. 23, 1987 (MUTAEX); sce-ham-ovr 3 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 1, 1982 (ENMUDM); msc-ham-ovr 2 mg/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 373, 1982 (JTEHD6); dna-mam-lym 20 umol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 81, 1983 (PAACA3); dna-rbt-oth 8100 nmol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 19, p. 241, 1983 (CALEDQ); dna-rbt-oth 8100 nmol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 19, p. 241, 1983 (CALEDQ); dna-rbt-lng 8100 nmol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 19, p. 241, 1983 (CALEDQ); dns-rbt-lng 2500 ng/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 175, p. 259, 1986 (MUREAV); mmo-sat 0.33 ug/plate (+/-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 38, p. 1, 2000 (FCTOD7); mmo-sat 2.5 mg/plate/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 491, p. 195, 2001 (MUREAV); mmo-sat 2.5 mg/plate/48H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 491, p. 195, 2001 (MUREAV) TE: V01-R60-J60 orl-rat TDLo: 396 mg/kg/16W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4256, 1988 (CNREA8); V01-R60 ipr-rat TDLo: 20 mg/kg/4W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 13, p. 279, 1986 (DTESD7); V01-V10 scu-rat TDLo: 160 mg/kg/10W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 15, p. 1, 1982 (CALEDQ); V01-J60 ipr-mus TDLo: 1575 mg/kg/6W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1449, 1984 (CRNGDP); V01-R60-V10 scu-rat TD :198 mg/kg/8W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1158, 1984 (CNREA8); V03-R60-V10 scu-rat TD :99 mg/kg/8W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1158, 1984 (CNREA8); V02-J60 ipr-mus TD :1780 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 122, 1984 (PAACA3); V03-N62-T61 scu-rat TD :160 mg/kg/10W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 25, p. 239, 1985 (CALEDQ); V01-R60 ipr-rat TD :95566 ug/kg/4W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 51, p. 2902, 1991 (CNREA8); V02-R60 scu-rat TD :91857 ug/kg/4W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 51, p. 2902, 1991 (CNREA8); V01-R60 ipr-rat TD :29671 ug/kg/4W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1187, 1991 (CRNGDP); V02-R60 orl-rat TD :495 mg/kg/8W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 16, p. 431, 1995 (CRNGDP); V01-R60-R25 orl-rat TDLo: 100 mg/kg/20W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 151, p. 7, 2000 (CALEDQ) MD: J30-L70 ihl-rat TCLo: 500 ug/m3/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3383 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 321, 1989 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 321, 1989 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 321, 1989 (IMEMDT) SL: EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Toxicity studies, RPT# TOX-34, October 2000 Record 1013 of 1119 in RTECS (through 2003/06) AN: UR2482000 PN: Pyrene,-4-nitro- SY: 4-Nitropyrene- RN: Current: 57835-92-4 BRN: 1979733 BHR: 4-05-00-02471 UD: 200006 MF: C16-H9-N-O2 MW: 247.26 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1 nmol/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 173, 1985 (MUREAV); mmo-sat 50 ng/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 394, p. 103, 1997 (MUREAV); dnr-bcs 100 ng/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 174, p. 89, 1986 (MUREAV); dna-hmn-lng 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); msc-hmn-lym 800 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 322, p. 233, 1994 (MUREAV); dna-rat-lvr 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV); mtr-mus-emb 20 mg/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 32, p. 611, 1994 (FCTOD7); dna-ham-lng 3 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 419, p. 91, 1998 (MUREAV) TE: V01-R60 ipr-rat TDLo: 147 mg/kg/4W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 51, p. 2902, 1991 (CNREA8); V01-R60 par-rat TDLo: 15207 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 51, p. 2902, 1991 (CNREA8); V01-L60 ipr-mus TDLo: 27700 ug/kg/15D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 1317, 1986 (CRNGDP) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 367, 1989 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 367, 1989 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 46, p. 367, 1989 (IMEMDT) SL: NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1014 of 1119 in RTECS (through 2003/06) AN: UR8400000 PN: Pyridine- SY: Azabenzene-; Azine-; NCI-C55301-; Pyridin- (German); Piridina- (Italian); Pirydyna- (Polish); Pyridine- (ACGIH:OSHA); RCRA-waste-number-U196- RN: Current: 110-86-1 UD: 200302 MF: C5-H5-N MW: 79.11 WL: T6NJ CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,839,1986 (85JCAE) ME: mmo-sat 6 mmol/L/2H (-S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 4152, 1979 (CNREA8); sln-smc 10900 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 163, p. 23, 1986 (MUREAV); dns-mus-orl 700 mg/kg JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 20, p. 389, 2000 (JJATDK) TE: V02-M60 orl-rat TDLo: 24024 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-470, 2000 (NTPTR*); V01-L60 orl-mus TDLo: 25480 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-470, 2000 (NTPTR*); V03-M61 orl-rat TDLo: 17472 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-106687 (NTIS**); V01-P61 orl-rat TDLo: 7350 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-106687 (NTIS**); V02-T61 orl-rat TDLo: 26208 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-106687 (NTIS**); V01-L60 orl-mus TDLo: 25480 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-106687 (NTIS**); V01-L60 orl-mus TDLo: 11025 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2000-106687 (NTIS**) ORNG: 891000000 ng/kg. [891.000000 mg/kg] D28-F07-F24 SRNG: 1121000000 ng/kg. [1121.000000 mg/kg] F19-K01-L30 AT: D28-F07-F24 orl-rat LD50: 891 mg/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 14-4/1970 (BIOFX*); D17-F07-J22 ihl-rat LC50: 28500 mg/m3/1H BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 14-4/1970 (BIOFX*); T/E unlistd ipr-rat LD50: 866 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB195-158 (NTIS**); T/E unlistd scu-rat LD50: 866 mg/kg Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 4, p. 185, 1971 (CTOXAO); F04-F07-J22 ivn-rat LD50: 360 mg/kg Pharmacological Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 5, p. 341, 1973 (PLRCAT); F04-F07-J22 orl-mus LD50: 1500 mg/kg Pharmacological Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 5, p. 341, 1973 (PLRCAT); T/E unlistd ipr-mus LD50: 950 mg/kg Progress in Biochemical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1965- v. 1, p. 542, 1965 (PBPHAW); F04-F07-J22 scu-mus LD50: 1250 mg/kg Pharmacological Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 5, p. 341, 1973 (PLRCAT); F04-F07-J22 ivn-mus LD50: 420 mg/kg Pharmacological Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 5, p. 341, 1973 (PLRCAT); G10-H02-J25 ivn-dog LD50: 880 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 4, p. 165, 1975 (TXCYAC); F19-K01-L30 skn-rbt LD50: 1121 mg/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 14-4/1970 (BIOFX*); C08-F01 ipr-rbt LDLo: 15 mg/kg Journal of Infectious Diseases. (Univ. of Chicago Press, Journals Div., POB 37005, Chicago, IL 60637) V.1- 1904- v. 42, p. 473, 1928 (JIDIAQ); T/E unlistd scu-rbt LDLo: 800 mg/kg "Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948 -,695,1948 (85IXA4); F01-F11-J30 orl-gpg LDLo: 4 gm/kg Journal of Physiology. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1878- v. 17, p. 272, 1894 (JPHYA7); T/E unlistd skn-gpg LD50: 1 gm/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,839,1986 (85JCAE); F01-F11-J30 ipr-gpg LDLo: 870 mg/kg Journal of Physiology. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1878- v. 17, p. 272, 1894 (JPHYA7); T/E unlistd par-frg LDLo: 870 mg/kg "Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948 -,695,1948 (85IXA4); T/E unlistd orl-mam LD50: 1500 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); T/E unlistd ihl-mam LC50: 10 gm/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); F07-F24 orl-mus TDLo: 500 mg/kg JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 20, p. 389, 2000 (JJATDK); L01-Y15 orl-mus LDLo: 1000 mg/kg JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 20, p. 389, 2000 (JJATDK) MD: U01 orl-rat TDLo: 2730 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-470, 2000 (NTPTR*); P02-Z01 orl-rat TDLo: 25 mg/kg/14W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 23(7), p. 30, 1958 (GISAAA); L70-N72 orl-rat TDLo: 4200 mg/kg/28D-C BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 14-4/1970 (BIOFX*); P28-Y01-Y40 ihl-rat TCLo: 1 mg/m3/24H/60D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(11), p. 3, 1966 (GISAAA); P28-Y21 ipr-rat TDLo: 494 mg/kg/5D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 85, p. 173, 1996 (TOLED5); L70 orl-mus TDLo: 420 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-470, 2000 (NTPTR*) TR: ACGIH TLV-TWA 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 5 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); TOXICOLOGY REVIEW Pharmacological Reviews. (Williams and Wilkins, 428 E. Preston St., Baltimore, MD 21202) V.1- 1949- v. 4, p. 1, 1952 (PAREAQ) SR: MSHA STANDARD-air: TWA 5 ppm (15 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 220, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (15 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (15 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (15 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (15 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 5 ppm (15 mg/m3), JAN 1993; OEL-AUSTRALIA: TWA 5 ppm (15 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 5 ppm (15 mg/m3), JAN 1999; OEL-BELGIUM: TWA 5 ppm (16 mg/m3), JAN 1993; OEL-DENMARK: TWA 5 ppm (15 mg/m3), JAN 1999; OEL-FINLAND: TWA 5 ppm (15 mg/m3), STEL 10 ppm (30 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 5 ppm (15 mg/m3), VLE 10 ppm, JAN 1999; OEL-GERMANY: MAK 5 ppm (15 mg/m3), JAN 1999; OEL-HUNGARY: TWA 5 mg/m3, STEL 10 mg/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (15 mg/m3), JAN 1999; OEL-NORWAY: TWA 5 ppm (15 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 mg/m3, JAN 1993; OEL-POLAND: MAC(TWA) 5 mg/m3, MAC(STEL) 30 mg/me, JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWEDEN: NGV 5 ppm (16 mg/m3), KTV 10 ppm (35 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 5 ppm (15 mg/m3), KZG-W 10 ppm (30 mg/m3), JAN 1999; OEL-TURKEY: TWA 5 ppm (15 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 5 ppm (16 mg/m3), STEL 10 ppm (33 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO PYRIDINE-air: 10H TWA 5 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 65080; NIS 22; TNF 1103; NOS 18; TNE 29286; NOES 1983: HZD 65080; NIS 32; TNF 1558; NOS 42; TNE 42908; TFE 10568 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110831/AS); EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Pyridine, 1613; NIOSH Analytical Method, 1996: Pyridine, 1613; NCI Carcinogenesis Studies (water), clear evidence: mouse; NTP Carcinogenesis studies (drinking water), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-470, 2000 (NTPTR*); NCI Carcinogenesis Studies (water), equivocal evidence: rat Record 1015 of 1119 in RTECS (through 2003/06) AN: US5647790 PN: 2-Pyridinecarboxylic-acid,-chromium-salt- SY: Chromium-2-pyridinecarboxylate-; Chromium(III) trispicolinate; Chromium, tris(picolinato)-; Chromium, tris(2-pyridinecarboxylato-N(1),O(2))- (9CI); Picolinic-acid,-chromium-salt- RN: Current: 14639-25-9 UD: 200302 MF: C18-H12-Cr-N3-O6 MW: 418.33 CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: slt-ham-ovr 20 mg/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 513, p. 135, 2002 (MUREAV) AT: F08 orl-man TDLo: 8571 ng/kg/90D-I American Journal of Psychiatry. (American Psychiatric Assoc., Circulation Dept., 1400 K St., NW, Washington, DC 20005) V.78- 1921- v. 150, p. 1560, 1993 (AJPSAO) SL: NTP Carcinogenesis studies, selected, October 2000 Record 1016 of 1119 in RTECS (through 2003/06) AN: US5950000 PN: Pyridine,-2-chloro- SY: alpha-Chloropyridine-; o-Chloropyridine- RN: Current: 109-09-1 UD: 200012 MF: C5-H4-Cl-N MW: 113.55 WL: T6NJ BG CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 5 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 176, p. 185, 1987 (MUREAV); sln-smc 4000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 163, p. 23, 1986 (MUREAV); mnt-mus-lym 1920 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 57, 1993 (MUREAV); mmo-mus-lym 400 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 57, 1993 (MUREAV); cyt-mus-lym 1920 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 57, 1993 (MUREAV); msc-mus-lym 1980 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 57, 1993 (MUREAV) SRNG: 64000000 ng/kg. [64.000000 mg/kg] L30 AT: F07-F25-L30 ihl-rat LCLo: 100 ppm/4H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 11, p. 361, 1967 (TXAPA9); F07-F25-L30 orl-mus LD50: 110 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 11, p. 361, 1967 (TXAPA9); F07-F25-L03 ipr-mus LD50: 130 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 11, p. 361, 1967 (TXAPA9); L30 skn-rbt LD50: 64 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 11, p. 361, 1967 (TXAPA9); F07-F25-L03 ipr-rbt LD50: 48 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 11, p. 361, 1967 (TXAPA9); T/E unlistd orl-bwd LD50: 1 gm/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 1017 of 1119 in RTECS (through 2003/06) AN: US6475000 PN: Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1) SY: 1-(N,N-Dimethylamino)-3-(p-chlorophenyl-3-alpha-pyridyl)propane maleate; 1-(p-Chlorphenyl)-1-(2-pyridyl)-3-dimethylaminopropan maleat (German); 1-p-Chlorophenyl-1-(2-pyridyl)-3-dimethylaminopropane maleate; 2-Pyridinepropanamine-; 2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-, (Z)-2-butenedioate (1:1) (9CI); Allerclor-; Allergin-; Alunex-; Antagonate-; C-Meton-; Carbinoxamide-maleate-; Chlor-trimeton-; Chlor-tripolon-; Chlormene-; Chloropheniramine-maleate-; Chloroprophenpyridamine-maleate-; Chlorpheniramine-maleate-; Histadur-dura-tabs-; Ibioton-; Lorphen-; M.P. chlorcaps T.D.; NCI-C55265-; Neorestamin-; Piriex-; Piriton-; Polaronil- (German); Pyridamal-100-; Synistamin-; Teldrin-; dl-2-(p-Chloro-alpha-2-(dimethylamino)ethylbenzyl)pyridine maleate; gamma-(4-Chlorophenyl)-N,N-dimethyl (Z)-2-butenedioate RN: Current: 113-92-8 UD: 200210 MF: C16-H19-Cl-N2.C4-H4-O4 MW: 390.90 WL: T6NJ BYR DG&2N1&1 &OV1U1VO CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mnt-ham-lng 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 411, p. 235, 1998 (MUREAV); cyt-ham-ovr 500 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-317, 1986 (NTPTR*); sce-ham-ovr 125 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-317, 1986 (NTPTR*) RE: T71-T75-T76 orl-mus TDLo: 420 mg/kg (1-21D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 18, p. 188, 1968 (ARZNAD); T25-T27 orl-mus TDLo: 4200 mg/kg (1-21D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 18, p. 188, 1968 (ARZNAD) TE: V02-N62 orl-mus TDLo: 51500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-146759/AS (NTIS**) ORNG: 306000000 ng/kg. [306.000000 mg/kg] D17-F12-F13 AT: D17-F12-F13 orl-rat LD50: 306 mg/kg Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 12, p. 1371, 1978 (KSRNAM); T/E unlistd scu-rat LD50: 365 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 185, 1971 (TXAPA9); T/E unlistd orl-mus LD50: 130 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 28, p. 1644, 1978 (ARZNAD); F12-F13 ipr-mus LD50: 76700 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 113, p. 72, 1955 (JPETAB); F12-F13 scu-mus LD50: 104 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 113, p. 72, 1955 (JPETAB); T/E unlistd ivn-mus LD50: 26100 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 23, p. 537, 1972 (TXAPA9); F11-F12 ivn-dog LD50: 97600 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 113, p. 72, 1955 (JPETAB); F11-F12 orl-gpg LD50: 198 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 113, p. 72, 1955 (JPETAB); F11-F12 scu-gpg LD50: 101 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 113, p. 72, 1955 (JPETAB); T/E unlistd ivn-gpg LD50: 68 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 113, p. 313, 1958 (AIPTAK); T/E unlistd orl-bwd LD50: 75 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 315, 1972 (TXAPA9) MD: Z01 orl-rat TDLo: 1120 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-317, 1986 (NTPTR*); F07-F11-Z01 orl-mus TDLo: 600 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-317, 1986 (NTPTR*) TR: TOXICOLOGY REVIEW Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- v. 12, p. 27, 1974 (JRPMAP) ND: NOHS 1974: HZD 84323; NIS 5; TNF 1601; NOS 12; TNE 7109; NOES 1983: HZD 84323; NIS 3; TNF 771; NOS 19; TNE 14566; TFE 10522 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat Record 1018 of 1119 in RTECS (through 2003/06) AN: US6825000 PN: Pyridine,-2-chloromethyl-,-hydrochloride- SY: 2-(Chloromethyl) pyridine, hydrochloride; NCI-C03907-; 2-Picolyl-chloride-hydrochloride-; 2-Pyridylmethylchloride-hydrochloride- RN: Current: 6959-47-3 UD: 199904 MF: C6-H6-Cl-N.Cl-H MW: 164.04 WL: T6NJ B1G &GH CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1 mg/plate (+/-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) APR1982 (NTPTB*); oms-esc 95250 nmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19, p. 98, 1992 (EMMUEG); slt-dmg-orl 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 161, 1995 (MUREAV) ORNG: 316000000 ng/kg. [316.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 316 mg/kg Progress Report for Contract No. NIH-NCI-E-C-72-3252, Submitted to the National Cancer Institute by Litton Bionetics, Inc. (Bethesda, MD) NCI-E-C-72-3252, 1973 (NCILB*); T/E unlistd orl-mus LD50: 316 mg/kg Progress Report for Contract No. NIH-NCI-E-C-72-3252, Submitted to the National Cancer Institute by Litton Bionetics, Inc. (Bethesda, MD) NCI-E-C-72-3252, 1973 (NCILB*) SL: EPA GENETOX PROGRAM 1988, Negative/limited: Carcinogenicity-mouse/rat; NCI Carcinogenesis Bioassay (gavage), no evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-178, 1979 (NCITR*) Record 1019 of 1119 in RTECS (through 2003/06) AN: US7875000 PN: Pyridine, 2,6-diamino-3-(phenylazo)-, monohydrochloride SY: Azodyne-; 2,6-Diamino-3-phenylazopyridine-hydrochloride-; 2,6-Diamino-3-(phenylazo)pyridine monohydrochloride; Diridone-; Dolonil-; Eucistin-; Giracid-; Mallofeen-; Mallophene-; NC-150-; NCI-C01672-; Nefrecil-; Phenazodine-; Phenazopyridine-hydrochloride-; Phenazopyridinium-chloride-; Phenylazodiaminopyridine-hydrochloride-; beta-Phenylazo-alpha,alpha'-diaminopyridine-hydrochloride-; 3-Phenylazo-2,6-diaminopyridine-hydrochloride-; Phenylazo-alpha,alpha'-diaminopyridine-monohydrochloride-; 3-(Phenylazo)-2,6-pyridinediamine, hydrochloride; Phenylazopyridine-hydrochloride-; Phenylazo-tablets-; Phenyl-idium-; Phenyl-idium-200-; 2,6-Pyridinediamine, 3-(phenylazo)-, monohydrochloride; Bisteril-; Pirid-; Pyridium-; Pyridivite-; Pyripyridium-; Pyrizin-; Sedural-; Thiosulfil-A-forte-; Urazium-; Uridinal-; Uriplex-; Urobiotic-250-; Urodine-; W-1655- RN: Current: 136-40-3 UD: 200006 MF: C11-H11-N5.Cl-H MW: 249.73 WL: T6NJ BZ CNUNR& FZ &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: dns-rat-lvr 60 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 315, p. 147, 1994 (MUREAV); mnt-mus-ipr 155 mg/kg/48H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); slt-mus-lym 20 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 17, p. 196, 1991 (EMMUEG); dnd-mus-orl 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 465, p. 11, 2000 (MUREAV); cyt-ham-ovr 30 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 10 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V01-K61 orl-rat TDLo: 225 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-99, 1978 (NCITR*); V01-L60 orl-mus TDLo: 81 gm/kg/80W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-99, 1978 (NCITR*); V03-K61 orl-rat TD :110 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-99, 1978 (NCITR*); V03-L60 orl-mus TD :40 gm/kg/78W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-99, 1978 (NCITR*) ORNG: 472000000 ng/kg. [472.000000 mg/kg] T/E unlistd AT: K12-M03-M11 orl-man TDLo: 114 mg/kg Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- v. 2, p. 539, 1983 (HUTODJ); B03 orl-man TDLo: 86 mg/kg/10D-I Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 106, p. 164, 1987 (AIMEAS); H01-M14-P24 orl-chd TDLo: 35 mg/kg American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 117, p. 369, 1969 (AJDCAI); F07-J24 orl-chd TDLo: 400 mg/kg American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 110, p. 105, 1965 (AJDCAI); K12-M11-U05 orl-wmn TDLo: 34 mg/kg Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 72, p. 89, 1970 (AIMEAS); J24-P23-P24 orl-chd TDLo: 125 mg/kg Clinical Pediatrics (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1962- v. 10, p. 537, 1971 (CPEDAM); K13-P05-U03 orl-wmn TDLo: 140 mg/kg Canadian Medical Association Journal. (Canadian Medical Assoc., POB 8650, Ottawa, ON K1G 0G8, Canada) V.1- 1911- v. 91, p. 756, 1964 (CMAJAX); T/E unlistd orl-rat LD50: 472 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 1, p. 42, 1959 (TXAPA9); F07-J02-J22 ipr-rat LDLo: 200 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 51, p. 200, 1934 (JPETAB); T/E unlistd ivn-mus LD50: 180 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#04014 (CSLNX*) MD: C07-L03-Z01 ivn-dog TDLo: 1 gm/kg/24D-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 51, p. 200, 1934 (JPETAB) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 24, p. 163, 1980 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 24, p. 163, 1980 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 312, 1987 (IMSUDL) ND: NOHS 1974: HZD 83539; NIS 1; TNF 68; NOS 6; TNE 2770; NOES 1983: HZD 83539; NIS 1; TNF 94; NOS 2; TNE 2546; TFE 1328 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-99, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1020 of 1119 in RTECS (through 2003/06) AN: UT1750000 PN: Pyridine, 2-((2-(dimethylamino)ethyl)-2-thenylamino)-, monohydrochloride SY: Barhist-; Compound-01013-; Coryzol-; 2-((2-(Dimethylamino)ethyl)-2-thenyl-amino)pyridine hydrochloride; N,N-Dimethyl-N'-(2-pyridyl)-N'-(2-thenyl)ethylenediamine hydrochloride; N,N-Dimethyl-N'-(2-thenyl)-N'-(2-pyridyl-ethylene-diamine hydrochloride); Dozar-; 1,2-Ethanediamine, N,N-dimethyl-N'-2-pyridinyl-N'-(2-thienylmethyl)-, monohydrochloride; Ethylenediamine, N,N-dimethyl-N'-(2-pyridyl)-N'-(2-thenyl)-, hydrochloride; Lullamin-; Methacon-; Methapyrilene-hydrochloride-; Methoxylene-; Blue-Line-; Capathyn-; Histadyl-; Histafed-; Pyrathyn-; Semikon-hydrochloride-; Somnicaps-; Tem-Histine-; Teralin-; Thenylene-hydrochloride-; Thenylpyramine-hydrochloride-; W-53-hydrochloride- RN: Current: 135-23-9 UD: 200012 MF: C14-H19-N3-S.Cl-H MW: 297.88 WL: T6NJ BNZN1&1&1- BT5SJ &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: mmo-sat 2500 ug/plate (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 243, 1988 (EMMUEG); mmo-smc 500 mg/L (-S9) IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 57, p. 721, 1984 (IAPUDO); mrc-smc 1250 mg/L IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 57, p. 721, 1984 (IAPUDO); mtr-rat-orl 350 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 49, p. 79, 1981 (ARTODN); dns-rat-orl 105 mg/kg/1W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2453, 1992 (CRNGDP); dns-rat-lvr 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3010, 1982 (CNREA8); oms-rat-lvr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 131, 1984 (MUREAV); mmo-mus-lym 300 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 285, 1987 (MUREAV); cyt-mus-lym 400 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 285, 1987 (MUREAV); msc-mus-lym 300 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 229, 1986 (ENMUDM); mnt-ham-lng 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 411, p. 235, 1998 (MUREAV); mtr-ham-emb 300 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 515, 1986 (ENMUDM); cyt-ham-ovr 2500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 77, 1994 (MUREAV); cyt-ham-lng 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 341, p. 77, 1994 (MUREAV) TE: V01-L60 orl-rat TDLo: 9100 mg/kg/26W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 66, p. 252, 1982 (TXAPA9); V01-L60 orl-rat TD :18200 mg/kg/26W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 66, p. 252, 1982 (TXAPA9); V01-L60 orl-rat TD :22 gm/kg/64W-C Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 209, p. 817, 1980 (SCIEAS); V01-L60 orl-rat TD :9625 mg/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 27, 1984 (FCTOD7); V03-L60 orl-rat TD :4813 mg/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 27, 1984 (FCTOD7); V03-L60 orl-rat TD :10080 mg/kg/24W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 74, p. 63, 1984 (TXAPA9) ORNG: 200000000 ng/kg. [200.000000 mg/kg] T/E unlistd AT: K05 orl-man TDLo: 429 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 90, p. 83, 1947 (JPETAB); T/E unlistd orl-rat LD50: 200 mg/kg Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 59, p. 1131, 1970 (JPMSAE); T/E unlistd scu-rat LD50: 150 mg/kg "Handbook of Analytical Toxicology," Sunshine, I., ed., Cleveland, OH, Chemical Rubber Co., 1969 -,73,1969 (29ZVAB); T/E unlistd orl-mus LD50: 182 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 90, p. 83, 1947 (JPETAB); F13-F23-J22 ipr-mus LD50: 90 mg/kg Bulletin of the Johns Hopkins Hospital. (Baltimore, MD) V.1-119, 1889-1966. For publisher information, see JHMJAX. v. 81, p. 55, 1947 (JHHBAI); F12 scu-mus LD50: 75 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 93, p. 210, 1948 (JPETAB); F12 ivn-mus LD50: 17500 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 93, p. 210, 1948 (JPETAB); T/E unlistd ivn-gpg LD50: 14600 ug/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 113, p. 313, 1958 (AIPTAK) MD: L30 orl-rat TDLo: 686 mg/kg/14W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-00-4407 (NTPTR*) ND: NOHS 1974: HZD 80458; NIS 5; TNF 197; NOS 12; TNE 4170; NOES 1983: HZD 80458; NIS 1; TNF 35; NOS 2; TNE 1698; TFE 1135 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9223, 8EHQ-0892-9286; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: rat Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 27, 1984 (FCTOD7); NCI Carcinogenesis Studies (feed), clear evidence: rat Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 209, p. 817, 1980 (SCIEAS); NTP Toxicity studies, RPT# TOX-46, October 2000 Record 1021 of 1119 in RTECS (through 2003/06) AN: UV9100000 PN: 4,6(1H,5H)-Pyrimidinedione, 5-ethyldihydro-5-phenyl- SY: 5-Aethyl-5-phenyl-hexahydropyrimidin-4,6-dion- (German); 5-Ethyldihydro-5-phenyl-4,6(1H,5H)-pyrimidinedione; 5-Ethylhexahydro-4,6-dioxo-5-phenylphrimidine-; 5-Ethylhexahydro-5-phenylpyrimidine-4,6-dione-; 5-Ethyl-5-phenylhexahydropyrimidine-4,6-dione-; Mylepsin-; Mylepsinum-; Mysedon-; Mysoline-; 5-Phenyl-5-aethylhexahydropyrimidindion-(4,6) (German); 5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione-; Cyral-; 2-Deoxyphenobarbital-; 2-Desoxyphenobarbital-; Desoxyphenobarbitone-; Hexadiona-; Hexamidine-; Hexamidine- (the antispasmodic); Lepimidin-; Lepsiral-; Majsolin-; Midone-; Milepsin-; Misodine-; Misolyne-; Mizodin-; Mizolin-; NCI-C56360-; Prilepsin-; Primacione-; Primaclone-; Primacone-; Primadon-; Primakton-; Primidon-; Primidone-; Prysoline-; ROE-101-; Sertan-; Pyrimidone-medi-pets- RN: Current: 125-33-7 BRN: 218034 BHR: 5-24-08-00102 UD: 200305 MF: C12-H14-N2-O2 MW: 218.28 WL: T6MV DVMTJ C2 CR CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 6666 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); cyt-hmn-leu 1 mg/L American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 116, p. 867, 1973 (AJOGAH); cyt-hmn-lym 375 mg/L Acta Geneticae Medicae et Gemellologiae. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1952- v. 21, p. 305, 1972 (AGMGAK); spm-mus-orl 875 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 34, p. 149, 1986 (TOLED5); mnt-ham-emb 250 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 392, p. 61, 1997 (MUREAV); mtr-mus-fbr 0.1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T43-T44-T47 orl-wmn TDLo: 10350 mg/kg (1-39W preg) Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 94, p. 835, 1979 (JOPDAB); T77-T81 orl-wmn TDLo: 10350 mg/kg (1-39W preg) Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- v. 94, p. 835, 1979 (JOPDAB); T43-T47-T74 orl-wmn TDLo: 2025 mg/kg (1-39W preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 32, p. 13, 1985 (TJADAB); T84-T86 unr-wmn TDLo: 10640 mg/kg (1-38W preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 26(1), p. 36A, 1982 (TJADAB); T46 orl-mus TDLo: 330 mg/kg (6-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 40, p. 365, 1977 (TXAPA9); T41 orl-mus TDLo: 990 mg/kg (6-16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 40, p. 365, 1977 (TXAPA9); T01 orl-mus TDLo: 875 mg/kg (5D male) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 34, p. 149, 1986 (TOLED5); T43 orl-mus TDLo: 275 mg/kg (6-16D preg) Epilepsia (New York). (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) Ser.1-3: 1909-55: Ser.4: V.1- 1959- v. 18, p. 1, 1977 (EPILAK); T16 orl-mus TDLo: 5.5 gm/kg (15W male/15W pre/3W preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-128396 (NTIS**); T51-T81 orl-mus TDLo: 233 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-128396 (NTIS**); T53 orl-mus TDLo: 233 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-128396 (NTIS**) TE: V01-L60 orl-mus TDLo: 18200 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-476, 2000 (NTPTR*); V03-N62 orl-rat TDLo: 56238 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2001-102004 (NTIS**); V01-L60 orl-mus TDLo: 25956 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB2001-102004 (NTIS**) ORNG: 1500000000 ng/kg. [1500.000000 mg/kg] T/E unlistd AT: F07-F27-K13 orl-wmn TDLo: 5 mg/kg Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 266, p. 102, 1954 (LANCAO); F01-F04-F17 orl-chd TDLo: 625 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 90, 1957 (BMJOAE); F07-F19-F25 orl-wmn TDLo: 450 mg/kg Archives of Neurology (Chicago). (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.3- 1960- v. 30, p. 255, 1974 (ARNEAS); F08-F10 orl-wmn TDLo: 38 gm/kg/7Y-I Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969- v. 17, p. 551, 1983 (DICPBB); T/E unlistd orl-rat LD50: 1500 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 691, 1982 (NIIRDN); T/E unlistd ipr-rat LD50: 240 mg/kg Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- v. 25, p. 305, 1991 (PCJOAU); T/E unlistd unr-rat LD50: >2 gm/kg British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 8, p. 230, 1953 (BJPCAL); T/E unlistd orl-mus LD50: 280 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 34, p. 271, 1975 (TXAPA9); F02 ipr-mus LD50: 332 mg/kg Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- v. 15, p. 403, 1981 (PCJOAU); F02 unr-mus LD50: 340 mg/kg Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- v. 43, p. 73, 1980 (RPTOAN); F02 ipr-mus TDLo: 34 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 50, p. 15, 1987 (FATOAO) MD: F19-U01-Z01 orl-rat TDLo: 10500 mg/kg/14D-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 151, 1992 (TOXID9); L30-U01 orl-rat TDLo: 17062 mg/kg/13W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 151, 1992 (TOXID9); F19-Z01 orl-mus TDLo: 27440 mg/kg/14D-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 151, 1992 (TOXID9); F07-F19-Z01 orl-mus TDLo: 89 gm/kg/13W-C Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 12, p. 151, 1992 (TOXID9); F05-F19 orl-mky TDLo: 2 gm/kg/4D-I British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. v. 8, p. 230, 1953 (BJPCAL); U01 orl-mus TDLo: 840 mg/kg/35D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-128396 (NTIS**) TR: TOXICOLOGY REVIEW Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969- v. 8, p. 690, 1974 (DICPBB); TOXICOLOGY REVIEW Australian Journal of Hospital Pharmacy. (B.R. Miller, POB 125, Heidelberg, Vic., Australia) V.1- 1971- v. 4(1), p. 5, 1974 (AUHPAI); TOXICOLOGY REVIEW Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. (ADIS Press International Inc., Suite B-30, Oxford Ct. Business Center, 582 Middletown Blvd., Langhorne, PA 19047) V.1- 1971- v. 8, p. 354, 1974 (DRUGAY); TOXICOLOGY REVIEW Proceedings of the Royal Society of Medicine. (New York, NY) V.1-70, 1907-77. For publisher information, see JRSMD9. v. 63, p. 48, 1970 (PRSMA4); TOXICOLOGY REVIEW British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 442, 1973 (BMJOAE); TOXICOLOGY REVIEW American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 131, p. 1337, 1977 (AJDCAI) ND: NOES 1983: HZD X4105; NIS 3; TNF 416; NOS 6; TNE 11085; TFE 6869 SL: NCI Carcinogenesis Studies (feed), clear evidence: mouse; NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NTP Carcinogenesis studies, test completed (post peer review), October 2000 Record 1022 of 1119 in RTECS (through 2003/06) AN: UX1400000 PN: Pyrocatechol,-4-tert-butyl- SY: 1,2-Benzenediol, 4-(1,1-dimethylethyl)-; 4-TBC-; 4-Tertiary-butyl-catechol-; 4-t-Butylcatechol-; 4-t-Butylpyrocatechol-; 4-tert-Butyl-1,2-benzenediol-; 4-tert-Butylpyrokatechin- (Czech); Synox-TBC-; p-t-Butylpyrocatechol- RN: Current: 98-29-3 BRN: 2043335 BHR: 4-06-00-06014 UD: 200204 MF: C10-H14-O2 MW: 166.24 WL: QR BQ DX1&1&1 CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 750 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,236,1986 (85JCAE); skn-hmn 1%/7D MOD Acta Dermato-Venereologica. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) V.1- 1920- v. 55, p. 190, 1970 (ADVEA4) ME: msc-mus-lym 80 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 523, 1988 (EMMUEG) ORNG: 2820000000 ng/kg. [2820.000000 mg/kg] T/E unlistd SRNL: 630000 nL/kg. [0.630000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2820 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 61, 1954 (AMIHBC); D28-F07-R21 skn-rat LDLo: 2 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0571349 (NTIS**); T/E unlistd ivn-mus LD50: 32 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#07874 (CSLNX*); T/E unlistd skn-rbt LD50: 630 uL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 61, 1954 (AMIHBC) ND: NOHS 1974: HZD 83681; NIS 7; TNF 362; NOS 13; TNE 3887; NOES 1983: HZD 83681; NIS 24; TNF 1695; NOS 43; TNE 27528; TFE 4295 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1023 of 1119 in RTECS (through 2003/06) AN: UX2800000 PN: Pyrogallol- SY: C.I. 76515; C.I. Oxidation Base 32; Benzene,-1,2,3-trihydroxy-; 1,2,3-Benzenetriol-; Fouramine-Brown-AP-; Fourrine-PG-; Fourrine-85-; Pyrogallic-acid-; 1,2,3-Trihydroxybenzen- (Czech); 1,2,3-Trihydroxybenzene- RN: Current: 87-66-1 BRN: 907431 BHR: 4-06-00-07327 UD: 200012 MF: C6-H6-O3 MW: 126.12 WL: QR BQ CQ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,235,1986 (85JCAE); eye-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,235,1986 (85JCAE) ME: mmo-sat 1 umol/plate (+/-S9) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 38, p. 533, 1983 (NEZAAQ); mmo-esc 78 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 412, p. 17, 1998 (MUREAV); dna-esc 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dnr-bcs 50 mg/L Eisei Kagaku. Hygienic Chemistry. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1953- v. 32, p. 171, 1986 (ESKGA2); mrc-smc 300 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 109, 1984 (MUREAV); sln-dmg-orl 125 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 91, 1981 (MUREAV); mnt-mus-ipr 252 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 91, 1981 (MUREAV); mnt-mus-orl 504 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 91, 1981 (MUREAV); cyt-mus-ipr 100 umol/kg Indian Journal of Medical Research. (Indian Council of Medical Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913- v. 59, p. 1442, 1971 (IJMRAQ); mnt-ham-lng 50 umol/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 82, p. 81, 1989 (EVHPAZ); cyt-ham-ovr 100 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 14, p. 251, 1981 (CALEDQ); sce-ham-lng 25 umol/L EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 82, p. 81, 1989 (EVHPAZ) RE: T25-T34 orl-rat TDLo: 3 gm/kg (6-15D preg) Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 2(4), p. 325, 1983 (JACTDZ); T12 scu-rat TDLo: 5 mg/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 57, p. 466, 1955 (ENDOAO) TE: V03-V10 scu-rat TDLo: 3950 mg/kg/58W-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 20, p. 117, 1979 (PAACA3) AT: F12-J22-K30 orl-hmn LDLo: 28 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,507,1969 (34ZIAG); F12-F13-K01 scu-man LDLo: 120 mg/kg Znetralbaltt fuer die Medizinischen Wissenschaften. (Berlin, Germany) v. 19, p. 545, 1881 (ZMWIAJ); T/E unlistd scu-rat LDLo: 650 mg/kg Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 17, p. 497, 1969 (JAFCAU); T/E unlistd orl-mus LD50: 300 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 38(8), p. 6, 1973 (GISAAA); T/E unlistd ipr-mus LD50: 400 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD691-490 (NTIS**); T/E unlistd scu-mus LD50: 566 mg/kg Zeitschrift fuer die Gesamte Innere Medizin und Ihre Grenzgebiete. (Buchexport, Postfach 160, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1946- v. 2, p. 333, 1947 (ZGIMAL); T/E unlistd orl-dog LDLo: 25 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 254, 1955 (HBTXAC); T/E unlistd scu-dog LDLo: 300 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 254, 1955 (HBTXAC); T/E unlistd ivn-dog LDLo: 80 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 1, p. 254, 1955 (HBTXAC); K05-J16 orl-rbt LD50: 1600 mg/kg American Journal of Veterinary Research. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.1- 1940- v. 23, p. 1264, 1962 (AJVRAH); T/E unlistd scu-rbt LDLo: 1 gm/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); D15-F18-F19 scu-frg LDLo: 200 mg/kg Revue Medicale de la Suisse Romande. (Societe Medicale de La Suisse Romande, 2 rue Bellefontaine, 1003 Lausanne, Switzerland) V.1- 1881- v. 15, p. 561, 1895 (RMSRA6); T/E unlistd orl-bwd LD50: 75 mg/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV) MD: Z01 orl-ckn TDLo: 98 gm/kg/4W-I Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 29, p. 568, 1970 (FEPRA7) TR: TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 75, 1978 (MUREAV) ND: NOHS 1974: HZD 81963; NIS 22; TNF 848; NOS 25; TNE 19191; NOES 1983: HZD 81963; NIS 8; TNF 2175; NOS 14; TNE 38038; TFE 24931 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 1024 of 1119 in RTECS (through 2003/06) AN: UY1575000 PN: Pyrrolidine,-1-nitroso- SY: N-Nitrosopyrrolidin- (German); N-Nitrosopyrrolidine-; 1-Nitrosopyrrolidine-; Pyrrole,-tetrahydro-N-nitroso-; RCRA-waste-number-U180- RN: Current: 930-55-2 Previous: 68374-63-0 BRN: 107615 BHR: 5-20-01-00521 UD: 200302 MF: C4-H8-N2-O MW: 100.14 WL: T5NTJ ANO CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 100 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 67, p. 21, 1979 (MUREAV); mmo-esc 7500 umol/L (+S9) IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 543, 1982 (IAPUDO); dnr-esc 400 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 53, 1977 (MUREAV); pic-esc 225 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); dnr-bcs 1500 ug/disc Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- v. 97, p. 320, 1977 (YKKZAJ); slt-dmg-orl 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 271, p. 59, 1992 (MUREAV); dnd-hmn-lng 100 umol/plate Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 59, p. 1401, 1977 (JNCIAM); dns-hmn-lvr 3200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); mtr-rat-lvr 10 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5087, 1983 (CNREA8); dnd-rat-orl 5 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-lvr 18 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dns-rat-lvr 500 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); msc-rat-lvr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 53, 1984 (MUREAV); hma-rat-sat 50 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1901, 1988 (CRNGDP); dnd-mus-ipr 600 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dns-mus-lvr 1 mmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 1, 1983 (ENMUDM); hma-mus-esc 48 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 263, 1994 (CRNGDP); mmo-ham-lng 10 mmol/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 1044, 1977 (CNREA8); dns-ham-lvr 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 1, 1983 (ENMUDM); mmo-sat 9 ug/plate/48H (+S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 523, 2001 (MUTAEX); mmo-sat 50 ug/plate/30M (+S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 638, 2000 (ARTODN) TE: V01-L60 orl-rat TDLo: 476 mg/kg/3.3Y-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1635, 1987 (CRNGDP); V02-J60-L60 orl-mus TDLo: 3235 mg/kg/92W-C "Chemical Tumour Problems," Nakahara, W., ed., Tokyo, Japanese Soc. for the Promotion of Science, 1970 -,129,1970 (85DUA4); V02-J60 ipr-mus TDLo: 100 mg/kg/7W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 71, p. 25, 1993 (CALEDQ); V02-J60-L60 scu-mus TDLo: 396 mg/kg/72W-I "Chemical Tumour Problems," Nakahara, W., ed., Tokyo, Japanese Soc. for the Promotion of Science, 1970 -,129,1970 (85DUA4); V01-L60 orl-ham TDLo: 465 mg/kg/52W-C Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 104, p. 75, 1982 (JCROD7); V01-D09-J60 ipr-ham TDLo: 1602 mg/kg/25W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 2849, 1981 (CNREA8); V01-D09-J60 unr-ham TDLo: 1602 mg/kg/25W-I IARC Publications. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.27- 1979- v. 41, p. 635, 1982 (IAPUDO); V02-D09-J60 ipr-ham TD :798 mg/kg/25W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 2849, 1981 (CNREA8); V03-L60 orl-rat TD :1350 mg/kg/30W-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 126, 1984 (PAACA3); V01-L60 orl-ham TD :704 mg/kg/39W-C Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 104, p. 75, 1982 (JCROD7); V01-L60-V08 orl-rat TD :792 mg/kg/2Y-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 26, p. 47, 1980 (IJCNAW); V01-L60 orl-rat TD :2250 mg/kg/50W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 12, p. 99, 1981 (CALEDQ); V01-L60 orl-rat TD :685 mg/kg/98W-C Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 161, 1977 (ZKKOBW); V01-L60 orl-rat TD :1599 mg/kg/76W-C Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 161, 1977 (ZKKOBW); V01-L60 orl-rat TD :4380 mg/kg/52W-C Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- v. 97, p. 320, 1977 (YKKZAJ); V01-L60 orl-ham TD :1049 mg/kg/64W-C Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 104, p. 75, 1982 (JCROD7); V01-L60 orl-rat TD :4033 mg/kg/62W-C IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 14, p. 429, 1976 (IARCCD) ORNG: 900000000 ng/kg. [900.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 900 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); T/E unlistd orl-mus LD50: 125 mg/kg "Chemical Tumour Problems," Nakahara, W., ed., Tokyo, Japanese Soc. for the Promotion of Science, 1970 -,129,1970 (85DUA4); T/E unlistd scu-mus LD50: 125 mg/kg "Chemical Tumour Problems," Nakahara, W., ed., Tokyo, Japanese Soc. for the Promotion of Science, 1970 -,129,1970 (85DUA4); T/E unlistd orl-ham LD50: 1023 mg/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 104, p. 75, 1982 (JCROD7) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 313, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 313, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; NIOSH Analytical Method, 1994: Nitrosamines, 2522; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #27 Record 1025 of 1119 in RTECS (through 2003/06) AN: VB4900000 PN: Quinoline,-1,2-dihydro-2,2,4-trimethyl- SY: Acetone-anil-; Acetone-anil- (quinoline deriv.); Agerite-resin-D-; 1,2-Dihydro-2,2,4-trimethylquinoline-; Flectol-A-; Flectol-pastilles-; NCI-C60902-; Polnox-R-; Good-rite-3140-; Hydroquin-; 2,2,4-Trimethyl-1,2-dihydrochinolin- (Czech); Trimethyl-1,2-dihydroquinoline-; 2,2,4-Trimethyl-1,2-dihydroquinoline-; Vulkanox HS/LG; Vulkanox HS/powder RN: Current: 147-47-7 UD: 200302 MF: C12-H15-N MW: 173.28 WL: T66 BM CHJ C1 C1 E1 CC: Tumorigen (C) TE: V02-M61 skn-rat TDLo: 26 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-456, 1997 (NTPTR*); V03-M61 skn-rat TDLo: 18540 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB98-101009 (NTIS**) ORNG: 2000000000 ng/kg. [2000.000000 mg/kg] F07 AT: F07 orl-rat LD50: 2 gm/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 31(1-3), p. 183, 1966 (HYSAAV); F07 orl-mus LD50: 1450 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 31(1-3), p. 183, 1966 (HYSAAV); T/E unlistd orl-rbt LD50: 2 gm/kg International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury, Shropshire SY4 4NR, UK) v. 3, p. 93, 1976 (IPSTB3) MD: L14-Z01 orl-rat TDLo: 12 gm/kg/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(2), p. 25, 1966 (GISAAA); M16-P28-U01 ihl-rat TCLo: 12500 ug/m3/4H/21W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 9(8), p. 32, 1965 (GTPZAB); L70-N74-U01 skn-rat TDLo: 18200 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-456, 1997 (NTPTR*) ND: NOHS 1974: HZD M2990; NIS 9; TNF 237; NOS 9; TNE 2135; NOES 1983: HZD M2990; NIS 2; TNF 190; NOS 8; TNE 8109; TFE 1529 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (dermal), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-456, 1997 (NTPTR*); NCI Carcinogenesis Studies (derm), equivocal evidence: rat; NCI Carcinogenesis Studies (derm), no evidence: mouse; NTP Carcinogenesis Studies (dermal), no evidence: mouse National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-456, 1997 (NTPTR*) Record 1026 of 1119 in RTECS (through 2003/06) AN: VC4200000 PN: 8-Quinolinol- SY: Bioquin-; 8-Chinolinol- (Czech); Fennosan-; Fennosan-HF-15-; Hydroxybenzopyridine-; 8-Hydroxy-chinolin- (German); 8-Hydroxyquinoline-; NCI-C55298-; 8-OQ-; Oxin-; Oxine-; Oxybenzopyridine-; Oxychinolin-; o-Oxychinolin- (German); Oxyquinoline-; 8-Oxyquinoline-; Phenopyridine-; 8-Quinol-; Quinophenol-; Tumex-; USAF-EK-794- RN: Current: 148-24-3 BRN: 114512 BHR: 5-21-03-00252 UD: 200210 MF: C9-H7-N-O MW: 145.17 WL: T66 BNJ JQ CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 11, p. 497, 1992 (JACTDZ); eye-rbt 100 mg MLD Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 11, p. 497, 1992 (JACTDZ) ME: mmo-sat 10 ug/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11(Suppl 12), p. 1, 1988 (EMMUEG); dna-esc 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); mmo-bcs 10 mmol/L (-S9) Fiziologicheski Aktivnye Veshchestva. Physiologically Active Substances. (Izdatel'stvo Naukova Dumka, Kiev, USSR) No.1- 1966- v. 6, p. 118, 1974 (FAVUAI); cyt-oin-par 600 mg/L Environment and Ecology. (Environment and Ecology, C/o Dr. S.K. Konar, Dept. of Zoology, Kalyani University, Kalyani 741253, West Bengal, India) V.1- 1983- v. 6, p. 311, 1988 (ENECEV); dni-hmn-hla 25 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); bfa-rat-sat 600 mg/kg Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 34, p. 231, 1985 (TXCYAC); mnt-mus-ipr 100 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 111, 1989 (TCMUD8); msc-mus-lym 400 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11, p. 91, 1988 (EMMUEG); oms-ham-ovr 40 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 45, 1992 (MUREAV); cyt-ham-ovr 7500 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 2600 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V03-R60-T61 orl-rat TDLo: 29 gm/kg/48W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 41, p. 985, 1968 (JNCIAM); V03-T63 ivg-rat TDLo: 33 gm/kg/82W-I Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 79, p. 245, 1965 (ARPAAQ); V03-J60-T63 skn-mus TDLo: 7200 mg/kg/50W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 16(8), p. 67, 1970 (VOONAW); V03-J60-T63 scu-mus TDLo: 900 mg/kg/21W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 16(8), p. 67, 1970 (VOONAW); V01-M60 imp-mus TDLo: 50 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 11, p. 212, 1957 (BJCAAI); V03-P61-T63 ivg-mus TDLo: 5600 mg/kg/35W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 16(8), p. 67, 1970 (VOONAW); V03-J60-T64 orl-rat TD :34 gm/kg/84W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 16(8), p. 67, 1970 (VOONAW); V02-M60 imp-mus TD :80 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 11, p. 212, 1957 (BJCAAI); V01-M60-V10 imp-mus TD :100 mg/kg British Medical Bulletin. (Longman Group UK Ltd., Longman House, Burnt Mill, Harlow, Essex CM20 2JE, UK) V.1- 1943- v. 14, p. 147, 1958 (BMBUAQ); V03-T63 ivg-mus TD :17 gm/kg/2Y-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 22(3), p. 68, 1976 (VOONAW); V02-J60 orl-rat TDLo: 129780 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB85-213361/AS (NTIS**) ORNG: 1200000000 ng/kg. [1200.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1200 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 602, 1966 (PCOC**); T/E unlistd ihl-rat LC50: >1210 mg/m3/6H Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 11, p. 497, 1992 (JACTDZ); T/E unlistd orl-mus LD50: 20 gm/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 271, 1982 (NIIRDN); T/E unlistd ipr-mus LD50: 43 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 42, p. 396, 1979 (FATOAO); T/E unlistd scu-mus LD50: 83600 ug/kg Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 1, p. 150, 1946 (PHARAT); T/E unlistd orl-gpg LD20: 1205 mg/kg Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 20, p. 413, 1979 (TJADAB); T/E unlistd unr-mam LD50: 1 gm/kg "Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971 -,410,1971 (30ZDA9) MD: F15-Q30-Z01 orl-rat TDLo: 45 gm/kg/15D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-276, 1985 (NTPTR*); U01 orl-rat TDLo: 60060 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-276, 1985 (NTPTR*); F15-Q30-Z01 orl-mus TDLo: 45 gm/kg/15D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-276, 1985 (NTPTR*); U01 orl-mus TDLo: 70434 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-276, 1985 (NTPTR*) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 13, p. 101, 1977 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 13, p. 101, 1977 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Internist. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1960- v. 15, p. 7, 1974 (INTEAG); TOXICOLOGY REVIEW Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 23, p. 6, 1971 (AEHLAU); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,250,1970 (85CVA2) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 81590; NIS 8; TNF 685; NOS 10; TNE 5733; NOES 1983: HZD 81590; NIS 6; TNF 857; NOS 10; TNE 13728; TFE 9645 SL: EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Carcinogenicity-mouse/rat, N crassa-aneuploidy; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1027 of 1119 in RTECS (through 2003/06) AN: VE3750000 PN: Radon- RN: Current: 10043-92-2 UD: 200006 CC: Tumorigen (C) SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 1028 of 1119 in RTECS (through 2003/06) AN: VG9625000 PN: Resorcinol- SY: C.I. 76505; C.I. Developer 4; C.I. Oxidation Base 31; m-Dihydroxybenzene-; 1,3-Dihydroxybenzene-; m-Dioxybenzene-; Nako-TGG-; Pelagol-Grey-RS-; Pelagol-RS-; Phenol,-m-hydroxy-; Resorcin-; Resorcine-; Benzene,-m-dihydroxy-; m-Benzenediol-; 1,3-Benzenediol-; Developer-O-; Developer-R-; Developer-RS-; Durafur-developer-G-; Fouramine-RS-; Fourrine-79-; Fourrine-EW-; m-Hydroquinone-; 3-Hydroxycyclohexadien-1-one-; m-Hydroxyphenol-; 3-Hydroxyphenol-; NCI-C05970-; RCRA-waste-number-U201-; Resorcinol- (ACGIH) RN: Current: 108-46-3 BRN: 906905 BHR: 4-06-00-05658 UD: 200302 MF: C6-H6-O2 MW: 110.12 WL: QR CQ CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 500 mg Industrial Hygiene Foundation of America, Chemical and Toxicological Series, Bulletin. (Pittsburgh, PA) 1947-69. v. 6, p. 1, 1967 (IHFCAY); skn-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,234,1986 (85JCAE); eye-rbt 100 mg SEV BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 11-4/1970 (BIOFX*) ME: mmo-sat 20 umol/plate (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 90, p. 91, 1981 (MUREAV); mrc-smc 1 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 109, 1984 (MUREAV); cyt-hmn-lym 80 mg/L Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 32, p. 533, 1982 (ARZNAD); cyt-hmn-oth 40 mg/L Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 32, p. 533, 1982 (ARZNAD); dnd-rat-lvr 10 mmol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 63, p. 47, 1992 (CALEDQ); cyt-ham-ovr 1600 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 14, p. 251, 1981 (CALEDQ); cyt-hmn-lym 0.002 pph "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 227, 1994 (VCVGK*) TE: V03-R60 skn-mus TDLo: 4800 mg/kg/12W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 19, p. 413, 1959 (CNREA8) ORNG: 301000000 ng/kg. [301.000000 mg/kg] F12-K01-J22 SRNG: 3360000000 ng/kg. [3360.000000 mg/kg] R10-U01 AT: T/E unlistd orl-hmn LDLo: 29 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,519,1969 (34ZIAG); F12-K01-J22 orl-rat LD50: 301 mg/kg BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 11-4/1970 (BIOFX*); T/E unlistd ihl-rat LCLo: 160 mg/m3/1H BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 11-4/1970 (BIOFX*); F13-F22-F24 scu-rat LDLo: 400 mg/kg Revue Medicale de la Suisse Romande. (Societe Medicale de La Suisse Romande, 2 rue Bellefontaine, 1003 Lausanne, Switzerland) V.1- 1881- v. 15, p. 561, 1895 (RMSRA6); T/E unlistd orl-mus LD50: 200 mg/kg Japanese Journal of Toxicology. (Yakugyo Jihosha, Hokushin Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo, 101, Japan) V.1- 1988- v. 4, p. 105, 1991 (JJTOEX); T/E unlistd ipr-mus LD50: 215 mg/kg Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 61, p. 291, 1966 (BEXBAN); T/E unlistd scu-mus LD50: 213 mg/kg Zeitschrift fuer die Gesamte Innere Medizin und Ihre Grenzgebiete. (Buchexport, Postfach 160, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1946- v. 2, p. 333, 1947 (ZGIMAL); T/E unlistd ivn-dog LDLo: 700 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); F12-P24 scu-cat LDLo: 110 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 72, p. 241, 1913 (AEXPBL); R10-U01 skn-rbt LD50: 3360 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 37, p. 596, 1976 (AIHAAP); F13-F22-F24 scu-gpg LDLo: 400 mg/kg Revue Medicale de la Suisse Romande. (Societe Medicale de La Suisse Romande, 2 rue Bellefontaine, 1003 Lausanne, Switzerland) V.1- 1881- v. 15, p. 561, 1895 (RMSRA6); C06-F12-G30 par-frg LDLo: 270 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 166, p. 437, 1932 (AEPPAE) MD: N74 orl-rat TDLo: 5400 mg/kg/17D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-403, 1992 (NTPTR*); L70-N72 orl-rat TDLo: 8450 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-403, 1992 (NTPTR*); N72 orl-rat TDLo: 504 mg/kg/28D-C BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. (1810 Frontage Rd., Northbrook, IL 60062) 11-4/1970 (BIOFX*); Z01 orl-mus TDLo: 3600 mg/kg/17D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-403, 1992 (NTPTR*); U01-Z01 orl-mus TDLo: 27300 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-403, 1992 (NTPTR*); R60-V30 orl-rat TDLo: 25750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-126381 (NTIS**); R60-V30 orl-mus TDLo: 115875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB93-126381 (NTIS**) TR: ACGIH TLV-TWA 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 20 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 10 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 155, 1977 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1119, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 155, 1977 (IMEMDT); IARC Cancer Review: Human No adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1119, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1119, 1999 (IMEMDT); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 75, 1978 (MUREAV); TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(3), p. 167, 1986 (JACTDZ) SR: OEL-AUSTRALIA: TWA 10 ppm (45 mg/m3), STEL 20 ppm, JAN 1993; OEL-AUSTRIA: MAK 10 ppm (45 mg/m3), JAN 1999; OEL-BELGIUM: TWA 10 ppm (45 mg/m3), STEL 20 ppm, JAN 1993; OEL-DENMARK: TWA 10 ppm (45 mg/m3), JAN 1999; OEL-FINLAND: TWA 10 ppm (45 mg/m3), STEL 20 ppm (90 mg/m3), JAN 1999; OEL-FRANCE: VME 10 ppm (45 mg/m3), JAN 1999; OEL-HUNGARY: TWA 45 mg/m3, STEL 90 mg/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 10 ppm (45 mg/m3), JAN 1999; OEL-NORWAY: TWA 10 ppm (45 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 45 mg/m3, MAC(STEL) 90 mg/m3, JAN 1999; OEL-SWEDEN: NGV 10 ppm (45 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 10 ppm (45 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 10 ppm (46 mg/m3), STEL 20 ppm (92 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO RESORCINAL-air: 10H TWA 10 ppm, STEL 20 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 67220; NIS 45; TNF 4488; NOS 42; TNE 40431; NOES 1983: HZD 67220; NIS 30; TNF 6842; NOS 43; TNE 100792; TFE 56465 SL: EPA GENETOX PROGRAM 1988, Negative: N crassa-aneuploidy, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis Studies (gavagae), no evidence: mouse, rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-403, 1992 (NTPTR*); NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1029 of 1119 in RTECS (through 2003/06) AN: VH1050000 PN: Resorcinol,-diglycidyl- SY: Araldite-ERE-1359-; Diglycidyl-ether-of-resorcinol-; 1,3-Diglycidyloxybenzene-; Diglycidyl-resorcinol-ether-; Oxirane, 2,2'-(1,3-phenylenebis(oxymethylene))bis-; 2,2'-(1,3-Phenylenebis(oxymethylene))bisoxirane; Resorcinol bis(2,3-epoxypropyl)ether; m-Bis(2,3-epoxypropoxy)benzene; 1,3-Bis(2,3-epoxypropoxy)benzene; meta-Bis(glycidyloxy)benzene; ERE-1359-; NCI-C54966-; RDGE-; Resorcinol-diglycidyl-ether-; Resorcinyl-diglycidyl-ether- RN: Current: 101-90-6 BRN: 203671 BHR: 5-17-03-00024 UD: 200210 MF: C12-H14-O4 MW: 222.26 WL: T3OTJ B1OR CO1- BT3OTJ CC: Tumorigen (C); Mutagen (M); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MOD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 17, p. 129, 1958 (AMIHAB) ME: mmo-sat 33 ug/plate (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 105, 1986 (MUREAV); sln-dmg-orl 5 pph Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 325, 1985 (ENMUDM); trn-dmg-orl 5 pph Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 325, 1985 (ENMUDM); msc-mus-lym 100 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 8 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 159, 1984 (MUREAV); sce-ham-ovr 50 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V01-K60 orl-rat TDLo: 6180 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-257, 1986 (NTPTR*); V01-K60 orl-mus TDLo: 25750 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-257, 1986 (NTPTR*); V03-R60 unr-mus TDLo: 6700 mg/kg Radiation Research, Supplement. (New York, NY) No.1-7, 1959-67. Discontinued. v. 3, p. 193, 1963 (RARSAM); V01-P62 orl-mus TD :51500 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-257, 1986 (NTPTR*); V01-K60 orl-mus TD :25750 mg/kg/2Y-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 28, p. 723, 1990 (FCTOD7); V01-K60 orl-rat TD :12875 mg/kg/2Y-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 28, p. 723, 1990 (FCTOD7); V01-K60 orl-rat TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-146734/AS (NTIS**); V01-K60 orl-mus TDLo: 25750 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-146734/AS (NTIS**) ORNG: 2570000000 ng/kg. [2570.000000 mg/kg] K07 AT: K07 orl-rat LD50: 2570 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 17, p. 129, 1958 (AMIHAB); F07-K17 ipr-rat LD50: 178 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 17, p. 129, 1958 (AMIHAB); F07 orl-mus LD50: 980 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 17, p. 129, 1958 (AMIHAB); F07-K17 ipr-mus LD50: 243 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 17, p. 129, 1958 (AMIHAB); F07 orl-rbt LD50: 1240 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 17, p. 129, 1958 (AMIHAB) MD: Z01 orl-rat TDLo: 5320 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-257, 1986 (NTPTR*); Z01 orl-rat TDLo: 13 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-257, 1986 (NTPTR*); Z01 orl-mus TDLo: 10500 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-257, 1986 (NTPTR*); Z01 orl-mus TDLo: 26 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-257, 1986 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 181, 1985 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1417, 1999 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 36, p. 181, 1985 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1417, 1999 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1417, 1999 (IMEMDT) SR: OEL-AUSTRIA: Carcinogen, JAN 1999 ND: NOHS 1974: HZD 83725; NIS 4; TNF 193; NOS 8; TNE 2994; NOES 1983: HZD 83725; NIS 5; TNF 28; NOS 7; TNE 1856; TFE 222 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 29, 1978; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1030 of 1119 in RTECS (through 2003/06) AN: VH1575000 PN: Resorcinol,-4-hexyl- SY: Ascaryl-; Crystoids-; Caprokol-; Cystoids-anthelmintic-; Gelovermin-; 4-Hexyl-1,3-benzenediol-; 4-Hexyl-1,3-dihydroxybenzene-; Hexylresorcin- (German); 4-Hexylresorcine-; Hexylresorcinol-; p-Hexylresorcinol-; 4-Hexylresorcinol-; 4-n-Hexylresorcinol-; NCI-C55787-; S.T. 37; Sucrets-; Worm-agen- RN: Current: 136-77-6 BRN: 2048312 BHR: 4-06-00-06048 UD: 200210 MF: C12-H18-O2 MW: 194.30 WL: QR CQ D6 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 2 mg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 219, p. 119, 1953 (AEPPAE) ME: dnr-esc 3 mg/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 188, p. 111, 1987 (MUREAV); mmo-mus-lym 5 ug/L (+S9) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-330, 1988 (NTPTR*); sce-ham-ovr 18 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-330, 1988 (NTPTR*) RE: T12 scu-rat TDLo: 5 mg/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 57, p. 466, 1955 (ENDOAO) TE: V03-N60 orl-mus TDLo: 64 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-330, 1988 (NTPTR*); V03-M04-N61 orl-mus TDLo: 32187.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-128607/AS (NTIS**) ORNG: 550000000 ng/kg. [550.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 550 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 53, p. 198, 1935 (JPETAB); T/E unlistd orl-mus LD50: 1040 mg/kg Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- v. 30, p. 147, 1975 (PHARAT); T/E unlistd ipr-mus LD50: 335 mg/kg Japanese Kokai Tokyo Koho Patents. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) #90-292213 (JKXXAF); T/E unlistd scu-mus LDLo: 750 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 148, 1959 (HBTXAC); T/E unlistd unr-mus LDLo: 100 mg/kg Annals of Tropical Medicine and Parasitology. (Grune and Stratton, Inc., POB 6280, Duluth, MN 55806) V.1- 1907- v. 32, p. 177, 1938 (ATMPA2); T/E unlistd orl-gpg LDLo: 400 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 28, p. 609, 1931 (PSEBAA); T/E unlistd par-frg LDLo: 100 mg/kg Saishin Igaku. Modern Medicine. (Saishin Igakusha, Senchuri Bldg., 3-6-1 Hirano-machi, Higashi-ku, Osaka 541, Japan) V.1- 1946- v. 5, p. 102, 1950 (SAIGAK) MD: Z01 orl-rat TDLo: 16250 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-330, 1988 (NTPTR*); Z01 orl-mus TDLo: 32500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-330, 1988 (NTPTR*); P61-V30 orl-rat TDLo: 32187.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-128607/AS (NTIS**); L60-V30 orl-mus TDLo: 32187.5 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-128607/AS (NTIS**) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (gavage), equivocal evidence: mouse; NCI Carcinogenesis Studies (gavage), no evidence: rat Record 1031 of 1119 in RTECS (through 2003/06) AN: VJ3850000 PN: Riddelline- SY: Riddeliin-; Riddeliine-; Riddeline-; Riddelliine-; Senecionan-11,16-dione,-13,19-didehydro-12,18-dihydroxy- (9CI) RN: Current: 23246-96-0 UD: 200207 MF: C18-H23-N-O6 MW: 349.42 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Natural-Product (N) ME: mmo-sat 1 mg/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11(Suppl 12), p. 1, 1988 (EMMUEG); dns-rat-orl 125 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 73, 1985 (ENMUDM); dns-rat-lvr 3200 ug/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5, p. 482, 1983 (ENMUDM); cyt-ham-ovr 300 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 3 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T81 orl-rat TDLo: 147 mg/kg (12W male/12W pre-3W post) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3350 (NTPTR*); T72-T77-T81 orl-mus TDLo: 4 gm/kg (12W male/12W pre-3W post) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3350 (NTPTR*) TE: V03-L60-P62 mul-rat TDLo: 210 mg/kg/52W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 11, p. 535, 1957 (BJCAAI) AT: T/E unlistd orl-rat LDLo: 25 mg/kg Journal of Pathology and Bacteriology. (London, UK) V.1-96, 1892-1968. For publisher information, see JPTLAS. v. 78, p. 471, 1959 (JPBAA7); F07-F16-R21 ivn-mus LD50: 105 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 78, p. 372, 1943 (JPETAB) MD: G70-J15-L30 orl-rat TDLo: 120 mg/kg/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3350 (NTPTR*); L70 orl-mus TDLo: 12 mg/kg/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3350 (NTPTR*); L70-P71-P73 orl-mus TDLo: 650 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3350 (NTPTR*) TR: IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 10, p. 313, 1976 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 10, p. 313, 1976 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SL: NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP Toxicity studies, RPT# TOX-27, October 2000; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 1032 of 1119 in RTECS (through 2003/06) AN: VN2230000 PN: Safflower-oil- SY: Fats-and-Glyceridic-oils,-safflower-; Oils,-glyceridic,-safflower-; Carthamus-tinctorius-oil-; Safflower-seed-oil-; Thistle-oil- RN: Current: 8001-23-8 Previous: 84988-98-7 UD: 200302 CC: Tumorigen (C); Natural-Product (N); Primary-Irritant (S) ID: skn-hmn 300 mg/3D-I MLD "Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar, eds., New York, Academic Press, Inc. 1977 -,127,1977 (85DKA8); eye-rbt 100 mg/24H MLD Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 4(5), p. 171, 1985 (JACTDZ) TE: V02-K60 orl-rat TDLo: 2600 mL/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-426, 1994 (NTPTR*); V02-K60 orl-rat TDLo: 1287500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-103958 (NTIS**) AT: T/E unlistd ipr-mus LD50: >50 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD691-490 (NTIS**) MD: P61-V30 orl-rat TDLo: 1287500 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-103958 (NTIS**) ND: NOHS 1974: HZD A1259; NIS 19; TNF 1098; NOS 26; TNE 8496; NOES 1983: HZD A1259; NIS 11; TNF 1221; NOS 18; TNE 11307; TFE 6108 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies (gavage) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-426, 1994 (NTPTR*) Record 1033 of 1119 in RTECS (through 2003/06) AN: VO6250000 PN: Salicylic acid, 5-((p-(2-pyridylsulfamoyl)phenyl)azo)- SY: Asulfidine-; Azopyrin-; Azulfidine-; Colo-Pleon-; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridylsulfamoyl)phenylazo)salicylic acid; Reupirin-; Salazopyrin-; Salazosulfapyridine-; Salicylazosulfapyridine-; Salisulf-; Accucol-; Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-; Benzosulfa-; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; SI-88-; S.A.S.-500; SASP-; Sulcolon-; Sulfasalazine-; Sulphasalazine-; W-T-Sasp-Oral- RN: Current: 599-79-1 BRN: 356241 BHR: 5-22-08-00433 UD: 200305 MF: C18-H14-N4-O5-S MW: 398.42 WL: T6NJ BSWMR DNUNR DQ CVQ CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mnt-hmn-lym 40 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 27, 1989 (MUREAV); sce-hmn-lym 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 222, p. 27, 1989 (MUREAV); mnt-mus-orl 5634 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 53, 1992 (MUREAV) RE: T43-T47 orl-wmn TDLo: 8100 mg/kg (1-40W preg) New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 318, p. 1128, 1988 (NEJMAG); T01 orl-rat TDLo: 8400 mg/kg (14D male) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 39, p. 191, 1999 (CGANE7); T01 orl-rat TDLo: 5460 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-457, 1997 (NTPTR*); T23 orl-rat TDLo: 8400 mg/kg (28D male) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 28, p. 273, 1983 (CCPTAY); T24 orl-rat TDLo: 16800 mg/kg (28D male) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 37, p. 539, 1988 (CCPTAY); T01 orl-rat TDLo: 7 gm/kg (35D male) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 37, p. 539, 1988 (CCPTAY); T02-T23 orl-rat TDLo: 8400 mg/kg (14D male) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 9, p. 315, 1995 (REPTED); T02 orl-mus TDLo: 43875 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-457, 1997 (NTPTR*); T35 orl-rat TDLo: 8400 mg/kg (28D male) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); T23-T24 orl-rat TDLo: 16800 mg/kg (28D male) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); T29 orl-rat TDLo: 23 gm/kg (15W male/15W pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-203710 (NTIS**); T81 orl-rat TDLo: 92 gm/kg (15W male/15W pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-203710 (NTIS**); T53 orl-rat TDLo: 100 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-203710 (NTIS**); T81 orl-rat TDLo: 400 mg/kg (multigenerations) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-203710 (NTIS**) TE: V01-M60 orl-rat TDLo: 177 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-457, 1997 (NTPTR*); V01-L60 orl-mus TDLo: 141 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-457, 1997 (NTPTR*); V02-M60 orl-rat TDLo: 177187.5 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-212708 (NTIS**); V03-M60 orl-rat TDLo: 177187.5 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-212708 (NTIS**); V03-L60 orl-mus TDLo: 351000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-212708 (NTIS**); V01-L60 orl-mus TDLo: 351000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-212708 (NTIS**); V02-M60 orl-rat TDLo: 175500 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB98-131014 (NTIS**); V02-L60 orl-mus TDLo: 1404000 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB98-131014 (NTIS**) ORNG: 15600000000 ng/kg. [15600.000000 mg/kg] T/E unlistd AT: C10-H30 orl-man TDLo: 122 gm/kg/8Y-I Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1925- v. 56, p. 106, 1980 (PGMJAO); J30-P16-P20 orl-man TDLo: 1286 mg/kg/30D-I Internal Medicine. (The Japanese Society of Internal Medicine, 34-3, 3-chome, Hongo, Bunkyo-ku, Tokyo 113, Japan) V.31- 1992- v. 31, p. 108, 1992 (IEDIEP); P14-P17-P30 orl-wmn TDLo: 570 mg/kg/11D-I Clinical and Experimental Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1976- v. 19, p. 419, 1994 (CEDEDE); L01 orl-chd TDLo: 3800 mg/kg/19D-I American Journal of Digestive Diseases. (New York, NY) V.5-22, 1938-55: New series: V.1-23, 1956-78. For publisher information, see DDSCDJ. v. 23, p. 956, 1978 (AJDDAL); K12-K13 orl-man TDLo: 7143 ug/kg New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 306, p. 409, 1982 (NEJMAG); P17 orl-man TDLo: 143 mg/kg/10D-I Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 102, p. 277, 1985 (AIMEAS); P15-P30-R01 orl-man LDLo: 3200 mg/kg/31D-I Journal of the Royal Society of Medicine. (Oxford Univ. Press, Walton St., Oxford OX2 6DP, UK) V.71- 1978- v. 73, p. 587, 1980 (JRSMD9); P23 orl-hmn TDLo: 429 mg/kg/10D-I New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 289, p. 491, 1973 (NEJMAG); F08-F27 orl-man TDLo: 357 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 29, p. 543, 1991 (JTCTDW); F27-K12-U25 orl-wmn TDLo: 140 mg/kg/2W-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 917, 1984 (LANCAO); F13-L14-P72 orl-wmn TDLo: 700 mg/kg/4W-I Clinical and Experimental Rheumatology. (Clinical and Experimental Rheumatology, via Santa Maria, 31, 56100 Pisa Italy) V.1- 1983- v. 10, p. 427, 1992 (CERHDP); L01-R03-S06 unr-wmn LDLo: 840 mg/kg/3W-I Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- v. 37, p. 315, 1982 (THERAP); F08-F19-K13 unr-man TDLo: 1300 mg/kg/4W-I Practitioner. (Morgan-Grampian Ltd., 40 Beresford St., Woolwich, London SE18 6BQ, UK) V.1- 1868- v. 204, p. 850, 1970 (PRACAK); R03-S25 unr-wmn TDLo: 2700 mg/kg/13W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 286, p. 1547, 1983 (BMJOAE); K12-K13 rec-man TDLo: 7143 ug/kg New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 306, p. 409, 1982 (NEJMAG); T/E unlistd orl-rat LD50: 15600 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 420, 1990 (NIIRDN); T/E unlistd scu-rat LD50: 3870 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 420, 1990 (NIIRDN); T/E unlistd ivn-rat LD50: 1520 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 420, 1990 (NIIRDN); T/E unlistd orl-mus LD50: 12500 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 420, 1990 (NIIRDN); T/E unlistd scu-mus LD50: 3 gm/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 420, 1990 (NIIRDN); T/E unlistd ivn-mus LD50: 1096 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 420, 1990 (NIIRDN); T/E unlistd orl-rbt LD50: >7500 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 26, p. 953, 1995 (IYKEDH) MD: P28-N74-U01 orl-rat TDLo: 32400 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-457, 1997 (NTPTR*); K30 orl-mus TDLo: 32400 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-457, 1997 (NTPTR*); U01-T01-T02 orl-rat TDLo: 25200 mg/kg/6W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); T01 orl-rat TDLo: 12600 mg/kg/6W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); T01 orl-rat TDLo: 16800 mg/kg/4W-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 55, 2000 (REPTED); K13 orl-hmn TDLo: 5250 mg/kg/24W-I British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 287, p. 1102, 1983 (BMJOAE); U01 orl-rat TDLo: 14000 mg/kg/35D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-203710 (NTIS**); N30-U01 orl-rat TDLo: 58800 mg/kg/21W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB92-203710 (NTIS**) TR: TOXICOLOGY REVIEW Dangerous Properties of Industrial Materials Report. (Van Nostrand Reinhold, 115 Fifth Ave., New York, NY 10003) V.1- 1981- v. 1(8), p. 8, 1981 (DPIRDU) ND: NOES 1983: HZD X5355; NIS 1; TNF 48; NOS 1; TNE 704; TFE 435 SL: EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-human; NCI Carcinogenesis Studies (gavage), clear evidence: mouse; NTP Carcinogenesis Studies (gavage), some evidence: rat National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-457, 1997 (NTPTR*); NCI Carcinogenesis Studies (gavage), equivocal evidence: rat Record 1034 of 1119 in RTECS (through 2003/06) AN: VQ3150000 PN: Sarcosine,-N-nitroso- SY: N-Nitrosomethylglycine-; N-Nitrososarcosine-; Nitroso-sarkosin- (German); NSAR-; Glycine,-N-methyl-N-nitroso-; N-Methyl-N-nitrosoglycine- RN: Current: 13256-22-9 BRN: 1756162 BHR: 0-04-00-00380 UD: 200007 MF: C3-H6-N2-O3 MW: 118.11 WL: QV1N1&NO CC: Tumorigen (C); Mutagen (M) TE: V03-K60 orl-rat TDLo: 29 gm/kg/41W-C Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 1077, 1969 (ARZNAD); V03-D45-J60 orl-mus TDLo: 118 gm/kg/56W-C Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 33, p. 596, 1974 (FEPRA7) AT: T/E unlistd orl-rat LD50: >5 gm/kg Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 50, p. 100, 1963 (NATWAY); T/E unlistd ipr-mus LD50: 184 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 1981, 1975 (CNREA8) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 327, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 327, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SR: OEL-FRANCE: Carcinogen, JAN 1993 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Host-mediated assay; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1035 of 1119 in RTECS (through 2003/06) AN: VS6650000 PN: Selenic-acid,-disodium-salt- SY: Disodium-selenate-; Natriumseleniat- (German); Sodium-selenate-; Sodium-selenium-oxide- (Na2SeO4); Sel-tox-SSO2-and-SS-20- RN: Current: 13410-01-0 UD: 200302 MF: O4-Se.2 Na MW: 188.94 WL: NA2 SE-O4 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 40 umol/L (+S9) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 36, p. 379, 1985 (ENVRAL); dnr-sat 10 ug/plate Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 10, p. 75, 1980 (CALEDQ); pic-esc 25 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); dnr-bcs 50 umol/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 175, 1979 (MUREAV); dns-hmn-fbr 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 49, p. 305, 1978 (MUREAV); cyt-hmn-lym 8 nmol/L Hereditas (Lund, Sweden). (Gjoerloffsgatan 121, S-261 34 Landskrona, Sweden) V.1- 1947- v. 98, p. 249, 1983 (HEREAY); dns-rat-lvr 100 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 10, p. 75, 1980 (CALEDQ); cyt-mus-orl 14 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 201, 1997 (MUREAV) RE: T01 orl-rat TDLo: 26 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3387 (NTPTR*); T44 orl-mus TDLo: 14 mg/kg (14D post) "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,83,1975 (32XPAD); T75-T81 orl-mus TDLo: 60 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 6, p. 361, 1986 (TCMUD8); T34 orl-ham TDLo: 18894 mg/kg (8D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 183, 1990 (REPTED) TE: V01-J60-P61 orl-rat TDLo: 128 mg/kg/2Y-C Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 101, p. 1531, 1971 (JONUAI) ORNG: 1600000 ng/kg. [1.600000 mg/kg] T/E unlistd AT: G06-K12-L14 orl-wmn TDLo: 53 mg/kg New Zealand Medical Journal. (New Zealand Medical Assoc., P.O. Box 156, Wellington, New Zealand) V.1- 1900- v. 87, p. 354, 1978 (NZMJAX); T/E unlistd orl-rat LD50: 1600 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 49(9), p. 66, 1984 (GISAAA); F23-J24-J30 ipr-rat LDLo: 8973 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 58, p. 454, 1936 (JPETAB); D35 scu-rat LDLo: 11336 ug/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 207, 1980 (ARTODN); T/E unlistd ivn-rat LDLo: 4786 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 60, p. 449, 1937 (JPETAB); T/E unlistd scu-cat LDLo: 20 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1289, 1935 (HBAMAK); T/E unlistd orl-rbt LD50: 2250 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 49(9), p. 66, 1984 (GISAAA); F12-F18-F01 ivn-rbt LDLo: 3600 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 60, p. 449, 1937 (JPETAB); T/E unlistd ipr-rat LD75: 5.25 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1406, 2001 (HBPTO*); T/E unlistd ipr-rat LDLo: 3.75 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1406, 2001 (HBPTO*); T/E unlistd ivn-rat LD50: 3 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1406, 2001 (HBPTO*); T/E unlistd ivn-rbt LD50: 2 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 265, 1993 (VCVN5*); G06-L30 orl-wmn TDLo: 22.3 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 269, 1993 (VCVN5*) MD: M11-M16-M30 orl-rat TDLo: 46 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3387 (NTPTR*); L30-L70-U01 orl-rat TDLo: 6031 mg/kg/6W-C Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 104, p. 306, 1974 (JONUAI); L02-P28-Y15 orl-rat TDLo: 385 mg/kg/22W-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 28, p. 349, 1974 (TXAPA9); U01-Z01 orl-rat TDLo: 301 mg/kg/18W-C Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information, see NTOTDY. v. 1, p. 275, 1979 (NETOD7); L30-M11-N73 orl-rat TDLo: 150 mg/kg/30D-C Eisei Kagaku. Hygienic Chemistry. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1953- v. 20, p. 29, 1974 (ESKGA2); J02-M30-Z01 orl-mus TDLo: 2894 mg/kg/1.8Y-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 24, p. 66, 1972 (AEHLAU); C06-P30-R03 orl-pig TDLo: 38320 ug/kg/16D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 217, 1996 (FAATDF); L30 orl-rat TDLo: 145.6 mg/kg/13W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1406, 2001 (HBPTO*); M30 orl-rat TDLo: 45.5 mg/kg/13W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1406, 2001 (HBPTO*); T01 orl-rat TDLo: 18.2 mg/kg/13W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1406, 2001 (HBPTO*); F16-M71 orl-mus TDLo: 182 mg/kg/13W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1406, 2001 (HBPTO*); T14 orl-mus TDLo: 91 mg/kg/13W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1406, 2001 (HBPTO*); F15-U03 orl-rat TDLo: 33 mg/kg/30D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-190616 (NTIS**); U01 orl-rat TDLo: 15 mg/kg/30D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-190616 (NTIS**); F15 orl-rat TDLo: 33 mg/kg/30D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-190616 (NTIS**); Z01 orl-rat TDLo: 24.2 mg/kg/22D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-190616 (NTIS**); K30-M71-N72 orl-rat TDLo: 24 mg/kg/30D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-190616 (NTIS**); U01 orl-rat TDLo: 33 mg/kg/7D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-190616 (NTIS**); T14 orl-rat TDLo: 33 mg/kg/30D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB96-190616 (NTIS**) TR: ACGIH TLV-TWA 0.2 mg(Se)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 245, 1975 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Chemical Reviews. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1924- v. 28, p. 179, 1941 (CHREAY); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Se,112,1976 (85DHAX) SR: MSHA STANDARD-air: TWA 0.2 mg(Se)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 224, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-BELGIUM: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-DENMARK: TWA 0.1 mg(Se)/m3, JAN 1999; OEL-FINLAND: TWA 0.1 mg(Se)/m3, STEL 0.3 mg(Se)/m3, JAN 1999; OEL-GERMANY: MAK 0.1 mg(Se)/m3, JAN 1999; OEL-HUNGARY: STEL 0.1 mg(Se)/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 0.1 mg(Se)/m3, JAN 1999; OEL-NORWAY: TWA 0.1 mg(Se)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.1 mg(Se)/m3, JAN 1993; OEL-SWEDEN: NGV 0.1 mg(Se)/m3, JAN 1999; OEL-SWITZERLAND: TWA 0.1 mg(Se)/m3, JAN 1999; OEL-TURKEY: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.1 mg(Se)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV SL: EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS-human fibroblast; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Toxicity studies, RPT# TOX-38, October 2000 Record 1036 of 1119 in RTECS (through 2003/06) AN: VS7350000 PN: Selenious-acid,-disodium-salt- SY: Disodium-selenite-; Natriumselenit- (German) RN: Current: 10102-18-8 UD: 200302 MF: O3-Se.2 Na MW: 172.94 WL: NA2 SE-O3 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 1 umol/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 175, 1979 (MUREAV); dnr-sat 10 ug/plate Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 10, p. 75, 1980 (CALEDQ); pic-esc 25 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); dnr-bcs 50 umol/plate Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 66, p. 175, 1979 (MUREAV); mmo-smc 1 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 605, 1988 (MUREAV); mrc-smc 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 605, 1988 (MUREAV); dnd-hmn-fbr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 193, p. 237, 1988 (MUREAV); dns-hmn-fbr 80 umol/L/30M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 49, p. 305, 1978 (MUREAV); dni-hmn-fbr 80 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 49, p. 305, 1978 (MUREAV); dni-hmn-hla 10 umol/L Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1967- v. 177, p. 229, 1984 (AEMBAP); oms-hmn-hla 50 umol/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 25, p. 219, 1985 (TOLED5); oms-hmn-fbr 80 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 49, p. 305, 1978 (MUREAV); cyt-hmn-lym 80 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 503, 1989 (MUREAV); cyt-hmn-fbr 80 umol/L Biological Trace Element Research. (Humana Press Inc., POB 2148, Clifton, NJ 07015) V.1- 1979- v. 2, p. 81, 1980 (BTERDG); sce-hmn-leu 7900 nmol/L/19H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 359, 1978 (MUREAV); sce-hmn-lym 7900 nmol/L Biological Trace Element Research. (Humana Press Inc., POB 2148, Clifton, NJ 07015) V.1- 1979- v. 2, p. 81, 1980 (BTERDG); dns-rat-lvr 100 umol/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 10, p. 75, 1980 (CALEDQ); cyt-rat-lym 7500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 169, p. 61, 1986 (MUREAV); cyt-rat-ivn 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 169, p. 61, 1986 (MUREAV); spm-rat-orl 4200 ug/kg/5W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 309, p. 29, 1994 (MUREAV); dnd-mus-leu 20 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 43, p. 1137, 1992 (BCPCA6); dns-mus-mmr 50 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 4361, 1984 (CNREA8); cyt-mus-orl 7 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 201, 1997 (MUREAV); cyt-ham-ipr 6650 ug/kg Hereditas (Lund, Sweden). (Gjoerloffsgatan 121, S-261 34 Landskrona, Sweden) V.1- 1947- v. 93, p. 101, 1980 (HEREAY); sce-ham-ipr 6650 ug/kg Hereditas (Lund, Sweden). (Gjoerloffsgatan 121, S-261 34 Landskrona, Sweden) V.1- 1947- v. 93, p. 101, 1980 (HEREAY); sce-ham-lng 2 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 18, p. 109, 1983 (CALEDQ) RE: T02-T09 orl-rat TDLo: 384 mg/kg (34W male) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 58, p. 183, 1987 (RCOCB8); T01 orl-rat TDLo: 15 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3387 (NTPTR*); T25-T34 orl-mus TDLo: 999 mg/kg (1-19D preg) Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 109, p. 1646, 1979 (JONUAI); T72 orl-mus TDLo: 50 mg/kg (8-12D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 541, 1982 (JTEHD6); T26-T72-T81 orl-mus TDLo: 112 mg/kg (6-13D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 29, 1987 (TCMUD8); T75 orl-mus TDLo: 50 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 4, p. 403, 1984 (TCMUD8); T34 scu-mus TDLo: 45995 ug/kg (7-12D preg) Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 19, p. 39, 1979 (ENVRAL); T13-T31-T34 scu-mus TDLo: 1729 ug/kg (16D preg) Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 23, p. 95, 1985 (INHEAO); T72-T81 scu-mus TDLo: 7890 ug/kg (12D preg) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 36, p. 313, 1981 (NEZAAQ); T34 ivn-mus TDLo: 2836 ug/kg (12D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 21, p. 35, 1984 (TOLED5); T76-T81 orl-pig TDLo: 1003 mg/kg (1-16W preg) Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 18, p. 141, 1959 (JANSAG); T34 orl-ham TDLo: 17290 mg/kg (8D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 183, 1990 (REPTED) ORNG: 7000000 ng/kg. [7.000000 mg/kg] F07-J22-K12 AT: K01-K12-K13 orl-man TDLo: 24 mg/kg Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 39, p. 304, 1997 (VHTODE); F07-J22-K12 orl-rat LD50: 7 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 20, p. 89, 1971 (TXAPA9); F23-J24-J30 ipr-rat LDLo: 5476 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 58, p. 454, 1936 (JPETAB); T/E unlistd ivn-rat LD50: 3 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd par-rat LD50: 6570 ug/kg Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 17, p. 171, 1980 (CTOXAO); T/E unlistd orl-mus LD50: 7080 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(2), p. 14, 1970 (GISAAA); T/E unlistd scu-mus LD50: 13 mg/kg Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 17, p. 491, 1975 (SAIGBL); C08-G30-J30 ivn-mus LD50: 5 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 2, p. 383, 1981 (NRTXDN); C08-F17-J22 icv-mus LD50: 300 ug/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 2, p. 383, 1981 (NRTXDN); T/E unlistd scu-dog LDLo: 4 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); G04-J26-K12 ivn-dog LD50: 1916 ug/kg Proceedings of the South Dakota Academy of Science. (Univ. of South Dakota, Vermillion, SD 57069) V.1- 1916- v. 36, p. 173, 1957 (PSDAA2); T/E unlistd orl-rbt LD50: 2250 ug/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 35(1-3), p. 176, 1970 (HYSAAV); T/E unlistd ipr-rbt LDLo: 4 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); F12-N22 scu-rbt LDLo: 6 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 24, p. 251, 1926 (PSEBAA); T/E unlistd ivn-rbt LDLo: 1971 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 33, p. 270, 1928 (JPETAB); T/E unlistd ims-rbt LD50: 2530 ug/kg Archiv fuer Experimentelle Veterinaermedizin. (S. Hirzel Verlag, Postfach 506, Leipzig DDR-7010, Ger. Dem. Rep.) V.6- 1952- v. 30, p. 627, 1976 (AXVMAW); T/E unlistd par-rbt LDLo: 1971 ug/kg Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 17, p. 171, 1980 (CTOXAO); T/E unlistd orl-pig LDLo: 13 mg/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(1), p. 45, 1986 (JACTDZ); A11-F07-J15 ivn-pig LDLo: 6570 ug/kg American Journal of Veterinary Research. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.1- 1940- v. 34, p. 1227, 1973 (AJVRAH); J22-K12-U01 ims-pig LDLo: 2190 ug/kg Journal of the American Veterinary Medical Association. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.48- 1915- v. 165, p. 543, 1974 (JAVMA4); T/E unlistd orl-gpg LD50: 5060 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(2), p. 14, 1970 (GISAAA); T/E unlistd par-ckn LD50: 8500 ug/kg Neuropharmacology. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.9- 1970- v. 25, p. 493, 1990 (NEPHBW); T/E unlistd orl-dom LDLo: 3300 ug/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(1), p. 45, 1986 (JACTDZ); G07-J26-K12 orl-hor LD50: 13 mg/kg American Journal of Veterinary Research. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.1- 1940- v. 41, p. 1925, 1980 (AJVRAH); T/E unlistd orl-ctl LDLo: 9900 ug/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 5(1), p. 45, 1986 (JACTDZ); D07-F07-J22 ims-dom LD50: 1533 ug/kg Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 29, p. 233, 1987 (VHTODE); Y12 scu-rat TDLo: 0.3 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 266, 1993 (VCVN5*); L70 scu-rat TDLo: 0.5 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 266, 1993 (VCVN5*) MD: U01-Z01 orl-rat TDLo: 5397 mg/kg/6W-C Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 104, p. 306, 1974 (JONUAI); M05-M70-N19 orl-rat TDLo: 152 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3387 (NTPTR*); P05-Z01 orl-rat TDLo: 1966 mg/kg/1Y-C Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 10, p. 213, 1935 (JONUAI); J02-M30-Z01 orl-mus TDLo: 942 mg/kg/2Y-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 24, p. 66, 1972 (AEHLAU); P28-Y15 orl-rbt TDLo: 2541 ug/kg/33W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 35(2), p. 14, 1970 (GISAAA); U01-Y12-Y15 orl-pig TDLo: 13 gm/kg/5W-C Journal of Animal Science. (American Soc. of Animal Science, 309 W. Clark St., Champaign, IL 61820) V.1- 1942- v. 59, p. 733, 1984 (JANSAG); U01-Y12-Y40 orl-dck TDLo: 168 mg/kg/6W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 27, p. 263, 1989 (JTEHD6); P72-Y15 orl-dck TDLo: 58800 ug/kg/12W-C Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 19, p. 836, 1990 (AECTCV); L30-M05 orl-rbt TDLo: 45 mg/kg/50D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 271, 1989 (VCVN5*); Y10-Y15-Y21 scu-rat TDLo: 5 mg/kg/5D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 271, 1989 (VCVN5*) TR: ACGIH TLV-TWA 0.2 mg(Se)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 9, p. 245, 1975 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Chemical Reviews. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1924- v. 28, p. 179, 1941 (CHREAY); TOXICOLOGY REVIEW Physiological Reviews. (American Physiological Soc., 9650 Rockville Pike, Bethesda, MD 20814) V.1- 1921- v. 23, p. 305, 1943 (PHREA7); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Se,112,1976 (85DHAX) SR: MSHA STANDARD-air: TWA 0.2 mg(Se)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 224, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-AUSTRIA: MAK 0.1 mg(Se)/m3, JAN 1999; OEL-BELGIUM: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-DENMARK: TWA 0.1 mg(Se)/m3, JAN 1999; OEL-FINLAND: TWA 0.1 mg(Se)/m3, STEL 0.3 mg(Se)/m3, JAN 1999; OEL-GERMANY: MAK 0.1 mg(Se)/m3, JAN 1999; OEL-HUNGARY: STEL 0.1 mg(Se)/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 0.1 mg(Se)/m3, JAN 1999; OEL-NORWAY: TWA 0.1 mg(Se)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.1 mg(Se)/m3, JAN 1993; OEL-SWEDEN: NGV 0.1 mg(Se)/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 0.1 mg(Se)/m3, JAN 1999; OEL-TURKEY: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.1 mg(Se)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 84379; NIS 5; TNF 480; NOS 5; TNE 1198; NOES 1983: HZD 84379; NIS 7; TNF 741; NOS 19; TNE 10544; TFE 3736 SL: EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human lymphocytes; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro UDS-human fibroblast; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9100; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-38, October 2000 Record 1037 of 1119 in RTECS (through 2003/06) AN: VT0525000 PN: Selenium-sulfide- SY: NCI-C50033-; RCRA-waste-number-U205-; Selenium-monosulfide-; Selenium-sulphide-; Selensulfid- (German); Sulfur-selenide- RN: Current: 7446-34-6 UD: 200302 MF: S-Se MW: 111.02 WL: SE S CC: Tumorigen (C); Drug (D); Mutagen (M) ME: mmo-sat 1 mg/plate (+S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); mmo-sat 333 ug/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11(Suppl 12), p. 1, 1988 (EMMUEG); mnt-rat-orl 12500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 33, 1996 (MUREAV); cyt-mus-ipr 10 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 25, p. 302, 1995 (EMMUEG); msc-mus-lym 100 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 5 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 1 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) TE: V01-L60-P61 orl-rat TDLo: 11 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-194, 1980 (NCITR*); V01-L60-J60 orl-mus TDLo: 72 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-194, 1980 (NCITR*) ORNG: 38000000 ng/kg. [38.000000 mg/kg] T/E unlistd AT: C06-F24-J22 orl-mus LD50: 3700 mg/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 24, p. 341, 1969 (ATXKA8); T/E unlistd orl-rbt LDLo: 55 mg/kg Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*); T/E unlistd orl-mus LD50: 370 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 266, 1993 (VCVN5*); T/E unlistd orl-rat LD50: 38 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 266, 1993 (VCVN5*) MD: L30-M30-P30 orl-mus TDLo: 6562 mg/kg/7.5W-I Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 24, p. 341, 1969 (ATXKA8) TR: ACGIH TLV-TWA 0.2 mg(Se)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: MSHA STANDARD-air: TWA 0.2 mg(Se)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 224, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.2 mg(Se)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-AUSTRIA: MAK 0.1 mg(Se)/m3, JAN 1999; OEL-BELGIUM: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-DENMARK: TWA 0.1 mg(Se)/m3, JAN 1999; OEL-FINLAND: TWA 0.1 mg(Se)/m3, STEL 0.3 mg(Se)/m3, JAN 1999; OEL-GERMANY: MAK 0.1 mg(Se)/m3, JAN 1999; OEL-HUNGARY: STEL 0.1 mg(Se)/m3, JAN 1993; OEL-JAPAN: OEL 0.1 mg(Se)/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.1 mg(Se)/m3, JAN 1999; OEL-NORWAY: TWA 0.1 mg(Se)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.1 mg(Se)/m3, MAC(STEL) 0.3 mg(Se)/m3, JAN 1999; OEL-SWEDEN: NGV 0.1 mg(Se)/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 0.1 mg(Se)/m3, JAN 1999; OEL-TURKEY: TWA 0.2 mg(Se)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.1 mg(Se)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 84568; NIS 3; TNF 279; NOS 6; TNE 6046; NOES 1983: HZD 84568; NIS 2; TNF 148; NOS 5; TNE 2965; TFE 2491 SL: On EPA IRIS database; NCI Carcinogenesis Bioassay (gavage), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-194, 1980 (NCITR*); NCI Carcinogenesis Bioassay (dermal), inadequate studies: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-197, 1980 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1038 of 1119 in RTECS (through 2003/06) AN: VV7325000 PN: Silica,-crystalline---cristobalite- SY: Cristobalite-; alpha-Crystobalite-; Crysvarl-; Metacristobalite-; 43-63C-; Calcined-diatomaceous-earth-; Calcined-diatomite-; Silica,-crystalline-cristobalite- (ACGIH:OSHA); WGL-300-; W-006- RN: Current: 14464-46-1 Previous: 1317-48-2; 105269-70-3 UD: 200210 MF: O2-Si MW: 60.09 WL: SI O2 CC: Tumorigen (C); Human-Data (P) TE: V01-P62 ipl-rat TDLo: 90 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 57, p. 509, 1976 (JNCIAM); V03-P62 ipl-rat TD :100 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 41, p. 908, 1980 (BJCAAI) AT: J12-J21-J22 ihl-hmn TCLo: 16 mppcf/8H/17.9Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB246-697 (NTIS**); J12 itr-rat LDLo: 200 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 10, p. 9, 1953 (BJIMAG) MD: J12-J13-J30 ihl-mus TCLo: 70 mg/m3/5H/12D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 17, p. 99, 1998 (JEPOEC); J17-J30 ihl-mus TCLo: 43 mg/m3/5H/9D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 17, p. 81, 1998 (JEPOEC) TR: ACGIH TLV-TWA 0.05 mg/m3 (R) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.05 mg/m3 (j, cristobalite) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); TOXICOLOGY REVIEW Annals of Allergy. (American College of Allergists, POB 20671, Bloomington, MN 55420) V.1- 1943- v. 35, p. 165, 1975 (ANAEA3); TOXICOLOGY REVIEW "Experimental Lung Cancer: Carcinogenesis and Bioassays, International Symposium, 1974," Karbe, E., and J.F. Park, eds., Springer-Verlag New York, Inc., 1974 -,93,1974 (31BYAP) SR: MSHA STANDARD-respirable dust in air: TWA 10 mg/m3/2(% resp. SiO2+2) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); MSHA STANDARD-total dust in air: TWA 30 mg/m3/2(% SiO2+3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 5 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 20 mppcf/(%SiO2+5) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OEL-AUSTRIA: MAK 0.15 mg/m3, JAN 1999; OEL-BELGIUM: TWA 0.05 mg/m3, JAN 1993; OEL-FINLAND: TWA 0.1 mg/m3, JAN 1999; OEL-FRANCE: VME 10/(2X+2), JAN 1999; OEL-GERMANY: MAK 0.15 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.075 mg/m3, JAN 1999; OEL-NORWAY: TWA 0.05 mg/m3 (resp.), JAN 1999; OEL-RUSSIA: STEL 1 mg/m3 (total dust), JAN 1993; OEL-SWEDEN: NGV 0.05 mg/m3 (resp. Dust), JAN 1999; OEL-SWITZERLAND: MAK-W 0.15 mg/m3, JAN 1999; OEL-THAILAND: TWA 10 mg/m3, JAN 1993; OEL-UNITED KINGDOM: TWA0.3 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO SILICA, cryst. cristobalite-air: 10H CA TWA 0.05 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD T0624; NIS 33; TNF 2072; NOS 43; TNE 31369; TFE 2228 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Silica, crystalline, by XRD, 7500, by VIS, 7600, by IR, 7602; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID-125G, SUPERSEDED BY ID142 Record 1039 of 1119 in RTECS (through 2003/06) AN: VV7328000 PN: Silica,-crystalline---fused- SY: Accusand-; Amorphous-quartz-; Amorphous-silica-; Borsil-P-; Cryptocrystalline-quartz-; Denka-F-90-; Denka-FB-44-; EF-10-; F-125-; F-44-; FS-74-; Fused-quartz-; Fused-silica-; Fuselex-; Fuselex-RD-120-; Fuselex-RD-40-60-; Fuselex-ZA-30-; GP-11I-; GP-7I-; MR-84-; Microcrystalline-quartz-; Nalcast-; Optocil-; Optocil- (quartz); QG-100-; Quartz-glass-; Quartz-sand-; Quarzsand- (German); RD-120-; RD-8-; Rancosil-; S-Col-; SGA-; Silica,-amorphous-fused- (ACGIH); Silica,-fused-; Silica,-fused- (OSHA); Silica,-vitreous- (9CI); Silicon-dioxide-; Silicone-dioxide-; Siltex-; Spectrosil-; Suprasil-; Suprasil-W-; Vitreosil-IR-; Vitreous-quartz-; Vitreous-silica-; Vitrified-silica-; Y-40- RN: Current: 60676-86-0 Previous: 37224-34-3; 37224-35-4; 55126-05-1 UD: 200210 MF: O2-Si MW: 60.09 WL: SI O2 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C) TE: V03-K60-V10 imp-rat TDLo: 400 mg/kg Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 41, p. 534, 1954 (NATWAY) AT: J13-K12-U01 ipr-rat LDLo: 400 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 9, p. 389, 1954 (AMIHBC); J07-J15 itr-rat LDLo: 120 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 9, p. 389, 1954 (AMIHBC); F07-F11-K30 ipr-mus LDLo: 40 mg/kg British Journal of Experimental Pathology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1920- v. 3, p. 75, 1922 (BJEPA5); F12-F18-J26 ivn-cat LDLo: 5 mg/kg Journal of Laboratory and Clinical Medicine. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1915- v. 26, p. 774, 1941 (JLCMAK); F07-G30-J30 ivn-rbt LDLo: 35 mg/kg British Journal of Experimental Pathology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1920- v. 3, p. 75, 1922 (BJEPA5) MD: J70 ihl-rat TCLo: 197 mg/m3/6H/26W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(6), p. 28, 1978 (GTPZAB) TR: ACGIH TLV-TWA 0.1 mg/m3 (R) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 mg/m3 (j, silica fused) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT) SR: MSHA STANDARD-respirable dust in air: TWA 10 mg/m3/% resp. SiO2+2 "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); MSHA STANDARD-total dust in air: TWA 30 mg/m3/% SiO2+3 "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 10 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 10 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 10 mg/m3/(% resp SiO2+2), resp. dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 0.3 mg/m3, JAN 1999; OEL-FINLAND: TWA 5 mg/m3, JAN 1999; OEL-GERMANY: MAK 0.3 mg/m3, JAN 1999; OEL-NORWAY: TWA 0.05 mg/m3 (resp. dust), JAN 1999; OEL-SWITZERLAND: MAK-W 0.3 mg/m3, JAN 1999; OEL-UNITED KINGDOM: TWA 0.08 mg/m3, respirable dust, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO SILICA, fused-air: 10H CA TWA 0.05 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M4331; NIS 8; TNF 480; NOS 14; TNE 6475; NOES 1983: HZD M4331; NIS 68; TNF 4174; NOS 60; TNE 52205; TFE 7320 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 1040 of 1119 in RTECS (through 2003/06) AN: VV7330000 PN: Silica,-crystalline---quartz- SY: Agate-; Amethyst-; Chalcedony-; Cherts-; Crystalline-silica-; Crystallized-silicon-dioxide-; D & D; DQ12-; Flint-; Flintshot-; Gold-bond-R-; Imsil-; Min-U-Sil-; Novaculite-; Onyx-; Quartz-; Quartz-silica-; Quazo-puro- (Italian); Rock-crystal-; Rose-quartz-; SF-35-; Sand-; Sicron-F-300-; Siderite- (SiO2); Sikron-F-100-; Sil-Co-Sil-; Silica-; Silica-dust-; Silica-flour- (powdered crystalline silica); Silica,-crystalline-quartz- (ACGIH:OSHA); Silicon-oxide,-di- (sand); Silver-bond-B-; Snowit-; TGL-16319-; Tiger-eye-; W-12-; W-12- (Filler); alpha-Quartz- RN: Current: 14808-60-7 Previous: 1317-79-9 UD: 200305 MF: O2-Si MW: 60.09 WL: SI O2 CC: Tumorigen (C); Mutagen (M); Organometallic (O); Human-Data (P) ME: mnt-hmn-lng 40 ug/cm2 Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 335, p. 27, 1995 (MUREAV); mnt-ham-lng 160 ug/cm2 Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 335, p. 27, 1995 (MUREAV); dnd-rat-itr 6 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 716, 2001 (ARTODN) TE: V01-L60 ihl-rat TCLo: 50 mg/m3/6H/71W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 499, 1986 (ENVRAL); V01-V10 ipr-rat TDLo: 45 mg/kg Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC. v. 162, p. 467, 1976 (ZHPMAT); V03-P62 ivn-rat TDLo: 90 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 57, p. 509, 1976 (JNCIAM); V01-P62 ipl-rat TDLo: 90 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 57, p. 509, 1976 (JNCIAM); V01-J60 itr-rat TDLo: 111 mg/kg Cancer Research Monographs. (Praeger Pub., 521 Fifth Ave., New York, NY 10175) V.1- 1983- v. 2, p. 243, 1986 (CREMEX); V03-J60 itr-rat TDLo: 100 mg/kg/19W-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 34, p. 47, 1980 (EVHPAZ); V02-K60-V10 imp-rat TDLo: 900 mg/kg Acta Unio Internationalis Contra Cancrum. (Louvain, Belgium) V.1-20, 1936-64. For publisher information, see IJCNAW. v. 10, p. 119, 1954 (AICCA6); V03-M60 imp-mus TDLo: 4000 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 22, p. 825, 1968 (BJCAAI); V02-V10 ipl-ham TDLo: 83 mg/kg "Experimental Lung Cancer: Carcinogenesis and Bioassays, International Symposium, 1974," Karbe, E., and J.F. Park, eds., Springer-Verlag New York, Inc., 1974 -,92,1974 (31BYAP); V03-P62 ipr-rat TD :90 mg/kg/4W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 57, p. 509, 1976 (JNCIAM); V02-K60 ipr-rat TD :450 mg/kg/4W-I Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- v. 59, p. 318, 1972 (NATWAY); V03-V10 imp-rat TD :4554 mg/kg Clinical Orthopaedics and Related Research. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) No.26- 1963- v. 88, p. 223, 1972 (CORTBR); V03-J61 ipl-rat TD :200 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 48, p. 797, 1972 (JNCIAM); V01-P62-J60 ipl-rat TD :100 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 41, p. 908, 1980 (BJCAAI); V03-J12-J60 ipl-rat TD :100 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 41, p. 836, 1980 (AIHAAP); V02-J60 ipl-rat TD :100 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 79, p. 797, 1987 (JJIND8) AT: J12-J21-J22 ihl-hmn TCLo: 16 mppcf/8H/17.9Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB246-697 (NTIS**); L30 ihl-hmn LCLo: 300 ug/m3/10Y-I Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 271, p. 324, 1976 (ANYAA9); T/E unlistd ivn-rat LDLo: 90 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 57, p. 509, 1976 (JNCIAM); J12 itr-rat LDLo: 200 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 10, p. 9, 1953 (BJIMAG); T/E unlistd ivn-mus LDLo: 40 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 1, p. 241, 1940 (JNCIAM); J30-Y03 itr-mus LD :>20 mg/kg American Review of Respiratory Disease. (American Lung Assoc., 1740 Broadway, New York, NY 10019) V.80- 1959- v. 141(Suppl), p. A3-A937, 1990 (ARDSBL); T/E unlistd ivn-dog LDLo: 20 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 27, p. 1007, 1933 (BIJOAK); J12-J30-U09 ihl-rat TCLo: 200 mg/kg American Journal of Physiology. (American Physiological Soc., 9650 Rockville Pike, Bethesda, MD 20814) V.1- 1898- v. 267, p. L686, 1994 (AJPHAP); J12-J30 itr-rat LDLo: 250 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 19, p. 403, 1986 (JTEHD6); J30-J70-Y03 itr-rat TDLo: 240 mg/kg/1H In Vitro Effects of Mineral Dusts (Third International Workshop, E. G. Beck, J. Bignon, Editors: Berlin, Springer-Verlag) 1985. v. -, p. 453, 1985 (IVIEM*); J13 itr-rat TDLo: 1.5 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 716, 2001 (ARTODN); K12-K30 orl-rat TDLo: 120 gm/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. #86940001000, 1994 (EPASR*) MD: J12-P27-S02 ihl-rat TCLo: 80 mg/m3/26W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 31(1), p. 24, 1987 (GTPZAB); Y03-Y12-Y40 ihl-rat TCLo: 108 mg/m3/6H/3D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 107, p. 350, 1991 (TXAPA9); J30-N74-P72 ihl-rat TCLo: 58 mg/m3/13W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 29, p. 341, 1991 (FCTOD7); J30 ihl-mus TCLo: 1475 ug/m3/8H/21W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 39, p. 331, 1986 (ENVRAL); N73-S04 ihl-mus TCLo: 4932 ug/m3/24H/39W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 21, p. 298, 1980 (ENVRAL); J30-J70-Y21 ihl-gpg TCLo: 28 mg/m3/3W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 68, p. 152, 1983 (TXAPA9); J13-J70 ihl-ham TCLo: 3 mg/m3/6H/78W-I Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 10, p. 699, 1998 (INHTE5); J30-Y10 ihl-dom TCLo: 1000 gm/m3/10D-I Experimental Lung Research. (Hemisphere Publishing, c/o Taylor and Francis 1900 Frost Road, Suite 101, Bristol, PA 19007) V.1- 1980- v. 15, p. 409, 1989 (EXLRDA); P30-P72 itr-rat TDLo: 2.88 mg/kg/12W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 175, p. 63, 2002 (TXCYAC); J30-P30-P72 itr-rat TDLo: 11.52 mg/kg/12W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 175, p. 63, 2002 (TXCYAC) TR: ACGIH TLV-TWA 0.05 mg/m3 (R) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 mg/m3 (j, quartz) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); TOXICOLOGY REVIEW "Experimental Lung Cancer: Carcinogenesis and Bioassays, International Symposium, 1974," Karbe, E., and J.F. Park, eds., Springer-Verlag New York, Inc., 1974 -,94,1974 (31BYAP) SR: MSHA STANDARD-respirable dust in air: TWA 10 mg/m3/% resp. SiO2+2 "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); MSHA STANDARD-total dust in air: TWA 30 mg/m3/2(SiO2+3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 10 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 10 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 30 mg/m3/(%SiO2+2), total dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 250 mppcf/(%SiO2+5) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 250 mppcf/(%SiO2+5) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 0.15 mg/m3, JAN 1999; OEL-BELGIUM: TWA 0.1 mg/m3, JAN 1993; OEL-FINLAND: TWA 0.2 mg/m3, JAN 1999; OEL-FRANCE: VME 10/(X+2), JAN 1999; OEL-GERMANY: MAK 0.15 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.075 mg/m3, JAN 1999; OEL-NORWAY: TWA 0.1 mg/m3 (resp. dust), JAN 1999; OEL-NORWAY: TWA 0.3 mg/m3 (total dust), JAN 1999; OEL-RUSSIA: STEL 14 mg/m3, JAN 1993; OEL-SWEDEN: NGV 0.1 mg/m3 (resp. dust), JAN 1999; OEL-SWITZERLAND: MAK-W 0.15 mg/m3, JAN 1999; OEL-THAILAND: TWA 10 mg/m3 (resp. dust), JAN 1993; OEL-THAILAND: TWA 30 mg/m3 (total dust), JAN 1993; OEL-UNITED KINGDOM: TWA 0.3 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO SILICA, crystalline quartz-air: 10H CA TWA 0.05 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 66495; NIS 59; TNF 4077; NOS 82; TNE 81221; NOES 1983: HZD X6478; NIS 2; TNF 135; NOS 10; TNE 8927; TFE 741; NOES 1983: HZD 66495; NIS 254; TNF 53724; NOS 173; TNE 944731; TFE 112888 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 36, 1981; NIOSH Analytical Method, 1994: Silica, crystalline in coal mine dust, by IR, 7603; NIOSH Analytical Method, 1994: Silica, crystalline, by XRD, 7500, by VIS, 7600, by IR, 7602; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID142; OSHA ANALYTICAL METHOD #ID-125G Record 1041 of 1119 in RTECS (through 2003/06) AN: VV7335000 PN: Silica,-crystalline---tridymite- SY: Christensenite-; Silica,-crystalline-tridymite- (ACGIH:OSHA); Tridimite- (French); Tridymite-; Tridymite-118-; alpha-Tridymite- RN: Current: 15468-32-3 Previous: 1317-94-8; 12414-70-9 UD: 200210 MF: O2-Si MW: 60.09 WL: SI O2 CC: Tumorigen (C); Mutagen (M); Human-Data (P) ME: sce-hmn-lym 13514 ug/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 47, p. 110, 1990 (BJIMAG) TE: V03-P62 ipl-rat TDLo: 100 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 41, p. 908, 1980 (BJCAAI); V03-J60 itr-mus TDLo: 400 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 15, p. 6, 1974 (PAACA3) AT: J12-J21-J22 ihl-hmn TCLo: 16 mppcf/8H/17.9Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB246-697 (NTIS**); J12 itr-rat LDLo: 200 mg/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 10, p. 9, 1953 (BJIMAG) TR: ACGIH TLV-TWA 0.05 mg/m3 (R) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.05 mg/m3 (j, tridymite) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 68, p. 41, 1997 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 341, 1987 (IMSUDL) SR: MSHA STANDARD-respirable dust in air: TWA 10 mg/m3/2(% resp. SiO2+2) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); MSHA STANDARD-total dust in air: TWA 30 mg/m3/2(% resp. SiO2+3) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 5 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OEL-AUSTRIA: MAK 0.15 mg/m3, JAN 1999; OEL-BELGIUM: TWA 0.05 mg/m3, JAN 1993; OEL-FINLAND: TWA 0.1 mg/m3, JAN 1999; OEL-FRANCE: VME 10/(2X+2), JAN 1999; OEL-GERMANY: MAK 0.15 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.075 mg/m3, JAN 1999; OEL-NORWAY: TWA 0.15 mg/m3 (total dust), JAN 1999; OEL-NORWAY: TWA 0.05 mg/m3 (resp. dust), JAN 1999; OEL-SWEDEN: NGV 0.05 mg/m3 (resp. Dust), JAN 1999; OEL-SWITZERLAND: MAK-W 0.15 mg/m3, JAN 1999; OEL-THAILAND: TWA 10 mg/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.23 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO SILICA, crystalline tridymite-air: 10H CA TWA 0.05 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD 74617; NIS 1; TNF 21; NOS 1; TNE 2042; TFE 351 SL: NIOSH Analytical Method, 1994: Silica, crystalline, by XRD, 7500, by VIS, 7600, by IR, 7602; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID-125G Record 1042 of 1119 in RTECS (through 2003/06) AN: VV7336000 PN: Silica,-crystalline---tripoli- SY: Randanite-; Silica,-crystalline-tripoli- (ACGIH:OSHA); Tripoli- RN: Current: 1317-95-9 UD: 200210 CC: Tumorigen (C) MD: J02-J30-Y03 ihl-rat TCLo: 100 mg/m3/3D-I American Review of Respiratory Disease. (American Lung Assoc., 1740 Broadway, New York, NY 10019) V.80- 1959- v. 141(Suppl), p. A3-A937, 1990 (ARDSBL) TR: ACGIH TLV-TWA 0.1 mg/m3 (R) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 mg/m3 (respirable dust) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 39, 1987 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 341, 1987 (IMSUDL) SR: MSHA STANDARD-respirable dust in air: TWA 10 mg/m3/% resp. SiO2+2 "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); MSHA STANDARD-total dust in air: TWA 30 mg/m3/% SiO2+3 "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 33, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 10 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 10 mg/m3/(% resp SiO2+2) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OEL-BELGIUM: TWA 0.1 mg/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.3 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO SILICA, crystalline tripoli-air: 10H CA TWA 0.05 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 74655; NIS 33; TNF 3594; NOS 26; TNE 20803; NOES 1983: HZD X9247; NIS 1; TNF 52; NOS 1; TNE 156; NOES 1983: HZD X9681; NIS 3; TNF 90; NOS 1; TNE 1635; NOES 1983: HZD 74655; NIS 29; TNF 2287; NOS 19; TNE 22615; TFE 3267 SL: NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID213 Record 1043 of 1119 in RTECS (through 2003/06) AN: VV9100000 PN: Silicic-acid,-beryllium-zinc-salt- SY: Beryllium-zinc-silicate-; Zinc-beryllium-silicate- RN: Current: 39413-47-3 Previous: 63089-82-7 UD: 200012 WL: BE ZN SI-O4 CC: Tumorigen (C); Mutagen (M) TE: V03-Q60 ivn-rbt TDLo: 100 mg/kg/2W-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 1, p. 519, 1950 (LANCAO); V03-J60-Q60 ims-rbt TDLo: 20 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 20, p. 778, 1966 (BJCAAI); V03-Q60-V10 par-rbt TDLo: 17 mg(Be)/kg Bulletin du Cancer. (SPPIF, B.P.22, F-41353 Vineuil, France) V.53- 1966- v. 62, p. 49, 1975 (BUCABS); V03-J60-Q60 imp-rbt TDLo: 10 mg/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 88, p. 89, 1969 (ARPAAQ); V03-J60-Q60 ivn-rbt TD :500 mg/kg/10W-I Journal of Bone and Joint Surgery, British Volume. (10 Shattuck St., Boston, MA 02115) V.30- 1948- v. 36, p. 543, 1954 (JBSUAK); V03-Q60 ivn-rbt TD :500 mg/kg/6W-I Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 5, p. 221, 1946 (FEPRA7) TR: ACGIH TLV-SUSPECTED HUMAN CARCINOGEN "Documentation of the Threshold Limit Values and Biological Exposure Indices," 5th ed., Cincinnati, OH, American Conference of Governmental Industrial Hygienists, Inc., 1986 6,1/BEI,1997 (85INA8); ACGIH TLV-TWA 0.002 mg(Be)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Suspected human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 1, p. 17, 1972 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 23, p. 143, 1980 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 58, p. 41, 1993 (IMEMDT); TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 105, 1971 (FCTXAV) SR: OSHA PEL (Gen Indu): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.002 mg(Be)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-AUSTRALIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-FINLAND: TWA 0.002 mg(Be)/m3, STEL 0.006 mg(Be)/m3, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.002 mg(Be)/m3, C2 Carcinogen. JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-INDIA: TWA 0.002 mg(Be)/m3, Carcinogen, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 0.002 mg(Be)/m3, JAN 1999; OEL-NORWAY: TWA 0.001 mg(Be)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 0.001 mg(Be)/m3, MAC(STEL) 0.003 mg(Be)/m3, JAN 1999; OEL-RUSSIA: STEL 0.001 mg(Be)/m3, Carcinogen, JAN 1993; OEL-SWITZERLAND: MAK-W 0.002 mg(Be)/m3, Carcinogen, JAN 1999; OEL-SWITZERLAND: TWA 0.002 mg(Be)/m3, Carcinogen JAN 1993; OEL-THAILAND: TWA 0.002 mg(Be)/m3, STEL 0.005 mg(Be)/m3, JAN 1993; OEL-TURKEY: TWA 0.002 mg(Be)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 0.002 mg(Be)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO BERYLLIUM-air: CA not to exceed 0.0005 mg(Be)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1044 of 1119 in RTECS (through 2003/06) AN: VW5485000 PN: Silybum marianum (linn.) Gaertn., extract SY: Milk-thistle-extract- RN: Current: 84604-20-6 UD: 200012 CC: Tumorigen (C); Natural-Product (N) AT: T/E unlistd ipr-mus LD50: 681 mg/kg Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 22, p. 487, 1984 (IJEBA6) SL: NTP Carcinogenesis Studies, Selected, October 2000 Record 1045 of 1119 in RTECS (through 2003/06) AN: VW5503000 PN: Silymarin- RN: Current: 65666-07-1 UD: 200305 CC: Tumorigen (C); Mutagen (M); Natural-Product (N) ME: dnd-hmn-hla 400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 141, 1997 (MUREAV); dnd-hmn-lym 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 141, 1997 (MUREAV); oms-rat-ipr 200 mg/kg Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 61, p. 273, 1988 (RCOCB8); dni-hmn-oth 100 umol/L/5D Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 147, p. 77, 1999 (CALEDQ) AT: T/E unlistd orl-mus LD50: >1600 mg/kg German Offenlegungsschrift Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) #2423725 (GWXXBX); J02 ipr-gpg TDLo: 100 mg/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 437, p. 91, 2002 (EJPHAZ) MD: R60-V25-V30 skn-mus TDLo: 19200 mg/kg/40W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 811, 2000 (CRNGDP) SL: NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 1046 of 1119 in RTECS (through 2003/06) AN: VY8050000 PN: Sodium-azide- SY: Azide,-sodium-; Azoture-de-sodium- (French); Azydek-sodu- (Polish); NSC-3072-; Kazoe-; Natriumazid- (German); Natriummazide- (Dutch); NCI-C06462-; Nemazyd-; RCRA-waste-number-P105-; Sodium-azide- (ACGIH); Sodium,-azoture-de- (French); Sodium,-azoturo-di- (Italian); Smite-; U-3886- RN: Current: 26628-22-8 Previous: 12136-89-9 UD: 200302 MF: N3-Na MW: 65.02 WL: NA Z CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P) ME: mmo-sat 30 ng/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9(Suppl 9), p. 1, 1987 (ENMUDM); mmo-sat 1 ug/plate (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 5135, 1975 (PNASA6); mmo-esc 150 nmol/L (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); mmo-esc 33300 ng/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6(Suppl 2), p. 1, 1984 (ENMUDM); dnr-esc 5 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 119, p. 135, 1983 (MUREAV); pic-esc 1100 ng/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); mmo-omi 600 ppm (-S9) Proceedings of the Oklahoma Academy of Science. (Oklahoma Academy of Science, c/o Executive Secretary-Treasurer, Southwestern Oklahoma State Univ., Weatherford, OK 73096) V.1- 1910/1920- v. 34, p. 114, 1953 (POASAD); slt-dmg-orl 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 157, 1997 (MUREAV); mmo-eug 5 mg/L (-S9) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 5, p. 329, 1985 (TCMUD8); dlt-oin-orl 100 mg/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 37, p. 824, 1981 (EXPEAM); trn-oin-orl 100 mg/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 37, p. 824, 1981 (EXPEAM); dnd-hmn-leu 3 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 468, p. 93, 2000 (MUREAV); dni-hmn-hla 30 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); dni-hmn-fbr 50 mg/L Studia Biophysica. (Akademie-Verlag GmbH, Postfach 1233, Berlin DDR-1086, Ger. Dem. Rep.) V.1- 1966- v. 78, p. 165, 1980 (STBIBN); msc-rat-lvr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 293, 1980 (MUREAV); msc-mus-lym 500 mg/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 59, p. 61, 1979 (MUREAV); msc-ham-lng 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 293, 1980 (MUREAV); mmo-sat 1.5 ug/plate/44H Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 105, 2002 (FCTOD7); mmo-sat 1 ug/plate/3H (-S9) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 1, 2002 (FCTOD7); mmo-sat 2 ug/plate/48H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 472, p. 75, 2000 (MUREAV); mmo-sat 1 ug/plate/20M (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 494, p. 41, 2001 (MUREAV); mmo-sat 0.5 ug/plate/90M (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 490, p. 45, 2001 (MUREAV); mmo-sat 5 mg/plate/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 491, p. 195, 2001 (MUREAV); mmo-sat 0.5 ug/plate/72H (-S9) Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 303, 2001 (MUTAEX); mmo-sat 1 ug/plate/20M (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 324, 2001 (EMMUEG); mmo-sat 1.5 ug/plate/24H (+/-S9) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 65, p. 691, 2000 (BECTA6); mmo-sat 1.5 uL/plate (-S9) Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 42, p. 77, 2000 (VHTODE); mmo-sat 10 mg/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 161, 2002 (MUREAV); mmo-esc 10 ug/well/12H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 520, p. 161, 2002 (MUREAV); mmo-sat 1.5 ug/plate/2D (+/-S9) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 65, p. 691, 2000 (BECTA6); mmo-sat 20 mg/L/72H (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 52, 2000 (EMMUEG) TE: V03-N60-R60 orl-rat TDLo: 2730 mg/kg/78W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 75, 1981 (JJIND8); V03-N60-R60 orl-rat TD :5460 mg/kg/78W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 75, 1981 (JJIND8) ORNG: 27000000 ng/kg. [27.000000 mg/kg] T/E unlistd SRNG: 20000000 ng/kg. [20.000000 mg/kg] T/E unlistd SKNG: 50000000 ng/kg. [50.000000 mg/kg] T/E unlistd AT: F12-F24-G04 orl-wmn LDLo: 786 mg/kg Medical Toxicology and Adverse Drug Experience. (Adis International Ltd., Private Baq 65901, Mairangi Bay, Auckland 10, N.Z.) V.4- 1989- v. 4, p. 219, 1989 (MTAEEB); A03-G08-J15 orl-man LDLo: 29 mg/kg Medical Toxicology and Adverse Drug Experience. (Adis International Ltd., Private Baq 65901, Mairangi Bay, Auckland 10, N.Z.) V.4- 1989- v. 4, p. 219, 1989 (MTAEEB); F24-G08-G30 orl-man LDLo: 129 mg/kg Journal of Analytical Toxicology. (Preston Pub. Inc., POB 48312, Niles, IL 60648) V.1- 1977- v. 20, p. 134, 1996 (JATOD3); F12-G04-G09 orl-wmn LDLo: 14 mg/kg Journal of Forensic Sciences. (American Soc. for Testing and Materials, 1916 Race St., Philadelphia, PA 19103) V.1- 1956- v. 35, p. 193, 1990 (JFSCAS); F27-J22-K12 orl-wmn TDLo: 3 mg/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 20, p. 279, 1965 (ATXKA8); F01-F07-M30 orl-hmn TDLo: 710 ug/kg Journal of Clinical Pathology. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1947- v. 28, p. 350, 1975 (JCPAAK); D16-F07-F33 orl-man LDLo: 143 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 24, p. 339, 1986 (JTCTDW); G07-H02-P27 orl-man TDLo: 129 ug/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 40, p. 1407, 1998 (YAKUD5); G01-J30-Q30 orl-man TDLo: 1143 ug/kg British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 39, p. 308, 1982 (BJIMAG); T/E unlistd orl-rat LD50: 27 mg/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C32, 1991 (FMCHA2); D35-F12-J02 ihl-rat LC50: 37 mg/m3 "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 173, 1999 (STGNBT); T/E unlistd skn-rat LD50: 50 mg/kg "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 173, 1999 (STGNBT); T/E unlistd ipr-rat LDLo: 30 mg/kg Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878- v. 58, p. 607, 1943 (PHRPA6); C06-J30 scu-rat LD50: 45100 ug/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 12, p. 427, 1961 (MEPAAX); C06-J30 itr-rat LD50: 47500 ug/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 12, p. 427, 1961 (MEPAAX); T/E unlistd orl-mus LD50: 27 mg/kg Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*); D35-F12-J02 ihl-mus LC50: 32400 ug/m3 "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 173, 1999 (STGNBT); F12-F17-J26 ipr-mus LD50: 28 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30, p. 98, 1948 (JIHTAB); C06-J30 scu-mus LD50: 23060 ug/kg Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 12, p. 427, 1961 (MEPAAX); T/E unlistd ivn-mus LD50: 19 mg/kg Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*); T/E unlistd unr-mus LD50: 27 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 6, p. 160, 1952 (BJCAAI); D16-F12-H02 ivn-mky LDLo: 12 mg/kg Brain: Journal of Neurology. (Oxford Univ. Press, Walton St., Oxford OX2 6DP, UK) V.1- 1878- v. 95, p. 505, 1972 (BRAIAK); T/E unlistd skn-rbt LD50: 20 mg/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C32, 1991 (FMCHA2); T/E unlistd scu-rbt LDLo: 17 mg/kg Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 22, p. 160, 1966 (ATXKA8); T/E unlistd orl-bwd LD50: 23700 ug/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV); F24-J25-U28 ipr-rat LDLo: 3 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 25, 1993 (VCVN5*); T/E unlistd scu-mus LD50: 23 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 26, 1993 (VCVN5*); T/E unlistd scu-rat LD50: 45 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 26, 1993 (VCVN5*); T/E unlistd itr-rat LD50: 47.5 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 26, 1993 (VCVN5*) MD: U01-Z01 orl-rat TDLo: 5206 mg/kg/39D-C Public Health Reports. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1878- v. 58, p. 607, 1943 (PHRPA6); L70 orl-rat TDLo: 81250 ug/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-389, 1991 (NTPTR*); G70-L70-Z01 orl-rat TDLo: 240 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-389, 1991 (NTPTR*); Z01 scu-rat TDLo: 740 mg/kg/74D-I Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1950- v. 12, p. 427, 1961 (MEPAAX); L70 orl-mus TDLo: 81250 ug/kg/13W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 5, p. 195, 1985 (TOXID9); G06-H02-Y01 orl-mam TDLo: 240 mg/kg/30D-I "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 173, 1999 (STGNBT); G06-L14-M16 orl-mam TDLo: 45500 ug/kg/26W-I "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999 v. -, p. 173, 1999 (STGNBT); P61-N61-V30 orl-rat TDLo: 5150 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-135615 (NTIS**); R60-V30 orl-rat TDLo: 2575 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-135615 (NTIS**); J25-U28-Z01 ipr-rat TDLo: 15 mg/kg/5D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 25, 1989 (VCVN5*) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-CL 0.29 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6) SR: OEL-AUSTRALIA: TWA 0.1 ppm (0.3 mg/m3), JAN 1993; OEL-AUSTRIA: MAK 0.07 ppm (0.2 mg/m3), JAN 1999; OEL-BELGIUM: STEL 0.11 ppm (0.3 mg/m3), JAN 1993; OEL-DENMARK: TWA 0.3 mg/m3, JAN 1999; OEL-FINLAND: TWA 0.1 ppm (0.3 mg/m3), STEL 0.3 ppm (0.9 mg/m3), JAN 1999; OEL-FRANCE: VLE 0.1 ppm (0.3 mg/m3), JAN 1999; OEL-GERMANY: MAK 0.07 ppm (0.2 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.1 ppm (0.3 mg/m3), JAN 1999; OEL-NORWAY: TWA 0.3 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 0.07 ppm (0.2 mg/m3), JAN 1999; OEL-UNITED KINGDOM: STEL 0.3 mg(NaN3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO SODIUM AZIDE, as HN3-air: CL 0.1 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 68820; NIS 13; TNF 877; NOS 10; TNE 5953; NOES 1983: HZD 68820; NIS 19; TNF 3640; NOS 27; TNE 54959; TFE 38370 SL: EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-forward mutation, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Negative: TRP reversion; EPA GENETOX PROGRAM 1988, Inconclusive: Carcinogenicity-mouse/rat, TRP reversion; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 13, 1976; NCI Carcinogenesis Studies (gavage), no evidence: rat; OSHA ANALYTICAL METHOD #ID211 Record 1047 of 1119 in RTECS (through 2003/06) AN: VZ7525000 PN: Sodium-cyanide- SY: Cianuro-di-sodio- (Italian); Cyanide-of-sodium-; Cyanobrik-; Hydrocyanic-acid,-sodium-salt-; Cyanogran-; Cyanure-de-sodium- (French); Cymag-; Kyanid-sodny- (Czech); Prussiate-of-soda-; RCRA-waste-number-P106-; Sodium-cyanide- (ACGIH) RN: Current: 143-33-9 Previous: 13998-03-3 BRN: 3587243 BHR: 4-02-00-00050 UD: 200305 MF: C-N-Na MW: 49.01 WL: NA CN CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: sln-dmg-ihl 200 ppb Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 85, 1991 (MUREAV) RE: T01-T02 orl-rat TCLo: 2148 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3386 (NTPTR*); T02 orl-mus TDLo: 4177 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3386 (NTPTR*); T34-T46-T47 imp-ham TDLo: 5999 mg/kg (6-9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 64, p. 456, 1982 (TXAPA9); T25-T41 imp-ham TDLo: 5928 mg/kg (6-9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 64, p. 456, 1982 (TXAPA9); T39 orl-rat TDLo: 6 mg/kg (10D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 163, p. 149, 2000 (TXAPA9) ORNG: 6440000 ng/kg. [6.440000 mg/kg] T/E unlistd SRNG: 10400000 ng/kg. [10.400000 mg/kg] F07-F11-J22 AT: K30 orl-wmn LDLo: 40 mg/kg Forensic Science International. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.12- 1978- v. 38, p. 173, 1988 (FSINDR); K30 orl-chd LDLo: 100 mg/kg Forensic Science International. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.12- 1978- v. 38, p. 173, 1988 (FSINDR); T/E unlistd orl-hmn LDLo: 2800 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528336 (NTIS**); F16-K05 orl-man LDLo: 6557 ug/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 1, p. 18, 1945 (APTOA6); T/E unlistd orl-hmn LDLo: 2857 ug/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,191,1969 (34ZIAG); F08-F18 orl-man TDLo: 714 ug/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 20, p. 291, 1963 (APTOA6); T/E unlistd unr-man LDLo: 2206 ug/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 6440 ug/kg "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,13,1972 (28ZPAK); T/E unlistd ipr-rat LD50: 4300 ug/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 43(12), p. 90, 1978 (GISAAA); T/E unlistd ipr-mus LD50: 4900 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0528336 (NTIS**); T/E unlistd scu-mus LD50: 3600 ug/kg American Journal of Physiology. (American Physiological Soc., 9650 Rockville Pike, Bethesda, MD 20814) V.1- 1898- v. 179, p. 60, 1954 (AJPHAP); T/E unlistd unr-mus LD50: 10 mg/kg Igaku No Ayumi. Progress in Medicine. (Ishiyaku Shuppan K.K., 1-7-10, Honkomagom, Bunkyo-ku, Tokyo, Japan) V.1- 1946- v. 112, p. 861, 1980 (IGAYAY); T/E unlistd scu-dog LD50: 5360 ug/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 149, p. 113, 1952 (JAMAAP); T/E unlistd ivn-dog LDLo: 1300 ug/kg Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 6, p. 349, 1947 (FEPRA7); F07-F11-J22 skn-rbt LD50: 10400 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0536153 (NTIS**); T/E unlistd scu-rbt LDLo: 2200 ug/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 100, p. 1920, 1933 (JAMAAP); T/E unlistd ims-rbt LD50: 1666 ug/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 120, 1982 (JACTDZ); T/E unlistd ocu-rbt LD50: 5048 ug/kg Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 120, 1982 (JACTDZ); T/E unlistd scu-gpg LD50: 5800 ug/kg Medicina del Lavoro. Industrial Medicine. (Via S. Barnaba, 8, 20122 Milan, Italy) V.16- 1925- v. 46, p. 221, 1955 (MELAAD); D35-J30-K01 orl-ckn LD50: 21 mg/kg Journal of Wildlife Diseases. (Wildlife Disease Assoc., POB 886, Ames, IA 50010) V.6- 1970- v. 22, p. 538, 1986 (JWIDAW); F11-F19-J22 orl-qal LD50: 8500 ug/kg Journal of Wildlife Diseases. (Wildlife Disease Assoc., POB 886, Ames, IA 50010) V.6- 1970- v. 22, p. 538, 1986 (JWIDAW); T/E unlistd orl-dck LD50: 2500 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0530251 (NTIS**); C06-F12-F17 par-frg LDLo: 60 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 166, p. 437, 1932 (AEPPAE); T/E unlistd orl-dom LD50: 4 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 359, 1978 (TXAPA9); T/E unlistd orl-mam LD50: 8 mg/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 23, p. 211, 1979 (BECTA6); F11-F19-J22 orl-bwd LD50: 4 mg/kg Journal of Wildlife Diseases. (Wildlife Disease Assoc., POB 886, Ames, IA 50010) V.6- 1970- v. 22, p. 538, 1986 (JWIDAW); F22-F19-J20 orl-rat LD50: 4.7 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); T/E unlistd ivn-cat LDLo: 2 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); J22-F33-K01 ihl-mam TCLo: 40 mg/m3/25M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); J22-F33-K01 ihl-mam TCLo: 100 mg/m3/3M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); F40-F22 ihl-mam TCLo: 50 mg/m3/20M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); F40-F22 ihl-mam TCLo: 150 mg/m3/26M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); F40-F22 ihl-mam TCLo: 200 mg/m3/16M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); T/E unlistd ihl-mam LCLo: 150 mg/m3/62M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); T/E unlistd ihl-mam LCLo: 400 mg/m3/10M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); T/E unlistd unr-hmn LDLo: 1.43 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 342, 1988 (VCVN1*); T/E unlistd skn-rbt LD50: 300 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 343, 1988 (VCVN1*); J25 ivn-rat TDLo: 2 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 107, 1986 (FATOAO); A10-G06 ivn-cat LDLo: 0.5 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 210, 1981 (FATOAO) MD: N16 orl-rat TDLo: 837 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3386 (NTPTR*); F42-Y61-Y65 ipr-rat TDLo: 60 mg/kg/30D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 38, p. 51, 2000 (FCTOD7); A30-Y01 scu-rat TDLo: 12 mg/kg/3D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 343, 1988 (VCVN1*); A30-B30-U20 ipr-rat TDLo: 500 mg/kg/10D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 343, 1988 (VCVN1*) TR: ACGIH TLV-CL 5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW Galvano-Organo. (Paris, France) V.42-48, 1973-79. v. 47, p. 383, 1978 (GVOGAV) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OSHA PEL (Gen Indu): 8H TWA 5 mg(CN)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 mg(CN)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 mg(CN)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 mg(CN)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 5 mg/m3, Skin, JAN 1993; OEL-AUSTRIA: MAK 5 mg(CN)/m3, Skin, JAN 1999; OEL-DENMARK: TWA 5 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 5 mg(CN)/m3, Skin, JAN 1999; OEL-GERMANY: MAK 5 mg(CN)/m3, Skin, JAN 1999; OEL-POLAND: TWA 0.3 mg(CN)/m3, CEILING 10 mg(CN)/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 5 mg/m3, KZG-W 10 mg/m3, Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 5 mg(CN)/m3, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CYANIDE-air: CL 4.7 ppm(CN)/10M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 68950; NIS 68; TNF 3285; NOS 41; TNE 27329; NOES 1983: HZD 68950; NIS 74; TNF 4423; NOS 63; TNE 66484; TFE 15327 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101207/AS); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0693-9229; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-37, October 2000 Record 1048 of 1119 in RTECS (through 2003/06) AN: WB0350000 PN: Sodium-fluoride- SY: Alcoa-sodium-fluoride-; Antibulit-; Chemifluor-; Credo-; Disodium-difluoride-; FDA-0101-; Floridine-; Florocid-; Flozenges-; Fluoral-; Fluorigard-; Fluorineed-; Fluorinse-; Fluoritab-; Fluorident-; Fluoride,-sodium-; Fluorid-sodny- (Czech); Fluorocid-; Fluor-O-kote-; Fluorol-; Fluorure-de-sodium- (French); Flura-; Flura-drops-; Flura-gel-; Flura-loz-; Flurcare-; Flursol-; F1-Tabs-; Fungol-B-; GEL-II-; Gelution-; Gleem-; Luride-; Luride-lozi-tabs-; Luride-SF-; Nafeen-; NaFpak-; Na-frinse-; Nufluor-; Ossalin-; Ossin-; Pediaflor-; Pedident-; Pennwhite-; Pergantene-; Phos-Flur-; Point-two-; Predent-; Rescue-squad-; Roach-salt-; Cavi-trol-; Iradicav-; Karidium-; Karigel-; Kari-rinse-; Lea-Cov-; Lemoflur-; Natrium-fluoride-; NCI-C55221-; Rafluor-; Sodium-fluoride-cyclic-dimer-; Sodium-fluorure- (French); Sodium-hydrofluoride-; Sodium-monofluoride-; SO-Flo-; Stay-Flo-; Studafluor-; Super-dent-; T-Fluoride-; Thera-flur-; Thera-flur-N-; Trisodium-trifluoride- RN: Current: 7681-49-4 Previous: 39287-69-9 UD: 200305 MF: F-Na MW: 41.99 WL: NA F CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 20 mg/24H MOD "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,20,1972 (28ZPAK) ME: mmo-sat 1 mg/plate (+S9) Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 16(6), p. 41, 1982 (CYGEDX); dnr-bcs 86 mg/L Water Research. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1967- v. 14, p. 1613, 1980 (WATRAG); sln-dmg-orl 5 pph/24H Fluoride. (International Soc. for Fluoride Research, Inc., POB 692, Warren, MI 48090) V.3- 1970- v. 6, p. 113, 1973 (FLUOA4); sln-dmg-mul 60 ug/L Gigiena Naselennykh Mest. Hygiene in Populated Places. (Izdatel'stvo Zdorov'ya, Kiev, USSR) V.7- 1967- v. 15, p. 36, 1976 (GNAMAP); dns-hmn-fbr 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 139, p. 193, 1984 (MUREAV); dns-ham-oth 200 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 140, p. 43, 1984 (MUREAV); dni-hmn-fbr 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 279, p. 109, 1992 (MUREAV); cyt-hmn-fbr 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 139, p. 193, 1984 (MUREAV); cyt-hmn-lym 20 mg/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 2, p. 497, 1987 (MUTAEX); cyt-hmn-oth 952 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 353, 1991 (TIVIEQ); msc-hmn-lym 440 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 196, p. 61, 1988 (MUREAV); dnd-rat-lvr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 59, 1996 (MUREAV); dns-rat-lvr 36 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 172, p. 77, 1986 (MUREAV); oms-rat-scu 200 mmol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 35, p. 71, 1979 (EXPEAM); cyt-rat-bmr 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 343, p. 67, 1995 (MUREAV); cyt-rat-oth 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 7, 1996 (MUREAV); mnt-mus-orl 40 mg/kg Yichuan. Heredity. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1979- v. 8(5), p. 39, 1986 (ICHUDW); mnt-mus-ipr 10 mg/kg Caryologia. (Via G. LaPira 4, 50121 Florence, Italy) V.1- 1948- v. 40, p. 79, 1987 (CARYAB); mmo-mus-lym 300 ug/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 165, 1987 (MUREAV); cyt-mus-ipr 10 mg/kg Caryologia. (Via G. LaPira 4, 50121 Florence, Italy) V.1- 1948- v. 40, p. 79, 1987 (CARYAB); cyt-mus-orl 1 ppm/3W-C Fluoride. (International Soc. for Fluoride Research, Inc., POB 692, Warren, MI 48090) V.3- 1970- v. 15, p. 110, 1982 (FLUOA4); cyt-mus-oth 200 mg/L Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 29, p. 230, 1974 (AEHLAU); cyt-mus-scu 40 mg/kg Caryologia. (Via G. LaPira 4, 50121 Florence, Italy) V.1- 1948- v. 40, p. 79, 1987 (CARYAB); sce-mus-ipr 40 mg/kg Yichuan. Heredity. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1979- v. 8(5), p. 39, 1986 (ICHUDW); msc-mus-lym 20 mg/L/16H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 157, 1986 (MUTAEX); spm-mus-ipr 10 mg/kg/5D-C Caryologia. (Via G. LaPira 4, 50121 Florence, Italy) V.1- 1948- v. 40, p. 79, 1987 (CARYAB); mnt-ham-ovr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 99, 1996 (MUREAV); mtr-ham-emb 25 mg/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 2, p. 103, 1988 (TIVIEQ); dns-ham-emb 10 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 938, 1984 (CNREA8); dni-hmn-lng 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 279, p. 109, 1992 (MUREAV); oms-ham-lng 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 279, p. 109, 1992 (MUREAV); cyt-ham-emb 50 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 938, 1984 (CNREA8); cyt-ham-lng 25 mg/L Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 52, p. 889, 1987 (CYTOAN); cyt-ham-ovr 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 191, 1989 (MUREAV); sce-ham-emb 80 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 938, 1984 (CNREA8); sce-ham-ovr 66700 ug/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-393, 1990 (NTPTR*); cyt-dom-oth 25 mg/L Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 29, p. 230, 1974 (AEHLAU); cyt-mam-lng 300 umol/L Huanjing Kexue Xuebao. Environmental Sciences Journal. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1981- v. 3, p. 94, 1983 (HKXUDL); cyt-ctl-oth 10 mg/L Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 29, p. 230, 1974 (AEHLAU); cyt-mam-lym 4 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 183, 1993 (MUREAV); sce-mam-lng 3 mmol/L Huanjing Kexue Xuebao. Environmental Sciences Journal. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1981- v. 3, p. 94, 1983 (HKXUDL) RE: T01-T02-T23 orl-rat TDLo: 150 mg/kg (30D male) Journal of Environmental Biology. (Academy of Environmental Biology, India, 657/5, Civil Lines (South), Muzaffarnagar, 251001, India) V.1- 1980- v. 13, p. 55, 1992 (JEBIDP); T25 orl-rat TDLo: 221 mg/kg (1-20D preg) Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 101, p. 525, 1971 (JONUAI); T46 orl-rat TDLo: 240 mg/kg (11-14D preg) Nippon Shonika Gakkai Zasshi. Journal of the Japanese Pediatrics Society. (Nippon Shonika Gakkai, 1-29-8 Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.55- 1951- v. 73, p. 1900, 1969 (NIPOAC); T85 orl-rat TDLo: 128 mg/kg (85D pre) Zhonghua Binglixue Zazhi. (China International Book Trading Corporation, POB 2820, Beijing, The Peoples Republic of China) V.1-10, 1955-66. (Suspended 1967-81): V.11- 1982- v. 18, p. 290, 1989 (CHPLAB); T41 orl-rat TDLo: 255 mg/kg (85D pre) Zhonghua Binglixue Zazhi. (China International Book Trading Corporation, POB 2820, Beijing, The Peoples Republic of China) V.1-10, 1955-66. (Suspended 1967-81): V.11- 1982- v. 18, p. 290, 1989 (CHPLAB); T32 orl-rat TDLo: 150 mg/kg (6-15D preg) Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 7, p. 121, 1993 (WDZAEK); T31-T35 ipr-rat TDLo: 9 mg/kg (10-18D preg) Archives of Oral Biology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1959- v. 17, p. 371, 1972 (AOBIAR); T31-T35 scu-rat TDLo: 90 mg/kg (10-18D preg) Archives of Oral Biology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1959- v. 17, p. 371, 1972 (AOBIAR); T01-T02 itt-rat TDLo: 400 ug/kg (1D male) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 5, p. 505, 1991 (REPTED); T22-T71 orl-mus TDLo: 1240 mg/kg (8W male/8W pre-5D post) Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 103, p. 1319, 1973 (JONUAI); T29 orl-mus TDLo: 620 mg/kg (multigenerations) Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 103, p. 1319, 1973 (JONUAI); T44 orl-mus TDLo: 5600 ug/kg (14D post) "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,83,1975 (32XPAD); T01-T23 orl-mus TDLo: 300 ng/kg (30D male) Fluoride. (International Soc. for Fluoride Research, Inc., POB 692, Warren, MI 48090) V.3- 1970- v. 25, p. 71, 1992 (FLUOA4); T02 orl-rbt TDLo: 8800 mg/kg (125W male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 92, p. 353, 1991 (JRPFA4); T87 orl-rat TDLo: 12.9 mg/kg (multigeneration) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 601, 2001 (FCTOD7); T53 orl-rat TDLo: 3.4 mg/kg (multigeneration)) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 867, 2001 (FCTOD7); T46 orl-rat TDLo: 28 mg/kg (multigeneration)) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 867, 2001 (FCTOD7); T46-T59-T13 orl-rat TDLo: 560 mg/kg (6-19D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 23, p. 197, 2001 (NETEEC); T81-T83 orl-rat TDLo: 1.52 gm/kg (6-22D preg/21D post) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 1781, 2002 (FCTOD7); T83 orl-rat TDLo: 680 mg/kg (6-22D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 551, 2001 (FCTOD7) TE: V03-N62-Q60 orl-rat TDLo: 12617 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-393, 1990 (NTPTR*); V03-R60 orl-mus TDLo: 14 mg/kg/43W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); V03-R60 orl-mus TD :140 mg/kg/43W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); V03-R60 orl-mus TD :4200 mg/kg/30W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); V03-R60 orl-mus TD :2190 mg/kg/2Y-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); V03-R60 orl-mus TD :4217 mg/kg/30W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); V03-R60 orl-mus TD :4242 mg/kg/30W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); V03-R60 orl-mus TD :4368 mg/kg/30W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); V03-R60 orl-mus TD :87 gm/kg/97W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); V03-Q01-Q60 orl-rat TDLo: 7570.5 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB91-178137 (NTIS**) ORNG: 31000000 ng/kg. [31.000000 mg/kg] T/E unlistd AT: F16-F18-K13 orl-wmn LDLo: 90 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 81, p. 811, 1923 (JAMAAP); J24-K12-K13 orl-wmn LDLo: 360 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 100, p. 97, 1933 (JAMAAP); D28-J24 orl-wmn TDLo: 7 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 886, 1936 (BMJOAE); G06-J25-K13 orl-man TDLo: 1662 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 222, p. 816, 1972 (JAMAAP); F27-K01-K12 orl-hmn TDLo: 214 ug/kg Revue Medicale de Liege. (c/o Institute de Medicine, Rue Alex Bouvy, 13, 4020, Liege, Liege, Belgium) V.1- 1946- v. 12, p. 408, 1957 (RMLIAC); F11-Q01-Q30 orl-hmn LDLo: 71 mg/kg "Merck Index: an Encyclopedia of Chemicals, Drugs, and Biologicals", 11th ed., Rahway, NJ 07065, Merck and Co., Inc. 1989 11,1361,1989 (85KYAH); C10-S06 idr-hmn TDLo: 14 ug/kg Revue Medicale de Liege. (c/o Institute de Medicine, Rue Alex Bouvy, 13, 4020, Liege, Liege, Belgium) V.1- 1946- v. 12, p. 408, 1957 (RMLIAC); T/E unlistd ipr-rat LD50: 22 mg/kg U.S. Atomic Energy Commission, University of Rochester, Research and Development Reports. (Rochester, NY) UR-154, 1951 (XEURAQ); T/E unlistd scu-rat LD50: 175 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 2, p. 411, 1968 (OYYAA2); D09-D35-U01 ivn-rat LD50: 26 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 278, 1961 (TXAPA9); T/E unlistd skn-mus LDLo: 300 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 183, p. 427, 1936 (AEPPAE); K30-L30-M30 ipr-mus LD50: 38 mg/kg IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); T/E unlistd scu-mus LD50: 115 ug/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 68(3), p. 55P-74P, 1972 (NYKZAU); K30-L30-M30 ivn-mus LD50: 50830 ug/kg IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); T/E unlistd ipr-dog LDLo: 50 mg/kg U.S. Atomic Energy Commission, University of Rochester, Research and Development Reports. (Rochester, NY) UR-154, 1951 (XEURAQ); T/E unlistd scu-dog LDLo: 155 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1349, 1935 (HBAMAK); T/E unlistd ivn-mky LD50: 26600 ug/kg Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 22, p. 99, 1965 (APTOA6); T/E unlistd scu-cat LDLo: 14 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1349, 1935 (HBAMAK); T/E unlistd orl-rbt LD50: 200 mg/kg Journal of Economic Entomology. (Entomological Soc. of America, 4603 Calvert Rd., College Park, MD 20740) V.1- 1908- v. 61, p. 751, 1968 (JEENAI); T/E unlistd scu-rbt LDLo: 100 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1349, 1935 (HBAMAK); T/E unlistd scu-gpg LDLo: 100 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1349, 1935 (HBAMAK); T/E unlistd scu-frg LDLo: 448 mg/kg Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 124, p. 133, 1937 (CRSBAW); F07-K12-U01 orl-dom LD50: 100 mg/kg New Zealand Veterinary Journal. (New Zealand Veterinary Assoc., POB 524, Wellington, 1, New Zealand) V.1- 1952- v. 30, p. 199, 1982 (NEZTAF); T/E unlistd orl-bwd LD50: 110 mg/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 16, p. 483, 1987 (AECTCV); T/E unlistd orl-rat LD50: 31 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1409, 2001 (HBPTO*); T/E unlistd orl-mus LD50: 44 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1409, 2001 (HBPTO*); T/E unlistd orl-hmn LDLo: 32 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1409, 2001 (HBPTO*); T/E unlistd orl-chd LDLo: 8 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1409, 2001 (HBPTO*); K01-K13-K30 orl-hmn TDLo: 3.57 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1409, 2001 (HBPTO*); N24-P28-Y07 par-rat TDLo: 9 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 354, 1993 (VCVN5*); H02-M10-Y41 par-rat TDLo: 35 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 355, 1993 (VCVN5*); G04-C16-K13 orl-hmn LDLo: 0.07 mg/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 355, 1993 (VCVN5*); T/E unlistd ipr-mus LD :151 mg/kg Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.19- 1982- v. 39, p. 349, 2001 (JTCTDW) MD: L30 orl-rat TDLo: 639 mg/kg/30W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 146, p. 161, 2000 (TXCYAC); A30-F07-P28 orl-rat TDLo: 420 mg/kg/6W-C Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 17, p. 169, 1995 (NETEEC); F15-U01-Z01 orl-rat TDLo: 500 mg/kg/5D-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 3, p. 290, 1961 (TXAPA9); Q30-U07-Y03 orl-rat TDLo: 603 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 39(1), p. 17, 1974 (GISAAA); K30-Y37 orl-rat TDLo: 1500 mg/kg/60D-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 37, p. 70, 1986 (BECTA6); M30-Q01-Y01 ihl-rat TCLo: 1 mg/kg/5H/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(1), p. 15, 1980 (GTPZAB); M16-Y16 ipr-rat TDLo: 105 mg/kg/10D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 463, 1981 (TOLED5); U01-Z01 orl-mus TDLo: 160 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-393, 1990 (NTPTR*); Q30-U01-Z01 orl-mus TDLo: 21840 mg/kg/26W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-393, 1990 (NTPTR*); P28-P71-P72 orl-mus TDLo: 402 mg/kg/35D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 44, p. 21, 1988 (TOLED5); K15-P30-U07 orl-rbt TDLo: 5460 mg/kg/78W-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 62, p. 14, 1993 (ENVRAL); Q30-U07-U08 orl-rbt TDLo: 6930 mg/kg/99W-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 67, p. 573, 1993 (ARTODN); P08-P71-P72 orl-rbt TDLo: 3650 mg/kg/1Y-I Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 30, p. 388, 1983 (BECTA6); P30-Y10-Y16 orl-rbt TDLo: 1327 mg/kg/30D-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 5, p. 11, 1985 (JJATDK); P28-Y40-Z01 unr-dom TDLo: 700 mg/kg/10W-C Indian Veterinary Journal. (Dr. R. Krishnamurti, G.M.V.C., 8 Avenue Rd., Madras 600 034, India) V.1- 1924- v. 66, p. 1089, 1989 (IVEJAC); U01 orl-rat TDLo: 527.1 mg/kg/21D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 49, p. 417, 1994 (TJADAB); F16 orl-rat TDLo: 1260 mg/kg/10W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 601, 2001 (FCTOD7); F15-U01 orl-rat TDLo: 1617 mg/kg/10W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 601, 2001 (FCTOD7); P30-Y01 orl-mus TDLo: 30 mg/kg/30D-C Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 9, p. 139, 1995 (WDZAEK); F16-U01 orl-rat TDLo: 9.2 gm/kg/47W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 867, 2001 (FCTOD7); U01 orl-rat TDLo: 18.8 gm/kg/47W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 867, 2001 (FCTOD7); F17-P30-Y01 orl-rat TDLo: 1.2 gm/kg/60D-I Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 6, p. 187, 1998 (ETOPFR); A30-L30-Q01 ihl-mam TCLo: 1 mg/m3/5H/17W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 355, 1989 (VCVN5*); F15-U01 ims-rat TDLo: 1520 mg/kg/38D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 40, p. 1781, 2002 (FCTOD7) TR: ACGIH TLV-TWA 2.5 mg(F)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 237, 1982 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 208, 1987 (IMSUDL); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3); TOXICOLOGY REVIEW Acta Medica Scandinavica, Supplement. (Almqvist and Wiksell, POB 45150, S-10430 Stockholm, Sweden) No.1-730, 1921-88. v. 400, p. 5, 1963 (AMSSAQ); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6); TOXICOLOGY REVIEW Industrial Medicine and Surgery. (Northbrook, IL) V.18-42, 1949-73. For publisher information, see IOHSA5. v. 19, p. 535, 1950 (IMSUAI) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 2.5 mg(F)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 116, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 2.5 mg(F)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 2.5 mg(F)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 2.5 mg(F)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 2.5 mg(F)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2.5 mg(F)/m3, JAN 1993; OEL-AUSTRIA: MAK 2.5 mg(F)/m3, JAN 1999; OEL-BELGIUM: TWA 2.5 mg(F)/m3, JAN 1993; OEL-FINLAND: TWA 2.5 mg(F)/m3, JAN 1999; OEL-FRANCE: VME 2 mg/m3, JAN 1993; OEL-FRANCE: VME 2 mg(F)/m3, JAN 1999; OEL-GERMANY: MAK 2.5 mg(F)/m3, JAN 1999; OEL-HUNGARY: TWA 1 mg(F)/m3, STEL 2 mg(F)/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-K 3.5 mg(F)/m3, JAN 1999; OEL-NORWAY: TWA 0.6 mg(F)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 2.5 mg(F)/m3, JAN 1993; OEL-POLAND: MAC(TWA) 1 mg(HF)/m3, MAC(STEL) 3 mg(HF)/m3, JAN 1999; OEL-RUSSIA: TWA 0.2 mg/m3, STEL 1 mg/m3, JAN 1993; OEL-SWEDEN: NGV 2 mg(F)/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 1.8 ppm (1.5 mg(F)/m3), KZG-W 3.6 ppm (3.0 mg(F)/m3), JAN 1999; OEL-THAILAND: TWA 2.5 mg(F)/m3, JAN 1993; OEL-TURKEY: TWA 2.5 mg(F)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 2.5 mg(F)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO FLUORIDES, INORGANIC-air: 10H TWA 2.5 mg(F)/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 84425; NIS 50; TNF 3763; NOS 50; TNE 25059; NOES 1983: HZD 84425; NIS 83; TNF 3970; NOS 69; TNE 84776; TFE 26602 SL: EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-nondisjunction, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Negative: In vivo SCE-nonhuman, S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-partial sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (water), equivocal evidence: rat; NCI Carcinogenesis Studies (water), no evidence: mouse Record 1049 of 1119 in RTECS (through 2003/06) AN: WF0250000 PN: Solanid-5-ene, 3-beta-((O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-3)) -beta-D-galactopyranosyl)oxy)- SY: Solanine-; alpha-Solanin-; alpha-Solanine- RN: Current: 20562-02-1 Previous: 125-97-3 BRN: 77607 BHR: 4-21-00-01402 UD: 200012 MF: C45-H73-N-O15 MW: 868.19 WL: T H6 F5 E5 B666 MN SUTJ A1 E1 G1 K1 VO- BT6OTJ EQ F1Q CO- BT6OTJ CQ DQ EQ F1& DO- BT6OTJ CQDQ EQ F1Q CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Natural-Product (N) ME: oms-hmn-fbr 66600 ug/L Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. v. 26, p. 105, 1975 (HUMAA7); msc-mus-ipr 330 mg/kg/3D-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 33, p. 191, 1995 (FCTOD7) RE: T53-T46 ipr-rat TDLo: 40 mg/kg (5-12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 8, p. 349, 1973 (TJADAB); T34 ipr-rat TDLo: 40 mg/kg (5-12D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 36, p. 227, 1976 (TXAPA9); T25 ipr-rat TDLo: 80 mg/kg (5-12D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 36, p. 227, 1976 (TXAPA9); T29 ipr-mus TDLo: 100 mg/kg (7-11D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 46, p. 257, 1976 (JRPFA4); T41 orl-ham TDLo: 200 mg/kg (8D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30, p. 371, 1984 (TJADAB) ORNG: 590000000 ng/kg. [590.000000 mg/kg] T/E unlistd AT: F27-K05-U25 orl-hmn TDLo: 2800 ug/kg Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology, Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977- v. 25, p. 13, 1983 (VHTODE); T/E unlistd unr-man LDLo: 2941 ug/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 590 mg/kg Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 8, p. 349, 1973 (TJADAB); T/E unlistd ipr-rat LD50: 67 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 36, p. 227, 1976 (TXAPA9); C08-J22-K12 ipr-mus LD50: 32 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 10, p. 395, 1972 (FCTXAV); F17-J24-J26 ipr-rbt LDLo: 20 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 81, 1971 (TXAPA9); T/E unlistd scu-rbt LDLo: 5 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1398, 1935 (HBAMAK); F17-J24-J26 ivn-rbt LDLo: 10 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 81, 1971 (TXAPA9); G07-J24 orl-dom LDLo: 500 mg/kg Schweizer Archiv fuer Tierheilkunde. (Orell Fuessli Graphische Betriebe AG, Postfach 1459, 8036 Zurich, Switzerland) V.1- 1859- v. 95, p. 97, 1953 (SATHAA); G07-J24 ivn-dom LDLo: 50 mg/kg Schweizer Archiv fuer Tierheilkunde. (Orell Fuessli Graphische Betriebe AG, Postfach 1459, 8036 Zurich, Switzerland) V.1- 1859- v. 95, p. 97, 1953 (SATHAA) MD: Z01 ipr-rat TDLo: 80 mg/kg/2D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 36, p. 227, 1976 (TXAPA9) TR: TOXICOLOGY REVIEW Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 17, p. 61, 1979 (FCTXAV) SL: NTP Carcinogenesis studies, selected, October 2000 Record 1050 of 1119 in RTECS (through 2003/06) AN: WG1925000 PN: Sorbaldehyde- SY: 1,3-Pentadiene-1-carboxaldehyde-; 2,4-Hexadienal-; 2,4-Hexadienal, (E,E)-; 3-Propyleneacrolein-; Hexa-2,4-dienal-; Sorbic-aldehyde-; trans,trans-2,4-Hexadienal- RN: Current: 142-83-6 BRN: 1698401 BHR: 4-01-00-03545 UD: 200207 MF: C6-H8-O MW: 96.14 WL: VH1U2U2 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 500 nmol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 148, p. 25, 1985 (MUREAV); mmo-sat 50 ng/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19, p. 338, 1992 (EMMUEG) ORNG: 300000000 ng/kg. [300.000000 mg/kg] T/E unlistd SRNL: 270000 nL/kg. [0.270000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 300 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 337, 1988 (FCTOD7); T/E unlistd ihl-rat LCLo: 2000 ppm/4H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 61, 1954 (AMIHBC); T/E unlistd skn-rbt LD50: 270 uL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 10, p. 61, 1954 (AMIHBC); T/E unlistd skn-gpg LDLo: 2500 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 337, 1988 (FCTOD7) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (gavage), clear evidence: mouse, rat; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 1051 of 1119 in RTECS (through 2003/06) AN: WG2932500 PN: Sorbitan, monooleate polyoxyethylene deriv. SY: Armotan-pmo-20-; Atlox-1087-; Atlox-8916TF-; Crill-10-; Crill-11-; Crillet-4-; Crill-S-10-; Drewmulse-poe-smo-; Durfax-80-; Emsorb-6900-; Ethoxylated-sorbitan-monooleate-; MO-55F-; Monitan-; Montanox-80-; Olothorb-; Polyethylene-oxide-sorbitan-mono-oleate-; Polyoxyethylene-sorbitan-monooleate-; Polyoxyethylene (20) sorbitan mono-oleate; Polyoxyethylene-sorbitan-oleate-; Polysorban-80-; Polysorbate-80-; Polysorbate 80 B.P.C.; Polysorbate 80, U.S.P.; Polysorbate-81-; Romulgin-O-; Sorbital-0-20-; Sorbitan mono-9-octadecenoate poly(oxy-1,2-ethanediyl) derivatives; Capmul-poe-O-; Glycosperse-O-20-; Glycosperse-O-20-VEG-; Glycosperse-O-20X-; Hodag-SVO-9-; NCI-C60286-; Nikkol-TO-; Nikkol-TO-10-; Protasorb-O-20-; Sorbimacrogol-oleate-; Sorbimacrogol-oleate-300-; Sorethytan (20) monooleate; Sorlate-; Sorbon-T-80-; SVO-9-; TO-10-; Tween-80-; Tween-81-; Tween-80-A- RN: Current: 9005-65-6 UD: 200302 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 150 mg MLD Archives of Ophthalmology (Chicago). (AMA, 535 N. Dearborn St., Chicago, IL 60610) New series: V.1-44(3), 1929-50: V.64- 1960- v. 40, p. 668, 1948 (AROPAW) ME: dni-hmn-lym 20 ppm Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 45, p. 630, 1971 (BBRCA9); dni-mus-oth 20 ppm Environmental Physiology and Biochemistry. (Copenhagen, Denmark) V.2-5, 1972-75. Discontinued. v. 5, p. 84, 1975 (ENPBBC) RE: T75-T76 orl-rat TDLo: 635 gm/kg (multigenerations) Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 60, p. 489, 1956 (JONUAI); T75 orl-rat TDLo: 1270 gm/kg (84D pre-21D post) Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 60, p. 489, 1956 (JONUAI); T13-T14-T86 ipr-rat TDLo: 80 uL/kg (4D post) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 183, 1993 (FCTOD7) TE: V03-N61 orl-rat TDLo: 2163 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-415, 1992 (NTPTR*); V03-V10 scu-rat TDLo: 10 gm/kg/27W-I Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 9, p. 463, 1971 (FCTXAV); V03-N61 orl-rat TDLo: 2163000 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-189331/AS (NTIS**) ORNL: 34500000 nL/kg. [34.500000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 34500 uL/kg Food Research. (Champaign, IL) V.1-25, 1936-60. For publisher information, see JFDSAZ. v. 21, p. 348, 1956 (FOREAE); T/E unlistd ipr-rat LD50: 6804 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 35, p. 804, 1985 (ARZNAD); T/E unlistd ivn-rat LD50: 1790 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 53A, p. 254, 1974 (FAONAU); T/E unlistd orl-mus LD50: 25 gm/kg Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- v. 101, p. 173, 1962 (BCFAAI); T/E unlistd ipr-mus LD50: 7600 mg/kg Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.4- 1979- v. 5, p. 467, 1979 (PHTHDT); T/E unlistd ivn-mus LD50: 4500 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 18, p. 666, 1968 (ARZNAD); F05-G30 ivn-dog LDLo: 500 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 28, p. 1586, 1978 (ARZNAD); F05-G30 ivn-cat LDLo: 500 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 28, p. 1586, 1978 (ARZNAD); T/E unlistd orl-mam LD50: 25 gm/kg Zhongguo Yaoxue Zazhi. Chinese Pharmacuetical Journal. (China International Book Trading Corp., POB 2820, Beijing, Peop. China) V.24- 1989- v. 26, p. 459, 1991 (ZYZAEU); T/E unlistd ivn-mam LD50: 5800 mg/kg Zhongguo Yaoxue Zazhi. Chinese Pharmacuetical Journal. (China International Book Trading Corp., POB 2820, Beijing, Peop. China) V.24- 1989- v. 26, p. 459, 1991 (ZYZAEU) MD: U01 orl-rat TDLo: 42 gm/kg/2W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-415, 1992 (NTPTR*) TR: TOXICOLOGY REVIEW Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 32, p. 245, 1974 (ARTODN) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 80605; NIS 18; TNF 1388; NOS 32; TNE 24861; NOES 1983: HZD X8582; NIS 38; TNF 6365; NOS 70; TNE 162120; TFE 112349 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 1052 of 1119 in RTECS (through 2003/06) AN: WJ5600000 PN: 4,4'-Stilbenediol,-alpha,alpha'-diethyl- SY: (E)-4,4'-(1,2-Diethylvinylene)diphenol; 3,4'(4,4'-Dihydroxyphenyl)hex-3-ene; 3,4-Bis(p-hydroxyphenyl)-3-hexene; 3-Hexene,3,4-bis(p-hydroxyphenyl)-; 4,4'-(1,2-Diethyl-1,2-ethenediyl)bis-phenol; 4,4'-Dihydroxy-alpha,beta-diethylstilbene-; 4,4'-Dihydroxydiethylstilbene-; 4,4'-Stilbenediol, alpha,alpha'-diethyl-, (E)-; 4,4'-Stilbenediol,2,2'-diethyl-; Acnestrol-; Agostilben-; Antigestil-; Bio-des-; Bufon-; Climaterine-; Comestrol-; Comestrol-estrobene-; Cyren-; Cyren-A-; DEB-; DES- (synthetic estrogen); Dawe's-destrol-; Di-Estryl-; Dibestrol-; Dibestrol-'2'-premix-; Dicorvin-; Diethylstilbesterol-; Diethylstilbestrol-; Diethylstilboesterol-; Dietilestilbestrol- (Spanish); Distilbene-; Domestrol-; Dyestrol-; Estilbin-MCO-; Estrobene-; Estromenin-; Estrosyn-; Fonatol-; Grafestrol-; Gynopharm-; Hi-Bestrol-; Idroestril-; Iscovesco-; Makarol-; Menostilbeen-; Micrest-; Microest-; Milestrol-; NSC-3070-; Neo-Oestranol-1-; Oekolp-; Oestrogenine-; Oestrol-vetag-; Oestromenin-; Oestromensil-; Oestromensyl-; Oestromienin-; Oestromon-; Pabestrol-; Palestrol-; Percutatrine-oestrogenique-iscovesco-; Phenol 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-; Protectona-; RCRA-waste-number-U089-; Rumestrol-1-; Rumestrol-2-; Sedestran-; Serral-; Sexocretin-; Sibol-; Sintestrol-; Stibilium-; Stil-; Stil-Rol-; Stilbestrol-; Stilbetin-; Stilboefral-; Stilboestroform-; Stilboestrol-; Stilbol-; Stilkap-; Synestrin-; Synthoestrin-; Synthofolin-; Syntofolin-; Tampovagan-stilboestrol-; Tylosterone-; Vagestrol-; alpha,alpha'-Diethyl-(E)-4,4'-stilbenediol; alpha,alpha'-Diethyl-4,4'-stilbenediol-; alpha,alpha'-Diethylstilbenediol-; trans-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol; trans-Diethylstilbesterol-; trans-Diethylstilbestrol-; trans-Diethylstilboesterol-; trans-alpha,alpha'-Diethyl-4,4'-stilbenediol- RN: Current: 56-53-1 BRN: 2056095 BHR: 4-06-00-06856 UD: 200305 MF: C18-H20-O2 MW: 268.38 WL: QR DY2&UY2&R DQ CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Hormone (H); Natural-Product (N) ME: mmo-esc 50 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 97, 1984 (MUREAV); dnr-esc 2900 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 145, 1992 (MUREAV); dnd-bcs 2 mg/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); mmo-smc 1 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 49, 1982 (MUREAV); mmo-smc 25 mg/L (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 759, 1991 (CRNGDP); mrc-smc 10 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 243, 1985 (PMRSDJ); cyt-smc 20 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 294, p. 263, 1981 (NATUAS); sln-smc 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mnt-hmn-lym 30 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 34, 1989 (EMMUEG); dnd-hmn-fbr 300 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 267, 1985 (ENMUDM); dnd-hmn-leu 20 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 34, p. 3251, 1985 (BCPCA6); dnd-hmn-lvr 18 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 36, p. 19, 1987 (CALEDQ); dns-hmn-lvr 5600 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 36, p. 19, 1987 (CALEDQ); dns-hmn-hla 1 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dni-hmn-fbr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 183, p. 89, 1987 (MUREAV); dni-hmn-lym 10 umol/L Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 146, p. 401, 1974 (PSEBAA); dni-hmn-hla 100 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); oms-hmn-oth 20 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 741, 1984 (CRNGDP); oms-hmn-fbr 6 mg/kg Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 75, 1990 (TIVIEQ); cyt-hmn-lym 100 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 457, 1985 (PMRSDJ); sce-hmn-lvr 10 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 406, 1984 (ENMUDM); sce-hmn-fbr 133 nmol/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 281, p. 392, 1979 (NATUAS); sce-hmn-lym 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 893, 1982 (CNREA8); sln-hmn-lym 6 mmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 99, 1986 (MUTAEX); sln-hmn-fbr 6 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 240, p. 241, 1990 (MUREAV); msc-hmn-lym 20 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 497, 1985 (PMRSDJ); mtr-rat-orl 12600 mg/kg/6W Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 387, 1988 (CRNGDP); mtr-rat-emb 1020 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dna-rat-scu 1800 ug/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 42, p. 251, 1982 (CBINA8); dna-rat-orl 2200 ug/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 42, p. 251, 1982 (CBINA8); dnd-rat-lvr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 69, 1987 (MUREAV); dnd-rat-lvr 5600 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 36, p. 19, 1987 (CALEDQ); dns-rat-lvr 5600 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 36, p. 19, 1987 (CALEDQ); dns-rat-orl 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 320, p. 189, 1994 (MUREAV); bfa-rat-ovr 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 263, 1985 (MUREAV); sce-rat-lvr 100 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3851, 1984 (CNREA8); sln-rat-orl 25 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 303, 1997 (CRNGDP); mnt-mus-lym 37 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 165, 1993 (MUREAV); mnt-mus-ipr 3200 ug/kg Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 686, 1981 (PMRSDJ); mnt-mus-scu 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 181, 1991 (MUREAV); mnt-mus-oth 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 181, 1991 (MUREAV); mmo-mus-lym 5200 ug/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 37, 1988 (EMMUEG); mtr-mus-emb 5 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 797, 1982 (CRNGDP); dnd-mus-lym 20 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 34, p. 771, 1985 (BCPCA6); dns-mus-ipr 60 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 211, 1984 (ENMUDM); dns-mus-scu 400 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 14, 1988 (CNREA8); cyt-mus-ipr 165 ug/kg Microbios Letters. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1976- v. 13, p. 27, 1980 (MILEDM); cyt-mus-emb 5 mg/L Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30(1), p. 32A, 1984 (TJADAB); sce-mus-ipr 200 mg/kg Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 62, 1989 (MUTAEX); sce-mus-oth 100 nmol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 75, p. 575, 1985 (JJIND8); sce-mus-fbr 1 mg/L Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 41, p. 285, 1984 (ONCOBS); sce-mus-scu 200 mg/L Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 11, p. 135, 1991 (TCMUD8); msc-mus-lym 25 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 555, 1985 (PMRSDJ); spm-mus-ipr 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 69, p. 149, 1980 (MUREAV); spm-mus-scu 125 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 261, p. 181, 1991 (MUREAV); mnt-ham-lng 1 mmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 99, 1986 (MUTAEX); mnt-ham-emb 7500 ug/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31(Suppl), p. 204, 1986 (TOLED5); mmo-ham-emb 1 mg/L (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 1415, 1986 (CRNGDP); mtr-ham-imp 240 mg/kg/33W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 1020, 1989 (CNREA8); mtr-ham-emb 10 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3040, 1982 (CNREA8); mtr-ham-kdy 1160 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 626, 1981 (PMRSDJ); dna-ham-scu 6900 ug/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 42, p. 251, 1982 (CBINA8); dnd-ham-ovr 10 umol/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 367, 1985 (PMRSDJ); dnd-ham-emb 9 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 1329, 1986 (CRNGDP); dna-ham-ipr 200 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 773, 1991 (CRNGDP); dna-ham-ipr 40 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 2137, 1994 (CRNGDP); dns-ham-emb 1 mg/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 184, 1983 (PAACA3); oms-ham-emb 3 mg/kg Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 4, p. 75, 1990 (TIVIEQ); cyt-ham-scu 160 mg/kg/20W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 311, p. 191, 1994 (MUREAV); cyt-ham-lvr 3 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 397, 1985 (PMRSDJ); cyt-ham-fbr 15 mg/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); cyt-ham-lng 7500 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 427, 1985 (PMRSDJ); cyt-ham-ovr 7500 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 413, 1985 (PMRSDJ); sce-ham-fbr 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); sln-ham-emb 1 mg/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 27, p. 39, 1986 (PAACA3); sln-ham-lvr 3 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 397, 1985 (PMRSDJ); sln-ham-fbr 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 171, p. 31, 1986 (MUREAV); sln-ham-lng 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 263, p. 269, 1991 (MUREAV); msc-ham-emb 1 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 212, p. 1402, 1981 (SCIEAS); spm-ham-ipr 40 mg/kg/5D-C Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 6(3/4), p. 323, 1986 (JEPOEC); mnt-dom-oth 10 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 219, 1992 (TIVIEQ); dnd-mam-lym 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 235, 1996 (MUREAV); dnr-mus-tes 0.000001 mg/L/72H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 483, p. 27, 2001 (MUREAV); mtr-mus-fbr 0.1 umol/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T19 orl-wmn TDLo: 2500 ug/kg (5D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 24, p. 95, 1973 (FESTAS); T14-T22 orl-wmn TDLo: 5 mg/kg (5D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 14, p. 375, 1976 (CCPTAY); T01-T02 orl-man TDLo: 1065 mg/kg (30W male) Acta Societatis Medicorum Upsaliensis. (Uppsala, Sweden) V.55-76, 1950-71. For publisher information, see UJMSAP. v. 73, p. 199, 1968 (ASUPAZ); T02 orl-man TDLo: 521 mg/kg (2Y male) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 5, p. 421, 1954 (FESTAS); T53-T91 orl-wmn TDLo: 1730 mg/kg (1-39W preg) New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 292, p. 334, 1975 (NEJMAG); T91 orl-wmn TDLo: 147 mg/kg (7-34W preg) Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 122, p. 36, 1979 (JOURAA); T91 orl-wmn TDLo: 21 mg/kg (13-15W preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 137, p. 220, 1980 (AJOGAH); T22 orl-wmn TDLo: 5 mg/kg (1-5D preg) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 218, p. 562, 1971 (JAMAAP); T29 orl-wmn TDLo: 24 mg/kg (34W pre) Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 105, p. 7, 1966 (ACEDAB); T22 unr-wmn TDLo: 1 mg/kg (4D preg) International Congress Series--Excerpta Medica. (Excerpta Medica, Inc., POB 3085, Princeton, NJ 08540) No.1- 1952- v. (133), p. 406, 1967 (EXMDA4); T53 unr-wmn TDLo: 8400 ug/kg (4-9W preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 19, p. 1004, 1959 (JCEMAZ); T53 unr-wmn TDLo: 24500 ug/kg (14-20W preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 19, p. 1004, 1959 (JCEMAZ); T53-T82-T91 unr-wmn TDLo: 150 mg/kg (7-34W preg) Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 117, p. 477, 1977 (JOURAA); T53 unr-wmn TDLo: 8400 ug/kg (4-9W preg) Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 19, p. 1004, 1959 (JCEMAZ); T29 orl-rat TDLo: 770 ug/kg (7D pre) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 13, p. 376, 1956 (JOENAK); T17-T81 orl-rat TDLo: 473 ug/kg (1-22D preg/21D post) Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- v. 66, p. 321, 1958 (JONUAI); T02-T03 orl-rat TDLo: 100 ug/kg (10D male) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 120, p. 725, 1965 (PSEBAA); T83 orl-rat TDLo: 100 ug/kg (15D preg) Journal of Steroid Biochemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1969- v. 9, p. 595, 1978 (JSTBBK); T13 orl-rat TDLo: 6300 ng/kg (7D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T25 orl-rat TDLo: 100 ug/kg (5D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 14, p. 487, 1976 (CCPTAY); T16-T71 orl-rat TDLo: 405 mg/kg (10-18D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 583, 1991 (BIREBV); T02-T03 skn-rat TDLo: 12 mg/kg (30D male) Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963- v. 10, p. 687, 1967 (STEDAM); T13 ipr-rat TDLo: 10 ug/kg (1D pre) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 36, p. 13, 1992 (JTEHD6); T22 scu-rat TDLo: 50 ug/kg (1-5D preg) Acta Pharmacologica et Toxicologica, Supplementun. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) No.1- 1947- v. 36(3), p. 81, 1975 (APTSAI); T13 scu-rat TDLo: 1300 ng/kg (1D pre) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 49, p. 83, 1965 (ACENA7); T53-T71 scu-rat TDLo: 3 mg/kg (19-21D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 90, p. 1597, 1980 (BEXBAN); T12-T13-T29 scu-rat TDLo: 250 ug/kg (1D pre) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 49, p. 193, 1965 (ACENA7); T29 scu-rat TDLo: 10 ug/kg (1D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 7, p. 260, 1972 (BIREBV); T87 scu-rat TDLo: 1 mg/kg (19D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 6, p. 107, 1979 (CALEDQ); T53-T81 scu-rat TDLo: 6 ug/kg (15-18D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4872, 1983 (CNREA8); T02 scu-rat TDLo: 4680 ug/kg (3D male) Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information, see NTOTDY. v. 1, p. 123, 1979 (NETOD7); T13 ivn-rat TDLo: 3 ug/kg (3D pre) Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- v. 5, p. 63, 1979 (JZKEDZ); T48 par-rat TDLo: 6 ug/kg (16-19D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 82, p. 1561, 1976 (BEXBAN); T22 orl-mus TDLo: 108 ug/kg (1-3D preg) Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) V.1- 1948- v. 49, p. 83, 1965 (ACENA7); T29 orl-mus TDLo: 19 ug/kg (4-6D preg) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 20, p. 299, 1960 (JOENAK); T12-T13 orl-mus TDLo: 72 ug/kg (3D pre) Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221 005, India) V.1- 1968(?)- v. 11, p. 287, 1979 (INJPD2); T13 orl-mus TDLo: 4 ug/kg (4D pre) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 681, 1984 (FCTOD7); T29 orl-mus TDLo: 644 ug/kg (7D pre) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 13, p. 376, 1956 (JOENAK); T91 ipr-mus TDLo: 1 mg/kg (16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 21, p. 313, 1980 (TJADAB); T22 ipr-mus TDLo: 280 mg/kg (28D pre) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 70, p. 60, 1981 (JPMSAE); T22 scu-mus TDLo: 36 ug/kg (1-3D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 9, p. 277, 1965 (JRPFA4); T91 scu-mus TDLo: 8 ug/kg (9-16D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 2, p. 527, 1977 (JTEHD6); T53 scu-mus TDLo: 10 ug/kg (15D preg) Acta Anatomica. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.1- 1945- v. 134, p. 312, 1989 (ACATA5); T54 scu-mus TDLo: 100 ug/kg (16D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 47, p. 279, 1979 (TXAPA9); T12 scu-mus TDLo: 800 ug/kg (9-16D preg) Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 20, p. 103, 1979 (PAACA3); T13 scu-mus TDLo: 2520 ng/kg (3D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T26-T29 par-mus TDLo: 24 ug/kg (4-6D preg) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 20, p. 299, 1960 (JOENAK); T91 par-mus TDLo: 1 mg/kg (17D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 73, 1983 (TJADAB); T81-T87 par-mus TDLo: 700 ug/kg (11-17D preg) American Zoologist. (American Soc. of Zoologists, Box 2739, California Lutheran College, Thousand Oaks, CA 91360) V.1- 1961- v. 39, p. 25A, 1999 (AMZOAF); T22 ivg-mus TDLo: 280 mg/kg (28D pre) Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- v. 70, p. 60, 1981 (JPMSAE); T03 ims-dog TDLo: 450 ug/kg (18D male) Acta Societatis Medicorum Upsaliensis. (Uppsala, Sweden) V.55-76, 1950-71. For publisher information, see UJMSAP. v. 71, p. 311, 1966 (ASUPAZ); T91 orl-mky TDLo: 7200 ug/kg (18-23W preg) Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- v. 26, p. 309, 1981 (JRPMAP); T22 orl-mky TDLo: 1200 ug/kg (1-6D preg) International Congress Series--Excerpta Medica. (Excerpta Medica, Inc., POB 3085, Princeton, NJ 08540) No.1- 1952- v. (133), p. 406, 1967 (EXMDA4); T22 orl-mky TDLo: 1 mg/kg (1-6D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 115, p. 101, 1973 (AJOGAH); T22 orl-mky TDLo: 7 mg/kg (14-24W preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 1, p. 253, 1987/1988 (REPTED); T02-T03 orl-rbt TDLo: 120 ug/kg (8D male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 55, 1972 (TXAPA9); T24 scu-rbt TDLo: 15 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T34 scu-rbt TDLo: 6 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 20, p. 211, 1969 (FESTAS); T24 scu-rbt TDLo: 1500 ug/kg (3D pre) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 117, p. 167, 1973 (AJOGAH); T29 ims-rbt TDLo: 5 ug/kg (1-3D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 10, p. 155, 1959 (FESTAS); T24-T34 unr-rbt TDLo: 50 ug/kg (1-25D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 2, p. 85, 1970 (CCPTAY); T24-T26 orl-ham TDLo: 2250 ug/kg (1-9D preg) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T13 orl-ham TDLo: 70 ug/kg (7D pre) Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- v. 3, p. 347, 1971 (CCPTAY); T01-T02 ipr-ham TDLo: 40 mg/kg (5D male) Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 6(3/4), p. 323, 1986 (JEPOEC); T29 scu-ham TDLo: 2 mg/kg (1D preg) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 76, p. 1213, 1965 (ENDOAO); T02 imp-ham TDLo: 160 mg/kg (45W male) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 57, p. 255, 1955 (ENDOAO); T72 orl-mam TDLo: 1038 ug/kg (30D pre/1-53D preg) Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. v. 15, p. 575, 1956 (FEPRA7); T53 scu-mam TDLo: 62 ug/kg (20-26D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 28A, 1983 (TJADAB); T75 orl-rat TDLo: 144 ug/kg (28D pre-22D post) Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 30, p. 130, 1999 (RTOPDW); T26-T53 orl-rat TDLo: 1160 mg/kg (2W pre-22D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T53 scu-mus TDLo: 14 ng/kg (11-17D preg) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 94, p. 2056, 1997 (PNASA6); T65 ipr-mus TDLo: 2000 ug/kg (16-17D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 53, p. 1546, 1993 (CNREA8); T85 orl-mus TDLo: 0.28 ug/kg (11-17D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 77, p. 343, 1995 (TOLED5); T13-T25-T34 scu-mus TDLo: 1500 ug/kg (6-22D preg) Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 87, p. 255, 2000 (PHTOEH); T53 scu-mus TDLo: 400 ug/kg (15-18D preg) Anatomy and Embryology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.146- 1974- v. 175, p. 53, 1986 (ANEMDG); T35-T75 orl-rat TDLo: 585 mg/kg (6-18D preg) "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 236, 1994 (VCVGK*); T81 orl-rat TDLo: 22 ug/kg (22D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T53-T91 orl-rat TDLo: 220 ug/kg (22D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T53-T81-T91 orl-rat TDLo: 570 ug/kg (2W pre-22W post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T26-T73-T81 orl-rat TDLo: 1130 ug/kg (10W pre-22D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T53-T91 orl-rat TDLo: 1130 ug/kg (10W pre-22D post) EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 1136, 1995 (EVHPAZ); T52-T53-T81 scu-gpg TDLo: 540 ug/kg (29-65D preg) Hormones and Behavior. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 21, p. 402, 1987 (HOBEAO); T85-T86-T91 scu-gpg TDLo: 540 ug/kg (29-65D preg) Hormones and Behavior. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969- v. 21, p. 402, 1987 (HOBEAO); T53 scu-mus TDLo: 800 ug/kg (9-16D preg) Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 151, p. 1370, 1994 (JOURAA); T25-T35-T34 orl-rat TDLo: 0.585 mg/kg (6-18D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30, p. 341, 1984 (TJADAB); T82 scu-mus TDLo: 0.18 ug/kg (9-16D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 38, p. 364, 1982 (FESTAS); T53-T72 scu-mus TDLo: 180 ug/kg (9-16D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 38, p. 364, 1982 (FESTAS); T25-T27-T86 scu-mus TDLo: 1800 ug/kg (9-16D preg) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 38, p. 364, 1982 (FESTAS); T25-T34 orl-rat TDLo: 585 mg/kg (6-18D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30, p. 341, 1984 (TJADAB); T75-T81 orl-rat TDLo: 585 ug/kg (6-18D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); T75-T81 orl-rat TDLo: 495 ug/kg (8-18D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); T75-T81 orl-rat TDLo: 405 ug/kg (10-18D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); T75-T81 orl-rat TDLo: 135 ug/kg (18-20D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); T35 orl-rat TDLo: 135 ug/kg (3-5D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); T34-T39-T53 ivn-dom TDLo: 350 ug/kg (111-117D preg) Journal of reproduction and fertility. Abstract series. (Cambridge, U.K. : Journals of Reproduction and Fertility Ltd. : Colchester, U.K. : Biochemical Society Book Depot (distributor)) V.1-26 1988-2000. Continued by: Reproduction (Cambridge, England). Abstract series v. Jul, p. 19, 2000 (JRFAB*); T53-T82 scu-mus TDLo: 800 ug/kg (9-16D preg) Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 138, p. 1446, 1987 (JOURAA); T53-T91 orl-wmn TDLo: 2.52 mg/kg (6-8W preg) New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. -, p. 334, 1975 (NEJMAG); T29-T72 orl-mus TDLo: 210 gm/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB84136746 (NTIS**); T22-T72 orl-mus TDLo: 882 gm/kg (21W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB84136746 (NTIS**); T49-T53-T91 orl-mus TDLo: 10 mg/kg (15D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV); T49-T53-T91 unr-mus TDLo: 10 mg/kg (17D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV); T46 scu-mus TDLo: 40 mg/kg (9-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-130175 (NTIS**); T29-T35 scu-mus TDLo: 80 mg/kg (9-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-130175 (NTIS**); T16-T26 orl-mus TDLo: 269.5 mg/kg (7D male/7D pre/21D preg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85167674/AS (NTIS**); T34-T35 scu-mus TDLo: 800 mg/kg (9-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-130175 (NTIS**); T44 scu-mus TDLo: 800 mg/kg (9-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-130175 (NTIS**); T34-T35-T59 scu-mus TDLo: 800 mg/kg (9-16D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-130175 (NTIS**); T22-T26-T81 orl-mus TDLo: 1132 mg/kg (21W pre) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85167674/AS (NTIS**); T81 orl-mus TDLo: 1132 mg/kg (21W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85167674/AS (NTIS**); T72 orl-mus TDLo: 52.5 mg/kg (7D male/7D pre/21D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85167674/AS (NTIS**); T25-T34 orl-rat TDLo: 225 ug/kg (6-20D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 174, p. 173, 2002 (TXCYAC); T53-T91 scu-mus TDLo: 800 ug/kg (9-16D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV); T76 scu-rat TDLo: 200 ug/kg (multigenerations) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV); T53 scu-rat TDLo: 3 ug/kg (multigenerations) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV); T52-T53-T91 scu-rat TDLo: 6 ug/kg (15-18D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV); T16-T52-T75 scu-rat TDLo: 60 ug/kg (10-13D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV); T52-T75-T53 scu-rat TDLo: 600 ug/kg (15-19D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV); T27 scu-rat TDLo: 6000 ug/kg (10-13D preg) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 19, p. 854, 1978 (BIREBV) TE: V01-T64 orl-wmn TDLo: 7655 ug/kg/4Y-C British Journal of Obstetrics and Gynaecology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.82- 1975- v. 82, p. 417, 1975 (BJOGAS); V01-T65-T69 orl-wmn TDLo: 21 mg/kg (13-15W preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 137, p. 220, 1980 (AJOGAH); V01-M61 unr-man TDLo: 18250 ug/kg/7Y-I Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 112, p. 160, 1974 (JOURAA); V01-J60-L60 unr-man TDLo: 184 mg/kg/12Y-C JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 240, p. 1510, 1978 (JAMAAP); V01-R60 mul-man TDLo: 25 mg/kg/2Y-C Urologia. (Libreria Editrice Canova, Via della Liberazione, 40, 31100 Treviso, Italy) V.1- 1934- v. 19, p. 180, 1952 (UROTAQ); V01-L60 orl-rat TDLo: 103 gm/kg/2Y-C Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 19, p. 489, 1969 (AEHLAU); V02-T65-R60 scu-rat TDLo: 6 ug/kg (15-18D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 5, p. 1059, 1979 (JTEHD6); V02-A60 imp-rat TD :100 mg/kg/5W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4158, 1988 (CNREA8); V01-R60 imp-rat TDLo: 11500 ug/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 455, 1981 (JJIND8); V01-R60-V15 orl-mus TDLo: 263 ug/kg/50W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 33, p. 971, 1964 (JNCIAM); V01-T65-T64 ipr-mus TDLo: 1 mg/kg (17D preg) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 73, p. 133, 1984 (JJIND8); V01-T65-T61 scu-mus TDLo: 800 ug/kg (9-16D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 5145, 1985 (CNREA8); V01-T65-T64 scu-mus TDLo: 800 ug/kg (9-16D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 3988, 1980 (CNREA8); V03-Q30-R60 par-mus TDLo: 340 mg/kg/34W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 2, p. 759, 1942 (CNREA8); V03-P61-U01 imp-mus TDLo: 8 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 2, p. 65, 1941 (JNCIAM); V03-J61-P61 ivg-mus TDLo: 5280 ug/kg/44W-I Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 75, p. 543, 1959 (ANYAA9); V03-V15-J61 scu-dog TDLo: 17 mg/kg/29W-I Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. v. 37, p. 549, 1959 (AJEBAK); V03-T63 par-dog TDLo: 12 mg/kg/23W-I Australian Journal of Experimental Biology and Medical Science. (Adelaide, S.A., Australia) V.1-64, 1924-86. v. 40, p. 139, 1962 (AJEBAK); V01-N62 imp-mky TDLo: 48 mg/kg Laboratory Animal Science. (American Assoc. for Laboratory Animal Science, 210 N. Hammes Ave., Suite 205, Joliet, IL 60435) V.21- 1971- v. 23, p. 493, 1973 (LBASAE); V03-T69-M61 orl-gpg TDLo: 144 mg/kg/12W-I Revista de la Sociedad Argentina de Biologia. (Sociedad Argentina de Biologia, Instituto de Biologia y Medicina Experimental, Obligado 2490, 1428 Buenos Aires, Argentina) V.1- 1925- v. 25, p. 215, 1949 (RSABAC); V03-T64 imp-gpg TDLo: 1080 ug/kg Boletin de la Sociedad de Biologia de Santiago de Chile. (Santiago, Chile) V.1-12, 1943-55. Discontinued. v. 8, p. 142, 1951 (BSBSAS); V03-T69 orl-ham TDLo: 40 mg/kg (15D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 1, p. 139, 1976 (CALEDQ); V01-R60-V10 scu-ham TDLo: 66 mg/kg/44W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 31, p. 181, 1986 (CALEDQ); V02-M05-M61 scu-ham TDLo: 816 mg/kg/1Y-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 66, p. 195, 1947 (PSEBAA); V01-M61-N60 imp-ham TDLo: 160 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 8, p. 451, 1954 (BJCAAI); V01-M61 imp-ham TD :160 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 61, p. 1, 1956 (ZEKBAI); V02-L60 orl-man TD :69 mg/kg/5Y-C Journal of Urology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1917- v. 128, p. 1044, 1982 (JOURAA); V02-T65-N60 scu-rat TD :1 mg/kg (19D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 6, p. 107, 1979 (CALEDQ); V01-R60 imp-rat TD :25 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 773, 1979 (CNREA8); V02-P62-R60 scu-mus TD :230 mg/kg/39W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 56, p. 482, 1949 (ZEKBAI); V01-M61 imp-ham TD :360 mg/kg/12W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2678, 1983 (CNREA8); V01-M61 imp-ham TD :864 mg/kg/12W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4638, 1983 (CNREA8); V01-N60-R60 imp-rat TD :20 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 4781, 1983 (CNREA8); V01-R60 orl-mus TD :1075 ug/kg/4W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 229, 1987 (FCTOD7); V01-M61 orl-man TD :45990 ug/kg/3Y-C British Journal of Urology. (Longman Group Ltd., POB 11318, Birmingham, AL 35202) V.1- 1929- v. 51, p. 6, 1979 (BJURAN); V03-T64 scu-mus TDLo: 5 ug/kg/5D-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 483, p. 107, 2001 (MUREAV) AT: F10-F13 orl-wmn TDLo: 375 ug/kg/30D-I American Journal of Psychiatry. (American Psychiatric Assoc., Circulation Dept., 1400 K St., NW, Washington, DC 20005) V.78- 1921- v. 151, p. 1246, 1994 (AJPSAO); R25 skn-hmn TDLo: 60 ug/kg/14D American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 20, p. 469, 1959 (AIHAAP); T/E unlistd orl-rat LD50: >3 gm/kg Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- v. 8, p. 413, 1983 (DRFUD4); T/E unlistd ipr-rat LD50: 34 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 24, p. 142, 1973 (TXAPA9); T/E unlistd orl-mus LD50: >3 gm/kg Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- v. 8, p. 413, 1983 (DRFUD4); T/E unlistd ipr-mus LD50: 538 mg/kg Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- v. 8, p. 413, 1983 (DRFUD4); T/E unlistd scu-mus LDLo: 500 mg/kg Klinische Wochenscrift. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1922- v. 18, p. 156, 1939 (KLWOAZ); T/E unlistd ivn-mus LD50: 300 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 18, p. 666, 1968 (ARZNAD); N17 ipr-rat TDLo: 30 ug/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 358, 1969 (TXAPA9) MD: M04 orl-rat TDLo: 1200 ug/kg/20D-I Turkish Journal of Medical Science. (Scientific and Technical Research Council of Turkey, POB 5, Kizilay, Ankara 06420, Turkey) V.17- 1993- v. 28, p. 369, 1998 (TJMEEA); P28-Y15-Y40 orl-rat TDLo: 300 mg/kg/30D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 114, p. 127, 1992 (TXAPA9); P28-Y15-Y40 orl-rat TDLo: 910 mg/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 114, p. 127, 1992 (TXAPA9); L70-N71-Z74 orl-rat TDLo: 252 mg/kg/42D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 26, p. 227, 1988 (FCTOD7); P28-Y40 orl-rat TDLo: 1400 ug/kg/14D-I Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 74, p. 48, 2000 (ARTODN); N30-P26 ipr-mus TDLo: 30 mg/kg/5D-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 17, p. 265, 1997 (JJATDK); L70-N73-Y07 scu-mus TDLo: 2800 ug/kg/2W-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 6, p. 455, 1983 (DCTODJ); N13 orl-rat TDLo: 280 mg/kg/4W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 114, p. 127, 1992 (TXAPA9); U01 orl-rat TDLo: 0.6 mg/kg/60D-C Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 30, p. 130, 1999 (RTOPDW); Z74 scu-mus TDLo: 5 ug/kg/5D-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 483, p. 107, 2001 (MUREAV); L30-T01-T02 orl-rat TDLo: 1.4 mg/kg/14D-I Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 14, p. 355, 2000 (REPTED); F15-N17-Z74 orl-rat TDLo: 0.89 ug/kg/4D-C Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 21, p. 235, 2001 (JAPTO*); N73-U01-Z74 scu-mus TDLo: 14.5 mg/kg/5D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 60, p. 185, 2000 (JTEHD6); U01-N74-N73 scu-mus TDLo: 14.5 mg/kg/5D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 60, p. 185, 2000 (JTEHD6); Y07-Y53 scu-rat TDLo: 105 mg/kg/5D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 45, p. 47, 1995 (JTEHD6); N17-T13-Z74 scu-rat TDLo: 7142.8 ug/kg/5D-I Journal of Steroid Biochemistry and Molecular Biology. (Pergamon Press, c/o Elsevier Science, POB 945, New York, NY 10159) V.37- 1990- v. 42, p. 23, 1992 (JSBBEZ); N17-U01-Z74 par-rat TDLo: 7.1 mg/kg/5D-I Journal of Steroid Biochemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1969- v. 29, p. 527, 1988 (JSTBBK); U01 par-rat TDLo: 14.2 mg/kg/10D-I Journal of Steroid Biochemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1969- v. 29, p. 527, 1988 (JSTBBK); N16 scu-rat TDLo: 833.2 ug/kg/2D-I Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 105, p. 211, 1985 (JOENAK); T13 scu-rat TDLo: 30 mg/kg/5D-I American Journal of Anatomy. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1-192, 1901-91. v. 164, p. 145, 1982 (AJANA2); N17-T13 scu-mus TDLo: 27777.7 ug/kg/5D-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 204, p. 110, 1993 (PSEBAA); T13-Z74 scu-mus TDLo: 277.7 mg/kg/5D-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 74, p. 121, 1985 (JJIND8); T01-U01-Z73 scu-rat TDLo: 5500 ug/kg/11D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 59, p. 1084, 1998 (BIREBV); N17-Z74 orl-mus TDLo: 2.5 ug/kg/4D-C Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 10, p. 410, 1962 (JAFCAU); U01-Z71-Z74 scu-rat TDLo: 200 ug/kg/7D-I EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 103, p. 708, 1995 (EVHPAZ); T11-T12 par-mus TDLo: 250 ug/kg/5D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 29, 1986 (TJADAB); U01 orl-rat TDLo: 180 ug/kg/4D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); U01 orl-rat TDLo: 135 ug/kg/3D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); U01 orl-rat TDLo: 810 ug/kg/18D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); U01 orl-rat TDLo: 405 ug/kg/9D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); F15 orl-rat TDLo: 180 ug/kg/2D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); N30-Y53 orl-rat TDLo: 180 ug/kg/13D-I Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 44, p. 575, 1991 (BIREBV); N17-R25-V05 scu-rat TDLo: 1.1 mg/kg/11D-C Journal of Steroid Biochemistry and Molecular Biology. (Pergamon Press, c/o Elsevier Science, POB 945, New York, NY 10159) V.37- 1990- v. 60, p. 153, 1997 (JSBBEZ); N17-T13-Z74 scu-mus TDLo: 2 ug/kg/3D-I Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 34, p. 215, 1966 (JOENAK); P27 scu-mus TDLo: 12.5 mg/kg/5D-I Cellular Immunology. (Academic Press, 6277 Sea Harbor Drive, Orlando, FL 32887) V.1- 1970- v. 51, p. 55, 1980 (CLIMB8); U01 orl-mus TDLo: 6451.2 ug/kg/12W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); Z01 orl-mus TDLo: 11904 ug/kg/88W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); Z01 orl-mus TDLo: 9600 ug/kg/71W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); Z01 orl-mus TDLo: 17280 ug/kg/64W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); Z01 orl-mus TDLo: 15360 ug/kg/57W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); Z01 orl-mus TDLo: 32226 ug/kg/58W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); Z01 orl-mus TDLo: 15360 ug/kg/28W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); N62 orl-mus TDLo: 18432 ug/kg/68W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); N62 orl-mus TDLo: 11904 ug/kg/88W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); N62 orl-mus TDLo: 4128 ug/kg/122W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); N62 orl-mus TDLo: 2136 ug/kg/127W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); N62 orl-mus TDLo: 122.4 ug/kg/145W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); N62 orl-mus TDLo: 4608 ug/kg/137W-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 269, 1990 (JTEHD6); T12 ipr-mus TDLo: 0.275 mg/kg/5D-I Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 34, p. 29, 1986 (TJADAB); T13-T64 scu-mus TDLo: 500 ug/kg/5D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 50, p. 7677, 1990 (CNREA8); P27-S02 scu-mus TDLo: 12.5 mg/kg/5D-I Cellular Immunology. (Academic Press, 6277 Sea Harbor Drive, Orlando, FL 32887) V.1- 1970- v. 51, p. 55, 1980 (CLIMB8); U01 scu-mus TDLo: 20 mg/kg/8D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-130175 (NTIS**); L70 scu-mus TDLo: 800 mg/kg/8D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-130175 (NTIS**); F16 scu-mus TDLo: 400 mg/kg/4D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB95-130175 (NTIS**); T12-Y09 ims-rat TDLo: 1740 ug/kg/2D-I Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 63, p. 15, 1987 (CBINA8); N71-T14 orl-mus TDLo: 1131.9 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85167674/AS (NTIS**); N71-T02-Z72 orl-mus TDLo: 1131.9 mg/kg/21W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. #PB85167674/AS (NTIS**) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 21, p. 173, 1979 (IMEMDT); IARC Cancer Review: Human Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 273, 1987 (IMSUDL); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 273, 1987 (IMSUDL); TOXICOLOGY REVIEW Clinical Obstetrics and Gynecology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1958- v. 16(4), p. 37, 1973 (COGYAK); TOXICOLOGY REVIEW Internist. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1960- v. 15, p. 7, 1974 (INTEAG); TOXICOLOGY REVIEW Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. v. 5, p. 447, 1965 (ARVPAX); TOXICOLOGY REVIEW Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- v. 1, p. 173, 1953 (ACRSAJ); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 13, p. 271, 1970 (ADCSAJ); TOXICOLOGY REVIEW Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- v. 51, p. 671, 1960 (ACEDAB); TOXICOLOGY REVIEW Archives of Pathology and Laboratory Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-5(2), 1926-28: V.100- 1976- v. 101, p. 1, 1977 (APLMAS); TOXICOLOGY REVIEW American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 131, p. 1337, 1977 (AJDCAI); TOXICOLOGY REVIEW Advances in Sex Hormone Research. (Baltimore, MD) V.1-3, 1975-77. Discontinued. v. 3, p. 309, 1977 (ASHRDD); TOXICOLOGY REVIEW Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 66, p. 175, 1979 (RRCRBU); TOXICOLOGY REVIEW Journal of Surgical Oncology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1969- v. 9, p. 293, 1977 (JSONAU); TOXICOLOGY REVIEW New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 285, p. 390, 1971 (NEJMAG); TOXICOLOGY REVIEWS Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 14, p. 83, 2001 (TOPADD) ND: NOHS 1974: HZD 84601; NIS 3; TNF 172; NOS 11; TNE 5812; NOES 1983: HZD 84601; NIS 1; TNF 100; NOS 3; TNE 1492; TFE 934 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-BALB/c-3T3, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test, In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Inconclusive: SHE-clonal assay, E coli polA without S9; EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-human, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: In vitro UDS-human fibroblast; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; NTP Carcinogenesis studies, on test (prechronic studies), October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1053 of 1119 in RTECS (through 2003/06) AN: WJ8930000 PN: Solvent naphtha (petroleum), medium aliph. SY: Medium-aliphatic-solvent-naphtha- (petroleum) RN: Current: 64742-88-7 UD: 200012 CC: Tumorigen (C) SL: EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 1054 of 1119 in RTECS (through 2003/06) AN: WK4990000 PN: Streptomycin, sulfate (2:3) (salt) SY: Agrimycin-17-; Agristrep-; AS-15-; Strepsulfat-; Strepvet-; Streptomycin-sesquisulfate-; Phytomycin-; Plantomycin-; Strepcin-; Strep-gran-; Streptomycin-sulfate-; Streptomycin sulphate B.P; Streptorex-; Vetstrep- RN: Current: 3810-74-0 Previous: 298-39-5 UD: 200207 MF: C42-H78-N14-O24.H6-O12-S3 MW: 1457.58 WL: T6OTJ CM1 DQ EQ F1Q BO- CT5OTJ DVH DQ E1 BO- AL6TJ BQ CQ CMYZUM EQ FMYZUM &S-O4 (2:3) CC: Agricultural-Chemical-and-Pesticide (A); Drug (D); Mutagen (M); Natural-Product (N); Human-Data (P); Reproductive-Effector (T) ME: mmo-sat 10 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-sat 1 mg/plate (-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) JAN1982 (NTPTB*) RE: T42 ims-wmn TDLo: 1700 mg/kg (26-39W preg) Acta Paediatrica Latina. (Editrice Arti Grafiche Emiliane, Postale 10110427, 42100 Reggio Emilia, Italy) V.1- 1948- v. 11, p. 1, 1958 (APLAAQ); T22-T81 orl-rat TDLo: 37 gm/kg (multigenerations) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 17, p. 109, 1979 (OYYAA2); T35 unr-mus TDLo: 1200 mg/kg (9-11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 14, p. 250, 1976 (TJADAB) ORNG: 430000000 ng/kg. [430.000000 mg/kg] T/E unlistd AT: C08-F17-J30 ipr-inf TDLo: 170 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 1, p. 557, 1961 (BMJOAE); T/E unlistd orl-rat LD50: 430 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,106,1982 (85GMAT); T/E unlistd scu-rat LD50: 600 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 12, p. 597, 1962 (ARZNAD); T/E unlistd orl-mus LD50: 430 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,106,1982 (85GMAT); T/E unlistd scu-mus LD50: 403 mg/kg Antibiotics Annual. (New York, NY) 1953-60. For publisher information, see AMACCQ. v. 4, p. 574, 1956/1957 (ABANAE); T/E unlistd ivn-mus LD50: 90200 ug/kg Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. v. 18, p. 444, 1973 (ANTBAL); F07-F15-K12 orl-ham LD50: 400 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 14, p. 510, 1969 (TXAPA9); T/E unlistd ipr-rat LD50: 1219 mg/kg Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 1, p. 150, 2001 (HBPTO*) MD: M03 orl-rat TDLo: 548 gm/kg/2Y-C Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 11, p. 505, 1976 (OYYAA2); D40 scu-rat TDLo: 1500 mg/kg/6D-I Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 86, p. 377, 1985 (NYKZAU); M03 orl-mus TDLo: 1095 gm/kg/2Y-C Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 11, p. 487, 1976 (OYYAA2); D43 scu-cat TDLo: 11651 mg/kg/93D-I Antibiotics Annual. (New York, NY) 1953-60. For publisher information, see AMACCQ. v. 4, p. 564, 1956/1957 (ABANAE); F19-U01 scu-cat TDLo: 3 gm/kg/30D-I Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 6, p. 379, 1956 (ARZNAD); F19 scu-cat TDLo: 4200 mg/kg/42D-I Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher information, see AMACCQ. v. -, p. 138, 1963 (AACHAX); F19-U01-Z01 ims-cat TDLo: 1350 mg/kg/27D-I Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 41, p. 555, 1952 (JAPMA8) TR: TOXICOLOGY REVIEW Panminerva Medica. (Edizioni Minerva Medica, Casella Postale 491, Turin, Italy) V.1- 1959- v. 16, p. 9, 1974 (PMMDAE) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 83938; NIS 2; TNF 104; NOS 3; TNE 819; NOES 1983: HZD 83938; NIS 3; TNF 296; NOS 8; TNE 4472; TFE 2183 SL: EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY Record 1055 of 1119 in RTECS (through 2003/06) AN: WL4040000 PN: Styrene,-beta-bromo-beta-nitro- SY: Benzene, (2-bromo-2-nitroethenyl)- (9CI); beta-Bromo-beta-nitrostyrene-; (2-Bromo-2-nitrovinyl)benzene; Giv-cide-BNS-; Giv-gard-; Slime-trol- RN: Current: 7166-19-0 UD: 200012 MF: C8-H6-Br-N-O2 MW: 228.06 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1600 ng/plate (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19(Suppl 21), p. 2, 1992 (EMMUEG) MD: K30-P71-Y03 orl-rat TDLo: 3 gm/kg/4W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3389 (NTPTR*); K30-L70-P05 orl-mus TDLo: 6 gm/kg/4W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3389 (NTPTR*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOES 1983: HZD X2401; NIS 4; TNF 124; NOS 7; TNE 9451; TFE 837 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Toxicity studies, RPT# TOX-40, October 2000 Record 1056 of 1119 in RTECS (through 2003/06) AN: WL5075000 PN: Styrene,-methyl- SY: 3--and-4-Vinyl-toluene- (mixed isomers); Ethenylmethylbenzene-; Methylstyrene-; Methylvinylbenzene-; NCI-C56406-; Toluene,-vinyl- (mixed isomers); Tolylethylene-; Vinyl-toluene-; Vinyl-toluene- (ACGIH:OSHA); Vinyl-toluene- (mixed isomers); Vinyltoluene- RN: Current: 25013-15-4 Previous: 1321-45-5 BRN: 1209317 BHR: 4-05-00-01369 UD: 200302 MF: C9-H10 MW: 118.19 WL: 1U1R X1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 100% MOD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); eye-rbt 90 mg MLD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB) ME: mnt-mus-ipr 200 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 8, p. 247, 1981 (TOLED5); msc-mus-lym 60 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG) RE: T25-T34 ipr-rat TDLo: 3750 mg/kg (1-15D preg) Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 7(Suppl 4), p. 66, 1981 (SWEHDO) ORNG: 2255000000 ng/kg. [2255.000000 mg/kg] D17-F07-R21 AT: D07-D35 ihl-hmn TCLo: 400 ppm AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); D17-F07-R21 orl-rat LD50: 2255 mg/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 77, 1990 (ATDAEI); T/E unlistd skn-rat LDLo: 4500 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 34(9), p. 40, 1969 (GISAAA); D17-F07-R21 ipr-rat LD50: 2324 mg/kg Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- v. 1, p. 77, 1990 (ATDAEI); J15-K30-P01 orl-mus LD50: 3160 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 34(7-9), p. 334, 1969 (HYSAAV); J15-K30-P01 ihl-mus LC50: 3020 mg/m3/4H Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 34(7-9), p. 334, 1969 (HYSAAV); T/E unlistd skn-mus LDLo: 4500 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 34(9), p. 40, 1969 (GISAAA) MD: D17-L30-L70 ihl-rat TCLo: 1300 ppm/6H/15D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-375, 1990 (NTPTR*); C15-C16 ihl-rat TCLo: 332 ppm/6H/21W-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 30, p. 27, 1986 (TOLED5); D17-L70 ihl-rat TCLo: 1000 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-375, 1990 (NTPTR*); C16 ihl-rat TCLo: 100 ppm/6H/15W-I Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 5, p. 100, 1982 (ATSUDG); J30-L01-Z01 ihl-mus TCLo: 200 ppm/6H/15D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-375, 1990 (NTPTR*); D07-J30-U01 ihl-mus TCLo: 160 ppm/6H/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-375, 1990 (NTPTR*); F13 ihl-gpg TCLo: 29 mg/m3/4H/16W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0572508 (NTIS**); P01-P14-P72 ihl-rat TCLo: 5000 mg/m3/6H/100D-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 207, 1990 (VCVGH*); J60-V30 ihl-mus TCLo: 618 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-260035 (NTIS**); L60-P62-V30 ihl-mus TCLo: 618 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-260035 (NTIS**) TR: ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 373, 1994 (IMEMDT); IARC Cancer Review: Animal Lack Carcinogenicity IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 373, 1994 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 60, p. 373, 1994 (IMEMDT) SR: MSHA STANDARD-air: TWA 100 ppm (480 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 278, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 100 ppm (480 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (480 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (480 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (480 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 50 ppm (240 mg/m3), STEL 100 ppm, JAN 1993; OEL-AUSTRIA: MAK 100 ppm (480 mg/m3), JAN 1999; OEL-BELGIUM: TWA 50 ppm (242 mg/m3), STEL 100 ppm (483 mg/m3), JAN 1993; OEL-DENMARK: TWA 25 ppm (120 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 50 ppm (240 mg/m3), STEL 100 ppm (480 mg/m3), JAN 1999; OEL-FRANCE: VME 50 ppm (240 mg/m3), JAN 1999; OEL-GERMANY: MAK 100 ppm (480 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 50 ppm (240 mg/m3), JAN 1999; OEL-NORWAY: TWA 50 ppm (240 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (480 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 300 mg/m3, JAN 1999; OEL-RUSSIA: STEL 50 mg/m3, JAN 1993; OEL-SWEDEN: NGV 10 ppm (50 mg/m3), KTV 75 ppm (150 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (240 mg/m3) KZG-W 100 ppm (480 mg/m3), JAN 1999; OEL-TURKEY: TWA 100 ppm (480 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 100 ppm (491 mg/m3), STEL 150 ppm, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO VINYL TOLUENE-air: 10H TWA 100 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 76510; NIS 61; TNF 7016; NOS 59; TNE 73140; NOES 1983: HZD 76510; NIS 24; TNF 2028; NOS 31; TNE 25353; TFE 3889 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrocarbons, aromatic, 1501; NCI Carcinogenesis Studies (inhal), no evidence: mouse, rat Record 1057 of 1119 in RTECS (through 2003/06) AN: WL5075300 PN: Styrene,-alpha-methyl- SY: 1-Methyl-1-phenylethylene-; 2-Phenylpropene-; 2-Phenylpropylene-; Benzene, (1-methylethenyl)-; Isopropenil-benzolo- (Italian); Isopropenyl-benzeen- (Dutch); Isopropenyl-benzol- (German); alpha-Methyl-styrene-; alpha-Methyl-styrene- (ACGIH:OSHA); alpha-Methyl-styrene,-fume-; alpha-Methyl-styrol- (German); alpha-Methylstyreen- (Dutch); alpha-Methylstyrene-; alpha-Metil-stirolo- (Italian); as-Methylphenylethylene-; beta-Phenylpropene-; beta-Phenylpropylene- RN: Current: 98-83-9 UD: 200210 MF: C9-H10 MW: 118.19 WL: 1YR&U1 CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 100% MOD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); eye-rbt 91 mg MLD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB) ME: sce-hmn-lym 330 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 116, p. 379, 1983 (MUREAV) ORNG: 4900000000 ng/kg. [4900.000000 mg/kg] T/E unlistd AT: D07-D35 ihl-hmn TCLo: 600 ppm AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); T/E unlistd orl-rat LD50: 4900 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); T/E unlistd ihl-rat LCLo: 3000 ppm "Toxicology and Biochemistry of Aromatic Hydrocarbons," Gerarde, H., New York, Elsevier, 1960 -,131,1960 (28ZRAQ); F12-J24-U28 orl-mus LD50: 4500 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 28(12), p. 14, 1963 (GISAAA); T/E unlistd skn-rbt LDLo: 16 mL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 5/24/1977 (UCDS**); T/E unlistd ihl-gpg LCLo: 3000 ppm "Toxicology and Biochemistry of Aromatic Hydrocarbons," Gerarde, H., New York, Elsevier, 1960 -,131,1960 (28ZRAQ) MD: M13-P72 orl-rat TDLo: 15 gm/kg/30D-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(6), p. 38, 1979 (GTPZAB); F23-H02-U01 ihl-rat TCLo: 50 mg/m3/6H/22W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 28(12), p. 14, 1963 (GISAAA); A11-M16-P30 ihl-rat TCLo: 5 mg/m3/24H/13W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(2), p. 3, 1966 (GISAAA); U01 orl-mus TDLo: 15 gm/kg/30D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 29(4), p. 24, 1964 (GISAAA); M13-P72-U01 orl-rat TDLo: 1400 mg/kg/4W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 203, 1990 (VCVGH*); Z01 ihl-rat TCLo: 3000 ppm/7H/24W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 203, 1990 (VCVGH*); Z01 ihl-gpg TCLo: 3000 ppm/7H/24W-I "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 203, 1990 (VCVGH*) TR: ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 50 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*) SR: MSHA STANDARD: air-CL 100 ppm (480 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 170, 1971 (DTLVS*); OSHA PEL (Gen Indu): CL 100 ppm (480 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 100 ppm (480 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 100 ppm (480 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 100 ppm (480 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 50 ppm (240 mg/m3), STEL 100 ppm, JAN 1993; OEL-AUSTRIA: MAK 100 ppm (480 mg/m3), JAN 1999; OEL-BELGIUM: TWA 50 ppm (242 mg/m3), STEL 100 ppm (484 mg/m3), JAN 1993; OEL-DENMARK: TWA 50 ppm (240 mg/m3), JAN 1999; OEL-FINLAND: TWA 100 ppm (480 mg/m3), STEL 150 ppm (720 mg/m3), JAN 1999; OEL-FRANCE: VME 50 ppm (240 mg/m3), JAN 1999; OEL-GERMANY: MAK 100 ppm (480 mg/m3), JAN 1999; OEL-NORWAY: TWA 50 ppm (240 mg/m3), JAN 1999; OEL-RUSSIA: STEL 5 mg/m3, JAN 1993; OEL-SWITZERLAND: MAK-W 50 ppm (240 mg/m3), JAN 1999; OEL-THAILAND: TWA 100 ppm (480 mg/m3), JAN 1993; OEL-UNITED KINGDOM: STEL 100 ppm (491 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO alpha-METHYLSTYRENE-air: 10H TWA 50 ppm, STEL 100 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD M1533; NIS 20; TNF 1933; NOS 32; TNE 24824; NOES 1983: HZD M1533; NIS 3; TNF 354; NOS 4; TNE 3214 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9275; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Hydrocarbons, aromatic, 1501; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 1058 of 1119 in RTECS (through 2003/06) AN: WM3407000 PN: Succinamic acid, 3-amino-N-(alpha-carboxyphenethyl)-, N-methyl ester, stereoisomer SY: 3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester, stereoisomer; Aspartame-; Aspartylphenylalanine-methyl-ester-; N-L-alpha-Aspartyl-L-phenylalanine-1-methyl-ester-; Dipeptide-sweetener-; Nutrasweet-; L-Phenylalanine,-N-L-alpha-aspartyl-,-1-methyl-ester- (9CI); Canderel-; Equal-; Methyl-aspartylphenylalanate-; 1-Methyl-N-L-alpha-aspartyl-L-phenylalanine-; Sweet-dipeptide- RN: Current: 22839-47-0 Previous: 53906-69-7 UD: 200012 MF: C14-H18-N2-O5 MW: 294.34 CC: Tumorigen (C); Reproductive-Effector (T); Human-Data (P) RE: T85 orl-rat TDLo: 275 gm/kg (2W male/2W pre-16D post) Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information, see NTOTDY. v. 1, p. 79, 1979 (NETOD7); T81 orl-rat TDLo: 106 gm/kg (12D post) Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(5-6), p. 375, 1980 (JEPTDQ); T76 orl-rat TDLo: 449 gm/kg (2W male/2W pre-21D post) Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information, see NTOTDY. v. 1, p. 79, 1979 (NETOD7); T85 orl-mus TDLo: 4 gm/kg (15-18D preg) Research Communications in Psychology, Psychiatry and Behavior. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1976- v. 9, p. 385, 1985 (RCPBDC); T85 orl-gpg TDLo: 32500 mg/kg (1-65D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 11, p. 413, 1989 (NETEEC) AT: R01 orl-wmn TDLo: 3710 ug/kg Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 104, p. 207, 1986 (AIMEAS); T/E unlistd orl-rat LD50: >10 gm/kg Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (3), p. 37, 1996 (TOVEFN); T/E unlistd ipr-rat LD50: >5 gm/kg Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (3), p. 37, 1996 (TOVEFN); T/E unlistd orl-mus LD50: >10 gm/kg Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (3), p. 37, 1996 (TOVEFN); T/E unlistd ipr-mus LD50: >5 gm/kg Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (3), p. 37, 1996 (TOVEFN) MD: M16-U07 orl-rat TDLo: 1456 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 21, p. 91, 1981 (TXCYAC); F17-F41-U01 orl-rat TDLo: 1012 gm/kg/13W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(5-6), p. 341, 1980 (JEPTDQ); L30-N30-U30 ihl-rat TCLo: 4530 ug/m3/24H/6W-C Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (3), p. 37, 1996 (TOVEFN); A30 orl-mus TDLo: 19500 mg/kg/30D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 565, 1987 (FCTOD7) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NIOSH Analytical Method, 1994: Aspartame, 5031; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 1059 of 1119 in RTECS (through 2003/06) AN: WN0875000 PN: Succinic-anhydride- SY: Dihydro-2,5-furandione-; 2,5-Diketotetrahydrofuran-; Succinic-acid-anhydride-; Bernsteinsaure-anhydrid- (German); Butanedioic-anhydride-; 2,5-Furandione,-dihydro-; NCI-C55696-; Rikacid-SA-; Succinyl-anhydride-; Succinyl-oxide-; Tetrahydro-2,5-dioxofuran-; Tetrahydro-2,5-furandione- RN: Current: 108-30-5 BRN: 108441 BHR: 5-17-11-00006 UD: 200210 MF: C4-H4-O3 MW: 100.08 WL: T5VOVTJ CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: eye-rbt 750 ug SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA) ME: mmo-esc 2 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 97, 1984 (MUREAV); mtr-ham-emb 100 ug/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); mtr-mus-fbr 1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T59 ipr-mus TDLo: 79 mg/kg (8-10D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 2, p. 61, 1982 (TCMUD8) TE: V02-V10 scu-rat TDLo: 2600 mg/kg/65W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 19, p. 392, 1965 (BJCAAI) ORNG: 1510000000 ng/kg. [1510.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1510 mg/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-0282-0433 (EPASR*) MD: L70-Z01 orl-rat TDLo: 13 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-373, 1990 (NTPTR*); Z01 orl-rat TDLo: 2618 mg/kg/20D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-373, 1990 (NTPTR*); Z01 orl-mus TDLo: 10500 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-373, 1990 (NTPTR*); Z01 orl-mus TDLo: 19500 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-373, 1990 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 265, 1977 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 15, p. 265, 1977 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) ND: NOES 1983: HZD X4008; NIS 7; TNF 263; NOS 5; TNE 3059; TFE 1207 SL: EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: Host-mediated assay, L5178Y cells in vitro-TK test; EPA GENETOX PROGRAM 1988, Negative: E coli polA without S9, E coli polA with S9; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test, S cerevisiae-homozygosis; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat Record 1060 of 1119 in RTECS (through 2003/06) AN: WQ0900000 PN: Sulfide, bis(2-chloroethyl) SY: 1,1'-Thiobis(2-chloroethane); 1-Chloro-2-(beta-chloroethylthio)ethane; 2,2'-Dichloro-diethyl-sulphide-; 2,2'-Dichlorodiethyl-sulfide-; 2,2'-Dichloroethyl-sulphide-; Bis(2-chloroethyl)sulfide; Bis(2-chloroethyl)sulphide; Bis(beta-chloroethyl)sulfide; Di-2-chloroethyl-sulfide-; Distilled-mustard-; Gelbkreuz- (Czech); HD-; Kampstoff-lost-; Mustard-HD-; Mustard-gas-; Mustard-vapor-; Mustard,-sulfur-; S-mustard-; S-Lost-; Schwefel-lost-; Sulfur-mustard-; Sulfur-mustard-gas-; Sulphur-mustard-; Sulphur-mustard-gas-; Yellow-cross-liquid-; Yperite-; beta,beta'-Dichloroethyl-sulfide-; beta,beta-Dichlor-ethyl-sulphide-; bis(2-chloroethyl)sulfide RN: Current: 505-60-2 Previous: 69020-37-7 BRN: 1733595 BHR: 4-01-00-01407 UD: 200210 MF: C4-H8-Cl2-S MW: 159.08 WL: G2S2G CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-man 2 ppm/1H SEV National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A011-260 (NTIS**); skn-hmn 65 ug National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); eye-man 0.1 ppm/6H MOD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A011-260 (NTIS**); eye-rbt 0.2 ppm/30M MLD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A011-260 (NTIS**); eye-rbt 0.2 ppm/2M MLD National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A011-260 (NTIS**); eye-rbt 0.4 ul/24H SEV Journal of Applied Toxicology (John Wiley and Sons, Ltd., Oldlands Way Bognor Regis West Sussex, PO22 9SA England) V.1- 1981- v. 20, p. S173, 2000 (JAPTO*) ME: mmo-sat 10 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 257, p. 307, 1991 (MUREAV); mmo-esc 8 mg/L (+S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 3073, 1974 (CNREA8); dnr-esc 5 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 53, 1977 (MUREAV); slt-dmg-par 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 13, p. 19, 1971 (MUREAV); cyt-dmg-ihl 10 pph/15M-I Proceedings of the Royal Society of Edinburgh, Section B. (Edinburgh, Scotland, UK) V.61-74, 1943-74. v. 62, p. 271, 1946/1947 (PREBA3); sln-dmg-ihl 10 pph/15M-I Proceedings of the Royal Society of Edinburgh, Section B. (Edinburgh, Scotland, UK) V.61-74, 1943-74. v. 62, p. 271, 1946/1947 (PREBA3); dlt-dmg-ihl 10 pph/15M-I Proceedings of the Royal Society of Edinburgh, Section B. (Edinburgh, Scotland, UK) V.61-74, 1943-74. v. 62, p. 271, 1946/1947 (PREBA3); trn-dmg-ihl 10 pph/15M-I Proceedings of the Royal Society of Edinburgh, Section B. (Edinburgh, Scotland, UK) V.61-74, 1943-74. v. 62, p. 271, 1946/1947 (PREBA3); mmo-nsc 200 umol/L/30M (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 35, p. 581, 1949 (PNASA6); dnd-smc 500 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 44, p. 27, 1983 (CBINA8); dnd-hmn-oth 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 294, p. 235, 1993 (MUREAV); dnd-hmn-hla 2 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 4, p. 297, 1971/1972 (CBINA8); dns-hmn-hla 200 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 218, p. 970, 1968 (NATUAS); dni-hmn-oth 500 nmol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 245, 1992 (TIVIEQ); dni-hmn-hla 75 mg/L ICN-UCLA Symposia on Molecular and Cellular Biology. (Menlo Park, CA) V.1-23, 1974-81. v. 9, p. 41, 1979 (IUSMDJ); oms-hmn-hla 75 mg/L ICN-UCLA Symposia on Molecular and Cellular Biology. (Menlo Park, CA) V.1-23, 1974-81. v. 9, p. 41, 1979 (IUSMDJ); cyt-hmn-leu 4 mg/L Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001, 00-068 Warsaw 1, Poland) V.25-44, 1973-92. For publisher information, see PJPAE3 v. 39, p. 405, 1987 (PJPPAA); sce-hmn-leu 8 mg/L Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001, 00-068 Warsaw 1, Poland) V.25-44, 1973-92. For publisher information, see PJPAE3 v. 39, p. 405, 1987 (PJPPAA); cyt-rat-lym 20 ng/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 22, p. 207, 1974 (MUREAV); dlt-rat-ihl 100 ug/m3/12W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 13, 1973 (MUREAV); mnt-mus-ipr 8 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 257, p. 307, 1991 (MUREAV); mnt-mus-orl 10 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 257, p. 307, 1991 (MUREAV); dna-mus-ast 2 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 80, p. 496, 1961 (BIJOAK); dnd-mus-lym 1 mg/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 179, p. 179, 1969 (BBACAQ); cyt-mus-leu 20 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 6, 1973 (MUREAV); msc-mus-leu 20 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 6, 1973 (MUREAV); hma-mus-leu 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 6, 1973 (MUREAV); hma-mus-esc 8 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 3073, 1974 (CNREA8); dns-mam-lym 750 nmol/L Chromosomes Today. (George Allen and Unwin Ltd., 40 Museum St., London WC1A 1LU, UK) V.1- 1966- v. 3, p. 162, 1972 (CHRTBC); dnd-ckn-leu 30 mmol/L Tetrahedron Letters. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) 1959- v. (29), p. 2477, 1975 (TELEAY); dnd-rat-lvr 80 umol/L/18H Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 176, p. 24, 2001 (TXAPA9); dna-hmn-oth 100 umol/L/5M Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 138, p. 231, 2001 (CBINA8) RE: T34-T46 orl-rat TDLo: 20 mg/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 33, p. 70C, 1986 (TJADAB); T01-T24-T25 orl-rat TDLo: 25 mg/kg (10W male) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A214-556 (NTIS**); T81-T91 orl-rat TDLo: 68800 ug/kg (multigeneration) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 10, p. 311, 1996 (REPTED); T34 orl-rbt TDLo: 11200 ug/kg (6-18D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 33, p. 70C, 1986 (TJADAB) TE: V01-R60 ihl-rat TCLo: 100 ug/m3/1Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A011-260 (NTIS**); V02-J60-P61 ihl-mus TCLo: 1250 mg/m3/15M-C Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 82, p. 457, 1953 (PSEBAA); V03-V10 scu-mus TDLo: 6 mg/kg/6W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 14, p. 131, 1953 (JNCIAM); V02-J60 ivn-mus TDLo: 600 mg/kg/6D-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 11, p. 415, 1950 (JNCIAM); V03-R60 ihl-rat TDLo: 100 ug/m3/6.5H/1Y-I Journal of Toxicology and Environmental Health, Part A. (Taylor and Francis, 47 Runway Rd., Suite G, Levittown, PA 19057) V.53- 1998- v. 59, p. 471, 2000 (JTEHF8) ORNG: 17000000 ng/kg. [17.000000 mg/kg] T/E unlistd SRNG: 40000000 ng/kg. [40.000000 mg/kg] F12-F19-K13 SKNG: 5000000 ng/kg. [5.000000 mg/kg] F12-F19-K13 AT: T/E unlistd orl-hmn LD50: 700 ug/kg Journal of Toxicology and Environmental Health, Part A. (Taylor and Francis, 47 Runway Rd., Suite G, Levittown, PA 19057) V.53- 1998- v. 59, p. 471, 2000 (JTEHF8); T/E unlistd ihl-hmn LCLo: 23 ppm/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-270 (NTIS**); T/E unlistd skn-hmn LD50: 100 mg/kg Journal of Toxicology and Environmental Health, Part A. (Taylor and Francis, 47 Runway Rd., Suite G, Levittown, PA 19057) V.53- 1998- v. 59, p. 471, 2000 (JTEHF8); D07-D25-F12 skn-hmn LDLo: 64 mg/kg World Health Organization, Technical Report Series. (WHO, 1211 Geneva, 27, Switzerland) No.1- 1950- v. -, p. 24, 1970 (WHOTAC); T/E unlistd orl-rat LD50: 17 mg/kg Journal of Toxicology and Environmental Health, Part A. (Taylor and Francis, 47 Runway Rd., Suite G, Levittown, PA 19057) V.53- 1998- v. 59, p. 471, 2000 (JTEHF8); T/E unlistd ihl-rat LC50: 100 mg/m3/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); F12-F19-K13 skn-rat LD50: 5 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); F15-K12-U01 scu-rat LD50: 1500 ug/kg Canadian Journal of Research, Section E, Medical Sciences. (Ottawa, Ont., Canada) V.22-28, 1944-50. For publisher information, see CJBIAE. v. 25, p. 141, 1947 (CNRMAW); T/E unlistd ivn-rat LD50: 700 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 93, p. 1, 1948 (JPETAB); T/E unlistd ihl-mus LC50: 120 mg/m3/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd skn-mus LD50: 92 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 93, p. 1, 1948 (JPETAB); F12-F19-K13 scu-mus LD50: 20 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); T/E unlistd ivn-mus LD50: 8600 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 93, p. 1, 1948 (JPETAB); T/E unlistd ihl-dog LC50: 70 mg/m3/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd skn-dog LD50: 20 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); F12-F19-K13 scu-dog LDLo: 5 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); F12-F19-K13 ivn-dog LD50: 200 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); T/E unlistd ihl-mky LC50: 80 mg/m3/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd ihl-cat LC50: 70 mg/m3/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd ihl-rbt LC50: 280 mg/m3/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); F12-F19-K13 skn-rbt LD50: 40 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); F12-F19-K13 scu-rbt LD50: 20 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); T/E unlistd ivn-rbt LD50: 1100 ug/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 93, p. 1, 1948 (JPETAB); T/E unlistd ihl-gpg LC50: 200 mg/m3/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd skn-gpg LD50: 20 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); F12-F19-K13 scu-gpg LD50: 20 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); T/E unlistd ihl-dom LC50: 190 mg/m3/10M National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-508 (NTIS**); T/E unlistd skn-dom LD50: 50 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**); F12-F19-K13 scu-dom LD50: 40 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB158-507 (NTIS**) MD: G30-P01 orl-rat TDLo: 35 mg/kg/14D-I Journal of Toxicology and Environmental Health, Part A. (Taylor and Francis, 47 Runway Rd., Suite G, Levittown, PA 19057) V.53- 1998- v. 59, p. 471, 2000 (JTEHF8); U01 orl-rat TDLo: 19500 ug/kg/13W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 16, p. 5, 1996 (JJATDK); D26 ihl-dog TCLo: 100 ug/m3/6H/52W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD-A011-260 (NTIS**) TR: IARC Cancer Review: Human Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 259, 1987 (IMSUDL); IARC Cancer Review: Animal Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 259, 1987 (IMSUDL); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 259, 1987 (IMSUDL); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,63,1970 (85CVA2) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110815/AS); EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive/dose response: TRP reversion; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 1061 of 1119 in RTECS (through 2003/06) AN: WR3450000 PN: Sulfone, bis(p-chlorophenyl) SY: p-Chlorophenyl-sulfone-; 4-Chlorophenyl-sulfone-; p,p'-Dichlorodiphenyl-sulfone-; 4,4'-Dichlorodiphenyl-sulfone-; Di-p-chlorophenyl-sulfone-; Benzene, 1,1'-sulfonylbis(4-chloro- (9CI); Bis(p-chlorophenyl) sulfone; Bis(4-chlorophenyl) sulfone; 1,1'-Sulfonylbis(4-chlorobenzene) RN: Current: 80-07-9 BRN: 2052955 BHR: 4-06-00-01587 UD: 200207 MF: C12-H8-Cl2-O2-S MW: 287.16 WL: GR DSWR DG CC: Tumorigen (C) AT: K12 orl-rat LDLo: 7500 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0533718 (NTIS**); F11 orl-mus LD50: 24 gm/kg Helvetica Chimica Acta. (Verlag Helvetica Chimica Acta, Postfach, CH-4002 Basel, Switzerland) V.1- 1918- v. 29, p. 1317, 1946 (HCACAV) MD: A11-L14 orl-rat TDLo: 364 mg/kg/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 47(2), p. 84, 1982 (GISAAA) SR: OEL-RUSSIA: STEL 10 ppm, JAN 1993 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), no evidence: mouse, rat; NTP Carcinogenesis studies, test completed (post peer review), October 2000 Record 1062 of 1119 in RTECS (through 2003/06) AN: WS5600000 PN: Sulfuric-acid- SY: Acide-sulfurique- (French); Acido-solforico- (Italian); BOV-; Battery-acid-; Dihydrogen-sulfate-; Dipping-acid-; Electrolyte-acid-; Mattling-acid-; Oil-of-vitriol-; Schwefelsaeureloesungen- (German); Strong-inorganic-acid-mists-containing-sulfuric-acid-; Sulfuric-acid- (ACGIH:OSHA); Sulfuric-acid,-aerosol-; Sulphuric-acid-; Vitriol-Brown-Oil-; Zwavelzuuroplossingen- (Dutch) RN: Current: 7664-93-9 Previous: 119540-51-1; 127529-01-5 UD: 200302 MF: H2-O4-S MW: 98.08 WL: H2 S-O4 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 250 ug SEV American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- v. 29, p. 1363, 1946 (AJOPAA); eye-rbt 5 mg/30S rinse SEV Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 23, p. 281, 1982 (TXCYAC) ME: cyt-ham-ovr 4 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 225, p. 55, 1989 (MUREAV) RE: T46 ihl-rbt TCLo: 20 mg/m3/7H (6-18D preg) Journal of Environmental Science and Health, Part C: Environmental Health Sciences. New York, NY) V.13, 1978-79. v. 13, p. 251, 1979 (JEHSDH) ORNG: 2140000000 ng/kg. [2140.000000 mg/kg] T/E unlistd AT: Q01 ihl-hmn TCLo: 3 mg/m3/24W British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME 04046) V.1- 1944- v. 18, p. 63, 1961 (BJIMAG); J30 ihl-hmn TCLo: 1 mg/m3/3H Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 9, p. 731, 1997 (INHTE5); T/E unlistd unr-man LDLo: 135 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 2140 mg/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); T/E unlistd ihl-rat LC50: 510 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,107,1982 (85GMAT); T/E unlistd ihl-mus LC50: 320 mg/m3/2H "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,107,1982 (85GMAT); J30 ihl-gpg LC50: 18 mg/m3 Medicina del Lavoro. Industrial Medicine. (Via S. Barnaba, 8, 20122 Milan, Italy) V.16- 1925- v. 45, p. 590, 1954 (MELAAD); T/E unlistd ihl-mus LC50: 320 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 239, 1993 (VCVN5*); T/E unlistd ihl-rat LC50: 510 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 239, 1993 (VCVN5*); J04 ihl-gpg LCLo: 65 mg/m3/30M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 239, 1993 (VCVN5*); T/E unlistd ihl-mus LCLo: 461 mg/m3/7H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 239, 1993 (VCVN5*); T/E unlistd ihl-rat LCLo: 461 mg/m3/7H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 239, 1993 (VCVN5*); T/E unlistd ihl-rbt LCLo: 461 mg/m3/7H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 239, 1993 (VCVN5*); T/E unlistd ihl-cat LCLo: 461 mg/m3/7H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 239, 1993 (VCVN5*); T/E unlistd ihl-gpg LC50: 18 mg/m3/8H "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 239, 1993 (VCVN5*); F15-F17-J15 ihl-gpg TCLo: 8 mg/m3/5D "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 240, 1993 (VCVN5*); J21 ihl-hmn TCLo: 0.6 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 241, 1993 (VCVN5*); D35 ihl-hmn TCLo: 0.73 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 241, 1993 (VCVN5*); A10 ihl-hmn TCLo: 0.63 mg/m3 "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 241, 1993 (VCVN5*); J22 ihl-hmn TCLo: 3 mg/m3/5M "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 241, 1993 (VCVN5*) MD: F23-M16-Y01 ihl-rat TCLo: 784 ug/m3/24H/84D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 38(3), p. 6, 1973 (GISAAA); G70-J30-J70 ihl-dog TCLo: 900 ug/m3/21H/89W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 26, p. 16, 1973 (AEHLAU); J30 ihl-mky TCLo: 2 mg/m3/23H/78W-I Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 27, p. 16, 1973 (AEHLAU); J15-Z01 ihl-gpg TCLo: 30 mg/m3/7D-C Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 521, 1977 (JTEHD6); C16-M04 ihl-rat TCLo: 1.8 mg/m3/24H/65D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 243, 1989 (VCVN5*); J13-J15 ihl-gpg TCLo: 4 mg/m3/24H/18D-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 243, 1989 (VCVN5*); J30 ihl-mky TCLo: 2.4 mg/m3/24H/78W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 243, 1989 (VCVN5*); J30 ihl-hor TCLo: 0.1 mg/m3/5D/26W-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 244, 1989 (VCVN5*); J25 ihl-dog TCLo: 0.9 mg/m3/21H/620D-I "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 244, 1989 (VCVN5*); J25 ihl-mky TCLo: 2.4 mg/m3/24H/78W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. v. -, p. 244, 1989 (VCVN5*) TR: ACGIH TLV-TWA 1 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 3 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Human Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 54, p. 41, 1992 (IMEMDT); IARC Cancer Review: Group 1 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 54, p. 41, 1992 (IMEMDT); TOXICOLOGY REVIEW EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 10, p. 35, 1975 (EVHPAZ); TOXICOLOGY REVIEW Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 39, p. 299, 1978 (ARTODN) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 1 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 239, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 mg/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 1 mg/m3, JAN 1993; OEL-AUSTRALIA: TWA 1 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 1 mg/m3, JAN 1999; OEL-BELGIUM: TWA 1 mg/m3, STEL 3 mg/m3, JAN 1993; OEL-DENMARK: TWA 1 mg/m3, JAN 1999; OEL-FINLAND: TWA 1 mg/m3, STEL 3 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 1 mg/m3, VLE 3 mg/m3, JAN 1999; OEL-GERMANY: MAK 1 mg/m3, JAN 1999; OEL-HUNGARY: STEL 1 mg/m3, JAN 1993; OEL-JAPAN: OEL 1 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 1 mg/m3, JAN 1999; OEL-NORWAY: TWA 1 mg/m3, JAN 1999; OEL-POLAND: MAC(TWA) 1 mg/m3, MAC(STEL) 3 mg/m3, JAN 1999; OEL-RUSSIA: STEL 1 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 1 mg/m3, TKV 3 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 1 mg/m3, KZG-W 2 mg/m3, JAN 1999; OEL-THAILAND: TWA 1 mg/m3, JAN 1993; OEL-TURKEY: TWA 1 mg/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 1 mg/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO SULFURIC ACID-air: 10H TWA 1 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 70870; NIS 313; TNF 54746; NOS 143; TNE 499446; NOES 1983: HZD 70870; NIS 300; TNF 54516; NOS 182; TNE 775587; TFE 173653 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/122038); EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9247, 8EHQ-0892-9248; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Acids, inorganic, 7903; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen; OSHA ANALYTICAL METHOD #ID-113 Record 1063 of 1119 in RTECS (through 2003/06) AN: WS7875000 PN: Sulfuric-acid,-diethyl-ester- SY: Diethylester-kyseliny-sirove- (Czech); Diethyl-sulfate-; Diethyl-sulphate-; Diethyl-tetraoxosulfate-; Ethyl-sulfate-; Diaethylsulfat- (German) RN: Current: 64-67-5 Previous: 98503-29-8 UD: 200012 MF: C4-H10-O4-S MW: 154.20 WL: 2OSWO2 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 12/30/1971 (UCDS**) ME: mmo-sat 1 uL/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 79, 1984 (MUREAV); mmo-sat 5 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 141, 1978 (MUREAV); oms-sat 200 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 10 mmol/L (-S9) Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 79, p. 464, 1960 (JOBAAY); oms-esc 30 nmol/tube Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 5971, 1982 (PNASA6); dna-esc 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 65 mmol/L/20M Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 150, p. 497, 1959 (PRLBA4); mmo-bcs 5 mmol/L (-S9) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 39, p. 530, 1983 (EXPEAM); mmo-srm 2 gm/L (-S9) Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher information, see ARTODN. v. 28, p. 93, 1971 (ATXKA8); mmo-omi 3500 mg/L (-S9) Proceedings of the Hungarian Annual Meeting for Biochemistry. (Magyar Kemikusok Egyesulete, Anker Koz 1, 1061 Budapest, Hungary) V.1- 1961- v. 18, p. 165, 1978 (PHABDI); dnd-omi 9 gm/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 363, 1981 (CRNGDP); slt-dmg-orl 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 243, 1987 (MUREAV); sln-dmg-orl 1000 ppm/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 219, 1985 (MUREAV); sln-dmg-mul 5000 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 110, p. 49, 1983 (MUREAV); trn-dmg-mul 5000 ppm/3.5H-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 45, p. 355, 1977 (MUREAV); mmo-nsc 5000 ppm/40M (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 63, p. 281, 1969 (GENTAE); mmo-smc 5000 ppm/15M (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 78, p. 1101, 1974 (GENTAE); mrc-smc 20 mmol/L Zeitschrift fuer Vererbungslehre. (Berlin, Fed. Rep. Ger.) V.89-98, 1958-66. For publisher information, see MGGEAE. v. 98, p. 230, 1966 (ZEVBA5); mmo-asn 50 mmol/L (-S9) Revista Brasileira de Genetica. Brazilian Journal of Genetics. (Dr. F.A. Moura Duarte, Dep. de Genetica, Faculdade de Medicina de Ribeirao Preto, 14.100 Ribeirao Preto, Sao Paulo, Brazil) V.1- 1978- v. 9, p. 393, 1986 (RBGED3); mmo-ssp 15300 umol/L (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 14, p. 195, 1976 (CBINA8); slt-slw-par 30 ng/kg Kokuritsu Idengaku Kenkyusho Nenpo. Annual Report of the National Institute of Genetics. (Kokuritsu Idengaku Kenkyusho, 1111 Yata, Mishima, Shizuoka-ken 411, Japan) No. 1- 1949- v. (25), p. 42, 1974 (KIKNAJ); dlt-slw-par 100 umol/kg Nippon Sanshigaku Zasshi. Journal of Sericultural Science of Japan. (Nippon Sanshi Gakkai, 1-2 Owashi, Yatabe-machi, Tsukuba-gun, Ibaraki-ken, Japan) V.1- 1930- v. 46, p. 205, 1977 (NISZAQ); mnt-nml-mul 6 ppm/6D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 164, p. 245, 1986 (MUREAV); mnt-ham-lym 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 205, p. 409, 1988 (MUREAV); dnd-hmn-hla 20 mg Biochemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1962- v. 14, p. 1795, 1975 (BICHAW); dni-hmn-hla 600 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); cyt-hmn-lym 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 205, p. 409, 1988 (MUREAV); sln-hmn-lym 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 205, p. 409, 1988 (MUREAV); dnd-rat-ipr 39 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 175, 1987 (TCMUD8); dns-rat-lvr 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); mnt-mus-ipr 16 mg/kg/48H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); slt-mus-ipr 100 mg/kg/10W Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 75, p. 63, 1980 (MUREAV); dnd-mus-ipr 250 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dna-mus-ast 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dni-mus-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); cyt-mus-ipr 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 75, p. 63, 1980 (MUREAV); dlt-mus-ipr 100 mg/kg/10W-I Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 12(3), p. 163, 1976 (GNKAA5); dlt-mus-par 150 mg/kg "Laboratory Animals in Drug Testing, Symposium of the 5th International Committee on Laboratory Animals, Hanover, 1972," Speigel, A. ed., Stuttgart, Fed. Rep. Ger., Gustav Fischer Verlag, 1973 -,97,1973 (28QFAD); dlt-mus-unr 150 mg/kg Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 1004, 1974 (SOGEBZ); hma-mus-sat 2500 umol/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 19, p. 241, 1977 (CBINA8); mnt-ham-lng 250 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 205, p. 409, 1988 (MUREAV); dnd-ham-ovr 2500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 361, 1982 (MUREAV); cyt-ham-ovr 1297 umol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 432, 1989 (MUTAEX); sce-ham-lng 1 gm/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3270, 1984 (CNREA8); msc-ham-ovr 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 217, 1978 (MUREAV); msc-ham-lng 1 mg/L/1H Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 175, 1980 (CRNGDP); dna-mam-lym 100 mmol/L Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 80, p. 496, 1961 (BIJOAK) RE: T35 ivn-rat TDLo: 340 mg/kg (15D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD) TE: V03-K60 orl-rat TDLo: 3700 mg/kg/81W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); V03-V10 scu-rat TDLo: 800 mg/kg/32W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); V01-T65-A60 ivn-rat TDLo: 85 mg/kg (15D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD) ORNG: 880000000 ng/kg. [880.000000 mg/kg] T/E unlistd SRNL: 600000 nL/kg. [0.600000 mL/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 880 mg/kg Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 31, p. 60, 1949 (JIHTAB); T/E unlistd ihl-rat LCLo: 250 ppm/4H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 31, p. 343, 1949 (JIHTAB); T/E unlistd scu-rat LD50: 350 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); T/E unlistd orl-mus LD50: 647 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-270 (NTIS**); T/E unlistd skn-rbt LD50: 600 uL/kg Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 12/30/1971 (UCDS**) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 277, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 54, p. 213, 1992 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1405, 1999 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 198, 1987 (IMSUDL); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 54, p. 213, 1992 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1405, 1999 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1405, 1999 (IMEMDT) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.03 ppm (0.2 mg/m3), Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL-UNITED KINGDOM: TWA 0.05 ppm (0.32 mg/m3), Skin, Carcinogen. SEP 2000 ND: NOHS 1974: HZD 84284; NIS 4; TNF 116; NOS 11; TNE 1646; NOES 1983: HZD 84284; NIS 4; TNF 86; NOS 3; TNE 2260; TFE 165 SL: EPA GENETOX PROGRAM 1988, Positive: Aspergillus-forward mutation, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, N crassa-reversion; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion, S pombe-reversion; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Inconclusive: Cytogenetics-male germ cell, Mouse specific locus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1064 of 1119 in RTECS (through 2003/06) AN: WS8225000 PN: Sulfuric-acid,-dimethyl-ester- SY: DMS- (methyl sulfate); Dimethyl-monosulfate-; Dimethyl-sulfate-; Dimethyl-sulfate- (ACGIH:OSHA); Dimethyl-sulphate-; Dimethylester-kyseliny-sirove- (Czech); Dimethylsulfaat- (Dutch); Dimethylsulfat- (Czech); Dimetilsolfato- (Italian); Dwumetylowy-siarczan- (Polish); Methyl-sulfate-; Methyle (sulfate de) (French); RCRA-waste-number-U103-; Sulfate-de-methyle- (French); Sulfate-dimethylique- (French) RN: Current: 77-78-1 BRN: 635994 BHR: 4-01-00-01251 UD: 200302 MF: C2-H6-O4-S MW: 126.14 WL: 1OSWO1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 10 mg/24H open SEV AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); eye-rbt 100 mg/4S rinse SEV Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 573, 1982 (FCTOD7); eye-rbt 50 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1079,1986 (85JCAE) ME: mmo-sat 10 umol/plate (+S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 19, p. 241, 1977 (CBINA8); mmo-sat 4300 nmol/L/1H (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 75, p. 4465, 1978 (PNASA6); oms-sat 38 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); mmo-esc 20 umol/L (-S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); oms-esc 2 nmol/tube Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 5971, 1982 (PNASA6); dnr-esc 331 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 145, 1992 (MUREAV); dna-esc 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 65 mmol/L Proceedings of the Royal Society of London, Series B: Biological Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76- 1905- v. 150, p. 497, 1959 (PRLBA4); dnd-bcs 130 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 9, p. 141, 1970 (MUREAV); mmo-omi 1000 ppm/13M (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 67, p. 189, 1971 (GENTAE); mmo-omi 250 ppm (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 8, p. 412, 1972 (SOGEBZ); mmo-omi 2 mmol/L (-S9) Hereditas (Lund, Sweden). (Gjoerloffsgatan 121, S-261 34 Landskrona, Sweden) V.1- 1947- v. 46, p. 279, 1960 (HEREAY); dnr-omi 640 ug/plate Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 95, p. 463, 1976 (BIZNAT); dnd-omi 100 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 14, p. 101, 1976 (CBINA8); dnd-omi 200 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 13, p. 151, 1976 (CBINA8); oms-omi 100 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 14, p. 101, 1976 (CBINA8); slt-dmg-orl 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 243, 1987 (MUREAV); sln-dmg-orl 3800 umol/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 203, p. 1404, 1964 (NATUAS); mmo-nsc 1000 ppm/13M (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 67, p. 189, 1971 (GENTAE); mmo-smc 500 ppm/12M (-S9) Genetics. (Genetics Business Office, POB 64025, Baltimore, MD 21264) V.1- 1916- v. 78, p. 1101, 1974 (GENTAE); mrc-smc 1900 umol/L Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 17, p. 915, 1981 (SOGEBZ); mmo-ssp 590 umol/L (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 14, p. 195, 1976 (CBINA8); dna-hmn-hla 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dnd-hmn-lym 1 mmol/L Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 125, 1982 (JACTDZ); dnd-hmn-fbr 100 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 559, 1983 (CRNGDP); dns-hmn-lym 10 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 1285, 1992 (CRNGDP); dns-hmn-fbr 50 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 559, 1983 (CRNGDP); dns-hmn-hla 400 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 139, p. 155, 1984 (MUREAV); dni-hmn-hla 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); dni-hmn-fbr 75 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 559, 1983 (CRNGDP); cyt-hmn-unr 2 mg/m3 Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 301, 1985 (MUREAV); sce-hmn-fbr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 75, p. 63, 1980 (MUREAV); dnd-rat-ivn 80 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 75, p. 63, 1980 (MUREAV); dnd-rat-lvr 30 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 69, 1987 (MUREAV); dns-rat-lvr 100 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 3, p. 11, 1981 (ENMUDM); bfa-rat-ovr 300 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 263, 1985 (MUREAV); cyt-rat-ipr 350 mg/kg National Academy Science Letters (India). (National Academy of Sciences, India, 5-Lajpatrai Rd., Allahabad 211002, India) V.1- 1978- v. 3, p. 187, 1980 (NASLDX); cyt-rat-ihl 290 ug/m3/16W Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 30(9), p. 38, 1986 (GTPZAB); mnt-mus-ipr 12500 ug/kg/48H-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); dnd-mus-ihl 20 ug/kg Pesticide Biochemistry and Physiology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1971- v. 6, p. 101, 1976 (PCBPBS); dna-mus-ast 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dnd-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 467, p. 83, 2000 (MUREAV); dni-mus-orl 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); dni-mus-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); cyt-mus-ihl 240 ug/m3/10W Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 30(9), p. 38, 1986 (GTPZAB); hma-mus-sat 2500 umol/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 19, p. 241, 1977 (CBINA8); cyt-mus-ast 10 mmol/L Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 88, p. 49, 1970 (BIZNAT); dnd-ham-lng 800 umol/L/1H-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 795, 1980 (CRNGDP); dns-ham-lng 40 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 15, p. 117, 1976 (CBINA8); cyt-ham-lng 50 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 385, 1982 (CRNGDP); sce-ham-lng 10 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 385, 1982 (CRNGDP); msc-ham-ovr 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 217, 1978 (MUREAV); msc-ham-lng 1 mg/L/1H Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 1, p. 175, 1980 (CRNGDP); dna-mus-ipr 30 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 146, p. 155, 1999 (CALEDQ) RE: T35 ivn-rat TDLo: 100 mg/kg (15D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD) TE: V03-D09-P62 ihl-rat TCLo: 17 mg/m3/19W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); V03-V10 scu-rat TDLo: 50 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); V01-T65-A60 ivn-rat TDLo: 20 mg/kg (15D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD) ORNG: 205000000 ng/kg. [205.000000 mg/kg] T/E unlistd IHNG: 45000000 ng/m3/4H. [45.000000 mg/m3/4H] J22-J24-P01 AT: T/E unlistd ihl-hmn LCLo: 97 ppm/10M "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,226,1969 (34ZIAG); T/E unlistd orl-rat LD50: 205 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(3), p. 28, 1979 (GTPZAB); J22-J24-P01 ihl-rat LC50: 45 mg/m3/4H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 24(11), p. 55, 1980 (GTPZAB); T/E unlistd scu-rat LD50: 100 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 241, 1970 (ZEKBAI); T/E unlistd orl-mus LD50: 140 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(3), p. 28, 1979 (GTPZAB); D07-F07-J25 ihl-mus LC50: 280 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 23(3), p. 28, 1979 (GTPZAB); F15 orl-rbt LDLo: 45 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 47, p. 113, 1902 (AEXPBL); F23-R03 scu-rbt LDLo: 53 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 47, p. 113, 1902 (AEXPBL); F23 ivn-rbt LDLo: 50 mg/kg Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC. v. 47, p. 113, 1902 (AEXPBL); T/E unlistd ihl-gpg LC50: 32 ppm/1H "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1079,1986 (85JCAE) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 271, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 575, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 4, p. 271, 1974 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 575, 1999 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 575, 1999 (IMEMDT); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,63,1970 (85CVA2) SR: MSHA STANDARD-air: TWA 1 ppm (5 mg/m3) (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 92, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 1 ppm (5 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 1 ppm (5 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 1 ppm (5 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 1 ppm (5 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 0.1 ppm (0.5 mg/m3), Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-BELGIUM: TWA 0.1 ppm (0.52 mg/m3), Skin, Carcinogen, JAN 1993; OEL-DENMARK: TWA 0.01 ppm (0.05 mg/m3), Skin, JAN 1999; OEL-FINLAND: STEL 0.01 ppm (0.05 mg/m3), Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 0.1 ppm (0.5 mg/m3), C2 Carcinogen, JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-HUNGARY: STEL 0.1 mg/m3, Skin, Carcinogen, JAN 1993; OEL-JAPAN: OEL 0.1 ppm (0.52 mg/m3), Skin, 2A Carcinogen, JAN 1999; OEL-THE NETHERLANDS: TWA 1 ppm (0.5 mg/m3), Skin, Carcinogen, JAN 1999; OEL-NORWAY: TWA 0.01 ppm (0.05 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 0.5 mg/m3, MAC(STEL) 1 mg/m3, JAN 1999; OEL-RUSSIA: TWA 0.1 ppm, STEL 0.1 mg/m3, Skin, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.02 ppm (0.1 mg/m3), Skin, Carcinogen, JAN 1999; OEL-TURKEY: TWA 0.1 ppm (0.5 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: TWA 0.05 ppm (0.26 mg/m3), Skin, Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO DIMETHYL SULFATE-air: 8H CA TWA 0.1 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 26880; NIS 3; TNF 83; NOS 5; TNE 1249; NOES 1983: HZD 26880; NIS 5; TNF 185; NOS 23; TNE 10481; TFE 2455 SL: EPA GENETOX PROGRAM 1988, Positive: Aspergillus-forward mutation, Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-nonhuman; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: In vitro SCE-nonhuman, D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion, S pombe-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-human; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-partial sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Dimethyl sulfate, 2524; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1065 of 1119 in RTECS (through 2003/06) AN: WW2710000 PN: Talc (powder), containing no asbestos fibers SY: Agalite-; Asbestine-; B-13-; B-13- (mineral); B 13(mineral); B-9-; B-9- (talc); Beaver-White-200-; Beaver-White-325-; CP-10-40-; CP-38-33-; CT-8- (mineral); Cimflex-606-; Circron-MP-; Crown-Talc-W-83-; Crown-Talc-Z-; Crystalite-CRS-6002-; Cubic-Master-; Desertalc-57-; EX-IT-; Emtal-500-; Emtal-549-; Emtal-596-; Emtal-599-; FW-XO-; Fibrene-C-400-; Finntalc-C10-; Finntalc-M05-; Finntalc-M15-; Finntalc-P40-; Finntalc-PF-; IT-Extra-; LMR-100-; MP-12-50-; MP-25-38-; MP-40-27-; MP-45-26-; MST-; Micro-Ace-K1-; Micro-Ace-L1-; Micron-White-5000A-; Micron-White-5000P-; Micron-White-5000S-; Microtalco-IT-Extra-; Mistron-139-; Mistron-2SC-; Mistron-RCS-; Mistron-Star-; Mistron-frost-P-; Mistron-super-frost-; Mistron-vapor-; Mussolinite-; Nytal-200-; Nytal-400-; P-3-; P-3- (Mineral); PK-C-; PK-N-; Polytal-4641-; Polytal-4725-; Silicate: talc, containing no asbestos (OSHA); Steawhite-; Supreme-; Supreme-dense-; TY-80-; Talc-; Talc- (ACGIH); Talc,-containing-no-asbestos-fibers-; Talcan-PK-P-; Talcron-CP-44-31-; Talcum- RN: Current: 14807-96-6 Previous: 11119-41-8; 12420-12-1; 37232-12-5; 99638-63-8; 110540-41-5 UD: 200210 MF: H2-03-Si.3/4 Mg MW: 96.33 WL: .MG4.SI-O3*3 CC: Tumorigen (C); Natural-Product (N); Primary-Irritant (S) ID: skn-hmn 300 ug/3D-I MLD "Cutaneous Toxicity, Proceedings of the 3rd Conference, 1976," Drill, V.A., and P. Lazar, eds., New York, Academic Press, Inc. 1977 -,127,1977 (85DKA8) TE: V01-J61-N60 ihl-rat TCLo: 18 mg/m3/6H/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-421, 1993 (NTPTR*); V03-J60 ihl-rat TC :11 mg/m3/1Y-I "Dusts and Disease, Proceedings of the Conference on Occupational Exposures to Fibrous and Particulate Dust and Their Extension into the Environment, 1977," Lemen, R., and J.M. Dement, eds., Park Forest South, IL, Pathotox Pub., 1979 -,389,1979 (43GRAK) MD: J30 ihl-rat TCLo: 17 mg/m3/6H/26D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 49, p. 233, 1989 (ENVRAL); J30 ihl-mus TCLo: 20400 ug/m3/6H/26D-I Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 49, p. 233, 1989 (ENVRAL) TR: ACGIH TLV-TWA 2 mg/m3 (E,R) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 mg/m3 (e, j) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 185, 1987 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 42, p. 185, 1987 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 349, 1987 (IMSUDL) SR: OSHA PEL (Gen Indu): 8H TWA 20 mppcf, respirable dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 20 mppcf, respirable dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 20 mppcf Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 20 mppcf, respirable dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2.5 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 5 mg/m3, JAN 1999; OEL-BELGIUM: TWA 2 mg/m3, JAN 1993; OEL-FINLAND: TWA 5 mg/m3, JAN 1999; OEL-GERMANY: MAK 2 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 2 mg/m3 (resp. dust), JAN 1999; OEL-UNITED KINGDOM: TWA 1 mg/m3, respirable dust, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO TALC (containing no asbestos)-air: 10H 2 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. PHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 71055; NIS 243; TNF 38349; NOS 149; TNE 527353; NOES 1983: HZD X9093; NIS 2; TNF 273; NOS 2; TNE 4245; TFE 590; NOES 1983: HZD 71055; NIS 313; TNF 82650; NOS 192; TNE 1367384; TFE 348973 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (inhal), clear evidence: rat; NCI Carcinogenesis Studies (inhal), no evidence: mouse Record 1066 of 1119 in RTECS (through 2003/06) AN: XH8425000 PN: 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-phenylacetamido)-3,3- dimethyl-7-oxo-, trihydrate, D- (-)- SY: Acillin-; Amcap-; Amcill-; Aminobenzylpencillin-trihydrate-; Aminobenzylpenicillin-trihydrate-; Amperil-; Ampichel-; Ampicillin-trihydrate-; Ampikel-; Ampinova-; Amplin-; Cymbi-; Divercillin-; Lifeampil-; Liffampil-; Morepen-; NCI-C56086-; Pen-A-; Pensyn-; Polycillin-; Princillin-; Principen-; Ro-Ampen-; Ro-ampen-; Trafarbiot-; alpha-Aminobenzylpenicillin-trihydrate- RN: Current: 7177-48-2 UD: 200210 MF: C16-H19-N3-O4-S.3 H2-O MW: 403.50 WL: T45 ANV ESTJ CMVYZR& F1 F1 GVQ &QH 3 CC: Tumorigen (C); Drug (D); Reproductive-Effector (T) RE: T34 orl-rat TDLo: 1500 mg/kg (6-11D preg) Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. v. 18, p. 815, 1973 (ANTBAL); T46 orl-rat TDLo: 2800 mg/kg (7-13D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 3113, 1973 (KSRNAM); T26 orl-mus TDLo: 9100 mg/kg (7-13D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 3113, 1973 (KSRNAM); T46 orl-mus TDLo: 28 gm/kg (7-13D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 7, p. 3113, 1973 (KSRNAM) TE: V03-N61-P61 orl-rat TDLo: 386250 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB87-204160/AS (NTIS**) ORNG: 10000000000 ng/kg. [10000.000000 mg/kg] F11-F18-K12 AT: F11-F18-K12 orl-rat LD50: 10 gm/kg Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. v. 20, p. 653, 1975 (ANTBAL); F11-F18-K12 orl-mus LD50: 15200 mg/kg Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. v. 20, p. 653, 1975 (ANTBAL) MD: K12-U01 orl-rat TDLo: 33600 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-318, 1987 (NTPTR*); P30-S05-U01 ihl-rat TCLo: 5 mg/m3/5H/17W-I Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. v. 20, p. 653, 1975 (ANTBAL); K12-U01 orl-mus TDLo: 33600 mg/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-318, 1987 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 153, 1990 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 153, 1990 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 153, 1990 (IMEMDT) ND: NOHS 1974: HZD 81708; NIS 3; TNF 2339; NOS 4; TNE 5081; NOES 1983: HZD 81708; NIS 4; TNF 861; NOS 13; TNE 13014; TFE 7415 SL: NCI Carcinogenesis Studies (gavage), equivocal evidence: rat; NCI Carcinogenesis Studies (gavage), no evidence: mouse Record 1067 of 1119 in RTECS (through 2003/06) AN: XH9275000 PN: 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxy- acetamido)-, monopotassium salt SY: Apsin-VK-; Beromycin-; Beromycin- (penicillin); Betapen-VK-; Calciopen-K-; Cliacil-; Compocillin-VK-; D-alpha-Phenoxymethylpenicillinate-K-salt-; Distakaps-V-K-; Distaquaine-V-K-; Dowpen-V-K-; Fenoxypen-; Isocillin-; Megacillin-oral-; Oracil-VK-; Orapen-; Ospeneff-; Pedipen-; Pen-V-K-powder-; Pen-Vee-K-; Pen-Vee-K-powder-; Penagen-; Pencompren-; Penicillin-V-potassium-; Penicillin-V-potassium-salt-; Penicillin-VK-; Penicillin-potassium-phenoxymethyl-; Penvikal-; Phenoxymethylpenicillin-potassium-; Potassium-penicillin-V-; Potassium-penicillin-V-salt-; Potassium-phenoxymethylpenicillin-; Primcillin-; Qidpen-VK-; Robicillin-VK-; Rocillin-VK-; Roscopenin-; SK-Penicillin-VK-; Stabillin-VK-syrup-125-; Stabillin VK syrup 62.5; Sumapen-VK-; V-Cillin-K-; Veetids-; Vepen- RN: Current: 132-98-9 UD: 200207 MF: C16-H17-N2-O5-S.K MW: 388.51 WL: T45 ANV ESTJ CMV1OR& F1 F1 GVQ &-KA- CC: Tumorigen (C); Drug (D); Mutagen (M) ME: cyt-hmn-lym 3 gm/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 439, 1989 (MUTAEX); mmo-mus-lym 250 mg/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 103, 1988 (EMMUEG); cyt-ham-ovr 9 gm/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-336, 1988 (NTPTR*); sce-ham-ovr 500 mg/L National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-336, 1988 (NTPTR*) AT: T/E unlistd orl-rat LD50: >1040 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 18, p. 185, 1971 (TXAPA9); T/E unlistd ipr-rat LD50: 1750 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 12, p. 751, 1962 (ARZNAD); T/E unlistd ims-rat LD50: 1124 mg/kg Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001, 00-068 Warsaw 1, Poland) V.25-44, 1973-92. For publisher information, see PJPAE3 v. 29, p. 39, 1977 (PJPPAA); T/E unlistd orl-mus LD50: >4 gm/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 661, 1982 (NIIRDN); T/E unlistd ipr-mus LD50: 1351 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 661, 1982 (NIIRDN); T/E unlistd scu-mus LD50: >4 gm/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 661, 1982 (NIIRDN); T/E unlistd ivn-mus LD50: 1 gm/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 12, p. 751, 1962 (ARZNAD) MD: K30-U01 orl-rat TDLo: 195 gm/kg/13W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 56, p. 123, 1989 (TXCYAC); K30 orl-mus TDLo: 16250 mg/kg/13W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 56, p. 123, 1989 (TXCYAC) ND: NOHS 1974: HZD 82270; NIS 2; TNF 1844; NOS 3; TNE 3026; NOES 1983: HZD 82270; NIS 2; TNF 301; NOS 11; TNE 6483; TFE 3052 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat Record 1068 of 1119 in RTECS (through 2003/06) AN: XL1560000 PN: Thiocyanic-acid,-methylene-ester- SY: CP-17879-; Methylendirhodanid- (Czech); Methylendithiokyanat- (Czech); Methylenebis(thiocyanate); Methylenedirhodanid- (German); Methylene-dithiocyanate- RN: Current: 6317-18-6 BRN: 1743370 BHR: 3-03-00-00288 UD: 200012 MF: C3-H2-N2-S2 MW: 130.19 WL: NCS1SCN CC: Tumorigen (C); Reproductive-Effector (T) RE: T01 orl-rat TDLo: 260 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3381 (NTPTR*) ORNG: 55000000 ng/kg. [55.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 55 mg/kg Developments in Industrial Microbiology. (Soc. for Industrial Microbiology, 1401 Wilson Blvd., Arlington, VA 22209) V.1- 1960- v. 12, p. 404, 1971 (DIMCAL); T/E unlistd ivn-mus LD50: 3600 ug/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#03787 (CSLNX*); F07-J30-L30 skn-rbt LDLo: 398 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0545751 (NTIS**); F12-H02 scu-rbt LDLo: 20 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 150, p. 257, 1930 (AEPPAE) MD: K20-N74-Z01 orl-rat TDLo: 240 mg/kg/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3381 (NTPTR*); D07-P71-Y40 orl-rat TDLo: 520 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3381 (NTPTR*); L70-M70 orl-mus TDLo: 120 mg/kg/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3381 (NTPTR*); J02-K30-L30 orl-mus TDLo: 520 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-94-3381 (NTPTR*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 81675; NIS 8; TNF 159; NOS 3; TNE 1670; NOES 1983: HZD 81675; NIS 26; TNF 1056; NOS 24; TNE 24231; TFE 995 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9235; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-32, October 2000 Record 1069 of 1119 in RTECS (through 2003/06) AN: XO6950000 PN: Thorium-oxide- SY: Thorium-dioxide-; Thortrast-; Thorotrast-; Thoria-; Umbrathor- RN: Current: 1314-20-1 UD: 200302 MF: O2-Th MW: 264.00 CC: Tumorigen (C); Human-Data (P) TE: V01-L60 par-wmn TDLo: 1 gm/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 145, p. 700, 1967 (ANYAA9); V02-L60 unr-hmn TDLo: 2880 mg/kg American Journal of Roentgenology, Radium Therapy and Nuclear Medicine. (Springfield, IL) V.67-125, 1952-75. For publisher information, see AAJRDX. v. 83, p. 163, 1960 (AJRRAV); V01-V10 iat-hmn TDLo: 490 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 145, p. 776, 1967 (ANYAA9); V03-L60 ivn-rat TDLo: 160 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 145, p. 738, 1967 (ANYAA9); V03-V10 scu-mus TDLo: 20 gm/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 1, p. 349, 1940 (JNCIAM); V03-L60-P60 ivn-mus TDLo: 10 gm/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 10, p. 527, 1956 (BJCAAI); V03-P62-R60 ims-mus TDLo: 400 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 22, p. 152, 1962 (CNREA8); V03-P60-V10 ivn-rbt TDLo: 1500 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 145, p. 724, 1967 (ANYAA9); V03-R60-V10 par-gpg TDLo: 4 gm/kg/15W-I American Journal of Cancer. (New York, NY) V.15-40, 1931-40. For publisher information, see CNREA8. v. 35, p. 363, 1939 (AJCAA7); V01-V10 unr-ham TDLo: 2 gm/kg Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 57, p. 431, 1966 (GANNA2); V03-L60-P60 ivn-rbt TD :3600 mg/kg Pathologica et Microbiologia. (Basel, Switzerland) V.23-43, 1960-75. For publisher information, see ECEBDI. v. 25, p. 27, 1962 (PAMIAD); V03-L60-P60 ivn-rbt TD :300 mg(Th)/kg/2Y-I Acta Unio Internationalis Contra Cancrum. (Louvain, Belgium) V.1-20, 1936-64. For publisher information, see IJCNAW. v. 16, p. 425, 1960 (AICCA6); V02-L61-P60 par-hmn TD :700 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 145, p. 676, 1967 (ANYAA9); V02-L61-P60 par-hmn TD :1260 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 145, p. 676, 1967 (ANYAA9); V01-V10 iat-wmn TD :2 gm/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 145, p. 776, 1967 (ANYAA9); V03-J60-L60 ivn-mus TD :10 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 9, p. 253, 1955 (BJCAAI); V01-M61 par-wmn TD :2350 mg/kg European Urology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.1- 1975- v. 3, p. 69, 1977 (EUURAV); V01-L60-P62 iat-man TD :1190 mg/kg Acta Pathologica et Microbiologica Scandinavica. (Copenhagen, Denmark) V.1-77, 1924-69. For publisher information, see ACPADQ. v. 53, p. 147, 1961 (APMIAL); V01-L60-L61 iat-hmn TD :1302 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 41, p. 446, 1980 (BJCAAI) AT: T/E unlistd itr-rat LD50: >1140 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); K13-P05-U25 par-mam TDLo: 8 gm/kg "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 265, 1988 (VCVN1*) ND: NOES 1983: HZD X2987; NIS 14; TNF 146; NOS 9; TNE 2274; TFE 266 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 1070 of 1119 in RTECS (through 2003/06) AN: XO9625000 PN: 3-Thujanone, (1S,4R,5R)-(-)- SY: Bicyclo(3.1.0)hexan-3-one, 4-methyl-1-(1-methylethyl)-, (1S-1-alpha,4-alpha,5-alpha)- (9CI); (-)-3-Isothujone; 3-Thujanone, (-)-; Thujon-; Thujone-; (-)-Thujone; alpha-Thujone-; l-Thujone- RN: Current: 546-80-5 BRN: 4660369 UD: 200012 MF: C10-H16-O MW: 152.26 WL: L35 EVTJ AY1&1 D1 CC: Tumorigen (C); Drug (D) ORNG: 500000000 ng/kg. [500.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 500 mg/kg French Demande Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) #2448856 (FRXXBL); F12 ipr-rat LDLo: 120 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 65, p. 275, 1939 (JPETAB); F12 scu-mus LD50: 2157 ug/kg Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 29, p. 2, 1940 (JAPMA8); F12 scu-rbt LD50: 362 ug/kg Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 29, p. 2, 1940 (JAPMA8); F12 ivn-rbt LD50: 31 ug/kg Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 29, p. 2, 1940 (JAPMA8) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies, selected, October 2000 Record 1071 of 1119 in RTECS (through 2003/06) AN: XP2072000 PN: Thymidine,-3'-azido-3'-deoxy- SY: 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosy)-5-methylpyridimine-2,4-(1H,3H)-dione; 3'-Azido-3'-deoxythymidine-; 3'-Deoxy-3'-azidothymidine-; 3'-azido-3-deoxythimydine-; AZT-; Azidothymidine-; Aziodothymidine-; BW-A-509U-; Retrovir-; ZDV-; Zidovudine- RN: Current: 30516-87-1 UD: 200305 MF: C10-H13-N5-O4 MW: 267.28 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mnt-hmn-lym 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 321, p. 113, 1994 (MUREAV); dni-hmn-lym 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 5829, 1989 (CNREA8); oms-hmn-lym 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 321, p. 113, 1994 (MUREAV); cyt-hmn-lym 100 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 321, p. 113, 1994 (MUREAV); sce-hmn-lym 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 321, p. 113, 1994 (MUREAV); mnt-mus-ipr 170 mg/kg/2W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 368, p. 301, 1996 (MUREAV); cyt-mus-orl 600 mg/kg/3D-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 18, p. 168, 1991 (EMMUEG); cyt-ham-ovr 1 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 321, p. 113, 1994 (MUREAV); sce-ham-ovr 500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 321, p. 113, 1994 (MUREAV); dnd-mus-orl 6000 mg/kg/6D-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 1059, 2000 (CRNGDP) RE: T03-T09 orl-rat TDLo: 4200 mg/kg (4W male) Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 42, p. 1293, 1991 (BCPCA6); T25-T26 orl-rat TDLo: 23 gm/kg (85D male/26D pre-3W post) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 140, 1996 (FAATDF); T34-T72 orl-rat TDLo: 69 gm/kg (85D male/26D pre-3W post) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 140, 1996 (FAATDF); T72 orl-rat TDLo: 27900 mg/kg (26D pre-15D post) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 140, 1996 (FAATDF); T19-T81 orl-rat TDLo: 600 mg/kg (19-22D preg) Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973- v. 64, p. 479, 1999 (PBBHAU); T26-T34 orl-mus TDLo: 910 mg/kg (1-13D preg) Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- v. 36, p. 2370, 1992 (AMACCQ); T19-T81-T85 orl-mky TDLo: 1548 mg/kg (1-172D preg) Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. (Lippincott-Raven Publishers, 227 E. Washington Sq., Philadelphia, PA 19106) V.8- 1995- v. 18, p. 27, 1998 (JDSRET); T41 orl-mky TDLo: 285 mg/kg (9-22W preg) Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. (Lippincott-Raven Publishers, 227 E. Washington Sq., Philadelphia, PA 19106) V.8- 1995- v. 24, p. 100, 2000 (JDSRET); T25 orl-rbt TDLo: 6500 mg/kg (6-18D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 140, 1996 (FAATDF); T85 orl-mus TDLo: 7.4 gm/kg (10-22D preg/10D post) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 529, 2002 (NETEEC); T41-T85 orl-rat TDLo: 100 mg/kg (multigenerations) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 773, 2002 (NETEEC); T85 orl-mus TDLo: 3200 mg/kg (10-19D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 529, 2002 (NETEEC); T86 orl-rat TDLo: 50 mg/kg (multigenerations) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 24, p. 773, 2002 (NETEEC) TE: V02-T65 orl-mus TDLo: 7 gm/kg (12-18D preg) Molecular Carcinogenesis. (John Wiley and Sons, 605 Third Avenue, New York, NY 10158) V.1- 1988- v. 23, p. 45, 1998 (MOCAE8); V03-M61-N60 orl-mus TDLo: 63000 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-145807 (NTIS**); V01-T69 orl-mus TDLo: 31500 mg/kg/105W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB99-145807 (NTIS**) ORNG: 3084000000 ng/kg. [3084.000000 mg/kg] D28-F07 AT: R22 orl-wmn TDLo: 1 gm/kg/6W-I Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 107, p. 350, 1987 (AIMEAS); F12-F27 orl-man LDLo: 86 mg/kg/1W-I Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 1392, 1986 (LANCAO); P20-P25-P26 orl-man TDLo: 434 mg/kg/38D-I Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 107, p. 502, 1987 (AIMEAS); D20 unr-man TDLo: 69 mg/kg Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 114, p. 297, 1991 (AIMEAS); D28-F07 orl-rat LD50: 3084 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 129, 1996 (FAATDF); T/E unlistd ivn-rat LD50: >70 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #4804651 (USXXAM); T/E unlistd unr-rat LD50: >750 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #4857511 (USXXAM); D28-F07 orl-mus LD50: 3062 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 129, 1996 (FAATDF); T/E unlistd ivn-mus LD50: >70 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #4804651 (USXXAM); T/E unlistd unr-mus LD50: >750 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #4857511 (USXXAM); T/E unlistd orl-mus LD50: >750 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #5683990 (USXXAM); T/E unlistd orl-rat LD50: >750 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #5683990 (USXXAM); T/E unlistd ice-mus LD50: 10 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #5547684 (USXXAM) MD: P08-P71 orl-rat TDLo: 54600 mg/kg/1Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 129, 1996 (FAATDF); P05 orl-rat TDLo: 91 gm/kg/26W-I Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 39, p. 595, 1988 (YKYUA6); P08-P26-P71 orl-rat TDLo: 47 gm/kg/94D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 17, p. 159, 1991 (FAATDF); N73-S05-U01 orl-mus TDLo: 90 gm/kg/26W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 42, p. 209, 1998 (TOXID9); L30 orl-mus TDLo: 350 mg/kg/35D-C Hepatology (Baltimore). (Williams and Wilkins Co., Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1981- v. 29, p. 985, 1999 (HPTLD9); P08-P26-P71 orl-mus TDLo: 4700 mg/kg/94D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 17, p. 159, 1991 (FAATDF); P08-P71-P72 orl-mus TDLo: 14500 mg/kg/29D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 17, p. 159, 1991 (FAATDF); M03-P08-P71 ipr-mus TDLo: 6800 mg/kg/17D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 139, p. 324, 1996 (TXAPA9); P14-P17-U01 orl-dog TDLo: 7 gm/kg/2W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 129, 1996 (FAATDF); P05 orl-mky TDLo: 3094 mg/kg/13W-I Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 39, p. 595, 1988 (YKYUA6); P08-P70-P71 orl-mky TDLo: 18200 mg/kg/26W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 129, 1996 (FAATDF); P08-P71-P73 orl-mky TDLo: 12740 mg/kg/1Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 32, p. 129, 1996 (FAATDF); P07-P71 orl-mus TDLo: 6 gm/kg/25D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 55, p. 335, 2000 (TOSCF2); L30-P28-Y37 orl-mus TDLo: 1400 mg/kg/2W-I Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 297, p. 516, 2001 (JPETAB) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 73, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 73, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 76, p. 73, 2000 (IMEMDT) SL: NCI Carcinogenesis Studies (inhal), clear evidence: mouse; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 1072 of 1119 in RTECS (through 2003/06) AN: XP8700000 PN: Tin(II) chloride (1:2) SY: C.I. 77864; Dichlorotin-; Tin-dichloride-; NCI-C02722-; Stannous-chloride-; Stannous-dichloride-; Uniston-CR-HT-200- RN: Current: 7772-99-8 UD: 200302 MF: Cl2-Sn MW: 189.59 WL: SN G2 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: oms-esc 150 nmol/tube LARC Medical. (19 bis, rue d'Inkermann, 59000 Lille, France) V.1- 1981- v. 6, p. 252, 1986 (LAMEDS); pic-esc 50 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); sln-smc 6 mmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 1, p. 21, 1986 (MUTAEX); cyt-mus-ipr 150 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 25, p. 302, 1995 (EMMUEG); cyt-ham-ovr 25 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 25 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) RE: T39 orl-rat TDLo: 300 mg/kg (7-15D preg) Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946- v. 48, p. 247, 1993 (NEZAAQ); T02 itt-rat TDLo: 15167 ug/kg (1D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 7, p. 21, 1964 (JRPFA4) TE: V02-N62 orl-rat TDLo: 44100 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-242553 (NTIS**); V01-L60-P62 orl-rat TDLo: 73500 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-242553 (NTIS**) ORNG: 700000000 ng/kg. [700.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 700 mg/kg Food Research. (Champaign, IL) V.1-25, 1936-60. For publisher information, see JFDSAZ. v. 7, p. 313, 1942 (FOREAE); F07-F12 ipr-rat LD50: 316 mg/kg Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221 005, India) V.1- 1968(?)- v. 23, p. 153, 1991 (INJPD2); T/E unlistd ivn-rat LD50: 17 mg/kg United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) #5015462 (USXXAM); T/E unlistd orl-mus LD50: 250 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 50A, p. 101, 1972 (FAONAU); T/E unlistd ipr-mus LD50: 65598 ug/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 256, p. 1043, 1963 (COREAF); T/E unlistd ivn-mus LD50: 17800 ug/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#02202 (CSLNX*); T/E unlistd orl-dog LDLo: 500 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1420, 1935 (HBAMAK); T/E unlistd scu-dog LDLo: 159 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 1, p. 1, 1975 (EQSSDX); T/E unlistd ivn-dog LDLo: 20 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.) v. 4, p. 1420, 1935 (HBAMAK); T/E unlistd orl-rbt LD50: 10 gm/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 48A, p. 75, 1970 (FAONAU); T/E unlistd orl-gpg LDLo: 60 mg/kg FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued. v. 50A, p. 101, 1972 (FAONAU); F07-F24-U25 scu-gpg LDLo: 400 mg/kg British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 2, p. 217, 1913 (BMJOAE); T/E unlistd unr-mam LD50: 215 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(12), p. 17, 1990 (GISAAA) MD: P08-U01-U09 orl-rat TDLo: 8051 mg/kg/4W-C "Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley and Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979: pub. as 2nd rev. ed. in 1985. 2A,1946,1981 (38MKAJ); P28-Q30-U07 orl-rat TDLo: 190 mg/kg/90D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 9, p. 207, 1981 (TOLED5); L30-Q30-Y10 orl-rat TDLo: 540 mg/kg/90D-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 16, p. 267, 1980 (TXCYAC); L30-P28-Q30 orl-rat TDLo: 95841 ug/kg/3D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 5, p. 275, 1980 (TOLED5); A11-P28-P71 ihl-rat TCLo: 3 mg/m3/24H/5W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 55(12), p. 17, 1990 (GISAAA); K30-U01 orl-mus TDLo: 328 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-231, 1982 (NTPTR*); Z01 ims-mus TDLo: 360 mg/kg/8D-I Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 243, p. 2178, 1956 (COREAF); Z01 ims-rbt TDLo: 240 mg/kg/6D-I Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 243, p. 2178, 1956 (COREAF); Z01 ims-gpg TDLo: 240 mg/kg/6D-I Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 243, p. 2178, 1956 (COREAF); F15-K02-P20 orl-rat TDLo: 6300 mg/kg/4W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 408, 1988 (VCVN1*); A30-M30-T02 orl-rat TDLo: 16800 mg/kg/4W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 410, 1988 (VCVN1*); A30-M30 orl-rat TDLo: 14000 mg/kg/4W-C "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988. v. -, p. 410, 1988 (VCVN1*) TR: ACGIH TLV-TWA 2 mg(Sn)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); TOXICOLOGY REVIEW Food Research. (Champaign, IL) V.1-25, 1936-60. For publisher information, see JFDSAZ. v. 7, p. 313, 1942 (FOREAE) SR: MSHA STANDARD-air: TWA 2 mg(Sn)/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 257, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 2 mg(Sn)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 2 mg(Sn)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 2 mg(Sn)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 2 mg(Sn)/m3 Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2 mg(Sn)/m3, JAN 1993; OEL-AUSTRIA: MAK 2 mg/m3, JAN 1999; OEL-BELGIUM: TWA 2 mg(Sn)/m3, JAN 1993; OEL-DENMARK: TWA 2 mg)Sn)/m3, JAN 1999; OEL-FINLAND: TWA 2 mg(Sn)/m3, JAN 1999; OEL-GERMANY: MAK 2 mg(Sn)/m3, JAN 1999; OEL-HUNGARY: TWA 1 mg(Sn)/m3, STEL 2 mg(Sn)/m3, Skin, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 2 mg(Sn)/m3, JAN 1999; OEL-NORWAY: TWA 2 mg(Sn)/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 2 mg(Sn)/m3, JAN 1993; OEL-POLAND: TWA 2 mg(Sn)/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 2 mg(Sn)/m3, KZG-W 4 mg(Sn)/m3, JAN 1999; OEL-THAILAND: TWA 2 mg(Sn)/m3, JAN 1993; OEL-UNITED KINGDOM: TWA 2 mg(Sn)/m3, STEL 4 mg(Sn)/m3, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 69730; NIS 69; TNF 4037; NOS 43; TNE 50592; NOES 1983: HZD X8590; NIS 1; TNF 17; NOS 1; TNE 645; TFE 645; NOES 1983: HZD 69730; NIS 49; TNF 2435; NOS 40; TNE 43253; TFE 15296 SL: EPA GENETOX PROGRAM 1988, Negative: B subtilis rec assay, TRP reversion; EPA GENETOX PROGRAM 1988, Negative/limited: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 1073 of 1119 in RTECS (through 2003/06) AN: XR2050000 PN: Titanium,-dichloro-di-pi-cyclopentadienyl- SY: Dichlorobis(1,3-cyclopentadiene)titanium; Dichlorobiscyclopentadienyl-titanium-; Dichlorobis(eta(sup 5)-cyclopentadienyl)titanium; Dichlorobis(eta(sup 5)-2,4-cyclopentadien-1-yltitanium); Dichlorobis(pi-cyclopentadienyl)titanium; Dichlorodicyclopentadienyltitanium-; Dichlorodi-pi-cyclopentadienyltitanium-; Dichlorotitanocene-; Dicyclopentadienyldichlorotitanium-; Dicyclopentadienyltitanium-dichloride-; Titanium-ferrocene-; Titanocene-dichloride-; Biscyclopentadienyltitanium-dichloride-; Bis(cyclopentadienyl)dichlorotitanium; Bis(eta(sup 5)-cyclopentadienyl)titanium dichloride; NCI-C04502-; Titanium, dichlorobis(eta(sup 5)-2,4-cyclopentadien-1-yl- (9CI) RN: Current: 1271-19-8 UD: 200302 MF: C10-H10-Cl2-Ti MW: 249.00 WL: L50J 0-TI-GG- 0L50J CC: Tumorigen (C); Mutagen (M); Organometallic (O); Reproductive-Effector (T) ME: mmo-sat 100 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mtr-rat-emb 2960 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); mtr-mus-fbr 800 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); mtr-ham-emb 100 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8) RE: T34 ipr-mus TDLo: 30 mg/kg (10D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 33, p. 171, 1984 (TXCYAC); T43 ipr-mus TDLo: 60 mg/kg (10D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 33, p. 171, 1984 (TXCYAC) TE: V03-K60 orl-rat TDLo: 26 gm/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-399, 1991 (NTPTR*); V02-P62-V10 ims-rat TDLo: 720 mg/kg/2Y-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V02-P62-V10 ims-mus TDLo: 75 mg/kg Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V02-Q60-V10 ims-rat TD :900 mg/kg/2Y-I Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- v. 14, p. 68, 1971 (PWPSA8); V03-P62-V10 ims-rat TD :430 mg/kg/81W-I Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); V03-K60 orl-rat TDLo: 12875 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB92-129576/AS (NTIS**) AT: T/E unlistd ipr-rat LD50: 25 mg/kg Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); F07-F17 ipr-mus LD50: 60 mg/kg Progress Report for Contract No. PH-43-64-886, Submitted to the National Cancer Institute by The Institute of Chemical Biology, University of San Francisco. (San Francisco, CA 94117) PH43-64-886 (NCIUS*); T/E unlistd ivn-mus LD50: 180 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#00774 (CSLNX*) MD: M16-P08-Y15 orl-rat TDLo: 6 gm/kg/14D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-399, 1991 (NTPTR*); G70-N74-U01 orl-rat TDLo: 4030 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-399, 1991 (NTPTR*) SL: EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay, Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Positive/dose response: Cell transform.-BALB/c-3T3; EPA GENETOX PROGRAM 1988, Negative: Host-mediated assay, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (gavage), equivocal evidence: rat Record 1074 of 1119 in RTECS (through 2003/06) AN: XR7400000 PN: Tobacco,-smokeless,-aqueous-extract- SY: Smokeless-tobacco-extract- UD: 200007 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Natural-Product (N) ME: msc-hmn-lym 1 gm/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 927, 1991 (CRNGDP) RE: T25-T34 orl-mus TDLo: 4800 mg/kg (1-16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 40, p. 483, 1989 (TJADAB); T34-T35 scu-mus TDLo: 20480 ug/kg (7-14D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 8, p. 81, 1988 (TCMUD8); T46-T59 scu-mus TDLo: 41 mg/kg (6-13D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 8, p. 81, 1988 (TCMUD8) MD: L30 orl-rat TDLo: 1125 mg/kg/90D-I Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park Forest, IL 60466) V.5(4)- 1984- v. 14, p. 61, 1995 (JEPOEC) SL: NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 1075 of 1119 in RTECS (through 2003/06) AN: XS4725000 PN: p-Toluamide, N-isopropyl-alpha-(2-methylhydrazino)-, monohydrochloride SY: 1-(p-Isopropylcarbamoylbenzyl)-2-methylhydrazine hydrochloride; 1-Methyl-2-(p-isopropylcarbamoylbenzyl)hydrazine hydrochloride; 1-Methyl-2-p-(isopropylcarbamyol)benzohydrazine hydrochloride; 2-(p-(Isopropylcarbamoyl)benzyl)-1-methylhydrazine hydrochloride; Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-, monohydrochloride; Chlorhydrate de 1-methyl 2 p (isopropylcarbamoyl)benzyl-hydrazine (French); IBZ-; Ibenzmethyzin-hydrochloride-; Ibenzmethyzine-hydrochloride-; MBH-; Matulane-; N-Isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride; N-Isopropyl-p-(2-methylhydrazinomethyl)benzamide hydrochloride; NCI-C01810-; NSC-77213-; Natulan-hydrochloride-; PCZ-; Procarbazine-hydrochloride-; Ro-4-6467-; p-(N'-Methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride; p-Toluamide, N-isopropyl-alpha-(2-methylhydrazino)-, hydrochloride RN: Current: 366-70-1 UD: 200207 MF: C12-H19-N3-O.Cl-H MW: 257.80 WL: 1Y1&MVR D1MM1 &GH CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 5 ug/plate (+S9) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 42, p. 179, 1979 (ARTODN); mmo-sat 116 umol/plate (-S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1469, 1981 (CNREA8); mmo-esc 200 mg/L (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 347, 1983 (CRNGDP); dnr-esc 25 ug/plate Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 28, p. 159, 1985 (NULSAK); dnd-esc 25 gm/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 281, p. 507, 1972 (BBACAQ); sln-dmg-orl 130 mg/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 977, 1981 (EVSRBT); mmo-nsc 1 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 246, p. 193, 1991 (MUREAV); mmo-smc 34 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 51, 1979 (MUREAV); mrc-smc 17 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 51, 1979 (MUREAV); mmo-asn 10 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 80, p. 265, 1981 (MUREAV); mtr-rat-emb 9 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dnd-rat-ipr 25 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 563, 1985 (ENMUDM); dni-rat-orl 375 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 275, 1979 (MUREAV); dns-rat-ipr 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 135, 1988 (MUREAV); dni-rat-unr 135 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 6, p. 1059, 1980 (JTEHD6); mnt-mus-unr 12500 ug/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 3, p. 122, 1979 (EESADV); mnt-mus-orl 50 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9, p. 177, 1987 (ENMUDM); mnt-mus-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 411, 1989 (MUREAV); mmo-mus-lym 2500 ug/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 103, 1988 (EMMUEG); slt-mus-unr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); slt-mus-ipr 600 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 86, p. 329, 1981 (MUREAV); dnd-mus-ipr 1550 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 1469, 1981 (CNREA8); dna-mus-ipr 1 gm/kg/5D-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 2191, 1997 (CRNGDP); cyt-mus-unr 100 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 3, p. 122, 1979 (EESADV); cyt-mus-ipr 160 ug/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 977, 1981 (EVSRBT); sce-mus-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 126, p. 47, 1984 (MUREAV); dlt-mus-ipr 100 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 41, p. 287, 1979 (ARTODN); dlt-mus-unr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); msc-mus-unr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); msc-mus-lym 2500 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12(Suppl 13), p. 103, 1988 (EMMUEG); msc-mus-ipr 200 mg/kg/10D-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 18, p. 2191, 1997 (CRNGDP); hma-mus-esc 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 164, p. 19, 1986 (MUREAV); hma-mus-sat 1 mmol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 79, p. 107, 1980 (MUREAV); spm-mus-unr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 74, p. 77, 1980 (MUREAV); mtr-ham-emb 1 mg/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); dnd-ham-kdy 25 gm/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 281, p. 507, 1972 (BBACAQ); sce-ham-unr 10 mg/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 977, 1981 (EVSRBT); msc-ham-ovr 400 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 137, 1984 (MUREAV); msc-ham-oth 560 mg/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 977, 1981 (EVSRBT); msc-mus-lym 100 mg/L Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 977, 1981 (EVSRBT); dna-pig-orl 168 mg/kg/4W-C Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2153, 1992 (CRNGDP); dnd-mus-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); dnd-mus-orl 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV) RE: T35-T47 orl-rat TDLo: 120 mg/kg (9-14D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 381, 1972 (OYYAA2); T25-T26-T42 orl-rat TDLo: 60 mg/kg (1-12D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 161, p. 2127, 1967 (CRSBAW); T27 orl-rat TDLo: 120 mg/kg (1-12D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 161, p. 2127, 1967 (CRSBAW); T41 orl-rat TDLo: 4 mg/kg (13-16D preg) Journal of Comparative Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.75- 1965- v. 101, p. 421, 1989 (JCVPAR); T45-T46-T53 orl-rat TDLo: 360 mg/kg (9-14D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 381, 1972 (OYYAA2); T81 orl-rat TDLo: 30 mg/kg (12-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 32, p. 203, 1985 (TJADAB); T02 ipr-rat TDLo: 800 mg/kg (4W male) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 3, p. 43, 1989 (REPTED); T02-T03 orl-mus TDLo: 2100 mg/kg (30D male) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 365, 1972 (OYYAA2); T26-T27-T41 orl-mus TDLo: 60 mg/kg (7-9D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 163, p. 16, 1969 (CRSBAW); T42-T43-T46 orl-mus TDLo: 60 mg/kg (7-9D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 163, p. 16, 1969 (CRSBAW); T47 orl-mus TDLo: 120 mg/kg (8-13D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 381, 1972 (OYYAA2); T35-T45-T53 orl-mus TDLo: 360 mg/kg (8-13D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 381, 1972 (OYYAA2); T12-T13 orl-mus TDLo: 2100 mg/kg (30D pre) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 365, 1972 (OYYAA2); T24 ipr-mus TDLo: 200 mg/kg (1D male) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 41, p. 287, 1979 (ARTODN); T35 ipr-mus TDLo: 100 mg/kg (1D male) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 41, p. 287, 1979 (ARTODN); T01 ipr-mus TDLo: 400 mg/kg (1D male) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 55, p. 233, 1984 (ARTODN); T46-T55 orl-rbt TDLo: 200 mg/kg (14D preg) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 163, p. 16, 1969 (CRSBAW) TE: V03-P60-R60 orl-rat TDLo: 500 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 40, p. 1027, 1968 (JNCIAM); V01-A60-P62 ipr-rat TDLo: 1170 mg/kg/26W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-19, 1979 (NCITR*); V01-J60-N60 scu-rat TDLo: 300 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 21, p. 155, 1983 (CALEDQ); V03-T65-A60 ivn-rat TDLo: 125 mg/kg (22D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 22, p. 905, 1972 (ARZNAD); V01-J60-P61 orl-mus TDLo: 2 gm/kg/8W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 337, 1969 (JNCIAM); V01-A60-P62 ipr-mus TDLo: 2340 mg/kg/42W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-19, 1979 (NCITR*); V03-P61 ipr-mky TDLo: 4088 mg/kg/5Y-I Bristol-Myers Cancer Symposia. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1979- v. 3, p. 239, 1982 (BCSYDM); V03-P61-Q60 mul-mky TDLo: 3270 mg/kg/69W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2125, 1978 (CNREA8); V01-P62-R60 ipr-rat TD :4680 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V02-J60-P62 ipr-mus TD :1950 mg/kg/26W-I Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); V03-P60-R60 ipr-rat TD :500 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 40, p. 1027, 1968 (JNCIAM); V02-J60-P61 ipr-mus TD :1136 mg/kg/8W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 337, 1969 (JNCIAM); V01-A60-P62 ipr-mus TD :4680 mg/kg/52W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-19, 1979 (NCITR*); V01-A60-P62 ipr-rat TD :2340 mg/kg/26W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-19, 1979 (NCITR*); V03-P61-Q60 mul-mky TD :20 gm/kg/8Y-I Bristol-Myers Cancer Symposia. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1979- v. 3, p. 239, 1982 (BCSYDM); V03-J60-R60 orl-rat TD :1200 mg/kg/14W-C Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 41, p. 106, 1984 (ONCOBS); V02-J60-P61 ipr-mus TD :2560 mg/kg/8W-I Cancer Chemotherapy Reports. (Bethesda, MD) V.1-52, 1959-68. For publisher information, see CTRRDO. v. 39, p. 77, 1964 (CNCRA6); V02-J60-P61 orl-mus TD :2 gm/kg/8W-I Cancer Chemotherapy Reports. (Bethesda, MD) V.1-52, 1959-68. For publisher information, see CTRRDO. v. 39, p. 77, 1964 (CNCRA6) ORNG: 570000000 ng/kg. [570.000000 mg/kg] D17-F17-J22 AT: D17-F17-J22 orl-rat LD50: 570 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 355, 1972 (OYYAA2); T/E unlistd scu-rat LD50: 490 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 720, 1982 (NIIRDN); T/E unlistd ivn-rat LD50: 350 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 20, p. 1467, 1970 (ARZNAD); P14-P17-S05 unr-rat LD50: 785 mg/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 977, 1981 (EVSRBT); T/E unlistd orl-mus LD50: 560 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 4, p. 467, 1973 (IYKEDH); T/E unlistd ipr-mus LD50: 699 mg/kg Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 41, p. 287, 1979 (ARTODN); T/E unlistd scu-mus LD50: 710 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 4, p. 467, 1973 (IYKEDH); T/E unlistd ivn-mus LD50: 540 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 4, p. 467, 1973 (IYKEDH); P14-P17-S05 unr-mus LD50: 1320 mg/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 977, 1981 (EVSRBT); P14-P17-S05 unr-rbt LD50: 145 mg/kg Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- v. 24, p. 977, 1981 (EVSRBT) MD: N73-Z01-Z71 orl-rat TDLo: 2700 mg/kg/5W-I Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 365, 1972 (OYYAA2); P26-U01-Z01 orl-rat TDLo: 1890 mg/kg/27W-I Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 15, p. 1040, 1973 (YAKUD5); N73-Z01-Z71 orl-mus TDLo: 2100 mg/kg/5W-I Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 6, p. 365, 1972 (OYYAA2) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 311, 1981 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 311, 1981 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 327, 1987 (IMSUDL) ND: NOES 1983: HZD X4523; NIS 1; TNF 32; NOS 2; TNE 1328; TFE 289 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: Rodent dominant lethal, Host-mediated assay; EPA GENETOX PROGRAM 1988, Positive: Rodent heritable translocation; EPA GENETOX PROGRAM 1988, Positive: L5178Y cells in vitro-TK test, Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Positive: Mouse spot test, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Mouse specific locus; EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-mouse, Sperm morphology-rabbit; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Weakly Positive: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Weakly Positive: S cerevisiae-homozygosis, S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Positive/dose response: In vivo SCE-nonhuman; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-BALB/c-3T3; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-partial sex chrom. loss; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (ipr), clear evidence: mouse, rat Recent Results in Cancer Research. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1965- v. 52, p. 1, 1975 (RRCRBU); NCI Carcinogenesis Bioassay (ipr), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-19, 1979 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1076 of 1119 in RTECS (through 2003/06) AN: XS5250000 PN: Toluene- SY: Antisal-1a-; Benzene,-methyl-; CP-25-; Methacide-; Methane,-phenyl-; NCI-C07272-; Phenylmethane-; RCRA-waste-number-U220-; Methylbenzene-; Methylbenzol-; Tolueen- (Dutch); Toluen- (Czech); Tolueno- (Spanish); Toluol-; Toluolo- (Italian); Tolu-Sol-; Toluene- (ACGIH:OSHA) RN: Current: 108-88-3 UD: 200305 MF: C7-H8 MW: 92.15 WL: 1R CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-hmn 300 ppm Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 282, 1943 (JIHTAB); skn-rbt 435 mg MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 7/23/1970 (UCDS**); skn-rbt 500 mg MOD Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 563, 1982 (FCTOD7); skn-rbt 20 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,29,1986 (85JCAE); eye-rbt 870 ug MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 7/23/1970 (UCDS**); eye-rbt 2 mg/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,29,1986 (85JCAE); eye-rbt 100 mg/30S rinse MLD Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 20, p. 573, 1982 (FCTOD7); skn-pig 250 uL/24H MLD Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 161, p. 1, 2001 (TXCYAC) ME: dns-esc 1 pph Journal of Bacteriology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1916- v. 137, p. 397, 1979 (JOBAAY); dns-omi 1 pph/15M-C Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 12, p. 1195, 1973 (JOVIAM); sln-dmg-orl 1 pph Contaminacion Ambiental. (Centro de Ciencias de la Atmosfera, Universidad Nacional Autonoma de Mexico, 04510 Mexico City, Mexico) V.1- 1985- v. 1, p. 35, 1985 (CONAEL); oms-grh-ihl 20 pph/16H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 467, 1983 (MUREAV); dnd-rat-lvr 30 umol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); cyt-rat-ihl 5400 ug/m3/16W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(7), p. 33, 1981 (GTPZAB); cyt-rat-scu 9600 mg/kg/12D-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(10), p. 36, 1972 (GISAAA); mnt-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 294, 1985 (MUREAV); mnt-mus-ipr 433 ug/kg/24H Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 106, 1985 (ARTODN); sce-hmn-ihl 252 ug/L/19Y Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 519, p. 171, 2002 (MUREAV) RE: T34 orl-rat TDLo: 7280 mg/kg (6-19D preg) Pediatric Research. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1967- v. 36, p. 811, 1994 (PEREBL); T81-T83 orl-rat TDLo: 9100 mg/kg (6-19D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 12, p. 119, 1998 (REPTED); T86 orl-rat TDLo: 16 mL/kg (6-21D preg) Pediatric Research. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1967- v. 47, p. 362, 2000 (PEREBL); T34-T46 ihl-rat TCLo: 1500 mg/m3/24H (1-8D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 11, p. 55, 1978 (TXCYAC); T46 ihl-rat TCLo: 1000 mg/m3/24H (7-14D preg) Folia Morphologica (Prague). (Plenum Pub. Corp. 233 Spring St., New York, NY 10013) V.13- 1965- v. 28, p. 286, 1980 (FMORAO); T19-T86 ihl-rat TCLo: 2000 ppm/6H (7-17D preg) Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 20, p. 109, 1995 (JTSCDR); T34-T85 ihl-rat TCLo: 800 mg/m3/6H (14-20D preg) Brazilian Journal of Medical and Biological Research. (Associacao Brasileira de Divulgacao Cientifica, Faculdade de Medicina de Ribeirao Preto, USP, 141000 Ribeirao Preto, SP, Brazil) V.14- 1981- v. 23, p. 533, 1990 (BJMRDK); T91 ihl-rat TCLo: 1200 ppm/6H (9-12D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 71, p. 258, 1997 (ARTODN); T35 orl-mus TDLo: 9 gm/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 41A, 1979 (TJADAB); T34 orl-mus TDLo: 15 gm/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 41A, 1979 (TJADAB); T43 orl-mus TDLo: 30 gm/kg (6-15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 41A, 1979 (TJADAB); T34 ihl-mus TCLo: 500 mg/m3/24H (6-13D preg) Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 11, p. 55, 1978 (TXCYAC); T46 ihl-mus TCLo: 1000 ppm/6H (2-17D preg) Tokai Journal of Experimental and Clinical Medicine. (Tokai Univ. Press, Shinjuku Toka Bldg., 3-27-4 Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1976- v. 7, p. 265, 1982 (TJEMDR); T46-T83 ihl-mus TCLo: 400 ppm/7H (7-16D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 145, 1986 (FAATDF); T53 ihl-mus TCLo: 200 ppm/7H (7-16D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 6, p. 145, 1986 (FAATDF); T27 ihl-rbt TCLo: 1 gm/m3/24H (7-20D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 425, 1985 (ATSUDG); T47 ihl-rbt TDLo: 100 ppm/6H (6-18D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 66, p. 373, 1992 (ARTODN); T85 ihl-ham TCLo: 800 mg/m3/6H (6-11D preg) Brazilian Journal of Medical and Biological Research. (Associacao Brasileira de Divulgacao Cientifica, Faculdade de Medicina de Ribeirao Preto, USP, 141000 Ribeirao Preto, SP, Brazil) V.14- 1981- v. 23, p. 533, 1990 (BJMRDK); T34-T35 ihl-rat TCLo: 6000 mg/m3 (4D preg) "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 145, 1990 (VCVGH*); T34-T35 ihl-rat TCLo: 6000 mg/m3 (21D preg) "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 145, 1990 (VCVGH*); T43 orl-mus TDLo: 8700 mg/kg (6-15D preg) "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 145, 1990 (VCVGH*); T41-T81 ihl-rat TCLo: 1800 ppm (7-20D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 75, p. 103, 2001 (ARTODN) ORNG: 636000000 ng/kg. [636.000000 mg/kg] T/E unlistd SRNL: 14100000 nL/kg. [14.100000 mL/kg] T/E unlistd IHNG: 49000000000 ng/m3/4H. [49000.000000 mg/m3/4H] T/E unlistd AT: G30-J15-L30 orl-man LDLo: 719 uL/kg Forensic Science International. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.12- 1978- v. 41, p. 255, 1989 (FSINDR); T/E unlistd orl-hmn LDLo: 50 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 883, 1980 (YAKUD5); A11-F25-P26 ihl-hmn TCLo: 200 ppm JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 123, p. 1106, 1943 (JAMAAP); F08-F17-F42 ihl-man TCLo: 100 ppm Work, Environment, Health. (Helsinki, Finland) V.1-11, 1962-74. For publisher information, see SWEHDO. v. 9, p. 131, 1972 (WEHRBJ); T/E unlistd orl-rat LD50: 636 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 2, p. 567, 1981 (NRTXDN); T/E unlistd ihl-rat LC50: 49 gm/m3/4H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 23, 1988 (GTPZAB); T/E unlistd ipr-rat LD50: 1332 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); T/E unlistd ivn-rat LD50: 1960 mg/kg Medicina del Lavoro. Industrial Medicine. (Via S. Barnaba, 8, 20122 Milan, Italy) V.16- 1925- v. 54, p. 486, 1963 (MELAAD); T/E unlistd unr-rat LD50: 6900 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(12), p. 64, 1980 (GISAAA); T/E unlistd ihl-mus LC50: 400 ppm/24H Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 2, p. 567, 1981 (NRTXDN); T/E unlistd ipr-mus LD50: 59 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 2, p. 567, 1981 (NRTXDN); T/E unlistd scu-mus LD50: 2250 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 8, p. 237, 1987 (NRTXDN); T/E unlistd unr-mus LD50: 2 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(12), p. 64, 1980 (GISAAA); T/E unlistd ihl-rbt LCLo: 55000 ppm/40M Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 26, p. 69, 1944 (JIHTAB); T/E unlistd skn-rbt LD50: 14100 uL/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 30, p. 470, 1969 (AIHAAP); T/E unlistd ivn-rbt LDLo: 130 mg/kg Haematologica. (Il Pensiero Scientifico Editore, Via Panama 48, I-00198, Rome, Italy) V.1- 1920- v. 58, p. 491, 1973 (HAEMAX); F01-F07-F33 ihl-gpg LCLo: 1600 ppm Journal of Industrial Hygiene. (Cambridge, MA) V.1-17, 1919-35. For publisher information, see AEHLAU. v. 10, p. 261, 1928 (JIDHAN); T/E unlistd ipr-gpg LD50: 500 mg/kg Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- v. 2, p. 567, 1981 (NRTXDN); E08-F12-F17 scu-frg LDLo: 920 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 130, p. 250, 1928 (AEPPAE); T/E unlistd orl-mam LD50: 4 gm/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); T/E unlistd ihl-mam LC50: 30 gm/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); F23-J30 ipr-mam LDLo: 1750 mg/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 7, p. 276, 1927 (AJHYA2); A30-E08-E16 ihl-rat TCLo: 1000 ppm/6H Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 22, p. 603, 2001 (NETEEC); P28-Y37 orl-rbt TDLo: 500 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 25, p. 87, 1988 (JTEHD6) MD: D44-U01 orl-rat TDLo: 42380 mg/kg/49D-I Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 10, p. 525, 1989 (NETEEC); M13-M16 orl-rat TDLo: 27645 mg/kg/3W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 5, p. 62, 1985 (TOXID9); A70-L70-M70 orl-rat TDLo: 162 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-371, 1990 (NTPTR*); M30-U01-Z01 ihl-rat TCLo: 1600 ppm/20H/7D-I American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 7, p. 276, 1927 (AJHYA2); M70-U01-Y15 ihl-rat TCLo: 12000 ppm/10M/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 61, p. 302, 1981 (TXAPA9); P08-P30-U01 ihl-rat TCLo: 300 ppm/6H/2Y-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 315, 1983 (FAATDF); G70-L70-M70 ihl-rat TCLo: 2500 ppm/6.5H/15W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-371, 1990 (NTPTR*); A30-M30-Y64 ihl-rat TCLo: 1500 ppm/6H/26W-I Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 68, p. 384, 1991 (PHTOEH); A70-U01-Y37 ihl-rat TCLo: 320 ppm/24H/30D-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 45, p. 123, 1987 (TXCYAC); D44-F41 scu-rat TDLo: 10500 mg/kg/7D-I Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 8, p. 103, 1986 (NTOTDY); D07 ihl-rat TCLo: 300 mg/m3/5H/21D-I Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 13, p. 365, 1980 (BCTKAG); F19-Q30-U01 ihl-rat TCLo: 2200 ppm/8H/23W-I Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 13, p. 387, 1991 (NETEEC); M16-Y03-Y15 ipr-rat TDLo: 11058 ug/kg/30D-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 9, p. 479, 1993 (TIHEEC); A70-L70-M70 orl-mus TDLo: 227 gm/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-371, 1990 (NTPTR*); L70-N74-S05 orl-mus TDLo: 2940 mg/kg/4W-C Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 49, p. 93, 1989 (ENVRAL); L70-M70-U01 ihl-mus TCLo: 12000 ppm/10M/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 61, p. 302, 1981 (TXAPA9); L70-Z01 ihl-mus TCLo: 1250 ppm/6H/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-371, 1990 (NTPTR*); F07-P71-P72 ihl-mus TCLo: 1000 ppm/6H/20D-I Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- v. 2, p. 363, 1977 (JTSCDR); P70-P72 orl-mus TDLo: 8400 mg/kg/14D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 17, p. 317, 1994 (DCTODJ); F23 ihl-rbt TCLo: 50 mg/m3/4H/26W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(9), p. 105, 1967 (GISAAA); T01 ihl-rat TCLo: 6000 ppm/2H/5W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 139, p. 193, 1999 (TXCYAC); N12-Y61 ihl-rat TCLo: 500 ppm/6H/3D-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 5, p. 393, 1980 (TOLED5); R10 skn-rbt TCLo: 217 mg/kg/2D-C "Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances: Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990. v. -, p. 148, 1990 (VCVGH*); A30 orl-mus TDLo: 95.2 mg/kg/4W-C Immunopharmacology. (New York, Elsevier/North-Holland) V. 1-49, 1978-2000 v. 21, p. 23, 1991 (IMMPH*); N12 orl-mus TDLo: 1134 mg/kg/14D-C Immunopharmacology. (New York, Elsevier/North-Holland) V. 1-49, 1978-2000 v. 21, p. 23, 1991 (IMMPH*); P27-S02 orl-mus TDLo: 2268 mg/kg/4W-C Immunopharmacology. (New York, Elsevier/North-Holland) V. 1-49, 1978-2000 v. 21, p. 23, 1991 (IMMPH*) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 50 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 47, p. 79, 1989 (IMEMDT); IARC Cancer Review: Animal No Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 829, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 47, p. 79, 1989 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 829, 1999 (IMEMDT); IARC Cancer Review: Group3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 829, 1999 (IMEMDT); TOXICOLOGY REVIEW Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 22, p. 373, 1971 (AEHLAU); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 11, p. 549, 1977 (CTOXAO); TOXICOLOGY REVIEW Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see FSINDR. v. 2, p. 67, 1973 (FNSCA6); TOXICOLOGY REVIEW Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 47, p. 75, 1978 (MUREAV); TOXICOLOGY REVIEW Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. v. 11(5), p. 549, 1977 (CTOXAO); TOXICOLOGY REVIEW Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 6(1), p. 77, 1987 (JACTDZ); TOXICOLOGY REVIEW Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 4, p. 49, 1988 (TIHEEC); TOXICOLOGY REVIEW Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher information, see NETEEC. v. 3, p. 407, 1981 (NTOTDY) SR: MSHA STANDARD-air: TWA 100 ppm (375 mg/m3) (skin) "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. v. 3, p. 29, 1973 (DTLWS*); OSHA PEL (Gen Indu): 8H TWA 200 ppm;CL 300;Pk 500/10M Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 200 ppm (750 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 200 ppm (750 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 200 ppm (750 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 100 ppm (375 mg/m3), STEL 150 ppm, JAN 1993; OEL-AUSTRIA: MAK 100 ppm (380 mg/m3), JAN 1999; OEL-BELGIUM: TWA 100 ppm (377 mg/m3), STEL 150 ppm (565 mg/m3), JAN 1993; OEL-DENMARK: TWA 35 ppm (130 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 100 ppm (375 mg/m3), STEL 150 ppm, Skin, JAN 1999; OEL-FRANCE: VME 100 ppm (375 mg/m3), VLE 150 ppm (550 mg/m3), JAN 1999; OEL-GERMANY: MAK 50 ppm (190 mg/m3), JAN 1999; OEL-HUNGARY: TWA 100 mg/m3, STEL 300 mg/m3, Skin, JAN 1993; OEL-JAPAN: OEL 50 ppm (188 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 40 ppm (150 mg/m3), JAN 1999; OEL-NORWAY: TWA 25 ppm (94 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 100 ppm (375 mg/m3), JAN 1993; OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 350 mg/m3, JAN 1999; OEL-RUSSIA: TWA 100 ppm, STEL 50 mg/m3, JAN 1993; OEL-SWEDEN: NGV 50 ppm (200 mg/m3), TKV 100 ppm (400 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (190 mg/m3), KZG-W 250 ppm (950 mg/m3), JAN 1999; OEL-THAILAND: TWA 200 ppm, STEL 300 ppm, JAN 1993; OEL-TURKEY: TWA 200 ppm (750 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 50 ppm (191 mg/m3), STEL 150 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO TOLUENE-air: 10H TWA 100 ppm, STEL 150 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 73300; NIS 412; TNF 125516; NOS 206; TNE 1589482; NOES 1983: HZD 73300; NIS 399; TNF 128510; NOS 232; TNE 2015881; TFE 391255 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/2000/108028); EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE, In vitro SCE-human; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Toluene in blood, 8002; NIOSH Analytical Method, 1994: Hydrocarbons, BP 36-126 degree C, 1500; NIOSH Analytical Method, 1994: Hydrocarbons, aromatic, 1501; NIOSH Analytical Method, 1994: Toluene (passive), 4000; NCI Carcinogenesis Studies (inhal), no evidence: mouse, rat; OSHA ANALYTICAL METHOD #111 Record 1077 of 1119 in RTECS (through 2003/06) AN: XS9093000 PN: Toluene,-alpha-chloro-p-nitro- SY: Benzene, 1-(chloromethyl)-4-nitro- (9CI); p-(Chloromethyl)nitrobenzene; 1-(Chloromethyl)-4-nitrobenzene; 4-(Chloromethyl)nitrobenzene; alpha-Chloro-p-nitrotoluene-; p-Nitrobenzyl-chloride- RN: Current: 100-14-1 UD: 199710 MF: C7-H6-Cl-N-O2 MW: 171.59 WL: WNR D1G CC: Mutagen (M) ME: mmo-sat 5 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 170, p. 11, 1986 (MUREAV); mmo-sat 100 ug/plate (-S9) NTP Technical Bulletin. (National Toxicology Program, Landow Bldg. 3A-06, 7910 Woodmont Ave., Bethesda, MD 20205) APR1982 (NTPTB*); dnr-bcs 50 ug/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 170, p. 11, 1986 (MUREAV); sce-ham-ovr 100 umol/L JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 3, p. 203, 1983 (JJATDK) ORNG: 1809000000 ng/kg. [1809.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1809 mg/kg Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 3, p. 265, 1991 (INHTE5); T/E unlistd ihl-rat LCLo: 280 mg/m3/4H Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 4, p. 66, 1984 (TOXID9) MD: U01-Y15 ihl-rat TCLo: 20 mg/m3/6H/2W-I Inhalation Toxicology. (Published by Taylor and Francis Health, 11 New Fetter Lane, London EC4P 4EE) V.1- 1989- v. 3, p. 265, 1991 (INHTE5) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 Record 1078 of 1119 in RTECS (through 2003/06) AN: XS9145000 PN: Toluene,-p-chloro-alpha,alpha,alpha-trifluoro- SY: Benzene, 1-chloro-4-(trifluoromethyl)- (9CI); p-Chlorobenzotrifluoride-; (p-Chlorophenyl)trifluoromethane; p-Chlorotrifluoromethylbenzene-; 1-Chloro-4-(trifluoromethyl)benzene; p-Chloro-alpha,alpha,alpha-trifluorotoluene-; alpha,alpha,alpha-Trifluoro-4-chlorotoluene-; p-(Trifluoromethyl)chlorobenzene; p-Trifluoromethylphenyl-chloride- RN: Current: 98-56-6 Previous: 92709-16-5 BRN: 510203 BHR: 4-05-00-00815 UD: 200012 MF: C7-H4-Cl-F3 MW: 180.56 CC: Tumorigen (C); Mutagen (M) ME: dns-hmn-emb 1 gm/L Annali dell'Istituto Superiore di Sanita. (Istituto Poligrafico e Zecca dello Stato, Piazza Verdi, 10 Rome, Italy) V.1- 1965- v. 18, p. 123, 1982 (AISSAW) ORNG: 13000000000 ng/kg. [13000.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 13 gm/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 28(5), p. 49, 1984 (GTPZAB); T/E unlistd ihl-rat LC50: 22 gm/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 28(5), p. 49, 1984 (GTPZAB); T/E unlistd orl-mus LD50: 11500 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 28(5), p. 49, 1984 (GTPZAB); T/E unlistd ihl-mus LC50: 20 gm/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 28(5), p. 49, 1984 (GTPZAB) MD: L70-M70-P28 orl-rat TDLo: 5600 mg/kg/14D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 460, 1992 (FAATDF); L70-M70-P28 orl-rat TDLo: 28 gm/kg/28D-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 781, 1987 (FCTOD7); P28-P71-Y01 ihl-rat TCLo: 440 mg/m3/24H/17W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 51(10), p. 82, 1986 (GISAAA); P28-U07-Y40 ihl-rat TCLo: 500 ppm/6H/4W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0570838 (NTIS**); L30-L70 ihl-rat TCLo: 250 ppm/6H/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0557557 (NTIS**); L70-P28-Y37 orl-mus TDLo: 14 gm/kg/14D-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 18, p. 460, 1992 (FAATDF) SR: OEL-RUSSIA: STEL 20 mg/m3, Skin, JAN 1993 ND: NOHS 1974: HZD 84021; NIS 1; TNF 5; NOS 2; TNE 20 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0493-8771; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-14, October 2000 Record 1079 of 1119 in RTECS (through 2003/06) AN: XS9625000 PN: Toluene-2,4-diamine- SY: 3-Amino-p-toluidine-; 5-Amino-o-toluidine-; 1,3-Benzenediamine,-4-methyl-; Benzofur-MT-; C.I. 76035; C.I. Oxidation Base 20; C.I. Oxidation Base 35; C.I. Oxidation Base 200; Developer-14-; Developer-B-; Developer-DB-; Developer-DBJ-; Developer-MC-; Developer-MT-; Developer-MT-CF-; Developer-MTD-; Developer-T-; 1,3-Diamino-4-methylbenzene-; 2,4-Diamino-1-methylbenzene-; 2,4-Diaminotoluen- (Czech); 2,4-Diaminotoluene-; 2,4-Diamino-1-toluene-; 2,4-Diaminotoluol-; Eucanine-GB-; Fourrine-94-; Fourrine-M-; Fouramine-; Fouramine-J-; MTD-; Nako-TMT-; NCI-C02302-; Pelagol-Grey-J-; Pelagol-J-; Pontamine-developer-TN-; RCRA-waste-number-U221-; Renal-MD-; TDA-; Tertral-G-; 2,4-Tolamine-; m-Toluenediamine-; Brown-for-Fur-T-; 4-Methyl-1,3-benzenediamine-; 4-Methyl-m-phenylenediamine-; m-Toluylendiamin- (Czech); Tolylene-2,4-diamine-; 2,4-Tolylenediamine-; m-Toluylenediamine-; m-Tolyenediamine-; m-Tolylenediamine-; Zoba-GKE- RN: Current: 95-80-7 BRN: 2205839 BHR: 4-13-00-00235 UD: 200302 MF: C7-H10-N2 MW: 122.19 WL: ZR CZ D1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,477,1986 (85JCAE); eye-rbt 100 mg/24H MOD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,477,1986 (85JCAE); eye-rbt 100 mg/24H Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health Organization) 1- 1976- v. IP:74, p. 1, 1987 (TAEHC*); skn-rbt 500 mg/24H Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health Organization) 1- 1976- v. IP:75, p. 1, 1987 (TAEHC*) ME: mmo-sat 10 mg/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 5(Suppl 1), p. 3, 1983 (ENMUDM); mmo-sat 10 ug/plate (-S9) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 76, p. 291, 1986 (JJIND8); oms-sat 60 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); pic-esc 100 mmol/L Medycyna Doswiadczalna i Mikrobiologia. For English translation, see EXMMAV. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1949- v. 31, p. 11, 1979 (MDMIAZ); sln-dmg-par 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 56, p. 31, 1977 (MUREAV); sln-dmg-orl 15200 mmol/L/3D Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 181, 1977 (MUREAV); dnd-hmn-fbr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 127, p. 107, 1984 (MUREAV); dns-hmn-lvr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 1075, 1989 (CNREA8); mnt-rat-orl 300 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 2233, 1991 (CRNGDP); dna-rat-orl 84 mg/kg/3W-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 367, p. 209, 1996 (MUREAV); dnd-rat-ipr 37 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1285, 1985 (CRNGDP); dns-rat-orl 150 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 553, 1982 (ENMUDM); dns-rat-lvr 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 315, p. 147, 1994 (MUREAV); bfa-rat-sat 70 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 76, p. 291, 1986 (JJIND8); dnd-mus-ipr 240 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 391, p. 201, 1997 (MUREAV); dnd-mus-orl 60 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 440, p. 1, 1999 (MUREAV); dni-mus-ipr 111 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 91, p. 75, 1981 (MUREAV); sce-mus-ipr 9 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 108, p. 225, 1983 (MUREAV); msc-mus-lym 198 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 115, 1984 (MUREAV); mtr-ham-emb 500 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 3, p. 45, 1977 (CALEDQ); oms-ham-ovr 6 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 45, 1992 (MUREAV); cyt-ham-ovr 4 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 265, p. 45, 1992 (MUREAV); msc-ham-ovr 2 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 115, 1984 (MUREAV); mtr-mus-fbr 10 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T21 orl-rat TDLo: 1260 mg/kg (10W male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 16, p. 753, 1985 (JTEHD6); T01-T03 orl-rat TDLo: 1260 mg/kg (10W male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 16, p. 763, 1985 (JTEHD6); T01-T02 orl-rat TDLo: 210 mg/kg (1W male) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 25, p. 435, 1988 (JTEHD6); T26-T72 orl-mus TDLo: 1200 mg/kg (6-13D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 29, 1987 (TCMUD8) TE: V01-L60-R60 orl-rat TDLo: 2100 mg/kg/90W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 1107, 1979 (JJIND8); V01-L60-P62 orl-mus TDLo: 8050 mg/kg/101W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-162, 1979 (NCITR*); V01-L60-P62 orl-mus TD :17 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-162, 1979 (NCITR*); V01-L60-P62 orl-rat TD :5030 mg/kg/84W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-162, 1979 (NCITR*); V01-L60 orl-rat TD :9000 mg/kg/36W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 29, p. 1137, 1969 (CNREA8); V01-L60 orl-mus TD :8400 mg/kg/2Y-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 70, p. 453, 1979 (GANNA2); V01-L60 orl-mus TD :16800 mg/kg/2Y-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 70, p. 453, 1979 (GANNA2) AT: T/E unlistd ipr-rat LD50: 325 mg/kg Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(1-2), p. 149, 1979 (JEPTDQ); F07-G08-J26 scu-rat LDLo: 350 mg/kg Zeitschrift fuer Experimentelle Pathologie und Therapie. (Berlin, Ger.) V.1-22, 1905-21. For publisher information, see REXMAS. v. 17, p. 59, 1915 (ZEPTAT); T/E unlistd ipr-mus LD50: 480 mg/kg Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 3(1-2), p. 149, 1979 (JEPTDQ); T/E unlistd scu-dog LDLo: 200 mg/kg U.S. Public Health Service, Public Health Bulletin. (Washington, DC) v. 271, p. 56, 1941 (XPHBAO); A30-F12-J26 scu-rbt LDLo: 400 mg/kg Zeitschrift fuer Experimentelle Pathologie und Therapie. (Berlin, Ger.) V.1-22, 1905-21. For publisher information, see REXMAS. v. 17, p. 59, 1915 (ZEPTAT); T/E unlistd orl-rat LD50: 590 mg/kg/24H Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health Organization) 1- 1976- v. -, p. 1, 1987 (TAEHC*); T/E unlistd skn-rbt LD50: 650 mg/kg/24H Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health Organization) 1- 1976- v. -, p. 1, 1987 (TAEHC*) MD: M30-Z01 orl-rat TDLo: 36500 mg/kg/2Y-I Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health Organization) 1- 1976- v. -, p. 1, 1987 (TAEHC*); T01-T02-T03 orl-rat TDLo: 1050 mg/kg/70D -C Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health Organization) 1- 1976- v. IP:74, p. 67, 1987 (TAEHC*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 16, p. 83, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 16, p. 83, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-POLAND: MAC(TWA) 0.04 mg/m3, MAC(STEL) 0.1 mg/m3, JAN 1999; OEL-RUSSIA: STEL 2 mg/m3, Skin, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1993; OEL-SWITZERLAND: MAK-W 0.1 mg/m3, Carcinogen, JAN 1999 ND: NIOSH REL TO TOLUENEDIAMINE-air: CA lowest feasible concentration National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X5386; NIS 6; TNF 130; NOS 15; TNE 8511; TFE 396 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Negative: N crassa-aneuploidy, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Inconclusive: SHE-clonal assay; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, PROPOSED RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 27009, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH CURRENT INTELLIGENCE BULLETIN 53, DECEMBER 1989; NIOSH Analytical Method, 1994: 2, 4-Toluenediamine, 5516; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-162, 1979 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Carcinogenesis studies, test completed (peer review), October 2000; OSHA ANALYTICAL METHOD #ID-65 Record 1080 of 1119 in RTECS (through 2003/06) AN: XT0370000 PN: Toluene-2,6-diamine,-dihydrochloride- SY: 1,3-Benzenediamine,-2-methyl-,-dihydrochloride-; 2,6-Diaminotoluene-dihydrochloride-; NCI-C50317- RN: Current: 15481-70-6 UD: 200012 MF: C7-H10-N2.2 Cl-H MW: 195.11 WL: ZR CZ B1 &GH 2 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 10 ug/plate (-S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); mnt-mus-ipr 93750 ug/kg/3D-C Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 21, p. 160, 1993 (EMMUEG); msc-mus-lym 200 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-ovr 250 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); cyt-ham-lng 250 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 241, p. 175, 1990 (MUREAV); sce-ham-ovr 50 mg/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS) AT: T/E unlistd orl-rat LDLo: 1 gm/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NCI-TR-200, 1980 (NTPTR*); T/E unlistd orl-mus LDLo: 100 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NCI-TR-200, 1980 (NTPTR*) MD: N05-P26 orl-rat TDLo: 54600 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NCI-TR-200, 1980 (NTPTR*); Z01 orl-mus TDLo: 5040 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NCI-TR-200, 1980 (NTPTR*) SL: EPA GENETOX PROGRAM 1988, Negative: Carcinogenicity-mouse/rat; NCI Carcinogenesis Bioassay (feed), no evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-200, 1980 (NCITR*); NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1081 of 1119 in RTECS (through 2003/06) AN: XT2975000 PN: Toluene,-m-nitro- SY: 1-Methyl-3-nitrobenzene-; 3-Methylnitrobenzene-; 3-Nitrotoluene-; 3-Nitrotoluol-; Benzene,-1-methyl-3-nitro- (9CI); MNT-; Nitrotoluene,-meto-; m-Methylnitrobenzene-; m-Nitrotoluene-; m-Nitrotoluene- (ACGIH:OSHA); meta-Nitrotoluol- RN: Current: 99-08-1 UD: 200210 MF: C7-H7-N-O2 MW: 137.15 WL: WNR C1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: sce-ham-ovr 115 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T14 orl-rat TDLo: 31122 mg/kg (13W pre) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); T01-T02 orl-rat TDLo: 60151 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*) ORNG: 1072000000 ng/kg. [1072.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1072 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-270 (NTIS**); A11-L03-P24 ihl-rat LC50: 693 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB); T/E unlistd orl-mus LD50: 330 mg/kg Chemical Abstracts. (Chemical Abstracts Service, Box 3012, Columbus, OH 43210) V.1- 1907- v. 73, p. 91015e, 1970 (CHABA8); A11-L03-P24 ihl-mus LC50: 425 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB); A11-L03-P24 orl-rbt LD50: 1750 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB); T/E unlistd orl-gpg LD50: 3600 mg/kg Chemical Abstracts. (Chemical Abstracts Service, Box 3012, Columbus, OH 43210) V.1- 1907- v. 73, p. 91015e, 1970 (CHABA8) MD: M70-P73-Z73 orl-rat TDLo: 31122 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); L70-M70-Z73 orl-mus TDLo: 67613 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); N74-P70 orl-mus TDLo: 5600 mg/kg/14D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 17, p. 359, 1994 (DCTODJ); M13-M16 ihl-mam TCLo: 30 mg/m3/4H/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB) TR: ACGIH TLV-TWA 2 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT) SR: OSHA PEL (Gen Indu): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2 ppm (11 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 2 ppm (11 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 2 ppm (11 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 2 ppm (12 mg/m3), JAN 1999; OEL-FRANCE: VME 2 ppm (11 mg/m3), Skin, JAN 1999; OEL-GERMANY: MAK 5 ppm (30 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 1 ppm (5.5 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 3 mg/m3, MAC(STEL) 9 mg/m3, JAN 1999; OEL-SWEDEN: NGV 1 ppm (6 mg/m3), KTV 2 ppm *(11 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 2 ppm (11 mg/m3), KZG-W 4 ppm (22 mg/m3), Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 5 ppm (29 mg/m3), STEL 10 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO m-NITROTOLUENE-air: 10H TWA 2 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Toxicity studies, RPT# TOX-23, October 2000 Record 1082 of 1119 in RTECS (through 2003/06) AN: XT3150000 PN: Toluene,-o-nitro- SY: 1-Methyl-2-nitrobenzene-; 2-Methylnitrobenzene-; 2-Nitrotoluene-; 2-Nitrotoluol-; Benzene,-1-methyl-2-nitro- (9CI); Nitrotoluene,-ortho-; ONT-; o-Methylnitrobenzene-; o-Nitrotoluene-; o-Nitrotoluene- (ACGIH:OSHA); ortho-Nitrotoluol- RN: Current: 88-72-2 Previous: 57158-05-1 UD: 200305 MF: C7-H7-N-O2 MW: 137.15 WL: WNR B1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: dna-rat-orl 150 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 51, p. 131, 1984 (CBINA8); dns-rat-orl 200 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2836, 1983 (CNREA8); dns-rat-lvr 500 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 147, 1995 (EMMUEG); sce-ham-ovr 355 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T01-T02 orl-rat TDLo: 32123 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); T14 orl-rat TDLo: 69154 mg/kg (13W pre) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); T01 orl-mus TDLo: 140 gm/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*) TE: V02-T69 orl-rat TDLo: 54600 mg/kg/26W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3936 (NTPTR*); V03-R60 orl-rat TDLo: 27.4 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-L60-R60 orl-rat TDLo: 87.6 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-L60-R60 orl-rat TDLo: 10.1 gm/kg/12W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-J60-L60 orl-rat TDLo: 25.2 gm/kg/12W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-R60 orl-rat TDLo: 45.6 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-L60-R60 orl-rat TDLo: 182.5 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-H60-K61 orl-mus TDLo: 109.5 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-K61-L60 orl-mus TDLo: 219 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC) ORNG: 891000000 ng/kg. [891.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 891 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-270 (NTIS**); A11-L03-P24 ihl-rat LC50: 790 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB); T/E unlistd orl-mus LD50: 970 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(8), p. 50, 1981 (GTPZAB); A11-L03-P24 ihl-mus LC50: 328 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB); A11-L03-P24 orl-rbt LD50: 1750 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB) MD: L70-P73-Z73 orl-rat TDLo: 32123 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); L70-U01-Z73 orl-rat TDLo: 54600 mg/kg/26W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3936 (NTPTR*); D03-L70-M70 orl-mus TDLo: 70343 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); P70 orl-mus TDLo: 8400 mg/kg/14D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 17, p. 359, 1994 (DCTODJ); U01 orl-mus TDLo: 6825 mg/kg/13W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); U01 orl-mus TDLo: 33600 mg/kg/8W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); U01 orl-rat TDLo: 3937.5 mg/kg/15W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); U01 orl-rat TDLo: 21000 mg/kg/30W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC) TR: ACGIH TLV-TWA 2 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT) SR: OSHA PEL (Gen Indu): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2 ppm (11 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 2 ppm (11 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 2 ppm (11 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 2 ppm (12 mg/m3), JAN 1999; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-NORWAY: TWA 1 ppm (5.5 mg/m3), JAN 1999; OEL-SWEDEN: NGV 1 ppm (6 mg/m3), KTV 2 ppm (11 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: Skin, Carcinogen, JAN 1999; OEL-UNITED KINGDOM: TWA 5 ppm (29 mg/m3), STEL 10 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO o-NITROTOLUENE-air: 10H TWA 2 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 81910; NIS 2; TNF 20; NOS 2; TNE 285 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: mouse, rat; NTP Toxicity studies, RPT# TOX-23, October 2000; NTP Toxicity studies, RPT# TOX-44, October 2000; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 1083 of 1119 in RTECS (through 2003/06) AN: XT3325000 PN: Toluene,-p-nitro- SY: 1-Methyl-4-nitrobenzene-; 4-Methylnitrobenzene-; 4-Nitrotoluene-; 4-Nitrotoluol-; Benzene,-1-methyl-4-nitro- (9CI); NCI-C60537-; Nitrotoluene,-para-; PNT-; p-Methylnitrobenzene-; p-Nitrotoluene-; p-Nitrotoluene- (ACGIH:OSHA); para-Nitrotoluol- RN: Current: 99-99-0 UD: 200305 MF: C7-H7-N-O2 MW: 137.15 WL: WNR D1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 10 ug/plate (+/-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 163, 1982 (ENMUDM); dnr-bcs 5 mg/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 170, p. 11, 1986 (MUREAV); dns-rat-lvr 100 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 26, p. 147, 1995 (EMMUEG); cyt-ham-ovr 500 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 200 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T01-T02 orl-rat TDLo: 65793 mg/kg (13W male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); T13 ipr-rat TDLo: 30 mg/kg (1D pre) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 36, p. 13, 1992 (JTEHD6) TE: V03-R60 orl-rat TDLo: 80850 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NIH No. 01-4432 (NTIS**); V03-T69 orl-rat TDLo: 91875 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NIH No. 01-4432 (NTIS**); V03-J60 orl-mus TDLo: 507150 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NIH No. 01-4432 (NTIS**); V03-T69 orl-rat TDLo: 91.3 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-R60 orl-rat TDLo: 109.5 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); V03-J60 orl-mus TDLo: 438 gm/kg/2Y-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC) ORNG: 1960000000 ng/kg. [1960.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1960 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(8), p. 50, 1981 (GTPZAB); A11-L03-P24 ihl-rat LC50: 975 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB); J30-L03-U01 skn-rat LD50: >16 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 24(9), p. 15, 1959 (GISAAA); F19-J24-J26 ipr-rat LD50: 940 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 24(9), p. 15, 1959 (GISAAA); T/E unlistd orl-mus LD50: 1231 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-270 (NTIS**); A11-L03-P24 ihl-mus LC50: 419 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB); A11-L03-P24 orl-rbt LD50: 1750 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 22(7), p. 52, 1978 (GTPZAB) MD: M70-P70-Y15 orl-rat TDLo: 65793 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); L70-U01 orl-mus TDLo: 73983 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-93-3346 (NTPTR*); L70-N73-S04 orl-mus TDLo: 8400 mg/kg/14D-I Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 17, p. 317, 1994 (DCTODJ); P61-V30 orl-rat TDLo: 40425 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NIHNo.01-4432 (NTIS**); T61-V30 orl-rat TDLo: 176400 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NIHNo.01-4432 (NTIS**); R60-V30 orl-rat TDLo: 194775 mg/kg/105W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. NIHNo.01-4432 (NTIS**); U01 orl-mus TDLo: 16800 mg/kg/4W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); U01 orl-mus TDLo: 33600 mg/kg/8W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC); U01 orl-rat TDLo: 7000 mg/kg/4W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 183, p. 221, 2003 (TXCYAC) TR: ACGIH TLV-TWA 2 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 65, p. 409, 1996 (IMEMDT) SR: OSHA PEL (Gen Indu): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (30 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2 ppm (11 mg/m3), Skin, JAN 1993; OEL-AUSTRIA: MAK 2 ppm (11 mg/m3), Skin, JAN 1999; OEL-BELGIUM: TWA 2 ppm (11 mg/m3), Skin, JAN 1993; OEL-DENMARK: TWA 2 ppm (12 mg/m3), JAN 1999; OEL-GERMANY: MAK 5 ppm (30 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 1 ppm (5.5 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 3 mg/m4, MAC(STEL) 9 mg/m3, JAN 1999; OEL-SWEDEN: NGV 1 ppm (6 mg/m3), KTV 2 ppm (11 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 2 ppm (11 mg/m3), KZG-W 4 ppm (22 mg/m3), Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 5 ppm (29 mg/m3), STEL 10 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO p-NITROTOLUENE-air: 10H TWA 2 ppm (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD X6955; NIS 1; TNF 21; NOS 5; TNE 4354; TFE 729 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), equivocal evidence: rat; NTP Toxicity studies, RPT# TOX-23, October 2000; NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1084 of 1119 in RTECS (through 2003/06) AN: XT9275000 PN: Toluene,-alpha,alpha,alpha-trichloro- SY: 1-(Trichloromethyl)benzene; Benzene, (trichloromethyl)-; Benzenyl-chloride-; Benzenyl-trichloride-; Benzoic-trichloride-; Benzotrichloride-; Benzyl-trichloride-; Benzylidyne-chloride-; Chlorure-de-benzenyle- (French); Phenyl-chloroform-; Phenyltrichloromethane-; RCRA-waste-number-U023-; Toluene-trichloride-; Trichloormethylbenzeen- (Dutch); Trichlormethylbenzol- (German); Trichloromethylbenzene-; Trichlorophenylmethane-; Triclorometilbenzene- (Italian); Triclorotoluene- (Italian); alpha,alpha,alpha-Trichlorotoluene-; omega,omega,omega-Trichlorotoluene- RN: Current: 98-07-7 BRN: 508152 BHR: 4-05-00-00820 UD: 200302 MF: C7-H5-Cl3 MW: 195.47 WL: GXGGR CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 10 ug/plate (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 11(Suppl 12), p. 1, 1988 (EMMUEG); mmo-sat 500 nmol/plate/20M (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 143, 1978 (MUREAV); mmo-esc 500 nmol/plate/20M (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 143, 1978 (MUREAV); dnr-bcs 2600 nmol/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 143, 1978 (MUREAV); dnd-hmn-oth 100 ug/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 27, p. 94, 1986 (PAACA3); cyt-rat-ihl 1 ppm/6H/4W-I Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 164, p. 272, 1986 (MUREAV) TE: V01-J60-K60 orl-mus TDLo: 1380 mg/kg/25W-I Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki, 213 Japan) V.1- 1963- v. 31, p. 127, 1993 (INHEAO); V02-J60-R60 ihl-mus TCLo: 1620 ppb/30M/22W-I Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959- v. 28, p. 352, 1986 (SAIGBL); V01-J60-R60 skn-mus TDLo: 9200 mg/kg/50W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 72, p. 655, 1981 (GANNA2); V01-J60 ipr-mus TDLo: 287 mg/kg/8W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 33, p. 167, 1986 (CALEDQ); V01-J60-R60 skn-mus TD :16320 mg/kg/31W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 72, p. 655, 1981 (GANNA2); V01-J60-R60 skn-mus TD :17600 mg/kg/42W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 72, p. 655, 1981 (GANNA2); V01-J60-R60 skn-mus TD :34000 mg/kg/31W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 72, p. 655, 1981 (GANNA2); V01-P62-R60 skn-mus TD :35200 mg/kg/42W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 72, p. 655, 1981 (GANNA2); V03-J60 ipr-mus TD :288 mg/kg/8W-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 27, p. 94, 1986 (PAACA3); V03-M61-P62 ipr-mus TD :1440 mg/kg/8W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 33, p. 167, 1986 (CALEDQ) ORNG: 1300000000 ng/kg. [1300.000000 mg/kg] T/E unlistd SRNG: 4000000000 ng/kg. [4000.000000 mg/kg] F13-L30-R03 AT: F23-J25-U01 ihl-rat LC50: 19 ppm/2H IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 73, 1982 (IMEMDT); T/E unlistd orl-mus LD50: 702 mg/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) FYI-OTS-1180-0107 (TSCAT*); A11-F17-J25 ihl-mus LC50: 8 ppm/2H IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 73, 1982 (IMEMDT); F13-L30-R03 skn-rbt LD50: 4 gm/kg Office of Toxic Substances Report. (U.S. Environmental Protection Agency, Office of Toxic Substances, 401 M St., SW, Washington, DC 20460) FYI-OTS-1180-0107 (TSCAT*); E08-F17 scu-frg LDLo: 2150 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. v. 130, p. 250, 1928 (AEPPAE); T/E unlistd orl-mam LD50: 1300 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 40(1), p. 92, 1975 (GISAAA); T/E unlistd ihl-mam LC50: 60 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 30(3), p. 6, 1986 (GTPZAB); T/E unlistd orl-rat LD50: 1300 mg/kg "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 42, 1984 (VCVGK*); T/E unlistd ihl-mus LC50: 60 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 42, 1984 (VCVGK*); T/E unlistd ihl-rat LC50: 150 mg/m3/2H "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 42, 1984 (VCVGK*) MD: A30-H02-P14 ihl-rat TCLo: 100 mg/m3/2H/9W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 28(10), p. 30, 1963 (GISAAA); Z01 ihl-rat TCLo: 49 mg/m3/4W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0536269 (NTIS**); J30-L30-M30 ihl-rat TCLo: 100 mg/m3/2H/7D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 43, 1994 (VCVGK*); M16 ihl-rat TCLo: 30 mg/m3/2H/20D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 43, 1994 (VCVGK*); L30-L70-Y07 orl-rat TDLo: 0.84 mg/kg/28D-C "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 43, 1994 (VCVGK*); P72-R11-R21 skn-rbt TDLo: 1500 mg/kg/3D-I "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994. v. -, p. 43, 1994 (VCVGK*) TR: ACGIH TLV-Suspected Human Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-CL 0.1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 73, 1982 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 453, 1999 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 453, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 29, p. 73, 1982 (IMEMDT) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-RUSSIA: STEL 0.2 mg/m3, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000 ND: NOES 1983: HZD X7402; NIS 1; TNF 43; NOS 1; TNE 171 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, B subtilis rec assay; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1085 of 1119 in RTECS (through 2003/06) AN: XU2975000 PN: o-Toluidine- SY: 1-Amino-2-methylbenzene-; 1-Methyl-2-aminobenzene-; 2-Amino-1-methylbenzene-; 2-Aminotoluene-; 2-Methyl-1-aminobenzene-; 2-Methylaniline-; 2-Methylbenzenamine-; 2-Toluidine-; Aniline,-2-methyl-; Benzenamine,-2-methyl- (9CI); C.I. 37077; RCRA-waste-number-U328-; o-Aminotoluene-; o-Methylaniline-; o-Methylbenzenamine-; o-Toluidin- (Czech); o-Toluidine- (ACGIH:OSHA); o-Toluidyna- (Polish); o-Tolylamine-; ortho-Toluidine- RN: Current: 95-53-4 UD: 200210 MF: C7-H9-N MW: 107.17 WL: ZR B1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 10 mg/24H open MLD American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 95, 1962 (AIHAAP); skn-rbt 500 mg/24H MLD "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,460,1986 (85JCAE); eye-rbt 750 ug/24H SEV "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,460,1986 (85JCAE) ME: mmo-sat 40 ug/plate (-S9) Proceedings of the Japan Academy, Series B: Physical and Biological Sciences. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.53- 1977- v. 53, p. 34, 1977 (PJABDW); mmo-sat 250 ng/plate (+S9) Arab Gulf Journal of Scientific Research. (Arab Bureau of Education for the Gulf States, POB 3908, Riyadh, 11481, Saudi Arabia) V.7 No.2- 1989- v. 13, p. 13, 1995 (AGSREJ); dnr-esc 20 uL/plate JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); pic-esc 100 mmol/L Medycyna Doswiadczalna i Mikrobiologia. For English translation, see EXMMAV. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1949- v. 31, p. 11, 1979 (MDMIAZ); slt-dmg-orl 1 mmol/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 313, 1985 (PMRSDJ); mmo-smc 378 mg/L (+/-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 271, 1985 (PMRSDJ); mrc-smc 378 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 271, 1985 (PMRSDJ); mnt-nml-mul 4 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 292, p. 83, 1993 (MUREAV); mnt-hmn-lym 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 291, p. 93, 1993 (MUREAV); mmo-hmn-lym 300 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 497, 1985 (PMRSDJ); dns-hmn-hla 50 uL/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 347, 1985 (PMRSDJ); dni-hmn-hla 4 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); sce-hmn-lym 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 211, p. 77, 1989 (MUREAV); msc-hmn-lym 450 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 497, 1985 (PMRSDJ); dnd-rat-lvr 319 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 353, 1985 (PMRSDJ); dns-rat-lvr 1 mmol/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 371, 1985 (PMRSDJ); bfa-rat-sat 300 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 79, p. 173, 1980 (MUREAV); bfa-rat-ovr 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 263, 1985 (MUREAV); cyt-rat-lvr 175 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 387, 1985 (PMRSDJ); sce-rat-lvr 21800 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 387, 1985 (PMRSDJ); mmo-mus-lym 12500 ug/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 525, 1985 (PMRSDJ); mmo-mus-emb 250 mg/L (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 639, 1985 (PMRSDJ); mtr-mus-emb 500 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 659, 1985 (PMRSDJ); dnd-mus-ipr 100 mg/kg Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 5, p. 355, 1982 (ATSUDG); dnd-mus-orl 600 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 440, p. 1, 1999 (MUREAV); dni-mus-ipr 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); dni-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV); msc-mus-lym 10 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 587, 1985 (PMRSDJ); mtr-ham-emb 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 665, 1985 (PMRSDJ); dnd-ham-ovr 20 mmol/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 367, 1985 (PMRSDJ); cyt-ham-lvr 12 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 397, 1985 (PMRSDJ); cyt-ham-lng 1 gm/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 427, 1985 (PMRSDJ); cyt-ham-ovr 250 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 413, 1985 (PMRSDJ); sce-ham-ipr 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); sce-ham-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 113, p. 33, 1983 (MUREAV); sce-ham-ovr 125 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 451, 1985 (PMRSDJ); sce-ham-lng 2500 umol/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 469, 1985 (PMRSDJ); sln-ham-lvr 60 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 397, 1985 (PMRSDJ) RE: T01-T86 skn-rat TDLo: 9520 mg/kg (17W male) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 27(9), p. 47, 1983 (GTPZAB); T14-T81-T86 skn-rat TDLo: 9520 mg/kg (17W pre) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 27(9), p. 47, 1983 (GTPZAB); T12-T14 skn-rat TDLo: 952 mg/kg (17W pre) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 27(9), p. 47, 1983 (GTPZAB) TE: V02-P60 orl-rat TDLo: 109 gm/kg/2Y-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 25, p. 619, 1987 (FCTOD7); V02-J60-T65 scu-mus TDLo: 320 mg/kg (15-21D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1402, 1974 (BEXBAN); V03-M60 scu-rbt TDLo: 840 mg/kg/14W-I IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT); V03-M60 orl-rat TD :7250 mg/kg/23W-C Acta Pathologica et Microbiologica Scandinavica. (Copenhagen, Denmark) V.1-77, 1924-69. For publisher information, see ACPADQ. v. 26, p. 447, 1949 (APMIAL) ORNG: 670000000 ng/kg. [670.000000 mg/kg] P05-P08-P24 SRNL: 3250000 nL/kg. [3.250000 mL/kg] T/E unlistd IHPB: 862000 ppb/4H. [862.000000 ppm/4H] F07-F11-J24 AT: M10-M14-P24 ihl-man TCLo: 25 mg/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 14(8), p. 7, 1970 (GTPZAB); P05-P08-P24 orl-rat LD50: 670 mg/kg IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT); F07-F11-J24 ihl-rat LC50: 862 ppm/4H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0570956 (NTIS**); P05-P08-P24 orl-mus LD50: 520 mg/kg IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT); T/E unlistd ipr-mus LD50: 150 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD691-490 (NTIS**); F24-J22-P24 orl-cat LDLo: 150 mg/kg U.S. Public Health Service, Public Health Bulletin. (Washington, DC) v. 271, p. 49, 1941 (XPHBAO); P05-P08-P24 orl-rbt LD50: 840 mg/kg IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT); T/E unlistd skn-rbt LD50: 3250 uL/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 23, p. 95, 1962 (AIHAAP); F24-J22-P24 orl-frg LDLo: 151 mg/kg U.S. Public Health Service, Public Health Bulletin. (Washington, DC) v. 271, p. 49, 1941 (XPHBAO); T/E unlistd orl-mam LD50: 1700 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB) MD: P27-U01-Z01 orl-rat TDLo: 1125 mg/kg/5D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 285, 1983 (FAATDF); M13-P05-U01 orl-rat TDLo: 10200 mg/kg/30D-I Vsesoyuznyi Institut Nauchnoi i Tekhnicheskoi Informatsii (VINITI). All-Union Institute of Scientific and Technical Information. (Moscow, USSR) Use information broker to obtain publications. #4035-77 (VINIT*) TR: ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 2 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT) SR: MSHA STANDARD-air: TWA 5 ppm (22 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 261, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 5 ppm (22 mg/m3) (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 2 ppm (9 mg/m3), Skin, Carcinogen, JAN 1993; OEL-AUSTRIA: Skin, Carcinogen, JAN 1999; OEL-BELGIUM: TWA 2 ppm (8.8 mg/m3), Skin, Carcinogen JAN 1993; OEL-DENMARK: TWA 2 ppm (9 mg/m3), Skin, JAN 1999; OEL-FINLAND: TWA 5 ppm (22 mg/m3), STEL 10 ppm (44 mg/m3), Skin, Carcinogen, JAN 1999; OEL-FRANCE: VME 2 ppm (9 mg/m3), C2 Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen (salts), JAN 1993; OEL-GERMANY: Skin, Carcinogen, JAN 1999; OEL-JAPAN: OEL 1 ppm (4.4 mg/m3), Skin, 2B Carcinogen, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 2 ppm (9 mg/m3), Skin, Carcinogen, JAN 1999; OEL-NORWAY: TWA 1 ppm (4.5 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 5 ppm (22 mg/m3), Skin, JAN 1993; OEL-POLAND: MAC(TWA) 3 mg/m3, MAC(STEL) 9 mg/m3, JAN 1999; OEL-RUSSIA: TWA 0.5 mg/m3, STEL 1 mg/m3, Skin, Carcinogen, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 0.1 ppm (0.5 mg/m3), Skin, Carcinogen, JAN 1999; OEL-TURKEY: TWA 5 ppm (22 mg/m3), Skin, JAN 1993; OEL-UNITED KINGDOM: Carcinogen, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO o-TOLUIDINE-air: CA lowest feasible concentration (Sk) National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 73470; NIS 21; TNF 2912; NOS 20; TNE 13053; NOES 1983: HZD 73470; NIS 32; TNF 2517; NOS 25; TNE 30019; TFE 15501 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9; EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Amines, aromatic, 2002; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; OSHA ANALYTICAL METHOD #ID-73 Record 1086 of 1119 in RTECS (through 2003/06) AN: XU5000000 PN: o-Toluidine,-4-chloro- SY: 2-Amino-5-chlorotoluene-; 2-Methyl-4-chloroaniline-; 3-Chloro-6-aminotoluene-; 4-Chloro-2-methylaniline-; 4-Chloro-2-methylbenzeneamine-; 4-Chloro-2-toluidine-; 4-Chloro-6-methylaniline-; 4-Chloro-o-toluidine-; 4-Chloro-ortho-toluidine-; 5-Chloro-2-aminotoluene-; Benzenamine,-4-chloro-2-methyl- (9CI); Brentamine-Fast-Red-TR-Base-; Daito-Red-Base-TR-; Diazo-Fast-Red-TRA-; Fast-Red-5CT-Base-; Fast-Red-Base-TR-; Fast-Red-TR-; Fast-Red-TRO-Base-; Kako-Red-TR-Base-; Kambamine-Red-TR-; Mitsui-Red-TR-Base-; Red-Base-NTR-; Red-TR-Base-; Sanyo-Fast-Red-TR-Base-; Tulabase-Fast-Red-TR- RN: Current: 95-69-2 BRN: 878505 BHR: 4-12-00-01796 UD: 200204 MF: C7-H8-Cl-N MW: 141.61 WL: ZR DG B1 CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 400 ug/plate (+S9) Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 19, p. 95, 1984 (JPFCD2); mmo-sat 200 nmol/plate (-S9) Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 34, p. 157, 1986 (JAFCAU); dnr-sat 250 mg/disc Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 19, p. 95, 1984 (JPFCD2); dnr-esc 2 gm/disc Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 19, p. 95, 1984 (JPFCD2); oms-hmn-hla 1 mmol/L Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 11, p. 184, 1974 (BECTA6); dns-rat-lvr 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 221, p. 263, 1989 (MUREAV); dnd-mus-orl 600 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 440, p. 1, 1999 (MUREAV); dni-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 305, 1977 (MUREAV) TE: V03-Q60 orl-mus TDLo: 6720 mg/kg/80W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0543864 (NTIS**) ORNG: 1058000000 ng/kg. [1058.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1058 mg/kg Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 1, p. 301, 1976 (NNGADV); F19-K13-P24 scu-cat LDLo: 310 mg/kg Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For publisher information, see ZHPMAT. v. 110, p. 12, 1933 (AHBAAM); T/E unlistd orl-bwd LD50: 75 mg/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 77, p. 564, 2000 (IMEMDT) SR: OEL-AUSTRIA: Carcinogen, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: MAK-W 2 ppm (12 mg/m3), Skin, Carcinogen, JAN 1999 ND: NOHS 1974: HZD T0066; NIS 2; TNF 77; NOS 3; TNE 1397; NOES 1983: HZD T0066; NIS 1; TNF 16; NOS 1; TNE 250; TFE 250 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-8896; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1087 of 1119 in RTECS (through 2003/06) AN: XU5250000 PN: o-Toluidine,-4-chloro-,-hydrochloride- SY: 2-Amino-5-chlorotoluene-hydrochloride-; Azanil-Red-Salt-TRD-; Azoene-Fast-Red-TR-Salt-; Azogene-Fast-Red-TR-; Azoic-Diazo-Component-11-Base-; Benzenamine,-4-chloro-2-methyl-,-hydrochloride-; CGA-72647-; Chlorhydrate-de-4-chloroorthotoluidine- (French); 5-Chloro-2-aminotoluene-hydrochloride-; 4-Chloro-2-methylaniline-hydrochloride-; 4-Chloro-6-methylaniline-hydrochloride-; 4-Chloro-2-methylbenzenamine-hydrochloride-; 4-Chloro-o-toluidine-hydrochloride-; 4-Chloro-2-toluidine-hydrochloride-; C.I. 37085; C.I. Azoic Diazo Component 11; Daito-Red-Salt-TR-; Devol-Red-K-; Devol-Red-TR-; Diazo-Fast-Red-TR-; Diazo-Fast-Red-TRA-; Fast-Red-5CT-Salt-; Fast-Red-Salt-TR-; Fast-Red-Salt-TRA-; Fast-Red-Salt-TRN-; Fast-Red-TR-Salt-; NCI-C02368-; Neutrosel-Red-TRVA-; Ofna-perl-Salt-RRA-; RCRA-waste-number-U049-; Red-TRS-Salt-; Sanyo-Fast-Red-Salt-TR-; Brentamine-Fast-Red-TR-Salt-; Hindasol-Red-TR-Salt-; Kromon-Green-B-; 2-Methyl-4-chloroaniline-hydrochloride- RN: Current: 3165-93-3 UD: 200009 MF: C7-H8-Cl-N.Cl-H MW: 178.07 WL: ZR DG B1 &GH CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 1 umol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 317, 1980 (MUREAV); slt-mus-orl 300 mg/kg/3D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 219, 1984 (MUREAV); dnd-ham-lng 3 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 77, p. 317, 1980 (MUREAV); cyt-ham-ovr 400 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 50 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V01-H60 orl-mus TDLo: 49 gm/kg/78W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(2), p. 325, 1978 (JEPTDQ); V01-H60 orl-mus TD :104 gm/kg/99W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-165, 1979 (NCITR*); V01-H60 orl-mus TD :108 gm/kg/78W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(2), p. 325, 1978 (JEPTDQ); V01-L60 orl-mus TD :216 gm/kg/78W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(2), p. 325, 1978 (JEPTDQ); V01-L60 orl-mus TD :97 gm/kg/78W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(2), p. 325, 1978 (JEPTDQ) AT: T/E unlistd ipr-rat LD50: 560 mg/kg Progress Report for Contract No. NIH-NCI-E-68-1311, Submitted to the National Cancer Institute by Bio-Research Consultants, Inc. (9 Commercial Ave., Cambridge, MA 02141) NCI-E-68-1311, 1973 (NCIBR*); T/E unlistd ipr-mus LD50: 680 mg/kg Progress Report for Contract No. NIH-NCI-E-68-1311, Submitted to the National Cancer Institute by Bio-Research Consultants, Inc. (9 Commercial Ave., Cambridge, MA 02141) NCI-E-68-1311, 1973 (NCIBR*) MD: L30 orl-rat TDLo: 21900 mg/kg/2Y-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0545249-1 (NTIS**); L30-M30-N30 orl-rat TDLo: 21600 mg/kg/60D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0537818-1 (NTIS**); M16 orl-mus TDLo: 7380 mg/kg/60D-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0543159 (NTIS**) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 123, 1990 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 16, p. 277, 1978 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 16, p. 277, 1978 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 48, p. 123, 1990 (IMEMDT) ND: NOES 1983: HZD X1279; NIS 1; TNF 45; NOS 2; TNE 682; TFE 425 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-165, 1979 (NCITR*); NCI Carcinogenesis Bioassay (feed), no evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-165, 1979 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1088 of 1119 in RTECS (through 2003/06) AN: XU7350000 PN: o-Toluidine,-hydrochloride- SY: 1-Amino-2-methylbenzene-hydrochloride-; 2-Amino-1-methylbenzene-hydrochloride-; o-Aminotoluene-hydrochloride-; 2-Aminotoluene-hydrochloride-; Benzenamine,-2-methyl-,-hydrochloride-; 1-Methyl-2-aminobenzene-hydrochloride-; 2-Methyl-1-aminobenzene-hydrochloride-; NCI-C02335-; RCRA-waste-number-U222-; o-Methylaniline-hydrochloride-; 2-Methylaniline-hydrochloride-; o-Methylbenzenamine-hydrochloride-; 2-Methylbenzenamine-hydrochloride-; o-Tolylamine-hydrochloride-; 2-Toluidine-hydrochloride-; o-Toluidin-hydrochloride- RN: Current: 636-21-5 UD: 200012 MF: C7-H9-N.Cl-H MW: 143.63 WL: ZR B1 &GH CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 50 ug/plate (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 351, 1981 (PMRSDJ); mmo-esc 50 ug/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 351, 1981 (PMRSDJ); dnr-esc 500 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 195, 1981 (PMRSDJ); pic-esc 2500 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 224, 1981 (PMRSDJ); dnd-bcs 20 uL/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); slt-dmg-orl 1 mmol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 24, p. 75, 1994 (EMMUEG); dnr-smc 300 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 491, 1981 (PMRSDJ); sln-smc 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); sce-mus-ipr 300 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 207, 1989 (EMMUEG); mtr-ham-kdy 250 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 638, 1981 (PMRSDJ); mtr-ham-emb 750 mg/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 2, p. 103, 1988 (TIVIEQ) TE: V01-P60-R60 orl-rat TDLo: 117 gm/kg/101W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-153, 1979 (NCITR*); V01-H60-L60 orl-mus TDLo: 146 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-153, 1979 (NCITR*); V01-P60-H60 orl-rat TD :159 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-153, 1979 (NCITR*); V01-H60-L60 orl-mus TD :262 gm/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-153, 1979 (NCITR*); V01-R60-P60 orl-rat TD :125 gm/kg/73W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 16, p. 103, 1982 (CALEDQ); V01-H60 orl-mus TD :1210 gm/kg/78W-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 2(2), p. 325, 1978 (JEPTDQ); V01-P60-R60 orl-rat TD :233 gm/kg/101W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-153, 1979 (NCITR*); V01-H60-L60 orl-mus TD :2142 gm/kg/2Y-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT); V01-H60 orl-mus TD :12936 gm/kg/77W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT); V01-M60-P60 orl-rat TD :2121 gm/kg/2Y-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT); V01-M60-P60 orl-rat TD :4242 gm/kg/2Y-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT); V01-M60-N60 orl-rat TD :12936 gm/kg/77W-C IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT) ORNG: 2951000000 ng/kg. [2951.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 2951 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 167, p. 223, 1969 (JPETAB); T/E unlistd ipr-rat LD50: 150 mg/kg Progress Report for Contract No. NIH-NCI-E-68-1311, Submitted to the National Cancer Institute by Bio-Research Consultants, Inc. (9 Commercial Ave., Cambridge, MA 02141) NCI-E-68-1311, 1973 (NCIBR*); T/E unlistd orl-mus LD50: 1100 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 25(8), p. 50, 1981 (GTPZAB); T/E unlistd ipr-mus LD50: 113 mg/kg Progress Report for Contract No. NIH-NCI-E-68-1311, Submitted to the National Cancer Institute by Bio-Research Consultants, Inc. (9 Commercial Ave., Cambridge, MA 02141) NCI-E-68-1311, 1973 (NCIBR*) MD: M70-N73-U01 orl-rat TDLo: 27300 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3936 (NTPTR*); L30-L70-Z73 orl-rat TDLo: 54600 mg/kg/26W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NIH-96-3936 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 27, p. 155, 1982 (IMEMDT) ND: NOES 1983: HZD X8305; NIS 2; TNF 32; NOS 3; TNE 355 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-153, 1979 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen; NTP Toxicity studies, RPT# TOX-44, October 2000 Record 1089 of 1119 in RTECS (through 2003/06) AN: XU8800000 PN: o-Toluidine, 4-(o-tolylazo)- SY: 2',3-Dimethyl-4-aminoazobenzene-; 2-Amino-5-azotoluene-; 2-Methyl-4-((2-methylphenyl)azo)benzenamine; 4'-Amino-2,3'-dimethylazobenzene-; 4'-Amino-2:3'-azotoluene; 4-(o-Tolylazo)-o-toluidine; 4-Amino-2',3-dimethylazobenzene-; 5-(o-Tolylazo)-2-aminotoluene; AAT-; Aminoazotoluene- (indicator); Benzenamine, 2-methyl-4-((2-methylphenyl)azo)- (9CI); Brasilazina-Oil-Yellow-R-; C.I. 11160; C.I. 11160B; C.I. Solvent Yellow 3; Fast-Garnet-GBC-Base-; Fast-Oil-Yellow-; Fast-Yellow-AT-; Fat-Yellow-B-; Hidaco-Oil-Yellow-; OAAT-; Oil-Yellow-21-; Oil-Yellow-2681-; Oil-Yellow-2R-; Oil-Yellow-AT-; Oil-Yellow-C-; Oil-Yellow-I-; Oil-Yellow-T-; Organol-Yellow-2T-; Orthoaminoasotoluol-; Somalia-Yellow-R-; Sudan-Yellow-RRA-; Toluazotoluidine-; Tulabase-Fast-Garnet-GB-; Tulabase-Fast-Garnet-GBC-; Waxakol-Yellow-NL-; Zlut-rozpoustedlova-3- (Czech); o-AT-; o-Amidoazotoluol- (German); o-Aminoazotoluene-; o-Aminoazotolueno- (Spanish); o-Aminoazotoluol-; o-Tolueneazo-o-toluidine-; o-Toluol-azo-o-toluidin- (German) RN: Current: 97-56-3 BRN: 745567 BHR: 4-16-00-00528 UD: 200207 MF: C14-H15-N3 MW: 225.32 WL: ZR B1 DNUNR B1 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 25 ng/plate (-S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 6155, 1985 (CNREA8); dnr-esc 25 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 873, 1979 (JJIND8); dna-esc 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); mmo-nsc 1000 ppm (-S9) Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 71, p. 1072, 1958 (ANYAA9); dns-rat-lvr 200 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 255, 1984 (MUREAV); dns-rat-orl 200 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 101, 1985 (ENMUDM); bfa-rat-sat 500 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 156, p. 131, 1985 (MUREAV); sce-rat-lvr 90 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); sce-rat-oth 45 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); mnt-mus-ipr 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 389, p. 3, 1997 (MUREAV); mmo-mus-lym 19 mg/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 189, p. 223, 1987 (MUREAV); dni-mus-orl 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); sce-mus-ipr 115 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 108, p. 225, 1983 (MUREAV); mtr-ham-emb 1 mg/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); dns-ham-lvr 200 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 136, p. 255, 1984 (MUREAV); sce-ham-fbr 45 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 93, p. 409, 1982 (MUREAV); mtr-nml-oth 250 ug/L Annals of Occupational Hygiene. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 20, p. 297, 1977 (AOHYA3); dns-mus-orl 200 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 999, 2001 (FCTOD7); slt-mus-ipr 300 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 491, p. 211, 2001 (MUREAV); dnd-mus-ipr 400 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); dnd-mus-orl 800 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV) RE: T51-T65 orl-mus TDLo: 480 mg/kg (multigeneration) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 203, 1989 (CALEDQ) TE: V02-L60 orl-rat TDLo: 15 gm/kg/57W-C British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 3, p. 387, 1949 (BJCAAI); V02-J60-L60 orl-mus TDLo: 480 mg/kg Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 85, p. 201, 1978 (BEXBAN); V01-T65-L60 orl-mus TDLo: 480 mg/kg (17-19D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 46, p. 203, 1989 (CALEDQ); V02-L60 ipr-mus TDLo: 800 mg/kg Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 58, p. 323, 1967 (GANNA2); V01-T65-J60 scu-mus TDLo: 4000 mg/kg (15-21D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 78, p. 1402, 1974 (BEXBAN); V02-L60 scu-mus TDLo: 2800 mg/kg/28W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 20, p. 431, 1958 (JNCIAM); V01-M60 imp-mus TDLo: 80 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 22, p. 825, 1968 (BJCAAI); V03-L60-V10 mul-mus TDLo: 400 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 1, p. 397, 1941 (CNREA8); V03-M60 orl-dog TDLo: 4500 mg/kg/2Y-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 13, p. 1497, 1953 (JNCIAM); V03-L60 orl-mus TD :5280 mg/kg/88D-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 16, p. 107, 1955 (JNCIAM); V03-L60 scu-mus TD :4000 mg/kg/39W-I American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 51, p. 307, 1967 (AJPAA4); V03-J60 orl-mus TD :80 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 7, p. 431, 1947 (JNCIAM); V03-J60-L60 scu-mus TD :80 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 7, p. 431, 1947 (JNCIAM); V03-L60 orl-rat TD :31250 mg/kg/35W-C Nippon Byori Gakkai Kaishi. Journal of the Japanese Pathological Society. (c/o Tokyo Daigaku Igakubu Byorigaku Kyoshitsu, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan) V.1- 1911- v. 24, p. 523, 1934 (NIBKAW); V03-J60-R60 orl-mus TD :3640 mg/kg/25W-C Arkhiv Biologicheskikh Nauk. Archives of Biological Sciences. For French translation, see ASBUAN. (Moscow, USSR) V.1-64, 1892-1941. Discontinued. v. 56(12), p. 53, 1939 (AKBNAE); V02-J60-L60 orl-mus TD :13440 mg/kg/32W-C Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 v. 34, p. 202, 1979 (FRPPAO); V03-K60-L60 imp-mus TD :3200 mg/kg/35W-C Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 86, p. 1374, 1978 (BEBMAE); V02-T65-L60 orl-mus TD :480 mg/kg (16-21D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 85, p. 201, 1978 (BEXBAN); V03-L60 orl-mus TD :34080 mg/kg/2Y-C Eksperimental'naya Onkologiya. Experimental Oncology. (V/O Mezhdunarodnaya Kniga, 113095 Mosow, USSR) V.1- 1979- v. 9(4), p. 73, 1987 (EKSODD) AT: T/E unlistd orl-rat LDLo: 1500 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 26, p. 619, 1966 (CNREA8); T/E unlistd orl-mus LDLo: 800 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 10, p. 927, 1950 (JNCIAM); T/E unlistd scu-mus LDLo: 1200 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 10, p. 927, 1950 (JNCIAM); T/E unlistd orl-dog LD50: 300 mg/kg "Prehled Prumyslove Toxikologie: Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986 -,1315,1986 (85JCAE) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 8, p. 61, 1975 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 8, p. 61, 1975 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- v. 23, p. 6, 1971 (AEHLAU); TOXICOLOGY REVIEW Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 71, p. 32, 1968 (ZEKBAI); TOXICOLOGY REVIEW Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- v. 13, p. 271, 1970 (ADCSAJ) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-SWITZERLAND: Carcinogen, JAN 1999; OEL-UNITED KINGDOM: Carcinogen, SEP 2000 ND: NOHS 1974: HZD M1409; NIS 6; TNF 200; NOS 14; TNE 3811; NOES 1983: HZD M1409; NIS 4; TNF 229; NOS 5; TNE 1449 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: N crassa-forward mutation, E coli polA with S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Negative: Host-mediated assay, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9, In vitro SCE-nonhuman; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1090 of 1119 in RTECS (through 2003/06) AN: XW5250000 PN: Toxaphene- SY: Agricide-maggot-killer- (F); Alltox-; Anatox-; Attac-4-2-; Attac-4-4-; Attac-6-; Attac-6-3-; Attac-8-; Camphechlor-; Camphochlor-; Camphoclor-; Camphofene-huileux-; Chlorinated-camphene-; Chlorinated-camphene- (OSHA); Chlorinated camphene 60% (ACGIH); Clor-Chem-T-590-; Compound-3956-; Cristoxo-90-; ENT-9,735-; Estonox-; Fasco-terpene-; Geniphene-; Hercules-3956-; Kamfochlor-; Latka-3956- (Czech); M-5055-; Melipax-; NCI-C00259-; PCC-; Phenacide-; Phenatox-; Polychlorocamphene-; RCRA-waste-number-P123-; Strobane-T-90-; Strobane-T-; Toxafeen- (Dutch); Toxakil-; Toxaphen- (German); Toxaphene- (OSHA); Toxaphene-fume-; Toxon-63-; Toxyphen-; Vertac-toxaphene-90- RN: Current: 8001-35-2 Previous: 8022-04-6 UD: 200210 MF: C10-H10-Cl8 MW: 413.80 WL: L55 A CYTJ CU1 D1 D1 XG XG XG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Natural-Product (N); Human-Data (P); Primary-Irritant (S); Reproductive-Effector (T) ID: skn-mam 500 mg MOD JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 149, p. 1135, 1952 (JAMAAP) ME: mmo-sat 100 ug/plate (+S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8(Suppl 7), p. 1, 1986 (ENMUDM); mmo-sat 500 ug/plate (-S9) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 205, p. 591, 1979 (SCIEAS); pic-esc 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 193, 1987 (MUREAV); cyt-ofs-mul 1500 ug/kg/10D-C Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- v. 94, p. 441, 1975 (BIZNAT); sce-hmn-lym 10 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 52, p. 221, 1983 (ARTODN); mtr-mus-emb 12400 ug/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 659, 1985 (PMRSDJ); sce-ham-lng 5 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 230, p. 29, 1990 (MUREAV); pic-esc 0.381 mmol/L (+S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 36, p. 206, 2000 (EMMUEG) RE: T01 orl-rat TDLo: 280 mg/kg (10W male) Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 45(5), p. 14, 1980 (GISAAA); T85 orl-rat TDLo: 900 ug/kg (5-22D preg) Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 9, p. 247, 1980 (AECTCV); T46 orl-rat TDLo: 150 mg/kg (7-16D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 15, p. 660, 1976 (BECTA6); T34 orl-rat TDLo: 250 mg/kg (7-16D preg) Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 15, p. 660, 1976 (BECTA6); T81 orl-mus TDLo: 375 mg/kg (8-12D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 10, p. 541, 1982 (JTEHD6); T46 orl-mus TDLo: 100 mg/kg (8D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 5, p. 3, 1985 (TCMUD8); T86-T91 orl-mus TDLo: 375 mg/kg (8-12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 4, p. 403, 1984 (TCMUD8); T59 orl-rat TDLo: 88 mg/kg (22D preg) "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); T59 orl-ham TDLo: 64 mg/kg (16D preg) "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); T59 orl-rat TDLo: 280 mg/kg (10W pre) "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); T59 orl-ham TDLo: 280 mg/kg (10W pre) "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*) TE: V03-P62 orl-rat TDLo: 30 gm/kg/80W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-137, 1979 (NCITR*); V01-L60 orl-mus TDLo: 6600 mg/kg/80W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-137, 1979 (NCITR*); V01-L60 orl-mus TD :13 gm/kg/80W-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-137, 1979 (NCITR*) ORNG: 50000000 ng/kg. [50.000000 mg/kg] T/E unlistd SRNG: 1025000000 ng/kg. [1025.000000 mg/kg] F13-F15-H05 SKNG: 600000000 ng/kg. [600.000000 mg/kg] T/E unlistd AT: F07-F12-F24 orl-hmn LDLo: 28 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 -,598,1969 (34ZIAG); F12-J24-J30 orl-man LDLo: 29 mg/kg "Clinical Memoranda on Economic Poisons," U.S. Dept. HEW, Public Health Service, Communicable Disease Center, Atlanta, GA, 1956 v. -, p. -, 1956 (CMEP**); R01 skn-hmn TDLo: 657 mg/kg "Clinical Memoranda on Economic Poisons," U.S. Dept. HEW, Public Health Service, Communicable Disease Center, Atlanta, GA, 1956 v. -, p. 1, 1956 (CMEP**); T/E unlistd unr-man LDLo: 44 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 50 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 17, p. 614, 1967 (ARZNAD); T/E unlistd skn-rat LD50: 600 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 13, 1978 (SPEADM); D17-J22-K12 ipr-rat LDLo: 70 mg/kg Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966- v. 19, p. 47, 1978 (BECTA6); T/E unlistd par-rat LD50: 90 mg/kg Defense des Vegetaux. (Federation Nationale des Groupements de Protection des Cultures, 149, rue de Bercy, 75595 Paris Cedex, 12, France) V.1- 1947- v. 26, p. 5, 1972 (DEVEAA); T/E unlistd unr-rat LD50: 240 mg/kg Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 8(1), p. 23, 1974 (CYGEDX); T/E unlistd orl-mus LD50: 112 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 13, 1978 (SPEADM); T/E unlistd ihl-mus LCLo: 2000 mg/m3/2H JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 149, p. 1135, 1952 (JAMAAP); T/E unlistd ipr-mus LD50: 42 mg/kg Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 22, p. 653, 1974 (JAFCAU); T/E unlistd unr-mus LD50: 45 mg/kg Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc., 150 Fifth Ave., New York, NY 10011) V.8- 1974- v. 8(1), p. 23, 1974 (CYGEDX); T/E unlistd orl-dog LD50: 15 mg/kg Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park, MD 20740) v. 78-1, p. 13, 1978 (SPEADM); T/E unlistd orl-rbt LD50: 75 mg/kg "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A054,1984 (85JFAN); F13-F15-H05 skn-rbt LD50: 1025 mg/kg Journal of Economic Entomology. (Entomological Soc. of America, 4603 Calvert Rd., College Park, MD 20740) V.1- 1908- v. 46, p. 702, 1953 (JEENAI); T/E unlistd orl-gpg LD50: 250 mg/kg "Wirksubstanzen der Pflanzenschutz und Schadlingsbekampfungsmittel," Perkow, W., Berlin, Verlag Paul Parey, 1971-1976 -,-,1971/1976 (85DPAN); T/E unlistd orl-ham LD50: 200 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 48, p. A192, 1979 (TXAPA9); T/E unlistd orl-dck LD50: 31 mg/kg Down to Earth. (Dow Chemical USA, Agricultural Products Dept., Midland, MI 48640) V.1- 1945- v. 35, p. 25, 1979 (DOEAAH); F22-J20-U28 ihl-mus LC50: 2000 mg/m3/2H "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 302, 1998 (VCVPS*); F22-J20-U28 orl-mus LD50: 45 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 302, 1998 (VCVPS*); F22-J20-U28 orl-rat LD50: 40 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 302, 1998 (VCVPS*); F22-J20-U28 orl-gpg LD50: 250 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 302, 1998 (VCVPS*); F22-J20-U28 orl-rbt LD50: 25 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 302, 1998 (VCVPS*); F22-F23 orl-dog LD50: 15 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 302, 1998 (VCVPS*); F22-F23 orl-cat TDLo: 70 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 302, 1998 (VCVPS*); T/E unlistd orl-rat TDLo: 300 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 302, 1998 (VCVPS*); Y20 orl-hmn LDLo: 60 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 303, 1998 (VCVPS*); F40-F11-J22 skn-rat LD50: 940 mg/kg "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 303, 1998 (VCVPS*) MD: L70-M70-Y07 orl-rat TDLo: 4186 mg/kg/13W-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 406, 1986 (FAATDF); L30 orl-rat TDLo: 328 mg/kg/39W-C AMA Archives of Pathology. (Chicago, IL) V.50(4)-69, 1950-60. For publisher information, see APLMAS. v. 64, p. 614, 1957 (AMPLAO); L70-Y03 orl-dog TDLo: 385 mg/kg/13W-I Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 406, 1986 (FAATDF); S02 orl-mky TDLo: 95 mg/kg/34W-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 54, p. 335, 2000 (TOXID9); L70-M04-U01 orl-gpg TDLo: 120 mg/kg/60D-I Journal of Environmental Biology. (Academy of Environmental Biology, India, 657/5, Civil Lines (South), Muzaffarnagar, 251001, India) V.1- 1980- v. 13, p. 315, 1992 (JEBIDP); A10-C06-F07 unr-ckn TDLo: 480 mg/kg/10D-I Fiziologichnyi Zhurnal. (Izdatel'stvo Naukova Dumka, ul. Repina, 3, 252601 Kiev, Ukraine) V. 24- 1978- v. 27, p. 557, 1981 (FIZHDO); N72-N75-U01 orl-qal TDLo: 126 mg/kg/18W-C Poultry Science. (Poultry Science Assoc., Inc., 309 W. Clark St., Champaign, IL 61820) V.1- 1921- v. 53, p. 125, 1974 (POSCAL); N30 orl-rat TDLo: 1875 mg/kg/25D-I Regulatory Toxicology and Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- v. 24, p. 184, 1996 (RTOPDW); P28 orl-mky TDLo: 6.3 mg/kg/9W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 467, 2001 (FCTOD7); P28-R03-R22 orl-mky TDLo: 392 mg/kg/70W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 467, 2001 (FCTOD7); S04 orl-mky TDLo: 148 mg/kg/53W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 947, 2001 (FCTOD7); S02-S04 orl-mky TDLo: 296 mg/kg/46W-I Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 947, 2001 (FCTOD7); S04 orl-mky TDLo: 268 mg/kg/34W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 1243, 2001 (FCTOD7); N73-N74 orl-mky TDLo: 364 mg/kg/52W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 1243, 2001 (FCTOD7); L70-N19-N73 orl-mky TDLo: 364 mg/kg/52W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 39, p. 1243, 2001 (FCTOD7); F07-F15-S02 orl-rat TDLo: 120 mg/kg/4W-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); Q30 orl-rbt TDLo: 456.2 mg/kg/26W-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); Z01 unr-mam TDLo: 73 gm/kg/2Y-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); T12 orl-rat TDLo: 88 mg/kg/22D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); T12 orl-ham TDLo: 64 mg/kg/16D-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); T12 orl-rat TDLo: 280 mg/kg/10W-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); T12 orl-ham TDLo: 280 mg/kg/10W-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*); G04-F03-F27 ihl-hmn TCLo: 20 mg/m3/3Y-I "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998. v. -, p. 304, 1998 (VCVPS*) TR: ACGIH TLV-TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 1 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.5 mg/m3;STEL 1 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); TOXICOLOGY REVIEW Annals of Allergy. (American College of Allergists, POB 20671, Bloomington, MN 55420) V.1- 1943- v. 35, p. 165, 1975 (ANAEA3); TOXICOLOGY REVIEW Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970. v. 80, p. 485, 1973 (DTTIAF); TOXICOLOGY REVIEW Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 56, p. 107, 1975 (RREVAH) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); MSHA STANDARD-air: TWA 0.5 mg/m3 (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 45, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 0.5 mg/m3 (skin) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-AUSTRALIA: TWA 0.5 mg/m3, STEL 1 mg/m3, Skin, JAN 1993; OEL-AUSTRIA: MAK 0.5 mg/m3, Skin, JAN 1999; OEL-BELGIUM: TWA 0.5 mg/m3, STEL 1 mg/m3, Skin, JAN 1993; OEL-DENMARK: TWA 0.5 mg/m3, Skin, JAN 1999; OEL-FINLAND: TWA 0.5 mg/m3, STEL 1.5 mg/m3, Skin, JAN 1999; OEL-FRANCE: VME 0.5 mg/m3, Skin, C3 Carcinogen, JAN 1999; OEL-GERMANY: MAK 0.5 mg/m3 (total dust), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.5 mg/m3, Skin, JAN 1999; OEL-NORWAY: TWA 0.5 mg/m3, JAN 1999; OEL-THE PHILIPPINES: TWA 0.5 mg/m3, Skin, JAN 1993; OEL-SWITZERLAND: MAK-W 0.5 mg/m3, Skin, JAN 1999; OEL-THAILAND: TWA 0.5 mg/m3, JAN 1993; OEL-TURKEY: TWA 0.5 mg/m3, Skin, JAN 1993; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO CHLORINATED CAMPHENE-air: CA lowest feasible conc. National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 73500; NIS 1; TNF 68; NOS 2; TNE 203 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/97/121057/AS); EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Chlorinated camphene, 5039; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-37, 1979 (NCITR*); NCI Carcinogenesis Bioassay (feed), equivocal evidence: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-37, 1979 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1091 of 1119 in RTECS (through 2003/06) AN: XY2625000 PN: Triazene,-1,3-diphenyl- SY: Aniline, N-(phenylazo)-; DAAB-; Diazoaminobenzen- (Czech); Diazoaminobenzene-; p-Diazoaminobenzene-; Diazoaminobenzol- (German); 1,3-Diphenyltriazene-; Cellofor- (Czech) RN: Current: 136-35-6 BRN: 957560 BHR: 4-16-00-00904 UD: 200012 MF: C12-H11-N3 MW: 197.26 WL: RNUNMR CC: Tumorigen (C); Mutagen (M) ME: mmo-sat 300 ng/plate (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 9(Suppl 9), p. 1, 1987 (ENMUDM) TE: V03-K60 orl-mus TDLo: 1480 mg/kg/59D-C Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 29, p. 209, 1935 (GANNA2); V03-R60-V10 skn-mus TDLo: 30 gm/kg/46W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 2, p. 290, 1948 (BJCAAI) MD: L70-N73-P05 skn-rat TDLo: 2400 mg/kg/16D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 109(Suppl 1), p. 69, 1999 (TOLED5); L70-N73-P05 skn-mus TDLo: 2400 mg/kg/16D-I Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 109(Suppl 1), p. 69, 1999 (TOLED5) SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (prechronic studies), October 2000 Record 1092 of 1119 in RTECS (through 2003/06) AN: XY5250000 PN: s-Triazine, 2-chloro-4,6-bis(ethylamino)- SY: A-2079-; Aktinit-S-; Aquazine-; Azotop-; Batazine-FLO-; 2,4-Bis(aethylamino)-6-chlor-1,3,5-triazin (German); CET-; 2-Chloro-4,6-bis(ethylamino)-s-triazine; 2-Chloro-4,6-bis(ethylamino)-1,3,5-triazine; 6-Chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine-; G-27692-; Geigy-27,692-; Gesatop-; Gesatop-50-; Premazine-; Primatol-S-; Princep-; Printop-; Radocon-; Radokor-; Simanex-; Simatsin-neste-; Simazin-; Simazine-; Simazine-80W-; Symazine-; Tafazine-; Tafazine-50-W-; Taphazine-; 2,4-Bis(ethylamino)-6-chloro-s-triazine; Bitemol-S-50-; CAT- (herbicide); CDT-; Cekusan-; Cekusima-; Cekuzina-S-; H-1803-; Herbatoxol-S-; Herbazin-; Herbazin-50-; Herbex- (pesticide); Herboxy-; Hungazin-DT-; Triazine-A-384-; 1,3,5-Triazine-2,4-diamine,-6-chloro-N,N'-diethyl- (9CI); W-6658-; Yrodazin- RN: Current: 122-34-9 Previous: 11141-20-1; 12764-71-5; 39291-64-0; 119603-94-0 BRN: 10895 BHR: 4-26-00-01208 UD: 200302 MF: C7-H12-Cl-N5 MW: 201.69 WL: T6N CN ENJ BM2 DM2 FG CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Primary-Irritant (S) ID: skn-rbt 500 mg open MLD Ciba-Geigy Toxicology Data/Indexes. (Ciba-Geigy Corp., 556 Morris Ave., Summit, NJ 07901) v. -, p. -, 1977 (CIGET*); eye-rbt 80 mg MOD Ciba-Geigy Toxicology Data/Indexes. (Ciba-Geigy Corp., 556 Morris Ave., Summit, NJ 07901) v. -, p. -, 1977 (CIGET*) ME: sln-dmg-par 396 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 691, 1977 (JTEHD6); sln-dmg-orl 2000 ppm Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 15, p. 867, 1980 (JPFCD2); dlt-dmg-par 396 umol/L Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 691, 1977 (JTEHD6); dlt-dmg-orl 6000 ppm Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 3, p. 691, 1977 (JTEHD6); sce-hmn-lym 1 mg/L Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 60, p. 2149, 1984 (BSIBAC); msc-mus-lym 400 mg/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-138973 (NTIS**) RE: T25-T26 orl-rat TDLo: 3120 mg/kg (6-15D preg) Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 15, p. 83, 1981 (CHYCDW); T46 orl-rat TDLo: 780 mg/kg (6-15D preg) Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 15, p. 83, 1981 (CHYCDW); T34 orl-rat TDLo: 25 gm/kg (6-15D preg) Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. v. 15, p. 83, 1981 (CHYCDW); T19 orl-rat TDLo: 500 mg/kg (6-15D preg) Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 15, p. 315, 1990 (NNGADV); T34-T46 ihl-rat TCLo: 17 mg/m3/2H (7-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB277-077 (NTIS**); T19-T25 orl-rat TDLo: 6 gm/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0535324 (NTIS**); T19 orl-rbt TDLo: 975 mg/kg (7-19D preg) Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 15, p. 315, 1990 (NNGADV) TE: V03-R60 orl-rat TDLo: 4380 mg/kg/2Y-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0543187 (NTIS**); V03-K60-V10 scu-rat TDLo: 16 gm/kg/61W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 16(1), p. 82, 1970 (VOONAW); V03-V10 scu-mus TDLo: 35 gm/kg/87W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 16(1), p. 82, 1970 (VOONAW); V01-T69 orl-rat TDLo: 36.5 gm/kg/2Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1514, 2001 (HBPTO*) ORNG: 971000000 ng/kg. [971.000000 mg/kg] T/E unlistd IHNG: 9800000000 ng/m3/4H. [9800.000000 mg/m3/4H] T/E unlistd AT: T/E unlistd orl-rat LD50: 971 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 299, 1986 (FAATDF); T/E unlistd ihl-rat LC50: 9800 mg/m3/4H Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C275, 1991 (FMCHA2); T/E unlistd skn-rat LD50: >5 gm/kg Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 15, p. 315, 1990 (NNGADV); F18-K12-M10 orl-mus LDLo: 5 gm/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 27(8), p. 22, 1962 (GISAAA); T/E unlistd ivn-mus LD50: 100 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#04003 (CSLNX*); T/E unlistd unr-rat LD50: 1390 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 7(5), p. 54, 1963 (GTPZAB); T/E unlistd orl-rbt LD50: >5 gm/kg "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A369,1984 (85JFAN); T/E unlistd skn-rbt LD50: >10200 mg/kg Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- v. 37, p. 427, 1986 (YKYUA6); T/E unlistd orl-pgn LD50: >5 gm/kg "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A369,1984 (85JFAN); T/E unlistd orl-ckn LD50: >5 gm/kg "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc. of Chemistry, 1983-86 A369,1984 (85JFAN); F07-F23-R21 orl-mam LD50: 2014 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB288-416 (NTIS**); T/E unlistd unr-mam LD50: 1400 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 44(6), p. 81, 1979 (GISAAA) MD: F15-P73-U01 orl-rat TDLo: 43680 mg/kg/2Y-C Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 15, p. 315, 1990 (NNGADV); L30-P71-U01 orl-rat TDLo: 10 gm/kg/7W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 7(5), p. 54, 1963 (GTPZAB); M30 orl-rat TDLo: 21840 mg/kg/13W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0555005 (NTIS**); F15-P05-U01 orl-mus TDLo: 79800 mg/kg/95W-C Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 15, p. 315, 1990 (NNGADV); F15-U01 orl-dog TDLo: 4550 mg/kg/13W-C Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 15, p. 315, 1990 (NNGADV); P05-U01 orl-dog TDLo: 910 mg/kg/52W-C Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 15, p. 315, 1990 (NNGADV); N72-U01 orl-rat TDLo: 4200 mg/kg/14D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 43, p. 155, 1994 (JTEHD6); N30 orl-rat TDLo: 1400 mg/kg/14D-I Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 43, p. 155, 1994 (JTEHD6); T13-V05 orl-rat TDLo: 600 mg/kg/2D-I Journal of Toxicology and Environmental Health, Part A. (Taylor and Francis, 47 Runway Rd., Suite G, Levittown, PA 19057) V.53- 1998- v. 43, p. 183, 1994 (JTEHF8); U01 orl-rat TDLo: 11.34 gm/kg/90D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1512, 2001 (HBPTO*); U01 orl-dog TDLo: 12.06 gm/kg/90D-I Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1512, 2001 (HBPTO*); U01 orl-mus TDLo: 72.27 gm/kg/78W-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1514, 2001 (HBPTO*); U01 orl-rat TDLo: 3869 mg/kg/2Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1514, 2001 (HBPTO*); P30-Z01 orl-rat TDLo: 3869 mg/kg/2Y-C Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001 v. 2, p. 1514, 2001 (HBPTO*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 625, 1999 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 495, 1991 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 495, 1991 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 625, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 73, p. 625, 1999 (IMEMDT); TOXICOLOGY REVIEW Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970. v. 80, p. 485, 1973 (DTTIAF) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD M4125; NIS 1; TNF 29; NOS 1; TNE 173; NOES 1983: HZD M4125; NIS 1; TNF 13; NOS 6; TNE 356 SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-nondisjunction; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-partial sex chrom. loss; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 1093 of 1119 in RTECS (through 2003/06) AN: XZ3017500 PN: 1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- SY: 4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one; 5-AC-; 5-Azacytidine-; Antibiotic-U-18496-; Azacitidine-; Azacytidine-; Ladakamycin-; Mylosar-; NCI-C01569-; NSC-102816-; U-18496-; WR-183027-; s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- (8CI) RN: Current: 320-67-2 BRN: 620461 UD: 200210 MF: C8-H12-N4-O5 MW: 244.24 WL: T6NVN ENJ DZ A- BT5OTJ CQ DQ E1Q CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 45 mg/24H rinse Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 14, p. 117, 1979 (TXCYAC) ME: mmo-sat 2 ug/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 121, p. 1, 1983 (MUREAV); mmo-sat 3 ug/plate (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 19(Suppl 21), p. 2, 1992 (EMMUEG); mmo-esc 1 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 193, p. 229, 1988 (MUREAV); oms-esc 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 193, p. 229, 1988 (MUREAV); pic-esc 20 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 166, p. 9, 1986 (MUREAV); mmo-omi 10 mg/L (-S9) Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 74, p. 154, 1976 (VIRLAX); mmo-omi 15 mg/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 16, p. 1000, 1975 (JOVIAM); mmo-omi 5 mg/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 2, p. 1228, 1968 (JOVIAM); mmo-omi 25 mg/L (-S9) Journal of Virology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1967- v. 7, p. 295, 1971 (JOVIAM); oms-omi 25 gm/L Microbial Genetics Bulletin. (Ohio State Univ., College of Biological Science, Dept. of Microbiology, 484 W. 12th Ave., Columbus, OH 43210) No.1- 1950- v. 30, p. 9, 1969 (MGBUA3); slt-dmg-orl 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 195, 1985 (MUREAV); mrc-dmg-orl 244 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 266, p. 93, 1992 (MUREAV); sln-dmg-orl 1 gm/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 135, 1989 (EMMUEG); dnd-hmn-hla 120 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 226, p. 185, 1989 (MUREAV); dnd-hmn-fbr 1 umol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 2352, 1982 (PNASA6); dni-hmn-oth 5 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 2155, 1988 (CRNGDP); dni-hmn-leu 3 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 763, 1983 (CNREA8); cyt-hmn-lym 10 umol/L Human Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.31- 1976- v. 71, p. 342, 1985 (HUGEDQ); sce-hmn-lym 9 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 14, p. 6, 1989 (EMMUEG); msc-hmn-lym 100 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 160, p. 249, 1986 (MUREAV); dns-rat-ipr 50 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 37, 1976 (CNREA8); oms-rat-scu 25 mg/kg Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 32, p. 293, 1985 (NEOLA4); mnt-mus-ipr 39 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 271, p. 13, 1992 (MUREAV); mnt-mus-lym 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 300, p. 165, 1993 (MUREAV); mtr-mus-fbr 750 ug/L Cell Biology International Reports. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 10, p. 789, 1986 (CBRPDS); mtr-mus-emb 250 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2202, 1977 (CNREA8); dns-mus-ipr 3 mg/kg Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 20, p. 243, 1973 (NEOLA4); dni-mus-ipr 7143 ug/kg/3D-C Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 12, p. 3, 1965 (NEOLA4); oms-mus-ipr 7143 ug/kg/3D-C Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 12, p. 3, 1965 (NEOLA4); oms-mus-ipr 3 mg/kg Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 20, p. 243, 1973 (NEOLA4); oms-mus-emb 10 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 30, p. 1463, 1974 (EXPEAM); cyt-mus-ipr 3 mg/kg Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 20, p. 243, 1973 (NEOLA4); cyt-mus-emb 10 umol/L Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 30, p. 1463, 1974 (EXPEAM); msc-mus-lym 22 ug/L/3H-C Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 27, p. 90, 1986 (PAACA3); mnt-ham-emb 5 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 21, 1992 (MUREAV); mtr-ham-emb 200 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 21, 1992 (MUREAV); oms-ham-emb 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 283, p. 21, 1992 (MUREAV); cyt-ham-emb 5 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2202, 1977 (CNREA8); cyt-ham-lng 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 212, p. 253, 1989 (MUREAV); sce-ham-ovr 10 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 8, p. 1059, 1987 (CRNGDP); sce-ham-fbr 2500 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 39, p. 797, 1979 (CNREA8); msc-ham-lng 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 212, p. 253, 1989 (MUREAV); msc-ham-ovr 12 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 28, p. 100, 1996 (EMMUEG); cyt-mam-lym 400 nmol/L Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.12- 1973- v. 41, p. 71, 1986 (CGCGBR); cyt-mus-fbr 1 umol/L/8H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 109, 2001 (MUTAEX); cyt-hmn-oth 20 umol/L/5H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 109, 2001 (MUTAEX); cyt-hmn-mmr 6 umol/L/8H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 109, 2001 (MUTAEX) RE: T25 ipr-rat TDLo: 5 mg/kg (5D preg) International Journal of Developmental Biology. (University of the Basque Country Press, POB 1397, E-48080, Bilbao, Spain) V.33- 1989- v. 43, p. 843, 1999 (IJDBE5); T34-T35 ipr-rat TDLo: 1 mg/kg (9D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 29, p. 201, 1990 (JTEHD6); T34-T46 ipr-rat TDLo: 600 ug/kg (13D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 29, p. 59, 1989 (CGANE7); T72-T81-T85 ipr-rat TDLo: 4 mg/kg (17D preg) Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 22, p. 963, 1984 (FCTOD7); T46 ipr-rat TDLo: 450 ug/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 35, p. 247, 1987 (TJADAB); T72-T75 ipr-mus TDLo: 5 mg/kg (12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 7, 1987 (TCMUD8); T34-T35 ipr-mus TDLo: 500 ug/kg (7D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 41, p. 147, 1990 (TJADAB); T33-T41 ipr-mus TDLo: 1 mg/kg (7D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 30(1), p. 9A, 1984 (TJADAB); T25-T34-T41 ipr-mus TDLo: 2 mg/kg (10D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 55, p. 143, 1984 (ARTODN); T43-T46-T59 ipr-mus TDLo: 2 mg/kg (11D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 55, p. 143, 1984 (ARTODN); T81-T85 par-mus TDLo: 500 ug/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 19, p. 327, 1979 (TJADAB); T86 par-mus TDLo: 100 ug/kg (12D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 193, p. 665, 1979 (ANREAK); T41 par-mus TDLo: 500 ug/kg (12D preg) Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information, see NTOTDY. v. 1, p. 129, 1979 (NETOD7); T81 unr-mus TDLo: 500 ug/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 17, p. 43A, 1978 (TJADAB); T33 unr-mus TDLo: 4 mg/kg (15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 4, p. 234, 1971 (TJADAB) TE: V03-J60-T61 ipr-rat TDLo: 190 mg/kg/38W-I Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 1583, 1984 (CRNGDP); V01-P62-R60 ipr-mus TDLo: 100 mg/kg/50W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 37, p. 51, 1987 (CALEDQ); V01-T65-P62 unr-mus TDLo: 1 mg/kg (16D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 32, p. 33A, 1985 (TJADAB); V02-P62 ipr-mus TD :284 mg/kg/43W-I National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-42, 1978 (NCITR*); V02-J60 ipr-mus TD :100 mg/kg/50W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 37, p. 51, 1987 (CALEDQ); V02-J60 ipr-mus TD :90 mg/kg/8W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 3069, 1973 (CNREA8); V01-P62-T65 ipr-mus TD :1 mg/kg (12D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 27, p. 81, 1985 (CALEDQ) AT: P14-P15 ivn-wmn TDLo: 6 mg/kg/10D-I Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 56, p. 413, 1972 (CCROBU); K12-K13 ivn-wmn TDLo: 500 ug/kg Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 56, p. 413, 1972 (CCROBU); T/E unlistd orl-mus LD50: 572 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 19, p. 382, 1971 (TXAPA9); T/E unlistd ipr-mus LD50: 68 mg/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 22, p. 53, 1966 (EXPEAM); F19-K12-U01 ivn-mus LD50: 229 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-211432 (NTIS**); P30 ivn-dog LD50: 7200 ug/kg Advances in Pharmacology and Chemotherapy. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.7-20, 1969-84. v. 14, p. 285, 1977 (AVPCAQ); T/E unlistd orl-qal LD50: >100 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 6, p. 149, 1982 (EESADV); T/E unlistd orl-bwd LD50: 100 mg/kg Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- v. 12, p. 355, 1983 (AECTCV) MD: F07-F23-U01 ivn-mus TDLo: 32500 ug/kg/5D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-211432 (NTIS**); P26-Y15-Z01 ivn-mky TDLo: 30800 ug/kg/14D-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB210-642 (NTIS**); P14-U01-Z01 ipr-ham TDLo: 180 mg/kg/9W-I Experimental and Molecular Pathology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1962- v. 53, p. 34, 1990 (EXMPA6) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 37, 1981 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 47, 1990 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 37, 1981 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 47, 1990 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 50, p. 47, 1990 (IMEMDT) ND: NOES 1983: HZD X5101; NIS 1; TNF 88; NOS 3; TNE 1069; TFE 698 SL: EPA GENETOX PROGRAM 1988, Positive: Cell transform.-C3H/10T1/2; EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; NCI Carcinogenesis Bioassay (ipr), clear evidence: mouse National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-42, 1978 (NCITR*); NCI Carcinogenesis Bioassay (ipr), inadequate studies: rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-42, 1978 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1094 of 1119 in RTECS (through 2003/06) AN: XZ3850000 PN: s-Triazole,-3-amino- SY: 1H-1,2,4-Triazol-3-amine-; 3,A-T-; 3-Amino-1,2,4-triazole-; 3-Amino-1,2,4-triazole- (ACGIH); 3-Amino-1H-1,2,4-triazole-; 3-Amino-s-triazole-; 3-Aminotriazole-; AT-; ATA-; Amino-triazole-weedkiller-90-; Aminotriazol-spritzpulver-; Aminotriazole- (plant regulator); Amitol-; Amitrol-; Amitrol-90-; Amitrol-T-; Amitrole-; Amitrole- (ACGIH); Amizol-; Campaprim-A-1544-; Cytrol-; Cytrole-; Diurol-; Diurol-5030-; ENT-25445-; Elmasil-; Emisol-; Emisol-50-; Emisol-F-; Herbidal-total-; Herbizole-; Kleer-lot-; Orga-414-; RCRA-waste-number-U011-; Radoxone-TL-; Ramizol-; Simazol-; Solution-concentree-T271-; Triazolamine-; USAF-XR-22-; Vorox-; Vorox-AA-; Vorox-AS-; Weedar-ADS-; Weedar-AT-; Weedazin-; Weedazin-arginit-; Weedazol-; Weedex-granulat-; X-All-liquid- RN: Current: 61-82-5 Previous: 155-25-9 UD: 200302 MF: C2-H4-N4 MW: 84.10 WL: T5MN DNJ CZ CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 50 ug/plate (-S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 351, 1981 (PMRSDJ); mmo-esc 50 ug/plate (+S9) Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 351, 1981 (PMRSDJ); dna-esc 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 15 gm/L Virology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1955- v. 99, p. 257, 1979 (VIRLAX); dnd-bcs 1 mg/disc Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 175, 1981 (PMRSDJ); mmo-omi 1 mg/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 277, 1978 (MUREAV); slt-dmg-orl 500 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 242, p. 169, 1990 (MUREAV); dnr-smc 100 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 502, 1981 (PMRSDJ); mrc-smc 300 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 491, 1981 (PMRSDJ); sln-smc 50 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 468, 1981 (PMRSDJ); mrc-asn 600 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 288, 1985 (MUREAV); sln-asn 600 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 288, 1985 (MUREAV); dni-hmn-fbr 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 183, p. 89, 1987 (MUREAV); mtr-rat-emb 80 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); mtr-mus-emb 125 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 21, 1988 (EMMUEG); hma-mus-sat 12 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); mtr-ham-emb 10 mg/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 7, p. 211, 1981 (TOLED5); mtr-ham-kdy 250 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 1, p. 638, 1981 (PMRSDJ); msc-ham-emb 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 140, p. 205, 1984 (MUREAV); mtr-mus-fbr 0.01 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T52 orl-rat TDLo: 700 ug/kg (22D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 145, p. 284, 1963 (ANREAK); T34 orl-mus TDLo: 2600 mg/kg (6-18D preg) Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 33, p. 41, 1974 (ARTODN); T34-T35 orl-mus TDLo: 1935 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**); T26-T34-T35 scu-mus TDLo: 4176 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**) TE: V01-N60-N62 orl-rat TDLo: 4595 mg/kg/2.5Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 69, p. 161, 1983 (TXAPA9); V01-L60 orl-mus TDLo: 113 gm/kg/3W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 42, p. 1101, 1969 (JNCIAM); V02-N62 orl-rat TD :3670 mg/kg/2Y-C Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 132, p. 296, 1960 (SCIEAS); V01-N62 orl-rat TD :122 gm/kg/70W-C Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 57, p. 861, 1976 (JNCIAM); V01-N62 orl-rat TD :105 gm/kg/60W-C Nagoya Medical Journal. (Nagoya City Univ. Medical School, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan) V.1- 1953- v. 23, p. 83, 1978 (NMJOAA); V03-L60 orl-mus TD :366 gm/kg/26W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 29, p. 145, 1985 (TOLED5) ORNG: 1100000000 ng/kg. [1100.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1100 mg/kg Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- v. 10, p. 97, 1965 (RREVAH); T/E unlistd skn-rat LD50: >10 gm/kg World Review of Pest Control. (London, UK) V.1-10, 1962-71. Discontinued. v. 9, p. 119, 1970 (WRPCA2); T/E unlistd orl-mus LD50: 14700 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 33, 1966 (PCOC**); T/E unlistd ipr-mus LD50: 200 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd ivn-mus LD50: >5 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 13, p. 597, 1977 (OYYAA2); T/E unlistd orl-qal LD50: >316 mg/kg Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 6, p. 149, 1982 (EESADV) MD: N05 orl-rat TDLo: 313 mg/kg/90D-C Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3), 1977-81(?). For publisher information, see JEPOEC. v. 1(1), p. 147, 1977 (JEPTDQ); N30-P28 orl-ham TDLo: 4704 mg/kg/28W-C Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 60, p. 343, 1987 (ARTODN); N30 orl-rat TDLo: 300 mg/kg/3D-C Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 94, p. 131, 1982 (JOENAK); N05 orl-rat TDLo: 700 mg/kg/7D-C Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 94, p. 131, 1982 (JOENAK); N05 orl-rat TDLo: 26250 mg/kg/30W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 57, p. 861, 1976 (JJIND8); N60 orl-rat TDLo: 61250 mg/kg/70W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 57, p. 861, 1976 (JJIND8) TR: ACGIH TLV-TWA 0.2 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Confirmed Animal Carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 0.2 mg/m3 The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 31, 1974 (IMEMDT); IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 7, p. 31, 1974 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); TOXICOLOGY REVIEW Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970. v. 80, p. 485, 1973 (DTTIAF); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,250,1970 (85CVA2) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-AUSTRALIA: TWA 0.2 mg/m3, JAN 1993; OEL-AUSTRIA: MAK 0.2 mg/m3, JAN 1999; OEL-BELGIUM: TWA 0.2 mg/m3, JAN 1993; OEL-DENMARK: TWA 0.2 mg/m3, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-GERMANY: MAK 0.2 mg/m3, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.2 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 0.2 mg/m3, JAN 1999; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO AMITROLE-air: 8H CA TWA 0.2 mg/m3 National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOES 1983: HZD 84718; NIS 3; TNF 8; NOS 4; TNE 693; TFE 24 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, SHE-clonal assay; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo, Host-mediated assay; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Negative: D melanogaster-nondisjunction, N crassa-aneuploidy; EPA GENETOX PROGRAM 1988, Negative: E coli polA without S9, E coli polA with S9; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1095 of 1119 in RTECS (through 2003/06) AN: YE0175000 PN: Triethylamine- SY: (Diethylamino)ethane; N,N-Diethylethanamine-; Ethanamine,-N,N-diethyl-; TEN-; Triaethylamin- (German); Triethylamine- (ACGIH:OSHA); Trietilamina- (Italian) RN: Current: 121-44-8 UD: 200210 MF: C6-H15-N MW: 101.22 WL: 2N2&2 CC: Tumorigen (C); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 365 mg open MLD Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817) 3/23/1970 (UCDS**) ME: cyt-rat-ihl 1 mg/m3 Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 36(11), p. 9, 1971 (GISAAA) ORNG: 460000000 ng/kg. [460.000000 mg/kg] T/E unlistd SRNL: 570000 nL/kg. [0.570000 mL/kg] T/E unlistd AT: D14 ihl-hmn TCLo: 12 mg/m3/11W-C International Archives of Occupational and Environmental Health. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.35- 1975- v. 57, p. 297, 1986 (IAEHDW); D14-D26-D35 ihl-hmn TCLo: 6500 ug/m3/4H Occupational and Environmental Medicine. (BMJ Publishing Group, POB 299, London WC1H 9TD, United Kingdom) V.51- 1994- v. 56, p. 1, 1999 (OEMEEM); D26 ihl-hmn TCLo: 20 mg/m3/8H Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 4, p. 45, 1990 (WDZAEK); T/E unlistd orl-rat LD50: 460 mg/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); T/E unlistd ihl-rat LCLo: 1000 ppm/4H AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); T/E unlistd ipr-rat LDLo: 75 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 31, p. 238, 1968 (FATOAO); F07-F13-F18 orl-mus LD50: 546 mg/kg Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71. Discontinued. v. 30(7-9), p. 351, 1965 (HYSAAV); F07-J30-L03 ihl-mus LC50: 6 gm/m3 Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 7, p. 56, 1965 (TPKVAL); T/E unlistd ipr-mus LD50: 405 mg/kg Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- v. 97, p. 1117, 1977 (YKKZAJ); T/E unlistd skn-rbt LD50: 570 uL/kg AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. v. 4, p. 119, 1951 (AMIHBC); T/E unlistd ihl-gpg LCLo: 1000 ppm/4H Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 30, p. 2, 1948 (JIHTAB); T/E unlistd ihl-mam LC50: 6 gm/m3 Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 14, p. 80, 1975 (TPKVAL) MD: U01 orl-rat TDLo: 4223 mg/kg/11W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 30(9), p. 28, 1965 (GISAAA); A30 orl-rat TDLo: 210 mg/kg/30W-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 4, p. 45, 1990 (WDZAEK); J06-P73-U01 ihl-rat TCLo: 50 mg/m3/3H/26W-I Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow, USSR) No.1- 1961- v. 7, p. 56, 1965 (TPKVAL); J30 ihl-mus TCLo: 3 mg/m3/3H/26W-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 4, p. 45, 1990 (WDZAEK); G30-J30-L30 ihl-rbt TCLo: 420 mg/m3/7H/6W-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 4, p. 45, 1990 (WDZAEK) TR: ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 3 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 1 ppm (skin) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*) SR: MSHA STANDARD-air: TWA 25 ppm (100 mg/m3) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 268, 1971 (DTLVS*); OSHA PEL (Gen Indu): 8H TWA 25 ppm (100 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 25 ppm (100 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 25 ppm (100 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 25 ppm (100 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRALIA: TWA 10 ppm (40 mg/m3), STEL 15 ppm, JAN 1993; OEL-AUSTRIA: MAK 2.5 ppm (10 mg/m3), JAN 1999; OEL-BELGIUM: TWA 10 ppm (41 mg/m3), STEL 15 ppm, JAN 1993; OEL-DENMARK: TWA 10 ppm (40 mg/m3), JAN 1999; OEL-FINLAND: TWA 10 mg/m3, STEL 20 mg/m3, Skin, JAN 1999; OEL-FRANCE: VLE 10 ppm (40 mg/m3), JAN 1999; OEL-GERMANY: MAK 10 ppm (40 mg/m3), JAN 1999; OEL-HUNGARY: TWA 20 mg/m3, STEL 40 mg/m3, JAN 1993; OEL-THE NETHERLANDS: MAC-TGG 5 ppm (20 mg/m3), MAC-K 10 ppm, Skin, JAN 1999; OEL-NORWAY: TWA 10 ppm (40 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 25 ppm (100 mg/m3), JAN 1993; OEL-RUSSIA: STEL 10 mg/m3, Skin, JAN 1993; OEL-SWEDEN: NGV 2 ppm (8 mg/m3), KTV 10 ppm (40 mg/m3), JAN 1999; OEL-SWITZERLAND: MAK-W 10 ppm (40 mg/m3), KZG-W 20 ppm (80 mg/m3), JAN 1999; OEL-TURKEY: TWA 25 ppm (100 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 10 ppm (42 mg/m3), STEL 15 ppm (63 mg/m3), SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NOHS 1974: HZD 74175; NIS 15; TNF 959; NOS 21; TNE 10558; NOES 1983: HZD X6415; NIS 1; TNF 5; NOS 1; TNE 622; TFE 55; NOES 1983: HZD 74175; NIS 74; TNF 3153; NOS 52; TNE 68091; TFE 9701 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP Carcinogenesis studies, selected, October 2000 Record 1096 of 1119 in RTECS (through 2003/06) AN: YJ7700000 PN: Trioctanoin- SY: Octanoic-acid,-1,2,3-propanetriyl-ester-; Octanoic-acid-triglyceride-; Octanoin,-tri- (8CI); Caprylic-acid-triglyceride-; Glycerol-tricaprylate-; Glycerol-trioctanoate-; Glyceryl-trioctanoate-; Panacete-800-; Rato-; Sefsol-800-; Tricaprylic-glyceride-; Tricaprylin-; Trioctanoylglycerol- RN: Current: 538-23-8 BRN: 1717202 BHR: 4-02-00-00991 UD: 200302 MF: C27-H50-O6 MW: 470.77 WL: 7VO1YOV7&1OV7 CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) RE: T76-T81 orl-rat TDLo: 250 gm/kg (7D pre-21D post) Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 3, p. 180, 1972 (IYKEDH) TE: V02-K60 orl-rat TDLo: 2600 mL/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-426, 1994 (NTPTR*); V02-K60 orl-rat TDLo: 2575000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-103958 (NTIS**) ORNG: 33300000000 ng/kg. [33300.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 33300 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); F17 ipr-rat LD :>27800 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); F17 scu-rat LD :>27800 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); T/E unlistd ivn-rat LDLo: 4 gm/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); T/E unlistd orl-mus LD50: 29600 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); F17 ipr-mus LD :>27800 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); F17 scu-mus LD :>27800 mg/kg Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); F23 ivn-mus LD50: 3700 mg/kg Acta Physiologica Scandinavica. (Karolinska Institutet, S-10401 Stockholm, Sweden) V.1- 1940- v. 40, p. 338, 1957 (APSCAX) MD: M70-Z01-Z73 orl-rat TDLo: 1860 mg/kg/31D-I Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); L30-P28-Z01 orl-rat TDLo: 4368 mg/kg/26W-I Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 4, p. 871, 1970 (OYYAA2); P61-V30 orl-rat TDLo: 5150000 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB95-103958 (NTIS**) ND: NOES 1983: HZD X7437; NIS 1; TNF 16; NOS 1; TNE 1430; TFE 996 SL: EPA GENETOX PROGRAM 1988, Inconclusive: Mouse spot test; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP Carcinogenesis studies (gavage) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-426, 1994 (NTPTR*) Record 1097 of 1119 in RTECS (through 2003/06) AN: YM4730000 PN: 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol, 6-beta,7-beta-epoxy-, (-)-tropate (ester),hydrobromide, trihydrate SY: Beldavrin-; Kwells-; Screen-; Scopos-; Scopolamine-hydrobromide-trihydrate-; Tripton- RN: Current: 6533-68-2 UD: 200302 MF: C17-H21-N-O4.Br-H.3 H2-O MW: 438.37 CC: Tumorigen (C); Drug (D); Mutagen (M) ME: mnt-ham-emb 3500 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 392, p. 61, 1997 (MUREAV) AT: F07-F12-J22 scu-mus LD50: 1413 mg/kg Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- v. 17, p. 60, 1970 (TOIZAG) MD: U01 orl-rat TDLo: 4800 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-445, 1997 (NTPTR*); N74-U01 orl-rat TDLo: 1470 mg/kg/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-445, 1997 (NTPTR*); Z01 orl-mus TDLo: 28800 mg/kg/16D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-445, 1997 (NTPTR*); D16-U01 orl-mus TDLo: 1470 mg/kg/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-445, 1997 (NTPTR*); P61-V30 orl-rat TDLo: 18200 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-208946 (NTIS**); L60-V30 orl-mus TDLo: 18200 mg/kg/104W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB97-208946 (NTIS**) SL: NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat Record 1098 of 1119 in RTECS (through 2003/06) AN: YP2860000 PN: L-Tyrosine,-3-hydroxy-alpha-methyl-,-hydrate- (2:3) SY: Hyperpax-; Methyl-dopa-sesquihydrate-; alpha-Methyldopa-sesquihydrate- RN: Current: 41372-08-1 UD: 200210 MF: C10-H13-N-O4.3/2 H2-O MW: 238.27 CC: Tumorigen (C); Drug (D); Reproductive-Effector (T) RE: T01-T09-T23 orl-rat TDLo: 2980 mg/kg (65D male) National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-348, 1989 (NTPTR*) TE: V03-M61 orl-mus TDLo: 604 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-348, 1989 (NTPTR*); V03-M61 orl-mus TDLo: 545076 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-216527/AS (NTIS**) MD: Z01 orl-rat TDLo: 17500 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-348, 1989 (NTPTR*); L70-M30 orl-rat TDLo: 68250 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-348, 1989 (NTPTR*) SL: NCI Carcinogenesis Studies (feed), equivocal evidence: mouse; NCI Carcinogenesis Studies (feed), no evidence: rat Record 1099 of 1119 in RTECS (through 2003/06) AN: YQ2293000 PN: Undecanoic-acid,-11-amino- SY: Aminoundecanoic-acid-; 11-Aminoundecanoic-acid-; 11-Aminoundecylic-acid-; NCI-C50613- RN: Current: 2432-99-7 BRN: 1767291 BHR: 4-04-00-02823 UD: 200302 MF: C11-H23-N-O2 MW: 201.35 WL: Z10VQ CC: Tumorigen (C); Mutagen (M) ME: mtr-ham-emb 2500 mmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 8, p. 515, 1986 (ENMUDM); sce-ham-ovr 500 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V01-M60 orl-rat TDLo: 655 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-216, 1982 (NTPTR*); V02-R60 orl-rat TD :328 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-216, 1982 (NTPTR*); V02-L60 orl-rat TDLo: 327600 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-225640 (NTIS**); V01-M60 orl-rat TDLo: 655200 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-225640 (NTIS**); V01-P62 orl-mus TDLo: 648900 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB82-225640 (NTIS**) AT: U01 orl-rat LDLo: 14700 ug/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-216, 1982 (NTPTR*) MD: M30 orl-rat TDLo: 68250 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-216, 1982 (NTPTR*) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 239, 1986 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 39, p. 239, 1986 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) ND: NOES 1983: HZD X1682; NIS 1; TNF 24; NOS 2; TNE 1534; TFE 1168 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), clear evidence: rat; NCI Carcinogenesis Studies (feed), equivocal evidence: mouse Record 1100 of 1119 in RTECS (through 2003/06) AN: YR1400000 PN: Uracil,-6-propyl-2-thio- SY: Propilthiouracil-; 6-Propil-tiouracile- (Italian); 2,3-Dihydro-6-propyl-2-thioxo-4(1H)-pyrimidinone; 2-Mercapto-4-hydroxy-6-n-propylpyrimidine-; 2-Mercapto-6-propyl-4-pyrimidone-; 2-Mercapto-6-propylpyrimid-4-one-; Procasil-; Propacil-; Propycil-; 6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione; Propyl-thiorist-; Propyl-thiorit-; Propylthiouracil-; 4-Propyl-2-thiouracil-; 6-Propylthiouracil-; 6-Propyl-2-thiouracil-; 6-n-Propylthiouracil-; 6-n-Propyl-2-thiouracil-; Prothycil-; Propyl-thyracil-; Propythiouracil-; Prothiucil-; Prothiurone-; Prothyran-; Protiural-; PTU- (thyreostatic); 4(1H)-Pyrimidinone, 2,3-dihydro-6-propyl-2-thioxo-; 2-Thio-4-oxo-6-propyl-1,3-pyrimidine-; 2-Thio-6-propyl-1,3-pyrimidin-4-one-; 6-Thio-4-propyluracil-; Thiuragyl-; Thyreostat-II- RN: Current: 51-52-5 UD: 200305 MF: C7-H10-N2-O-S MW: 170.25 WL: T6MYMVJ BUS F3 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-smc 1 gm/L (-S9) Chemistry and Industry (London). (Royal Soc. of Chemistry, Distribution Centre, Blackhorse Rd., Letchworth, Herts SG6 1HN, UK) V.1- 1923- v. (21), p. 847, 1980 (CHINAG); dni-hmn-lym 100 mg/L Journal of Clinical Endocrinology and Metabolism. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.12- 1952- v. 43, p. 1406, 1976 (JCEMAZ) RE: T52-T77 orl-wmn TDLo: 1818 mg/kg (33D pre/1-39W preg) JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 159, p. 848, 1955 (JAMAAP); T52-T77 orl-wmn TDLo: 1092 mg/kg (14-40W preg) Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 46, p. 145, 1957 (AIMEAS); T52-T71-T72 orl-rat TDLo: 4600 mg/kg (70D pre/1-22D preg) Proceedings of the Iowa Academy of Science. (Iowa Academy of Science, Exec. Dir., Univ. of Northern Iowa, Cedar Falls, IA 50613) V.1- 1887/93- v. 69, p. 624, 1962 (PIAIA9); T34-T52 orl-rat TDLo: 400 mg/kg (20-21D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 198, p. 637, 1980 (ANREAK); T41-T85 orl-rat TDLo: 240 mg/kg (10-21D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 11, p. 251, 1989 (NETEEC); T52-T53-T86 orl-rat TDLo: 500 mg/kg (18-22D preg/20D post) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 62, p. 213, 1974 (JOENAK); T76-T81 orl-rat TDLo: 1050 mg/kg (21D post) Proceedings of the Iowa Academy of Science. (Iowa Academy of Science, Exec. Dir., Univ. of Northern Iowa, Cedar Falls, IA 50613) V.1- 1887/93- v. 69, p. 624, 1962 (PIAIA9); T02-T09-N07 orl-rat TDLo: 10 mL/kg (25D post) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 100, p. 85, 1994 (JRPFA4); T34-T52 orl-rbt TDLo: 330 mg/kg (11-25D preg) Surgery. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1937- v. 41, p. 619, 1957 (SURGAZ); T72-T52 orl-gpg TDLo: 1470 mg/kg (38-58D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 115, p. 359, 1953 (ANREAK); T52 par-mam TDLo: 615 ug/kg (29-32D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 175, p. 290, 1973 (ANREAK); T52 orl-rat TDLo: 19 mg/kg (6D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 243, 1995 (TOXID9); T52 orl-rat TDLo: 2.8 mg/kg (16-22D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 243, 1995 (TOXID9); T52-T85 orl-rat TDLo: 14 mg/kg (16-22D preg/21D post) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 15, p. 243, 1995 (TOXID9); T41-T52 orl-rat TDLo: 18 mg/kg (7-22D preg/21D post) Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 9, p. 103, 2001 (ETOPFR) TE: V03-N60 orl-mus TDLo: 600 gm/kg/73W-C Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 112, p. 365, 1963 (PSEBAA); V02-N62 orl-gpg TDLo: 37 gm/kg/2Y-C Growth. (Southern Bio-Research Institute, Florida Southern College, Lakeland, FL 33802) V.1- 1937- v. 27, p. 305, 1963 (GROWAH); V01-N62 orl-ham TDLo: 653 gm/kg/70W-C Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 21, p. 952, 1968 (CANCAR) ORNG: 1250000000 ng/kg. [1250.000000 mg/kg] T/E unlistd AT: C08 orl-man TDLo: 257 mg/kg Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1925- v. 73, p. 445, 1997 (PGMJAO); M03-M05-M11 orl-man TDLo: 42857 ug/kg/10D-I American Journal of Kidney Diseases. (Grune and Stratton, Inc., Journal Subscription Dept., POB 6280, Duluth, MN 55806) V.1- 1981- v. 24, p. 575, 1994 (AJKDDP); H30-P15 orl-wmn LDLo: 480 mg/kg/9W-I Southern Medical Journal. (Southern Medical Assoc., POB 2446, Birmingham, AL 35205) V.1- 1908- v. 75, p. 1297, 1982 (SMJOAV); L01-L12 orl-chd TDLo: 900 mg/kg/60D-I Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- v. 82, p. 228, 1975 (AIMEAS); L30 orl-wmn TDLo: 900 mg/kg/21W-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 140, p. 1184, 1980 (AIMDAP); L01 orl-chd TDLo: 165 mg/kg/2W-I Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969- v. 19, p. 669, 1985 (DICPBB); L01 orl-wmn LDLo: 84 mg/kg/2W-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 142, p. 838, 1982 (AIMDAP); L30 orl-man TDLo: 116 mg/kg/11W-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 135, p. 319, 1975 (AIMDAP); L04-L12 orl-wmn TDLo: 693 mg/kg/11W-I Southern Medical Journal. (Southern Medical Assoc., POB 2446, Birmingham, AL 35205) V.1- 1908- v. 87, p. 943, 1994 (SMJOAV); L12-M16 orl-chd TDLo: 1785 mg/kg/17W-I Journal of Pediatric Gastroenterology and Nutrition. (Raven Press, 1185 Avenue of the Americas, New York, NY 10036) V.1- 1982- v. 7, p. 776, 1988 (JPGND6); H08-L02-P27 unr-wmn LDLo: 6 mg/kg New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 249, p. 814, 1953 (NEJMAG); T/E unlistd orl-rat LD50: 1250 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 157, p. 659, 1946 (NATUAS); T/E unlistd ipr-rat LDLo: 400 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 97, p. 478, 1949 (JPETAB); T/E unlistd unr-rat LDLo: 750 ug/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 732, 1982 (NIIRDN); T/E unlistd unr-mus LDLo: 750 ug/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. 6, p. 732, 1982 (NIIRDN); N08 orl-rat TDLo: 8.5 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 47, p. 77, 1950 (BIJOAK) MD: N75-P28-Y15 orl-rat TDLo: 910 mg/kg/13W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 36, p. 49, 1976 (TXAPA9); N08-N75-P28 orl-rat TDLo: 1400 mg/kg/4W-C Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 36, p. 148, 1998 (IJEBA6); N30-N75-P28 orl-rat TDLo: 12600 ug/kg/21D-C Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 49, p. 263, 1999 (TOSCF2); N30-N75-P28 unr-rat TDLo: 18200 mg/kg/2W-I Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 73(Suppl 2), p. 113, 1993 (PHTOEH); P30-S25-U01 orl-cat TDLo: 1974 mg/kg/25W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 114, p. 155, 1996 (TXCYAC); N30 ipr-rat TDLo: 3750 ug/kg/15D-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 51, p. 54, 1999 (TOSCF2); L70-N75-U01 ipr-rat TDLo: 26 ug/kg/14W-I Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 ) V. 41, Jan. 1998- v. 51, p. 54, 1999 (TOSCF2); N08-Y53 orl-rat TDLo: 18 mg/kg/36D-C Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Feb.1996- v. 9, p. 103, 2001 (ETOPFR); N07-N75 orl-rat TDLo: 140 mg/kg/14D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 111, p. 263, 1991 (TXAPA9); L30-N30-Y07 orl-rat TDLo: 70 mg/kg/7D-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 111, p. 263, 1991 (TXAPA9); A30-N08 orl-rat TDLo: 1400 mg/kg/14D-C Histochemical journal. (Dordrecht : Kluwer Academic Publishers, 1999-) V.1- 1968- v. 27, p. 370, 1995 (HICHJ*); N30-N74-U01 orl-rat TDLo: 7980 mg/kg/19W-C Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 78, p. 1335, 1987 (JJCREP) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); TOXICOLOGY REVIEW Pediatric Clinics of North America. (W.B. Saunders Co., W. Washington Sq., Philadelphia, PA 19105) V.1- 1954- v. 8, p. 413, 1961 (PCNAA8); TOXICOLOGY REVIEW Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 165, p. 38, 2002 (TJADAB); TOXICOLOGY REVIEW Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 65, p. 38, 2002 (TJADAB); TOXICOLOGY REVIEW New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 304, p. 538, 1981 (NEJMAG); TOXICOLOGY REVIEW Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 128, p. 117, 2002 (TOLED5) ND: NOHS 1974: HZD 83947; NIS 1; TNF 33; NOS 1; TNE 297; NOES 1983: HZD 83947; NIS 6; TNF 330; NOS 12; TNE 3331; TFE 1666 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1101 of 1119 in RTECS (through 2003/06) AN: YS2625000 PN: Urea, 1,3-bis(2-chloroethyl)-1-nitroso- SY: BCNU-; Nitrumon-; NSC-409962-; BiCnu-; N,N'-Bis(2-chloroethyl)-N-nitrosourea; Bis(2-chloroethyl)nitrosourea; 1,3-Bis(beta-chloroethyl)-1-nitrosourea; 1,3-Bis-(2-chloroethyl)-1-nitrosourea; Bischloroethylnitrosourea-; Carmubris-; Carmustin-; Carmustine-; FDA-0345-; NCI-C04773-; SK-27702-; SRI-1720-; Urea, N,N'-bis(2-chloroethyl)-N-nitroso- (9CI) RN: Current: 154-93-8 BRN: 2049744 UD: 200006 MF: C5-H9-Cl2-N3-O2 MW: 214.07 WL: ONN2GVM2G CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 33 ug/plate (+S9) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 5, p. 319, 1985 (TCMUD8); mmo-sat 10 ug/plate (-S9) American Journal of Hospital Pharmacy. (American Soc. of Hospital Pharmacists, 4630 Montgomery Ave., Bethesda, MD 20814) V.15- 1958- v. 43, p. 344, 1986 (AJHPA9); mmo-esc 300 umol/L (-S9) Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 53, p. 421, 1983 (APTOA6); dnr-esc 7 mmol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 92, p. 177, 1978 (ZKKOBW); dna-esc 25 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); pic-esc 50 ug/plate Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 2819, 1983 (CNREA8); sln-dmg-orl 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 57, p. 297, 1978 (MUREAV); mmo-smc 500 mg/L (-S9) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 279, 1989 (CNREA8); mrc-smc 500 umol/L/16H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 45, 1977 (MUREAV); sce-nml-oth 3 umol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 265, 1983 (PAACA3); dnd-hmn-emb 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1352, 1984 (CNREA8); dnd-hmn-lng 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 672, 1978 (CNREA8); dna-hmn-hla 25 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); dnd-hmn-oth 50 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 879, 1986 (CRNGDP); dnd-hmn-oth 60 mg/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 43, p. 1101, 1992 (BCPCA6); oms-hmn-hla 10 mg/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 349, p. 389, 1974 (BBACAQ); dni-hmn-leu 1 umol/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 425, p. 463, 1976 (BBACAQ); dni-hmn-hla 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); dni-hmn-lym 50 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 51, p. 191, 1984 (CBINA8); sce-hmn-lym 5 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 1899, 1989 (CNREA8); sce-hmn-oth 4 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 879, 1986 (CRNGDP); dnd-rat-ipr 100 umol/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 514, 1984 (CNREA8); dnd-rat-oth 50 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 3186, 1980 (CNREA8); bfa-rat-sat 80 mg/kg Hinyokika Kiyo. Journal of Urology. (Kyoto Daigaku Igakubu, Hinyokikagaku Kyoshitsu, 54 Kawara-machi, Shogain, Sakyo-ku, Kyoto 606, Japan) V.1- 1955- v. 26, p. 813, 1980 (HIKYAJ); cyt-rat-oth 5 mg/L European Journal of Cancer (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 1- 1965- v. 15, p. 461, 1979 (EJCAAH); sce-rat-oth 1 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 473, 1983 (CNREA8); mnt-mus-ipr 1450 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 44, p. 87, 1977 (MUREAV); mmo-mus-lym 200 ug/L (+S9) Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 1, p. 277, 1978 (DCTODJ); dnd-mus-ipr 150 umol/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 110, p. 185, 1985 (JCROD7); dnd-mus-leu 20 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 3856, 1984 (CNREA8); dni-mus-ipr 30 mg/kg Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 59, p. 531, 1975 (CCROBU); dni-mus-leu 1 mg/L Acta Medica Kinki University. (Kinki Univ. Medical Assoc., 380 Nishiyama, Sayama-cho, Minami-kawachi-gun, Osaka-fu, Japan) V.1- 1976- v. 11, p. 57, 1986 (AMKUDT); dni-mus-bmr 20 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 4185, 1985 (CNREA8); oms-mus-bmr 40 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 4185, 1985 (CNREA8); oms-mus-leu 1 mg/L Acta Medica Kinki University. (Kinki Univ. Medical Assoc., 380 Nishiyama, Sayama-cho, Minami-kawachi-gun, Osaka-fu, Japan) V.1- 1976- v. 11, p. 57, 1986 (AMKUDT); cyt-mus-ipr 9050 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 44, p. 87, 1977 (MUREAV); sce-mus-ivn 4400 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2813, 1982 (CNREA8); sce-mus-unr 8800 ug/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 2, p. 245, 1980 (ENMUDM); sce-mus-lym 1500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 106, p. 85, 1982 (MUREAV); sce-mus-lym 100 gm/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 106, p. 85, 1982 (MUREAV); msc-mus-lym 200 ug/L Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 1, p. 277, 1978 (DCTODJ); msc-ham-lng 3 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 321, 1982 (ENMUDM); hma-mus-sat 25 mg/kg Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 60, p. 1495, 1978 (JNCIAM); hma-mus-leu 4 mg/kg Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 23, p. 3097, 1974 (BCPCA6); spm-mus-ipr 33 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); mnt-ham-lng 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 301, p. 149, 1993 (MUREAV); dnd-ham-lng 8500 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 3379, 1978 (CNREA8); dni-ham-ipr 15 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 1957, 1974 (CNREA8); cyt-ham-lng 3200 ug/L Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 27, p. 95, 1981 (GMCRDC); sce-ham-lng 12 umol/L Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 9, p. 541, 1987 (FAATDF); msc-ham-lng 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 2719, 1980 (CNREA8); msc-ham-ovr 4 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 460, 1975 (CNREA8); dnd-mam-lym 10 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1887, 1984 (CNREA8) RE: T46-T47-T53 ipr-rat TDLo: 8 mg/kg (6-9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 30, p. 422, 1974 (TXAPA9); T41-T42-T45 ipr-rat TDLo: 8 mg/kg (6-9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 30, p. 422, 1974 (TXAPA9); T26-T24 ipr-rat TDLo: 9 mg/kg (9W male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 30, p. 422, 1974 (TXAPA9); T34 ipr-rat TDLo: 4 mg/kg (6-9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 30, p. 422, 1974 (TXAPA9); T01 ipr-mus TDLo: 11 mg/kg (1D male) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); T72-T75-T81 ipr-mus TDLo: 40 mg/kg (12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 7, 1987 (TCMUD8); T34 ivn-rbt TDLo: 6500 ug/kg (6-18D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 30, p. 422, 1974 (TXAPA9) TE: V03-J60-K60 ipr-rat TDLo: 15 mg/kg/7W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); V03-J60 ivn-rat TDLo: 16 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V03-R21-R60 skn-mus TDLo: 276 mg/kg/23W-I Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 36, p. 1211, 1980 (EXPEAM); V03-J60-K60 ipr-mus TDLo: 98 mg/kg/26W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); V03-K60 ivn-rat TD :26 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V03-J60 ivn-rat TD :45 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V03-J60-K60 ivn-rat TD :51 mg/kg/24W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7) ORNG: 20000000 ng/kg. [20.000000 mg/kg] T/E unlistd AT: J30-K13-P26 ivn-chd LDLo: 78 mg/kg/52W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 42, p. 74, 1978 (CANCAR); K13-P14-P17 ivn-hmn TDLo: 125 mg/kg Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- v. 16, p. 273, 1972 (ACRSAJ); K13-P14-P17 ivn-hmn TDLo: 6 mg/kg Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 709, 1976 (CTRRDO); J13-J22-J24 par-wmn LDLo: 1566 mg/kg JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- v. 244, p. 687, 1980 (JAMAAP); T/E unlistd orl-rat LD50: 20 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 166, p. 104, 1969 (JPETAB); T/E unlistd ipr-rat LD50: 17420 ug/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); F19-K12-U01 scu-rat LD50: 83200 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 9, p. 766, 1978 (IYKEDH); J16-K06-P26 ivn-rat LD50: 13800 ug/kg Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- v. 37, p. 177, 1980 (ONCOBS); F19-K12-U01 ims-rat LD50: 79600 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 9, p. 766, 1978 (IYKEDH); K12-L12-M10 orl-mus LD50: 19 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 405, 1972 (TXAPA9); T/E unlistd ipr-mus LD50: 21260 ug/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); K12-L12-M10 scu-mus LD50: 24 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 405, 1972 (TXAPA9); T/E unlistd ivn-mus LD50: 45 mg/kg Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 118, p. 756, 1965 (PSEBAA); F19-K12-U01 ims-mus LD50: 86300 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- v. 9, p. 766, 1978 (IYKEDH); T/E unlistd unr-mus LD50: 42 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 46, p. 2703, 1986 (CNREA8); T/E unlistd orl-dog LDLo: 5 mg/kg Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- v. 16, p. 273, 1972 (ACRSAJ); T/E unlistd ivn-dog LDLo: 2 mg/kg Cancer Chemotherapy Reports, Part 1. (Washington, DC) V.52(6)-59, 1968-75. For publisher information, see CTRRDO. v. 57, p. 33, 1973 (CCROBU); K30-P14-P30 ivn-mky LDLo: 10 mg/kg Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5, 1964-75. For publisher information, see CTRRDO. v. 2, p. 202, 1965 (CCSUBJ); V30 par-ham LD10: 18 mg/kg Journal of Surgical Oncology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1969- v. 15, p. 355, 1980 (JSONAU) MD: J30-Z01 unr-rat TDLo: 30 mg/kg/9D-I Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 48, p. 325, 1999 (TOXID9) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 79, 1981 (IMEMDT); IARC Cancer Review: Human Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 79, 1981 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 150, 1987 (IMSUDL); TOXICOLOGY REVIEW National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB282-265 (NTIS**) ND: NOES 1983: HZD X3594; NIS 1; TNF 373; NOS 7; TNE 14122; TFE 10338 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion; NCI Carcinogenesis Studies (ipr), clear evidence: mouse Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NCI Carcinogenesis Studies (ipr), some evidence: rat Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1102 of 1119 in RTECS (through 2003/06) AN: YS4900000 PN: Urea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso- SY: Belustine-; 1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-; NSC-79037-; CCNU-; Cecenu-; Ceenu-; Chloroethylcyclohexylnitrosourea-; N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea; 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea; (Chloro-2-ethyl)-1-cyclohexyl-3-nitrosourea; CINU-; (Cloro-2-etil)-1-cicloesil-3-nitrosourea (Italian); ICIG-1109-; Lomustine-; NCI-C04740-; RB-1509-; SRI-2200-; Urea, N-(2-chloroethyl)-N'-cyclohexyl-N-nitroso- (9CI) RN: Current: 13010-47-4 BRN: 2125058 UD: 200006 MF: C9-H16-Cl-N3-O2 MW: 233.73 WL: L6TJ AMVNNO&2G CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P) ME: mmo-sat 100 ug/plate (+S9) Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 60, p. 1495, 1978 (JNCIAM); mmo-sat 7 ug/plate (-S9) Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 28, p. 159, 1985 (NULSAK); dns-sat 5 ug Experimental Cell Biology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.44- 1976- v. 50, p. 271, 1982 (ECEBDI); mmo-esc 300 umol/L (-S9) Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH v. 53, p. 421, 1983 (APTOA6); dnr-esc 700 ng/plate Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 1958- v. 28, p. 159, 1985 (NULSAK); dnd-esc 1 mmol/L Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 71, p. 674, 1980 (GANNA2); dnd-hmn-emb 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1352, 1984 (CNREA8); dna-hmn-hla 30 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 3371, 1978 (CNREA8); dns-hmn-lym 10 mg/L Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 v. 36, p. 947, 1981 (FRPSAX); oms-hmn-hla 10 mg/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 349, p. 389, 1974 (BBACAQ); dni-hmn-leu 1 umol/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 425, p. 463, 1976 (BBACAQ); dni-hmn-lym 10 mg/L Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 v. 36, p. 947, 1981 (FRPSAX); cyt-hmn-lym 700 ug/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 265, 1991 (MUREAV); sce-hmn-lym 14 umol/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 209, 1988 (EMMUEG); dna-rat-oth 5 mg/L Radiation Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1954- v. 76, p. 441, 1978 (RAREAE); dni-rat-orl 30 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 275, 1979 (MUREAV); sce-rat-mmr 1 umol/L Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 35, p. 1171, 1986 (BCPCA6); hma-rat-oth 30 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 17, p. 164, 1976 (PAACA3); dna-mus-ipr 50 mg/kg Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 250, 1983 (PAACA3); dnd-mus-ivn 48 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 37, p. 2262, 1977 (CNREA8); dnd-mus-bmr 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2605, 1982 (CNREA8); dnd-mus-leu 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 2605, 1982 (CNREA8); dnd-mus-unr 50 umol/L/5H Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 17, p. 164, 1976 (PAACA3); oms-mus-leu 1 pmol Analytical Biochemistry. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1960- v. 83, p. 678, 1977 (ANBCA2); dni-mus-ipr 57 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 1957, 1974 (CNREA8); dni-mus-oth 100 mg/L Revista de Chirurgui, Oncologie, Radiologie, ORL, Oftalmologie, Stomatologie, Seria: Oncologia. (Rompresfilatelia, POB 12-201, Bucharest, Romania) V.13(4)- 1974- v. 19, p. 183, 1980 (ONCODU); dni-mus-leu 25 umol/L "Nitrosoureas: Current Status and New Development," Prestayko, A.W. et al., eds., New York, Academic Press, Inc., 1981 -,95,1981 (45ZJA3); spm-mus-ipr 40 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); dnd-ham-lng 5500 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 3379, 1978 (CNREA8); sce-ham-ovr 20 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 577, 1983 (CNREA8); msc-ham-lng 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 2719, 1980 (CNREA8); msc-ham-ovr 4 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 460, 1975 (CNREA8); dnd-mam-lym 10 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1887, 1984 (CNREA8) RE: T25-T41-T42 ipr-rat TDLo: 16 mg/kg (6-9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 34, p. 456, 1975 (TXAPA9); T45-T47-T53 ipr-rat TDLo: 16 mg/kg (6-9D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 34, p. 456, 1975 (TXAPA9); T25-T26 ipr-rat TDLo: 22500 ug/kg (9W male) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 34, p. 456, 1975 (TXAPA9); T34-T46 ipr-rat TDLo: 8 mg/kg (9-12D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 34, p. 456, 1975 (TXAPA9); T01 ipr-mus TDLo: 9 mg/kg (1D male) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 122, 1982 (CNREA8); T34-T73-T27 ivn-rbt TDLo: 39 mg/kg (6-18D preg) Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 34, p. 456, 1975 (TXAPA9) TE: V03-L60 orl-rat TDLo: 50 mg/kg Pathologie Biologie. (Expansion Scientifique Francaise, 15, rue St. Benoit, F-75278 Paris Cedex 06, France) V.17- 1969- v. 35, p. 139, 1987 (PTBIAN); V03-J60-R60 ipr-rat TDLo: 60 mg/kg/7W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); V03-K60 ivn-rat TDLo: 64 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V03-R21-R60 skn-mus TDLo: 276 mg/kg/23W-I Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 36, p. 1211, 1980 (EXPEAM); V03-P61-P62 ipr-mus TDLo: 98 mg/kg/26W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); V03-J60-K60 ivn-rat TD :127 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V03-J60 ivn-rat TD :178 mg/kg/42W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7) ORNG: 70000000 ng/kg. [70.000000 mg/kg] K12-L12-M10 AT: F08-P25-U25 orl-wmn LDLo: 28 mg/kg/1W-I Annals of Pharmacotherpy. (Harvey Whitney Books Co., POB 42696, Cincinnati, OH 45242) V. 26- 1992- v. 29, p. 384, 1995 (APHRER); F14-K13 orl-hmn TDLo: 30 mg/kg Cancer Chemotherapy Reports, Part 3. (Washington, DC) V.1-6, 1968-75. For publisher information, see CTRRDO. v. 3, p. 33, 1972 (CCYPBY); K13-P14-P17 orl-hmn TDLo: 3 mg/kg Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 709, 1976 (CTRRDO); K12-L12-M10 orl-rat LD50: 70 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 405, 1972 (TXAPA9); T/E unlistd ipr-rat LD50: 50350 ug/kg National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*); K12-L12-M10 orl-mus LD50: 38 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 405, 1972 (TXAPA9); K12-L12-M10 ipr-mus LD50: 53 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 405, 1972 (TXAPA9); K12-L12-M10 scu-mus LD50: 54 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 405, 1972 (TXAPA9); V30 ivn-mus LD10: 40 mg/kg Antibiotics and Chemotherapy (Basel). (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.17- 1971- v. 23, p. 64, 1978 (ANBCB3); T/E unlistd unr-mus LD50: 30 mg/kg European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- v. 12, p. 397, 1977 (EJMCA5); T/E unlistd orl-dog LDLo: 10 mg/kg Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- v. 16, p. 273, 1972 (ACRSAJ); T/E unlistd ivn-dog LDLo: 5 mg/kg Cancer Chemotherapy Reports, Part 3. (Washington, DC) V.1-6, 1968-75. For publisher information, see CTRRDO. v. 4(3), p. 13, 1973 (CCYPBY); M03-P23-U05 ivn-mky LDLo: 20 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-246 (NTIS**) MD: P14-P26-U01 orl-dog TDLo: 35 mg/kg/14D-I Progress Report Submitted to the National Cancer Institute by Mason Research Institute. (Worcester, MA) v. -, p. 313, 1967 (NCIMR*); L03-P05-P26 orl-mky TDLo: 140 mg/kg/14D-I Progress Report Submitted to the National Cancer Institute by Mason Research Institute. (Worcester, MA) v. -, p. 313, 1967 (NCIMR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 137, 1981 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 26, p. 137, 1981 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 150, 1987 (IMSUDL) ND: NOES 1983: HZD X4755; NIS 1; TNF 103; NOS 3; TNE 2457; TFE 1069 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive/dose response: Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation; NCI Carcinogenesis Studies (ipr), clear evidence: mouse Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NCI Carcinogenesis Studies (ipr), no evidence: rat Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1103 of 1119 in RTECS (through 2003/06) AN: YS5000000 PN: Urea, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitroso- SY: NSC-95441-; Urea, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitroso-, trans-; 1-(2-Chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea; 1-(2-Chloroethyl)-3-(trans-4-methyl-cyclohexyl)-1-nitrosourea; N-(2-Chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea; ICIG-1110-; Lomustine,-methyl-; ME-Ccnu-; Methyl-ccnu-; trans-Methyl-ccnu-; NCI-C04955-; Semustine-; Urea, N-(2-chloroethyl)-N'-(4-methylcyclohexyl)-N-nitroso- RN: Current: 13909-09-6 UD: 200006 MF: C10-H18-Cl-N3-O2 MW: 247.76 WL: L6TJ AMVNNO&2G D1 CC: Tumorigen (C); Drug (D); Mutagen (M); Human-Data (P); Primary-Irritant (S) ID: skn-rbt 5 mg/24H rinse Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 14, p. 117, 1979 (TXCYAC) ME: mmo-sat 100 nmol/plate (+/-S9) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 149, 1980 (JJIND8); dna-esc 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); mrc-smc 238 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 239, 1988 (MUREAV); dni-hmn-leu 1 umol/L Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- v. 425, p. 463, 1976 (BBACAQ); oms-hmn-lym 2 mg/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 44, p. 153, 1988 (TOLED5); cyt-hmn-lym 2 mg/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 44, p. 153, 1988 (TOLED5); sce-hmn-lym 1 mg/L Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 44, p. 153, 1988 (TOLED5); mnt-mus-orl 4 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 286, p. 101, 1993 (MUREAV); mnt-mus-ipr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 286, p. 101, 1993 (MUREAV); dns-mus-ipr 4 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2420, 1975 (CNREA8); dni-mus-ipr 4 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2420, 1975 (CNREA8); dni-mus-oth 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5837, 1983 (CNREA8); dni-ham-ipr 40 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 1957, 1974 (CNREA8); cyt-ham-ovr 5 mg/L Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 33, p. 33, 1986 (NEOLA4); sce-ham-ovr 1 mg/L Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 33, p. 33, 1986 (NEOLA4); dnd-mam-lym 2 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 1887, 1984 (CNREA8) TE: V01-P61 orl-hmn TDLo: 22 mg/kg/60W-C New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 309, p. 1079, 1983 (NEJMAG); V01-J60-R60 ipr-rat TDLo: 30 mg/kg/7W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); V03-K60 ivn-rat TDLo: 32 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V01-P61-P62 ipr-mus TDLo: 117 mg/kg/26W-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); V03-K60 ivn-rat TD :64 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V03-A60-K60 ivn-rat TD :127 mg/kg/60W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V03-J60-K60 ivn-rat TD :203 mg/kg/48W-I Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15, 1977-87. Discontinued v. 8, p. 273, 1980 (DTESD7); V01-P61 orl-wmn TD :73 mg/kg/3Y-I New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 302, p. 120, 1980 (NEJMAG) AT: K13-P14-P17 orl-hmn TDLo: 90 mg/kg Cancer Chemotherapy Reports, Part 3. (Washington, DC) V.1-6, 1968-75. For publisher information, see CTRRDO. v. 4, p. 257, 1973 (CCYPBY); K13-P14-P17 orl-hmn TDLo: 6 mg/kg Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 709, 1976 (CTRRDO); M04 orl-chd LDLo: 5550 mg/kg/30W-I New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 300, p. 1200, 1979 (NEJMAG); M04 orl-chd TDLo: 37950 mg/kg/2Y-I New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA 02115) V.198- 1928- v. 300, p. 1200, 1979 (NEJMAG); T/E unlistd scu-rat LDLo: 100 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 540, 1986 (TXAPA9); F17-F31 orl-mus LD50: 49900 ug/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB269-473 (NTIS**); T/E unlistd ipr-mus LD10: 37 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 194, 1974 (CNREA8); T/E unlistd unr-mus LD50: 30 mg/kg European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- v. 12, p. 397, 1977 (EJMCA5); T/E unlistd orl-dog LDLo: 25 mg/kg Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- v. 16, p. 273, 1972 (ACRSAJ); K12-P15-U28 ivn-dog LDLo: 14 mg/kg Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 1559, 1976 (CTRRDO); T/E unlistd orl-mky LDLo: 100 mg/kg Cancer Chemotherapy Reports, Part 3. (Washington, DC) V.1-6, 1968-75. For publisher information, see CTRRDO. v. 4(3), p. 13, 1973 (CCYPBY); K12-P26-P30 ivn-mky LDLo: 45 mg/kg Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. v. 60, p. 1559, 1976 (CTRRDO) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 150, 1987 (IMSUDL); IARC Cancer Review: Human Sufficient Evidence IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 150, 1987 (IMSUDL); IARC Cancer Review: Group 1 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 150, 1987 (IMSUDL) ND: NOES 1983: HZD X1943; NIS 1; TNF 8; NOS 1; TNE 229; TFE 82 SL: NCI Carcinogenesis Studies (ipr), clear evidence: rat Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NCI Carcinogenesis Studies (ipr), no evidence: mouse Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1935, 1977 (CANCAR); NTP 9th Report on Carcinogens, 2000: Known to be human carcinogen Record 1104 of 1119 in RTECS (through 2003/06) AN: YS6300000 PN: Urea, 3-(p-chlorophenyl)-1,1-dimethyl- SY: 1,1-Dimethyl-3-(p-chlorophenyl)urea; 1-(4-Chloro phenyl)-3,3-dimethyluree (French); 1-(p-Chlorophenyl)-3,3-dimethylurea; 3-(4-Chloor-fenyl)-1,1-dimethylureum (Dutch); 3-(4-Chlor-phenyl)-1,1-dimethyl-harnstoff (German); 3-(4-Chlorophenyl)-1,1-dimethylurea; 3-(4-Cloro-fenil)-1,1-dimetil-urea (Italian); 3-(p-Chlorophenyl)-1,1-dimethylurea; CMU-; Chlorfenidim-; Herbicides,-monuron-; Karmex W. monuron herbicide; Karmex-monuron-herbicide-; Lirobetarex-; Monuron-; Monurox-; N'-(4-Chlorophenyl)-N,N-dimethylurea; N,N-Dimethyl-N'-(4-chlorophenyl)urea; N-(p-Chlorophenyl)-N',N'-dimethylurea; NCI-C02846-; Telvar-; Telvar W. monuron weedkiller; Telvar-monuron-weedkiller-; USAF-P-8-; USAF-XR-41- RN: Current: 150-68-5 BRN: 2097922 BHR: 4-12-00-01191 UD: 200210 MF: C9-H11-Cl-N2-O MW: 198.67 WL: GR DMVN1&1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 1 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 353, 1978 (MUREAV); cyt-oin 10 mg/L Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 52, p. 841, 1987 (CYTOAN); dns-hmn-fbr 100 umol/L National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB268-647 (NTIS**); mnt-mus-ipr 14 mg/kg Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 52, p. 841, 1987 (CYTOAN); dni-mus-orl 200 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 58, p. 353, 1978 (MUREAV); cyt-mus-ipr 14 mg/kg Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 52, p. 841, 1987 (CYTOAN); msc-mus-lym 58 pph National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB84-138973 (NTIS**); spm-mus-ipr 14 mg/kg Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- v. 52, p. 841, 1987 (CYTOAN); mtr-ham-emb 5 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 291, 1983 (CRNGDP); cyt-ham-ovr 1300 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 100 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) RE: T42 orl-mus TDLo: 1935 mg/kg (6-15D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**); T24-T26-T31 scu-mus TDLo: 1935 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**); T34-T42-T43 scu-mus TDLo: 1935 mg/kg (6-14D preg) National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB223-160 (NTIS**) TE: V01-M61-L60 orl-rat TDLo: 46350 mg/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR 266, 1988 (NTPTR*); V01-J60-L60 orl-mus TDLo: 4320 mg/kg/16W-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 16(10), p. 51, 1970 (VOONAW); V01-J60-L60 orl-rat TD :58 gm/kg/18W-C Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 16(10), p. 51, 1970 (VOONAW); V01-L60 orl-rat TDLo: 32445 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-109615/AS (NTIS**); V01-M61 orl-rat TDLo: 64890 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-109615/AS (NTIS**) ORNG: 1053000000 ng/kg. [1053.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 1053 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 299, 1986 (FAATDF); T/E unlistd skn-rat LD50: >2500 mg/kg Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 7, p. 299, 1986 (FAATDF); T/E unlistd unr-rat LD50: 3600 mg/kg Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976- v. 15, p. 929, 1980 (JPFCD2); T/E unlistd orl-mus LD50: 1920 mg/kg National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-266, 1988 (NTPTR*); T/E unlistd ipr-mus LD50: 1 gm/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd skn-rbt LD50: >2500 mg/kg World Review of Pest Control. (London, UK) V.1-10, 1962-71. Discontinued. v. 9, p. 119, 1970 (WRPCA2); T/E unlistd orl-gpg LDLo: 670 mg/kg Pharmacological Reviews. (Williams and Wilkins, 428 E. Preston St., Baltimore, MD 21202) V.1- 1949- v. 14, p. 225, 1962 (PAREAQ); T/E unlistd unr-mam LD50: 3500 mg/kg "Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971 -,231,1971 (30ZDA9) MD: S02 orl-rat TDLo: 3 gm/kg/9W-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 35(3), p. 352, 1972 (FATOAO); P24-P71-P72 orl-rat TDLo: 13620 mg/kg/61W-C Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 31, p. 285, 1993 (FCTOD7); P30-Z01 orl-rat TDLo: 54600 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-266, 1988 (NTPTR*); Z01 orl-mus TDLo: 273 gm/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-266, 1988 (NTPTR*); N60-P61-V30 orl-rat TDLo: 32445 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-109615/AS (NTIS**); P61-R60-V30 orl-rat TDLo: 32445 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-109615/AS (NTIS**); L60-V30 orl-mus TDLo: 432600 mg/kg/103W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB89-109615/AS (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 167, 1976 (IMEMDT); IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 467, 1991 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 167, 1976 (IMEMDT); IARC Cancer Review: Human No Available Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 467, 1991 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 467, 1991 (IMEMDT); TOXICOLOGY REVIEW Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970. v. 80, p. 485, 1973 (DTTIAF) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 84626; NIS 1; TNF 7; NOS 1; TNE 84 SL: EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast, TRP reversion; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: B subtilis rec assay, E coli polA without S9; EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Studies (feed), clear evidence: rat; NCI Carcinogenesis Studies (feed), no evidence: mouse Record 1105 of 1119 in RTECS (through 2003/06) AN: YT3150000 PN: Urea,-1-ethyl-1-nitroso- SY: 1-Ethyl-1-nitrosomocovina- (Czech); 1-Ethyl-1-nitrosourea-; AENH- (German); Aethylnitroso-harnstoff- (German); Carbamide,-N-ethyl-N-nitroso-; ENU-; Ethylnitrosourea-; N-Ethyl-N-nitroso-urea-; N-Ethyl-N-nitrosourea-; N-Ethylnitrosourea-; N-Nitroso-N-ethylurea-; N-ethyl-N-nitrosourea-; NEU-; NSC-45403-; Nitrosoethylurea-; RCRA-waste-number-U176- RN: Current: 759-73-9 BRN: 1761174 BHR: 3-04-00-00233 UD: 200305 MF: C3-H7-N3-O2 MW: 117.13 WL: ZVN2&NO CC: Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 250 ug/plate (+S9) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 893, 1979 (JJIND8); mmo-sat 100 ug/plate (-S9) Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 72, p. 5135, 1975 (PNASA6); pic-sat 25 umol/L Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 10, p. 640, 1974 (MOPMA3); mmo-esc 2600 umol/L/10M (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 43, p. 11, 1977 (MUREAV); oms-esc 8 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); dnr-esc 1 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 46, p. 53, 1977 (MUREAV); dnd-esc 1800 umol/L European Journal of Biochemistry. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1967- v. 56, p. 433, 1975 (EJBCAI); dns-esc 8 mmol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 92, p. 177, 1978 (ZKKOBW); pic-esc 10 mg/L Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. v. 23, p. 91, 1972 (APMBAY); dnr-bcs 2 mg/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 97, p. 1, 1982 (MUREAV); dnd-bcs 30 nmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 41, p. 4368, 1981 (CNREA8); mmo-omi 10 ng/disc (-S9) Issledovaniya po Genetike. (Izdatel'stvo Leningradskogo Universiteta, Leningrad, USSR) No.1- 1961- v. 8, p. 82, 1979 (ISGEAK); mmo-omi 1 pph (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 7, p. 948, 1971 (SOGEBZ); mmo-omi 1200 ppm (-S9) Mikrobiologicheskii Zhurnal (Kiev). Journal of Microbiology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.40- 1978- v. 44(5), p. 32, 1982 (MZHUDX); mmo-omi 100 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 1, 1969 (MUREAV); mmo-omi 1500 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 16, p. 265, 1972 (MUREAV); mmo-omi 500 mg/L (-S9) Dopovidi Akademii Nauk Ukrains'koi RSR, Seriya B: Geologichini, Khimichni ta Biologichni Nauki. Transactions of the Academy of Sciences of the Ukranian SSR, Series B. (V/O Mezhdunarodnaya Kniga, 113095, Moscow, USSR) 1976- v. (9), p. 70, 1981 (DANND6); dnd-omi 10 gm/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 2, p. 363, 1981 (CRNGDP); dnd-omi 250 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 13, p. 151, 1976 (CBINA8); pic-omi 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 36, p. 265, 1976 (MUREAV); slt-dmg-ihl 3 mg/L Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 4(9), p. 47, 1968 (GNKAA5); slt-dmg-mul 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 122, p. 123, 1983 (MUREAV); slt-dmg-orl 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 182, p. 243, 1987 (MUREAV); sln-dmg-orl 30 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 483, 1984 (ENMUDM); sln-dmg-ihl 16 mg/L/47H Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 1172, 1974 (SOGEBZ); dlt-dmg-ihl 16 mg/L/47H Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 1172, 1974 (SOGEBZ); msc-dmg 800 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 253, p. 103, 1991 (MUREAV); mmo-nsc 1 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 43, 1984 (MUREAV); mrc-smc 4000 ppm JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 901, 1979 (JJIND8); mmo-clr 5 mmol/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 20, p. 452, 1975 (FOMIAZ); mmo-eug 40 mg/L (-S9) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 5, p. 329, 1985 (TCMUD8); mnt-nml-mul 8500 nmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 17, 1989 (MUTAEX); dnd-sal-spr 2600 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 5, p. 155, 1984 (CRNGDP); sce-oin-oth 25 mg/L Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 46, p. 181, 1986 (CYTBAI); dnd-hmn-oth 1 mmol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 149, 1992 (TIVIEQ); dnd-hmn-lvr 1800 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dnd-hmn-fbr 1500 ug/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 276, p. 85, 1978 (NATUAS); dnd-hmn-hla 20 mg Biochemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1962- v. 14, p. 1795, 1975 (BICHAW); dnd-hmn-lym 1 mmol/L Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 125, 1982 (JACTDZ); dns-hmn-lvr 320 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dns-hmn-hla 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-oth 25 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5846, 1983 (CNREA8); dns-hmn-oth 25 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5846, 1983 (CNREA8); dns-hmn-oth 350 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 5846, 1983 (CNREA8); dni-hmn-hla 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); cyt-hmn-lng 200 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 41, p. 37, 1988 (CALEDQ); cyt-hmn-fbr 100 umol/L/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 34, p. 415, 1976 (MUREAV); cyt-hmn-lym 25 mg/L Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. v. 29, p. 319, 1975 (HUMAA7); sce-hmn-lng 10 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 41, p. 37, 1988 (CALEDQ); sce-hmn-oth 200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3100, 1988 (CNREA8); sce-hmn-fbr 100 umol/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 265, p. 347, 1977 (NATUAS); msc-hmn-fbr 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 95, 1984 (MUREAV); msc-hmn-lym 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 160, p. 95, 1986 (MUREAV); mnt-rat-ipr 140 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 1053, 1986 (CRNGDP); mtr-rat-par 10 ng/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 709, 1983 (CNREA8); mtr-rat-emb 500 ug/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 799, 1973 (JNCIAM); dnd-rat-tes 60 mg/L Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279, Princeton, NJ 08540) V.1- 1984- v. 1(3), p. 181, 1985 (CBTOE2); dnd-rat-lvr 2 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 46, p. 165, 1983 (CBINA8); dnd-rat-ivn 29 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 7, p. 175, 1987 (TCMUD8); dnd-rat-ivn 500 umol/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 157, 1989 (TCMUD8); dnd-rat-fbr 1700 umol/L Dissertation Abstracts International, B: The Sciences and Engineering. (University Microfilms International, 300 N. Zeeb Rd., Ann Arbor, MI 48106) V.30- 1969- v. 39, p. 5889, 1979 (DABBBA); dnd-rat-orl 370 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-oth 150 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 276, p. 85, 1978 (NATUAS); dns-rat-oth 1 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 2898, 1980 (CNREA8); dns-rat-spr 1 mmol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 6, p. 273, 1984 (ENMUDM); dns-rat-oth 1 mmol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-rat-ipr 150 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 135, 1988 (MUREAV); dns-rat-lvr 320 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); oms-rat-par 100 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 79, p. 255, 1973 (ZKKOBW); bfa-rat-ovr 75 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 143, p. 263, 1985 (MUREAV); cyt-rat-ipr 100 mg/kg Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. v. 29, p. 319, 1975 (HUMAA7); sce-rat-oth 200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3100, 1988 (CNREA8); sce-rat-oth 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 473, 1983 (CNREA8); msc-rat-ipr 100 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 263, p. 257, 1991 (MUREAV); mnt-mus-ipr 12500 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 278, p. 113, 1992 (MUREAV); mnt-mus-orl 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 377, 1989 (MUREAV); mtr-mus-emb 150 mg/L Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- v. 5, p. 659, 1985 (PMRSDJ); mtr-mus-ipr 25 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 3620, 1989 (CNREA8); dnd-mus-ipr 2 mmol/kg "Biology of Radiation Carcinogenesis, Symposium, 1975," Yuhas, J.M., et al., eds., New York, Raven Press, 1976 -,165,1976 (33AQAA); dnd-mus-lym 4990 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 155, 1988 (MUREAV); dns-mus-oth 1 mmol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-mus-oth 320 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); cyt-mus-ipr 63 mg/kg Progress in Clinical and Biological Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1975- v. 209B, p. 477, 1986 (PCBRD2); sce-mus-par 70200 ug/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 30, 1985 (ENMUDM); msc-mus-lym 200 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 110, p. 147, 1983 (MUREAV); msc-mus-par 70200 ug/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7(Suppl 3), p. 30, 1985 (ENMUDM); msc-mus-ipr 50 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 22, p. 71, 1993 (EMMUEG); hma-mus-sat 12 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); hma-mus-esc 190 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 161, 1992 (MUREAV); trn-mus-ipr 100 mg/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 44, p. 253, 1988 (EXPEAM); mtr-ham-ipr 200 mg/kg Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50: V.70-99, 1960-75. For publisher information, see APLMAS. v. 95, p. 380, 1973 (ARPAAQ); mtr-ham-emb 500 ug/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); mtr-ham-kdy 250 ug/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 19, p. 55, 1981 (TXCYAC); dnd-ham-lng 300 umol/L/1H Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 732, 1976 (BBRCA9); dnd-ham-ovr 5 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 26, p. 233, 1979 (CBINA8); dns-ham-oth 1 mmol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-ham-oth 320 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dni-ham-ovr 5 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 400, p. 169, 1998 (MUREAV); cyt-ham-orl 100 mg/kg Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- v. 36, p. 396, 1985 (TRENAF); cyt-ham-fbr 125 mg/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); cyt-hmn-lng 200 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 41, p. 37, 1988 (CALEDQ); cyt-ham-ovr 684 umol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 4, p. 432, 1989 (MUTAEX); sce-ham-emb 3 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1565, 1985 (CRNGDP); sce-hmn-lng 10 ug/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 41, p. 37, 1988 (CALEDQ); sce-ham-ovr 1500 umol/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 346, 1982 (ENMUDM); msc-ham-ovr 20 umol/L/2H Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 26, p. 233, 1979 (CBINA8); msc-ham-lng 500 umol/L/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 111, p. 341, 1983 (MUREAV); dns-gpg-oth 1 mmol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-gpg-oth 10 mmol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dna-mam-lym 100 umol/L Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 70, p. 693, 1979 (GANNA2); dns-rbt-oth 15 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 661, 1985 (CRNGDP); oms-mam-lym 1 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 46, p. 179, 1983 (CBINA8); dns-pig-oth 320 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-pig-oth 3200 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-ctl-oth 320 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); dns-ctl-oth 3200 umol/L Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 10, p. 215, 1980 (PPTCBY); cyt-mky-scu 500 umol/kg Forschungsberichte des Landes Nordrhein-Westfalen. (Westdeutscher Verlag GmbH, Postfach 300 620, 5090 Leverkusen 3, Fed. Rep. Ger.) 1960- v. (3121), p. 1, 1982 (FLNWAR); dna-hmn-fbr 1 mmol/L/2H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 484, p. 3, 2001 (MUREAV); sce-mus-ipr 0.025 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 478, p. 185, 2001 (MUREAV); mmo-esc 20 mmol/L/5M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 479, p. 63, 2001 (MUREAV); dnd-ham-oth 200 mg/L/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 471, p. 29, 2000 (MUREAV); mnt-mus-fbr 0.85 mmol/L/30M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 472, p. 105, 2000 (MUREAV); slt-mus-fbr 0.85 mmol/L/30M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 472, p. 105, 2000 (MUREAV); dnd-mus-ipr 25 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); dnd-mus-orl 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 493, p. 39, 2001 (MUREAV); slt-mus-oth 75 mg/L/4H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 17, p. 105, 2002 (MUTAEX); slt-mus-orl 7 gm/kg/5W Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 16, p. 103, 2002 (MUTAEX); slt-mus-ipr 40 mg/kg Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 38, p. 30, 2001 (EMMUEG); slt-mus-ipr 6 mg/kg/7D Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 38, p. 30, 2001 (EMMUEG); dnd-dmg-orl 0.5 mmol/L/12H Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 503, p. 11, 2002 (MUTAEX); slt-esc 1.5 gm/L/45M Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 508, p. 107, 2002 (MUREAV) RE: T13-T34 orl-rat TDLo: 440 mg/kg (7-17D preg) Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- v. 23, p. 981, 1982 (OYYAA2); T25-T35-T59 orl-rat TDLo: 125 mg/kg (7-16D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 41, p. 265, 1983 (RCOCB8); T26-T53 orl-rat TDLo: 150 mg/kg (7-16D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 41, p. 265, 1983 (RCOCB8); T41-T42 orl-rat TDLo: 100 mg/kg (7-16D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 41, p. 265, 1983 (RCOCB8); T31-T34 orl-rat TDLo: 75 mg/kg (7-16D preg) Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- v. 41, p. 265, 1983 (RCOCB8); T35-T41 ipr-rat TDLo: 20 mg/kg (9D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 112, 1973 (IARCCD); T81-T85 ipr-rat TDLo: 15 mg/kg (18D preg) Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information, see NTOTDY. v. 2, p. 297, 1980 (NETOD7); T33 ipr-rat TDLo: 40 mg/kg (15D preg) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 33, p. 521, 1977 (EXPEAM); T41-T71-T75 ipr-rat TDLo: 15 mg/kg (18D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 1263, 1978 (CNREA8); T72-T76 ipr-rat TDLo: 60 mg/kg (18D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 1263, 1978 (CNREA8); T25-T34-T35 ivn-rat TDLo: 30 mg/kg (8D preg) Nagasaki Igakkai Zasshi. Journal of Nagasaki Medical Association. (Nagasaki Igakkai, c/o Nagasaki Daigaku Igakubu, 12-4 Sakamoto-machi, Nagasaki 852, Japan) V.1- 1923- v. 55, p. 60, 1980 (NAGZAC); T41-T76-T81 ivn-rat TDLo: 80 mg/kg (12D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 127, 1973 (IARCCD); T46 ivn-rat TDLo: 80 mg/kg (15D preg) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 210, p. 1378, 1966 (NATUAS); T83 ivn-rat TDLo: 50 mg/kg (20D preg) Journal of Neurochemistry. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1956- v. 29, p. 771, 1977 (JONRA9); T34-T41 ivn-rat TDLo: 20 mg/kg (9D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 19, p. 81, 1979 (SEIJBO); T31 ivn-rat TDLo: 20 mg/kg (4D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 1, 1973 (IARCCD); T35-T41-T42 par-rat TDLo: 20 mg/kg (9D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 112, 1973 (IARCCD); T26-T42-T46 unr-rat TDLo: 30 mg/kg (9D preg) Nagasaki Igakkai Zasshi. Journal of Nagasaki Medical Association. (Nagasaki Igakkai, c/o Nagasaki Daigaku Igakubu, 12-4 Sakamoto-machi, Nagasaki 852, Japan) V.1- 1923- v. 53, p. 56, 1978 (NAGZAC); T25-T41 unr-rat TDLo: 20 mg/kg (9D preg) Nagasaki Igakkai Zasshi. Journal of Nagasaki Medical Association. (Nagasaki Igakkai, c/o Nagasaki Daigaku Igakubu, 12-4 Sakamoto-machi, Nagasaki 852, Japan) V.1- 1923- v. 53, p. 45, 1978 (NAGZAC); T43-T47 unr-rat TDLo: 40 mg/kg (9D preg) Nagasaki Igakkai Zasshi. Journal of Nagasaki Medical Association. (Nagasaki Igakkai, c/o Nagasaki Daigaku Igakubu, 12-4 Sakamoto-machi, Nagasaki 852, Japan) V.1- 1923- v. 53, p. 45, 1978 (NAGZAC); T53 unr-rat TDLo: 100 mg/kg (12D preg) Nagasaki Igakkai Zasshi. Journal of Nagasaki Medical Association. (Nagasaki Igakkai, c/o Nagasaki Daigaku Igakubu, 12-4 Sakamoto-machi, Nagasaki 852, Japan) V.1- 1923- v. 53, p. 45, 1978 (NAGZAC); T46 ipr-mus TDLo: 100 mg/kg (2D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 36, p. 83, 1996 (CGANE7); T25-T34 ipr-mus TDLo: 25 mg/kg (2D preg) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 36, p. 83, 1996 (CGANE7); T01-T02 ipr-mus TDLo: 50 mg/kg (1D male) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 17, p. 77, 1983 (TOLED5); T25-T35-T41 ipr-mus TDLo: 58500 ug/kg (8D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 151, 1974 (CNREA8); T42-T45-T46 ipr-mus TDLo: 58500 ug/kg (8D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 34, p. 151, 1974 (CNREA8); T22-T24-T43 ipr-mus TDLo: 250 mg/kg (5D male) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 301, 1996 (TCMUD8); T76 ipr-mus TDLo: 75 mg/kg (9D preg) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 193, 1982 (MUREAV); T33-T82 scu-mus TDLo: 351 mg/kg (6-16D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 3, p. 219, 1983 (TCMUD8); T83 ivn-mus TDLo: 80 mg/kg (15D preg) Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967-80. For publisher information, see EXPADD. v. 15, p. 105, 1978 (EXPTAX); T41-T91 ivn-mus TDLo: 80 mg/kg (15D preg) Neuropatologia Polska. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1- 1963- v. 14, p. 115, 1976 (NUPOBT); T41 par-mus TDLo: 80 mg/kg (15D preg) "Brain Tumors and Chemical Injuries to the Central Nervous System, Proceedings of the International Neuropathological Symposium, Warsaw, 1976," Mossakowski, M.J., ed., Warsaw, Poland, Panstwowy Zaklad Wydawnictw Lekarskich, 1978 -,30,1978 (43XWAI); T29 unr-mus TDLo: 30 mg/kg (9D preg) Progress in Clinical and Biological Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1975- v. 109, p. 339, 1982 (PCBRD2); T71-T81-T86 ipr-rbt TDLo: 100 mg/kg (18-27D preg) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 607, 1980 (JJIND8); T46 ipr-pig TDLo: 70 mg/kg (14D preg) Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 25, p. 1606, 1975 (ARZNAD); T42-T41-T43 ipr-ham TDLo: 58565 ug/kg (8D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 29, p. 1151, 1969 (CNREA8); T47-T46-T25 ipr-ham TDLo: 58565 ug/kg (8D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 29, p. 1151, 1969 (CNREA8); T35 ipr-mus TDLo: 50 mg/kg (6D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T42-T81-T53 ipr-mus TDLo: 50 mg/kg (8D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T77-T82 ipr-mus TDLo: 50 mg/kg (8D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T43-T46-T72 ipr-mus TDLo: 50 mg/kg (10D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T81-T53-T77 ipr-mus TDLo: 50 mg/kg (10D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T91-T82 ipr-mus TDLo: 50 mg/kg (10D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T81-T53-T77 ipr-mus TDLo: 50 mg/kg (12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T91-T82 ipr-mus TDLo: 50 mg/kg (12D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T81 ipr-mus TDLo: 50 mg/kg (16D preg) Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 16, p. 183, 1996 (TCMUD8); T65-T91 ivn-rat TDLo: 75 mg/kg (21D preg) Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 67, 1984 (FATOAO) TE: V01-T65-A60 orl-rat TDLo: 10 mg/kg (19D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 2, p. 93, 1976 (CALEDQ); V01-P61 orl-rat TDLo: 374 mg/kg/2W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 75, p. 743, 1985 (JJIND8); V03-T65-A60 skn-rat TDLo: 350 mg/kg (16-22D preg) Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 81, p. 169, 1974 (ZKKOBW); V01-T65-R60 ipr-rat TDLo: 10 mg/kg (15D preg) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 218, p. 682, 1982 (SCIEAS); V01-A60-R60 ipr-rat TDLo: 45 mg/kg Anticancer Research. (5 Argyropoulou St., Kato Patissia, Athens 907, Greece) V.1- 1981- v. 4, p. 5, 1984 (ANTRD4); V01-R60 scu-rat TDLo: 5 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 769, 1985 (CRNGDP); V03-A60 ivn-rat TDLo: 17 mg/kg Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967-80. For publisher information, see EXPADD. v. 17, p. 394, 1979 (EXPTAX); V01-T65-A60 ivn-rat TDLo: 50 mg/kg (15D preg) Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 73, p. 371, 1970 (ZEKBAI); V03-T65-A60 unr-rat TDLo: 5 mg/kg (13D preg) Xenobiotica. (Taylor and Francis Ltd., 4 John St., London WC1N 2ET, UK) V.1- 1971- v. 3, p. 271, 1973 (XENOBH); V02-J60 orl-mus TDLo: 20 mg/kg/24W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 313, 1984 (TXAPA9); V01-R60 skn-mus TDLo: 9370 ug/kg/50W-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 114, p. 245, 1988 (JCROD7); V01-T65-J60 ipr-mus TDLo: 20 mg/kg (19D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 23(3), p. 41, 1977 (VOONAW); V01-L60 ipr-mus TDLo: 10 mg/kg (13D preg) Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 3620, 1989 (CNREA8); V01-J60 ipr-mus TDLo: 32 mg/kg/4W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 52, p. 91, 1990 (CALEDQ); V03-T65-J60 par-mus TDLo: 100 mg/kg (18D preg) Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 17, p. 122, 1976 (PAACA3); V01-T65-P61 par-mus TDLo: 58565 ug/kg (18D preg) Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1965, 1973 (JNCIAM); V03-T65-A60 ipr-dog TDLo: 100 mg/kg (53D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 12, p. 161, 1981 (CALEDQ); V03-N60-T65 ivn-dog TDLo: 30 mg/kg (59D preg) Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie. (VEB Gustav Fischer Verlag, Postfach 176, Jena DDR-6900, Ger. Dem. Rep.) V.1- 1890- v. 121, p. 54, 1977 (ZAPPAN); V03-H60-N62 ivn-mky TDLo: 610 mg/kg/2Y-I Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 18, p. 53, 1977 (PAACA3); V02-T65-M61 ipr-rbt TDLo: 100 mg/kg (15-24D preg) JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 607, 1980 (JJIND8); V02-T65-M61 ivn-rbt TDLo: 80 mg/kg (25D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 85, p. 369, 1978 (BEXBAN); V03-M61-T65 par-rbt TDLo: 160 mg/kg (25D preg) Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie. (VEB Gustav Fischer Verlag, Postfach 176, Jena DDR-6900, Ger. Dem. Rep.) V.1- 1890- v. 121, p. 54, 1977 (ZAPPAN); V03-T65-R60 ivn-pig TDLo: 120 mg/kg (20-31D preg) Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 34, p. 25, 1969 (ARGEAR); V03-T65-A60 orl-ham TDLo: 60 mg/kg (11D preg) Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 71, p. 320, 1968 (ZEKBAI); V02-R60 skn-ham TDLo: 107 mg/kg/20W-C Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 233, 1977 (ZKKOBW); V01-B60-T65 ipr-ham TDLo: 100 mg/kg (16D preg) American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- v. 135, p. 251, 1989 (AJPAA4); V02-K60-L60 ipr-ham TDLo: 274 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 829, 1983 (CNREA8); V03-C60-R60 scu-ham TDLo: 100 mg/kg Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 84, p. 512, 1993 (JJCREP); V03-N60-T65 ivn-ham TDLo: 80 mg/kg (15D preg) Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie. (VEB Gustav Fischer Verlag, Postfach 176, Jena DDR-6900, Ger. Dem. Rep.) V.1- 1890- v. 121, p. 54, 1977 (ZAPPAN); V02-T65-T61 ipr-rat TD :10 mg/kg (21D preg) Journal of Soviet Oncology. (New York, NY) V.1-5, 1980-84. v. 5, p. 396, 1984 (JSONDX); V01-J60-M61 ipr-mus TD :30 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 18, p. 131, 1983 (CALEDQ); V03-G60-K60 orl-rat TD :180 mg/kg Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- v. 381, p. 250, 1982 (ANYAA9); V03-K60-P61 orl-rat TD :520 mg/kg/1Y-I Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 2, p. 73, 1972 (PPTCBY); V03-T65-A60 ivn-rat TD :20 mg/kg (18D preg) Nagasaki Igakkai Zasshi. Journal of Nagasaki Medical Association. (Nagasaki Igakkai, c/o Nagasaki Daigaku Igakubu, 12-4 Sakamoto-machi, Nagasaki 852, Japan) V.1- 1923- v. 54, p. 130, 1979 (NAGZAC); V03-T65-A60 ivn-rbt TD :150 mg/kg (8-10D preg) Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 89, p. 331, 1977 (ZKKOBW); V03-T65-A60 ivn-rat TD :10 mg/kg (16D preg) Acta Neuropathologica. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1961- v. 34, p. 21, 1976 (ANPTAL); V03-T65-A60 ivn-rat TD :20 mg/kg (17D preg) Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 1, p. 345, 1976 (CALEDQ); V03-T65-M61 ivn-rbt TD :70 mg/kg (25D preg) Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 25, p. 453, 1978 (NEOLA4); V01-K60 orl-rat TDLo: 50 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 168, p. 117, 2001 (CALEDQ); V01-M61-T65 ivn-rat TDLo: 75 mg/kg Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. -, p. 956, 1992 (VOONC*); V01-A60-T65 ivn-rat TDLo: 75 mg/kg Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. -, p. 1073, 1992 (VOONC*); V01-A60-T65 ivn-rat TDLo: 75 mg/kg Experimental Oncology (Journal of ucrainian section of European institute of ecology and cancer, Kiev-22, Vaselkovskaya str., 25, Kiev-22) V.1- 1979- v. 15, p. 23, 1993 (EXONC*); V01-A60-T65 ivn-rat TDLo: 75 mg/kg Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. -, p. 69, 1992 (VOONC*) ORNG: 300000000 ng/kg. [300.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 300 mg/kg Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- v. 2, p. 73, 1972 (PPTCBY); T/E unlistd scu-rat LD50: 240 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 74, p. 141, 1970 (ZEKBAI); T/E unlistd ivn-rat LD50: 240 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 222, p. 1064, 1969 (NATUAS); T/E unlistd orl-mus LD50: 960 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 377, 1989 (MUREAV); T/E unlistd ipr-mus LD50: 490 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 223, p. 377, 1989 (MUREAV) MD: Z01 ipr-mus TDLo: 1 gm/kg/5D-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 22(10), p. 72, 1976 (VOONAW) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 191, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 191, 1978 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Internist. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1960- v. 15, p. 7, 1974 (INTEAG) SR: OEL-FRANCE: Carcinogen, JAN 1993 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: In vivo cytogenetics-nonhuman bone marrow; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-partial sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, Rodent heritable translocation; EPA GENETOX PROGRAM 1988, Positive: Mouse spot test, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9, Histidine reversion-Ames test; EPA GENETOX PROGRAM 1988, Positive: In vitro SCE-human, Mouse specific locus; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS-human fibroblast, UDS in mouse germ cells; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro cytogenetics-human lymphocyte; EPA GENETOX PROGRAM 1988, Positive/dose response: In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Inconclusive: SHE-clonal assay; EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster-reciprocal translocation; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1106 of 1119 in RTECS (through 2003/06) AN: YT7875000 PN: Urea,-N-methyl-N-nitroso- SY: Methylnitrosourea-; N-Nitroso-N-methylcarbamide-; N-Nitroso-N-methyl-harnstoff- (German); Nitrosomethylurea-; N-Nitroso-N-methylurea-; 1-Nitroso-1-methylurea-; NMH-; NMU-; NSC-23909-; Carbamide,-N-methyl-N-nitroso-; Methylnitroso-harnstoff- (German); N-Methyl-N-nitroso-harnstoff- (German); 1-Methyl-1-nitrosomocovina- (Czech); N-Methyl-N-nitrosourea-; 1-Methyl-1-nitrosourea-; Methylnitrosouree- (French); MNU-; RCRA-waste-number-U177-; SKI-24464-; SRI-859-; Urea,-1-methyl-1-nitroso- RN: Current: 684-93-5 Previous: 820-60-0; 126742-50-5 UD: 200305 MF: C2-H5-N3-O2 MW: 103.10 WL: ZVN1&NO CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 15600 ng/plate (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 130, p. 79, 1984 (MUREAV); mmo-sat 100 ug/plate (-S9) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 26, p. 89, 1985 (TOLED5); oms-sat 12 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 192, p. 239, 1987 (MUREAV); pic-sat 25 umol/L Molecular Pharmacology. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1965- v. 10, p. 640, 1974 (MOPMA3); mmo-esc 20 umol/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 135, p. 87, 1984 (MUREAV); oms-esc 40 nmol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 79, 1985 (MUREAV); mmo-esc 970 umol/L (+S9) Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 12, p. 1161, 1991 (CRNGDP); dnr-esc 50 nmol/plate Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 458, 1973 (CNREA8); dns-esc 10 mmol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 92, p. 177, 1978 (ZKKOBW); pic-esc 25 mg/L Applied Microbiology. (Washington, DC) V.1-30, 1953-75. For publisher information, see AEMIDF. v. 23, p. 91, 1972 (APMBAY); mmo-bcs 5 gm/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 42, p. 19, 1977 (MUREAV); oms-bcs 170 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 15, p. 101, 1972 (MUREAV); mmo-hmi 1 mmol/L (-S9) Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 1, p. 249, 1979 (ENMUDM); mmo-omi 100 mmol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 141, p. 23, 1975 (MGGEAE); mmo-omi 1 pph (-S9) Doklady Biological Sciences (English Translation). Translation of DANKAS: Biological Section. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.112- 1957- v. 183, p. 668, 1968 (DKBSAS); mmo-omi 400 ug/plate (-S9) Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 22, p. 297, 1978 (CBINA8); mmo-omi 10 mg/L (-S9) Folia Microbiologica (Prague). (Academia, Vodickova 40, 112 29 Prague 1, Czechoslavakia) V.4- 1959- v. 26, p. 62, 1981 (FOMIAZ); mmo-omi 10 ng/disc (-S9) Issledovaniya po Genetike. (Izdatel'stvo Leningradskogo Universiteta, Leningrad, USSR) No.1- 1961- v. 8, p. 82, 1979 (ISGEAK); mmo-omi 1 pph/24H-C (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 10, p. 522, 1974 (SOGEBZ); mmo-omi 1 pph (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 7, p. 948, 1971 (SOGEBZ); mmo-omi 500 ppm/1H (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 12, p. 772, 1976 (SOGEBZ); mmo-omi 500 ppm (-S9) Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 8, p. 412, 1972 (SOGEBZ); mmo-omi 2000 ppm (-S9) Mikrobiologiya. Microbiology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1932- v. 49, p. 93, 1980 (MIKBA5); mmo-omi 1000 ppm/6H-C (-S9) Mikrobiologicheskii Zhurnal (Kiev). Journal of Microbiology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.40- 1978- v. 44(5), p. 32, 1982 (MZHUDX); mmo-omi 100 mmol/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 1, 1969 (MUREAV); mmo-omi 100 mmol/L/60M (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 7, p. 19, 1969 (MUREAV); mmo-omi 1 gm/L (-S9) Dopovidi Akademii Nauk Ukrains'koi RSR, Seriya B: Geologichini, Khimichni ta Biologichni Nauki. Transactions of the Academy of Sciences of the Ukranian SSR, Series B. (V/O Mezhdunarodnaya Kniga, 113095, Moscow, USSR) 1976- v. (9), p. 70, 1981 (DANND6); mmo-omi 100 ppm (-S9) Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii. Journal of Microbiology, Epidemiology, and Immunology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.14- 1935- v. 48(3), p. 23, 1971 (ZMEIAV); dnd-omi 500 umol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 73, p. 2629, 1976 (PNASA6); dnd-omi 4200 umol/L Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 90, p. 37, 1977 (ZKKOBW); dnd-omi 40 mg/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 13, p. 151, 1976 (CBINA8); pic-omi 100 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 36, p. 265, 1976 (MUREAV); slt-dmg-mul 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 122, p. 123, 1983 (MUREAV); dns-dmg-emb 2 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 112, p. 215, 1983 (MUREAV); sln-dmg-orl 1000 ppm Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 207, p. 164, 1965 (NATUAS); sln-dmg-ihl 667 uL/L/48H Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 8, p. 877, 1972 (SOGEBZ); sln-dmg-par 1 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 149, p. 193, 1985 (MUREAV); spm-dmg-ihl 33 gm/L Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 7, p. 1030, 1971 (SOGEBZ); mmo-nsc 400 ug/plate (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 53, p. 297, 1978 (MUREAV); mmo-smc 100 mmol/L/1M (-S9) Zeitschrift fuer Vererbungslehre. (Berlin, Fed. Rep. Ger.) V.89-98, 1958-66. For publisher information, see MGGEAE. v. 95, p. 82, 1964 (ZEVBA5); mrc-smc 50 mmol/L Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 103, p. 11, 1968 (MGGEAE); mmo-asn 500 mg/L (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 23, p. 41, 1974 (MUREAV); mmo-clr 2 mmol/L (-S9) Biologia (Bratislava). (PNS-Ustredna Expedicia a Dovoz Tlace, Gottwaldovo nam. 6, 813 81 Bratislava, Czechoslovakia) V.8- 1953- v. 28, p. 469, 1973 (BLOAAO); mnt-nml-mul 5 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 298, p. 25, 1992 (MUREAV); mnt-nml-mul 5 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 298, p. 25, 1992 (MUREAV); dnd-nml-lvr 1 mmol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 99, 1983 (PAACA3); sce-oin-oth 25 mg/L Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- v. 46, p. 181, 1986 (CYTBAI); dnd-hmn-oth 300 umol/L Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 6, p. 149, 1992 (TIVIEQ); mtr-hmn-mmr 500 ug/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 27, p. 136, 1986 (PAACA3); mtr-hmn-oth 1 mg/L Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 47, p. 1543, 1981 (CANCAR); mtr-hmn-hla 5 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 448, 1968 (NATUAS); dnd-hmn-lvr 1800 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dnd-hmn-oth 112 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 44, p. 55, 1984 (CNREA8); dnd-hmn-hla 1200 ug Biochemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1962- v. 14, p. 1795, 1975 (BICHAW); dnd-hmn-lym 1 mmol/L Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. v. 1(3), p. 125, 1982 (JACTDZ); dnd-hmn-fbr 200 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 3104, 1983 (CNREA8); dna-hmn-oth 3200 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dns-hmn-fbr 1 mmol/L/1H International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 16, p. 284, 1975 (IJCNAW); dns-hmn-hla 10 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 2621, 1978 (CNREA8); dns-hmn-oth 100 umol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 69, p. 557, 1982 (JJIND8); dns-hmn-lvr 320 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dni-hmn-lym 10 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 50, p. 251, 1978 (MUREAV); dni-hmn-hla 50 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 427, 1982 (MUREAV); dni-hmn-fbr 1500 umol/L Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 33, p. 699, 1986 (NEOLA4); dnd-hmn-oth 10 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 441, p. 215, 1999 (MUREAV); oms-hmn-hla 15 umol/L ICN-UCLA Symposia on Molecular and Cellular Biology. (Menlo Park, CA) V.1-23, 1974-81. v. 9, p. 41, 1979 (IUSMDJ); cyt-hmn-lym 4 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 160, p. 95, 1986 (MUREAV); cyt-hmn-fbr 500 umol/L/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 43, p. 387, 1977 (MUREAV); cyt-hmn-hla 100 nmol/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 9, p. 21, 1978 (TXCYAC); sce-hmn-oth 25 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3100, 1988 (CNREA8); sce-hmn-lym 410 ug/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 40, p. 4775, 1980 (CNREA8); msc-hmn-lym 2500 nmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 94, p. 467, 1982 (MUREAV); msc-hmn-fbr 200 umol/L Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 25, p. 102, 1984 (PAACA3); mnt-rat-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 390, p. 51, 1997 (MUREAV); dnd-rat-ipr 82480 ug/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 55, p. 61, 1990 (CALEDQ); mtr-rat-oth 250 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 7, p. 2059, 1986 (CRNGDP); mtr-rat-orl 300 umol/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 43, p. 313, 1983 (CBINA8); dna-rat-oth 1800 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dna-rat-oth 300 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); mtr-rat-ipr 60 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 275, p. 60, 1978 (NATUAS); mtr-rat-lvr 25 mg/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 33, p. 606, 1973 (CNREA8); mtr-rat-kdy 5 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 448, 1968 (NATUAS); mtr-rat-oth 5 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 448, 1968 (NATUAS); dnd-rat-ivn 500 umol/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 157, 1989 (TCMUD8); dnd-rat-ivn 50 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 1589, 1978 (CNREA8); dnd-rat-par 3846 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 36, p. 4114, 1976 (CNREA8); dnd-rat-orl 560 ug/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 47, p. 3485, 1987 (CNREA8); dnd-rat-lvr 300 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 181, 1987 (MUREAV); dns-rat-lvr 320 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 4144, 1988 (CNREA8); dnd-rat-unr 80 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 15, p. 101, 1976 (CBINA8); dns-rat-oth 100 mmol/L Shika Kiso Igakkai Zasshi. Journal of the Japanese Association for Basic Dentistry. (Shika Kiso Igakkai, Hanayama Bldg., 1-44-2 Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1959- v. 22, p. 300, 1980 (SHKKAN); mtr-rat-oth 100 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 198, p. 115, 1988 (MUREAV); oms-rat-lvr 35 umol/L Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 93(3), p. 25, 1982 (BEBMAE); dni-rat-ipr 50 mg/kg Verhandlungen der Deutschen Gesellschaft fuer Pathologie. (Gustav Fischer Verlag, Postfach 720143, D-7000 Stuttgart 70, Fed. Rep. Ger.) V.1- 1898- v. 53, p. 553, 1969 (VDGPAN); oms-rat-ipr 100 mg/kg Verhandlungen der Deutschen Gesellschaft fuer Pathologie. (Gustav Fischer Verlag, Postfach 720143, D-7000 Stuttgart 70, Fed. Rep. Ger.) V.1- 1898- v. 53, p. 553, 1969 (VDGPAN); oms-rat-par 100 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. v. 79, p. 255, 1973 (ZKKOBW); dns-rat-oth 3200 umol/L Journal of Oral Pathology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.1- 1972- v. 10, p. 113, 1981 (JOPHBO); dns-rat-oth 3200 umol/L Journal of Oral Pathology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.1- 1972- v. 10, p. 113, 1981 (JOPHBO); dns-rat-oth 3200 umol/L Journal of Oral Pathology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.1- 1972- v. 10, p. 113, 1981 (JOPHBO); dns-rat-oth 3200 umol/L Journal of Oral Pathology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.1- 1972- v. 10, p. 113, 1981 (JOPHBO); dns-rat-ipr 150 mg/kg Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 7, p. 889, 1985 (ENMUDM); dnd-rat-oth 1 mmol/L Diabetes. (American Diabetes Assoc., 2 Park Ave., New York, NY 10016) V.1- 1952- v. 35, p. 866, 1986 (DIAEAZ); dnd-rat-ipr 700 umol/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 55, p. 61, 1990 (CALEDQ); dna-rat-ipr 60 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 2183, 1996 (CRNGDP); cyt-rat-lym 900 umol/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 258, p. 611, 1975 (NATUAS); cyt-rat-ipr 200 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 21, p. 34, 1973 (MUREAV); oms-rat-orl 30 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 348, p. 169, 1995 (MUREAV); sce-rat-oth 100 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 48, p. 3100, 1988 (CNREA8); msc-rat-ipr 30 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 17, p. 2183, 1996 (CRNGDP); hma-rat-smc 825 mg/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 3, p. 41, 1983 (TCMUD8); mnt-mus-ipr 180 umol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 204, p. 703, 1988 (MUREAV); mnt-mus-orl 5 mg/kg Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 28, p. 633, 1990 (FCTOD7); slt-mus-ipr 5 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 92, p. 193, 1982 (MUREAV); mtr-mus-oth 125 mg/L Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 55, p. 31, 1990 (CALEDQ); mtr-mus-orl 90 mg/kg/8D-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 49, p. 1236, 1989 (CNREA8); mtr-mus-emb 200 mg/L Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. v. 4, p. 321, 1982 (ENMUDM); mtr-mus-fbr 100 ug/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1235, 1982 (CRNGDP); dnd-mus-ipr 56200 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 54, p. 39, 1978 (MUREAV); dnd-mus-leu 1 mmol/L/1H Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2780, 1975 (CNREA8); dnd-mus-emb 18 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1119, 1982 (CRNGDP); dna-mus-oth 2700 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dns-mus-ipr 50 mg/kg Bolletino della Societe Italiana di Biologia Sperimentale. (Casa Editrice Idelson, Via A. de Gasperi, 55, 80133 Naples, Italy) V.2- 1927- v. 54, p. 827, 1978 (BSIBAC); oms-mus-leu 80 mg/kg INSERM Symposium. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) No.1- 1975- v. 19, p. 85, 1981 (INSSDM); dns-mus-skn 80 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 881, 1982 (CRNGDP); dns-mus-scu 1500 umol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 5216, 1982 (CNREA8); dni-mus-par 100 mg/kg Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 22(10), p. 61, 1976 (VOONAW); dni-mus-oth 1 mmol/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 1321, 1980 (JJIND8); dni-mus-oth 1 mg/L/1H Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 864, 1982 (CNREA8); dni-mus-ipr 20 gm/kg Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 51, p. 605, 1981 (ARGEAR); dni-mus-oth 80 mg/kg INSERM Symposium. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) No.1- 1975- v. 19, p. 85, 1981 (INSSDM); dna-mus-oth 700 nmol Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- v. 24, p. 65, 1983 (PAACA3); dnd-mus-ivn 10 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 16, p. 325, 1977 (CBINA8); dns-mus-oth 5 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 9, p. 1197, 1988 (CRNGDP); cyt-mus-ipr 8248 ug/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 29, p. 89, 1975 (MUREAV); cyt-mus-orl 50 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 71, p. 133, 1983 (JJIND8); sce-mus-ipr 60 umol/kg Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- v. 9, p. 219, 1989 (TCMUD8); sce-mus-ipr 25 mg/kg Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 11, p. 337, 1983 (JTEHD6); sce-mus-mmr 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 147, p. 165, 1985 (MUREAV); dlt-mus-ipr 125 mg/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 177, p. 171, 1987 (MUREAV); msc-mus-lym 1 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 125, p. 291, 1984 (MUREAV); hma-mus-srm 40 mg/kg Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 117, p. 197, 1972 (MGGEAE); hma-mus-sat 800 mg/kg Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 13, p. 737, 1977 (SOGEBZ); hma-mus-esc 500 umol/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 148, p. 1, 1985 (MUREAV); spm-mus-unr 50 mg/kg Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1965- v. 16, p. 1397, 1980 (GNKAA5); mnt-ham-emb 1 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 203, p. 397, 1988 (MUREAV); mmo-ham-lng 100 umol/L (+S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 187, p. 181, 1987 (MUREAV); mtr-ham-kdy 20 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 264, p. 722, 1976 (NATUAS); mtr-ham-lng 5 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 448, 1968 (NATUAS); mtr-ham-ovr 5 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 448, 1968 (NATUAS); mtr-ham-emb 5 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 448, 1968 (NATUAS); dnd-ham-lng 100 umol/L/1H Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 72, p. 732, 1976 (BBRCA9); dnd-ham-ovr 500 umol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 26, p. 233, 1979 (CBINA8); dns-ham-lng 3 mmol/L/1H Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 3, p. 49, 1971 (CBINA8); dns-ham-emb 3200 umol/L Journal of Oral Pathology. (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.1- 1972- v. 10, p. 113, 1981 (JOPHBO); dni-ham-lng 2 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 4, p. 261, 1983 (CRNGDP); cyt-ham-ovr 440 umol/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 24, p. 289, 1986 (FCTOD7); cyt-ham-ipr 100 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 2, p. 277, 1978 (TOLED5); cyt-ham-fbr 100 mg/L/48H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 48, p. 337, 1977 (MUREAV); cyt-ham-lng 1 mg/L Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 4, p. 41, 1980 (ATSUDG); cyt-ham-oth 100 mg/L Soviet Genetics. English translation of GNKAA5. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.2- 1966- v. 12, p. 304, 1976 (SOGEBZ); sce-ham-fbr 1 mmol/L Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 58, p. 1635, 1977 (JNCIAM); sce-ham-ovr 60 umol/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 24, p. 289, 1986 (FCTOD7); sce-ham-lng 1 umol/L Zhongguo Yixue Kexueyuan Xuebao. Journal of the Chinese Academy of Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1979- v. 5, p. 57, 1983 (CIHPDR); sce-ham-ipr 50 umol/kg Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 39, p. 757, 1983 (EXPEAM); sce-ham-oth 240 umol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 1627, 1985 (CRNGDP); msc-ham-ipr 100 mg/kg Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 2, p. 277, 1978 (TOLED5); msc-ham-ovr 35 umol/L Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- v. 24, p. 289, 1986 (FCTOD7); msc-ham-lng 50 umol/L/1H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 111, p. 341, 1983 (MUREAV); msc-ham-oth 50 mg/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 16, p. 89, 1972 (MUREAV); dnd-gpg-orl 10300 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1443, 1982 (CRNGDP); mtr-mky-kdy 50 mg/L British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 31, p. 338, 1975 (BJCAAI); mtr-rbt-kdy 5 mg/L Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 220, p. 448, 1968 (NATUAS); dna-mam-lym 100 umol/L Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 70, p. 693, 1979 (GANNA2); oms-mam-lym 1 mmol/L Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 46, p. 179, 1983 (CBINA8); dnd-oin-orl 0.1 umol/tube Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 480-481, p. 139, 2001 (MUREAV); mmo-sat 10 ug/l/48H Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 138, p. 37, 1999 (CALEDQ); mtr-mus-fbr 1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG); spm-mus-ipr 50 mg/kg Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. 43, p. 623, 1997 (VOONC*); slt-ham-ovr 0.5 mg/L/9D Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 16, p. 260, 1990 (EMMUEG) RE: T41 orl-rat TDLo: 45 mg/kg (13D preg) Pathology, Research and Practice. (Gustav Fisher Verlag, Postfach 720143, D-7000 Stuttgart 70, Fed. Rep. Ger.) V.162- 1978- v. 163, p. 1, 1978 (PARPDS); T33-T41 ipr-rat TDLo: 5 mg/kg (15D preg) Biologicheskie Nauki (Moscow). (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.3- 1965- v. 20(9), p. 65, 1977 (BINKBT); T41-T81-T85 ipr-rat TDLo: 5 mg/kg (13D preg) Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 31(Suppl), p. 81, 1986 (TOLED5); T43-T46 ipr-rat TDLo: 10 mg/kg (13D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 112, 1973 (IARCCD); T35 ipr-rat TDLo: 5 mg/kg (9D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 112, 1973 (IARCCD); T31-T34 ipr-rat TDLo: 10 mg/kg (9D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 112, 1973 (IARCCD); T43 scu-rat TDLo: 10 mg/kg (14D preg) Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 10, p. 839, 1972 (FCTXAV); T81 ivn-rat TDLo: 10 mg/kg (12D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 127, 1973 (IARCCD); T76 ivn-rat TDLo: 5 mg/kg (12D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 127, 1973 (IARCCD); T59 ivn-rat TDLo: 10 mg/kg (10D preg) Naunyn-Schmiedebergs Archiv fuer Pharmakologie und Experimentelle Pathologie. (Berlin, Ger.) V.254-263, 1966-69. For publisher information, see NSAPCC. v. 257, p. 296, 1967 (APEPA2); T41-T46 ivn-rat TDLo: 7500 ug/kg (13D preg) Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967-80. For publisher information, see EXPADD. v. 13, p. 11, 1977 (EXPTAX); T35 ivn-rat TDLo: 3 mg/kg (10D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 45, 1973 (IARCCD); T41-T43-T46 par-rat TDLo: 20 mg/kg (13D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 1, p. 179, 1968 (TJADAB); T39 par-rat TDLo: 20 mg/kg (13D preg) Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- v. 157, p. 365, 1967 (ANREAK); T31 unr-rat TDLo: 21 mg/kg (1-7D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 1, 1973 (IARCCD); T41 unr-rat TDLo: 21 mg/kg (8-14D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 1, 1973 (IARCCD); T25-T72 unr-rat TDLo: 21 mg/kg (1-7D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 20(12), p. 76, 1974 (VOONAW); T33-T46 ipr-mus TDLo: 10 mg/kg (11D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 25(2), p. 59A, 1982 (TJADAB); T23-T25-T59 ipr-mus TDLo: 100 mg/kg (1D male) Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589 Japan) V.27- 1987- v. 34, p. 65, 1994 (CGANE7); T43-T46-T53 ipr-mus TDLo: 20 mg/kg (2D preg) Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- v. 3, p. 27, 1989 (REPTED); T34-T35 ipr-mus TDLo: 1 mg/kg (4D preg) Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 40, p. 879, 1984 (EXPEAM); T33-T49 ivn-mus TDLo: 25 mg/kg (15D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 24(1), p. 30A, 1981 (TJADAB); T71-T76 orl-gpg TDLo: 32500 ug/kg (34-58D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 12, p. 105, 1975 (TJADAB) TE: V01-R60 orl-rat TDLo: 6 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 45, p. 4827, 1985 (CNREA8); V01-R60-V10 skn-rat TDLo: 576 mg/kg/24W-I Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- v. 55, p. 117, 1985 (ARGEAR); V01-T65-A60 ipr-rat TDLo: 20 mg/kg (18D preg) International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 15, p. 385, 1975 (IJCNAW); V01-K60-N60 ipr-rat TDLo: 240 mg/kg/6W-I Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 84, p. 139, 1993 (JJCREP); V01-R60 scu-rat TDLo: 1250 ug/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 6, p. 769, 1985 (CRNGDP); V03-T65-B60 ivn-rat TDLo: 20 mg/kg (22D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 127, 1973 (IARCCD); V01-R60 ivn-rat TDLo: 20 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 3, p. 1473, 1982 (CRNGDP); V03-T65-A60 ivn-rat TDLo: 10 mg/kg (15D preg) Kyoto-furitsu Ika Daigaku Zasshi. Journal of the Kyoto Prefectural School of Medicine. (Kyoto-furitsu Ika Daigaku Igakkai, Hirokoji, Kawaramachi-dori, Kamigyo-ku, Kyoto 602, Japan) V.1- 1927- v. 84, p. 23, 1975 (KFIZAO); V03-D29 ocu-rat TDLo: 800 ug/kg Experimental Eye Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1961- v. 42, p. 83, 1986 (EXERA6); V03-T65-A60 par-rat TDLo: 5 mg/kg (21D preg) IARC Scientific Publications. (Geneva, Switzerland) No.1-26, 1971-78. For publisher information, see IAPUDO. v. 4, p. 1, 1973 (IARCCD); V01-M60 par-rat TDLo: 5 mg/kg/2W-I British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 45, p. 337, 1982 (BJCAAI); V03-Q01-Q60 par-rat TDLo: 80 mg/kg/2W-I Shika Kiso Igakkai Zasshi. Journal of the Japanese Association for Basic Dentistry. (Shika Kiso Igakkai, Hanayama Bldg., 1-44-2 Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1959- v. 25, p. 819, 1983 (SHKKAN); V01-M60-M61 unr-rat TDLo: 10 mg/kg "Health and Sugar Substitutes, Proceedings of the ERGOB Conference on Sugar Substitutes, Geneva, 1978," Guggenheim, B., ed., Basel, Switzerland, S. Karger AG, 1979 -,64,1978 (40RMA7); V01-T65-A60 unr-rat TDLo: 20 mg/kg (21D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 20(12), p. 76, 1974 (VOONAW); V01-T65-M61 unr-rat TDLo: 20 mg/kg (21D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 20(12), p. 76, 1974 (VOONAW); V01-K60 rec-rat TDLo: 30 mg/kg/5W-I Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher information, see JJCREP. v. 73, p. 377, 1982 (GANNA2); V01-A60-R60 mul-rat TDLo: 150 mg/kg/30W-I Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie. (VEB Gustav Fischer Verlag, Postfach 176, Jena DDR-6900, Ger. Dem. Rep.) V.1- 1890- v. 114, p. 447, 1971 (ZAPPAN); V01-K60 orl-mus TDLo: 200 mg/kg/10W-I Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 83, p. 915, 1992 (JJCREP); V02-J60 orl-mus TDLo: 300 mg/kg/8W-I Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 82, p. 19, 1986 (TXAPA9); V01-R60 skn-mus TDLo: 8248 ug/kg/50W-I Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 114, p. 245, 1988 (JCROD7); V01-K60-P62 ipr-mus TDLo: 50 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 24, p. 588, 1970 (BJCAAI); V01-T65-J60 scu-mus TDLo: 75 mg/kg (14-19D preg) Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 17(8), p. 75, 1971 (VOONAW); V02-T65-J60 ivn-mus TDLo: 50 mg/kg (15D preg) Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. v. 21, p. 261, 1981 (SEIJBO); V01-P61 ivn-mus TDLo: 50 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 30, p. 325, 1974 (BJCAAI); V01-K61-V10 rec-mus TDLo: 360 mg/kg/2W-I Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 148, p. 166, 1975 (PSEBAA); V03-A60 ivn-dog TDLo: 240 mg/kg/52W-I Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- v. 26, p. 303, 1970 (EXPEAM); V03-V10 par-dog TDLo: 3009 mg/kg/34W-I JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 921, 1980 (JJIND8); V03-J22-V10 imp-dog TDLo: 183 mg/kg/21W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 65, p. 921, 1980 (JJIND8); V03-K60 orl-mky TDLo: 20 gm/kg/6Y-I Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- v. 40, p. 1950, 1977 (CANCAR); V03-A60 ivn-rbt TDLo: 150 mg/kg/30W-I Zeitschrift fuer Neurologie. (Berlin, Ger.) V.198-206, 1970-74. For publisher information, see JNRYA9. v. 198, p. 65, 1970 (ZSNUAI); V02-T65-M61 ivn-rbt TDLo: 40 mg/kg (25D preg) Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- v. 85, p. 369, 1978 (BEXBAN); V03-K61 orl-pig TDLo: 1170 mg/kg/5Y-I Research in Experimental Medicine. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.157- 1972- v. 169, p. 33, 1976 (REXMAS); V01-K61 orl-gpg TDLo: 440 mg/kg/44W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 35, p. 2269, 1975 (CNREA8); V01-K60-L60 ipr-gpg TDLo: 180 mg/kg/18W-I Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- v. 24, p. 57, 1977 (NEOLA4); V02-K61 rec-gpg TDLo: 168 mg/kg/42W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 54, p. 785, 1975 (JNCIAM); V01-K60 orl-ham TDLo: 20 mg/kg/5W-I Archives of Oral Biology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1959- v. 25, p. 623, 1980 (AOBIAR); V03-R60-V10 skn-ham TDLo: 155 mg/kg/13W-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 214, p. 611, 1967 (NATUAS); V02-K60-L60 ipr-ham TDLo: 30 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 829, 1983 (CNREA8); V01-V10 scu-ham TDLo: 146 mg/kg/41W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 51, p. 1295, 1973 (JNCIAM); V03-K60-Q60 ivn-ham TDLo: 60 mg/kg/13W-I Koku Geka Gakkai Zasshi. Oral Surgery. (Tokyo, Japan) v. 25, p. 262, 1968 (KGGZAL); V01-D09-J60 itr-ham TDLo: 36 mg/kg/26W-I International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 6, p. 217, 1970 (IJCNAW); V01-J60 unr-ham TDLo: 400 mg/kg/10W-I Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 24, p. 330, 1979 (PEXTAR); V01-K60 orl-grb TDLo: 21 uL/kg/20W-I Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam, Netherlands) V.76- 1985- v. 89, p. 97, 1998 (JJCREP); V02-N60 ivn-grb TDLo: 38 mg/kg/15W-I Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. v. 55, p. 637, 1975 (JNCIAM); V01-M60-M61 par-rat TD :7500 ug/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 42, p. 129, 1980 (BJCAAI); V01-R60 ivn-rat TD :50 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 71, p. 625, 1983 (JJIND8); V01-P60-P62 ivn-mus TD :50 mg/kg Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979- v. 108, p. 214, 1984 (JCROD7); V01-J60 itr-ham TD :300 mg/kg/15W-I Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- v. 24, p. 345, 1979 (PEXTAR); V01-K60-K61 rec-rat TD :60 mg/kg/3W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 38, p. 4427, 1978 (CNREA8); V01-K60-P62 ipr-mus TD :12500 ug/kg Gerontology (Basel). (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.22- 1976- v. 28, p. 114, 1982 (GERNDJ); V01-M61 par-rat TD :7500 ug/kg/3W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 8, p. 3, 1979 (CALEDQ); V01-M61-R60 ivn-rat TD :100 mg/kg/2W-I Experimental Pathology (1981). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.19- 1981- v. 19, p. 81, 1981 (EXPADD); V01-R60 ivn-rat TD :25 mg/kg/8D-I Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 267, p. 620, 1977 (NATUAS); V02-K60-L60 ipr-ham TD :71 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 43, p. 829, 1983 (CNREA8); V01-K61 scu-rat TDLo: 50 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 168, p. 23, 2001 (CALEDQ); V03-M60 itr-mus TDLo: 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 477, p. 125, 2001 (MUREAV); V01-R60 skn-mus TD :200 mg/kg/3W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 173, p. 133, 2001 (CALEDQ); V01-J30 iut-mus TDLo: 10 mg/kg/3W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 158, p. 133, 2000 (CALEDQ); V01-J30 ipr-mus TDLo: 25 mg/kg/2W-I Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 158, p. 185, 2000 (CALEDQ); V02-J30 ipr-rat TDLo: 80 mg/kg/2W Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 154, p. 121, 2000 (CALEDQ); V01-J30 ipr-rat TDLo: 50 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 149, p. 171, 2000 (CALEDQ); V01-R60 ipr-rat TDLo: 50 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 21, p. 827, 2000 (CRNGDP); V02-T64 iut-mus TDLo: 10 mg/kg Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 22, p. 587, 2001 (CRNGDP); V01-R60 ipr-rat TDLo: 37.5 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 162, p. 155, 2001 (CALEDQ); V02-R60 ipr-rat TDLo: 20 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 162, p. 155, 2001 (CALEDQ); V01 ivn-rat TDLo: 50 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 138, p. 37, 1999 (CALEDQ); V01-K60 orl-mus TDLo: 302.4 mg/kg/5W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 139, p. 167, 1999 (CALEDQ); V02-L60-J60 ipr-mus TDLo: 20 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 143, p. 71, 1999 (CALEDQ); V02-J60 ipr-mus TDLo: 20 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 143, p. 71, 1999 (CALEDQ); V01-T69 ipr-rat TDLo: 50 mg/kg Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 126, 2001 (JTPAE7); V01-K60-R60 ipr-mus TDLo: 75 mg/kg Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7); V01-R60 ivn-rat TDLo: 50 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 92, p. 1836, 2000 (JJIND8); V01-R60 ivn-rat TDLo: 50 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 92, p. 1836, 2000 (JJIND8); V01-R60 idr-rat TDLo: 60 mg/kg Experimental Oncology (Journal of ucrainian section of European institute of ecology and cancer, Kiev-22, Vaselkovskaya str., 25, Kiev-22) V.1- 1979- v. 15, p. 23, 1993 (EXONC*); V01-M61-P61 ivn-rat TDLo: 50 mg/kg Voprosi oncologii (Questions of oncology. Journal of Petrov's Institute of Oncology, B. Zelenina str, 43a, Spb 197110, Russia) V.1- 1955- v. -, p. 195, 1992 (VOONC*) ORNG: 110000000 ng/kg. [110.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 110 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); T/E unlistd ipr-rat LD50: 110 mg/kg Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 222, p. 1064, 1969 (NATUAS); T/E unlistd ivn-rat LD50: 108 mg/kg Naunyn-Schmiedebergs Archiv fuer Pharmakologie und Experimentelle Pathologie. (Berlin, Ger.) V.254-263, 1966-69. For publisher information, see NSAPCC. v. 257, p. 296, 1967 (APEPA2); M30 imp-rat LDLo: 30 mg/kg Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- v. 5, p. 139, 1972 (CBINA8); T/E unlistd ipr-mus LD50: 144 mg/kg Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 30, p. 11, 1970 (CNREA8); T/E unlistd scu-ham LD50: 113 mg/kg British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- v. 29, p. 359, 1974 (BJCAAI); T/E unlistd ivn-ham LDLo: 42 mg/kg Journal of Pathology and Bacteriology. (London, UK) V.1-96, 1892-1968. For publisher information, see JPTLAS. v. 92, p. 35, 1966 (JPBAA7); T/E unlistd orl-mam LD50: 110 mg/kg Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 17, p. 107, 1975 (GMCRDC); T/E unlistd ivn-mam LD50: 110 mg/kg Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- v. 17, p. 107, 1975 (GMCRDC); T/E unlistd ipr-rat LD :50 mg/kg Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 169, p. 147, 2001 (CALEDQ); T/E unlistd ipr-mus LDLo: 75 mg/kg Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi- shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988 v. 29, p. 458, 2001 (JTPAE7) MD: Z01 ipr-mus TDLo: 150 mg/kg/5D-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 22(10), p. 72, 1976 (VOONAW); Q01 orl-ham TDLo: 320 mg/kg/16W-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 27, p. 226, 1999 (TOPADD); C18-Y37 ivn-rat TDLo: 360 mg/kg/6D-I Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967-80. For publisher information, see EXPADD. v. 18, p. 444, 1980 (EXPTAX) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 227, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 227, 1978 (IMEMDT); IARC Cancer Review: Group 2A IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL); TOXICOLOGY REVIEW Archives of Pathology and Laboratory Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-5(2), 1926-28: V.100- 1976- v. 107, p. 54, 1983 (APLMAS); TOXICOLOGY REVIEW "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 -,49,1975 (32XPAD); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 129, 1983 (BLFSBY); TOXICOLOGY REVIEW Nutrition and Cancer. (Franklin Institute Press, POB 2266, Phildelphia, PA 19103) V.1- 1978- v. 3, p. 109, 1981 (NUCADQ); TOXICOLOGY REVIEW Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- v. 24, p. 253, 1983 (BLFSBY) SR: OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, In vitro cytogenetics-human; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-whole sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-partial sex chrom. loss; EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay, Rodent heritable translocation; EPA GENETOX PROGRAM 1988, Positive: Mouse spot test, N crassa-forward mutation; EPA GENETOX PROGRAM 1988, Positive: N crassa-reversion, E coli polA without S9; EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test, In vitro SCE-nonhuman; EPA GENETOX PROGRAM 1988, Positive: Mouse specific locus, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; EPA GENETOX PROGRAM 1988, Positive: In vitro UDS-human fibroblast, In vitro UDS in rat liver; EPA GENETOX PROGRAM 1988, Positive: UDS in mouse germ cells, V79 cell culture-gene mutation; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae gene conversion, S cerevisiae-aneuploidy; EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-reversion; EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal; EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1107 of 1119 in RTECS (through 2003/06) AN: YU2800000 PN: Urea,-2-thio- SY: Tsizp-34-; Isothiourea-; Pseudothiourea-; RCRA-waste-number-U219-; Sulourea-; Thiocarbamide-; Thiocarbonic-acid-diamide-; Thiomocovina- (Czech); beta-Thiopseudourea-; 2-Thiopseudourea-; Thiourea-; 2-Thiourea-; THU-; Urea,-thio- (8CI); USAF-EK-497- RN: Current: 62-56-6 UD: 200305 MF: C-H4-N2-S MW: 76.13 WL: ZYZUS CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-rbt 14% Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 30(3), p. 42, 1986 (GTPZAB) ME: mmo-sat 150 ug/plate (+S9) Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International, Tokyo 100-31, Japan) V.25- 1961- v. 44, p. 3017, 1980 (ABCHA6); dnr-esc 329 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 272, p. 145, 1992 (MUREAV); dna-esc 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); mmo-smc 52600 umol/L (-S9) Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.99- 1967- v. 174, p. 39, 1979 (MGGEAE); dni-hmn-fbr 60 mmol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 183, p. 89, 1987 (MUREAV); dni-hmn-lym 20 mmol/L Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing and Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- v. 79, p. 1171, 1982 (PNASA6); dni-hmn-hla 140 mmol/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 13, p. 2389, 1992 (CRNGDP); mtr-rat-emb 100 mg/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); dnd-rat-lvr 30 mmol/L Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26 OCT 1982 (SinJF#); dns-rat-lvr 10 mmol/L Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 42, p. 3010, 1982 (CNREA8); msc-mus-lym 18 mmol/L Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- v. 3, p. 193, 1988 (MUTAEX); hma-mus-sat 125 mg/kg JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 62, p. 911, 1979 (JJIND8); mtr-ham-emb 100 ug/L International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- v. 19, p. 642, 1977 (IJCNAW); mtr-ham-emb 100 ug/L JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1303, 1981 (JJIND8); msc-ham-lng 10 mmol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 58, p. 5, 1985 (ARTODN) RE: T41-T46 orl-rat TDLo: 240 mg/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 13, p. 263, 1976 (TJADAB); T25 orl-rat TDLo: 1 gm/kg (12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 23, p. 335, 1981 (TJADAB); T52 orl-rat TDLo: 1400 mg/kg (16-22D preg) Acta Medica Academiae Scientiarum Hungaricae. (Budapest, Hungary) V.1-39, 1950-82. v. 32, p. 271, 1975 (AMASA4); T34 orl-rat TDLo: 4800 mg/kg (17-22D preg/10D post) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 31, p. 57A, 1985 (TJADAB); T25 orl-mus TDLo: 1 gm/kg (10D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 23, p. 335, 1981 (TJADAB); T13-T19 orl-ham TDLo: 22400 mg/kg (10W pre) Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- v. 36, p. 719, 1987 (BIREBV); T01-T09 orl-dom TDLo: 9 gm/kg (90D male) Theriogenology. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022) V.1- 1974- v. 25, p. 263, 1986 (THGNBO) TE: V01-D29-D45 orl-rat TDLo: 78 gm/kg/56W-C Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 17, p. 302, 1957 (CNREA8); V01-D29-D45 mul-rat TDLo: 151 gm/kg/52W-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 17, p. 302, 1957 (CNREA8); V02-L60 orl-rat TD :18 gm/kg/2Y-C Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 108, p. 626, 1948 (SCIEAS); V03-L60 orl-rat TD :40 gm/kg/2Y-C Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 108, p. 626, 1948 (SCIEAS); V03-L50-J30 orl-rat TD :1950 mg/kg/2Y-C Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 11, p. 88, 1967 (TXAPA9); V03-R60 mul-rat TD :179 gm/kg/1Y-I Cancer Research. (Public Ledger Building, Suit 816, 6th and Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- v. 14, p. 494, 1954 (CNREA8); V03-N62 orl-rat TD :90 gm/kg/1Y-I British Journal of Experimental Pathology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1920- v. 28, p. 46, 1947 (BJEPA5) ORNG: 125000000 ng/kg. [125.000000 mg/kg] T/E unlistd AT: P01-P13-P20 orl-wmn TDLo: 1660 mg/kg/5W Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 246, p. 179, 1944 (LANCAO); T/E unlistd unr-man LDLo: 147 mg/kg "Poisoning: Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970 2,73,1970 (85DCAI); T/E unlistd orl-rat LD50: 125 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 177, 1959 (HBTXAC); T/E unlistd ipr-rat LD50: 436 mg/kg Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. v. 3, p. 597, 1965 (FCTXAV); T/E unlistd ipr-mus LD50: 100 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. AD277-689 (NTIS**); T/E unlistd orl-rbt LDLo: 6985 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 177, 1959 (HBTXAC); T/E unlistd scu-gpg LDLo: 4 gm/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 177, 1959 (HBTXAC); T/E unlistd scu-frg LDLo: 10 gm/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59 v. 5, p. 177, 1959 (HBTXAC); T/E unlistd orl-mam LDLo: 1 gm/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 30(3), p. 42, 1986 (GTPZAB); T/E unlistd ipr-mam LD50: 3500 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 30(3), p. 42, 1986 (GTPZAB); N08 orl-rat TDLo: 4 mg/kg Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- v. 47, p. 77, 1950 (BIJOAK) MD: N75 orl-rat TDLo: 2550 mg/kg/5W-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 97, p. 349, 1949 (JPETAB); F17-N08-Z72 ihl-rat TCLo: 25 mg/m3/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 30(3), p. 42, 1986 (GTPZAB); J06-J16-N75 ihl-rat TCLo: 47200 ug/m3/39W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 16(6), p. 51, 1972 (GTPZAB); A30-L03-N08 orl-dom TDLo: 4500 mg/kg/90D-I Indian Veterinary Journal. (Dr. R. Krishnamurti, G.M.V.C., 8 Avenue Rd., Madras 600 034, India) V.1- 1924- v. 69, p. 111, 1992 (IVEJAC) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 79, p. -, 2000 (IMEMDT); TOXICOLOGY REVIEW "Oncology 1970, Proceedings of the Tenth International Cancer Congress," Chicago, Year Book Medical Pub., 1971 5,250,1970 (85CVA2); TOXICOLOGY REVIEW Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 128, p. 117, 2002 (TOLED5) SR: OEL-AUSTRIA: Suspected Carcinogen, JAN 1999; OEL-FINLAND: Carcinogen, JAN 1999; OEL-FRANCE: Carcinogen, JAN 1993; OEL-GERMANY: Carcinogen, JAN 1999; OEL-RUSSIA: STEL 0.3 mg/m3, JAN 1993; OEL-SWEDEN: Carcinogen, JAN 1999 ND: NOHS 1974: HZD 82272; NIS 29; TNF 1179; NOS 25; TNE 12517; NOES 1983: HZD 82272; NIS 50; TNF 2999; NOS 57; TNE 37571; TFE 10969 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat, Cell transform.-SA7/F344 rat; EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay, Cell transform.-RLV F344 rat embryo; EPA GENETOX PROGRAM 1988, Positive: Host-mediated assay; EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE, E coli polA with S9; EPA GENETOX PROGRAM 1988, Negative: Histidine reversion-Ames test, Sperm morphology-mouse; EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis; EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1108 of 1119 in RTECS (through 2003/06) AN: YV7120000 PN: Valeric acid, 2,2-dimethyl-5-(2,5-xylyloxy)- SY: CI-719-; 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid; 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid; Gemfibrozil-; Lopid-; Pentanoic acid, 5-(2,5-dimethylphenoxy)-2,2-dimethyl- (9CI) RN: Current: 25812-30-0 BRN: 1881200 UD: 200305 MF: C15-H22-O3 MW: 250.37 WL: QVX1&1&3OR B1 E1 CC: Tumorigen (C); Drug (D); Reproductive-Effector (T); Human-Data (P) RE: T81 orl-rat TDLo: 2648 mg/kg (15-22D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 454, 1987 (FAATDF); T23 orl-rat TDLo: 18910 mg/kg (61D male) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 8, p. 454, 1987 (FAATDF) TE: V01-L60-T61 orl-rat TDLo: 218 gm/kg/2Y-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1105, 1981 (JJIND8); V03-L60 orl-mus TDLo: 16 gm/kg/78W-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1105, 1981 (JJIND8); V02-N60-T61 orl-rat TD :22 gm/kg/2Y-C JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. v. 67, p. 1105, 1981 (JJIND8) ORNG: 1414000000 ng/kg. [1414.000000 mg/kg] F05-F07-J25 AT: F18-M03 orl-man TDLo: 18 gm/kg/3Y-I Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1908- v. 151, p. 1873, 1991 (AIMDAP); F05-F07-J25 orl-rat LD50: 1414 mg/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 25, p. 645, 1997 (YACHDS); F07 ipr-rat LD50: 445 mg/kg Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (6), p. 38, 1995 (TOVEFN); F07 orl-mus LD50: 2218 mg/kg Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (6), p. 38, 1995 (TOVEFN); F07-K13-K30 orl-dog LDLo: 2 gm/kg Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 25, p. 699, 1997 (YACHDS) MD: L30-P73-Y03 orl-rat TDLo: 10920 mg/kg/1Y-C Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 25, p. 673, 1997 (YACHDS); L70 orl-rat TDLo: 2864 mg/kg/13D-C JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 17, p. 47, 1996 (JJATDK); L30-M70-P26 orl-rat TDLo: 13650 mg/kg/13W-C Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 25, p. 653, 1997 (YACHDS); L30-L70-Y11 orl-rat TDLo: 16800 mg/kg/6W-I Warasan Phesatchasat. Journal of Pharmaceutical Sciences. (Mahidol University, Faculty of Pharmacy, Sri-Ayudhya Rd., Bangkok, Thailand) V.1- 1974- v. 25(2), p. 1, 1998 (VPSADN); K12-M30-U01 ipr-rat TDLo: 4 gm/kg/5D-I Biochemistry and Molecular Biology International. (Academic Press, Locked BAG 16, Marrickville NSW 2204, Australia) V.29- 1993- v. 47, p. 519, 1999 (BMBIES); L70-P30-Y15 orl-dog TDLo: 13650 mg/kg/13W-C Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 25, p. 703, 1997 (YACHDS); L70-P30-Y15 orl-dog TDLo: 54600 mg/kg/1Y-C Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- v. 25, p. 725, 1997 (YACHDS); N30-P28 ipr-qal TDLo: 5600 mg/kg/4W-I Indian Journal of Experimental Biology. (Publications and Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- v. 34, p. 987, 1996 (IJEBA6); L30-Y20-Y37 orl-rat TDLo: 1260 mg/kg/3D-C Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- v. 62, p. 803, 2001 (BCPCA6) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 427, 1996 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 427, 1996 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 66, p. 427, 1996 (IMEMDT); TOXICOLOGY REVIEW Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 128, p. 159, 2002 (TOLED5) SL: NTP Carcinogenesis studies, test completed (peer review), October 2000 Record 1109 of 1119 in RTECS (through 2003/06) AN: YW2460000 PN: Vanadium-pentoxide- (fume) SY: RCRA-waste-number-P120-; Vanadium- (OSHA); Vanadium-pentoxide,-fume-; Vanadium-pentoxide,-fume- (ACGIH); Vanadium-pentoxide,-nonfused-form,-fume- (ACGIH) RN: Current: 1314-62-1 UD: 200210 MF: O5-V2 MW: 181.88 WL: .VA2.O5 CC: Tumorigen (C) MD: M03-P28-Y01 ihl-rat TCLo: 27 ug/m3/24H/70D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 31(7), p. 8, 1966 (GISAAA); M70-P71-Y08 ihl-rat TCLo: 100 ug/m3/24H/17W-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 46(2), p. 17, 1981 (GISAAA) TR: ACGIH TLV-TWA 0.05 mg(V2O5)/m3 (R) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); TOXICOLOGY REVIEW "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 V,46,1974 (85DHAX) SR: MSHA STANDARD-air: TWA 0.05 mg/m3 (fume) The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 v. 3, p. 275, 1971 (DTLVS*); OSHA PEL (Gen Indu): CL 0.1 mg(V2O5)/m3, fume Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): CL 0.1 mg(V2O5)/m3, fume Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): CL 0.1 mg(V2O5)/m3, fume Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): CL 0.1 mg(V2O5)/m3, fume Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OSHA PEL (Fed Cont): CL 0.5 mg(V2O5)/m3, dust Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-AUSTRIA: MAK 0.05 mg/m3, JAN 1999; OEL-JAPAN: OEL 0.1 mg(V2O5)/m3, JAN 1999; OEL-POLAND: MAC(TWA) 0.05 mg/m3, MAC(STEL) 0.1 mg/m3, JAN 1999; OEL-SWEDEN: NGV 0.2 mg(V)/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 50 ppm (175 mg/m3), JAN 1999; OEL-UNITED KINGDOM: TWA 0.5 mg(V)/m3, total inhalable dust, SEP 2000; OEL-UNITED KINGDOM: TWA 0.04 mg(V)/m3, fume and respirable dust, SEP 2000; OEL-UNITED KINGDOM: TWA 5 mg/m3, SEP 2000 ND: NIOSH REL TO VANADIUM (as V2O5), resp dust/fume-air: CL 0.05 mg/m3/15M National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 76210; NIS 7; TNF 333; NOS 12; TNE 2562; NOES 1983: HZD 76210; NIS 6; TNF 67; NOS 17; TNE 4468; TFE 541 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NIOSH Analytical Method, 1994: Vanadium oxides, 7504; NIOSH Analytical Method, 1996: Elements by ICP, 7300; NTP Carcinogenesis studies, on test (two year studies), October 2000; OSHA ANALYTICAL METHOD #ID-185 Record 1110 of 1119 in RTECS (through 2003/06) AN: YZ0875000 PN: Vinylamine,-N-methyl-N-nitroso- SY: Ethenylamine,-N-methyl-N-nitroso-; N-Nitrosomethylvinylamine-; NMVA-; N-Methyl-N-nitroso-ethenylamine-; N-Methyl-N-nitrosovinylamine-; Methylvinylnitrosamin- (German); Methylvinylnitrosamine-; MVNA-; RCRA-waste-number-P084- RN: Current: 4549-40-0 BRN: 2070750 UD: 200007 MF: C3-H6-N2-O MW: 86.11 WL: ONN1&1U1 CC: Tumorigen (C); Mutagen (M) TE: V03-K60 orl-rat TDLo: 110 mg/kg/52W-C Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 1077, 1969 (ARZNAD); V03-D09 ihl-rat TDLo: 2700 ug/kg/30M/33W-I Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI); V03-K60 ihl-rat TD :50 mg/kg/50D Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 19, p. 1077, 1969 (ARZNAD); V03-D09 ihl-rat TD :44 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 66, p. 1, 1964 (ZEKBAI) ORNG: 24000000 ng/kg. [24.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 24 mg/kg Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. v. 69, p. 103, 1967 (ZEKBAI) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 257, 1978 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 17, p. 257, 1978 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 56, 1987 (IMSUDL) SR: OEL-FRANCE: Carcinogen, JAN 1993 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1111 of 1119 in RTECS (through 2003/06) AN: ZE1980000 PN: Xylan,-hydrogen-sulfate,-sodium-salt- SY: Elmiron- (sodium pentosan polysulfate); Firezym-; HOE/BAY 946; Polysaccharides-from-Larix-decidua,-sodium-sulfated-; Sodium-xylan-sulfate- RN: Current: 37319-17-8 Previous: 51601-83-3; 52439-66-4; 56367-92-1 UD: 200204 CC: Tumorigen (C); Drug (D); Reproductive-Effector (T) RE: T48-T53 orl-rat TDLo: 9000 mg/kg (multigeneration) Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- v. 42, p. 101, 1998 (TOXID9) AT: T/E unlistd ipr-rat LD50: 295 mg/kg Thrombosis Research. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1972- v. 64, p. 413, 1991 (THBRAA) SL: NTP Carcinogenesis studies, on test (two year studies), October 2000 Record 1112 of 1119 in RTECS (through 2003/06) AN: ZE2100000 PN: Xylene- SY: Benzene,-dimethyl-; Dimethylbenzene- (OSHA); Ksylen- (Polish); Methyl-toluene-; NCI-C55232-; RCRA-waste-number-U239-; Violet-3-; Xiloli- (Italian); Xylene- (ACGIH:OSHA); Xylenen- (Dutch); Xylenes-; Xylol-; Xylole- (German) RN: Current: 1330-20-7 BRN: 1901563 BHR: 4-05-00-00951 UD: 200210 MF: C8-H10 MW: 106.18 WL: 1R X1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Primary-Irritant (S) ID: eye-hmn 200 ppm Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 282, 1943 (JIHTAB); skn-rbt 100% MOD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); skn-rbt 500 mg/24H MOD "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,24,1972 (28ZPAK); eye-rbt 87 mg MLD AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); eye-rbt 5 mg/24H SEV "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972 -,24,1972 (28ZPAK) RE: T46 ihl-rat TCLo: 250 mg/m3/24H (7-15D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 425, 1985 (ATSUDG); T25-T34-T43 ihl-rat TCLo: 50 mg/m3/6H (1-21D preg) Journal of Hygiene, Epidemiology, Microbiology, and Immunology. (Avicenum, Malostranske namesti 28, 11802 Prague 1, Czechoslovakia) V.1- 1957- v. 27, p. 337, 1983 (JHEMA2); T46-T59-T81 ihl-rat TCLo: 50 mg/m3/6H (1-21D preg) Journal of Hygiene, Epidemiology, Microbiology, and Immunology. (Avicenum, Malostranske namesti 28, 11802 Prague 1, Czechoslovakia) V.1- 1957- v. 27, p. 337, 1983 (JHEMA2); T46-T85 ihl-rat TDLo: 200 ppm/6H (4-20D preg) Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- v. 73, p. 20, 1993 (PHTOEH); T34-T43-T46 orl-mus TDLo: 20600 ug/kg (6-15D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 97, 1982 (JTEHD6); T25 orl-mus TDLo: 31 mg/kg (6-15D preg) Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- v. 9, p. 97, 1982 (JTEHD6); T81-T86 ihl-mus TCLo: 4000 ppm/6H (6-12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 28, p. 22A, 1983 (TJADAB); T34 ihl-mus TCLo: 2000 ppm/6H (6-12D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 28, p. 22A, 1983 (TJADAB); T34-T46 ihl-mus TCLo: 1 gm/m3/12H (6-15D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 425, 1985 (ATSUDG); T34 ihl-rbt TCLo: 500 mg/m3/24H (7-20D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 425, 1985 (ATSUDG); T27 ihl-rbt TCLo: 1 gm/m3/24H (7-20D preg) Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- v. 8, p. 425, 1985 (ATSUDG) ORNG: 4300000000 ng/kg. [4300.000000 mg/kg] L30-M30 IHPB: 5000000 ppb/4H. [5000.000000 ppm/4H] T/E unlistd AT: T/E unlistd orl-hmn LDLo: 50 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- v. 22, p. 883, 1980 (YAKUD5); F01-J24-P30 ihl-man LCLo: 10000 ppm/6H British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- v. 3, p. 442, 1970 (BMJOAE); D07-D25-J30 ihl-hmn TCLo: 200 ppm Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For publisher information, see AEHLAU. v. 25, p. 282, 1943 (JIHTAB); L30-M30 orl-rat LD50: 4300 mg/kg AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher information, see AEHLAU. v. 14, p. 387, 1956 (AMIHAB); T/E unlistd ihl-rat LC50: 5000 ppm/4H Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 123, 1974 (NPIRI*); T/E unlistd ipr-rat LD50: 2459 mg/kg Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1967- v. 40, p. 411, 1986 (ENVRAL); T/E unlistd scu-rat LD50: 1700 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 123, 1974 (NPIRI*); T/E unlistd orl-mus LD50: 2119 mg/kg EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- v. 106(Suppl 2), p. 497, 1998 (EVHPAZ); T/E unlistd ipr-mus LD50: 1548 mg/kg Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For publisher information, see IAEHDW. v. 18, p. 109, 1960 (AGGHAR); T/E unlistd skn-rbt LD50: >1700 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) v. 1, p. 123, 1974 (NPIRI*); T/E unlistd ivn-rbt LDLo: 129 mg/kg Haematologica. (Il Pensiero Scientifico Editore, Via Panama 48, I-00198, Rome, Italy) V.1- 1920- v. 58, p. 491, 1973 (HAEMAX); J30-L03 ihl-gpg LCLo: 450 ppm Journal of Industrial Hygiene. (Cambridge, MA) V.1-17, 1919-35. For publisher information, see AEHLAU. v. 10, p. 261, 1928 (JIDHAN); L03-Y16 ipr-gpg LDLo: 2 gm/kg American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH 44311) V.19- 1958- v. 35, p. 21, 1974 (AIHAAP); T/E unlistd orl-mam LD50: 4300 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); T/E unlistd ihl-mam LC50: 30 gm/m3 Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 32(10), p. 25, 1988 (GTPZAB); C08-F12-F33 ipr-mam LDLo: 2 gm/kg American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 7, p. 276, 1927 (AJHYA2) MD: Z01 orl-rat TDLo: 28 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-327, 1986 (NTPTR*); L70-N72-U01 orl-rat TDLo: 63 gm/kg/90D-I Bromatologia i Chemia Toksykologiczna. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.4- 1971- v. 21, p. 187, 1988 (BCTKAG); F01-P71-Z01 ihl-rat TCLo: 1600 ppm/20H/7D-I American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. v. 7, p. 276, 1927 (AJHYA2); A11-P72 ihl-rat TCLo: 15 mg/m3/24H/85D-C Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 32(3), p. 3, 1967 (GISAAA); D40 ihl-rat TCLo: 800 ppm/14H/6W-I JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 7, p. 55, 1987 (JJATDK); L30-M30-Y07 ihl-rat TCLo: 300 ppm/6H/18W-I Xenobiotica. (Taylor and Francis Ltd., 4 John St., London WC1N 2ET, UK) V.1- 1971- v. 10, p. 435, 1980 (XENOBH); P28-Y03-Y15 ipr-rat TDLo: 12740 ug/kg/30D-I Toxicology and Industrial Health. (Princeton Scientific Pub. Co., POB 2155, Princeton, NJ 08540) V.1- 1985- v. 9, p. 479, 1993 (TIHEEC); A30-Y17 ipr-rat TDLo: 4128 mg/kg/3D-I Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 15, p. 51, 1993 (NETEEC); U01 orl-mus TDLo: 28 gm/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-327, 1986 (NTPTR*); Y03-Z73 ihl-mus TCLo: 1250 mg/m3/2H/60D-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 6, p. 202, 1992 (WDZAEK); P30 ihl-mky TCLo: 100 mg/m3/90D-I Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu, Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987 v. 4, p. 170, 1990 (WDZAEK) TR: ACGIH TLV-TWA 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-Not classifiable as a human carcinogen The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-STEL 150 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 2002 (DTLVS*); ACGIH TLV-TWA 100 ppm The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 TLV/BEI, 1999 (DTLVS*); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 47, p. 125, 1989 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1189, 1999 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 47, p. 125, 1989 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1189, 1999 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 71, p. 1189, 1999 (IMEMDT); TOXICOLOGY REVIEW Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1977/78- v. 8, p. 281, 1985 (DCTODJ) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OSHA PEL (Gen Indu): 8H TWA 100 ppm (435 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1910.1000, 1994 (CFRGBR); OSHA PEL (Construc): 8H TWA 100 ppm (435 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1926.55, 1994 (CFRGBR); OSHA PEL (Shipyard): 8H TWA 100 ppm (435 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 29, 1915.1000, 1993 (CFRGBR); OSHA PEL (Fed Cont): 8H TWA 100 ppm (435 mg/m3) Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) 41, 50-204.50, 1994 (CFRGBR); OEL-ARAB Republic of Egypt: TWA 0.5 ppm (0.9 mg/m3), JAN 1993; OEL-DENMARK: TWA 35 ppm (150 mg/m3), Skin, JAN 1999; OEL-AUSTRIA: MAK 100 ppm (440 mg/m3), JAN 1999; OEL-JAPAN: OEL 100 ppm (430 mg/m3), JAN 1999; OEL-FINLAND: TWA 100 ppm (435 mg/m3), STEL 150 ppm, Skin, JAN 1999; OEL-NORWAY: TWA 25 ppm (108 mg/m3), JAN 1999; OEL-GERMANY: MAK 100 ppm (440 mg/m3), JAN 1999; OEL-HUNGARY: TWA 100 mg/m3, STEL 300 mg/m3, JAN 1993; OEL-JAPAN: OEL 100 ppm (430 mg/m3), JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 50 ppm (210 mg/m3), Skin, JAN 1999; OEL-NORWAY: TWA 25 ppm (108 mg/m3), JAN 1999; OEL-THE PHILIPPINES: TWA 0.1 mg/m3, JAN 1993; OEL-POLAND: MAC(TWA) 100 mg/m3, MAC(STEL) 350 mg/m3, JAN 1999; OEL-SWEDEN: NGV 50 ppm (200 mg/m3), KTV 100 ppm (450 mg/m3), Skin, JAN 1999; OEL-SWITZERLAND: MAK-W 100 ppm (435 mg/m3), KZG-W 200 ppm (870 mg/m3), JAN 1999; OEL-THAILAND: TWA 100 ppm (435 mg/m3), JAN 1993; OEL-TURKEY: TWA 100 ppm (435 mg/m3), JAN 1993; OEL-UNITED KINGDOM: TWA 100 ppm (441 mg/m3), STEL 150 ppm, Skin, SEP 2000; OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV,; OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV ND: NIOSH REL TO XYLENE, isomers-air: 10H TWA 100 ppm, STEL 150 ppm National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. DHHS #92-100, 1992 (NIOSH*); NOHS 1974: HZD 76720; NIS 367; TNF 99920; NOS 193; TNE 1016020; NOES 1983: HZD 76720; NIS 401; TNF 139914; NOS 230; TNE 2145039; TFE 408656 SL: ATSDR TOXICOLOGY PROFILE (NTIS** PB/95/264404); EPA GENETOX PROGRAM 1988, Negative: In vitro SCE-human lymphocytes, In vitro SCE-human; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 47, p. 26992, 82 (FEREAC); EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9180, 8EHQ-0892-9184; On EPA IRIS database; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NTP CARCINOGENESIS STUDIES (GAVAGE), NO EVIDENCE: MOUSE, RAT National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-327, 1986 (NTPTR*); NIOSH Analytical Method, 1994: Hydrocarbons, aromatic, 1501; NIOSH Analytical Method, 1996: Volatile organic compound, 2549; NCI Carcinogenesis Studies (gavage), no evidence: mouse, rat Record 1113 of 1119 in RTECS (through 2003/06) AN: ZE5100000 PN: Xylenesulfonic-acid,-sodium-salt- SY: Benzenesulfonic-acid,-dimethyl-,-sodium-salt-; Conco-SXS-; Cyclophil-sxs30-; Eltesol-SX-30-; Hydrotrope-; NCI-C55403-; Naxonate-; Naxonate-G-; Sodium-dimethylbenzenesulfonate-; Sodium-xylenesulfonate-; Stepanate-X-; Surco-SXS-; Technical-grade-sodium-xylenesulfonate-; Ultrawet-40SX- RN: Current: 1300-72-7 UD: 200207 MF: C8-H10-O3-S.Na MW: 209.23 WL: WSQR X1 X1 &-NA- CC: Tumorigen (C) MD: L70 skn-rat TDLo: 3380 mg/kg/17D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-464, 1998 (NTPTR*); R03 skn-rat TDLo: 35 gm/kg/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-464, 1998 (NTPTR*); L70 skn-mus TDLo: 20800 mg/kg/17D-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-464, 1998 (NTPTR*); R03 skn-mus TDLo: 91 gm/kg/14W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-464, 1998 (NTPTR*) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC) ND: NOHS 1974: HZD 82789; NIS 202; TNF 46184; NOS 138; TNE 436075; NOES 1983: HZD 82789; NIS 235; TNF 38210; NOS 170; TNE 893666; TFE 336431 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (derm), no evidence: mouse, rat Record 1114 of 1119 in RTECS (through 2003/06) AN: ZE8320000 PN: Xylenol,-phosphate- (3:1) SY: Dimethylphenol-phosphate- (3:1); Phenol, dimethyl-, phosphate (3:1) (9CI); Trixylenyl-phosphate-; Trixylyl-phosphate-; Coalite-NTP-; Durad-22OX-; Phosflex-179-; Xylenol,-phosphate- (3:1); Xylyl-phosphate- RN: Current: 25155-23-1 Previous: 174956-83-3; 95660-61-0 UD: 200010 MF: C24-H27-O4-P MW: 410.48 CC: Z Other (Z) AT: T/E unlistd orl-mus LD50: 11800 mg/kg "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982 -,118,1982 (85GMAT) ND: NOHS 1974: HZD M4624; NIS 5; TNF 82; NOS 19; TNE 3105; NOES 1983: HZD M4624; NIS 32; TNF 1934; NOS 40; TNE 28581; TFE 5415 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 Record 1115 of 1119 in RTECS (through 2003/06) AN: ZE9275000 PN: 2,6-Xylidine- SY: 1-Amino-2,6-dimethylbenzene-; 2,6-Dimethylaniline-; 2,6-Dimethylbenzenamine-; 2,6-Dimethylphenylamine-; 2,6-Xylylamine-; 2-Amino-1,3-dimethylbenzene-; 2-Amino-1,3-xylene-; 2-Amino-m-xylene-; Aniline,-2,6-dimethyl-; DMA-; NCI-C56188- RN: Current: 87-62-7 BRN: 636332 BHR: 4-12-00-02521 UD: 200210 MF: C8-H11-N MW: 121.20 WL: ZR B1 F1 CC: Tumorigen (C); Mutagen (M); Natural-Product (N) ME: mmo-sat 50 umol/plate (-S9) Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953- v. 34, p. 157, 1986 (JAFCAU); pic-esc 39 ug/well Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 260, p. 349, 1991 (MUREAV); cyt-ham-ovr 1 gm/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG); sce-ham-ovr 301 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 10(Suppl 10), p. 1, 1987 (EMMUEG) TE: V01-D09-N60 orl-rat TDLo: 107 gm/kg/2Y-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-278, 1990 (NTPTR*); V01-D09-V16 orl-rat TDLo: 27846 mg/kg/26W-I Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- v. 15, p. 39, 2002 (TOPADD); V01-D09 orl-rat TDLo: 131040 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-256363 (NTIS**); V01-D09-L60 orl-rat TDLo: 109200 mg/kg/104W-C National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB90-256363 (NTIS**); V01-D09-V16 orl-rat TDLo: 65520 mg/kg/52W-C Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- v. 142, p. 161, 1999 (CALEDQ) ORNG: 840000000 ng/kg. [840.000000 mg/kg] F07-J24-P27 AT: F07-J24-P27 orl-rat LD50: 840 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 22, p. 153, 1972 (TXAPA9); T/E unlistd orl-mus LD50: 707 mg/kg National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB214-270 (NTIS**) MD: P27 orl-rat TDLo: 3150 mg/kg/20D-C Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 3, p. 285, 1983 (FAATDF); Z01 orl-rat TDLo: 6200 mg/kg/2W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-278, 1990 (NTPTR*); L30-L70-Y03 orl-rat TDLo: 13300 mg/kg/4W-I Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 12, p. 63, 1979 (TXCYAC); A70-L70-P70 orl-rat TDLo: 20150 mg/kg/13W-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-278, 1990 (NTPTR*) TR: IARC Cancer Review: Animal Sufficient Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 323, 1993 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 323, 1993 (IMEMDT); IARC Cancer Review: Group 2B IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 57, p. 323, 1993 (IMEMDT) SR: OEL-DENMARK: TWA 0.5 ppm (2.5 mg/m3), Skin, JAN 1999; OEL-FRANCE: VME 2 ppm (10 mg/m3), Skin, JAN 1999; OEL-THE NETHERLANDS: MAC-TGG 0.5 ppm (2.5 mg/m3), JAN 1999; OEL-POLAND: MAC(TWA) 10 mg/m3, JAN 1999; OEL-SWITZERLAND: MAK-W 2 ppm (10 mg/m3), Skin, JAN 1999; OEL-UNITED KINGDOM: TWA 2 ppm (10 mg/m3), STEL 10 ppm, Skin, SEP 2000 ND: NOES 1983: HZD X7951; NIS 1; TNF 21; NOS 5; TNE 4354; TFE 729 SL: EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(d) unpublished health/safety studies; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: rat Record 1116 of 1119 in RTECS (through 2003/06) AN: ZG0350000 PN: 3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-11,17-alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester) SY: Anquil-; Apoplon-; Banasil-; 3,4,5-Trimethoxybenzoyl-methyl-reserpate-; Triserpin-; USAF-CB-27-; Vio-Serpine-; Bioserpine-; Crystoserpine-; Deserpine-; Diutensen-R-; Elserpine-; ENT-50146-; Escaspere-; Eserpine-; Eskaserp-; Gilucard-; Hiposerpil-; Kitine-; Klimanosid-; Lemiserp-; Loweserp-; Mayserpine-; Methylreserpate-3,4,5-trimethoxybenzoic-acid-; Naquival-; NCI-C50157-; Quiescin-; Raucap-; Raulen-; Raupasil-; Raupoid-; Raurine-; Rausan-; Rau-Sed-; Rausedan-; Rausedil-; Rausedyl-; Rauserpol-; Rausingle-; RCRA-waste-number-U200-; Recipin-; Resaltex-; Resedril-; Resedrex-; Rese-Lar-; Reser-AR-; Reserbal-; Resercaps-; Resercen-; Reserfia-; Reserjen-; Reserlor-; Reserp-; Reserpal-; Reserpamed-; Reserpanca-; Reserpene-; Reserpex-; Reserpidefe-; Reserpil-; Reserpine-; Reserpoid-; Reserpur-; Resersana-; Reserutin-; Resiatric-; Residine-; Resocalm-; Resomine-; Resperin-; Resperine-; Respital-; Restran-; Rezerpin-; Riserpa-; Rivased-; Rivasin-; Rolserp-; Salupres-; Salutensin-; Sandril-; Sedaraupin-; Sedserp-; Seominal-; Serfin-; Serfolia-; Serp-AFD-; Serpaloid-; Serpanray-; Serpasil-; Serpasil-premix-; Serpasol-; Serpate-; Serpatone-; Serpazil-; Serpazol-; Serpedin-; Serpen-; Serpentina-; Serpiloid-; Serpine- (pharmaceutical); Serpivite-; Serplex-K-; Serpogen-; Serpoid-; Serpone-; Serpresan-; Serpyrit-; Sertabs-; Sertina-; Temposerpine- RN: Current: 50-55-5 BRN: 102014 BHR: 4-25-00-01319 UD: 200305 MF: C33-H40-N2-O9 MW: 608.75 WL: T F6 D5 C666 EM ON&&TTTJ HO1 SOVR CO1 DO1 EO1& TO1 UVO1 CC: Tumorigen (C); Drug (D); Mutagen (M); Reproductive-Effector (T); Human-Data (P); Natural-Product (N) ME: dns-sat 1 ug Experimental Cell Biology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.44- 1976- v. 50, p. 271, 1982 (ECEBDI); dna-esc 20 umol/L Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 89, p. 95, 1981 (MUREAV); mtr-rat-emb 2200 ng/plate JAT, Journal of Applied Toxicology. (John Wiley and Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- v. 1, p. 190, 1981 (JJATDK); mnt-mus-ipr 2 mg/kg Bulletin of the Philippine Biochemical Society. (Philippine Biochemical Soc., POB 593, Manila, Philippines) V.1- 1978- v. 2, p. 52, 1979 (BPBSDA); cyt-mus-ipr 30 mg/kg/48H Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- v. 12, p. 298, 1978 (PCJOAU); dlt-mus-ipr 200 ug/kg Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967- v. 12(3), p. 19, 1978 (KHFZAN); mtr-ham-emb 4 mg/L Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- v. 15, p. 11, 1994 (CRNGDP); sce-ham-ovr 2 mg/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 133, 1989 (EMMUEG); sln-ham-ipr 4 ng/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 327, p. 237, 1995 (MUREAV); mtr-mus-fbr 1 mg/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 35, p. 300, 2000 (EMMUEG) RE: T75-T77 ivn-wmn TDLo: 200 ug/kg (39W preg) American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50: V.100- 1960- v. 90, p. 286, 1955 (AJDCAI); T71 unr-wmn TDLo: 4800 ug/kg (32-39W preg) AMA Archives of General Psychiatry. (Chicago, IL) V.1-2, 1959-60. For publisher information, see ARGPAQ. v. 2, p. 606, 1960 (AGPSA3); T21 orl-rat TDLo: 11130 ug/kg (21D male) Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- v. 200, p. 585, 1963 (NATUAS); T24 orl-rat TDLo: 17500 mg/kg (3-9D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 100, p. 555, 1959 (PSEBAA); T14 orl-rat TDLo: 6 mg/kg (60D pre) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 156, p. 587, 1962 (CRSBAW); T22 orl-rat TDLo: 21217 ug/kg (30W pre) Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- v. 156, p. 587, 1962 (CRSBAW); T12 ipr-rat TDLo: 2 mg/kg (2D pre) Tokushima Journal of Experimental Medicine. (Univ. of Tokushima, School of Medicine, 3, Kuramoto-cho, Tokushima, Japan) V.1- 1954- v. 23, p. 1, 1976 (TJXMAH); T71-T81-T85 ipr-rat TDLo: 700 ug/kg (8-14D preg) Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- v. 27, p. 318, 1961 (PEDIAU); T31-T35 ipr-rat TDLo: 2500 ug/kg (19D preg) Nippon Sanka Fujinka Gakkai Zasshi. Journal of the Japan Society of Obstetrics and Gynecology. (Nippon Sanka Fujinka Gakkai Zasshi, Hoken Kaikan Bekkan, 1-1 Sadohara-cho, Ichigaya, Shijuku-ku, Tokyo 162, Japan) V.1- 1949- v. 30, p. 161, 1978 (NISFAY); T14 scu-rat TDLo: 1 mg/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 65, p. 563, 1959 (ENDOAO); T02-T03 scu-rat TDLo: 1250 ug/kg (5D male) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 28, p. 177, 1972 (JRPFA4); T85 scu-rat TDLo: 400 ug/kg (11-14D preg) Experimental Neurology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 6, p. 263, 1962 (EXNEAC); T47-T86 scu-rat TDLo: 3 mg/kg (12-15D preg) Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2 v. 13, p. 652, 1989 (FAATDF); T81-T83-T86 scu-rat TDLo: 1500 ug/kg (12-15D preg) Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.9- 1987- v. 11, p. 515, 1989 (NETEEC); T12 scu-rat TDLo: 2 mg/kg (12-17D preg) Prostaglandins. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022) V.1- 1972- v. 9, p. 75, 1975 (PRGLBA); T29 scu-rat TDLo: 400 ug/kg (1D pre) Endocrinology (Baltimore). (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- v. 78, p. 225, 1966 (ENDOAO); T47-T83 scu-rat TDLo: 4 mg/kg (16-19D preg) Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- v. 27, p. 35A, 1983 (TJADAB); T42-T25-T34 ims-rat TDLo: 800 ug/kg (9D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 118, p. 857, 1965 (PSEBAA); T43-T19-U01 ims-rat TDLo: 800 ug/kg (9D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 118, p. 857, 1965 (PSEBAA); T46 ims-rat TDLo: 1 mg/kg (9D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 118, p. 857, 1965 (PSEBAA); T41 ims-rat TDLo: 1500 ug/kg (10D preg) Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- v. 118, p. 857, 1965 (PSEBAA); T24 par-rat TDLo: 9 mg/kg (1-9D preg) "Agents Affecting Fertility, a Symposium, 1964," Austin, C.R., and J.S. Perry, eds., Boston, Little, Brown and Co., 1965 -,290,1965 (15QWAW); T02-T21 unr-rat TDLo: 3750 ug/kg (15D male) Annales d'Endocrinologie. (Masson Editeur, 120 Blvd. Saint-Germain, F-25280 Paris Cedex 06, France) V.1- 1939- v. 23, p. 281, 1962 (ANENAG); T35 unr-rat TDLo: 50 mg/kg (8D preg) Akushcherstvo i Ginekologiya (Moscow). (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) No.1- 1936- v. 43(12), p. 10, 1967 (AKGIAO); T46 orl-mus TDLo: 600 ug/kg (7-12D preg) Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- v. 4, p. 2937, 1970 (KSRNAM); T29 ipr-mus TDLo: 10 mg/kg (1D preg) Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 13, p. 345, 1967 (JRPFA4); T29 scu-mus TDLo: 120 ug/kg (1D pre) Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1939- v. 35, p. 161, 1966 (JOENAK); T29 par-mus TDLo: 400 ug/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 12, p. 346, 1961 (FESTAS); T13 par-mus TDLo: 3200 ug/kg (1D pre) Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- v. 12, p. 346, 1961 (FESTAS); T29 unr-mus TDLo: 1600 ug/kg (1D pre) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 83, p. 1405, 1962 (AJOGAH); T09 orl-dog TDLo: 32 ug/kg (1D male) Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 80, p. 239, 1982 (NYKZAU); T14 scu-mky TDLo: 100 mg/kg (14W pre) Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 124, p. 726, 1956 (SCIEAS); T71-T75 scu-gpg TDLo: 170 ug/kg (35-68D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 92, p. 711, 1965 (AJOGAH); T77-T83 scu-gpg TDLo: 340 ug/kg (35-68D preg) American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- v. 92, p. 711, 1965 (AJOGAH) TE: V01-R60 orl-wmn TDLo: 456 ug/kg/1Y-C Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 672, 1974 (LANCAO); V01-L60-P62 orl-rat TDLo: 54 mg/kg/77W-C Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. (Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV. v. 254, p. 1535, 1962 (COREAF); V02-K60-R60 scu-rat TDLo: 132 mg/kg/2.5Y-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 32(7), p. 76, 1986 (VOONAW); V01-R60-U01 orl-mus TDLo: 433 mg/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-193, 1980 (NCITR*); V02-J60-R60 scu-mus TDLo: 200 mg/kg/2Y-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 32(7), p. 76, 1986 (VOONAW); V01-N61-R60 orl-rat TD :216 mg/kg/2Y-C National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-193, 1980 (NCITR*); V02-R60 orl-wmn TD :73 mg/kg/2Y-C Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 672, 1974 (LANCAO); V02-A60 orl-wmn TD :24 mg/kg/13Y-C Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 672, 1974 (LANCAO); V02-R60 orl-wmn TD :16 mg/kg/3Y-C Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- v. 2, p. 672, 1974 (LANCAO); V02-K60-N62 orl-rat TD :340 mg/kg/3Y-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 32(7), p. 76, 1986 (VOONAW); V02-P60-R60 orl-mus TD :1120 mg/kg/2Y-I Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37: V.1- 1955- v. 32(7), p. 76, 1986 (VOONAW) ORNG: 420000000 ng/kg. [420.000000 mg/kg] F25 AT: F25 orl-rat LD50: 420 mg/kg Pesticide Science. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1970- v. 11, p. 555, 1980 (PSSCBG); A11 ipr-rat LD50: 44 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 110, p. 20, 1957 (AIPTAK); T/E unlistd scu-rat LD50: 25 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- v. 56, p. 377, 1960 (NYKZAU); T/E unlistd ivn-rat LD50: 15 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 -,111,1972 (27ZQAG); T/E unlistd orl-mus LD50: >50 mg/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 1453, 1995 (NIIRDN); T/E unlistd ipr-mus LD50: 5 mg/kg European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- v. 10, p. 519, 1975 (EJMCA5); T/E unlistd scu-mus LD50: 5610 ug/kg Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) v. -, p. 1453, 1995 (NIIRDN); F05-F17-K12 ivn-mus LD50: 21 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 14, p. 1040, 1964 (ARZNAD); T/E unlistd ivn-dog LD50: 500 ug/kg "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973 -,234,1973 (27ZIAQ); U28 ipr-rbt LD50: 7 mg/kg Journal of Drug Research. (National Organization for Drug Research and Control, POB 29, Cairo, Egypt) V.2- 1969- v. 6(3), p. 19, 1974 (JDGRAX); T/E unlistd ivn-rbt LD50: 15 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 -,111,1972 (27ZQAG); T/E unlistd scu-gpg LD50: 65 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 137, p. 375, 1962 (AIPTAK); T/E unlistd ivn-gpg LDLo: 16 mg/kg Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 23, p. 600, 1973 (ARZNAD); T/E unlistd orl-bwd LD50: 100 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 315, 1972 (TXAPA9); K13 ivn-rat TDLo: 0.3 mg/kg European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967- v. 421, p. 181, 2001 (EJPHAZ); U25 unr-rat TDLo: 5 mg/kg Farmakologiya i Toksikologiya (Kiev). Pharmacology and Toxicology. (Kievskii Nauchno- Issledovatel'skii Institut Farmakologii i Toksikologii, Kiev, USSR) No.1- 1964- v. 159, p. 23, 1986 (FATOBP); U28 ipr-mus TDLo: 2.5 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 298, p. 581, 2001 (JPETAB); U28 scu-mus TDLo: 2 mg/kg Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 298, p. 1142, 2001 (JPETAB); D28 ipr-mus TDLo: 2.5 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 47, p. 10, 1985 (FATOAO); U28 ipr-rat TDLo: 5 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 270, 1981 (FATOAO); D28-U28 ipr-mus TDLo: 2 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 44, p. 275, 1981 (FATOAO) MD: P71-U01-Y15 orl-rat TDLo: 945 mg/kg/75W-C Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- v. 1, p. 201, 1978 (TOLED5); Z01 scu-rat TDLo: 54 mg/kg/9W-I Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- v. 124, p. 237, 1960 (AIPTAK); N04 scu-rat TDLo: 0.4 mg/kg/5D-I Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 28, p. 167, 1972 (JRPFA4); T03 scu-rat TDLo: 200 ug/kg/5D-I Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- v. 28, p. 167, 1972 (JRPFA4); K06 ipr-rat TDLo: 6 mg/kg/3D-I Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 49, p. 81, 1986 (FATOAO) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 24, p. 211, 1980 (IMEMDT); IARC Cancer Review: Human Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 24, p. 211, 1980 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- v. 7, p. 330, 1987 (IMSUDL); TOXICOLOGY REVIEW Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960- v. 5, p. 480, 1964 (CLPTAT); TOXICOLOGY REVIEW Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. v. 4, p. 263, 1966 (ADVPA3) ND: NOHS 1974: HZD 84711; NIS 1; TNF 68; NOS 6; TNE 2770; NOES 1983: HZD 84711; NIS 2; TNF 142; NOS 10; TNE 5611; TFE 2414 SL: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; EPA GENETOX PROGRAM 1988, Inconclusive: Aspergillus-aneuploidy; EPA TSCA Section 8(b) CHEMICAL INVENTORY; NCI Carcinogenesis Bioassay (feed), clear evidence: mouse, rat National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205. For publisher information, see NTPTR*. NCI-TR-193, 1980 (NCITR*); NTP 9th Report on Carcinogens, 2000: Reasonably anticipated to be human carcinogen Record 1117 of 1119 in RTECS (through 2003/06) AN: ZH0525000 PN: Zinc, bis(dimethyldithiocarbamato)- SY: Aaprotect-; Aavolex-; Aazira-; Accelerator-L-; Aceto-ZDED-; Alcobam-ZM-; Bis(N,N-dimetil-ditiocarbammato) di zinco (Italian); Bis(dimethylcarbamodithioato-S,S')zinc; Bis(dimethyldithiocarbamato)zinc; Bis-dimethyldithiocarbamate-de-zinc- (French); Carbamic-acid,-dimethyldithio-,-zinc-salt- (2:1); Carbazinc-; Corona-corozate-; Corozate-; Cuman-; Cuman-L-; Cymate-; Dimethylcarbamodithioic-acid,-zinc-complex-; Dimethylcarbamodithioic-acid,-zinc-salt-; Dimethyldithiocarbamate-zinc-salt-; Dimethyldithiocarbamic-acid,-zinc-salt-; Drupina-90-; ENT-988-; Eptac-1-; Fuclasin-; Fuclasin-Ultra-; Fuklasin-; Fungostop-; Hermat-ZDM-; Hexazir-; Karbam-White-; Methasan-; Methazate-; Methyl-Ziram-; Methyl-zimate-; Methyl-zineb-; Mezene-; Milbam-; Molurame-; Mycronil-; NCI-C50442-; Orchard-brand-ziram-; Pomarsol-Z-forte-; Prodaram-; Rhodiacid-; Soxinal-PZ-; Soxinol-PZ-; Tricarbamix-Z-; Triscabol-; Tsimat-; Tsiram- (Russian); USAF-P-2-; Vancide-MZ-96-; Vulcacure-ZM-; Vulkacit-L-; Vulkacite-L-; Z-75-; Z-C-spray-; ZDMC-; Zarlate-; Zerlate-; Zimate-; Zinc-N,N-dimethyldithiocarbamate-; Zinc bis(dimethyldithiocarbamate); Zinc bis(dimethyldithiocarbamoyl)disulphide; Zinc bis(dimethylthiocarbamoyl)disulfide; Zinc-dimethyldithiocarbamate-; Zink-(N,N-dimethyl-dithiocarbamat) (German); Zink-bis(N,N-dimethyl-dithiocarbamaat) (Dutch); Zink-bis(N,N-dimethyl-dithiocarbamat) (German); Ziradin-; Ziram-; Ziram-technical-; Ziramvis-; Zirasan-; Zirasan-90-; Zirberk-; Zirex-90-; Ziride-; Zirthane-; Zitox- RN: Current: 137-30-4 Previous: 8059-74-3; 8070-07-3; 12768-61-5; 12773-04-5; 14459-91-7; 17125-91-6; 31300-71-7; 55870-88-7; 98391-07-2; 111922-61-3 UD: 200302 MF: C6-H12-N2-S4.Zn MW: 305.81 WL: 1N1&YUS&S-ZN-SYUS&N1&1 CC: Agricultural-Chemical-and-Pesticide (A); Tumorigen (C); Mutagen (M); Reproductive-Effector (T) ME: mmo-sat 5 ug/plate (+/-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 68, p. 313, 1979 (MUREAV); dnd-esc 1 umol/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 46, p. 277, 1980 (ARTODN); dnr-bcs 600 ng/disc Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 40, p. 19, 1976 (MUREAV); slt-dmg-orl 130 ppm Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 224, p. 161, 1989 (MUREAV); sln-dmg-orl 500 mg/L Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki, 29, Finland) V.1- 1975- v. 9(Suppl 2), p. 27, 1983 (SWEHDO); dni-hmn-lym 1 mg/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 101, 1980 (ARTODN); cyt-hmn-lym 10 nmol/L Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 4, p. 331, 1975 (TXCYAC); dnd-rat-ipr 50 mg/kg Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 302, p. 1, 1993 (MUREAV); dni-rat-oth 100 ug/L Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- v. 45, p. 101, 1980 (ARTODN); mnt-mus-unr 350 mg/kg/24H Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 208, p. 57, 1988 (MUREAV); cyt-mus-orl 1750 mg/kg/5D-C Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 208, p. 57, 1988 (MUREAV); msc-mus-lym 62500 ng/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 12, p. 85, 1988 (EMMUEG); cyt-ham-ovr 25 ug/L Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- v. 236, p. 933, 1987 (SCIEAS); sce-ham-ovr 25 ug/L Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 13, p. 133, 1989 (EMMUEG); mnt-hmn-lym 10 mg/L/21H (-S9) Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- v. 497, p. 89, 2001 (MUREAV); mtr-mus-fbr 1 ug/L/21D (-S9) Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- v. 37, p. 231, 2001 (EMMUEG) RE: T25-T46 orl-rat TDLo: 500 mg/kg (6-15D preg) Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 7, p. 531, 1983 (EESADV); T34 orl-rat TDLo: 250 mg/kg (6-15D preg) Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 7, p. 531, 1983 (EESADV); T47 orl-rat TDLo: 1 gm/kg (6-15D preg) Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 7, p. 531, 1983 (EESADV); T24 orl-rat TDLo: 500 mg/kg (6-15D preg) Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- v. 7, p. 531, 1983 (EESADV) TE: V01-N62-R60 orl-rat TDLo: 12978 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-238, 1982 (NTPTR*); V03-L60-R60 imp-rat TDLo: 60 mg/kg Voprosy Pitaniya. Problems of Nutrition. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1932-41: V.11- 1952- v. 29, p. 71, 1970 (VPITAR); V03-J60 orl-mus TDLo: 840 mg/kg/13W-I Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- v. 37(9), p. 25, 1972 (GISAAA); V01-N62-R60 orl-rat TD :25956 mg/kg/2Y-I National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-238, 1982 (NTPTR*); V01-L60-R60 orl-rat TD :13160 mg/kg/94W-I Voprosy Pitaniya. Problems of Nutrition. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1932-41: V.11- 1952- v. 29, p. 71, 1970 (VPITAR); V01-N62 orl-rat TDLo: 7931 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-202622 (NTIS**); V02-J60 orl-mus TDLo: 87962 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-202622 (NTIS**); V01-J60 orl-mus TDLo: 178808 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-202622 (NTIS**) ORNG: 267000000 ng/kg. [267.000000 mg/kg] T/E unlistd AT: T/E unlistd orl-rat LD50: 267 mg/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-1090-1045 (EPASR*); T/E unlistd ihl-rat LC50: 26 mg/m3/2H National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. OTS0540394 (NTIS**); T/E unlistd skn-rat LD50: >6 gm/kg Farm Chemicals Handbook. (Meister Pub., 37841 Euclid Ave., Willoughy, OH 44094) v. -, p. C329, 1991 (FMCHA2); T/E unlistd ipr-rat LD50: 8700 ug/kg Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 17, p. S155, 1992 (NNGADV); T/E unlistd scu-rat LD50: 69 mg/kg Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 17, p. S155, 1992 (NNGADV); T/E unlistd unr-rat LD50: 1230 mg/kg Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued. v. 3, p. 618, 1975 (EQSSDX); F07-F17 orl-mus LD50: 480 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 28, p. 230, 1965 (FATOAO); D26-F07-J22 ihl-mus LC50: >1056 mg/m3/2H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 12(4), p. 12, 1968 (GTPZAB); T/E unlistd ipr-mus LD50: 15500 ug/kg Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 17, p. S155, 1992 (NNGADV); T/E unlistd scu-mus LD50: 309 mg/kg Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 17, p. S155, 1992 (NNGADV); T/E unlistd ivn-mus LD50: 18 mg/kg U.S. Army Armament Research and Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) NX#04886 (CSLNX*); T/E unlistd orl-rbt LD50: 400 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) v. -, p. 1250, 1966 (PCOC**); T/E unlistd skn-rbt LD50: >2 gm/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. (U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown. 8EHQ-1090-1045 (EPASR*); F24 ipr-rbt LDLo: 50 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 41, p. 662, 1952 (JAPMA8); T/E unlistd orl-gpg LD50: 200 mg/kg Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- v. 32, p. 356, 1969 (FATOAO); F24 ipr-gpg LDLo: 30 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 41, p. 662, 1952 (JAPMA8); T/E unlistd unr-mam LD50: 1400 mg/kg "Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971 -,213,1971 (30ZDA9); T/E unlistd orl-bwd LD50: 100 mg/kg Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- v. 21, p. 315, 1972 (TXAPA9) MD: U01-Z01 orl-rat TDLo: 22750 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-238, 1983 (NTPTR*); F15-N73-N75 orl-rat TDLo: 80080 mg/kg/2Y-C Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 17, p. S155, 1992 (NNGADV); U01 orl-rat TDLo: 45 gm/kg/30D-C Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. v. 41, p. 662, 1952 (JAPMA8); L70-N73-P28 orl-rat TDLo: 770 mg/kg/4W-C Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 17, p. S155, 1992 (NNGADV); P05-P71-P72 ihl-rat TCLo: 5 mg/m3/4H/17W-I Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI v. 12(4), p. 12, 1968 (GTPZAB); K12-Z01 orl-mus TDLo: 16800 mg/kg/14D-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-238, 1983 (NTPTR*); U01-Z01 orl-mus TDLo: 27300 mg/kg/13W-C National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-238, 1983 (NTPTR*); F12-Z01 orl-dog TDLo: 9125 mg/kg/1Y-C Journal of Pharmacology and Experimental Therapeutics. (Williams and Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- v. 118, p. 174, 1956 (JPETAB); K12 orl-dog TDLo: 28 mg/kg/4W-C Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 17, p. S155, 1992 (NNGADV); K12-P28 orl-dog TDLo: 3640 mg/kg/2Y-C Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976- v. 17, p. S155, 1992 (NNGADV); U07 orl-rat TDLo: 4368 mg/kg/104W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); P71 orl-rat TDLo: 10.9 gm/kg/26W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); U01 orl-rat TDLo: 54.6 gm/kg/13W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); Q30 orl-rat TDLo: 327.6 gm/kg/78W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); C18 orl-rat TDLo: 436.8 gm/kg/104W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); P71 orl-rat TDLo: 2184 mg/kg/52W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); U07 orl-rat TDLo: 109.2 gm/kg/26W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); N75 orl-rat TDLo: 218.4 gm/kg/52W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); C18-Q30 orl-rat TDLo: 436.8 gm/kg/104W-C Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- v. 54, p. 45, 1989 (TXCYAC); R60-V30 orl-rat TDLo: 18746 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-202622 (NTIS**); L60-V30 orl-mus TDLo: 141316 mg/kg/103W-I National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific and Technical Information. PB83-202622 (NTIS**) TR: IARC Cancer Review: Animal Limited Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 423, 1991 (IMEMDT); IARC Cancer Review: Animal Inadequate Evidence IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 259, 1976 (IMEMDT); IARC Cancer Review: Human No Adequate Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 12, p. 259, 1976 (IMEMDT); IARC Cancer Review: Human No Available Data IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 423, 1991 (IMEMDT); IARC Cancer Review: Group 3 IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- v. 53, p. 423, 1991 (IMEMDT) SR: EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- v. 54, p. 7740, 1989 (FEREAC); OEL-SWEDEN: NGV 1 mg/m3, KTV 2 mg/m3, JAN 1999 ND: NOHS 1974: HZD 80305; NIS 5; TNF 267; NOS 27; TNE 3838; NOES 1983: HZD 80305; NIS 20; TNF 2044; NOS 23; TNE 34594; TFE 5542 SL: EPA GENETOX PROGRAM 1988, Negative: S cerevisiae gene conversion; EPA GENETOX PROGRAM 1988, Inconclusive: B subtilis rec assay, D melanogaster Sex-linked lethal; EPA TSCA Section 8(b) CHEMICAL INVENTORY; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0493-8821, 8EHQ-0892-8916; EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-8918; EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001; NCI Carcinogenesis Studies (feed), clear evidence: rat; NCI Carcinogenesis Studies (feed), equivocal evidence: mouse Record 1118 of 1119 in SERFILE 2003 TI: National-Toxicology-Program-technical-report-series TA: Natl-Toxicol-Program-Tech-Rep-Ser AT: Technical-report-series; NTP-technical-report PD: Series no. 201- PP: Research-Triangle-Park-NC PB: Environmental-Health-Information-Service URL: http://ehis.niehs.nih.gov/ntp/docs/ntp.html PT: Periodicals FR: Irregular NT: Title from cover. Place of publication varies. Vols. for 1980- issued as NIH publication ; no. 82-1757, etc. Some vols. issued out of chronological order. Vols. 202-205 issued in 1980 with earlier title. No. 206 published in 1980. Also available on the World Wide Web. Continues: National Cancer Institute carcinogenesis technical report series. IA: Index-medicus; MEDLINE; PubMed; Chemical-abstracts MI: Currently-Indexed LA: Not-Supplied LS: Not-Supplied IS: 0888-8051 CO: NTPSE3 NLM: W1 NA766 MESH: Biological-Assay; Carcinogens; Neoplasms,-Experimental; Toxicology DE: Toxicology SD: HE 20.3564 ( HE203564 ); HE 20.3159/2 ( HE2031592 ) CAT: 8500747 AN: N06667500 UD: 200111 Record 1119 of 1119 in SERFILE 2003 TI: Toxicity-report-series TA: Toxic-rep-ser; Toxic-Rep-Ser AT: National-Toxicology-Program-toxicity-report-series; NTP-toxicity-report PT: Not-Supplied NT: Description based on: no. 16 (1992). Includes draft reports; drafts issued prior to title change have earlier title. Issued by the National Toxicology Program. IA: Index-medicus; MEDLINE; PubMed; Chemical-abstracts MI: Currently-Indexed LA: Not-Supplied LS: Not-Supplied IS: 1521-4621 CO: NTPTF7 NLM: sn 98004754 ; W1 TO891S MESH: Toxins.; Carcinogens.; Hazardous-Substances.; Toxicity-Tests. DE: Toxicology SD: HE 20.3564/2: ( HE2035642 ) CAT: 101122696 AN: 28613992 UD: 200111